PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Shiina, S; Sakakibara, R; Doi, H; Tateno, F; Sato, M; Masaka, T; Kishi, M; Tsuyusaki, Y; Ogata, T; Aiba, Y; Tateno, H				Shiina, Shunsuke; Sakakibara, Ryuji; Doi, Hirokazu; Tateno, Fuyuki; Sato, Mitsutoshi; Masaka, Tohru; Kishi, Masahiko; Tsuyusaki, Yohei; Ogata, Tsuyoshi; Aiba, Yosuke; Tateno, Hiromi			Levodopa Does Not Worsen Gastric Emptying in Parkinson's Disease	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Letter							MOTILITY		[Shiina, Shunsuke; Doi, Hirokazu; Masaka, Tohru] Toho Univ, Sakura Med Ctr, Dept Internal Med, Pharmaceut Unit, Sakura, Japan; [Sakakibara, Ryuji; Tateno, Fuyuki; Kishi, Masahiko; Tsuyusaki, Yohei; Ogata, Tsuyoshi; Aiba, Yosuke; Tateno, Hiromi] Toho Univ, Sakura Med Ctr, Dept Internal Med, Div Neurol, Sakura, Japan; [Sato, Mitsutoshi] Toho Univ, Sch Pharmaceut Sci, Dept Chem Pharmacol, Narashino, Chiba, Japan	Shiina, S (reprint author), Toho Univ, Sakura Med Ctr, Dept Internal Med, Pharmaceut Unit, Sakura, Japan.						HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Doi H, 2014, MOVEMENT DISORD, V29, P562, DOI 10.1002/mds.25777; Doi H, 2012, J NEUROL SCI, V319, P86, DOI 10.1016/j.jns.2012.05.010; Tateno F, 2011, PARKINSONISM RELAT D, V17, P662, DOI 10.1016/j.parkreldis.2011.06.002; Dive A, 2000, INTENS CARE MED, V26, P901, DOI 10.1007/s001340051279; Marrinan S, 2014, MOVEMENT DISORD, V29, P23, DOI 10.1002/mds.25708; Hardoff R, 2001, MOVEMENT DISORD, V16, P1041, DOI 10.1002/mds.1203; Tanaka Y, 2011, J NEUROL, V258, P421, DOI 10.1007/s00415-010-5769-z; ROBERTSON DRC, 1992, EUR J CLIN PHARMACOL, V42, P409; Sakakibara R, 2011, PARKINSONS DIS, V2011, DOI DOI 10.4061/2011/924605	10	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	OCT	2015	63	10					2185	2186		10.1111/jgs.13675		2	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CU8PQ	WOS:000363805800033		
J	Tateno, F; Sakakibara, R; Nagao, T; Tuyusaki, Y; Aiba, Y; Tateno, H; Kishi, M; Ogata, T				Tateno, Fuyuki; Sakakibara, Ryuji; Nagao, Takeki; Tuyusaki, Yohei; Aiba, Yosuke; Tateno, Hiromi; Kishi, Masahiko; Ogata, Tsuyoshi			Deep Brain Stimulation Ameliorates Postural Hypotension in Parkinson's Disease	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Letter							ORTHOSTATIC HYPOTENSION; SUBTHALAMIC NUCLEUS; LEVODOPA; SYSTEM		[Tateno, Fuyuki; Sakakibara, Ryuji; Tuyusaki, Yohei; Aiba, Yosuke; Tateno, Hiromi; Kishi, Masahiko; Ogata, Tsuyoshi] Toho Univ, Sakura Med Ctr, Dept Neurol, Dept Internal Med, Sakura, Japan; [Nagao, Takeki] Toho Univ, Sakura Med Ctr, Dept Neurosurg, Sakura, Japan	Tateno, F (reprint author), Toho Univ, Sakura Med Ctr, Dept Neurol, Dept Internal Med, Sakura, Japan.						Stemper B, 2006, NEUROLOGY, V67, P1781, DOI 10.1212/01.wnl.0000244416.30605.f1; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Pursiainen V, 2012, ACTA NEUROL SCAND, V126, pe20, DOI 10.1111/j.1600-0404.2012.01648.x; Okun MS, 2012, NEW ENGL J MED, V367, P1529, DOI 10.1056/NEJMct1208070; Ludwig J, 2007, J NEUROL NEUROSUR PS, V78, P742, DOI 10.1136/jnnp.2006.103739; Sakakibara R, 2000, J NEUROL NEUROSUR PS, V68, P65, DOI 10.1136/jnnp.68.1.65; Goldstein DS, 2005, HYPERTENSION, V46, P1333, DOI 10.1161/01.HYP.0000188052.69549.e4; Senard JM, 2001, DRUG AGING, V18, P495, DOI 10.2165/00002512-200118070-00003; Zibetti M, 2007, EUR NEUROL, V58, P218, DOI 10.1159/000107943	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	OCT	2015	63	10					2186	2189		10.1111/jgs.13674		4	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CU8PQ	WOS:000363805800034		
J	Fukuda, S; Kuriyama, N; Egawa, M				Fukuda, Shimpei; Kuriyama, Nagato; Egawa, Masato			Acupuncture for Gait Disturbance in Parkinson's Disease: Immediate Effects of Acupuncture Treatment	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Letter									[Fukuda, Shimpei; Egawa, Masato] Meiji Univ Integrat Med, Dept Hlth Promoting & Geriatr Acupuncture & Moxib, Kyoto, Japan; [Kuriyama, Nagato] Kyoto Prefectural Univ Med, Dept Epidemiol Community Hlth & Med, Kyoto, Japan	Fukuda, S (reprint author), Meiji Univ Integrat Med, Dept Hlth Promoting & Geriatr Acupuncture & Moxib, Kyoto, Japan.						Kang JM, 2007, BRAIN RES, V1131, P211, DOI 10.1016/j.brainres.2006.10.089; Chae Y, 2009, MOVEMENT DISORD, V24, P1794, DOI 10.1002/mds.22673; Yang JL, 2011, BRAIN BEHAV IMMUN, V25, P1452, DOI 10.1016/j.bbi.2011.05.012; Cristian A, 2005, MOVEMENT DISORD, V20, P1185, DOI 10.1002/mds.20503; MURRAY MP, 1978, AM J PHYS MED REHAB, V57, P278; Mitoma H, 2010, INTERNAL MED, V49, P2401, DOI 10.2169/internalmedicine.49.3511; Tomlinson C.L., 2012, COCHRANE DB SYST REV, V8	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	OCT	2015	63	10					2189	2190		10.1111/jgs.13690		2	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CU8PQ	WOS:000363805800035		
J	Hirose, D; Hanyu, H; Fukusawa, R; Hatanaka, H; Namioka, N; Okita, M				Hirose, Daisuke; Hanyu, Haruo; Fukusawa, Raita; Hatanaka, Hirokuni; Namioka, Nayuta; Okita, Misa			Circulating Levels of Advanced Glycation End Products in Diabetes Mellitus-Related Dementia	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Letter							ALZHEIMERS-DISEASE		[Hirose, Daisuke; Hanyu, Haruo; Fukusawa, Raita; Hatanaka, Hirokuni; Namioka, Nayuta; Okita, Misa] Tokyo Med Univ, Dept Geriatr Med, Tokyo 1608402, Japan	Hirose, D (reprint author), Tokyo Med Univ, Dept Geriatr Med, Tokyo 1608402, Japan.						Shuvaev VV, 2001, NEUROBIOL AGING, V22, P397, DOI 10.1016/S0197-4580(00)00253-0; Valente T, 2010, NEUROBIOL DIS, V37, P67, DOI 10.1016/j.nbd.2009.09.008; Hanyu H, 2015, J AM GERIATR SOC, V63, P1721, DOI 10.1111/jgs.13581; Fukasawa R, 2014, GERIATR GERONTOL INT, V14, P229, DOI 10.1111/ggi.12140; Girones X, 2004, FREE RADICAL BIO MED, V36, P1241, DOI 10.1016/j.freeradbiomed.2004.02.006; Bar KJ, 2003, NEUROBIOL AGING, V24, P333, DOI 10.1016/S0197-4580(02)00086-6; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Fukasawa R, 2015, J NEUROL SCI, V349, P45, DOI 10.1016/j.jns.2014.12.023; Fukazawa R, 2013, DEMENT GERIATR COGN, V35, P280, DOI 10.1159/000348407; Meli M., 2002, Journal of Alzheimer's Disease, V4, P93	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	OCT	2015	63	10					2196	2198		10.1111/jgs.13683		3	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CU8PQ	WOS:000363805800039		
J	Okumura, A; Rasmussen, AL; Halfmann, P; Feldmann, F; Yoshimura, A; Feldmann, H; Kawaoka, Y; Harty, RN; Katze, MG				Okumura, Atsushi; Rasmussen, Angela L.; Halfmann, Peter; Feldmann, Friederike; Yoshimura, Akihiko; Feldmann, Heinz; Kawaoka, Yoshihiro; Harty, Ronald N.; Katze, Michael G.			Suppressor of Cytokine Signaling 3 Is an Inducible Host Factor That Regulates Virus Egress during Ebola Virus Infection	JOURNAL OF VIROLOGY			English	Article							VESICULAR STOMATITIS-VIRUS; INNATE ANTIVIRAL RESPONSE; DENDRITIC CELLS; MATRIX PROTEIN; RECEPTOR 4; SOCS-BOX; VP40 PROTEIN; GLYCOPROTEIN; INTERACTS; MOTIF	Ebola virus (EBOV) initially targets monocytes and macrophages, which can lead to the release of proinflammatory cytokines and chemokines. These inflammatory cytokines are thought to contribute to the development of circulatory shock seen in fatal EBOV infections. The VP40 matrix protein is a key viral structural protein that is critical for virion egress. Physical and functional interactions between VP40 and host proteins such as Tsg101 and Nedd4 facilitate efficient release of VP40-driven viruslike particles (VLPs) and infectious virus. Here, we show that host suppressor of cytokine signaling 3 (SOCS3) can also bind to EBOV VP40, leading to enhanced ubiquitinylation and egress of VP40. Indeed, titers of infectious EBOV derived from SOCS3 knockout mouse embryonic fibroblasts (MEFs) were significantly reduced compared to those from wild-type (WT) MEFs at 24 and 48 h postinfection. Importantly, this reduced virus yield could be rescued back to WT levels by exogenously expressing SOCS3. Lastly, we show that SOCS3 expression is induced by EBOV glycoprotein (GP) expression and that VLPs containing EBOV VP40 and GP induced production of proinflammatory cytokines, which induced SOCS3 for negative-feedback regulation. These data indicate that host innate immune protein SOCS3 may play an important role in budding and pathogenesis of EBOV. IMPORTANCE The VP40 matrix protein is a key structural protein critical for Ebola virus budding. Physical and functional interactions between VP40 and host proteins such as Tsg101 and Nedd4 facilitate efficient release of VLPs and infectious virus. We reported that host TLR4 is a sensor for Ebola GP on VLPs and that the resultant TLR4 signaling pathways lead to the production of proinflammatory cytokines. Host SOCS3 regulates the innate immune response by controlling and limiting the proinflammatory response through negative-feedback inhibition of cytokine receptors. We present evidence that Ebola virus VLPs stimulate induction of SOCS3 as well as proinflammatory cytokines, and that expression of human SOCS3 enhances budding of Ebola VLPs and infectious virus via a mechanism linked to the host ubiquitinylation machinery.	[Okumura, Atsushi; Rasmussen, Angela L.; Katze, Michael G.] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [Katze, Michael G.] Washington Natl Primate Res Ctr, Seattle, WA USA; [Halfmann, Peter; Kawaoka, Yoshihiro] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Influenza Res Inst, Madison, WI 53706 USA; [Okumura, Atsushi; Feldmann, Friederike; Feldmann, Heinz] NIAID, Virol Lab, Div Intramural Res, NIH,Rocky Mt Labs, Hamilton, MT USA; [Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol, Tokyo, Japan; [Kawaoka, Yoshihiro] Japan Sci & Technol Agcy, ERATO Infect Induced Host Responses Project, Kawaguchi, Saitama, Japan; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Special Pathogens, Tokyo, Japan; [Harty, Ronald N.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	Katze, MG (reprint author), Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA.	honey@uw.edu			National Institute of Allergy and Infectious Diseases [R21 AI077014, R21 AI090284, U54 AI081680, U19 AI109761]; Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health	This study was supported in part by National Institute of Allergy and Infectious Diseases grants R21 AI077014 and R21 AI090284 to R.N.H., U54 AI081680 to Y.K., and U54 AI081680 and U19 AI109761 to M.G.K. and by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.	Bray M, 2005, INT J BIOCHEM CELL B, V37, P1560, DOI 10.1016/j.biocel.2005.02.018; Zimmermann S, 2006, J IMMUNOL, V176, P1840; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Yasukawa H, 2000, ANNU REV IMMUNOL, V18, P143, DOI 10.1146/annurev.immunol.18.1.143; Takada A, 2000, VIROLOGY, V278, P20, DOI 10.1006/viro.2000.0601; Okumura A, 2010, J VIROL, V84, P27, DOI 10.1128/JVI.01462-09; Harty RN, 2001, J VIROL, V75, P10623, DOI 10.1128/JVI.75.22.10623-10629.2001; Warfield KL, 2004, J EXP MED, V200, P169, DOI 10.1084/jem.20032141; Shimojima M, 2006, J VIROL, V80, P10109, DOI 10.1128/JVI.01157-06; Craven RC, 1999, J VIROL, V73, P3359; Baize S, 2002, CLIN EXP IMMUNOL, V128, P163, DOI 10.1046/j.1365-2249.2002.01800.x; Bourette RP, 2001, J BIOL CHEM, V276, P22133, DOI 10.1074/jbc.M101878200; Licata JM, 2003, J VIROL, V77, P1812, DOI 10.1128/JVI.77.3.1812-1819.2003; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Harty RN, 2000, P NATL ACAD SCI USA, V97, P13871, DOI 10.1073/pnas.250277297; Martinez O, 2007, VIROLOGY, V364, P342, DOI 10.1016/j.virol.2007.03.020; Jayakar HR, 2000, J VIROL, V74, P9818, DOI 10.1128/JVI.74.21.9818-9827.2000; Qureshi ST, 1999, TRENDS GENET, V15, P291, DOI 10.1016/S0168-9525(99)01782-5; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Okumura A, 2006, P NATL ACAD SCI USA, V103, P1440, DOI 10.1073/pnas.0510518103; Zhao DC, 2007, J INFECTION, V54, P393, DOI 10.1016/j.jinf.2006.06.005; Cardenas WB, 2006, J VIROL, V80, P5168, DOI 10.1128/JVI.02199-05; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Malakhova OA, 2008, J BIOL CHEM, V283, P8783, DOI 10.1074/jbc.C800030200; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Simmons G, 2003, J VIROL, V77, P13433, DOI 10.1128/JVI.77.24.13433-13438.2003; Sasaki A, 2003, J BIOL CHEM, V278, P2432, DOI 10.1074/jbc.C200608200; Dalpke A, 2008, IMMUNOBIOLOGY, V213, P225, DOI 10.1016/j.imbio.2007.10.008; Yang ZY, 1998, SCIENCE, V279, P1034, DOI 10.1126/science.279.5353.1034; Feldmann H, 1996, J VIROL, V70, P2208; Harty RN, 1999, J VIROL, V73, P2921; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Hill-Batorski L, 2013, J VIROL, V87, P13795, DOI 10.1128/JVI.02422-13; Kamizono S, 2001, J BIOL CHEM, V276, P12530, DOI 10.1074/jbc.M010074200; Hoshino K, 1999, J IMMUNOL, V162, P3749; Miyoshi H, 2005, J HEPATOL, V43, P757, DOI 10.1016/j.jhep.2005.03.028; Okumura A, 2008, P NATL ACAD SCI USA, V105, P3974, DOI 10.1073/pnas.0710629105; Beutler B, 2000, CURR OPIN MICROBIOL, V3, P23, DOI 10.1016/S1369-5274(99)00046-6; Akhtar LN, 2011, J VIROL, V85, P1912, DOI 10.1128/JVI.01857-10; Licata JM, 2004, J VIROL, V78, P7344, DOI 10.1128/JVI.78.14.7344-7351.2004; Bosio CM, 2004, VIROLOGY, V326, P280, DOI 10.1016/j.virol.2004.05.025; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; Wahl-Jensen V, 2005, J VIROL, V79, P2413, DOI 10.1128/JVI79.4.2413-2419.2005; Timmins J, 2003, J MOL BIOL, V326, P493, DOI 10.1016/S0022-2836(02)01406-7; Ryo A, 2008, P NATL ACAD SCI USA, V105, P294, DOI 10.1073/pnas.0704831105; Basler CF, 2003, J VIROL, V77, P7945, DOI 10.1128/JVI.77.14.7945-7956.2003; Reid SP, 2006, J VIROL, V80, P5156, DOI 10.1128/JVI.02349-05; Mahller YY, 2008, CANCER GENE THER, V15, P733, DOI 10.1038/cgt.2008.40; Pauli EK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000196; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Wool-Lewis RJ, 1998, VIROLOGY, V72, P3155	51	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	OCT	2015	89	20					10399	10406		10.1128/JVI.01736-15		8	Virology	Virology	CU3ZG	WOS:000363464700021		
J	Koga, R; Sugita, Y; Noda, T; Yanagi, Y; Ohno, S				Koga, Ritsuko; Sugita, Yukihiko; Noda, Takeshi; Yanagi, Yusuke; Ohno, Shinji			Actin-Modulating Protein Cofilin Is Involved in the Formation of Measles Virus Ribonucleoprotein Complex at the Perinuclear Region	JOURNAL OF VIROLOGY			English	Article							V-PROTEIN; C-PROTEIN; INTERFERON INDUCTION; LIM-KINASE; CELLULAR RECEPTOR; CELLS; PHOSPHORYLATION; REPLICATION; EXPRESSION; REORGANIZATION	In measles virus (MV)-infected cells, the ribonucleoprotein (RNP) complex, comprised of the viral genome and the nucleocapsid (N) protein, phosphoprotein (P protein), and large protein, assembles at the perinuclear region and synthesizes viral RNAs. The cellular proteins involved in the formation of the RNP complex are largely unknown. In this report, we show that cofilin, an actin-modulating host protein, interacts with the MV N protein and aids in the formation of the RNP complex. Knockdown of cofilin using the short hairpin RNA reduces the formation of the RNP complex after MV infection and that of the RNP complex-like structure after plasmid-mediated expression of MV N and P proteins. A lower level of formation of the RNP complex results in the reduction of viral RNA synthesis. Cofilin phosphorylation on the serine residue at position 3, an enzymatically inactive form, is increased after MV infection and the phosphorylated form of cofilin is preferentially included in the complex. These results indicate that cofilin plays an important role in MV replication by increasing formation of the RNP complex and viral RNA synthesis. IMPORTANCE Many RNA viruses induce within infected cells the structure called the ribonucleoprotein (RNP) complex in which viral RNA synthesis occurs. It is comprised of the viral genome and proteins that include the viral RNA polymerase. The cellular proteins involved in the formation of the RNP complex are largely unknown. In this report, we show that cofilin, an actin-modulating host protein, binds to the measles virus (MV) nucleocapsid protein and plays an important role in the formation of the MV RNP complex and MV RNA synthesis. The level of the phosphorylated form of cofilin, enzymatically inactive, is increased after MV infection, and the phosphorylated form is preferentially associated with the RNP complex. Our findings determined with cofilin will help us better understand the mechanism by which the RNP complex is formed in virus-infected cells and develop new antiviral drugs targeting the RNP complex.	[Koga, Ritsuko; Yanagi, Yusuke; Ohno, Shinji] Kyushu Univ, Fac Med, Dept Virol, Fukuoka 812, Japan; [Sugita, Yukihiko; Noda, Takeshi] Univ Tokyo, Inst Med Sci, Div Virol, Tokyo, Japan	Yanagi, Y (reprint author), Kyushu Univ, Fac Med, Dept Virol, Fukuoka 812, Japan.	yyanagi@virology.med.kyushu-u.ac.jp; soono@virology.med.kyushu-u.ac.jp			JSPS KAKENHI [24115005]; Ministry of Health, Labor and Welfare of Japan (the Research Committee of Prion Disease and Slow Virus Infection)	This study was supported by JSPS KAKENHI grant number 24115005 and by a grant from the Ministry of Health, Labor and Welfare of Japan (the Research Committee of Prion Disease and Slow Virus Infection).	Lazaro-Dieguez F, 2008, J CELL SCI, V121, P1415, DOI 10.1242/jcs.017665; Yokota S, 2003, VIROLOGY, V306, P135, DOI 10.1016/S0042-6822(02)00026-0; NIWA H, 1991, GENE, V108, P193; Takeda M, 2000, J VIROL, V74, P6643, DOI 10.1128/JVI.74.14.6643-6647.2000; Childs K, 2012, J VIROL, V86, P3411, DOI 10.1128/JVI.06405-11; BELLINI WJ, 1985, J VIROL, V53, P908; Nakatsu Y, 2008, J VIROL, V82, P8296, DOI 10.1128/JVI.00108-08; Pfaller CK, 2008, J VIROL, V82, P12365, DOI 10.1128/JVI.01321-08; Xiang YF, 2012, J VIROL, V86, P8440, DOI 10.1128/JVI.00609-12; Komune N, 2011, J VIROL, V85, P13019, DOI 10.1128/JVI.05942-11; Fontana JM, 2008, VIROLOGY, V374, P71, DOI 10.1016/j.virol.2007.12.031; Muller N, 2006, TRAFFIC, V7, P849, DOI 10.1111/j.1600-0854.2006.00426.x; HUBER M, 1991, VIROLOGY, V185, P299, DOI 10.1016/0042-6822(91)90777-9; Takeda M, 2008, J VIROL, V82, P11979, DOI 10.1128/JVI.00867-08; Shaffer JA, 2003, VIROLOGY, V315, P389, DOI 10.1016/S0042-6822(03)00537-3; Lahaye X, 2009, J VIROL, V83, P7948, DOI 10.1128/JVI.00554-09; Kousaka K, 2008, GENESIS, V46, P246, DOI 10.1002/dvg.20389; Arber S, 1998, NATURE, V393, P805; CATTANEO R, 1989, CELL, V56, P759, DOI 10.1016/0092-8674(89)90679-X; Wakimoto H, 2013, J VIROL, V87, P1974, DOI 10.1128/JVI.02371-12; Heath CM, 2001, J CELL BIOL, V153, P449, DOI 10.1083/jcb.153.3.449; Nakatsu Y, 2013, J VIROL, V87, P4683, DOI 10.1128/JVI.02189-12; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Palosaari H, 2003, J VIROL, V77, P7635, DOI 10.1128/JVI.77.13.7635-7644.2003; Toshima J, 2001, J BIOL CHEM, V276, P31449, DOI 10.1074/jbc.M102988200; Tober C, 1998, J VIROL, V72, P8124; Hoenen T, 2012, J VIROL, V86, P11779, DOI 10.1128/JVI.01525-12; Ono N, 2001, J VIROL, V75, P4399, DOI 10.1128/JVI.75.9.4399-4401.2001; Ikegame S, 2010, J VIROL, V84, P372, DOI 10.1128/JVI.01690-09; Iwasaki M, 2011, P NATL ACAD SCI USA, V108, P15384, DOI 10.1073/pnas.1107382108; Toshima J, 2001, MOL BIOL CELL, V12, P1131; Wen XY, 2014, J VIROL, V88, P6906, DOI 10.1128/JVI.00023-14; NISHIDA E, 1984, BIOCHEMISTRY-US, V23, P5307, DOI 10.1021/bi00317a032; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; Bravo-Cordero JJ, 2013, NAT REV MOL CELL BIO, V14, P405, DOI 10.1038/nrm3609; Devaux P, 2004, J VIROL, V78, P11632, DOI 10.1128/JVI.78.21.11632-11640.2004; Nakatsu Y, 2006, J VIROL, V80, P11861, DOI 10.1128/JVI.00751-06; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; Wileman T, 2006, SCIENCE, V312, P875, DOI 10.1126/science.1126766; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Davis ME, 2014, CELL HOST MICROBE, V16, P19, DOI 10.1016/j.chom.2014.06.007; Tatsuo H, 2000, NATURE, V406, P893; Takeda M, 2005, J VIROL, V79, P14346, DOI 10.1128/JVI.79.22.14346-14354.2005; Iwasaki M, 2009, J VIROL, V83, P10374, DOI 10.1128/JVI.01056-09; Yang N, 1998, NATURE, V393, P809; Dietzel E, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-249; Griffin DE, 2013, FIELDS VIROLOGY, P1042; Heinrich BS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000958; Katoh H, 2015, J VIROL, V89, P3188, DOI 10.1128/JVI.03343-14; Komarova AV, 2011, MOL CELL PROTEOMICS, V10; Menager P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000315; Noyce RS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002240; Ramachandran Aparna, 2008, J Virol, V82, P8330, DOI 10.1128/JVI.00831-08	53	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	OCT	2015	89	20					10524	10531		10.1128/JVI.01819-15		8	Virology	Virology	CU3ZG	WOS:000363464700032		
J	Sato, K; Sueyoshi, H; Yamada, K				Sato, Kaoru; Sueyoshi, Hitoshi; Yamada, Katsumi			Characterization of complex phase steel using backscattered electron images with controlled collection angles	MICROSCOPY			English	Article						scanning electron microscope; backscattered electron image; Z contrast; channeling contrast; complex phase steel; martensite; crystallographic defects; multiple scattering	CHANNELING CONTRAST; MICROSCOPY	For optimizing the microstructure of complex phase (CP) steels, characterization using scanning electron microscopy (SEM) is powerful because it allows observations from very low to high magnification. SEM specimens of steels are often etched in order to distinguish between the different phases by producing topographic information. This is however an 'indirect' method of characterization, which does not give precise structural information. We have developed a new technique for the selective imaging of the martensite (M) phase in a ferritic (F)-M complex phase steel. Backscattered electron (BSE) images at 15-20 kV were recorded by systematically changing the collection angle theta, where theta is measured from the specimen surface. When theta was 30-45A degrees, strong channeling contrast was observed. For lower values of theta, it is the low energy loss electrons that mainly contribute to the contrast. As theta increases, the M phase exhibits brighter contrast. When theta exceeds 60A degrees, a selective imaging of the M phase is achieved. This is not because martensite has a larger mean atomic number than ferrite, but is due to the fact that martensite has a high crystallographic defect density. Anomalously bright M contrast is due to multiple scattering of BSE due to the high density of planar defects and dislocations. Low angle BSE allows high resolution characterization of complex microstructures, while high angle BSE gives quantitative assessment of the distribution and the volume fraction of the martensite phase.	[Sato, Kaoru] JFE Steel Corp, Steel Res Lab, Chuo Ku, Chiba, Chiba 2600835, Japan; [Sueyoshi, Hitoshi] JFE Steel Corp, Intellectual Property Div, Chiyoda Ku, Tokyo 1000011, Japan; [Yamada, Katsumi] JFE Steel Corp, Steel Res Lab, Fukuyama, Hiroshima 7218510, Japan	Sato, K (reprint author), JFE Steel Corp, Steel Res Lab, Chuo Ku, 1 Kawasaki Cho, Chiba, Chiba 2600835, Japan.	ka-sato@jfe-steel.co.jp					Kaneko Y, 2002, J JPN I MET, V66, P1297; Aoyama T, 2011, ISIJ INT, V51, P1487, DOI 10.2355/isijinternational.51.1487; Mikmekova S, 2013, MICROSCOPY-JPN, V62, P589, DOI 10.1093/jmicro/dft036; Wilkinson AJ, 1997, MICRON, V28, P279, DOI 10.1016/S0968-4328(97)00032-2; Sato K, 2001, INST PHYS CONF SER, P77; Aoyama T, 2014, SURF INTERFACE ANAL, V46, P1291, DOI 10.1002/sia.5564; Gutierrez-Urrutia I, 2012, SCRIPTA MATER, V66, P343, DOI 10.1016/j.scriptamat.2011.11.027; Hoffmann K E, 1982, ELECTRON BEAM INTERA, P209; Jaksch H, 2008, MICROSCOPY MICROA S2, V14, P1226; Kanda K, MONTE CARLO SIMULATI; MATSUMURA O, 1987, T IRON STEEL I JPN, V27, P570; Ng BC, 1997, MAT SCI ENG A-STRUCT, V240, P150, DOI 10.1016/S0921-5093(97)00574-1; Reimer L, 1998, SCANNING ELECT MICRO; Speich G R, 1981, FUNDAMENTALS DUAL PH, P3	14	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0744	1477-9986		MICROSCOPY-JPN	Microscopy	OCT	2015	64	5					297	304		10.1093/jmicro/dfv022		8	Microscopy	Microscopy	CT5EU	WOS:000362831900001		
J	Takagi, Y; Kono, M; Yamamoto, S; Wada, A; Morikawa, T				Takagi, Yuri; Kono, Mari; Yamamoto, Shiori; Wada, Atsushi; Morikawa, Takashi			Comparison of optical data from flow cytometry and microscopy of leukocytes after exposure to specific reagents	MICROSCOPY			English	Article						flow cytometry; electron microscopy; fluorescent microscopy; leukocytes; scatter light intensity; fluorescent intensity	TRITON X-100; RESISTANCE	Flow cytometry and microscopy are equally important in cell analysis. However, few reports have compared the optical data (cell size, internal complexity and fluorescent signal) from flow cytometry and microscopy. In this study, we compared the scattergram from XN-series, a flow cytometry based hematology analyzer with microscopic images of similarly treated leukocytes, and investigated the correlation between the appearance in the scattergram and cell size, internal complexity and fluorescence intensity. Healthy human peripheral blood was analyzed using the XN analyzer. For microscopic comparison, five types of leukocytes (monocytes, lymphocytes, basophils, neutrophils and eosinophils) were isolated from the peripheral blood by centrifugation and magnetic cell sorting, treated with a specific reagent and analyzed using electron microscopy, laser microscopy and confocal laser microscopy. Cell size, residual internal structures and fluorescence intensity correlated with intensity of forward-scattering, side scattering and fluorescent light. In this study, optical data from a clinically used hematology analyzer was clarified using microscopic images.	[Takagi, Yuri; Kono, Mari; Yamamoto, Shiori; Wada, Atsushi; Morikawa, Takashi] Sysmex Corp, Sci Res, Sci Affairs, Nishi Ku, Kobe, Hyogo 6512241, Japan	Takagi, Y (reprint author), Sysmex Corp, Sci Res, Sci Affairs, Nishi Ku, 1-3-2 Murotani, Kobe, Hyogo 6512241, Japan.	kono.mari@sysmex.co.jp					Alberts B., 2002, MOL BIOL CELL; Spyropoulos B, 2011, CLIN LAB, V57, P131; ERENPREISA J, 1983, ACTA MORPHOL HUNG, V31, P387; El Kirat K, 2007, BBA-BIOMEMBRANES, V1768, P2300, DOI 10.1016/j.bbamem.2007.05.006; Lingwood D, 2007, NAT PROTOC, V2, P2159, DOI 10.1038/nprot.2007.294; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; Kono M, 2013, CYTOM PART A, V83A, P396, DOI 10.1002/cyto.a.22262; Holowka David, 2009, Biochem J, V424, pe5, DOI 10.1042/BJ20091623; Mizutani T, 1999, Patent no. US, Patent No. 6004816; Ochi Y, 2011, SYSMEX J S2, V34, P31; YANG S-C, 1989, Taiwan yixuehui zazhi, V88, P1128	11	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0744	1477-9986		MICROSCOPY-JPN	Microscopy	OCT	2015	64	5					305	310		10.1093/jmicro/dfv023		6	Microscopy	Microscopy	CT5EU	WOS:000362831900002		
J	Aoyama, T; Nagoshi, M; Sato, K				Aoyama, Tomohiro; Nagoshi, Masayasu; Sato, Kaoru			Quantitative analysis of angle-selective backscattering electron image of iron oxide and steel	MICROSCOPY			English	Article						scanning electron microscopy; backscattered electron; contrast; primary electron energy; take-off angle	ENERGY; CONTRAST	The contrasts in backscattered electron ( BSE) images, such as topographic, channeling and mean atomic number ( Z) contrasts, were investigated quantitatively fromthe cross section of a heat- treated steel sheet using a scanning electron microscope ( SEM). High primary electron energy ( EP) enhances Z contrast, whereas low EP improves channeling contrast. A high take- off angle (theta; measured from the specimen surface) also enhances Z contrast, whereas low. improves channeling contrast. When theta becomes very low, topographic information is enhanced and superimposed on channeling contrast due to the tilt effect of BSE. The relationship of the behaviors of the Z contrast and the channeling contrast can be understood by the detection ratio of low- loss electrons ( LLEs) to the inelastic BSE components emitted from the sample surface; LLEs contribute to channeling contrast, and their ratio increaseswith decreasing EP and theta. The systematic results obtained in this study are useful for controlling SEM conditions in order to enhance the target information in BSE images for practicalmaterials of interest.	[Aoyama, Tomohiro] JFE Steel Corp, Steel Res Lab, Fukuyama, Hiroshima 7218510, Japan; [Nagoshi, Masayasu] JFE Steel Corp, Steel Res Lab, Kawasaki Ku, Kawasaki, Kanagawa 2100855, Japan; [Sato, Kaoru] JFE Steel Corp, Steel Res Lab, Chuo Ku, Chiba, Chiba 2600835, Japan	Aoyama, T (reprint author), JFE Steel Corp, Steel Res Lab, 1 Kokan Cho, Fukuyama, Hiroshima 7218510, Japan.	to-aoyama@jfe-steel.co.jp					Liu Z, 2013, MICROSCOPY-JPN, V62, P109, DOI 10.1093/jmicro/dfs098; Aoyama T, 2011, ISIJ INT, V51, P1487, DOI 10.2355/isijinternational.51.1487; Mikmekova S, 2013, MICROSCOPY-JPN, V62, P589, DOI 10.1093/jmicro/dft036; AUTRATA R, 1989, SCANNING MICROSCOPY, V3, P739; Nagoshi M, 2013, ULTRAMICROSCOPY, V124, P20, DOI 10.1016/j.ultramic.2012.08.011; NIEDRIG H, 1982, J APPL PHYS, V53, pR15, DOI 10.1063/1.331005; Aoyama T, 2014, SURF INTERFACE ANAL, V46, P1291, DOI 10.1002/sia.5564; Berger D, 2002, SCANNING, V24, P70; Hoffmann K E, 1982, ELECTRON BEAM INTERA, P209; Kawano T, 2006, JFE TECH REP, V13, P5; Nagoshi M, 2006, P AS STEEL 06 FUK JA, P836; Nagoshi M, 2003, J SURF FINISH SOC JP, V54, P31; Newbury D E, 1986, ADV SCANNING ELECT M; Niedrig H, 1982, ELECTRON BEAM INTERA, P51; Reimer L, 1993, IMAGE FORMATION LOW; Reimer L, 1998, SCANNING ELECT MICRO; Sato K., 2004, Oyo Buturi, V73; Sato K, 2010, P 17 INT MICR C IMC1, pI3; Umbaugh S E, 2010, DIGITAL IMAGE PROCES	19	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0744	1477-9986		MICROSCOPY-JPN	Microscopy	OCT	2015	64	5					319	325		10.1093/jmicro/dfv026		7	Microscopy	Microscopy	CT5EU	WOS:000362831900004		
J	Hayatsu, M; Suzuki, S				Hayatsu, Manabu; Suzuki, Suechika			Electron probe X-ray microanalysis studies on the distribution change of intra- and extracellular calcium in the elongation zone of horizontally reoriented soybean roots	MICROSCOPY			English	Article						calcium; cryosection; electron probe X-ray microanalysis; gravitropic response; horizontally reorientated root; soybean root	ZEA-MAYS; MAIZE COLEOPTILES; AVENA COLEOPTILE; COLUMELLA CELLS; GRAVITY; AUXIN; GRAVITROPISM; TRANSPORT; MOVEMENT	To clarify the contribution of Ca to the gravitropic response, quantitative X-ray microanalyses were performed on cryosections of roots of soybean seedlings reoriented horizontally from their original vertical orientation. After reorientation, the roots bent gradually toward the ground at the elongation zone. The concentrations of Ca in the cell walls, cytoplasmic matrices and central vacuoles of cortical cells were measured in the upper and lower halves of the elongation zone at 0, 30, 60 and 120 min after reorientation. The Ca concentration did not significantly change in the cytoplasmic matrices or vacuoles. Additionally, the Ca concentration did not change significantly in cell walls at 30 min after reorientation; however, beyond 30 min, this concentration significantly increased gradually in the lower half of the elongation zone and decreased in the upper half of the elongation zone, indicating a typical asymmetrical distribution of Ca. These results suggest that Ca moves apoplastically in soybean roots to produce an asymmetrical Ca distribution in the elongation zone, which contributes to root curvature. The possible role of Ca in accelerating or repressing the effect of auxin is also discussed in this study.	[Hayatsu, Manabu; Suzuki, Suechika] Kanagawa Univ, Fac Sci, Dept Biol Sci, Hiratsuka, Kanagawa 2591293, Japan; [Hayatsu, Manabu; Suzuki, Suechika] Kanagawa Univ, Res Inst Integrated Sci, Hiratsuka, Kanagawa 2591293, Japan	Hayatsu, M (reprint author), Kanagawa Univ, Fac Sci, Dept Biol Sci, Hiratsuka, Kanagawa 2591293, Japan.	hayatsu-bio@kanagawa-u.ac.jp					Saito C, 2005, PLANT CELL, V17, P548, DOI 10.1105/tpc.104.026138; HASENSTEIN KH, 1988, PLANT PHYSIOL, V86, P890, DOI 10.1104/pp.86.3.890; Hayatsu M, 2014, J PLANT PHYSIOL, V171, P1385, DOI 10.1016/j.jplph.2014.06.008; SIEVERS A, 1984, Z PFLANZENPHYSIOL, V114, P195; TORIYAMA H, 1972, PLANT PHYSIOL, V49, P72, DOI 10.1104/pp.49.1.72; GEHRING CA, 1990, NATURE, V345, P528, DOI 10.1038/345528a0; MOORE R, 1986, AM J BOT, V73, P574, DOI 10.2307/2444263; BJORKMAN T, 1991, PLANTA, V185, P379, DOI 10.1007/BF00201060; LEE JS, 1983, PLANT PHYSIOL, V73, P874, DOI 10.1104/pp.73.4.874; COOIL BJ, 1957, PLANTA, V48, P696, DOI 10.1007/BF01911596; Hayatsu M, 2012, J ELECTRON MICROSC, V61, P57, DOI 10.1093/jmicro/dfr095; YOUNG LM, 1990, PLANT PHYSIOL, V92, P792, DOI 10.1104/pp.92.3.792; Chen RJ, 1999, PLANT PHYSIOL, V120, P343, DOI 10.1104/pp.120.2.343; JARVIS MC, 1984, PLANT CELL ENVIRON, V7, P153, DOI 10.1111/1365-3040.ep11614586; TAGAWA T, 1957, PLANT PHYSIOL, V32, P207, DOI 10.1104/pp.32.3.207; SACK FD, 1985, PLANTA, V164, P56, DOI 10.1007/BF00391025; Band LR, 2012, P NATL ACAD SCI USA, V109, P4668, DOI 10.1073/pnas.1201498109; MOORE R, 1987, ANN BOT-LONDON, V59, P667; Bennet-Clark T A, 1956, CHEM MODE ACTION PLA, P284; Colodny N, 1927, BIOL ZENTRALBL, V47, P604; Ebashi S, 1968, Prog Biophys Mol Biol, V18, P123, DOI 10.1016/0079-6107(68)90023-0; MOORE R, 1985, ANN BOT-LONDON, V56, P173; WENT F. W., 1928, REC TRAV BOT NEERL, V25, P1	23	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0744	1477-9986		MICROSCOPY-JPN	Microscopy	OCT	2015	64	5					327	334		10.1093/jmicro/dfv031		8	Microscopy	Microscopy	CT5EU	WOS:000362831900005		
J	Adhika, DR; Tanaka, M; Daio, T; Higashida, K				Adhika, Damar Rastri; Tanaka, Masaki; Daio, Takeshi; Higashida, Kenji			Crack tip shielding observed with high-resolution transmission electron microscopy	MICROSCOPY			English	Article						HRTEM; brittle-to-ductile transition; dislocation shielding effect; fracture toughness; geometric phase analysis	BRITTLE DUCTILE TRANSITION; SILICON SINGLE-CRYSTALS; FRACTURE-TOUGHNESS; DISLOCATIONS; MULTIPLICATION; TOMOGRAPHY; MODEL	The dislocation shielding field at a crack tip was experimentally proven at the atomic scale by measuring the local strain in front of the crack tip using high-resolution transmission electron microscopy (HRTEM) and geometric phase analysis (GPA). Single crystalline (110) silicon wafers were employed. Cracks were introduced using a Vickers indenter at room temperature. The crack tip region was observed using HRTEM followed by strain measurements using GPA. The measured strain field at the crack tip was compressive owing to dislocation shielding, which is in good agreement with the strain field calculated from elastic theory.	[Adhika, Damar Rastri; Tanaka, Masaki; Higashida, Kenji] Kyushu Univ, Dept Mat Sci & Engn, Nishi Ku, Fukuoka 8190395, Japan; [Daio, Takeshi] Kyushu Univ, Dept Hydrogen Energy Syst, Nishi Ku, Fukuoka 8190395, Japan	Tanaka, M (reprint author), Kyushu Univ, Dept Mat Sci & Engn, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	masaki@zaiko.kyushu-u.ac.jp			JSPS KAKENHI [24686079, 15H04147]; Kazato Research Foundation	The authors thank JSPS KAKENHI (#24686079, #15H04147) and Kazato Research Foundation for partly supporting this research. Funding to pay the Open Access publication charges for the article was provided by JSPS KAKENHI.	NIIHARA K, 1983, J MATER SCI LETT, V2, P221, DOI 10.1007/BF00725625; BREDE M, 1988, ACTA METALL MATER, V36, P2003, DOI 10.1016/0001-6160(88)90302-1; Tanaka M, 2005, MAT SCI ENG A-STRUCT, V400, P426, DOI 10.1016/j.msea.2005.02.084; RICE JR, 1974, PHILOS MAG, V29, P73, DOI 10.1080/14786437408213555; SAMUELS J, 1989, P ROY SOC LOND A MAT, V421, P1, DOI 10.1098/rspa.1989.0001; Tanaka M, 2011, J MATER RES, V26, P508, DOI 10.1557/jmr.2010.99; Higashida K, 2008, MAT SCI ENG A-STRUCT, V483-84, P13, DOI 10.1016/j.msea.2006.12.174; Tanaka M, 2006, INT J FRACTURE, V139, P383, DOI 10.1007/s10704-006-0021-7; Higashida K, 1997, MAT SCI ENG A-STRUCT, V237, P72, DOI 10.1016/S0921-5093(97)00118-4; MALIS T, 1988, J ELECTRON MICR TECH, V8, P193, DOI 10.1002/jemt.1060080206; HIRSCH PB, 1989, P ROY SOC LOND A MAT, V421, P25, DOI 10.1098/rspa.1989.0002; Tanaka M, 2011, MATER TRANS, V52, P352, DOI 10.2320/matertrans.MB201024; STJOHN C, 1975, PHILOS MAG, V32, P1193; NARITA N, 1989, MATER T JIM, V30, P895; Michot G, 1999, MAT SCI ENG A-STRUCT, V272, P83, DOI 10.1016/S0921-5093(99)00473-6; Hirth J. P., 1982, THEORY DISLOCATIONS; Hytch M.J., 1997, SCANNING MICROSCOPY, V11, P53; Thomson R, 1986, SOLID STATE PHYS ADV	18	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0744	1477-9986		MICROSCOPY-JPN	Microscopy	OCT	2015	64	5					335	340		10.1093/jmicro/dfv032		6	Microscopy	Microscopy	CT5EU	WOS:000362831900006		
J	Seki, T; Abe, E				Seki, Takehito; Abe, Eiji			Local cluster symmetry of a highly ordered quasicrystalline Al58Cu26Ir16 extracted through multivariate analysis of STEM images	MICROSCOPY			English	Article						STEM; quasicrystals; atomic-resolution imaging; structure analysis; image analysis	TRANSMISSION ELECTRON-MICROSCOPY; NONNEGATIVE MATRIX FACTORIZATION; UNIT-CELL MODEL; TRANSLATIONAL SYMMETRY; CO; QUASICRYSTAL; ATOMS	The structure of a highly ordered Al58Cu26Ir16 decagonal quasicrystal (d-QC), which is constructed by a periodic stack of quasiperiodic atomic planes, was investigated using aberration-corrected scanning transmission electron microscopy. The entire quasiperiodic structure can be well described based on the pentagonal Penrose lattice decorated with a decagonal columnar cluster 2 nm across, and the individual clusters apparently showed up with localized atomic disorder to various degree that blurs the underlying cluster symmetry. Multivariate analysis of the cluster images with principal component analysis has successfully extracted two fundamental clusters, which are with definite mirror and 10-fold-rotation symmetries; this is the first solid example of the d-QC composed of multiple fundamental clusters with different symmetry. Consequently, it is found that all the observed variations can be reasonably interpreted by a linear combination between these two fundamental clusters of mirror and 10-fold symmetries, indicating that the possible atomic disorder is strongly restricted by these particular symmetries. Characteristic distributions of the mirror/10-fold clusters on the pentagonal Penrose lattice are also described.	[Seki, Takehito; Abe, Eiji] Univ Tokyo, Dept Mat Sci & Engn, Tokyo 1138656, Japan	Abe, E (reprint author), Univ Tokyo, Dept Mat Sci & Engn, Tokyo 1138656, Japan.	abe@material.t.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [26630290];  [25-10561]	Part of this study is supported by grants-in-aid for scientific research (Houga, No. 26630290) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. T.S. acknowledges the support by grants-in-aid for JSPS Fellows (No. 25-10561).	Abe E, 2011, SCANNING TRANSMISSIO, P583; Pennycook SJ, 2011, J ELECTRON MICROSC, V60, pS213, DOI 10.1093/jmicro/dfr030; Yamamoto A, 1996, ACTA CRYSTALLOGR A, V52, P509, DOI 10.1107/S0108767396000967; Abe E, 2012, CHEM SOC REV, V41, P6787, DOI 10.1039/c2cs35303b; Abe E, 2004, NAT MATER, V3, P759, DOI 10.1038/nmat1244; Coddens G, 1999, PHYS REV B, V60, P270, DOI 10.1103/PhysRevB.60.270; Kuczera P, 2012, ACTA CRYSTALLOGR B, V68, P578, DOI 10.1107/S0108768112041134; Borisevich A, 2010, ACS NANO, V4, P6071, DOI 10.1021/nn1011539; Berry MW, 2007, COMPUT STAT DATA AN, V52, P155, DOI 10.1016/j.csda.2006.11.006; Lee DD, 1999, NATURE, V401, P788; Yamamoto Y, 2014, MICROSCOPY-JPN, V63, P209, DOI 10.1093/jmicro/dfu001; Yamamoto A, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.144202; Taniguchi S, 2008, PHILOS MAG, V88, P1949, DOI 10.1080/14786430802035683; BENDERSKY L, 1985, PHYS REV LETT, V55, P1461, DOI 10.1103/PhysRevLett.55.1461; Dellby N, 2001, J ELECTRON MICROSC, V50, P177, DOI 10.1093/jmicro/50.3.177; LUBENSKY TC, 1986, PHYS REV LETT, V57, P1440, DOI 10.1103/PhysRevLett.57.1440; Abe E, 2001, J ELECTRON MICROSC, V50, P187, DOI 10.1093/jmicro/50.3.187; Yan Y, 1998, PHYS REV LETT, V81, P5145, DOI 10.1103/PhysRevLett.81.5145; Nicoletti O, 2013, NATURE, V502, P80, DOI 10.1038/nature12469; Steurer W, 2004, Z KRISTALLOGR, V219, P391, DOI 10.1524/zkri.219.7.391.35643; Francoual S, 2006, PHILOS MAG, V86, P1029, DOI 10.1080/14786430500Z63496; Steinhardt PJ, 1998, NATURE, V396, P55, DOI 10.1038/23902; ELSER V, 1985, PHYS REV LETT, V55, P2883, DOI 10.1103/PhysRevLett.55.2883; Abe E, 2000, PHYS REV LETT, V84, P4609, DOI 10.1103/PhysRevLett.84.4609; Abe E, 2003, NATURE, V421, P347, DOI 10.1038/nature01337; Krivanek OL, 2013, MICROSCOPY-JPN, V62, P3, DOI 10.1093/jmicro/dfs089; Tsuda K, 1996, PHILOS MAG A, V74, P697; SHECHTMAN D, 1984, PHYS REV LETT, V53, P1951, DOI 10.1103/PhysRevLett.53.1951; PENNYCOOK SJ, 1991, ULTRAMICROSCOPY, V37, P14, DOI 10.1016/0304-3991(91)90004-P; BEELI C, 1994, PHILOS MAG B, V70, P215, DOI 10.1080/01418639408241802; Hiraga K, 1997, ADV IMAG ELECT PHYS, V101, P37, DOI 10.1016/S1076-5670(08)70260-X; Saitoh K, 1997, JPN J APPL PHYS 2, V36, pL1400; Seki T, 2014, MICROSCOPY, V63, pi17; Tsai A P, 1999, PHYS PROPERTIES QUAS, P5	34	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0744	1477-9986		MICROSCOPY-JPN	Microscopy	OCT	2015	64	5					341	349		10.1093/jmicro/dfv035		9	Microscopy	Microscopy	CT5EU	WOS:000362831900007		
J	Kaku, H; Inoue, K; Muranaka, Y; Park, P; Ikeda, K				Kaku, Hiroki; Inoue, Kanako; Muranaka, Yoshinori; Park, Pyoyun; Ikeda, Kenichi			Rapid contrast evaluation method based on affinity beads and backscattered electron imaging for the screening of electron stains	MICROSCOPY			English	Article						non-isotope; uranyl acetate; contrast; samarium chloride; backscattered electron image; scanning electron microscope	URANYL ACETATE; MICROSCOPY; SUBSTITUTE; SECTIONS	Uranyl salts are toxic and radioactive; therefore, several studies have been conducted to screen for substitutes of electron stains. In this regard, the contrast evaluation process is time consuming and the results obtained are inconsistent. In this study, we developed a novel contrast evaluation method using affinity beads and a backscattered electron image (BSEI), obtained using scanning electron microscopy. The contrast ratios of BSEI in each electron stain treatment were correlated with those of transmission electron microscopic images. The affinity beads bound to cell components independently. Protein and DNA samples were enhanced by image contrast treated with electron stains; however, this was not observed for sugars. Protein-conjugated beads showed an additive effect of image contrast when double-stained with lead. However, additive effect of double staining was not observed in DNA-conjugated beads. The varying chemical properties of oligopeptides showed differences in image contrast when treated with each electron stain. This BSEI-based evaluation method not only enables screening for alternate electron stains, but also helps analyze the underlying mechanisms of electron staining of cellular structures.	[Kaku, Hiroki; Inoue, Kanako; Park, Pyoyun; Ikeda, Kenichi] Kobe Univ, Grad Sch Agr Sci, Nada Ku, Kobe, Hyogo 6578501, Japan; [Inoue, Kanako; Muranaka, Yoshinori] Osaka Univ, Res Ctr Ultra High Voltage Electron Microscopy, Ibaraki, Osaka 5670047, Japan	Ikeda, K (reprint author), Kobe Univ, Grad Sch Agr Sci, Nada Ku, Kobe, Hyogo 6578501, Japan.	ikeken@phoenix.kobe-u.ac.jp			program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN); Japan Society for the Promotion of Science [22580048, 25450059]; Science and Technology Research Promotion for Agriculture, Forestry, Fisheries and Food Industry	This study was supported by the program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN), Science and Technology Research Promotion for Agriculture, Forestry, Fisheries and Food Industry and by a Grant-in-Aid for Scientific Research C (No. 22580048 and 25450059) from the Japan Society for the Promotion of Science.	Ikeda K, 2011, MICROSC RES TECHNIQ, V74, P825, DOI 10.1002/jemt.20964; STEMPAK JG, 1964, J CELL BIOL, V22, P697, DOI 10.1083/jcb.22.3.697; Sarsfield MJ, 2004, J AM CHEM SOC, V126, P1036, DOI 10.1021/ja039101y; KELLENBERGER E, 1958, J BIOPHYS BIOCHEM CY, V4, P671, DOI 10.1083/jcb.4.6.671; Inaga S, 2007, ARCH HISTOL CYTOL, V70, P43, DOI 10.1679/aohc.70.43; Yamaguchi K, 2010, J ELECTRON MICROSC, V59, P113, DOI 10.1093/jmicro/dfp045; Nakakoshi M, 2011, J ELECTRON MICROSC, V60, P401, DOI 10.1093/jmicro/dfr084; Hayat MA, 2000, PRINCIPLES AND TECHNIQUES OF ELECTRON MICROSCOPY: BIOLOGICAL APPLICATIONS, FOURTH EDITION, P242; Horiuchi Y, 2007, J ELECT MICROSC TECH, V21, P21; Ministry of Education Culture Sports Science and Technology, 2009, GBT47892 MIN PUBL HL, P1; Sato T, 1968, J Electron Microsc (Tokyo), V17, P158; WATSON ML, 1958, J BIOPHYS BIOCHEM CY, V4, P475, DOI 10.1083/jcb.4.4.475	12	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0744	1477-9986		MICROSCOPY-JPN	Microscopy	OCT	2015	64	5					361	368		10.1093/jmicro/dfv041		8	Microscopy	Microscopy	CT5EU	WOS:000362831900009		
J	Sato, K; Miyazaki, H; Gondo, T; Miyazaki, S; Murayama, M; Hata, S				Sato, K.; Miyazaki, H.; Gondo, T.; Miyazaki, S.; Murayama, M.; Hata, S.			Development of a novel straining holder for transmission electron microscopy compatible with single tilt-axis electron tomography	MICROSCOPY			English	Article						in situ transmission electron microscopy; in situ deformation; electron tomography; dynamic 3D observation	ALUMINUM; DISLOCATIONS; DEFORMATION; CONTRAST; IRON	We have developed a newly designed straining specimen holder for in situ transmission electron microscopy (TEM) compatible with high-angle single tilt-axis electron tomography. The holder can deform a TEM specimen under tensile stress with the strain rate between 1.5 x 10(-6) and 5.2 x 10(-3) s(-1). We have also confirmed that the maximum tilt angle of the specimen holder reaches +/- 60 degrees with a rectangular shape aluminum specimen. The new specimen holder, termed as 'straining and tomography holder', will have wide range potential applications in materials science.	[Sato, K.] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Miyazaki, H.; Gondo, T.] Mel Build Corp, Nishi Ku, Fukuoka 8190052, Japan; [Miyazaki, S.] FEI Co Japan Ltd, Minato Ku, Tokyo 1080075, Japan; [Murayama, M.] Virginia Tech, Dept Mat Sci & Engn, Blacksburg, VA 24061 USA; [Hata, S.] Kyushu Univ, Dept Engn Sci Elect & Mat, Kasuga, Fukuoka 8168580, Japan	Sato, K (reprint author), Tohoku Univ, Inst Mat Res, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	ksato@imr.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [25102703]; Japan Science Technology Agency (JST) 'Development of systems and technology for advanced measurement and analysis' program	This study was supported by the Grant-in-Aid for Scientific Research on Innovative Area, 'Bulk Nanostructured Metals' (No. 25102703) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT). K.S. and S.H. acknowledge the financial support from the Japan Science Technology Agency (JST) 'Development of systems and technology for advanced measurement and analysis' program.	Tsuji N, 2002, SCRIPTA MATER, V47, P893, DOI 10.1016/S1359-6462(02)00282-8; Midgley PA, 2003, ULTRAMICROSCOPY, V96, P413, DOI 10.1016/S0304-3991(03)00105-0; FUJITA H, 1969, J PHYS SOC JPN, V26, P1437, DOI 10.1143/JPSJ.26.1437; Huang XX, 2006, SCIENCE, V312, P249, DOI 10.1126/science.1124268; POCZA JF, 1969, J VAC SCI TECHNOL, V6, P472; Liu GS, 2011, J MATER RES, V26, P514, DOI 10.1557/jmr.2010.83; SAKA H, 1972, J PHYS SOC JPN, V32, P702, DOI 10.1143/JPSJ.32.702; Kacher J, 2012, ACTA MATER, V60, P6657, DOI 10.1016/j.actamat.2012.08.036; Miyajima Y, 2010, MAT SCI ENG A-STRUCT, V528, P776, DOI 10.1016/j.msea.2010.09.058; Hata S, 2011, ULTRAMICROSCOPY, V111, P1168, DOI 10.1016/j.ultramic.2011.03.021; FUJITA H, 1967, J PHYS SOC JPN, V23, P1349, DOI 10.1143/JPSJ.23.1349; Kimura K, 2005, J ELECTRON MICROSC, V54, P373, DOI 10.1093/jmicro/dfi060; Kubel C, 2005, MICROSC MICROANAL, V11, P378, DOI 10.1017/S1431927605050361; Kacher J, 2012, MICRON, V43, P1099, DOI 10.1016/j.micron.2012.01.017; Dehm G, 2012, IN SITU ELECT MICROS	15	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0744	1477-9986		MICROSCOPY-JPN	Microscopy	OCT	2015	64	5					369	375		10.1093/jmicro/dfv021		7	Microscopy	Microscopy	CT5EU	WOS:000362831900010		
J	Nagao, Y; Kimura, K; Wang, SJ; Fujiwara, T; Mizoguchi, A				Nagao, Yasuaki; Kimura, Kazushi; Wang, Shujie; Fujiwara, Takeshi; Mizoguchi, Akira			Real-Time Histological Imaging of Kidneys Stained With Food Dyes Using Multiphoton Microscopy	MICROSCOPY RESEARCH AND TECHNIQUE			English	Article						glomerulus; renal tubule; filtration	MODULATING FLUORESCENCE PROPERTIES; TERM TOXICITY; DDY MICE; ERYTHROSINE; VIVO; STRAIN	We have developed a real-time imaging technique for diagnosis of kidney diseases which is composed of two steps, staining renal cells safely with food dyes and optical sectioning of living renal tissue to obtain histological images by multiphoton microscopy (MPM). Here, we demonstrated that the MPM imaging with food dyes, including erythrosine and indigo carmine, could be used as fluorescent agents to visualize renal functions and structures such as glomerular bloodstreams, glomerular filtration, and morphology of glomeruli and renal tubules. We also showed that the kidneys of IgA nephropathy model-mice stained with the food dyes presented histopathological characteristics different from those observed in normal kidneys. The use of the food dyes enhances the quality of tissue images obtained by MPM and offers the potential to contribute to a clinical real-time diagnosis of kidney diseases. Microsc. Res. Tech. 78: 847-858, 2015. (C) 2015 Wiley Periodicals, Inc.	[Nagao, Yasuaki; Kimura, Kazushi; Wang, Shujie; Fujiwara, Takeshi; Mizoguchi, Akira] Mie Univ, Grad Sch Med, Dept Neural Regenerat & Cell Commun, Tsu, Mie 5148507, Japan; [Kimura, Kazushi] Hokkaido Bunkyo Univ, Fac Human Sci, Dept Phys Therapy, Eniwa, Japan	Mizoguchi, A (reprint author), Mie Univ, Grad Sch Med, Dept Neural Regenerat & Cell Commun, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	k-kimura@do-bunkyodai.ac.jp; amizomie@doc.medic.mie-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23300284]	Contract grant sponsor: Grants-in-Aid for Fundamental Scientific Research (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Contract grant number: 23300284.	Tanaka T, 2001, FOOD CHEM TOXICOL, V39, P447, DOI 10.1016/S0278-6915(00)00163-0; BUTTERWORTH KR, 1976, FOOD COSMET TOXICOL, V14, P525, DOI 10.1016/S0015-6264(76)80001-6; Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100; Konig K, 1996, OPT LETT, V21, P1090, DOI 10.1364/OL.21.001090; Ueno T, 2004, J AM CHEM SOC, V126, P14079, DOI 10.1021/ja048241k; Muso E, 1996, KIDNEY INT, V50, P1946, DOI 10.1038/ki.1996.517; Yu WM, 2005, AM J PHYSIOL-CELL PH, V289, pC1197, DOI 10.1152/ajpcell.00197.2005; Dela Cruz JM, 2010, BIOMED OPT EXPRESS, V1, P1320, DOI 10.1364/BOE.1.001320; Hall AM, 2011, J AM SOC NEPHROL, V22, P1297, DOI 10.1681/ASN.2010101054; Koike Y, 2011, J THROMB THROMBOLYS, V32, P138, DOI 10.1007/s11239-011-0600-y; Chequer FMD, 2012, FOOD CHEM TOXICOL, V50, P3447, DOI 10.1016/j.fct.2012.07.042; Haas M, 1997, AM J KIDNEY DIS, V29, P829, DOI 10.1016/S0272-6386(97)90456-X; Miyawaki S, 1997, NEPHRON, V76, P201; Satoh M, 2010, MICROCIRCULATION, V17, P103, DOI 10.1111/j.1549-8719.2009.00010.x; Tanaka K, 2012, ONCOL REP, V28, P1822, DOI 10.3892/or.2012.1983; Miura T, 2003, J AM CHEM SOC, V125, P8666, DOI 10.1021/ja035282s; Rogart JN, 2008, CLIN GASTROENTEROL H, V6, P95, DOI 10.1016/j.cgh.2007.10.008; Mpountoukas P, 2010, FOOD CHEM TOXICOL, V48, P2934, DOI 10.1016/j.fct.2010.07.030; Blackburn SC, 2014, SEMIN PEDIATR SURG, V23, P326, DOI 10.1053/j.sempedsurg.2014.06.002; Boekel J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-123; HOOSON J, 1975, FOOD COSMET TOXICOL, V13, P167, DOI 10.1016/S0015-6264(75)80001-0; Garg AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034475; GAUNT I. F., 1967, FOOD COSMET TOXICOL, V5, P187, DOI 10.1016/S0015-6264(67)82966-3; Japanese Society of Nephrology, 2009, EV BAS PRACT GUID 20, P7; Kang JJ, 2006, AM J PHYSIOL-RENAL, V291, P495; Liu SX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041331; Nagai K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066759; Schiessl IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052499	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1059-910X	1097-0029		MICROSC RES TECHNIQ	Microsc. Res. Tech.	OCT	2015	78	10					847	858		10.1002/jemt.22535		12	Anatomy & Morphology; Biology; Microscopy	Anatomy & Morphology; Life Sciences & Biomedicine - Other Topics; Microscopy	CU7NH	WOS:000363726700001		
J	Murphy, KE; Gysbers, AM; Abbott, SK; Spiro, AS; Furuta, A; Cooper, A; Garner, B; Kabuta, T; Halliday, GM				Murphy, Karen E.; Gysbers, Amanda M.; Abbott, Sarah K.; Spiro, Adena S.; Furuta, Akiko; Cooper, Antony; Garner, Brett; Kabuta, Tomohiro; Halliday, Glenda M.			Lysosomal-associated membrane protein 2 isoforms are differentially affected in early Parkinson's disease	MOVEMENT DISORDERS			English	Article						-synuclein; chaperone-mediated autophagy (CMA); LAMP2; nucleic acid autophagy; Parkinson's disease	CHAPERONE-MEDIATED AUTOPHAGY; LEWY BODY DISEASE; ALPHA-SYNUCLEIN; LAMP-2 GENE; SELECTIVE PATHWAY; IN-VITRO; DEGRADATION; EXPRESSION; RECEPTOR; LIPIDS	Lysosomes are the primary catabolic compartment for the degradation of intracellular proteins through autophagy. The presence of abnormal intracellular -synuclein-positive aggregates in Parkinson's disease (PD) indicates that the degradative capacity of lysosomes is impaired in PD. Specific dysfunction of chaperone-mediated autophagy (CMA) in PD is suggested by reductions in the CMA membrane receptor, lysosomal-associated membrane protein (LAMP) 2A, although whether LAMP2A is the only LAMP2 isoform affected by PD is unknown. Messenger RNA (mRNA) and protein expression of all three LAMP2 isoforms was assessed in brain extracts from regions with and without PD-related increases in -synuclein in autopsy samples from subjects in the early pathological stage of PD (n=9), compared to age- and postmortem delay-matched controls (n=10). In the early stages of PD, mRNA expression of all LAMP2 isoforms was not different from controls, with LAMP2B and LAMP2C protein levels also unchanged in PD. The selective loss of LAMP2A protein directly correlated with the increased levels of -synuclein and decreased levels of the CMA chaperone heat shock cognate protein 70 in the same PD samples, as well as with the accumulation of cytosolic CMA substrate proteins. Our data show that LAMP2 protein isoforms are differentially affected in the early stages of PD, with LAMP2A selectively reduced in association with increased -synuclein, and suggests that dysregulation of CMA-mediated protein degradation occurs before substantial -synuclein aggregation in PD. (c) 2015 International Parkinson and Movement Disorder Society.	[Murphy, Karen E.; Gysbers, Amanda M.; Halliday, Glenda M.] Neurosci Res Australia, Sydney, NSW, Australia; [Murphy, Karen E.; Halliday, Glenda M.] Univ New S Wales, Fac Med, Sch Med Sci, Sydney, NSW, Australia; [Abbott, Sarah K.; Spiro, Adena S.; Garner, Brett] Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [Abbott, Sarah K.; Spiro, Adena S.; Garner, Brett] Univ Wollongong, Fac Sci Med & Hlth, Sch Biol Sci, Wollongong, NSW, Australia; [Furuta, Akiko; Kabuta, Tomohiro] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, Kodaira, Tokyo, Japan; [Cooper, Antony] Garvan Inst Med Res, Sydney, NSW, Australia; [Cooper, Antony] Univ New S Wales, Fac Med, St Vincents Clin Sch, Sydney, NSW, Australia; [Cooper, Antony] Univ New S Wales, Fac Sci, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia	Halliday, GM (reprint author), Neurosci Res Australia, Barker St, Randwick, NSW 2031, Australia.	g.halliday@neura.edu.au	Halliday, Glenda/E-8555-2011	Halliday, Glenda/0000-0003-0422-8398	National Health and Medical Research Council of Australia (NHMRC) [1008307, 1010839]; Ministry of Health, Education, Culture, Sports, Science and Technology, Japan [23590244]; Japan Society for the Promotion of Science [24680038]; University of New South Wales; Rebecca Cooper grant	This work was supported by project grants from the National Health and Medical Research Council of Australia (NHMRC; # 1008307 [to G.M.H. and B.G.] and # 1010839 [to A.A.C.]) and, in part, by a Grant-in-Aid for Scientific Research (C) from the Ministry of Health, Education, Culture, Sports, Science and Technology, Japan (# 23590244; to A.F.), a Grant-in-Aid for Young Scientists (A) from the Japan Society for the Promotion of Science (# 24680038; to T.K.) and a University of New South Wales grant and a Rebecca Cooper grant (to G.M.H.).	Alvarez-Erviti L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.73; Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200; Zhou JX, 2011, ACTA NEUROPATHOL, V121, P695, DOI 10.1007/s00401-011-0815-1; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Mak SK, 2010, J BIOL CHEM, V285, P13621, DOI 10.1074/jbc.M109.074617; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Bandyopadhyay U, 2008, MOL CELL BIOL, V28, P5747, DOI 10.1128/MCB.02070-07; HATEM CL, 1995, J CELL SCI, V108, P2093; Bar-On P, 2008, J NEUROCHEM, V105, P1656, DOI 10.1111/j.1471-4159.2008.05254.x; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Wu GH, 2011, BRAIN RES, V1394, P105, DOI 10.1016/j.brainres.2011.04.013; Dickson DW, 2009, LANCET NEUROL, V8, P1150, DOI 10.1016/S1474-4422(09)70238-8; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; KONECKI DS, 1995, BIOCHEM BIOPH RES CO, V215, P757, DOI 10.1006/bbrc.1995.2528; Furuta K, 1999, ARCH BIOCHEM BIOPHYS, V365, P75, DOI 10.1006/abbi.1999.1147; Koga H, 2011, NEUROBIOL DIS, V43, P29, DOI 10.1016/j.nbd.2010.07.006; GOUGH NR, 1995, DNA CELL BIOL, V14, P863, DOI 10.1089/dna.1995.14.863; Li WM, 2011, CELL MOL LIFE SCI, V68, P749, DOI 10.1007/s00018-010-0565-6; Lue LF, 2012, BRAIN PATHOL, V22, P745, DOI 10.1111/j.1750-3639.2012.00585.x; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Fujiwara Y, 2013, AUTOPHAGY, V9, P403, DOI 10.4161/auto.23002; Huang J, 2012, CLIN BIOCHEM, V45, P1229, DOI 10.1016/j.clinbiochem.2012.06.016; Xilouri M, 2013, BRAIN, V136, P2130, DOI 10.1093/brain/awt131; Cuervo AM, 2003, EMBO J, V22, P47, DOI 10.1093/emboj/cdg002; Kaushik S, 2007, AUTOPHAGY, V3, P387; Chu YP, 2009, NEUROBIOL DIS, V35, P385, DOI 10.1016/j.nbd.2009.05.023; Kiffin R, 2007, J CELL SCI, V120, P782, DOI 10.1242/jcs.001073; Kaushik S, 2006, EMBO J, V25, P3921, DOI 10.1038/sj.emboj.7601283; Gai WP, 2000, EXP NEUROL, V166, P324, DOI 10.1006/exnr.2000.7527; Anguiano J, 2013, NAT CHEM BIOL, V9, P374, DOI 10.1038/nchembio.1230; Alvarez-Erviti L, 2010, ARCH NEUROL-CHICAGO, V67, P1464, DOI [10.1001/archneurol.2010.198, 10.1001/archneuro1.2010.198]; Fujiwara Y, 2013, AUTOPHAGY, V9, P1167, DOI 10.4161/auto.24880; Murphy KE, 2014, BRAIN, V137, P834, DOI 10.1093/brain/awt367; Agarraberes FA, 1997, J CELL BIOL, V137, P825, DOI 10.1083/jcb.137.4.825; Pang SC, 2012, NEUROSCI LETT, V526, P63, DOI 10.1016/j.neulet.2012.07.044; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Yang Q, 2009, SCIENCE, V323, P124, DOI 10.1126/science.1166088; Cuervo AM, 1998, MOL BIOL CELL, V9, P1995; Fantini J, 2011, BBA-BIOMEMBRANES, V1808, P2343, DOI 10.1016/j.bbamem.2011.06.017; Saftig P, 2010, BIOCHEM SOC T, V38, P1420, DOI 10.1042/BST0381420; Dehay B, 2010, J NEUROSCI, V30, P12535, DOI 10.1523/JNEUROSCI.1920-10.2010; Bosco DA, 2006, NAT CHEM BIOL, V2, P249, DOI 10.1038/nchembio782; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Abbott SK, 2013, LIPIDS, V48, P307, DOI 10.1007/s11745-013-3760-z; Crews L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009313; Mijaljica D, 2011, AUTOPHAGY, V7, P673, DOI 10.4161/auto.7.7.14733; Morris J C, 1997, Int Psychogeriatr, V9 Suppl 1, P173, DOI 10.1017/S1041610297004870; Morris JC, 1997, INT PSYCHOGERIATR S, V9, P177; Murphy Karen E, 2013, Acta Neuropathol Commun, V1, P11, DOI 10.1186/2051-5960-1-11; Rodriguez-Navarro JA, 2012, P NATL ACAD SCI USA, V109, pE705, DOI 10.1073/pnas.1113036109; Sala G, 2014, BRAIN RES, V1546, P46, DOI 10.1016/j.brainres.2013.12.017; The National Institute on Aging and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease, 1997, NEUROBIOL AGING S, V18, pS1	54	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0885-3185	1531-8257		MOVEMENT DISORD	Mov. Disord.	OCT	2015	30	12					1639	1647		10.1002/mds.26141		9	Clinical Neurology	Neurosciences & Neurology	CU2GU	WOS:000363342800010		
J	Thanabalasingam, D; Kumar, NS; Jayasinghe, L; Fujimoto, Y				Thanabalasingam, Dharushana; Kumar, N. Savitri; Jayasinghe, Lalith; Fujimoto, Yoshinori			Endophytic Fungus Nigrospora oryzae from a Medicinal plant Coccinia grandis, a High Yielding New Source of Phenazine-1-carboxamide	NATURAL PRODUCT COMMUNICATIONS			English	Article						Coccinia grandis; Endophytic fungi; Nigrospora oryzae; Phenazine-l-carboxylic acid; Phenazine-l-carboxamide		Nigrospora oryzae was isolated as an endophytic fungus from the leaves of Coccinia grandis, a popular medicinal plant used to control diabetes. Fermentation of the fungus in potato dextrose broth and chromatographic purification of the ethyl acetate extracts of the broth and mycelium yielded two phenazine secondary metabolites, which were identified as phenazine-l-carboxylic acid (1) and phenazine-l-carboxamide (2) by comparing their spectral data with those reported in the literature. Compound 2, isolated in high yield (1 g/4 L medium), showed strong antifungal activity against the plant pathogen Cladosporium cladosporioides. This is the first report of the isolation of N. oryzae as an endophytic fungus of C. grandis. These phenazines have never been isolated from any fungal source. Antifungal activity of 2 against C. cladosporioides is reported for the first time.	[Thanabalasingam, Dharushana; Kumar, N. Savitri; Jayasinghe, Lalith; Fujimoto, Yoshinori] Inst Fundamental Studies, Kandy, Sri Lanka; [Fujimoto, Yoshinori] Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, Tokyo 1528551, Japan	Jayasinghe, L (reprint author), Inst Fundamental Studies, Hantana Rd, Kandy, Sri Lanka.	ulbj2003@yahoo.com					MEYER BN, 1982, PLANTA MED, V45, P31, DOI 10.1055/s-2007-971236; Strobel SA, 2007, NAT CHEM BIOL, V3, P356, DOI 10.1038/nchembio0707-356; Pierson LS, 2010, APPL MICROBIOL BIOT, V86, P1659, DOI 10.1007/s00253-010-2509-3; MAZZOLA M, 1992, APPL ENVIRON MICROB, V58, P2616; Kumar RS, 2005, J APPL MICROBIOL, V98, P145, DOI 10.1111/j.1365-2672.2004.02435.x; Tepe B, 2007, FOOD CHEM, V100, P985, DOI 10.1016/j.foodchem.2005.10.062; D'Abrosca B, 2005, PHYTOCHEMISTRY, V66, P2681, DOI 10.1016/j.phytochem.2005.09.011; HOMANS AL, 1970, J CHROMATOGR, V51, P327, DOI 10.1016/S0021-9673(01)96877-3; Strobel GA, 2003, MICROBES INFECT, V5, P535, DOI 10.1016/S1286-4579(03)00073-X; Raio A, 2011, BIOL CONTROL, V58, P133, DOI 10.1016/j.biocontrol.2011.04.012; Bhardwaj A, 2014, WORLD J PHARM PHARM, V3, P228; Jayaweera DMA, 1980, MED PLANTS USED CE 2; Li DL, 2014, REC NAT PROD, V8, P330; Mazumder P. M., 2008, Natural Product Radiance, V7, P15; Rane MR, 2001, J SCI IND RES INDIA, V66, P627; Rathod DP, 2014, AUSTIN J BIOTECHNOLO, V1, P5; Sachin N, 2013, SCI CORRESPONDENCE, V104, P178; Zhao J, 2010, CURRENT RES TECHNOLO, V1, P567	18	0	0	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	OCT	2015	10	10					1659	1660				2	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	CU7JZ	WOS:000363713800008		
J	Bandara, HMSKH; Kumar, NS; Jayasinghe, L; Masubuti, H; Fujimoto, Y				Bandara, H. M. S. K. H.; Kumar, N. Savitri; Jayasinghe, Lalith; Masubuti, Hironori; Fujimoto, Yoshinori			A 3-Vinyl Cephem Derivative, a Useful Intermediate in the Synthesis of Cepham Antibiotics, from Aspergillus awamori Associated with Banana Fruit	NATURAL PRODUCT COMMUNICATIONS			English	Article						3-Vinyl cephem; Aspergillus awamori; Musa acuminata; Fungal metabolites; Cepham antibiotics	METABOLITES; NIGER; NIGRAGILLIN; INHIBITORS	Aspergillus awamori was isolated from a diseased banana fruit, Musa acuminata cv. Ambul. The fungus was fermented in potato dextrose broth and on potato dextrose agar media and the fungal media were extracted with EtOAc. Chromatographic separation of the EtOAc extracts furnished 4-methoxybenzyl 7-phenylacetamido-3-vinyl-3-cephem-4-carboxylate (1), along with three naphtho-gamma-pyrones, flavasperone (2), foncesinone A (3) and aurasperone A (4), and three alkaloids, aspernigrin A (5), pestalamide C (6) and nigragillin (7). Compound 1, a known key intermediate in the chemical synthesis of cepham antibiotics, was isolated from a natural source for the first time. Compound 1 is the first 3-vinyl cephem derivative of microbial origin.	[Bandara, H. M. S. K. H.; Kumar, N. Savitri; Jayasinghe, Lalith; Fujimoto, Yoshinori] Inst Fundamental Studies, Kandy, Sri Lanka; [Masubuti, Hironori; Fujimoto, Yoshinori] Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, Tokyo 1528551, Japan	Jayasinghe, L (reprint author), Inst Fundamental Studies, Hantana Rd, Kandy, Sri Lanka.	ulbj2003@yahoo.com					Aly HA, 2011, FUNGAL DIVERS, V50, P3; Nickavar B, 2008, IRAN J PHARM RES, V7, P297; Siriwardane AMDA, 2015, NAT PROD RES, V29, P1384, DOI 10.1080/14786419.2015.1025230; Chao MY, 2009, ORG PROCESS RES DEV, V13, P924, DOI 10.1021/op900053j; Sakurai M, 2002, J ANTIBIOT, V55, P685; ISOGAI A, 1975, AGR BIOL CHEM TOKYO, V39, P739; Ding G, 2008, J NAT PROD, V71, P1861, DOI 10.1021/np800357g; GHOSAL S, 1979, J AGR FOOD CHEM, V27, P1347, DOI 10.1021/jf60226a018; Lin S, 2014, J FUNCT FOODS, V7, P278, DOI 10.1016/j.jff.2014.02.001; Nielsen KF, 2009, ANAL BIOANAL CHEM, V395, P1225, DOI 10.1007/s00216-009-3081-5; Campos FR, 2005, MAGN RESON CHEM, V43, P962, DOI 10.1002/mrc.1654; Ye YH, 2005, J NAT PROD, V68, P1106, DOI 10.1021/np050059p; Souza SA, 2013, GENET MOL BIOL, V36, P252, DOI 10.1590/S1415-47572013000200016; TAKAO T, 1994, BIOSCI BIOTECH BIOCH, V58, P1780; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Photita W, 2004, FUNGAL DIVERS, V16, P131; HOMANS AL, 1970, J CHROMATOGR, V51, P327, DOI 10.1016/S0021-9673(01)96877-3; HUANG SP, 1992, J ANTIBIOT, V45, P1939; Song YC, 2004, FEMS MICROBIOL LETT, V241, P67, DOI 10.1016/j.femsle.2004.10.005; Herr A, 2014, METAB ENG, V25, P131, DOI 10.1016/j.ymben.2014.07.002; Núñez-Trujillo G., 2013, Journal of Horticulture, Forestry and Biotechnology, V17, P22; Gaurave K., 2012, INT J PHARM PHARM SC, V4, P659; KOYAMA K, 1988, J PHARMACOBIO-DYNAM, V11, P630; Krishnaraju AV, 2005, INT J APPL SCI ENG, V2, P125; Kumar VJ, 2010, PHARM CHEM, V2, P230; Shaaban Mohamed, 2012, Org Med Chem Lett, V2, P6, DOI 10.1186/2191-2858-2-6; TDeG Baratelli, 2011, BIOCHEM SYST ECOL, V41, P119	27	0	0	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	OCT	2015	10	10					1663	1666				4	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	CU7JZ	WOS:000363713800010		
J	Onoda, K; Yamaguchi, S				Onoda, Keiichi; Yamaguchi, Shuhei			Dissociative contributions of the anterior cingulate cortex to apathy and depression: Topological evidence from resting-state functional MRI	NEUROPSYCHOLOGIA			English	Article						Apathy; Depression; Graph theory; Resting state functional MRI; Anterior cingulate cortex; Salience network	CEREBRAL-BLOOD-FLOW; ALZHEIMERS-DISEASE; BASAL GANGLIA; PARKINSONS-DISEASE; POSTSTROKE APATHY; FRONTOTEMPORAL DEMENTIA; NETWORK CONNECTIVITY; HEALTHY-INDIVIDUALS; PREFRONTAL CORTEX; BRAIN PERFUSION	Apathy is defined as a mental state characterized by a lack of goal-directed behavior. However, the underlying mechanisms of apathy remain to be fully understood. Apathy shares certain symptoms with depression and both these affective disorders are known to be associated with dysfunctions of the frontal cortex-basal ganglia circuits. It is expected that clarifying differences in neural mechanisms between the two conditions would lead to an improved understanding of apathy. The present study was designed to investigate whether apathy and depression depend on different network properties of the frontal cortex-basal ganglia circuits, by using resting state fMRI. Resting-state fMRI measurement and neuropsychological testing were conducted on middle-aged and older adults (N=392). Based on graph theory, we estimated nodal efficiency (functional integration), local efficiency (functional segregation), and betweenness centrality. We conducted multiple regression analyses for the network parameters using age, sex, apathy, and depression as predictors. Interestingly, results indicated that the anterior cingulate cortex showed lower nodal efficiency, local efficiency, and betweenness centrality in apathy, whereas in depression, it showed higher nodal efficiency and betweenness centrality. The anterior cingulate cortex constitutes the so-called "salience network", which detects salient experiences. Our results indicate that apathy is characterized by decreased salience-related processing in the anterior cingulate cortex, whereas depression is characterized by increased salience-related processing. (C) 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Onoda, Keiichi; Yamaguchi, Shuhei] Shimane Univ, Dept Neurol, Izumo, Shimane 6938501, Japan	Onoda, K (reprint author), Shimane Univ, Dept Neurol, 89-1 Enya Cho, Izumo, Shimane 6938501, Japan.	onodak1@med.shimane-u.ac.jp			Japan Society for the Promotion of Science [26870375]	This study was supported by Grants-in-Aid for Scientific Research of Japan Society for the Promotion of Science (Grant number: 26870375). None of the authors have any conflict of interest regarding the findings presented in this manuscript.	Hama S, 2007, INT J GERIATR PSYCH, V22, P1046, DOI 10.1002/gps.1866; Guo WB, 2012, PROG NEURO-PSYCHOPH, V37, P153, DOI 10.1016/j.pnpbp.2012.01.011; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63; Ott BR, 1996, J NEUROPSYCH CLIN N, V8, P41; Farb NAS, 2013, CORTEX, V49, P1856, DOI 10.1016/j.cortex.2012.09.008; Knutson KM, 2014, HUM BRAIN MAPP, V35, P943, DOI 10.1002/hbm.22225; Stanton BR, 2013, J NEUROL, V260, P2481, DOI 10.1007/s00415-013-6989-9; Benoit M, 2002, PSYCHIAT RES-NEUROIM, V114, P103, DOI 10.1016/S0925-4927(02)00003-3; Bora E, 2012, PSYCHOL MED, V42, P671, DOI 10.1017/S0033291711001668; Spalletta G, 2013, HUM BRAIN MAPP, V34, P3193, DOI 10.1002/hbm.22137; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Kim JW, 2011, AM J GERIAT PSYCHIAT, V19, P644, DOI 10.1097/JGP.0b013e31820dcc73; Kang JY, 2012, ALZ DIS ASSOC DIS, V26, P217, DOI 10.1097/WAD.0b013e318231e5fc; Benoit M, 2004, INT J GERIATR PSYCH, V19, P864, DOI 10.1002/gps.1163; Harris AL, 2014, TRANSL STROKE RES, V5, P292, DOI 10.1007/s12975-013-0293-y; Hama S, 2011, PSYCHOGERIATRICS, V11, P68, DOI 10.1111/j.1479-8301.2011.00358.x; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5; Massimo L, 2009, DEMENT GERIATR COGN, V27, P96, DOI 10.1159/000194658; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Grool AM, 2014, NEUROLOGY, V82, P1628, DOI 10.1212/WNL.0000000000000378; Tunnard C, 2011, INT J GERIATR PSYCH, V26, P741, DOI 10.1002/gps.2603; Zhu XL, 2012, BIOL PSYCHIAT, V71, P611, DOI 10.1016/j.biopsych.2011.10.035; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Yao ZJ, 2009, J AFFECT DISORDERS, V115, P430, DOI 10.1016/j.jad.2008.10.013; Dubois B, 2000, NEUROLOGY, V55, P1621; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; Lanctot KL, 2007, DEMENT GERIATR COGN, V24, P65, DOI 10.1159/000103633; Wigg CMD, 1999, ARQ NEURO-PSIQUIAT, V57, P547, DOI 10.1590/S0004-282X1999000400002; Ota M, 2012, INT J GERIATR PSYCH, V27, P722, DOI 10.1002/gps.2779; Peters F, 2006, DEMENT GERIATR COGN, V21, P373, DOI 10.1159/000091898; Marshall GA, 2007, ARCH NEUROL-CHICAGO, V64, P1015, DOI 10.1001/archneur.64.7.1015; Starkstein SE, 2006, J NEUROL NEUROSUR PS, V77, P8, DOI 10.1136/jnnp.2005.069575; Ohtani T, 2014, SCHIZOPHR RES, V157, P190, DOI 10.1016/j.schres.2014.05.016; Holthoff VA, 2005, BIOL PSYCHIAT, V57, P412, DOI 10.1016/j.biopsych.2004.11.035; Kostic VS, 2011, J NEUROL SCI, V310, P61, DOI [10.1016/j.jns.2011.05.036, 10.1016/j.jns.2011.08.036]; Caeiro L, 2013, CEREBROVASC DIS, V35, P23, DOI 10.1159/000346076; Delmaire C, 2013, HUM BRAIN MAPP, V34, P2141, DOI 10.1002/hbm.22055; Okada K, 1997, STROKE, V28, P2437; Onoda K, 2011, CEREBROVASC DIS, V31, P6, DOI 10.1159/000319771; Wu QZ, 2011, HUM BRAIN MAPP, V32, P1290, DOI 10.1002/hbm.21108; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Alexopoulos GS, 2013, J AFFECT DISORDERS, V149, P398, DOI 10.1016/j.jad.2012.11.023; de Marco G, 2006, NEUROIMAGE, V30, P1030, DOI 10.1016/j.neuroimage.2005.10.001; PORRINO LJ, 1981, J COMP NEUROL, V198, P121, DOI 10.1002/cne.901980111; Skidmore FM, 2013, NEUROIMAGE, V81, P484, DOI 10.1016/j.neuroimage.2011.07.012; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Paz R, 2013, CURR OPIN NEUROBIOL, V23, P381, DOI [10.1016/j.conb.2013.01.008, 10.1016/j.conb.2013.1.008]; Bruen PD, 2008, BRAIN, V131, P2455, DOI 10.1093/brain/awn151; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; [Anonymous], 1975, J PSYCHIATR RES, DOI DOI 10.1016/0022-3956(75)90026-6; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Adams KB, 2001, GERONTOLOGIST, V41, P768; STARKSTEIN SE, 1992, J NEUROPSYCH CLIN N, V4, P134; Apostolova LG, 2007, DEMENT GERIATR COGN, V24, P91, DOI 10.1159/000103914; Anand A, 2009, PSYCHIAT RES-NEUROIM, V171, P189, DOI 10.1016/j.pscychresns.2008.03.012; Rushworth MFS, 2011, NEURON, V70, P1054, DOI 10.1016/j.neuron.2011.05.014; Kerestes R, 2014, NEUROIMAGE-CLIN, V4, P209, DOI 10.1016/j.nicl.2013.11.009; Ye T, 2012, EUR J RADIOL, V81, P4035, DOI 10.1016/j.ejrad.2011.04.058; Brodaty H, 2010, INT PSYCHOGERIATR, V22, P426, DOI 10.1017/S1041610209991335; Tagariello P, 2009, ARCH GERONTOL GERIAT, V49, P246, DOI 10.1016/j.archger.2008.09.002; Chakravarthy VS, 2010, BIOL CYBERN, V103, P237, DOI 10.1007/s00422-010-0401-y; Kenny ER, 2010, AM J GERIAT PSYCHIAT, V18, P643, DOI 10.1097/JGP.0b013e3181cabd0e; Baggio HC, 2015, MOVEMENT DISORD, V30, P671, DOI 10.1002/mds.26137; BECHTOLDT HP, 1962, PSYCHOL REC, V12, P147; Bohr Iwo Jerzy, 2012, Front Psychiatry, V3, P116, DOI 10.3389/fpsyt.2012.00116; Buckner Randy L, 2013, Dialogues Clin Neurosci, V15, P351; Dutta A, 2014, PSYCHIAT RES-NEUROIM, V224, P139, DOI 10.1016/j.pscychresns.2014.10.003; Horn D. I., 2010, FRONT SYST NEUROSCI, V4, P33, DOI DOI 10.3389/FNSYS.2010.00033; Kamat R, 2014, J CLIN EXP NEUROPSYC, V36, P854, DOI 10.1080/13803395.2014.950636; Kobayashi S, 1987, JPN J NEUROPSYCHOL, V3, P67; Marin R.S., 1991, J NEUROPSYCHIATRY CL, V3, P243; Murakami T., 2012, AM J GERIAT PSYCHIAT, V21, P1; Okada K, 1998, JPN J STROKE, V20, P318; Pennuto M., 2013, PSYCHOL MED, P1; Siegel JS, 2014, NEUROIMAGE-CLIN, V6, P320, DOI 10.1016/j.nicl.2014.09.012; Yang S., 2014, EUR J NEUROL, V22, P341	76	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	OCT	2015	77						10	18		10.1016/j.neuropsychologia.2015.07.030		9	Behavioral Sciences; Neurosciences; Psychology, Experimental	Behavioral Sciences; Neurosciences & Neurology; Psychology	CU8SX	WOS:000363815500002		
J	Miyatani, F; Kuriyama, N; Watanabe, I; Nomura, R; Nakano, K; Matsui, D; Ozaki, E; Koyama, T; Nishigaki, M; Yamamoto, T; Mizuno, T; Tamura, A; Akazawa, K; Takada, A; Takeda, K; Yamada, K; Nakagawa, M; Ihara, M; Kanamura, N; Friedland, RP; Watanabe, Y				Miyatani, F.; Kuriyama, N.; Watanabe, I.; Nomura, R.; Nakano, K.; Matsui, D.; Ozaki, E.; Koyama, T.; Nishigaki, M.; Yamamoto, T.; Mizuno, T.; Tamura, A.; Akazawa, K.; Takada, A.; Takeda, K.; Yamada, K.; Nakagawa, M.; Ihara, M.; Kanamura, N.; Friedland, R. P.; Watanabe, Y.			Relationship between Cnm-positive Streptococcus mutans and cerebral microbleeds in humans	ORAL DISEASES			English	Article						Cnm-positive Streptococcus Mutans; microbleeds; collagen-binding protein; Magnetic Resonance Imaging; stroke intracranial hemorrhage	RISK-FACTORS; HEMORRHAGIC STROKE; ISCHEMIC-STROKE; ROTTERDAM SCAN; ECHO MRI; ASSOCIATION; PREVALENCE; LEUKOARAIOSIS; INFLAMMATION; DYSFUNCTION	OBJECTIVE: Cerebral hemorrhage has been shown to occur in animals experimentally infected with Streptococcus mutans carrying the collagen-binding Cnm gene. However, the relationship between cerebral microbleeds and oral hygiene, with a focus on Cnm gene-positive S. mutans infection, remains unclear. MATERIAL AND METHODS: One hundred and thirty-nine subjects participated. The presence or absence of Cnm-positive S. mutans and its collagen-binding activity were investigated using saliva samples, and relationship with cerebral microbleeds detected on MRI investigated, including clinical information and oral parameters. RESULTS: Fifty-one subjects were identified as Cnm-positive S. mutans carriers (36.7%), with cerebral microbleeds being detected in 43 (30.9%). A significantly larger number of subjects carried Cnm-positive S. mutans in the cerebral microbleeds (+) group. S. mutans with Cnm collagen-binding ability was detected in 39 (28.1%) of all subjects, and the adjusted odds ratio for cerebral microbleeds in the Cnm-positive group was 14.4. Regarding the presence of cerebral microbleeds, no significant differences were noted in the number of remaining teeth, dental caries, or in classic arteriosclerosis risk factors. CONCLUSIONS: The occurrence of cerebral microbleeds was higher in subjects carrying Cnm-positive S. mutans, indicating that the presence of Cnm-positive S. mutans increases cerebral microbleeds, and is an independent risk for the development of cerebrovascular disorders.	[Miyatani, F.; Watanabe, I.; Matsui, D.; Nishigaki, M.; Yamamoto, T.; Kanamura, N.] Kyoto Prefectural Univ Med, Dept Dent Med, Kyoto 6028566, Japan; [Miyatani, F.; Kuriyama, N.; Watanabe, I.; Matsui, D.; Ozaki, E.; Koyama, T.; Watanabe, Y.] Kyoto Prefectural Univ Med, Dept Epidemiol Community Hlth & Med, Kyoto 6028566, Japan; [Nomura, R.; Nakano, K.] Osaka Univ, Grad Sch Dent, Dept Pediat Dent, Osaka, Japan; [Kuriyama, N.; Mizuno, T.; Tamura, A.; Nakagawa, M.] Kyoto Prefectural Univ Med, Dept Neurol, Kyoto, Japan; [Akazawa, K.; Takeda, K.] Kyoto Prefectural Univ Med, Dept Radiol, Kyoto, Japan; [Takada, A.; Takeda, K.] Kyoto Ind Hlth Assoc, Kyoto 6048472, Japan; [Ihara, M.] Natl Cerebral & Cardiovasc Ctr, Dept Stroke & Cerebrovasc Dis, Osaka, Japan; [Friedland, R. P.] Univ Louisville, Dept Neurol, Louisville, KY 40292 USA	Kuriyama, N (reprint author), Kyoto Prefectural Univ Med, Dept Epidemiol Community Hlth & Med, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	nkuriyam@koto.kpu-m.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [221S0001, 14448834];  [17015018];  [23390176]	This study was supported in part by a Grant-in-Aid for Scientific Research on Priority Areas of Cancer (17015018) and on Innovative Areas (221S0001) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, a Grant-in-Aid for Scientific Research (B) (23390176), and Grant-in-Aid for Young Scientists (B) (14448834) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Nomura R, 2009, J MED MICROBIOL, V58, P469, DOI 10.1099/jmm.0.007559-0; Tuttolomondo A, 2012, CURR PHARM DESIGN, V18, P4289; Bokura H, 2011, STROKE, V42, P1867, DOI 10.1161/STROKEAHA.110.601922; Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7; Cheng AL, 2013, STROKE, V44, P2782, DOI 10.1161/STROKEAHA.113.002267; Kato H, 2002, STROKE, V33, P1536, DOI 10.1161/01.STR.0000018012.65108.86; Jeerakathil T, 2004, STROKE, V35, P1831, DOI 10.1161/01.STR.0000131809.35202.1b; Ohshima Y, 2013, J NUTR HEALTH AGING, V17, P456, DOI 10.1007/s12603-012-0419-z; Poels MMF, 2010, STROKE, V41, pS103, DOI 10.1161/STROKEAHA.110.595181; Suzuki K, 2011, CEREBROVASC DIS, V31, P100, DOI 10.1159/000321506; Kim CK, 2012, J NEUROL, V259, P2599, DOI 10.1007/s00415-012-6546-y; Koennecke HC, 2006, NEUROLOGY, V66, P165, DOI 10.1212/01.wnl.0000194266.55694.1e; Gregoire SM, 2012, CEREBROVASC DIS, V33, P430, DOI 10.1159/000336237; SHINTON R, 1989, BRIT MED J, V298, P789; Cordonnier C, 2007, BRAIN, V130, P1988, DOI 10.1093/brain/aw1387; Poels MMF, 2012, NEUROLOGY, V78, P326, DOI 10.1212/WNL.0b013e3182452928; Tanaka A, 1999, STROKE, V30, P1637; Kuriyama N, 2013, ARCH GERONTOL GERIAT, V56, P55, DOI 10.1016/j.archger.2011.11.009; Haacke EM, 2004, MAGNET RESON MED, V52, P612, DOI 10.1002/mrm.20198; Laditka JN, 2014, DISABIL HEALTH J, V7, P472, DOI 10.1016/j.dhjo.2014.06.005; Werring DJ, 2004, BRAIN, V127, P2265, DOI 10.1093/brain/awh253; TANAKA H, 1982, STROKE, V13, P62; Wiseman S, 2014, CEREBROVASC DIS, V37, P64, DOI 10.1159/000356789; Naka H, 2004, AM J NEURORADIOL, V25, P714; Poels MMF, 2011, STROKE, V42, P656, DOI 10.1161/STROKEAHA.110.607184; Nakano K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1491; Shoamanesh A, 2015, NEUROLOGY, V84, P825, DOI 10.1212/WNL.0000000000001279; Yamashiro Kazuo, 2014, Cerebrovasc Dis Extra, V4, P212, DOI 10.1159/000369294; Yates Paul A, 2014, Front Neurol, V4, P205, DOI 10.3389/fneur.2013.00205	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1354-523X	1601-0825		ORAL DIS	Oral Dis.	OCT	2015	21	7					886	893		10.1111/odi.12360		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CU7SO	WOS:000363742000009		
J	Tomizawa, D				Tomizawa, Daisuke			Recent progress in the treatment of infant acute lymphoblastic leukemia	PEDIATRICS INTERNATIONAL			English	Review						acute lymphoblastic leukemia; epigenetics; hematopoietic stem cell transplantation; infant; mixed lineage leukemia	STEM-CELL TRANSPLANTATION; CHILDRENS ONCOLOGY GROUP; MLL GENE REARRANGEMENTS; MINIMAL RESIDUAL DISEASE; HEMATOPOIETIC-CELL; PROGNOSTIC-SIGNIFICANCE; FUSION LEUKEMIA; FLT3 EXPRESSION; JAPAN; RISK	Treatment of infants with acute lymphoblastic leukemia (ALL), especially those with mixed lineage leukemia (MLL) rearrangement (MLL-r), which account for approximately 80% of cases, is still a major challenge for pediatric hematologists and oncologists worldwide. Continuing efforts by collaborative clinical study groups in Europe, North America, and Japan have rescued approximately half of the MLL-r ALL patients with intensive chemotherapy with or without allogeneic hematopoietic stem cell transplantation. Recent progress has clarified the unique mechanism of MLL-r ALL: the aberrant methylation and histone modifications via DOT1L and other related molecules by MLL fusion proteins lead to leukemogenetic gene expression, thus to overt leukemia. In order to overcome this dismal subtype of ALL, novel targeted therapy based on leukemia biology is urgently needed. Due to the extreme rarity of the disease, collaboration between the study groups in Europe (Interfant), North America (Children's Oncology Group), and Japan (Japanese Pediatric Leukemia/Lymphoma Study Group) is under way.	[Tomizawa, Daisuke] Natl Ctr Child Hlth & Dev, Div Leukemia & Lymphoma, Childrens Canc Ctr, Tokyo 1578535, Japan	Tomizawa, D (reprint author), Natl Ctr Child Hlth & Dev, Div Leukemia & Lymphoma, Childrens Canc Ctr, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	tomizawa-d@ncchd.go.jp			Cancer Research from Ministry of Health, Labour, and Welfare of Japan; Clinical Cancer Research	The author acknowledges all the individuals who were involved in infant ALL studies in Japan, especially Drs Eiichi Ishii (Department of Pediatrics, Ehime University Graduate School of Medicine) and Katsuyoshi Koh (Department of Hematology/Oncology, Saitama Children's Medical Center) for their strong leadership. Infant ALL studies in Japan are supported by Grants for Clinical Cancer Research and Grants-in-Aid for Cancer Research from the Ministry of Health, Labour, and Welfare of Japan. The author also acknowledges Dr Julian Tang of the Department of Education for Clinical Research, National Center for Child Health and Development, for critical comments and assistance with the manuscript. The author declares that he has no conflicts of interest.	Daigle SR, 2013, BLOOD, V122, P1017, DOI 10.1182/blood-2013-04-497644; Hilden JM, 2006, BLOOD, V108, P441, DOI 10.1182/blood-2005-07-3011; Imamura T, 2002, BRIT J HAEMATOL, V119, P119, DOI 10.1046/j.1365-2141.2002.03803.x; Van der Velden VHJ, 2009, LEUKEMIA, V23, P1073, DOI 10.1038/leu.2009.17; Dordelmann M, 1999, BLOOD, V94, P1209; Kawashima N, 2013, INT J HEMATOL, V97, P147, DOI 10.1007/s12185-012-1246-z; Mann G, 2010, BLOOD, V116, P2644, DOI 10.1182/blood-2010-03-273532; Kato M, 2015, BRIT J HAEMATOL, V168, P564, DOI 10.1111/bjh.13174; Stam RW, 2005, BLOOD, V106, P2484, DOI 10.1182/blood-2004-09-3667; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Sanders JE, 2005, BLOOD, V105, P3749, DOI 10.1182/blood-2004-08-3312; Stumpel DJPM, 2009, BLOOD, V114, P5490, DOI 10.1182/blood-2009-06-227660; Stam RW, 2007, BLOOD, V110, P2774, DOI 10.1182/blood-2007-05-091934; Brown P, 2005, BLOOD, V105, P812, DOI 10.1182/blood-2004-06-2498; ISHII E, 1991, MED PEDIATR ONCOL, V19, P28, DOI 10.1002/mpo.2950190106; Taki T, 1996, LEUKEMIA, V10, P1303; Andersson AK, 2015, NAT GENET, V47, P330, DOI 10.1038/ng.3230; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Tomizawa D, 2009, PEDIATR BLOOD CANCER, V52, P808, DOI 10.1002/pbc.21975; Dreyer ZE, 2011, J CLIN ONCOL, V29, P214, DOI 10.1200/JCO.2009.26.8938; Kikuchi A, 2009, INT J HEMATOL, V90, P492, DOI 10.1007/s12185-009-0402-6; Stumpel DJPM, 2012, LEUKEMIA, V26, P682, DOI 10.1038/leu.2011.278; Conter V, 2010, BLOOD, V115, P3206, DOI 10.1182/blood-2009-10-248146; Nagayama J, 2006, BLOOD, V107, P4663, DOI 10.1182/blood-2005-11-4728; Lonnerholm G, 2009, PEDIATR BLOOD CANCER, V52, P596, DOI 10.1002/pbc.21925; Spector LG, 2005, CANCER EPIDEM BIOMAR, V14, P651, DOI 10.1158/1055-9965.EPI-04-0602; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Gale KB, 1997, P NATL ACAD SCI USA, V94, P13950, DOI 10.1073/pnas.94.25.13950; Stam RW, 2003, BLOOD, V101, P1270, DOI 10.1182/blood-2002-05-1600; Nishimura S, 1999, INT J HEMATOL, V69, P244; Salzer WL, 2012, PEDIATR BLOOD CANCER, V59, P834, DOI 10.1002/pbc.24132; Tomizawa D, 2007, LEUKEMIA, V21, P2258, DOI 10.1038/sj.leu.2404903; Corker E, 2012, BRIT J HAEMATOL, V159, P104, DOI 10.1111/j.1365-2141.2012.09228.x; Coustan-Smith E, 1998, LANCET, V351, P550, DOI 10.1016/S0140-6736(97)10295-1; Pui CH, 2009, NEW ENGL J MED, V360, P2730, DOI 10.1056/NEJMoa0900386; Horibe K, 2013, INT J HEMATOL, V98, P74, DOI 10.1007/s12185-013-1364-2; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Greaves MF, 2003, BLOOD, V102, P2321, DOI 10.1182/blood-2002-12-3817; Sakaki H, 2009, INT J HEMATOL, V90, P653, DOI 10.1007/s12185-009-0446-7; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Meyer C, 2013, LEUKEMIA, V27, P2165, DOI 10.1038/leu.2013.135; Hunger SP, 2012, J CLIN ONCOL, V30, P1663, DOI 10.1200/JCO.2011.37.8018; Yokoyama A, 2010, CANCER CELL, V17, P198, DOI 10.1016/j.ccr.2009.12.040; Isoyama K, 2002, BRIT J HAEMATOL, V118, P999, DOI 10.1046/j.1365-2141.2002.03754.x; Pieters R, 1998, LEUKEMIA, V12, P1344, DOI 10.1038/sj.leu.2401129; Vora A, 2013, LANCET ONCOL, V14, P199, DOI 10.1016/S1470-2045(12)70600-9; Koh K, 2015, LEUKEMIA, V29, P290, DOI 10.1038/leu.2014.172; Kosaka Y, 2004, BLOOD, V104, P3527, DOI 10.1182/blood-2004-04-1390; Pieters R, 2007, LANCET, V370, P240, DOI 10.1016/S0140-6736(07)61126-X; Pui CH, 2002, LANCET, V359, P1909, DOI 10.1016/S0140-6736(02)08782-2; Stumpel DJPM, 2013, EUR J CANCER, V49, P175, DOI 10.1016/j.ejca.2012.07.013; Aoki Y, 2014, BLOOD, V125, P967; Dreyer ZE, 2015, PEDIATR BLOOD CANCER, V62, P419, DOI 10.1002/pbc.25322; Hoffman Lindsey M, 2014, Front Oncol, V4, P63, DOI 10.3389/fonc.2014.00063; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; De Lorenzo P, 2014, LEUKEMIA, V28, P428, DOI 10.1038/leu.2013.280; Mori M, 2014, PEDIATR INFECT DIS J, V33, P1183, DOI 10.1097/INF.0000000000000392; VansDongen JJ, 1998, LANCET, V352, P1731	59	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					811	819		10.1111/ped.12758		9	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600001		
J	Yokoyama, U				Yokoyama, Utako			Prostaglandin E-mediated molecular mechanisms driving remodeling of the ductus arteriosus	PEDIATRICS INTERNATIONAL			English	Review						arterial intima; ductus arteriosus; prostaglandin E; prostanoid receptor EP4; vascular remodeling	SMOOTH-MUSCLE-CELLS; GESTATIONAL-AGE; EP4 RECEPTOR; IN-VIVO; PROSTANOID RECEPTORS; EXTRACELLULAR-MATRIX; NEOINTIMAL FORMATION; VASCULAR-TONE; FETAL RABBIT; EXPRESSION	The ductus arteriosus (DA), a fetal arterial connection between the pulmonary arteries and aorta, normally closes after birth. Persistent DA patency usually has life-threatening consequences. In certain DA-dependent congenital heart diseases, however, patient survival depends on maintaining DA patency. Complete closure of the DA involves both functional closure, induced by muscle contraction, and anatomical closure, achieved through morphological and molecular remodeling. Anatomical closure of the DA is associated with the formation of intimal thickening, which is characterized by deposition of extracellular matrix in the subendothelial region, sparse elastic fiber formation, and migration of medial smooth muscle cells into the subendothelial space. In addition, fetal molecular remodeling that is suitable for postnatal muscle contraction has been observed in the DA. After the second trimester, high concentration of prostaglandin E-2 (PGE(2)) causes the DA to dilate through the remainder of the fetal period. Emerging evidence from studies using pharmacological approaches and genetically modified mice suggests that, in addition to its vasodilatory effect, this chronic exposure to PGE(2) promotes DA-specific anatomical and molecular remodeling through EP4, one of four receptor subtypes for PGE(2). Signals that are downstream of PGE(2)-EP4, such as cyclic AMP (cAMP)-protein kinase A (PKA), exchange protein activated by cAMP (Epac), phospholipase C, and Wnt/-catenin, may be involved in the regulation of intimal thickening, elastogenesis, and contraction-related genes. Understanding the physiological role of PGE(2) in DA remodeling could enable more effective regulation of PDA, both in isolation and in the context of congenital cardiac anomalies.	[Yokoyama, Utako] Yokohama City Univ, Cardiovasc Res Inst, Yokohama, Kanagawa 2360004, Japan	Yokoyama, U (reprint author), Yokohama City Univ, Cardiovasc Res Inst, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	utako@yokohama-cu.ac.jp			Ministry of Health, Labor and Welfare of Japan; Yokohama Foundation for Advanced Medical Science; Kanae Foundation for the Promotion for Medical Science; Miyata Cardiology Research Promotion Funds; Takeda Science Foundation; Vehicle Racing Commemorative Foundation	The author is grateful to Yoshihiro Ishikawa and Susumu Minamisawa for instruction and support. This work was supported by a Grant-in-Aid for Scientific Research (KAKENHI) from the Ministry of Health, Labor and Welfare of Japan and by grants from Yokohama Foundation for Advanced Medical Science, Kanae Foundation for the Promotion for Medical Science, Miyata Cardiology Research Promotion Funds, Takeda Science Foundation, and Vehicle Racing Commemorative Foundation. The author declares no conflicts of interest.	COCEANI F, 1978, PROSTAGLANDINS, V15, P551, DOI 10.1016/0090-6980(78)90051-5; Huang JH, 2008, J CLIN INVEST, V118, P515, DOI [10.1172/JCI33304, 10.1172/JC133304]; Kurzrok R, 1930, P SOC EXP BIOL MED, V28, P268; Kim C, 2006, EUR J CELL BIOL, V85, P651, DOI 10.1016/j.ejcb.2006.02.004; FRIEDMAN WF, 1976, NEW ENGL J MED, V295, P526, DOI 10.1056/NEJM197609022951003; Jager BV, 1942, AM J PATHOL, V18, P595; Kajimoto H, 2007, CIRCULATION, V115, P1777, DOI 10.1161/CIRCULATIONAHA.106.649566; BUTCHER RW, 1968, J BIOL CHEM, V243, P1713; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; CLYMAN RI, 1978, PROSTAGLANDINS, V16, P259, DOI 10.1016/0090-6980(78)90028-X; CLYMAN RI, 1980, J PEDIATR-US, V97, P455, DOI 10.1016/S0022-3476(80)80205-8; SILVER MM, 1981, HUM PATHOL, V12, P1123; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Leonhardt A, 2003, BRIT J PHARMACOL, V138, P655, DOI 10.1038/sj.bjp.0705092; TODA T, 1980, J ANAT, V131, P25; NAKANISHI T, 1993, CIRC RES, V72, P1218; Wagenseil JE, 2009, PHYSIOL REV, V89, P957, DOI 10.1152/physrev.00041.2008; Goss AM, 2011, DEV BIOL, V356, P541, DOI 10.1016/j.ydbio.2011.06.011; HONDA A, 1993, J BIOL CHEM, V268, P7759; Smith GCS, 1998, PHARMACOL REV, V50, P35; WALSH RS, 1987, SURGERY, V102, P313; TADA T, 1990, ACTA ANAT, V139, P326; Momma K, 2005, PEDIATR RES, V58, P971, DOI 10.1203/01.pdr.0000182182.49476.24; Yokoyama U, 2013, PHARMACOL REV, V65, P1010, DOI 10.1124/pr.112.007195; Momma K, 2009, NEONATOLOGY, V96, P69, DOI 10.1159/000203336; COCEANI F, 1986, CAN J PHYSIOL PHARM, V64, P737; Reeve HL, 2001, J PHYSIOL-LONDON, V533, P253, DOI 10.1111/j.1469-7793.2001.0253b.x; Michelakis E, 2000, LANCET, V356, P134, DOI 10.1016/S0140-6736(00)02452-1; COCEANI F, 1973, CAN J PHYSIOL PHARM, V51, P220; Yokoyama U, 2008, P NATL ACAD SCI USA, V105, P6386, DOI 10.1073/pnas.0801490105; Kajino H, 2004, PEDIATR RES, V56, P586, DOI 10.1203/01.PDR.0000139409.25014.35; Reese J, 2009, PEDIATR RES, V66, P155, DOI 10.1203/PDR.0b013e3181aa07eb; Goldbarg S, 2003, PEDIATR RES, V54, P204, DOI 10.1203/01.PDR.0000072519.61060.E5; TristaniFirouzi M, 1996, J CLIN INVEST, V98, P1959, DOI 10.1172/JCI118999; Bokenkamp R, 2006, PEDIATR RES, V60, P407, DOI 10.1203/01.pdr.0000238243.37116.a6; Yokoyama U, 2008, J BIOL CHEM, V283, P28702, DOI 10.1074/jbc.M804223200; Yokoyama U, 2006, AM J PHYSIOL-HEART C, V290, pH1660, DOI 10.1152/ajpheart.00100.2004; SLOMP J, 1992, ATHEROSCLEROSIS, V93, P25, DOI 10.1016/0021-9150(92)90197-O; Ichikawa Y, 2012, CIRC J, V76, P2456, DOI 10.1253/circj.CJ-12-0215; Yokoyama U, 2014, CIRCULATION, V129, P487, DOI 10.1161/CIRCULATIONAHA.113.004726; Clyman RI, 2001, CIRCULATION, V103, P1806; Slomp J, 1997, ARTERIOSCL THROM VAS, V17, P1003; SMITH GCS, 1994, J PHARMACOL EXP THER, V271, P390; Waleh N, 2004, CIRCULATION, V110, P2326, DOI 10.1161/01.CIR.0000145159.16637.5D; Bouayad A, 2001, SEMIN PERINATOL, V25, P70, DOI 10.1053/sper.2001.23186; DEREEDER EG, 1988, AM J PATHOL, V132, P574; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; Banu SK, 2009, MOL ENDOCRINOL, V23, P1291, DOI 10.1210/me.2009-0017; TADA T, 1985, ACTA PATHOL JAPON, V35, P23; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; BERGSTROM S, 1957, ACTA CHEM SCAND, V11, P1086, DOI 10.3891/acta.chem.scand.11-1086; KIM HS, 1993, CIRCULATION, V88, P1804; Yokoyama U, 2008, AM J PHYSIOL-HEART C, V295, pH1547, DOI 10.1152/ajpheart.01317.2007; Segi E, 1998, BIOCHEM BIOPH RES CO, V246, P7, DOI 10.1006/bbrc.1998.8461; Yokoyama U, 2010, CIRC RES, V106, P1882, DOI 10.1161/CIRCRESAHA.109.214924; Momma K, 2005, PROSTAG OTH LIPID M, V78, P117, DOI 10.1016/j.prostaglandins.2005.04.006; Nguyen MT, 1997, NATURE, V390, P78; Yokoyama Utako, 2010, Journal of Smooth Muscle Research, V46, P77; Yokoyama U, 2006, J CLIN INVEST, V116, P3026, DOI 10.1172/JCI28639; NORTON ME, 1993, NEW ENGL J MED, V329, P1602, DOI 10.1056/NEJM199311253292202; Smith GCS, 2001, J CARDIOVASC PHARM, V37, P697, DOI 10.1097/00005344-200106000-00007; Loftin CD, 2001, P NATL ACAD SCI USA, V98, P1059, DOI 10.1073/pnas.031573498; Gruzdev A, 2012, PROSTAG OTH LIPID M, V97, P109, DOI 10.1016/j.prostaglandins.2012.02.001; Rheinlaender C, 2006, PEDIATR RES, V60, P270, DOI 10.1203/01.pdr.0000233066.28496.7c; ELLIOTT RB, 1975, LANCET, V1, P140; Clyman RI, 2006, BIOL NEONATE, V89, P330, DOI 10.1159/000092870; Long XC, 2007, P NATL ACAD SCI USA, V104, P16570, DOI 10.1073/pnas.0708253104; Hammerman C, 1998, PEDIATRICS, V102, part. no., DOI 10.1542/peds.102.5.e56; Bhattacharya M, 1999, CIRCULATION, V100, P1751; Chen JX, 2012, PEDIATR RES, V72, P122, DOI 10.1038/pr.2012.58; desReeder EG, 1990, ANAT EMBRYOL BERL, V182, P473; desRooij J, 1998, NATURE, V396, P474; GITTENBERGERDEGROOT AC, 1985, J AM COLL CARDIOL, V6, P394; GITTENBERGERDEGROOT AC, 1980, CIRCULATION, V62, P183; GITTENBERGERDEGROOT AC, 1980, J PEDIATR-US, V96, P88, DOI 10.1016/S0022-3476(80)80337-4; GITTENBERGERDEGROOT AC, 1978, BRIT HEART J, V40, P215; GITTENBERGERDEGROOT AC, 1977, BRIT HEART J, V39, P610; Hermes- DeSantis ER, 2006, J PERINATOL S1, V26, pS22; Hermes-DeSantis ER, 2006, J PERINATOL, V26, pS14, DOI 10.1038/sj.jp.7211465; Klapholz-Brown Z, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000945; VAN DORPD, 1964, Biochim Biophys Acta, V90, P204	82	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					820	827		10.1111/ped.12769		8	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600002		
J	Oue, T; Fukuzawa, M; Koshinaga, T; Okita, H; Nozaki, M; Chin, M; Kaneko, Y; Tanaka, Y; Haruta, M; Tsuchiya, K; Kuwajima, S; Takimoto, T				Oue, Takaharu; Fukuzawa, Masahiro; Koshinaga, Tsugumichi; Okita, Hajime; Nozaki, Miwako; Chin, Motoki; Kaneko, Yasuhiko; Tanaka, Yukichi; Haruta, Masayuki; Tsuchiya, Kunihiko; Kuwajima, Shigeko; Takimoto, Tetsuya			Management of pediatric renal tumor: Past and future trials of the Japan Wilms Tumor Study Group	PEDIATRICS INTERNATIONAL			English	Review						prognostic factor; rhabdoid tumor of the kidney; risk classification; treatment; Wilms tumor	HISTOLOGY	The Japan Wilms Tumor Study group (JWiTS) was founded in 1996 to improve outcomes for children with renal tumor in Japan, and a nationwide multicenter cooperative study was initiated thereafter. JWiTS-1 (1996-2005) was analyzed, and JWiTS-2 (2005-2014) is now under analysis; the following problems have been identified and used to decide future study protocol: (i) there has been a decline in survival rate for patients with rhabdoid tumor of the kidney (RTK) and new treatment strategies are required; (ii) the survival rate for bilateral Wilms tumors (BWT) has improved, but results for renal preservation are unsatisfactory; (iii) the prognosis of stage IV favorable nephroblastoma is very good, suggesting that the current protocols provide overtreatment, particularly for patients with lung metastasis; and (iv) no effective biological risk factors exist for predicting the outcome of Wilms tumor, and a study of the genetic changes of these tumors is necessary to determine biological markers for use in risk classification. To solve these issues, the development of a new risk classification of pediatric renal tumors is required. In addition, different study protocols should be developed according to the risk-based classification of the patients. Further, a new study protocol for BWT began in 2015, and new study protocols are being prepared for RTK, and for Wilms tumor with lung metastasis. In addition, an analysis of biological markers with regard to risk classification is to be performed. Furthermore, to create new protocols for patients with rare renal tumors, international collaboration with Children's Oncology Group and International Society of Pediatric Oncology is necessary.	[Oue, Takaharu; Fukuzawa, Masahiro; Koshinaga, Tsugumichi; Okita, Hajime; Nozaki, Miwako; Chin, Motoki; Kaneko, Yasuhiko; Tanaka, Yukichi; Haruta, Masayuki; Tsuchiya, Kunihiko; Kuwajima, Shigeko; Takimoto, Tetsuya] Japan Wilms Tumor Study Grp JWiTS, Tokyo, Japan	Oue, T (reprint author), Hyogo Coll Med, Dept Pediat Surg, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	ta-oue@hyo-med.ac.jp			Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and development, AMED	This research is partially supported by the Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and development, AMED. The authors declare no conflicts of interest.	Yamamoto M, 2006, J PEDIAT HEMATOL ONC, V28, P286, DOI 10.1097/01.mph.0000212901.84146.5a; Shamberger RC, 1999, ANN SURG, V229, P292, DOI 10.1097/00000658-199902000-00019; Watanabe K, 2013, INT J CLIN ONCOL, V18, P955, DOI 10.1007/s10147-013-0616-8; Kinoshita Y, 2012, J PEDIATR SURG, V47, P2205, DOI 10.1016/j.jpedsurg.2012.09.009; Oue T, 2009, PEDIATR SURG INT, V25, P923, DOI 10.1007/s00383-009-2449-0; Ohshima J, 2012, PEDIATR BLOOD CANCER, V59, P499, DOI 10.1002/pbc.24093; Grundy PE, 2012, PEDIATR BLOOD CANCER, V59, P631, DOI 10.1002/pbc.24123; DANGIO GJ, 1976, CANCER, V38, P633, DOI 10.1002/1097-0142(197608)38:2<633::AID-CNCR2820380203>3.0.CO;2-S; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; Grundy PE, 2005, J CLIN ONCOL, V23, P7312, DOI 10.1200/JCO.2005.01.2799; D'Angio GJ, 2007, LIFETIME DATA ANAL, V13, P463, DOI 10.1007/s10985-007-9062-0; Oue T, 2014, PEDIATR BLOOD CANCER, V61, P1184, DOI [10.1002/pbc.24979, 10.1002/pbc.24971]; Dome Jeffrey S, 2014, Am Soc Clin Oncol Educ Book, P215, DOI 10.14694/EdBook_AM.2014.34.215; Grundy Paul, 2005, Curr Probl Cancer, V29, P221; Malempati S, 2012, PEDIAT BLOOD CANC, V15, P5; van den Heuvel-Eibrink MM, 2011, PEDIATR BLOOD CANCER, V56, P733, DOI 10.1002/pbc.22922	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					828	831		10.1111/ped.12787		4	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600003		
J	Tanoue, K; Matsui, K				Tanoue, Koji; Matsui, Kiyoshi			Differences between abusive head trauma and physical abuse in Japan	PEDIATRICS INTERNATIONAL			English	Article						abusive head trauma; child abuse; physical abuse; risk factor	SHAKEN-BABY-SYNDROME; AGE-RELATED INCIDENCE; YOUNG-CHILDREN; CHANGE KNOWLEDGE; CONTROLLED-TRIAL; UNITED-STATES; POPULATION; CHILDHOOD; SHAKING; PARENTS	Background We examined differences in characteristics between abusive head trauma (AHT) and physical abuse (PA). Methods We examined 45 AHT patients and 119 PA patients during the period 1 April 2000-31 March 2014, at Kanagawa Children's Medical Center (Kanagawa, Japan). We compared patient age, young maternal or parental age, being the first child, child factors (chronic illness, developmental disabilities and preterm birth), parental factors (substance abuse/alcohol abuse and depression or other mental illness), environmental factors (single-parent home, non-biologically related man living in the home and family or intimate partner violence). Logistic regression was used to examine predictors of differences between AHT and PA for children <1year of age. Results There were differences in characteristics between AHT and PA in those <1year old in child factors (OR, 3.47; 95%CI: 1.01-11.9) and environmental factors (OR, 14.2; 95%CI: 1.45-139). Conclusions The risk factors for AHT differ from those of PA. We speculate that AHT is not merely physical abuse of young infants; the characteristics of AHT differ significantly from those of PA. These observations are important for understanding and thereby preventing child abuse.	[Tanoue, Koji; Matsui, Kiyoshi] Kanagawa Childrens Med Ctr, Dept Gen Med, Mutsukawa, Kanagawa, Japan	Tanoue, K (reprint author), Kanagawa Childrens Med Ctr, Minami Ku, 2-138-4 Mutsukawa, Yokohama, Kanagawa 2328555, Japan.	ktanoue@kcmc.jp			Kanagawa Prefectural Hospitals Child Health Care and Research Fund	This study was supported by Kanagawa Prefectural Hospitals Child Health Care and Research Fund. The authors declare no conflicts of interest.	KRUGMAN RD, 1993, PEDIATRICS, V92, P872; Flaherty EG, 2010, PEDIATRICS, V126, P833, DOI 10.1542/peds.2010-2087; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Ettaro L, 2004, CHILD ABUSE NEGLECT, V28, P1099, DOI 10.1016/j.chiabu.2004.06.006; Barr RG, 2009, PEDIATRICS, V123, P972, DOI 10.1542/peds.2008-0908; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Reijneveld SA, 2004, LANCET, V364, P1340, DOI 10.1016/S0140-6736(04)17191-2; Barr RG, 2005, J DEV BEHAV PEDIATR, V26, P14; Barr RG, 2009, CAN MED ASSOC J, V180, P727, DOI 10.1503/cmaj.081419; Lee C, 2007, J DEV BEHAV PEDIATR, V28, P288, DOI 10.1097/DBP.0b013e3180327b55; Fujiwara T, 2008, PEDIATRICS, V122, pE841, DOI 10.1542/peds.2008-0387; Brewster AL, 1998, CHILD ABUSE NEGLECT, V22, P91, DOI 10.1016/S0145-2134(97)00132-4; St James-Roberts I, 2006, PEDIATRICS, V117, pE1146, DOI 10.1542/peds.2005-2387; Bechtel K, 2004, PEDIATRICS, V114, P165, DOI 10.1542/peds.114.1.165; SCHMITT BD, 1987, CHILD ABUSE NEGLECT, V11, P421, DOI 10.1016/0145-2134(87)90015-9; Barr RG, 2006, CHILD ABUSE NEGLECT, V30, P7, DOI 10.1016/j.chiabu.2005.06.009; CICCHETTI D, 1995, J AM ACAD CHILD PSY, V34, P541, DOI 10.1097/00004583-199505000-00008; Dias Mark S, 2005, Pediatrics, V115, pe470, DOI 10.1542/peds.2004-1896; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Krugman RD, 1985, PEDIATRICIAN, V12, P68; Niederkrotenthaler T, 2013, CHILD ABUSE NEGLECT, V37, P446, DOI 10.1016/j.chiabu.2013.02.002	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					845	848		10.1111/ped.12632		4	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600006		
J	Liu, JF; Sekine, M; Tatsuse, T; Fujimura, Y; Hamanishi, S; Zheng, XY				Liu, Jufen; Sekine, Michikazu; Tatsuse, Takashi; Fujimura, Yuko; Hamanishi, Shimako; Zheng, Xiaoying			Association among number, order and type of siblings and adolescent mental health at age 12	PEDIATRICS INTERNATIONAL			English	Article						birth cohort; mental health; quality of life; sibling	TOYAMA BIRTH COHORT; QUALITY-OF-LIFE; HIGH-SCHOOL STUDENTS; GENDER-DIFFERENCES; CHILDREN; CHILDHOOD; DEPRESSION; JAPAN; VICTIMIZATION; OVERWEIGHT	Background Although the sibling relationship is a unique one, the effects of the number and type of siblings on mental health among adolescents have not been reported. Methods Japanese children (total, 9276; boys, 4654; girls, 4622), all 12years old, and from the Japanese Toyama Birth Cohort Study, were followed up until 2002. Subject self-reported mental health was obtained from the Japanese version of the Dartmouth Primary Care Co-operative Project (COOP) charts. The associations between number and type of siblings and self-reported mental health were examined. Results There was a significant difference in mental health between different sibling pairs, with brother pairs and brother/sister pairs having a positive effect on adolescent mental health, compared with those in sister pairs. Girls with brothers had better self-reported mental health than those without. The adjusted OR of good mental health was 1.44 (95%CI:1.00-2.08) for those with an older brother and 1.67 (95%CI: 1.17-2.38) for those with a younger brother compared with those without. Boys with a younger sister had a higher OR of good self-reported health than those without (OR,1.62; 95%CI: 1.08-2.43). Conclusions Children with siblings had better mental health status than those without, which has practical implications for Asian countries and worldwide considering the declining fertility.	[Liu, Jufen] Peking Univ, Inst Reprod & Child Hlth, Minist Hlth, Key Lab Reprod Hlth,Dept Epidemiol & Biostat,Sch, Beijing 100871, Peoples R China; [Zheng, Xiaoying] Peking Univ, Inst Populat Res, Beijing 100871, Peoples R China; [Liu, Jufen; Sekine, Michikazu; Tatsuse, Takashi; Fujimura, Yuko; Hamanishi, Shimako] Toyama Univ, Dept Epidemiol & Hlth Policy, Grad Sch Med & Pharmaceut Sci, Toyama 9300194, Japan	Sekine, M (reprint author), Toyama Univ, Dept Epidemiol & Hlth Policy, Grad Sch Med & Pharmaceut Sci, 2630 Sugitani, Toyama 9300194, Japan.	sekine@med.u-toyama.ac.jp			Nishiyama Takahito Fund of University of Toyama; National Natural Science Foundation of China [81202265]; Ministry of Health and Welfare [H10-Child-020]; Ministry of Health, Labour and Welfare [H13-Health-022]; Toyama Medical Association; Japan Heart Foundation	We thank all the children and their parents who participated in this study. We are indebted to the principals and school nurses in Toyama Prefecture for their help and cooperation in the study. We also acknowledge the contribution of Ms Yasuko Yamazaki for data collection and general management of this study. This work was supported in part by Nishiyama Takahito Fund of University of Toyama and the National Natural Science Foundation of China (grant no. 81202265). The Toyama birth cohort study has been supported by grants from the Ministry of Health and Welfare (H10-Child-020), the Ministry of Health, Labour and Welfare (H13-Health-022), Toyama Medical Association, and the Japan Heart Foundation. We authors declare no conflicts of interest.	Tucker CJ, 2001, J FAM PSYCHOL, V15, P254, DOI 10.1037//0893-3200.15.2.254; Lindhout IE, 2003, J ANXIETY DISORD, V17, P593, DOI 10.1016/S0887-6185(02)00230-X; Piccinelli M, 2000, BRIT J PSYCHIAT, V177, P486, DOI 10.1192/bjp.177.6.486; Chen X, 2005, CHILD CARE HLTH DEV, V31, P433, DOI 10.1111/j.1365-2214.2005.00529.x; Buist KL, 2013, CLIN PSYCHOL REV, V33, P97, DOI 10.1016/j.cpr.2012.10.007; McGuinness TM, 2012, J PSYCHOSOC NURS MEN, V50, P17, DOI 10.3928/02793695-20120508-05; Bearman SK, 2008, J ABNORM CHILD PSYCH, V36, P1251, DOI 10.1007/s10802-008-9248-2; Noller P, 2005, PERS RELATIONSHIP, V12, P1, DOI 10.1111/j.1350-4126.2005.00099.x; Chen XL, 2003, J EPIDEMIOL, V13, P278; Chen XL, 2005, PREV MED, V40, P668, DOI 10.1016/j.ypmed.2004.09.034; Fagan AA, 2003, J ADOLESCENCE, V26, P547, DOI 10.1016/S0140-1971(03)00055-1; Karmaus W, 2002, J EPIDEMIOL COMMUN H, V56, P209, DOI 10.1136/jech.56.3.209; Wang HB, 2008, QUAL LIFE RES, V17, P257, DOI 10.1007/s11136-007-9301-6; Afifi M., 2007, SMJ Singapore Medical Journal, V48, P385; Tucker CJ, 2014, CHILD ABUSE NEGLECT, V38, P1599, DOI 10.1016/j.chiabu.2014.05.007; Wang HB, 2007, PREV MED, V44, P45, DOI 10.1016/j.ypmed.2006.07.015; Silberg J, 1999, ARCH GEN PSYCHIAT, V56, P225, DOI 10.1001/archpsyc.56.3.225; Hankin BL, 1999, ANN MED, V31, P372, DOI 10.3109/07853899908998794; Imaizumi Y, 2011, TWIN RES HUM GENET, V14, P179, DOI 10.1375/twin.14.2.179; MEREDITH WH, 1992, J PSYCHOL, V126, P411; Gass K, 2007, J CHILD PSYCHOL PSYC, V48, P167, DOI 10.1111/j.1469-7610.2006.01699.x; Feinberg ME, 2012, CLIN CHILD FAM PSYCH, V15, P43, DOI 10.1007/s10567-011-0104-5; BUHRMESTER D, 1990, CHILD DEV, V61, P1387, DOI 10.1111/j.1467-8624.1990.tb02869.x; [Anonymous], 2009, SURV POP SOC SEC; Steinberg L, 2007, DEV PSYCHOL, V43, P1531, DOI 10.1037/0012-1649.43.6.1531; Bogolyubova O, 2015, J INTERPERS VIOLENCE, V30, P1153, DOI 10.1177/0886260514539849; Lim Jae Woo, 2011, Korean J Pediatr, V54, P429, DOI 10.3345/kjp.2011.54.11.429; Ochiai H, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-766; Sekine Michikazu, 2002, J Epidemiol, V12, P33; Yi Siyan, 2012, Asian J Psychiatr, V5, P132, DOI 10.1016/j.ajp.2012.04.002	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					849	855		10.1111/ped.12629		7	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600007		
J	Naito, M; Aoki, S; Kamide, A; Miyamura, K; Honda, M; Nagai, A; Mezawa, H; Hashimoto, K				Naito, Makiko; Aoki, Sayaka; Kamide, Anri; Miyamura, Kohei; Honda, Manami; Nagai, Akira; Mezawa, Hidetoshi; Hashimoto, Keiji			Gait analysis in Down syndrome pediatric patients using a sheet-type gait analyzer: Pilot study	PEDIATRICS INTERNATIONAL			English	Article						Down syndrome; flat feet; gait analysis; gait development	CHILDREN	Background Children with Down syndrome (DS), who are likely to suffer from a large number of muscloskeletal problems, tend to have a unique pattern of walking in clinical settings. Despite such apparent uniqueness, few studies have empirically investigated gait development pattern in DS children, especially at an earlier age. We therefore conducted gait analysis in young DS children who are prescribed insoles, to explore how their gait patterns develop, using the gait parameters identified by Sutherland et al. as determinants of gait maturity of typical children. Methods Participants consisted of 63 DS children (31 boys) aged 1-6 years (mean, 4years 1month) with a diagnosis of flat feet who were prescribed orthotic insoles. A 2.4m sheet-type gait analyzer was used to analyze gait pattern. We measured the following variables: walking velocity (cm/min), cadence (steps/min), step length (cm), and single-limb stance phase ratio (%), and examined their relationship with age on regression analysis. Results Walking velocity and step length were significantly and positively related to age. Cadence was also significantly, but negatively associated with age. In contrast, SLS phase ratio did not have a statistically significant relationship with age. Conclusion Down syndrome children have unique gait development patterns. Although walking velocity, cadence, and step length were found to develop with age, as in typical children, SLS phase ratio did not change with age in DS children. Further studies with a larger sample are necessary to replicate these findings.	[Naito, Makiko; Aoki, Sayaka; Kamide, Anri; Miyamura, Kohei; Honda, Manami; Mezawa, Hidetoshi; Hashimoto, Keiji] Natl Ctr Child Hlth & Dev, Div Rehabil Med, Tokyo 1578535, Japan; [Naito, Makiko; Aoki, Sayaka; Kamide, Anri; Miyamura, Kohei; Honda, Manami; Mezawa, Hidetoshi; Hashimoto, Keiji] Natl Ctr Child Hlth & Dev, Dev Evaluat Ctr, Tokyo 1578535, Japan; [Naito, Makiko; Nagai, Akira] Natl Ctr Child Hlth & Dev, Div Gen Pediat & Interdisciplinary Med, Tokyo 1578535, Japan; [Aoki, Sayaka; Mezawa, Hidetoshi] Natl Ctr Child Hlth & Dev, Div Allergy, Tokyo 1578535, Japan; [Honda, Manami] Nico Childrens Clin, Tokyo, Japan	Naito, M (reprint author), Natl Ctr Child Hlth & Dev, Div Gen Pediat & Interdisciplinary Med, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	m.aiba0520@gmail.com					Hausdorff JM, 1999, J APPL PHYSIOL, V86, P1040; BECK RJ, 1981, J BONE JOINT SURG AM, V63, P1452; Presson AP, 2013, J PEDIATR-US, V163, P1163, DOI 10.1016/j.jpeds.2013.06.013; SUTHERLAND DH, 1980, J BONE JOINT SURG AM, V62, P336; Merrick J, 2000, J PEDIATR ORTHOP B, V9, P185; [Anonymous], 1996, GAIT POSTURE, DOI 10.1016/0966-6362(95)01057-2; Diamond L., 1992, SYNDROME ADV MED CAR, P111; Kanbayashi H, 1988, B SPEC ED, V13, P9; Tawada S., 2011, J CLIN REHABIL, V20, P529; Yamamoto T, 2006, J JPN PEDIAT ORTHOP, V15, P252	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					860	863		10.1111/ped.12691		4	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600009		
J	Isojima, T; Kushima, R; Goishi, K; Tsuchida, S; Watanabe, T; Takahashi, N; Kitanaka, S				Isojima, Tsuyoshi; Kushima, Reiko; Goishi, Keiji; Tsuchida, Shinya; Watanabe, Toyoko; Takahashi, Naoto; Kitanaka, Sachiko			Mineral status of premature infants in early life and linear growth at age 3	PEDIATRICS INTERNATIONAL			English	Article						metabolic bone disease of prematurity; mineral supplementation; short stature; very low-birthweight infant	METABOLIC BONE-DISEASE; BIRTH-WEIGHT INFANTS; PRETERM INFANTS; ALKALINE-PHOSPHATASE; INORGANIC-PHOSPHATE; CATCH-UP; CHILDHOOD; RICKETS; FAILURE; HEALTH	Background Preterm infants are at significant risk of reduced bone mineral content and subsequent bone disease (metabolic bone disease of prematurity, MBDP). MBDP is frequently found in very low-birthweight (VLBW) infants, but long-term height prognosis is not well known. Methods VLBW infants from two major neonatal intensive care units were studied. Medical records were reviewed. A total of 143 subjects were analyzed after excluding subjects who died, or who had severe complications that could affect linear growth, Silver-Russell syndrome, severe cholestasis, and/or chromosomal abnormality. The relationship between MBDP and height at age 3 was investigated. Results Height standard deviation score (SDS) at age 3 negatively correlated with peak serum alkaline phosphatase (ALP) activity in early life (r=-0.30, P=0.0003) and positively correlated with serum phosphorus (P) at peak ALP (r=0.33, P=0.0002). In addition, serum P independently affected height SDS at 3 years of age (=0.19, P=0.018), and was significantly different between infants with and without catch-up growth in height (difference: 0.23mmol/L, 95%CI: 0.09-0.36, P=0.0010). Conclusions MBDP, particularly hypophosphatemia in the early period of life, is associated with linear growth until 3 years of age in VLBW infants.	[Isojima, Tsuyoshi; Goishi, Keiji; Tsuchida, Shinya; Takahashi, Naoto; Kitanaka, Sachiko] Univ Tokyo, Grad Sch Med, Dept Pediat, Bunkyo Ku, Tokyo 1138655, Japan; [Kushima, Reiko; Tsuchida, Shinya; Watanabe, Toyoko] Tokyo Metropolitan Bokutoh Hosp, Dept Neonatol, Sumida Ku, Tokyo, Japan	Kitanaka, S (reprint author), Univ Tokyo, Grad Sch Med, Dept Pediat, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	sachi-tky@umin.ac.jp					Backstrom MC, 2000, ACTA PAEDIATR, V89, P867, DOI 10.1080/080352500750043792; Cooke RWI, 2004, ARCH DIS CHILD, V89, P201, DOI 10.1136/adc.2003.030197; MCINTOSH N, 1986, LANCET, V2, P981; Rigo J, 2000, CLIN PERINATOL, V27, P147, DOI 10.1016/S0095-5108(05)70011-7; Ericson A, 1998, ARCH DIS CHILD, V78, pF171; KOO WWK, 1989, J PEDIATR ORTHOPED, V9, P326; BISHOP N, 1989, ARCH DIS CHILD, V64, P1403; Kimata M, 2010, BONE, V47, P938, DOI 10.1016/j.bone.2010.08.006; Morley R, 2006, J CLIN ENDOCR METAB, V91, P906, DOI 10.1210/jc.2005-1479; Fewtrell MS, 2009, BONE, V45, P142, DOI 10.1016/j.bone.2009.03.657; Senterre T, 2012, ACTA PAEDIATR, V101, pE64, DOI 10.1111/j.1651-2227.2011.02443.x; LUCAS A, 1989, ARCH DIS CHILD, V64, P902; Visser F, 2012, ACTA PAEDIATR, V101, P562, DOI 10.1111/j.1651-2227.2012.02626.x; Monset-Couchard M, 2000, BIOL NEONATE, V78, P161, DOI 10.1159/000014265; Masumoto K, 2008, PEDIATR RES, V63, P686, DOI 10.1203/PDR.0b013e31816c8fcc; Huysman WA, 2003, ARCH DIS CHILD, V88, P46; Fewtrell MS, 2000, J PEDIATR-US, V137, P668, DOI 10.1067/mpd.2000.108953; Viswanathan S, 2014, JPEN-PARENTER ENTER, V38, P982, DOI 10.1177/0148607113499590; Dusick AM, 2003, SEMIN PERINATOL, V27, P302, DOI 10.1016/S0146-0005(03)00044-2; Rigo J, 2007, ACTA PAEDIATR, V96, P969, DOI 10.1111/j.1651-2227.2007.00336.x; Harrison CM, 2008, ACTA PAEDIATR, V97, P407, DOI 10.1111/j.1651-2227.2007.00721.x; Chan GM, 2008, J PERINATOL, V28, P619, DOI 10.1038/jp.2008.59; SPARKS JW, 1984, SEMIN PERINATOL, V8, P74; Bonsante F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072880; Fewtrell MS, 2011, AM J CLIN NUTR, V94, p1870S, DOI 10.3945/ajcn.110.000844; Forsen T, 1999, BRIT MED J, V319, P1403; Hack M, 2003, PEDIATRICS, V112, pE30, DOI 10.1542/peds.112.1.e30; Hovi P, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000135; Itabashi K, 2010, JPN J PEDIAT, V117, P1771; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Paneth N., 2012, AVERYS DIS NEWBORN, P1; Tanaka T, 2011, J JPN ASS HUM AUXOL, V17, P84; Yamadate S., 2005, RINSHOKAGAKU, V34, P6	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					864	869		10.1111/ped.12657		6	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600010		
J	Sakazume, S; Kido, Y; Murakami, N; Matsubara, T; Numabe, H				Sakazume, Satoru; Kido, Yasuhiro; Murakami, Nobuyuki; Matsubara, Tomoyo; Numabe, Hironao			Additional patients with 4q deletion: Severe growth delay and polycystic kidney disease associated with 4q21q22 loss	PEDIATRICS INTERNATIONAL			English	Article						4q21q22 deletion; developmental delay; growth delay; polycystic kidney disease	LONG ARM; MICRODELETION; CHROMOSOME-4; RETARDATION	BackgroundTo the best of our knowledge, this is the third report concerning 4q21q22 deletions. In this report, we describe the cases of two girls with 4q deletion and polycystic kidney disease. G-banding confirmed the deletion in one patient but not in the other. MethodsWe describe the cases of two girls with 4q deletion and polycystic kidney disease. Chromosomal deletions were mapped to 4q21-22. One patient had a simple 4q contiguous gene deletion, whereas the other patient had a complicated chromosomal rearrangement. In patient 1, a smaller part of the 4q deletion was translocated to the 3p region. ResultsFifty-four genes and 72 genes were deleted in patients 1 and 2, respectively. In both patients, 52 genes were consistently deleted. ConclusionThe present two patients had a similar phenotype, including severe growth and developmental retardation, and a characteristic facial appearance. The loss of RPKG2 and RASGEF1B causes severe growth defect. PKD2 loss causes kidney cysts.	[Sakazume, Satoru; Kido, Yasuhiro; Murakami, Nobuyuki; Matsubara, Tomoyo] Dokkyo Med Univ, Koshigaya Hosp, Dept Pediat, Saitama, Japan; [Numabe, Hironao] Ochanomizu Univ, Grad Sch Human Genet & Sci, Dept Genet Counseling, Tokyo 112, Japan	Sakazume, S (reprint author), Haramachi Red Cross Hosp, Dept Pediat, 698 Higasi Agatsuma, Agatsuma Dist, Gunma 3770822, Japan.	saka377@gmail.com			Dokkyo Medical University, Investigator-Initiated Research Grant, Japan [2012-01-6]; JSPS KAKENHI [24 591 524]; Japan Foundation for Pediatric Research	This research was partially supported by a Dokkyo Medical University, Investigator-Initiated Research Grant (No.2012-01-6), Japan. This research was supported by JSPS KAKENHI 24 591 524, Grant-in-Aid for Scientific Research (C), and the Japan Foundation for Pediatric Research. The authors declare no conflicts of interest.	Harada N, 2002, CLIN GENET, V61, P226, DOI 10.1034/j.1399-0004.2002.610311.x; Bhoj E, 2013, AM J MED GENET A, V161, P2327, DOI 10.1002/ajmg.a.36061; MCDERMOTT A, 1980, HUM GENET, V53, P305; MITCHELL JA, 1981, AM J MED GENET, V8, P73, DOI 10.1002/ajmg.1320080110; Bonnet C, 2010, J MED GENET, V47, P377, DOI 10.1136/jmg.2009.071902	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					880	883		10.1111/ped.12742		4	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600013		
J	Kakuya, F; Kinebuchi, T; Fujiyasu, H; Tanaka, R; Okubo, H; Kano, H				Kakuya, Fujio; Kinebuchi, Takahiro; Fujiyasu, Hiroaki; Tanaka, Ryosuke; Okubo, Hitoshi; Kano, Hiroki			Clinical findings in 10 children with H275Y influenza A(H1N1)pdm09 virus infection	PEDIATRICS INTERNATIONAL			English	Article						antiviral resistance; clinical effectiveness; H275Y substitution; influenza A(H1N1)pdm09; neuraminidase inhibitor	OSELTAMIVIR-RESISTANT; NEURAMINIDASE MUTATION; COMMUNITY CLUSTER; JAPAN; PERAMIVIR; FITNESS	BackgroundLittle is known about the clinical effectiveness of neuraminidase inhibitors against H275Y influenza A(H1N1)pdm09 virus. A cluster of H275Y influenza A(H1N1)pdm09 virus with cross-resistance to oseltamivir and peramivir was detected among untreated community patients in Hokkaido, Japan, during the 2013-2014 influenza season. MethodsThis was a retrospective observational study. Specimens from nasopharyngeal swabs underwent rapid testing and single-nucleotide polymorphism identification on real-time polymerase chain reaction. We collected clinical data from the H275Y group and a 275H wild-type comparison group. All children were given one of four neuraminidase inhibitors. ResultsTwenty-eight children infected with influenza A(H1N1)pdm09 virus were analyzed. Ten viruses had the H275Y substitution, while the other 18 had wild-type 275H. Mean fever duration after treatment and after onset was 25.3h (95%CI: 14.1-36.5) and 48.9h (95%CI: 34.4-63.3) in the H275Y group, respectively, and 26.1h (95%CI: 18.7-33.6) and 46.3h (95%CI: 35.7-56.8) in the 275H group, respectively. In the H275Y group, three patients were treated with oseltamivir, one with peramivir, five with zanamivir, and one with laninamivir. All of them had mild symptoms and received only outpatient care. Fever duration was 7.5-21.0h and 18.0-66.0h after treatment and after onset, respectively, in the patients treated with oseltamivir and peramivir, and 20.5-42.0h and 42.0-88.0h, respectively, in those treated with zanamivir and laninamivir. ConclusionFever in the H275Y children treated with oseltamivir and peramivir resolved rapidly during the 2013-2014 influenza season.	[Kakuya, Fujio; Fujiyasu, Hiroaki; Tanaka, Ryosuke; Okubo, Hitoshi] Furano Kyokai Hosp, Dept Pediat, Furano, Hokkaido 0768765, Japan; [Kinebuchi, Takahiro; Kano, Hiroki] Furano Kyokai Hosp, Clin Lab, Furano, Hokkaido 0768765, Japan	Kakuya, F (reprint author), Furano Kyokai Hosp, Dept Pediat, 1-30 Sumiyoshi Cho, Furano, Hokkaido 0768765, Japan.	f768fk@furano.ne.jp					Hurt AC, 2012, J INFECT DIS, V206, P148, DOI 10.1093/infdis/jis337; Brookes DW, 2011, J ANTIMICROB CHEMOTH, V66, P466, DOI 10.1093/jac/dkq486; Kawai N, 2009, CLIN INFECT DIS, V49, P1828, DOI 10.1086/648424; Nakauchi M, 2011, J MED VIROL, V83, P1121, DOI 10.1002/jmv.22101; Boivin G, 2013, INFLUENZA OTHER RESP, V7, P18, DOI 10.1111/irv.12176; Okomo-Adhiambo M, 2010, VIRUSES-BASEL, V2, P2269, DOI 10.3390/v2102269; Takashita E, 2013, INFLUENZA OTHER RESP, V7, P1390, DOI 10.1111/irv.12132; Pinilla LT, 2012, J VIROL, V86, P10651, DOI 10.1128/JVI.07244-11; Baranovich T, 2010, J CLIN VIROL, V47, P23, DOI 10.1016/j.jcv.2009.11.003; Sugaya N, 2010, ANTIMICROB AGENTS CH, V54, P2575, DOI 10.1128/AAC.01755-09; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Saito R, 2010, PEDIATR INFECT DIS J, V29, P898, DOI 10.1097/INF.0b013e3181de9d24; Abed Y, 2012, ANTIMICROB AGENTS CH, V56, P4375, DOI 10.1128/AAC.00753-12; Chugai Pharmaceutical, 2013, TAM OS PHOSPH PACK I; Duan SS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001022; Hurt AC, 2011, EUROSURVEILLANCE, V16, P24; National Institute of Infectious Diseases Japan, ANT AG RES INFL VIR; National Institute of Infectious Diseases Japan, INFECT AGENTS SURVEI; Shionogi, 2013, RAP PER HYDR PACK IN; Takashita E, 2014, EUROSURVEILLANCE, V19, P4, DOI 10.2807/1560-7917.ES2014.19.1.20666	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					888	892		10.1111/ped.12658		5	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600015		
J	Tsuchiya, S; Ohashi, K				Tsuchiya, Sayaka; Ohashi, Kazutomo			Childbirth expense support and small-for-gestational-age infants in Japan	PEDIATRICS INTERNATIONAL			English	Article						birthweight; low birthweight; poverty; small for gestational age; socioeconomic factor	BIRTH-WEIGHT; SOCIOECONOMIC-STATUS; FETAL-GROWTH; HEALTH; METAANALYSIS; PREGNANCY; OUTCOMES; RISK; INEQUALITIES; TRENDS	BackgroundPoor nutritional status during the fetal period could cause perinatal and lifelong health disadvantages in neonates. The aim of this study was to investigate the background of pregnant women receiving childbirth expense support (CES), pregnancy outcome, and neonatal anthropometric data. MethodsA retrospective cohort study was conducted using 823 antenatal and delivery records in a perinatal center located in one of the poorest areas in Japan. Neonates who were small for gestational age (SGA) were compared between the CES and the non-CES groups. ResultsThe incidences of low birthweight (LBW) and SGA were significantly higher in the group receiving CES (14.6% and 14.6%, respectively). The adjusted OR of CES was 2.78 (95%CI: 1.32-5.87) and the adjusted OR of maternal smoking was 5.03 (95%CI: 2.74-9.21), indicating that CES and maternal smoking were directly associated with SGA. ConclusionsCES recipients had a higher prevalence of SGA infants. CES was independently associated with SGA. Previous studies have shown that smoking is a major risk factor for SGA. Further studies are needed to identify risk factors of SGA specific to CES recipients.	[Tsuchiya, Sayaka; Ohashi, Kazutomo] Osaka Univ, Grad Sch Med, Div Hlth Sci, Suita, Osaka 5650871, Japan	Ohashi, K (reprint author), Osaka Univ, Grad Sch Med, Div Hlth Sci, 1-7 Yamadaoka, Suita, Osaka 5650871, Japan.	ohashi@sahs.med.osaka-u.ac.jp			Fumiko Yamaji Trust for Academic Nursing Education and Research, Tokyo, Japan	We thank all the subjects and staff at the center. We also thank Dr Haruyasu Fujita for his support with the statistical analysis. This study was supported by Fumiko Yamaji Trust for Academic Nursing Education and Research, Tokyo, Japan.	Lee BJ, 2010, CHILD YOUTH SERV REV, V32, P1670, DOI 10.1016/j.childyouth.2010.07.009; Dashe JS, 2000, OBSTET GYNECOL, V96, P321, DOI 10.1016/S0029-7844(00)00943-1; Zhang J, 2010, AM J OBSTET GYNECOL, V202, P522, DOI 10.1016/j.ajog.2009.10.889; Mu M, 2012, ARCH CARDIOVASC DIS, V105, P99, DOI 10.1016/j.acvd.2011.10.006; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)71146-6; Harder T, 2007, AM J EPIDEMIOL, V165, P849, DOI 10.1093/aje/kwk071; Teramoto S, 2006, PEDIATR INT, V48, P274, DOI 10.1111/j.1442-200X.2006.02203.x; Barker DJP, 2006, CLIN OBSTET GYNECOL, V49, P270, DOI 10.1097/00003081-200606000-00009; Tsukamoto H, 2007, PEDIATR INT, V49, P985, DOI 10.1111/j.1442-200X.2007.02494.x; Moser K, 2003, J EPIDEMIOL COMMUN H, V57, P687, DOI 10.1136/jech.57.9.687; Colman GJ, 2003, AM J PREV MED, V24, P29, DOI 10.1016/S0749-3797(02)00574-3; Kramer MS, 2000, PAEDIATR PERINAT EP, V14, P194, DOI 10.1046/j.1365-3016.2000.00266.x; Leonardi-Bee J, 2008, ARCH DIS CHILD-FETAL, V93, pF351, DOI 10.1136/adc.2007.133553; Fujiwara T, 2013, AM J EPIDEMIOL, V177, P1042, DOI 10.1093/aje/kws355; Berg G, 2012, PLOS ONE, V7; Japan Society of Obstetrics and Gynecology and Japan Association of Obstetricians and Gynecologists, 2014, GUID OBST PRACT JAP; Joseph KS, 2007, CAN MED ASSOC J, V177, P583, DOI 10.1503/cmaj.061198; Kawachi I, 2002, HLTH NATIONS WHY INE; Kohara M, 2010, JPN J LABOUR STUD, V595, P15; Kurazawa K, 2010, J JPN SOC PERINAT NE, V46, P1091; Ministry of Health Labour and Welfare Japan, 2010, VIT STAT; Ministry of Health Labour and Welfare Japan, FRAUD PUBL ASS JAP; Ministry of Health Labour and Welfare Japan, IMP RES TAX; Ministry of Health Labour and Welfare Japan, 2014, NAT HLTH NUTR SURV; OECD, 2013, CRIS SQUEEZ INC PUTS; Ogawa Y, 1998, ACTA NEONAT JPN, V34, P624; Raisanen S, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-28; Statistics Bureau Ministry of Internal Affairs and Communications Japan, 2012, STAT BUR ANN REP LAB; Weightman AL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000964; Wilkinson R., 2003, SOCIAL DETERMINANTS; Wilkinson R. G., 1996, UNHEALTHY SOC AFFLIC	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					897	901		10.1111/ped.12633		5	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600017		
J	Shirasu, A; Ashida, A; Matsumura, H; Nakakura, H; Tamai, H				Shirasu, Akihiko; Ashida, Akira; Matsumura, Hideki; Nakakura, Hyogo; Tamai, Hiroshi			Clinical characteristics of rotavirus gastroenteritis with urinary crystals	PEDIATRICS INTERNATIONAL			English	Article						ammonium acid urate stone; rotavirus gastroenteritis; uric acid crystal	RENAL-FAILURE; CHILDREN; ACIDOSIS; INFANTS	BackgroundRotavirus gastroenteritis is severe and often results in dehydration and pre-renal azotemia. In addition, some patients with acute obstructive uropathy due to ammonium acid urate stones, developing approximately 6-7 days after the onset of rotavirus gastroenteritis, have been reported, mainly in Japan. The pathophysiological mechanism responsible for stone formation has not been clarified. In the present study, we investigated the clinical characteristics of these patients, and analyzed the pathophysiology underlying the formation of urinary stones. MethodsA total of 164 patients were enrolled. All had acute gastroenteritis due to rotavirus infection and were treated at Osaka Medical College Hospital and affiliated hospitals between January 2009 and May 2011. All were younger than 15 years of age, and their laboratory data, including urinalysis, were available. ResultsAmong the enrolled patients, 30 (20 boys and 10 girls aged 0.2-10 years; median, 1.5 years; interquartile range, 1-3 years) had crystals in their urine. Most of the patients were admitted approximately 2 days after onset of gastroenteritis and had hyperuricemia and aciduria. The crystals consisted mainly of uric acid, and rarely of ammonium acid urate. ConclusionIn order for ammonium acid urate stones to form in patients with acute obstructive uropathy associated with rotavirus gastroenteritis, prolonged continuous acidosis with hyperuricemia, might be necessary. Therefore, normalization of metabolic acidosis is important in order to prevent the onset of obstructive uropathy associated with rotavirus gastroenteritis.	[Shirasu, Akihiko; Ashida, Akira; Matsumura, Hideki; Nakakura, Hyogo; Tamai, Hiroshi] Osaka Med Coll, Dept Pediat, Takatsuki, Osaka 5698686, Japan	Ashida, A (reprint author), Osaka Med Coll, Dept Pediat, 2-7 Daigakumachi, Takatsuki, Osaka 5698686, Japan.	ped006@poh.osaka-med.ac.jp					Ashida A, 2012, CLIN NEPHROL, V77, P49, DOI 10.5414/CN107098; Fujinaga S, 2005, PEDIATR NEPHROL, V20, P239, DOI 10.1007/s00467-004-1675-x; DICK WH, 1990, J UROLOGY, V143, P244; Kaneko K, 2010, PEDIATR NEPHROL, V25, P2187, DOI 10.1007/s00467-010-1490-5; Uemura O, 2011, CLIN EXP NEPHROL, V15, P694, DOI 10.1007/s10157-011-0452-y; Hoppe B, 1997, J UROLOGY, V158, P557, DOI 10.1016/S0022-5347(01)64550-6; Bernstein DI, 2009, PEDIATR INFECT DIS J, V28, pS50, DOI 10.1097/INF.0b013e3181967bee; Morita T, 2010, CLIN NEPHROL, V73, P398; Fujita T, 2009, PEDIATR NEPHROL, V24, P2467, DOI 10.1007/s00467-009-1222-x; TIZIANELLO A, 1982, J CLIN INVEST, V69, P240, DOI 10.1172/JCI110436; TALLETT S, 1977, PEDIATRICS, V60, P217; SIMPSON DP, 1971, MEDICINE, V50, P503, DOI 10.1097/00005792-197111000-00002; Barrett KE, 2012, GANONGS REV MED PHYS, P711	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					917	921		10.1111/ped.12626		5	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600020		
J	Iwasaki, H; Fujita, Y; Hara, M				Iwasaki, Hiroki; Fujita, Yukihiko; Hara, Mitsuhiko			Susceptibility-weighted imaging in acute-stage pediatric convulsive disorders	PEDIATRICS INTERNATIONAL			English	Article						child; laterality; regional; seizure; susceptibility-weighted imaging	STATUS EPILEPTICUS; SWI	Background: The aim of this preliminary study was to investigate the clinical use of acute-stage susceptibility-weighted imaging (SWI) in children with prolonged convulsive disorder. Methods: Ten children with prolonged convulsive disorder who underwent SWI within 2 h after termination of seizure (acute-stage SWI group) and 15 control children who underwent SWI >2 h after their seizures terminated or for other purposes were enrolled. The cerebral venous vasculature was compared between the groups. The acute-stage SWI group was further divided into three subgroups: normal group, those with regional low signals in the cerebral veins (regional group) and those with diffuse low signals in the cerebral veins (generalized group). Inter-ictal electroencephalography (EEG) and venous blood gas findings during seizure activity were compared between these subgroups. Results: All patients in the acute-stage SWI group had low cerebral vein signal. Four patients were assigned to the regional group and six patients to the generalized group. Decrease of venous pH and the increase of venous pCO(2) during seizure activity was more prominent in the regional group than in the generalized group. In the regional group, low-signal areas in the cerebral veins were consistent with abnormal areas on EEG; these low-signal areas resolved completely in all patients on follow-up SWI. Ten patients in the control group had normal SWI, and five had a generalized low signal. Conclusions: Acute-stage SWI may be a useful alternative for identifying lateralization of seizures in children with prolonged convulsive disorder.	[Iwasaki, Hiroki] Tama Hokubu Med Ctr, Dept Pediat, Tokyo 1898511, Japan; [Fujita, Yukihiko] Nihon Univ, Sch Med, Dept Pediat & Child Hlth, Tokyo, Japan; [Hara, Mitsuhiko] Tokyo Metropolitan Hiroo Gen Hosp, Dept Pediat, Tokyo, Japan	Iwasaki, H (reprint author), Tama Hokubu Med Ctr, Dept Pediat, 1-7-1 Aoba Cho, Tokyo 1898511, Japan.	ilsayakkum@ae.auone-net.jp					Aellen J, 2014, EUR RADIOL, V24, P2980, DOI 10.1007/s00330-014-3284-9; Sedlacik J, 2010, AM J NEURORADIOL, V31, P901, DOI 10.3174/ajnr.A1960; Iwasaki H, 2014, PEDIATR NEUROL, V50, P171, DOI 10.1016/j.pediatrneurol.2013.09.004; Sehgal V, 2005, J MAGN RESON IMAGING, V22, P439, DOI 10.1002/jmri.20404; Lee YJ, 2014, CLIN NEURORADIOL, V24, P69, DOI 10.1007/s00062-013-0204-3; Verschuuren S, 2012, AM J ROENTGENOL, V198, pW440, DOI 10.2214/AJR.11.8049; Smith AJ, 2002, P NATL ACAD SCI USA, V99, P10765, DOI 10.1073/pnas.132272199; Haacke EM, 2004, MAGNET RESON MED, V52, P612, DOI 10.1002/mrm.20198; Schridde U, 2008, CEREB CORTEX, V18, P1814, DOI 10.1093/cercor/bhm208; Ida M., 2011, SUSCEPTIBILITY WEIGH	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					922	929		10.1111/ped.12678		8	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600021		
J	Hartini, S; Hapsara, S; Herini, SE; Takada, S				Hartini, Sri; Hapsara, Sunartini; Herini, Siti E.; Takada, Satoshi			Verifying the Indonesian version of the Child Behavior Checklist	PEDIATRICS INTERNATIONAL			English	Article						assessment; Child Behavior Checklist; emotional and behavioral problems; Indonesia; validity	UNITED-STATES; CRITERION VALIDITY; CBCL; RELIABILITY; TRF	Background: The Child Behavior Checklist for Ages 6-18 (CBCL/6-18) is widely used to assess emotional and behavioral problems in children in the USA and Europe. Given that Indonesia has a more traditional culture that is different from the USA and Europe, it is possible that the CBCL is not effective in assessing the emotional and behavioral problems of Indonesian children, due to a difference in culture. Moreover, the validity and reliability of the Indonesian version of the CBCL/6-18 have not been tested. The purpose of this study was therefore to test the validity and reliability of the Indonesian version of the CBCL/6-18. Methods: Three hundred and eight mothers of children attending public primary schools participated in this study by completing the self-administered questionnaire. Results: All items of the CBCL were positively correlated with total score (0.15-0.59), and total problems score had high internal consistency (r=0.94). The correlations between questionnaire items and the eight subscales of the CBCL ranged from 0.10 to 0.74 and from 0.12 to 0.64 for the internalizing and externalizing scales, respectively (P<0.01). The eight subscales of the CBCL had good internal consistency (0.61-0.87). Conclusions: The CBCL/6-18 is a valid and reliable instrument to measure emotional and behavioral problems in Indonesian children aged 6-12 years.	[Hartini, Sri; Takada, Satoshi] Kobe Univ, Grad Sch Hlth Sci, Kobe, Hyogo 6540142, Japan; [Hartini, Sri] Gadjah Mada Univ, Sch Nursing, Yogyakarta, Indonesia; [Hapsara, Sunartini; Herini, Siti E.] Gadjah Mada Univ, Fac Med, Yogyakarta, Indonesia	Takada, S (reprint author), Kobe Univ, Grad Sch Hlth Sci, Suma Ku, 7-10-2 Tomogaoka, Kobe, Hyogo 6540142, Japan.	satoshi@kobe-u.ac.jp					Achenbach TM, 2001, MANUAL ASEBA SCH AGE; Agency of Statistics Indonesia, 2010, POP IND RES POP CENS; Roessner V, 2007, EUR ARCH PSY CLIN N, V257, P352, DOI 10.1007/s00406-007-0738-y; French DC, 2005, INT J BEHAV DEV, V29, P304, DOI 10.1080/01650250544000080; French DC, 2002, CHILD DEV, V73, P1143, DOI 10.1111/1467-8624.00463; French DC, 2005, SOC DEV, V14, P458, DOI 10.1111/j.1467-9507.2005.00311.x; Ang RP, 2012, CHILD PSYCHIAT HUM D, V43, P70, DOI 10.1007/s10578-011-0253-2; Senaratna B. C. V., 2008, Ceylon Medical Journal, V53, P40; Leung PWL, 2006, J CHILD PSYCHOL PSYC, V47, P970, DOI 10.1111/j.1469-7610.2005.01570.x; Brown S, 2013, CHILD WELFARE, V3, P119; Doost MT, 2011, IRAN J PEDIATR, V3, P331; Heubeck BG, 2000, J ABNORM CHILD PSYCH, V28, P439, DOI 10.1023/A:1005131605891; Itani T, 2001, SHOUNI NO SEISHIN TO, V41, P243; Jastrowski M, 2009, J CHILD FAM STUD, V5, P606; Rahman FN, 2013, PEDIATR INT, V55, P422; Rescorla L, 2007, J EMOT BEHAV DISORD, V15, P130, DOI 10.1177/10634266070150030101; Souza DC, 2007, J TRAUMA STRESS, V20, P263	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					936	941		10.1111/ped.12669		6	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600023		
J	Murata, S; Aomatsu, T; Yoden, A; Tamai, H				Murata, Shinya; Aomatsu, Tomoki; Yoden, Atsushi; Tamai, Hiroshi			Fasting and bed rest, even for a relatively short period, are risk factors for ceftriaxone-associated pseudolitiasis	PEDIATRICS INTERNATIONAL			English	Article						bed rest; biliary pseudolithiasis; ceftriaxone; cholelithiasis; fasting	BILIARY PSEUDOLITHIASIS; GALLBLADDER; CHILDREN; PRECIPITATIONS; THERAPY; SLUDGE	Background: Cholelithiasis is one of the side-effects of ceftriaxone (CTRX). Reportedly, the cholelithiasis resolves relatively soon after cessation of CTRX, hence, it is called pseudolithiasis. Previous reports have suggested that biliary pseudolithiasis can cause not only gallstone attacks, but also severe adverse events, such as cholecystitis and pancreatitis. The purpose of this study was to prospectively elucidate the risk factors and clinical features of CTRX-associated pseudolithiasis in pediatric patients. Methods: We prospectively examined the incidence and clinical outcome of CTRX-associated biliary pseudolithiasis. Subjects included infants and children who were admitted to hospital with acute disease. Ultrasonography was used to confirm the absence of stones and sludge in the gallbladder before CTRX therapy, and in assessment of pseudolithiasis on days 3, 5, 7 and 10 after initiation of CTRX in all subjects. The pseudolithiasis group was then compared with the non-pseudolithiasis group in terms of age, sex, CTRX dose, CTRX duration, duration of fever, fasting period, period of bed rest, and blood test results. Results: Sixty patients were enrolled in the study. Eleven of them had biliary pseudolithiasis on ultrasonography (18.3%). Formation of biliary pseudolithiasis was prevalent in the fasting and bed rest groups, appearing relatively early in these groups. Conclusions: Special attention should be paid to the degree of oral intake and patient activity when CTRX is prescribed. We recommend regular ultrasonographic follow up of patients receiving CTRX, to evaluate the formation of biliary pseudolithiasis.	[Murata, Shinya] Hirakata City Hosp, Dept Pediat, Hirakata, Osaka 5731013, Japan; [Aomatsu, Tomoki; Yoden, Atsushi; Tamai, Hiroshi] Osaka Med Coll, Dept Pediat, Takatsuki, Osaka 569, Japan	Murata, S (reprint author), Hirakata City Hosp, Dept Pediat, 2-14-1 Kinya Honmachi, Hirakata, Osaka 5731013, Japan.	wildwind1980@live.jp					SHIFFMAN ML, 1990, GASTROENTEROLOGY, V99, P1772; Acun C, 2004, ANN TROP PAEDIATR, V24, P25, DOI 10.1179/027249304225013349; RICHARDS DM, 1984, DRUGS, V27, P469, DOI 10.2165/00003495-198427060-00001; Ruggiero S, 2010, J CHEMOTHERAPY, V22, P63; Palanduz A, 2000, J CLIN ULTRASOUND, V28, P166, DOI 10.1002/(SICI)1097-0096(200005)28:4<166::AID-JCU2>3.0.CO;2-G; SCHAAD UB, 1988, LANCET, V2, P1411; Biner B, 2006, J CLIN ULTRASOUND, V34, P217, DOI 10.1002/jcu.20228; SCHAAD UB, 1986, PEDIATR INFECT DIS J, V5, P708, DOI 10.1097/00006454-198611000-00026; Kim S, 2006, PEDIATR SURG INT, V22, P562, DOI 10.1007/s00383-006-1656-1; Papadopoulou F, 1999, ACTA PAEDIATR, V88, P1352, DOI 10.1080/080352599750030077; PARK HZ, 1991, GASTROENTEROLOGY, V100, P1665; RICCABONA M, 1993, KLIN PADIATR, V205, P421, DOI 10.1055/s-2007-1025261; Fishman DS, 2011, PEDIAT GASTROINTESTI, P866, DOI 10.1016/B978-1-4377-0774-8.10079-X; Frederick JS, 2011, NELSON TEXT PEDIAT, P1707; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2, DOI 10.1097/01.PCC.0000149131.72248.E6; Kawasaki T., 1967, JAP J ALLERG, V16, P178; Kimura M, 2006, J JPN PEDIAT SOC, V110, P773; Lee SP, 2003, TXB GASTROENTEROLOGY, P2177	18	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					942	946		10.1111/ped.12625		5	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600024		
J	Tamura, A; Minami, K; Tsuda, Y; Yoshikawa, N				Tamura, Akira; Minami, Koichi; Tsuda, Yuuko; Yoshikawa, Norishige			Total parenteral nutrition treatment efficacy in adolescent eating disorders	PEDIATRICS INTERNATIONAL			English	Article						adolescent females; alkaline phosphatase; eating disorders; gonadotropins; total parenteral nutrition	ANOREXIA-NERVOSA PATIENTS; HOSPITALIZED ADOLESCENTS; WEIGHT-GAIN; RECOVERY; CHILDREN; INDICATORS; EVOLUTION; BULIMIA; STAY; DSM	Background: Management of adolescent patients with severe eating disorders who refuse treatment for weight loss is complicated. Nutritional rehabilitation is most important during the growth period; thus, strong support in the form of total parenteral nutrition (TPN) as soon as possible is necessary in severe cases. No studies involving detailed, long-term follow up have evaluated biochemical markers and gonadotropin in patients undergoing TPN treatment. Methods: Twenty-five adolescent female patients admitted to hospital received TPN immediately, and biochemical marker and gonadotropin levels were measured and analyzed. If subsequent weight gain was observed, TPN treatment was gradually reduced and stopped. Results: No patients dropped out of the study. A significant increase in weight was observed during hospitalization (average, 8.0kg). Under this treatment, serum total bilirubin was significantly decreased at 3 months, total cholesterol was significantly decreased at 2 months, and alkaline phosphatase (ALP) was significantly increased at 3 and 6 months. Follicle-stimulating hormone response significantly preceded both luteinizing hormone response and appetite recovery. After this treatment, nine of the 25 patients were readmitted for recurrence of appetite loss. Two patients required additional TPN treatment, but seven immediately recovered their appetite after hospitalization without TPN treatment. Bodyweight gain per day was significantly lower and ALP on admission was significantly higher in patients with than without recurrence. Conclusions: Most patients had a remarkable recovery of appetite without refusal behaviors and without evidence of malnutrition after admission. Nutrition maintenance with TPN support is particularly important during the growth period.	[Tamura, Akira; Minami, Koichi; Tsuda, Yuuko; Yoshikawa, Norishige] Wakayama Med Univ, Dept Pediat, Wakayama 6410012, Japan	Tamura, A (reprint author), Wakayama Med Univ, Dept Pediat, 811-1 Kimiidera, Wakayama 6410012, Japan.	tamy@wakayama-med.ac.jp					Agostino H, 2013, J ADOLESCENT HEALTH, V53, P590, DOI 10.1016/j.jadohealth.2013.06.005; American Pyschiatric Association, 1994, DIAGN STAT MAN MENT; Golden NH, 2013, J ADOLESCENT HEALTH, V53, P573, DOI 10.1016/j.jadohealth.2013.05.014; Nova E, 2004, CLIN NUTR, V23, P1353, DOI 10.1016/j.clnu.2004.05.004; ISAACS AJ, 1980, ACTA ENDOCRINOL-COP, V94, P145; ARDEN MR, 1990, J ADOLESCENT HEALTH, V11, P199, DOI 10.1016/0197-0070(90)90348-6; Nova E, 2001, EUR J CLIN NUTR, V55, P547, DOI 10.1038/sj.ejcn.1601181; Mehler PS, 2007, INT J EAT DISORDER, V40, P285, DOI 10.1002/eat.20371; Nogal P, 2009, NEUROENDOCRINOL LETT, V30, P32; Peebles R, 2006, J ADOLESCENT HEALTH, V39, P800, DOI 10.1016/j.jadohealth.2006.05.013; Nicholls D, 2000, INT J EAT DISORDER, V28, P317, DOI 10.1002/1098-108X(200011)28:3<317::AID-EAT9>3.0.CO;2-#; Whitelaw M, 2010, J ADOLESCENT HEALTH, V46, P577, DOI 10.1016/j.jadohealth.2009.11.207; Nova E, 2008, J HUM NUTR DIET, V21, P23, DOI 10.1111/j.1365-277X.2007.00833.x; GARNER DM, 1979, PSYCHOL MED, V9, P273; Pike KM, 1998, CLIN PSYCHOL REV, V18, P447, DOI 10.1016/S0272-7358(98)00014-2; Garber AK, 2013, J ADOLESCENT HEALTH, V53, P579, DOI 10.1016/j.jadohealth.2013.07.014; MORDASINI R, 1978, METABOLISM, V27, P71, DOI 10.1016/0026-0495(78)90125-7; Le Grange D, 2012, INT J EAT DISORDER, V45, P711, DOI 10.1002/eat.22006; Campbell K, 2014, PEDIATRICS, V134, P582, DOI 10.1542/peds.2014-0194; Couturier J, 2006, INT J EAT DISORDER, V39, P550, DOI 10.1002/eat.20309; MIRA M, 1987, ANN CLIN BIOCHEM, V24, P29; Thomas JJ, 2009, PSYCHOL BULL, V135, P407, DOI 10.1037/a0015326; WELTZIN TE, 1991, AM J PSYCHIAT, V148, P1675; Meguerditchian C, 2009, J AM COLL NUTR, V28, P397; MORGAN HG, 1988, BRIT J PSYCHIAT, V152, P367, DOI 10.1192/bjp.152.3.367; Rosen David S, 2003, Adolesc Med, V14, P49; Tachikawa H, 2004, Eat Weight Disord, V9, P107	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					947	953		10.1111/ped.12717		7	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600025		
J	Ino, T; Kurosawa, K				Ino, Toshihiro; Kurosawa, Kazuo			Screening for secondhand smoke in schoolchildren in Japan	PEDIATRICS INTERNATIONAL			English	Article						biomarker; carcinogen; cotinine; screening; secondhand smoke	MATERNAL SMOKING; TOBACCO; EXPOSURE; BIOMARKERS; PREGNANCY; CHILDREN; METABOLITES	BackgroundThere is no systematic screening for secondhand smoke exposure in children. MethodsIn 2002, we began a secondhand smoke screening (SSS) program for grade 4 elementary schoolchildren with the cooperation of public administration. The SSS program consisted of urinary cotinine measurement in children and a questionnaire survey of their parents. ResultsMore than 1200 schoolchildren were enrolled in this program annually. The level of urinary cotinine in 30% of the children was >5ng/mL, whereas in half of them it was undetectable. The major risk factor affecting cotinine level was mother's smoking. Average cotinine was significantly high in children who had a history of short stature, decayed tooth and/or periodontal disease, and frequent stridor. In addition, the highest level of cotinine was detected in children whose father and/or mother smoked in the living room and the lowest level of cotinine was detected in children whose father and/or mother smoked on the veranda or outside the door. These levels, however, were two-fivefold higher than in children whose parents did not smoke. On follow-up questionnaire survey 4years after initial SSS, significant elevated motivation for smoking cessation was noted. ConclusionsThe SSS program is a very simple mass screen that can be done using only a urine test and is very effective for motivating parents to stop smoking with regard to cost benefit.	[Ino, Toshihiro; Kurosawa, Kazuo] Gunma Paz Coll, Fac Hlth Sci, Takasaki, Gumma, Japan; [Ino, Toshihiro] Ino Clin, Kumagaya, Saitama 3600014, Japan	Ino, T (reprint author), Ino Clin, 1-12-24 Hakoda, Kumagaya, Saitama 3600014, Japan.	ino-t@sk9.so-net.ne.jp			Ministry of Health, Labor, and Welfare [H21-third-regular-005]; Japan Society for the Promotion of Science [23591514]	We would like to express our gratitude to the pediatric doctors of the Kumagaya Medical Association and the members of the Board of Education in Kumagaya-RC City. This study was supported by grants from the Ministry of Health, Labor, and Welfare (H21-third-regular-005) and from the Japan Society for the Promotion of Science (23591514). The authors declare no conflicts of interest.	Benowitz NL, 1996, EPIDEMIOL REV, V18, P188; Hecht SS, 2001, CANCER EPIDEM BIOMAR, V10, P1109; Hecht SS, 2014, CANCER PREV RES, V7, P639, DOI 10.1158/1940-6207.CAPR-14-0095; Ino T, 2011, PEDIATR INT, V53, P851, DOI 10.1111/j.1442-200X.2011.03383.x; Ino T, 2010, PEDIATR INT, V52, P94, DOI 10.1111/j.1442-200X.2009.02883.x; Saffer H, 2000, J HEALTH ECON, V19, P1117, DOI 10.1016/S0167-6296(00)00054-0; Hatsukami DK, 2008, LANCET, V371, P2027, DOI 10.1016/S0140-6736(08)60871-5; Benowitz NL, 1999, ENVIRON HEALTH PERSP, V107, P349, DOI 10.2307/3434427; Llaquet H, 2010, ANAL BIOANAL CHEM, V396, P379, DOI 10.1007/s00216-009-2831-8; Ino T, 2006, PREV MED, V42, P427, DOI 10.1016/j.ypmed.2006.01.012; Matsumoto Akiko, 2010, Environmental Health and Preventive Medicine, V15, P211, DOI 10.1007/s12199-009-0129-2; Asomaning K, 2008, LUNG CANCER, V61, P13, DOI 10.1016/j.lungcan.2007.11.013; Johansson AK, 2004, PEDIATRICS, V113, pE291, DOI 10.1542/peds.113.4.e291; Lovasi GS, 2010, AM J EPIDEMIOL, V171, P54, DOI 10.1093/aje/kwp358; Lodovici M, 2009, INT J ENV RES PUB HE, V6, P874, DOI 10.3390/ijerph6030874; Ino T, 2011, J CLIN LAB ANAL, V25, P354, DOI 10.1002/jcla.20485; Ino T, 2012, INT J OBESITY, V36, P554, DOI 10.1038/ijo.2011.255; Ino T, 2006, NIHONSHOUNIKAGAKKAIZ, V110, P1105; Ino T, 2008, JUDOUKITSUEN KAITAIS; Ino T, 2008, HEART, V40, P124; Ministry of Health Labor and Welfare, TOB OR HLTH; OECD, EC ENV SOC STAT; Ohta M, 2007, JPN J MED PHARM SCI, V58, P589; Yamato Hiroshi, 2004, Nihon Kokyuki Gakkai Zasshi, V42, P616	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					961	967		10.1111/ped.12630		7	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600027		
J	Makino, S; Kunishima, S; Ikumi, A; Awaguni, H; Shinozuka, J; Tanaka, S; Maruyama, R; Imashuku, S				Makino, Shigeru; Kunishima, Shinji; Ikumi, Aki; Awaguni, Hitoshi; Shinozuka, Jun; Tanaka, Shin-ichiro; Maruyama, Rikken; Imashuku, Shinsaku			Sporadic Epstein syndrome with macrothrombocytopenia, sensorineural hearing loss and renal failure	PEDIATRICS INTERNATIONAL			English	Article						de novo mutation; Epstein syndrome; macrothrombocytopenia; MYH9 disorder; sporadic case	MYH9 R702 MUTATIONS; FECHTNER SYNDROMES; DISORDERS; DISEASE	We report here a sporadic case of Epstein syndrome, one of the MYH9 disorders. A Japanese boy was first noted to have thrombocytopenia at 3years of age. Blood smear showed giant platelets but no Dohle-like bodies in the neutrophils. He had no family history of thrombocytopenia, hearing loss, and/or renal failure. Thrombocytopenia took a chronic course and platelet count fluctuated in the range 18 000-46 000/L, not responding to i.v. immunoglobulin or prednisolone treatment. The patient had episodes of gross nasal bleeding at 7 and 18years of age. Mild hearing loss was suspected at 6, and proteinuria was first noted at 14years of age. At the development of renal failure at 24years of age, he was identified to have de novo R702H MYH9 mutation. This case illustrates the importance of suspecting MYH9 disorder even in cases of chronic macrothrombocytopenia without family history.	[Makino, Shigeru; Ikumi, Aki; Awaguni, Hitoshi; Shinozuka, Jun; Tanaka, Shin-ichiro; Maruyama, Rikken] Uji Tokushukai Med Ctr, Dept Pediat, Uji, Kyoto 6110042, Japan; [Imashuku, Shinsaku] Uji Tokushukai Med Ctr, Div Lab Med, Uji, Kyoto 6110042, Japan; [Kunishima, Shinji] Natl Hosp Org Nagoya Med Ctr, Clin Res Ctr, Nagoya, Aichi, Japan	Imashuku, S (reprint author), Uji Tokushukai Med Ctr, Div Lab Med, Uji, Kyoto 6110042, Japan.	shinim95@mbox.kyoto-inet.or.jp					Arrondel C, 2002, J AM SOC NEPHROL, V13, P65; Sekine T, 2010, KIDNEY INT, V78, P207, DOI 10.1038/ki.2010.21; EPSTEIN CJ, 1972, AM J MED, V52, P299, DOI 10.1016/0002-9343(72)90017-4; Pecci A, 2010, BLOOD, V116, P5832, DOI 10.1182/blood-2010-08-304725; Kunishima S, 2003, LAB INVEST, V83, P115, DOI 10.1097/01.LAB.0000050960.48774.17; Kunishima S, 2010, CURR OPIN HEMATOL, V17, P405, DOI 10.1097/MOH.0b013e32833c069c; Kunishima S, 2007, EUR J HAEMATOL, V78, P220, DOI 10.1111/j.1600-0609.2006.00806.x; Balduini CL, 2011, BRIT J HAEMATOL, V154, P161, DOI 10.1111/j.1365-2141.2011.08716.x; Pecci A, 2008, NEPHROL DIAL TRANSPL, V23, P2690, DOI 10.1093/ndt/gfn277; Pecci A, 2014, HUM MUTAT, V35, P236, DOI 10.1002/humu.22476	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					977	981		10.1111/ped.12736		5	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600031		
J	Asano, T; Narazaki, H; Kaizu, K; Matsukawa, S; Takema-Tochikubo, Y; Fujii, S; Saitoh, N; Mashiko, K; Fujino, O				Asano, Takeshi; Narazaki, Hidehiko; Kaizu, Kiyohiko; Matsukawa, Shouhei; Takema-Tochikubo, Yuki; Fujii, Shuichi; Saitoh, Nobuyuki; Mashiko, Kunihiko; Fujino, Osamu			Neglect-induced pseudo-thrombotic thrombocytopenic purpura due to vitamin B12 deficiency	PEDIATRICS INTERNATIONAL			English	Article						neglect; pseudo-thrombotic thrombocytopenic purpura; vitamin B12 deficiency	CHILD	Although thrombotic thrombocytopenic purpura (TTP) is rare, early diagnosis and treatment are important for decreasing the mortality rate. Acquired vitamin B12 deficiency is frequently overlooked because of its rarity in developed countries, particularly in children and adolescents. The hematological changes in vitamin B12 deficiency present as megaloblastic anemia, increased lactate dehydrogenase, vasoconstriction, increased platelet aggregation, and abnormal activation of the coagulation followed by microangiopathy as well as neutropenia and thrombocytopenia. We report herein the case of a 15-year-old girl who had been neglected, which might have caused pseudo-TTP through malnutrition, particularly vitamin B12 deficiency. When we encounter cases of TTP in children, clinicians must be aware of the possibility of malnutrition, particularly with vitamin B12 deficiency, even in developed countries, and investigate the cause of malnutrition including neglect.	[Asano, Takeshi; Narazaki, Hidehiko; Kaizu, Kiyohiko; Matsukawa, Shouhei; Takema-Tochikubo, Yuki; Fujii, Shuichi; Fujino, Osamu] Chiba Hokusoh Hosp, Nippon Med Sch, Dept Pediat, Inzai City, Chiba 2701694, Japan; [Saitoh, Nobuyuki; Mashiko, Kunihiko] Chiba Hokusoh Hosp, Nippon Med Sch, Dept Emergency & Crit Care Med, Inzai City, Chiba 2701694, Japan	Asano, T (reprint author), Chiba Hokusoh Hosp, Nippon Med Sch, Dept Pediat, 1715 Kamagari, Inzai City, Chiba 2701694, Japan.	VFF13540@nifty.ne.jp					Green R, 2012, HEMATOL-AM SOC HEMAT, P492, DOI 10.1182/asheducation-2012.1.492; Nappo F, 1999, JAMA-J AM MED ASSOC, V281, P2113, DOI 10.1001/jama.281.22.2113; Simsek OP, 2004, J PEDIAT HEMATOL ONC, V26, P834; Motto D, 2012, SEMIN NEPHROL, V32, P208, DOI 10.1016/j.semnephrol.2012.02.007; Dimond A, 2009, PEDIATR BLOOD CANCER, V52, P420, DOI 10.1002/pbc.21788; Johnson CF, 2004, NELSON TXB PEDIAT, P129; Scully M, 2012, BRIT J HAEMATOL, V158, P323, DOI 10.1111/j.1365-2141.2012.09167.x	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					988	990		10.1111/ped.12718		3	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600034		
J	Taniguchi, K; Ono, H; Sato, A; Kinomoto, S; Tagawa, N; Umehara, N; Kato, H; Sago, H				Taniguchi, Kosuke; Ono, Hiroshi; Sato, Anna; Kinomoto, Satoko; Tagawa, Naomi; Umehara, Nagayoshi; Kato, Hitoshi; Sago, Haruhiko			Strict management of a pregnant patient with giant coronary artery aneurysm due to Kawasaki disease	PEDIATRICS INTERNATIONAL			English	Article						coronary aneurysm; Kawasaki disease; low-dose aspirin; pregnancy; unfractionated heparin	AMERICAN-HEART-ASSOCIATION; PROFESSIONALS; GUIDELINES; STATEMENT; DIAGNOSIS; THERAPY	Coronary artery aneurysms (CAA) may occur in Kawasaki disease (KD). Patients with giant CAA (diameter >8mm), in particular, have higher risk of myocardial infarction. Previous reports have demonstrated the necessity of anticoagulation therapy in such cases. The management of patients with KD complicated by giant CAA later in life, however, remains controversial. Here, we describe the strict management in the case of a 28-year-old pregnant Japanese woman with KD with giant CAA (diameter, 11mm). Instead of warfarin, the patient was given low-dose aspirin and i.v. unfractionated heparin during pregnancy to prevent thrombosis in the giant CAA. At 38weeks of gestation, she had spontaneous delivery of a healthy baby. No thrombotic or bleeding complications were observed. The strict anticoagulation therapy resulted in successful pregnancy and delivery without any adverse events.	[Taniguchi, Kosuke; Sato, Anna; Kinomoto, Satoko; Tagawa, Naomi; Umehara, Nagayoshi; Sago, Haruhiko] Natl Ctr Child Hlth & Dev, Ctr Maternal Fetal Neonatal & Reproduct Med, Setagaya Ku, Tokyo 1578535, Japan; [Ono, Hiroshi; Kato, Hitoshi] Natl Ctr Child Hlth & Dev, Div Cardiol, Setagaya Ku, Tokyo 1578535, Japan	Sago, H (reprint author), Natl Ctr Child Hlth & Dev, Ctr Maternal Fetal Neonatal & Reproduct Med, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	sagou-h@ncchd.go.jp					Abbassi-Ghanavati M, 2009, OBSTET GYNECOL, V114, P1326, DOI 10.1097/AOG.0b013e3181c2bde8; Tsuda E, 2006, CARDIOL YOUNG, V16, P173, DOI 10.1017/S1047951106000126; Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78; Nishimura RA, 2014, CIRCULATION, V129, pE521, DOI 10.1161/CIR.0000000000000031; Onouchi Z, 2005, CIRC J, V69, P265, DOI 10.1253/circj.69.265; Suda K, 2009, CIRC J, V73, P1319; Hirsh J, 2001, CIRCULATION, V103, P2994; Ogawa S, 2010, CIRC J, V74, P1989, DOI 10.1253/circj.CJ-10-74-0903	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					990	992		10.1111/ped.12679		3	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600035		
J	Yamaga, K; Kobayashi, E; Kubota, D; Setsu, N; Tanaka, Y; Minami, Y; Tanzawa, Y; Nakatani, F; Kawai, A; Chuman, H				Yamaga, Kensaku; Kobayashi, Eisuke; Kubota, Daisuke; Setsu, Nokitaka; Tanaka, Yuya; Minami, Yusuke; Tanzawa, Yoshikazu; Nakatani, Fumihiko; Kawai, Akira; Chuman, Hirokazu			Pediatric myositis ossificans mimicking osteosarcoma	PEDIATRICS INTERNATIONAL			English	Article						child; humerus; myositis ossificans; osteosarcoma; periosteal reaction		Myositis ossificans (MO) is a rare benign cause of heterotopic bone formation in soft tissue that most commonly affects young adults, typically following trauma. We report the case of an 11-year-old girl who developed MO mimicking osteosarcoma in her right shoulder. Plain radiography and computed tomography showed poorly defined flocculated densities in the soft tissue and a periosteal reaction along the proximal humerus. On magnetic resonance imaging, the mass displayed an ill-defined margin and inhomogeneous signal change. Histologically, the mass had a pseudosarcomatous appearance. Based on these findings, the patient was initially misdiagnosed with osteosarcoma at another hospital. The diagnosis was difficult because the patient was 11years old and had no trauma history, with atypical radiographic changes and a predilection for the site of origin for osteosarcomas. We finally made the correct diagnosis of MO by carefully reviewing and reflecting on the pathological differences between stages.	[Yamaga, Kensaku; Kobayashi, Eisuke; Kubota, Daisuke; Setsu, Nokitaka; Tanaka, Yuya; Minami, Yusuke; Tanzawa, Yoshikazu; Nakatani, Fumihiko; Kawai, Akira; Chuman, Hirokazu] Natl Canc Ctr, Div Musculoskeletal Oncol, Tokyo 1040045, Japan	Yamaga, K (reprint author), Natl Canc Ctr, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	y10142527@gmail.com					Yoshida A, 2010, MODERN PATHOL, V23, P1279, DOI 10.1038/modpathol.2010.124; Koob M, 2010, PEDIATR RADIOL, V40, P34, DOI 10.1007/s00247-010-1769-5; OGILVIEHARRIS DJ, 1980, J BONE JOINT SURG AM, V62, P1274; Gindele A, 2000, PEDIATR RADIOL, V30, P451, DOI 10.1007/s002479900168; DESMET AA, 1992, SKELETAL RADIOL, V21, P503; NORMAN A, 1970, RADIOLOGY, V96, P301; NUOVO MA, 1992, SKELETAL RADIOL, V21, P87; Goldblum JR, 2013, ENZINGER WEISSS SOFT, P926; Rosenberg AE, 2013, WHO CLASSIFICATION T, P50	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					996	999		10.1111/ped.12672		4	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600037		
J	Tanaka, Y; Miyamoto, T; Yoshitake, S; Naito, Y; Kobayashi, T				Tanaka, Yuki; Miyamoto, Takashi; Yoshitake, Shuichi; Naito, Yuji; Kobayashi, Tomio			Rare combination of congenital heart disease and pulmonary alveolar proteinosis	PEDIATRICS INTERNATIONAL			English	Article						congenital heart disease; lung disease; neonate; pulmonary alveolar proteinosis; total anomalous pulmonary venous return		Here, we describe a case of total anomalous pulmonary venous return with coarctation of the aorta that was diagnosed as pulmonary alveolar proteinosis at autopsy in a male infant. Surgical repair was performed at 1day of age, but the infant died on postoperative day 51 due to respiratory insufficiency without any evidence of pulmonary venous obstruction. He had been unexpectedly diagnosed with pulmonary alveolar proteinosis and pulmonary hypoplasia on autopsy. Congenital pulmonary alveolar proteinosis is a serious condition with a high mortality rate, which should be considered in the differential diagnosis in patients with a clinical picture of pulmonary venous obstruction, because most patients are unable to survive without proper treatment. In this report, we address specific issues that should be discussed in such cases based on our recent experience.	[Tanaka, Yuki; Miyamoto, Takashi; Yoshitake, Shuichi; Naito, Yuji] Gunma Childrens Med Ctr, Dept Pediat Cardiovasc Surg, Shibukawa, Gunma 3778577, Japan; [Kobayashi, Tomio] Gunma Childrens Med Ctr, Pediat Cardiol, Shibukawa, Gunma 3778577, Japan	Tanaka, Y (reprint author), Gunma Childrens Med Ctr, Dept Pediat Cardiovasc Surg, 779 Shimohakoda, Shibukawa, Gunma 3778577, Japan.	tfjgp484@yahoo.co.jp					deMello DE, 2001, PEDIATR PATHOL MOL M, V20, P413; ROSEN SH, 1958, NEW ENGL J MED, V258, P1123, DOI 10.1056/NEJM195806052582301; Dirksen U, 1997, J CLIN INVEST, V100, P2211, DOI 10.1172/JCI119758; Seymour JF, 2002, AM J RESP CRIT CARE, V166, P215, DOI 10.1164/rccm.2109105; Ben-Dov I, 1999, ISRAEL MED ASSOC J, V1, P75; Hamvas A, 2007, NEONATOLOGY, V91, P311, DOI 10.1159/000101347	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					999	1001		10.1111/ped.12695		3	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600038		
J	Sakai, T; Sawai, T; Shimizu, Y; Morimune, T; Okuda, Y; Maruo, Y; Iyoda, S; Takeuchi, Y				Sakai, Tomoyuki; Sawai, Toshihiro; Shimizu, Yasuyo; Morimune, Takao; Okuda, Yusuke; Maruo, Yoshihiro; Iyoda, Sunao; Takeuchi, Yoshihiro			Escherichia coli O121:H19 infection identified on microagglutination assay and PCR	PEDIATRICS INTERNATIONAL			English	Article						atypical hemolytic uremic syndrome; Escherichia coli O121; microagglutination assay; non-O157 STEC strain	HEMOLYTIC-UREMIC SYNDROME; NON-O157 SHIGA TOXIN; ECULIZUMAB; O157; O111; FOOD	Non-O157 Shiga toxin-producing Escherichia coli (STEC) strains are increasingly recognized as foodborne pathogens that trigger hemolytic uremic syndrome (HUS). The detection and isolation of these strains is important, but distinguishing their bacteriological profiles is difficult. A 2-year-old girl developed HUS with mild renal involvement 22days after consuming barbecued meat. Clinical and laboratory findings gradually improved without specific treatment. Because neither enterohemorrhagic E. coli (EHEC) nor Shiga toxins were detected in stool cultures in a clinical laboratory and the patient tested negative for circulating antibodies to O157 lipopolysaccharide, the case was initially diagnosed as probable atypical HUS. Subsequent serodiagnostic microagglutination assay and polymerase chain reaction-based molecular testing, however, indicated the presence of the EHEC O121:H19 strain with stx2. Thus, to correctly diagnose and treat HUS, a system for detecting non-O157 STEC in a clinical setting is urgently needed.	[Sakai, Tomoyuki; Sawai, Toshihiro; Morimune, Takao; Okuda, Yusuke; Maruo, Yoshihiro; Takeuchi, Yoshihiro] Shiga Univ Med Sci, Dept Pediat, Otsu, Shiga 5202192, Japan; [Shimizu, Yasuyo] Nagahama Red Cross Hosp, Dept Pediat, Shiga, Japan; [Iyoda, Sunao] Natl Inst Infect Dis, Dept Bacteriol 1, Tokyo, Japan	Sakai, T (reprint author), Shiga Univ Med Sci, Dept Pediat, Otsu, Shiga 5202192, Japan.	sakai-tomoyuki@umin.ac.jp					Wang F, 2013, FOODBORNE PATHOG DIS, V10, P665, DOI 10.1089/fpd.2012.1448; Operario DJ, 2014, J CLIN MICROBIOL, V52, P1003, DOI 10.1128/JCM.02855-13; Sawai T, 2014, PEDIATR INT, V56, P1, DOI 10.1111/ped.12274; Johnson KE, 2006, CLIN INFECT DIS, V43, P1587, DOI 10.1086/509573; Mellmann A, 2005, CLIN INFECT DIS, V41, P785, DOI 10.1086/432722; Ardissino G, 2014, AM J KIDNEY DIS, V64, P633, DOI 10.1053/j.ajkd.2014.01.434; Isobe J, 2014, J CLIN MICROBIOL, V52, P1112, DOI 10.1128/JCM.03469-13; Niaudet P., UPTODATE OVERVIEW HE; Saini A, 2015, CLIN PEDIATR, V54, P387, DOI 10.1177/0009922814534520; Salvadori Maurizio, 2013, World J Nephrol, V2, P56, DOI 10.5527/wjn.v2.i3.56	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					1001	1003		10.1111/ped.12699		3	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600039		
J	Kunitsu, T; Koshida, S; Tanaka, K; Nakahara, S; Yanagi, T; Maruo, Y; Takeuchi, Y; Kubota, Y				Kunitsu, Tomoaki; Koshida, Shigeki; Tanaka, Katsunori; Nakahara, Sayuri; Yanagi, Takahide; Maruo, Yoshihiro; Takeuchi, Yoshihiro; Kubota, Yoshihiro			Neonatal Meckel diverticulum: Obstruction due to a short mesodiverticular band	PEDIATRICS INTERNATIONAL			English	Article						bowel obstruction; intestinal obstruction; Meckel diverticulum; mesodiverticular band; neonate	INTESTINAL-OBSTRUCTION	This is the first report of symptomatic Meckel diverticulum in a newborn, in which direct compression by a short mesodiverticular band (MDB) caused intestinal obstruction. A short MDB can cause intestinal obstruction due to direct compression. There are two mechanisms by which Meckel diverticulum with MDB can cause intestinal obstruction: internal hernia and direct compression. Onset of intestinal obstruction due to direct compression by a short MDB might be earlier than that for internal hernia with long MDB.	[Kunitsu, Tomoaki; Koshida, Shigeki; Tanaka, Katsunori; Nakahara, Sayuri; Yanagi, Takahide; Maruo, Yoshihiro; Takeuchi, Yoshihiro] Shiga Univ Med Sci, Dept Pediat, Otsu, Shiga, Japan; [Kubota, Yoshihiro] Shiga Univ Med Sci, Dept Breast & Gen Surg, Otsu, Shiga, Japan	Kunitsu, T (reprint author), Saiseikai Shiga Hosp, 2-4-1 Ohashi, Rittoshi, Shiga 5203046, Japan.	tkunitsu@gmail.com					PFALZGRAF RR, 1988, ARCH PATHOL LAB MED, V112, P182; SINGH RB, 1995, PEDIATR SURG INT, V10, P269; DSOUZA CR, 1993, SURGERY, V114, P984; Park JJ, 2005, ANN SURG, V241, P529, DOI 10.1097/01.sla.0000154270.14308.5f; SEAGRAM CGF, 1968, CAN J SURG, V11, P369; Sun C, 2012, J ULTRAS MED, V31, P2035; Vork JC, 2003, FORENSIC SCI INT, V138, P114, DOI 10.1016/j.forsciint.2003.08.013; Prasad T R Sai, 2006, JSLS, V10, P310; RUTHERFO.RB, 1966, SURGERY, V59, P618; WILLIAMS RS, 1981, BRIT J SURG, V68, P477, DOI 10.1002/bjs.1800680712	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					1007	1009		10.1111/ped.12694		3	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600041		
J	Watanabe, H; Ayusawa, M; Kato, M; Chou, A; Komori, A; Abe, Y; Matsumura, M; Kamiyama, H; Izumi, H; Takahashi, S				Watanabe, Hirofumi; Ayusawa, Mamoru; Kato, Masataka; Chou, Ami; Komori, Akiko; Abe, Yuriko; Matsumura, Masaharu; Kamiyama, Hiroshi; Izumi, Hiroyuki; Takahashi, Shori			Idiopathic pulmonary hemosiderosis complicated by Down syndrome	PEDIATRICS INTERNATIONAL			English	Article						Down syndrome; hemolytic anemia; hemoptysis; idiopathic pulmonary hemosiderosis; prednisolone		We report the case of a 9-year-old girl with Down syndrome (DS) diagnosed with idiopathic pulmonary hemosiderosis (IPH). Although acute pneumonia complicated by hemolytic anemia was suspected, IPH was finally diagnosed on bronchoscopy. Treatment with prednisolone achieved good clinical response. An association between IPH and DS was not able to be identified, but immunological issues in DS may contribute to the onset of IPH. Recurrent and intractable respiratory symptoms with marked infiltrative shadows in the bilateral lungs and complicated by severe anemia in patients with DS should suggest IPH.	[Watanabe, Hirofumi; Ayusawa, Mamoru; Kato, Masataka; Chou, Ami; Komori, Akiko; Abe, Yuriko; Matsumura, Masaharu; Kamiyama, Hiroshi; Izumi, Hiroyuki; Takahashi, Shori] Nihon Univ, Sch Med, Dept Pediat & Child Hlth, Itabashi Ku, Tokyo 1738610, Japan; [Izumi, Hiroyuki] Itabashi Med Assoc Hosp, Itabashi Ku, Tokyo, Japan	Watanabe, H (reprint author), Nihon Univ, Sch Med, Dept Pediat & Child Hlth, Itabashi Ku, 30-1 Ooyaguchikamichou, Tokyo 1738610, Japan.	mehi11016@g.nihon-u.ac.jp					Aceti A, 2012, SARCOIDOSIS VASC DIF, V29, P58; Akio N, 1992, NIHON KYOBU SHIKKAN, V30, P1749; Sethi GR, 2011, PEDIATR PULM, V46, P302, DOI 10.1002/ppul.21357; Saeed MM, 1999, CHEST, V116, P721, DOI 10.1378/chest.116.3.721; Nuesslein TG, 2006, PAEDIATR RESPIR REV, V7, P45, DOI 10.1016/j.prrv.2005.11.003; Ram G, 2011, CLIN EXP IMMUNOL, V164, P9, DOI 10.1111/j.1365-2249.2011.04335.x; NOVO E, 1993, AM J MED GENET, V46, P384, DOI 10.1002/ajmg.1320460408; Gencer M, 2007, CAN RESPIR J, V14, P490; Mourato Felipe Alves, 2014, Rev Paul Pediatr, V32, P159, DOI 10.1590/0103-0582201432218913; Sato Y, CASE REPORT IDIOPATH; Taruhisa K, 1995, IRYO, V49, P580; Taytard J, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-161	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					1009	1012		10.1111/ped.12690		4	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600042		
J	Okada, S; Hasegawa, S; Suzuki, Y; Ichimura, T; Kaneyasu, H; Shimomura, M; Wakabayashi-Takahara, M; Nakamura, K; Kobayashi, M; Ohga, S				Okada, Seigo; Hasegawa, Shunji; Suzuki, Yasuo; Ichimura, Takuya; Kaneyasu, Hidenobu; Shimomura, Maiko; Wakabayashi-Takahara, Midori; Nakamura, Kazuhiro; Kobayashi, Masao; Ohga, Shouichi			Remission of autoimmune neutropenia after development of Kawasaki disease	PEDIATRICS INTERNATIONAL			English	Article						autoimmune neutropenia; granulocyte colony-stimulating factor; Kawasaki disease; transforming growth factor-beta 1	CHILDREN; NEUTROPHILS; ACTIVATION	We report the second case of the association of Kawasaki disease (KD) and autoimmune neutropenia (AIN). A 21-month-old female diagnosed as having AIN of infancy developed a complete KD when severe neutropenia continued. The patient suffered from no coronary artery leions, and well responded to a single high-dose gamma-globulin therapy. The cytokine profile of the neutropenic infant was representative of the typical KD. Neutrophil counts notably increased during the convalescent phase of KD, and were then normalized forthwith. The prompt resolutions of KD and AIN paralleled the increase of circulating transforming growth factor (TGF)-beta 1 levels. The clinical course of the patient was contrasted to that of the first reported case of a patient who developed severe and refractory KD after the high dose granulocyte-colony stimulating factor (G-CSF) therapy.	[Okada, Seigo; Hasegawa, Shunji; Suzuki, Yasuo; Ichimura, Takuya; Kaneyasu, Hidenobu; Shimomura, Maiko; Wakabayashi-Takahara, Midori; Ohga, Shouichi] Yamaguchi Univ, Grad Sch Med, Dept Pediat, Ube, Yamaguchi 7558505, Japan; [Nakamura, Kazuhiro; Kobayashi, Masao] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pediat, Minami Ku, Hiroshima, Japan	Okada, S (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Pediat, 1-1-1 Minamikogushi, Ube, Yamaguchi 7558505, Japan.	p002um@yamaguchi-u.ac.jp			Ministry of Health, Labour and Welfare of Japan	This work was supported in part by a grant from the Ministry of Health, Labour and Welfare of Japan. The authors declare no conflicts of interest.	Yoshimura K, 2009, EUR J PEDIATR, V168, P1037, DOI 10.1007/s00431-008-0872-1; Matsubara T, 1997, SCAND J RHEUMATOL, V26, P314; Kobayashi T, 2006, CIRCULATION, V113, P2606, DOI 10.1161/CIRCULATIONAHA.105.592865; Biezeveld MH, 2005, CLIN EXP IMMUNOL, V141, P183, DOI 10.1111/j.1365-2249.2005.02829.x; Nakamura K, 2009, BRIT J HAEMATOL, V145, P642, DOI 10.1111/j.1365-2141.2009.07662.x; FURUKAWA S, 1992, EUR J PEDIATR, V151, P44, DOI 10.1007/BF02073890; Kanai T, 2011, CIRCULATION, V124, P2822, DOI 10.1161/CIRCULATIONAHA.111.028423; Ueno K, 2011, PEDIATR INT, V53, P388, DOI 10.1111/j.1442-200X.2011.03376.x; Wang YJ, 2013, ARTHRITIS RHEUM-US, V65, P805, DOI 10.1002/art.37815; Travis MA, 2014, ANNU REV IMMUNOL, V32, P51, DOI 10.1146/annurev-immunol-032713-120257; KAVERI SV, 1991, CLIN EXP IMMUNOL, V86, P192; Kobayashi M, 2002, BLOOD, V99, P3468, DOI 10.1182/blood.V99.9.3468; Fujimaru T, 2014, CYTOKINE, V70, P156, DOI 10.1016/j.cyto.2014.07.003; Ni FF, 2014, CLIN EXP IMMUNOL, V178, P384, DOI 10.1111/cei.12418	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					1012	1014		10.1111/ped.12701		3	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600043		
J	Keino, D; Tsuzuki, Y; Mori, T; Kakuage, S; Nakano, M; Asoh, K; Mori, T; Kinoshita, A; Yamamoto, H				Keino, Dai; Tsuzuki, Yoshimitsu; Mori, Takashi; Kakuage, Shiori; Nakano, Marie; Asoh, Kentaro; Mori, Tetsuya; Kinoshita, Akitoshi; Yamamoto, Hitoshi			Infective endocarditis associated with acute leukemia: Report of two cases	PEDIATRICS INTERNATIONAL			English	Article						acute leukemia; daptomycin; infective endocarditis; Staphylococcus aureus	STAPHYLOCOCCUS-AUREUS BACTEREMIA; AGRANULOCYTOSIS	There have been few reports regarding infective endocarditis (IE) in patients with leukemia. In the first case, a 15-year-old girl with Down syndrome was diagnosed with acute lymphoblastic leukemia. On admission, methicillin-sensitive Staphylococcus aureus (MSSA) was detected on blood culture. Echocardiography was performed because MSSA was detected repeatedly even after treatment. Vegetation in all of the atria and ventricles met the Duke criteria defining IE. She died of multiple organ failure 21days after diagnosis. In the second case, an 11-year-old boy with acute myeloid leukemia underwent peripheral blood stem cell transplantation (PBSCT). He had fever 68 days after PBSCT, and methicillin-resistant S. aureus (MRSA) was detected on blood culture. Echocardiography showed vegetation in the right atrium and ventricle. Daptomycin was administered for 7weeks, and recurrence was not observed. IE should be considered when S. aureus bacteremia is documented even in patients with leukemia.	[Keino, Dai; Tsuzuki, Yoshimitsu; Mori, Takashi; Kakuage, Shiori; Nakano, Marie; Asoh, Kentaro; Mori, Tetsuya; Kinoshita, Akitoshi; Yamamoto, Hitoshi] St Marianna Univ, Sch Med, Dept Pediat, Kawasaki, Kanagawa 2168511, Japan	Keino, D (reprint author), St Marianna Univ, Sch Med, Dept Pediat, Miyamae Ku, 2-16-1 Sugao, Kawasaki, Kanagawa 2168511, Japan.	d2keino@marianna-u.ac.jp					Kuruvilla J, 2007, BIOL BLOOD MARROW TR, V13, P925, DOI 10.1016/j.bbmt.2007.04.006; Skov R, 1995, SCAND J INFECT DIS, V27, P563, DOI 10.3109/00365549509047068; ESPERSEN F, 1987, ACTA MED SCAND, V222, P465; Mondejar PL, 1997, REV CLIN ESP, V197, P814; SOTMAN SB, 1980, AM J MED, V69, P814, DOI 10.1016/S0002-9343(80)80005-2; BELIK J, 1980, ACTA PAEDIATR SCAND, V69, P731, DOI 10.1111/j.1651-2227.1980.tb07141.x; LIEPMAN MK, 1984, CANCER, V54, P804, DOI 10.1002/1097-0142(19840901)54:5<804::AID-CNCR2820540506>3.0.CO;2-C; Tomizawa D, 2013, LEUKEMIA, V27, P2413, DOI 10.1038/leu.2013.153; Fowler VG, 2006, NEW ENGL J MED, V355, P653, DOI 10.1056/NEJMoa053783; Antachopoulos C, 2012, INFECTION, V40, P367, DOI 10.1007/s15010-011-0240-3; DWYER DE, 1994, MED J AUSTRALIA, V160, P709; Dwyer DE, 1994, MED J AUSTRALIA, V160, P716	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					1017	1020		10.1111/ped.12700		4	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600045		
J	Sato, N; Sugiura, T; Nagasaki, R; Suzuki, K; Ito, K; Kato, T; Inukai, S; Saitoh, S				Sato, Nikiko; Sugiura, Tokio; Nagasaki, Rika; Suzuki, Kazutaka; Ito, Koichi; Kato, Takenori; Inukai, Sachiko; Saitoh, Shinji			Effects of tolvaptan on congestive heart failure complicated with chylothorax in a neonate	PEDIATRICS INTERNATIONAL			English	Article						chylothorax; congestive heart failure; neonate; surgery for congenital heart disease; tolvaptan	HYPONATREMIA; ANTAGONIST; TRIAL	Tolvaptan is an oral vasopressin type 2 receptor antagonist that can be used for heart failure patients with hyponatremia or symptomatic congestion. Although the effects of tolvaptan in adults have been well documented, only limited information is available in children. The case of a neonate with congestive heart failure complicated with chylothorax after palliative surgery for transposition of the great arteries treated with tolvaptan is reported. Slow up-titration to 0.1mg/kg successfully increased urine output and improved refractory congestive heart failure without hypernatremia. Subsequently, bodyweight and chylothorax decreased gradually. Moreover, the use of tolvaptan reduced the dosage of furosemide. Tolvaptan could be an alternative drug for neonates with congestive heart failure. Further large studies are needed to confirm the efficacy and identify the appropriate dose of tolvaptan in neonates.	[Sato, Nikiko; Sugiura, Tokio; Nagasaki, Rika; Suzuki, Kazutaka; Ito, Koichi; Kato, Takenori; Inukai, Sachiko; Saitoh, Shinji] Nagoya City Univ, Grad Sch Med Sci, Dept Pediat & Neonatol, Nagoya, Aichi 4678601, Japan	Sugiura, T (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Pediat & Neonatol, Mizuho Ku, 1 Kawasumi, Nagoya, Aichi 4678601, Japan.	tokio@med.nagoya-cu.ac.jp					Horibata Y, 2014, CARDIOL YOUNG, V24, P155, DOI 10.1017/S1047951112002272; Chan EH, 2005, ANN THORAC SURG, V80, P1864, DOI 10.1016/j.athoracsur.2005.04.048; Udelson JE, 2008, J AM COLL CARDIOL, V52, P1540, DOI 10.1016/j.jacc.2008.08.013; Sharkey AJ, 2012, TEX HEART I J, V39, P428; O'Connell JB, 2012, POSTGRAD MED, V124, P29, DOI 10.3810/pgm.2012.03.2534; Schrier RW, 2006, NEW ENGL J MED, V355, P2099, DOI 10.1056/NEJMoa065181; Regen RB, 2013, PEDIATR CARDIOL, V34, P1463, DOI 10.1007/s00246-013-0671-y; Konstam MA, 2007, JAMA-J AM MED ASSOC, V297, P1319, DOI 10.1001/jama.297.12.1319; Yi Joo-Hark, 2011, Electrolyte Blood Press, V9, P50, DOI 10.5049/EBP.2011.9.2.50	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					1020	1022		10.1111/ped.12697		3	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600046		
J	Sakakibara, K; Okayama, Y; Fukushima, K; Kaji, S; Muraoka, M; Arao, Y; Shimada, A				Sakakibara, Kanae; Okayama, Yoshiki; Fukushima, Kenji; Kaji, Shunsaku; Muraoka, Michiko; Arao, Yujiro; Shimada, Akira			Japanese family with congenital factor VII deficiency	PEDIATRICS INTERNATIONAL			English	Article						factor VII deficiency; hepaplastin test; mutation; vitamin K	MUTATIONS; GENE	Congenital factor VII (FVII) deficiency is a rare bleeding disorder with autosomal recessive inheritance. The present female patient was diagnosed with congenital FVII deficiency because of low hepaplastin test (HPT), although vitamin K was given. Heterozygous p.A191T mutation was detected in the peripheral blood, and the same mutation was also found in the mother and sister. To the best of our knowledge, this is the fourth reported case of p.A191T mutation of FVII in the literature and the first to be reported in Japan. FVII coagulation activity (FVII:C) in asymptomatic heterozygous carriers is mildly reduced. Therefore, some patients may not be accurately diagnosed with congenital FVII deficiency. In infants with low HPT without vitamin K deficiency, congenital FVII deficiency should be considered.	[Sakakibara, Kanae] Okayama Univ Hosp, Div Med Support, Tsuyama, Okayama, Japan; [Muraoka, Michiko; Shimada, Akira] Okayama Univ Hosp, Dept Pediat, Tsuyama, Okayama, Japan; [Sakakibara, Kanae; Arao, Yujiro] Okayama Univ, Grad Sch Hlth Sci, Field Med Technol, Tsuyama, Okayama, Japan; [Okayama, Yoshiki; Fukushima, Kenji; Kaji, Shunsaku] Tsuyama Cent Hosp, Dept Pediat, Tsuyama, Okayama, Japan	Shimada, A (reprint author), Okayama Univ Hosp, Dept Pediat, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	pajj236e@okayama-u.ac.jp					Herrmann FH, 2009, HAEMOPHILIA, V15, P267, DOI 10.1111/j.1365-2516.2008.01910.x; McVey JH, 2001, HUM MUTAT, V17, P3, DOI 10.1002/1098-1004(2001)17:1<3::AID-HUMU2>3.0.CO;2-V; Borensztajn K, 2005, THROMB RES, V116, P115, DOI 10.1016/j.thromres.2004.11.005; TUDDENHAM EGD, 1995, THROMB HAEMOSTASIS, V74, P313; OHARA PJ, 1987, P NATL ACAD SCI USA, V84, P5158, DOI 10.1073/pnas.84.15.5158; Landau D, 2009, HAEMOPHILIA, V15, P774, DOI 10.1111/j.1365-2516.2009.02004.x; Erduran E, 1998, HAEMOSTASIS, V28, P14; Giansily-Blaizot M, 2001, EUR J HUM GENET, V9, P105, DOI 10.1038/sj.ejhg.5200593; Mariani G, 2009, SEMIN THROMB HEMOST, V35, P400, DOI 10.1055/s-0029-1225762	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					1023	1024		10.1111/ped.12696		2	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600047		
J	Kobayashi, R; Suzuki, D; Hori, D; Kishimoto, K; Sano, H; Nakazawa, A; Yasuda, K; Kobayashi, K				Kobayashi, Ryoji; Suzuki, Daisuke; Hori, Daiki; Kishimoto, Kenji; Sano, Hirozumi; Nakazawa, Atsuko; Yasuda, Kazue; Kobayashi, Kunihiko			Spontaneous improvement in a pediatric patient with peripheral T-cell lymphoma	PEDIATRICS INTERNATIONAL			English	Article						child; hemophagocytic syndrome; peripheral T-cell lymphoma	HEMOPHAGOCYTIC SYNDROME; CHILDHOOD	Peripheral T-cell lymphoma (PTCL) is rare in children, and it has a poor prognosis compared with other types of lymphoma. We report the case of a 7-year-old boy with spontaneous improvement of PTCL complicated by hemophagocytic syndrome as the initial symptom. He complained of pain and swelling of the right neck and presented with high fever. Pancytopenia, liver dysfunction, elevated ferritin and soluble interleukin 2 receptor were noted on laboratory tests. Peripheral blood plasma and white blood cells were positive for Epstein-Barr virus (EBV) genome but, after several days, the fever abated and laboratory data improved. On histopathology of lymph node biopsy, he was diagnosed as having PTCL not otherwise specified (PTCL-NOS) with EBV infection. He received no chemotherapy and was disease free at the last follow up, 6years 8months after onset. This is probably the first case of spontaneous improvement in PTCL-NOS. Careful treatment planning is therefore necessary in PTCL-NOS, given the possibility of spontaneous improvement of symptoms.	[Kobayashi, Ryoji; Suzuki, Daisuke; Hori, Daiki; Kishimoto, Kenji; Sano, Hirozumi; Yasuda, Kazue; Kobayashi, Kunihiko] Sapporo Hokuyu Hosp, Dept Pediat, Shiroishi Ku, Sapporo, Hokkaido 0030006, Japan; [Nakazawa, Atsuko] Natl Ctr Child Hlth & Dev, Dept Pathol, Setagaya Ku, Tokyo, Japan	Kobayashi, R (reprint author), Sapporo Hokuyu Hosp, Dept Pediat, Shiroishi Ku, Higashi Sapporo 6-6, Sapporo, Hokkaido 0030006, Japan.	r-koba@jacls.jp					Windsor R, 2008, PEDIATR BLOOD CANCER, V50, P784, DOI 10.1002/pbc.21293; Kobayashi R, 2010, PEDIATR BLOOD CANCER, V54, P212, DOI 10.1002/pbc.22329; Medhi K, 2008, J PEDIAT HEMATOL ONC, V30, P558, DOI 10.1097/MPH.0b013e31817588e8; Brodkin DE, 2008, J PEDIAT HEMATOL ONC, V30, P938, DOI 10.1097/MPH.0b013e31817e4b25; Imashuku S, 1997, INT J HEMATOL, V66, P135; Lim GY, 2009, PEDIATR RADIOL, V39, P57, DOI 10.1007/s00247-008-1002-y; Hutchison RE, 2008, PEDIATR BLOOD CANCER, V51, P29, DOI 10.1002/pbc.21543; Tong HY, 2008, LEUKEMIA LYMPHOMA, V49, P81, DOI 10.1080/10428190701713630; International T cell lymphomas Project, 2008, J CLIN ONCOL, V26, P4124, DOI 10.1200/JCO.2008.16.4558	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					1035	1037		10.1111/ped.12784		3	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600051		
J	Higashigawa, M; Maeyama, T; Yoshino, A; Matsuda, K; Ito, M; Maji, T; Ichimi, R				Higashigawa, Masamune; Maeyama, Takatoshi; Yoshino, Ayako; Matsuda, Kazuyuki; Ito, Mitsue; Maji, Tomoaki; Ichimi, Ryouji			Incidence of childhood primary immune thrombocytopenic purpura	PEDIATRICS INTERNATIONAL			English	Article						child; immune thrombocytopenic purpura; incidence		There is a discrepancy in the reported incidence of childhood immune thrombocytopenic purpura (ITP) between Europe (2.9-5.3 per 100 000 persons) and Japan (1.91). Ise district is a suitable area in which to conduct epidemiological study because there is little fluctuation in the sociodemographic factors. We performed a retrospective population-based study to clarify the incidence of primary childhood ITP. We calculated person-years for children aged <15 years based on the Ise district demographics between 2002 and 2012. The calculated person-years were 298 533. The number of hospitalized patients in Ise district was 25 (M/F, 14/11) during the study period. The calculated incidence was therefore 8.4 per 100 000 person-years. It is possible that the difference in incidence between the present calculation and that of the European studies is due to variation in accuracy and/or registration criteria between the studies.	[Higashigawa, Masamune; Maeyama, Takatoshi; Yoshino, Ayako; Matsuda, Kazuyuki; Ito, Mitsue; Maji, Tomoaki; Ichimi, Ryouji] Ise Red Cross Hosp, Dept Pediat, Ise, Mie 5168512, Japan	Higashigawa, M (reprint author), Ise Red Cross Hosp, Dept Pediat, 1-471-2 Funae, Ise, Mie 5168512, Japan.	higashigawa@hotmail.com					LILLEYMAN JS, 1994, ARCH DIS CHILD, V71, P251; Watts RG, 2004, CLIN PEDIATR, V43, P691, DOI 10.1177/000992280404300802; Zeller B, 2000, PEDIATR HEMAT ONCOL, V17, P551; COHN J, 1976, SCAND J HAEMATOL, V16, P226; BoltonMaggs PHB, 1997, LANCET, V350, P620, DOI 10.1016/S0140-6736(97)04143-3; Kurata Y, 2011, INT J HEMATOL, V93, P329, DOI 10.1007/s12185-011-0791-1; Shirahata A, 2006, INT J HEMATOL, V83, P29, DOI 10.1532/IJH97.05123	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					1041	1043		10.1111/ped.12788		3	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600053		
J	Yamamoto-Hanada, K; Futamura, M; Kitazawa, H; Ohya, Y; Kobayashi, F; Kusuda, T; Sanefuji, M; Oda, M; Mitsubuchi, H; Shibata, E; Tsuji, M; Kayama, F; Nakano, Y; Suda, E; Michikawa, T; Katoh, T; Saito, H				Yamamoto-Hanada, Kiwako; Futamura, Masaki; Kitazawa, Hiroshi; Ohya, Yukihiro; Kobayashi, Fumio; Kusuda, Takeshi; Sanefuji, Masafumi; Oda, Masako; Mitsubuchi, Hiroshi; Shibata, Eiji; Tsuji, Mayumi; Kayama, Fujio; Nakano, Yuko; Suda, Eiko; Michikawa, Takehiro; Katoh, Takahiko; Saito, Hirohisa			Relieving pain and distress during venipuncture: Pilot study of the Japan Environment and Children's Study (JECS)	PEDIATRICS INTERNATIONAL			English	Article						distress; lidocaine/prilocaine cream; pain; psychological intervention in venipuncture		Pain management for needle-related procedures is poor in Japan. In many countries the use of lidocaine/prilocaine cream for the relief of pain associated with venipuncture has been approved. In children, a psychological approach has also been shown to be effective in reducing pain with venipuncture. We developed a multidisciplinary procedure that combines a cream (2.5% lidocaine and 2.5% prilocaine) and pharmacological approaches such as preparation, education, positioning and distraction. We evaluated the feasibility and acceptability of the procedure for young children. Among 132 pediatric participants, 58.3% did not cry during venipuncture. According to caregiver questionnaire, 71.9% felt that the multidisciplinary procedure eliminated the fear of needle-related procedures in the children; 90.9% were satisfied with it and 75.8% thought it should be applied to all children undergoing venipuncture. The present results suggest that the multidisciplinary procedure is feasible, acceptable and suitable for use in children undergoing venipuncture.	[Yamamoto-Hanada, Kiwako; Futamura, Masaki; Kitazawa, Hiroshi; Ohya, Yukihiro; Saito, Hirohisa] Natl Ctr Child Hlth & Dev, Med Support Ctr Japan Environm & Childrens Study, Tokyo 1578535, Japan; [Yamamoto-Hanada, Kiwako; Kobayashi, Fumio] Aichi Med Univ, Sch Med, Dept Hlth & Psychosocial Med, Nagoya, Aichi, Japan; [Kusuda, Takeshi] Kyushu Univ Hosp, Dept Pediat, Fukuoka 812, Japan; [Sanefuji, Masafumi] Kyushu Univ, Res Ctr Environm & Dev Sci, Fukuoka 812, Japan; [Shibata, Eiji] Univ Occupat & Environm Hlth, Sch Med, Dept Obstet & Gynecol, Fukuoka, Japan; [Tsuji, Mayumi] Univ Occupat & Environm Hlth, Sch Med, Dept Environm Hlth, Fukuoka, Japan; [Oda, Masako; Mitsubuchi, Hiroshi; Katoh, Takahiko] Kumamoto Univ, Japan Environm & Childrens Study, South Kyushu & Okinawa Reg Ctr, Kumamoto, Japan; [Kayama, Fujio] Jichi Med Univ, Sch Med, Dept Environm & Prevent Med, Shimotsuke, Tochigi, Japan; [Nakano, Yuko] Jichi Med Univ, Sch Med, Dept Pediat, Shimotsuke, Tochigi, Japan; [Suda, Eiko; Michikawa, Takehiro] Natl Inst Environm Studies, Natl Ctr Japan Environm & Childrens Study, Ibaraki, Japan; [Kitazawa, Hiroshi] Miyagi Childrens Hosp, Dept Gen Pediat, Sendai, Miyagi, Japan	Yamamoto-Hanada, K (reprint author), Natl Ctr Child Hlth & Dev, Med Support Ctr Japan Environm & Childrens Study, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	yamamoto-k@ncchd.go.jp		Yamamoto-Hanada, Kiwako/0000-0003-1288-9620	Ministry of the Environment, Japan	We are extremely grateful to all study participants and members of the pilot study for the JECS. We thank Ms Megumi Aiyoshi, a child life specialist, for advice. We thank Dr Julian Tang of the Department of Education for Clinical Research, National Center for Child Health and Development, for assistance with the manuscript. This study was supported by a grant for Japan Environment and Children's Pilot Study from the Ministry of the Environment, Japan. The findings and conclusions of this article are solely the responsibility of the authors and do not represent the official views of the aforementioned government. The authors declare no conflicts of interest.	Inal S, 2012, INT J NURS PRACT, V18, P210, DOI 10.1111/j.1440-172X.2012.02016.x; Taddio A, 2010, CAN MED ASSOC J, V182, P1989, DOI 10.1503/cmaj.092048; HARRISON A, 1991, PAIN, V45, P299, DOI 10.1016/0304-3959(91)90054-2; Eden L, 2014, PEDIAT HLTH MED THER, V5, P127; Kawamoto T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-25; McLure H A, 2005, Minerva Anestesiol, V71, P59; Rogers Tanya L, 2004, J Pediatr Nurs, V19, P33, DOI 10.1016/j.pedn.2003.09.005; Uman LS, 2013, COCHRANE DB SYST REV, V10	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					1044	1047		10.1111/ped.12818		4	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600054		
J	Tagawa, M; Wakabayashi, H				Tagawa, Manabu; Wakabayashi, Hiroto			Ingested large fish hook in the stomach of a 2-year-old boy	PEDIATRICS INTERNATIONAL			English	Editorial Material									[Tagawa, Manabu; Wakabayashi, Hiroto] Takeda Gen Hosp, Dept Gastroenterol, Fukushima, Japan; [Tagawa, Manabu] Univ Tsukuba, Univ Tsukuba Hosp, Dept Pediat, Tsukuba, Ibaraki 3058576, Japan	Tagawa, M (reprint author), Univ Tsukuba, Univ Tsukuba Hosp, Dept Pediat, 2-1-1 Amakubo, Tsukuba, Ibaraki 3058576, Japan.	manabutagawa@jeans.ocn.ne.jp					Iwamuro M, 2009, GASTROINTEST ENDOSC, V70, P550, DOI 10.1016/j.gie.2009.04.023; Pan Cheng-Ching, 2010, J Emerg Med, V38, pe45, DOI 10.1016/j.jemermed.2007.08.062	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					1048	1048		10.1111/ped.12729		1	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600055		
J	Onoda, T; Meguro, T; Kanno, M; Ohta, H; Nakamura, M; Ohtake, H; Mitsui, T				Onoda, Tadashi; Meguro, Toru; Kanno, Miyako; Ohta, Hiroshi; Nakamura, Megumi; Ohtake, Hiroya; Mitsui, Tetsuo			Giant thymolipoma in a young child initially diagnosed as cardiomegaly	PEDIATRICS INTERNATIONAL			English	Editorial Material									[Onoda, Tadashi; Meguro, Toru; Kanno, Miyako; Mitsui, Tetsuo] Yamagata Univ, Dept Pediat, Fac Med, Yamagata, Yamagata 9909585, Japan; [Ohta, Hiroshi; Nakamura, Megumi] Yamagata Univ, Dept Surg 2, Fac Med, Yamagata, Yamagata 9909585, Japan; [Ohtake, Hiroya] Yamagata Univ, Dept Pathol, Fac Med, Yamagata, Yamagata 9909585, Japan; [Onoda, Tadashi] Yamagata Prefectural Cent Hosp, Dept Pediat, Yamagata, Japan	Onoda, T (reprint author), Yamagata Univ, Dept Pediat, Fac Med, 2-2-2 Iida Nishi, Yamagata, Yamagata 9909585, Japan.	onoda-t@med.id.yamagata-u.ac.jp					Halnon NJ, 2005, PEDIATR RES, V57, P42, DOI 10.1203/01.PDR.0000147735.19342.DE; Sauce D, 2009, J CLIN INVEST, V119, P3070, DOI 10.1172/JCI39269; Hudacko R, 2009, ANN DIAGN PATHOL, V13, P185, DOI 10.1016/j.anndiagpath.2008.02.006; MORAN CA, 1995, MODERN PATHOL, V8, P741; Parakh A, 2014, PAEDIATR INT CHILD H, V34, P230, DOI 10.1179/2046905513Y.0000000108	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					1051	1052		10.1111/ped.12786		2	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600057		
J	Morioka, I; Yamana, K; Kurokawa, D; Nishida, K; Nagasaka, M; Fujita, K; Fukushima, S; Tokuda, O; Iwatani, S; Koda, T				Morioka, Ichiro; Yamana, Keiji; Kurokawa, Daisuke; Nishida, Kosuke; Nagasaka, Miwako; Fujita, Kaori; Fukushima, Sachiyo; Tokuda, Oshi; Iwatani, Sota; Koda, Tsubasa			How long is transient tachypnea of the newborn dependent on oxygen supplementation?	PEDIATRICS INTERNATIONAL			English	Letter									[Morioka, Ichiro; Yamana, Keiji; Kurokawa, Daisuke; Nishida, Kosuke; Nagasaka, Miwako; Fujita, Kaori; Fukushima, Sachiyo; Tokuda, Oshi; Iwatani, Sota; Koda, Tsubasa] Kobe Univ, Grad Sch Med, Dept Pediat, Kobe, Hyogo 6500017, Japan	Morioka, I (reprint author), Kobe Univ, Grad Sch Med, Dept Pediat, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	ichim@med.kobe-u.ac.jp					Ochi F, 2015, PEDIATR INT, V57, P263, DOI 10.1111/ped.12505; Welty S, 2005, AVERYS DIS NEWBORN, P697	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					1054	1055		10.1111/ped.12768		2	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600059		
J	Takakura, M; Shimizu, M; Inoue, N; Tasaki, Y; Ishikawa, S; Ohta, K; Yachie, A				Takakura, Maiko; Shimizu, Masaki; Inoue, Natsumi; Tasaki, Yuko; Ishikawa, Sayaka; Ohta, Kazuhide; Yachie, Akihiro			Iodine-induced non-autoimmune hypothyroidism in a patient with steroid-resistant nephrotic syndrome	PEDIATRICS INTERNATIONAL			English	Letter							CHILDREN		[Takakura, Maiko; Shimizu, Masaki; Inoue, Natsumi; Tasaki, Yuko; Ishikawa, Sayaka; Yachie, Akihiro] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Sch Med, Dept Pediat, Kanazawa, Ishikawa 9208641, Japan; [Ohta, Kazuhide] Kanazawa Med Ctr, Dept Pediat, Kanazawa, Ishikawa, Japan	Shimizu, M (reprint author), Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Sch Med, Dept Pediat, 13-1 Takaramachi, Kanazawa, Ishikawa 9208641, Japan.	shimizum@staff.kanazawa-u.ac.jp					Kapoor K, 2014, CLIN EXP NEPHROL, V18, P113, DOI 10.1007/s10157-013-0800-1; Dagan A, 2012, NEPHROL DIAL TRANSPL, V27, P2171, DOI 10.1093/ndt/gfr665; Padovani RP, 2012, THYROID, V22, P926, DOI 10.1089/thy.2012.0099; FONSECA V, 1991, LANCET, V338, P475, DOI 10.1016/0140-6736(91)90546-2; CORRADI A, 1990, ARZNEIMITTEL-FORSCH, V40-2, P830; Bando Y, 2002, EXP CLIN ENDOCR DIAB, V110, P408, DOI 10.1055/s-2002-36427; Ho JD, 2014, J THYROID RES, V2014	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					1055	1056		10.1111/ped.12759		2	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600060		
J	Yana, E; Mayama, S				Yana, Ekkachai; Mayama, Shigeki			Two new taxa of Achnanthidium and Encyonema (Bacillariophyceae) from the Yom River, Thailand, with special reference to the areolae occlusions implying ontogenetic relationship	PHYCOLOGICAL RESEARCH			English	Article						Achnanthidium pseudoconspicuum var; yomensis; Encyonema yuwadeeanum; hymen; new species; new variety; South-East Asia; valve ontogeny	BENTHIC DIATOMS; NITZSCHIA; MORPHOLOGY; MODEL	We discovered two new taxa of Achnanthidium and Encyonema occurring with high abundance in the upstream of the Yom River, which is one of four major rivers in Northern Thailand. Achnanthidium pseudoconspicuum var. yomensis var. nov. closely resembles Achnanthidium pseudoconspicuum var. pseudoconspicuum in scanning electron microscopy (SEM), but has clearly different valve morphometry under the light microscopy (LM). Achnanthidium pseudoconspicuum var. yomensis is also similar to A.japonicum in valve morphology under LM, but differs to this species based on SEM observation. Encyonema yuwadeeanum sp. nov. shows similarities to Encyonema leei and Encyonema subkukenanum, but differs in valve shape and/or polar fissure shape. We discuss the possible valve ontogenetic relationship between Achnanthidium and Cymbellales based on the detailed areolae structures of these two new taxa.	[Yana, Ekkachai] Chiang Mai Univ, Fac Sci, Environm Sci Program, Chiang Mai 50000, Thailand; [Yana, Ekkachai] Lampang Rajabhat Univ, Environm Sci Program, Fac Sci, Lampang, Thailand; [Mayama, Shigeki] Tokyo Gakugei Univ, Dept Biol, Koganei, Tokyo 184, Japan	Yana, E (reprint author), Chiang Mai Univ, Fac Sci, Environm Sci Program, Chiang Mai 50000, Thailand.	ekkachai_y@hotmail.co.th			Center of Excellence on Environmental Health, Toxicology and Management of Chemicals and Graduate School, Chiang Mai University, Thailand	We thank Nina Lundholm for sending type material and slides from the Foged's Collection, Copenhagen. This study was partly supported by a grant from the Center of Excellence on Environmental Health, Toxicology and Management of Chemicals and Graduate School, Chiang Mai University, Thailand.	Willis L, 2010, PLANT ECOL EVOL, V143, P297, DOI 10.5091/plecevo.2010.415; Mayama S, 2004, PHYCOL RES, V52, P129; Suphan S, 2010, CHIANG MAI J SCI, V37, P326; REICHARDT E, 1988, NOVA HEDWIGIA, V47, P81; [Anonymous], 1975, NOVA HEDWIGIA S, V53, P323; Kermarrec L, 2011, DIATOM RES, V26, P305, DOI 10.1080/0269249X.2011.633255; Sumper M, 2002, SCIENCE, V295, P2430, DOI 10.1126/science.1070026; KOBAYASI H, 1985, HYDROBIOLOGIA, V127, P97, DOI 10.1007/BF00004189; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Bukhtiyarova LN, 2006, NOVA HEDWIGIA, P85; Tremarin PI, 2011, NOVA HEDWIGIA, V92, P107, DOI 10.1127/0029-5035/2011/0092-0107; MartinezGoss MR, 1997, P ACAD NAT SCI PHILA, V147, P119; Juttner I, 2011, DIATOM RES, V26, P21, DOI 10.1080/0269249X.2011.573707; Kobayasi H, 1997, NOVA HEDWIGIA, V65, P147; Rimet F, 2011, DIATOM RES, V26, P273, DOI 10.1080/0269249X.2011.597988; Cox EJ, 2012, J PHYCOL, V48, P1, DOI 10.1111/j.1529-8817.2011.01081.x; Kroger N, 2007, CURR OPIN CHEM BIOL, V11, P662, DOI 10.1016/j.cbpa.2007.10.009; Cox E.J., 2004, DIATOM, V20, P33; Cox E.J., 1981, P 6 S REC FOSS DIAT, P267; Eaton AE, 2005, STANDARD METHOD EXAM; Foged N, 1971, NOVA HEDWIGIA, V22, P267; Fujita Y., 2005, DIATOM, V21, P71; Helmcke J. G., 1962, DIATOMEENSCHALEN E 2; Hustedt F., 1937, ARCH HYDROBIOL S, V15, P638; Hustedt F., 1937, ARCH HYDROBIOL S, V16, p[1937, 274]; Hustedt Friedrich, 1942, INTERNAT REV GES HYDROBIOL U HYDROGR, V42, P1, DOI 10.1002/iroh.19420420102; HUSTEDT F., 1937, ARCH HYDROBIOL S, V15, p[131, 638, 9]; Hustedt F., 1937, ARCH HYDROBIOL S, V15, P187; Hustedt F., 1937, ARCH HYDROBIOL S, V15, P393; HUSTEDT F., 1937, ARCH HYDROBIOL S, V16, P1; Kobayashi H., 1986, Proceedings IECON '86. 1986 International Conference on Industrial Electronics, Control and Instrumentation. Industrial Applications of Mini, Micro and Personal Computers (Cat. No.86CH2334-1); Kobayasi H., 1986, DIATOM, V2, P83; Kobayasi H., 2006, H KOBAYASIS ATLAS JA; Krammer K., 1997, CYMBELLOIDEN DIATO 1, V36; Krammer K., 1997, CYMBELLOIDEN DIATO 2, V37; Krammer K., 1982, MICROMORPHOLOGY DIAT, V11; Kulikovskiy M. S., 2012, LAKE BAIKAL HOTSPOT, V23; Lee J. H., 1994, DIATOM, V9, P17; Lee J. H., 1992, DIATOM, V7, P45; Leelahakriengkrai P., 2010, ASIA, V3, P82; Leelahakriengkrai P, 2011, INT J AGRIC BIOL, V13, P309; Mann D. G., 1981, P 6 S REC FOSS DIAT, P279; Martinez-Goss M. R., 2010, PHILIPP J SCI, V139, P207; Martinez-Goss M. R., 2001, SCI DILIMAN, V13, P1; Martinez-Goss M. R., 2011, PHILIPP J SCI, V140, P7; MAYAMA S, 1991, Japanese Journal of Phycology, V39, P131; Metzeltin D., 2003, DIATOMAS URUGUAYAS; Ohtsuka T., 2009, DIATOM, V25, P134; Ohtsuka T., 2004, DIATOM, V20, P145; Okuno H., 1974, DIATOMEENSCHALEN ELE, P825; Pekthong T., 2001, CHIANG MAI J SCI, V28, P97; Podzorski A. C., 1987, FRESHWATER MARINE DI, V13; Potapova G. M., 2004, DIATOM RES, V19, P33; Potapova G. M., 2014, PHYTOTAXA, V184, P115; Potapova G. M., 2012, DIATOM RES, V27, P29; Ross R., 1979, NOVA HEDWIGIA BEIH, V64, P513; ROUND F. E., 1990, DIATOMS BIOL MORPHOL; Salleh A., 1995, DIATOM, V10, P49; Salleh A., 1994, DIATOM, V9, P73; Suzawa T., 2011, DIATOM, V27, P58; Suzuki H, 2014, PHYTOTAXA, V161, P219; Suzuki H., 2012, PHYTOTAXA, V68, P35; Watanabe T., 1987, DIATOM, V3, P33; Whitton B. A., 1996, USE ALGAE MONITORING; Yamakawa S., 1997, DIATOM, V13, P233; Yana E., 2013, INT J APPL ENV SCI, V8, P1935	66	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1322-0829	1440-1835		PHYCOL RES	Phycol. Res.	OCT	2015	63	4					239	252		10.1111/pre.12109		14	Marine & Freshwater Biology	Marine & Freshwater Biology	CU6SF	WOS:000363663000001		
J	Miyamura, S; Nagumo, T; Maegawa, M; Hori, T				Miyamura, Shinichi; Nagumo, Tamotsu; Maegawa, Miyuki; Hori, Terumitsu			Rearrangement of the flagellar apparatuses and eyespots of isogametes during the fertilization of the marine green alga, Monostroma nitidum (Ulvophyceae, Chlorophyta)	PHYCOLOGICAL RESEARCH			English	Article						basal body; cell fusion; eyespot; flagellar apparatus; gamete; mating structure; microtubular root; Monostroma	FINE-STRUCTURAL ASPECTS; ULVA-LACTUCA ULVALES; ULOTHRIX-FLACCA VAR; CELL-FUSION SITE; CHLAMYDOMONAS-REINHARDTII; MATING STRUCTURE; SPATIAL ARRANGEMENT; BASAL BODY; ULTRASTRUCTURE; ZYGOTES	Behaviors of the flagellar apparatuses (flagella, basal bodies, microtubular roots, etc.), mating structures and eyespots of gametes during the fertilization of Monostroma nitidum were studied using field emission scanning electron microscopy and transmission electron microscopy. The biflagellate isogamete (mt(+) and mt(-)) mating structure has a position that is converse between mt(+) and mt(-) gametes relative to the flagellar beat plane and the eyespot. After the adhesion of mt(+) and mt(-) gametes, gamete fusion occurred between the two mating structures. The cell fusion plane expanded to the cell surface as circumscribed by 1s-2d roots in mt(+) gamete and 1d-2s roots in the mt(-) gamete. Two sets of flagellar apparatuses lay side by side in the planozygote and soon become mutually close. The no.1 basal body of mt(+) gamete and the no.2 basal body of mt(-) gamete rotated in a counterclockwise direction, as viewed from the cell anterior. Then, the no. 2 basal body of mt(+) gamete and the no. 1 basal body of mt(-) gamete slid into a face to face position. Finally, four flagella and basal bodies exhibited a cruciate arrangement. The basal bodies of the opposing pair (no. 1 and no. 2) were offset in a counterclockwise orientation by the basal body diameter. The 1s and 2d roots of the mt(+) gamete lay nearly parallel to the 1d and 2s roots of the mt(-) gamete, respectively, at the cell fusion plane. Because of the asymmetric localization of the mating structure, association, and subsequent rearrangement of basal bodies and microtubular roots, two eyespots lay on the same side of the planozygote. After the settlement of the planozygote, the flagellar apparatus started to disintegrate in the zygote cytoplasm.	[Miyamura, Shinichi] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Hori, Terumitsu] Lab Ginkgo Sci, Tsukuba, Ibaraki, Japan; [Nagumo, Tamotsu] Nippon Dent Univ Tokyo, Dept Biol, Tokyo, Japan; [Maegawa, Miyuki] Mie Univ, Fac Bioresources, Lab Phycol, Tsu, Mie 514, Japan	Miyamura, S (reprint author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan.	shinichi.miyamura.fw@u.tsukuba.ac.jp			KAKENHI [22570084, 20370025, 22370024, 25291070]	This work was partly supported by a KAKENHI Grant-in-Aid for Scientific Research (C) (No. 22570084) and (b) (No. 20370025, 22370024, 25291070).	Mogi Y, 2008, J PHYCOL, V44, P1290, DOI 10.1111/j.1529-8817.2008.00573.x; O'kelly CJ, 2004, J PHYCOL, V40, P209, DOI 10.1046/j.1529-8817.2004.03104.x; ANDERSEN RA, 1991, PROTOPLASMA, V164, P1, DOI 10.1007/BF01320809; Calado AJ, 2006, J PHYCOL, V42, P434, DOI 10.1111/j.1529-8817.2006.00195.x; Miyamura S, 2010, PHYCOL RES, V58, P258, DOI 10.1111/j.1440-1835.2010.00585.x; OKELLY CJ, 1984, PLANT SYST EVOL, V144, P179, DOI 10.1007/BF00984132; BERGERPERROT Y, 1986, PROTOPLASMA, V134, P17, DOI 10.1007/BF01276372; WEISS RL, 1984, J CELL SCI, V67, P133; FOREST CL, 1983, EXP CELL RES, V148, P143, DOI 10.1016/0014-4827(83)90194-5; JONSSON S, 1974, CR ACAD SCI D NAT, V278, P1557; Callow ME, 1997, J PHYCOL, V33, P938, DOI 10.1111/j.0022-3646.1997.00938.x; ROBENEK H, 1981, J CELL SCI, V50, P149; HEIMANN K, 1989, PROTOPLASMA, V148, P106, DOI 10.1007/BF02079329; KORNMANN P, 1977, HELGOLAND WISS MEER, V29, P1, DOI 10.1007/BF01611137; Miyamura S, 2009, CYTOLOGIA, V74, P409; Nagasato C, 2005, J PLANT RES, V118, P361, DOI 10.1007/s10265-005-0244-0; RINGO DL, 1967, J CELL BIOL, V33, P543, DOI 10.1083/jcb.33.3.543; MELKONIAN M, 1980, J CELL SCI, V46, P149; GOODENOUGH UW, 1975, J CELL BIOL, V67, P623, DOI 10.1083/jcb.67.3.623; HOFFMAN LR, 1973, J PHYCOL, V9, P62, DOI 10.1111/j.0022-3646.1973.00062.x; Kreimer G, 2009, CURR GENET, V55, P19, DOI 10.1007/s00294-008-0224-8; MOESTRUP O, 1989, PROTOPLASMA, V148, P41, DOI 10.1007/BF01403990; MELKONIAN M, 1989, PLANT SYST EVOL, V164, P93, DOI 10.1007/BF00940432; BERGERPERROT Y, 1993, PHYCOLOGIA, V32, P356, DOI 10.2216/i0031-8884-32-5-356.1; FOSTER KW, 1980, MICROBIOL REV, V44, P572; Miyamura S, 2007, PHYCOL RES, V55, P47, DOI 10.1111/j.1440-1835.2006.00444.x; Miyamura S, 2005, J PHYCOL, V41, P114, DOI 10.1111/j.1529-8817.2005.04124.x; HOLMES JA, 1989, J CELL SCI, V94, P273; Geimer S, 2004, J CELL SCI, V117, P2663, DOI 10.1242/jcs.01120; JONSSON S, 1984, B SOC BOT FR-LETT, V131, P247; CAVALIER.T, 1974, J CELL SCI, V16, P529; CLAYTON MN, 1992, BRIT PHYCOL J, V27, P219; FLETCHER RL, 1992, BRIT PHYCOL J, V27, P303; FRIEDMAN.I, 1968, J CELL SCI, V3, P115; Gaffal K. P., 1991, ENDOCYT CELL RES, V8, P151; Graham L. E., 2009, ALGAE; HORIGUCHI T, 1991, Journal of Phycology, V27, P32; HORI T, 1988, Japanese Journal of Phycology, V36, P113; Kida W., 1967, J FAC FISH PREF U MI, V7, P81; Margulis L., 1989, HDB PROTOCTISTA; Melkonian M., 1984, Progress phycol. Res., V3, P193; Miyamura Shinichi, 2003, Phycological Research, V51, P143, DOI 10.1111/j.1440-1835.2003.tb00180.x; Miyamura Shinichi, 2005, Cytologia (Tokyo), V70, P93, DOI 10.1508/cytologia.70.93; Moestrup O., 2000, FLAGELLATES UNITY DI, P69; Nakayama Takeshi, 2000, Phycological Research, V48, P63, DOI 10.1046/j.1440-1835.2000.00186.x; TATEWAKI M, 1969, Scientific Papers of the Institute of Algological Research Faculty of Science Hokkaido University, V6, P1	46	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1322-0829	1440-1835		PHYCOL RES	Phycol. Res.	OCT	2015	63	4					284	299		10.1111/pre.12108		16	Marine & Freshwater Biology	Marine & Freshwater Biology	CU6SF	WOS:000363663000005		
J	Nishihara, GN; Yamada, C; Kimura, R; Terada, R				Nishihara, Gregory N.; Yamada, Chizuru; Kimura, Ryutaro; Terada, Ryuta			Under slow flow conditions, daily rates of canopy photosynthesis of marine macrophytes were insensitive to model choice and flow-rate	PHYCOLOGICAL RESEARCH			English	Article						canopy respiration; gross photosynthesis; hydrodynamics; mass transport; net photosynthesis; state-space model	KELP MACROCYSTIS-PYRIFERA; ECOSYSTEM METABOLISM; BOUNDARY-LAYERS; WATER-FLOW; THALASSIA-TESTUDINUM; AQUATIC MACROPHYTES; NITRATE UPTAKE; OXYGEN; MACROALGAE; COMMUNITY	Water motion drives the flux of suspended and dissolved material (e.g., nutrients, gametes, and dissolved oxygen) to and from macrophyte canopies, and is one of the most important mechanisms that can regulate the growth, survival, and persistence of marine macrophytes populations. At small spatial scales (e.g., lamina or leaves and individuals), increasing flow-rates have been demonstrated to enhance physiological processes, especially photosynthesis rates, and we expected a similar response at the canopy scale. We conducted seven experiments over 25 days using a pair of open-air flow-chambers under natural light, temperature, and seawater conditions. In the four marine macrophyte (Sargassum piluliferum, S.siliquastrum, S.thunbergii, and Zostera marina) canopies examined, an increase in flow-rate did not enhance photosynthesis rates. The odds that daily gross photosynthesis rates increase with a decrease in flow-rates was 1.77 to 1. We also examined if two non-linear equations and one linear equation, often used to describe the relationship between photosynthesis to photosynthetic photon flux density (PPFD), biased estimates of the daily rates of photosynthesis and respiration. It was revealed that the functional form of the equation strongly influenced photosynthesis and respiration rate estimates at short time scales (i.e., minutes), however, daily rates were insensitive to the type of equation used to model the relationship between photosynthesis and PPFD. We suggest that the predominance of photosynthesis rates occurring in under-saturating PPFD conditions (> 40 % of daylight hours) may be one of the reasons for this insensitivity.	[Nishihara, Gregory N.] Nagasaki Univ, Inst East China Sea Res, Nagasaki 852, Japan; [Yamada, Chizuru] Nagasaki Univ, Fac Fisheries, Nagasaki 852, Japan; [Kimura, Ryutaro] Pacific Consultants Co Ltd, Tokyo, Japan; [Terada, Ryuta] Kagoshima Univ, Fac Fisheries, Kagoshima 890, Japan	Nishihara, GN (reprint author), Nagasaki Univ, Inst East China Sea Res, Nagasaki 852, Japan.	greg@nagasaki-u.ac.jp	Terada, Ryuta/O-2813-2013	Terada, Ryuta/0000-0003-3193-6592	Japanese Ministry of Education, Culture, Sport and Technology [22510033, 25450260]; Ministry of Education, Culture, Sports, Science and Technology, Japan (Sustainable Aquatic Food and Environment Project in the East China Sea)	This research was sponsored in part by a Grant-in-Aid for Scientific Research (#22510033 and #25450260) from the Japanese Ministry of Education, Culture, Sport and Technology (RT and GNN) and in part by a grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan (Sustainable Aquatic Food and Environment Project in the East China Sea) to GNN.	Raven JA, 2012, PHOTOSYNTH RES, V113, P105, DOI 10.1007/s11120-012-9768-z; Cornwall CE, 2013, LIMNOL OCEANOGR, V58, P121, DOI 10.4319/lo.2013.58.1.0121; Enriquez S, 2006, MAR ECOL PROG SER, V323, P119, DOI 10.3354/meps323119; Nishihara GN, 2010, PHYCOL RES, V58, P29, DOI 10.1111/j.1440-1835.2009.00555.x; KOCH EW, 1994, MAR BIOL, V118, P767, DOI 10.1007/BF00347527; EHLERINGER J, 1977, PLANT PHYSIOL, V59, P86, DOI 10.1104/pp.59.1.86; Holtgrieve GW, 2010, LIMNOL OCEANOGR, V55, P1047, DOI 10.4319/lo.2010.55.3.1047; Nishihara GN, 2011, ECOL RES, V26, P1051, DOI 10.1007/s11284-011-0854-z; Cornelisen CD, 2004, J MARINE SYST, V49, P177, DOI 10.1016/j.jmarsys.2003.05.008; Nishihara GN, 2006, LIMNOL OCEANOGR, V51, P2734; Chen ZB, 2013, WATER RESOUR RES, V49, P5537, DOI 10.1002/wrcr.20403; Champenois W, 2012, LIMNOL OCEANOGR, V57, P347, DOI 10.4319/lo.2012.57.1.0347; Rominger JT, 2011, J FLUID MECH, V680, P636, DOI 10.1017/jfm.2011.199; Hurd CL, 1996, MAR BIOL, V126, P205, DOI 10.1007/BF00347445; Stevens CL, 1997, HYDROBIOLOGIA, V346, P119, DOI 10.1023/A:1002914015683; Cornelisen CD, 2006, MAR ECOL PROG SER, V312, P1, DOI 10.3354/meps312001; Staehr PA, 2010, LIMNOL OCEANOGR, V55, P817, DOI 10.4319/lo.2009.55.2.0817; Staehr PA, 2012, LIMNOL OCEANOGR, V57, P1317, DOI 10.4319/lo.2012.57.5.1317; Pedersen MF, 2012, MAR ECOL PROG SER, V451, P45, DOI 10.3354/meps09594; Stephens TA, 2014, MAR ECOL PROG SER, V515, P97, DOI 10.3354/meps10974; Hume AC, 2011, LIMNOL OCEANOGR, V56, P86, DOI 10.4319/lo.2011.56.1.0086; Hepburn CD, 2007, MAR ECOL PROG SER, V339, P99, DOI 10.3354/meps339099; Gaylord B, 2012, J EXP BIOL, V215, P997, DOI 10.1242/jeb.059824; JASSBY AD, 1976, LIMNOL OCEANOGR, V21, P540; Mass T, 2010, P NATL ACAD SCI USA, V107, P2527, DOI 10.1073/pnas.0912348107; Stewart HL, 2003, ECOLOGY, V84, P2999, DOI 10.1890/02-0092; Yvon-Durocher G, 2012, NATURE, V487, P472, DOI 10.1038/nature11205; Hanson PC, 2008, LIMNOL OCEANOGR-METH, V6, P454; Batt RD, 2012, LIMNOL OCEANOGR-METH, V10, P20, DOI 10.4319/lom.2012.10.20; Tanino Y, 2009, PHYS FLUIDS, V21, DOI 10.1063/1.3119862; Binzer T, 2006, LIMNOL OCEANOGR, V51, P2722; WHEELER WN, 1980, MAR BIOL, V56, P103, DOI 10.1007/BF00397128; Cornwall CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097235; Duarte CM, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003793; Gelman A., 2013, BAYESIAN DATA ANAL; Gelman A, 1992, STAT SCI, V7, P457, DOI DOI 10.1214/SS/1177011136; Staehr PA, 2011, AQUAT SCI, V74, P155; Stan Development Team, 2014, STAN A C LIB PROB SA; Gacia E, 2003, ESTUAR COAST SHELF S, V56, P909, DOI 10.1016/S0272-7714(02)00286-X	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1322-0829	1440-1835		PHYCOL RES	Phycol. Res.	OCT	2015	63	4					307	317		10.1111/pre.12098		11	Marine & Freshwater Biology	Marine & Freshwater Biology	CU6SF	WOS:000363663000007		
J	Nasruddin; Nakajima, Y; Mukai, K; Komatsu, E; Rahayu, HSE; Nur, M; Ishijima, T; Enomoto, H; Uesugi, Y; Sugama, J; Nakatani, T				Nasruddin; Nakajima, Yukari; Mukai, Kanae; Komatsu, Emi; Rahayu, Heni Setyowati Esti; Nur, Muhammad; Ishijima, Tatsuo; Enomoto, Hiroshi; Uesugi, Yoshihiko; Sugama, Junko; Nakatani, Toshio			A Simple Technique to Improve Contractile Effect of Cold Plasma Jet on Acute Mouse Wound by Dropping Water	PLASMA PROCESSES AND POLYMERS			English	Article						cold plasma; plasma jet; wound healing; in vivo; myofibroblast	DRY CONDITIONS; DERMAL REPAIR; NITRIC-OXIDE; MEDICINE; MOIST	A simple technique is tested to improve the contractile effect of a cold plasma jet on acute wounds of mice. Distilled water on the order of microliters is dropped onto wounds before treatment. To assess the fate of the water, an infrared thermal imager is applied. To evaluate the healing effect, macroscopic and immunohistological studies are conducted. Regarding the wound contractile effect, we show that combination treatment of plasma with dropped water seemed to have a greater effect than plasma treatment alone. Plasma may modify the wound surface through such water, chemically and physically. The histological stiffness of the wound surface during maturation and remodeling, however, may also influence the fate of the water during treatment.	[Nasruddin; Nakajima, Yukari; Mukai, Kanae; Komatsu, Emi] Kanazawa Univ, Grad Sch Med Pharmaceut & Hlth Sci, Grad Course Nursing Sci, Kanazawa, Ishikawa 9200942, Japan; [Nasruddin; Rahayu, Heni Setyowati Esti] Muhammadiyah Univ Magelang, Fac Hlth Sci, Magelang 56172, Central Java, Indonesia; [Nur, Muhammad] Diponegoro Univ, Dept Phys, Semarang, Indonesia; [Ishijima, Tatsuo; Enomoto, Hiroshi; Uesugi, Yoshihiko] Kanazawa Univ, Res Ctr Sustainable Energy & Technol, Kanazawa, Ishikawa 9200942, Japan; [Enomoto, Hiroshi] Kanazawa Univ, Inst Sci & Engn, Fac Mech Engn, Kanazawa, Ishikawa 9200942, Japan; [Uesugi, Yoshihiko] Kanazawa Univ, Inst Sci & Engn, Fac Elect & Comp Engn, Kanazawa, Ishikawa 9200942, Japan; [Sugama, Junko; Nakatani, Toshio] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Div Nursing, Fac Hlth Sci, Kanazawa, Ishikawa 9200942, Japan	Nakatani, T (reprint author), Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Div Nursing, Fac Hlth Sci, 5-11-80 Kodatsuno, Kanazawa, Ishikawa 9200942, Japan.	nakatosi@staff.kanazawa-u.ac.jp			Directorate General of Higher Education (DIKTI), Indonesia through the Joint Scholarship Program DIKTI-Kanazawa University, Japan; JSPS [25293430, 25390107]	Nasruddin would like to acknowledge the help of the Directorate General of Higher Education (DIKTI), Indonesia, which supported him financially during his PhD study through the Joint Scholarship Program DIKTI-Kanazawa University, Japan. Part of this study was supported by JSPS KAKEN Grant Number 25293430 and 25390107.	Jones V, 2006, BRIT MED J, V332, P777, DOI 10.1136/bmj.332.7544.777; Teschke M, 2005, IEEE T PLASMA SCI, V33, P310, DOI 10.1109/TPS.2005.845377; Heinlin J, 2013, WOUND REPAIR REGEN, V21, P800, DOI 10.1111/wrr.12078; Lloyd G, 2010, PLASMA PROCESS POLYM, V7, P194, DOI 10.1002/ppap.200900097; Xia ZD, 2000, WOUND REPAIR REGEN, V8, P138, DOI 10.1046/j.1524-475x.2000.00138.x; Kong MG, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/17/174018; Witte MB, 2002, AM J SURG, V183, P406, DOI 10.1016/S0002-9610(02)00815-2; Volotskova O, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/5/053019; DYSON M, 1988, J INVEST DERMATOL, V91, P434, DOI 10.1111/1523-1747.ep12476467; Sato T, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/37/372001; Singer AJ, 1999, NEW ENGL J MED, V341, P738; Kanazawa S, 2011, PLASMA SOURCES SCI T, V20, DOI 10.1088/0963-0252/20/3/034010; Yonemori S, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/12/125401; Ninomiya K, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/42/425401; DYSON M, 1992, J INVEST DERMATOL, V99, P729, DOI 10.1111/1523-1747.ep12614460; Roy S, 2006, MOL THER, V13, P211, DOI 10.1016/j.ymthe.2005.07.684; Laroussi M, 2009, IEEE T PLASMA SCI, V37, P714, DOI 10.1109/TPS.2009.2017267; ARMSTRONG WA, 1963, CAN J CHEM, V41, P1575, DOI 10.1139/v63-215; Roy S, 2003, CIRC RES, V92, P264, DOI 10.1161/01.RES.0000056770.30922.E6; Baronski S., 2012, WOUND CARE ESSENTIAL; BRANEMAR.PI, 1967, J BONE JOINT SURG AM, VA 49, P48; Broughton G, 2006, PLAST RECONSTR SURG, V117, p12S, DOI 10.1097/01.prs.0000225430.42531.c2; Fernandez R., 2012, COCHRANE DB SYST REV, P2; Flur J. W., 2011, EXP DERMATOL, V21, P130; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Metelmann H.-R., 2014, CONTRIB PLASM PHYS, V54, P104; Nasruddin Y, 2014, CLIN PLASMA MED, V2, P28; Soneja A, 2005, PHARMACOL REP, V57, P108; Stoffels E, 2007, CONTRIB PLASM PHYS, V47, P40, DOI 10.1002/cttp.200710007; Tanaka A., 2004, EURO WOUND MANAGE AS, V4, P13; Weltmann KD, 2011, EUR PHYS J-APPL PHYS, V55, DOI 10.1051/epjap/2011100452	31	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1612-8850	1612-8869		PLASMA PROCESS POLYM	Plasma Process. Polym.	OCT	2015	12	10					1128	1138		10.1002/ppap.201400236		11	Physics, Applied; Physics, Fluids & Plasmas; Physics, Condensed Matter; Polymer Science	Physics; Polymer Science	CU7OR	WOS:000363731700010		
J	Cools, P; Sainz-Garcia, E; De Geyter, N; Nikiforov, A; Blajan, M; Shimizu, K; Alba-Elias, F; Leys, C; Morent, R				Cools, Pieter; Sainz-Garcia, Elisa; De Geyter, Nathalie; Nikiforov, Anton; Blajan, Marius; Shimizu, Kazuo; Alba-Elias, Fernando; Leys, Christophe; Morent, Rino			Influence of DBD Inlet Geometry on the Homogeneity of Plasma-Polymerized Acrylic Acid Films: The Use of a Microplasma-Electrode Inlet Configuration	PLASMA PROCESSES AND POLYMERS			English	Article						acrylic acid; deposition homogeneity; microplasma-electrode; optical reflectance spectroscopy; plasma polymerization; XPS	DIELECTRIC BARRIER DISCHARGE; SURFACE MODIFICATION; MEDIUM PRESSURE; CELLS; DEPOSITION; POLY(L-LACTIDE); BIOMATERIALS; PERFORMANCE; IMPROVEMENT; ADHESION	Multiple vapor inlet systems have been developed to enhance the homogeneity of deposited polyacrylic acid films via medium and atmospheric pressure plasma technology. Different inlet systems were experimentally tested and optical reflectance spectrometry (OPS) was used to measure the differences in thickness of the films along the exposed surface. Standard deviations of more than 65% were reduced to less than 10%. COMSOL models point to the gas flow as the main contributor to the film homogeneity. OPS analysis of the best set-up shows a linear relationship between thickness and exposure time (100-200 nm/min). XPS C1s deconvolution indicates a preservation of +50% of the -COOH groups and a significant incorporation of other oxygen containing groups.	[Cools, Pieter; De Geyter, Nathalie; Nikiforov, Anton; Leys, Christophe; Morent, Rino] Univ Ghent, Fac Engn & Architecture, Dept Appl Phys, RUPT, B-9000 Ghent, Belgium; [Sainz-Garcia, Elisa; Alba-Elias, Fernando] Univ La Rioja, Dept Mech Engn, Logrono 26004, La Rioja, Spain; [Blajan, Marius; Shimizu, Kazuo] Shizuoka Univ, Grad Sch Engn, Hamamatsu, Shizuoka 4328561, Japan; [Shimizu, Kazuo] Shizuoka Univ, Org Innovat & Social Collaborat, Hamamatsu, Shizuoka 4328561, Japan	Cools, P (reprint author), Univ Ghent, Fac Engn & Architecture, Dept Appl Phys, RUPT, St Pietersnieuwstr 41 B4, B-9000 Ghent, Belgium.	Pieter.cools@ugent.be	Alba-Elias, Fernando/M-2037-2014	Alba-Elias, Fernando/0000-0002-3918-0155	European Research Council under the European Union [279022]	This research has received funding from the European Research Council under the European Union's Seventh Framework Program (FP/2007-2013)/ERC Grant Agreement n. 279022 (PLASMAPOR). The author E. Sainz-Garcia would like to thank the program of predoctoral contracts for the information of research staff funded by the autonomous community of La Rioja.	Prabhakaran MP, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/45/455102; Daw R, 1998, BIOMATERIALS, V19, P1717, DOI 10.1016/S0142-9612(98)00080-5; Jacobs T, 2013, J MATER SCI-MATER M, V24, P469, DOI 10.1007/s10856-012-4807-z; Zhao Y, 2013, APPL SURF SCI, V283, P181, DOI 10.1016/j.apsusc.2013.06.078; Nakagawa M, 2006, J BIOMED MATER RES A, V77A, P112, DOI 10.1002/jbm.a.30521; Jafari R, 2006, REACT FUNCT POLYM, V66, P1757, DOI 10.1016/j.reactfunctpolym.2006.08.006; De Geyter N, 2010, SURF COAT TECH, V204, P3272, DOI 10.1016/j.surfcoat.2010.03.037; Teraoka F, 2006, DENT MATER J, V25, P560; Morent R, 2010, APPL SURF SCI, V257, P372, DOI 10.1016/j.apsusc.2010.06.080; Barry JJA, 2005, ADV FUNCT MATER, V15, P1134, DOI [10.1002/adfm.200400562, 10.1005/adfm.200400562]; Jacobs T, 2012, PLASMA CHEM PLASMA P, V32, P1039, DOI 10.1007/s11090-012-9394-8; Ward LJ, 2003, CHEM MATER, V15, P1466, DOI 10.1021/cm020289e; Morent R, 2010, PLASMA CHEM PLASMA P, V30, P525, DOI 10.1007/s11090-010-9233-8; Morent R, 2011, PROG ORG COAT, V70, P336, DOI 10.1016/j.porgcoat.2010.09.031; Hegemann D, 2009, PLASMA PROCESS POLYM, V6, P246, DOI 10.1002/ppap.200800089; Berthiaume F, 2011, ANNU REV CHEM BIOMOL, V2, P403, DOI 10.1146/annurev-chembioeng-061010-114257; Morent R, 2009, PLASMA CHEM PLASMA P, V29, P103, DOI 10.1007/s11090-009-9167-1; Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027; Alexander MR, 1998, SURF INTERFACE ANAL, V26, P961, DOI 10.1002/(SICI)1096-9918(199812)26:13<961::AID-SIA432>3.0.CO;2-7; Wagner HE, 2003, VACUUM, V71, P417, DOI 10.1016/S0042-207X(02)00765-0; Gancarz I, 1999, ACTA POLYM, V50, P317, DOI 10.1002/(SICI)1521-4044(19990901)50:9<317::AID-APOL317>3.0.CO;2-Q; De Geyter N, 2009, PROG ORG COAT, V64, P230, DOI 10.1016/j.porgcoat.2008.07.029; Blajan M, 2012, IEEE T PLASMA SCI, V40, P1730, DOI 10.1109/TPS.2012.2190994; De Geyter N, 2007, SURF COAT TECH, V201, P7066, DOI 10.1016/j.surfcoat.2007.01.008; Benson RS, 2002, NUCL INSTRUM METH B, V191, P752, DOI 10.1016/S0168-583X(02)00647-X; Martins A, 2009, SMALL, V5, P1195, DOI 10.1002/smll.200801648; Carton O, 2012, PLASMA PROCESS POLYM, V9, P984, DOI 10.1002/ppap.201200044; Cheng ZY, 2004, BIOMATERIALS, V25, P1991, DOI 10.1016/j.biomaterials.2003.08.038; Blajan M, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4749825; Desmet T, 2009, BIOMACROMOLECULES, V10, P2351, DOI 10.1021/bm900186s; Gupta B, 2002, BIOMATERIALS, V23, P863, DOI 10.1016/S0142-9612(01)00195-8; Detomaso L, 2005, BIOMATERIALS, V26, P3831, DOI 10.1016/j.biomaterials.2004.10.011; Khorasani MT, 2008, RADIAT PHYS CHEM, V77, P280, DOI 10.1016/j.radphyschem.2007.05.013; OToole L, 1996, MACROMOLECULES, V29, P5172, DOI 10.1021/ma9518417; Morent R, 2011, PLASMA PROCESS POLYM, V8, P171, DOI 10.1002/ppap.201000153; Haddow DB, 2003, J BIOMED MATER RES A, V64A, P80, DOI 10.1002/jbm.a.10356; Colombo V, 2014, PLASMA PROCESS POLYM, V11, P247, DOI 10.1002/ppap.201300141; Da Ponte G, 2011, EUR PHYS J-APPL PHYS, V56, P7; Mattioli-Belmonte M, 2005, J BIOACT COMPAT POL, V20, P343, DOI 10.1177/0883911505055159; Palumbo F., 1999, PLASMAS POLYM, V4, P133, DOI 10.1023/A:1021896808872; Shimizu K, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.11PJ01; Shimizu K, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.08HB05	42	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1612-8850	1612-8869		PLASMA PROCESS POLYM	Plasma Process. Polym.	OCT	2015	12	10					1153	1163		10.1002/ppap.201500007		11	Physics, Applied; Physics, Fluids & Plasmas; Physics, Condensed Matter; Polymer Science	Physics; Polymer Science	CU7OR	WOS:000363731700012		
J	Shoji, M; Ujiie, Y; Harada, R; Kayanuma, M; Shigeta, Y; Murakawa, T; Hayashi, H				Shoji, Mitsuo; Ujiie, Yuzuru; Harada, Ryuhei; Kayanuma, Megumi; Shigeta, Yasuteru; Murakawa, Takeshi; Hayashi, Hideyuki			Molecular dynamics study on the key catalytic intermediates of threonine synthase	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Shoji, Mitsuo; Ujiie, Yuzuru; Harada, Ryuhei; Kayanuma, Megumi; Shigeta, Yasuteru] Univ Tsukuba, Tsukuba, Ibaraki 305, Japan; [Murakawa, Takeshi; Hayashi, Hideyuki] Osaka Med Coll, Takatsuki, Osaka, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PB-027	18	18				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100032		
J	Kubo, T; Naimuddin, M; Ono, S				Kubo, Tai; Naimuddin, Mohammed; Ono, Seigo			In vitro evolution from pluripotent peptide libraries with natural neurotoxin scaffolds to target receptors, proteases and trophic factors	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Kubo, Tai; Naimuddin, Mohammed; Ono, Seigo] Natl Inst Adv Ind Sci & Technol, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PB-088	55	56				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100092		
J	Saito, K; Konogami, T; Yang, YW; Yamashita, Y; Iga, M; Hoshikawa, T; Kataoka, H				Saito, Kazuki; Konogami, Tadafumi; Yang, Yiwen; Yamashita, Yusuke; Iga, Masatoshi; Hoshikawa, Tamari; Kataoka, Hiroshi			Preparation of insect prothoracicotropic hormone with complicated disulfide-bond structure, by the heterologous expression in Brevibacillus choshinensis	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Saito, Kazuki; Konogami, Tadafumi; Yang, Yiwen; Yamashita, Yusuke; Iga, Masatoshi; Hoshikawa, Tamari; Kataoka, Hiroshi] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Tokyo 1138654, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PC-004	58	58				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100097		
J	Konogami, T; Yang, YW; Ogihara, MH; Hikiba, J; Kataoka, H; Saito, K				Konogami, Tadafumi; Yang, Yiwen; Ogihara, Mari H.; Hikiba, Juri; Kataoka, Hiroshi; Saito, Kazuki			Role of the disulfide bridges in the transmembrane region of the insect prothoracicotropic-hormone receptor, Torso	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Konogami, Tadafumi; Yang, Yiwen; Ogihara, Mari H.; Hikiba, Juri; Kataoka, Hiroshi; Saito, Kazuki] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Tokyo 1138654, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PC-005	59	59				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100098		
J	Matsumiya, M; Kakizaki, H; Ikeda, M				Matsumiya, Masahiro; Kakizaki, Hiromi; Ikeda, Mana			Glycoside hydrolase family18 chitinase from the stomach of fish: characteristics of isozymes	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc			PENNAHIA-ARGENTATUS; SILVER CROAKER; PURIFICATION		[Matsumiya, Masahiro; Kakizaki, Hiromi; Ikeda, Mana] Nihon Univ, Coll Bioresource Sci, Tokyo 102, Japan							Ikeda M, 2009, PROTEIN EXPRES PURIF, V65, P214, DOI 10.1016/j.pep.2009.01.015; Ikeda M, 2013, PROCESS BIOCHEM, V48, P1324, DOI 10.1016/j.procbio.2013.06.016; Ikeda M, 2012, BIOSCI BIOTECH BIOCH, V76, P971, DOI 10.1271/bbb.110989; Matsumiya M, 2006, BIOSCI BIOTECH BIOCH, V70, P971, DOI 10.1271/bbb.70.971; Ikeda M., 2014, J CHITIN CHITOSAN SC, V2, P106	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PC-009	61	61				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100102		
J	Kim, J; Kinoshita, M; Ikegami, T; Kurisu, G; Goto, Y; Hase, T; Lee, YH				Kim, Juyaen; Kinoshita, Misaki; Ikegami, Takahisa; Kurisu, Genji; Goto, Yuji; Hase, Toshiharu; Lee, Young-Ho			Delicate Balance of Noncovalent Forces Control the Electron Transfer Complex between Ferredoxin and Sulfite Reductase to Optimize Enzymatic Activity	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Kim, Juyaen; Kinoshita, Misaki; Ikegami, Takahisa; Kurisu, Genji; Goto, Yuji; Hase, Toshiharu; Lee, Young-Ho] Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan; [Ikegami, Takahisa] Yokohama City Univ, Yokohama, Kanagawa, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PC-015	64	65				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100108		
J	Ikenoue, T; Young-Ho, L; Uenoyama, T; Otzen, D; Goto, Y				Ikenoue, Tatsuya; Young-Ho, Lee; Uenoyama, Tetsuhei; Otzen, Daniel; Goto, Yuji			Establishment of thermodynamics of protein aggregation using isothermal titration calorimetry	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Ikenoue, Tatsuya; Young-Ho, Lee; Uenoyama, Tetsuhei; Goto, Yuji] Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan; [Otzen, Daniel] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus C, Denmark								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PD-010	77	77				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100128		
J	Sato, D; Ohtomo, H; Kurobe, A; Takebe, S; Yamada, Y; Fujiwara, K; Ikeguchi, M				Sato, Daisuke; Ohtomo, Hideaki; Kurobe, Atsushi; Takebe, Satsuki; Yamada, Yoshiteru; Fujiwara, Kazuo; Ikeguchi, Masamichi			Repulsion between net charges of subunits during ferritin assembly	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Sato, Daisuke; Ohtomo, Hideaki; Kurobe, Atsushi; Takebe, Satsuki; Fujiwara, Kazuo; Ikeguchi, Masamichi] Soka Univ, Grad Sch Engn, Dept Bioinformat, Aliso Viejo, CA USA; [Yamada, Yoshiteru] JASRI SPring 8, Sayo Dist, Hyogo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PD-029	87	88				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100147		
J	Kakimoto, T; Nakano, H; Nakai, Y; Shiozaki, K; Akioka, K; Otomaru, K; Matsumoto, M; Nagano, M; Sugimoto, Y; Kanouchi, H				Kakimoto, Toshiaki; Nakano, Hideya; Nakai, Yuji; Shiozaki, Kazuhiro; Akioka, Kohei; Otomaru, Konosuke; Matsumoto, Mitsuharu; Nagano, Masanobu; Sugimoto, Yasushi; Kanouchi, Hiroaki			Kurozu Increases HSPA1A Expression and Ameliorates Cognitive Dysfunction in Aged SAM P8 Mice	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Kakimoto, Toshiaki; Nakano, Hideya; Kanouchi, Hiroaki] Kagoshima Univ, Dept Vet Pathobiol, Kagoshima 890, Japan; [Nakai, Yuji] Hirosaki Univ, Inst Food Sci, Hirosaki, Aomori, Japan; [Shiozaki, Kazuhiro] Kagoshima Univ, Fac Fisheries, Kagoshima 890, Japan; [Akioka, Kohei] Kagoshima Univ, Dept Vet Histopathol, Kagoshima 890, Japan; [Otomaru, Konosuke] Kagoshima Univ, Vet Clin Training Ctr, Kagoshima 890, Japan; [Matsumoto, Mitsuharu] Kagoshima Univ, Dept Vet Anat, Kagoshima 890, Japan; [Sugimoto, Yasushi] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 890, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PD-034	90	90				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100152		
J	Lee, YH; Ikenoue, T; Kawata, Y; Goto, Y				Lee, Young-Ho; Ikenoue, Tatsuya; Kawata, Yasushi; Goto, Yuji			Cold Denaturation of Alpha-Synuclein Amyloid Fibrils	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Lee, Young-Ho; Ikenoue, Tatsuya; Goto, Yuji] Osaka Univ, Inst Prot Res, Lab Prot Folding, Suita, Osaka 565, Japan; [Kawata, Yasushi] Tottori Univ, Dept Chem & Biotechnol, Tottori, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PD-035	91	91				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100153		
J	Park, S; Hwang, IW; Kato, T; Park, E; Terzic, A				Park, Sungjo; Hwang, In-Wook; Kato, Tatsuya; Park, Enoch; Terzic, Andre			High-fidelity recombinant protein production in a silkworm bioreactor	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Park, Sungjo; Hwang, In-Wook; Terzic, Andre] Mayo Clin, Ctr Regenerat Med, Rochester, MN USA; [Kato, Tatsuya; Park, Enoch] Shizuoka Univ, Lab Biotechnol, Shizuoka 4228529, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PE-019	112	112				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100192		
J	Sugimoto, Y; Kamada, Y; Nawata, Y; Kusakabe, T				Sugimoto, Yasushi; Kamada, Yoshiki; Nawata, Yusuke; Kusakabe, Takahiro			Amyloidogenic lysozyme accumulates in the endoplasmic reticulum tangling with GRP78/BiP and evokes ER stress	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Sugimoto, Yasushi; Kamada, Yoshiki; Nawata, Yusuke] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 890, Japan; [Kusakabe, Takahiro] Kyushu Univ, Grad Sch Agr Sci, Fukuoka 812, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PF-029	135	136				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100230		
J	Fujitani, H				Fujitani, Hideaki			Dynamical structure changes in binding of pharmaceutical target proteins	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Fujitani, Hideaki] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo 1138654, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PH-007	148	148				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100247		
J	Kamiya, N; Bekker, GJ; Shiraki, T; Nakamura, H				Kamiya, Narutoshi; Bekker, Gert-Jan; Shiraki, Takuma; Nakamura, Haruki			In-vitro and in-silico studies of ligand binding to the nuclear receptor PPARgamma using FRET and MD	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc			MOLECULAR-DYNAMICS SIMULATIONS		[Kamiya, Narutoshi; Bekker, Gert-Jan; Nakamura, Haruki] Osaka Univ, IPR, Suita, Osaka 565, Japan; [Shiraki, Takuma] Kinki Univ, Higashiosaka, Osaka 577, Japan							Fukuda I, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3582791; Kamiya N, 2013, CHEM PHYS LETT, V568, P26, DOI 10.1016/j.cplett.2013.03.014; Mashimo T, 2013, J CHEM THEORY COMPUT, V9, P5599, DOI 10.1021/ct400342e; Arakawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076606; Fukuda I, 2014, J CHEM PHYS, V140; Nishikawa Y, 2014, J MOL BIOL, V426, P3232, DOI 10.1016/j.jmb.2014.06.023	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PH-012	151	151				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100252		
J	Matsushita, Y; Sekiguchi, H; Ohta, N; Ikezaki, K; Goto, Y; Sasaki, Y				Matsushita, Yufuku; Sekiguchi, Hiroshi; Ohta, Noboru; Ikezaki, Keigo; Goto, Yuji; Sasaki, Yuji			Time-resolved X-ray Observations of Nano-scale Protein Assembly Networks	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Matsushita, Yufuku; Ikezaki, Keigo; Sasaki, Yuji] Univ Tokyo, Grad Sch Frontier Sci, Adv Mat Sci, Tokyo 1138654, Japan; [Sekiguchi, Hiroshi; Ohta, Noboru] SPring 8, Sayo, Kyoto, Japan; [Goto, Yuji; Sasaki, Yuji] Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PH-018	154	155				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100258		
J	Seo, D; Sakurai, H; Setif, P; Sakurai, T				Seo, Daisuke; Sakurai, Hidehiro; Setif, Pierre; Sakurai, Takeshi			Differences in redox reactions with NADP plus /H between ferredoxin-NADP plus oxidoreductases from Bacillus subtilis and Rhodopseudomonas palustris	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Seo, Daisuke; Sakurai, Takeshi] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Sakurai, Hidehiro] Kanagawa Univ, Res Inst Photobiol Hydrogen Prod, Kanagawa, Japan; [Setif, Pierre] CEA, iBiTecS, New Delhi, India								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PH-024	158	158				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100264		
J	Sljoka, A; Bezginov, A				Sljoka, Adnan; Bezginov, Alexandr			Transmission of rigidity at a distance - new insights into allosteric signalling in G-Protein Coupled Receptors	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Sljoka, Adnan] Kyoto Univ, Kyoto 6068501, Japan; [Bezginov, Alexandr] Univ Toronto, Toronto, ON M5S 1A1, Canada								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PH-027	159	160				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100267		
J	Yonetani, T; Kanaori, K				Yonetani, Takashi; Kanaori, Kenji			Oxygen-Affinity and Cooperativity of Hemoglobin (Hb) are Regulated by 4D Structural Changes (Protein Dynamics), rather than 3D Structural Changes	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc			LOW-TEMPERATURE PHOTODISSOCIATION; HEMOPROTEINS; MYOGLOBIN		[Yonetani, Takashi] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Kanaori, Kenji] Kyoto Inst Technol, Dept Biomol Engn, Kyoto, Japan							Laberge M, 2008, BIOPHYS J, V94, P2737, DOI 10.1529/biophysj.107.114942; Yonetani T, 2002, J BIOL CHEM, V277, P34508, DOI 10.1074/jbc.M203135200; YAMAMOTO H, 1977, BIOINORG CHEM, V7, P189, DOI 10.1016/S0006-3061(00)80093-9; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; IIZUKA T, 1974, BIOCHIM BIOPHYS ACTA, V351, P182, DOI 10.1016/0005-2795(74)90180-9; IIZUKA T, 1974, BIOCHIM BIOPHYS ACTA, V371, P126, DOI 10.1016/0005-2795(74)90161-5; Yonetani T, 2013, BBA-PROTEINS PROTEOM, V1834, P1873, DOI 10.1016/j.bbapap.2013.04.026; Yonetani T, 2008, BBA-PROTEINS PROTEOM, V1784, P1146, DOI 10.1016/j.bbapap.2008.04.025; YONETANI T, 1974, J BIOL CHEM, V249, P2168	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PH-029	160	161				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100269		
J	Sato, Y; Tanaka, Y; Sekiguchi, H; Inaba, S; Maruno, T; Sasaki, YC; Kobayashi, Y; Azuma, T; Oda, M				Sato, Yusui; Tanaka, Yusuke; Sekiguchi, Hiroshi; Inaba, Satomi; Maruno, Takahiro; Sasaki, Yuji C.; Kobayashi, Yuji; Azuma, Takachika; Oda, Masayuki			Generation of single-chain Fv antibody against (4-hydroxy-3-nitrophenyl)acetyl and analysis of its structural dynamics	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Sato, Yusui; Tanaka, Yusuke; Inaba, Satomi; Oda, Masayuki] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Kyoto, Japan; [Sekiguchi, Hiroshi] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo, Japan; [Maruno, Takahiro; Kobayashi, Yuji] Osaka Univ, Grad Sch Engn, Suita, Osaka 565, Japan; [Sasaki, Yuji C.] Univ Tokyo, Grad Sch Frontier Sci, Tokyo 1138654, Japan; [Azuma, Takachika] Tokyo Univ Sci, Res Inst Biol Sci, Tokyo 162, Japan							Furukawa, 1999, IMMUNITY, V11, P329; Murakami, 2010, MOL IMMUNOL, V48, P48; Sagawa, 2003, MOL IMMUNOL, V39, P801; Sekiguchi, 2014, SCI REP, V4, P6384	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PH-033	163	164				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100273		
J	Sekiguchi, H; Matsushita, Y; Nishino, Y; Ikezaki, K; Miyazawa, A; Kubo, T; Huron, C; Changeux, JP; Corringer, PJ; Sasaki, Y				Sekiguchi, Hiroshi; Matsushita, Yufuku; Nishino, Yuri; Ikezaki, Keigo; Miyazawa, Atsuo; Kubo, Tai; Huron, Christele; Changeux, Jean-Pierre; Corringer, Pierre-Jean; Sasaki, Yuji			Single Molecule Motion Map of Pentameric Ligand Gated Ion Channel by Diffracted X-ray Tracking	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Sekiguchi, Hiroshi] JASRI SPring 8, Res & Utilizat Div, Sayo, Japan; [Matsushita, Yufuku; Ikezaki, Keigo; Sasaki, Yuji] Univ Tokyo, Grad Sch Frontier Sci, Tokyo 1138654, Japan; [Nishino, Yuri; Miyazawa, Atsuo] Univ Hyogo, Grad Sch Sci, Kobe, Hyogo 6500044, Japan; [Kubo, Tai] Natl Inst Adv Ind Sci & Technol, Tokyo, Japan; [Huron, Christele; Changeux, Jean-Pierre; Corringer, Pierre-Jean] Inst Pasteur, Paris, France							Sasaki YC, 2000, PHYS REV E, V62, P3843, DOI 10.1103/PhysRevE.62.3843; Sekiguchi H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06384; Sekiguchi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064176	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PH-039	167	167				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100279		
J	Oda, T; Fuchita, N; Motoshima, H; Watanabe, K				Oda, Tokuro; Fuchita, Naoki; Motoshima, Hiroyuki; Watanabe, Keiichi			X-ray crystallographic analysis of cold-adapted and thermostable glucokinase	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Oda, Tokuro; Fuchita, Naoki; Motoshima, Hiroyuki; Watanabe, Keiichi] Saga Univ, Dept Appl Biochem & Food Sci, Saga, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PH-048	174	174				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100288		
J	Ojima-Kato, T; Fukui, K; Kojima, T; Nakano, H				Ojima-Kato, Teruyo; Fukui, Kansuke; Kojima, Takaaki; Nakano, Hideo			Leucine Zipper fused Fab; Enhancement of active Fab formation in E. coli in vitro and in vivo expression systems	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Ojima-Kato, Teruyo] Aichi Sci & Technol Fdn, Nagoya, Aichi, Japan; [Ojima-Kato, Teruyo; Fukui, Kansuke; Kojima, Takaaki; Nakano, Hideo] Nagoya Univ, Nagoya, Aichi 4648601, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PI-031	194	194				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100318		
J	Nakatsuji, M; Inoue, H; Kohno, M; Saito, M; Tsuge, S; Shimizu, S; Ishibashi, O; Inui, T				Nakatsuji, Masatoshi; Inoue, Haruka; Kohno, Masaki; Saito, Mayu; Tsuge, Syogo; Shimizu, Shota; Ishibashi, Osamu; Inui, Takashi			A novel drug delivery system for poorly water-soluble anti-tumor drug SN-38 utilizing intravital transporter protein	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Nakatsuji, Masatoshi; Inoue, Haruka; Kohno, Masaki; Saito, Mayu; Tsuge, Syogo; Shimizu, Shota; Ishibashi, Osamu; Inui, Takashi] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Sakai, Osaka, Japan			Inui, Takashi/G-1069-2011				Fukuhara A., 2012, J CONTROL RELEASE, V158, P143	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PI-045	201	202				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100332		
J	Akanuma, S				Akanuma, Satoshi			Essential and non-essential amino acid species for an ancestral protein	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Akanuma, Satoshi] Waseda Univ, Fac Human Sci, Tokyo, Japan							Akanuma, 2013, P NATL ACAD SCI USA, V110, P11067	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PI-047	202	203				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100334		
J	Yagi, S; Akanuma, S; Yamagishi, A				Yagi, Sota; Akanuma, Satoshi; Yamagishi, Akihiko			De novo design of protein-protein interaction using hydrophobic and electrostatic interactions	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Yagi, Sota; Yamagishi, Akihiko] Tokyo Univ Pharm & Life Sci, Dept Appl Life Scien, Tokyo, Japan; [Akanuma, Satoshi] Waseda Univ, Fac Human Sci, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PI-048	203	204				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100335		
J	Kaji, A; Niiro, H; Akanuma, S; Uchida, T; Yamagishi, A				Kaji, Asumi; Niiro, Hiroya; Akanuma, Satoshi; Uchida, Tetsuya; Yamagishi, Akihiko			Designing of a novel platinum-binding amino acid sequence on a protein surface	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Kaji, Asumi; Niiro, Hiroya; Uchida, Tetsuya; Yamagishi, Akihiko] Tokyo Univ Pharm & Life Sci, Tokyo, Japan; [Akanuma, Satoshi] Waseda Univ, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PI-050	204	204				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100337		
J	Nemoto, N; Okawa, R; Yoshikawa, Y; Miyajima, T; Kobayashi, S				Nemoto, Naoto; Okawa, Ryoya; Yoshikawa, Yuki; Miyajima, Toshiki; Kobayashi, Shota			In vitro selection of liposome anchoring peptide by cDNA display	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Nemoto, Naoto; Okawa, Ryoya; Yoshikawa, Yuki; Miyajima, Toshiki; Kobayashi, Shota] Saitama Univ, Grad Sch Sci & Engn, Saitama, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PI-049	204	204				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100336		
J	Nakane, S; Matsuda, Z				Nakane, Shuhei; Matsuda, Zene			Generation of fluorescent protein-tagged gp120 mutants to analyze the intracellular distribution of HIV-1 envelope protein	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					Univ Tokyo, Inst Med Sci, Res Ctr Asian Infect Dis, Tokyo 1138654, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PI-054	207	207				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100341		
J	Zhang, K; Voet, A; Noguchi, H; Addy, C; Tame, J				Zhang, Kam; Voet, Arnout; Noguchi, Hiroki; Addy, Christine; Tame, Jeremy			RE3volutionary computational design of symmetric proteins that biomineralize nano-crystals	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Noguchi, Hiroki; Addy, Christine; Tame, Jeremy] Yokohama City Univ, GSMLS, Drug Design Lab, Yokohama, Kanagawa, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PI-057	208	208				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100344		
J	Shimizu, S; Nakatsuji, M; Yamaguchi, K; Sano, Y; Miyamoto, Y; Inui, T				Shimizu, Shota; Nakatsuji, Masatoshi; Yamaguchi, Keisuke; Sano, Yuya; Miyamoto, Yuya; Inui, Takashi			Construction of protein capsule possessing drugs controlled release ability	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Shimizu, Shota; Nakatsuji, Masatoshi; Yamaguchi, Keisuke; Sano, Yuya; Miyamoto, Yuya; Inui, Takashi] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Sakai, Osaka, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PI-063	211	212				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100350		
J	Miyamoto, T; Kuribayashi, M; Nagao, S; Shomura, Y; Higuchi, Y; Hirota, S				Miyamoto, Takaaki; Kuribayashi, Mai; Nagao, Satoshi; Shomura, Yasuhito; Higuchi, Yoshiki; Hirota, Shun			Formation of Cytochrome cb562 Oligomers by Domain Swapping	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Miyamoto, Takaaki; Kuribayashi, Mai; Nagao, Satoshi; Hirota, Shun] Nara Inst Sci & Technol, Grad Sch Mat Sci, Nara, Japan; [Shomura, Yasuhito] Ibaraki Univ, Grad Sch Sci & Engn, Mito, Ibaraki, Japan; [Higuchi, Yoshiki] Univ Hyogo, Grad Sch Life Sci, Dept Life Sci, Kobe, Hyogo 6500044, Japan							Nagao S, 2012, DALTON T, V41, P11378, DOI 10.1039/c2dt30893b; Hirota S, 2010, P NATL ACAD SCI USA, V107, P12854, DOI 10.1073/pnas.1001839107; Feng HQ, 2005, P NATL ACAD SCI USA, V102, P5026, DOI 10.1073/pnas.0501372102; Parui P. P., 2012, BIOCHEMISTRY-US, V52, P8732	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PI-064	212	213				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100351		
J	Ito, Y; Enomoto, Y; Umemura, S; Fujiyama, A; Mieno, R; Kato, Y; Kato, D				Ito, Yuji; Enomoto, Yurie; Umemura, Shuhei; Fujiyama, Aiko; Mieno, Ryoko; Kato, Yukiko; Kato, Dai-ichiro			Identification of disease-related antigen-specific human antibodies by a method that combines biopanning and high throughput sequencing from patient-derived scFv antibody library	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Ito, Yuji; Enomoto, Yurie; Umemura, Shuhei; Fujiyama, Aiko; Mieno, Ryoko; Kato, Yukiko; Kato, Dai-ichiro] Kagoshima Univ, Grad Sch Sci & Engn, Kagoshima 890, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PI-069	215	215				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100356		
J	Kameshita, I; Sueyoshi, N; Sugiyama, Y				Kameshita, Isamu; Sueyoshi, Noriyuki; Sugiyama, Yasunori			Multi-PTK antibody: a powerful tool to detect a wide variety of protein tyrosine kinases (PTKs)	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Kameshita, Isamu; Sueyoshi, Noriyuki; Sugiyama, Yasunori] Kagawa Univ, Takamatsu, Kagawa 760, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PJ-028	251	251				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100418		
J	Uchikoga, N; Ohue, M; Matsuzaki, Y; Akiyama, Y				Uchikoga, Nobuyuki; Ohue, Masahito; Matsuzaki, Yuri; Akiyama, Yutaka			Post-docking analysis by physicochemical properties of protein-protein interactions generated from rigid-body docking processes	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Uchikoga, Nobuyuki] Chuo Univ, Dept Phys, Concepcion, Chile; [Ohue, Masahito] Tokyo Tech, Grad Sch Inform Sci & Engn, Tokyo, Japan; [Matsuzaki, Yuri; Akiyama, Yutaka] Tokyo Tech, ACLS, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PJ-033	253	253				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100422		
J	Inaba, S; Numoto, N; Morii, H; Ikura, T; Abe, R; Ito, N; Oda, M				Inaba, Satomi; Numoto, Nobutaka; Morii, Hisayuki; Ikura, Teikichi; Abe, Ryo; Ito, Nobutoshi; Oda, Masayuki			Structural and thermodynamic analysis of co-stimulation receptor CD28 phosphopeptide interactions with Grb2, Gads, and PI3-kinese SH2 domains	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Inaba, Satomi; Oda, Masayuki] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Kyoto, Japan; [Numoto, Nobutaka; Ikura, Teikichi; Ito, Nobutoshi] Tokyo Med & Dent Univ, Med Res Inst, Tokyo, Japan; [Morii, Hisayuki] Natl Inst Adv Ind Sci & Technol, Tokyo, Japan; [Abe, Ryo] Tokyo Univ Sci, Res Inst Biomed Sci, Tokyo 162, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PL-040	287	287				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100481		
J	Kusakabe, T; Mon, H; Lee, J				Kusakabe, Takahiro; Mon, Hiroaki; Lee, JaeMan			Novel kinetochore protein complex from silkworm holocentric chromosomes	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Kusakabe, Takahiro; Mon, Hiroaki; Lee, JaeMan] Kyushu Univ, Grad Sch, Fukuoka 812, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PL-041	288	288				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100482		
J	Fukuda, I; Kamiya, N; Wang, H; Kasahara, K; Nakamura, H				Fukuda, Ikuo; Kamiya, Narutoshi; Wang, Han; Kasahara, Kota; Nakamura, Haruki			Development and application of novel non-Ewald methods for calculating electrostatic interactions in molecular simulations	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Fukuda, Ikuo; Kamiya, Narutoshi; Kasahara, Kota; Nakamura, Haruki] Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan; [Wang, Han] Free Univ Berlin, Berlin, Germany							Fukuda I, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3582791; [Anonymous], 2014, J CHEM PHYS; Arakawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076606; Fukuda Ikuo, 2012, Biophysical Reviews, V4, DOI 10.1007/s12551-012-0089-4; Fukuda I., 2013, J CHEM PHYS, V139; Fukuda I, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4739789; Kamiya N., 2013, J CHEM THEORY COMPUT, V26, P568; Kasahara K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112419; Nishikawa Y, 2014, J MOL BIOL, V426, P3232, DOI 10.1016/j.jmb.2014.06.023	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PL-047	290	290				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100486		
J	Minami, S; Chikenji, G; Ota, M				Minami, Shintaro; Chikenji, George; Ota, Motonori			Non-sequential protein structure alignment program MICAN and its applications	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Minami, Shintaro; Ota, Motonori] Nagoya Univ, Dept Info Sci, Nagoya, Aichi 4648601, Japan; [Chikenji, George] Nagoya Univ, Dept Comp Schi & Engn, Nagoya, Aichi 4648601, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PL-058	296	296				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100497		
J	Kuwahara, J; Uwatoko, C; Hibino, E; Matsuzaki, K; Hoshino, M				Kuwahara, Jun; Uwatoko, Chisana; Hibino, Emi; Matsuzaki, Katsumi; Hoshino, Masaru			Glutamine-rich activation domain of transcription factor Sp1-biochemical activity and structure	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Hibino, Emi; Matsuzaki, Katsumi; Hoshino, Masaru] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PL-085	312	312				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100524		
J	Chaplin, WJ; Lund, MN; Handberg, R; Basu, S; Buchhave, LA; Campante, TL; Davies, GR; Huber, D; Latham, DW; Latham, CA; Serenelli, A; Antia, HM; Appourchaux, T; Ball, WH; Benomar, O; Casagrande, L; Christensen-Dalsgaard, J; Coelho, HR; Creevey, OL; Elsworth, Y; Garcia, RA; Gaulme, P; Hekker, S; Kallinger, T; Karoff, C; Kawaler, SD; Kjeldsen, H; Lundkvist, MS; Marcadon, F; Mathur, S; Miglio, A; Mosser, B; Regulo, C; Roxburgh, IW; Aguirre, VS; Stello, D; Verma, K; White, TR; Bedding, TR; Barclay, T; Buzasi, DL; Dehuevels, S; Gizon, L; Houdek, G; Howell, SB; Salabert, D; Soderblom, DR				Chaplin, W. J.; Lund, M. N.; Handberg, R.; Basu, S.; Buchhave, L. A.; Campante, T. L.; Davies, G. R.; Huber, D.; Latham, D. W.; Latham, C. A.; Serenelli, A.; Antia, H. M.; Appourchaux, T.; Ball, W. H.; Benomar, O.; Casagrande, L.; Christensen-Dalsgaard, J.; Coelho, H. R.; Creevey, O. L.; Elsworth, Y.; Garcia, R. A.; Gaulme, P.; Hekker, S.; Kallinger, T.; Karoff, C.; Kawaler, S. D.; Kjeldsen, H.; Lundkvist, M. S.; Marcadon, F.; Mathur, S.; Miglio, A.; Mosser, B.; Regulo, C.; Roxburgh, I. W.; Aguirre, V. Silva; Stello, D.; Verma, K.; White, T. R.; Bedding, T. R.; Barclay, T.; Buzasi, D. L.; Dehuevels, S.; Gizon, L.; Houdek, G.; Howell, S. B.; Salabert, D.; Soderblom, D. R.			Asteroseismology of Solar-Type Stars with K2: Detection of Oscillations in C1 Data	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF THE PACIFIC			English	Article							CANDIDATE HOST STARS; MAIN-SEQUENCE STARS; RED-GIANT STARS; BOLOMETRIC CORRECTIONS; FUNDAMENTAL PROPERTIES; KEPLER; PARAMETERS; MISSION; DETECTABILITY; AMPLITUDES	We present the first detections by the NASA K2 mission of oscillations in solar-type stars, using short-cadence data collected during K2 Campaign 1 (C1). We understand the asteroseismic detection thresholds for Cl-like levels of photometric performance, and we can detect oscillations in subgiants having dominant oscillation frequencies around 1000 mu Hz. Changes to the operation of the fine-guidance sensors are expected to give significant improvements in the high-frequency performance from C3 onwards. A reduction in the excess high-frequency noise by a factor of 2.5 in amplitude would bring main-sequence stars with dominant oscillation frequencies as high as similar or equal to 2500 mu Hz into play as potential asteroseismic targets for K2.	[Chaplin, W. J.; Lund, M. N.; Handberg, R.; Campante, T. L.; Davies, G. R.; Coelho, H. R.; Elsworth, Y.; Miglio, A.] Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England; [Chaplin, W. J.; Lund, M. N.; Handberg, R.; Campante, T. L.; Davies, G. R.; Huber, D.; Christensen-Dalsgaard, J.; Coelho, H. R.; Elsworth, Y.; Hekker, S.; Karoff, C.; Kjeldsen, H.; Lundkvist, M. S.; Miglio, A.; Aguirre, V. Silva; Stello, D.; Bedding, T. R.; Houdek, G.] Aarhus Univ, Dept Phys & Astron, SAC, DK-8000 Aarhus C, Denmark; [Basu, S.] Yale Univ, Dept & Astron, New Haven, CT 06520 USA; [Buchhave, L. A.; Latham, D. W.; Latham, C. A.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Buchhave, L. A.] Univ Copenhagen, Nat Hist Museum Denmark, Ctr Star & Planet Format, DK-1350 Copenhagen, Denmark; [Huber, D.; Stello, D.; Bedding, T. R.] Univ Sydney, Sch Phys, Sydney Inst Astron, Sydney, NSW 2006, Australia; [Huber, D.] SETI Inst, Mountain View, CA 94043 USA; [Serenelli, A.] Inst Ciencias Espacio ICE CSIC IEEC, Cerdanyola Del Valles 08193, Spain; [Antia, H. M.; Verma, K.] Tata Inst Fundamental Res, Bombay 400005, Maharashtra, India; [Appourchaux, T.; Marcadon, F.] Univ Paris 11, CNRS, Inst Astrophys Spatiale, UMR8617, F-91405 Orsay, France; [Ball, W. H.; White, T. R.; Gizon, L.] Univ Gottingen, Inst Astrophys, D-37077 Gottingen, Germany; [Benomar, O.] Univ Tokyo, Tokyo 1130033, Japan; [Casagrande, L.] Australian Natl Univ, Mt Stromlo Observ, Res Sch Astron & Astrophys, Weston, ACT 2611, Australia; [Creevey, O. L.] Univ Nice Sophia Antipolis, Lab Lagrange, UMR 7293, CNRS, Nice, France; [Creevey, O. L.] Observ Cote Azur, F-06003 Nice, France; [Garcia, R. A.; Salabert, D.] Univ Paris Diderot, Ctr Saclay, Lab AIM Paris Saclay, IRFU SAp,Ctr Saclay, F-91191 Gif Sur Yvette, France; [Gaulme, P.] New Mexico State Univ, Dept Astron, Las Cruces, NM 88003 USA; [Gaulme, P.] Apache Point Observ, Sunspot, NM 88349 USA; [Hekker, S.; Gizon, L.] Max Planck Inst Sonnensyst Forsch, D-37077 Gottingen, Germany; [Kallinger, T.] Univ Vienna, Inst Astron, A-1180 Vienna, Austria; [Kawaler, S. D.] Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA; [Mathur, S.] Space Sci Inst, Boulder, CO 80301 USA; [Mosser, B.] PSL Res Univ, Observ Paris, LESIA, CNRS, F-92195 Meudon, France; [Mosser, B.] Univ Paris 06, Univ Denis Diderot, F-92195 Meudon, France; [Regulo, C.] Inst Astrofis Canarias, Tenerife 38205, Spain; [Regulo, C.] Univ La Laguna, Dept Astrofis, E-38206 Tenerife, Spain; [Roxburgh, I. W.] Queen Mary Univ London, Astron Unit, London E1 4NS, England; [Barclay, T.; Howell, S. B.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Barclay, T.] Bay Area Environm Res Inst, Sonoma, CA 95476 USA; [Buzasi, D. L.] Florida Gulf Coast Univ, Dept Chem & Phys, South Ft Myers, FL 33965 USA; [Dehuevels, S.] Univ Toulouse, IRAP, UPS OMP, F-31028 Toulouse, France; [Gizon, L.] New York Univ, Ctr Space Sci, Abu Dhabi, U Arab Emirates; [Soderblom, D. R.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Soderblom, D. R.] Johns Hopkins Univ, Dept Phys & Astron, Ctr Astrophys Sci, Baltimore, MD 21218 USA	Chaplin, WJ (reprint author), Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England.				NASA's Science Mission Directorate	Funding for this Discovery mission is provided by NASA's Science Mission Directorate. The authors wish to thank the entire Kepler team, without whom these results would not be possible. We also thank all funding councils and agencies that have supported the activities of KASC Working Group 1.	Handberg R, 2014, MON NOT R ASTRON SOC, V445, P2698, DOI 10.1093/mnras/stu1823; Chaplin WJ, 2011, SCIENCE, V332, P213, DOI 10.1126/science.1201827; Miglio A, 2013, MON NOT R ASTRON SOC, V429, P423, DOI 10.1093/mnras/sts345; Verner GA, 2011, MON NOT R ASTRON SOC, V415, P3539, DOI 10.1111/j.1365-2966.2011.18968.x; Buchhave LA, 2012, NATURE, V486, P375, DOI 10.1038/nature11121; Mosser B, 2009, ASTRON ASTROPHYS, V508, P877, DOI 10.1051/0004-6361/200912944; Creevey OL, 2013, MON NOT R ASTRON SOC, V431, P2419, DOI 10.1093/mnras/stt336; Carney BW, 2001, ASTRON J, V122, P3419, DOI 10.1086/324233; Howell SB, 2014, PUBL ASTRON SOC PAC, V126, P398; Hekker S, 2010, MON NOT R ASTRON SOC, V402, P2049, DOI 10.1111/j.1365-2966.2009.16030.x; Quirion PO, 2010, ASTROPHYS J, V725, P2176, DOI 10.1088/0004-637X/725/2/2176; Arentoft T, 2008, ASTROPHYS J, V687, P1180, DOI 10.1086/592040; Garcia RA, 2010, SCIENCE, V329, P1032, DOI 10.1126/science.1191064; Houdek G, 1999, ASTRON ASTROPHYS, V351, P582; Chaplin WJ, 2013, ANNU REV ASTRON ASTR, V51, P353, DOI 10.1146/annurev-astro-082812-140938; KJELDSEN H, 1995, ASTRON ASTROPHYS, V293, P87; Basu S, 2010, ASTROPHYS J, V710, P1596, DOI 10.1088/0004-637X/710/2/1596; Rodrigues TS, 2014, MON NOT R ASTRON SOC, V445, P2758, DOI 10.1093/mnras/stu1907; Bazot M, 2012, MON NOT R ASTRON SOC, V427, P1847, DOI 10.1111/j.1365-2966.2012.21818.x; BROWN TM, 1991, ASTROPHYS J, V368, P599, DOI 10.1086/169725; Serenelli AM, 2013, MON NOT R ASTRON SOC, V429, P3645, DOI 10.1093/mnras/sts648; Chaplin WJ, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/1/54; Benomar O, 2012, MON NOT R ASTRON SOC, V420, P2178, DOI 10.1111/j.1365-2966.2011.20184.x; Campante TL, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/2/123; Campante T. L., 2012, THESIS U PORTO; Casagrande L, 2010, ASTRON ASTROPHYS, V512, DOI 10.1051/0004-6361/200913204; Chaplin WJ, 2011, ASTROPHYS J LETT, V732, DOI 10.1088/2041-8205/732/1/L5; Chaplin WJ, 2014, ASTROPHYS J SUPPL S, V210, DOI 10.1088/0067-0049/210/1/1; Christensen-Dalsgaard J, 2008, J PHYS CONF SER, V118, DOI 10.1088/1742-6596/118/1/012039; Drimmel R, 2003, ASTRON ASTROPHYS, V409, P205, DOI 10.1051/0004-6361:20031070; Pinsonneault MH, 2014, ASTROPHYS J SUPPL S, V215, DOI 10.1088/0067-0049/215/2/19; Fiiresz G., 2008, THESIS U SZEGED; Flower PJ, 1996, ASTROPHYS J, V469, P355, DOI 10.1086/177785; Gai N, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/2/63; Gilliland RL, 2010, PUBL ASTRON SOC PAC, V122, P131; Gilliland RL, 2011, ASTROPHYS J, V726, DOI 10.1088/0004-637X/726/1/2; Gilliland RL, 2010, ASTROPHYS J LETT, V713, pL160, DOI 10.1088/2041-8205/713/2/L160; Hecker S., 2013, ASTRON ASTROPHYS, V556, P59; Hekker S., 2014, ASTRON ASTROPHYS, V564, P105; Huber D, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/2/127; Huber D., 2009, COMMUN ASTEROSEISMOL, V160, P74; Kallinger T., 2010, ASTRON ASTROPHYS, V522, P1; Lund MN, 2015, ASTROPHYS J, V806, DOI 10.1088/0004-637X/806/1/30; Lundkvist M., 2014, ASTRON ASTROPHYS, V566, P82; Mathur S., 2010, ASTRON ASTROPHYS, V511, P46; Roxburgh IW, 2009, ASTRON ASTROPHYS, V506, P435, DOI 10.1051/0004-6361/200911906; Samadi R., 2010, ASTRON ASTROPHYS, V509, P15; Aguirre VS, 2015, MON NOT R ASTRON SOC, V452, P2127, DOI 10.1093/mnras/stv1388; Steno D., 2009, APJ, V700, P1589; Torres G, 2010, ASTRON J, V140, P1158, DOI 10.1088/0004-6256/140/5/1158; van Leeuwen F, 2007, ASTRON ASTROPHYS, V474, P653, DOI 10.1051/0004-6361:20078357	51	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0004-6280	1538-3873		PUBL ASTRON SOC PAC	Publ. Astron. Soc. Pac.	OCT	2015	127	956					1038	1044				7	Astronomy & Astrophysics	Astronomy & Astrophysics	CU5VM	WOS:000363600100007		
J	Oseki, S; Oyabu, S; Ishihara, D; Enya, K; Haze, K; Kotani, T; Kaneda, H; Nishiyama, M; Abe, L; Yamamuro, T				Oseki, S.; Oyabu, S.; Ishihara, D.; Enya, K.; Haze, K.; Kotani, T.; Kaneda, H.; Nishiyama, M.; Abe, L.; Yamamuro, T.			Coronagraphic Demonstration Experiment Using Aluminum Mirrors for Space Infrared Astronomical Observations	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF THE PACIFIC			English	Article							CHECKERBOARD PUPIL MASK; CONTRAST	For future space infrared astronomical coronagraphy, we perform experimental studies on the application of aluminum mirrors to a coronagraph. Cooled reflective optics is required for broadband mid-infrared observations in space, while high-precision optics are required for coronagraphy. For the coronagraph instrument originally proposed for the next-generation infrared astronomical satellite project SPICA (SCI: SPICA Coronagraph Instrument), we fabricated and evaluated the optics consisting of high-precision aluminum off-axis mirrors with diamond-turned surfaces, and conducted a coronagraphic demonstration experiment using the optics with a coronagraph mask. We first measured the wave front errors (WFEs) of the aluminum mirrors with a He Ne Fizeau interferometer to confiati that the power spectral densities of the WFEs satisfy the SCI requirements. Then we integrated the minors into an optical system and evaluated the overall performance of the system. As a result, we estimate the total WFE of the optics to be 33 nm (rms), each mirror contributing 10-20 mu (rms) for the central 14 mm area of the optics, and obtain a contrast of 10(-5.4) as a coronagraph in the visible light. At a wavelength of 5 Am, the coronagraphic system is expected to achieve a contrast of similar to 10(-7) based on our model calculation with the measured optical performance. Thus our experiment demonstrates that aluminum mirror optics is applicable to a highly WFE-sensitive instrument such as a coronagraph in space.	[Oseki, S.; Oyabu, S.; Ishihara, D.; Kaneda, H.; Nishiyama, M.] Nagoya Univ, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Enya, K.; Haze, K.] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan; [Kotani, T.] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Abe, L.] Lab Univ Astrophysque Nice, UMR 6525, F-06108 Nice, France; [Yamamuro, T.] Optcraft, Sagamihara, Kanagawa 2291101, Japan	Oseki, S (reprint author), Nagoya Univ, Grad Sch Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.	oseki@u.phys.nagoya-u.ac.jp					Vanderbei RJ, 2003, ASTROPHYS J, V599, P686, DOI 10.1086/379238; Vanderbei RJ, 2004, ASTROPHYS J, V615, P555, DOI 10.1086/423947; Belikov R, 2007, P SOC PHOTO-OPT INS, V6693, pY6930, DOI 10.1117/12.734976; Haze K, 2011, PUBL ASTRON SOC JPN, V63, P873; Kasdin NJ, 2005, APPL OPTICS, V44, P1117, DOI 10.1364/AO.44.001117; Haze K, 2009, ADV SPACE RES, V43, P181, DOI 10.1016/j.asr.2008.10.007; Enya K, 2007, ASTRON ASTROPHYS, V461, P783, DOI 10.1051/0004-6361:20066351; Enya K, 2011, ADV SPACE RES, V48, P323, DOI 10.1016/j.asr.2011.03.010; Enya K, 2008, ASTRON ASTROPHYS, V480, P899, DOI 10.1051/0004-6361:20078627; Borde PJ, 2006, ASTROPHYS J, V638, P488, DOI 10.1086/498669; Carlotti A., 2011, ARXIV11084050; Enya K, 2010, PUBL ASTRON SOC JPN, V62, P1407; Enya K, 2012, PROC SPIE, V8442, DOI 10.1117/12.925524; Enya K, 2011, PROC SPIE, V8146, DOI 10.1117/12.893508; Haze K., 2012, THESIS GRADUATE U AD; Kasdin N. J., 2005, P SOC PHOTO-OPT INS, V5905, P128; Spergel D. N., 2001, ARXIVASTROPH0101142; Vanderbei RJ, 2003, ASTROPHYS J, V590, P593, DOI 10.1086/374971	18	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0004-6280	1538-3873		PUBL ASTRON SOC PAC	Publ. Astron. Soc. Pac.	OCT	2015	127	956					1077	1083				7	Astronomy & Astrophysics	Astronomy & Astrophysics	CU5VM	WOS:000363600100010		
J	Nakanishi, J; Morimoto, Y; Ogura, I; Kobayashi, N; Naya, M; Ema, M; Endoh, S; Shimada, M; Ogami, A; Myojyo, T; Oyabu, T; Gamo, M; Kishimoto, A; Igarashi, T; Hanai, S				Nakanishi, Junko; Morimoto, Yasuo; Ogura, Isamu; Kobayashi, Norihiro; Naya, Masato; Ema, Makoto; Endoh, Shigehisa; Shimada, Manabu; Ogami, Akira; Myojyo, Toshihiko; Oyabu, Takako; Gamo, Masashi; Kishimoto, Atsuo; Igarashi, Takuya; Hanai, Sosuke			Risk Assessment of the Carbon Nanotube Group	RISK ANALYSIS			English	Article						CNT; CNT toxicity; OEL; risk assessment	IN-VIVO GENOTOXICITY; INTRATRACHEAL INSTILLATION; INHALATION EXPOSURE; TITANIUM-DIOXIDE; PULMONARY TOXICITY; LUNG-CANCER; COMET ASSAY; PART B; SINGLE; RATS	This study assessed the health risks via inhalation and derived the occupational exposure limit (OEL) for the carbon nanotube (CNT) group rather than individual CNT material. We devised two methods: the integration of the intratracheal instillation (IT) data with the inhalation (IH) data, and the biaxial approach. A four-week IH test and IT test were performed in rats exposed to representative materials to obtain the no observed adverse effect level, based on which the OEL was derived. We used the biaxial approach to conduct a relative toxicity assessment of six types of CNTs. An OEL of 0.03 mg/m(3) was selected as the criterion for the CNT group. We proposed that the OEL be limited to 15 years. We adopted adaptive management, in which the values are reviewed whenever new data are obtained. The toxicity level was found to be correlated with the Brunauer-Emmett-Teller (BET)-specific surface area (BET-SSA) of CNT, suggesting the BET-SSA to have potential for use in toxicity estimation. We used the published exposure data and measurement results of dustiness tests to compute the risk in relation to particle size at the workplace and showed that controlling micron-sized respirable particles was of utmost importance. Our genotoxicity studies indicated that CNT did not directly interact with genetic materials. They supported the concept that, even if CNT is genotoxic, it is secondary genotoxicity mediated via a pathway of genotoxic damage resulting from oxidative DNA attack by free radicals generated during CNT-elicited inflammation. Secondary genotoxicity appears to involve a threshold.	[Nakanishi, Junko; Ogura, Isamu; Ema, Makoto; Gamo, Masashi; Igarashi, Takuya; Hanai, Sosuke] Natl Inst Adv Ind Sci & Technol, Res Inst Sci Safety & Sustainabil, Tsukuba, Ibaraki, Japan; [Morimoto, Yasuo; Ogami, Akira; Myojyo, Toshihiko; Oyabu, Takako] Univ Occupat & Environm Hlth, Inst Ind Ecol Sci, Kitakyushu, Fukuoka 807, Japan; [Kobayashi, Norihiro] Natl Inst Hlth Sci, Div Environm Chem, Tokyo, Japan; [Naya, Masato] Publ Interest Inc Fdn, BSRC, Iwata, Japan; [Endoh, Shigehisa] Natl Inst Adv Ind Sci & Technol, Res Inst Environm Management Technol, Tsukuba, Ibaraki, Japan; [Shimada, Manabu] Hiroshima Univ, Fac Engn, Dept Chem Engn, Higashihiroshima 724, Japan; [Kishimoto, Atsuo] Univ Tokyo, Grad Sch Publ Policy, Policy Alternat Res Inst, Tokyo, Japan	Nakanishi, J (reprint author), AIST, 16-1 Onogawa, Tsukuba, Ibaraki 3058569, Japan.	j-nakanishi@aist.go.jp			New Energy and Industrial Technology Development Organization of Japan (NEDO) grant "Evaluating risks associated with manufactured nanomaterials" [P06041]	This study was supported by the New Energy and Industrial Technology Development Organization of Japan (NEDO) grant "Evaluating risks associated with manufactured nanomaterials" (P06041).	Allion KL, 2009, ADV DRUG DELIV, V61, P457; Magdolenova Z, 2014, NANOTOXICOLOGY, V8, P233, DOI 10.3109/17435390.2013.773464; Sargent LM, 2012, MUTAT RES-GEN TOX EN, V745, P28, DOI 10.1016/j.mrgentox.2011.11.017; Methner M, 2010, J OCCUP ENVIRON HYG, V7, P163, DOI 10.1080/15459620903508066; Aschberger K, 2010, CRIT REV TOXICOL, V40, P759, DOI 10.3109/10408444.2010.506638; Di Giorgio ML, 2011, MUTAT RES-GEN TOX EN, V722, P20, DOI 10.1016/j.mrgentox.2011.02.008; Kuempel ED, 2012, ANN OCCUP HYG, V56, P491, DOI 10.1093/annhyg/mes040; Driscoll KE, 2000, TOXICOL SCI, V55, P24, DOI 10.1093/toxsci/55.1.24; Nagai H, 2011, P NATL ACAD SCI USA, V108, pE1330, DOI 10.1073/pnas.1110013108; Morimoto Y, 2012, NANOTOXICOLOGY, V6, P587, DOI 10.3109/17435390.2011.594912; Ogura I, 2011, J NANOPART RES, V13, P1265, DOI 10.1007/s11051-010-0119-8; Sakamoto Y, 2009, J TOXICOL SCI, V34, P65; Hext PM, 2005, ANN OCCUP HYG, V49, P461, DOI 10.1093/annhyg/mei012; Morimoto Y, 2012, NANOTOXICOLOGY, V6, P766, DOI 10.3109/17435390.2011.620719; Hata K, 2004, SCIENCE, V306, P1362, DOI 10.1126/science.1104962; Maynard AD, 2004, J TOXICOL ENV HEAL A, V67, P87, DOI 10.1080/15287390490253688; Wirkes A, 2010, J APPL PHYSIOL, V109, P1662, DOI 10.1152/japplphysiol.00674.2010; Pauluhn J, 2010, REGUL TOXICOL PHARM, V57, P78, DOI 10.1016/j.yrtph.2009.12.012; Lee JH, 2010, INHAL TOXICOL, V22, P369, DOI 10.3109/08958370903367359; Castranova V, 2013, ACCOUNTS CHEM RES, V46, P642, DOI 10.1021/ar300004a; Schins RPF, 2007, INHAL TOXICOL, V19, P189, DOI 10.1080/08958370701496202; Nel AE, 2013, ACS NANO, V7, P6422, DOI 10.1021/nn4037927; Ema M, 2012, REGUL TOXICOL PHARM, V63, P188, DOI 10.1016/j.yrtph.2012.03.014; Bolt HM, 2004, TOXICOL LETT, V151, P29, DOI 10.1016/j.toxlet.2004.04.004; Takagi A, 2008, J TOXICOL SCI, V33, P105, DOI 10.2131/jts.33.105; Maruya KA, 2014, INTEGR ENVIRON ASSES, V10, P69, DOI 10.1002/ieam.1483; Ema M, 2011, REGUL TOXICOL PHARM, V61, P276, DOI 10.1016/j.yrtph.2011.08.007; Schulte PA, 2010, J NANOPART RES, V12, P1971, DOI 10.1007/s11051-010-0008-1; Han JH, 2008, INHAL TOXICOL, V20, P741, DOI 10.1080/08958370801942238 ; Shimada M, 2009, ENVIRON SCI TECHNOL, V43, P5529, DOI 10.1021/es9008773; Ema M, 2013, J APPL TOXICOL, V33, P1053, DOI 10.1002/jat.2810; Kobayashi N, 2011, INHAL TOXICOL, V23, P814, DOI 10.3109/08958378.2011.614968; Ema M, 2013, J APPL TOXICOL, V33, P933, DOI 10.1002/jat.2772; Warheit DB, 2003, EXP LUNG RES, V29, P593, DOI 10.1080/01902140390240104; Moller P, 2010, FREE RADICAL RES, V44, P1, DOI 10.3109/10715760903300691; Sargent LM, 2009, ENVIRON MOL MUTAGEN, V50, P708, DOI 10.1002/em.20529; Baan RA, 2007, INHAL TOXICOL, V19, P213, DOI 10.1080/08958370701497903; Kobayashi N, 2010, TOXICOLOGY, V276, P143, DOI 10.1016/j.tox.2010.07.021; Hubbard R, 2000, AM J RESP CRIT CARE, V161, P5; Seto T, 2010, AEROSOL SCI TECH, V44, P734, DOI 10.1080/02786826.2010.487881; Naya M, 2012, REGUL TOXICOL PHARM, V64, P124, DOI 10.1016/j.yrtph.2012.05.020; Toyokuni S, 2013, ADV DRUG DELIVER REV, V65, P2098, DOI 10.1016/j.addr.2013.05.011; Peigney A, 2001, CARBON, V39, P507, DOI 10.1016/S0008-6223(00)00155-X; Johnson DR, 2010, ENVIRON HEALTH PERSP, V118, P49, DOI 10.1289/ehp.0901076; Naya M, 2011, REGUL TOXICOL PHARM, V61, P192, DOI 10.1016/j.yrtph.2011.07.008; Lanone S, 2006, CURR MOL MED, V6, P651, DOI 10.2174/156652406778195026; Pauluhn J, 2010, TOXICOL SCI, V113, P226, DOI 10.1093/toxsci/kfp247; Greim H, 2007, INHAL TOXICOL, V19, P199, DOI 10.1080/08958370701497689; Borm PJA, 2004, INT J CANCER, V110, P3, DOI 10.1002/ijc.20064; Shvedova AA, 2013, SMALL, V9, P1691, DOI 10.1002/smll.201201470; Okamoto S, 1998, INT ARCH OCC ENV HEA, V71, P111, DOI 10.1007/s004200050257; Singh N, 2009, BIOMATERIALS, V30, P3891, DOI 10.1016/j.biomaterials.2009.04.009; Lai DY, 2012, WIRES NANOMED NANOBI, V4, P1, DOI 10.1002/wnan.162; Johnston H, 2013, CRIT REV TOXICOL, V43, P1, DOI 10.3109/10408444.2012.738187; Miller FJ, 2000, INHAL TOXICOL, V12, P19, DOI 10.1080/089583700196536; Applied Research Associates Inc. (ARA), MULT PATH PART DOS M; Asakura M, 2010, J OCCUP HEALTH, V52, P155; ECHA, 2011, GUID INF REQ CHEM SA; Ema M, 2011, JAP J ENV TOXICOL, V14, P81; Endoh Shigehisa, 2010, Journal of the Society of Powder Technology, Japan, V47, DOI 10.4164/sptj.47.600; Fujita K, 2014, NANOTOXICOLOGY, V9, P1; Hinds WC, 1999, AEROSOL TECHNOLOGY P, P182; Borm PYA, 2000, INHAL TOXICOL, V12, P1; ISO, 2014, 18637 ISO PDTR; Luizi F, 2009, EUR RESP CAR C PRAG; Ma-Hock L, 2009, TOXICOL SCI, V12, P468; Methner Mark M, 2008, J Occup Environ Hyg, V5, pD63, DOI 10.1080/15459620802059393; Nakanishi J, 2011, P06041 NEDO; National Research Council, 2013, RES PROGR ENV HLTH S; Ogura I, 2012, P06041 NEDO; Sargent LM, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-3; Shevedova AA, 2014, AM J PHYSIOL-LUNG C, V306, pL170; Shvedova AA, 2008, AM J PHYSIOL-LUNG C, V295, pL552, DOI 10.1152/ajplung.90287.2008; Shvedova AA, 2012, TOXICOLOGY APPL PHAR, V261, P21; Shvedova AA, 2009, PHARMACOL THERAPEUT, V12, P192; Siegrist KJ, 2014, PARTICLE FIBRE TOXIC, V11, DOI 1i86/1743-8977-11-6; Takaya M, 2010, J OCCUP HLTH LOND, V52, P182; U. S. NIOSH, 2013, DHHS NIOSH PUBLICATI, V65; U.S. NIOSH, 2009, DHHS NIOSH PUBLICATI, V2009-125	79	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0272-4332	1539-6924		RISK ANAL	Risk Anal.	OCT	2015	35	10					1940	1956		10.1111/risa.12394		17	Public, Environmental & Occupational Health; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods	Public, Environmental & Occupational Health; Mathematics; Mathematical Methods In Social Sciences	CU4BE	WOS:000363470200012		
J	Seki, K; Nagy, A; Jackman, CM; Crary, F; Fontaine, D; Zarka, P; Wurz, P; Milillo, A; Slavin, JA; Delcourt, DC; Wiltberger, M; Ilie, R; Jia, X; Ledvina, SA; Liemohn, MW; Schunk, RW				Seki, K.; Nagy, A.; Jackman, C. M.; Crary, F.; Fontaine, D.; Zarka, P.; Wurz, P.; Milillo, A.; Slavin, J. A.; Delcourt, D. C.; Wiltberger, M.; Ilie, R.; Jia, X.; Ledvina, S. A.; Liemohn, M. W.; Schunk, R. W.			A Review of General Physical and Chemical Processes Related to Plasma Sources and Losses for Solar System Magnetospheres	SPACE SCIENCE REVIEWS			English	Review						Planetary magnetosphere; Plasma sources; General processes	INTERPLANETARY MAGNETIC-FIELD; PHOTON-STIMULATED DESORPTION; AURORAL KILOMETRIC RADIATION; KELVIN-HELMHOLTZ VORTICES; MAGNETOPAUSE RECONNECTION RATE; ELECTRON-CYCLOTRON MASER; RING CURRENT COMPOSITION; ENERGETIC NEUTRAL ATOMS; SINGLE-PARTICLE ORBITS; MONTE-CARLO-SIMULATION	The aim of this paper is to provide a review of general processes related to plasma sources, their transport, energization, and losses in the planetary magnetospheres. We provide background information as well as the most up-to-date knowledge of the comparative studies of planetary magnetospheres, with a focus on the plasma supply to each region of the magnetospheres. This review also includes the basic equations and modeling methods commonly used to simulate the plasma sources of the planetary magnetospheres. In this paper, we will describe basic and common processes related to plasma supply to each region of the planetary magnetospheres in our solar system. First, we will describe source processes in Sect. 1. Then the transport and energization processes to supply those source plasmas to various regions of the magnetosphere are described in Sect. 2. Loss processes are also important to understand the plasma population in the magnetosphere and Sect. 3 is dedicated to the explanation of the loss processes. In Sect. 4, we also briefly summarize the basic equations and modeling methods with a focus on plasma supply processes for planetary magnetospheres.	[Seki, K.] Nagoya Univ, Solar Terr Environm Lab, Nagoya, Aichi 4648601, Japan; [Nagy, A.; Slavin, J. A.; Ilie, R.; Jia, X.; Liemohn, M. W.] Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; [Jackman, C. M.] Univ Southampton, Dept Phys & Astron, Southampton SO17 1BJ, Hants, England; [Crary, F.] Univ Colorado, Lab Atmospher & Space Phys, Boulder, CO 80303 USA; [Fontaine, D.; Delcourt, D. C.] Ecole Polytech, CNRS EP UPMC UPSud, Lab Phys Plasmas, F-91128 Palaiseau, France; [Zarka, P.] Univ Paris Diderot, CNRS, Observ Paris, LESIA, F-92195 Meudon, France; [Wurz, P.] Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; [Milillo, A.] INAF, Inst Space Astrophys & Planetol, Rome, Italy; [Wiltberger, M.] Natl Ctr Atmospher Res, High Altitude Observ, Boulder, CO 80212 USA; [Ledvina, S. A.] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; [Schunk, R. W.] Utah State Univ, Ctr Atmospher & Space Sci, Logan, UT 84322 USA	Seki, K (reprint author), Nagoya Univ, Solar Terr Environm Lab, Nagoya, Aichi 4648601, Japan.	seki@stelab.nagoya-u.ac.jp	Wiltberger, Michael/B-8781-2008; 	Wiltberger, Michael/0000-0002-4844-3148; Milillo, Anna/0000-0002-0266-2556	JSPS and MEXT of Japan [24340118]; GEMSIS project at STEL, Nagoya University; Royal Astronomical Society Fellowship; Science and Technology Facilities Council Ernest Rutherford Fellowship; JPL [1467206]; NASA [NNH12AU10I, NNH11AR82I, NNX12AK34G, NNX12AM74G]; National Science Foundation; NSF [AGS 1203232]	This work was partially supported by Grant-In-Aid for Scientific Research (B) 24340118 from JSPS and MEXT of Japan. KS also thanks for supports from the GEMSIS project at STEL, Nagoya University. CMJ's work at Southampton was supported by a Royal Astronomical Society Fellowship and a Science and Technology Facilities Council Ernest Rutherford Fellowship. FC is funded by JPL contract 1467206. MW is supported by NASA grants NNH12AU10I and NNH11AR82I. The National Center for Atmospheric Research is sponsored by the National Science Foundation. XJ is supported by NASA grants NNX12AK34G and NNX12AM74G, and by NSF grant AGS 1203232.	Andersen H., 1981, SPUTTERING PARTICLE; Wiltberger M, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2010JA015579; Marconi ML, 2007, ICARUS, V190, P155, DOI 10.1016/j.icarus.2007.02.016; SISCOE G, 1975, GEOPHYS RES LETT, V2, P158, DOI 10.1029/GL002i004p00158; Pontius DH, 1997, GEOPHYS RES LETT, V24, P2961, DOI 10.1029/97GL53157; DiBraccio GA, 2013, J GEOPHYS RES-SPACE, V118, P997, DOI 10.1002/jgra.50123; Zoennchen JH, 2011, ANN GEOPHYS-GERMANY, V29, P2211, DOI 10.5194/angeo-29-2211-2011; MEYERVERNET N, 1995, ICARUS, V116, P202, DOI 10.1006/icar.1995.1121; Nykyri K, 2006, ANN GEOPHYS-GERMANY, V24, P2619; HUANG TS, 1992, J GEOPHYS RES, V97, P1511, DOI 10.1029/91JA02611; Vogt MF, 2014, J GEOPHYS RES-SPACE, V119, P821, DOI 10.1002/2013JA019393; GOSLING JT, 1990, GEOPHYS RES LETT, V17, P1833, DOI 10.1029/GL017i011p01833; Slavin JA, 2009, SCIENCE, V324, P606, DOI 10.1126/science.1172011; Ilie R, 2013, J ATMOS SOL-TERR PHY, V99, P92, DOI 10.1016/j.jastp.2012.03.010; Zoennchen JH, 2010, ANN GEOPHYS-GERMANY, V28, P1221, DOI 10.5194/angeo-28-1221-2010; SMITH PH, 1978, SPACE SCI REV, V22, P301; Muller M, 2002, PLANET SPACE SCI, V50, P1101, DOI 10.1016/S0032-0633(02)00048-X; Yakshinskiy BV, 1999, NATURE, V400, P642; BRICE NM, 1970, ICARUS, V13, P173, DOI 10.1016/0019-1035(70)90048-5; Hess S, 2009, PLANET SPACE SCI, V57, P23, DOI 10.1016/j.pss.2008.10.006; Lai HR, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2011JA017263; Toth G, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2005JA011126; Winglee RM, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA000214; HILL TW, 1976, J GEOPHYS RES-SPACE, V81, P4561, DOI 10.1029/JA081i025p04561; SPJELDVIK WN, 1977, J GEOPHYS RES-SPACE, V82, P2801, DOI 10.1029/JA082i019p02801; CONNERNEY JEP, 1984, NATURE, V312, P136, DOI 10.1038/312136a0; DEVRIES AE, 1984, J PHYS CHEM-US, V88, P4510, DOI 10.1021/j150664a014; CAAN MN, 1973, J GEOPHYS RES, V78, P8087, DOI 10.1029/JA078i034p08087; Bhardwaj A, 2000, REV GEOPHYS, V38, P295, DOI 10.1029/1998RG000046; Thomsen MF, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2010JA015267; Cowley SWH, 2004, ANN GEOPHYS-GERMANY, V22, P1379; CHIU YT, 1978, J GEOPHYS RES-SPACE, V83, P629, DOI 10.1029/JA083iA02p00629; Wurz P, 2007, ICARUS, V191, P486, DOI 10.1016/j.icarus.2007.04.034; Ledvina SA, 2008, SPACE SCI REV, V139, P143, DOI 10.1007/s11214-008-9384-6; Keika K, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2006JA011789; HAREL M, 1981, J GEOPHYS RES-SPACE, V86, P2217, DOI 10.1029/JA086iA04p02217; HARING RA, 1984, NUCL INSTRUM METH B, V5, P483, DOI 10.1016/0168-583X(84)90005-3; Bolton SJ, 2004, CAMB PLANET, P671; Toth G, 2012, J COMPUT PHYS, V231, P870, DOI 10.1016/j.jcp.2011.02.006; Yau AW, 1997, SPACE SCI REV, V80, P1, DOI 10.1023/A:1004947203046; BURTON RK, 1975, J GEOPHYS RES-SPACE, V80, P4204, DOI 10.1029/JA080i031p04204; De Keyser J, 2010, ANN GEOPHYS-GERMANY, V28, P2027, DOI 10.5194/angeo-28-2027-2010; Newell PT, 1998, J GEOPHYS RES-SPACE, V103, P4739, DOI 10.1029/97JA03622; Frederick-Frost KM, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2006JA011942; Matsumoto Y, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2004JA010988; Nichols JD, 2006, ANN GEOPHYS-GERMANY, V24, P393; REIMANN CT, 1984, SURF SCI, V147, P227, DOI 10.1016/0039-6028(84)90177-8; FAHR HJ, 1974, SPACE SCI REV, V15, P483; FONTAINE D, 1985, J GEOPHYS RES-SPACE, V90, P8343, DOI 10.1029/JA090iA09p08343; Yakshinskiy BV, 2001, J GEOPHYS RES-PLANET, V106, P33303, DOI 10.1029/2000JE001345; Wing S, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013950; Johnson RE, 2002, ICARUS, V156, P136, DOI 10.1006/icar.2001.6763; Wu XY, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2000JA000190; Krupp N, 2004, CAMB PLANET, P617; Oieroset M, 1999, J GEOPHYS RES-SPACE, V104, P6987, DOI 10.1029/1998JA900177; Fox JL, 2001, J GEOPHYS RES-SPACE, V106, P21305, DOI 10.1029/2001JA000069; Ziegler JF, 2004, NUCL INSTRUM METH B, V219, P1027, DOI 10.1016/j.nimb.2004.01.208; PERREAULT P, 1978, GEOPHYS J ROY ASTR S, V54, P547, DOI 10.1111/j.1365-246X.1978.tb05494.x; Feldstein YI, 2001, ANN GEOPHYS-GERMANY, V19, P495; PRANGE R, 1992, ADV SPACE RES-SERIES, V12, P379, DOI 10.1016/0273-1177(92)90413-R; Fukazawa K, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031784; Mauk BH, 2003, NATURE, V421, P920, DOI 10.1038/nature01431; Tam SWY, 2007, J ATMOS SOL-TERR PHY, V69, P1984, DOI 10.1016/j.jastp.2007.08.006; Paschmann G, 2013, SPACE SCI REV, V178, P385, DOI 10.1007/s11214-012-9957-2; Jackman CM, 2014, J GEOPHYS RES-SPACE, V119, P5465, DOI 10.1002/2013JA019388; Kivelson MG, 1998, J GEOPHYS RES-PLANET, V103, P19963, DOI 10.1029/98JE00227; Fok MC, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2006JA011839; ROOSENDAAL HE, 1982, NUCL INSTRUM METHODS, V194, P579, DOI 10.1016/0029-554X(82)90584-5; Ergun RE, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2005JA011253; LYSAK RL, 1990, SPACE SCI REV, V52, P33, DOI 10.1007/BF00704239; FARRUGIA CJ, 1995, J GEOPHYS RES-SPACE, V100, P19245, DOI 10.1029/95JA01080; Slavin JA, 1998, GEOPH MONOG SERIES, V105, P225; BURTON RK, 1975, SCIENCE, V189, P717, DOI 10.1126/science.189.4204.717; Mozer FS, 2001, J GEOPHYS RES-SPACE, V106, P5763, DOI 10.1029/2000JA900117; BAGENAL F, 1981, J GEOPHYS RES-SPACE, V86, P8447, DOI 10.1029/JA086iA10p08447; Pryor WR, 2011, NATURE, V472, P331, DOI 10.1038/nature09928; Slavin JA, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2012JA017926; COWLEY SWH, 1982, REV GEOPHYS, V20, P531, DOI 10.1029/RG020i003p00531; SONNERUP BU, 1971, J GEOPHYS RES, V76, P8211, DOI 10.1029/JA076i034p08211; Terada N, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013937; MOZER FS, 1980, SPACE SCI REV, V27, P155; Nose M, 2000, J GEOPHYS RES-SPACE, V105, P7669, DOI 10.1029/1999JA000318; Jackman CM, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA016682; Garcia KS, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2010JA015730; McAndrews HJ, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2007JA012581; Jia XZ, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2011JA017367; Ganguli SB, 1996, REV GEOPHYS, V34, P311, DOI 10.1029/96RG00497; SCHUNK RW, 1980, REV GEOPHYS, V18, P813, DOI 10.1029/RG018i004p00813; POTTER AE, 1995, GEOPHYS RES LETT, V22, P3289, DOI 10.1029/95GL03181; SCURRY L, 1991, J GEOPHYS RES, V96, P9541, DOI 10.1029/91JA00569; HEIKKILA WJ, 1977, J GEOPHYS RES-SPACE, V82, P1610, DOI 10.1029/JA082i010p01610; Delamere PA, 2013, J GEOPHYS RES-SPACE, V118, P393, DOI 10.1029/2012JA018197; Thorne RM, 1997, GEOPHYS RES LETT, V24, P2131, DOI 10.1029/97GL01788; Mura A, 2009, ICARUS, V200, P1, DOI 10.1016/j.icarus.2008.11.014; Fama M, 2008, SURF SCI, V602, P156, DOI 10.1016/j.susc.2007.10.002; Szego K, 2000, SPACE SCI REV, V94, P429, DOI 10.1023/A:1026568530975; Hansen KC, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022835; Jia XZ, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2009JA014375; Masters A, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2010JA015351; Cassidy T, 2010, SPACE SCI REV, V153, P299, DOI 10.1007/s11214-009-9625-3; Terasawa T, 1997, GEOPHYS RES LETT, V24, P935, DOI 10.1029/96GL04018; Mangano V, 2007, PLANET SPACE SCI, V55, P1541, DOI 10.1016/j.pss.2006.10.008; Cassidy TA, 2005, ICARUS, V176, P499, DOI 10.1016/j.icarus.2005.02.013; Khurana KK, 2007, ICARUS, V191, P193, DOI 10.1016/j.icarus.2007.04.022; WESTLEY MS, 1995, NATURE, V373, P405, DOI 10.1038/373405a0; IPAVICH FM, 1984, GEOPHYS RES LETT, V11, P504, DOI 10.1029/GL011i005p00504; MCELROY MB, 1973, SPACE SCI REV, V14, P460, DOI 10.1007/BF00214756; Paschmann G, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035297; Ogawa Y, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2007JA012791; Burlaga LF, 2001, PLANET SPACE SCI, V49, P1619, DOI 10.1016/S0032-0633(01)00098-8; MICHEL FC, 1974, PLANET SPACE SCI, V22, P1501, DOI 10.1016/0032-0633(74)90015-4; PRITCHETT PL, 1986, PHYS FLUIDS, V29, P2919, DOI 10.1063/1.865492; BROWN WL, 1986, NUCL INSTRUM METH B, V13, P295, DOI 10.1016/0168-583X(86)90516-1; FRANK LA, 1967, J GEOPHYS RES, V72, P3753, DOI 10.1029/JZ072i015p03753; Wurz P, 2003, ICARUS, V164, P1, DOI 10.1016/S0019-1035(03)00123-4; LYONS LR, 1980, J GEOPHYS RES-SPACE, V85, P17, DOI 10.1029/JA085iA01p00017; Wilson RJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040225; Hasegawa H, 2004, NATURE, V430, P755, DOI 10.1038/nature02799; Powell KG, 1999, J COMPUT PHYS, V154, P284, DOI 10.1006/jcph.1999.6299; BROWN WL, 1984, NUCL INSTRUM METH B, V1, P307, DOI 10.1016/0168-583X(84)90085-5; Waite JH, 2001, NATURE, V410, P787, DOI 10.1038/35071018; Brambles OJ, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2010JA015469; Jia XZ, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2012JA017575; Wanliss JA, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2005JA011034; Shi M, 1995, J GEOPHYS RES-PLANET, V100, P26387, DOI 10.1029/95JE03099; Yakshinskiy BV, 2005, SURF SCI, V593, P202, DOI 10.1016/j.susc.2005.062; Borovsky JE, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2007JA012645; Forsyth RJ, 1996, J GEOPHYS RES, V101, P395, DOI 10.1029/95JA02977; Jackman CM, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2004JA010614; SERGEEV VA, 1993, J GEOPHYS RES, V98, P7609, DOI 10.1029/92JA02587; Wurz P, 2010, PLANET SPACE SCI, V58, P1599, DOI 10.1016/j.pss.2010.08.003; CLADIS JB, 1986, GEOPHYS RES LETT, V13, P893, DOI 10.1029/GL013i009p00893; Fuselier SA, 2011, SPACE SCI REV, V160, P95, DOI 10.1007/s11214-011-9820-x; EICHHORN G, 1978, PLANET SPACE SCI, V26, P469, DOI 10.1016/0032-0633(78)90068-5; FITE WL, 1958, PHYS REV, V112, P1161, DOI 10.1103/PhysRev.112.1161; Carlson CW, 1998, GEOPHYS RES LETT, V25, P2013, DOI 10.1029/98GL01592; Baragiola RA, 2003, NUCL INSTRUM METH B, V209, P294, DOI 10.1016/S0168-583X(02)02052-9; Ono Y, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013918; Majeed T, 1996, J GEOPHYS RES-PLANET, V101, P7589, DOI 10.1029/96JE00115; Ostgaard N, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2002JA009749; Fukazawa K, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028373; DUNGEY JW, 1961, PHYS REV LETT, V6, P47, DOI 10.1103/PhysRevLett.6.47; Yu YQ, 2013, J GEOPHYS RES-SPACE, V118, P1711, DOI 10.1029/2012JA018411; Killen R, 2007, SPACE SCI REV, V132, P433, DOI 10.1007/s11214-007-9232-0; Clarke JT, 2012, GEOPHYS MONOGR SER, V197, P113, DOI 10.1029/2011GM001199; SERGEEV VA, 1983, PLANET SPACE SCI, V31, P1147, DOI 10.1016/0032-0633(83)90103-4; Andre M, 1997, SPACE SCI REV, V80, P27, DOI 10.1023/A:1004921619885; McFadden JP, 1999, J GEOPHYS RES-SPACE, V104, P14453, DOI 10.1029/1998JA900167; ROSENBAUER H, 1975, J GEOPHYS RES-SPACE, V80, P2723, DOI 10.1029/JA080i019p02723; Marklund GT, 2009, SPACE SCI REV, V142, P1, DOI 10.1007/s11214-008-9373-9; ASHOURABDALLA M, 1992, GEOPHYS RES LETT, V19, P1739, DOI 10.1029/92GL01810; MITCHELL DG, 1990, GEOPHYS RES LETT, V17, P583, DOI 10.1029/GL017i005p00583; Raeder J, 2008, SPACE SCI REV, V141, P535, DOI 10.1007/s11214-008-9421-5; BANKS PM, 1969, J GEOPHYS RES, V74, P6317, DOI 10.1029/JA074i026p06317; Phan TD, 2013, GEOPHYS RES LETT, V40, P11, DOI 10.1029/2012GL054528; Masters A, 2009, PLANET SPACE SCI, V57, P1769, DOI 10.1016/j.pss.2009.02.010; Cassidy TA, 2013, PLANET SPACE SCI, V77, P64, DOI 10.1016/j.pss.2012.07.008; Krimigis SM, 2005, SCIENCE, V307, P1270, DOI 10.1126/science.1105978; CHAMBERLAIN JW, 1963, PLANET SPACE SCI, V11, P901, DOI 10.1016/0032-0633(63)90122-3; Grocott A, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2009JA014330; SPJELDVIK WN, 1978, J GEOPHYS RES-SPACE, V83, P1583, DOI 10.1029/JA083iA04p01583; Russell CT, 1998, SCIENCE, V280, P1061, DOI 10.1126/science.280.5366.1061; Kivelson MG, 2004, ADV SPACE RES, V33, P2061, DOI 10.1016/j.asr.2003.08.042; Cooper JF, 2001, ICARUS, V149, P133, DOI 10.1006/icar.2000.6498; Chane E, 2013, J GEOPHYS RES-SPACE, V118, P2157, DOI 10.1002/jgra.50258; Killen RM, 1999, REV GEOPHYS, V37, P361, DOI 10.1029/1999RG900001; MOZER FS, 1977, PHYS REV LETT, V38, P292, DOI 10.1103/PhysRevLett.38.292; Winske D, 2003, LECT NOTES PHYS, V615, P136, DOI 10.1007/3-540-36530-3_8; Ray LC, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013969; WILLIAMS DJ, 1981, PLANET SPACE SCI, V29, P1195, DOI 10.1016/0032-0633(81)90124-0; Shematovich VI, 2005, ICARUS, V173, P480, DOI 10.1016/j.icarus.2004.08.013; Galopeau PHM, 1995, J GEOPHYS RES-PLANET, V100, P26397, DOI 10.1029/95JE02132; AXFORD WI, 1964, PLANET SPACE SCI, V12, P45, DOI 10.1016/0032-0633(64)90067-4; Kitamura N, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2011JA017459; DELCOURT DC, 1994, GEOPHYS RES LETT, V21, P1543, DOI 10.1029/94GL01291; Plainaki C, 2010, ICARUS, V210, P385, DOI 10.1016/j.icarus.2010.06.041; SONNERUP BU, 1974, J GEOPHYS RES, V79, P1546, DOI 10.1029/JA079i010p01546; PILIPP WG, 1978, J GEOPHYS RES-SPACE, V83, P5670, DOI 10.1029/JA083iA12p05670; Cassidy TA, 2007, ICARUS, V191, P755, DOI 10.1016/j.icarus.2007.04.033; Jackman CM, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2008JA013083; Jackman CM, 2014, SPACE SCI REV, V182, P85, DOI 10.1007/s11214-014-0060-8; Bailey J, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA016531; Lyon JG, 2004, J ATMOS SOL-TERR PHY, V66, P1333, DOI 10.1016/j.jastp.2004.03.020; Paranicas C, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014127; Smyth WH, 2006, ICARUS, V181, P510, DOI 10.1016/j.icarus.2005.10.019; Prange R, 1998, J GEOPHYS RES-PLANET, V103, P20195, DOI 10.1029/98JE01128; WU CS, 1979, ASTROPHYS J, V230, P621, DOI 10.1086/157120; Slavin JA, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2011JA016900; ANICICH VG, 1993, J PHYS CHEM REF DATA, V22, P1469; Sundberg T, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2011JA017268; Gosling JT, 2005, GEOPHYS RES LETT, V32, DOI [10.1029/2005GL022406, 10.1029/2005GL023357]; Kozyra JU, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA000023; Kidder A, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013100; STUART GW, 1959, PHYS REV LETT, V2, P417, DOI 10.1103/PhysRevLett.2.417; Slavin JA, 2014, J GEOPHYS RES-SPACE, V119, P8087, DOI 10.1002/2014JA020319; KNIGHT S, 1973, PLANET SPACE SCI, V21, P741, DOI 10.1016/0032-0633(73)90093-7; Orsini S, 1999, NUOVO CIMENTO C, V22, P633; EICHHORN G, 1978, PLANET SPACE SCI, V26, P463, DOI 10.1016/0032-0633(78)90067-3; Lavraud B, 2013, J GEOPHYS RES-SPACE, V118, P1089, DOI 10.1002/jgra.50145; Mitchell DG, 2003, SPACE SCI REV, V109, P63, DOI 10.1023/B:SPAC.0000007513.55076.00; Prange R, 1996, NATURE, V379, P323, DOI 10.1038/379323a0; Pallier L, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018041; PELLINEN RJ, 1978, J GEOPHYS RES-SPACE, V83, P1544, DOI 10.1029/JA083iA04p01544; Hess S, 2007, PLANET SPACE SCI, V55, P89, DOI 10.1016/j.pss.2006.05.016; Kronberg EA, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2007JA012880; Bonfond B, 2012, GEOPHYS MONOGR SER, V197, P133, DOI 10.1029/2011GM001169; CHEN J, 1986, J GEOPHYS RES, V91, P1499, DOI 10.1029/JA091iA02p01499; Slavin JA, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2002JA009557; Kivelson MG, 1997, GEOPHYS RES LETT, V24, P2127, DOI 10.1029/97GL02202; JOHNSON RE, 1983, ASTRON ASTROPHYS, V123, P343; Bruno M, 2007, PLANET SPACE SCI, V55, P1494, DOI 10.1016/j.pss.2006.10.006; BRECHT SH, 1988, COMPUT PHYS COMMUN, V48, P135, DOI 10.1016/0010-4655(88)90031-8; Bagenal F, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016294; BIERSACK JP, 1984, APPL PHYS A-MATER, V34, P73, DOI 10.1007/BF00614759; Jia XZ, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2012JA018183; Gershman DJ, 2013, J GEOPHYS RES-SPACE, V118, P7181, DOI 10.1002/2013JA019244; Grocott A, 2003, ANN GEOPHYS-GERMANY, V21, P509; MCNUTT RL, 1979, NATURE, V280, P803, DOI 10.1038/280803a0; Plainaki C, 2012, ICARUS, V218, P956, DOI 10.1016/j.icarus.2012.01.023; SOLOMON SC, 1993, GEOPHYS RES LETT, V20, P185, DOI 10.1029/93GL00081; Delcourt DC, 2002, J ATMOS SOL-TERR PHY, V64, P551, DOI 10.1016/S1364-6826(02)00012-3; EVANS DS, 1974, J GEOPHYS RES, V79, P2853, DOI 10.1029/JA079i019p02853; Phan TD, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023355; Abe T, 1996, J GEOMAGN GEOELECTR, V48, P319; THOMAS BT, 1980, J GEOPHYS RES-SPACE, V85, P6861, DOI 10.1029/JA085iA12p06861; Kabin K, 2000, ICARUS, V143, P397, DOI 10.1006/icar.1999.6252; Glocer A, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2009JA014053; Yau AW, 2007, J ATMOS SOL-TERR PHY, V69, P1936, DOI 10.1016/j.jastp.2007.08.010; Kim YH, 2014, J GEOPHYS RES-SPACE, V119, P384, DOI 10.1002/2013JA019022; HARRIS EG, 1962, NUOVO CIMENTO, V23, P115, DOI 10.1007/BF02733547; Ieda A, 1998, J GEOPHYS RES-SPACE, V103, P4453, DOI 10.1029/97JA03240; Luhmann JG, 2006, ICARUS, V181, P465, DOI 10.1016/j.icarus.2005.11.022; Nykyri K, 2001, GEOPHYS RES LETT, V28, P3565, DOI 10.1029/2001GL013239; ASHOURABDALLA M, 1994, J GEOPHYS RES, V99, P14891, DOI 10.1029/94JA00141; AXFORD WI, 1961, CAN J PHYS, V39, P1433; Badman S.V., 2007, ANN GEOPHYS, V25, P94; Bagenal F, 2007, J ATMOS SOL-TERR PHY, V69, P387, DOI 10.1016/j.jastp.2006.08.012; BARGATZE LF, 1985, J GEOPHYS RES-SPACE, V90, P6387, DOI 10.1029/JA090iA07p06387; Behrisch R., 2007, SPUTTERING PARTICLE; Bird G. A., 1994, MOL GAS DYNAMICS DIR; Birkeland K, 1910, CR HEBD ACAD SCI, V150, P246; Bishop J, 1996, J GEOPHYS RES, V101, P17325, DOI 10.1029/95JA03468; BORING JW, 1984, NUCL INSTRUM METH B, V1, P321, DOI 10.1016/0168-583X(84)90087-9; Borovsky JE, 1998, J GEOPHYS RES-SPACE, V103, P17617, DOI 10.1029/97JA02986; BROWN DG, 1995, J GEOPHYS RES, V100, P17499, DOI 10.1029/95JA00592; BUCHNER J, 1989, J GEOPHYS RES, V94, P11821, DOI 10.1029/JA094iA09p11821; Burch JL, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022611; Cecconi B, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013830; Chappell C.R., 2015, SPACE SCI R IN PRESS; Chen F. F., 1984, INTRO PLASMA PHYS CO; CINTALA MJ, 1992, J GEOPHYS RES-PLANET, V97, P947; CONNERNEY JEP, 1993, SCIENCE, V262, P1035, DOI 10.1126/science.262.5136.1035; Cravens T.E., 1997, PHYS SOLAR SYSTEM PL, DOI [10.1017/CBO9780511529467, DOI 10.1017/CBO9780511529467]; Delamere PA, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2010JA015347; Delcourt DC, 1996, J GEOPHYS RES, V101, P17409, DOI 10.1029/96JA01006; DELCOURT DC, 1990, J GEOPHYS RES, V95, P20853, DOI 10.1029/JA095iA12p20853; Delcourt DC, 1999, J GEOPHYS RES-SPACE, V104, P22635, DOI 10.1029/1999JA900251; Dessler A.J., 1983, PHYS JOVIAN MAGNETOS, V395, DOI [http://dx.doi.org/10.1017/CBO9780511564574.013, DOI 10.1017/CBO9780511564574.013]; Dessler J., 1959, J GEOPHYS RES, V64, P2239, DOI [10.1029/JZ064i012p02239, DOI 10.1029/JZ064I012P02239]; Eckstein W., 2007, SPUTTERING PARTICLE, P21; Fuselier SA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044140; Gombosi T.I., 1998, PHYS SPACE ENV; Hasegawa H, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2009JA014042; Hill TW, 1974, GEOPHYS RES LETT, V1, DOI 10.1029/GL001i001p00003; Hill TW, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022620; HODGES RR, 1994, J GEOPHYS RES, V99, P23229, DOI 10.1029/94JA02183; Hofer W.O., 1991, SPUTTERING PARTICLE, P15; HONES EW, 1977, J GEOPHYS RES-SPACE, V82, P5633, DOI 10.1029/JA082i035p05633; Hones Jr E. W., 1976, PHYSICS SOLAR PLANET, P559; Huba J.D., 2005, P ISSS MARCH, V7, P26; HUFF RL, 1988, J GEOPHYS RES, V93, P11445, DOI 10.1029/JA093iA10p11445; Imber S.M., 2014, J GEOPHYS RES UNPUB; Jackman CM, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029764; Johnson R.E., 1990, ENERGETIC CHARGED PA, VX, P19; Johnson R.E., 2009, EUROPA, P507; Johnson R.E, 2001, ADV SERIES PHYS CHEM, V11, P390; Jorgensen M., 1931, J GEOPHYS RES, V106, P1931, DOI [10.1029/2000JA000124, DOI 10.1029/2000JA000124]; Keika K., 2003, AGU FALL M, pA565; Keiling A., 2004, GEOPHYS RES LETT, V31; Krall N., 1986, PRINCIPLES PLASMA PH; Krupp N, 2001, J GEOPHYS RES-SPACE, V106, P26017, DOI 10.1029/2000JA900138; Lagg A., 2003, GEOPHYS RES LETT, V30; Liemohn M.W., 2005, INNER MAGNETOSPHERE, V155, P211; Lipatov A., 2002, HYBRID MULTISCALE SI; LOUARN P, 1990, J GEOPHYS RES, V95, P5983, DOI 10.1029/JA095iA05p05983; Masters A, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051372; Matsumoto Y, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA014637; MAUK BH, 1986, J GEOPHYS RES, V91, P3423, DOI 10.1029/JA091iA12p13423; Meinel B., 1951, ASTROPHYS J, V113, P50, DOI [10.1086/145375, DOI 10.1086/145375]; Moore TE, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000194; Mottez F, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016367; Nagy A.F., 1980, J GEOPHYS RES, V85, P7795, DOI 10.1029/JA085iA13p07795; Nakamura TKM, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2007JA012803; NEISHTADT AI, 1987, PMM-J APPL MATH MEC+, V51, P586; Norqvist P, 1996, J GEOPHYS RES, V101, P13179, DOI 10.1029/95JA03596; Northrop T. G., 1963, ADIABATIC MOTION CHA; NORTHROP TG, 1982, J GEOPHYS RES-SPACE, V87, P6045, DOI 10.1029/JA087iA08p06045; Ogino T.R., 1998, J GEOPHYS RES, V84, P47; PARKER EN, 1958, ASTROPHYS J, V128, P664, DOI 10.1086/146579; Paschmann G., 2003, AURORAL PLASMA PHYS; PEYMIRAT C, 1994, J GEOPHYS RES, V99, P11155, DOI 10.1029/93JA02546; Plainaki C, 2015, ICARUS, V245, P306, DOI 10.1016/j.icarus.2014.09.018; Plainaki C, 2013, PLANET SPACE SCI, V88, P42, DOI 10.1016/j.pss.2013.08.011; RAIRDEN RL, 1986, J GEOPHYS RES, V91, P3613, DOI 10.1029/JA091iA12p13613; ROUX A, 1993, J GEOPHYS RES, V98, P11657, DOI 10.1029/92JA02309; Sandholt PE, 1998, J GEOPHYS RES-SPACE, V103, P20279, DOI 10.1029/98JA01541; Schunk R., 2009, IONOSPHERES; Schunk RW, 1997, J GEOPHYS RES-SPACE, V102, P11625, DOI 10.1029/97JA00292; SHABANSK.VP, 1971, SPACE SCI REV, V12, P299, DOI 10.1007/BF00165511; Sigmund P., 1969, THEORY SPUTTERING; SISCOE GL, 1977, J GEOPHYS RES-SPACE, V82, P1641, DOI 10.1029/JA082i010p01641; SLAVIN JA, 1984, J GEOPHYS RES-SPACE, V89, P2708, DOI 10.1029/JA089iA05p02708; SPEISER TW, 1965, J GEOPHYS RES, V70, P4219, DOI 10.1029/JZ070i017p04219; Strangeway RJ, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010829; Sugiura M., 1964, HOURLY VALUES EQUATO, V35, P9; Teolis BD, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.245422; Thomas N., 2004, JUPITER PLANET SATEL, P560; Treumann RA, 2006, ASTRON ASTROPHYS REV, V13, P229, DOI 10.1007/s00159-006-0001-y; Vasyliunas V., 1970, PARTICLES FIELDS MAG; Vogt MF, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA015098; Wolf R.A., 1979, SPACE SCI REV, V17, P535; ZWAN BJ, 1976, J GEOPHYS RES-SPACE, V81, P1636, DOI 10.1029/JA081i010p01636; YEE KS, 1966, IEEE T ANTENN PROPAG, VAP14, P302; Zarka P, 1998, J GEOPHYS RES-PLANET, V103, P20159, DOI 10.1029/98JE01323; Ziegler J. F., 1984, STOPPING RANGES IONS, V1	325	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0038-6308	1572-9672		SPACE SCI REV	Space Sci. Rev.	OCT	2015	192	1-4					27	89		10.1007/s11214-015-0170-y		63	Astronomy & Astrophysics	Astronomy & Astrophysics	CU7MF	WOS:000363723000003		
J	Raines, JM; DiBraccio, GA; Cassidy, TA; Delcourt, DC; Fujimoto, M; Jia, X; Mangano, V; Milillo, A; Sarantos, M; Slavin, JA; Wurz, P				Raines, J. M.; DiBraccio, G. A.; Cassidy, T. A.; Delcourt, D. C.; Fujimoto, M.; Jia, X.; Mangano, V.; Milillo, A.; Sarantos, M.; Slavin, J. A.; Wurz, P.			Plasma Sources in Planetary Magnetospheres: Mercury	SPACE SCIENCE REVIEWS			English	Review							BIDIRECTIONAL REFLECTANCE SPECTROSCOPY; PHOTON-STIMULATED DESORPTION; MESSENGER ORBITAL OBSERVATIONS; SOLAR-WIND INTERACTION; ION MASS-SPECTROMETRY; NEUTRAL SODIUM ATOMS; FLUX-TRANSFER EVENTS; MAGNETIC-FIELD; POTASSIUM ATMOSPHERES; SPATIAL-DISTRIBUTION		[Raines, J. M.; DiBraccio, G. A.; Jia, X.; Slavin, J. A.] Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; [DiBraccio, G. A.] NASA, Goddard Space Flight Ctr, Solar Syst Explorat Div, Greenbelt, MD 20771 USA; [Cassidy, T. A.] Univ Colorado, Lab Atmospher & Space Phys, Boulder, CO 80303 USA; [Delcourt, D. C.] Univ Paris 06, CNRS, Ecole Polytech, LPP, F-75252 Paris, France; [Fujimoto, M.] JAXA, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2525210, Japan; [Mangano, V.; Milillo, A.] INAF, Inst Space Astrophys & Planetol, Rome, Italy; [Sarantos, M.] NASA, Goddard Space Flight Ctr, Heliophys Sci Div, Greenbelt, MD 20771 USA; [Wurz, P.] Univ Bern, Inst Phys, CH-3012 Bern, Switzerland	Raines, JM (reprint author), Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA.	jraines@umich.edu		Milillo, Anna/0000-0002-0266-2556	NASA Planetary Atmospheres program [NNX14AJ46G]; Solar System Workings program [NNX15AH28G]; Heliophysics Supporting Research program [NNX15AJ68G]; Discovery Data Analysis program [NNX15AK88G, NNX15AL01G]; NASA Discovery Program [NASW-00002, NAS5-97271]	This work was supported by the NASA Planetary Atmospheres program through grant NNX14AJ46G. Additional support was provided through the Solar System Workings program through grant NNX15AH28G, the Heliophysics Supporting Research program through grant NNX15AJ68G and the Discovery Data Analysis program through grants NNX15AK88G and NNX15AL01G. The MESSENGER project is supported by the NASA Discovery Program under contracts NASW-00002 to the Carnegie Institution of Washington and NAS5-97271 to the Johns Hopkins University Applied Physics Laboratory.	Anderson BJ, 2014, GEOPHYS RES LETT, V41, P7444, DOI 10.1002/2014GL061677; ANGELOPOULOS V, 1994, J GEOPHYS RES, V99, P21257, DOI 10.1029/94JA01263; Leblanc F, 2007, PLANET SPACE SCI, V55, P1069, DOI 10.1016/j.pss.2006.11.008; Winglee RM, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013750; DiBraccio GA, 2013, J GEOPHYS RES-SPACE, V118, P997, DOI 10.1002/jgra.50123; BAKER DN, 1986, J GEOPHYS RES, V91, P8742, DOI 10.1029/JA091iA08p08742; Killen RM, 2004, ICARUS, V171, P1, DOI 10.1016/j.icarus.2004.04.007; BAUMJOHANN W, 1989, GEOPHYS RES LETT, V16, P295, DOI 10.1029/GL016i004p00295; Sundberg T, 2011, PLANET SPACE SCI, V59, P2051, DOI 10.1016/j.pss.2011.05.008; Lepping RP, 1996, J GEOMAGN GEOELECTR, V48, P589; HAPKE B, 1984, ICARUS, V59, P41, DOI 10.1016/0019-1035(84)90054-X; Slavin JA, 2009, SCIENCE, V324, P606, DOI 10.1126/science.1172011; Cremonese G, 2005, ICARUS, V177, P122, DOI 10.1016/j.icarus.2005.03.022; Muller M, 2002, PLANET SPACE SCI, V50, P1101, DOI 10.1016/S0032-0633(02)00048-X; Yakshinskiy BV, 1999, NATURE, V400, P642; SISCOE GL, 1975, J GEOPHYS RES-SPACE, V80, P4359, DOI 10.1029/JA080i031p04359; Yakshinskiy BV, 2004, ICARUS, V168, P53, DOI 10.1016/j.icarus.2003.12.007; Yau AW, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2012JA017803; CAAN MN, 1973, J GEOPHYS RES, V78, P8087, DOI 10.1029/JA078i034p08087; Slavin JA, 2010, SCIENCE, V329, P665, DOI 10.1126/science.1188067; McClintock WE, 2009, SCIENCE, V324, P610, DOI 10.1126/science.1172525; Wurz P, 2001, PLANET SPACE SCI, V49, P1643, DOI 10.1016/S0032-0633(01)00102-7; Delcourt DC, 2011, ANN GEOPHYS-GERMANY, V29, P987, DOI 10.5194/angeo-29-987-2011; Wang YC, 2010, ICARUS, V209, P46, DOI 10.1016/j.icarus.2010.05.020; HUEBNER WF, 1992, ASTROPHYS SPACE SCI, V195, P1, DOI 10.1007/BF00644558; Wurz P, 2007, ICARUS, V191, P486, DOI 10.1016/j.icarus.2007.04.034; HONES EW, 1984, GEOPHYS RES LETT, V11, P1046, DOI 10.1029/GL011i010p01046; Boardsen SA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043606; Imber SM, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016026; Potter AE, 2006, ICARUS, V181, P1, DOI 10.1016/j.icarus.2005.10.026; Seki K, 2013, J GEOPHYS RES-SPACE, V118, P3233, DOI 10.1002/jgra.50181; Zurbuchen TH, 2011, SCIENCE, V333, P1862, DOI 10.1126/science.1211302; Winslow RM, 2014, GEOPHYS RES LETT, V41, P4463, DOI 10.1002/2014GL060258; Gershman DJ, 2014, GEOPHYS RES LETT, V41, P5740, DOI 10.1002/2014GL060468; Alexeev II, 2010, ICARUS, V209, P23, DOI 10.1016/j.icarus.2010.01.024; Lavraud B, 2005, SURV GEOPHYS, V26, P135, DOI 10.1007/s10712-005-1875-3; Glassmeier KH, 2007, SPACE SCI REV, V132, P511, DOI 10.1007/s11214-007-9244-9; POTTER AE, 1986, ICARUS, V67, P336, DOI 10.1016/0019-1035(86)90113-2; Huang CS, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2009JA014232; Orsini S, 2014, ICARUS, V239, P281, DOI 10.1016/j.icarus.2014.05.031; Zurbuchen TH, 2008, SCIENCE, V321, P90, DOI 10.1126/science.1159314; SLAVIN JA, 1992, GEOPHYS RES LETT, V19, P825, DOI 10.1029/92GL00394; Masters A, 2013, J GEOPHYS RES-SPACE, V118, P4381, DOI 10.1002/jgra.50428; Schmidt CA, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2011JA017217; Cassidy TA, 2015, ICARUS, V248, P547, DOI 10.1016/j.icarus.2014.10.037; Anderson BJ, 2011, SCIENCE, V333, P1859, DOI 10.1126/science.1211001; Killen RM, 2015, ICARUS, V250, P230, DOI 10.1016/j.icarus.2014.11.035; Kidder A, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2008JA013038; Milillo A, 2010, PLANET SPACE SCI, V58, P40, DOI 10.1016/j.pss.2008.06.005; BENNINGHOVEN A, 1975, SURF SCI, V53, P596, DOI 10.1016/0039-6028(75)90158-2; Liljeblad E, 2014, J GEOPHYS RES-SPACE, V119, DOI 10.1002/2014JA020614; Domingue DL, 1997, ICARUS, V128, P75, DOI 10.1006/icar.1997.5725; Slavin JA, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2012JA017926; RUSSELL CT, 1989, GEOPHYS RES LETT, V16, P1253, DOI 10.1029/GL016i011p01253; SLAVIN JA, 1979, J GEOPHYS RES-SPACE, V84, P2076, DOI 10.1029/JA084iA05p02076; Vervack RJ, 2010, SCIENCE, V329, P672, DOI 10.1126/science.1188572; LEPPING RP, 1995, GEOPHYS RES LETT, V22, P1193; Massetti S, 2003, ICARUS, V166, P229, DOI 10.1016/j.icarus.2003.08.005; Sarantos M, 2011, PLANET SPACE SCI, V59, P1992, DOI 10.1016/j.pss.2011.05.002; Pfleger M, 2015, PLANET SPACE SCI, V115, P90, DOI 10.1016/j.pss.2015.04.016; Benna M, 2010, ICARUS, V209, P3, DOI 10.1016/j.icarus.2009.11.036; McLain JL, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2010JE003714; Raeder J, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2010JA015876; ELPHIC RC, 1991, GEOPHYS RES LETT, V18, P2165, DOI 10.1029/91GL02669; OGILVIE KW, 1977, J GEOPHYS RES-SPACE, V82, P1807, DOI 10.1029/JA082i013p01807; Mura A, 2009, ICARUS, V200, P1, DOI 10.1016/j.icarus.2008.11.014; Leblanc F, 2003, ICARUS, V164, P261, DOI 10.1016/S0019-1035(03)00147-7; MCGRATH MA, 1986, NATURE, V323, P694, DOI 10.1038/323694a0; Hidalgo MA, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA900100; HORWITZ JL, 1984, GEOPHYS RES LETT, V11, P1111, DOI 10.1029/GL011i011p01111; Kivelson MG, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2007JA012302; Lammer H, 2003, ICARUS, V166, P238, DOI 10.1016/j.icarus.2003.08.012; Milan SE, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2003JA010350; Killen RM, 2001, J GEOPHYS RES-PLANET, V106, P20509, DOI 10.1029/2000JE001401; Paral J, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044413; Richer E, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2012JA017898; Mangano V, 2007, PLANET SPACE SCI, V55, P1541, DOI 10.1016/j.pss.2006.10.008; Boardsen SA, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2012JA017822; Korth H, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049451; NESS NF, 1974, SCIENCE, V185, P151, DOI 10.1126/science.185.4146.151; Burlaga LF, 2001, PLANET SPACE SCI, V49, P1619, DOI 10.1016/S0032-0633(01)00098-8; HOOD LL, 1979, J GEOPHYS RES-SPACE, V84, P2641, DOI 10.1029/JA084iA06p02641; Yakshinskiy BV, 2000, SURF REV LETT, V7, P75, DOI 10.1016/S0218-625X(00)00011-7; Anderson BJ, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2012JE004159; Sundberg T, 2010, PLANET SPACE SCI, V58, P1434, DOI 10.1016/j.pss.2010.06.008; SUESS ST, 1979, J GEOPHYS RES-SPACE, V84, P3306, DOI 10.1029/JA084iA07p03306; Wurz P, 2003, ICARUS, V164, P1, DOI 10.1016/S0019-1035(03)00123-4; Imber SM, 2014, J GEOPHYS RES-SPACE, V119, P5613, DOI 10.1002/2014JA019884; Winslow RM, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051472; Yakshinskiy BV, 2005, SURF SCI, V593, P202, DOI 10.1016/j.susc.2005.062; SERGEEV VA, 1993, J GEOPHYS RES, V98, P7609, DOI 10.1029/92JA02587; Tanaka KG, 2011, PLANET SPACE SCI, V59, P510, DOI 10.1016/j.pss.2010.04.014; Wurz P, 2010, PLANET SPACE SCI, V58, P1599, DOI 10.1016/j.pss.2010.08.003; BROADFOOT AL, 1976, GEOPHYS RES LETT, V3, P577, DOI 10.1029/GL003i010p00577; Potter AE, 2002, METEORIT PLANET SCI, V37, P1165; CLADIS JB, 1986, GEOPHYS RES LETT, V13, P893, DOI 10.1029/GL013i009p00893; Yagi M, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA015226; Boardsen SA, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036034; Raines JM, 2011, PLANET SPACE SCI, V59, P2004, DOI 10.1016/j.pss.2011.02.004; OGILVIE KW, 1974, SCIENCE, V185, P145, DOI 10.1126/science.185.4146.145; Doressoundiram A, 2009, ASTRON J, V137, P3859, DOI 10.1088/0004-6256/137/4/3859; Raines JM, 2013, J GEOPHYS RES-SPACE, V118, P1604, DOI 10.1029/2012JA018073; Bida TA, 2000, NATURE, V404, P159, DOI 10.1038/35004521; SHIOKAWA K, 1994, J GEOMAGN GEOELECTR, V46, P231; DUNGEY JW, 1961, PHYS REV LETT, V6, P47, DOI 10.1103/PhysRevLett.6.47; Killen R, 2007, SPACE SCI REV, V132, P433, DOI 10.1007/s11214-007-9232-0; Domingue DL, 2007, SPACE SCI REV, V131, P161, DOI 10.1007/s11214-007-9260-9; Sarantos M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052001; SIMPSON JA, 1974, SCIENCE, V185, P160, DOI 10.1126/science.185.4146.160; Raines JM, 2014, J GEOPHYS RES-SPACE, V119, DOI 10.1002/2014JA020120; Potter AE, 1999, PLANET SPACE SCI, V47, P1441, DOI 10.1016/S0032-0633(99)00070-7; ASHOURABDALLA M, 1992, GEOPHYS RES LETT, V19, P1739, DOI 10.1029/92GL01810; WANG YX, 1984, J VAC SCI TECHNOL A, V2, P732, DOI 10.1116/1.572560; Kallio E, 2003, ANN GEOPHYS-GERMANY, V21, P2133; MITCHELL DG, 1990, GEOPHYS RES LETT, V17, P583, DOI 10.1029/GL017i005p00583; Leblanc F, 2010, ICARUS, V209, P280, DOI 10.1016/j.icarus.2010.04.020; Baker DN, 1996, J GEOPHYS RES-SPACE, V101, P12975, DOI 10.1029/95JA03753; HAPKE B, 1986, ICARUS, V67, P264, DOI 10.1016/0019-1035(86)90108-9; POTTER A, 1985, SCIENCE, V229, P651, DOI 10.1126/science.229.4714.651; Schmidt CA, 2013, J GEOPHYS RES-SPACE, V118, P4564, DOI 10.1002/jgra.50396; Mouawad N, 2011, ICARUS, V211, P21, DOI 10.1016/j.icarus.2010.10.019; Killen RM, 1999, REV GEOPHYS, V37, P361, DOI 10.1029/1999RG900001; Kameda S, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039036; Winslow RM, 2013, J GEOPHYS RES-SPACE, V118, P2213, DOI 10.1002/jgra.50237; Ho GC, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2012JA017983; Killen R, 2009, ASTROPHYS J SUPPL S, V181, P351, DOI 10.1088/0067-0049/181/2/351; Benkhoff J, 2010, PLANET SPACE SCI, V58, P2, DOI 10.1016/j.pss.2009.09.020; Burger MH, 2010, ICARUS, V209, P63, DOI 10.1016/j.icarus.2010.05.007; Anderson BJ, 2007, SPACE SCI REV, V131, P417, DOI 10.1007/s11214-007-9246-7; Cladis JB, 2000, GEOPHYS RES LETT, V27, P915, DOI 10.1029/1999GL010737; Sarantos M, 2001, PLANET SPACE SCI, V49, P1629, DOI 10.1016/S0032-0633(01)00100-3; Burger MH, 2014, ICARUS, V238, P51, DOI 10.1016/j.icarus.2014.04.049; Orsini S, 2010, PLANET SPACE SCI, V58, P166, DOI 10.1016/j.pss.2008.09.012; Mura A, 2007, PLANET SPACE SCI, V55, P1569, DOI 10.1016/j.pss.2006.11.028; Stern SA, 1999, REV GEOPHYS, V37, P453, DOI 10.1029/1999RG900005; Poppe AR, 2013, J GEOPHYS RES-PLANET, V118, P1934, DOI 10.1002/jgre.20148; Leblanc F, 2011, ICARUS, V216, P551, DOI 10.1016/j.icarus.2011.09.028; Slavin JA, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2011JA016900; Slavin JA, 2008, SCIENCE, V321, P85, DOI 10.1126/science.1159040; Farrell WM, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2012JE004070; Sundberg T, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2011JA017268; SHELLEY EG, 1972, J GEOPHYS RES, V77, P6104, DOI 10.1029/JA077i031p06104; Delcourt DC, 2003, ANN GEOPHYS-GERMANY, V21, P1723; Potter AE, 2007, ICARUS, V186, P571, DOI 10.1016/j.icarus.2006.09.025; Smith MF, 1996, REV GEOPHYS, V34, P233, DOI 10.1029/96RG00893; Korth H, 2014, J GEOPHYS RES-SPACE, V119, P2917, DOI 10.1002/2013JA019567; Slavin JA, 2014, J GEOPHYS RES-SPACE, V119, P8087, DOI 10.1002/2014JA020319; Slavin JA, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010878; McClintock WE, 2007, SPACE SCI REV, V131, P481, DOI 10.1007/s11214-007-9264-5; Mall U, 1998, GEOPHYS RES LETT, V25, P3799, DOI 10.1029/1998GL900003; Mangano V, 2013, PLANET SPACE SCI, V82-83, P1, DOI 10.1016/j.pss.2013.03.002; Ashour-Abdalla M, 2011, NAT PHYS, V7, P360, DOI [10.1038/nphys1903, 10.1038/NPHYS1903]; HILL TW, 1976, GEOPHYS RES LETT, V3, P429, DOI 10.1029/GL003i008p00429; Potter AE, 1997, PLANET SPACE SCI, V45, P95, DOI 10.1016/S0032-0633(96)00100-6; SMYTH WH, 1995, ASTROPHYS J, V441, P839, DOI 10.1086/175407; Slavin JA, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2002JA009557; Sarantos M, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036207; Leblanc F, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035322; Bruno M, 2007, PLANET SPACE SCI, V55, P1494, DOI 10.1016/j.pss.2006.10.006; Ip WH, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA009171; Wang YC, 2011, ICARUS, V216, P387, DOI 10.1016/j.icarus.2011.09.023; Delcourt DC, 2013, ANN GEOPHYS-GERMANY, V31, P1673, DOI 10.5194/angeo-31-1673-2013; Gershman DJ, 2013, J GEOPHYS RES-SPACE, V118, P7181, DOI 10.1002/2013JA019244; Gershman DJ, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2012JA017829; Sprague AL, 1997, ICARUS, V129, P506, DOI 10.1006/icar.1997.5784; Delcourt DC, 2002, J ATMOS SOL-TERR PHY, V64, P551, DOI 10.1016/S1364-6826(02)00012-3; Kabin K, 2000, ICARUS, V143, P397, DOI 10.1006/icar.1999.6252; Kuznetsova MM, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2007JA012316; Jia XZ, 2015, J GEOPHYS RES-SPACE, V120, P4763, DOI 10.1002/2015JA021143; Smith DE, 2012, SCIENCE, V336, P214, DOI 10.1126/science.1218809; JOHNSON RE, 1991, GEOPHYS RES LETT, V18, P2169, DOI 10.1029/91GL02095; DiBraccio GA, 2015, PLANET SPACE SCI, V115, P77, DOI 10.1016/j.pss.2014.12.016; ARMSTRONG TP, 1975, J GEOPHYS RES-SPACE, V80, P4015, DOI 10.1029/JA080i028p04015; Ieda A, 1998, J GEOPHYS RES-SPACE, V103, P4453, DOI 10.1029/97JA03240; Andrews GB, 2007, SPACE SCI REV, V131, P523, DOI 10.1007/s11214-007-9272-5; LEPPING RP, 1990, J GEOPHYS RES, V95, P11957, DOI 10.1029/JA095iA08p11957; SHEMANSKY DE, 1977, REV GEOPHYS, V15, P491, DOI 10.1029/RG015i004p00491; Baker DN, 2013, J GEOPHYS RES-SPACE, V118, P45, DOI 10.1029/2012JA018064; Behrisch R., 2007, SPUTTERING PARTICLE, P110; Borin P, 2010, ASTRON ASTROPHYS, V517, DOI 10.1051/0004-6361/201014312; BROADFOO.AL, 1974, SCIENCE, V185, P166, DOI 10.1126/science.185.4146.166; Broadfoot A. L., 1977, Space Science Instrumentation, V3; BUCHNER J, 1989, J GEOPHYS RES, V94, P11821, DOI 10.1029/JA094iA09p11821; Burger MH, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2012JE004158; Christon S. P, 1987, MAGNETOTAIL PHYS, P393; CINTALA MJ, 1992, J GEOPHYS RES-PLANET, V97, P947; Cowley S. W. H., 1984, AGU MONOGRAPH MAGNET, V30, P228; Cowley S. W. H., 1982, J GEOPHYS RES, V20, P531; Delcourt D. C., 2002, Geophysical Research Letters, V29, DOI 10.1029/2001GL013829; Delcourt DC, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL054085; Delcourt DC, 1996, J GEOPHYS RES, V101, P17409, DOI 10.1029/96JA01006; DiBraccio G. A., 2015, GEOPHYS RES IN PRESS; ERAKER JH, 1986, J GEOPHYS RES, V91, P9973, DOI 10.1029/JA091iA09p09973; FAIRFIEL.DH, 1971, J GEOPHYS RES, V76, P6700, DOI 10.1029/JA076i028p06700; Fjelbo G., 1976, ICARUS, V29, P407, DOI 10.1016/0019-1035(76)90063-4; Gershman D. J., 2015, J GEOPHYS R IN PRESS; HAPKE B, 1981, J GEOPHYS RES, V86, P3039, DOI 10.1029/JB086iB04p03039; Hesse M., 1998, NEW PERSPECTIVES EAR, DOI [10.1029/GM105p0139, DOI 10.1029/GM105P0139]; Hidalgo MA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013875; Hunten D. M., 1988, MERCURY, P562; Leblanc F, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038089; MCPHERRO.RL, 1973, J GEOPHYS RES, V78, P3131, DOI 10.1029/JA078i016p03131; MOLDWIN MB, 1992, J GEOPHYS RES, V97, P19259, DOI 10.1029/92JA01598; Muller Joachim, 2012, Icarus, V218, DOI 10.1016/j.icarus.2011.12.028; Paral J., 2009, ADV GEOSCI, V15, P1; Paral J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2676; Runov A, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016316; Russell C. T., 1988, MERCURY, P514; RUSSELL CT, 1985, J GEOPHYS RES-SPACE, V90, P1067, DOI 10.1029/JA090iA11p11067; SCHINDLE.K, 1974, J GEOPHYS RES, V79, P2803, DOI 10.1029/JA079i019p02803; SLAVIN JA, 1993, J GEOPHYS RES, V98, P15425, DOI 10.1029/93JA01467; Slavin JA, 2007, SPACE SCI REV, V131, P133, DOI 10.1007/s11214-007-9154-x; Solomon C. S., 2007, SPACE SCI REV, V131, P3; SPEISER TW, 1965, J GEOPHYS RES, V70, P4219, DOI 10.1029/JZ070i017p04219; Strangeway R. J., 2010, AGU FALL M, P1893; Travnicek P., 2010, ICARUS, V209, P11, DOI [10.1016/j.icarus.2010.01.008, DOI 10.1016/J.ICARUS.2010.01.008]; Travnicek P., 2007, GEOPHYS RES LETT, V34, P5104, DOI [10.1029/2006GL028518, DOI 10.1029/2006GL028518]; Vervack R. J., 2011, AGU FALL M ABSTR A2, VA2; Vilas F., 1988, MERCURY; ZWAN BJ, 1976, J GEOPHYS RES-SPACE, V81, P1636, DOI 10.1029/JA081i010p01636	220	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0038-6308	1572-9672		SPACE SCI REV	Space Sci. Rev.	OCT	2015	192	1-4					91	144		10.1007/s11214-015-0193-4		54	Astronomy & Astrophysics	Astronomy & Astrophysics	CU7MF	WOS:000363723000004		
J	Maeda, A; Eguchi, H; Nakahata, K; Lo, PC; Yamanaka, K; Kawamura, T; Matsuura, R; Sakai, R; Asada, M; Okuyama, H; Miyagawa, S				Maeda, Akira; Eguchi, Hiroshi; Nakahata, Kengo; Lo, Pei-Chi; Yamanaka, Kazuaki; Kawamura, Takuji; Matsuura, Rei; Sakai, Rieko; Asada, Mayumi; Okuyama, Hiroomi; Miyagawa, Shuji			Monocytic MDSCs regulate macrophage-mediated xenogenic cytotoxicity	TRANSPLANT IMMUNOLOGY			English	Article						Myeloid-derived suppressor cells (MDSCs); Xenotransplantation; Indoleamine 2,3-dioxygenase (IDO); Macrophage-mediated cytotoxicity	NATURAL-KILLER-CELL; SUPPRESSOR-CELLS; XENOGRAFT REJECTION; LOCAL EXPRESSION; RESPONSES; ALLOGRAFT; SURVIVAL; SUBSETS; MICE	Background: Xenotransplantation is considered to be one of the most attractive strategies for overcoming the worldwide shortage of organs. However, many obstructions need to be overcome before it will achieve clinical use in patients. One such obstacle is the development of an effective immunosuppressive strategy. We previously reported that myeloid-derived suppressor cells (MDSCs), a heterogeneous population of progenitor and immature myeloid cells, suppress xenogenic CTL-mediated cytotoxicity. Because of their heterogeneous nature, MDSC can function via several suppressive mechanisms that disrupt both innate and adaptive immunity. Since macrophages play a pivotal role in the rejection of a xenograft, in this study, we evaluated the suppressive effects of MDSC against macrophage-mediated xenogenic rejection. Materials and methods: To evaluate the effect of monocyte-derived MDSCs on xenogenic immune reactions, a CFSE(carboxyfluorescein diacetate, succinimidyl ester)assay was employed to assess cytotoxicity. Results: While, in the absence of activation, primed MDSCs had no detectable effect on macrophage-induced cytotoxicity against SEC cells, LPS-activated MDSCs were found to significantly suppress xenogenic cytotoxicity. A CFSE cytotoxicity assay revealed that MDSCs significantly suppressed macrophage-induced cytotoxicity. Furthermore, an indoleamine 2,3 dioxygenase (IDO) inhibitor, 1-methyl tryptophan (1-MT), abolished the MDSC-induced suppression of macrophage-mediated xeno-rejection, indicating that MDSCs may suppress macrophage-mediated cytotoxicity in an IDO-dependent manner. Conclusion: These findings indicate that MDSCs have great potential for immunosuppressing macrophagemediated xeno-rejection. (C) 2015 Elsevier B.V. All rights reserved.	[Maeda, Akira; Eguchi, Hiroshi; Nakahata, Kengo; Lo, Pei-Chi; Yamanaka, Kazuaki; Kawamura, Takuji; Matsuura, Rei; Sakai, Rieko; Asada, Mayumi; Okuyama, Hiroomi; Miyagawa, Shuji] Osaka Univ, Grad Sch Med, Dept Surg, Suita, Osaka 5650871, Japan	Maeda, A (reprint author), Osaka Univ, Grad Sch Med, Dept Surg, Div Organ Transplantat, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ZUL06720@nifty.com			 [T264619440]	The authors wish to thank Dr. Milton. S. Feather for his editing of the manuscript. This work was supported by Grants-in Aid for Scientific Research (#T264619440), Japan.	Lin Y, 1997, J IMMUNOL, V158, P5658; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Chiarugi A, 2003, J LEUKOCYTE BIOL, V73, P172, DOI 10.1189/jlb.0502220; Fox A, 2001, J IMMUNOL, V166, P2133; FAST DJ, 1991, INFECT IMMUN, V59, P2987; Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x; Wennberg L, 1997, XENOTRANSPLANTATION, V4, P228, DOI 10.1111/j.1399-3089.1997.tb00187.x; Jalili RB, 2010, DIABETES, V59, P2219, DOI 10.2337/db09-1560; Miki T, 2001, TRANSPLANT P, V33, P129, DOI 10.1016/S0041-1345(00)02792-5; Dolcetti L, 2010, EUR J IMMUNOL, V40, P22, DOI 10.1002/eji.200939903; Youn JI, 2008, J IMMUNOL, V181, P5791; Li YY, 2006, J INVEST DERMATOL, V126, P128, DOI 10.1038/sj.jid.5700022; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Dorling A, 1996, EUR J IMMUNOL, V26, P1378, DOI 10.1002/eji.1830260630; Li JP, 2007, AM J PHYSIOL-HEART C, V293, pH3415, DOI 10.1152/ajpheart.00532.2007; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Vollbrecht T, 2012, AIDS, V26, pF31, DOI 10.1097/QAD.0b013e328354b43f; Fox A, 1998, TRANSPLANTATION, V66, P1407, DOI 10.1097/00007890-199812150-00002; Maeda A, 2014, XENOTRANSPLANTATION, V21, P46, DOI 10.1111/xen.12067; Yi SN, 2003, J IMMUNOL, V170, P2750; Sekkai D, 1997, ARCH BIOCHEM BIOPHYS, V340, P117, DOI 10.1006/abbi.1997.9913; Cadili A, 2008, TRANSPL P, V40, P3289, DOI 10.1016/j.transproceed.2008.08.125; Maeda A, 2014, TRANSPL P, V46, P1254, DOI 10.1016/j.transproceed.2013.11.025; Melillo G., 1994, J BIOL CHEM, V269, P190; Montero AJ, 2012, J IMMUNOTHER, V35, P107, DOI 10.1097/CJI.0b013e318242169f; Morris SM, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3135pe27; Morris SM, 2007, J NUTR, V137, p1602S; Poormasjedi-Meibod MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071044; Puga Yung Gisella, 2009, Curr Opin Organ Transplant, V14, P154, DOI 10.1097/MOT.0b013e328329250d; Schuurman HJ, 2003, XENOTRANSPLANTATION, V10, P293, DOI 10.1034/j.1399-3089.2003.02092.x; Youn J. I., 2013, NAT IMMUNOL, V3, P211	31	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0966-3274	2210-3384		TRANSPL IMMUNOL	Transpl. Immunol.	OCT	2015	33	2					140	145		10.1016/j.trim.2015.07.002		6	Immunology; Transplantation	Immunology; Transplantation	CU8TY	WOS:000363818200013		
J	Tanaka, S; Hayashi, T; Sugaya, S; Osabe, M; Ueno, Y; Tani, Y; Hirayama, F				Tanaka, S.; Hayashi, T.; Sugaya, S.; Osabe, M.; Ueno, Y.; Tani, Y.; Hirayama, F.			A hollow-fibre column system to effectively prepare washed platelets	VOX SANGUINIS			English	Article						hollow fibre; platelet; transfusion reactions; washed platelets	ANAPHYLACTIC TRANSFUSION REACTIONS; SOLUTION M-SOL; HLA CLASS-I; ALLERGIC REACTIONS; WASHING PLATELETS; ADVERSE-REACTIONS; BACTERIAL-GROWTH; PLASMA; FEBRILE; STORAGE	Background and Objectives We developed a hollow-fibre column system specifically adapted to prepare washed platelet concentrates (WPCs). This study was performed to evaluate the efficacy of the hollow-fibre column system for preparing WPCs. Materials and Methods First, the percentages of platelet (PLT) recovery and remaining plasma proteins were calculated by determining the PLT count, volume and plasma protein levels in both the prewash and postwash. Secondly, washed PLTs and unwashed control PLTs were stored for 5 days, and the changes during this 5-day storage of in vitro PLT characteristics were determined. Results The hollow-fibre column system effectively removed >98% of plasma in platelet concentrates (PCs), and the PLT recovery was 97% on an average. The CD62P-expression level on washed PLTs immediately after washing was approximately twofold higher than that on prewashed PLTs as well as on PLTs washed via manual methods or cell washing devices. Until day 5 during storage, PLT aggregability, hypotonic shock response and swirling scores of washed PLTs were not significantly different from those of the control PCs. Conclusion Our novel hollow-fibre column system proved valuable in preparing washed PLTs with <2% of residual plasma proteins and high recovery of PLTs.	[Tanaka, S.; Hayashi, T.; Tani, Y.; Hirayama, F.] Japanese Red Cross Kinki Block Blood Ctr, Ibaraki, Osaka 5670085, Japan; [Sugaya, S.; Osabe, M.; Ueno, Y.] Toray Industries Ltd, Otsu, Shiga, Japan	Tanaka, S (reprint author), Japanese Red Cross Kinki Block Blood Ctr, Dept Preparat Dev, 7-5-17 Saito Asagi, Ibaraki, Osaka 5670085, Japan.	tanakas1113@leto.eonet.ne.jp					HEDDLE NM, 1993, TRANSFUSION, V33, P794, DOI 10.1046/j.1537-2995.1993.331094054613.x; Tobian AAR, 2011, TRANSFUSION, V51, P1676, DOI 10.1111/j.1537-2995.2010.03008.x; Chapman CE, 2009, TRANSFUSION, V49, P440, DOI 10.1111/j.1537-2995.2008.01948.x; Hirayama J, 2007, TRANSFUSION, V47, P960, DOI 10.1111/j.1537-2995.2007.01229.x; Oikawa S, 2012, VOX SANG, V102, P110, DOI 10.1111/j.1423-0410.2011.01520.x; Hirayama J, 2011, TRANSFUSION, V51, P1592, DOI 10.1111/j.1537-2995.2011.03102.x; Kluter H, 1999, TRANSFUSION, V39, P1179, DOI 10.1046/j.1537-2995.1999.39111179.x; Holme S, 1998, TRANSFUSION, V38, P31, DOI 10.1046/j.1537-2995.1998.38198141495.x; Ghio M, 1999, BLOOD, V93, P1770; Dumont LJ, 2011, TRANSFUSION, V51, P1079, DOI 10.1111/j.1537-2995.2010.02941.x; Mathai J, 2009, TRANSFUS APHER SCI, V41, P139, DOI 10.1016/j.transci.2009.07.012; Blumberg N, 2006, TRANSFUSION, V46, P1813, DOI 10.1111/j.1537-2995.2006.00979.x; Jacobs JFM, 2011, NEW ENGL J MED, V364, P1981, DOI 10.1056/NEJMc1101692; Paglino JC, 2004, TRANSFUSION, V44, P16, DOI 10.1046/j.0041-1132.2004.00608.x; Veeraputhiran M, 2011, TRANSFUSION, V51, P1030, DOI 10.1111/j.1537-2995.2010.02897.x; CHAMBERS LA, 1990, TRANSFUSION, V30, P219, DOI 10.1046/j.1537-2995.1990.30390194340.x; Azuma H, 2009, TRANSFUSION, V49, P214, DOI 10.1111/j.1537-2995.2008.01918.x; Kelley WE, 2009, TRANSFUSION, V49, P1917, DOI 10.1111/j.1537-2995.2009.02209.x; Schoenfeld H, 2004, ANESTH ANALG, V99, P17, DOI 10.1213/01.ANE.0000116930.28250.15; BUCK SA, 1987, TRANSFUSION, V27, P391, DOI 10.1046/j.1537-2995.1987.27587320530.x; Ringwald J, 2006, TRANSFUSION, V46, P236, DOI 10.1111/j.1537-2995.2006.00716.x; Shimada E, 2002, TRANSFUSION, V42, P766, DOI 10.1046/j.1537-2995.2002.00117.x; Imoto S, 2010, TRANSFUSION MED, V20, P95, DOI 10.1111/j.1365-3148.2009.00972.x; HEDDLE NM, 1994, NEW ENGL J MED, V331, P625, DOI 10.1056/NEJM199409083311001; SANDLER SG, 1995, TRANSFUS MED REV, V9, P1, DOI 10.1016/S0887-7963(05)80026-4	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0042-9007	1423-0410		VOX SANG	Vox Sang.	OCT	2015	109	3					239	247		10.1111/vox.12284		9	Hematology	Hematology	CV0GC	WOS:000363926900005		
J	Omoto, K; Tashiro, S; Shionoya, M				Omoto, Kenichiro; Tashiro, Shohei; Shionoya, Mitsuhiko			Host-Guest Interactions by Metal-to-Metal Dative Bonding: Recognition of Ruthenocene by a Metallo-Host	ZEITSCHRIFT FUR ANORGANISCHE UND ALLGEMEINE CHEMIE			English	Article						Metallo-host; Metal-metal bonding; Dative bonding; Ruthenium; Metallocenes	LEWIS-ACIDS; REACTION-PRODUCTS; 1-1 COMPLEXES; MOLECULES; OXIDATION; CHEMISTRY; PALLADIUM(II); FERROCENE; LIGANDS; HGCL2	Host-guest complexation driven by metal-to-metal dative bonding was studied using a mono-nuclear Ag-I complex of 2,9-bis(9-anthracenyl)-1,10-phenanthroline as a simple metallo-host. This host molecule can capture a ruthenocene with a Ru-Ag dative bond in solution as revealed by NMR spectroscopy and ESI-TOF MS spectrometry. Single-crystal XRD analysis of the host-guest complex revealed a Ru-Ag type dative bond with a significant change in the coordination arrangement of the central Ru atom of ruthenocene. The binding constant for the host-guest complexation was estimated to be over 10(4) M-1 in CD2Cl2 at 300 K.	[Omoto, Kenichiro; Tashiro, Shohei; Shionoya, Mitsuhiko] Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan	Shionoya, M (reprint author), Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	shionoya@chem.s.u-tokyo.ac.jp			JSPS KAKENHI [26248016]	This study was supported by JSPS KAKENHI Grant Number 26248016 for M.S. K.O. thanks Advanced Leading Graduate Course for Photon Science (ALPS).	AKABORI S, 1987, CHEM LETT, P1783, DOI 10.1246/cl.1987.1783; Gramigna KM, 2013, ORGANOMETALLICS, V32, P5966, DOI 10.1021/om400494t; DROEGE MW, 1987, INORG CHEM, V26, P1309, DOI 10.1021/ic00255a023; Amendola V, 2001, COORDIN CHEM REV, V219, P821, DOI 10.1016/S0010-8545(01)00368-X; Bianchini C, 2004, J MOL CATAL A-CHEM, V224, P35, DOI 10.1016/j.molcata.2004.06.029; Russell AD, 2012, CHEM-EUR J, V18, P8000, DOI 10.1002/chem.201201129; Xia W, 2013, CHEM COMMUN, V49, P5085, DOI 10.1039/c3cc41903g; Amouri H, 2012, CHEM REV, V112, P2015, DOI 10.1021/cr200345v; Campbell MG, 2011, NAT CHEM, V3, P949, DOI [10.1038/nchem.1197, 10.1038/NCHEM.1197]; Omoto K, 2014, J AM CHEM SOC, V136, P17946, DOI 10.1021/ja5106249; Green JC, 1998, CHEM SOC REV, V27, P263; Yamaguchi T, 2001, J AM CHEM SOC, V123, P743, DOI 10.1021/ja002906a; Metallinos C, 2006, J ORGANOMET CHEM, V691, P2044, DOI 10.1016/j.jorganchem.2006.01.012; Mayoral MJ, 2013, J AM CHEM SOC, V135, P2148, DOI 10.1021/ja312628g; Koshevoy IO, 2010, ANGEW CHEM INT EDIT, V49, P8864, DOI 10.1002/anie.201004386; Bauer J, 2012, CHEM REV, V112, P4329, DOI 10.1021/cr3000048; Goshe AJ, 2003, J AM CHEM SOC, V125, P444, DOI 10.1021/ja028910z; Yamaguchi T, 2004, CHEM LETT, V33, P190, DOI 10.1246/cl.2004.190; Pyykko P, 1997, CHEM REV, V97, P597, DOI 10.1021/cr940396v; Sculfort S, 2011, CHEM SOC REV, V40, P2741, DOI 10.1039/c0cs00102c; Siebler D, 2011, DALTON T, V40, P3558, DOI 10.1039/c0dt01528h; Lin SB, 2013, J AM CHEM SOC, V135, P15830, DOI 10.1021/ja406696k; WATANABE M, 1990, B CHEM SOC JPN, V63, P1455, DOI 10.1246/bcsj.63.1455; Swarts JC, 2009, INORG CHEM, V48, P2156, DOI 10.1021/ic802105b; HARDGROVE GL, 1959, ACTA CRYSTALLOGR, V12, P28, DOI 10.1107/S0365110X59000081; Mizuta T, 2008, ORGANOMETALLICS, V27, P2457, DOI 10.1021/om800057w; Kersting B, 2009, ADV INORG CHEM, V61, P407, DOI 10.1016/S0898-8838(09)00207-4; Wasio NA, 2014, NATURE, V507, P86, DOI 10.1038/nature12993; Schmidbaur H, 2015, ANGEW CHEM INT EDIT, V54, P746, DOI 10.1002/anie.201405936; Durola F, 2014, ACCOUNTS CHEM RES, V47, P633, DOI 10.1021/ar4002153; SATO SD, 1989, B CHEM SOC JPN, V62, P3963, DOI 10.1246/bcsj.62.3963; Fukino T, 2014, SCIENCE, V344, P499, DOI 10.1126/science.1252120; Green AG, 2013, INORG CHEM, V52, P5603, DOI 10.1021/ic400773s; Katz MJ, 2008, CHEM SOC REV, V37, P1884, DOI 10.1039/b709061g; Watanabe M, 1998, B CHEM SOC JPN, V71, P1071, DOI 10.1246/bcsj.71.1071; Muraoka T, 2006, NATURE, V440, P512, DOI 10.1038/nature04635; MANN KR, 1974, INORG CHEM, V13, P1180, DOI 10.1021/ic50135a033; McConnell AJ, 2015, CHEM REV, V115, P7729, DOI 10.1021/cr500632f; Gramage-Doria R, 2013, COORDIN CHEM REV, V257, P776, DOI 10.1016/j.ccr.2012.10.006; MORRISON WH, 1972, INORG CHEM, V11, P2912, DOI 10.1021/ic50118a011; SATO S, 1989, B CHEM SOC JPN, V62, P532, DOI 10.1246/bcsj.62.532; Enders M, 2002, ORGANOMETALLICS, V21, P1111, DOI 10.1021/om010937o; Diez A, 2011, COORDIN CHEM REV, V255, P2426, DOI 10.1016/j.foodhyd.2010.12.024; Krogman JP, 2014, CHEM COMMUN, V50, P5115, DOI 10.1039/c3cc47537a; WATANABE M, 1988, B CHEM SOC JPN, V61, P827, DOI 10.1246/bcsj.61.827; Cordero B, 2008, DALTON T, P2832, DOI 10.1039/b801115j; Grocka I, 2013, ANGEW CHEM INT EDIT, V52, P1044, DOI 10.1002/anie.201208289; HENDRICK.DN, 1972, INORG CHEM, V11, P808, DOI 10.1021/ic50110a030; Ito T., 2003, METAL ASSEMBLED COMP, P3; Kaifer A. E., 1999, SUPRAMOLECULAR ELECT; KROGMANN K, 1969, ANGEW CHEM INT EDIT, V8, P35, DOI 10.1002/anie.196900351; Murahashi T, 2012, NAT CHEM, V4, P52, DOI 10.1038/nchem.1202; Osuga T, 2014, ANGEW CHEM INT EDIT, V53, P11186, DOI 10.1002/anie.201404892; ROSENBLUM M, 1963, J AM CHEM SOC, V85, P1450, DOI 10.1021/ja00893a015	54	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	0044-2313	1521-3749		Z ANORG ALLG CHEM	Z. Anorg. Allg. Chem.	OCT	2015	641	12-13			SI		2056	2059		10.1002/zaac.201500630		4	Chemistry, Inorganic & Nuclear	Chemistry	CT3EC	WOS:000362689000004		
J	Toda, T; Kuwata, S; Ikariya, T				Toda, Tatsuro; Kuwata, Shigeki; Ikariya, Takao			Synthesis and Structures of Ruthenium and Iron Complexes Bearing an Unsymmetrical Pincer-type Ligand with Protic Pyrazole and Tertiary Aminoalkyl Arms	ZEITSCHRIFT FUR ANORGANISCHE UND ALLGEMEINE CHEMIE			English	Article						Iron; Ruthenium; N ligands; Tridentate ligands; Hydrogen bonds	N-HETEROCYCLIC CARBENE; CATALYTIC APPLICATIONS; BOND ACTIVATION; DONOR LIGANDS; REACTIVITIES	A protic pyrazole-armed NNN-type pincer ligand 2-(5-tertbutylpyrazol-3-yl)-6-(diethylaminomethyl) pyridine (LH) with a tertiary aminomethyl tether was synthesized as a new template for metalligand bifunctional catalysts furnished with proton-responsive pyrazole and hemilabile amine as the cooperating units. Treatment of LH with trans-[ RuCl2(Me2SO) 4] and anhydrous FeCl2 led to the formation of the pincer-type ruthenium complex [ RuCl2(Me2SO-S)(LH)] (2) and iron complex [ FeCl2(LH)] (3), respectively. Detailed structures of 2 (CH2Cl2)-C-. and 3 were determined by X-ray crystallography. The Bronsted acidic pyrazole NH group proved to be engaged in intra-or intermolecular hydrogen bonding. Catalytic hydrogenation of acetophenone with the protic pincer-type complexes 2 and 3 was also investigated.	[Toda, Tatsuro; Kuwata, Shigeki; Ikariya, Takao] Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Appl Chem, Tokyo 1528552, Japan; [Kuwata, Shigeki] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	Kuwata, S (reprint author), Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Appl Chem, 2-12-1 O Okayama, Tokyo 1528552, Japan.	skuwata@apc.titech.ac.jp; tikariya@apc.titech.ac.jp	Kuwata, Shigeki/C-4920-2011	Kuwata, Shigeki/0000-0002-3165-9882	Ministry of Education, Culture, Sports, Science and Technology, Japan [22225004]; PRESTO program on "Molecular Technology and Creation of New Functions" from JST	We thank Grant-in-Aid for Scientific Research (S; no. 22225004) from Ministry of Education, Culture, Sports, Science and Technology, Japan. This work was partially supported by the PRESTO program on "Molecular Technology and Creation of New Functions" from JST (to SK). TT acknowledges a Japan Society for the Promotion of Science Research Fellowship for Young Scientists.	ADDISON AW, 1984, J CHEM SOC DALTON, P1349, DOI 10.1039/dt9840001349; Bauer I, 2015, CHEM REV, V115, P3170, DOI 10.1021/cr500425u; Gunanathan C, 2011, ACCOUNTS CHEM RES, V44, P588, DOI 10.1021/ar2000265; O'Reilly RK, 2004, POLYHEDRON, V23, P2921, DOI 10.1016/j.poly.2004.09.001; Umehara K, 2014, INORG CHIM ACTA, V413, P136, DOI 10.1016/j.ica.2013.12.041; Yoshinari A, 2012, CHEM-ASIAN J, V7, P1417, DOI 10.1002/asia.201200014; Bratsos I, 2010, INORG SYN, V35, P148; FLACK HD, 1983, ACTA CRYSTALLOGR A, V39, P876, DOI 10.1107/S0108767383001762; Zhang J, 2006, INORG CHIM ACTA, V359, P1955, DOI 10.1016/j.ica.2005.11.039; Toda T, 2014, CHEM-EUR J, V20, P9539, DOI 10.1002/chem.201403179; Li HF, 2015, COORDIN CHEM REV, V293, P116, DOI 10.1016/j.ccr.2014.11.010; Umehara K, 2013, J AM CHEM SOC, V135, P6754, DOI 10.1021/ja3122944; Kohl SW, 2009, SCIENCE, V324, P74, DOI 10.1126/science.1168600; ALTOMARE A, 1994, J APPL CRYSTALLOGR, V27, P435, DOI 10.1107/S002188989400021X; Ikariya T, 2011, B CHEM SOC JPN, V84, P1, DOI 10.1246/bcsj.20100249; Kuwata S, 2011, CHEM-EUR J, V17, P3542, DOI 10.1002/chem.201003296; Younus HA, 2015, ADV SYNTH CATAL, V357, P283, DOI 10.1002/adsc.201400777; Zhang J, 2005, J AM CHEM SOC, V127, P10840, DOI 10.1021/ja052862b; [Anonymous], 2000, CRYSTALSTRUCTURE 4 0, P2000; Bain GA, 2008, J CHEM EDUC, V85, P532; O'Reilly ME, 2014, CHEM SOC REV, V43, P6325, DOI 10.1039/c4cs00111g; Gunanathan C, 2014, CHEM REV, V114, P12024, DOI 10.1021/cr5002782; Deng QH, 2014, ACCOUNTS CHEM RES, V47, P3162, DOI 10.1021/ar5002457; Bhattacharya P, 2011, COMMENT INORG CHEM, V32, P88, DOI 10.1080/02603594.2011.618855; Britovsek GJP, 2005, DALTON T, P945, DOI 10.1039/b414813d; Jozak T, 2010, EUR J INORG CHEM, P5135, DOI 10.1002/ejic.201000802; Kuwata S, 2014, CHEM COMMUN, V50, P14290, DOI 10.1039/c4cc04457f; Morris RH, 2015, ACCOUNTS CHEM RES, V48, P1494, DOI 10.1021/acs.accounts.5b00045; Olguin J, 2011, COORDIN CHEM REV, V255, P203, DOI 10.1016/j.ccr.2010.08.002; Quintard A., 2014, ANGEW CHEM, V126, P4124; Quintard A, 2014, ANGEW CHEM INT EDIT, V53, P4044, DOI 10.1002/anie.201310788; Storr T, 2005, EUR J INORG CHEM, P2685, DOI 10.1002/ejic.200500018; Szabo KJ, 2014, PINCER AND PINCER-TYPE COMPLEXES: APPLICATIONS IN ORGANIC SYNTHESIS AND CATALYSIS, P1, DOI 10.1002/9783527681303; van Koten G, 2013, TOP ORGANOMETAL CHEM, V40, P1, DOI 10.1007/978-3-642-31081-2_1	34	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	0044-2313	1521-3749		Z ANORG ALLG CHEM	Z. Anorg. Allg. Chem.	OCT	2015	641	12-13			SI		2135	2139		10.1002/zaac.201500558		5	Chemistry, Inorganic & Nuclear	Chemistry	CT3EC	WOS:000362689000015		
J	Arduengo, AJ; Calabrese, JC; Marshall, WJ; Runyon, JW; Schiel, C; Schinnen, C; Tamm, M; Uchiyama, Y				Arduengo, Anthony J., III; Calabrese, Joseph C.; Marshall, William J.; Runyon, Jason W.; Schiel, Christian; Schinnen, Christoph; Tamm, Matthias; Uchiyama, Yosuke			Imidazol-2-ylidene Reactivity towards Cyanocarbons	ZEITSCHRIFT FUR ANORGANISCHE UND ALLGEMEINE CHEMIE			English	Article						Carbenes; Cyanogens; Tetrazole; Tetracyanoethylene; Cyanocarbon	N-HETEROCYCLIC CARBENES; PHOTOELECTRON-SPECTROSCOPY; TETRACYANOETHYLENE; ADDUCT; ANION; CONDENSATION; CHEMISTRY	The interaction of electron rich imidazol-2-ylidenes with electron poor cyanocarbons is reported. Contrary to previous reports of electron transfer products from imidazol-2-ylidenes and tetracyanoethylene, a number of ring forming cyanocarbon ring structures are isolated and characterized. Cyanation of the imidazole ring was explored by the addition of cyanogen chloride to imidazol-2-ylidenes. Backbone cyanation often occurs when hydrogen atoms are in the C-4/5 positions. When tetrasubstituted imidazol-2-ylidenes are employed, 2-cyanoimidazolium halide salts can be isolated. These salts maintain an electrophilic cyano group and are precursors to thermally stable high nitrogen content imidazolium tetrazolides.	[Arduengo, Anthony J., III; Runyon, Jason W.; Schiel, Christian; Schinnen, Christoph] Univ Alabama, Dept Chem, Tuscaloosa, AL 35401 USA; [Calabrese, Joseph C.; Marshall, William J.; Tamm, Matthias] DuPont Cent Res & Dev, Wilmington, DE 19880 USA; [Uchiyama, Yosuke] Kitasato Univ, Sch Sci, Dept Chem, Minami Ku, Sagamihara, Kanagawa 2520373, Japan	Arduengo, AJ (reprint author), Univ Alabama, Dept Chem, 250 Hackberry Lane, Tuscaloosa, AL 35401 USA.	aj@ajarduengo.net			Kitasato University Research Grant for Young Researchers; E. I. du Pont de Nemours and Co.; University of Alabama	We gratefully acknowledge support for this research from the Kitasato University Research Grant for Young Researchers, E. I. du Pont de Nemours and Co., and The University of Alabama. The generous donation of reagents from Innovative Valency LLC enabled some of the studies herein. A.J.A. acknowledges the Saxon Endowment of The University of Alabama and would like to thank David Dixon for helpful discussions. Y.U. and J.W.R. thank Kenneth Belmore for his assistance with NMR spectroscopy.	WEBSTER OW, 1966, J AM CHEM SOC, V88, P3046, DOI 10.1021/ja00965a028; Mallah E, 2011, Z NATURFORSCH B, V66, P545; Eberspacher M, 2009, HELV CHIM ACTA, V92, P977; Fu DW, 2009, Z ANORG ALLG CHEM, V635, P2631, DOI 10.1002/zaac.200900251; Uchiyama Y, 2014, AUST J CHEM, V67, P405, DOI 10.1071/CH13460; Klapotke TM, 2011, INORG CHEM, V50, P2732, DOI 10.1021/ic200071q; ARDUENGO AJ, 1991, J AM CHEM SOC, V113, P9704, DOI 10.1021/ja00025a063; ARDUENGO AJ, 1991, J AM CHEM SOC, V113, P361, DOI 10.1021/ja00001a054; Kronig S, 2011, INORG CHEM, V50, P7344, DOI 10.1021/ic201290g; ARDUENGO AJ, 1994, J AM CHEM SOC, V116, P3625, DOI 10.1021/ja00087a069; Khuseynov D, 2012, CHEM PHYS LETT, V550, P15, DOI 10.1016/j.cplett.2012.08.035; WEBSTER OW, 1962, J AM CHEM SOC, V84, P3678, DOI 10.1021/ja00878a017; Kuhn N, 2002, Z ANORG ALLG CHEM, V628, P1721, DOI 10.1002/1521-3749(200208)628:8<1721::AID-ZAAC1721>3.0.CO;2-9; Baier H, 2013, Z ANORG ALLG CHEM, V639, P1731, DOI 10.1002/zaac.201300250; ARDUENGO AJ, 1994, J AM CHEM SOC, V116, P6641, DOI 10.1021/ja00094a020; ARDUENGO AJ, 1992, J AM CHEM SOC, V114, P5530, DOI 10.1021/ja00040a007; BRADFORTH SE, 1993, J CHEM PHYS, V98, P800, DOI 10.1063/1.464244; Arduengo AJ, 1997, J AM CHEM SOC, V119, P12742, DOI 10.1021/ja973241o; Kuhn N, 2004, Z ANORG ALLG CHEM, V630, P495, DOI 10.1002/zaac.200300401; FARES V, 1995, J AM CHEM SOC, V117, P11580, DOI 10.1021/ja00151a024; Arduengo A. J., 2015, PHOSPHORUS IN PRESS; Fischer D, 2015, NEW J CHEM, V39, P1619, DOI 10.1039/c4nj01351d; ARDUENGO AJ, 1995, J AM CHEM SOC, V117, P572, DOI 10.1021/ja00106a082; Grasa GA, 2004, CHEM COMMUN, P2890, DOI 10.1039/b410986d; Ikhile MI, 2010, ACTA CRYSTALLOGR E, V66, pM1493, DOI 10.1107/S1600536810043989; Ito M., 1974, Jpn. Tokkyo Koho., Patent No. [JP 49020182 B 19740523, 49020182, JP49020182 B 19740523]; Joo YH, 2009, EUR J ORG CHEM, P3573, DOI 10.1002/ejoc.200900389; Ramnial T, 2004, CHEM COMMUN, P1054, DOI 10.1039/b314110a; Richter H, 2009, SYNLETT, P193, DOI 10.1055/s-0028-1087676	29	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	0044-2313	1521-3749		Z ANORG ALLG CHEM	Z. Anorg. Allg. Chem.	OCT	2015	641	12-13			SI		2190	2198		10.1002/zaac.201500578		9	Chemistry, Inorganic & Nuclear	Chemistry	CT3EC	WOS:000362689000022		
J	Maeta, N; Yamamoto, J; Fuku-En, SI; Shang, R; Yamamoto, Y				Maeta, Naoto; Yamamoto, Junki; Fuku-en, Shin-ichi; Shang, Rong; Yamamoto, Yohsuke			Synthesis of New Dipyrido-Annulated N-Heterocyclic Carbenes with Aryl Substituents	ZEITSCHRIFT FUR ANORGANISCHE UND ALLGEMEINE CHEMIE			English	Article						Singlet carbene; N-Heterocyclic carbene; Annulated carbene; Gold	OXO GOLD CARBENES; NHC-LIGANDS; CATALYSIS; COMPLEXES; CHEMISTRY; REACTIVITY; CARBON; ACIDS	4,8- Aryl- substituted 2,10- di- tert- butyldipyrido[ 1,2- c; 2 -,1 - e]- imidazolium salts were synthesized from a newly prepared dibromoprecursor by use of Suzuki- Miyaura coupling. The corresponding carbenes were generated from the imidazolium salts by deprotonation. The trifluoromethyl- substituted derivative ( 10a) was trapped by AuCl( SMe2) to give an N- heterocyclic carbene- coordinated gold( I) complex ( 12a), in which the central AuI atom is well protected by the arylsubstituents of the NHC ligand.	[Maeta, Naoto; Yamamoto, Junki; Fuku-en, Shin-ichi; Shang, Rong; Yamamoto, Yohsuke] Hiroshima Univ, Grad Sch Sci, Dept Chem, Higashihiroshima 7398526, Japan	Yamamoto, Y (reprint author), Hiroshima Univ, Grad Sch Sci, Dept Chem, 1-3-1 Kagamiyama, Higashihiroshima 7398526, Japan.	yyama@sci.hiroshima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [24109002, 26288017]	This work was supported by a Grant-in-Aid for Science Research on Innovative Areas (No. 24109002, Stimuli-responsive Chemical Species) and for Science Research B (No. 26288017) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. Fuku-en, S.-i. acknowledges a JSPS Fellowship for Young Scientists. We thank Dr. Kajiya, Ms. Amimoto, and Ms. Kawata of Natural Science Center for Basic Research and Development (N-BARD), Hiroshima University for high-resolution mass spectrometry measurements and single-crystal X-ray structural analysis.	Freakley SJ, 2015, CATAL LETT, V145, P71, DOI 10.1007/s10562-014-1432-0; Gatineau D, 2013, ISR J CHEM, V53, P892, DOI 10.1002/ijch.201300059; Riener K, 2014, CHEM REV, V114, P5215, DOI 10.1021/cr4006439; Kunz D, 2010, Z NATURFORSCH B, V65, P861; Li ZG, 2008, CHEM REV, V108, P3239, DOI 10.1021/cr068434l; Sugawara S, 2012, CHEM COMMUN, V48, P9735, DOI 10.1039/c2cc33510g; Arcadi A, 2008, CHEM REV, V108, P3266, DOI 10.1021/cr068435d; Soleilhavoup M, 2015, ACCOUNTS CHEM RES, V48, P256, DOI 10.1021/ar5003494; Zhang Y, 2014, NAT PROD REP, V31, P489, DOI 10.1039/c3np70075e; Jahnke MC, 2015, COORDIN CHEM REV, V293, P95, DOI 10.1016/j.ccr.2015.01.014; Frenking G, 2014, CHEM SOC REV, V43, P5106, DOI 10.1039/c4cs00073k; Gorin DJ, 2008, CHEM REV, V108, P3351, DOI 10.1021/cr068430g; Noisier AFM, 2014, CHEM REV, V114, P8775, DOI [10.1021/cr500200x, 10.1021/cr500200X]; Furstner A, 2007, ANGEW CHEM INT EDIT, V46, P3410, DOI 10.1002/anie.200604335; Fliedel C, 2014, COORDIN CHEM REV, V275, P63, DOI 10.1016/j.ccr.2014.04.003; Murphy LJ, 2015, CHEM COMMUN, V51, P3942, DOI 10.1039/c4cc08510h; Brooner REM, 2013, ANGEW CHEM INT EDIT, V52, P11714, DOI 10.1002/anie.201303468; Obradors C, 2014, CHEM COMMUN, V50, P16, DOI 10.1039/c3cc45518a; Wang YZ, 2014, INORG CHEM, V53, P11815, DOI 10.1021/ic502231m; Goodwin JA, 2015, CHEM COMMUN, V51, P8730, DOI 10.1039/c5cc00120j; Fuku-en S, 2013, INORG CHEM, V52, P11700, DOI 10.1021/ic402301u; Levin E, 2015, CHEM REV, V115, P4607, DOI 10.1021/cr400640e; Nonnenmacher M, 2005, J ORGANOMET CHEM, V690, P5647, DOI 10.1016/j.jorganchem.2005.07.033; Fuku-en S, 2014, CHEM LETT, V43, P468, DOI 10.1246/cl.131074; Bellemin-Laponnaz S, 2014, CHEM REV, V114, P8747, DOI 10.1021/cr500227y; Braunschweig H, 2014, ORGANOMETALLICS, V33, P6271, DOI 10.1021/om500875g; CALDER IC, 1963, TETRAHEDRON LETT, P95; Fuerstner A., 2014, ACCOUNTS CHEM RES, V47, P925; Gierz V, 2012, EUR J INORG CHEM, P1423, DOI 10.1002/ejic.201100905; Hashmi ASK, 2014, ACCOUNTS CHEM RES, V47, P864, DOI 10.1021/ar500015k; Izquierdo F, 2014, CHEM COMMUN, V50, P14926, DOI 10.1039/c4cc05289g; Jahnke MC, 2015, CHEM LETT, V44, P226, DOI 10.1246/cl.141052; Kuwata S, 2014, CHEM COMMUN, V50, P14290, DOI 10.1039/c4cc04457f; Nonnenmacher M, 2006, CHEM COMMUN, P1378, DOI 10.1039/b517816a; Nonnenmacher M., 2008, ORGANOMETALLICS, V27, P1561, DOI 10.1021/om701196c; Wang YM, 2014, ACCOUNTS CHEM RES, V47, P889, DOI 10.1021/ar400188g; Weiss R, 2000, EUR J INORG CHEM, P1935; Weiss R, 1998, ANGEW CHEM INT EDIT, V37, P344, DOI 10.1002/(SICI)1521-3773(19980216)37:3<344::AID-ANIE344>3.0.CO;2-H; Yeom HS, 2014, ACCOUNTS CHEM RES, V47, P966, DOI 10.1021/ar4001839; Zhang DH, 2014, ACCOUNTS CHEM RES, V47, P913, DOI 10.1021/ar400159r; Zhang LM, 2014, ACCOUNTS CHEM RES, V47, P877, DOI 10.1021/ar400181x	41	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	0044-2313	1521-3749		Z ANORG ALLG CHEM	Z. Anorg. Allg. Chem.	OCT	2015	641	12-13			SI		2199	2203		10.1002/zaac.201500565		5	Chemistry, Inorganic & Nuclear	Chemistry	CT3EC	WOS:000362689000023		
J	Didas, SA; Choi, S; Chaikittisilp, W; Jones, CW				Didas, Stephanie A.; Choi, Sunho; Chaikittisilp, Watcharop; Jones, Christopher W.			Amine-Oxide Hybrid Materials for CO2 Capture from Ambient Air	ACCOUNTS OF CHEMICAL RESEARCH			English	Review							CARBON-DIOXIDE CAPTURE; ETHYLENE POLYMERIZATION CATALYSTS; METAL-ORGANIC FRAMEWORK; SIMULATED FLUE-GAS; MESOPOROUS SILICA; HYPERBRANCHED AMINOSILICAS; ADSORPTION PROPERTIES; STRUCTURAL-CHANGES; SITE ISOLATION; SINGLE-SITE	CONSPECTUS: Oxide supports functionalized with amine moieties have been used for decades as catalysts and chromatographic media. Owing to the recognized impact of atmospheric CO2 on global climate change, the study of the use of amine-oxide hybrid materials as CO2 sorbents has exploded in the past decade. While the majority of the work has concerned separation of CO2 from dilute mixtures such as flue gas from coal-fired power plants, it has been recognized by us and others that such supported amine materials are also perhaps uniquely suited to extract CO2 from ultradilute gas mixtures, such as ambient air. As unique, low temperature chemisorbents, they can operate under ambient conditions, spontaneously extracting CO2 from ambient air, while being regenerated under mild conditions using heat or the combination of heat and vacuum. This Account describes the evolution of our activities on the design of amine-functionalized silica materials for catalysis to the design, characterization, and utilization of these materials in CO2 separations. New materials developed in our laboratory, such as hyperbranched aminosilica materials, and previously known amine-oxide hybrid compositions, have been extensively studied for CO2 extraction from simulated ambient air (400 ppm of CO2). The role of amine type and structure (molecular, polymeric), support type and structure, the stability of the various compositions under simulated operating conditions, and the nature of the adsorbed CO2 have been investigated in detail. The requirements for an effective, practical air capture process have been outlined and the ability of amine oxide hybrid materials to meet these needs has been discussed. Ultimately, the practicality of such a "direct air capture" process is predicated not only on the physicochemical properties of the sorbent, but also how the sorbent operates in a practical process that offers a scalable gas solid contacting strategy. In this regard, the utility of low pressure drop monolith contactors is suggested to offer a practical mode of amine sorbent/air contacting for direct air capture.	[Didas, Stephanie A.; Jones, Christopher W.] Georgia Inst Technol, Sch Chem & Biomol Eng, Atlanta, GA 30332 USA; [Choi, Sunho] Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA; [Chaikittisilp, Watcharop] Univ Tokyo, Dept Chem Syst Engn, Bunkyo Ku, Tokyo 1138656, Japan	Jones, CW (reprint author), Georgia Inst Technol, Sch Chem & Biomol Eng, 311 Ferst Dr, Atlanta, GA 30332 USA.	cjones@chbe.gatech.edu			US Department of Energy [DE-FE0002438]; Camille and Henry Dreyfus Foundation	Our work in CO<INF>2</INF> capture from ambient air was catalyzed by an initial and ongoing collaboration with Dr. Peter Eisenberger and Global Thermostat, LLC. Additional funds in support of materials and/or process research in the area of direct air capture were provided by the US Department of Energy (DE-FE0002438) and the Camille and Henry Dreyfus Foundation. Ongoing collaborations with Dr. Bill Addiego, of Corning Inc., have significantly enriched our work on monolith contactors.	Nomura A, 2014, CHEM-EUR J, V20, P6381, DOI 10.1002/chem.201304954; Lee WR, 2014, ENERG ENVIRON SCI, V7, P744, DOI 10.1039/c3ee42328j; Hicks JC, 2006, CHEM MATER, V18, P5022, DOI 10.1021/cm061382w; TSUDA T, 1992, CHEM LETT, P2161, DOI 10.1246/cl.1992.2161; McKittrick MW, 2004, J AM CHEM SOC, V126, P3052, DOI 10.1021/ja031725g; Gebald C, 2013, ENVIRON SCI TECHNOL, V47, P10063, DOI 10.1021/es401731p; Hu YL, 2014, CHEMSUSCHEM, V7, P734, DOI 10.1002/cssc.201301163; Sakwa-Novak MA, 2014, ACS APPL MATER INTER, V6, P9245, DOI 10.1021/am501500q; Li W, 2010, ACS APPL MATER INTER, V2, P3363, DOI 10.1021/am100786z; Choi S, 2012, J PHYS CHEM LETT, V3, P1136, DOI 10.1021/jz300328j; Lu WG, 2012, ANGEW CHEM INT EDIT, V51, P7480, DOI 10.1002/anie.201202176; Calleja G, 2011, TOP CATAL, V54, P135, DOI 10.1007/s11244-011-9652-7; Didas SA, 2012, CHEMSUSCHEM, V5, P2058, DOI 10.1002/cssc.201200196; Lu WG, 2013, J PHYS CHEM C, V117, P4057, DOI 10.1021/jp311512q; McDonald TM, 2012, J AM CHEM SOC, V134, P7056, DOI 10.1021/ja300034j; Drese JH, 2009, ADV FUNCT MATER, V19, P3821, DOI 10.1002/adfm.200901461; Bollini P, 2011, J MATER CHEM, V21, P15100, DOI 10.1039/c1jm12522b; Sanz R, 2013, J MATER CHEM A, V1, P1956, DOI 10.1039/c2ta01343f; Choi S, 2011, ENVIRON SCI TECHNOL, V45, P2420, DOI 10.1021/es102797w; Brunelli NA, 2012, J AM CHEM SOC, V134, P13950, DOI 10.1021/ja305601g; Phan NTS, 2006, ANGEW CHEM INT EDIT, V45, P2209, DOI 10.1002/anie.200503445; Heydari-Gorji A, 2011, MICROPOR MESOPOR MAT, V145, P146, DOI 10.1016/j.micromeso.2011.05.010; Wurzbacher JA, 2011, ENERG ENVIRON SCI, V4, P3584, DOI 10.1039/c1ee01681d; Bollini P, 2011, ENERG FUEL, V25, P2416, DOI 10.1021/ef200140z; Belmabkhout Y, 2010, CHEM ENG SCI, V65, P3695, DOI 10.1016/j.ces.2010.02.044; Jones CW, 2011, ANNU REV CHEM BIOMOL, V2, P31, DOI 10.1146/annurev-chembioeng-061010-114252; Choi S, 2009, CHEMSUSCHEM, V2, P796, DOI 10.1002/cssc.200900036; Drese JH, 2012, MICROPOR MESOPOR MAT, V151, P231, DOI 10.1016/j.micromeso.2011.10.031; Kim HJ, 2000, J COLLOID INTERF SCI, V227, P247, DOI 10.1006/jcis.2000.6861; Chaikittisilp W, 2011, IND ENG CHEM RES, V50, P14203, DOI 10.1021/ie201584t; Gebald C, 2011, ENVIRON SCI TECHNOL, V45, P9101, DOI 10.1021/es202223p; Li W, 2010, CHEMSUSCHEM, V3, P899, DOI 10.1002/cssc.201000131; Alkhabbaz MA, 2014, J AM CHEM SOC, V136, P13170, DOI 10.1021/ja507655x; Lunn JD, 2009, CHEM MATER, V21, P3638, DOI 10.1021/cm901025n; Nomura A, 2013, ACS APPL MATER INTER, V5, P5569, DOI 10.1021/am400810s; Xu XC, 2002, ENERG FUEL, V16, P1463, DOI 10.1021/ef020058u; Hicks JC, 2006, LANGMUIR, V22, P2676, DOI 10.1021/la053024y; Chaikittisilp W, 2011, CHEM-EUR J, V17, P10556, DOI 10.1002/chem.201101480; Brunelli NA, 2012, CHEM MATER, V24, P2433, DOI 10.1021/cm300753z; Serna-Guerrero R, 2010, CHEM ENG SCI, V65, P4166, DOI 10.1016/j.ces.2010.04.029; Long W, 2013, ACS CATAL, V3, P1700, DOI 10.1021/cs3007395; Choi S, 2011, CHEMSUSCHEM, V4, P628, DOI 10.1002/cssc.201000355; Hicks JC, 2008, J AM CHEM SOC, V130, P2902, DOI 10.1021/ja077795v; Yu KQ, 2004, ORGANOMETALLICS, V23, P4089, DOI 10.1021/om049765w; McKittrick MW, 2005, J MOL CATAL A-CHEM, V237, P26, DOI 10.1016/j.molcata.2005.04.037; Chaikittisilp W, 2011, ENERG FUEL, V25, P5528, DOI 10.1021/ef201224v; Kulkarni AR, 2012, IND ENG CHEM RES, V51, P8631, DOI 10.1021/ie300691c; Goeppert A, 2011, J AM CHEM SOC, V133, P20164, DOI 10.1021/ja2100005; Heydari-Gorji A, 2012, IND ENG CHEM RES, V51, P6887, DOI 10.1021/ie3003446; Chaikittisilp W, 2013, CHEM MATER, V25, P613, DOI 10.1021/cm303931q; Stuckert NR, 2011, ENVIRON SCI TECHNOL, V45, P10257, DOI 10.1021/es202647a; McKittrick MW, 2003, CHEM MATER, V15, P1132, DOI 10.1021/cm020952z; TSUDA T, 1992, J CHEM SOC CHEM COMM, P1659, DOI 10.1039/c39920001659; Hammache S, 2013, ENERG FUEL, V27, P6899, DOI 10.1021/ef401562w; Bali S, 2014, CHEMSUSCHEM, V7, P3145, DOI 10.1002/cssc.201402373; Jones C. W., 2012, 2012 US FRONT ENG S; Jones C. W., 2012, U.S. Patent, Patent No. [US8298986 B2, 8298986, 8,298,986]; Keith DW, 2006, CLIMATIC CHANGE, V74, P17, DOI 10.1007/s10584-005-9026-x; Lackner K. S., 1999, P 24 INT TECHN C COA, P885; Lu WG, 2015, CHEMSUSCHEM, V8, P433, DOI 10.1002/cssc.201402622; McDonald TM, 2015, NATURE, V519, P303, DOI 10.1038/nature14327; Rosenholm JM, 2006, CHEM COMMUN, P3909, DOI 10.1039/b607886a; Sayari A., 2012, J AM CHEM SOC, V134, P13834; Zeman FS, 2004, WORLD RESOURCE REV, V16, P157	64	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0001-4842	1520-4898		ACCOUNTS CHEM RES	Accounts Chem. Res.	OCT	2015	48	10					2680	2687		10.1021/acs.accounts.5b00284		8	Chemistry, Multidisciplinary	Chemistry	CU2IT	WOS:000363347900005		
J	Kunieda, K; Tsutsuki, H; Ida, T; Kishimoto, Y; Kasamatsu, S; Sawa, T; Goshima, N; Itakura, M; Takahashi, M; Akaike, T; Ihara, H				Kunieda, Kohei; Tsutsuki, Hiroyasu; Ida, Tomoaki; Kishimoto, Yusuke; Kasamatsu, Shingo; Sawa, Tomohiro; Goshima, Naoki; Itakura, Makoto; Takahashi, Masami; Akaike, Takaaki; Ihara, Hideshi			8-Nitro-cGMP Enhances SNARE Complex Formation through S-Guanylation of Cys90 in SNAP25	ACS CHEMICAL NEUROSCIENCE			English	Article						8-Nitroguanosine 3 ',5 '-cyclic monophosphate; protein S-guanylation; redox signaling; SNAP25; SNARE complex; neuronal nitric oxide synthase	NITRATED CYCLIC-GMP; NITRIC-OXIDE; 8-NITROGUANOSINE 3',5'-CYCLIC-MONOPHOSPHATE; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; TYROSINE NITRATION; VESICLE FUSION; SPINAL-CORD; PC12 CELLS; SNAP-25	Nitrated guanine nucleotide 8-nitroguanosine 3',5'-cyclic monophosphate (8-nitro-cGMP) generated by reactive oxygen/nitrogen species causes protein S-guanylation. However, the mechanism of 8-nitro-cGMP formation and its protein targets in the normal brain have not been identified. Here, we investigated 8-nitro-cGMP generation and protein S-guanylation in the rodent brain. Immunohistochemistry indicated that 8-nitro-cGMP was produced by neurons, such as pyramidal cells and interneurons. Using liquid chromatography-tandem mass spectrometry, we determined endogenous 8-nitro-cGMP levels in the brain as 2.92 +/- 0.10 pmol/mg protein. Based on S-guanylation proteomics, we identified several S-guanylated neuronal proteins, including SNAP25 which is a core member of the soluble N-ethylmaleimide sensitive factor attachment protein receptor (SNARE) complex. SNAP25 post-translational modification including palmitoylation, phosphorylation, and oxidation, are known to regulate neurotransmission. Our results demonstrate that S-guanylation of SNAP25 enhanced the stability of the SNARE complex, which was further promoted by Ca2+-dependent activation of neuronal nitric oxide synthase. Using site-directed mutagenesis, we identified SNAP25 cysteine 90 as the main target of S-guanylation which enhanced the stability of the SNARE complex. The present study revealed a novel target of redox signaling via protein S-guanylation in the nervous system and provided the first substantial evidence of 8-nitro-cGMP function in the nervous system.	[Kunieda, Kohei; Kishimoto, Yusuke; Ihara, Hideshi] Osaka Prefecture Univ, Dept Biol Sci, Grad Sch Sci, Sakai, Osaka 5998531, Japan; [Tsutsuki, Hiroyasu; Sawa, Tomohiro] Kumamoto Univ, Grad Sch Med Sci, Dept Microbiol, Kumamoto 8608556, Japan; [Ida, Tomoaki; Kasamatsu, Shingo; Akaike, Takaaki] Tohoku Univ, Grad Sch Med, Dept Environm Hlth Sci & Mol Toxicol, Sendai, Miyagi 9808575, Japan; [Goshima, Naoki] Natl Inst Adv Ind Sci & Technol, Quantitat Prote Team, Mol Profiling Res Ctr Drug Discovery, Tokyo 1350064, Japan; [Itakura, Makoto; Takahashi, Masami] Kitasato Univ, Sch Med, Dept Biochem, Sagamihara, Kanagawa 2520374, Japan	Ihara, H (reprint author), Osaka Prefecture Univ, Dept Biol Sci, Grad Sch Sci, Naka Ku, 1-1 Gakuen Cho, Sakai, Osaka 5998531, Japan.	ihara@b.s.osakafu-u.ac.jp			Ministry of Education, Culture, Sports, Sciences and Technology (MEXT) [22500337, 25430069, 20117001, 20117005, 26111011]; Japan Science and Technology Agency (JST) Precursory Research for Embryonic Science and Technology (PRESTO) program [09801194]; Nagase Science and Technology Foundation	This work was supported, in part by the Ministry of Education, Culture, Sports, Sciences and Technology (MEXT) Grants-in-Aid for Scientific Research (Grant Numbers 22500337 and 25430069), Grants-in-Aid for Scientific Research on Innovative Areas (Research in a Proposed Area; Grant Number 20117001), and the Japan Science and Technology Agency (JST) Precursory Research for Embryonic Science and Technology (PRESTO) program (Grant Number 09801194).; This work was supported, in part by the Ministry of Education, Culture, Sports, Sciences and Technology (MEXT) Grants-inAid for Scientific Research (Grant Numbers 22500337 and 25430069), Grants-in-Aid for Scientific Research on Innovative Areas (Research in a Proposed Area;Grant Number 20117005 and 26111011), and the Nagase Science and Technology Foundation.	BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; Hsieh HL, 2013, BIOMED RES INT, DOI 10.1155/2013/484613; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Kakizawa S, 2012, NEUROBIOL AGING, V33, P535, DOI 10.1016/j.neurobiolaging.2010.04.016; Calabrese V, 2007, NAT REV NEUROSCI, V8, P766, DOI 10.1038/nrn2214; Sawa T, 2007, NAT CHEM BIOL, V3, P727, DOI 10.1038/nchembio.2007.33; Ahmed KA, 2012, BIOCHEM J, V441, P719, DOI 10.1042/BJ20111130; McKee AG, 2010, J NEUROCHEM, V112, P991, DOI 10.1111/j.1471-4159.2009.06516.x; Sorensen JB, 2002, P NATL ACAD SCI USA, V99, P1627, DOI 10.1073/pnas.251673298; YOSHIDA A, 1992, J BIOL CHEM, V267, P24925; Izawa T, 2008, BRAIN RES, V1195, P120, DOI 10.1016/j.brainres.2007.12.022; Kataoka M, 2000, J NEUROCHEM, V74, P2058, DOI 10.1046/j.1471-4159.2000.0742058.x; Antonucci F, 2013, EMBO REP, V14, P645, DOI 10.1038/embor.2013.75; Di Stasi AMM, 2002, J NEUROCHEM, V82, P420, DOI 10.1046/j.1471-4159.2002.00980.x; Taniguchi M, 2007, J BIOL CHEM, V282, P7869, DOI 10.1074/jbc.M609457200; Song T, 2007, BIOCHEM J, V401, P391, DOI 10.1042/BJ20060580; Rahaman MM, 2014, ANTIOXID REDOX SIGN, V20, P295, DOI 10.1089/ars.2012.4606; Okamoto S, 2014, CELL REP, V8, P217, DOI 10.1016/j.celrep.2014.06.005; Schopfer FJ, 2003, TRENDS BIOCHEM SCI, V28, P646, DOI 10.1016/j.tibs.2003.10.006; Iida Y, 2013, NEUROSCI RES, V75, P184, DOI 10.1016/j.neures.2013.01.002; Greaves J, 2009, MOL BIOL CELL, V20, P1845, DOI 10.1091/mbc.E08-09-0944; Nishida M, 2012, NAT CHEM BIOL, V8, P714, DOI [10.1038/nchembio.1018, 10.1038/NCHEMBIO.1018]; Madhusoodanan KS, 2007, NEUROCHEM RES, V32, P681, DOI 10.1007/s11064-006-9167-y; Giniatullin AR, 2006, J NEUROCHEM, V98, P1789, DOI 10.1111/j.1471-4159.2006.03997.x; Hou QL, 2004, EUR J NEUROSCI, V20, P1593, DOI 10.1111/j.1460-9568.2004.03600.x; Mohrmann R, 2010, SCIENCE, V330, P502, DOI 10.1126/science.1193134; Kataoka M, 2006, NEUROSCI LETT, V407, P258, DOI 10.1016/j.neulet.2006.08.055; Kasamatsu S, 2014, BIOCHEM J, V459, P251, DOI 10.1042/BJ20131262; Brunger AT, 2009, ANNU REV BIOCHEM, V78, P903, DOI 10.1146/annurev.biochem.77.070306.103621; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Hou QL, 2006, BIOCHEM BIOPH RES CO, V347, P955, DOI 10.1016/j.bbrc.2006.06.184; Meffert MK, 1996, NEURON, V16, P1229, DOI 10.1016/S0896-6273(00)80149-X; Matsushita K, 2003, CELL, V115, P139, DOI 10.1016/S0092-8674(03)00803-1; Taqatqeh F, 2009, J NEUROSCI, V29, P9344, DOI 10.1523/JNEUROSCI.1902-09.2009; Baca M, 2013, BRAIN RES, V1532, P85, DOI 10.1016/j.brainres.2013.08.012; Halemani ND, 2010, TRAFFIC, V11, P394, DOI 10.1111/j.1600-0854.2009.01020.x; Wang YJ, 2012, INT J BIOCHEM CELL B, V44, P2288, DOI 10.1016/j.biocel.2012.09.011; Di Domenico F, 2009, NEUROCHEM RES, V34, P727, DOI 10.1007/s11064-009-9924-9; Fujii S, 2010, J BIOL CHEM, V285, P23970, DOI 10.1074/jbc.M110.145441; Greber S, 1999, ELECTROPHORESIS, V20, P928; Akaike T, 2013, J BIOCHEM, V153, P131, DOI 10.1093/jb/mvs145; BARK IC, 1995, P NATL ACAD SCI USA, V92, P1510, DOI 10.1073/pnas.92.5.1510; Graham ME, 2002, ANN NY ACAD SCI, V971, P210; Ida T, 2014, P NATL ACAD SCI USA, V111, P7606, DOI 10.1073/pnas.1321232111; Ihara H, 2011, NITRIC OXIDE-BIOL CH, V25, P169, DOI 10.1016/j.niox.2011.04.015; Kataoka M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025158; Pozzi D, 2008, P NATL ACAD SCI USA, V105, P323, DOI 10.1073/pnas.0706211105; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Sawa T, 2013, NITRIC OXIDE-BIOL CH, V34, P10, DOI 10.1016/j.niox.2013.04.004; Yarnamori S., 2014, NEUROSCI LETT, V561, P182	50	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7193			ACS CHEM NEUROSCI	ACS Chem. Neurosci.	OCT	2015	6	10					1715	1725		10.1021/acschemneuro.5b00196		11	Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences & Neurology	CU3OS	WOS:000363435300006		
J	Kudo, K; Furutani, M; Arimitsu, K				Kudo, Kenji; Furutani, Masahiro; Arimitsu, Koji			Imidazole Derivatives with an Intramolecular Hydrogen Bond as Thermal Latent Curing Agents for Thermosetting Resins	ACS MACRO LETTERS			English	Article							GLYCIDYL ETHER REACTIONS; EPOXY-RESIN; MECHANISM; MICROENCAPSULATION; CATALYSIS	Epoxy resins are important thermosetting resins widely used in industrial applications. Though imidazoles as curing agents have attracted particular attention because of their high reactivity in chain polymerizations with epoxides, polymerization of a liquid epoxy resin containing imidazoles proceeds gradually even at room temperature. This makes it difficult to use such mixtures as one-component materials for industrial applications. To improve the shelf life of the mixutures, we have developed a very simple and powerful thermal latent curing agent, a 2-(2-hydroxyphenyl)imidazole derivative (1), having an intramolecular hydrogen bond between the phenolic hydroxyl group and the nitrogen atom of the imidazole ring, leading to suppression of reactivity of 1 toward epoxy resins at room temperature. It was confirmed that high reactivity of 1 toward epoxy resins at 150 degrees C was based on breakage of the intramolecular hydrogen, whereas the epoxy resin composition showed long-term storage stability at room temperature.	[Kudo, Kenji; Furutani, Masahiro; Arimitsu, Koji] Tokyo Univ Sci, Fac Sci & Technol, Dept Pure & Appl Chem, Noda, Chiba 2788510, Japan; [Kudo, Kenji] Nippon Synthet Chem Ind Co Ltd, Cent Res Lab, Ibaraki, Osaka 5670052, Japan	Arimitsu, K (reprint author), Tokyo Univ Sci, Fac Sci & Technol, Dept Pure & Appl Chem, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	arimitsu@rs.noda.tus.ac.jp					Ham YR, 2010, J IND ENG CHEM, V16, P728, DOI 10.1016/j.jiec.2010.07.011; Rocks J, 2004, POLYMER, V45, P6799, DOI 10.1016/j.polymer.2004.07.066; SHECHTER L, 1956, IND ENG CHEM, V48, P86, DOI 10.1021/ie50553a028; Hart KR, 2015, POLYMER, V67, P174, DOI 10.1016/j.polymer.2015.04.068; MATUSZAK CA, 1976, J CHEM EDUC, V53, P280; Hamerton I, 1996, J MATER CHEM, V6, P305, DOI 10.1039/jm9960600305; SHECHTER L, 1956, IND ENG CHEM, V48, P94, DOI 10.1021/ie50553a029; Shin MJ, 2013, J APPL POLYM SCI, V129, P1036, DOI 10.1002/app.38767; HEISE MS, 1989, MACROMOLECULES, V22, P99, DOI 10.1021/ma00191a020; Chiang TH, 2006, INT J ADHES ADHES, V26, P520, DOI 10.1016/j.ijadhadh.2005.07.004; Maka H, 2012, IND ENG CHEM RES, V51, P5197, DOI 10.1021/ie202321j; FARKAS A, 1968, J APPL POLYM SCI, V12, P159, DOI 10.1002/app.1968.070120115; RICCIARDI F, 1983, J POLYM SCI POL CHEM, V21, P1475, DOI 10.1002/pol.1983.170210520; BARTON JM, 1994, J MATER CHEM, V4, P379, DOI 10.1039/jm9940400379; Wong FF, 2007, J APPL POLYM SCI, V104, P3292, DOI 10.1002/app.26002; Foces-Foces C, 1998, J MOL STRUCT, V440, P193, DOI 10.1016/S0022-2860(97)00270-6; Nishikubo T, 1996, POLYM J, V28, P795, DOI 10.1295/polymj.28.795; Fantini M, 2010, J COMB CHEM, V12, P181, DOI 10.1021/cc900152y; Silverstein R. M., 2005, SPECTROMETRIC IDENTI	19	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-1653			ACS MACRO LETT	ACS Macro Lett.	OCT	2015	4	10					1085	1088		10.1021/acsmacrolett.5b00601		4	Polymer Science	Polymer Science	CU2PI	WOS:000363365000006		
J	Artar, M; Souren, ERJ; Terashima, T; Meijer, EW; Palmans, ARA				Artar, Muge; Souren, Erik R. J.; Terashima, Takaya; Meijer, E. W.; Palmans, Anja R. A.			Single Chain Polymeric Nanoparticles as Selective Hydrophobic Reaction Spaces in Water	ACS MACRO LETTERS			English	Article							CATALYTIC-ACTIVITY; NOBEL LECTURE; OXIDATION; ALCOHOLS; SHAPE; ARCHITECTURE; SURFACTANT; ACYLATION; COMPLEX; ENZYMES	A Ru(II)-based catalyst trapped within an amphiphilic, folded polymer is employed for the oxidation of secondary alcohols to their corresponding ketones using tBuOOH as the oxidant. Under the applied catalytic conditions, the polymer catalyst forms a compartmentalized structure with a hydrophobic interior. We selected secondary alcohols that differ in hydrophobicity, reactivity, and steric hindrance as substrates, with the aim to elucidate how this affects the rate and the end conversion of the oxidation reaction. Our investigations show that the Ru(II)-based catalyst is very efficient for oxidation reactions in water. Moreover, high selectivity toward the more hydrophobic substrate is observed, which originates from the hydrophobic interior of the compartmentalized catalyst system. This hydrophobic selectivity is also observed in the reverse reaction, the transfer hydrogenation.	[Artar, Muge; Souren, Erik R. J.; Meijer, E. W.; Palmans, Anja R. A.] Eindhoven Univ Technol, Lab Macromol & Organ Chem, NL-5600 MB Eindhoven, Netherlands; [Artar, Muge; Souren, Erik R. J.; Meijer, E. W.; Palmans, Anja R. A.] Eindhoven Univ Technol, Inst Complex Mol Syst, NL-5600 MB Eindhoven, Netherlands; [Terashima, Takaya] Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Nishikyo Ku, Kyoto 6158510, Japan	Meijer, EW (reprint author), Eindhoven Univ Technol, Lab Macromol & Organ Chem, POB 513, NL-5600 MB Eindhoven, Netherlands.	e.w.meijer@tue.nl; a.palmans@tue.nl			The Netherlands Organization for Scientific Research (ECHO Grant) [713.011.001]; Dutch Ministry of Education, Culture and Science (Gravity Program) [024.001.035]; European Research Council (ERC Grant) [246829]	This work was financially supported by The Netherlands Organization for Scientific Research (ECHO Grant 713.011.001), the Dutch Ministry of Education, Culture and Science (Gravity Program 024.001.035), and the European Research Council (FP7/2007-2013, ERC Grant Agreement 246829). A.P. would like to thank Prof. Dr.). Meuldijk (TU/e) for insightful discussions. The ICMS Animation Studio (TU/e) is acknowledged for providing the art work.	Altintas O, 2012, MACROMOL RAPID COMM, V33, P958, DOI 10.1002/marc.201200049; Biscoe MR, 2005, J AM CHEM SOC, V127, P10812, DOI 10.1021/ja053660i; Terashima T, 2014, MACROMOLECULES, V47, P589, DOI 10.1021/ma402355v; Hamasaka G, 2011, ANGEW CHEM INT EDIT, V50, P4876, DOI 10.1002/anie.201100827; Ge ZS, 2007, MACROMOLECULES, V40, P3538, DOI 10.1021/ma070550i; WEISZ PB, 1979, SCIENCE, V206, P57, DOI 10.1126/science.206.4414.57; TSUJI Y, 1984, J ORGANOMET CHEM, V270, P333, DOI 10.1016/0022-328X(84)80381-2; Dusselier M, 2015, SCIENCE, V349, P78, DOI 10.1126/science.aaa7169; ENGBERTS JBFN, 1992, PURE APPL CHEM, V64, P1653, DOI 10.1351/pac199264111653; Artar M, 2014, J POLYM SCI POL CHEM, V52, P12, DOI 10.1002/pola.26970; Chen BT, 2015, ACS CATAL, V5, P1313, DOI 10.1021/cs5020018; Gonzalez-Burgos M, 2015, CHEM SOC REV, V44, P6122, DOI 10.1039/c5cs00209e; Terashima T, 2011, J AM CHEM SOC, V133, P4742, DOI 10.1021/ja2004494; Sanchez-Sanchez A, 2014, ACS MACRO LETT, V3, P439, DOI 10.1021/mz5001477; van Oers MCM, 2014, CHEM COMMUN, V50, P4040, DOI 10.1039/c3cc48865a; Willenbacher J, 2015, POLYM CHEM-UK, V6, P4358, DOI 10.1039/c5py00389j; Helms B, 2006, ADV SYNTH CATAL, V348, P1125, DOI 10.1002/adsc.200606095; Helms B, 2005, MACROMOLECULES, V38, P5411, DOI 10.1021/ma050701m; Liu Y, 2011, J AM CHEM SOC, V133, P14260, DOI 10.1021/ja206644d; Garcia-Viloca M, 2004, SCIENCE, V303, P186, DOI 10.1126/science.1088172; Terashima T, 2011, J POLYM SCI POL CHEM, V49, P1061, DOI 10.1002/pola.24501; Moore BL, 2014, POLYM CHEM-UK, V5, P3487, DOI 10.1039/c3py01734f; Perez-Baena I, 2013, ACS MACRO LETT, V2, P775, DOI 10.1021/mz4003744; SANGSTER J, 1989, J PHYS CHEM REF DATA, V18, P1111; ten Brink GJ, 2000, SCIENCE, V287, P1636; Stals PJM, 2014, MACROMOLECULES, V47, P2947, DOI 10.1021/ma500273g; Berdugo C, 2013, CHEM COMMUN, V49, P10608, DOI 10.1039/c3cc45623d; YALKOWSKY SH, 1980, J PHARM SCI, V69, P912, DOI 10.1002/jps.2600690814; Lyon CK, 2015, POLYM CHEM-UK, V6, P181, DOI 10.1039/c4py01217h; Huerta E, 2013, ANGEW CHEM INT EDIT, V52, P2906, DOI 10.1002/anie.201207123; Cotanda P, 2012, CHEM COMMUN, V48, P10280, DOI 10.1039/c2cc35655d; Gillissen MAJ, 2013, MACROMOLECULES, V46, P4120, DOI 10.1021/ma4006846; Aliende C, 2012, ORGANOMETALLICS, V31, P6106, DOI 10.1021/om3004702; Artar M, 2014, ACS SYM SER, V1170, P313; Haimov A., 2006, J AM CHEM SOC, V128, P15697; Mavila S, 2014, CHEM SCI, V5, P4196, DOI 10.1039/c4sc01231c; MURAHASHI SI, 1993, SYNTHESIS-STUTTGART, P433; Noyori R, 2002, ANGEW CHEM INT EDIT, V41, P2008, DOI 10.1002/1521-3773(20020617)41:12<2008::AID-ANIE2008>3.0.CO;2-4; Warshel A, 2014, ANGEW CHEM INT EDIT, V53, P10020, DOI 10.1002/anie.201403689; WARSHEL A, 1978, P NATL ACAD SCI USA, V75, P5250, DOI 10.1073/pnas.75.11.5250	40	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-1653			ACS MACRO LETT	ACS Macro Lett.	OCT	2015	4	10					1099	1103		10.1021/acsmacrolett.5b00652		5	Polymer Science	Polymer Science	CU2PI	WOS:000363365000009		
J	Seo, JH; Fushimi, M; Matsui, N; Takagaki, T; Tagami, J; Yui, N				Seo, Ji-Hun; Fushimi, Mayu; Matsui, Naoko; Takagaki, Tomohiro; Tagami, Junji; Yui, Nobuhiko			UV-Cleavable Polyrotaxane Cross-Linker for Modulating Mechanical Strength of Photocurable Resin Plastics	ACS MACRO LETTERS			English	Article							NITROBENZYL; CHEMISTRY; POLYMERS; RELEASE; MODEL	A UV-cleavable supramolecular cross-linker was designed to effectively control the mechanical strength of photocurable resin plastics. The resin monomer-soluble polyrotaxane (PRX) cross-linker was synthesized by introducing a hydrophobic n-butyl group and a cross-linkable methacrylate group in a-cyclodextrin threading to a polyethylene glycol containing UV-cleavable end groups. The UV-cleavable PRX cross-linker was completely dissolved in 2-hydroxyethytl methacrylate (HEMA) and camphorquinone, representative photocurable resin components. The dumbbell-like stiff resin plastic was prepared by irradiating the mixture with 450 nm blue light. The stiffened resin plastic maintained its ultimate tensile strength (UTS) under visible light irradiation. However, the UTS of the resin plastic was remarkably decreased to 40% of the original value once the plastic was exposed to 254 nm UV light. This indicates that the suggested UV-cleavable PRX cross-linker is effective in modulating the mechanical strength of photocurable resin plastics.	[Seo, Ji-Hun; Fushimi, Mayu; Yui, Nobuhiko] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan; [Matsui, Naoko; Takagaki, Tomohiro; Tagami, Junji] Tokyo Med & Dent Univ, Cardiol & Operat Dent, Tokyo 1138510, Japan; [Seo, Ji-Hun] Korea Univ, Dept Mat Sci & Engn, Seoul 136701, South Korea	Yui, N (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan.	yui.org@tmd.ac.jp			Japan Society for the Promotion of Science (JSPS) [KAKEN 24700477, KAKEN 24650274]	The authors acknowledge Dr. Atsushi Tamura and Dr. Yoshinori Arisaka, Tokyo Medical and Dental University, for their help and advice in a course of experiments. This research was financially supported by Grant-in-Aid for Young Scientists B (KAKEN 24700477: J.-H. S.) and Grant-in-Aid for Challenging Exploratory Research (KAKEN 24650274: N.Y.) from the Japan Society for the Promotion of Science (JSPS).	Aksommuang J., 2007, DENT MATER, V23, P226; Chen Y, 2010, CHEM SOC REV, V39, P495, DOI 10.1039/b816354p; Rueggeberg FA, 2011, DENT MATER, V27, P39, DOI 10.1016/j.dental.2010.10.021; Fomina N, 2010, J AM CHEM SOC, V132, P9540, DOI 10.1021/ja102595j; Tamura A, 2013, BIOMATERIALS, V34, P2480, DOI 10.1016/j.biomaterials.2012.12.006; Dunn WJ, 2002, AM J ORTHOD DENTOFAC, V122, P236, DOI 10.1067/mod.2002.123949; Kretschy N, 2015, ANGEW CHEM INT EDIT, V54, P8555, DOI 10.1002/anie.201502125; Wenz G, 2006, CHEM REV, V106, P782, DOI 10.1021/cr970027+; Ilie N, 2014, CLIN ORAL INVEST, V18, P1081, DOI 10.1007/s00784-013-1085-1; Ryf S, 2012, EUR J ORTHODONT, V34, P25, DOI 10.1093/ejo/cjq128; Pardo R, 2011, CHEM SOC REV, V40, P672, DOI 10.1039/c0cs00065e; Thomas SW, 2012, MACROMOL CHEM PHYS, V213, P2443, DOI 10.1002/macp.201200486; Klinger D, 2011, MACROMOLECULES, V44, P9758, DOI 10.1021/ma201706r; Yang J, 2014, CHEM COMMUN, V50, P3993, DOI 10.1039/c4cc00590b; Ye Q, 2007, J BIOMED MATER RES A, V80A, P342, DOI 10.1002/jbm.a.30890; Masson F, 2004, PROG ORG COAT, V49, P1, DOI 10.1016/S0300-9440(03)00122-X; Holmes CP, 1997, J ORG CHEM, V62, P2370, DOI 10.1021/jo961602x; Griffin DR, 2012, J AM CHEM SOC, V134, P13103, DOI 10.1021/ja305280w; Han DH, 2011, MACROMOLECULES, V44, P437, DOI 10.1021/ma102778d; HARADA A, 1994, J AM CHEM SOC, V116, P3192, DOI 10.1021/ja00087a004; Doh J, 2004, J AM CHEM SOC, V126, P9170, DOI 10.1021/ja048261m; CAMERON JF, 1991, J AM CHEM SOC, V113, P4303, DOI 10.1021/ja00011a038; Brown AA, 2009, LANGMUIR, V25, P1744, DOI 10.1021/la8032308; Zhao H, 2012, MACROMOLECULES, V45, P1723, DOI 10.1021/ma201924h; Kasko AM, 2010, FUTURE MED CHEM, V2, P1669, DOI [10.4155/fmc.10.253, 10.4155/FMC.10.253]; Formina N., 2012, ADV DRUG DELIVERY RE, V64, P1005; Leonard Daniel L, 2002, J Esthet Restor Dent, V14, P286, DOI 10.1111/j.1708-8240.2002.tb00524.x; Seo JH, 2014, BEILSTEIN J ORG CHEM, V10, P2623, DOI 10.3762/bjoc.10.274; Yamashita A, 2006, NAT PROTOC, V1, P2861, DOI 10.1038/nprot.2006.438; Zhu CC, 2014, BIOMACROMOLECULES, V15, P3474, DOI 10.1021/bm500990z	30	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-1653			ACS MACRO LETT	ACS Macro Lett.	OCT	2015	4	10					1154	1157		10.1021/acsmacrolett.5b00619		4	Polymer Science	Polymer Science	CU2PI	WOS:000363365000020		
J	Inutsuka, M; Horinouchi, A; Tanaka, K				Inutsuka, Manabu; Horinouchi, Ayanobu; Tanaka, Keiji			Aggregation States of Polymers at Hydrophobic and Hydrophilic Solid Interfaces	ACS MACRO LETTERS			English	Article							SUM-FREQUENCY GENERATION; GLASS-TRANSITION TEMPERATURE; MOLECULAR-DYNAMICS SIMULATIONS; POLYSTYRENE THIN-FILMS; POLY(METHYL METHACRYLATE); VIBRATIONAL SPECTROSCOPY; PMMA SURFACE; MOBILITY; CHAINS; RELAXATION	Aggregation states of polystyrene (PS) and poly(methyl methacrylate) (PMMA) at hydrophobic deuterate-doctadecyltrichlorosilane (OTS-d) and hydrophilic SiOx interfaces are discussed, focusing on the interaction strength between polymer and substrate. Sum-frequency generation spectroscopy revealed that PS exhibited oriented phenyl groups along the normal direction at the interface in a spin-coated film because of the centrifugal force generated during the film solidification process, whereas it did not in a solvent-cast film. This result was common for both hydrophobic and hydrophilic substrates. That is, the aggregation states of PS depended little on which kind of substrate was used. This is because the interaction between PS and the surfaces is weak. In the case of a PMMA film on the hydrophobic OTS-d substrate, the interfacial local conformation was also dependent on the method of film preparation. PMMA at the hydrophilic SiOx interface, however, exhibited oriented ester methyl groups along the direction normal to the interface, regardless of the film preparation method. This is due to a stronger interaction via hydrogen bonding between carbonyl groups of PMMA and the substrate surface.	[Inutsuka, Manabu; Horinouchi, Ayanobu; Tanaka, Keiji] Kyushu Univ, Dept Appl Chem, Fukuoka 8190395, Japan; [Tanaka, Keiji] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Fukuoka 8190395, Japan	Tanaka, K (reprint author), Kyushu Univ, Dept Appl Chem, Fukuoka 8190395, Japan.	k-tanaka@cstf.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [25102535, 15H02183]; JST SENTANKEISOKU [13A0004]	We deeply thank Dr. Tomoyasu Hirai in Kyushu University for helping the preparation of OTS-d-modified prisms and substrates. This research was partly supported by Grant-in-Aids for the Scientific Research on Innovative Areas "New Polymeric Materials Based on Element-Blocks" (No. 25102535) program and for Scientific Research (A; No. 15H02183) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. We also thank the support from the JST SENTANKEISOKU (13A0004).	Ogata Y, 2013, ACS MACRO LETT, V2, P856, DOI 10.1021/mz400322q; de Gennes PG, 2000, EUR PHYS J E, V2, P201, DOI 10.1007/PL00013665; Tanaka K, 2009, J PHYS CHEM B, V113, P4571, DOI 10.1021/jp810370f; Calchera AR, 2012, ACS APPL MATER INTER, V4, P3493, DOI 10.1021/am300585a; Balazs AC, 2006, SCIENCE, V314, P1107, DOI 10.1126/science.1130557; Wang J, 2002, J AM CHEM SOC, V124, P7016, DOI 10.1021/ja012387r; Horinouchi A, 2012, MACROMOLECULES, V45, P4638, DOI 10.1021/ma3002559; WALLACE WE, 1995, PHYS REV E, V52, pR3329; Stafford CM, 2006, MACROMOLECULES, V39, P5095, DOI 10.1021/ma060790i; Zuo B, 2013, SOFT MATTER, V9, P9376, DOI 10.1039/c3sm51658j; Padding JT, 2002, J CHEM PHYS, V117, P925, DOI 10.1063/1.1481859; Gautam KS, 2000, PHYS REV LETT, V85, P3854, DOI 10.1103/PhysRevLett.85.3854; Forrest JA, 1996, PHYS REV LETT, V77, P2002, DOI 10.1103/PhysRevLett.77.2002; Chen Z, 2002, ANNU REV PHYS CHEM, V53, P437, DOI 10.1146/annurev.physchem.53.091801.115126; Schonherr H, 2003, MACROMOLECULES, V36, P1188, DOI 10.1021/ma020685i; O'Connell PA, 2005, SCIENCE, V307, P1760, DOI 10.1126/science.1105658; Frank B, 1996, MACROMOLECULES, V29, P6531, DOI 10.1021/ma960749n; Ouyang JY, 2004, NAT MATER, V3, P918, DOI 10.1038/nmat1269; Tsuruta H, 2012, MACROMOLECULES, V45, P4643, DOI 10.1021/ma3007202; REITER G, 1992, PHYS REV LETT, V68, P75, DOI 10.1103/PhysRevLett.68.75; SHEN YR, 1989, NATURE, V337, P519, DOI 10.1038/337519a0; Paeng K, 2011, J AM CHEM SOC, V133, P8444, DOI 10.1021/ja2022834; DeMaggio GB, 1997, PHYS REV LETT, V78, P1524, DOI 10.1103/PhysRevLett.78.1524; Briggman KA, 2001, J PHYS CHEM B, V105, P2785, DOI 10.1021/jp0037495; Li BL, 2015, ACS MACRO LETT, V4, P548, DOI 10.1021/acsmacrolett.5b00185; Fryer DS, 2001, MACROMOLECULES, V34, P5627, DOI 10.1021/ma001932q; Wang J, 2001, J PHYS CHEM B, V105, P12118, DOI 10.1021/jp013161d; Kim H, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.068302; Tanaka K, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2335593; Horinouchi A, 2013, RSC ADV, V3, P9446, DOI 10.1039/c3ra40631h; Horinouchi A, 2014, LANGMUIR, V30, P6565, DOI 10.1021/la500829p; Rao A, 2004, LANGMUIR, V20, P7183, DOI 10.1021/la049413u; Zhu H, 2014, LANGMUIR, V30, P11609, DOI 10.1021/la502333u; KEDDIE JL, 1994, EUROPHYS LETT, V27, P59, DOI 10.1209/0295-5075/27/1/011; Kim GM, 2001, POLYMER, V42, P1095, DOI 10.1016/S0032-3861(00)00468-7; Ellison CJ, 2003, NAT MATER, V2, P695, DOI 10.1038/nmat980; Fukao K, 2000, PHYS REV E, V61, P1743, DOI 10.1103/PhysRevE.61.1743; Miyazaki T, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.061803; Fujii Y, 2009, MACROMOLECULES, V42, P7418, DOI 10.1021/ma901851w; Jena KC, 2011, J PHYS CHEM C, V115, P15570, DOI 10.1021/jp205712c; BEAUCAGE G, 1993, J POLYM SCI POL PHYS, V31, P319, DOI 10.1002/polb.1993.090310310; Koga T, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.225901; Efremov MY, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.085703; Zhang LH, 2015, POLYMER, V65, P105, DOI 10.1016/j.polymer.2015.03.056; Grohens Y, 2002, EUR PHYS J E, V8, P217, DOI 10.1140/epje/i2001-10088-4; Tanaka K, 2003, LANGMUIR, V19, P6573, DOI 10.1021/la034542g; Tateishi Y, 2010, POLYM CHEM-UK, V1, P303, DOI 10.1039/b9py00227h; Curtis AD, 2013, VIB SPECTROSC, V68, P71, DOI 10.1016/j.vibspec.2013.05.011; Yang ZH, 2010, SCIENCE, V328, P1676, DOI 10.1126/science.1184394; Tanaka K, 2000, MACROMOLECULES, V33, P7588, DOI 10.1021/ma000406w; Kim JH, 2000, LANGMUIR, V16, P4064, DOI 10.1021/la991618t; Long D, 2001, EUR PHYS J E, V4, P371, DOI 10.1007/s101890170120; Fakhraai Z, 2008, SCIENCE, V319, P600, DOI 10.1126/science.1151205; Zax DB, 2000, J CHEM PHYS, V112, P2945, DOI 10.1063/1.480867; HIROSE C, 1992, J CHEM PHYS, V96, P997, DOI 10.1063/1.462120; Jean YC, 1997, PHYS REV B, V56, pR8459; Napolitano S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1259; Xu JQ, 2014, SOFT MATTER, V10, P8992, DOI 10.1039/c4sm01743a	58	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-1653			ACS MACRO LETT	ACS Macro Lett.	OCT	2015	4	10					1174	1178		10.1021/acsmacrolett.5b00592		5	Polymer Science	Polymer Science	CU2PI	WOS:000363365000024		
J	Nakanotani, H; Furukawa, T; Adachi, C				Nakanotani, Hajime; Furukawa, Taro; Adachi, Chihaya			Light Amplification in an Organic Solid-State Film with the Aid of Triplet-to-Singlet Upconversion	ADVANCED OPTICAL MATERIALS			English	Article							ACTIVATED DELAYED FLUORESCENCE; EMITTING-DIODES; DYE-LASERS; THIN-FILMS; EFFICIENCY; EMISSION; DEVICES; ELECTROLUMINESCENCE; POLYMERS	Organic laser dyes can be optically excited to achieve light amplification. The buildup of an excessive population of triplets is generally believed to limit the duration of the light amplification because of optical losses through excited-state absorption, so triplet excitons are usually eliminated by using a triplet quencher. However, destroying the triplets limits the electroluminescence efficiency of organic materials under electrical pumping and is counterproductive to realizing electrically pumped organic laser devices. Herein, light amplification is reported which constructively uses triplet states in an optically pumped organic film. In this system, the triplets are converted into singlets by reverse intersystem crossing in a "triplet harvester," and then the singlets are resonantly transferred to the singlet state of the laser dye. Since this approach permits the constructive use of triplets, not only gain-narrowed emission but also enhanced electroluminescence efficiency was observed, indicating that the threshold current density for lasing might be reduced.	[Nakanotani, Hajime; Furukawa, Taro; Adachi, Chihaya] Kyushu Univ, Ctr Organ Photon & Elect Res OPERA, Nishi Ku, Fukuoka 8190395, Japan; [Nakanotani, Hajime; Adachi, Chihaya] Kyushu Univ, Ctr Organ Photon & Elect Res OPERA, Adachi Mol Exciton Engn Project, JST,ERATO,Nishi Ku, Fukuoka 8190395, Japan; [Nakanotani, Hajime; Adachi, Chihaya] Kyushu Univ, Int Inst Carbon Neutral Energy Res CNER WPI I2, Nishi Ku, Fukuoka 8190395, Japan	Nakanotani, H (reprint author), Kyushu Univ, Ctr Organ Photon & Elect Res OPERA, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	nakanotani@cstf.kyushu-u.ac.jp; adachi@cstf.kyushu-u.ac.jp			Japan Science and Technology Agency (JST); ERATO; Adachi Molecular Exciton Engineering Project;  [26810110]	H.N. and T.F. contributed equally to this work. The authors would like to acknowledge Ms. Kei Morimoto for assistance with the sample preparation, Ms. Asuka Yoshizaki for discussions about the design of OLED architecture, Mr. Munetomo Inoue for the construction of the STA measurement system, and Mr. Kou Yoshida for helpful discussions about energy transfer processes. The authors also thank Dr. W.J. Potscavage, Jr., for his kind assistance with the preparation of this manuscript. This work was supported by the Japan Science and Technology Agency (JST), ERATO, Adachi Molecular Exciton Engineering Project, and Grant-in-Aid for Young Scientists B; Grant Numbers 26810110.	Adachi C., 2006, SPIE INT S OPT PHOT; Masui K, 2013, ORG ELECTRON, V14, P2721, DOI 10.1016/j.orgel.2013.07.010; Togashi K, 2012, J MATER CHEM, V22, P20689, DOI 10.1039/c2jm33669c; Hide F, 1996, SCIENCE, V273, P1833, DOI 10.1126/science.273.5283.1833; Baldo MA, 1999, PHYS REV B, V60, P14422, DOI 10.1103/PhysRevB.60.14422; Kasemann D, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.115208; Kozlov VG, 1997, NATURE, V389, P362, DOI 10.1038/38693; Frolov SV, 1997, PHYS REV LETT, V78, P729, DOI 10.1103/PhysRevLett.78.729; Uoyama H, 2012, NATURE, V492, P234, DOI 10.1038/nature11687; KARL N, 1972, PHYS STATUS SOLIDI A, V13, P651, DOI 10.1002/pssa.2210130237; Chen HF, 2009, J MATER CHEM, V19, P8112, DOI 10.1039/b913423a; MARLING JB, 1970, IEEE J QUANTUM ELECT, VQE 6, P570, DOI 10.1109/JQE.1970.1076525; Endo A, 2009, ADV MATER, V21, P4802, DOI 10.1002/adma.200900983; Baldo MA, 2000, NATURE, V403, P750; Berggren M, 1997, NATURE, V389, P466; Zhang YF, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.241301; Tessler N, 1996, NATURE, V382, P695, DOI 10.1038/382695a0; Smith LH, 2004, APPL PHYS LETT, V84, P2986, DOI 10.1063/1.1712036; Lehnhardt M, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.165206; Zhang QS, 2014, NAT PHOTONICS, V8, P326, DOI 10.1038/NPHOTON.2014.12; SOROKIN PP, 1966, IBM J RES DEV, V10, P162; HERMES RE, 1993, APPL PHYS LETT, V63, P877, DOI 10.1063/1.109887; Schols S, 2009, CHEMPHYSCHEM, V10, P1071, DOI 10.1002/cphc.200900054; Marling JB, 1970, APPL PHYS LETT, V17, P527, DOI 10.1063/1.1653296; SOFFER BH, 1967, APPL PHYS LETT, V10, P266, DOI 10.1063/1.1754804; Tanaka D, 2007, JPN J APPL PHYS 2, V46, pL10, DOI 10.1143/JJAP.46.L10; Nakanotani H, 2007, ADV FUNCT MATER, V17, P2328, DOI 10.1002/adfm.200700069; Lempicki A., 1970, APPL PHYS LETT, V16, P267; Matsushima T, 2007, JPN J APPL PHYS 2, V46, pL861, DOI 10.1143/JJAP.46.L861; Nakanotani H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5016; Schols S, 2011, DEVICE ARCHITECTURE AND MATERIALS FOR ORGANIC LIGHT-EMITTING DEVICES: TARGETING HIGH CURRENT DENSITIES AND CONTROL OF THE TRIPLET CONCENTRATION, P1, DOI 10.1007/978-94-007-1608-7	31	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	2195-1071			ADV OPT MATER	Adv. Opt. Mater.	OCT	2015	3	10					1381	1388		10.1002/adom.201500236		8	Materials Science, Multidisciplinary; Optics	Materials Science; Optics	CU1IG	WOS:000363273600011		
J	Miah, AG; Saima, U; Hamano, K; Schellander, K				Miah, A. G.; Saima, U.; Hamano, K.; Schellander, K.			Physiological roles of relaxin in prefertilizing activities of spermatozoa	ANIMAL REPRODUCTION SCIENCE			English	Review						Relaxin; Physiological roles; Prefertilizing activities; Spermatozoa	PROTEIN-TYROSINE PHOSPHORYLATION; MOUSE SPERM CAPACITATION; THAWED BOVINE SPERMATOZOA; RAT ATRIAL MYOCYTES; ACROSOME REACTION; IMMUNOREACTIVE RELAXIN; BOAR SPERMATOZOA; SEMINAL PLASMA; IN-VITRO; SIGNAL-TRANSDUCTION	Relaxin was first introduced in 1926 by Frederick Hisaw. Previously, it was considered only having a role in pregnancy of mammals due to its important roles in pregnancy and parturition. In the last decade, the physiological role of relaxin in male reproduction has received attention, and it has become clear that relaxin can no longer be considered strictly as only a hormone of female reproduction. The accessory glands (especially the prostate gland) of the male reproductive system are the source of seminal relaxin, which is secreted into the seminal plasma and saturates the spermatozoa at the time of ejaculation. Several studies have reported that relaxin has important roles in improving motility in human spermatozoa. Investigations into the role of relaxin in other physiological sperm phenomena such as capacitation, acrosome reaction, and their mediating factors associated with successful fertilization have intensified. This review aims to provide up-to-date information about the physiological roles of relaxin in sperm motility, capacitation, acrosome reaction, and their mediating factors. Some studies demonstrated that relaxin increased the total motility and progressive motility. Several studies showed that relaxin not only increased sperm motility but also increased the rate of sperm capacitation and acrosome reaction. Though few studies revealed that relaxin improved the sperm prefertilizing activities through increasing the utilization of glucose and mediating the cholesterol efflux, Ca2+-influx, intracellular CAMP and protein tyrosine phosphorylation. Thus, the review concludes that the supplementation of relaxin into capacitating medium may have a beneficial role in prefertilizing activities of fresh and cryopreserved spermatozoa. (C) 2015 Elsevier B.V. All rights reserved.	[Miah, A. G.; Saima, U.] Hajee Mohammad Danesh Sci & Technol Univ, Fac Vet & Anim Sci, Dinajpur 5200, Bangladesh; [Hamano, K.] Shinshu Univ, Fac Agr, Nagano 3994598, Japan; [Schellander, K.] Univ Bonn, Inst Anim Sci, D-53115 Bonn, Germany	Miah, AG (reprint author), Hajee Mohammad Danesh Sci & Technol Univ, Fac Vet & Anim Sci, Dept Genet & Anim Breeding, Dinajpur 5200, Bangladesh.	agmiah2009@gmail.com					Florman HM, 1998, BIOL REPROD, V59, P12, DOI 10.1095/biolreprod59.1.12; Bailey JL, 2000, J ANDROL, V21, P1; Visconti PE, 1999, J BIOL CHEM, V274, P3235, DOI 10.1074/jbc.274.5.3235; PARKS JE, 1992, THERIOGENOLOGY, V38, P209, DOI 10.1016/0093-691X(92)90231-F; Bathgate RAD, 2002, J BIOL CHEM, V277, P1148, DOI 10.1074/jbc.M107882200; Breitbart H, 1999, REV REPROD, V4, P151; Pommer AC, 2003, BIOL REPROD, V68, P1208, DOI 10.1095/biolreprod.102.011106; Barros C, 1996, CELL BIOL INT, V20, P33, DOI 10.1006/cbir.1996.0006; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; ROGERS BJ, 1979, BIOL REPROD, V21, P365, DOI 10.1095/biolreprod21.2.365; Ferlin A, 2012, J ANDROL, V33, P474, DOI 10.2164/jandrol.110.012625; KOHSAKA T, 1992, J REPROD FERTIL, V95, P397; Sidhu KS, 2004, REPRODUCTION, V127, P95, DOI 10.1530/rep.1.00073; Hisaw FL, 1926, P SOC EXP BIOL MED, V23, P661; VANDEVOORT CA, 1995, J ANDROL, V16, P327; PUSCH HH, 1987, ANDROLOGIA, V19, P514; Visconti PE, 1997, DEV BIOL, V192, P351, DOI 10.1006/dbio.1997.8768; Garde J, 2000, J REPROD FERTIL, V118, P57, DOI 10.1530/reprod/118.1.57; Miah AG, 2006, J REPROD DEVELOP, V52, P773, DOI 10.1262/jrd.18037; Familiari G, 2006, INT REV CYTOL, V249, P53, DOI 10.1016/S0074-7696(06)49002-1; Tsujii Hirotada, 2006, Reproductive Medicine and Biology, V5, P255, DOI 10.1111/j.1447-0578.2006.00150.x; DASGUPTA S, 1993, J REPROD FERTIL, V99, P135; CARRELL DT, 1995, ENDOCR RES, V21, P697; Breitbart H, 2002, MOL CELL ENDOCRINOL, V187, P139, DOI 10.1016/S0303-7207(01)00704-3; Samuel CS, 2003, LAB INVEST, V83, P1055, DOI 10.1097/01.LAB.0000079784.81186.B9; Pons-Rejraji H, 2009, REPROD FERT DEVELOP, V21, P525, DOI 10.1071/RD07170; Sherwood OD, 2004, ENDOCR REV, V25, P205, DOI 10.1210/er.2003-0013; Miah Abdul Gaffar, 2008, Reproductive Medicine and Biology, V7, P29, DOI 10.1111/j.1447-0578.2007.00198.x; Cardoso LC, 2010, REPRODUCTION, V139, P185, DOI 10.1530/REP-09-0146; FRASER LR, 1992, J REPROD FERTIL, V96, P363; HUDSON P, 1984, EMBO J, V3, P2333; FRASER LR, 1987, J REPROD FERTIL, V81, P77; Ivell R, 2002, TRENDS ENDOCRIN MET, V13, P343, DOI 10.1016/S1043-2760(02)00664-1; VANDUREN DBPJ, 1987, FERTIL STERIL, V47, P456; DUBOIS MP, 1978, CELL TISSUE RES, V187, P201; LEYTON L, 1989, CELL, V57, P1123, DOI 10.1016/0092-8674(89)90049-4; Cormier N, 1997, J ANDROL, V18, P461; JUANG HH, 1990, ANIM REPROD SCI, V22, P47, DOI 10.1016/0378-4320(90)90037-G; Watson PF, 2000, ANIM REPROD SCI, V60, P481, DOI 10.1016/S0378-4320(00)00099-3; Pukazhenthi BS, 1998, MOL REPROD DEV, V49, P48, DOI 10.1002/(SICI)1098-2795(199801)49:1<48::AID-MRD6>3.0.CO;2-O; Kadirvel G, 2009, ANIM REPROD SCI, V116, P244, DOI 10.1016/j.anireprosci.2009.02.003; SCHIEFERSTEIN G, 1989, INT J FERTIL, V34, P215; Visconti PE, 1998, BIOL REPROD, V59, P1, DOI 10.1095/biolreprod59.1.1; Mukai C, 2004, BIOL REPROD, V71, P540, DOI 10.1095/biolreprod.103.026054; Miah Abdul Gaffar, 2006, Reproductive Medicine and Biology, V5, P215, DOI 10.1111/j.1447-0578.2006.00144.x; Gianesello L, 2009, ANN NY ACAD SCI, V1160, P192, DOI 10.1111/j.1749-6632.2008.03789.x; ZHOU R, 1990, BIOCHEM BIOPH RES CO, V172, P47, DOI 10.1016/S0006-291X(05)80171-8; LESSING JB, 1985, FERTIL STERIL, V44, P406; DECOOMAN S, 1983, FERTIL STERIL, V39, P111; Tardif S, 2001, BIOL REPROD, V65, P784, DOI 10.1095/biolreprod65.3.784; Kohsaka T, 2003, INT J ANDROL, V26, P115, DOI 10.1046/j.1365-2605.2003.00409.x; CHASSIN D, 1995, GENOMICS, V29, P465; LEBOUC Y, 1986, FEBS LETT, V196, P108, DOI 10.1016/0014-5793(86)80223-X; LOUMAYE E, 1980, J CLIN ENDOCR METAB, V50, P1142; ADHAM IM, 1993, J BIOL CHEM, V268, P26668; Sasaki Y, 2001, INT J ANDROL, V24, P24, DOI 10.1046/j.1365-2605.2001.00259.x; Marin-Briggiler CI, 2003, FERTIL STERIL, V79, P1396, DOI 10.1016/S0015-0282(03)00267-X; Green CE, 2001, REPRODUCTION, V122, P889, DOI 10.1530/rep.0.1220889; Thomas AD, 2006, THERIOGENOLOGY, V65, P1531, DOI 10.1016/j.theriogenology.2005.08.022; Perez LJ, 1996, THERIOGENOLOGY, V45, P1037, DOI 10.1016/0093-691X(96)00031-3; CHAN SYW, 1984, IRCS MED SCI-BIOCHEM, V12, P879; Visconti PE, 2002, J REPROD IMMUNOL, V53, P133, DOI 10.1016/S0165-0378(01)00103-6; Leclerc P, 1996, BIOL REPROD, V55, P684, DOI 10.1095/biolreprod55.3.684; Osheroff JE, 1999, MOL HUM REPROD, V5, P1017, DOI 10.1093/molehr/5.11.1017; Visconti PE, 1999, BIOL REPROD, V61, P76, DOI 10.1095/biolreprod61.1.76; LESSING JB, 1986, J REPROD MED, V31, P304; Cross NL, 1998, BIOL REPROD, V59, P7, DOI 10.1095/biolreprod59.1.7; NAZ RK, 1991, J CELL SCI, V99, P157; Harrison RAP, 1996, MOL REPROD DEV, V45, P378; Miah AG, 2007, ANIM SCI J, V78, P495, DOI 10.1111/j.1740-0929.2007.00468.x; JUANG HH, 1989, ANIM REPROD SCI, V20, P21, DOI 10.1016/0378-4320(89)90110-3; Miah AG, 2011, ANIM REPROD SCI, V125, P30, DOI 10.1016/j.anireprosci.2011.03.010; Lok S, 2000, BIOL REPROD, V62, P1593, DOI 10.1095/biolreprod62.6.1593; Kulanand J, 2001, ANDROLOGIA, V33, P95, DOI 10.1046/j.1439-0272.2001.00410.x; Williams AC, 2001, J ANDROL, V22, P680; Gunnersen JM, 1996, MOL CELL ENDOCRINOL, V118, P85, DOI 10.1016/0303-7207(96)03770-7; Cerolini S, 2001, REPRODUCTION, V121, P395, DOI 10.1530/rep.0.1210395; BELL GI, 1984, NATURE, V310, P775, DOI 10.1038/310775a0; Kalab P, 1998, MOL REPROD DEV, V51, P304, DOI 10.1002/(SICI)1098-2795(199811)51:3<304::AID-MRD10>3.3.CO;2-#; FLORMAN HM, 1992, DEV BIOL, V152, P304, DOI 10.1016/0012-1606(92)90137-6; PURSEL VG, 1978, BIOL REPROD, V19, P69, DOI 10.1095/biolreprod19.1.69; PARK JM, 1988, AM J OBSTET GYNECOL, V158, P974; Aitken RJ, 1998, J CELL SCI, V111, P645; Conklin D, 1999, GENOMICS, V60, P50, DOI 10.1006/geno.1999.5899; CORONEL CE, 1987, BIOL REPROD, V37, P1097, DOI 10.1095/biolreprod37.5.1097; DARINBEN.A, 1973, AUST J BIOL SCI, V26, P1409; de Lamirande E, 1997, Rev Reprod, V2, P48, DOI 10.1530/ror.0.0020048; Filonzi M, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-29; Fuchs U., 1988, ANDROLOGIA, V21, P297; Fuchs U, 1993, Zentralbl Gynakol, V115, P117; Gagnon C., 1990, CONTROLS SPERM MOTIL; Han Young-Joon, 2006, J Reprod Dev, V52, P657, DOI 10.1262/jrd.18038; Hsu Y.H., 2002, SCIENCE, V295, P671; Hudson P., 1983, NATURE, V301; Kohsaka Tetsuya, 2001, Journal of Reproduction and Development, V47, P197, DOI 10.1262/jrd.47.197; Kohsaka T., 1988, 11 INT C AN REPR ART; Martinez P, 1996, FRONT BIOSCI, V1, P103; MEERA P, 1995, AM J PHYSIOL-CELL PH, V269, pC312; Naz R. K, 1996, FRONT BIOSCI, V1, P206; Naz Rajesh K, 2004, Reprod Biol Endocrinol, V2, P75, DOI 10.1186/1477-7827-2-75; Piedras-Renteria ES, 1997, AM J PHYSIOL-HEART C, V272, pH1798; Piedras-Renteria ES, 1997, AM J PHYSIOL-HEART C, V272, pH1791; Sherwood O. David, 1994, P861; Steinetz B.G., 1959, RECENT PROGR ENDOCRI, P389	104	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-4320	1873-2232		ANIM REPROD SCI	Anim. Reprod. Sci.	OCT	2015	161						1	15		10.1016/j.anireprosci.2015.07.013		15	Agriculture, Dairy & Animal Science; Reproductive Biology	Agriculture; Reproductive Biology	CU2JW	WOS:000363350800001		
J	Faruque, OM; Miwa, H; Yasuda, M; Fujii, Y; Kaneko, T; Sato, S; Okazaki, S				Faruque, Omar M.; Miwa, Hiroki; Yasuda, Michiko; Fujii, Yoshiharu; Kaneko, Takakazu; Sato, Shusei; Okazaki, Shin			Identification of Bradyrhizobium elkanii Genes Involved in Incompatibility with Soybean Plants Carrying the Rj4 Allele	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							III SECRETION SYSTEM; SINORHIZOBIUM-FREDII USDA257; CULTIVAR-SPECIFIC NODULATION; FUNCTIONAL-ANALYSIS; RHIZOBIUM-MELILOTI; HOST-SPECIFICITY; RECEPTOR KINASE; JAPONICUM; PROTEINS; BACTERIA	Symbioses between leguminous plants and soil bacteria known as rhizobia are of great importance to agricultural production and nitrogen cycling. While these mutualistic symbioses can involve a wide range of rhizobia, some legumes exhibit incompatibility with specific strains, resulting in ineffective nodulation. The formation of nodules in soybean plants (Glycine max) is controlled by several host genes, which are referred to as Rj genes. The soybean cultivar BARC2 carries the Rj4 gene, which restricts nodulation by specific strains, including Bradyrhizobium elkanii USDA61. Here we employed transposon mutagenesis to identify the genetic locus in USDA61 that determines incompatibility with soybean varieties carrying the Rj4 allele. Introduction of the Tn5 transposon into USDA61 resulted in the formation of nitrogen fixation nodules on the roots of soybean cultivar BARC2 (Rj4 Rj4). Sequencing analysis of the sequence flanking the Tn5 insertion revealed that six genes encoding a putative histidine kinase, transcriptional regulator, DNA-binding transcriptional activator, helix-turn-helix-type transcriptional regulator, phage shock protein, and cysteine protease were disrupted. The cysteine protease mutant had a high degree of similarity with the type 3 effector protein XopD of Xanthomonas campestris. Our findings shed light on the diverse and complicated mechanisms that underlie these highly host-specific interactions and indicate the involvement of a type 3 effector in Rj4 nodulation restriction, suggesting that Rj4 incompatibility is partly mediated by effector-triggered immunity.	[Faruque, Omar M.; Miwa, Hiroki; Yasuda, Michiko; Fujii, Yoshiharu; Okazaki, Shin] Tokyo Univ Agr & Technol, Grad Sch Agr, Tokyo, Japan; [Kaneko, Takakazu] Kyoto Sangyo Univ, Fac Life Sci, Kyoto 603, Japan; [Sato, Shusei] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 980, Japan	Okazaki, S (reprint author), Tokyo Univ Agr & Technol, Grad Sch Agr, Tokyo, Japan.	sokazaki@cc.tuat.ac.jp			 [25450082]	This work was supported in part by a grant-in-aid (number 25450082) to S.O.	Freiberg C, 1997, NATURE, V387, P394, DOI 10.1038/387394a0; RUMJANEK NG, 1993, APPL ENVIRON MICROB, V59, P4371; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; STACEY G, 1995, FEMS MICROBIOL LETT, V127, P1; SADOWSKY MJ, 1992, APPL ENVIRON MICROB, V58, P720; MEINHARDT LW, 1993, MOL MICROBIOL, V9, P17, DOI 10.1111/j.1365-2958.1993.tb01665.x; Zhukov V, 2008, MOL PLANT MICROBE IN, V21, P1600, DOI 10.1094/MPMI-21-12-1600; Stauffer LT, 2005, FEMS MICROBIOL LETT, V242, P333, DOI 10.1016/j.femsle.2004.11.027; Indrasumunar A, 2010, PLANT CELL PHYSIOL, V51, P201, DOI 10.1093/pcp/pcp178; SADOWSKY MJ, 1987, APPL ENVIRON MICROB, V53, P2624; HERRERO M, 1990, J BACTERIOL, V172, P6557; Nishimura R, 2002, NATURE, V420, P426, DOI 10.1038/nature01231; Tsurumaru H, 2008, SOIL SCI PLANT NUTR, V54, P197, DOI 10.1111/j.1747-0765.2007.00225.x; Kim JG, 2011, MOL PLANT PATHOL, V12, P715, DOI [10.1111/j.1364-3703.2011.00706.x, 10.1111/J.1364-3703.2011.00706.X]; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Jones KM, 2008, P NATL ACAD SCI USA, V105, P704, DOI 10.1073/pnas.0709338105; Devine TE, 1996, PLANT SOIL, V186, P173, DOI 10.1007/BF00035072; DEVINE TE, 1993, PLANT SOIL, V149, P205, DOI 10.1007/BF00016610; Dixon R, 2004, NAT REV MICROBIOL, V2, P621, DOI 10.1038/nrmicro954; ROSSBACH S, 1991, MOL MICROBIOL, V5, P39, DOI 10.1111/j.1365-2958.1991.tb01824.x; Okazaki S, 2010, MOL PLANT MICROBE IN, V23, P223, DOI 10.1094/MPMI-23-2-0223; Radutoiu S, 2007, EMBO J, V26, P3923, DOI 10.1038/sj.emboj.7601826; DAVID M, 1988, CELL, V54, P671, DOI 10.1016/S0092-8674(88)80012-6; Okazaki S, 2009, FEMS MICROBIOL LETT, V295, P88, DOI 10.1111/j.1574-6968.2009.01593.x; Lorio JC, 2010, APPL ENVIRON MICROB, V76, P4185, DOI 10.1128/AEM.00437-10; Deakin WJ, 2009, NAT REV MICROBIOL, V7, P312, DOI 10.1038/nrmicro2091; LEROUGE P, 1990, NATURE, V344, P781, DOI 10.1038/344781a0; Krishnan HB, 2003, MOL PLANT MICROBE IN, V16, P617, DOI 10.1094/MPMI.2003.16.7.617; Loh J, 2003, APPL ENVIRON MICROB, V69, P10, DOI 10.1128/AEM.69.1.10-17.2003; GOTTFERT M, 1992, MOL PLANT MICROBE IN, V5, P257, DOI 10.1094/MPMI-5-257; Indrasumunar A, 2011, PLANT J, V65, P39, DOI 10.1111/j.1365-313X.2010.04398.x; Tsukui T, 2013, APPL ENVIRON MICROB, V79, P1048, DOI 10.1128/AEM.03297-12; Soto MJ, 2009, CELL MICROBIOL, V11, P381, DOI [10.1111/j.1462-5822.2008.01282.x, 10.1111/j.1462-5822.2009.01282.x]; GROB P, 1994, FEMS MICROBIOL LETT, V120, P349, DOI 10.1016/0378-1097(94)90495-2; Cullimore JV, 2001, TRENDS PLANT SCI, V6, P24, DOI 10.1016/S1360-1385(00)01810-0; Tan CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117067; Yang SM, 2010, P NATL ACAD SCI USA, V107, P18735, DOI 10.1073/pnas.1011957107; Viprey V, 1998, MOL MICROBIOL, V28, P1381, DOI 10.1046/j.1365-2958.1998.00920.x; D'Haeze W, 2004, TRENDS MICROBIOL, V12, P555, DOI 10.1016/j.tim.2004.10.009; Kwon YM, 2000, J MICROBIOL METH, V41, P195, DOI 10.1016/S0167-7012(00)00159-7; Limpens E, 2003, SCIENCE, V302, P630, DOI 10.1126/science.1090074; GOTTFERT M, 1989, MOL GEN GENET, V215, P407, DOI 10.1007/BF00427037; de Lyra MDCP, 2006, INT MICROBIOL, V9, P125; TRESE AT, 1995, EUPHYTICA, V81, P279, DOI 10.1007/BF00025618; CALDWELL BE, 1966, CROP SCI, V6, P427; Liu JJ, 2010, PLANT CELL REP, V29, P419, DOI 10.1007/s00299-010-0826-8; Bellato C, 1997, MICROBIOL-UK, V143, P1381; BROUGHTO.WJ, 1971, BIOCHEM J, V125, P1075; Hayashi M, 2011, BREEDING SCI, V61, P544, DOI 10.1270/jsbbs.61.544; Krause A, 2002, MOL PLANT MICROBE IN, V15, P1228, DOI 10.1094/MPMI.2002.15.12.1228; Sambrook J., 2012, MOL CLONING LAB MANU; Searle IR, 2003, SCIENCE, V299, P109, DOI 10.1126/science.1077937; Simon R, 1983, NAT BIOTECHNOL, V1, P784, DOI DOI 10.1038/NBT1183-784	53	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	OCT	2015	81	19					6710	6717		10.1128/AEM.01942-15		8	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CU3XO	WOS:000363459800019		
J	Ono, HK; Sato'o, Y; Narita, K; Naito, I; Hirose, S; Hisatsune, J; Asano, K; Hu, DL; Omoe, K; Sugai, M; Nakane, A				Ono, Hisaya K.; Sato'o, Yusuke; Narita, Kouji; Naito, Ikunori; Hirose, Shouhei; Hisatsune, Junzo; Asano, Krisana; Hu, Dong-Liang; Omoe, Katsuhiko; Sugai, Motoyuki; Nakane, Akio			Identification and Characterization of a Novel Staphylococcal Emetic Toxin	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							ENTEROTOXIN GENE; SHOCK-SYNDROME; AUREUS; SUPERANTIGENS; RESISTANT; INFECTION; PROTEIN; CLUSTER; GENOME	Staphylococcal enterotoxins (SEs) produced by Staphylococcus aureus have superantigenic and emetic activities, which cause toxic shock syndrome and staphylococcal food poisoning, respectively. Our previous study demonstrated that the sequence of SET has a low level of similarity to the sequences of other SEs and exhibits atypical bioactivities. Hence, we further explored whether there is an additional SET-related gene in S. aureus strains. One SET-like gene was found in the genome of S. aureus isolates that originated from a case of food poisoning, a human nasal swab, and a case of bovine mastitis. The deduced amino acid sequence of the SET-like gene showed 32% identity with the amino acid sequence of SET. The SET-like gene product was designated SElY. In the food poisoning and nasal swab isolates, mRNA encoding SElY was highly expressed in the early log phase of cultivation, whereas a high level of expression of this mRNA was found in the bovine mastitis isolate at the early stationary phase. To estimate whether SElY has both superantigenic and emetic activities, recombinant SElY was prepared. Cell proliferation and cytokine production were examined to assess the superantigenic activity of SElY. SElY exhibited superantigenic activity in human peripheral blood mononuclear cells but not in mouse splenocytes. In addition, SElY exhibited emetic activity in house musk shrews after intraperitoneal and oral administration. However, the stability of SElY against heating and pepsin and trypsin digestion was different from that of SET and SEA. From these results, we identified SElY to be a novel staphylococcal emetic toxin.	[Ono, Hisaya K.; Narita, Kouji; Hirose, Shouhei; Asano, Krisana; Nakane, Akio] Hirosaki Univ, Grad Sch Med, Dept Microbiol & Immunol, Hirosaki, Aomori, Japan; [Sato'o, Yusuke; Hisatsune, Junzo; Sugai, Motoyuki] Hiroshima Univ, Dept Bacteriol, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan; [Naito, Ikunori; Omoe, Katsuhiko] Gifu Univ, Doctoral Course, United Grad Sch Vet Sci, Gifu, Japan; [Naito, Ikunori; Omoe, Katsuhiko] Iwate Univ, Fac Agr, Dept Vet Med, Morioka, Iwate 020, Japan; [Hu, Dong-Liang] Kitasato Univ, Sch Vet Med, Lab Zoonoses, Towada, Aomori, Japan	Nakane, A (reprint author), Hirosaki Univ, Grad Sch Med, Dept Microbiol & Immunol, Hirosaki, Aomori, Japan.	a27k03n0@hirosaki-u.ac.jp			JSPS KAKENHI [20580338, 23390100]; Sasakawa scientific research grant from The Japan Science Society	This study was supported in part by JSPS KAKENHI grant numbers 20580338 (to K.O.) and 23390100 (to A.N.) and a Sasakawa scientific research grant from The Japan Science Society.	Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16; Li SJ, 2011, J APPL MICROBIOL, V110, P729, DOI 10.1111/j.1365-2672.2010.04927.x; Williams RJ, 2000, INFECT IMMUN, V68, P4407, DOI 10.1128/IAI.68.8.4407-4415.2000; Sato'o Y, 2013, MICROBIOL IMMUNOL, V57, P91, DOI 10.1111/1348-0421.12007; Thomas DY, 2006, INFECT IMMUN, V74, P4724, DOI 10.1128/IAI.00132-06; Ono HK, 2012, FEMS IMMUNOL MED MIC, V64, P392, DOI 10.1111/j.1574-695X.2011.00924.x; BETLEY MJ, 1985, SCIENCE, V229, P185, DOI 10.1126/science.3160112; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Jarraud S, 2001, J IMMUNOL, V166, P669; Lina G, 2004, J INFECT DIS, V189, P2334, DOI 10.1086/420852; Joost I, 2009, J INFECT DIS, V199, P1471, DOI 10.1086/598484; Duquenne M, 2010, APPL ENVIRON MICROB, V76, P1367, DOI 10.1128/AEM.01736-09; Chi YI, 2002, J BIOL CHEM, V277, P22839, DOI 10.1074/jbc.M201932200; Ono HK, 2008, INFECT IMMUN, V76, P4999, DOI 10.1128/IAI.00045-08; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; NAKANE A, 1992, INFECT IMMUN, V60, P523; Omoe K, 2003, INFECT IMMUN, V71, P6088, DOI 10.1128/IAI.71.10.6088-6094.2003; Munson SH, 1998, INFECT IMMUN, V66, P3337; McCormick JK, 2001, ANNU REV MICROBIOL, V55, P77, DOI 10.1146/annurev.micro.55.1.77; UCHIYAMA T, 1993, J IMMUNOL, V151, P4407; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; HOVDE CJ, 1994, MOL MICROBIOL, V13, P897, DOI 10.1111/j.1365-2958.1994.tb00481.x; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; SU YC, 1995, APPL ENVIRON MICROB, V61, P1438; Hu DL, 2003, INFECT IMMUN, V71, P567, DOI 10.1128/IAI.71.1.567-570.2003; Wilson GJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002271	26	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	OCT	2015	81	20					7034	7040		10.1128/AEM.01873-15		7	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CU3YC	WOS:000363461300010		
J	Ogawa, T				Ogawa, Tomoko			Goldilocks mastectomy for obese Japanese females with breast ptosis	ASIAN JOURNAL OF SURGERY			English	Article						breast cancer; breast reconstruction; subcutaneous mastectomy	SHAPED INCISION	The Goldilocks mastectomy is a method that uses redundant mastectomy flap tissue breast cancer; sue alone to create a breast mound in female American patients with macromastia. Goldilocks breast mastectomy was performed for obese Japanese females with breast ptosis, and its indications reconstruction; were considered for Japanese female patients. This report presents the results of five patients subcutaneous who underwent Goldilocks mastectomy, including one with bilateral breast cancer. The mastectomy average age of the patients was 72 years (range: 67-76 years). The body mass index (BMI) was more than 25 in all the cases. Four patients had invasive ductal carcinoma, and one patient had noninvasive ductal carcinoma of bilateral breasts. The cosmetic results were found to be good in two cases [a patient with bilateral breast cancer and a severely obese patient (BMI = 39)]. The cosmetic results in the other three cases were poor. Although the reconstructed breast size was small, this procedure resulted in better cosmetic results than what would be achieved with the usual method of mastectomy for Japanese patients with bilateral breast cancer and severely obese Japanese patients. Copyright (C) 2013, Asian Surgical Association. Published by Elsevier Taiwan LLC. All rights reserved.	Mie Univ, Dept Breast Surg, Grad Sch Med, Tsu, Mie 5148507, Japan	Ogawa, T (reprint author), Mie Univ, Dept Breast Surg, Grad Sch Med, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	mokomoko@clin.medic.mie-u.ac.jp					Richardson H, 2012, INT J SURG, V10, P522, DOI 10.1016/j.ijsu.2012.08.003; Mirza M, 2003, ANN ROY COLL SURG, V85, P131, DOI 10.1308/003588403321219984; Szynglarewicz B, 2009, INT J GYNECOL CANCER, V19, P1454, DOI 10.1111/IGC.0b013e3181b692e0; NOWACKI MP, 1988, SURG GYNECOL OBSTET, V167, P251; Macmillan RD, 2009, BREAST SURG COMPANIO, P67	5	1	1	ELSEVIER SINGAPORE PTE LTD	SINGAPORE	3 KILLINEY ROAD 08-01, WINSLAND HOUSE 1, SINGAPORE, 239519, SINGAPORE	1015-9584	0219-3108		ASIAN J SURG	Asian J. Surg.	OCT	2015	38	4					232	235		10.1016/j.asjsur.2013.07.003		4	Surgery	Surgery	CU2NS	WOS:000363360800010		
J	Maki, T; Hara, K; Kobayashi, F; Kurosaki, Y; Kakikawa, M; Matsuki, A; Chen, B; Shi, GY; Hasegawa, H; Iwasaka, Y				Maki, Teruya; Hara, Kazutaka; Kobayashi, Fumihisa; Kurosaki, Yasunori; Kakikawa, Makiko; Matsuki, Atsushi; Chen, Bin; Shi, Guangyu; Hasegawa, Hiroshi; Iwasaka, Yasunobu			Vertical distribution of airborne bacterial communities in an Asian-dust downwind area, Noto Peninsula	ATMOSPHERIC ENVIRONMENT			English	Article						Airborne bacteria; Asian dust; Bioaerosol; Free troposphere; Phylogenetic analysis	HIGH-ELEVATION SITE; CLOUD-WATER; PHYLOGENETIC DIVERSITY; BIOLOGICAL PARTICLES; DOME FRANCE; EAST SEA; ICE; MICROORGANISMS; ATMOSPHERE; JAPAN	Bacterial populations transported from ground environments to the atmosphere get dispersed throughout downwind areas and can influence ecosystem dynamics, human health, and climate change. However, the vertical bacterial distribution in the free troposphere was rarely investigated in detail. We collected aerosols at altitudes of 3000 m, 1000 m, and 10 m over the Noto Peninsula, Japan, where the westerly winds carry aerosols from continental and marine areas. During the sampling period on March 10, 2012, the air mass at 3000 m was transported from the Chinese desert region by the westerly winds, and a boundary layer was formed below 2000 m. Pyrosequencing targeting 16S rRNA genes (16S rDNA) revealed that the bacterial community at 3000 m was predominantly composed of terrestrial bacteria, such as Bacillus and Actinobacterium species. In contrast, those at 1000 m and 10 m included marine bacteria belonging to the classes Cyanobacteria and Alphaproteobacteria. The entire 16S rDNA sequences in the clone libraries were identical to those of the terrestrial and marine bacterial species, which originated from the Chinese desert region and the Sea of Japan, respectively. The origins of air masses and meteorological conditions contribute to vertical variations in the bacterial communities in downwind atmosphere. (C) 2015 Elsevier Ltd. All rights reserved.	[Maki, Teruya; Kobayashi, Fumihisa; Hasegawa, Hiroshi] Kanazawa Univ, Coll Sci & Engn, Kanazawa, Ishikawa 9201192, Japan; [Hara, Kazutaka; Kurosaki, Yasunori] Tottori Univ, Arid Land Res Ctr, Tottori 6800001, Japan; [Kakikawa, Makiko; Matsuki, Atsushi] Kanazawa Univ, Inst Nat & Environm Technol, Kanazawa, Ishikawa 9201192, Japan; [Chen, Bin; Shi, Guangyu] Chinese Acad Sci, Inst Atmospher Phys, Beijing 100029, Peoples R China; [Iwasaka, Yasunobu] Univ Shiga Prefecture, Community Res Serv Grp, Hikoneshi, Shiga 5228533, Japan	Maki, T (reprint author), Kanazawa Univ, Coll Sci & Engn, Kanazawa, Ishikawa 9201192, Japan.	makiteru@se.kanazawa-u.ac.jp			Encouragement of Young Scientists from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [26304003, 26340049]; Mitsui & Co., Ltd. Environment Fund [R11-G4-1076]; Strategic International Collaborative Research Program (SICORP) [7201006051]; National Natural Science Foundation of China [41475136]; International Science & Technology Cooperation Program of China [2013DFG22820]	Trajectories were produced by the NOAA Air Resources Laboratory (ARL) and provided for the HYSPLIT transport and dispersion model and/or READY website (http://www.ready.noaa.gov). Members of Hokkaido System Science Co., Ltd. and Fasmac Co., Ltd. helped with the pyrosequencing analyses. This research was supported by a Grant-in-Aid for the Encouragement of Young Scientists (26304003, 26340049) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The Mitsui & Co., Ltd. Environment Fund (R11-G4-1076) also supported this work, as did the Strategic International Collaborative Research Program (SICORP: 7201006051), the National Natural Science Foundation of China (41475136) and International Science & Technology Cooperation Program of China (2013DFG22820).	Bowers RM, 2011, ISME J, V5, P601, DOI 10.1038/ismej.2010.167; An S, 2013, MICROB ECOL, V66, P850, DOI 10.1007/s00248-013-0276-2; Morris CE, 2008, ISME J, V2, P321, DOI 10.1038/ismej.2007.113; Vaitilingom M, 2012, ATMOS ENVIRON, V56, P88, DOI 10.1016/j.atmosenv.2012.03.072; Hua NP, 2007, AEROBIOLOGIA, V23, P291, DOI 10.1007/s10453-007-9076-9; Maidak BL, 1997, NUCLEIC ACIDS RES, V25, P109, DOI 10.1093/nar/25.1.109; Gorbushina AA, 2007, ENVIRON MICROBIOL, V9, P2911, DOI 10.1111/j.1462-2920.2007.01461.x; Hara K, 2012, ATMOS ENVIRON, V47, P20, DOI 10.1016/j.atmosenv.2011.11.050; Ulrich A, 2008, MICROB ECOL, V55, P512, DOI 10.1007/s00248-007-9296-0; Choi DH, 2009, FEMS MICROBIOL ECOL, V69, P439, DOI 10.1111/j.1574-6941.2009.00729.x; Brinkmeyer R, 2003, APPL ENVIRON MICROB, V69, P6610, DOI 10.1128/AEM.69.11.6610-6619.2003; RUSSELL WC, 1975, NATURE, V253, P461, DOI 10.1038/253461a0; Sattler B, 2001, GEOPHYS RES LETT, V28, P239, DOI 10.1029/2000GL011684; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; Polymenakou PN, 2008, ENVIRON HEALTH PERSP, V116, P292, DOI 10.1289/ehp.10684; Pratt KA, 2009, NAT GEOSCI, V2, P397, DOI 10.1038/NGEO521; Maki T, 2010, SCI TOTAL ENVIRON, V408, P4556, DOI 10.1016/j.scitotenv.2010.04.002; COLWELL RK, 1994, PHILOS T ROY SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Fahlgren C, 2010, APPL ENVIRON MICROB, V76, P3015, DOI 10.1128/AEM.02092-09; Temkiv TS, 2012, FEMS MICROBIOL ECOL, V81, P684, DOI 10.1111/j.1574-6941.2012.01402.x; Ichinose T, 2005, ENVIRON TOXICOL PHAR, V20, P48, DOI 10.1016/j.etap.2004.10.009; Asker D, 2008, SYST APPL MICROBIOL, V31, P43, DOI 10.1016/j.syapm.2007.10.002; Griffin DW, 2007, CLIN MICROBIOL REV, V20, P459, DOI 10.1128/CMR.00039-06; Woo AC, 2013, ATMOS ENVIRON, V74, P291, DOI 10.1016/j.atmosenv.2013.03.047; Vaitilingom M, 2013, P NATL ACAD SCI USA, V110, P559, DOI 10.1073/pnas.1205743110; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Bowers RM, 2012, ATMOS ENVIRON, V50, P41, DOI 10.1016/j.atmosenv.2012.01.005; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; Smith DJ, 2013, APPL ENVIRON MICROB, V79, P1134, DOI 10.1128/AEM.03029-12; Womack AM, 2010, PHILOS T R SOC B, V365, P3645, DOI 10.1098/rstb.2010.0283; ZHAO DW, 1988, ATMOS ENVIRON, V22, P349, DOI 10.1016/0004-6981(88)90040-6; Maki T, 2008, AIR QUAL ATMOS HLTH, V1, P81, DOI 10.1007/s11869-008-0016-9; Kourtev PS, 2011, ATMOS ENVIRON, V45, P5399, DOI 10.1016/j.atmosenv.2011.06.041; Cao SJ, 2010, INT J SYST EVOL MICR, V60, P2023, DOI 10.1099/ijs.0.017681-0; Mohler O, 2007, BIOGEOSCIENCES, V4, P1059; Bottos EM, 2014, MICROB ECOL, V67, P120, DOI 10.1007/s00248-013-0296-y; Amato P, 2007, ATMOS ENVIRON, V41, P8253, DOI 10.1016/j.atmosenv.2007.06.022; Latifi A, 2009, FEMS MICROBIOL REV, V33, P258, DOI 10.1111/j.1574-6976.2008.00134.x; Delort AM, 2010, ATMOS RES, V98, P249, DOI 10.1016/j.atmosres.2010.07.004; Maki T, 2013, ATMOS ENVIRON, V74, P73, DOI 10.1016/j.atmosenv.2013.03.029; Mostajir B, 1995, AQUAT MICROB ECOL, V9, P259, DOI 10.3354/ame009259; Brown JKM, 2002, SCIENCE, V297, P537, DOI 10.1126/science.1072678; Joly M, 2013, ATMOS ENVIRON, V70, P392, DOI 10.1016/j.atmosenv.2013.01.027; DeLeon-Rodriguez N, 2013, P NATL ACAD SCI USA, V110, P2575, DOI 10.1073/pnas.1212089110; Jaenicke R, 2005, SCIENCE, V308, P73, DOI 10.1126/science.1106335; Song J, 2009, FEMS MICROBIOL LETT, V295, P141, DOI 10.1111/j.1574-6968.2009.01623.x; Jeon EM, 2011, ATMOS ENVIRON, V45, P4313, DOI 10.1016/j.atmosenv.2010.11.054; Bowers RM, 2009, APPL ENVIRON MICROB, V75, P5121, DOI 10.1128/AEM.00447-09; Yi H, 2005, INT J SYST EVOL MICR, V55, P409, DOI 10.1099/ijs.0.63273-0; Bauermeister A, 2011, MICROB ECOL, V61, P715, DOI 10.1007/s00248-010-9785-4; Griffin Dale W., 2003, Aerobiologia, V19, P143, DOI 10.1023/B:AERO.0000006530.32845.8d; Iwasaka Y, 2009, AIR QUAL ATMOS HLTH, V2, P29, DOI 10.1007/s11869-009-0031-5; Iwasaka Y., 1988, TELLUS, V40B, P494, DOI DOI 10.1111/11600-0889.198811300119.X; Kellogg Christina A., 2004, Aerobiologia, V20, P99, DOI 10.1023/B:AERO.0000032947.88335.bb; Kobayashi F., 2015, AIR QUAL AT IN PRESS; Liu B, 2014, CLIN IMMUNOL, V10, P10; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Maki T, 2014, SCI TOTAL ENVIRON, V488, P75, DOI 10.1016/j.scitotenv.2014.04.044; Rodo X, 2011, SCI REP-UK, V1, DOI 10.1038/srep00152; Roling W.F.M., 2005, ADV METHODS, P25; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Tanaka D., 2011, Bulletin of Glaciological Research, V29, P31, DOI 10.5331/bgr.29.31; Wu XiaoDan, 2011, Acta Agriculturae Zhejiangensis, V23, P409; Yamaguchi N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00525	64	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1352-2310	1873-2844		ATMOS ENVIRON	Atmos. Environ.	OCT	2015	119						282	293		10.1016/j.atmosenv.2015.08.052		12	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	CT8PJ	WOS:000363078200027		
J	Garzon, JP; Huertas, JI; Magana, M; Huertas, ME; Cardenas, B; Watanabe, T; Maeda, T; Wakamatsu, S; Blanco, S				Garzon, Jessica P.; Huertas, Jose I.; Magana, Miguel; Huertas, Maria E.; Cardenas, Beatriz; Watanabe, Takuro; Maeda, Tsuneaki; Wakamatsu, Shinji; Blanco, Salvador			Volatile organic compounds in the atmosphere of Mexico City	ATMOSPHERIC ENVIRONMENT			English	Article						Volatile organic compound; Toxic volatile organic compound; Ozone; Ozone formation potential	ON-ROAD MEASUREMENTS; SOURCE APPORTIONMENT; METROPOLITAN-AREA; AIR-QUALITY; EMISSION SOURCES; OZONE FORMATION; VEHICLE EMISSIONS; FLUX MEASUREMENTS; SOUTHERN TAIWAN; FIELD CAMPAIGN	The Mexico City Metropolitan Area (MCMA) is one of the most polluted megacities in North America. Therefore, it is an excellent benchmark city to understand atmospheric chemistry and to implement pilot countermeasures. Air quality in the MCMA is not within acceptable levels, mainly due to high ground levels of ozone (O-3). Tropospheric O-3 is a secondary pollutant formed from the oxidation of volatile organic compounds (VOCs) in the presence of nitrogen oxides and sunlight. To gain a better understanding of O-3 formation in megacities, evaluate the effectiveness of already-implemented countermeasures, and identify new cost-effective alternatives to reduce tropospheric O-3 concentrations, researchers and environmental authorities require updated concentrations for a broader range of VOCs. Moreover, in an effort to protect human health and the environment, it is important to understand which VOCs exceed reference safe values or most contribute to O-3 formation, as well as to identify the most probable emission sources of those VOCs. In this work, 64 VOCs, including 36 toxic VOCs, were measured at four sites in the MCMA during 2011-2012. VOCs related to liquefied petroleum gas leakages exhibited the highest concentrations. Toxic VOCs with the highest average concentrations were acetone and ethanol. The toxic VOC benzene represented the highest risk to Mexican citizens, and toluene contributed the most to O-3 formation. Correlation analysis indicated that the measured VOCs come from vehicular emissions and solvent-related industrial sources. (C) 2015 Elsevier Ltd. All rights reserved.	[Garzon, Jessica P.; Huertas, Jose I.] Tecnol Monterrey, Toluca, Mexico; [Magana, Miguel; Blanco, Salvador] Natl Inst Ecol & Climate Change, Mexico City, DF, Mexico; [Watanabe, Takuro; Maeda, Tsuneaki] Natl Inst Adv Ind Sci & Technol, Tsukuba, Japan; [Wakamatsu, Shinji] Ehime Univ, Matsuyama, Ehime, Japan; [Huertas, Maria E.] Univ Tecnol Bolivar, Cartagena, Colombia	Huertas, JI (reprint author), Tecnol Monterrey, Toluca, Mexico.	jhuertas@itesm.mx	Huertas Cardozo, Jose/K-6256-2014	Huertas Cardozo, Jose/0000-0003-4508-6453	Japan Science and Technology Agency (JST); Japan International Cooperation Agency (JICA)	This work was conducted as part of the "Joint Research Project on Formation Mechanism of Ozone, VOCs, and PM<INF>2.5</INF> and Proposal of Countermeasure Scenarios" undertaken by the Science and Technology Research Partnership for Sustainable Development (SATREPS) funded by the Japan Science and Technology Agency (JST) and the Japan International Cooperation Agency (JICA). The authors acknowledge the contributions of the National Institute of Ecology (INECC), the Secretariat of the Environment of Mexico City (SMA-GDF), and SEMARNAT for supporting the field campaign and for providing data from the Air Quality Monitoring Network. We thank Eng. Susana Gonzalez from INECC for processing the data acquired during the field campaign.	Thornhill DA, 2010, ATMOS CHEM PHYS, V10, P3629; Sun Y, 2011, J COMPUT GRAPH STAT, V20, P316, DOI 10.1198/jcgs.2011.09224; Atkinson R, 2000, ATMOS ENVIRON, V34, P2063, DOI 10.1016/S1352-2310(99)00460-4; Yang KL, 2005, ATMOS ENVIRON, V39, P3221, DOI 10.1016/j.atmosenv.2005.02.003; Riuttanen L, 2013, ATMOS CHEM PHYS, V13, P2153, DOI 10.5194/acp-13-2153-2013; Zalel A, 2008, ENVIRON POLLUT, V156, P553, DOI 10.1016/j.envpol.2008.01.016; CHATFIELD RB, 1987, J GEOPHYS RES-ATMOS, V92, P4208, DOI 10.1029/JD092iD04p04208; Wohrnschimmel H, 2010, ATMOS CHEM PHYS, V10, P9027, DOI 10.5194/acp-10-9027-2010; Velasco E, 2009, ATMOS CHEM PHYS, V9, P7325; Yokelson RJ, 2013, ATMOS CHEM PHYS, V13, P89, DOI 10.5194/acp-13-89-2013; Sillman S, 1999, ATMOS ENVIRON, V33, P1821, DOI 10.1016/S1352-2310(98)00345-8; Velasco E, 2008, ATMOS CHEM PHYS, V8, P3061; Emmons LK, 2010, ATMOS CHEM PHYS, V10, P6195, DOI 10.5194/acp-10-6195-2010; Suthawaree J, 2012, ATMOS RES, V104, P245, DOI 10.1016/j.atmosres.2011.10.019; Zhang J, 2008, ATMOS CHEM PHYS, V8, P4983; Hu L, 2013, ATMOS CHEM PHYS, V13, P3379, DOI 10.5194/acp-13-3379-2013; Schmitz T, 2000, ATMOS ENVIRON, V34, P4639, DOI 10.1016/S1352-2310(00)00303-4; NICKERSON EC, 1992, ATMOS ENVIRON B-URB, V26, P445, DOI 10.1016/0957-1272(92)90051-S; Chen JJ, 2012, ATMOS ENVIRON, V55, P448, DOI 10.1016/j.atmosenv.2012.02.082; Lee SC, 2002, CHEMOSPHERE, V48, P375; Leuchner M, 2010, ATMOS ENVIRON, V44, P4056, DOI 10.1016/j.atmosenv.2009.02.029; Na K, 2005, ATMOS ENVIRON, V39, P5517, DOI 10.1016/j.atmosenv.2005.06.005; Song Y, 2008, ENVIRON POLLUT, V156, P174, DOI 10.1016/j.envpol.2007.12.014; Parrish DD, 2012, ATMOS CHEM PHYS, V12, P3273, DOI 10.5194/acp-12-3273-2012; Jorquera H, 2004, ATMOS ENVIRON, V38, P4243, DOI 10.1016/j.atmosenv.2004.04.030; Watson JG, 2001, ATMOS ENVIRON, V35, P1567, DOI 10.1016/S1352-2310(00)00461-1; Chang CC, 2005, ATMOS ENVIRON, V39, P867, DOI 10.1016/j.atmosenv.2004.10.037; Velasco E, 2007, ATMOS CHEM PHYS, V7, P329; Goldstein AH, 1996, J GEOPHYS RES-ATMOS, V101, P9149, DOI 10.1029/96JD00334; Arriaga-Colina JL, 2004, ATMOS ENVIRON, V38, P2523, DOI 10.1016/j.atmosenv.2004.01.033; Ogawa H, 2011, INT J ENGINE RES, V12, P30, DOI 10.1243/14680874JER595; Gelencser A, 1997, ENVIRON SCI TECHNOL, V31, P2869, DOI 10.1021/es970004c; Streit GE, 1996, ATMOS ENVIRON, V30, P723, DOI 10.1016/1352-2310(95)00275-8; Molina LT, 2010, ATMOS CHEM PHYS, V10, P8697, DOI 10.5194/acp-10-8697-2010; Zavala M, 2006, ATMOS CHEM PHYS, V6, P5129; Liu PWG, 2008, SCI TOTAL ENVIRON, V398, P154, DOI 10.1016/j.scitotenv.2008.02.053; Baker AK, 2008, ATMOS ENVIRON, V42, P170, DOI 10.1016/j.atmosenv.2007.09.007; Molina LT, 2007, ATMOS CHEM PHYS, V7, P2447; Apel EC, 2010, ATMOS CHEM PHYS, V10, P2353; Rogers TM, 2006, INT J MASS SPECTROM, V252, P26, DOI 10.1016/j.ijms.2006.01.027; Zheng J, 2013, ATMOS ENVIRON, V70, P521, DOI 10.1016/j.atmosenv.2012.11.030; de Foy B, 2008, ATMOS CHEM PHYS, V8, P1209; Kirstine WV, 2012, ATMOS CHEM PHYS, V12, P545, DOI 10.5194/acp-12-545-2012; Lei W, 2007, ATMOS CHEM PHYS, V7, P1347; Ruiz ME, 1996, ATMOSFERA, V9, P119; Bravo H, 2002, ATMOS ENVIRON, V36, P3843, DOI 10.1016/S1352-2310(02)00292-3; Zhang RY, 2003, P NATL ACAD SCI USA, V100, P1505, DOI 10.1073/pnas.252763799; Na K, 2004, CHEMOSPHERE, V55, P585, DOI 10.1016/j.chemosphere.2004.01.010; Karl T, 2009, ATMOS CHEM PHYS, V9, P271; Tsai DH, 2008, J ENVIRON MONITOR, V10, P109, DOI 10.1039/b714479b; Arnold S.R., 2007, J GEOPHYS RES ATMOS, V112; BLAKE DR, 1995, SCIENCE, V269, P953, DOI 10.1126/science.269.5226.953; Carter W.P.L., 2010, CALIF AIR RESOUR BOA, V1, P1; CARTER WPL, 1994, J AIR WASTE MANAGE, V44, P881; Environmental Agency of Japan, 1999, ADM AIR POLL CONTR; European Concerted Action, 1991, 10 EUR CONC ACT; Institute for Governance & Sustainable Development, 2013, PRIM SHORT LIV CLIM; Islas V.H.S., 2011, P INT TRANSPORT FORU, V14, P1; Lindfors Virpi, 2000, Boreal Environment Research, V5, P95; MARI: Mexico City Air Quality Initiative, 1994, LA12699 MEX PETR I L; Martins LD, 2008, QUIM NOVA, V31, P2009, DOI 10.1590/S0100-40422008000800018; Mehta D, 2009, J PHYS CHEM A, V113, P12942, DOI 10.1021/jp905074j; Ministry of the Environment of the Government of Japan, 1997, ENV QUAL STAND JAP A; Molina L.T., 2009, WMO B, V58, P48; Murray F., 2000, CLEAN PRODUCT PROCES, V2, P28, DOI 10.1007/s100980050048; National Institute for Occupational Safety and Health, 2007, NAT I OCC SAF HLTH P; Occupational Safety and Health Standards, 2012, TOX HAZ SUBST ID CLA; Secretaria de Energia del Gobierno Federal de Mexico, 2008, LIQ PETR GAS MARK OU; Secretaria de Medio Ambiente del Distrito Federal, 2012, INV EM ZON METR VALL; Secretaria de Medio Ambiente del Distrito Federal, 2013, BAS DAT SIST MON ATM; Secretaria de Medio Ambiente del Distrito Federal, 2012, CAL AIR CIUD MEX 25; Secretaria de Medio Ambiente del Distrito Federal, 2010, CAL AIR CIUD MEX INF; Secretaria de Medio Ambiente del Distrito Federal e instituto Nacional de Ecologla y Cambio Ciimatico, 2008, INF TECN MON EV CONC; Secretaria de Medio Ambiente y Recursos Naturales de Mexico, 2010, INV EM ZON METR VALL; Secretaria del Trabajo y Prevision Social de Mexico, 2002, NORM OF MEX NOM 010; United Nations, 2011, WORLD URB PROSP 2011; USEPA, 1999, EPA625R96010B; Vardar N., 2008, ATMOS ENVIRON, V42, P5685; Velasco E., 2005, GEOPHYS RES LETT, V32; von Schneidemesser E, 2010, ATMOS ENVIRON, V44, P5053, DOI 10.1016/j.atmosenv.2010.09.010; White M.L., 2008, J GEOPHYS RES ATMOS, V113; Yuan Z.B., 2009, J GEOPHYS RES ATMOS, V114	82	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1352-2310	1873-2844		ATMOS ENVIRON	Atmos. Environ.	OCT	2015	119						415	429		10.1016/j.atmosenv.2015.08.014		15	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	CT8PJ	WOS:000363078200040		
J	Ahadian, S; Sadeghian, RB; Salehi, S; Ostrovidov, S; Bae, H; Ramalingam, M; Khademhosseini, A				Ahadian, Samad; Sadeghian, Ramin Banan; Salehi, Sahar; Ostrovidov, Serge; Bae, Hojae; Ramalingam, Murugan; Khademhosseini, Ali			Bioconjugated Hydrogels for Tissue Engineering and Regenerative Medicine	BIOCONJUGATE CHEMISTRY			English	Review							MESENCHYMAL STEM-CELLS; ENDOTHELIAL GROWTH-FACTOR; CHITOSAN/POLY(VINYL ALCOHOL) HYDROGEL; POLY(ETHYLENE GLYCOL) HYDROGELS; BONE MORPHOGENETIC PROTEIN-2; ARTICULAR-CARTILAGE DEFECTS; AGAROSE-GELATIN CONJUGATE; HYALURONIC-ACID HYDROGEL; SKELETAL-MUSCLE TISSUE; ALGINATE HYDROGELS	Hydrogels are hydrophilic polymer networks with high water content, which have played an important role as scaffolds for cells, as carriers for various biomolecules (e.g., drugs, genes, and soluble factors), and as injectable biomaterials in tissue engineering (TE) and regenerative medicine. Bioconjugation is an approach for improving the performance of hydrogels using cell-responsive components, such as proteins and peptides, which have high affinity to regulate cellular behaviors and tissue morphogenesis. However, the current knowledge on the role of those bioconjugated moieties in controlling cellular functions and tissue morphogenesis and bioconjugation methods are limited in the context of TE and organogenesis. Moreover, micro- and nanofabrication techniques have been used to manipulate bioconjugated hydrogels for regulating cell behaviors and function. This Review therefore describes synthesis, characteristics, and manipulation of various bioconjugated hydrogels and their potential in TE applications with special emphasis on preclinical/clinical translation.	[Ahadian, Samad; Sadeghian, Ramin Banan; Salehi, Sahar; Ostrovidov, Serge; Ramalingam, Murugan; Khademhosseini, Ali] Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Bae, Hojae; Khademhosseini, Ali] Konkuk Univ, Coll Anim Biosci & Technol, Dept Bioind Technol, Seoul 143701, South Korea; [Ramalingam, Murugan] Christian Med Coll & Hosp, Inst Stem Cell Biol & Regenerat Med, Ctr Stem Cell Res, Vellore 632002, Tamil Nadu, India; [Khademhosseini, Ali] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Biomed Engn,Dept Med, Cambridge, MA 02139 USA; [Khademhosseini, Ali] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Khademhosseini, Ali] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Khademhosseini, Ali] King Abdulaziz Univ, Fac Sci, Dept Phys, Jeddah 21569, Saudi Arabia	Khademhosseini, A (reprint author), Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan.	alik@rics.bwh.harvard.edu			World Premier International Research Center Initiative (WPI), MEXT, Japan	This work was supported by the World Premier International Research Center Initiative (WPI), MEXT, Japan.	Al-Abboodi A, 2014, ADV HEALTHC MATER, V3, P1655, DOI 10.1002/adhm.201400072; Hutson CB, 2011, TISSUE ENG PT A, V17, P1713, DOI [10.1089/ten.TEA.2010.0666, 10.1089/ten.tea.2010.0666]; Mather BD, 2006, PROG POLYM SCI, V31, P487, DOI 10.1016/j.progpolymsci.2006.03.001; Cao LP, 2015, J MATER CHEM B, V3, P1268, DOI 10.1039/c4tb01705f; Lu SY, 2015, ACS APPL MATER INTER, V7, P13029, DOI 10.1021/acsami.5b03143; Reis LA, 2012, ACTA BIOMATER, V8, P1022, DOI 10.1016/j.actbio.2011.11.030; Sharma B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004838; Szlachcic A, 2011, BIOTECHNOL ADV, V29, P436, DOI 10.1016/j.biotechadv.2011.03.005; Jun Y, 2013, BIOMATERIALS, V34, P8122, DOI 10.1016/j.biomaterials.2013.07.079; Nichol JW, 2009, SOFT MATTER, V5, P1312, DOI 10.1039/b814285h; Censi R, 2012, J CONTROL RELEASE, V161, P680, DOI 10.1016/j.jconrel.2012.03.002; Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612; da Costa JP, 2014, BIOTECHNOL ADV, V32, P952, DOI 10.1016/j.biotechadv.2014.04.013; Normand V, 2000, BIOMACROMOLECULES, V1, P730, DOI 10.1021/bm005583j; Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n; Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007; Leach JB, 2005, BIOMATERIALS, V26, P125, DOI 10.1016/j.biomaterials.2004.02.018; Freeman I, 2008, BIOMATERIALS, V29, P3260, DOI 10.1016/j.biomaterials.2008.04.025; Leach JB, 2004, J BIOMED MATER RES A, V70A, P74, DOI 10.1002/jbm.a.30063; Tang YJ, 2012, CARBOHYD POLYM, V88, P46, DOI 10.1016/j.carbpol.2011.11.058; Wu LL, 2005, J MEMBRANE SCI, V250, P167, DOI 10.1016/j.memsci.2004.10.024; Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008; Du YA, 2011, BIOTECHNOL BIOENG, V108, P1693, DOI 10.1002/bit.23102; Nimmo CM, 2011, BIOCONJUGATE CHEM, V22, P2199, DOI 10.1021/bc200281k; Koehler KC, 2013, BIOMATERIALS, V34, P4150, DOI 10.1016/j.biomaterials.2013.02.020; Boere KWM, 2014, ACTA BIOMATER, V10, P2602, DOI 10.1016/j.actbio.2014.02.041; Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247; Daniele MA, 2014, BIOMATERIALS, V35, P1845, DOI 10.1016/j.biomaterials.2013.11.009; Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210; Russell RGG, 2008, OSTEOPOROSIS INT, V19, P733, DOI 10.1007/s00198-007-0540-8; Luo TZ, 2013, EUR POLYM J, V49, P2998, DOI 10.1016/j.eurpolymj.2013.05.013; Annabi N, 2013, BIOMATERIALS, V34, P5496, DOI 10.1016/j.biomaterials.2013.03.076; Dhoot NO, 2004, J BIOMED MATER RES A, V71A, P191, DOI 10.1002/jbm.a.30103; Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0; Annabi N, 2014, ADV MATER, V26, P85, DOI 10.1002/adma.201303233; Stegemann JP, 2007, TISSUE ENG, V13, P2601, DOI 10.1089/ten.2007.0196; Lee J, 2012, ACTA BIOMATER, V8, P2549, DOI 10.1016/j.actbio.2012.03.030; Vunjak-Novakovic G, 2010, TISSUE ENG PART B-RE, V16, P169, DOI 10.1089/ten.TEB.2009.0352; Ibusuki S, 2003, TISSUE ENG, V9, P371, DOI 10.1089/107632703764664846; Dreesmann L, 2007, BIOMATERIALS, V28, P5536, DOI 10.1016/j.biomaterials.2007.08.040; Tanimizu N, 2007, INT REV CYTOL, V259, P1, DOI 10.1016/S0074-7969(06)59001-1; Ahadian S, 2014, BIOSENS BIOELECTRON, V59, P166, DOI 10.1016/j.bios.2014.03.031; Duan B, 2015, TISSUE ENG PART C-ME, V21, P795, DOI [10.1089/ten.TEC.2014.0589, 10.1089/ten.tec.2014.0589]; Teng SH, 2009, MATER LETT, V63, P2510, DOI 10.1016/j.matlet.2009.08.051; Chong SF, 2013, SMALL, V9, P942, DOI 10.1002/smll.201201774; Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202; Kolesky DB, 2014, ADV MATER, V26, P3124, DOI 10.1002/adma.201305506; Leslie-Barbick JE, 2011, TISSUE ENG PT A, V17, P221, DOI 10.1089/ten.TEA.2010.0202; MOONEY DJ, 1995, J CELL SCI, V108, P2311; Greiner A, 2007, ANGEW CHEM INT EDIT, V46, P5670, DOI 10.1002/anie.200604646; Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804; Ferris CJ, 2015, J MATER CHEM B, V3, P1106, DOI 10.1039/c4tb01727g; Wong DY, 2010, MACROMOLECULES, V43, P2824, DOI 10.1021/ma9023679; Hu M, 2010, BIOMATERIALS, V31, P863, DOI 10.1016/j.biomaterials.2009.10.002; Oh EJ, 2010, J CONTROL RELEASE, V141, P2, DOI 10.1016/j.jconrel.2009.09.010; Ichikawa H, 2003, J BIOMED MATER RES A, V67A, P609, DOI 10.1002/jbm.a.10128; Phelps EA, 2012, ADV MATER, V24, P64, DOI 10.1002/adma.201103574; Han J, 2011, CARBOHYD POLYM, V83, P270, DOI 10.1016/j.carbpol.2010.07.057; Nuttelman CR, 2008, PROG POLYM SCI, V33, P167, DOI 10.1016/j.progpolymsci.2007.09.006; Murphy WL, 2007, ANGEW CHEM INT EDIT, V46, P3066, DOI 10.1002/anie.200604808; Moon JJ, 2009, TISSUE ENG PT A, V15, P579, DOI 10.1089/ten.tea.2008.0196; Choi B, 2015, ACTA BIOMATER, V12, P30, DOI 10.1016/j.actbio.2014.10.013; Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004; MUZZARELLI RAA, 1988, CARBOHYD POLYM, V8, P1, DOI 10.1016/0144-8617(88)90032-X; Obregon R, 2014, J NANOSCI NANOTECHNO, V14, P487, DOI 10.1166/jnn.2014.9051; Rice JJ, 2013, ADV HEALTHC MATER, V2, P57, DOI 10.1002/adhm.201200197; Chan BK, 2012, MACROMOL BIOSCI, V12, P1490, DOI 10.1002/mabi.201200234; Hiraoka M, 2009, BIOCONJUGATE CHEM, V20, P976, DOI 10.1021/bc9000068; Sackmann EK, 2014, NATURE, V507, P181, DOI 10.1038/nature13118; Sheridan MH, 2000, J CONTROL RELEASE, V64, P91, DOI 10.1016/S0168-3659(99)00138-8; Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]; Selimovic S, 2012, POLYMERS-BASEL, V4, P1554, DOI 10.3390/polym4031554; Jin R, 2007, BIOMATERIALS, V28, P2791, DOI 10.1016/j.biomaterials.2007.02.032; Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307; Chiu YC, 2009, CHEM MATER, V21, P1677, DOI 10.1021/cm803520j; Rosso F, 2005, J CELL PHYSIOL, V203, P465, DOI 10.1002/jcp.20270; Cerqueira MT, 2014, ACS APPL MATER INTER, V6, P19668, DOI 10.1021/am504520j; Vermonden T, 2012, CHEM REV, V112, P2853, DOI 10.1021/cr200157d; Lau HK, 2015, BIOMACROMOLECULES, V16, P28, DOI 10.1021/bm501361c; Simon-Yarza T, 2012, THERANOSTICS, V2, P541, DOI 10.7150/thno.3682; Waris E, 2008, BIOMATERIALS, V29, P2509, DOI 10.1016/j.biomaterials.2008.02.013; Liong M, 2011, BIOCONJUGATE CHEM, V22, P2390, DOI 10.1021/bc200490r; Tang YF, 2009, J BIOMED MATER RES A, V91A, P953, DOI 10.1002/jbm.a.32240; Fichna J, 2003, BIOCONJUGATE CHEM, V14, P3, DOI 10.1021/bc025542f; Hosseini V, 2012, TISSUE ENG PT A, V18, P2453, DOI [10.1089/ten.TEA.2012.0181, 10.1089/ten.tea.2012.0181]; Zamora-Mora V, 2014, CARBOHYD POLYM, V111, P348, DOI 10.1016/j.carbpol.2014.04.087; Shin H, 2012, BIOMATERIALS, V33, P3143, DOI 10.1016/j.biomaterials.2011.12.050; Losel R, 2010, MACROMOL BIOSCI, V10, P1177, DOI 10.1002/mabi.201000101; Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9; Wang LS, 2014, ACTA BIOMATER, V10, P2539, DOI 10.1016/j.actbio.2014.02.022; Bellan LM, 2012, ADV MATER, V24, P5187, DOI 10.1002/adma.201200810; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Rafat M, 2008, BIOMATERIALS, V29, P3960, DOI 10.1016/j.biomaterials.2008.06.017; Buttafoco L, 2005, J CONTROL RELEASE, V101, P322; Gruber HE, 2006, BIOMATERIALS, V27, P371, DOI 10.1016/j.biomaterials.2005.06.032; Qi BW, 2013, EXP BIOL MED, V238, P23, DOI 10.1258/ebm.2012.012223; Bubenikova S, 2012, CARBOHYD POLYM, V88, P1239, DOI 10.1016/j.carbpol.2012.01.089; Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; Bertassoni LE, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/2/024105; Sakai S, 2007, BIOTECHNOL LETT, V29, P731, DOI 10.1007/s10529-007-9312-y; Hu M, 2009, BIOMATERIALS, V30, P3523, DOI 10.1016/j.biomaterials.2009.03.004; Saito H, 2007, J BIOACT COMPAT POL, V22, P589, DOI 10.1177/0883911507084653; Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106; Park H, 2005, BIOMATERIALS, V26, P7095, DOI 10.1016/j.biomaterials.2005.05.083; Mahou R, 2012, J MATER SCI-MATER M, V23, P171, DOI 10.1007/s10856-011-4512-3; Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044; Lim HL, 2014, BIOMATER SCI-UK, V2, P603, DOI 10.1039/c3bm60288e; SAWHNEY AS, 1992, BIOMATERIALS, V13, P863, DOI 10.1016/0142-9612(92)90180-V; Lin XX, 2015, TISSUE ENG PART B-RE, V21, P177, DOI [10.1089/ten.TEB.2015.0004, 10.1089/ten.teb.2015.0004]; Drinnan CT, 2010, J CONTROL RELEASE, V147, P180, DOI 10.1016/j.jconrel.2010.03.026; Wang DA, 2007, NAT MATER, V6, P385, DOI 10.1038/nmat1890; Hu JM, 2012, CHEM SOC REV, V41, P5933, DOI 10.1039/c2cs35103j; Schense JC, 1999, BIOCONJUGATE CHEM, V10, P75, DOI 10.1021/bc9800769; Madl CM, 2014, BIOMACROMOLECULES, V15, P445, DOI 10.1021/bm401726u; Li YL, 2012, CHEM SOC REV, V41, P2193, DOI 10.1039/c1cs15203c; Hosseini V, 2014, SMALL, V10, P4851, DOI 10.1002/smll.201400263; Ferreira AM, 2012, ACTA BIOMATER, V8, P3191, DOI 10.1016/j.actbio.2012.06.014; Rabbany SY, 2010, CELL TRANSPLANT, V19, P399, DOI 10.3727/096368909X481782; Zhang HW, 2011, BIOMACROMOLECULES, V12, P1428, DOI 10.1021/bm101192b; MacNeil S, 2008, MATER TODAY, V11, P26, DOI 10.1016/S1369-7021(08)70087-7; Liu JH, 2005, EUR J PHARM SCI, V25, P237, DOI 10.1016/j.ejps.2005.02.013; Yu F, 2013, CARBOHYD POLYM, V97, P188, DOI 10.1016/j.carbpol.2013.04.046; Derby B, 2012, SCIENCE, V338, P921, DOI 10.1126/science.1226340; Seidlits SK, 2011, ACTA BIOMATER, V7, P2401, DOI 10.1016/j.actbio.2011.03.024; Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021; Coutinho DF, 2010, BIOMATERIALS, V31, P7494, DOI 10.1016/j.biomaterials.2010.06.035; Katti DS, 2004, J BIOMED MATER RES B, V70B, P286, DOI 10.1002/jbm.b.30041; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471; Ryu JH, 2011, BIOMACROMOLECULES, V12, P2653, DOI 10.1021/bm200464x; Wang T, 2006, CURR MED CHEM, V13, P525, DOI 10.2174/092986706776055742; Jeon O, 2013, TISSUE ENG PT A, V19, P1424, DOI [10.1089/ten.TEA.2012.0581, 10.1089/ten.tea.2012.0581]; Lahiri DK, 2002, DRUG DEVELOP RES, V56, P267, DOI 10.1002/ddr.10081; Shu XZ, 2003, BIOMATERIALS, V24, P3825, DOI 10.1016/S0142-9612(03)00267-9; Li YL, 2014, CARBOHYD POLYM, V110, P87, DOI 10.1016/j.carbpol.2014.03.058; Jin R, 2010, ACTA BIOMATER, V6, P1968, DOI 10.1016/j.actbio.2009.12.024; Jeon O, 2010, TISSUE ENG PT A, V16, P2915, DOI 10.1089/ten.TEA.2010.0096; Brown BN, 2014, TRANSL RES, V163, P268, DOI 10.1016/j.trsl.2013.11.003; Wu ATH, 2015, BIOMACROMOLECULES, V16, P166, DOI 10.1021/bm501356c; Huo Q, 2007, COLLOID SURFACE B, V59, P1, DOI 10.1016/j.colsurfb.2007.04.019; Hahn SK, 2006, INT J PHARM, V322, P44, DOI 10.1016/j.ijpharm.2006.05.024; Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097; Shin HH, 2014, J MATER CHEM B, V2, P2508, DOI 10.1039/c3tb20984a; Sadri-Ardekani H, 2015, ADV DRUG DELIVER REV, V82-83, P145, DOI 10.1016/j.addr.2014.10.019; Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389; Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016; Wojtecki RJ, 2011, NAT MATER, V10, P14, DOI [10.1038/nmat2891, 10.1038/NMAT2891]; Ossipov DA, 2006, MACROMOLECULES, V39, P1709, DOI 10.1021/ma052545p; Lee KY, 2000, NATURE, V408, P998; Hollister SJ, 2009, ADV MATER, V21, P3330, DOI 10.1002/adma.200802977; Cheng F, 2011, POLYM CHEM-UK, V2, P2122, DOI 10.1039/c1py00123j; Yavvari PS, 2015, J MATER CHEM B, V3, P899, DOI 10.1039/c4tb01307g; Sakai S, 2007, J BIOSCI BIOENG, V103, P22, DOI 10.1263/jbb.103.22; Yamada Y, 2013, BIOMATERIALS, V34, P6539, DOI 10.1016/j.biomaterials.2013.05.044; Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009; Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963; Baskin JM, 2007, P NATL ACAD SCI USA, V104, P16793, DOI 10.1073/pnas.0707090104; Lee SH, 2008, BIOMATERIALS, V29, P2962, DOI 10.1016/j.biomaterials.2008.04.004; Custodio CA, 2014, ADV HEALTHC MATER, V3, P797, DOI 10.1002/adhm.201300603; Shah SS, 2011, SOFT MATTER, V7, P3133, DOI 10.1039/c0sm00771d; Tamariz E, 2011, J MATER SCI-MATER M, V22, P2097, DOI 10.1007/s10856-011-4385-5; Au AY, 2012, J BIOMED MATER RES A, V100A, P342, DOI 10.1002/jbm.a.33277; Andrianov AK, 1998, BIOMATERIALS, V19, P109, DOI 10.1016/S0142-9612(97)00227-5; van Dijk M, 2010, BIOMACROMOLECULES, V11, P1608, DOI 10.1021/bm1002637; Khademhosseini A, 2009, SCI AM, V300, P64; Prokoph S, 2012, BIOMATERIALS, V33, P4792, DOI 10.1016/j.biomaterials.2012.03.039; Li JJ, 2013, BIOMATERIALS, V34, P9071, DOI 10.1016/j.biomaterials.2013.08.031; Ostrovidov S, 2014, BIOMATERIALS, V35, P6268, DOI 10.1016/j.biomaterials.2014.04.021; Liu SQ, 2009, BIOMATERIALS, V30, P1453, DOI 10.1016/j.biomaterials.2008.11.023; Jabbari E, 2011, CURR OPIN BIOTECH, V22, P655, DOI 10.1016/j.copbio.2011.01.003; Park KM, 2011, J MATER CHEM, V21, P13180, DOI 10.1039/c1jm12527c; Burdick JA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2271; Carballo-Molina OA, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00013; Cezar CA, 2015, ADV DRUG DELIVER REV, V84, P188, DOI 10.1016/j.addr.2014.09.008; Deng CC, 2015, ACS MACRO LETT, V4, P220, DOI 10.1021/acsmacrolett.5b00018; Desai RM, 2015, BIOMATERIALS, V50, P30, DOI 10.1016/j.biomaterials.2015.01.048; Foster E, 2015, EUR POLYM J, V72, P726, DOI 10.1016/j.eurpolymj.2014.12.033; Gao GF, 2015, BIOTECHNOL J, V10, P1568, DOI 10.1002/biot.201400635; Sameiro M, 2009, CHEM REV, V109, P190, DOI 10.1021/cr0783840; Grover GN, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/1/014011; Harris J. M., 1992, INTRO BIOTECHNICAL B; Hernandez-Montiel HL, 2008, J COMP NEUROL, V506, P387, DOI 10.1002/cne.21503; Holzapfel BM, 2013, ADV DRUG DELIVER REV, V65, P581, DOI 10.1016/j.addr.2012.07.009; Hou JX, 2015, POLYM CHEM-UK, V6, P2204, DOI 10.1039/c4py01757a; Hulsart-Billstrom G, 2013, BIOMACROMOLECULES, V14, P3055, DOI 10.1021/bm400639e; Jaiswal JK, 2003, NAT BIOTECHNOL, V21, P47, DOI 10.1038/nbt.767; Jha AK, 2015, BIOMATERIALS, V47, P1, DOI 10.1016/j.biomaterials.2014.12.043; Kim J, 2015, J BIOL ENG, V9, DOI 10.1186/1754-1611-9-1; Kim B, 2005, BIOMATERIALS, V26, P3597, DOI 10.1016/j.biomaterials.2004.09.045; Levato R., 2014, BIOFABRICATION, V6, P1; Li Z, 2015, ACTA BIOMATER, V13, P88, DOI 10.1016/j.actbio.2014.11.002; Madden L, 2015, ELIFE, V4, DOI 10.7554/eLife.04885; Madeira C, 2015, TRENDS BIOTECHNOL, V33, P35, DOI 10.1016/j.tibtech.2014.11.003; Miklas JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072956; Mosiewicz Katarzyna A, 2013, Nat Mater, V12, P1072, DOI [10.1038/nmat3766, 10.1038/NMAT3766]; Noh SS, 2015, TISSUE ENG PT A, V21, P1275, DOI [10.1089/ten.TEA.2014.0182, 10.1089/ten.tea.2014.0182]; Oh SH, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-014-5365-3; Ostrovidov S, 2014, TISSUE ENG PART B-RE, V20, P403, DOI [10.1089/ten.TEB.2013.0534, 10.1089/ten.teb.2013.0534]; Pardue Erin L, 2008, Organogenesis, V4, P203; Qasaimeh MA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1471; Saldoetsakun D., 2009, BIOMATERIALS, V30, P6151; Siddiqui N, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.41534; Spiller KL, 2011, TISSUE ENG PART B-RE, V17, P281, DOI [10.1089/ten.TEB.2011.0077, 10.1089/ten.teb.2011.0077]; TABELING P., 2010, INTRO MICROFLUIDICS; Raja STK, 2015, J MATER CHEM B, V3, P1230, DOI 10.1039/c4tb01196a; Wade RJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7639; Wen Jessica, 2012, Am J Cardiovasc Dis, V2, P20; Wong W.H., 1997, SYNTHETIC BIODEGRADA, P51; Yang JA, 2014, PROG POLYM SCI, V39, P1973, DOI 10.1016/j.progpolymsci.2014.07.006; Zahedi P., 2009, POLYM ADVAN TECHNOL, V21, P77; ZALIPSKY S, 1995, BIOCONJUGATE CHEM, V6, P150, DOI 10.1021/bc00032a002; Zouraq F. A., 2013, REGENERATIVE MED TIS	213	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1043-1802			BIOCONJUGATE CHEM	Bioconjugate Chem.	OCT	2015	26	10					1984	2001		10.1021/acs.bioconjchem.5b00360		18	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Multidisciplinary; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	CU3PU	WOS:000363438100002		
J	Mano, H; Nishikawa, M; Yasuda, K; Ikushiro, S; Saito, N; Takano, M; Kittaka, A; Sakaki, T				Mano, Hiroki; Nishikawa, Miyu; Yasuda, Kaori; Ikushiro, Shinichi; Saito, Nozomi; Takano, Masashi; Kittaka, Atsushi; Sakaki, Toshiyuki			Development of Novel Bioluminescent Sensor to Detect and Discriminate between Vitamin D Receptor Agonists and Antagonists in Living Cells	BIOCONJUGATE CHEMISTRY			English	Article							D-RESISTANT RICKETS; LUCIFERASE COMPLEMENTARY ASSAY; 1,25-DIHYDROXYVITAMIN D-3; 25-HYDROXYVITAMIN D-3; FIREFLY LUCIFERASE; ACTIVE VITAMIN-D3; NUCLEAR RECEPTOR; LIGAND; BONE; GENE	Active forms of vitamin D regulate the expression of multiple genes that play essential roles in calcium and phosphate homeostasis, cell differentiation, and the immune system via the vitamin D receptor (VDR). Many vitamin D analogs have been synthesized for clinical use in the treatment of type I rickets, osteoporosis, renal osteodystrophy, psoriasis, leukemia, and breast cancer. We have constructed two fusion proteins containing split-luciferase and the ligand binding domain (LBD) of the VDR designated as LucN-LBD-LucC and LucC-LBD-LucN. Remarkably, the LucC-LBD-LucN, which has the C-terminal domain of luciferase at the N-terminus of the fusion protein, was a significantly better biosensor than LucN-LBD-LucC. Addition of the VDR agonists to COS-7 cells expressing LucC-LBD-LucN dramatically reduced luciferase activity. In contrast, the VDR antagonist significantly increased the chimeric luciferase activity in a dose- and time-dependent manner. Our results on chimeric luciferases containing the LBDs of mutant VDRs derived from patients with vitamin D-dependent type II rickets indicated that our system could detect a conformational change of the LBD of the VDR likely based on a positional change of the helix 12, which occurs upon ligand binding. This novel system to detect and discriminate between VDR agonists and antagonists could be useful for the screening and identification of chemical compounds that bind to normal or mutant VDRs with high affinity.	[Mano, Hiroki; Nishikawa, Miyu; Yasuda, Kaori; Ikushiro, Shinichi; Sakaki, Toshiyuki] Toyama Prefectural Univ, Fac Engn, Dept Biotechnol, Imizu, Toyama 9390398, Japan; [Nishikawa, Miyu; Sakaki, Toshiyuki] TOPU BIO Res Co Ltd, Imizu Inst, Imizu, Toyama 9390398, Japan; [Saito, Nozomi; Takano, Masashi; Kittaka, Atsushi] Teikyo Univ, Fac Pharmaceut Sci, Itabashi Ku, Tokyo 1738605, Japan	Sakaki, T (reprint author), Toyama Prefectural Univ, Fac Engn, Dept Biotechnol, Imizu, Toyama 9390398, Japan.	tsakaki@pu-toyama.ac.jp					Samuel S, 2008, NUTR REV, V66, pS116, DOI 10.1111/j.1753-4887.2008.00094.x; Rochel N, 2000, MOL CELL, V5, P173, DOI 10.1016/S1097-2765(00)80413-X; Nakabayashi M, 2013, J MED CHEM, V56, P6745, DOI 10.1021/jm400537h; Sprague SM, 2010, CLIN J AM SOC NEPHRO, V5, P512, DOI 10.2215/CJN.03850609; Shaffer PL, 2005, BIOCHEMISTRY-US, V44, P2678, DOI 10.1021/bi0477182; Matsumoto T, 2007, J STEROID BIOCHEM, V103, P584, DOI 10.1016/j.jsbmb.2006.12.088; Swami S, 2001, BONE, V28, P319, DOI 10.1016/S8756-3282(00)00432-4; Matsumoto T, 2005, J CLIN ENDOCR METAB, V90, P5031, DOI 10.1210/jc.2004-2552; Saito N, 2004, TETRAHEDRON, V60, P7951, DOI 10.1016/j.tet.2004.05.113; Munetsuna E, 2014, MOL CELL ENDOCRINOL, V382, P960, DOI 10.1016/j.mce.2013.11.014; Heaney RP, 2005, J STEROID BIOCHEM, V97, P13, DOI 10.1016/j.jsbmb.2005.06.020; Yamamoto K, 2000, P NATL ACAD SCI USA, V97, P1467, DOI 10.1073/pnas.020522697; Roodman GD, 2005, J CLIN INVEST, V115, P200, DOI 10.1172/JCI200524281; Ataei F, 2013, BIOSENS BIOELECTRON, V41, P642, DOI 10.1016/j.bios.2012.09.037; Malloy PJ, 1999, ENDOCR REV, V20, P156, DOI 10.1210/er.20.2.156; Ishimoto T, 2012, BIOCONJUGATE CHEM, V23, P923, DOI 10.1021/bc200491j; Tashiro K, 2007, BIOCHEM BIOPH RES CO, V358, P259, DOI 10.1016/j.bbrc.2007.04.103; Meyer MB, 2013, J STEROID BIOCHEM, V136, P120, DOI 10.1016/j.jsbmb.2012.08.006; Sakaki T, 2005, FRONT BIOSCI, V10, P119; Ozawa T, 2006, ANAL CHIM ACTA, V556, P58, DOI 10.1016/j.aca.2005.06.026; Carlberg C, 2004, J STEROID BIOCHEM, V89-90, P227, DOI 10.1016/j.jsbmb.2004.03.112; Paulmurugan R, 2007, ANAL CHEM, V79, P2346, DOI 10.1021/ac062053q; Fan F, 2008, ACS CHEM BIOL, V3, P346, DOI 10.1021/cb8000414; Azad T, 2014, ANAL BIOANAL CHEM, V406, P5541, DOI 10.1007/s00216-014-7980-8; Saito N, 2006, J MED CHEM, V49, P7063, DOI 10.1021/jm060797q; Rachez C, 2000, MOL CELL BIOL, V20, P2718, DOI 10.1128/MCB.20.8.2718-2726.2000; Kittaka A, 2003, CHEM PHARM BULL, V51, P357; Paulmurugan R, 2006, P NATL ACAD SCI USA, V103, P15883, DOI 10.1073/pnas.0607385103; Cantorna MT, 2004, AM J CLIN NUTR, V80, p1717S; Feldman David, 2014, Bonekey Rep, V3, P510, DOI 10.1038/bonekey.2014.5; Kolek OI, 2005, AM J PHYSIOL-GASTR L, V289, pG1036, DOI 10.1152/ajpgi.00243.2005; Leyssens C, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00122; Lou YR, 2010, J STEROID BIOCHEM, V118, P162, DOI 10.1016/j.jsbmb.2009.11.011; Matsumoto T, 2012, CURR OSTEOPOROS REP, V10, P248, DOI 10.1007/s11914-012-0116-1	34	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1043-1802			BIOCONJUGATE CHEM	Bioconjugate Chem.	OCT	2015	26	10					2038	2045		10.1021/acs.bioconjchem.5b00433		8	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Multidisciplinary; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	CU3PU	WOS:000363438100007		
J	Futami, J; Nonomura, H; Kido, M; Niidoi, N; Fujieda, N; Hosoi, A; Fujita, K; Mandai, K; Atago, Y; Kinoshita, R; Honjo, T; Matsushita, H; Uenaka, A; Nakayama, E; Kakimi, K				Futami, Junichiro; Nonomura, Hidenori; Kido, Momoko; Niidoi, Naomi; Fujieda, Nao; Hosoi, Akihiro; Fujita, Kana; Mandai, Komako; Atago, Yuki; Kinoshita, Rie; Honjo, Tomoko; Matsushita, Hirokazu; Uenaka, Akiko; Nakayama, Eiichi; Kakimi, Kazuhiro			Sensitive Multiplexed Quantitative Analysis of Autoantibodies to Cancer Antigens with Chemically S-Cationized Full-Length and Water-Soluble Denatured Proteins	BIOCONJUGATE CHEMISTRY			English	Article							CELL LUNG-CANCER; CANCER/TESTIS ANTIGENS; COLORECTAL-CANCER; TESTIS ANTIGENS; HIGH-THROUGHPUT; ANTIBODY; IMMUNOTHERAPY; DETERMINANTS; SPECIFICITY; MICROARRAY	Humoral immune responses against tumor-associated antigens (TAAs) or cancer/testis antigens (CTAs) aberrantly expressed in tumor cells are frequently observed in cancer patients. Recent clinical studies have elucidated that anticancer immune responses with increased levels of anti-TAA/CTA antibodies improve cancer survival rates. Thus, these antibody levels are promising biomarkers for diagnosing the efficiency of cancer immunotherapy. Full-length antigens are favored for detecting anti-TAA/CTA antibodies because candidate antigen proteins contain multiple epitopes throughout their structures. In this study, we developed a methodology to prepare purified water-soluble and full-length antigens by using cysteine sulfhydryl group cationization (S-cationization) chemistry. S-Cationized antigens can be prepared from bacterial inclusion bodies, and they exhibit improved protein solubility but preserved antigenicity. Anti-TAA/CTA antibodies detected in cancer patients appeared to recognize linear epitopes, as well as conformational epitopes, and because the frequency of cysteine side-residues on the epitope-paratope interface was low, any adverse effects of S-cationization were virtually negligible for antibody binding. Furthermore, S-cationized antigen-immobilized Luminex beads could be successfully used in highly sensitive quantitative-multiplexed assays. Indeed, patients with a more broadly induced serum anti-TAA/CTA antibody level showed improved progression-free survival after immunotherapy. The comprehensive anti-TAA/CTA assay system, which uses S-cationized full-length and water-soluble recombinant antigens, may be a useful diagnostic tool for assessing the efficiency of cancer immunotherapy.	[Futami, Junichiro; Nonomura, Hidenori; Kido, Momoko; Niidoi, Naomi; Fujita, Kana; Mandai, Komako; Atago, Yuki; Kinoshita, Rie; Honjo, Tomoko] Okayama Univ, Grad Sch Nat Sci & Technol, Dept Med Bioengn, Okayama 7008530, Japan; [Fujieda, Nao; Hosoi, Akihiro] Medinet Co Ltd, Yokohama, Kanagawa 2220033, Japan; [Fujieda, Nao; Hosoi, Akihiro; Matsushita, Hirokazu; Kakimi, Kazuhiro] Tokyo Univ Hosp, Dept Immunotherapeut, Tokyo 1138655, Japan; [Uenaka, Akiko; Nakayama, Eiichi] Kawasaki Univ Med Welf, Fac Hlth & Welf, Okayama 7010193, Japan	Futami, J (reprint author), Okayama Univ, Grad Sch Nat Sci & Technol, Dept Med Bioengn, Okayama 7008530, Japan.	futamij@okayama-u.ac.jp			JSPS KAKENHI [23360370]; Development of Innovative Research on Cancer Therapeutics	This work was supported in part by JSPS KAKENHI (Grant Number 23360370 awarded to J. Futami) and a research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct awarded to K. Kakimi). We thank Emeritus Professor Hidenori Yamada for many helpful discussions.	Gnjatic S, 2010, P NATL ACAD SCI USA, V107, P5088, DOI 10.1073/pnas.0914213107; Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x; Futami J, 2007, EXPERT OPIN DRUG DIS, V2, P261, DOI 10.1517/17460441.2.2.261; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; OKAZAKI K, 1985, ANAL BIOCHEM, V145, P87, DOI 10.1016/0003-2697(85)90330-6; Yao YB, 2012, BIOCHEM BIOPH RES CO, V423, P613, DOI 10.1016/j.bbrc.2012.06.050; BARLOW DJ, 1986, NATURE, V322, P747, DOI 10.1038/322747a0; Inoue M, 1998, BIOTECHNOL APPL BIOC, V28, P207; Blankenstein T, 2012, NAT REV CANCER, V12, P307, DOI 10.1038/nrc3246; Marabelle A, 2013, J CLIN INVEST, V123, P2447, DOI 10.1172/JCI64859; Chatterjee M, 2006, CANCER RES, V66, P1181, DOI 10.1158/0008-5472.CAN-04-2962; Vanneman M, 2012, NAT REV CANCER, V12, P237, DOI 10.1038/nrc3237; Kawabata R, 2007, INT J CANCER, V120, P2178, DOI 10.1002/ijc.22583; Ramaraj T, 2012, BBA-PROTEINS PROTEOM, V1824, P520, DOI 10.1016/j.bbapap.2011.12.007; Chen HD, 2014, CANCER LETT, V346, P178, DOI 10.1016/j.canlet.2014.01.007; Murata H, 2006, BIOCHEMISTRY-US, V45, P6124, DOI 10.1021/bi052642a; Tompa P, 2004, FASEB J, V18, P1169, DOI 10.1096/fj.04-1584rev; Pedersen JW, 2013, BRIT J CANCER, V108, P107, DOI 10.1038/bjc.2012.517; Corbiere V, 2011, CANCER RES, V71, P1253, DOI 10.1158/0008-5472.CAN-10-2693; Beeton-Kempen N, 2014, INT J CANCER, V135, P1842, DOI 10.1002/ijc.28832; Gnjatic S, 2009, J IMMUNOL METHODS, V341, P50, DOI 10.1016/j.jim.2008.10.016; Ohue Y, 2012, INT J CANCER, V131, pE649, DOI 10.1002/ijc.27359; Bjerre M, 2009, VET IMMUNOL IMMUNOP, V130, P53, DOI 10.1016/j.vetimm.2009.01.007; Kringelum JV, 2013, MOL IMMUNOL, V53, P24, DOI 10.1016/j.molimm.2012.06.001; Wada H, 2014, J IMMUNOTHER, V37, P84, DOI 10.1097/CJI.0000000000000017; Gnjatic Sacha, 2009, V520, P11, DOI 10.1007/978-1-60327-811-9_2; Gelbart Y, 2004, PROTEIN EXPRES PURIF, V34, P183, DOI 10.1016/j.pep.2003.12.006; Kakimi K, 2011, INT J CANCER, V129, P2836, DOI 10.1002/ijc.25955; Rajagopalan K, 2011, J CELL BIOCHEM, V112, P3256, DOI 10.1002/jcb.23252; Miura K, 2002, BIOCHEM BIOPH RES CO, V294, P1040, DOI 10.1016/S0006-291X(02)00585-5; Costa S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00063; Suyama T, 2010, PROSTATE, V70, P1778, DOI 10.1002/pros.21214; Almeida LG, 2009, NUCLEIC ACIDS RES, V37, pD816, DOI 10.1093/nar/gkn673; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Patil A, 2010, INT J MOL SCI, V11, P1930, DOI 10.3390/ijms11041930; Peng HP, 2014, P NATL ACAD SCI USA, V111, pE2656, DOI 10.1073/pnas.1401131111; Shan Q, 2013, CANCER LETT, V328, P160, DOI 10.1016/j.canlet.2012.08.019; Sakamoto M, 2011, J IMMUNOTHER, V34, P202, DOI 10.1097/CJI.0b013e318207ecfb; Vinion-Dubiel AD, 2001, INFECT IMMUN, V69, P4329, DOI 10.1128/IAI.69.7.4329-4336.2001; Newton Dianne L, 2003, Methods Mol Biol, V207, P283; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Huang J, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-7; Jia J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095444; Mallorqui-Fernandez G, 2000, J MOL BIOL, V300, P1297, DOI 10.1006/jmbi.2000.3939; Middleton CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103867; Ohue Y, 2014, CLIN CANCER RES, V20, P5052, DOI 10.1158/1078-0432.CCR-14-0742; Olsen Dana, 2014, Front Oncol, V4, P105, DOI 10.3389/fonc.2014.00105; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; US Food and Drug Administration, 2014, IN VITR COMP DIAGN D	49	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1043-1802			BIOCONJUGATE CHEM	Bioconjugate Chem.	OCT	2015	26	10					2076	2084		10.1021/acs.bioconjchem.5b00328		9	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Multidisciplinary; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	CU3PU	WOS:000363438100012		
J	Kamada, K; Ito, D; Soh, N				Kamada, Kai; Ito, Daiki; Soh, Nobuaki			Visible-Light-Induced Activity Control of Peroxidase Bound to Fe-Doped Titanate Nanosheets with Nanometric Lateral Dimensions	BIOCONJUGATE CHEMISTRY			English	Article							HORSERADISH-PEROXIDASE; CATALYTIC-ACTIVITY; ENZYME-ACTIVITY; CARBON DOTS; PHOSPHATE; LAYERS	Catalytic performance of horseradish peroxidase (HRP) electrostatically adsorbed on nanometric and semiconducting Fe-doped titanate (FT) nanosheets was successfully manipulated by visible light illumination. A colloidal solution of FT with a narrow band gap corresponding to a visible light region was fabricated through a hydrolysis reaction of metals sources. HRP could be easily bound to the FT at pH = 4 through an electrostatic interaction between them, and the formed HRP-FT was utilized for the visible-light-driven enzymatic reaction. Under exposure to visible light with enough energy for band gap excitation of the FT, catalytic activity of HRP-FT was dramatically enhanced as compared with free (unbound) HRP and was simply adjusted by light intensity. In addition, wavelength dependence of an enzymatic reaction rate was analogous to an optical absorption spectrum of the FT. These results substantiated an expected reaction mechanism in which the photoenzymatic reaction was initiated by band gap excitation of FT followed by transferring holes generated in the valence band of irradiated FT to HRP. The excited HRP oxidized substrates (amplex ultrared: AUR) accompanied by two-electron reduction to regenerate the resting state. In addition, the catalytic activity was dearly switched by turning on and off the light source.	[Kamada, Kai; Ito, Daiki] Nagasaki Univ, Grad Sch Engn, Dept Chem & Mat Engn, Nagasaki 8528521, Japan; [Soh, Nobuaki] Saga Univ, Fac Agr, Saga 8408502, Japan	Kamada, K (reprint author), Nagasaki Univ, Grad Sch Engn, Dept Chem & Mat Engn, Nagasaki 8528521, Japan.	kkamada@nagasaki-u.ac.jp			JSPS KAKENHI [26410244, 15K05542]	The present work was partly supported by JSPS KAKENHI Grant No. 26410244 and 15K05542.	Besselink R, 2010, J PHYS CHEM C, V114, P21281, DOI 10.1021/jp108687q; Kamada K, 2014, RSC ADV, V4, P43052, DOI 10.1039/c4ra05665e; Miljevic M, 2014, ADV FUNCT MATER, V24, P907, DOI 10.1002/adfm.201301484; Kamada K, 2012, J PHYS CHEM C, V116, P20694, DOI 10.1021/jp3046559; Wang QG, 2004, J AM CHEM SOC, V126, P14346, DOI 10.1021/ja047224s; Bretschneider JC, 2009, SMALL, V5, P2549, DOI 10.1002/smll.200900544; Kamada K, 2015, J PHYS CHEM B, V119, P5309, DOI 10.1021/jp512038x; Fruk L, 2007, CHEMBIOCHEM, V8, P2195, DOI 10.1002/cbic.200700594; Kamada K, 2011, J PHYS CHEM C, V115, P13232, DOI 10.1021/jp203332v; Ohya T, 2002, CHEM MATER, V14, P3082, DOI 10.1021/cm0200588; Harada M, 2002, J PHOTOCH PHOTOBIO A, V148, P273, DOI 10.1016/S1010-6030(02)00053-9; Li H, 2014, J MATER CHEM B, V2, P5652, DOI 10.1039/c4tb00705k; Kohse S, 2014, CHEMCATCHEM, V6, P3511, DOI 10.1002/cctc.201402442; Sovic D, 2011, ELECTROCHIM ACTA, V56, P9953, DOI 10.1016/j.electacta.2011.08.077; Kumar CV, 1997, CHEM MATER, V9, P863, DOI 10.1021/cm960634y; Shimoboji T, 2003, BIOCONJUGATE CHEM, V14, P517, DOI 10.1021/bc025615v; Kamada K, 2011, CHEM MATER, V23, P2968, DOI 10.1021/cm200672f; Kamada K, 2010, J MATER CHEM, V20, P5646, DOI 10.1039/c0jm00173b; Kohse S, 2013, J AM CHEM SOC, V135, P9407, DOI 10.1021/ja400700x; Li H, 2015, ACS APPL MATER INTER, V7, P10004, DOI 10.1021/acsami.5b02386; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551	21	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1043-1802			BIOCONJUGATE CHEM	Bioconjugate Chem.	OCT	2015	26	10					2161	2166		10.1021/acs.bioconjchem.5b00464		6	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Multidisciplinary; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	CU3PU	WOS:000363438100021		
J	Kotani, Y; Ohgami, Y; Ishiwata, T; Arai, J; Kiryu, S; Inoue, Y				Kotani, Yasunori; Ohgami, Yoshimi; Ishiwata, Takayuki; Arai, Jun-ichirou; Kiryu, Shigeru; Inoue, Yusuke			Source analysis of stimulus-preceding negativity constrained by functional magnetic resonance imaging	BIOLOGICAL PSYCHOLOGY			English	Article						Stimulus preceding negativity; Insular cortex; Dipole modeling; Salience network	RIGHT-HEMISPHERE PREPONDERANCE; ANTERIOR INSULAR CORTEX; TIME-ESTIMATION TASK; FEEDBACK STIMULI; PHYSIOLOGICAL CONDITION; REWARD ANTICIPATION; ATTENTION; NETWORKS; BRAIN; CONNECTIVITY	The stimulus-preceding negativity (SPN) is an event-related potential (ERP) reflecting anticipation. The anterior insular cortex is assumed to be one of the physiological sources of the SPN. However, the precise neural substrates of the SPN have yet to be confirmed. We therefore performed separate functional magnetic resonance imaging (fMRI) and ERP studies using the same time estimation task, followed by fMRI-constrained ERP source analysis. Dipole locations were determined by the fMRI results, while the time courses of dipole activities were modeled by the ERP data. Analysis revealed that the right anterior insula was significantly activated before delivery of the feedback stimulus, whereas the left anterior insula was not, and that the SPN mainly arose from four groups of brain regions related to, respectively: (1) the salience network, (2) reward expectation, (3) perceptual anticipation, and (4) arousal. The results suggest that the SPN pertains to multiple brain functions with complex interactions. (C) 2015 Elsevier B.V. All rights reserved.	[Kotani, Yasunori; Ohgami, Yoshimi] Tokyo Inst Technol, Dept Human Syst Sci, Meguro Ku, Tokyo 152, Japan; [Ishiwata, Takayuki] Rikkyo Univ, Dept Sport & Wellness, Niiza, Saitama, Japan; [Arai, Jun-ichirou] Daikin Ind Ltd, Technol & Innovat Ctr Preparat Off, Minato Ku, Tokyo, Japan; [Kiryu, Shigeru] Univ Tokyo, Inst Med Sci, Dept Radiol, Minato Ku, Tokyo, Japan; [Inoue, Yusuke] Kitasato Univ, Sch Med, Dept Diagnost Radiol, Minami Ku, Sagamihara, Kanagawa 228, Japan	Kotani, Y (reprint author), Tokyo Inst Technol, Dept Human Syst Sci, Meguro Ku, 2-12-1 Ohokayama, Tokyo 152, Japan.	kotani@hum.titech.ac.jp			Japan Society for the Promotion of Science (JSPS) [23500724]	We thank Yumiko Kuramoto, Taro Tomatsu, and Tatsuya Yoshihiro for their assistance with data collection and analysis. This research was supported by a Grant-in-Aid for Scientific Research (C) 23500724 from the Japan Society for the Promotion of Science (JSPS).	BRUNIA CHM, 1988, BIOL PSYCHOL, V26, P165, DOI 10.1016/0301-0511(88)90018-X; Ham T, 2013, J NEUROSCI, V33, P7091, DOI 10.1523/JNEUROSCI.4692-12.2013; Kotani Y, 2003, PSYCHOPHYSIOLOGY, V40, P818, DOI 10.1111/1469-8986.00082; Kotani Y, 2009, NEUROSCI LETT, V450, P75, DOI 10.1016/j.neulet.2008.11.032; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Brunia CHM, 2000, EXP BRAIN RES, V130, P328, DOI 10.1007/s002219900293; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Bledowski C, 2004, J NEUROSCI, V24, P9353, DOI 10.1523/JNEUROSCI.1897-04.2004; Kosillo P, 2010, BRAIN STRUCT FUNCT, V214, P623, DOI 10.1007/s00429-010-0267-8; Becker MPI, 2014, J NEUROSCI, V34, P3005, DOI 10.1523/JNEUROSCI.3684-13.2014; Tsukamoto T, 2006, NEUROSCI LETT, V399, P39, DOI 10.1016/j.neulet.2006.01.061; Pujol J, 2002, NEUROIMAGE, V15, P103, DOI 10.1006/nimg.2001.0928; Foti D, 2012, PSYCHOPHYSIOLOGY, V49, P617, DOI 10.1111/j.1469-8986.2011.01343.x; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Gu XS, 2013, J COMP NEUROL, V521, P3371, DOI 10.1002/cne.23368; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Brunia CHM, 2011, CLIN NEUROPHYSIOL, V122, P858, DOI 10.1016/j.clinph.2010.12.039; Frishkoff Gwen A, 2004, Brain Res Cogn Brain Res, V20, P329; van Boxtel GJM, 2004, J PSYCHOPHYSIOL, V18, P61, DOI 10.1027/0269-8803.18.23.61; Spati J, 2014, HUM BRAIN MAPP, V35, P4428, DOI 10.1002/hbm.22484; Viinikainen M, 2010, HUM BRAIN MAPP, V31, P1030, DOI 10.1002/hbm.20915; Kotani Y, 2001, PSYCHOPHYSIOLOGY, V38, P873, DOI 10.1111/1469-8986.3860873; Touroutoglou A, 2012, NEUROIMAGE, V60, P1947, DOI 10.1016/j.neuroimage.2012.02.012; Gerardin E, 2000, CEREB CORTEX, V10, P1093, DOI 10.1093/cercor/10.11.1093; Kotani Y, 1999, BIOL PSYCHOL, V50, P1, DOI 10.1016/S0301-0511(98)00047-7; Masaki H, 2010, NEUROREPORT, V21, P277, DOI 10.1097/WNR.0b013e3283360bc3; Ohgami Y, 2004, PSYCHOPHYSIOLOGY, V41, P729, DOI 10.1111/j.1469-8986.2004.00203.x; Poli S, 2007, INT J PSYCHOPHYSIOL, V65, P32, DOI 10.1016/j.ijpsycho.2007.02.008; Ohgami Y, 2014, PSYCHOPHYSIOLOGY, V51, P843, DOI 10.1111/psyp.12234; DAMEN EJP, 1994, PSYCHOPHYSIOLOGY, V31, P129, DOI 10.1111/j.1469-8986.1994.tb01033.x; Ohgami Y, 2006, PSYCHOPHYSIOLOGY, V43, P227, DOI 10.1111/j.1469-8986.2006.00396.x; [Anonymous], 1985, CLIN NEUROPHYSIOL; Brunia CHM, 2004, EXP BRAIN RES, V156, P231, DOI 10.1007/s00221-003-1780-2; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sladky R, 2011, NEUROIMAGE, V58, P588, DOI 10.1016/j.neuroimage.2011.06.078; BERG P, 1991, CLIN PHYS PHYSIOL M, V12, P49, DOI 10.1088/0143-0815/12/A/010; Moris J, 2013, PSYCHOPHYSIOLOGY, V50, P931, DOI 10.1111/psyp.12073; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Nelson SM, 2010, BRAIN STRUCT FUNCT, V214, P669, DOI 10.1007/s00429-010-0260-2; Eckert MA, 2009, HUM BRAIN MAPP, V30, P2530, DOI 10.1002/hbm.20688; Mattox ST, 2006, CLIN NEUROPHYSIOL, V117, P2144, DOI 10.1016/j.clinph.2006.05.026; Kucyi A, 2012, J NEUROPHYSIOL, V108, P3382, DOI 10.1152/jn.00674.2012; Bocker Koen B. E., 1994, Brain Topography, V7, P71, DOI 10.1007/BF01184839; Catena A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040252; Luck S., 2014, INTRO EVENT RELATED; Scherg M., 2010, BESA RES TUTORIAL 1; Scherg Michael, 1992, Brain Topography, V5, P103, DOI 10.1007/BF01129037; Singh-Curry V., 2009, NEUROPSYCHOLOGIA, V47, P1434; Stavropoulos KKM, 2014, SOC COGN AFFECT NEUR, V9, P1569, DOI 10.1093/scan/nst149; Van der Molen Melle J W, 2013, Front Hum Neurosci, V7, P936, DOI 10.3389/fnhum.2013.00936	54	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0301-0511	1873-6246		BIOL PSYCHOL	Biol. Psychol.	OCT	2015	111						53	64		10.1016/j.biopsycho.2015.08.005		12	Psychology, Biological; Behavioral Sciences; Psychology; Psychology, Experimental	Psychology; Behavioral Sciences	CU4HM	WOS:000363488500006		
J	Miyamoto, H; Matsueda, S; Moritsuka, A; Shimokawa, K; Hirata, H; Nakashima, M; Sasaki, H; Fumoto, S; Nishida, K				Miyamoto, Hirotaka; Matsueda, Satoshi; Moritsuka, Akihiro; Shimokawa, Kenta; Hirata, Haruna; Nakashima, Mikiro; Sasaki, Hitoshi; Fumoto, Shintaro; Nishida, Koyo			Evaluation of hypothermia on the in vitro metabolism and binding and in vivo disposition of midazolam in rats	BIOPHARMACEUTICS & DRUG DISPOSITION			English	Article						therapeutic hypothermia; midazolam; CYP3A2; protein binding; distribution	MILD THERAPEUTIC HYPOTHERMIA; DRUG-METABOLISM; CARDIAC-ARREST; PHARMACOKINETICS; CLEARANCE; 1-AMINOBENZOTRIAZOLE; CYTOCHROME-P-450; INHIBITION; SYSTEM; ELIMINATION	The effect of hypothermia on the in vivo pharmacokinetics of midazolam was evaluated, with a focus on altered metabolism in the liver and binding to serum proteins. Rat primary hepatocytes were incubated with midazolam (which is metabolized mainly by CYP3A2) at 37, 32 or 28 degrees C. The Michaelis-Menten constant (K-m) and maximum velocity (V-max) of midazolam were estimated using the Michaelis-Menten equation. The K-m of CYP3A2 midazolam remained unchanged, but the V-max decreased at 28 degrees C. In rats, whose temperature was maintained at 37, 32 or 28 degrees C by a heat lamp or ice pack, the plasma concentrations of midazolam were higher, whereas those in the brain and liver were unchanged at 28 degrees C. The tissue/plasma concentration ratios were, however, increased significantly. The unbound fraction of midazolam in serum at 28 degrees C was half that at 37 degrees C. These pharmacokinetic changes associated with hypothermic conditions were due to reductions in CYP3A2 activity and protein binding. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Miyamoto, Hirotaka; Matsueda, Satoshi; Shimokawa, Kenta; Hirata, Haruna; Nakashima, Mikiro; Fumoto, Shintaro; Nishida, Koyo] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528521, Japan; [Moritsuka, Akihiro; Sasaki, Hitoshi] Nagasaki Univ Hosp, Dept Hosp Pharm, Nagasaki, Japan	Nishida, K (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.	dds.yakuzai@gmail.com			JSPS [26860108]	We thank Keiko Abe and Yurika Hori for their skillful assistance. This work was supported by JSPS KAKENHI Grant Number 26860108.	YAMAOKA K, 1978, J PHARMACOKINET BIOP, V6, P547, DOI 10.1007/BF01062109; Desjardins JP, 1995, J PHARMACOL EXP THER, V275, P1608; Iida Y, 2001, THER DRUG MONIT, V23, P192, DOI 10.1097/00007691-200106000-00002; Fukuoka N, 2004, RESUSCITATION, V60, P225, DOI 10.1016/j.resuscitation.2003.09.017; Imaoka S, 1996, BIOCHEM PHARMACOL, V51, P1041, DOI 10.1016/0006-2952(96)00052-4; Jurica J, 2007, J CHROMATOGR B, V852, P571, DOI 10.1016/j.jchromb.2007.02.034; Tveita T, 1996, CAN J PHYSIOL PHARM, V74, P376, DOI 10.1139/cjpp-74-4-376; Tortorici MA, 2007, CRIT CARE MED, V35, P2196, DOI 10.1097/01.CCM.0000281517.97507.6E; Field JM, 2010, CIRCULATION, V122, pS640, DOI 10.1161/CIRCULATIONAHA.110.970889; ARENDT RM, 1987, PSYCHOPHARMACOLOGY, V93, P72, DOI 10.1007/BF02439589; Empey PE, 2012, CRIT CARE MED, V40, P1221, DOI 10.1097/CCM.0b013e31823779f9; MICO BA, 1988, BIOCHEM PHARMACOL, V37, P2515, DOI 10.1016/0006-2952(88)90240-7; Doan KMM, 2002, J PHARMACOL EXP THER, V303, P1029, DOI 10.1124/jpet.102.039255; MATHEWS JM, 1985, J PHARMACOL EXP THER, V235, P186; Holzer M, 2002, NEW ENGL J MED, V346, P549; Imanaga J, 2011, PHARMACOGENET GENOM, V21, P84, DOI 10.1097/FPC.0b013e32834300cc; MOSCHITTO LJ, 1983, J PHARM PHARMACOL, V35, P179; IMAOKA S, 1988, J BIOCHEM-TOKYO, V104, P481; Scherrmann JM, 2009, CHEM BIODIVERS, V6, P1933, DOI 10.1002/cbdv.200900171; HUIJZER JC, 1989, DRUG METAB DISPOS, V17, P37; Hostler D, 2010, DRUG METAB DISPOS, V38, P781, DOI 10.1124/dmd.109.031377; Nishida K, 2007, BIOL PHARM BULL, V30, P1763, DOI 10.1248/bpb.30.1763; Ghibellini G, 2007, CLIN PHARMACOL THER, V81, P406, DOI 10.1038/sj.clpt.6100059; Miyamoto H, 2013, J PHARM PHARMACOL, V65, P1536, DOI 10.1111/jphp.12130; Caldwell JE, 2000, ANESTHESIOLOGY, V92, P84, DOI 10.1097/00000542-200001000-00018; MUGFORD CA, 1992, FUND APPL TOXICOL, V19, P43, DOI 10.1016/0272-0590(92)90026-E; Franke RM, 2008, CLIN PHARMACOL THER, V84, P704, DOI 10.1038/clpt.2008.94; Nagilla Rakesh, 2006, Journal of Pharmacological and Toxicological Methods, V53, P106, DOI 10.1016/j.vasen.2005.08.005; Baranczewski P, 2006, PHARMACOL REP, V58, P453; ECC Committee SaTFotAHA, 2005, CIRCULATION, V112, DOI 10.1161/CIRCULATIONAHA.105.166566; Guengrich FP, 1999, ANNU REV PHARMACOL, V39, P1, DOI 10.1146/annurev.pharmtox.39.1.1; Hallifax D, 2006, DRUG METAB DISPOS, V34, P1829, DOI 10.1124/dmd.106.010413; NIES A S, 1976, Clinical Pharmacokinetics, V1, P135, DOI 10.2165/00003088-197601020-00005; Ortiz de Montellano PR, 1981, BIOCHEM J, V195, P761; Pang K S, 1977, J Pharmacokinet Biopharm, V5, P625, DOI 10.1007/BF01059688; SCHUBERT A, 1995, J NEUROSURG ANESTH, V7, P139, DOI 10.1097/00008506-199504000-00021; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; WONG KC, 1983, WESTERN J MED, V138, P227	38	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2782	1099-081X		BIOPHARM DRUG DISPOS	Biopharm. Drug Dispos.	OCT	2015	36	7					481	489		10.1002/bdd.1960		9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CU3EC	WOS:000363405900006		
J	Iwatani, J; Ishida, T; Donishi, T; Ukai, S; Shinosaki, K; Terada, M; Kaneoke, Y				Iwatani, Jun; Ishida, Takuya; Donishi, Tomohiro; Ukai, Satoshi; Shinosaki, Kazuhiro; Terada, Masaki; Kaneoke, Yoshiki			Use of T1-weighted/T2-weighted magnetic resonance ratio images to elucidate changes in the schizophrenic brain	BRAIN AND BEHAVIOR			English	Article						magnetic resonance imaging; myelin; nucleus accumbens; schizophrenia; T1-weighted/T2-weighted ratio; ventral putamen	WHITE-MATTER INTEGRITY; REDUCED CORTICAL THICKNESS; PREFRONTAL CORTEX; 1ST-EPISODE SCHIZOPHRENIA; REGISTRATION ALGORITHM; LIKELIHOOD ESTIMATION; INTERSTITIAL-CELLS; NUCLEUS-ACCUMBENS; PYRAMIDAL NEURONS; T2-WEIGHTED MRI	Introduction: One leading hypothesis suggests that schizophrenia (SZ) is a neurodevelopmental disorder caused by genetic defects in association with environmental risk factors that affect synapse and myelin formation. Recent magnetic resonance imaging (MRI) studies of SZ brain showed both gray matter (GM) reduction and white matter (WM) fractional anisotropy reduction. In this study, we used T1-weighted (T1w)/T2-weighted (T2w) MRI ratio images, which increase myelin-related signal contrast and reduce receiver-coil bias. Methods: We measured T1w/T2w ratio image signal intensity in 29 patients with SZ and 33 healthy controls (HCs), and then compared them against bias-corrected T1w images. Results: Mean T1w/T2w ratio signal intensity values across all SZ GM and WM voxels were significantly lower than those for the HC values (analysis of covariance with age, gender, handedness, and premorbid intelligence quotient as nuisance covariates). SZ mean WM T1w/T2w ratio values were related to Global Assessment of Functioning (GAF) scores and were inversely related to the positive psychotic symptoms of the Positive and Negative Syndrome Scale. Voxel-based analysis revealed significantly lower T1w/T2w ratio image signal intensity values in the right ventral putamen in SZ GM. T1w image intensities did not differ between the SZ and HC groups. Conclusions: T1-weighted/T2-weighted ratio imaging increased the detectability of SZ pathological changes. Reduced SZ brain signal intensity is likely due to diminished myelin content; therefore, mapping myelin-related SZ brain changes using T1w/T2w ratio images may be useful for studies of SZ brain abnormalities.	[Iwatani, Jun; Ishida, Takuya; Ukai, Satoshi; Shinosaki, Kazuhiro] Wakayama Med Univ, Dept Neuropsychiat, Grad Sch, Wakayama 6418509, Japan; [Ishida, Takuya; Donishi, Tomohiro; Kaneoke, Yoshiki] Wakayama Med Univ, Dept Syst Neurophysiol, Grad Sch, Wakayama 6418509, Japan; [Terada, Masaki] Wakayama Minami Radiol Clin, Wakayama 6410012, Japan	Ishida, T (reprint author), Wakayama Med Univ, Dept Syst Neurophysiol, Grad Sch, 811-1 Kimiidera, Wakayama 6418509, Japan.	ishitaku@wakayama-med.ac.jp			Japan Society for the Promotion of Science [24591303, 25350994]	This study was supported by a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (24591303 and 25350994) to Y.K and T.D.	Roussos P, 2012, ARCH GEN PSYCHIAT, V69, P7, DOI 10.1001/archgenpsychiatry.2011.110; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Lutti A, 2014, NEUROIMAGE, V93, P176, DOI 10.1016/j.neuroimage.2013.06.005; Lieberman JA, 2005, ARCH GEN PSYCHIAT, V62, P361, DOI 10.1001/archpsyc.62.4.361; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; MELTZER HY, 1976, SCHIZOPHRENIA BULL, V2, P19; Wilke M, 2001, NEUROIMAGE, V13, P814, DOI 10.1006/nimg.2001.0751; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; Kubicki M, 2007, J PSYCHIAT RES, V41, P15, DOI 10.1016/j.jspychires.2005.05.005; Glasser MF, 2011, J NEUROSCI, V31, P11597, DOI 10.1523/JNEUROSCI.2180-11.2011; Fjell AM, 2011, J NEUROSCI, V31, P18060, DOI 10.1523/JNEUROSCI.4735-11.2011; Selemon LD, 2003, ARCH GEN PSYCHIAT, V60, P69; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261; Raij TT, 2009, BRAIN, V132, P2994, DOI 10.1093/brain/awp186; Takahashi N, 2013, NEUROBIOL DIS, V53, P49, DOI 10.1016/j.nbd.2012.11.001; Garey L, 2010, J ANAT, V217, P324, DOI 10.1111/j.1469-7580.2010.01231.x; Stuber C, 2014, NEUROIMAGE, V93, P95, DOI 10.1016/j.neuroimage.2014.02.026; Friston KJ, 1998, SCHIZOPHR RES, V30, P115, DOI 10.1016/S0920-9964(97)00140-0; CROW TJ, 1977, PSYCHOL MED, V7, P213; Davis KL, 2003, ARCH GEN PSYCHIAT, V60, P443, DOI 10.1001/archpsyc.60.5.443; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Uranova NA, 2004, SCHIZOPHR RES, V67, P269, DOI 10.1016/S0920-9964(03)00181-6; Douaud G, 2007, BRAIN, V130, P2375, DOI 10.1093/brain/awm184; Whitford TJ, 2012, SCHIZOPHRENIA BULL, V38, P486, DOI 10.1093/schbul/sbq105; Billeke P, 2015, BIOL PSYCHIAT, V78, P421, DOI 10.1016/j.biopsych.2015.02.012; Mamah D, 2007, SCHIZOPHR RES, V89, P59, DOI 10.1016/j.schres.2006.08.031; Kirkpatrick B, 2003, J NERV MENT DIS, V191, P563, DOI 10.1097/01.nmd.0000087181.61164.e1; Dean B, 2009, CURR OPIN PSYCHIATR, V22, P154, DOI 10.1097/YCO.0b013e328323d52e; Ridgway GR, 2009, NEUROIMAGE, V44, P99, DOI 10.1016/j.neuroimage.2008.08.045; Rajkowska G, 1998, ARCH GEN PSYCHIAT, V55, P215, DOI 10.1001/archpsyc.55.3.215; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Glahn DC, 2008, BIOL PSYCHIAT, V64, P774, DOI 10.1016/j.biopsych.2008.03.031; Pfefferbaum A, 1999, PSYCHIAT RES-NEUROIM, V91, P93, DOI 10.1016/S0925-4927(99)00023-2; Tomassy GS, 2014, SCIENCE, V344, P319, DOI 10.1126/science.1249766; Grydeland H, 2013, J NEUROSCI, V33, P18618, DOI 10.1523/JNEUROSCI.2811-13.2013; Akbarian S, 1996, ARCH GEN PSYCHIAT, V53, P425; Flynn SW, 2003, MOL PSYCHIATR, V8, P811, DOI 10.1038/sj.mp.4001337; Tkachev D, 2007, INT J NEUROPSYCHOPH, V10, P557, DOI 10.1017/S1461145706007334; Kubota M, 2011, SCHIZOPHR RES, V125, P21, DOI 10.1016/j.schres.2010.10.004; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Iritani S, 2007, NEUROPATHOLOGY, V27, P604, DOI 10.1111/j.1440-1789.2007.00798.x; Iosifescu DV, 1997, NEUROIMAGE, V6, P13, DOI 10.1006/nimg.1997.0274; Kubota M, 2013, JAMA PSYCHIAT, V70, P12, DOI 10.1001/archgenpsychiatry.2012.1023; Bennett MR, 2011, PROG NEUROBIOL, V95, P275, DOI 10.1016/j.pneurobio.2011.08.003; Ellison-Wright I, 2008, AM J PSYCHIAT, V165, P1015, DOI 10.1176/appi.ajp.2008.07101562; Kubicki M, 2002, AM J PSYCHIAT, V159, P813, DOI 10.1176/appi.ajp.159.5.813; Goldman AL, 2009, ARCH GEN PSYCHIAT, V66, P467, DOI 10.1001/archgenpsychiatry.2009.24; Sasamoto A, 2014, SCHIZOPHRENIA BULL, V40, P420, DOI 10.1093/schbul/sbt030; Selemon LD, 1998, J COMP NEUROL, V392, P402; Tamnes CK, 2012, J NEUROSCI, V32, P972, DOI 10.1523/JNEUROSCI.4779-11.2012; Glasser MF, 2014, NEUROIMAGE, V93, P165, DOI 10.1016/j.neuroimage.2013.03.060; Bengtsson-Tops A, 1999, EUR PSYCHIAT, V14, P256, DOI 10.1016/S0924-9338(99)00173-X; Kirkpatrick B, 1999, SYNAPSE, V34, P95, DOI 10.1002/(SICI)1098-2396(199911)34:2<95::AID-SYN2>3.0.CO;2-I; Kuroki N, 2006, AM J PSYCHIAT, V163, P2103, DOI 10.1176/appi.ajp.163.12.2103; Ellison-Wright I, 2009, SCHIZOPHR RES, V108, P3, DOI 10.1016/j.schres.2008.11.021; Koch K, 2013, CORTEX, V49, P722, DOI 10.1016/j.cortex.2012.02.001; Lauer M, 2001, J NEURAL TRANSM, V108, P645, DOI 10.1007/s007020170042; Lang EJ, 2003, J NEUROPHYSIOL, V89, P2259, DOI 10.1152/jn.00922.2002; Meyer-Lindenberg AS, 2005, ARCH GEN PSYCHIAT, V62, P379, DOI 10.1001/archpsyc.62.4.379; Hoffman RE, 2011, BIOL PSYCHIAT, V69, P407, DOI 10.1016/j.biopsych.2010.09.050; Schultz CC, 2010, SCHIZOPHR RES, V116, P204, DOI 10.1016/j.schres.2009.11.001; Garey LJ, 1998, J NEUROL NEUROSUR PS, V65, P446, DOI 10.1136/jnnp.65.4.446; Lee SH, 2013, SCHIZOPHR RES, V143, P231, DOI 10.1016/j.schres.2012.11.029; Selemon LD, 1999, BIOL PSYCHIAT, V45, P17, DOI 10.1016/S0006-3223(98)00281-9; Knochel C, 2012, SCHIZOPHR RES, V140, P129, DOI 10.1016/j.schres.2012.06.001; Sugai T, 2004, ANN NY ACAD SCI, V1025, P84, DOI 10.1196/annals.1316.011; Tkachev D, 2003, LANCET, V362, P798, DOI 10.1016/S0140-6736(03)14289-4; Dazzan P, 2005, NEUROPSYCHOPHARMACOL, V30, P765, DOI 10.1038/sj.npp.1300603; Skelly LR, 2008, SCHIZOPHR RES, V98, P157, DOI 10.1016/j.schres.2007.10.009; Brandt Gerrit N, 2008, Wien Med Wochenschr, V158, P84, DOI 10.1007/s10354-007-0478-7; Brett M., HUMAN BRAIN MAPPING; Ganzetti M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00671; Roussos P, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00005; Haroutunian V, 2014, GLIA, V62, P1856, DOI 10.1002/glia.22716; Inada T, 2008, JPN J CLIN PSYCHOPHA, V11, P887; Inagaki A., 2006, JPN J CLIN PSYCHOPHA, V9, P1443; Nelson HE, 1982, NATL ADULT READING T; Rolland B., 2014, SCHIZOPHR B, V41, P291; Shafee R, 2015, NEUROIMAGE, V105, P473, DOI 10.1016/j.neuroimage.2014.10.054; Teraguchi M., 2013, J MAGN RESON IMAGING, V40, P1199	80	0	0	JOHN WILEY & SONS INC	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	OCT	2015	5	10							e00399	10.1002/brb3.399		14	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	CU3KJ	WOS:000363423500013		
J	Yamamoto, M; Kushima, I; Kimura, H; Hayashi, A; Kawano, N; Aleksic, B; Iidaka, T; Ozaki, N				Yamamoto, Maeri; Kushima, Itaru; Kimura, Hiroki; Hayashi, Akiko; Kawano, Naoko; Aleksic, Branko; Iidaka, Tetsuya; Ozaki, Norio			White matter microstructure between the pre-SMA and the cingulum bundle is related to response conflict in healthy subjects	BRAIN AND BEHAVIOR			English	Article						Attention; connectivity; diffusion tractography; fractional anisotropy; functional MRI	MEDIAL FRONTAL-CORTEX; EVENT-RELATED FMRI; INDIVIDUAL-DIFFERENCES; COGNITIVE CONTROL; IMAGING TRACTOGRAPHY; ANTERIOR CINGULATE; LEARNING SUCCESS; BRAIN IMAGES; OLDER-ADULTS; DIFFUSION	Introduction: Response conflict involves selectively attending to relevant information and suppressing distracting, irrelevant information. The medial frontal cortex (MFC) is considered to be involved in response conflict. However, it remains unclear which white matter connectivity is associated with response conflict. This study aimed to delineate the neural connectivity of response conflict in healthy subjects and investigate the association between white matter microstructure and performance of a response conflict task. Method: Twenty-eight healthy subjects underwent functional magnetic resonance imaging (fMRI) during the Flanker task and diffusion MRI. We identified the presupplementary motor area (pre-SMA) using fMRI. Furthermore, we delineated the white matter connectivity between the pre-SMA and the cingulum bundle (CB), which is located in the MFC, using probabilistic tractography. We calculated the mean diffusivity (MD), index of white matter microstructure, of this tract and evaluate the association between MD and performance of the Flanker task. Result: The mean MD of this tract was significantly and positively associated with performance of the Flanker task. Conclusion: The present study suggests the white matter connectivity between the pre-SMA and the CB is related to the response conflict in healthy subjects and finer white matter microstructure is associated with smaller response conflict.	[Yamamoto, Maeri; Kushima, Itaru; Kimura, Hiroki; Hayashi, Akiko; Kawano, Naoko; Aleksic, Branko; Iidaka, Tetsuya; Ozaki, Norio] Nagoya Univ, Grad Sch Med, Dept Psychiat, Nagoya, Aichi 4668550, Japan; [Kushima, Itaru] Nagoya Univ, Inst Adv Res, Nagoya, Aichi 4668550, Japan; [Kawano, Naoko] Nagoya Univ, Inst Innovat Future Soc, Nagoya, Aichi 4668550, Japan	Iidaka, T (reprint author), Nagoya Univ, Grad Sch Med, Dept Psychiat, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	iidaka@med.nagoya-u.ac.jp	Aleksic, Branko/G-1540-2011; Ozaki, Norio/M-8908-2014; KUSHIMA, Itaru/M-8872-2014	Aleksic, Branko/0000-0001-8982-4580; Ozaki, Norio/0000-0002-7360-4898; 	Japan Agency for Medical Research and development, AMED	Funding for this study was provided by research grants from Grant-in-Aid for "Integrated research on neuropsy-chiatric disorders" carried out under the Strategic Research Program for Brain Sciences from Japan Agency for Medical Research and development, AMED, the Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from AMED and "Glial assembly: a new regulatory machinery of brain function and disorders".	Morecraft RJ, 2012, BRAIN RES BULL, V87, P457, DOI 10.1016/j.brainresbull.2011.12.005; Schulte T, 2005, CEREB CORTEX, V15, P1384, DOI 10.1093/cercor/bhi020; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; O'Sullivan M, 2001, NEUROLOGY, V57, P632; Chaddock-Heyman L, 2013, BIOL PSYCHOL, V94, P109, DOI 10.1016/j.biopsycho.2013.05.008; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Wong FCK, 2011, J NEUROSCI, V31, P8780, DOI 10.1523/JNEUROSCI.0999-11.2011; Weissman DH, 2003, NEUROIMAGE, V19, P1361, DOI 10.1016/S1053-8119(03)00167-8; Taylor PCJ, 2007, J NEUROSCI, V27, P11343, DOI 10.1523/JNEUROSCI.2877-07.2007; Johansen-Berg H, 2007, NEUROIMAGE, V36, pT16, DOI 10.1016/j.neuroimage.2007.03.041; Della-Maggiore V, 2009, HUM BRAIN MAPP, V30, P4048, DOI 10.1002/hbm.20828; Ullsperger M, 2001, NEUROIMAGE, V14, P1387, DOI 10.1006/nimg.2001.0935; Fjell AM, 2012, NEUROIMAGE, V61, P195, DOI 10.1016/j.neuroimage.2012.03.007; Casey BJ, 2000, P NATL ACAD SCI USA, V97, P8728, DOI 10.1073/pnas.97.15.8728; Rae CL, 2015, J NEUROSCI, V35, P786, DOI 10.1523/JNEUROSCI.3093-13.2015; Durston S, 2003, NEUROIMAGE, V20, P2135, DOI 10.1016/j.neuroimage.2003.08.004; Doyon J, 2002, P NATL ACAD SCI USA, V99, P1017, DOI 10.1073/pnas.022615199; Nachev P, 2007, NEUROIMAGE, V36, pT155, DOI 10.1016/j.neuroimage.2007.03.034; Bunge SA, 2002, NEUROIMAGE, V17, P1562, DOI 10.1006/nimg.2002.1252; Takahashi M, 2010, NEUROSCI LETT, V477, P72, DOI 10.1016/j.neulet.2010.04.031; Rudebeck SR, 2009, J NEUROSCI, V29, P14987, DOI 10.1523/JNEUROSCI.4707-09.2009; Gold BT, 2007, NEUROPSYCHOLOGIA, V45, P2439, DOI 10.1016/j.neuropsychologia.2007.04.011; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Baird AA, 2005, J COGNITIVE NEUROSCI, V17, P687, DOI 10.1162/0898929053467569; Zheng Z, 2014, HUM BRAIN MAPP, V35, P1325, DOI 10.1002/hbm.22256; Catani M, 2006, CURR OPIN NEUROL, V19, P599, DOI 10.1097/01.wco.0000247610.44106.3f; Turken AU, 2008, NEUROIMAGE, V42, P1032, DOI 10.1016/j.neuroimage.2008.03.057; Tomassini V, 2011, HUM BRAIN MAPP, V32, P494, DOI 10.1002/hbm.21037; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Kantarci K, 2011, NEUROLOGY, V77, P26, DOI 10.1212/WNL.0b013e31822313dc; Klingberg T, 2000, NEURON, V25, P493, DOI 10.1016/S0896-6273(00)80911-3; Garavan H, 2003, NEUROIMAGE, V20, P1132, DOI 10.1016/S1053-8119(03)00334-3; Behrens TEJ, 2003, MAGNET RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Johansen-Berg H, 2010, CURR OPIN NEUROL, V23, P351, DOI 10.1097/WCO.0b013e32833b7631; Stuphorn V, 2000, NATURE, V408, P857; Nachev P, 2005, CURR BIOL, V15, P122, DOI 10.1016/j.cub.2005.01.006; Fuentemilla L, 2009, J NEUROSCI, V29, P8698, DOI 10.1523/JNEUROSCI.5270-08.2009; Madden DJ, 2004, NEUROIMAGE, V21, P1174, DOI 10.1016/j.neuroimage.2003.11.004; Fan J, 2009, BRAIN COGNITION, V70, P209, DOI 10.1016/j.bandc.2009.02.002; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Isoda M, 2007, NAT NEUROSCI, V10, P240, DOI 10.1038/nn1830; Floel A, 2009, NEUROIMAGE, V47, P1974, DOI 10.1016/j.neuroimage.2009.05.046; Tamnes CK, 2012, J NEUROSCI, V32, P972, DOI 10.1523/JNEUROSCI.4779-11.2012; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Wolbers T, 2006, NEUROIMAGE, V32, P1450, DOI 10.1016/j.neuroimage.2006.05.011; Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; Cauda F, 2012, NEUROIMAGE, V62, P343, DOI 10.1016/j.neuroimage.2012.04.012; Bennett IJ, 2013, NEUROSCI BIOBEHAV R, V37, P1201, DOI 10.1016/j.neubiorev.2013.04.008; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Hazeltine E, 2000, J COGNITIVE NEUROSCI, V12, P118, DOI 10.1162/089892900563984; Usami K, 2013, NEUROPSYCHOLOGIA, V51, P1011, DOI 10.1016/j.neuropsychologia.2013.02.002; Ge HT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078831; Jbabdi Saad, 2011, Brain Connect, V1, P169, DOI 10.1089/brain.2011.0033; LesBihan D, 2003, NAT REV NEUROSCI, V4, P469; Niogi S, 2010, FRONT NEUROANAT, V4, DOI 10.3389/neuro.05.002.2010; Schmahmann J. D., 2006, FIBER PATHWAYS BRAIN; vansVeen, 2001, NEUROIMAGE, V14, P1302	62	0	0	JOHN WILEY & SONS INC	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	OCT	2015	5	10							e00375	10.1002/brb3.375		11	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	CU3KJ	WOS:000363423500006		
J	Ikota, H; Nobusawa, S; Arai, H; Kato, Y; Ishizawa, K; Hirose, T; Yokoo, H				Ikota, Hayato; Nobusawa, Sumihito; Arai, Hideo; Kato, Yukinari; Ishizawa, Keisuke; Hirose, Takanori; Yokoo, Hideaki			Evaluation of IDH1 status in diffusely infiltrating gliomas by immunohistochemistry using anti-mutant and wild type IDH1 antibodies	BRAIN TUMOR PATHOLOGY			English	Article						Glioma; IDH1; Immunohistochemistry	ISOCITRATE DEHYDROGENASE 1; MUTATIONS; DIFFERENTIATION; IDH1-R132G; INHIBITOR; TUMORS; CELLS	Glioma cells with the isocitrate dehydrogenase (IDH) 1 G395A mutation are strongly immunopositive for mIDH1(R132H), an antibody against mutant IDH1(R132H) (clone H09). However, we encountered some gliomas which were ambiguously positive for mIDH1(R132H) despite having the IDH1 G395A mutation. The aim of this study was to establish an evaluation procedure of IDH1 status by immunohistochemistry. Forty-three diffusely infiltrating gliomas were studied, and four of eight anaplastic oligoastrocytomas with the IDH1 G395A mutation were modestly or weakly positive for both the mIDH1(R132H) and an antibody against wild type IDH1, RcMab-1. Based on our staining results, the IDH1 expression of both wild and mutated types seemed to be codominant and also to be evenly suppressed under a certain condition. We propose a procedure for determining IDH1 status. If a glioma is weakly positive for mIDH1(R132H), immunohistochemistry for RcMab-1 should be performed. If the tumor cells are strongly positive for RcMab-1, the IDH1 G395A mutation is judged to be absent on the grounds that IDH1 expression is not suppressed. If the tumor cells are weakly positive for both mIDH1(R132H) and RcMab-1, then a conclusion should be made after DNA sequencing. This procedure is useful for practical evaluation of IDH1 status.	[Ikota, Hayato; Nobusawa, Sumihito; Yokoo, Hideaki] Gunma Univ, Grad Sch Med, Dept Human Pathol, Maebashi, Gumma 3718511, Japan; [Arai, Hideo] Gunma Univ Hosp, Dept Diagnost Pathol, Maebashi, Gumma, Japan; [Kato, Yukinari] Tohoku Univ, Grad Sch Med, Dept Reg Innovat, Sendai, Miyagi 980, Japan; [Ishizawa, Keisuke] Saitama Med Univ, Dept Pathol, Saitama, Japan; [Hirose, Takanori] Kobe Univ, Dept Pathol Reg Commun, Kobe, Hyogo 657, Japan	Ikota, H (reprint author), Gunma Univ, Grad Sch Med, Dept Human Pathol, 3-39-22 Showa Machi, Maebashi, Gumma 3718511, Japan.	ikota@gunma-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science [24790346]	We thank Mr. Koji Isoda and Mr. Yu Otaki (Gunma University) for their excellent technical assistance. This work was supported in part by Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Y.K.), and a Grant-in-Aid for Young Scientists (B) (No. 24790346) from the Japan Society for the Promotion of Science (to H.I.).	Reitman ZJ, 2010, J NATL CANCER I, V102, P932, DOI 10.1093/jnci/djq187; Ishizawa K, 2012, CLIN NEUROPATHOL, V31, P67, DOI 10.5414/NP300402; Schumacher T, 2014, NATURE, V512, P324, DOI 10.1038/nature13387; Ikota H, 2011, BRAIN TUMOR PATHOL, V28, P107, DOI 10.1007/s10014-010-0016-y; Kato Y, 2009, BIOCHEM BIOPH RES CO, V390, P547, DOI 10.1016/j.bbrc.2009.10.001; Hirose T, 2013, HUM PATHOL, V44, P2353, DOI 10.1016/j.humpath.2013.02.013; Takano S, 2012, J NEURO-ONCOL, V108, P361, DOI 10.1007/s11060-012-0837-0; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Ichimura K, 2012, BRAIN TUMOR PATHOL, V29, P131, DOI 10.1007/s10014-012-0090-4; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Capper D, 2010, BRAIN PATHOL, V20, P245, DOI 10.1111/j.1750-3639.2009.00352.x; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Wang F, 2013, SCIENCE, V340, P622, DOI 10.1126/science.1234769; Takano S, 2011, BRAIN TUMOR PATHOL, V28, P115, DOI 10.1007/s10014-011-0023-7; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Kaneko Mika Kato, 2013, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V32, P224, DOI 10.1089/mab.2013.0006; Capper D, 2009, ACTA NEUROPATHOL, V118, P599, DOI 10.1007/s00401-009-0595-z; Kato Y, 2013, BIOCHEM BIOPH RES CO, V432, P564, DOI 10.1016/j.bbrc.2013.02.049; Arita H, 2015, BRAIN TUMOR PATHOL, V32, P79, DOI 10.1007/s10014-014-0197-x; Kato Y, 2014, BRAIN TUMOR PATHOL, V32, P3; Louis DN, 2007, WHO CLASSIFICATION T	24	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1433-7398	1861-387X		BRAIN TUMOR PATHOL	Brain Tumor Pathol.	OCT	2015	32	4					237	244		10.1007/s10014-015-0222-8		8	Oncology; Clinical Neurology; Pathology	Oncology; Neurosciences & Neurology; Pathology	CU1DV	WOS:000363260700002		
J	Ishida, J; Kurozumi, K; Ichikawa, T; Otani, Y; Onishi, M; Fujii, K; Shimazu, Y; Oka, T; Shimizu, T; Date, I				Ishida, Joji; Kurozumi, Kazuhiko; Ichikawa, Tomotsugu; Otani, Yoshihiro; Onishi, Manabu; Fujii, Kentaro; Shimazu, Yosuke; Oka, Tetsuo; Shimizu, Toshihiko; Date, Isao			Evaluation of extracellular matrix protein CCN1 as a prognostic factor for glioblastoma	BRAIN TUMOR PATHOLOGY			English	Article						Glioma; CCN1; MGMT; Prognostic marker	IMMEDIATE-EARLY GENE; O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; PROMOTER HYPERMETHYLATION; ENDOMETRIAL CANCER; TUMOR PROGRESSION; MGMT EXPRESSION; POOR-PROGNOSIS; CYR61; GROWTH; CELLS	Recently, research efforts in identifying prognostic molecular biomarkers for malignant glioma have intensified. Cysteine-rich protein 61 (CCN1) is one of the CCN family of matricellular proteins that promotes cell growth and angiogenesis in cancers through its interaction with several integrins. In this study, we investigated the relationships among CCN1, O-6-methylguanine-DNA methyltransferase expression, the tumor removal rate, and prognosis in 46 glioblastoma patients treated at the Okayama University Hospital. CCN1 expression was high in 31 (67 %) of these patients. The median progression-free survival (PFS) and overall survival (OS) times of patients with high CCN1 expression was significantly shorter than those of patients with low CCN1 expression (p < 0.005). In a multivariate Cox analysis, CCN1 proved to be an independent prognostic factor for patient survival [PFS, hazard ratio (HR) = 3.53 (1.55-8.01), p = 0.003 and OS, HR = 3.05 (1.35-6.87), p = 0.007]. Moreover, in the 31 patients who underwent gross total resection, the PFS and OS times of those with high CCN1 expression were significantly shorter than those with low CCN1 expression. It was concluded that CCN1 might emerge as a significant prognostic factor regarding the prognosis of glioblastoma patients.	[Ishida, Joji; Kurozumi, Kazuhiko; Ichikawa, Tomotsugu; Otani, Yoshihiro; Onishi, Manabu; Fujii, Kentaro; Shimazu, Yosuke; Oka, Tetsuo; Shimizu, Toshihiko; Date, Isao] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurol Surg, Kita Ku, Okayama 7008558, Japan	Kurozumi, K (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurol Surg, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	kkuro@md.okayama-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology [20890133, 21791364, 19591675, 22591611]	We thank Dr. Koichi Ichimura in the Division of Brain Tumor Translational Research, National Cancer Center Research Institute, for advice concerning the MGMT pyrosequencing assay, and M. Arao and N. Uemori for their technical assistance. This study was supported by Grants-in-aid of Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology to K.K. (Nos. 20890133 and 21791364), and T.I. (Nos. 19591675 and 22591611).	Xie D, 2004, CLIN CANCER RES, V10, P2072, DOI 10.1158/1078-0432.CCR-0659-03; Parisi MS, 2006, BONE, V38, P671, DOI 10.1016/j.bone.2005.10.005; Esteller M, 2000, CANCER RES, V60, P2368; Massague J, 2008, MOL CELL, V29, P149, DOI 10.1016/j.molcel.2008.01.006; von Deimling A, 2011, BRAIN PATHOL, V21, P74, DOI 10.1111/j.1750-3639.2010.00454.x; Wick W, 2011, NEURO-ONCOLOGY, V13, P566, DOI 10.1093/neuonc/nor039; Chien WW, 2004, J BIOL CHEM, V279, P53087, DOI 10.1074/jbc.M410254200; De Salvo M, 2011, INT J RADIAT BIOL, V87, P518, DOI 10.3109/09553002.2011.556173; Haseley A, 2012, CANCER RES, V72, P1353, DOI 10.1158/0008-5472.CAN-11-2526; Watari H, 2009, GYNECOL ONCOL, V112, P229, DOI 10.1016/j.ygyno.2008.09.039; Pistollato F, 2010, STEM CELLS, V28, P851, DOI 10.1002/stem.415; Xie D, 2001, J BIOL CHEM, V276, P14187; Esteller M, 1999, CANCER RES, V59, P793; Stupp R, 2014, LANCET ONCOL, V15, P1100, DOI 10.1016/S1470-2045(14)70379-1; Kurozumi K, 2008, MOL THER, V16, P1382, DOI 10.1038/mt.2008.112; Maeta N, 2007, ONCOLOGY-BASEL, V73, P118, DOI 10.1159/000121000; Sabile AA, 2012, J BONE MINER RES, V27, P58, DOI 10.1002/jbmr.535; OBRIEN TP, 1990, MOL CELL BIOL, V10, P3569; Tang QL, 2011, ORAL SURG ORAL MED O, V112, P228, DOI 10.1016/j.tripleo.2011.02.030; Xie JJ, 2011, EJSO-EUR J SURG ONC, V37, P669, DOI 10.1016/j.ejso.2011.05.009; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Xie D, 2004, CANCER RES, V64, P1987, DOI 10.1158/0008-5472.CAN-03-0666; Lafuente JV, 2000, NEUROPATHOLOGY, V20, P176, DOI 10.1046/j.1440-1789.2000.00329.x; Sanai N, 2011, J NEUROSURG, V115, P3, DOI 10.3171/2011.2.JNS10998; Brell M, 2005, CLIN CANCER RES, V11, P5167, DOI 10.1158/1078-0432.CCR-05-0230; Chintalapudi MR, 2008, CARCINOGENESIS, V29, P696, DOI 10.1093/carcin/bgn019; Fujii K, 2013, CANCER GENE THER, V20, P437, DOI 10.1038/cgt.2013.38; Chahal M, 2010, NEURO-ONCOLOGY, V12, P822, DOI 10.1093/neuonc/noq017; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Miyazaki M, 2014, NEUROPATHOLOGY, V34, P268, DOI 10.1111/neup.12091; Walsh CT, 2008, FASEB J, V22, P4011, DOI 10.1096/fj.08-113266; Lalezari S, 2013, NEURO-ONCOLOGY, V15, P370, DOI 10.1093/neuonc/nos308; Babic AM, 1998, P NATL ACAD SCI USA, V95, P6355, DOI 10.1073/pnas.95.11.6355; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Bendas Gerd, 2012, Int J Cell Biol, V2012, P676731, DOI 10.1155/2012/676731; Burke E, 2013, ACTA NEUROPATHOL COM, V1, P1; Chen PP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000534; Haque I, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-8; Ishida J, 2014, TRANSL ONCOL, V7, pe291; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; PEGG AE, 1990, CANCER RES, V50, P6119; Shimazu Y, 2015, GENE THER, V22, P146, DOI 10.1038/gt.2014.100; Zhou ZQ, 2009, BMC CANCER, V22, P291	43	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1433-7398	1861-387X		BRAIN TUMOR PATHOL	Brain Tumor Pathol.	OCT	2015	32	4					245	252		10.1007/s10014-015-0227-3		8	Oncology; Clinical Neurology; Pathology	Oncology; Neurosciences & Neurology; Pathology	CU1DV	WOS:000363260700003		
J	Yano, H; Ohe, N; Nakayama, N; Nomura, Y; Miwa, K; Shinoda, J; Iwama, T				Yano, Hirohito; Ohe, Naoyuki; Nakayama, Noriyuki; Nomura, Yu-ichi; Miwa, Kazuhiro; Shinoda, Jun; Iwama, Toru			Dynamic study of methionine positron emission tomography in patients with glioblastoma with oligodendroglial components	BRAIN TUMOR PATHOLOGY			English	Article						Glioblastoma with oligodendroglial component; PET; Methionine; Dynamic; Pathology	GENETIC ALTERATIONS; IDH1 MUTATION; BRAIN-TUMORS; PROGNOSIS; GLIOMAS; 1P; CLASSIFICATION; CHEMOTHERAPY; RADIOTHERAPY; EXPRESSION	Anaplastic oligoastrocytoma (AOA) with necrosis is classified as glioblastoma (GBM) with oligodendroglioma component (GBMO), according to the 2007 World Health Organization classification. The prognosis of GBMO remains controversial because definitive diagnostic criteria regarding the percentage of the oligodendroglial components (OC) in the GBM do not exist. We previously reported dynamic methionine (MET) positron emission tomography (PET) in patients with these tumors. A significant decrease in the MET signal was seen in oligodendrocytic tumors, in contrast to a significant MET increase in GBMs. In this study, we analyzed the dynamic MET PET signal in four patients with primary (n = 2) and secondary (n = 2) GBMOs. Static PET scanning was performed in three consecutive phases. Both cases of primary GBMOs and one case of secondary GBMO presented with a gradual decrease in MET PET signal over the consecutive phases. In contrast, the remaining case of secondary GBMO presented with a pattern of slight increase. It is likely that the dynamic change of MET in patients with GBMO resemble those in patients with oligodendroglial tumor, however, further studies are needed to confirm them. We discuss the mechanisms from a viewpoint of pathological findings.	[Yano, Hirohito; Ohe, Naoyuki; Nakayama, Noriyuki; Iwama, Toru] Gifu Univ, Grad Sch Med, Dept Neurosurg, Gifu 5011194, Japan; [Nomura, Yu-ichi; Shinoda, Jun] Kizawa Mem Hosp, Chubu Med Ctr Prolonged Traumat Brain Dysfunct, Dept Neurosurg, Minokamo 5058503, Japan; [Miwa, Kazuhiro] Gifu Prefectural Gero Hot Spring Hosp, Dept Neurosurg, Gero 5092292, Japan	Yano, H (reprint author), Gifu Univ, Grad Sch Med, Dept Neurosurg, 1-1 Yanagido, Gifu 5011194, Japan.	hirohito@gifu-u.ac.jp			MSD	This work was supported by a grant from MSD. The funders had no role in the study design, data collection and analysis, publication decision, or manuscript preparation.	Aki T, 2012, J NEURO-ONCOL, V109, P115, DOI 10.1007/s11060-012-0873-9; Kraus JA, 2001, ACTA NEUROPATHOL, V101, P311; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Saito T, 2013, AM J NEURORADIOL, V34, P85, DOI 10.3174/ajnr.A3173; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Pinto LW, 2008, VIRCHOWS ARCH, V452, P481, DOI 10.1007/s00428-007-0562-9; Homma T, 2006, J NEUROPATH EXP NEUR, V65, P846, DOI 10.1097/01.jnen.0000235118.75182.94; Wang YZ, 2012, NEURO-ONCOLOGY, V14, P518, DOI 10.1093/neuonc/nor232; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; McDonald JM, 2005, CANCER, V104, P1468, DOI 10.1002/cncr.21338; Ha SY, 2013, J NEURO-ONCOL, V112, P439, DOI 10.1007/s11060-013-1073-y; Jiang HH, 2014, J NEURO-ONCOL, V116, P395, DOI 10.1007/s11060-013-1311-3; Nakamura H, 2011, BRAIN TUMOR PATHOL, V28, P185, DOI 10.1007/s10014-011-0039-z; He J, 2001, J NEUROPATH EXP NEUR, V60, P863; van den Bent MJ, 2006, EUR J CANCER, V42, P582, DOI 10.1016/j.ejca.2005.06.031; Appin CL, 2013, BRAIN PATHOL, V23, P454, DOI 10.1111/bpa.12018; Giannini C, 2008, BRAIN PATHOL, V18, P360, DOI 10.1111/j.1750-3639.2008.00129.x; Hegi ME, 2012, ACTA NEUROPATHOL, V123, P841, DOI 10.1007/s00401-011-0938-4; Coons SW, 1997, CANCER, V79, P1381, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1381::AID-CNCR16>3.0.CO;2-W; Miller CR, 2006, J CLIN ONCOL, V24, P5419, DOI 10.1200/JCO.2006.08.1497; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Klink B, 2011, CELL ONCOL, V34, P261, DOI 10.1007/s13402-011-0034-8; Miyazaki M, 2014, NEUROPATHOLOGY, V34, P268, DOI 10.1111/neup.12091; Salvati M, 2009, J NEURO-ONCOL, V94, P129, DOI 10.1007/s11060-009-9815-6; Myung JK, 2014, TRANSL ONCOL, V7, P712, DOI 10.1016/j.tranon.2014.10.002; Singh VY, 2014, NEUROL INDIA, V62, P32, DOI 10.4103/0028-3886.128275; Decaestecker C, 1998, J NEUROPATH EXP NEUR, V57, P791, DOI 10.1097/00005072-199808000-00008; Figarella-Branger D, 2014, BRAIN PATHOL; Hilton DA, 2004, HISTOPATHOLOGY, V44, P555, DOI 10.1111/j.1365-2559.2004.01887.x; Kanno H, 2012, PLOS ONE, V7, P7; Vordermark D, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-247	31	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1433-7398	1861-387X		BRAIN TUMOR PATHOL	Brain Tumor Pathol.	OCT	2015	32	4					253	260		10.1007/s10014-015-0218-4		8	Oncology; Clinical Neurology; Pathology	Oncology; Neurosciences & Neurology; Pathology	CU1DV	WOS:000363260700004		
J	Matsumura, N; Nobusawa, S; Ikota, H; Hirato, J; Hirose, T; Yokoo, H; Nakazato, Y				Matsumura, Nozomi; Nobusawa, Sumihito; Ikota, Hayato; Hirato, Junko; Hirose, Takanori; Yokoo, Hideaki; Nakazato, Yoichi			Coexpression of cyclin D1 and alpha-internexin in oligodendroglial tumors	BRAIN TUMOR PATHOLOGY			English	Article						Cyclin D1; Alpha-internexin; Oligodendroglioma; Oligodendrocyte precursor cells; Immunohistochemistry	III BETA-TUBULIN; NEURONAL MARKERS; 1P/19Q STATUS; EXPRESSION; DIFFERENTIATION; PROLIFERATION; ASTROCYTOMAS; LOCALIZATION; CARCINOMA; CANCER	Oligodendroglial tumors with neuronal differentiation cases have been reported in recent studies. Oligodendrocyte precursor cells (OPCs) give rise to both oligodendrocytes and neurons; however, little is known about the association between OPCs and oligodendroglial tumors with neuronal differentiation. Previously, we observed the coexpression of cyclin D1, one of the OPC markers, and alpha-internexin (INA) in oligodendroglial tumor cells. INA is a neuronal marker, and has been indicated as an immunohistochemical surrogate of chromosome 1p/19q co-deletion in oligodendroglial tumors. In this study, we investigated the expression status in 83 gliomas immunohistochemically, and found that cyclin D1-positive cells were commonly detected in gliomas. There was no correlation between the cyclin D1 and Ki-67 labeling indices, suggesting an unrecognized role of cyclin D1 other than a cell cycle regulator in gliomas. Cyclin D1/INA double-positive cells were consistently observed in oligodendroglial tumors regardless of histological grade. In 2 cases of oligodendroglioma with neuronal differentiation, the tumor cells of neuronal morphology showed higher expression of INA, suggesting INA expression may be associated with a bona fide neuronal phenotype. The prevalence of cyclin D1/INA double-positive cells is a distinct feature of oligodendroglial tumors. This new characteristic finding may have practical utility in glioma classification.	[Matsumura, Nozomi; Nobusawa, Sumihito; Ikota, Hayato; Yokoo, Hideaki] Gunma Univ, Grad Sch Med, Dept Human Pathol, Maebashi, Gunma 3718511, Japan; [Hirato, Junko] Gunma Univ Hosp, Dept Pathol, Maebashi, Gunma, Japan; [Hirose, Takanori] Hyogo Canc Ctr, Dept Diagnost Pathol, Akashi, Hyogo, Japan; [Nakazato, Yoichi] Hidaka Hosp, Dept Pathol, Takasaki, Gunma, Japan	Matsumura, N (reprint author), Gunma Univ, Grad Sch Med, Dept Human Pathol, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.	nozomim@gunma-u.ac.jp					Giannini C, 2002, AM J SURG PATHOL, V26, P479, DOI 10.1097/00000478-200204000-00010; Sahm F, 2014, ACTA NEUROPATHOL, V128, P551, DOI 10.1007/s00401-014-1326-7; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Mitew S, 2014, NEUROSCIENCE, V276, P29, DOI 10.1016/j.neuroscience.2013.11.029; Ducray F, 2009, NEUROLOGY, V72, P156, DOI 10.1212/01.wnl.0000339055.64476.cb; Sallinen SL, 1999, J PATHOL, V188, P289; Vyberg M, 2007, HISTOPATHOLOGY, V50, P887, DOI 10.1111/j.1365-2559.2007.02686.x; Hirose T, 2013, HUM PATHOL, V44, P2353, DOI 10.1016/j.humpath.2013.02.013; Liu W, 2013, MEDIAT INFLAMM, DOI 10.1155/2013/651207; Zhao X, 2010, MED ONCOL, V27, P985, DOI 10.1007/s12032-009-9320-y; Tanaka Y, 2012, BRAIN TUMOR PATHOL, V29, P221, DOI 10.1007/s10014-011-0078-5; Katsetos CD, 2001, ARCH PATHOL LAB MED, V125, P613; Arici DS, 2009, NEOPLASMA, V56, P63; Jares P, 2007, NAT REV CANCER, V7, P750, DOI 10.1038/nrc2230; Katsetos CD, 2002, J NEUROPATH EXP NEUR, V61, P307; Eigenbrod S, 2011, J NEUROPATH EXP NEUR, V70, P970, DOI 10.1097/NEN.0b013e3182333ef5; Perry A, 2010, ACTA NEUROPATHOL, V120, P237, DOI 10.1007/s00401-010-0695-9; Perry A, 2002, J NEUROPATH EXP NEUR, V61, P947; Shamma A, 2000, INT J ONCOL, V16, P261; Barnes DM, 1998, BREAST CANCER RES TR, V52, P1, DOI 10.1023/A:1006103831990; Donev K, 2010, NEUROPATH APPL NEURO, V36, P411, DOI 10.1111/j.1365-2990.2010.01078.x; GERDES J, 1984, J IMMUNOL, V133, P1710; Miller RH, 2002, PROG NEUROBIOL, V67, P451, DOI 10.1016/S0301-0082(02)00058-8; Nobs L, 2013, GLIA, V61, P1443, DOI 10.1002/glia.22533; Chojnacki A, 2008, ANN NEUROL, V64, P127, DOI 10.1002/ana.21421; Wang JY, 2012, J NEURO-ONCOL, V106, P473, DOI 10.1007/s11060-011-0692-4; Wharton SB, 2002, J CLIN NEUROSCI, V9, P165, DOI 10.1054/jocn.2001.1055; Bailey P, 1929, J PATHOL BACTERIOL, V32, P735, DOI 10.1002/path.1700320403; Durand B, 1997, EMBO J, V16, P306, DOI 10.1093/emboj/16.2.306; Buckley PG, 2011, J NEUROPATH EXP NEUR, V70, P177, DOI 10.1097/NEN.0b013e31820c765b; Barrows Brad D, 2012, Turk Patoloji Derg, V28, P95, DOI 10.5146/tjpath.2012.01107; Ducray F, 2008, MOL CANCER, V7, P1, DOI DOI 10.1186/1476-4598-7-41; Liang S, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-138; Louis DN, 2007, WHO CLASSIFICATION T; Matsumoto Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027628; Matsumura N, 2014, BRAIN TUMOR PATHOL, V31, P17, DOI 10.1007/s10014-012-0133-x; Nagaishi M, 2014, BRAIN TUMOR PATHOL, V31, P257, DOI 10.1007/s10014-013-0168-7; Reifenberger G, 2007, WHO CLASSIFICATION T, P54; Seiler R, 2014, MODERN PATHOL, V27, P87, DOI 10.1038/modpathol.2013.125	39	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1433-7398	1861-387X		BRAIN TUMOR PATHOL	Brain Tumor Pathol.	OCT	2015	32	4					261	267		10.1007/s10014-015-0228-2		7	Oncology; Clinical Neurology; Pathology	Oncology; Neurosciences & Neurology; Pathology	CU1DV	WOS:000363260700005		
J	Nakada, S; Minato, H; Takegami, T; Kurose, N; Ikeda, H; Kobayashi, M; Sasagawa, Y; Akai, T; Kato, T; Yamamoto, N; Nojima, T				Nakada, Satoko; Minato, Hiroshi; Takegami, Tsutomu; Kurose, Nozomu; Ikeda, Hiroko; Kobayashi, Masako; Sasagawa, Yasuo; Akai, Takuya; Kato, Takashi; Yamamoto, Norio; Nojima, Takayuki			NAB2-STAT6 fusion gene analysis in two cases of meningeal solitary fibrous tumor/hemangiopericytoma with late distant metastases	BRAIN TUMOR PATHOLOGY			English	Article						Hemangiopericytoma; Solitary fibrous tumor; Meningeal tumor; Immunohistochemistry; NAB2-STAT6 fusion gene	TUMOR; HEMANGIOPERICYTOMA; STAT6; MENINGIOMA; EXPRESSION; DIAGNOSIS; VARIANTS; EGR-1	We present two cases of meningeal solitary fibrous tumor (SFT)/hemangiopericytoma (HPC) with immunohistochemistry of STAT6 and analysis of NAB2-STAT6 fusion genes. Case 1 was a 37-year-old male with a left middle fossa tumor; case 2 was a 68-year-old female with a cerebellar tumor. They showed late metastasis to the lung or bone 8 or 13 years, respectively, after the first surgery. Histology of both primary and metastatic tumors showed a cellular hemangiopericytomatous pattern with nuclear atypia. The primary tumors showed nuclear staining of STAT6, but both metastatic tumors showed nuclear and cytoplasmic STAT6. DNA sequencing revealed two kinds of NAB2-STAT6 fusion genes. One consisted of exon 6 of NAB2, intron 6 of NAB2, and the middle of exon 17 of STAT6 (observed in the primary and metastatic tumors of case 1); the other consisted of exon 6 of NAB2 and the beginning of exon 17 of STAT6 (observed in the metastatic tumor of case 2). The primary tumor of case 2 had both fusion genes. To the best of our knowledge, we are the first to report NAB2-STAT6 fusion gene analysis in primary and metastatic meningeal SFT/HPCs and a case showed different fusion gene status in the metastatic tumor.	[Nakada, Satoko; Minato, Hiroshi; Kurose, Nozomu; Nojima, Takayuki] Kanazawa Med Univ, Dept Pathol & Lab Med, Kanazawa, Ishikawa, Japan; [Takegami, Tsutomu] Kanazawa Med Univ, Med Res Inst, Dept Life Sci, Kanazawa, Ishikawa, Japan; [Ikeda, Hiroko] Kanazawa Univ Hosp, Sect Diagnost Pathol, Kanazawa, Ishikawa, Japan; [Kobayashi, Masako] Kanazawa Municipal Hosp, Dept Pathol, Kanazawa, Ishikawa, Japan; [Sasagawa, Yasuo; Akai, Takuya] Kanazawa Med Univ, Dept Neurosurg, Kanazawa, Ishikawa, Japan; [Kato, Takashi; Yamamoto, Norio] Kanazawa Univ Hosp, Dept Orthoped, Kanazawa, Ishikawa, Japan	Minato, H (reprint author), Kanazawa Med Univ, Dept Pathol & Lab Med, Kanazawa, Ishikawa, Japan.	hminato@kanazawa-med.ac.jp			Ministry of Health, Labor and Welfare [H26-084]; JSPS KAKENHI [26460660]	The authors specially thank Mr. Manabu Yamashita for technical assistance of fusion gene analysis. This study was supported in part by the Health and Labor Sciences Research Expenses for Commission, Applied Research for Innovative Treatment of Cancer from the Ministry of Health, Labor and Welfare H26-084 (T. N.) and by JSPS KAKENHI Grant Number 26460660 (H. M.).	Robinson DR, 2013, NAT GENET, V45, P180, DOI 10.1038/ng.2509; Rajaram V, 2004, HUM PATHOL, V35, P1413, DOI 10.1016/j.humpath.2004.07.017; Chmielecki J, 2013, NAT GENET, V45, P131, DOI 10.1038/ng.2522; Bhattacharyya S, 2013, J PATHOL, V229, P286, DOI 10.1002/path.4131; Mohajeri A, 2013, GENE CHROMOSOME CANC, V52, P873, DOI 10.1002/gcc.22083; Doyle LA, 2014, MODERN PATHOL, V27, P1231, DOI 10.1038/modpathol.2013.247; Svaren J, 1996, MOL CELL BIOL, V16, P3545; Guillou L, 2000, HUM PATHOL, V31, P1108, DOI 10.1053/hupa.2000.9777; Shirakawa T, 2011, J BIOL CHEM, V286, P4003, DOI 10.1074/jbc.M110.168435; Barthelmess S, 2014, AM J PATHOL, V184, P1209, DOI 10.1016/j.ajpath.2013.12.016; Doyle LA, 2014, MODERN PATHOL, V27, P390, DOI 10.1038/modpathol.2013.164; Schweizer L, 2013, ACTA NEUROPATHOL, V125, P651, DOI 10.1007/s00401-013-1117-6; Perry A, 1997, AM J SURG PATHOL, V21, P1354, DOI 10.1097/00000478-199711000-00010; Fountas KN, 2006, NEUROSURG REV, V29, P145, DOI 10.1007/s10143-005-0001-9; Damodaran O, 2014, J CLIN NEUROSCI, V21, P1310, DOI 10.1016/j.jocn.2013.11.026; Fletcher CDM, 2013, WHO CLASSIFICATION T, P80; Koelsche C, 2014, HISTOPATHOLOGY, V65, P613, DOI 10.1111/his.12431; Paulus W, 2007, WHO CLASSIFICATION T, P173; Reich N. C., 2013, JAK STAT, V2, DOI DOI 10.4161/JKST.27080; Yoshida A, 2014, AM J SURG PATHOL, V38, P552, DOI 10.1097/PAS.0000000000000137	20	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1433-7398	1861-387X		BRAIN TUMOR PATHOL	Brain Tumor Pathol.	OCT	2015	32	4					268	274		10.1007/s10014-015-0220-x		7	Oncology; Clinical Neurology; Pathology	Oncology; Neurosciences & Neurology; Pathology	CU1DV	WOS:000363260700006		
J	Tashiro, R; Kanamori, M; Suzuki, H; Utsunomiya, A; Meguro, K; Uenohara, H; Tominaga, T				Tashiro, Ryosuke; Kanamori, Masayuki; Suzuki, Hiroyoshi; Utsunomiya, Akihiro; Meguro, Kuniaki; Uenohara, Hiroshi; Tominaga, Teiji			Diffuse large B cell lymphoma of the cranial vault: two case reports	BRAIN TUMOR PATHOLOGY			English	Article						Cranial vault; Diffuse large B cell lymphoma; Skull; Pathological findings	MALIGNANT-LYMPHOMA; DURA-MATER; SKULL; SCALP; BONE	Malignant lymphoma of the cranial vault is a rare entity and the tumor growth patterns are not well understood. Here we report two cases of malignant lymphoma involving the scalp and epidural space with slight changes in the intervening skull. A 63-year-old woman presented with a scalp mass in her right frontal area. Computed tomography (CT) and magnetic resonance (MR) imaging demonstrated mass lesions in the scalp and epidural space with slight osteolytic changes in the intervening skull. She underwent resection of the lesions. A 53-year-old man presented with a mass in his right frontal area. CT and MR imaging showed mass lesions in the scalp and epidural space without changes in the skull. He underwent resection of the lesions. The histopathological diagnosis was diffuse large B cell lymphoma in both cases. Microscopic examination of the intervening skull found that the bone marrow was diffusely replaced by lymphoma cells, and lymphoma cells extended to the extra- or intra-cranial space along the emissary veins without destruction of the cortical or trabecular bone. These histopathological findings explain the radiological findings and provide the clues to elucidate the mechanism of extension of cranial vault lymphoma.	[Tashiro, Ryosuke; Kanamori, Masayuki; Utsunomiya, Akihiro; Uenohara, Hiroshi] Sendai Med Ctr, Dept Neurosurg, Miyagino Ku, Sendai, Miyagi 9838520, Japan; [Suzuki, Hiroyoshi] Sendai Med Ctr, Dept Pathol & Lab Med, Sendai, Miyagi 9838520, Japan; [Meguro, Kuniaki] Sendai Med Ctr, Dept Hematol, Sendai, Miyagi 9838520, Japan; [Tominaga, Teiji] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Sendai, Miyagi 980, Japan	Kanamori, M (reprint author), Sendai Med Ctr, Dept Neurosurg, Miyagino Ku, 2-8-8 Miyagino, Sendai, Miyagi 9838520, Japan.	mkanamori@med.tohoku.ac.jp					Abdelwahab IF, 2007, SKELETAL RADIOL, V36, P335, DOI 10.1007/s00256-006-0096-2; Salunke P, 2013, NEUROL INDIA, V61, P201, DOI 10.4103/0028-3886.111161; Fukushima Y, 2007, ACTA NEUROCHIR, V149, P601, DOI 10.1007/s00701-007-1156-7; El Asri AC, 2012, ACTA NEUROCHIR, V154, P257, DOI 10.1007/s00701-011-1124-0; Ochiai H, 2010, NEUROL MED-CHIR, V50, P595; HOLTAS S, 1985, J COMPUT ASSIST TOMO, V9, P725, DOI 10.1097/00004728-198507010-00011; Mulligan ME, 1999, AM J ROENTGENOL, V173, P1691; Yoon SH, 2008, J NEUROSURG, V108, P1018, DOI 10.3171/JNS/2008/108/5/1018; Khalid M, 2010, JBR-BTR, V93, P296; TOMASZEK DE, 1984, SURG NEUROL, V21, P182, DOI 10.1016/0090-3019(84)90339-2; MORIOKA T, 1994, SURG NEUROL, V42, P117, DOI 10.1016/0090-3019(94)90370-0; Gonzalez-Bonet LG, 2008, ACTA NEUROCHIR, V150, P507, DOI 10.1007/s00701-007-1416-6; Nishimoto T, 2003, NEUROL SURG TOKYO, V31, P43; da Rocha AJ, 2010, J NEURO-ONCOL, V100, P9, DOI 10.1007/s11060-010-0137-5; Christine PH, 2004, BLOOD, V103, P275; Horstman AL, 2004, HAEMATOLOGICA, V89, pe42; Ko Myeong-Jin, 2013, Brain Tumor Res Treat, V1, P32, DOI 10.14791/btrt.2013.1.1.32; Kosugi Shigeki, 2013, J Clin Exp Hematop, V53, P215; Martin J, 2012, CASE REP NEUROL MED, V2012; Muin I A, 1997, Med J Malaysia, V52, P86; Razaei-Kalantari K, 2012, IRAN J RADIOL, V9, P88; Viella LM, 2007, J NEUROONCOL, V83, P181; Yuki K, 1989, Neurol Med Chir (Tokyo), V29, P762, DOI 10.2176/nmc.29.762	23	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1433-7398	1861-387X		BRAIN TUMOR PATHOL	Brain Tumor Pathol.	OCT	2015	32	4					275	280		10.1007/s10014-015-0225-5		6	Oncology; Clinical Neurology; Pathology	Oncology; Neurosciences & Neurology; Pathology	CU1DV	WOS:000363260700007		
J	Momota, H; Kato, S; Fujii, M; Tsujiuchi, T; Takahashi, Y; Kojima, S; Wakabayashi, T				Momota, Hiroyuki; Kato, Seiichi; Fujii, Masazumi; Tsujiuchi, Takashi; Takahashi, Yoshiyuki; Kojima, Seiji; Wakabayashi, Toshihiko			Primary peripheral T-cell lymphoma, not otherwise specified, of the central nervous system in a child	BRAIN TUMOR PATHOLOGY			English	Article						Peripheral T-cell lymphoma; Central nervous system; Radiochemotherapy; Pediatric	EXPERIENCE; DIAGNOSIS; JAPAN	Primary peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), is a rare disease that infrequently involves the central nervous system (CNS), and it is even rarer in pediatric patients. Here, we report of a 13-year-old male with primary CNS PTCL-NOS who exhibited a malignant clinical course with recurrence after radiochemotherapy followed by bone marrow transplantation; he died 43 months after diagnosis. Pathology revealed the proliferation of cytotoxic T-cells and clonal T-cell receptor gene rearrangements. Although the optimal therapy for PTCL remains controversial, intensive radiochemotherapy may be required for some patients.	[Momota, Hiroyuki; Fujii, Masazumi; Tsujiuchi, Takashi; Wakabayashi, Toshihiko] Nagoya Univ Hosp, Dept Neurosurg, Showa Ku, Nagoya, Aichi 4668560, Japan; [Kato, Seiichi] Nagoya Univ Hosp, Dept Pathol, Nagoya, Aichi, Japan; [Kato, Seiichi] Nagoya Univ Hosp, Clin Labs, Nagoya, Aichi, Japan; [Takahashi, Yoshiyuki; Kojima, Seiji] Nagoya Univ Hosp, Dept Pediat, Nagoya, Aichi, Japan	Momota, H (reprint author), Univ Tokyo, Inst Med Sci, Dept Surg Neurooncol, Div Innovat Canc Therapy,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	momota-nsu@umin.ac.jp			Japan Society for the Promotion of Science (JSPS) [24590478]	This work was supported by Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (C) (24590478) to Hiroyuki Momota.	Windsor R, 2008, PEDIATR BLOOD CANCER, V50, P784, DOI 10.1002/pbc.21293; Shibamoto Y, 2008, NEURO-ONCOLOGY, V10, P560, DOI 10.1215/15228517-2008-028; Lee DK, 2002, CLIN NEUROPATHOL, V21, P149; Asano N, 2005, AM J SURG PATHOL, V29, P1284, DOI 10.1097/01.pas.0000173238.17331.6b; Weisenburger DD, 2011, BLOOD, V117, P3402, DOI 10.1182/blood-2010-09-310342; Lim T, 2011, ANN HEMATOL, V90, P1391, DOI 10.1007/s00277-011-1225-0; Lueth M, 2012, J PEDIAT HEMATOL ONC, V34, pE66, DOI 10.1097/MPH.0b013e318219f95e; Kato Y, 2014, INTERNAL MED, V53, P1197, DOI 10.2169/internalmedicine.53.1902; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Liu D, 2003, AM J SURG PATHOL, V27, P682, DOI 10.1097/00000478-200305000-00012; Choi JS, 2003, AM J SURG PATHOL, V27, P919, DOI 10.1097/00000478-200307000-00007; Iqbal J, 2010, BLOOD, V115, P1026, DOI 10.1182/blood-2009-06-227579; Al Mahmoud R, 2012, J PEDIAT HEMATOL ONC, V34, P611, DOI 10.1097/MPH.0b013e3182707592; Ogura R, 2013, NEUROPATHOLOGY, V33, P436, DOI 10.1111/neup.12005; Bataille B, 2000, J NEUROSURG, V92, P261, DOI 10.3171/jns.2000.92.2.0261; Ferreri AJM, 2002, NEUROLOGY, V58, P1513; Demetriades AK, 2003, BRIT J NEUROSURG, V17, P473, DOI 10.1080/02688690310001613880; Kato S, 2012, HISTOPATHOLOGY, V61, P186, DOI 10.1111/j.1365-2559.2012.04199.x; Harder A, 2003, ACTA NEUROPATHOL, V105, P65, DOI 10.1007/s00401-002-0619-4; Takiyama A, 2008, NEUROPATHOLOGY, V28, P640, DOI 10.1111/j.1440-1789.2008.00903.x; El-Mallawany NK, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2012.8; Kato S, 2015, AM J SURG PATHOL, V39, P462, DOI 10.1097/PAS.0000000000000323; Fujita M, 2000, PATHOL INT, V50, P696	23	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1433-7398	1861-387X		BRAIN TUMOR PATHOL	Brain Tumor Pathol.	OCT	2015	32	4					281	285		10.1007/s10014-015-0229-1		5	Oncology; Clinical Neurology; Pathology	Oncology; Neurosciences & Neurology; Pathology	CU1DV	WOS:000363260700008		
J	Noshiro, S; Wanibuchi, M; Akiyama, Y; Okawa, S; Ohtaki, S; Sugino, T; Iihoshi, S; Mikami, T; Sugita, S; Hasegawa, T; Mikuni, N				Noshiro, Shouhei; Wanibuchi, Masahiko; Akiyama, Yukinori; Okawa, Satoshi; Ohtaki, Shunya; Sugino, Toshiya; Iihoshi, Satoshi; Mikami, Takeshi; Sugita, Shintaro; Hasegawa, Tadashi; Mikuni, Nobuhiro			IgG4-related disease initially presented as an orbital mass lesion mimicking optic nerve sheath meningioma	BRAIN TUMOR PATHOLOGY			English	Article						IgG4-related disease; Orbital tumor; Optic nerve sheath meningioma	SYSTEMIC-DISEASE; SERUM IGG4; TUMORS	We report a case of an optic nerve mass lesion associated with IgG4-related disease. A 39-year-old man presented with right blurred vision and proptosis 8 years before admission. Magnetic resonance imaging showed a mass lesion in the center of the right orbit, which was diagnosed as optic nerve sheath meningioma by neuroradiologists and neurosurgeons. Irradiation was selected for treatment of the lesion on the basis of the radiological diagnosis; subsequently, the lesion gradually reduced in size. However, regrowth of an optic nerve mass lesion observed during the previous 2 years caused remarkable exophthalmos, and removal of the orbital mass lesion was performed via a transcranial orbital approach. Pathological examinations resulted in a diagnosis of IgG4-related disease, and hematological tests revealed an elevated level of serum IgG4. Additional radiological examinations showed mass lesions in the left maxillary nerve, bilateral inferior alveolar nerves, paravertebral tissue, and left kidney. Treatment with oral steroids has produced a reduction in the size of these lesions.	[Noshiro, Shouhei; Wanibuchi, Masahiko; Akiyama, Yukinori; Okawa, Satoshi; Ohtaki, Shunya; Sugino, Toshiya; Iihoshi, Satoshi; Mikami, Takeshi; Mikuni, Nobuhiro] Sapporo Med Univ, Sch Med, Dept Neurosurg, Chuo Ku, Sapporo, Hokkaido 0608543, Japan; [Sugita, Shintaro; Hasegawa, Tadashi] Sapporo Med Univ, Sch Med, Dept Surg Pathol, Sapporo, Hokkaido 0608543, Japan	Wanibuchi, M (reprint author), Sapporo Med Univ, Sch Med, Dept Neurosurg, Chuo Ku, South 1,West 16, Sapporo, Hokkaido 0608543, Japan.	wanibuti@sapmed.ac.jp					Plaza JA, 2011, ARCH OPHTHALMOL-CHIC, V129, P421, DOI 10.1001/archophthalmol.2011.16; Masaki Y, 2009, ANN RHEUM DIS, V68, P1310, DOI 10.1136/ard.2008.089169; Umehara H, 2012, MOD RHEUMATOL, V22, P21, DOI 10.1007/s10165-011-0571-z; Mendenhall WM, 2010, AM J CLIN ONCOL-CANC, V33, P304, DOI 10.1097/COC.0b013e3181a07567; Oyama T, 2011, JPN J OPHTHALMOL, V55, P304, DOI 10.1007/s10384-011-0003-9; Ebbo M, 2012, MEDICINE, V91, P49, DOI 10.1097/MD.0b013e3182433d77; Yamamoto M, 2012, MOD RHEUMATOL, V22, P419, DOI 10.1007/s10165-011-0532-6; Shields JA, 2004, OPHTHALMOLOGY, V111, P997, DOI 10.1016/j.orphtha.2003.01.002; Ohtsuka K, 2005, JPN J OPHTHALMOL, V49, P49, DOI 10.1007/s10384-004-0147-y; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Espinoza Gabriela M, 2010, Curr Rheumatol Rep, V12, P443, DOI 10.1007/s11926-010-0128-8; Nagai Kazuki, 2011, J Med Case Rep, V5, P427, DOI 10.1186/1752-1947-5-427; Turbin Roger E, 2004, Cancer Control, V11, P334; Yamamoto Motohisa, 2008, Nihon Rinsho Meneki Gakkai Kaishi, V31, P1	14	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1433-7398	1861-387X		BRAIN TUMOR PATHOL	Brain Tumor Pathol.	OCT	2015	32	4					286	290		10.1007/s10014-015-0223-7		5	Oncology; Clinical Neurology; Pathology	Oncology; Neurosciences & Neurology; Pathology	CU1DV	WOS:000363260700009		
J	Yamamoto, T; Matsubara, T; Satomi, K; Sakamoto, N; Matsuda, M; Muroi, A; Ishikawa, E; Akutsu, H; Nakai, K; Matsumura, A				Yamamoto, Tetsuya; Matsubara, Teppei; Satomi, Kaishi; Sakamoto, Noriaki; Matsuda, Masahide; Muroi, Ai; Ishikawa, Eiichi; Akutsu, Hiroyoshi; Nakai, Kei; Matsumura, Akira			Rosette-forming glioneuronal tumor originating in the hypothalamus	BRAIN TUMOR PATHOLOGY			English	Article						Hypothalamus; Rosette-forming glioneuronal tumor; Precocious puberty	DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMOR; CENTRAL-NERVOUS-SYSTEM; OF-THE-LITERATURE; KIAA1549-BRAF FUSION; 4TH-VENTRICLE RGNT; PATIENT; VENTRICLE; DIAGNOSIS; COMPONENT; FEATURES	Rosette-forming glioneuronal tumors (RGNT) of the fourth ventricle are slow-growing tumors that primarily involve the fourth ventricular region. We here report the first patient, an 8-year-old girl, with an RGNT originating in the hypothalamus and manifesting with precocious puberty. After partial removal, the remaining tumor showed rapid enlargement, and the pathologic diagnosis at the second surgery revealed histopathologic features similar to those found in the initial samples, including biphasic patterns of neurocytic rosettes and GFAP-stained astrocytic components. These tumor cells had mildly atypical nuclei; however, mitotic figures and necrosis were absent. Eosinophilic granular bodies and a glomeruloid vasculature were found, but Rosenthal fibers were absent. The Ki-67 proliferative index was 3.5 % (vs 1.1 % at the initial surgery). No recurrence was recorded during the 3-year period after the proton radiotherapy.	[Yamamoto, Tetsuya; Matsubara, Teppei; Matsuda, Masahide; Muroi, Ai; Ishikawa, Eiichi; Akutsu, Hiroyoshi; Nakai, Kei; Matsumura, Akira] Univ Tsukuba, Fac Med, Dept Neurosurg, Tsukuba, Ibaraki 3058575, Japan; [Satomi, Kaishi; Sakamoto, Noriaki] Univ Tsukuba, Fac Med, Dept Pathol, Tsukuba, Ibaraki 3058575, Japan	Yamamoto, T (reprint author), Univ Tsukuba, Fac Med, Dept Neurosurg, Tennodai 1-1-1, Tsukuba, Ibaraki 3058575, Japan.	yamamoto_neurosurg@md.tsukuba.ac.jp					Marhold F, 2008, J NEURO-ONCOL, V90, P301, DOI 10.1007/s11060-008-9661-y; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Jacques TS, 2006, NEUROPATH APPL NEURO, V32, P217, DOI 10.1111/j.1365-2990.2005.00692.x; Solis OE, 2011, J NEURO-ONCOL, V102, P477, DOI 10.1007/s11060-010-0335-1; Chiba K, 2014, CHILD NERV SYST, V30, P351, DOI 10.1007/s00381-013-2216-3; Li YM, 2009, J INT MED RES, V37, P958; Alturkustani M, 2012, CAN J NEUROL SCI, V39, P95; Johnson M, 2006, J NEUROSURG, V105, P129, DOI 10.3171/jns.2006.105.1.129; Thurston B, 2013, CHILD NERV SYST, V29, P839, DOI 10.1007/s00381-012-1993-4; Chakraborti S, 2012, VIRCHOWS ARCH, V461, P581, DOI 10.1007/s00428-012-1313-0; Anan M, 2009, HUM PATHOL, V40, P898, DOI 10.1016/j.humpath.2008.11.010; Wendt S, 2014, PEDIATR BLOOD CANCER, V61, P664, DOI 10.1002/pbc.24825; Shah MN, 2010, J NEUROS-PEDIATR, V5, P98, DOI 10.3171/2009.7.PEDS09113; Karafin M, 2011, CLIN NEUROPATHOL, V30, P297, DOI 10.5414/NP300374; Xiong J, 2012, NEUROPATHOLOGY, V32, P301, DOI 10.1111/j.1440-1789.2011.01261.x; Gessi M, 2012, J NEURO-ONCOL, V110, P21, DOI 10.1007/s11060-012-0940-2; Preusser M, 2003, ACTA NEUROPATHOL, V106, P506, DOI 10.1007/s00401-003-0758-2; Scheithauer BW, 2009, NEUROSURGERY, V64, P771, DOI 10.1227/01.NEU.0000340979.81362.F3; Albanese A, 2005, J NEURO-ONCOL, V71, P195, DOI 10.1007/s11060-004-1375-1; Joseph V, 2009, NEUROPATHOLOGY, V29, P309, DOI 10.1111/j.1440-1789.2008.00953.x; Wang Y, 2009, ACTA NEUROPATHOL, V118, P813, DOI 10.1007/s00401-009-0569-1; Frydenberg E, 2010, J CLIN NEUROSCI, V17, P1326, DOI 10.1016/j.jocn.2010.03.003; Podlesek D, 2011, J NEURO-ONCOL, V103, P727, DOI 10.1007/s11060-010-0408-1; Luan SH, 2010, CLIN NEUROL NEUROSUR, V112, P362, DOI 10.1016/j.clineuro.2010.01.006; Zhang J, 2013, J CLIN NEUROSCI, V20, P335, DOI 10.1016/j.jocn.2012.09.003; Matyja E, 2011, NEUROPATHOLOGY, V31, P427, DOI 10.1111/j.1440-1789.2010.01168.x; Ghosal N, 2010, DIAGN CYTOPATHOL, V38, P590, DOI 10.1002/dc.21269; Komori T, 2002, AM J SURG PATHOL, V26, P582, DOI 10.1097/00000478-200205000-00004; Kinno M, 2010, CYTOPATHOLOGY, V21, P194, DOI 10.1111/j.1365-2303.2008.00619.x; Sharma P, 2011, NEUROL INDIA, V59, P276, DOI 10.4103/0028-3886.79148; Rainov NG, 2010, CENT EUR NEUROSURG, V71, P219, DOI 10.1055/s-0029-1242760; Vajtai I, 2007, PATHOL RES PRACT, V203, P613, DOI 10.1016/j.prp.2007.04.009; Gao C, 2009, NEUROSCIENCES, V14, P292; Xiong J, 2013, NEUROPATHOLOGY, V33, P431, DOI 10.1111/neup.12000; Yin B, 2012, J NEURORADIOLOGY, V39, P129, DOI 10.1016/j.neurad.2011.02.004; Thommen F, 2013, CLIN NEUROPATHOL, V32, P370, DOI 10.5414/NP300612; Nandeesh BN, 2012, J CANCER RES THER, V8, P644, DOI 10.4103/0973-1482.106587; Arai A, 2010, NEUROL MED-CHIR, V50, P224; Tan CC, 2008, NEUROSURGERY, V63, P175, DOI 10.1227/01.NEU.0000319638.62586.52; Gessi M, 2011, NEUROPATHOLOGY, V31, P654, DOI 10.1111/j.1440-1789.2011.01220.x; Hsu C, 2012, BRIT J NEUROSURG, V26, P668, DOI 10.3109/02688697.2012.655808; Fushimi Y, 2011, JPN J RADIOL, V29, P445, DOI 10.1007/s11604-011-0566-x; Adachi J, 2005, SURG NEUROL, V63, P375, DOI 10.1016/j.surneu.2004.05.039; Lu JQ, 2009, NEUROSURGERY, V64, P1193, DOI 10.1227/01.NEU.0000345640.40566.48; Kemp S, 2012, J CLIN NEUROSCI, V19, P1180, DOI 10.1016/j.jocn.2011.12.013; Ellezam B, 2012, ACTA NEUROPATHOL, V123, P285, DOI 10.1007/s00401-011-0886-z; Cabezas SG, 2015, BRAIN TUMOR PATHOL, V32, P124, DOI 10.1007/s10014-014-0195-z; Pimentel José, 2008, Neurosurgery, V62, pE1162, DOI 10.1227/01.neu.0000325879.75376.63; Xu Junqing, 2012, Quant Imaging Med Surg, V2, P227, DOI 10.3978/j.issn.2223-4292.2012.09.03	49	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1433-7398	1861-387X		BRAIN TUMOR PATHOL	Brain Tumor Pathol.	OCT	2015	32	4					291	296		10.1007/s10014-015-0226-4		6	Oncology; Clinical Neurology; Pathology	Oncology; Neurosciences & Neurology; Pathology	CU1DV	WOS:000363260700010		
J	Tajika, A; Ogawa, Y; Takeshima, N; Hayasaka, Y; Furukawa, TA				Tajika, Aran; Ogawa, Yusuke; Takeshima, Nozomi; Hayasaka, Yu; Furukawa, Toshi A.			Replication and contradiction of highly cited research papers in psychiatry: 10-year follow-up	BRITISH JOURNAL OF PSYCHIATRY			English	Article							PLACEBO-CONTROLLED-TRIAL; A-DOUBLE-BLIND; ALZHEIMERS-DISEASE; EMPIRICAL-EVIDENCE; BIPOLAR MANIA; OLANZAPINE; BIAS; SCHIZOPHRENIA; INTERVENTIONS; METAANALYSES	Background Contradictions and initial overestimates are not unusual among highly cited studies. However, this issue has not been researched in psychiatry. Aims To assess how highly cited studies in psychiatry are replicated by subsequent studies. Method We selected highly cited studies claiming effective psychiatric treatments in the years 2000 through 2002. For each of these studies we searched for subsequent studies with a better-controlled design, or with a similar design but a larger sample. Results Among 83 articles recommending effective interventions, 40 had not been subject to any attempt at replication, 16 were contradicted; 11 were found to have substantially smaller effects and only 16 were replicated. The standardised mean differences of the initial studies were overestimated by 132%. Studies with a total sample size of 100 or more tended to produce replicable results. Conclusions Caution is needed when a study with a small sample size reports a large effect.	[Tajika, Aran; Ogawa, Yusuke; Takeshima, Nozomi; Hayasaka, Yu; Furukawa, Toshi A.] Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Hlth Promot & Human Behav, Kyoto 6068501, Japan	Tajika, A (reprint author), Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Hlth Promot & Human Behav,Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	aran.tajika28@gmail.com					Street JS, 2000, ARCH GEN PSYCHIAT, V57, P968, DOI 10.1001/archpsyc.57.10.968; Chinn S, 2000, STAT MED, V19, P3127, DOI 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M; Nieminen P, 2007, J CLIN EPIDEMIOL, V60, P939, DOI 10.1016/j.jclinepi.2006.11.014; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261; Cumming G, 2008, PERSPECT PSYCHOL SCI, V3, P286, DOI 10.1111/j.1745-6924.2008.00079.x; in 't Veld BA, 2001, NEW ENGL J MED, V345, P1515, DOI 10.1056/NEJMoa010178; McIntyre RS, 2009, BIPOLAR DISORD, V11, P673, DOI 10.1111/j.1399-5618.2009.00748.x; Breitner JC, 2011, ALZHEIMERS DEMENT, V7, P402, DOI 10.1016/j.jalz.2010.12.014; Tohen M, 2000, ARCH GEN PSYCHIAT, V57, P841, DOI 10.1001/archpsyc.57.9.841; Trikalinos TA, 2004, J CLIN EPIDEMIOL, V57, P1124, DOI 10.1016/j.jclinepi.2004.02.018; Pereira TV, 2012, JAMA-J AM MED ASSOC, V308, P1676, DOI 10.1001/jama.2012.13444; Ho PM, 2008, CIRCULATION, V118, P1675, DOI 10.1161/CIRCULATIONAHA.107.721357; Marshall M, 2000, BRIT J PSYCHIAT, V176, P249, DOI 10.1192/bjp.176.3.249; De Deyn PP, 2004, INT J GERIATR PSYCH, V19, P115, DOI 10.1002/gps.1032; Leucht S, 2012, BRIT J PSYCHIAT, V200, P97, DOI 10.1192/bjp.bp.111.096594; Savovic J, 2012, ANN INTERN MED, V157, P429, DOI 10.7326/0003-4819-157-6-201209180-00537; Wood L, 2008, BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; Cohen J., 1988, STAT POWER ANAL BEHA; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Higgins JPT, 2011, COCHRANE HDB SYSTEMA; Hunt GE, 2010, HARVARD REV PSYCHIAT, V18, P207, DOI 10.3109/10673229.2010.493742; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; loannidis J. P. A., 2005, JAMA-J AM MED ASSOC, V294, P218; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; US National Library of Medicine, 2015, FACT SHEET MEDLINE P	26	0	0	ROYAL COLLEGE OF PSYCHIATRISTS	LONDON	BRITISH JOURNAL OF PSYCHIATRY 17 BELGRAVE SQUARE, LONDON SW1X 8PG, ENGLAND	0007-1250	1472-1465		BRIT J PSYCHIAT	Br. J. Psychiatry	OCT	2015	207	4					357	362		10.1192/bjp.bp.113.143701		6	Psychiatry	Psychiatry	CU0QF	WOS:000363222900017		
J	Sato, A; Ikeda, K				Sato, Akira; Ikeda, Koichi			Visualization of diffusion phenomena in porous media by means of X-ray computed tomography (CT) scanning	CANADIAN GEOTECHNICAL JOURNAL			English	Article						diffusion; X-ray computed tomography (CT); visualization; porous media; permeation; rock	CO2	The migration of water and contamination materials in rock structures is a significant issue in projects that utilize deep underground locations such as "carbon-dioxide capture and storage" (CCS) and disposal of high-level nuclear waste. These phenomena are also important in the area of preservation of stone structures of cultural heritage signficance, as such stone structures are usually located outside, exposed to wind and rain. The migration of contamination materials in the underground environment, especially in porous rock mass, is governed mainly by water permeation and diffusion. In this study, one-dimensional diffusion testing was conducted and the process in the porous materials was visualized by X-ray computed tomography (CT) scanning. Diffusion is the process caused by the concentrate or density gradient, and is a suitable phenomenon for X-ray CT analysis. In this paper, information related to diffusion is extracted from X-ray CT image data and the distribution of concentration is estimated. From the obtained density distribution, diffusion coefficients are evaluated. One-dimensional permeation tests were also conducted and intrinsic permeabilities of porous materials are evaluated, then the relation between diffusion coefficients and intrinsic permeability is discussed.	[Sato, Akira; Ikeda, Koichi] Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto, Japan	Sato, A (reprint author), Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto, Japan.	asato@kumamoto-u.ac.jp					Suekane T, 2006, J THERM SCI TECH-JPN, V1, P1, DOI 10.1299/jtst.1.1; Ghaderi A, 2009, GEOPHYSICS, V74, pO17, DOI 10.1190/1.3054659; Chadwick RA, 2009, PETROL GEOSCI, V15, P59, DOI 10.1144/1354-079309-793; Cnudde V., 2013, P 1 INT C TOM MAT ST; Fukahori D., 2010, ADV XRAY TOMOGRAPHY, P287, DOI [10.1002/9780470612187.ch28, DOI 10.1002/9780470612187.CH28]; Lin W., 2000, CHISHITSU NEWS, V459, P61; Ota K., 2007, 044 JAEA; Polak A, 2003, J CONTAM HYDROL, V67, P95, DOI 10.1016/S0169-7722(03)00069-X; Sato A., 2010, J MMIJ, V126, P640, DOI [10.2473/journalofmmij.126.640, DOI 10.2473/JOURNALOFMMIJ.126.640]; Sato A., 2006, GEOMATERIALS, P315, DOI [10.1002/9780470612187.ch32, DOI 10.1002/9780470612187.CH32]; Sato A., 2011, P ISRM INT C ROCK ME, P1357; Sato A., 2013, MAT SCI APPL, V4, P18, DOI [10.4236/msa.2013.48A003, DOI 10.4236/MSA.2013.48A003]; Sato A., 2013, J MMIJ, V129, P529, DOI [10.2473/journalofmmij.129.529, DOI 10.2473/JOURNALOFMMIJ.129.529]; Walker A., 2012, SCI REPORTS, V2, P880, DOI [10.1038/srep00880, DOI 10.1038/SREP00880]; Yoshida H., 2002, J JAPAN SOC ENG GEOL, V43, P24, DOI 10.5110/jjseg.43.24	15	0	0	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	0008-3674	1208-6010		CAN GEOTECH J	Can. Geotech. J.	OCT	2015	52	10					1448	1456		10.1139/cgj-2014-0451		9	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CU4DB	WOS:000363475700005		
J	Maehara, O; Sato, F; Natsuizaka, M; Asano, A; Kubota, Y; Itoh, J; Tsunematsu, S; Terashita, K; Tsukuda, Y; Nakai, M; Sho, T; Suda, G; Morikawa, K; Ogawa, K; Chuma, M; Nakagawa, K; Ohnishi, S; Komatsu, Y; Whelan, KA; Nakagawa, H; Takeda, H; Sakamoto, N				Maehara, Osamu; Sato, Fumiyuki; Natsuizaka, Mitsuteru; Asano, Ayaka; Kubota, Yoshimasa; Itoh, Jun; Tsunematsu, Seiji; Terashita, Katsumi; Tsukuda, Yoko; Nakai, Masato; Sho, Takuya; Suda, Goki; Morikawa, Kenichi; Ogawa, Koji; Chuma, Makoto; Nakagawa, Koji; Ohnishi, Shunsuke; Komatsu, Yoshito; Whelan, Kelly A.; Nakagawa, Hiroshi; Takeda, Hiroshi; Sakamoto, Naoya			A pivotal role of Kruppel-like factor 5 in regulation of cancer stem-like cells in hepatocellular carcinoma	CANCER BIOLOGY & THERAPY			English	Article						acetylation; cancer stem cell; CD44; CD133; hepatocellular carcinoma; KLF5	TUMOR-INITIATING CELLS; EPITHELIAL-CELLS; EXTRAHEPATIC METASTASIS; STEM/PROGENITOR CELLS; TRANSCRIPTION FACTORS; CLINICAL-FEATURES; SELF-RENEWAL; BETA-CATENIN; LIVER-CANCER; KLF5	In hepatocellular carcinoma (HCC), there exists a highly tumorigenic subset of cells defined by high expression of CD44 and CD133 that has been reported to contain cancer stem-like cells (CSCs). Kruppel-like factor 5 (KLF5) regulates many factors involved in cell cycle, migration, inflammation, angiogenesis and stemness and has cancer-promoting effects in some cancers. While some reports have indicated that KLF5 may have important roles in regulation of CSCs, what role, if any, KLF5 plays in regulation of CSCs in HCC remains to be elucidated. Flow cytometric analysis of CD44 and CD133 in HCC cell lines revealed subpopulations of CD44(High)/CD133(High) and CD44(Low)/CD133(Low) cells. We subsequently sorted these subpopulations and identified KLF5 as a gene that is significantly upregulated in CD44(High)/CD44(High) cells via RNA sequencing using next generation sequencing technology. Moreover, KLF5 overexpression enriched the CD44(High)/CD133(High) subpopulation and, consistent with the up-regulation of CD44(High)/CD133(High) cells, KLF5 overexpressing cells were more resistant to anti-cancer drugs and displayed enhanced colony-formation capacity. By contrast, knock-down of KLF5 by siRNA diminished the CD44(High)/CD133(High) subpopulation. When KLF5 was acetylated by TGF-1, the KLF5-mediated CD44(High)/CD133(High) subpopulation enrichment was abrogated. Oppositely, ectopic expression of an acetylation-deficient KLF5 mutant further increased CD44(High)/CD133(High) subpopulations as compared to cell expressing wild-type KLF5. These findings provide novel mechanistic insight into a pivotal role for KLF5 in the regulation of CSCs in HCC.	[Maehara, Osamu; Sato, Fumiyuki; Natsuizaka, Mitsuteru; Asano, Ayaka; Kubota, Yoshimasa; Itoh, Jun; Tsunematsu, Seiji; Terashita, Katsumi; Tsukuda, Yoko; Nakai, Masato; Sho, Takuya; Suda, Goki; Morikawa, Kenichi; Ogawa, Koji; Ohnishi, Shunsuke; Komatsu, Yoshito; Sakamoto, Naoya] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido, Japan; [Maehara, Osamu; Asano, Ayaka; Nakagawa, Koji; Takeda, Hiroshi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Pathophysiol & Therapeut, Sapporo, Hokkaido, Japan; [Chuma, Makoto] Yokohama City Univ, Med Ctr, Gastroenterol Ctr, Yokohama, Kanagawa 232, Japan; [Whelan, Kelly A.; Nakagawa, Hiroshi] Univ Penn, Div Gastroenterol, Philadelphia, PA 19104 USA; [Whelan, Kelly A.; Nakagawa, Hiroshi] Abramson Canc Ctr, Philadelphia, PA USA	Natsuizaka, M (reprint author), Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido, Japan.	mitsuteru1975@huhp.hokudai.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI Grant [25860512, 26460933, 15K08943]; Japanese Health Labor Sciences Research Grant	This study was supported in part by the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI Grant Numbers 25860512, 26460933, and 15K08943, and Japanese Health Labor Sciences Research Grant.	Akita H, 2014, CANCER RES, V74, P5903, DOI 10.1158/0008-5472.CAN-14-0527; Mori A, 2009, MOL CANCER RES, V7, P1390, DOI 10.1158/1541-7786.MCR-08-0525; Dong Z, 2013, CELL PROLIFERAT, V46, P425, DOI 10.1111/cpr.12043; Ma YC, 2013, EUR J GASTROEN HEPAT, V25, P1007, DOI 10.1097/MEG.0b013e32836019d8; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Dong JT, 2009, CELL MOL LIFE SCI, V66, P2691, DOI 10.1007/s00018-009-0045-z; Zhang ZP, 2003, NUCLEIC ACIDS RES, V31, P2196, DOI 10.1093/nar/gkg310; Pagliuca A, 2013, ONCOGENE, V32, P4806, DOI 10.1038/onc.2012.495; Ohnishi S, 2003, BIOCHEM BIOPH RES CO, V308, P251, DOI 10.1016/S0006-291X(03)01356-1; Nejak-Bowen KN, 2010, HEPATOLOGY, V51, P1603, DOI 10.1002/hep.23538; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Schulze K, 2013, INT J CANCER, V133, P2165, DOI 10.1002/ijc.28230; Ohashi S, 2010, GASTROENTEROLOGY, V139, P2113, DOI 10.1053/j.gastro.2010.08.040; Tang KH, 2012, HEPATOLOGY, V55, P807, DOI 10.1002/hep.24739; Natsuizaka M, 2010, CARCINOGENESIS, V31, P1344, DOI 10.1093/carcin/bgq108; McConnell BB, 2011, GASTROENTEROLOGY, V141, P1302, DOI 10.1053/j.gastro.2011.06.086; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Nakaya T, 2014, CANCER RES, V74, P2882, DOI 10.1158/0008-5472.CAN-13-2574; Zhu Z, 2010, INT J CANCER, V126, P2067, DOI 10.1002/ijc.24868; Smith SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106966; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Du JX, 2008, J BIOL CHEM, V283, P31991, DOI 10.1074/jbc.M803612200; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Natsuizaka M, 2005, J GASTROEN HEPATOL, V20, P1781, DOI 10.1111/j.1440-1746.2005.03919.x; Ohashi S, 2011, CANCER RES, V71, P6836, DOI 10.1158/0008-5472.CAN-11-0846; Fujii Y, 2012, P NATL ACAD SCI USA, V109, P20584, DOI 10.1073/pnas.1208651109; Chen CS, 2005, J BIOL CHEM, V280, P41553, DOI 10.1074/jbc.M5061873200; Uchino K, 2011, CANCER-AM CANCER SOC, V117, P4475, DOI 10.1002/cncr.25960; Lee TKW, 2011, CELL STEM CELL, V9, P50, DOI 10.1016/j.stem.2011.06.005; Yang XR, 2010, GUT, V59, P953, DOI 10.1136/gut.2008.176271; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Nagano O, 2013, ONCOGENE, V32, P5191, DOI 10.1038/onc.2012.638; Yamashita T, 2007, CANCER RES, V67, P10831, DOI 10.1158/0008-5472.CAN-07-0908; Guo P, 2009, J BIOL CHEM, V284, P18184, DOI 10.1074/jbc.M109.007096; Yoo DJ, 2011, J GASTROEN HEPATOL, V26, P145, DOI 10.1111/j.1440-1746.2010.06341.x; Chanchevalap S, 2006, NUCLEIC ACIDS RES, V34, P1216, DOI 10.1093/nar/gkl014; Yang ZF, 2008, HEPATOLOGY, V47, P919, DOI 10.1002/hep.22082; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Li X, 2015, INT J CANCER, V136, P536, DOI 10.1002/ijc.29028; Luan Yi, 2014, World J Biol Chem, V5, P216, DOI 10.4331/wjbc.v5.i2.216; Noto JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054344; Oishi Naoki, 2014, Liver Cancer, V3, P71, DOI 10.1159/000343863; Shibata T, 2014, NAT REV GASTRO HEPAT, V11, DOI 10.1038/nrgastro.2014.6; Wan SS, 2014, GASTROENTEROLOGY, V147, P1393, DOI 10.1053/j.gastro.2014.08.039	46	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-4047	1555-8576		CANCER BIOL THER	Cancer Biol. Ther.	OCT	2015	16	10					1453	1461		10.1080/15384047.2015.1070992		9	Oncology	Oncology	CT8KC	WOS:000363064000006		
J	Kar, SP; Tyrer, JP; Li, QY; Lawrenson, K; Aben, KKH; Anton-Culver, H; Antonenkova, N; Chenevix-Trench, G; Baker, H; Bandera, EV; Bean, YT; Beckmann, MW; Berchuck, A; Bisogna, M; Bjorge, L; Bogdanova, N; Brinton, L; Brooks-Wilson, A; Butzow, R; Campbell, I; Carty, K; Chang-Claude, J; Chen, YA; Chen, ZH; Cook, LS; Cramer, D; Cunningham, JM; Cybulski, C; Dansonka-Mieszkowska, A; Dennis, J; Dicks, E; Doherty, JA; Dork, T; du Bois, A; Durst, M; Eccles, D; Easton, DF; Edwards, RP; Ekici, AB; Fasching, PA; Fridley, BL; Gao, YT; Gentry-Maharaj, A; Giles, GG; Glasspool, R; Goode, EL; Goodman, MT; Grownwald, J; Harrington, P; Harter, P; Hein, A; Heitz, F; Hildebrandt, MAT; Hillemanns, P; Hogdall, E; Hogdall, CK; Hosono, S; Iversen, ES; Jakubowska, A; Paul, J; Jensen, A; Ji, BT; Karlan, BY; Kjaer, SK; Kelemen, LE; Kellar, M; Kelley, J; Kiemeney, LA; Krakstad, C; Kupryjanczyk, J; Lambrechts, D; Lambrechts, S; Le, ND; Lee, AW; Lele, S; Leminen, A; Lester, J; Levine, DA; Liang, D; Lissowska, J; Lu, K; Lubinski, J; Lundvall, L; Massuger, L; Matsuo, K; McGuire, V; McLaughlin, JR; McNeish, IA; Menon, U; Modugno, F; Moysich, KB; Narod, SA; Nedergaard, L; Ness, RB; Nevanlinna, H; Odunsi, K; Olson, SH; Orlow, I; Orsulic, S; Weber, RP; Pearce, CL; Pejovic, T; Pelttari, LM; Permuth-Wey, J; Phelan, CM; Pike, MC; Poole, EM; Ramus, SJ; Risch, HA; Rosen, B; Rossing, MA; Rothstein, JH; Rudolph, A; Runnebaum, IB; Rzepecka, IK; Salvesen, HB; Schildkraut, JM; Schwaab, I; Shu, XO; Shvetsov, YB; Siddiqui, N; Sieh, W; Song, HL; Southey, MC; Sucheston-Campbell, LE; Tangen, IL; Teo, SH; Terry, KL; Thompson, PJ; Timorek, A; Tsai, YY; Tworoger, SS; van Altena, AM; Van Nieuwenhuysen, E; Vergote, I; Vierkant, RA; Wang-Gohrke, S; Walsh, C; Wentzensen, N; Whittemore, AS; Wicklund, KG; Wilkens, LR; Woo, YL; Wu, XF; Wu, AN; Yang, HN; Zheng, W; Ziogas, A; Sellers, TA; Monteiro, ANA; Freedman, ML; Gayther, SA; Pharoah, PDP				Kar, Siddhartha P.; Tyrer, Jonathan P.; Li, Qiyuan; Lawrenson, Kate; Aben, Katja K. H.; Anton-Culver, Hoda; Antonenkova, Natalia; Chenevix-Trench, Georgia; Baker, Helen; Bandera, Elisa V.; Bean, Yukie T.; Beckmann, Matthias W.; Berchuck, Andrew; Bisogna, Maria; Bjorge, Line; Bogdanova, Natalia; Brinton, Louise; Brooks-Wilson, Angela; Butzow, Ralf; Campbell, Ian; Carty, Karen; Chang-Claude, Jenny; Chen, Yian Ann; Chen, Zhihua; Cook, Linda S.; Cramer, Daniel; Cunningham, Julie M.; Cybulski, Cezary; Dansonka-Mieszkowska, Agnieszka; Dennis, Joe; Dicks, Ed; Doherty, Jennifer A.; Doerk, Thilo; du Bois, Andreas; Duerst, Matthias; Eccles, Diana; Easton, Douglas F.; Edwards, Robert P.; Ekici, Arif B.; Fasching, Peter A.; Fridley, Brooke L.; Gao, Yu-Tang; Gentry-Maharaj, Aleksandra; Giles, Graham G.; Glasspool, Rosalind; Goode, Ellen L.; Goodman, Marc T.; Grownwald, Jacek; Harrington, Patricia; Harter, Philipp; Hein, Alexander; Heitz, Florian; Hildebrandt, Michelle A. T.; Hillemanns, Peter; Hogdall, Estrid; Hogdall, Claus K.; Hosono, Satoyo; Iversen, Edwin S.; Jakubowska, Anna; Paul, James; Jensen, Allan; Ji, Bu-Tian; Karlan, Beth Y.; Kjaer, Susanne K.; Kelemen, Linda E.; Kellar, Melissa; Kelley, Joseph; Kiemeney, Lambertus A.; Krakstad, Camilla; Kupryjanczyk, Jolanta; Lambrechts, Diether; Lambrechts, Sandrina; Le, Nhu D.; Lee, Alice W.; Lele, Shashi; Leminen, Arto; Lester, Jenny; Levine, Douglas A.; Liang, Dong; Lissowska, Jolanta; Lu, Karen; Lubinski, Jan; Lundvall, Lene; Massuger, Leon; Matsuo, Keitaro; McGuire, Valerie; McLaughlin, John R.; McNeish, Iain A.; Menon, Usha; Modugno, Francesmary; Moysich, Kirsten B.; Narod, Steven A.; Nedergaard, Lotte; Ness, Roberta B.; Nevanlinna, Heli; Odunsi, Kunle; Olson, Sara H.; Orlow, Irene; Orsulic, Sandra; Weber, Rachel Palmieri; Pearce, Celeste Leigh; Pejovic, Tanja; Pelttari, Liisa M.; Permuth-Wey, Jennifer; Phelan, Catherine M.; Pike, Malcolm C.; Poole, Elizabeth M.; Ramus, Susan J.; Risch, Harvey A.; Rosen, Barry; Rossing, Mary Anne; Rothstein, Joseph H.; Rudolph, Anja; Runnebaum, Ingo B.; Rzepecka, Iwona K.; Salvesen, Helga B.; Schildkraut, Joellen M.; Schwaab, Ira; Shu, Xiao-Ou; Shvetsov, Yurii B.; Siddiqui, Nadeem; Sieh, Weiva; Song, Honglin; Southey, Melissa C.; Sucheston-Campbell, Lara E.; Tangen, Ingvild L.; Teo, Soo-Hwang; Terry, Kathryn L.; Thompson, Pamela J.; Timorek, Agnieszka; Tsai, Ya-Yu; Tworoger, Shelley S.; van Altena, Anne M.; Van Nieuwenhuysen, Els; Vergote, Ignace; Vierkant, Robert A.; Wang-Gohrke, Shan; Walsh, Christine; Wentzensen, Nicolas; Whittemore, Alice S.; Wicklund, Kristine G.; Wilkens, Lynne R.; Woo, Yin-Ling; Wu, Xifeng; Wu, Anna; Yang, Hannah; Zheng, Wei; Ziogas, Argyrios; Sellers, Thomas A.; Monteiro, Alvaro N. A.; Freedman, Matthew L.; Gayther, Simon A.; Pharoah, Paul D. P.		Australian Canc Study; Australian Ovarian Canc Study Grp	Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk	CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION			English	Article							GENOME-WIDE ASSOCIATION; TRANSCRIPTION FACTORS; SUSCEPTIBILITY LOCI; BREAST-CANCER; VARIANTS; MODELS; SET; POPULATION; CARCINOMA; PROFILES	Background: Genome-wide association studies (GWAS) have so far reported 12 loci associated with serous epithelial ovarian cancer (EOC) risk. We hypothesized that some of these loci function through nearby transcription factor (TF) genes and that putative target genes of these TFs as identified by coexpression may also be enriched for additional EOC risk associations. Methods: We selected TF genes within 1 Mb of the top signal at the 12 genome-wide significant risk loci. Mutual information, a form of correlation, was used to build networks of genes strongly coexpressed with each selected TF gene in the unified microarray dataset of 489 serous EOC tumors from The Cancer Genome Atlas. Genes represented in this dataset were subsequently ranked using a gene-level test based on results for germline SNPs from a serous EOC GWAS meta-analysis (2,196 cases/4,396 controls). Results: Gene set enrichment analysis identified six networks centered on TF genes (HOXB2, HOXB5, HOXB6, HOXB7 at 17q21.32 and HOXD1, HOXD3 at 2q31) that were significantly enriched for genes from the risk-associated end of the ranked list (P < 0.05 and FDR < 0.05). These results were replicated (P < 0.05) using an independent association study (7,035 cases/21,693 controls). Genes underlying enrichment in the six networks were pooled into a combined network. Conclusion: We identified a HOX-centric network associated with serous EOC risk containing several genes with known or emerging roles in serous EOC development. Impact: Network analysis integrating large, context-specific datasets has the potential to offer mechanistic insights into cancer susceptibility and prioritize genes for experimental characterization. (C) 2015 AACR.	[Kar, Siddhartha P.; Dennis, Joe; Easton, Douglas F.; Pharoah, Paul D. P.] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England; [Tyrer, Jonathan P.; Baker, Helen; Dicks, Ed; Easton, Douglas F.; Harrington, Patricia; Song, Honglin; Pharoah, Paul D. P.] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Oncol, Cambridge CB1 8RN, England; [Li, Qiyuan; Freedman, Matthew L.] Dana Farber Canc Inst, Dept Med Oncol, Ctr Funct Canc Epigenet, Boston, MA 02115 USA; [Lawrenson, Kate; Lee, Alice W.; Pearce, Celeste Leigh; Pike, Malcolm C.; Ramus, Susan J.; Wu, Anna; Gayther, Simon A.] Univ So Calif, Dept Prevent Med, Keck Sch Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Aben, Katja K. H.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, NL-6525 ED Nijmegen, Netherlands; [Aben, Katja K. H.] Comprehens Canc Ctr Netherlands, Utrecht, Netherlands; [Anton-Culver, Hoda; Ziogas, Argyrios] Univ Calif Irvine, Sch Med, Dept Epidemiol, Genet Epidemiol Res Inst, Irvine, CA 92717 USA; [Antonenkova, Natalia] Byelorussian Inst Oncol & Med Radiol Aleksandrov, Minsk, Byelarus; [Chenevix-Trench, Georgia; Australian Canc Study] QIMR Berghofer Med Res Inst, Canc Div, Brisbane, Qld, Australia; [Australian Ovarian Canc Study Grp] Peter MacCallum Canc Inst, East Melbourne, Vic, Australia; [Bandera, Elisa V.] Rutgers Canc Inst New Jersey, Canc Prevent & Control, New Brunswick, NJ USA; [Bean, Yukie T.; Kellar, Melissa; Pejovic, Tanja] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA; [Bean, Yukie T.; Kellar, Melissa; Pejovic, Tanja] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Beckmann, Matthias W.; Fasching, Peter A.; Hein, Alexander] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Gynecol & Obstet, Comprehens Canc Ctr Erlangen EMN, D-91054 Erlangen, Germany; [Berchuck, Andrew] Duke Univ, Med Ctr, Dept Obstet & Gynecol, Durham, NC 27710 USA; [Bisogna, Maria; Levine, Douglas A.] Mem Sloan Kettering Canc Ctr, Dept Surg, Gynecol Serv, New York, NY 10021 USA; [Bjorge, Line; Krakstad, Camilla; Salvesen, Helga B.; Tangen, Ingvild L.] Haukeland Hosp, Dept Gynecol & Obstet, N-5021 Bergen, Norway; [Bjorge, Line; Krakstad, Camilla; Salvesen, Helga B.; Tangen, Ingvild L.] Univ Bergen, Dept Clin Sci, Ctr Canc Biomarkers, Bergen, Norway; [Bogdanova, Natalia; Doerk, Thilo] Hannover Med Sch, Gynaecol Res Unit, Hannover, Germany; [Brinton, Louise; Ji, Bu-Tian; Wentzensen, Nicolas; Yang, Hannah] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Brooks-Wilson, Angela] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC, Canada; [Brooks-Wilson, Angela] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada; [Butzow, Ralf; Leminen, Arto; Nevanlinna, Heli; Pelttari, Liisa M.] Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland; [Butzow, Ralf; Leminen, Arto; Nevanlinna, Heli; Pelttari, Liisa M.] Univ Helsinki, Cent Hosp, HUS, Helsinki, Finland; [Butzow, Ralf] Univ Helsinki, Cent Hosp, Dept Pathol, Helsinki, Finland; [Campbell, Ian] Peter MacCallum Canc Ctr, Canc Genet Lab, Div Res, Melbourne, Vic, Australia; [Campbell, Ian; Southey, Melissa C.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Campbell, Ian] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia; [Carty, Karen; Glasspool, Rosalind; Paul, James] Beatson West Scotland Canc Ctr, Canc Res UK Clin Trials Unit, Glasgow, Lanark, Scotland; [Chang-Claude, Jenny; Rudolph, Anja] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Chen, Yian Ann; Chen, Zhihua] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Biostat, Tampa, FL 33682 USA; [Cook, Linda S.] Univ New Mexico, Dept Internal Med, Div Epidemiol & Biostat, Albuquerque, NM 87131 USA; [Cramer, Daniel; Terry, Kathryn L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Obstet & Gynecol Ctr, Boston, MA 02115 USA; [Cramer, Daniel; Terry, Kathryn L.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Cunningham, Julie M.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Dansonka-Mieszkowska, Agnieszka; Kupryjanczyk, Jolanta; Rzepecka, Iwona K.] Maria Sklodowska Curie Mem Canc Ctr, Dept Pathol & Lab Diagnost, Warsaw, Poland; [Dansonka-Mieszkowska, Agnieszka; Kupryjanczyk, Jolanta; Rzepecka, Iwona K.] Inst Oncol, Warsaw, Poland; [Doherty, Jennifer A.] Geisel Sch Med Dartmouth, Sect Biostat & Epidemiol, Dept Community & Family Med, Lebanon, NH USA; [du Bois, Andreas; Harter, Philipp; Heitz, Florian] Kliniken Essen Mitte, Dept Gynecol & Gynecol Oncol, Essen, Germany; [du Bois, Andreas; Harter, Philipp; Heitz, Florian] Dr Horst Schmidt Kliniken Wiesbaden, Dept Gynecol & Gynecol Oncol, Wiesbaden, Germany; [Duerst, Matthias; Runnebaum, Ingo B.] Univ Jena, Dept Gynecol, Jena Univ Hosp, Jena, Germany; [Eccles, Diana; Edwards, Robert P.] Princess Anne Hosp, Wessex Clin Genet Serv, Southampton, Hants, England; [Edwards, Robert P.; Modugno, Francesmary] Univ Pittsburgh, Ovarian Canc Ctr Excellence, Pittsburgh, PA USA; [Ekici, Arif B.] Univ Erlangen Nurnberg, Inst Human Genet, Univ Hosp Erlangen, Erlangen, Germany; [Fasching, Peter A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Fridley, Brooke L.] Univ Kansas, Med Ctr, Biostat & Informat Shared Resource, Kansas City, KS 66103 USA; [Gao, Yu-Tang] Shanghai Canc Inst, Shanghai, Peoples R China; [Gentry-Maharaj, Aleksandra; Menon, Usha] UCL, Elizabeth Garrett Anderson Inst Womens Hlth, Womens Canc, London, England; [Giles, Graham G.] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia; [Goode, Ellen L.; Vierkant, Robert A.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Goodman, Marc T.; Thompson, Pamela J.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Canc Prevent & Control, Los Angeles, CA 90048 USA; [Goodman, Marc T.; Thompson, Pamela J.] Cedars Sinai Med Ctr, Dept Biomed Sci, Commun & Populat Hlth Res Inst, Los Angeles, CA 90048 USA; [Cybulski, Cezary; Grownwald, Jacek; Jakubowska, Anna; Lubinski, Jan] Pomeranian Med Univ, Dept Genet & Pathol, Szczecin, Poland; [Hildebrandt, Michelle A. T.; Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Hillemanns, Peter] Hannover Med Sch, Dept Obstet, Hannover, Germany; [Hillemanns, Peter] Hannover Med Sch, Dept Gynaecol, Hannover, Germany; [Hogdall, Estrid; Jensen, Allan; Kjaer, Susanne K.] Danish Canc Soc, Res Ctr, Virus Lifestyle & Genes, Copenhagen, Denmark; [Hogdall, Estrid] Univ Copenhagen, Herlev Hosp, Dept Pathol, Mol Unit, Copenhagen, Denmark; [Hogdall, Claus K.; Kjaer, Susanne K.; Lundvall, Lene] Univ Copenhagen, Rigshosp, Dept Gynecol, DK-2100 Copenhagen, Denmark; [Hosono, Satoyo] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan; [Iversen, Edwin S.] Duke Univ, Dept Stat Sci, Durham, NC USA; [Karlan, Beth Y.; Lester, Jenny; Orsulic, Sandra; Walsh, Christine] Cedars Sinai Med Ctr, Womens Canc Program, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Kelemen, Linda E.] Med Univ S Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Kelley, Joseph] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA; [Lambrechts, Diether] VIB, Vesalius Res Ctr, Leuven, Belgium; [Lambrechts, Diether] Univ Leuven, Dept Oncol, Lab Translat Genet, Leuven, Belgium; [Lambrechts, Sandrina; Van Nieuwenhuysen, Els; Vergote, Ignace] Univ Hosp Leuven, Dept Oncol, Div Gynecol Oncol, Leuven, Belgium; [Le, Nhu D.] BC Canc Agcy, Canc Control Res, Vancouver, BC, Canada; [Lele, Shashi; Moysich, Kirsten B.; Sucheston-Campbell, Lara E.] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA; [Liang, Dong] Texas So Univ, Coll Pharm & Hlth Sci, Houston, TX 77004 USA; [Lissowska, Jolanta] Maria Sklodowska Curie Mem Canc Ctr, Dept Canc Epidemiol & Prevent, Warsaw, Poland; [Lissowska, Jolanta] Inst Oncol, Warsaw, Poland; [Lu, Karen] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; [Massuger, Leon; van Altena, Anne M.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Matsuo, Keitaro] Kyushu Univ, Dept Prevent Med, Fac Med Sci, Fukuoka 812, Japan; [McGuire, Valerie; Rothstein, Joseph H.; Sieh, Weiva; Whittemore, Alice S.] Stanford Univ, Dept Hlth Res & Policy Epidemiol, Sch Med, Stanford, CA 94305 USA; [McLaughlin, John R.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Prosserman Ctr Hlth Res, Toronto, ON M5G 1X5, Canada; [McNeish, Iain A.] Univ Glasgow, Inst Canc Sci, Wolfson Wohl Canc Res Ctr, Beatson Inst Canc Res, Glasgow, Lanark, Scotland; [Modugno, Francesmary] Magee Womens Res Inst, Womens Canc Res Program, Pittsburgh, PA USA; [Modugno, Francesmary] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Modugno, Francesmary] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA; [Modugno, Francesmary] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Narod, Steven A.] Womens Coll Res Inst, Toronto, ON, Canada; [Nedergaard, Lotte] Univ Copenhagen, Rigshosp, Dept Pathol, DK-2100 Copenhagen, Denmark; [Ness, Roberta B.] Univ Texas Houston, Sch Publ Hlth, Houston, TX USA; [Odunsi, Kunle] Roswell Pk Canc Inst, Dept Gynecol Oncol, Buffalo, NY 14263 USA; [Olson, Sara H.; Orlow, Irene; Pike, Malcolm C.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Weber, Rachel Palmieri] Duke Univ, Med Ctr, Dept Community & Family Med, Durham, NC 27710 USA; [Dansonka-Mieszkowska, Agnieszka; Permuth-Wey, Jennifer; Phelan, Catherine M.; Tsai, Ya-Yu; Sellers, Thomas A.; Monteiro, Alvaro N. A.] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Canc Epidemiol, Tampa, FL 33682 USA; [Poole, Elizabeth M.; Tworoger, Shelley S.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Div Network Med, Boston, MA 02115 USA; [Poole, Elizabeth M.; Tworoger, Shelley S.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Risch, Harvey A.] Yale Univ, Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT USA; [Rosen, Barry] Univ Toronto, Dept Gynecol Oncol, Princess Margaret Hosp, Toronto, ON, Canada; [Rosen, Barry] Univ Toronto, Fac Med, Dept Obstet & Gynecol, Toronto, ON, Canada; [Rossing, Mary Anne; Wicklund, Kristine G.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Program Epidemiol, Seattle, WA 98104 USA; [Rossing, Mary Anne] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Schildkraut, Joellen M.] Duke Univ, Med Ctr, Dept Community & Family Med, Durham, NC 27710 USA; [Schildkraut, Joellen M.] Duke Canc Inst, Canc Control & Populat Sci, Durham, NC USA; [Schwaab, Ira] Inst Humangenet Wiesbaden, Wiesbaden, Germany; [Shu, Xiao-Ou; Zheng, Wei] Vanderbilt Univ, Dept Med, Epidemiol Ctr, Div Epidemiol,Sch Med, Nashville, TN 37212 USA; [Shu, Xiao-Ou; Zheng, Wei] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Shvetsov, Yurii B.; Wilkens, Lynne R.] Univ Hawaii, Ctr Canc, Canc Epidemiol Program, Honolulu, HI 96822 USA; [Siddiqui, Nadeem] Glasgow Royal Infirm, Dept Gynaecol Oncol, Glasgow G4 0SF, Lanark, Scotland; [Teo, Soo-Hwang] Sime Darby Med Ctr, Canc Res Initiat Fdn, Subang Jaya, Malaysia; [Teo, Soo-Hwang; Woo, Yin-Ling] Univ Malaya, Fac Med, Univ Malaya Med Ctr, Univ Malaya Canc Res Inst, Kuala Lumpur, Malaysia; [Timorek, Agnieszka] Warsaw Med Univ, IInd Fac Med, Dept Obstet Gynecol & Oncol, Warsaw, Poland; [Timorek, Agnieszka] Brodnowski Hosp, Warsaw, Poland; [Wang-Gohrke, Shan] Univ Ulm, Dept Obstet & Gynecol, D-89069 Ulm, Germany; [Woo, Yin-Ling] Univ Malaya, Dept Obstet & Gynaecol, Univ Malaya Med Ctr, Kuala Lumpur, Malaysia	Kar, SP (reprint author), Univ Cambridge, Ctr Canc Genet Epidemiol, Strangeways Res Lab, Cambridge CB1 8RN, England.	sk718@medschl.cam.ac.uk	Dork, Thilo/J-8620-2012; Hein, Alexander/F-6999-2010; Bandera, Elisa/M-4169-2014; 	Hein, Alexander/0000-0003-2601-3398; Bandera, Elisa/0000-0002-8789-2755; Kjaer, Susanne/0000-0002-8347-1398; McNeish, Iain/0000-0002-9387-7586	European Commission [223175-HEALTH-F2-2009-223175]; U.S. National Cancer Institute GAME-ON Post-GWAS Initiative [U19-CA148112]; Ovarian Cancer Research Fund [PPD/RPCI.07]; Cancer Research UK Principal Research Fellowship; National Health and Medical Research Council of Australia; American Cancer Society Early Detection Professorship [SIOP-06-258-01-COUN]; Canadian Institutes of Health Research Investigator award [MSH-87734]; U.S. National Institute of Environmental Health Sciences [T32ES013678]; U.S. National Cancer Institute [1K99CA184415-01]; Gates Cambridge Scholarship; NIH [R01-CA168758, R13-CA165638, P50-CA159981, R03-CA115195, R01-CA114343, R01-CA149429, T32-CA009001, R01-CA172404, R01-CA074850, P30-CA124435, K07-CA143047, R01-CA076016]; Cancer Research UK [C315/A2621, C490/A6187, C490/A10119, C490/A10124, C536/A13086, C536/A6689]; American Cancer Society [CRTG-00-196-01-CCE]; California Cancer Research Program [00-01389V-20170, N01-CN25403, 2II0200]; Canadian Institutes for Health Research [MOP-86727]; Cancer Council Victoria; Cancer Council Queensland; Cancer Council New South Wales; Cancer Council South Australia; Cancer Council Tasmania; Cancer Foundation of Western Australia; Cancer Institute of New Jersey; Celma Mastry Ovarian Cancer Foundation; Danish Cancer Society [94-222-52]; ELAN Program of the University of Erlangen-Nuremberg; Eve Appeal; Helsinki University Central Hospital Research Fund; Helse Vest; Imperial Experimental Cancer Research Centre [C1312/A15589]; Norwegian Cancer Society; Norwegian Research Council; Ovarian Cancer Research Fund; Nationaal Kankerplan of Belgium; Ministry of Health Labour and Welfare of Japan; L&S Milken Foundation; Polish Ministry of Science and Higher Education [4 PO5C 028 14, 2 PO5A 068 27]; Malaysian Ministry of Higher Education [UM.C/HlR/MOHE/06]; Cancer Research Initiatives Foundation; Roswell Park Cancer Institute Alliance Foundation; U.S. National Institutes of Health [R03-CA115195, R01-CA114343, R01-CA149429, R01-CA074850, K07-CA143047, R01-CA076016, K07-CA095666, K22-CA138563, N01-CN55424, N01-PC067010, N01-PC035137, P01-CA017054, P01-CA087696, P30-CA15083, P50-CA105009, P50-CA136393, R01-CA014089, R01-CA016056, R01-CA017054, R01-CA049449, R01-CA050385, R01-CA054419, R01-CA058598, R01-CA058860, UM1-CA186107, P01-CA87969, R01-CA49449, UM1-CA176726, R01-CA67262, R01-CA061107, R01-CA061132, R01-CA063682, R01-CA064277, R01-CA067262, R01-CA071766, R01-CA080742, R01-CA080978, R01-CA083918, R01-CA087538, R01-CA092044, R01-095023, R01-CA106414, R01-CA122443, R01-CA112523, R01-CA126841, R01-CA136924, R03-CA113148, R37-CA070867, R37-CA70867, U01-CA069417, U01-CA071966]; U.S. Army Medical Research and Material Command [DAMD17-98-1-8659, DAMD17-01-1-0729, DAMD17-02-1-0666, DAMD17-02-1-0669, W81XWH-10-1-0280]; National Health and Medical Research Council of Australia [199600, 400281]; German Federal Ministry of Education and Research of Germany Programme of Clinical Biomedical Research [01 GB 9401]; state of Baden-Wurttemberg through Medical Faculty of the University of Ulm [P. 685]; Minnesota Ovarian Cancer Alliance; Mayo Foundation; Fred C. and Katherine B. Andersen Foundation; Lon V. Smith Foundation [LVS-39420]; Oak Foundation; OHSU Foundation; Mermaid I project; Rudolf-Bartling Foundation; Royal Marsden Hospital; WorkSafeBC; U.K. National Institute for Health Research Biomedical Research Centres at the University of Cambridge, Imperial College London, University College Hospital "Womens Health Theme"	Funding for the COGS infrastructure came from a European Commission's Seventh Framework Programme grant (agreement number 223175-HEALTH-F2-2009-223175). The scientific development and funding for this project were, in part, supported by the U.S. National Cancer Institute GAME-ON Post-GWAS Initiative (U19-CA148112). Funding for the Ovarian Cancer Association Consortium (OCAC) GWAS infrastructure came from the Ovarian Cancer Research Fund thanks to donations by the family and friends of Kathryn Sladek Smith (PPD/RPCI.07). D.F. Easton is supported by a Cancer Research UK Principal Research Fellowship. G. Chenevix-Trench is supported by the National Health and Medical Research Council of Australia. B.Y. Karlan is supported by an American Cancer Society Early Detection Professorship (SIOP-06-258-01-COUN). L.E. Keleman was supported by a Canadian Institutes of Health Research Investigator award (MSH-87734). A.W. Lee is supported by a T32 grant from the U.S. National Institute of Environmental Health Sciences (T32ES013678). K. Lawrenson is supported by a K99/R00 grant from the U.S. National Cancer Institute (1K99CA184415-01). S.P. Kar is supported by a Gates Cambridge Scholarship.; The following authors would like to acknowledge specific grant support from the NIH: J.A. Doherty (R01-CA168758), R.P. Edwards (R13-CA165638), K. Odunsi (P50-CA159981), C.L. Pearce (R03-CA115195), J. Permuth-Wey (R01-CA114343), C.M. Phelan (R01-CA149429), E.M. Poole (T32-CA009001), S.J. Ramus (R01-CA172404), H.A. Risch (R01-CA074850), J.H. Rothstein (P30-CA124435), W. Sieh (K07-CA143047), L.E. Sucheston-Campbell (P50-CA159981), Rachel Palmieri Weber (R01-CA076016); and from Cancer Research UK: A. Gentry-Maharaj (C315/A2621) and P.D.P. Pharoah (C490/A10119). Funding of the constituent studies of the OCAC GWAS and COGS are listed by funding agency with each grant number in parentheses: American Cancer Society (CRTG-00-196-01-CCE); the California Cancer Research Program (00-01389V-20170, N01-CN25403, 2II0200); the Canadian Institutes for Health Research (MOP-86727); Cancer Council Victoria; Cancer Council Queensland; Cancer Council New South Wales; Cancer Council South Australia; Cancer Council Tasmania; Cancer Foundation of Western Australia; the Cancer Institute of New Jersey; Cancer Research UK (C490/A6187, C490/A10119, C490/A10124, C536/A13086, and C536/A6689); the Celma Mastry Ovarian Cancer Foundation; the Danish Cancer Society (94-222-52); the ELAN Program of the University of Erlangen-Nuremberg; the Eve Appeal; the Helsinki University Central Hospital Research Fund; Helse Vest; Imperial Experimental Cancer Research Centre (C1312/A15589); the Norwegian Cancer Society; the Norwegian Research Council; the Ovarian Cancer Research Fund; Nationaal Kankerplan of Belgium; Grant-in-Aid for the Third Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health Labour and Welfare of Japan; the L&S Milken Foundation; the Polish Ministry of Science and Higher Education (4 PO5C 028 14, 2 PO5A 068 27); Malaysian Ministry of Higher Education (UM.C/HlR/MOHE/06) and Cancer Research Initiatives Foundation; the Roswell Park Cancer Institute Alliance Foundation; the U.S. National Institutes of Health (K07-CA095666, K07-CA143047, K22-CA138563, N01-CN55424, N01-PC067010, N01-PC035137, P01-CA017054, P01-CA087696, P30-CA15083, P50-CA105009, P50-CA136393, R01-CA014089, R01-CA016056, R01-CA017054, R01-CA049449, R01-CA050385, R01-CA054419, R01-CA058598, R01-CA058860, UM1-CA186107, P01-CA87969, R01-CA49449, UM1-CA176726, R01-CA67262, R01-CA061107, R01-CA061132, R01-CA063682, R01-CA064277, R01-CA067262, R01-CA071766, R01-CA074850, R01-CA076016, R01-CA080742, R01-CA080978, R01-CA083918, R01-CA087538, R01-CA092044, R01-095023, R01-CA106414, R01-CA122443, R01-CA112523, R01-CA114343, R01-CA126841, R01-CA136924, R01-CA149429, R03-CA113148, R03-CA115195, R37-CA070867, R37-CA70867, U01-CA069417, U01-CA071966, and Intramural research funds); the U.S. Army Medical Research and Material Command (DAMD17-98-1-8659, DAMD17-01-1-0729, DAMD17-02-1-0666, DAMD17-02-1-0669, and W81XWH-10-1-0280); the National Health and Medical Research Council of Australia (199600 and 400281); the German Federal Ministry of Education and Research of Germany Programme of Clinical Biomedical Research (01 GB 9401); the state of Baden-Wurttemberg through Medical Faculty of the University of Ulm (P. 685); the Minnesota Ovarian Cancer Alliance; the Mayo Foundation; the Fred C. and Katherine B. Andersen Foundation; the Lon V. Smith Foundation (LVS-39420); the Oak Foundation; the OHSU Foundation; the Mermaid I project; the Rudolf-Bartling Foundation; the U.K.; National Institute for Health Research Biomedical Research Centres at the University of Cambridge, Imperial College London, University College Hospital "Womens Health Theme" and the Royal Marsden Hospital; WorkSafeBC.	Fridley BL, 2011, EUR J HUM GENET, V19, P837, DOI 10.1038/ejhg.2011.57; Naora H, 2001, P NATL ACAD SCI USA, V98, P4060, DOI 10.1073/pnas.071594398; Song HL, 2009, NAT GENET, V41, P996, DOI 10.1038/ng.424; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Bahcall OG, 2013, NAT GENET, V45, P343, DOI 10.1038/ng.2592; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; di Pietro M, 2012, P NATL ACAD SCI USA, V109, P9077, DOI 10.1073/pnas.1116933109; Wang C, 2013, ANN RHEUM DIS, V72, P96, DOI 10.1136/annrheumdis-2012-201364; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Perets R, 2013, CANCER CELL, V24, P751, DOI 10.1016/j.ccr.2013.10.013; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Freedman ML, 2011, NAT GENET, V43, P513, DOI 10.1038/ng.840; Svingen T, 2006, HEREDITY, V97, P88, DOI 10.1038/sj.hdy.6800847; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Kobel M, 2013, CANCER EPIDEM BIOMAR, V22, P1677, DOI 10.1158/1055-9965.EPI-13-0391; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Cheng WJ, 2005, NAT MED, V11, P531, DOI 10.1038/nm1230; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Antoniou AC, 2010, NAT GENET, V42, P885, DOI 10.1038/ng.669; Bojesen SE, 2013, NAT GENET, V45, P371, DOI 10.1038/ng.2566; Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Bolton KL, 2010, NAT GENET, V42, P880, DOI 10.1038/ng.666; Sur I, 2013, CANCER RES, V73, P4180, DOI 10.1158/0008-5472.CAN-13-0789; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464; Li QY, 2013, CELL, V152, P633, DOI 10.1016/j.cell.2012.12.034; Califano A, 2012, NAT GENET, V44, P841, DOI 10.1038/ng.2355; Pharoah PDP, 2013, NAT GENET, V45, P362, DOI 10.1038/ng.2564; Rubin E, 2007, CANCER RES, V67, P1527, DOI 10.1158/0008-5475.CAN-06-4283; Antoniou Antonis C, 2006, Future Oncol, V2, P257, DOI 10.2217/14796694.2.2.257; Couch FJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003212; Cowper-Sallari R., 2012, NAT GENET, V44, P1191; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Fletcher MNC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3464; Goode LL, 2010, NAT GENET, V42, P874, DOI 10.1038/ng.668; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Kuchenbaecker KB, 2015, NAT GENET, V47, P164, DOI 10.1038/ng.3185; Lawrenson K, 2012, JOVE-J VIS EXP, DOI 10.3791/4206; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Michailidou K, 2013, NAT GENET, V45, P353; Parker HJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-637; Permuth-Wey J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2613; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Shen H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2629; Sur IK, 2012, SCIENCE, V338, P1360, DOI 10.1126/science.1228606; The Cancer Genome Atlas, DAT PORT INT GEN AN; The Cancer Genome Atlas, DAT PORT PROGN REL G; Wu Q, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-45	52	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1055-9965	1538-7755		CANCER EPIDEM BIOMAR	Cancer Epidemiol. Biomarkers Prev.	OCT	2015	24	10					1574	1584		10.1158/1055-9965.EPI-14-1270		11	Oncology; Public, Environmental & Occupational Health	Oncology; Public, Environmental & Occupational Health	CU3CR	WOS:000363401800016		
J	Koga-Yamakawa, E; Murata, M; Dovedi, SJ; Wilkinson, RW; Ota, Y; Umehara, H; Sugaru, E; Hirose, Y; Harada, H; Jewsbury, PJ; Yamamoto, S; Robinson, DT; Li, CJ				Koga-Yamakawa, Erina; Murata, Masashi; Dovedi, Simon J.; Wilkinson, Robert W.; Ota, Yosuke; Umehara, Hiroki; Sugaru, Eiji; Hirose, Yuko; Harada, Hideyuki; Jewsbury, Philip J.; Yamamoto, Setsuko; Robinson, David T.; Li, Chiang J.			TLR7 tolerance is independent of the type I IFN pathway and leads to loss of anti-tumor efficacy in mice	CANCER IMMUNOLOGY IMMUNOTHERAPY			English	Article						Toll-like receptor 7; Tolerance; DSR-6434; TLR7 downregulation; Cancer; Immunotherapy	PLASMACYTOID DENDRITIC CELLS; INTERFERON-PRODUCING CELLS; INNATE IMMUNE-RESPONSE; RECEPTOR 7; ADAPTIVE IMMUNITY; AGONIST; EXPRESSION; INDUCTION; SUBSETS; CANCER	Systemic administration of small molecule toll-like receptor (TLR)-7 agonists leads to potent activation of innate immunity and to the generation of anti-tumor immune responses. However, activation of TLRs with small molecule agonists may lead to the induction of TLR tolerance, defined as a state of hyporesponsiveness to subsequent agonism, which may limit immune activation, the generation of anti-tumor responses and clinical response. Our data reveal that dose scheduling impacts on the efficacy of systemic therapy with the selective TLR7 agonist, 6-amino-2-(butylamino)-9-((6-(2-(dimethylamino)ethoxy) pyridin-3-yl) methyl)-7,9-dihydro-8H-purin-8-one (DSR-6434). In a preclinical model of renal cell cancer, systemic administration of DSR-6434 dosed once weekly resulted in a significant anti-tumor response. However, twice weekly dosing of DSR-6434 led to the induction of TLR tolerance, and no anti-tumor response was observed. We show that TLR7 tolerance was independent of type I interferon (IFN) negative feedback because induction of TLR7 tolerance was also observed in IFN-alpha/beta receptor knockout mice treated with DSR-6434. Moreover, our data demonstrate that treatment of bone marrow-derived plasmacytoid dendritic cells (BM-pDC) with DSR-6434 led to downregulation of TLR7 expression. From our data, dose scheduling of systemically administered TLR7 agonists can impact on anti-tumor activity through the induction of TLR tolerance. Furthermore, TLR7 expression on pDC may be a useful biomarker of TLR7 tolerance and aid in the optimization of dosing schedules involving systemically administered TLR7 agonists.	[Koga-Yamakawa, Erina; Murata, Masashi; Ota, Yosuke; Umehara, Hiroki; Sugaru, Eiji; Hirose, Yuko; Yamamoto, Setsuko] Sumitomo Dainippon Pharma, Sumitomo Dainippon Pharma DSP Canc Inst, Konohana Ku, Osaka 5540022, Japan; [Dovedi, Simon J.; Wilkinson, Robert W.; Jewsbury, Philip J.; Robinson, David T.] AstraZeneca, Oncol Innovat Med & Early Dev iMed, Macclesfield SK10 4TG, Cheshire, England; [Umehara, Hiroki; Li, Chiang J.] Boston Biomed Inc, Cambridge, MA USA; [Harada, Hideyuki] Sumitomo Dainippon Pharma, Drug Res Div, Suita, Osaka 5640053, Japan	Koga-Yamakawa, E (reprint author), Sumitomo Dainippon Pharma, Sumitomo Dainippon Pharma DSP Canc Inst, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, Japan.	erina-koga@ds-pharma.co.jp; masashi-murata@ds-pharma.co.jp					Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Poovassery JS, 2012, J IMMUNOL, V189, P1757, DOI 10.4049/jimmunol.1200624; Mangsbo SM, 2008, J IMMUNOTHER, V31, P34; McKenna K, 2005, J VIROL, V79, P17, DOI 10.1128/JVI.79.1.17-27.2005; Bauer S, 2010, P NATL ACAD SCI USA, V107, pE139, DOI 10.1073/pnas.1008626107; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Fidock MD, 2011, CLIN PHARMACOL THER, V89, P821, DOI 10.1038/clpt.2011.60; Hornung V, 2002, J IMMUNOL, V168, P4531; Dummer R, 2008, CLIN CANCER RES, V14, P856, DOI 10.1158/1078-0432.CCR-07-1938; Nakamura T, 2013, BIOORG MED CHEM LETT, V23, P669, DOI 10.1016/j.bmcl.2012.11.114; Savarese E, 2006, BLOOD, V107, P3229, DOI 10.1182/blood-2005-07-2650; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; VOGEL SN, 1982, INFECT IMMUN, V38, P681; Cella M, 1999, NAT MED, V5, P919; Haeryfar SMM, 2005, TRENDS IMMUNOL, V26, P311, DOI 10.1016/j.it.2005.04.002; Bourquin C, 2011, CANCER RES, V71, P5123, DOI 10.1158/0008-5472.CAN-10-3903; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Lou YY, 2007, J IMMUNOL, V178, P1534; Nomura F, 2000, J IMMUNOL, V164, P3476; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Angelov GS, 2005, J IMMUNOL, V175, P189; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Swiecki M, 2011, J EXP MED, V208, P2367, DOI 10.1084/jem.20110654; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Geisel J, 2007, J IMMUNOL, V179, P5811; Hayashi T, 2009, P NATL ACAD SCI USA, V106, P2764, DOI 10.1073/pnas.0813037106; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Koga-Yamakawa E, 2013, INT J CANCER, V132, P580, DOI 10.1002/ijc.27691; Geller MA, 2010, CANCER IMMUNOL IMMUN, V59, P1877, DOI 10.1007/s00262-010-0914-1; Whiteside TL, 2001, CURR PROTOC IMMUNOL, V7, P18, DOI 10.1002/0471142735.im0718s35	34	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-7004	1432-0851		CANCER IMMUNOL IMMUN	Cancer Immunol. Immunother.	OCT	2015	64	10					1229	1239		10.1007/s00262-015-1730-4		11	Oncology; Immunology	Oncology; Immunology	CU0YZ	WOS:000363246900002		
J	Mitobe, Y; Yasunaga, J; Furuta, R; Matsuoka, M				Mitobe, Yuichi; Yasunaga, Jun-ichirou; Furuta, Rie; Matsuoka, Masao			HTLV-1 bZIP Factor RNA and Protein Impart Distinct Functions on T-cell Proliferation and Survival	CANCER RESEARCH			English	Article							LONG NONCODING RNAS; GENE-EXPRESSION; MESSENGER-RNA; HBZ GENE; REGULATES SURVIVIN; CANCER PATIENTS; LEUKEMIA-CELLS; YM155; TAX; OVEREXPRESSION	Infection of T cells with human T-cell leukemia virus type-1 (HTLV-1) induces clonal proliferation and is closely associated with the onset of adult T-cell leukemia-lymphoma (ATL) and inflammatory diseases. Although Tax expression is frequently suppressed in HTLV-1-infected cells, the accessory gene, HTLV-1 bZIP factor (HBZ), is continuously expressed and has been implicated in HTLV-1 pathogenesis. Here, we report that transduction of mouse T cells with specific mutants of HBZ that distinguish between its RNA and protein activity results in differential effects on T-cell proliferation and survival. HBZ RNA increased cell number by attenuating apoptosis, whereas HBZ protein induced apoptosis. However, both HBZ RNA and protein promoted S-phase entry of T cells. We further identified that the first 50 bp of the HBZ coding sequence are required for RNA-mediated cell survival. Transcriptional profiling of T cells expressing wild-type HBZ, RNA, or protein revealed that HBZ RNA is associated with genes involved in cell cycle, proliferation, and survival, while HBZ protein is more closely related to immunological properties of T cells. Specifically, HBZ RNA enhances the promoter activity of survivin, an inhibitor of apoptosis, to upregulate its expression. Inhibition of survivin using YM155 resulted in impaired proliferation of several ATL cell lines as well as a T-cell line expressing HBZ RNA. The distinct functions of HBZ RNA and protein may have several implications for the development of strategies to control the proliferation and survival mechanisms associated with HTLV-1 infection and ATL. (C) 2015 AACR.	[Mitobe, Yuichi; Yasunaga, Jun-ichirou; Furuta, Rie; Matsuoka, Masao] Kyoto Univ, Inst Virus Res, Lab Virus Control, Sakyo Ku, Kyoto 6068507, Japan; [Mitobe, Yuichi] Kyoto Univ, Grad Sch Biostudies, Dept Mammalian Regulatory Network, Sakyo Ku, Kyoto 6068507, Japan	Matsuoka, M (reprint author), Kyoto Univ, Inst Virus Res, Sakyo Ku, 53 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	jyasunag@virus.kyoto-u.ac.jp; mmatsuok@virus.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [25293219]; Japan Leukemia Research Fund; JSPS Core-to-Core Program A, Advanced Research Networks	This work was supported by a grant from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (M. Matsuoka; 25293219) and a grant from the Japan Leukemia Research Fund (M. Matsuoka). This study was supported in part by JSPS Core-to-Core Program A, Advanced Research Networks.	Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Hernandez JM, 2011, CLIN COLORECTAL CANC, V10, P188, DOI 10.1016/j.clcc.2011.03.014; Yoshida M, 2008, J VIROL, V82, P9359, DOI 10.1128/JVI.00242-08; Bangham CRM, 2009, EUR J IMMUNOL, V39, P1700, DOI 10.1002/eji.200939451; Lu J, 2009, J VIROL, V83, P7129, DOI 10.1128/JVI.00397-09; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; Li FZ, 1999, BIOCHEM J, V344, P305, DOI 10.1042/0264-6021:3440305; Cullen BR, 2013, NAT IMMUNOL, V14, P205, DOI 10.1038/ni.2537; Ryan BM, 2006, ANN ONCOL, V17, P597, DOI 10.1093/annonc/mdj121; Kapellos G, 2013, ANTICANCER RES, V33, P3475; Du K, 2011, BIOCHEM BIOPH RES CO, V404, P991, DOI 10.1016/j.bbrc.2010.12.097; Spizzo R, 2012, ONCOGENE, V31, P4577, DOI 10.1038/onc.2011.621; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Geisler S, 2013, NAT REV MOL CELL BIO, V14, P699, DOI 10.1038/nrm3679; Matsuoka M, 2011, ONCOGENE, V30, P1379, DOI 10.1038/onc.2010.537; Nanbo A, 2002, REV MED VIROL, V12, P321, DOI 10.1002/rmv.363; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; JACOBSON S, 1990, NATURE, V348, P245, DOI 10.1038/348245a0; Candeias MM, 2008, NAT CELL BIOL, V10, P1098, DOI 10.1038/ncb1770; Choy EYW, 2008, J EXP MED, V205, P2551, DOI 10.1084/jem.20072581; Nakahara T, 2007, CANCER RES, V67, P8014, DOI 10.1158/0008-5472.CAN-07-1343; Zhao T, 2009, BLOOD, V113, P2755, DOI 10.1182/blood-2008-06-161729; Satou Y, 2006, P NATL ACAD SCI USA, V103, P720, DOI 10.1073/pnas.0507631103; Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576; Gallo RC, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-17; Matsuoka M, 2013, CURR OPIN VIROL, V3, P684, DOI 10.1016/j.coviro.2013.08.010; Sugata K, 2012, BLOOD, V119, P434, DOI 10.1182/blood-2011-05-357459; Rende F, 2011, BLOOD, V117, P4855, DOI 10.1182/blood-2010-11-316463; Samanta M, 2008, ONCOGENE, V27, P4150, DOI 10.1038/onc.2008.75; Zhao TJ, 2011, BLOOD, V118, P1865, DOI 10.1182/blood-2010-12-326199; Kami K, 2004, SURGERY, V136, P443, DOI 10.1016/j.surg.2004.05.023; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Stern-Ginossar N, 2012, SCIENCE, V338, P1088, DOI 10.1126/science.1227919; Takeda S, 2004, INT J CANCER, V109, P559, DOI 10.1002/ijc.20007; Kamihira S, 2001, BRIT J HAEMATOL, V114, P63, DOI 10.1046/j.1365-2141.2001.02902.x; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; Che XF, 2006, BLOOD, V107, P4880, DOI 10.1182/blood-2005-08-3423; Cheng SM, 2015, BRIT J PHARMACOL, V172, P214, DOI 10.1111/bph.12935; Wolfe AL, 2014, NATURE, V513, P65, DOI 10.1038/nature13485; Kumar MS, 2014, NATURE, V505, P212, DOI 10.1038/nature12785; Lee N, 2015, CELL, V160, P607, DOI 10.1016/j.cell.2015.01.015; MacNamara A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001117; Masuda K, 2008, PLOS MED, V5, P805, DOI 10.1371/journal.pmed.0050094; Matsuoka M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-71; Rowan AG, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0116-6; Saito M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-19; Satou Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001274; Vernin C, 2014, CANCER RES, V74, P6082, DOI 10.1158/0008-5472.CAN-13-3564; Yamamoto-Taguchi N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003630; Yamauchi T, 2012, BIOCHEM BIOPH RES CO, V425, P711, DOI 10.1016/j.bbrc.2012.07.103	50	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	0008-5472	1538-7445		CANCER RES	Cancer Res.	OCT 1	2015	75	19					4143	4152		10.1158/0008-5472.CAN-15-0942		10	Oncology	Oncology	CU2ES	WOS:000363336800017		
J	Yamada, T; Amann, JM; Fukuda, K; Takeuchi, S; Fujita, N; Uehara, H; Iwakiri, S; Itoi, K; Shilo, K; Yano, S; Carbone, DP				Yamada, Tadaaki; Amann, Joseph M.; Fukuda, Koji; Takeuchi, Shinji; Fujita, Naoya; Uehara, Hisanori; Iwakiri, Shotaro; Itoi, Kazumi; Shilo, Konstantin; Yano, Seiji; Carbone, David P.			Akt Kinase-Interacting Protein 1 Signals through CREB to Drive Diffuse Malignant Mesothelioma	CANCER RESEARCH			English	Article							CELL LUNG-CANCER; PLEURAL MESOTHELIOMA; GROWTH-FACTOR; PHASE-II; GEFITINIB; RECEPTOR; THERAPY; PATHWAY; TARGET; GENE	Diffuse malignant mesothelioma (DMM) is a tumor of serosal membranes with propensity for progressive local disease. Because current treatment options are largely ineffective, novel therapeutic strategies based on molecular mechanisms and the disease characteristics are needed to improve the outcomes of patients with this disease. Akt kinase interacting protein 1 (Aki1; Freud-1/CC2D1A) is a scaffold protein for the PI3K-PDK1-Akt signaling module that helps determine receptor signal selectivity for EGFR. Aki1 has been suggested as a therapeutic target, but its potential has yet to be evaluated in a tumor setting. Here, we report evidence supporting its definition as a therapeutic target in DMM. In cell-based assays, Aki1 silencing decreased cell viability and caused cell-cycle arrest of multiple DMM cell lines via effects on the PKA-CREB1 signaling pathway. Blocking CREB activity phenocopied Aki1 silencing. Clinically, Aki1 was expressed in most human DMM specimens where its expression correlated with phosphorylated CREB1. Notably, Aki1 siRNA potently blocked tumor growth in an orthotopic implantation model of DMM when administered directly into the pleural cavity of tumor-bearing mice. Our findings suggest an important role for the Aki1-CREB axis in DMM pathogenesis and provide a preclinical rationale to target Aki1 by intrathoracic therapy in locally advanced tumors. (C) 2015 AACR.	[Yamada, Tadaaki; Amann, Joseph M.; Carbone, David P.] Ohio State Univ, Med Ctr, Dept Internal Med, Columbus, OH 43210 USA; [Yamada, Tadaaki; Fukuda, Koji; Takeuchi, Shinji; Yano, Seiji] Kanazawa Univ, Canc Res Inst, Div Med Oncol, Kanazawa, Ishikawa 920, Japan; [Fujita, Naoya] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Tokyo 170, Japan; [Uehara, Hisanori] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Mol & Environm Pathol, Tokushima 770, Japan; [Iwakiri, Shotaro; Itoi, Kazumi] Hyogo Kenritsu Amagasaki Hosp, Dept Resp Surg, Amagasaki, Hyogo, Japan; [Shilo, Konstantin] Ohio State Univ, Med Ctr, Dept Pathol, Columbus, OH 43210 USA	Carbone, DP (reprint author), Ohio State Univ, Med Ctr, 460 West 12th Ave, Columbus, OH 43210 USA.	syano@staff.kanazawa-u.ac.jp; david.carbone@osumc.edu			Ministry of Education, Culture, Sports, Science, and Technology of Japan [25860638, 22112010A01]; Dellapezze Family Foundation	This study was supported by Grants-in-Aid for Cancer Research (25860638 to T. Yamada), Scientific Research on Innovative Areas "Integrative Research on Cancer Microenvironment Network" (22112010A01 to S. Yano) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and the Dellapezze Family Foundation (D.P. Carbone).	Al-Tawashi A, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-47; Nakamura A, 2008, MOL CELL BIOL, V28, P5996, DOI 10.1128/MCB.00114-08; Giovannetti E, 2011, BRIT J CANCER, V105, P1542, DOI 10.1038/bjc.2011.400; Enns LC, 2010, AGEING RES REV, V9, P269, DOI 10.1016/j.arr.2010.02.004; Li Q, 2011, AM J PATHOL, V179, P1483, DOI 10.1016/j.ajpath.2011.05.060; Braeuer RR, 2011, SEMIN CANCER BIOL, V21, P83, DOI 10.1016/j.semcancer.2010.12.007; Pasello G, 2009, CURR DRUG TARGETS, V10, P1235; Nakataki E, 2006, CANCER SCI, V97, P183, DOI 10.1111/j.1349-7006.2006.00163.x; Seo HS, 2008, CANCER RES, V68, P6065, DOI 10.1158/0008-5472.CAN-07-5376; Shankar DB, 2005, CANCER CELL, V7, P351, DOI 10.1016/j.ccr.2005.02.018; Mani S, 2003, ANN NY ACAD SCI, V1002, P252, DOI 10.1196/annals.1281.028; Sakamoto KM, 2009, CLIN CANCER RES, V15, P2583, DOI 10.1158/1078-0432.CCR-08-1137; Yano S, 2008, CANCER RES, V68, P9479, DOI 10.1158/0008-5472.CAN-08-1643; Janne PA, 2002, CANCER RES, V62, P5242; Hirsch FR, 2006, J CLIN ONCOL, V24, P5034, DOI 10.1200/JCO.2006.06.3958; Al-Tawashi A, 2012, J BIOL CHEM, V287, P14644, DOI 10.1074/jbc.M111.261875; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763; Mezzapelle R, 2013, BRIT J CANCER, V108, P1743, DOI 10.1038/bjc.2013.130; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Broaddus VC, 1997, AM J RESP CELL MOL, V17, P657; Tortora G, 2002, ANN NY ACAD SCI, V968, P139; Garland LL, 2007, J CLIN ONCOL, V25, P2406, DOI 10.1200/JCO.2006.09.7634; Yamada T, 2013, ONCOGENE, V32, P4427, DOI 10.1038/onc.2012.446; Cho Er-Chieh, 2011, Critical Reviews in Oncogenesis, V16, P37; Kawaguchi K, 2009, CARCINOGENESIS, V30, P1097, DOI 10.1093/carcin/bgp097; Kaufman JM, 2014, J THORAC ONCOL, V9, P794, DOI 10.1097/JTO.0000000000000173; Shukla A, 2009, AM J PATHOL, V175, P2197, DOI 10.2353/ajpath.2009.090400; Morinaga K, 2001, IND HEALTH, V39, P65, DOI 10.2486/indhealth.39.65; Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/nmat3765, 10.1038/NMAT3765]; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Taniguchi T, 2007, CANCER SCI, V98, P438, DOI 10.1111/j.1349-7006.2006.00386.x; Govindan R, 2005, CLIN CANCER RES, V11, P2300, DOI 10.1158/1078-0432.CCR-04-1940; Ohtsubo K, 2014, PANCREAS, V43, P1093, DOI 10.1097/MPA.0000000000000168; Nanjo S, 2015, CANCER SCI, V106, P244, DOI 10.1111/cas.12600; Robinson BWS, 2005, NEW ENGL J MED, V353, P1591, DOI 10.1056/NEJMra050152; Westbom CM, 2014, AM J PATHOL, V184, P2816, DOI 10.1016/j.ajpath.2014.06.008; Zhang Xin, 2013, Zhongguo Fei Ai Za Zhi, V16, P153, DOI 10.3779/j.issn.1009-3419.2013.03.07	37	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	0008-5472	1538-7445		CANCER RES	Cancer Res.	OCT 1	2015	75	19					4188	4197		10.1158/0008-5472.CAN-15-0858		10	Oncology	Oncology	CU2ES	WOS:000363336800021		
J	Kaneko, S; Nakatani, Y; Takezaki, T; Hide, T; Yamashita, D; Ohtsu, N; Ohnishi, T; Terasaka, S; Houkin, K; Kondo, T				Kaneko, Sadahiro; Nakatani, Yuka; Takezaki, Tatsuya; Hide, Takuichiro; Yamashita, Daisuke; Ohtsu, Naoki; Ohnishi, Takanori; Terasaka, Shunsuke; Houkin, Kiyohiro; Kondo, Toru			Ceacam1L Modulates STAT3 Signaling to Control the Proliferation of Glioblastoma-Initiating Cells	CANCER RESEARCH			English	Article							SHP-2 TYROSINE PHOSPHATASE; NEURAL STEM-CELLS; SUBVENTRICULAR ZONE ASTROCYTES; EMBRYONIC ANTIGEN SSEA-1; CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR RECEPTOR; ADHESION MOLECULE-1; HUMAN GRANULOCYTES; CANCER; ADULT	Glioblastoma-initiating cells (GIC) are a tumorigenic cell subpopulation resistant to radiotherapy and chemotherapy, and are a likely source of recurrence. However, the basis through which GICs are maintained has yet to be elucidated in detail. We herein demonstrated that the carcinoembryonic antigen-related cell adhesion molecule Ceacam1L acts as a crucial factor in GIC maintenance and tumorigenesis by activating c-Src/STAT3 signaling. Furthermore, we showed that monomers of the cytoplasmic domain of Ceacam1L bound to c-Src and STAT3 and induced their phosphorylation, whereas oligomerization of this domain ablated this function. Our results suggest that Ceacam1L-dependent adhesion between GIC and surrounding cells play an essential role in GIC maintenance and proliferation, as mediated by signals transmitted by monomeric forms of the Ceacam1L cytoplasmic domain. (C) 2015 AACR.	[Kaneko, Sadahiro; Ohtsu, Naoki; Kondo, Toru] Hokkaido Univ, Inst Med Genet, Div Stem Cell Biol, Sapporo, Hokkaido 0600815, Japan; [Kaneko, Sadahiro; Terasaka, Shunsuke; Houkin, Kiyohiro] Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Sapporo, Hokkaido 0600815, Japan; [Nakatani, Yuka; Takezaki, Tatsuya; Hide, Takuichiro; Kondo, Toru] RIKEN, Ctr Dev Biol, Lab Cell Lineage Modulat, Kobe, Hyogo, Japan; [Takezaki, Tatsuya; Hide, Takuichiro] Kumamoto Univ, Grad Sch Med Sci, Dept Neurosurg, Kumamoto, Kumamoto, Japan; [Yamashita, Daisuke; Ohnishi, Takanori] Ehime Univ, Grad Sch Med, Dept Neurosurg, Toon, Ehime, Japan	Kondo, T (reprint author), Hokkaido Univ, Inst Med Genet, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0600815, Japan.	tkondo@igm.hokudai.ac.jp			Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT), Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported, in part, by a research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT), Ministry of Education, Culture, Sports, Science and Technology of Japan (T. Kondo).	Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Prosniak M, 2013, CLIN CANCER RES, V19, P3776, DOI 10.1158/1078-0432.CCR-12-1940; Ergun S, 2000, MOL CELL, V5, P311, DOI 10.1016/S1097-2765(00)80426-8; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Kondo T, 2004, GENE DEV, V18, P2963, DOI 10.1101/gad.309404; Bogoevska V, 2006, GLYCOBIOLOGY, V16, P197, DOI 10.1093/glycob/cwj057; Singh SK, 2003, CANCER RES, V63, P5821; Nagaishi T, 2006, ANN NY ACAD SCI, V1072, P155, DOI 10.1196/annals.1326.004; Kondo T, 2006, EUR J CANCER, V42, P1237, DOI 10.1016/j.ejca.2006.01.038; Schafer A, 2012, NEURO-ONCOLOGY, V14, P1452, DOI 10.1093/neuonc/nos270; Takanaga H, 2009, STEM CELLS, V27, P165, DOI 10.1634/stemcells.2008-0580; Park CC, 2001, J IMMUNOL, V167, P1644; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; Liu Y, 2010, ANTI-CANCER AGENT ME, V10, P512; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Chojnacki AK, 2009, NAT REV NEUROSCI, V10, P153, DOI 10.1038/nrn2571; Chong ZZ, 2007, HISTOL HISTOPATHOL, V22, P1251; Horst AK, 2006, J CLIN INVEST, V116, P1596, DOI 10.1172/JCI24340; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; You M, 1999, MOL CELL BIOL, V19, P2416; Muller MM, 2009, J CELL BIOL, V187, P569, DOI 10.1083/jcb.200904150; Thomas M, 2002, P NATL ACAD SCI USA, V99, P14640, DOI 10.1073/pnas.192581499; Silva CM, 2004, ONCOGENE, V23, P8017, DOI 10.1038/sj.onc.1208159; Poy MN, 2002, J BIOL CHEM, V277, P1076, DOI 10.1074/jbc.M108415200; Qu CK, 1999, P NATL ACAD SCI USA, V96, P8528, DOI 10.1073/pnas.96.15.8528; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; You M, 2001, J EXP MED, V193, P101, DOI 10.1084/jem.193.1.101; Abou-Rjaily GA, 2004, J CLIN INVEST, V114, P944, DOI 10.1172/JCI200421786; Lucka L, 2005, GLYCOBIOLOGY, V15, P87, DOI 10.1093/glycob/cwh139; Hide T, 2011, STEM CELLS, V29, P590, DOI 10.1002/stem.618; Arabzadeh A, 2013, ONCOGENE, V32, P849, DOI 10.1038/onc.2012.112; Bousquet C, 1999, J CLIN INVEST, V104, P1277, DOI 10.1172/JCI7924; Hide T, 2009, CANCER RES, V69, P7953, DOI 10.1158/0008-5472.CAN-09-2006; Metheny-Barlow LJ, 2003, CELL RES, V13, P309, DOI 10.1038/sj.cr.7290176; Yamashita D, 2015, CANCER RES, V75, P1123, DOI 10.1158/0008-5472.CAN-14-0938; FULLER GN, 1992, MUTAT RES, V276, P299, DOI 10.1016/0165-1110(92)90016-3; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Nakajima A, 2002, J IMMUNOL, V168, P1028; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Frisen J, 1998, CELL MOL LIFE SCI, V54, P935, DOI 10.1007/s000180050224; ALVAREZBUYLLA A, 1995, STEM CELLS, V13, P263; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; FOX N, 1981, DEV BIOL, V83, P391, DOI 10.1016/0012-1606(81)90487-5; Carpenter Richard L, 2014, Cancers (Basel), V6, P897, DOI 10.3390/cancers6020897; Fischer-Colbrie R, 2005, CURR PROTEIN PEPT SC, V6, P373; Garofalo S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7623; Markel G, 2002, J IMMUNOL, V168, P2803; Patru C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-66	49	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	0008-5472	1538-7445		CANCER RES	Cancer Res.	OCT 1	2015	75	19					4224	4234		10.1158/0008-5472.CAN-15-0412		11	Oncology	Oncology	CU2ES	WOS:000363336800024		
J	Roth, C; Shao-Horn, Y; Myers, D; Inukai, J				Roth, Christina; Shao-Horn, Yang; Myers, Deborah; Inukai, Junji			Batteries and Fuel Cells: Leading the Way to a Cleaner and Brighter Future	CHEMELECTROCHEM			English	Editorial Material									[Roth, Christina] Free Univ Berlin, Inst Chem & Biochem Phys & Theoret Chem, D-14195 Berlin, Germany; [Shao-Horn, Yang] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Myers, Deborah] Argonne Natl Lab, Chem Sci & Engn Div, Argonne, IL 60439 USA; [Inukai, Junji] Univ Yamanashi, Fuel Cell Nanomat Ctr, Kofu, Yamanashi 4000021, Japan	Roth, C (reprint author), Free Univ Berlin, Inst Chem & Biochem Phys & Theoret Chem, Takustr 3, D-14195 Berlin, Germany.	christina.roth@fu-berlin.de	Inukai, Junji/O-6304-2015	Inukai, Junji/0000-0002-7819-842X				0	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	2196-0216			CHEMELECTROCHEM	ChemElectroChem	OCT	2015	2	10			SI		1408	1409		10.1002/celc.201500385		2	Electrochemistry	Electrochemistry	CU2EP	WOS:000363336500001		
J	Nishida, K				Nishida, Kosuke			Optical Visualization and Spectroscopic Techniques for Probing Water Transport in a Polymer Electrolyte Fuel Cell	CHEMELECTROCHEM			English	Review						diagnostics; fuel cells; laser spectroscopy; optical visualization; water transport	GAS-DIFFUSION LAYERS; CROSS-SECTIONAL VISUALIZATION; RAY TOMOGRAPHIC MICROSCOPY; NEUTRON IMAGING TECHNIQUE; VAPOR PARTIAL-PRESSURE; 2-PHASE FLOW PHENOMENA; IN-SITU OBSERVATION; LIQUID WATER; CATHODE CHANNEL; DROPLET EMERGENCE	To solve the critical issues of water management in polymer electrolyte fuel cells (PEFCs), the comprehensive understanding of water transport in the catalyst layer, gas diffusion layer (GDL), electrolyte membrane and gas channel during cell operation is required. In this Minireview, optical visualization and laser spectroscopic techniques for investigating liquid water behavior and water vapor distribution in operating PEFCs are presented. Direct optical observation of water droplet buildup in the GDL and gas channel is conveniently performed using transparent cells. In addition, a novel visualization method using humidity test paper makes it possible to quantitatively measure the water vapor profile along a gas channel. Tunable diode laser absorption spectroscopy is available for noninvasive monitoring of water concentrations in flow channels with a high time resolution. These diagnostic techniques provide information useful for proper water management in PEFCs.	Kyoto Inst Technol, Fac Mech Engn, Sakyo Ku, Kyoto 6068585, Japan	Nishida, K (reprint author), Kyoto Inst Technol, Fac Mech Engn, Sakyo Ku, Kyoto 6068585, Japan.	knishida@kit.ac.jp			Japan Society for the Promotion of Science (JSPS) [22246024, 17760157, 20760134, 22760150]	This work was financially supported by a Grant-in-Aid for Young Scientists (B) (No. 17760157, 20760134, 22760150) and a Grant-in-Aid for Scientific Research (A) (No. 22246024) of the Japan Society for the Promotion of Science (JSPS). The author would like to thank Prof. Shuichiro Hirai (Tokyo Institute of Technology) and Prof. Shohji Tsushima (Osaka University) for their invaluable advice and support, and a number of current and former students in the Thermal Energy Engineering Laboratory at Kyoto Institute of Technology for useful discussions and technical assistance.	Zhang JB, 2006, ELECTROCHIM ACTA, V51, P2715, DOI 10.1016/j.electacta.2005.08.010; Basu S, 2006, J FUEL CELL SCI TECH, V3, P1, DOI 10.1115/1.2133799; Bazylak A, 2008, J POWER SOURCES, V176, P240, DOI 10.1016/j.jpowsour.2007.10.066; Yoshizawa K, 2008, J ELECTROCHEM SOC, V155, pB223, DOI 10.1149/1.2823003; Zhang FY, 2007, J ELECTROCHEM SOC, V154, pB1152, DOI 10.1149/1.2777987; Okuhata G, 2013, ECS TRANSACTIONS, V58, P1047, DOI 10.1149/05801.1047ecst; Basu S, 2006, J POWER SOURCES, V159, P987, DOI 10.1016/j.jpowsour.2005.11.091; Yang XG, 2004, ELECTROCHEM SOLID ST, V7, pA408, DOI 10.1149/1.1803051; Ludlow DJ, 2006, J POWER SOURCES, V162, P271, DOI 10.1016/j.jpowsour.2006.06.068; Sinha PK, 2007, J MATER CHEM, V17, P3089, DOI 10.1039/b703485g; Boillat P, 2008, ELECTROCHEM COMMUN, V10, P546, DOI 10.1016/j.elecom.2008.01.018; Trabold TA, 2006, INT J HEAT MASS TRAN, V49, P4712, DOI 10.1016/j.ijheatmasstransfer.2006.07.003; Kimball E, 2008, AICHE J, V54, P1313, DOI 10.1002/aic.11464; Oberholzer P, 2012, ELECTROCHEM COMMUN, V20, P67, DOI 10.1016/j.elecom.2012.03.038; Zhang FY, 2006, J ELECTROCHEM SOC, V153, pA225, DOI 10.1149/1.2138675; Lee SJ, 2010, INT J HYDROGEN ENERG, V35, P10457, DOI 10.1016/j.ijhydene.2010.07.173; Basu S, 2006, J POWER SOURCES, V162, P286, DOI 10.1016/j.jpowsour.2006.06.073; Chen YS, 2007, J POWER SOURCES, V170, P376, DOI 10.1016/j.jpowsour.2007.03.076; Tuber K, 2003, J POWER SOURCES, V124, P403, DOI 10.1016/S0378-7753(03)00797-3; Becker J, 2009, J ELECTROCHEM SOC, V156, pB1175, DOI 10.1149/1.3176876; Kandlikar SG, 2011, FUEL CELLS, V11, P814, DOI 10.1002/fuce.201000172; Sasabe T, 2010, INT J HYDROGEN ENERG, V35, P11119, DOI 10.1016/j.ijhydene.2010.06.050; Kramer D, 2005, ELECTROCHIM ACTA, V50, P2603, DOI 10.1016/j.electacta.2004.11.005; Dai W, 2009, INT J HYDROGEN ENERG, V34, P9461, DOI 10.1016/j.ijhydene.2009.09.017; Park J, 2008, INT J HYDROGEN ENERG, V33, P3373, DOI 10.1016/j.ijhydene.2008.03.019; Hickner MA, 2010, J ELECTROCHEM SOC, V157, pB32, DOI 10.1149/1.3250864; Kim SG, 2013, J POWER SOURCES, V230, P101, DOI 10.1016/j.jpowsour.2012.12.030; Ma HP, 2006, J POWER SOURCES, V162, P469, DOI 10.1016/j.jpowsour.2006.06.055; Owejan JP, 2006, INT J HEAT MASS TRAN, V49, P4721, DOI 10.1016/j.ijheatmasstransfer.2006.07.004; Gao B, 2009, J POWER SOURCES, V190, P493, DOI 10.1016/j.jpowsour.2008.12.135; Mench MM, 2003, J POWER SOURCES, V124, P90, DOI 10.1016/S0378-7753(03)00617-7; Lee Y, 2009, INT J HYDROGEN ENERG, V34, P7768, DOI 10.1016/j.ijhydene.2009.07.010; Turhan A, 2006, J POWER SOURCES, V160, P1195, DOI 10.1016/j.jpowsour.2006.03.027; Sinha PK, 2006, ELECTROCHEM SOLID ST, V9, pA344, DOI 10.1149/1.2203307; Bazylak A, 2009, INT J HYDROGEN ENERG, V34, P3845, DOI 10.1016/j.ijhydene.2009.02.084; Boillat P, 2010, ELECTROCHEM SOLID ST, V13, pB25, DOI 10.1149/1.3279636; Ishikawa Y, 2008, J POWER SOURCES, V179, P547, DOI 10.1016/j.jpowsour.2008.01.031; Liu X, 2007, ELECTROCHIM ACTA, V52, P3607, DOI 10.1016/j.electacta.2006.10.030; Eller J, 2011, J ELECTROCHEM SOC, V158, pB963, DOI 10.1149/1.3596556; Hiramitsu Y, 2010, J POWER SOURCES, V195, P5543, DOI 10.1016/j.jpowsour.2010.03.039; Bellows RJ, 1999, J ELECTROCHEM SOC, V146, P1099, DOI 10.1149/1.1391727; Nishida K, 2010, J POWER SOURCES, V195, P3365, DOI 10.1016/j.jpowsour.2009.12.073; Owejan JP, 2007, J POWER SOURCES, V171, P626, DOI 10.1016/j.jpowsour.2007.06.174; Turhan A, 2010, ELECTROCHIM ACTA, V55, P2734, DOI 10.1016/j.electacta.2009.11.095; Litster S, 2006, J POWER SOURCES, V154, P95, DOI 10.1016/j.jpowsour.2005.03.199; Weng FB, 2006, J POWER SOURCES, V157, P674, DOI 10.1016/j.jpowsour.2006.01.002; Liu X, 2008, INT J HYDROGEN ENERG, V33, P1040, DOI 10.1016/j.ijhydene.2007.11.018; Sugiura K, 2005, J POWER SOURCES, V145, P526, DOI [10.1016/j.jpowsour.2005.02.037, 10.1016/j.jpowersour.2005.02.037]; Qin CZ, 2012, J ELECTROCHEM SOC, V159, pB434, DOI 10.1149/2.004205jes; Mosdale R, 1996, J MEMBRANE SCI, V118, P269, DOI 10.1016/0376-7388(96)00110-X; Hickner MA, 2006, J ELECTROCHEM SOC, V153, pA902, DOI 10.1149/1.2184893; Yang XG, 2005, J ELECTROCHEM SOC, V152, pA759, DOI 10.1149/1.1864492; Dong Q, 2005, J POWER SOURCES, V139, P106, DOI 10.1016/j.jpowsour.2004.06.068; Sur R, 2010, J ELECTROCHEM SOC, V157, pB45, DOI 10.1149/1.3247355; Wu TC, 2012, J POWER SOURCES, V208, P248, DOI 10.1016/j.jpowsour.2012.02.026; Owejan JP, 2009, INT J HYDROGEN ENERG, V34, P3436, DOI 10.1016/j.ijhydene.2008.12.100; Anderson R, 2010, J POWER SOURCES, V195, P4531, DOI 10.1016/j.jpowsour.2009.12.123; Satija R, 2004, J POWER SOURCES, V129, P238, DOI 10.1016/j.jpowsour.2003.11.068; Liu X, 2006, J POWER SOURCES, V156, P267, DOI 10.1016/j.jpowsour.2005.06.027; Lee SK, 2010, ECS TRANSACTIONS, V33, P1457, DOI 10.1149/1.3484638; Fluckiger R, 2011, ELECTROCHIM ACTA, V56, P2254, DOI 10.1016/j.electacta.2010.12.016; Hussaini IS, 2009, J POWER SOURCES, V187, P444, DOI 10.1016/j.jpowsour.2008.11.030; Lu Z, 2009, INT J HYDROGEN ENERG, V34, P3445, DOI 10.1016/j.ijhydene.2008.12.025; Hussey DS, 2007, J POWER SOURCES, V172, P225, DOI 10.1016/j.jpowsour.2007.07.036; Frish MB, 2007, P SOC PHOTO-OPT INS, V6765, P76506, DOI 10.1117/12.738195; Nishida K, 2011, ECS TRANSACTIONS, V41, P419, DOI 10.1149/1.3635576; Nishida K, 2014, ECS TRANSACTIONS, V64, P853, DOI 10.1149/06403.0853ecst; Hakenjos A, 2004, J POWER SOURCES, V131, P213, DOI 10.1016/j.jpowsour.2003.11.081; Ge SH, 2007, ELECTROCHIM ACTA, V52, P4825, DOI 10.1016/j.electacta.2007.01.038; Deevanhxay P, 2011, INT J HYDROGEN ENERG, V36, P10901, DOI 10.1016/j.ijhydene.2011.05.160; Hartnig C, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2907485; Kowal JJ, 2006, J ELECTROCHEM SOC, V153, pA1971, DOI 10.1149/1.2258049; Ha T, 2008, J MECH SCI TECHNOL, V22, P1030, DOI 10.1007/s12206-008-0209-z; Nishida K, 2013, J POWER SOURCES, V234, P111, DOI 10.1016/j.jpowsour.2013.01.160; Lee SK, 2014, J ELECTROCHEM SOC, V161, pF58, DOI 10.1149/2.055401jes; Owejan JP, 2007, INT J HYDROGEN ENERG, V32, P4489, DOI 10.1016/j.ijhydene.2007.05.044; Spernjak D, 2007, J POWER SOURCES, V170, P334, DOI 10.1016/j.jpowsour.2007.04.020; Liu FQ, 2007, J MEMBRANE SCI, V287, P126, DOI 10.1016/j.memsci.2006.10.030; Ge SH, 2006, ELECTROCHEM SOLID ST, V9, pA499, DOI 10.1149/1.2337860; Turhan A, 2008, J POWER SOURCES, V180, P773, DOI 10.1016/j.jpowsour.2008.02.028; Kim S, 2009, J ELECTROCHEM SOC, V156, pB353, DOI 10.1149/1.3046136; Fukuyama Y, 2011, ECS TRANSACTIONS, V41, P583, DOI 10.1149/1.3635591; Kumbur EC, 2006, J POWER SOURCES, V161, P333, DOI 10.1016/j.jpowsour.2006.04.093; Ge S, 2007, J ELECTROCHEM SOC, V154, pB998, DOI 10.1149/1.2761830; Nishida K, 2015, J POWER SOURCES, V275, P447, DOI 10.1016/j.jpowsour.2014.11.059; Ishikawa Y, 2007, J POWER SOURCES, V163, P708, DOI 10.1016/j.jpowsour.2006.08.026; Lee SJ, 2008, J POWER SOURCES, V185, P867, DOI 10.1016/j.jpowsour.2008.08.101; Gopalan P, 2011, ECS TRANSACTIONS, V41, P479, DOI 10.1149/1.3635582; Zhu W, 2008, ECS TRANSACTIONS, V16, P995, DOI 10.1149/1.2981939; Fujii Y, 2008, ECS TRANSACTIONS, V16, P1635, DOI 10.1149/1.2982003; Manke I, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2731440; Dong Q, 2005, J ELECTROCHEM SOC, V152, pA2114, DOI 10.1149/1.2039628; Nam JH, 2009, INT J HEAT MASS TRAN, V52, P2779, DOI 10.1016/j.ijheatmasstransfer.2009.01.002; Spernjak D, 2009, J ELECTROCHEM SOC, V156, pB109, DOI 10.1149/1.3009585; Mukaide T, 2008, J SYNCHROTRON RADIAT, V15, P329, DOI 10.1107/S0909049508006638; Lu GQ, 2007, J POWER SOURCES, V164, P134, DOI 10.1016/j.jpowsour.2006.10.035; Oberholzer P, 2012, J ELECTROCHEM SOC, V159, pB235, DOI 10.1149/2.085202jes; Boillat P, 2012, J ELECTROCHEM SOC, V159, pF210, DOI 10.1149/2.017207jes; Fujii Y., 2007, ECS T, V11, P451, DOI 10.1149/1.2780959; Geiger AB, 2002, FUEL CELLS, V2, P92, DOI 10.1002/fuce.200290007; Li H, 2008, J POWER SOURCES, V178, P103, DOI 10.1016/j.jpowsour.2007.12.068; Nishida K., 2006, T JAPAN SOC MECH ENG, V72, P1627; Nishida K., 2010, P ASME 8 INT C FUEL, V1, P99; Pekula N, 2005, NUCL INSTRUM METH A, V542, P134, DOI 10.1016/j.nima.2005.01.090; Siegel JB, 2008, J ELECTROCHEM SOC, V155, pB1168, DOI 10.1149/1.2976356; Tsushima S, 2004, ELECTROCHEM SOLID ST, V7, pA269, DOI 10.1149/1.1774971; Utturkar A., 2011, P ASME 9 FUEL CELL S, P613; Weber AZ, 2005, J ELECTROCHEM SOC, V152, pA677, DOI 10.1149/1.1861194	108	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	2196-0216			CHEMELECTROCHEM	ChemElectroChem	OCT	2015	2	10			SI		1458	1470		10.1002/celc.201500135		13	Electrochemistry	Electrochemistry	CU2EP	WOS:000363336500004		
J	Nagase, K; Motegi, H; Yoneda, M; Nagumo, Y; Suga, T; Uchida, M; Inukai, J; Nishide, H; Watanabe, M				Nagase, Katsuya; Motegi, Haruki; Yoneda, Masakazu; Nagumo, Yuzo; Suga, Takeo; Uchida, Makoto; Inukai, Junji; Nishide, Hiroyuki; Watanabe, Masahiro			Visualization of Oxygen Partial Pressure and Numerical Simulation of a Running Polymer Electrolyte Fuel Cell with Straight Flow Channels to Elucidate Reaction Distributions	CHEMELECTROCHEM			English	Article						fuel cells; gas diffusion layer; numerical simulation; oxygen; straight gas-flow channel	LIQUID WATER DISTRIBUTION; NEUTRON-RADIOGRAPHY; OPERATING PEMFC; MEMBRANE; CATHODE; PEFC; GDLS; PERFORMANCE; BEHAVIOR; LAYER	Visualization of the oxygen partial pressure (p(O(2))) was performed at the surface of a gas diffusion layer (GDL) and the upper part of the gas-flow channel of the cathode of an operating polymer electrolyte fuel cell (PEFC) with straight flow channels by using an oxygen-sensitive luminescent dye film. The gradient of p(O(2)) inside a channel was clearly observed, even on the GDL surface across the channel. A numerical simulation was performed to understand the reaction distributions inside the PEFC. By visualization and numerical simulation, the distributions of p(O(2)), the current density, water concentration, and temperature in the operating PEFC were obtained, and the relationships between the parameters were studied. Supersaturated water inside the cell was found both experimentally and computationally. p(O(2)) and the water concentration were concluded to be the two most important factors in determining the distribution of power generation.	[Uchida, Makoto; Inukai, Junji; Watanabe, Masahiro] Univ Yamanashi, Fuel Cell Nanomat Ctr, Kofu, Yamanashi 4000021, Japan; [Nagase, Katsuya] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Kofu, Yamanashi 4008510, Japan; [Nagase, Katsuya] Takahata Precis Japan Co Ltd, Fuefuki, Yamanashi 4060843, Japan; [Motegi, Haruki; Yoneda, Masakazu] Mizuho Informat & Res Inst Inc, Chiyoda Ku, Tokyo 1018443, Japan; [Nagumo, Yuzo] Shimadzu Co Ltd, Kyoto 6190237, Japan; [Suga, Takeo; Nishide, Hiroyuki] Waseda Univ, Dept Appl Chem, Shinjuku Ku, Tokyo 1698555, Japan	Nagase, K (reprint author), Univ Yamanashi, Fuel Cell Nanomat Ctr, 6-43 Miyamae Cho, Kofu, Yamanashi 4000021, Japan.	jinukai@yamanashi.ac.jp	Inukai, Junji/O-6304-2015	Inukai, Junji/0000-0002-7819-842X	New Energy and Industrial Technology Development Organization (NEDO) of Japan; Japan Science and Technology Agency (JST)	This manuscript was prepared with the help of Prof. Donald A. Tryk of University of Yamanashi. The research was performed under funds for the "Research on Nanotechnology for High Performance Fuel Cells (HiPer-FC)" project supported by The New Energy and Industrial Technology Development Organization (NEDO) of Japan and the "Development of Systems and Technology for Advanced Measurement and Analysis" program by the Japan Science and Technology Agency (JST).	Weber AZ, 2008, ELECTROCHIM ACTA, V53, P7668, DOI 10.1016/j.electacta.2008.05.018; Hara M, 2012, ELECTROCHIM ACTA, V82, P277, DOI 10.1016/j.electacta.2012.04.099; Sinha PK, 2007, J MATER CHEM, V17, P3089, DOI 10.1039/b703485g; Hirakata S, 2013, ELECTROCHIM ACTA, V108, P304, DOI 10.1016/j.electacta.2013.06.150; Takada K, 2011, J POWER SOURCES, V196, P2635, DOI 10.1016/j.jpowsour.2010.10.097; Chen YS, 2007, J POWER SOURCES, V170, P376, DOI 10.1016/j.jpowsour.2007.03.076; Tuber K, 2003, J POWER SOURCES, V124, P403, DOI 10.1016/S0378-7753(03)00797-3; Markotter H, 2012, J POWER SOURCES, V219, P120, DOI 10.1016/j.jpowsour.2012.07.043; Feser JP, 2006, J POWER SOURCES, V161, P404, DOI 10.1016/j.jpowsour.2006.04.129; Feindel KW, 2007, PHYS CHEM CHEM PHYS, V9, P1850, DOI 10.1039/b617551a; Sugiura K, 2005, J POWER SOURCES, V145, P526, DOI [10.1016/j.jpowsour.2005.02.037, 10.1016/j.jpowersour.2005.02.037]; Hickner MA, 2006, J ELECTROCHEM SOC, V153, pA902, DOI 10.1149/1.2184893; Lee J, 2013, J POWER SOURCES, V227, P123, DOI 10.1016/j.jpowsour.2012.11.006; Liu X, 2006, J POWER SOURCES, V156, P267, DOI 10.1016/j.jpowsour.2005.06.027; Wang CY, 2004, CHEM REV, V104, P4727, DOI 10.1021/cr020718s; Hussaini IS, 2009, J POWER SOURCES, V187, P444, DOI 10.1016/j.jpowsour.2008.11.030; Inukai J, 2008, ANGEW CHEM INT EDIT, V47, P2792, DOI 10.1002/anie.200705516; Ishigami Y, 2014, J POWER SOURCES, V269, P556, DOI 10.1016/j.jpowsour.2014.07.017; Takada K, 2011, ELECTROCHEMISTRY, V79, P388; Turhan A, 2008, J POWER SOURCES, V180, P773, DOI 10.1016/j.jpowsour.2008.02.028; Nagase K, 2015, J POWER SOURCES, V273, P873, DOI 10.1016/j.jpowsour.2014.09.169; Lee SJ, 2008, J POWER SOURCES, V185, P867, DOI 10.1016/j.jpowsour.2008.08.101; Deevanhxay P, 2012, ELECTROCHEM COMMUN, V22, P33, DOI 10.1016/j.elecom.2012.05.028; Hyakutake T, 2011, MACROMOL CHEM PHYS, V212, P42, DOI 10.1002/macp.201000449; Ishigami Y, 2011, J POWER SOURCES, V196, P3003, DOI 10.1016/j.jpowsour.2010.11.092; Hickner MA, 2008, J ELECTROCHEM SOC, V155, pB294, DOI 10.1149/1.2825298; Li H, 2008, J POWER SOURCES, V178, P103, DOI 10.1016/j.jpowsour.2007.12.068; Inukai J., 2008, ANGEW CHEM, V120, P2834, DOI 10.1002/ange.200705516; Khajeh-Hosseini-Dalasm N, 2010, J ELECTROCHEM SOC, V157, pB1358, DOI 10.1149/1.3467794; Murakawa H, 2009, NUCL INSTRUM METH A, V605, P127, DOI 10.1016/j.nima.2009.01.142; Oberholzer P, 2013, J ELECTROCHEM SOC, V160, pF659, DOI 10.1149/2.119306jes; Tsushima S, 2004, ELECTROCHEM SOLID ST, V7, pA269, DOI 10.1149/1.1774971; Tsushima S., 2007, ECS T, V11, P435, DOI DOI 10.1149/1.2780957; Wang J., 2011, ENERGY SCI TECHNOL, V2, P1; Yoneda M., 2010, P ASME 8 INT C FUEL, V1, P497	35	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	2196-0216			CHEMELECTROCHEM	ChemElectroChem	OCT	2015	2	10			SI		1495	1501		10.1002/celc.201402385		7	Electrochemistry	Electrochemistry	CU2EP	WOS:000363336500008		
J	Tsushima, S; Hung, WH; Deevanhxay, P; Kobayashi, G; Kanno, R; Hirai, S				Tsushima, Shohji; Hung, Weihao; Deevanhxay, Phengxay; Kobayashi, Genki; Kanno, Ryoji; Hirai, Shuichiro			In Situ X-ray Visualization of the Lithiation Process in a Porous Graphite Electrode in an Operating Li-Ion Cell	CHEMELECTROCHEM			English	Article						in situ visualization; ion transport; lithiation; lithium-ion batteries; X-ray radiography	SURFACE-CHEMISTRY; CAPACITY FADE; LITHIUM; BATTERY; SPECTROSCOPY	An insitu X-ray radiography technique to observe an operating Li-ion cell was developed. Transient behaviors of lithiation processes in a porous graphite electrode were visualized in a specifically designed Li-ion cell consisting of a lithium-metal electrode and a graphite electrode, using a transmission X-ray microscope with high spatial and temporal resolution. X-ray attenuation profiles in both 15 and 30m thick graphite electrodes under discharge (lithiation) at the 2C rate were compared. X-ray attenuation was pronounced near the separator in the thicker graphite electrode during the lithiation process, whereas less variation was observed near the current collector in the electrode. These X-ray observations indicate less utilization of the thicker graphite electrode, presumably because of the longer Li-ion transport path and formation of a solid electrolyte interface layer in the porous electrode, resulting in less discharge capacity of the Li-ion cell.	[Tsushima, Shohji] Osaka Univ, Dept Mech Engn, Suita, Osaka 5650871, Japan; [Tsushima, Shohji; Hung, Weihao; Deevanhxay, Phengxay; Hirai, Shuichiro] Tokyo Inst Technol, Dept Mech & Control Engn, Meguro Ku, Tokyo 1528552, Japan; [Deevanhxay, Phengxay] Natl Univ Laos, Dept Chem, Viangchan 7322, Laos; [Kobayashi, Genki] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448585, Japan; [Kobayashi, Genki; Kanno, Ryoji] Tokyo Inst Technol, Dept Elect Chem, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Tsushima, S (reprint author), Osaka Univ, Dept Mech Engn, Suita, Osaka 5650871, Japan.	tsushima@mech.eng.osaka-u.ac.jp					Harris SJ, 2010, CHEM PHYS LETT, V485, P265, DOI 10.1016/j.cplett.2009.12.033; Aurbach D, 1999, ELECTROCHIM ACTA, V45, P67, DOI 10.1016/S0013-4686(99)00194-2; YADA K, 1989, J ELECTRON MICROSC, V38, P321; Sasabe T, 2010, INT J HYDROGEN ENERG, V35, P11119, DOI 10.1016/j.ijhydene.2010.06.050; Verma P, 2010, ELECTROCHIM ACTA, V55, P6332, DOI 10.1016/j.electacta.2010.05.072; Arora P, 2004, CHEM REV, V104, P4419, DOI 10.1021/cr020738u; Yin XM, 2010, J PHYS CHEM C, V114, P8084, DOI 10.1021/jp100224x; Liu J, 2010, J PHYS CHEM LETT, V1, P2120, DOI 10.1021/jz100634n; FULLER TF, 1994, J ELECTROCHEM SOC, V141, P1, DOI 10.1149/1.2054684; Owejan JP, 2012, ELECTROCHIM ACTA, V66, P94, DOI 10.1016/j.electacta.2012.01.047; Deevanhxay P, 2014, ELECTROCHIM ACTA, V135, P68, DOI 10.1016/j.electacta.2014.04.144; Yazami R, 1999, ELECTROCHIM ACTA, V45, P87, DOI 10.1016/S0013-4686(99)00195-4; Zhang Q, 2008, J POWER SOURCES, V179, P793, DOI 10.1016/j.jpowsour.2008.01.028; Goers D, 2004, J POWER SOURCES, V130, P221, DOI 10.1016/j.jpowsour.2003.11.065; Andersson AM, 2003, J POWER SOURCES, V119, P522, DOI 10.1016/S0378-7753(03)00277-5; BESENHARD JO, 1995, J POWER SOURCES, V54, P228, DOI 10.1016/0378-7753(94)02073-C; Christensen J, 2004, J ELECTROCHEM SOC, V151, pA1977, DOI 10.1149/1.1804812; Nelson Weker Johanna, 2015, Advanced Functional Materials, V25, DOI 10.1002/adfm.201403409; Sikha G, 2004, J ELECTROCHEM SOC, V151, pA1104, DOI 10.1149/1.1759972; Takamatsu D, 2012, ANGEW CHEM INT EDIT, V51, P11597, DOI 10.1002/anie.201203910; Takamatsu D., 2012, ANGEW CHEM, V124, P11765, DOI DOI 10.1002/ANGE.201203910; Yada K, 2009, SPECTROCHIM ACTA B, V64, P729, DOI 10.1016/j.sab.2009.06.016	22	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	2196-0216			CHEMELECTROCHEM	ChemElectroChem	OCT	2015	2	10			SI		1535	1540		10.1002/celc.201500141		6	Electrochemistry	Electrochemistry	CU2EP	WOS:000363336500013		
J	Takahashi, S; Mashio, T; Horibe, N; Akizuki, K; Ohma, A				Takahashi, Shinichi; Mashio, Tetsuya; Horibe, Norifumi; Akizuki, Ken; Ohma, Atsushi			Analysis of the Microstructure Formation Process and Its Influence on the Performance of Polymer Electrolyte Fuel-Cell Catalyst Layers	CHEMELECTROCHEM			English	Article						catalyst layer; fuel cells; inks; microporous materials; polymers	QUARTZ-CRYSTAL MICROBALANCE; CRYO-SEM; IMPEDANCE SPECTROSCOPY; PLATINUM NANOTUBES; PROTON TRANSPORT; IONOMER; OXYGEN; REDUCTION; INK; SOLVENT	To understand the formation process of the microstructure of the catalyst layer of a polymer electrolyte fuel cell (PEFC), we tried to observe the real structure of the catalyst ink by cryogenic scanning electron microscopy (cryo-SEM). Catalyst inks with different water/alcohol compositions were successfully visualized, and they correlated well with the particle-size distribution obtained by laser diffraction of the ink and the structures of the catalyst layers obtained by typical SEM. On the basis of other electrochemical characterization results, including current-voltage performance, oxygen reduction reaction kinetics, and mass-transport properties, the microstructures of the catalyst inks and the catalyst layers were proposed. The proposed microstructures can explain the relationship between the catalyst materials and the performance of the cathode catalyst layer of the membrane electrode assembly through its formation and apparent properties. It was also found that the microstructure of the catalyst ink plays an important role in performance.	[Takahashi, Shinichi; Mashio, Tetsuya; Horibe, Norifumi; Akizuki, Ken; Ohma, Atsushi] Nissan Motor Co Ltd, Div Res, Yokosuka, Kanagawa 2378523, Japan	Ohma, A (reprint author), Nissan Motor Co Ltd, Div Res, 1 Natsushima, Yokosuka, Kanagawa 2378523, Japan.	a-ohma@mail.nissan.co.jp					Malek K, 2007, J PHYS CHEM C, V111, P13627, DOI 10.1021/jp072692k; Iden H, 2013, J ELECTROANAL CHEM, V708, P87, DOI 10.1016/j.jelechem.2013.09.011; Shin SJ, 2002, J POWER SOURCES, V106, P146; Liu YX, 2009, J ELECTROCHEM SOC, V156, pB970, DOI 10.1149/1.3143965; Makharia R, 2005, J ELECTROCHEM SOC, V152, pA970, DOI 10.1149/1.1888367; Ohma A, 2010, ELECTROCHIM ACTA, V55, P8829, DOI 10.1016/j.electacta.2010.08.005; UCHIDA M, 1995, J ELECTROCHEM SOC, V142, P463, DOI 10.1149/1.2044068; Iden H, 2011, J ELECTROCHEM SOC, V158, pB987, DOI 10.1149/1.3598141; Sakai K, 2009, ECS TRANSACTIONS, V25, P1193, DOI 10.1149/1.3210674; Ishihara A, 2013, J PHYS CHEM C, V117, P18837, DOI 10.1021/jp405247m; Uchida M, 1998, J ELECTROCHEM SOC, V145, P3708, DOI 10.1149/1.1838863; Iden H, 2009, J ELECTROCHEM SOC, V156, pB1078, DOI 10.1149/1.3169514; Xu F, 2010, LANGMUIR, V26, P19199, DOI 10.1021/la1028228; Ma S, 2007, SOLID STATE IONICS, V178, P1568, DOI 10.1016/j.ssi.2007.10.007; Arumugam B, 2014, RSC ADV, V4, P27510, DOI 10.1039/c4ra04744c; Xie Z, 2008, ENERG ENVIRON SCI, V1, P184, DOI 10.1039/b808613n; Ito T, 2011, ELECTROCHEMISTRY, V79, P374; Ngo TT, 2013, J POWER SOURCES, V225, P293, DOI 10.1016/j.jpowsour.2012.10.055; Owejan JP, 2013, J ELECTROCHEM SOC, V160, pF824, DOI 10.1149/2.072308jes; Alia SM, 2013, ACS CATAL, V3, P358, DOI 10.1021/cs300664g; Ohma A, 2011, ELECTROCHIM ACTA, V56, P10832, DOI 10.1016/j.electacta.2011.04.058; Yano H, 2013, J ELECTROANAL CHEM, V688, P137, DOI 10.1016/j.jelechem.2012.09.028; Iden H, 2013, J ELECTROANAL CHEM, V693, P34, DOI 10.1016/j.jelechem.2013.01.026; Johnston CM, 2009, ECS TRANSACTIONS, V25, P1617, DOI 10.1149/1.3210717; Prakash SS, 2006, J MEMBRANE SCI, V283, P328, DOI 10.1016/j.memsci.2006.07.001; Omura J, 2011, LANGMUIR, V27, P6464, DOI 10.1021/la200694a; Park YC, 2015, J POWER SOURCES, V275, P384, DOI 10.1016/j.jpowsour.2014.10.149; Chen C, 2014, SCIENCE, V343, P1339, DOI 10.1126/science.1249061; Buss F, 2011, J COLLOID INTERF SCI, V359, P112, DOI 10.1016/j.jcis.2011.03.054; Prakash SS, 2008, J MEMBRANE SCI, V313, P135, DOI 10.1016/j.memsci.2008.01.006; Subbaraman R, 2010, J PHYS CHEM C, V114, P8414, DOI 10.1021/jp100814x; Papandrew AB, 2013, J ELECTROCHEM SOC, V160, pF848, DOI 10.1149/2.090308jes; Adzic R, 2012, ELECTROCATALYSIS-US, V3, P163, DOI 10.1007/s12678-012-0112-3; Kodama K, 2014, J ELECTROCHEM SOC, V161, pF649, DOI 10.1149/2.051405jes; Lefebvre MC, 1999, ELECTROCHEM SOLID ST, V2, P259, DOI 10.1149/1.1390804; Strong A, 2015, J ELECTROCHEM SOC, V162, pF513, DOI 10.1149/2.0251506jes; Masuda T, 2013, J PHYS CHEM C, V117, P15704, DOI 10.1021/jp404376t; Wang QP, 2004, J ELECTROANAL CHEM, V573, P61, DOI 10.1016/j.jelechem.2004.06.022; Fernandez R, 2005, J POWER SOURCES, V151, P18, DOI 10.1016/j.jpowsour.2005.02.048; Luo H, 2007, J COLLOID INTERF SCI, V316, P500, DOI 10.1016/j.jcis.2007.07.047; Cleveland C. A., 2010, EFFECT SOLVENT COMPO; Daimon H., 2013, ELECTROCHEMISTRY, V81; Eikerling M, 2006, J ELECTROCHEM SOC, V153, pE58, DOI 10.1149/1.2160435; Furuya Y., 2012, 221 ECS M, P1522; Huang DC, 2011, INT J ELECTROCHEM SC, V6, P2551; Iiyama A., 2011, OBJECTIVES R D CHALL; Mashio T., 2007, ECS T, V11, P529, DOI 10.1149/1.2780966; Mashio T., 2014, 65 ISE M LAUS SWITZ; More K. L., 2014, P 2014 DOE ANN MER R; Nishino Y., 2013, JSM BA SEM JUP US; Nonoyama N, 2011, J ELECTROCHEM SOC, V158, pB416, DOI 10.1149/1.3546038; Shibayama M., 2014, J APPL POLYM SCI, V131, P39841	52	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	2196-0216			CHEMELECTROCHEM	ChemElectroChem	OCT	2015	2	10			SI		1560	1567		10.1002/celc.201500131		8	Electrochemistry	Electrochemistry	CU2EP	WOS:000363336500016		
J	Samjeske, G; Higashi, K; Takao, S; Nagamatsu, S; Nagasawa, K; Sekizawa, O; Kaneko, T; Uruga, T; Iwasawa, Y				Samjeske, Gabor; Higashi, Kotaro; Takao, Shinobu; Nagamatsu, Shin-ichi; Nagasawa, Kensaku; Sekizawa, Oki; Kaneko, Takuma; Uruga, Tomoya; Iwasawa, Yasuhiro			In Situ Techniques to Study the Effects of Anode or Cathode Gas-Exchange Cycles on the Deterioration of Pt/C Cathode Catalysts in PEFCs	CHEMELECTROCHEM			English	Article						electron microscopy; fuel cells; gas-exchange effects; ORR activity; Pt/C catalyst degradation	MEMBRANE FUEL-CELL; ABSORPTION FINE-STRUCTURE; CARBON CORROSION; START-UP; PERFORMANCE DEGRADATION; MITIGATION STRATEGIES; INTERNAL CURRENTS; OXYGEN REDUCTION; SURFACE EVENTS; SHUT-DOWN	Repeated, quick anode gas-exchange (AGEX) or cathode gas-exchange (CGEX) cycles were applied to polymer electrolyte fuel cell (PEFC) membrane electrode assemblies (MEAs) with Pt/C cathode catalysts to simulate start-up/shut-down conditions and to examine a possible countermeasure for their effects on MEA cathode catalyst degradation. The peak height of the white line during insitu time-resolved X-ray absorption near-edge structure (XANES) spectra at the Pt L-III-edge decreased with an increasing number of AGEX cycles and only in the top region of the MEA cathode layer (close to the gas inlet of the fuel cell), not in the whole MEA area. End-of-life analysis after AGEX by using SEM and TEM revealed isolated Pt nanoparticles in micro-cracks and voids produced in the top region of the MEA cathode layer. The nanoparticle sizes remained almost unchanged for top, middle, and bottom regions of the MEA cathode layer. In the case of CGEX, a small increase in the Pt nanoparticle sizes in the top and bottom positions of the MEA cathode layer was observed. These findings support the role of carbon corrosion, leaving isolated, electrochemically inactive Pt nanoparticles as a consequence of the harsh reaction conditions caused by the reverse current decay mechanism during the start-up/shut-down phase, as in the case of AGEX cycles, to be the main cause for the cathode catalyst deterioration close to the anode gas inlet. On the other hand, the hydrogen gas feed to both the anode and cathode during start-up and shut-down processes seems to effectively suppress carbon corrosion and prevents a decrease in the performance.	[Samjeske, Gabor; Higashi, Kotaro; Takao, Shinobu; Nagamatsu, Shin-ichi; Nagasawa, Kensaku; Sekizawa, Oki; Kaneko, Takuma; Uruga, Tomoya; Iwasawa, Yasuhiro] Univ Electrocommun, Innovat Res Ctr Fuel Cells, Chofu, Tokyo 1828585, Japan; [Uruga, Tomoya] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan	Iwasawa, Y (reprint author), Univ Electrocommun, Innovat Res Ctr Fuel Cells, Chofu, Tokyo 1828585, Japan.	iwasawa@pc.uec.ac.jp			New Energy and Industrial Technology Development Organization (NEDO)	This work was supported by the New Energy and Industrial Technology Development Organization (NEDO). XAFS measurements were performed with the approval of SPring-8 (2013B7801, 2014A7801, 2014B7802).	Jo YY, 2011, J POWER SOURCES, V196, P9906, DOI 10.1016/j.jpowsour.2011.08.035; Yu XW, 2007, J POWER SOURCES, V172, P145, DOI 10.1016/j.jpowsour.2007.07.048; Inoue H, 2002, ELECTROCHIM ACTA, V47, P3777, DOI 10.1016/S0013-4686(02)00348-1; Yousfi-Steiner N, 2009, J POWER SOURCES, V194, P130, DOI 10.1016/j.jpowsour.2009.03.060; Lamibrac A, 2011, J POWER SOURCES, V196, P9451, DOI 10.1016/j.jpowsour.2011.07.013; Shao YY, 2007, J POWER SOURCES, V171, P558, DOI 10.1016/j.jpowsour.2007.07.004; Tang H, 2006, J POWER SOURCES, V158, P1306, DOI 10.1016/j.jpowsour.2005.10.059; Wang JJ, 2007, J POWER SOURCES, V171, P331, DOI 10.1016/j.jpowsour.2007.06.084; Borup R, 2007, CHEM REV, V107, P3904, DOI 10.1021/cr050182l; Baumgartner WR, 2008, J POWER SOURCES, V182, P413, DOI 10.1016/j.jpowsour.2008.01.001; Carrette L, 2001, FUEL CELLS, V1, P5, DOI 10.1002/1615-6854(200105)1:1<5::AID-FUCE5>3.0.CO;2-G; SRINIVASAN S, 1991, J POWER SOURCES, V36, P299, DOI 10.1016/0378-7753(91)87009-Z; Hitchcock AP, 2014, J POWER SOURCES, V266, P66, DOI 10.1016/j.jpowsour.2014.04.119; Wu JF, 2008, J POWER SOURCES, V184, P104, DOI 10.1016/j.jpowsour.2008.06.006; Hu JW, 2009, ELECTROCHIM ACTA, V54, P5583, DOI 10.1016/j.electacta.2009.04.073; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Maass S, 2008, J POWER SOURCES, V176, P444, DOI 10.1016/j.jpowsour.2007.08.053; Yu Y, 2011, J POWER SOURCES, V196, P5077, DOI 10.1016/j.jpowsour.2011.01.075; Ishiguro N, 2012, ACS CATAL, V2, P1319, DOI 10.1021/cs300228p; Brightman E, 2014, J POWER SOURCES, V267, P160, DOI 10.1016/j.jpowsour.2014.05.040; Ishiguro N, 2013, PHYS CHEM CHEM PHYS, V15, P18827, DOI 10.1039/c3cp52578c; Stambouli AB, 2002, RENEW SUST ENERG REV, V6, P295; Ettingshausen F, 2009, J POWER SOURCES, V194, P899, DOI 10.1016/j.jpowsour.2009.06.003; SRINIVASAN S, 1988, J POWER SOURCES, V22, P359, DOI 10.1016/0378-7753(88)80030-2; Ishiguro N, 2014, J PHYS CHEM C, V118, P15874, DOI 10.1021/jp504738p; Piela P, 2004, J ELECTROCHEM SOC, V151, pA2053, DOI 10.1149/1.1814472; Yu Y, 2012, J POWER SOURCES, V205, P10, DOI 10.1016/j.jpowsour.2012.01.059; Tada M, 2007, ANGEW CHEM INT EDIT, V46, P4310, DOI 10.1002/anie.200604732; Siroma Z, 2007, J POWER SOURCES, V172, P155, DOI 10.1016/j.jpowsour.2007.07.062; Samjeske G, 2013, PHYS CHEM CHEM PHYS, V15, P17208, DOI 10.1039/c3cp52323c; Kreitmeier S, 2012, J ELECTROCHEM SOC, V159, pF787, DOI 10.1149/2.019212jes; Linse N, 2012, J POWER SOURCES, V219, P240, DOI 10.1016/j.jpowsour.2012.07.037; Nagasawa K, 2014, PHYS CHEM CHEM PHYS, V16, P10075, DOI 10.1039/c3cp54457e; Ferreira PJ, 2005, J ELECTROCHEM SOC, V152, pA2256, DOI 10.1149/1.2050347; WILSON MS, 1992, J ELECTROCHEM SOC, V139, pL28, DOI 10.1149/1.2069277; Kim J, 2009, J POWER SOURCES, V192, P674, DOI 10.1016/j.jpowsour.2009.03.039; Zhang SS, 2009, J POWER SOURCES, V194, P588, DOI 10.1016/j.jpowsour.2009.06.073; Nagamatsu S, 2013, J PHYS CHEM C, V117, P13094, DOI 10.1021/jp402438e; Maranzana G, 2010, J POWER SOURCES, V195, P5990, DOI 10.1016/j.jpowsour.2009.10.093; Saida T, 2012, ANGEW CHEM INT EDIT, V51, P10311, DOI 10.1002/anie.201204478; Meyers JP, 2006, J ELECTROCHEM SOC, V153, pA1432, DOI 10.1149/1.2203811; Cai M, 2006, J POWER SOURCES, V160, P977, DOI 10.1016/j.jpowsour.2006.03.033; Ishigami Y, 2011, J POWER SOURCES, V196, P3003, DOI 10.1016/j.jpowsour.2010.11.092; Franco AA, 2008, J ELECTROCHEM SOC, V155, pB367, DOI 10.1149/1.2838165; Ishigami Y, 2012, ELECTROCHEM SOLID ST, V15, pB51, DOI 10.1149/2.018204esl; Kunimatsu M, 2005, J ELECTROCHEM SOC, V152, pE161, DOI 10.1149/1.1874732; Mathias M. F., 2005, Electrochemical Society Interface, V14; Reiser CA, 2005, ELECTROCHEM SOLID ST, V8, pA273, DOI 10.1149/1.1896466; Saida T., 2012, ANGEW CHEM, V124, P10457; Samjeske G., 2013, ECS T, V50, P1651; Srinivasan S., 2006, FUEL CELLS; Tada M., 2007, ANGEW CHEM, V119, P4388, DOI 10.1002/ange.200604732; Vielstich W., 2003, HDB FUEL CELLS	53	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	2196-0216			CHEMELECTROCHEM	ChemElectroChem	OCT	2015	2	10			SI		1595	1606		10.1002/celc.201500099		12	Electrochemistry	Electrochemistry	CU2EP	WOS:000363336500020		
J	Li, YH; Zeng, WJ; Lai, WY; Shimada, S; Wang, S; Wang, LH; Huang, W				Li, Yonghua; Zeng, Wenjin; Lai, Wenyong; Shimada, Shigeru; Wang, Shi; Wang, Lianhui; Huang, Wei			Synthesis, Structural Characterization and Reactivity of a Bis(phosphine)(silyl) Platinum(II) Complex	CHINESE JOURNAL OF CHEMISTRY			English	Article						silyl; chelating; platinum; multinuclear NMR	TRANSITION-METAL-COMPLEXES; SI-H; PALLADIUM COMPLEXES; CATALYZED REACTIONS; SILYL COMPLEXES; RECENT PROGRESS; SILICON; ACTIVATION; BONDS; DINUCLEAR	Treatment of 1,2-C6H4(SiH3)(SiH3) (1) with Pt(dmpe)(PEt3)(2) (dmpe=Me2PCH2CH2PMe2) in the ratio of 1:1 leads to the complex {1,2-C6H4(SiH2)(SiH2)}Pt-II (dmpe) (2), which can react with proton organic reagent bearing hydroxy group with low steric hindrance to form a tetra-alkoxy substituted silyl platinum(II) compound (3). Compounds 2 and 3 are the very rare examples of silyl transition-metal complexes derived from this chelating hydrosilane ligand. To the best of our knowledge, there are only 6 examples of silyl metal complexes prepared from this ligand with such structural features registered in the Cambridge Structural Database, among them, only one silyl platinum(II) compound is presented. The structures of complexes 2 and 3 were unambiguously determined by multinuclear NMR spectroscopic studies and single crystal X-ray analysis.	[Li, Yonghua; Zeng, Wenjin; Lai, Wenyong; Wang, Shi; Wang, Lianhui; Huang, Wei] Nanjing Univ Posts & Telecommun, Key Lab Organ Elect & Informat Displays, Jiangsu Natl Synerget Innovat Ctr Adv Mat SICAM, Nanjing 210023, Jiangsu, Peoples R China; [Li, Yonghua; Zeng, Wenjin; Lai, Wenyong; Wang, Shi; Wang, Lianhui; Huang, Wei] Nanjing Univ Posts & Telecommun, IAM, Jiangsu Natl Synerget Innovat Ctr Adv Mat SICAM, Nanjing, Jiangsu, Peoples R China; [Shimada, Shigeru] Natl Inst Adv Ind Sci & Technol, Res Inst Innovat Sustainable Chem, Tsukuba, Ibaraki 3058565, Japan	Li, YH (reprint author), Nanjing Univ Posts & Telecommun, Key Lab Organ Elect & Informat Displays, Jiangsu Natl Synerget Innovat Ctr Adv Mat SICAM, Nanjing 210023, Jiangsu, Peoples R China.	iamyhli@njupt.edu.cn			National Key Basic Research Program of China [2014CB648300]; National Natural Science Foundation of China [51173082, 51274159]; Natural Science Foundation of Jiangsu Province [BK20141425]; Natural Science Foundation of Colleges and Universities in Jiangsu Province [13KJB150028]; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions; Ministry of Education of China [IRT1148]	This work was financially supported by the National Key Basic Research Program of China (No. 2014CB648300), the National Natural Science Foundation of China (Nos. 51173082 and 51274159), the Natural Science Foundation of Jiangsu Province (No. BK20141425), the Natural Science Foundation of Colleges and Universities in Jiangsu Province (No. 13KJB150028), the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions and the Ministry of Education of China (No. IRT1148).	SHIMADA S, 1995, J AM CHEM SOC, V117, P8289, DOI 10.1021/ja00136a035; Yamada T, 2004, ORGANOMETALLICS, V23, P4771, DOI 10.1021/om049858d; Reichl JA, 1999, ADV ORGANOMET CHEM, V43, P197; SHARMA HK, 1995, CHEM REV, V95, P1351, DOI 10.1021/cr00037a010; HORN KA, 1995, CHEM REV, V95, P1317, DOI 10.1021/cr00037a009; Braddock-Wilking J, 2000, ORGANOMETALLICS, V19, P5500, DOI 10.1021/om000602r; Crabtree RH, 2002, SCIENCE, V295, P288, DOI 10.1126/science.1067921; SPEIER JL, 1957, J AM CHEM SOC, V79, P974, DOI 10.1021/ja01561a054; Braddock-Wilking J, 2004, ORGANOMETALLICS, V23, P4576, DOI 10.1021/om0400447; Okazaki M, 2002, COORDIN CHEM REV, V226, P167, DOI 10.1016/S0010-8545(01)00422-2; Tanabe M, 2003, ORGANOMETALLICS, V22, P2190, DOI 10.1021/om030081i; Yu XH, 2004, ORGANOMETALLICS, V23, P2210, DOI 10.1021/om049862p; CRABTREE RH, 1993, ANGEW CHEM INT EDIT, V32, P789, DOI 10.1002/anie.199307891; Fontaine FG, 2002, ORGANOMETALLICS, V21, P401, DOI 10.1021/om010757e; Zell T, 2011, DALTON T, V40, P1852, DOI 10.1039/c0dt01442g; Shimada S, 2005, ORGANOMETALLICS, V24, P6029, DOI 10.1021/om050498j; Boyle RC, 2003, J AM CHEM SOC, V125, P3228, DOI 10.1021/ja029853c; Turculet L, 2004, ORGANOMETALLICS, V23, P2488, DOI 10.1021/om030686e; Shimada S, 2007, P NATL ACAD SCI USA, V104, P7758, DOI 10.1073/pnas.0700450104; Chen WZ, 2002, SCIENCE, V295, P308, DOI 10.1126/science.1067027; Takaya J, 2013, J SYN ORG CHEM JPN, V71, P417; Suginome M, 2000, CHEM REV, V100, P3221, DOI 10.1021/cr9902805; Corey JY, 2011, CHEM REV, V111, P863, DOI 10.1021/cr900359c; Putzien S, 2010, PROG POLYM SCI, V35, P687, DOI 10.1016/j.progpolymsci.2010.01.007; Varchi G, 2006, CURR ORG CHEM, V10, P1341, DOI 10.2174/138527206778018230; HEYN RH, 1992, J AM CHEM SOC, V114, P1917, DOI 10.1021/ja00031a077; Shimada S, 1996, ANGEW CHEM INT EDIT, V35, P1856, DOI 10.1002/anie.199618561; Beck R, 2012, ORGANOMETALLICS, V31, P3599, DOI 10.1021/om300120x; Esteruelas MA, 2013, INORG CHEM, V52, P12108, DOI 10.1021/ic401931y; PIPER TS, 1956, NATURWISSENSCHAFTEN, V43, P129; Shimada S, 1999, ORGANOMETALLICS, V18, P291, DOI 10.1021/om980904h; Oestreich M, 2015, CHEM SOC REV, V44, P2202, DOI 10.1039/c4cs00451e; Li YH, 2010, J ORGANOMET CHEM, V695, P2057, DOI 10.1016/j.jorganchem.2010.05.023; Ogino H, 1998, ADV ORGANOMET CHEM, V42, P223, DOI 10.1016/S0065-3055(08)60544-4; Lee YJ, 2004, ORGANOMETALLICS, V23, P203, DOI 10.1021/om0341121; CLEARY BP, 1995, ORGANOMETALLICS, V14, P2297, DOI 10.1021/om00005a031; Yoo BR, 2011, CURR ORG CHEM, V15, P2743; SEITZ F, 1988, ANGEW CHEM INT EDIT, V27, P289, DOI 10.1002/anie.198802891; EABORN C, 1977, J ORGANOMET CHEM, V131, P377; Sanow LM, 2000, ORGANOMETALLICS, V19, P192, DOI 10.1021/om990871l; Shimada S, 2006, ORGANOMETALLICS, V25, P3796, DOI 10.1021/om0604019; YOSHIDA T, 1990, INORG SYN, V28, P122, DOI 10.1002/9780470132593.ch32; Li YH, 2010, ORGANOMETALLICS, V29, P4406, DOI 10.1021/om100626k; BONNY A, 1978, COORDIN CHEM REV, V25, P229, DOI 10.1016/S0010-8545(00)82061-5; Chan C. Y., 1995, CHEM J CHINESE U, V16, P1806; HOLMESSMITH RD, 1981, J CHEM SOC CHEM COMM, P937, DOI 10.1039/c39810000937; Kim BH, 2005, ADV ORGANOMET CHEM, V52, P143, DOI 10.1016/S0065-3055(04)52003-8; Marciniec B, 2005, COORDIN CHEM REV, V249, P2374, DOI 10.1016/j.ccr.2005.02.025; Schubert U., 1990, ADV ORGANOMET CHEM, V30, P151, DOI 10.1016/S0065-3055(08)60501-8; Sheldrick G. M., 1997, SHELXS 97 PROGRAM CR; Sheldrick G. M., 1997, SHELXL 97 PROGRAM CR	51	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1001-604X	1614-7065		CHINESE J CHEM	Chin. J. Chem.	OCT	2015	33	10					1206	1210		10.1002/cjoc.201500418		5	Chemistry, Multidisciplinary	Chemistry	CU0OY	WOS:000363218000016		
J	Xu, Z; Keiji, Y; Liu, XJ				Xu Zheng; Keiji, Yasuda; Liu Xiao-Jun			Quantitative calculation of reaction performance in sonochemical reactor by bubble dynamics	CHINESE PHYSICS B			English	Article						reaction field; cavitation; bubble dynamics; hydroxide radical	WATER-SOLUBLE SOLUTES; NUMERICAL-SIMULATION; FREQUENCY REACTOR; ULTRASOUND WAVES; PRESSURE FIELDS; CAVITATION; SONOLUMINESCENCE; TEMPERATURE; ENHANCEMENT; IRRADIATION	In order to design a sonochemical reactor with high reaction efficiency, it is important to clarify the size and intensity of the sonochemical reaction field. In this study, the reaction field in a sonochemical reactor is estimated from the distribution of pressure above the threshold for cavitation. The quantitation of hydroxide radical in a sonochemical reactor is obtained from the calculation of bubble dynamics and reaction equations. The distribution of the reaction field of the numerical simulation is consistent with that of the sonochemical luminescence. The sound absorption coefficient of liquid in the sonochemical reactor is much larger than that attributed to classical contributions which are heat conduction and shear viscosity. Under the dual irradiation, the reaction field becomes extensive and intensive because the acoustic pressure amplitude is intensified by the interference of two ultrasonic waves.	[Xu Zheng] Tongji Univ, Sch Phys Sci & Engn, Shanghai 200092, Peoples R China; [Xu Zheng; Keiji, Yasuda] Nagoya Univ, Dept Chem Engn, Nagoya, Aichi 4648603, Japan; [Liu Xiao-Jun] Nanjing Univ, Sch Phys, Nanjing 210093, Jiangsu, Peoples R China	Liu, XJ (reprint author), Nanjing Univ, Sch Phys, Nanjing 210093, Jiangsu, Peoples R China.	liuxiaojun@nju.edu.cn			National Natural Science Foundation of China [11404245, 11204129, 11211140039]	Project supported by the National Natural Science Foundation of China (Grant Nos. 11404245, 11204129, and 11211140039).	Chowdhury P, 2009, SCI TOTAL ENVIRON, V407, P2474, DOI 10.1016/j.scitotenv.2008.12.031; Klima J, 2007, ULTRASON SONOCHEM, V14, P19, DOI 10.1016/j.ultsonch.2006.01.001; Yasui K, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2790420; FLINT EB, 1991, SCIENCE, V253, P1397, DOI 10.1126/science.253.5026.1397; Yasui K, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2919119; Suslick KS, 2008, ANNU REV PHYS CHEM, V59, P659, DOI 10.1146/annurev.physchem.59.032607.093739; Servant G, 2000, ULTRASON SONOCHEM, V7, P217, DOI 10.1016/S1350-4177(00)00059-6; Yasui K, 1997, PHYS REV E, V56, P6750, DOI 10.1103/PhysRevE.56.6750; Brotchie A, 2007, J PHYS CHEM C, V111, P3066, DOI 10.1021/jp067524r; Yasui K, 1996, J PHYS SOC JPN, V65, P2830, DOI 10.1143/JPSJ.65.2830; HENGLEIN A, 1987, ULTRASONICS, V25, P6, DOI 10.1016/0041-624X(87)90003-5; Xu Z, 2013, ULTRASON SONOCHEM, V20, P452, DOI 10.1016/j.ultsonch.2012.04.011; Feng R, 2002, ULTRASON SONOCHEM, V9, P231, DOI 10.1016/S1350-4177(02)00083-4; HALL L, 1948, PHYS REV, V73, P775, DOI 10.1103/PhysRev.73.775; Gedanken A, 2004, ULTRASON SONOCHEM, V11, P47, DOI 10.1016/j.ultsonch.2004.01.037; Moholkar VS, 2000, ULTRASONICS, V38, P666, DOI 10.1016/S0041-624X(99)00204-8; Sivakumar M, 2002, CHEM ENG J, V85, P327, DOI 10.1016/S1385-8947(01)00179-6; Dahnke S, 1999, ULTRASON SONOCHEM, V6, P31, DOI 10.1016/S1350-4177(98)00026-1; Yasuda K, 1999, J CHEM ENG JPN, V32, P347, DOI 10.1252/jcej.32.347; Kanthale PM, 2007, CHEM ENG J, V127, P71, DOI 10.1016/j.cej.2006.09.023; Brotchie A, 2008, J PHYS CHEM C, V112, P10247, DOI 10.1021/jp801763v; BURTON CJ, 1948, J ACOUST SOC AM, V20, P186, DOI 10.1121/1.1906362; Servant G, 2001, ULTRASON SONOCHEM, V8, P163, DOI 10.1016/S1350-4177(01)00074-8; Kojima Y, 2010, ULTRASON SONOCHEM, V17, P978, DOI 10.1016/j.ultsonch.2009.11.020; Jamshidi R, 2012, CHEM ENG J, V189, P364, DOI 10.1016/j.cej.2012.02.029; Moholkar VS, 2004, AICHE J, V50, P58, DOI 10.1002/aic.10005; Yanagida H, 2000, ULTRASONICS, V38, P671, DOI 10.1016/S0041-624X(99)00203-6; Yasui K, 2007, ULTRASON SONOCHEM, V14, P605, DOI 10.1016/j.ultsonch.2006.09.010; Koda S, 2003, ULTRASON SONOCHEM, V10, P149, DOI 10.1016/S1350-4177(03)00084-1; Servant G, 2003, ULTRASON SONOCHEM, V10, P347, DOI 10.1016/S1350-4177(03)00105-6; Liu XZ, 2013, CHINESE PHYS B, V22, DOI 10.1088/1674-1056/22/2/024301; MITOME H, 1991, JPN J APPL PHYS 1, V30, P60; NEPPIRAS EA, 1980, PHYS REP, V61, P159, DOI 10.1016/0370-1573(80)90115-5	33	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1674-1056	1741-4199		CHINESE PHYS B	Chin. Phys. B	OCT	2015	24	10							104301	10.1088/1674-1056/24/10/104301		7	Physics, Multidisciplinary	Physics	CU2BU	WOS:000363327400045		
J	Hida, K; Sakai, T; Hayashi, M; Tamagawa, T; Abe, Y				Hida, Kumiko; Sakai, Tetsuya; Hayashi, Maya; Tamagawa, Takao; Abe, Yoichiro			Sympathotomy for palmar hyperhidrosis: the cutting versus clamping methods	CLINICAL AUTONOMIC RESEARCH			English	Article						Thoracic sympathotomy; Postoperative compensatory sweating; Postoperative satisfaction; Hyperhidrosis; Clamping method	ENDOSCOPIC THORACIC SYMPATHECTOMY; RANDOMIZED CONTROL TRIAL; THORACOSCOPIC SYMPATHECTOMY; COMPLICATIONS; ABLATION; T3	Endoscopic thoracic sympathectomy/sympathotomy for the treatment of palmar hyperhidrosis is generally performed by either cutting or clamping the sympathetic chain. However, it remains unclear as to which of these methods is more effective and has fewer side effects. This study was conducted to compare the effects of sympathotomy by cutting or clamping at T3 on two outcomes-postoperative palmar sweating and compensatory sweating; it also evaluated postoperative patient satisfaction. The participants were among 289 patients who underwent bilateral sympathotomy at T3 for palmar hyperhidrosis. These patients were sent questionnaires by mail to assess their self-reported degree of postoperative palmar sweating and compensatory sweating, as well as their level of satisfaction. Of the 92 patients who responded to the questionnaire, 54 had undergone sympathotomy by cutting (cutting group) and 38 by clamping (clamping group). The degree of postoperative palmar sweating was significantly lower in the cutting group than in the clamping group. However, compensatory sweating was significantly more severe in the cutting group than in the clamping group. No significant difference was observed in the degree of patient satisfaction between the groups. Sympathotomy by clamping at T3 was less effective in reducing the primary symptom of postoperative palmar sweating, but induced less compensatory sweating than did sympathotomy by cutting at T3. However, both methods were similar with regard to patient satisfaction. The degree of postoperative palmar sweating and the severity of compensatory sweating were inversely correlated with the degree of patient satisfaction.	[Hida, Kumiko; Hayashi, Maya; Tamagawa, Takao; Abe, Yoichiro] NTT Med Ctr Tokyo, Pain Clin, Shinagawa Ku, Tokyo 1418625, Japan; [Sakai, Tetsuya] Nagasaki Univ, Sch Med, Dept Anesthesiol, Nagasaki 8528501, Japan	Sakai, T (reprint author), Nagasaki Univ, Sch Med, Dept Anesthesiol, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	tscat@fb3.so-net.ne.jp					Dumont P, 2004, ANN THORAC SURG, V78, P1801, DOI 10.1016/j.athpracsur.2004.03.012; Yanagihara TK, 2010, J THORAC CARDIOV SUR, V140, P984, DOI 10.1016/j.jtcvs.2010.08.014; Atkinson JLD, 2011, MAYO CLIN PROC, V86, P721, DOI 10.4065/mcp.2011.0199; Findikcioglu A, 2014, THORAC CARDIOV SURG, V62, P445, DOI 10.1055/s-0033-1348920; Sugimura H, 2009, J THORAC CARDIOV SUR, V137, P1370, DOI 10.1016/j.jtcvs.2009.01.008; Baumgartner FJ, 2011, ANN THORAC SURG, V92, P2015, DOI 10.1016/j.athoracsur.2011.07.083; de Campos JRM, 2003, ANN THORAC SURG, V76, P886; Licht PB, 2004, ANN THORAC SURG, V78, P427, DOI 10.1016/j.athorascur.2004.02.087; Deng B, 2011, SURG ENDOSC, V25, P1893, DOI 10.1007/s00464-010-1482-3; Chang YT, 2007, ANN SURG, V246, P330, DOI 10.1097/SLA.0b013e3180caa466; Katara AN, 2007, SURG ENDOSC, V21, P1768, DOI 10.1007/s00464-007-9241-9; Cerfolio RJ, 2011, ANN THORAC SURG, V91, P1642, DOI 10.1016/j.athoracsur.2011.01.105; Rodriguez PM, 2008, EUR J CARDIO-THORAC, V34, P514, DOI 10.1016/j.ejcts.2008.05.036; Yano M, 2005, SURGERY, V138, P40, DOI 10.1016/j.surg.2005.03.026; Miller DL, 2009, J THORAC CARDIOV SUR, V138, P581, DOI 10.1016/j.jtcvs.2009.03.059; Li X, 2008, ANN THORAC SURG, V85, P1747, DOI 10.1016/j.athoracsur.2008.01.060; Aoki H, 2014, J ANESTH, V28, P210, DOI 10.1007/s00540-013-1692-7; Fibla Juan J, 2009, Interact Cardiovasc Thorac Surg, V9, P970, DOI 10.1510/icvts.2009.212365	18	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0959-9851	1619-1560		CLIN AUTON RES	Clin. Auton. Res.	OCT	2015	25	5					271	276		10.1007/s10286-015-0293-y		6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT8CR	WOS:000363043100001		
J	Sakai, T; Hida, K				Sakai, Tetsuya; Hida, Kumiko			In response: looking for a standardized approach in the surgical treatment of hyperhidrosis	CLINICAL AUTONOMIC RESEARCH			English	Letter									[Sakai, Tetsuya; Hida, Kumiko] Nagasaki Univ, Sch Med, Nagasaki 852, Japan	Sakai, T (reprint author), Nagasaki Univ, Sch Med, Nagasaki 852, Japan.	tscat@fb3.so-net.ne.jp					de Campos JRM, 2003, ANN THORAC SURG, V76, P886; Cerfolio RJ, 2011, ANN THORAC SURG, V91, P1642, DOI 10.1016/j.athoracsur.2011.01.105; Hida K, 2015, CLIN AUTON RES	3	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0959-9851	1619-1560		CLIN AUTON RES	Clin. Auton. Res.	OCT	2015	25	5					345	345		10.1007/s10286-015-0308-8		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT8CR	WOS:000363043100012		
J	Kurose, K; Ohue, Y; Wada, H; Iida, S; Ishida, T; Kojima, T; Doi, T; Suzuki, S; Isobe, M; Funakoshi, T; Kakimi, K; Nishikawa, H; Udono, H; Oka, M; Ueda, R; Nakayama, E				Kurose, Koji; Ohue, Yoshihiro; Wada, Hisashi; Iida, Shinsuke; Ishida, Takashi; Kojima, Takashi; Doi, Toshihiko; Suzuki, Susumu; Isobe, Midori; Funakoshi, Takeru; Kakimi, Kazuhiro; Nishikawa, Hiroyoshi; Udono, Heiichiro; Oka, Mikio; Ueda, Ryuzo; Nakayama, Eiichi			Phase Ia Study of FoxP3(+) CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients	CLINICAL CANCER RESEARCH			English	Article							T-CELL LEUKEMIA/LYMPHOMA; MONOCLONAL-ANTIBODY; LUNG-CANCER; LEUKEMIA-LYMPHOMA; TUMORS; EXPRESSION; CCR4; RESPONSES; MAB; MELANOMA	Purpose: FoxP3(+) Tregs inhibit immune responses against tumors. KW-0761 is a humanized anti-human CCR4 monoclonal antibody (mAb) that has antibody-dependent cellular cytotoxicity activity. Depletion of CCR4-expressing FoxP3(+) CD4 Tregs by KW-0761 infusion was investigated in solid cancer patients. Experimental Design: We conducted a phase Ia clinical trial of KW-0761 infusion in 7 lung and 3 esophageal cancer patients. Toxicity, clinical efficacy, changes in lymphocyte subpopulations, including Tregs, and induction of immune responses were analyzed. Results: The results showed that KW-0761 infusion in a dose range between0.1mg/kg and 1.0mg/kgwas safe andwell tolerated. Nodose-limiting toxicitywas observed. Four of 10 patients showed stable disease during treatment and were long survivors. The monitoring of FoxP3(+) Tregs in the peripheral blood mononuclear cells during treatment indicated efficient depletion of those cells, even at the lowest dose of 0.1 mg/kg used. The reduction in Th 1 CD4 T cells and CD8 T cells was limited, whereas a significant reduction was observed with Th 2 and Th 17 CD4 T cells. Immune responses to cancer/testis (CT) antigens and an autoantibody response to thyroid peroxidase were observed in some patients. Conclusions: The findings showed Tregs depletion and the possible occurrence of an immune response following KW-0761 infusion. Combined use of KW-0761 to deplete FoxP3(+) Tregs with other immunotherapies, such as cancer vaccines or checkpoint inhibitors, is a promising approach to augment immune responses. (C) 2015 AACR.	[Kurose, Koji; Ohue, Yoshihiro; Isobe, Midori; Oka, Mikio] Kawasaki Med Univ, Dept Resp Med, Kurashiki, Okayama, Japan; [Wada, Hisashi] Osaka Univ, Dept Clin Res Tumor Immunol, Grad Sch Med, Suita, Osaka, Japan; [Iida, Shinsuke; Ishida, Takashi] Nagoya City Univ, Dept Hematol & Oncol, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Kojima, Takashi; Doi, Toshihiko] Exploratory Oncol Res & Clin Trial Ctr, Kashiwa, Chiba, Japan; [Suzuki, Susumu; Ueda, Ryuzo] Aichi Med Univ, Dept Tumor Immunol, Nagakute, Aichi 48011, Japan; [Funakoshi, Takeru] Keio Univ, Sch Med, Dept Dermatol, Shinjuku Ku, Tokyo, Japan; [Kakimi, Kazuhiro] Tokyo Univ Hosp, Dept Immunotherapeut, Tokyo 113, Japan; [Nishikawa, Hiroyoshi] Osaka Univ, Immunol Frontier Res Ctr, Expt Immunol, Suita, Osaka, Japan; [Udono, Heiichiro] Okayama Univ, Dept Immunol, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama 7008530, Japan; [Nakayama, Eiichi] Kawasaki Univ Med Welf, Fac Hlth & Welf, Kurashiki, Okayama 7010193, Japan	Nakayama, E (reprint author), Kawasaki Univ Med Welf, 288 Matsushima, Kurashiki, Okayama 7010193, Japan.	uedaryu@aichi-med-u.ac.jp; nakayama@mw.kawasaki-m.ac.jp			Ministry of Health, Labour and Welfare, Japan [H24-applying-general-006]; Ministry of Education, Culture, Sports, Science and Technology of Japan; JSPS KAKENHI	This study was supported by grants-in-aid for Research on Applying Health Technology (H24-applying-general-006) from the Ministry of Health, Labour and Welfare, Japan, by a research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct), Ministry of Education, Culture, Sports, Science and Technology of Japan, and by JSPS KAKENHI.	Ishida T, 2003, CLIN CANCER RES, V9, P3625; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Onizuka S, 1999, CANCER RES, V59, P3128; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Jungbluth AA, 2001, INT J CANCER, V92, P856, DOI 10.1002/ijc.1282; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Bulliard Y, 2014, IMMUNOL CELL BIOL, V92, P475, DOI 10.1038/icb.2014.26; Vivier E, 2011, SCIENCE, V331, P44, DOI 10.1126/science.1198687; Sugiyama D, 2013, P NATL ACAD SCI USA, V110, P17945, DOI 10.1073/pnas.1316796110; Nouri-Aria KT, 2002, EUR J IMMUNOL, V32, P1933, DOI 10.1002/1521-4141(200207)32:7<1933::AID-IMMU1933>3.0.CO;2-R; Kitano S, 2014, CANCER IMMUNOL RES, V2, P812, DOI 10.1158/2326-6066.CIR-14-0013; Ishii T, 2010, CLIN CANCER RES, V16, P1520, DOI 10.1158/1078-0432.CCR-09-2697; Ishida T, 2012, J CLIN ONCOL, V30, P837, DOI 10.1200/JCO.2011.37.3472; Filipazzi P, 2007, J CLIN ONCOL, V25, P2546, DOI 10.1200/JCO.2006.08.5829; Kawabata R, 2007, INT J CANCER, V120, P2178, DOI 10.1002/ijc.22583; Nakagawa K, 2005, CLIN CANCER RES, V11, P5496, DOI 10.1158/1078-0432.CCR-05-0216; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Chen YT, 1997, P NATL ACAD SCI USA, V94, P1914, DOI 10.1073/pnas.94.5.1914; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624; Ohue Y, 2012, INT J CANCER, V131, pE649, DOI 10.1002/ijc.27359; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Kakimi K, 2011, INT J CANCER, V129, P2836, DOI 10.1002/ijc.25955; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Yoshie O, 2002, BLOOD, V99, P1505, DOI 10.1182/blood.V99.5.1505; Ko K, 2005, J EXP MED, V202, P885, DOI 10.1084/jem.20050940; Yamamoto K, 2010, J CLIN ONCOL, V28, P1591, DOI 10.1200/JCO.2009.25.3575; Ishida T, 2013, CANCER SCI, V104, P647, DOI 10.1111/cas.12116; Funt SA, 2014, ONCOLOGY WILLISTON P, P28; Isobe Midori, 2009, Cancer Immun, V9, P8; Kurose K, 2015, J THORAC ONCOL, V10, P74, DOI 10.1097/JTO.0000000000000364; Ohue Y, 2014, CLIN CANCER RES, V20, P5052, DOI 10.1158/1078-0432.CCR-14-0742; Sato Shuichiro, 2007, Cancer Immun, V7, P5; Uenaka Akiko, 2007, Cancer Immun, V7, P9	36	1	1	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1078-0432	1557-3265		CLIN CANCER RES	Clin. Cancer Res.	OCT 1	2015	21	19					4327	4336		10.1158/1078-0432.CCR-15-0357		10	Oncology	Oncology	CU2CQ	WOS:000363330500014		
J	Komatsu, M; Wheeler, HE; Chung, SY; Low, SK; Wing, C; Delaney, SM; Gorsic, LK; Takahashi, A; Kubo, M; Kroetz, DL; Zhang, W; Nakamura, Y; Dolan, ME				Komatsu, Masaaki; Wheeler, Heather E.; Chung, Suyoun; Low, Siew-Kee; Wing, Claudia; Delaney, Shannon M.; Gorsic, Lidija K.; Takahashi, Atsushi; Kubo, Michiaki; Kroetz, Deanna L.; Zhang, Wei; Nakamura, Yusuke; Dolan, M. Eileen			Pharmacoethnicity in Paclitaxel-Induced Sensory Peripheral Neuropathy	CLINICAL CANCER RESEARCH			English	Article							GENOME-WIDE ASSOCIATION; METASTATIC BREAST-CANCER; GENETIC-VARIANTS; CLINICAL-TRIAL; WHOLE-GENOME; CELL-LINE; CHEMOTHERAPY; PROTEIN; POPULATION; EXPRESSION	Purpose: Paclitaxel is used worldwide in the treatment of breast, lung, ovarian, and other cancers. Sensory peripheral neuropathy is an associated adverse effect that cannot be predicted, prevented, or mitigated. To better understand the contribution of germline genetic variation to paclitaxel-induced peripheral neuropathy, we undertook an integrative approach that combines genome-wide association study (GWAS) data generated from HapMap lymphoblastoid cell lines (LCL) and Asian patients. Methods: GWAS was performed with paclitaxel-induced cytotoxicity generated in 363 LCLs and with paclitaxel-induced neuropathy from 145 Asian patients. A gene-based approach was used to identify overlapping genes and compare with a European clinical cohort of paclitaxel-induced neuropathy. Neurons derived from human-induced pluripotent stem cells were used for functional validation of candidate genes. Results: SNPs near AIPL1 were significantly associated with paclitaxel-induced cytotoxicity in Asian LCLs (P < 10(-6)). Decreased expression of AIPL1 resulted in decreased sensitivity of neurons to paclitaxel by inducing neurite morphologic changes as measured by increased relative total outgrowth, number of processes and mean process length. Using a gene-based analysis, there were 32 genes that overlapped between Asian LCL cytotoxicity and Asian patient neuropathy (P < 0.05), including BCR. Upon BCR knockdown, there was an increase in neuronal sensitivity to paclitaxel as measured by neurite morphologic characteristics. Conclusions: We identified genetic variants associated with Asian paclitaxel-induced cytotoxicity and functionally validated the AIPL1 and BCR in a neuronal cell model. Furthermore, the integrative pharmacogenomics approach of LCL/patient GWAS may help prioritize target genes associated with chemotherapeutic-induced peripheral neuropathy. (C) 2015 AACR.	[Komatsu, Masaaki; Wheeler, Heather E.; Chung, Suyoun; Wing, Claudia; Delaney, Shannon M.; Gorsic, Lidija K.; Nakamura, Yusuke; Dolan, M. Eileen] Univ Chicago, Sect Hematol Oncol, Dept Med, Chicago, IL 60637 USA; [Chung, Suyoun] Natl Canc Ctr, Res Inst, Div Canc Dev Syst, Tokyo 104, Japan; [Low, Siew-Kee] RIKEN Ctr Integrat Med Sci, Lab Stat Anal, Core Genom Med, Yokohama, Kanagawa, Japan; [Low, Siew-Kee; Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Mol Med, Tokyo, Japan; [Kubo, Michiaki] RIKEN Ctr Integrat Med Sci, Lab Genotyping Dev, Core Genom Med, Yokohama, Kanagawa, Japan; [Kroetz, Deanna L.] Univ Calif San Francisco, Sch Pharm & Med, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Zhang, Wei] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA	Dolan, ME (reprint author), Univ Chicago, 900 East 57th St,Room 7100, Chicago, IL 60637 USA.	edolan@medicine.bsd.uchicago.edu			NIH/NIGMS Pharmacogenomics of Anticancer Agents Research Grant [U01GM61393]; NIH/NCI National Research Service Award [F32CA165823]; University of Chicago Breast Cancer SPORE Grant [NCI P50 CA125183]; NIH/NCI [R01 CA136765]; NIH/NIGMS Pharmacogenomics of Membrane Transporters [U01GM61390]; Japanese Ministry of Education, Culture, Sports, Science and Technology	This work is supported by the NIH/NIGMS Pharmacogenomics of Anticancer Agents Research Grant U01GM61393 (to M.E. Dolan), NIH/NCI National Research Service Award F32CA165823 (to H.E. Wheeler), University of Chicago Breast Cancer SPORE Grant NCI P50 CA125183 (to M.E. Dolan), NIH/NCI R01 CA136765 (to M.E. Dolan), and NIH/NIGMS Pharmacogenomics of Membrane Transporters grant U01GM61390. The Biobank Japan Project is funded by the Japanese Ministry of Education, Culture, Sports, Science and Technology. This work is part of the NIH Pharmacogenomics Research Network-RIKEN Center for Genomic Medicine Global Alliance.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Low SK, 2014, CLIN CANCER RES, V20, P2541, DOI 10.1158/1078-0432.CCR-13-2755; Huang RS, 2007, MOL CANCER THER, V6, P31, DOI 10.1158/1535-7163.MCT-06-0591; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310; Cox NJ, 2012, CLIN PHARMACOL THER, V92, P425, DOI 10.1038/clpt.2012.115; Kirschman LT, 2010, HUM MOL GENET, V19, P1076, DOI 10.1093/hmg/ddp571; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; LaPointe NE, 2013, NEUROTOXICOLOGY, V37, P231, DOI 10.1016/j.neuro.2013.05.008; Hershman DL, 2014, J CLIN ONCOL, V32, P1941, DOI 10.1200/JCO.2013.54.0914; Smith EML, 2013, JAMA-J AM MED ASSOC, V309, P1359, DOI 10.1001/jama.2013.2813; Loprinzi CL, 2011, J CLIN ONCOL, V29, P1472, DOI 10.1200/JCO.2010.33.0308; Pachman DR, 2011, CLIN PHARMACOL THER, V90, P377, DOI 10.1038/clpt.2011.115; Gamazon ER, 2010, BIOINFORMATICS, V26, P259, DOI 10.1093/bioinformatics/btp644; Oh D, 2010, J NEUROSCI, V30, P14134, DOI 10.1523/JNEUROSCI.1711-10.2010; Zhang W, 2008, AM J HUM GENET, V82, P631, DOI 10.1016/j.ajhg.2007.12.015; Wheeler HE, 2014, PHARMACOGENET GENOM, V24, P231, DOI 10.1097/FPC.0000000000000037; Wheeler HE, 2013, NAT REV GENET, V14, P23, DOI 10.1038/nrg3352; Pastinen T, 2005, HUM MOL GENET, V14, P3963, DOI 10.1093/hmg/ddi420; Njiaju UO, 2012, PHARMACOGENET GENOM, V22, P498, DOI 10.1097/FPC.0b013e328352f436; Duno M, 2013, GENE, V515, P372, DOI 10.1016/j.gene.2012.12.066; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Cavaletti G, 2011, LANCET ONCOL, V12, P1151, DOI 10.1016/S1470-2045(11)70131-0; Gamazon ER, 2010, P NATL ACAD SCI USA, V107, P9287, DOI 10.1073/pnas.1001827107; Huang RS, 2011, RNA BIOL, V8, P692, DOI 10.4161/rna.8.4.16029; Pulido R, 2013, HUM MOL GENET, V22, pR66, DOI 10.1093/hmg/ddt347; Moen EL, 2013, GENETICS, V194, P987, DOI 10.1534/genetics.113.151381; Hause RJ, 2014, AM J HUM GENET, V95, P194, DOI 10.1016/j.ajhg.2014.07.005; Park AR, 2012, J CELL SCI, V125, P4518, DOI 10.1242/jcs.105502; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Low SK, 2013, CANCER SCI, V104, P1074, DOI 10.1111/cas.12186; Jones SE, 2005, J CLIN ONCOL, V23, P5542, DOI 10.1200/JCO.2005.02.027; Wheeler HE, 2013, CLIN CANCER RES, V19, P491, DOI 10.1158/1078-0432.CCR-12-2618; Duan S, 2008, AM J HUM GENET, V82, P1101, DOI 10.1016/j.ajhg.2008.03.006; Zhan R, 2013, J NEUROSCI RES, V91, P335, DOI 10.1002/jnr.23162; Leandro-Garcia LJ, 2013, J MED GENET, V50, P599, DOI 10.1136/jmedgenet-2012-101466; Baldwin RM, 2012, CLIN CANCER RES, V18, P5099, DOI 10.1158/1078-0432.CCR-12-1590; Hartford CM, 2009, BLOOD, V113, P2145, DOI 10.1182/blood-2008-05-154302; Winer EP, 2004, J CLIN ONCOL, V22, P2061, DOI 10.1200/JCO.2004.08.048; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; O'Donnell PH, 2009, CLIN CANCER RES, V15, P4806, DOI 10.1158/1078-0432.CCR-09-0344; Crown J, 2000, LANCET, V355, P1176, DOI 10.1016/S0140-6736(00)02074-2; Laurent CE, 2004, EXP CELL RES, V299, P188, DOI 10.1016/j.yexcr.2004.05.010; Kaartinen V, 2002, DEV DYNAM, V223, P517, DOI 10.1002/dvdy.10071; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Diouf B, 2015, JAMA-J AM MED ASSOC, V313, P815, DOI 10.1001/jama.2015.0894; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; He X, 2013, AM J HUM GENET, V92, P667, DOI 10.1016/j.ajhg.2013.03.022; Huang PT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116372; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Niemi NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053803; Rivera E, 2015, CANCER CHEMOTH PHARM, V75, P659, DOI 10.1007/s00280-014-2607-5; Schneider BP, 2011, J CLIN ONCOL, V29; Stark AL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004192; Tan MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032330; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Wheeler HE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118020	56	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1078-0432	1557-3265		CLIN CANCER RES	Clin. Cancer Res.	OCT 1	2015	21	19					4337	4346		10.1158/1078-0432.CCR-15-0133		10	Oncology	Oncology	CU2CQ	WOS:000363330500015		
J	Lee, J; Condello, S; Yakubov, B; Emerson, R; Caperell-Grant, A; Hitomi, K; Xie, JW; Matei, D				Lee, Jiyoon; Condello, Salvatore; Yakubov, Bakhtiyor; Emerson, Robert; Caperell-Grant, Andrea; Hitomi, Kiyotaka; Xie, Jingwu; Matei, Daniela			Tissue Transglutaminase Mediated Tumor-Stroma Interaction Promotes Pancreatic Cancer Progression	CLINICAL CANCER RESEARCH			English	Article							DUCTAL ADENOCARCINOMA; OVARIAN-CANCER; EXTRACELLULAR-MATRIX; SUBSTRATE PEPTIDE; BREAST-CANCER; TGF-BETA; CELL; ACTIVATION; RESISTANCE; INHIBITION	Purpose: Aggressive pancreatic cancer is commonly associated with a dense desmoplastic stroma, which forms a protective niche for cancer cells. The objective of the study was to determine the functions of tissue transglutaminase (TG2), a Ca2+-dependent enzyme that cross-links proteins through transamidation and is abundantly expressed by pancreatic cancer cells in the pancreatic stroma. Experimental Design: Orthotopic pancreatic xenografts and coculture systems tested the mechanisms by which the enzyme modulates tumor-stroma interactions. Results: We show that TG2 secreted by cancer cells effectively molds the stroma by cross-linking collagen, which, in turn, activates fibroblasts and stimulates their proliferation. The stiff fibrotic stromal reaction conveys mechanical cues to cancer cells, leading to activation of the YAP/TAZ transcription factors, promoting cell proliferation and tumor growth. Stable knockdown of TG2 in pancreatic cancer cells leads to decreased size of pancreatic xenografts. Conclusions: Taken together, our results demonstrate that TG2 secreted in the tumor microenvironment orchestrates the crosstalk between cancer cells and stroma fundamentally affecting tumor growth. Our study supports TG2 inhibition in the pancreatic stroma as a novel strategy to block pancreatic cancer progression. (C) 2015 AACR.	[Lee, Jiyoon; Xie, Jingwu; Matei, Daniela] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Condello, Salvatore; Yakubov, Bakhtiyor; Caperell-Grant, Andrea; Matei, Daniela] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Emerson, Robert] Indiana Univ Sch Med, Dept Pathol, Indianapolis, IN 46202 USA; [Hitomi, Kiyotaka] Nagoya Univ, Grad Sch Pharmaceut Sci, Dept Basic Med Sci, Nagoya, Aichi 4648601, Japan; [Xie, Jingwu] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Xie, Jingwu; Matei, Daniela] Indiana Univ Melvin & Bren Simon Canc Ctr, Indianapolis, IN USA; [Matei, Daniela] Indiana Univ Sch Med, Dept Obstet & Gynecol, Indianapolis, IN 46202 USA; [Matei, Daniela] Richard L Roudebush VA Med Ctr, Indianapolis, IN USA	Matei, D (reprint author), Indiana Univ Sch Med, Joseph E Walther Hall,Room C218D,980 W Walnut St, Indianapolis, IN 46202 USA.	dmatei@iu.edu			National Cancer Institute [CA152502]; Project Development Team within the ICTSI NIH/NCRR [UL1TR001108]; IUPUI Signature Center Initiative	This work was made possible by funding from the National Cancer Institute (Award CA152502), a Project Development Team within the ICTSI NIH/NCRR (Grant Number UL1TR001108), and the IUPUI Signature Center Initiative.	Filiano AJ, 2008, FASEB J, V22, P2662, DOI 10.1096/fj.07-097709; Muerkoster SS, 2008, INT J CANCER, V123, P1751, DOI 10.1002/ijc.23703; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Adler JJ, 2013, P NATL ACAD SCI USA, V110, P17368, DOI 10.1073/pnas.1308236110; Collighan RJ, 2009, AMINO ACIDS, V36, P659, DOI 10.1007/s00726-008-0190-y; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Verderio EAM, 2004, AMINO ACIDS, V26, P387, DOI 10.1007/s00726-004-0094-4; Garrido-Laguna I, 2011, CLIN CANCER RES, V17, P5793, DOI 10.1158/1078-0432.CCR-11-0341; Mehta K, 2004, CLIN CANCER RES, V10, P8068, DOI 10.1158/1078-0432.CCR-04-1107; Belkin AM, 2011, FEBS J, V278, P4704, DOI 10.1111/j.1742-4658.2011.08346.x; Olsen KC, 2014, AM J RESP CELL MOL, V50, P737, DOI 10.1165/rcmb.2013-0092OC; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Swartz MA, 2012, CANCER RES, V72, P2473, DOI 10.1158/0008-5472.CAN-12-0122; Faye C, 2010, BIOCHEM J, V427, P467, DOI 10.1042/BJ20091594; Alvarez R, 2013, BRIT J CANCER, V109, P926, DOI 10.1038/bjc.2013.415; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; Verma A, 2006, CANCER RES, V66, P10525, DOI 10.1158/0008-5472.CAN-06-2387; Fukui M, 2013, FEBS J, V280, P1420, DOI 10.1111/febs.12133; Cao L, 2012, ONCOGENE, V31, P2521, DOI 10.1038/onc.2011.429; Jin X, 2011, J BIOL CHEM, V286, P37866, DOI 10.1074/jbc.M111.287490; Johnson KB, 2012, AM J PHYSIOL-HEART C, V302, pH1355, DOI 10.1152/ajpheart.00918.2011; Cheung W, 2008, PANCREATOLOGY, V8, P608, DOI 10.1159/000161012; Shweke N, 2008, AM J PATHOL, V173, P631, DOI 10.2353/ajpath.2008.080025; Olsen KC, 2011, AM J RESP CRIT CARE, V184, P699, DOI 10.1164/rccm.201101-0013OC; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Verma A, 2008, CLIN CANCER RES, V14, P1997, DOI 10.1158/1078-0432.CCR-07-1533; Condello S, 2015, ONCOGENE, V34, P2297, DOI 10.1038/onc.2014.178; Yakubov B, 2013, NEOPLASIA, V15, P609, DOI 10.1593/neo.121878; Shao MH, 2009, CANCER RES, V69, P9192, DOI 10.1158/0008-5472.CAN-09-1257; Willett CG, 2005, J CLIN ONCOL, V23, P4538, DOI 10.1200/JCO.2005.23.911; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; Gore J, 2014, CANCER CELL, V25, P711, DOI 10.1016/j.ccr.2014.05.026; Verma A, 2008, CLIN CANCER RES, V14, P2476, DOI 10.1158/1078-0432.CCR-07-4529; Miyamoto H, 2004, PANCREAS, V28, P38, DOI 10.1097/00006676-200401000-00006; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; Chau DYS, 2005, BIOMATERIALS, V26, P6518, DOI 10.1016/j.biomaterials.2005.04.017; Muerkoster S, 2004, CANCER RES, V64, P1331, DOI 10.1158/0008-5472.CAN-03-1860; Yamane A, 2010, FEBS J, V277, P3564, DOI 10.1111/j.1742-4658.2010.07765.x; Koay EJ, 2014, J CLIN INVEST, V124, P1525, DOI 10.1172/JCI73455; Erkan M, 2013, J PATHOL, V231, P4, DOI 10.1002/path.4213; Koay EJ, 2014, PHYS BIOL, V11, DOI 10.1088/1478-3975/11/6/065002; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Rich Lillian, 2005, Brazilian Journal of Morphological Sciences, V22, P97; Satpathy Minati, 2007, Cancer Res, V67, P7194, DOI 10.1158/0008-5472.CAN-07-0307; Shannon HE FM, 2015, PANCREAS, V44, P64; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Zhang WY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005049	50	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1078-0432	1557-3265		CLIN CANCER RES	Clin. Cancer Res.	OCT 1	2015	21	19					4482	4493		10.1158/1078-0432.CCR-15-0226		12	Oncology	Oncology	CU2CQ	WOS:000363330500030		
J	Umakoshi, H; Tanase-Nakao, K; Wada, N; Ichijo, T; Sone, M; Inagaki, N; Katabami, T; Kamemura, K; Matsuda, Y; Fujii, Y; Kai, T; Fukuoka, T; Sakamoto, R; Ogo, A; Suzuki, T; Tsuiki, M; Shimatsu, A; Naruse, M				Umakoshi, Hironobu; Tanase-Nakao, Kanako; Wada, Norio; Ichijo, Takamasa; Sone, Masakatsu; Inagaki, Nobuya; Katabami, Takuyuki; Kamemura, Kohei; Matsuda, Yuichi; Fujii, Yuichi; Kai, Tatsuya; Fukuoka, Tomikazu; Sakamoto, Ryuichi; Ogo, Atsushi; Suzuki, Tomoko; Tsuiki, Mika; Shimatsu, Akira; Naruse, Mitsuhide			Importance of contralateral aldosterone suppression during adrenal vein sampling in the subtype evaluation of primary aldosteronism	CLINICAL ENDOCRINOLOGY			English	Article							COMPUTED-TOMOGRAPHY; DIAGNOSIS; HYPERTENSION; EXPERIENCE	Objectives Adrenal vein sampling (AVS) is the standard criterion for the subtype diagnosis in primary aldosteronism (PA). Although lateralized index (LI) >= 4 after cosyntropin stimulation is the commonly recommended cut-off for unilateral aldosterone hypersecretion, many of the referral centres in the world use LI cut-off of <4 without sufficient evidence for its diagnostic accuracy. Aim The aim of the study was to establish the diagnostic significance of contralateral (CL) aldosterone suppression for the subtype diagnosis in patients with LI <4 in AVS. Design and patients A retrospective multicentre study was conducted in Japan. Of 124 PA patients subjected to unilateral adrenalectomy after successful AVS with cosyntropin administration, 29 patients with LI < 4 were included in the study. The patients were divided into Group A with CL suppression (n = 16) and Group B (n = 13) without CL suppression. Three outcome indices were assessed after 6 months postoperatively: normalization/significant improvement of hypertension, normalization of the aldosterone to renin ratio (ARR) and normalization of hypokalaemia. Results The normalization/significant improvement of hypertension was 81% in Group A and 54% in Group B (P = 0.2). The normalization of ARR was 100% in Group A and 46% in Group B (P = 0.004). Hypokalaemia was normalized in all patients of both groups. The overall cure rate of PA based on meeting all the three criteria was 81% in Group A and 31% in Group B (P = 0.01). Conclusions In patients with PA, where the LI is < 4 on AVS, CL suppression of aldosterone is an accurate predictor of a unilateral source of aldosterone excess. CL suppression data should be interpreted in conjunction with computed tomographic adrenal imaging findings to guide surgical management.	[Umakoshi, Hironobu; Tanase-Nakao, Kanako; Tsuiki, Mika; Shimatsu, Akira; Naruse, Mitsuhide] Natl Hosp Org Kyoto, Med Ctr, Dept Endocrinol Metab & Hypertens, Kyoto 6128555, Japan; [Wada, Norio] Sapporo City Hosp, Dept Endocrinol & Diabet, Sapporo, Hokkaido, Japan; [Ichijo, Takamasa] Saiseikai Yokohama City Toubu Hosp, Dept Endocrinol & Diabet, Yokohama, Kanagawa, Japan; [Sone, Masakatsu; Inagaki, Nobuya] Kyoto Univ, Grad Sch Med, Dept Diabet Endocrinol & Nutr, Kyoto, Japan; [Katabami, Takuyuki] St Marianna Univ, Sch Med, Yokohama City Seibu Hosp, Dept Endocrinol & Metab, Yokohama, Kanagawa, Japan; [Kamemura, Kohei] Akashi Med Ctr, Dept Cardiol, Akashi, Hyogo, Japan; [Matsuda, Yuichi] Sanda City Hosp, Dept Cardiol, Sanda, Hyogo, Japan; [Fujii, Yuichi] West Japan Railway Co, Hiroshima Gen Hosp, Dept Cardiol, Hiroshima, Japan; [Kai, Tatsuya] Saiseikai Tondabayashi Hosp, Dept Cardiol, Tondabayashi, Japan; [Fukuoka, Tomikazu] Matsuyama Red Cross Hosp, Dept Internal Med, Matsuyama, Ehime, Japan; [Sakamoto, Ryuichi; Ogo, Atsushi] Natl Hosp Org Kyushu, Med Ctr, Dept Endocrinol & Metab, Fukuoka, Japan; [Suzuki, Tomoko] Kitasato Univ, Sch Med, Dept Publ Hlth, Tokyo, Japan	Naruse, M (reprint author), Natl Hosp Org Kyoto, Med Ctr, Dept Endocrinol Metab & Hypertens, Fushimi Ku, 1-1 Mukaihata Cho, Kyoto 6128555, Japan.	mnaruse@kyotolan.hosp.go.jp			National Hospital Organization; Ministry of Health, Labor and Welfare, Japan	This study was supported in part by grants-in-aid for the study of primary aldosteronism from the National Hospital Organization and for the study of adrenal hormone disorders from the Ministry of Health, Labor and Welfare, Japan.	Rossi GP, 2008, HYPERTENSION, V51, P1366, DOI 10.1161/HYPERTENSIONAHA.108.111369; Rossi GP, 2006, J AM COLL CARDIOL, V48, P2293, DOI 10.1016/j.jacc.2006.07.059; Rossi GP, 2012, J CLIN ENDOCR METAB, V97, P1606, DOI 10.1210/jc.2011-2830; Kempers MJE, 2009, ANN INTERN MED, V151, P329; Magill SB, 2001, J CLIN ENDOCR METAB, V86, P1066, DOI 10.1210/jc.86.3.1066; Rossi GP, 2014, HYPERTENSION, V63, P151, DOI 10.1161/HYPERTENSIONAHA.113.02097; Auchus RJ, 2010, HORM METAB RES, V42, P411, DOI 10.1055/s-0030-1252060; Zarnegar R, 2008, ANN SURG, V247, P511, DOI 10.1097/SLA.0b013e318165c075; Stowasser M, 2001, J RENIN-ANGIO-ALDO S, V2, P156, DOI 10.3317/jraas.2001.022; Espiner EA, 2003, J CLIN ENDOCR METAB, V88, P3637, DOI 10.1210/jc.2002-022051; Wolley M, 2013, J HYPERTENS, V31, P2005, DOI 10.1097/HJH.0b013e328362add3; Rossi GP, 2001, J CLIN ENDOCR METAB, V86, P1083, DOI 10.1210/jc.86.3.1083; Young WF, 2004, SURGERY, V136, P1227, DOI 10.1016/j.surg.2004.06.051; Steichen O, 2012, HORM METAB RES, V44, P221, DOI 10.1055/s-0031-1299681; Funder JW, 2008, J CLIN ENDOCR METAB, V93, P3266, DOI 10.1210/jc.2008-0104; Waldmann J, 2011, WORLD J SURG, V35, P2422, DOI 10.1007/s00268-011-1221-5; Monticone S, 2014, J CLIN ENDOCR METAB, V99, P4158, DOI 10.1210/jc.2014-2345; Lim V, 2014, J CLIN ENDOCR METAB, V99, P2712, DOI 10.1210/jc.2013-4146; Miotto D, 2009, HYPERTENSION, V54, P885, DOI 10.1161/HYPERTENSIONAHA.109.134759; Sukor N, 2009, J CLIN ENDOCR METAB, V94, P2437, DOI 10.1210/jc.2008-2803; DOPPMAN JL, 1992, RADIOLOGY, V184, P677; Nishikawa T, 2011, ENDOCR J, V58, P711; Haase M, 2014, J CLIN ENDOCR METAB, V99, P4397, DOI 10.1210/jc.2014-2788; Monticone S., 2014, LANCET DIABETEENDO, V3, P296; Mulatero P, 2004, J CLIN ENDOCR METAB, V89, P1045, DOI 10.1210/jc.2003-031337; Shimamoto Kazuaki, 2014, Hypertens Res, V37, P253, DOI 10.1038/hr.2014.20	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0300-0664	1365-2265		CLIN ENDOCRINOL	Clin. Endocrinol.	OCT	2015	83	4					462	467		10.1111/cen.12761		6	Endocrinology & Metabolism	Endocrinology & Metabolism	CT8BJ	WOS:000363039700004		
J	Tanoshima, M; Kobayashi, T; Tanoshima, R; Beyene, J; Koren, G; Ito, S				Tanoshima, M.; Kobayashi, T.; Tanoshima, R.; Beyene, J.; Koren, G.; Ito, S.			Risks of Congenital Malformations in Offspring Exposed to Valproic Acid In Utero: A Systematic Review and Cumulative Meta-analysis	CLINICAL PHARMACOLOGY & THERAPEUTICS			English	Article							ANTIEPILEPTIC DRUGS; MAJOR MALFORMATIONS; PREGNANCY REGISTRY; UK-EPILEPSY; WOMEN; FETAL; LAMOTRIGINE; INFANTS	Despite extensive research efforts over decades, the teratogenic profile of valproic acid (VPA) remains obscure. We performed cumulative and conventional meta-analyses of cohort studies to determine the time profiles of signal emergence of VPA-associated congenital malformations (CMs) and to define risk estimates of each of the CMs. Fifty-nine studies were identified and analyzed. We found that the significant risk signals began to emerge over the last 10-20 years even before large-scale studies were performed: neural tube defect (the significant risk signal emerged in 1992); genitourinary and musculoskeletal anomalies (2004); cleft lip and/or palate (2005); and congenital heart defects (2006). At present, the risks of VPA-associated CMs are 2-7-fold higher than other common antiepileptic drugs. VPA should not be used as a first-line therapy in women of childbearing age unless it is the only option for the patient.	[Tanoshima, M.; Kobayashi, T.; Tanoshima, R.; Koren, G.; Ito, S.] Univ Toronto, Hosp Sick Children, Div Clin Pharmacol & Toxicol, Toronto, ON M5G 1X8, Canada; [Tanoshima, M.] Yokohama City Univ Med, Dept Obstet & Gynecol, Yokohama, Kanagawa, Japan; [Kobayashi, T.] Natl Ctr Child Hlth & Dev, Ctr Clin Res & Dev, Dept Dev Strategy, Yokohama, Kanagawa, Japan; [Tanoshima, R.] Yokohama City Univ Med, Dept Pediat, Yokohama, Kanagawa, Japan; [Beyene, J.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada	Ito, S (reprint author), Univ Toronto, Hosp Sick Children, Div Clin Pharmacol & Toxicol, Toronto, ON M5G 1X8, Canada.	shinya.ito@sickkids.ca			Japan Society of Clinical Pharmacology and Therapeutics; Joseph M. West Family Memorial Fund from the Post Graduate Medical Education at University of Toronto, Toronto, Canada	T.K. was financially supported by the Japan Society of Clinical Pharmacology and Therapeutics. R.T. was financially supported by the Joseph M. West Family Memorial Fund from the Post Graduate Medical Education at University of Toronto, Toronto, Canada during the period of this study. The authors do not have any competing interest to disclose.	Wyszynski DF, 2005, NEUROLOGY, V64, P961; Artama M, 2005, NEUROLOGY, V64, P1874, DOI 10.1212/01.WNL.0000163771.96962.1F; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Meador K, 2008, EPILEPSY RES, V81, P1, DOI 10.1016/j.eplepsyres.2008.04.022; Samren EB, 1997, EPILEPSIA, V38, P981, DOI 10.1111/j.1528-1157.1997.tb01480.x; Hernandez-Diaz S, 2012, NEUROLOGY, V78, P1692, DOI 10.1212/WNL.0b013e3182574f39; Koren G, 2006, CAN FAM PHYSICIAN, V52, P441; Tomson T, 2011, LANCET NEUROL, V10, P609, DOI 10.1016/S1474-4422(11)70107-7; Vajda FJE, 2007, J CLIN NEUROSCI, V14, P611, DOI 10.1016/j.jocn.2006.04.025; Viinikainen K, 2006, EPILEPSIA, V47, P186, DOI 10.1111/j.1528-1167.2006.00386.x; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Thomas SV, 2008, PEDIATR CARDIOL, V29, P604, DOI 10.1007/s00246-007-9161-4; Kaaja E, 2003, NEUROLOGY, V60, P575; Etwel F, 2014, ANNU REV PHARMACOL, V54, P295, DOI 10.1146/annurev-pharmtox-011613-135930; Vajda FJE, 2007, AUST NZ J OBSTET GYN, V47, P468, DOI 10.1111/j.1479-828X.2007.00781.x; Cunnington MC, 2011, NEUROLOGY, V76, P1817, DOI 10.1212/WNL.0b013e31821ccd18; Vajda FJE, 2012, AUST NZ J OBSTET GYN, V52, P49, DOI 10.1111/j.1479-828X.2011.01359.x; Vajda FJE, 2006, EUR J NEUROL, V13, P645, DOI 10.1111/j.1468-1331.2006.01359.x; Wide K, 2004, ACTA PAEDIATR, V93, P174, DOI 10.1080/08035250310021118; Vajda FJE, 2010, SEIZURE-EUR J EPILEP, V19, P558, DOI 10.1016/j.seizure.2010.07.019; Vajda FJE, 2012, J CLIN NEUROSCI, V19, P57, DOI 10.1016/j.jocn.2011.08.003; Morrow JI, 2009, J NEUROL NEUROSUR PS, V80, P506, DOI 10.1136/jnnp.2008.156109; Campbell E, 2014, J NEUROL NEUROSUR PS, V85, P1029, DOI 10.1136/jnnp-2013-306318; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kochen S., 2012, OPEN NEUROL J, V5, P63; Koren G, 2006, CAN FAM PHYSICIAN, V52, P447; Koren G, 2006, CAN FAM PHYSICIAN, V52, P444; Martinez Ferri. M., 2009, NEUROLOGIA, V24, P360; Moher D, 2009, BMJ-BRIT MED J, V339, P332, DOI DOI 10.1136/BMJ.B2535; Morrow J, 2006, J NEUROL NEUROSUR PS, V77, P193, DOI 10.1136/jnnp.2005.074203; Veiby G, 2014, J NEUROL, V261, P579, DOI 10.1007/s00415-013-7239-x; Wells G, NEWCASTLE OTTAWA SCA	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9236	1532-6535		CLIN PHARMACOL THER	Clin. Pharmacol. Ther.	OCT	2015	98	4					417	441		10.1002/cpt.158		25	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CU3DW	WOS:000363405200025		
J	Tokuyoshi, Y				Tokuyoshi, Yusuke			Virtual Spherical Gaussian Lights for Real-time Glossy Indirect Illumination	COMPUTER GRAPHICS FORUM			English	Article							IMPERFECT SHADOW MAPS; GLOBAL ILLUMINATION	Virtual point lights (VPLs) are well established for real-time global illumination. However, this method suffers from spiky artifacts and flickering caused by singularities of VPLs, highly glossy materials, high-frequency textures, and discontinuous geometries. To avoid these artifacts, this paper introduces a virtual spherical Gaussian light (VSGL) which roughly represents a set of VPLs. For a VSGL, the total radiant intensity and positional distribution of VPLs are approximated using spherical Gaussians and a Gaussian distribution, respectively. Since this approximation can be computed using summations of VPL parameters, VSGLs can be dynamically generated using mipmapped reflective shadow maps. Our VSGL generation is simple and independent from any scene geometries. In addition, reflected radiance for a VSGL is calculated using an analytic formula. Hence, we are able to render one-bounce glossy interreflections at real-time frame rates with smaller artifacts.	Sq Enix Co Ltd, Tokyo, Japan	Tokuyoshi, Y (reprint author), Sq Enix Co Ltd, Tokyo, Japan.	tokuyosh@square-enix.com					Banerjee A, 2005, J MACH LEARN RES, V6, P1345; Iwasaki K, 2014, COMPUT GRAPH FORUM, V33, P333, DOI 10.1111/cgf.12302; Simon F, 2015, COMPUT GRAPH FORUM, V34, P575, DOI 10.1111/cgf.12585; Yan LQ, 2012, COMPUT GRAPH FORUM, V31, P2267, DOI 10.1111/j.1467-8659.2012.03220.x; Laurijssen J, 2010, COMPUT GRAPH FORUM, V29, P1305, DOI 10.1111/j.1467-8659.2010.01726.x; Ritschel T, 2011, COMPUT GRAPH FORUM, V30, P2258, DOI 10.1111/j.1467-8659.2011.01998.x; Tsai YT, 2006, ACM T GRAPHIC, V25, P967, DOI 10.1145/1141911.1141981; Crassin C, 2011, COMPUT GRAPH FORUM, V30, P1921, DOI 10.1111/j.1467-8659.2011.02063.x; Ritschel T, 2012, COMPUT GRAPH FORUM, V31, P160, DOI 10.1111/j.1467-8659.2012.02093.x; Clarberg P, 2005, ACM T GRAPHIC, V24, P1166, DOI 10.1145/1073204.1073328; Barak T, 2013, COMPUT GRAPH FORUM, V32, P87, DOI 10.1111/cgf.12154; Dachsbacher C., 2006, I3D 06, P93; Dachsbacher C., 2005, I3D 05, P203; Dachsbacher C, 2014, COMPUT GRAPH FORUM, V33, P88, DOI 10.1111/cgf.12256; Dong Z., 2009, VISION MODELING VISU, P187; Haan M., 2009, ACM T GRAPHIC, V28, P5; Iwasaki K., 2012, ACM T GRAPHIC, V31; Kajiya J. T., 1986, ACM SIGGRAPH COMPUTE, V20, P143, DOI 10.1145/15886.15902; Keller A., 1997, P SIGGRAPH, V31, P49; Kivanek J., 2008, COMPUT GRAPH FORUM, V27, P1147; Kivanek J., 2010, ACM T GRAPHIC, V29; Luksch C., 2013, I3D 13, P87; Prutkin R., 2012, EUR, P9; Ritschel T., 2008, ACM T GRAPHIC, V27; Toksvig M., 2005, Journal of Graphics Tools, V10; Wald I., 2002, EGRW 02 P 13 EUR WOR, P15; Walter B., 2007, EGSR 07, V07, P195; Walter B, 2005, ACM T GRAPHIC, V24, P1098, DOI 10.1145/1073204.1073318; Wang J., 2009, ACM T GRAPHIC, V28; XU K., 2011, ACM T GRAPHIC, V30, P173; Xu K., 2013, ACM T GRAPHIC, V32; Xu K., 2014, ACM T GRAPHIC, V33	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0167-7055	1467-8659		COMPUT GRAPH FORUM	Comput. Graph. Forum	OCT	2015	34	7					89	98		10.1111/cgf.12748		10	Computer Science, Software Engineering	Computer Science	CU0OJ	WOS:000363216500009		
J	Iwamoto, N; Shum, HPH; Yang, LZ; Morishima, S				Iwamoto, Naoya; Shum, Hubert P. H.; Yang, Longzhi; Morishima, Shigeo			Multi-layer Lattice Model for Real-Time Dynamic Character Deformation	COMPUTER GRAPHICS FORUM			English	Article							ANIMATION; DRIVEN	Due to the recent advancement of computer graphics hardware and software algorithms, deformable characters have become more and more popular in real-time applications such as computer games. While there are mature techniques to generate primary deformation from skeletal movement, simulating realistic and stable secondary deformation such as jiggling of fats remains challenging. On one hand, traditional volumetric approaches such as the finite element method require higher computational cost and are infeasible for limited hardware such as game consoles. On the other hand, while shape matching based simulations can produce plausible deformation in real-time, they suffer from a stiffness problem in which particles either show unrealistic deformation due to high gains, or cannot catch up with the body movement. In this paper, we propose a unified multi-layer lattice model to simulate the primary and secondary deformation of skeleton-driven characters. The core idea is to voxelize the input character mesh into multiple anatomical layers including the bone, muscle, fat and skin. Primary deformation is applied on the bone voxels with lattice-based skinning. The movement of these voxels is propagated to other voxel layers using lattice shape matching simulation, creating a natural secondary deformation. Our multi-layer lattice framework can produce simulation quality comparable to those from other volumetric approaches with a significantly smaller computational cost. It is best to be applied in real-time applications such as console games or interactive animation creation.	[Iwamoto, Naoya] Waseda Univ, Tokyo, Japan; [Iwamoto, Naoya; Morishima, Shigeo] JST CREST, Tokyo, Japan; [Shum, Hubert P. H.; Yang, Longzhi] Northumbria Univ, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Morishima, Shigeo] Waseda Res Inst Sci & Engn, Tokyo, Japan	Shum, HPH (reprint author), Northumbria Univ, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England.	iwamoto@toki.waseda.jp; hubert.shum@northumbria.ac.uk; longzhi.yang@northumbria.ac.uk; shigeo@waseda.jp			Engineering and Physical Sciences Research Council (EPSRC) [EP/M002632/1]; CREST, JST	This project was supported in part by the Engineering and Physical Sciences Research Council (EPSRC) Ref: EP/M002632/1, and in part by CREST, JST.	Ali-Hamadi D, 2013, ACM T GRAPHIC, V32, DOI 10.1145/2508363.2508415; Chen CH, 2013, VISUAL COMPUT, V29, P241, DOI 10.1007/s00371-012-0759-z; Muller M, 2005, ACM T GRAPHIC, V24, P471, DOI 10.1145/1073204.1073216; Rhee T, 2011, IEEE T VIS COMPUT GR, V17, P368, DOI 10.1109/TVCG.2010.39; Teran J, 2005, IEEE T VIS COMPUT GR, V11, P317, DOI 10.1109/TVCG.2005.42; Angelidis A, 2007, SYMPOSIUM ON COMPUTER ANIMATION 2007: ACM SIGGRAPH/ EUROGRAPHICS SYMPOSIUM PROCEEDINGS, P129; Muller M, 2007, J VIS COMMUN IMAGE R, V18, P109, DOI 10.1016/j.jveir.2007.01.005; Deul C., 2013, VIRTUAL REALITY INTE, P4; Dionne O., 2013, P 12 ACM SIGGRAPH EU, P173; Diziol R., 2011, P ACM SIGGRAPH EUR S, P237; Fan Y., 2014, ACM T GRAPHIC, V33, P152; Faure F, 2011, ACM T GRAPHIC, V30, DOI 10.1145/1964921.1964968; Hahn F., 2013, P 12 ACM SIGGRAPH EU, P165; Hahn F., 2012, ACM T GRAPHIC, V31, P72; Jacobson A., 2012, ACM T GRAPHIC, V31, P77; Kavan L., 2012, ACM T GRAPHIC, V31, P196; Kim J., 2011, ACM T GRAPHIC, V30, P121; Liu L., 2013, ACM T GRAPHIC, V32, P215; MACKLIN M., 2014, ACM T GRAPHIC, V33, P153; McAdams A., 2011, ACM T GRAPHIC, V30, P37; Miller E., 2007, ACM SIGGRAPH 2007 SK, P4; Muller M., 2011, ACM T GRAPHIC, V30, P92; Muller M., 2011, VIRTUAL REALITY INTE, P83; Muller M., 2014, EUR ACM SIGGRAPH S C, P2; Nealen A., 2005, EUROGRAPHICS STATE A, P71; Pratscher M., 2005, S COMP AN, P3; Rivers A. R., 2007, ACM T GRAPH, V26; Rumman N. A., 2014, P 30 SPRING C COMP G, P83; Schwarz M., 2010, ACM SIGGRAPH ASIA 20, P179; Shi X., 2008, ACM T GRAPHIC, V27, P29, DOI DOI 10.1145/1360612.1360628; Steinemann D., 2008, P ACM SIGGRAPH EUR S, P87; Takamatsu Kenji, 2011, Journal of the Institute of Image Electronics Engineers of Japan, V40; Umetani N., 2014, ACM SIGGRAPH 2014 TA, P47	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0167-7055	1467-8659		COMPUT GRAPH FORUM	Comput. Graph. Forum	OCT	2015	34	7					99	109		10.1111/cgf.12749		11	Computer Science, Software Engineering	Computer Science	CU0OJ	WOS:000363216500010		
J	Fujisawa, M; Miura, KT				Fujisawa, Makoto; Miura, Kenjiro T.			An Efficient Boundary Handling with a Modified Density Calculation for SPH	COMPUTER GRAPHICS FORUM			English	Article							SMOOTHED PARTICLE HYDRODYNAMICS; INCOMPRESSIBLE SPH; CONTACT	We propose a new boundary handling method for smoothed particle hydrodynamics (SPH). Previous approaches required the use of boundary particles to prevent particles from sticking to the boundary. We address this issue by correcting the fundamental equations of SPH with the integration of a kernel function. Our approach is able to directly handle triangle mesh boundaries without the need for boundary particles. We also show how our approach can be integrated into a position-based fluid framework.	[Fujisawa, Makoto] Univ Tsukuba, Tsukuba, Ibaraki 305, Japan; [Miura, Kenjiro T.] Shizuoka Univ, Shizuoka 4228529, Japan	Fujisawa, M (reprint author), Univ Tsukuba, Tsukuba, Ibaraki 305, Japan.				JSPS KAKENHI [25730069, 25289021]	This work was supported by JSPS KAKENHI Grant Number 25730069 and 25289021. We also thank to anonymous reviewers for their constructive comments. The images in this paper were rendered using Mitsuba renderer<SUP>dagger</SUP>.	Akinci N., 2012, ACM T GRAPH, V31, P62; Akinci N, 2013, COMPUT ANIMAT VIRT W, V24, P195, DOI 10.1002/cav.1499; Ihmsen M, 2014, IEEE T VIS COMPUT GR, V20, P426, DOI 10.1109/TVCG.2013.105; Monaghan JJ, 2005, REP PROG PHYS, V68, P1703, DOI 10.1088/0034-4885/68/8/R01; Oh S, 2009, COMPUT ANIMAT VIRT W, V20, P215, DOI 10.1002/cav.290; Sloan PP, 2002, ACM T GRAPHIC, V21, P527; Becker M, 2007, SYMPOSIUM ON COMPUTER ANIMATION 2007: ACM SIGGRAPH/ EUROGRAPHICS SYMPOSIUM PROCEEDINGS, P209; Ferrand M, 2013, INT J NUMER METH FL, V71, P446, DOI 10.1002/fld.3666; LUCY LB, 1977, ASTRON J, V82, P1013, DOI 10.1086/112164; Kulasegaram S, 2004, COMPUT MECH, V33, P316, DOI 10.1007/s00466-003-0534-0; GINGOLD RA, 1977, MON NOT R ASTRON SOC, V181, P375; Ihmsen M, 2011, COMPUT GRAPH FORUM, V30, P99, DOI 10.1111/j.1467-8659.2010.01834.x; Muller M, 2007, J VIS COMMUN IMAGE R, V18, P109, DOI 10.1016/j.jveir.2007.01.005; Feldman J, 2007, INT J NUMER METH ENG, V72, P295, DOI 10.1002/nme.2010; Becker M, 2009, IEEE T VIS COMPUT GR, V15, P493, DOI 10.1109/TVCG.2008.107; Becker M., 2009, P EUR WORKSH NAT PHE, P2; Bell N., 2005, SCA 05, P77; Clavet S., 2005, ACM SIGGRAPH EUR S C, P219; Colagrossi A, 2003, J COMPUT PHYS, V191, P448, DOI 10.1016/S0021-9991(03)00324-3; Du P., 2012, P ACM SIGGRAPH INT C, P309; Harada T., 2007, P SPRING C COMP GRAP, P235; He X., 2014, ACM T GRAPHIC, V34, P7; Huber M, 2015, COMPUT GRAPH FORUM, V34, P14, DOI 10.1111/cgf.12455; IHMSEN M., 2014, EUROGRAPHICS 2014 ST, P21, DOI DOI 10.2312/EGST.20141034.2; Li SF, 1996, COMPUT METHOD APPL M, V139, P159, DOI 10.1016/S0045-7825(96)01082-1; Liu WK, 1997, COMPUT METHOD APPL M, V143, P113, DOI 10.1016/S0045-7825(96)01132-2; MACKLIN M., 2014, ACM T GRAPHIC, V33, P153; MACKLIN M., 2013, ACM T GRAPHIC, V32, P104, DOI DOI 10.1145/2461912.2461984.4; Mayrhofer A, 2015, NUMER ALGORITHMS, V68, P15, DOI 10.1007/s11075-014-9835-y; Muller M., 2003, SCA 03, P154; Muller M., 2004, SCA2004, P2; Panizzo A., 2004, THESIS U STUDI AQUIL, P2; Schechter H., 2012, ACM T GRAPHIC, V31, P61, DOI DOI 10.1145/2185520.2185557; Solenthaler B, 2009, ACM T GRAPHIC, V28, DOI 10.1145/1531326.1531346	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0167-7055	1467-8659		COMPUT GRAPH FORUM	Comput. Graph. Forum	OCT	2015	34	7					155	162		10.1111/cgf.12754		8	Computer Science, Software Engineering	Computer Science	CU0OJ	WOS:000363216500015		
J	Kubo, T; Shimose, S; Fujimori, J; Furuta, T; Ochi, M				Kubo, Tadahiko; Shimose, Shoji; Fujimori, Jun; Furuta, Taisuke; Ochi, Mitsuo			Prognostic value of PAX3/7-FOXO1 fusion status in alveolar rhabdomyosarcoma: Systematic review and meta-analysis	CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY			English	Review						Meta-analysis; Rhabdomyosarcoma; Fusion gene; PAX3/7-FOXO1; Survival	CHILDRENS ONCOLOGY GROUP; NONMETASTATIC RHABDOMYOSARCOMA; PEDIATRIC RHABDOMYOSARCOMA; RISK STRATIFICATION; MOLECULAR MARKER; GENE FUSIONS; EXPRESSION; PAX3-FKHR; TRANSLOCATION; FKHR	Purpose: The objective of this systematic review is to provide an unprecedented summary of the prognostic impact of PAX3/7-FOXO1 fusion status in alveolar rhabdomyosarcoma. Methods: Studies evaluating PAX3/7-FOXO1 fusion gene or its variants as a prognostic marker were systematically searched and comparative meta-analysis of overall survival was carried out. Results: A total of 7 studies comprising 993 patients with rhabdomyosarcoma were included. Three eligible studies showed no significant difference of survival between fusion positive and negative alveolar rhabdomyosarcoma. Four eligible studies showed that PAX3-FOXO1 fusion variant may indicate a lower survival probability than PAX7-FOXO1, although the effect did not reach a level of statistical significance (pooled hazard ratios, 1.66; 95% CI, 0.95-2.89; p = 0.07). Conclusions: There was no significant difference in the overall survival between patients with the positive and negative fusion gene, but there were indications of PAX3-FOXO1 being an unfavorable prognostic factor. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Kubo, Tadahiko; Shimose, Shoji; Fujimori, Jun; Furuta, Taisuke; Ochi, Mitsuo] Hiroshima Univ, Grad Sch Biomed Sci, Dept Orthopaed Surg, Hiroshima 7348551, Japan	Kubo, T (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Orthopaed Surg, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	kubot@hiroshima-ti.ac.jp					Meza JL, 2006, J CLIN ONCOL, V24, P3844, DOI 10.1200/JCO.2005.05.3801; Liberati A, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000100; DAVIS RJ, 1994, CANCER RES, V54, P2869; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Raney RB, 2001, J PEDIAT HEMATOL ONC, V23, P215, DOI 10.1097/00043426-200105000-00008; Lae M, 2007, J PATHOL, V212, P143, DOI 10.1002/path.2170; Kelly KM, 1997, J CLIN ONCOL, V15, P1831; SCRABLE H, 1989, GENE CHROMOSOME CANC, V1, P23, DOI 10.1002/gcc.2870010106; Williamson PR, 2002, STAT MED, V21, P3337, DOI 10.1002/sim.1303; Dumont SN, 2012, J CANCER RES CLIN, V138, P213, DOI 10.1007/s00432-011-1089-7; Slater O, 2007, J CLIN PATHOL, V60, P1187, DOI 10.1136/jcp.2006.040113; Davicioni E, 2006, CANCER RES, V66, P6936, DOI 10.1158/0008-5472.CAN-05-4578; Stegmaier S, 2012, J CLIN ONCOL, V30, P4039, DOI 10.1200/JCO.2012.43.5628; Kazanowska B, 2007, FETAL PEDIATR PATHOL, V26, P17, DOI 10.1080/15513810701394702; Stegmaier S, 2011, PEDIATR BLOOD CANCER, V57, P406, DOI 10.1002/pbc.22958; Wachtel M, 2004, CANCER RES, V64, P5539, DOI 10.1158/0008-5472.CAN-04-0844; Egger M, 1997, BRIT MED J, V315, P629; Arndt CAS, 2009, J CLIN ONCOL, V27, P5182, DOI 10.1200/JCO.2009.22.3768; Weihkopf T, 2008, EUR J CANCER, V44, P432, DOI 10.1016/j.ejca.2007.11.013; Liu Z, 2013, BRIT J CANCER, V108, P2299, DOI 10.1038/bjc.2013.185; Stevens MCG, 2005, J CLIN ONCOL, V23, P2618, DOI 10.1200/JCO.2005.08.130; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Sorensen PHB, 2002, J CLIN ONCOL, V20, P2672, DOI 10.1200/JCO.2002.03.137; FREDERICKS WJ, 1995, MOL CELL BIOL, V15, P1522; Missiaglia E, 2012, J CLIN ONCOL, V30, P1670, DOI 10.1200/JCO.2011.38.5591; Williamson D, 2010, J CLIN ONCOL, V28, P2151, DOI 10.1200/JCO.2009.26.3814; Anderson J, 2001, BRIT J CANCER, V85, P831, DOI 10.1054/bjoc.2001.2008; BARR FG, 1993, NAT GENET, V3, P113, DOI 10.1038/ng0293-113; Heerema-McKenney A, 2008, AM J SURG PATHOL, V32, P1513, DOI 10.1097/PAS.0b013e31817a909a; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Skapek SX, 2013, PEDIATR BLOOD CANCER, V60, P1411, DOI 10.1002/pbc.24532; Egufa-Aguilar P, 2010, ARCH MED RES, V41, P119; Higgins JPT, 2011, COCHRANE HDB SYSTEMA; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Weiss SW, 2008, ENZINGER WEISSS SOFT, P595	35	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1040-8428	1879-0461		CRIT REV ONCOL HEMAT	Crit. Rev. Oncol./Hematol.	OCT	2015	96	1					46	53		10.1016/j.critrevonc.2015.04.012		8	Oncology; Hematology	Oncology; Hematology	CT8LY	WOS:000363069300005		
J	Hatayama, Y; Nakamura, T; Suzuki, M; Azami, Y; Ono, T; Yamaguchi, H; Hayashi, Y; Tsukiyama, I; Hareyama, M; Kikuchi, Y; Takai, Y				Hatayama, Y.; Nakamura, T.; Suzuki, M.; Azami, Y.; Ono, T.; Yamaguchi, H.; Hayashi, Y.; Tsukiyama, I.; Hareyama, M.; Kikuchi, Y.; Takai, Y.			Preliminary results of proton-beam therapy for stage III non-small-cell lung cancer	CURRENT ONCOLOGY			English	Article						Proton-beam therapy; chemotherapy; stage III non-small-cell lung cancer	COOPERATIVE-ONCOLOGY-GROUP; RADIATION-THERAPY; CONCURRENT CHEMOTHERAPY; PHASE-II; RADIOTHERAPY; TRIAL; METAANALYSIS	Background We conducted a preliminary retrospective evaluation of the efficacy and toxicity of proton-beam therapy (PBT) for stage III non-small-cell lung cancer. Methods Between January 2009 and August 2013, 27 patients (26 men, 1 woman) with stage III non-small-cell lung cancer underwent PBT. The relative biologic effectiveness value of the proton beam was defined as 1.1. The beam energy and spread-out Bragg peak were fine-tuned such that the 90% isodose volume of the prescribed dose encompassed the planning target volume. Of the 27 patients, 11 underwent neoadjuvant chemotherapy. Cumulative survival curves were calculated using the Kaplan-Meier method. Treatment toxicities were evaluated using version 4 of the Common Terminology Criteria for Adverse Events. Results Median age of the patients was 72 years (range: 57-91 years), and median follow-up was 15.4 months (range: 7.8-36.9 months). Clinical stage was IIIA in 14 patients (52%) and IIIB in 13 (48%). The median dose of PBT was 77 GyE (range: 66-86.4 GyE). The overall survival rate in the cohort was 92.3% at 1 year and 51.1% at 2 years. Locoregional failure occurred in 7 patients, and distant metastasis, in 10. In 2 patients, initial failure was both locoregional and distant. The 1-year and 2-year rates of local control were 68.1% and 36.4% respectively. The 1-year and 2-year rates of progression-free survival were 39.9% and 21.4% respectively. Two patients experienced grade 3 pneumonitis. Conclusions For patients with stage III non-small-cell lung cancer, PBT can be an effective and safe treatment option.	[Hatayama, Y.; Nakamura, T.; Suzuki, M.; Azami, Y.; Ono, T.; Yamaguchi, H.; Hayashi, Y.; Tsukiyama, I.; Hareyama, M.; Kikuchi, Y.] Southern Tohoku Proton Therapy Ctr, Dept Radiat Oncol, Koriyama, Fukushima, Japan; [Takai, Y.] Hirosaki Univ, Grad Sch Med, Dept Radiol & Radiat Oncol, Hirosaki, Aomori, Japan	Hatayama, Y (reprint author), Southern Tohoku Proton Beam Therapy Ctr, Dept Radiat Oncol, 7-172 Yatsuyamada, Koriyama, Fukushima 9638052, Japan.	yonoki2005@gmail.com					Nakayama H, 2011, INT J RADIAT ONCOL, V81, P979, DOI 10.1016/j.ijrobp.2010.06.024; Sause W, 2000, CHEST, V117, P358, DOI 10.1378/chest.117.2.358; SAUSE WT, 1995, J NATL CANCER I, V87, P198, DOI 10.1093/jnci/87.3.198; Oshiro Y, 2014, J RADIAT RES, V55, P959, DOI 10.1093/jrr/rru034; Green MR, 2000, SEMIN RADIAT ONCOL, V10, P289, DOI 10.1053/srav.2000.9611; Nichols RC, 2011, CLIN LUNG CANCER, V12, P252, DOI 10.1016/j.cllc.2011.03.027; Pritchard RS, 1996, ANN INTERN MED, V125, P723; Oshiro Y, 2012, J THORAC ONCOL, V7, P370, DOI 10.1097/JTO.0b013e31823c485f; Okawara G, 2006, J THORAC ONCOL, V1, P377, DOI 10.1097/01243894-200605000-00019; Ando K, 2001, J RADIAT RES, V42, P79, DOI 10.1269/jrr.42.79; Dillman RO, 1996, J NATL CANCER I, V88, P1210, DOI 10.1093/jnci/88.17.1210; Seppenwoolde Y, 2001, SEMIN RADIAT ONCOL, V11, P247, DOI 10.1053/srao.2001.23482; Chang JY, 2011, CANCER-AM CANCER SOC, V117, P4707, DOI 10.1002/cncr.26080; FURUSE K, 1995, J CLIN ONCOL, V13, P869; Rancati T, 2003, RADIOTHER ONCOL, V67, P275, DOI 10.1016/S0167-8140(03)00119-1; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Hoppe BS, 2012, CLIN LUNG CANCER, V13, P352, DOI 10.1016/j.cllc.2011.11.008; PEREZ CA, 1987, CANCER, V59, P1874, DOI 10.1002/1097-0142(19870601)59:11<1874::AID-CNCR2820591106>3.0.CO;2-Z; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Bradley JD, 2015, LANCET ONCOL, V16, P187, DOI 10.1016/S1470-2045(14)71207-0; MARINO P, 1995, CANCER, V76, P593, DOI 10.1002/1097-0142(19950815)76:4<593::AID-CNCR2820760409>3.0.CO;2-N; Singer JM, 1998, BRIT J CANCER, V78, P1629, DOI 10.1038/bjc.1998.734; DILLMAN RO, 1990, NEW ENGL J MED, V323, P940, DOI 10.1056/NEJM199010043231403; Japan National Research and Development Institute National Cancer Research Center Cancer Control and Information Center, LAT CANC STAT; Kiura K, 2008, J CLIN ONCOL, V26; Non-small Cell Lung Cancer Collaborative Group, 1995, BMJ-BRIT MED J, V311, P899, DOI DOI 10.1136/BMJ.311.7010.899; Satouchi M, 2009, J CLIN ONCOL, V27	27	0	0	MULTIMED INC	TORONTO	66 MARTIN ST, TORONTO, ON L9T 2R2, CANADA	1198-0052			CURR ONCOL	Curr. Oncol.	OCT	2015	22	5					E370	E375		10.3747/co.22.2523		6	Oncology	Oncology	CU1YI	WOS:000363317900009		
J	Watanabe, Y; Yaginuma, H				Watanabe, Yuji; Yaginuma, Hiroyuki			Tangential cell migration during layer formation of chickoptic tectum	DEVELOPMENT GROWTH & DIFFERENTIATION			English	Review						cell migration; chick; embryonic development; layer formation; optic tectum	CLONALLY RELATED CELLS; CHICKEN OPTIC TECTUM; LAMINAR FORMATION; CEREBRAL-CORTEX; VISUAL-SYSTEM; DIFFERENTIATION; NEURONS; EMBRYO; HISTOGENESIS; LINEAGE	The laminated structure of the optic tectum is formed by radial and tangential cell migration during development. Studies of developing chick optic tectum have revealed two streams of tangential cell migration in the middle and superficial layers, which have distinctive origins, migratory paths, modes of migration, and destinations. We will review the process of the two types of tangential migrations, in order to elucidate their roles in the formation of the optic tectum layers.	[Watanabe, Yuji; Yaginuma, Hiroyuki] Fukushima Med Univ, Sch Med, Dept Neuroanat & Embryol, Fukushima 9601295, Japan	Watanabe, Y (reprint author), Fukushima Med Univ, Sch Med, Dept Neuroanat & Embryol, Fukushima 9601295, Japan.	yuji-w@fmu.ac.jp			Fukushima Medical University Research Project; JSPS KAKENHI [15K06740]	Our study was supported by Fukushima Medical University Research Project and JSPS KAKENHI Grant Number 15K06740.	GRAY GE, 1992, DEVELOPMENT, V114, P271; Karten HJ, 1997, J COMP NEUROL, V387, P449; Mey J, 2000, BRAIN RES REV, V32, P343, DOI 10.1016/S0165-0173(99)00022-3; COWAN WM, 1961, J ANAT, V95, P545; MARTINEZ S, 1992, DEV BRAIN RES, V66, P153, DOI 10.1016/0165-3806(92)90076-9; Watanabe Y, 2014, DEVELOPMENT, V141, P3572, DOI 10.1242/dev.110205; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; GOLDBERG S, 1974, DEV BIOL, V36, P24, DOI 10.1016/0012-1606(74)90188-2; Sugiyama S, 2003, DEVELOPMENT, V130, P451, DOI 10.1242/dev.00232; LAVAIL JH, 1971, BRAIN RES, V28, P421; ITASAKI N, 1992, NEURON, V8, P787, DOI 10.1016/0896-6273(92)90099-Y; DOMESICK VB, 1977, NEUROSCIENCE, V2, P459, DOI 10.1016/0306-4522(77)90011-2; MCCONNELL SK, 1988, J NEUROSCI, V8, P945; Wu CC, 2000, J COMP NEUROL, V417, P115; Tan SS, 2002, DEV BIOL, V241, P117, DOI 10.1006/dbio.2001.0505; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; LAVAIL JH, 1971, BRAIN RES, V28, P391, DOI 10.1016/0006-8993(71)90053-9; GRAY GE, 1988, P NATL ACAD SCI USA, V85, P7356, DOI 10.1073/pnas.85.19.7356; SENUT MC, 1987, DEV BRAIN RES, V32, P187, DOI 10.1016/0165-3806(87)90100-3; GRAY GE, 1991, NEURON, V6, P211, DOI 10.1016/0896-6273(91)90357-6; Omi M, 2014, DEVELOPMENT, V141, P2131, DOI 10.1242/dev.102905; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Huber GC, 1933, P NATL ACAD SCI USA, V19, P15, DOI 10.1073/pnas.19.1.15; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; PUELLES L, 1978, NEUROSCIENCE, V3, P307, DOI 10.1016/0306-4522(78)90079-9; Ramon, 1911, HISTOLOGIE SYSTEME N, V2	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1592	1440-169X		DEV GROWTH DIFFER	Dev. Growth Diff.	OCT	2015	57	8					539	543		10.1111/dgd.12238		5	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	CU3DK	WOS:000363403900001		
J	Hirate, Y; Hirahara, S; Inoue, K; Kiyonari, H; Niwa, H; Sasaki, H				Hirate, Yoshikazu; Hirahara, Shino; Inoue, Ken-ichi; Kiyonari, Hiroshi; Niwa, Hiroshi; Sasaki, Hiroshi			Par-aPKC-dependent and -independent mechanisms cooperatively control cell polarity, Hippo signaling, and cell positioning in 16-cell stage mouse embryos	DEVELOPMENT GROWTH & DIFFERENTIATION			English	Article						asymmetric cell division; cell polarity; Hippo signaling; Par-aPKC; preimplantation embryo	TROPHECTODERM FATE; 8-CELL STAGE; PATHWAY; BLASTOMERES; LINEAGE; INNER; CDX2; MASS; SPECIFICATION; BLASTOCYST	In preimplantation mouse embryos, the Hippo signaling pathway plays a central role in regulating the fates of the trophectoderm (TE) and the inner cell mass (ICM). In early blastocysts with more than 32 cells, the Par-aPKC system controls polarization of the outer cells along the apicobasal axis, and cell polarity suppresses Hippo signaling. Inactivation of Hippo signaling promotes nuclear accumulation of a coactivator protein, Yap, leading to induction of TE-specific genes. However, whether similar mechanisms operate at earlier stages is not known. Here, we show that slightly different mechanisms operate in 16-cell stage embryos. Similar to 32-cell stage embryos, disruption of the Par-aPKC system activated Hippo signaling and suppressed nuclear Yap and Cdx2 expression in the outer cells. However, unlike 32-cell stage embryos, 16-cell stage embryos with a disrupted Par-aPKC system maintained apical localization of phosphorylated Ezrin/Radixin/Moesin (p-ERM), and the effects on Yap and Cdx2 were weak. Furthermore, normal 16-cell stage embryos often contained apolar cells in the outer position. In these cells, the Hippo pathway was strongly activated and Yap was excluded from the nuclei, thus resembling inner cells. Dissociated blastomeres of 8-cell stage embryos form polar-apolar couplets, which exhibit different levels of nuclear Yap, and the polar cell engulfed the apolar cell. These results suggest that cell polarization at the 16-cell stage is regulated by both Par-aPKC-dependent and -independent mechanisms. Asymmetric cell division is involved in cell polarity control, and cell polarity regulates cell positioning and most likely controls Hippo signaling.	[Hirate, Yoshikazu; Sasaki, Hiroshi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Cell Fate Control, Chuo Ku, Kumamoto 8600811, Japan; [Hirahara, Shino] RIKEN, Ctr Dev Biol, Lab Embryon Induct, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Inoue, Ken-ichi; Kiyonari, Hiroshi] RIKEN, Ctr Life Sci Technol, Div Biofunct Dynam Imaging,Anim Resource Dev Unit, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Kiyonari, Hiroshi] RIKEN, Ctr Life Sci Technol, Div Biofunct Dynam Imaging,Genet Engn Team, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Niwa, Hiroshi] RIKEN, Ctr Dev Biol, Lab Pluripotent Cell Studies, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Niwa, Hiroshi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Stem Cell Biol, Chuo Ku, Kumamoto 8600811, Japan; [Sasaki, Hiroshi] Osaka Univ, Grad Sch Frontier BioSci, Lab Embryogenesis, Suita, Osaka 5650871, Japan	Sasaki, H (reprint author), Kumamoto Univ, Inst Mol Embryol & Genet, Dept Cell Fate Control, Chuo Ku, 2-2-1 Honjo, Kumamoto 8600811, Japan.	sasaki@fbs.osaka-u.ac.jp			RIKEN; MEXT KAKENHI [21116003]; JSPS KAKENHI [25440112]	We thank M. Shibata, T. Ideue, M. Harano, A. Katsuyama, and N. Fujita for their excellent technical assistance; K. Yamagata, V. Alarcon, and A. Shitamukai for plasmids; and A. Shimono for the Amot antibody. We are also grateful to the Laboratory for Animal Resources Development and Genetic Engineering, RIKEN CDB for collecting mouse embryos and housing mice, as well as the CARD, Kumamoto University for housing mice. This work was supported by grants from RIKEN (to H.S.), MEXT KAKENHI (Grant Number 21116003 to H.S.), and JSPS KAKENHI (Grant Number 25440112 to Y.H.).	Suwinska A, 2008, DEV BIOL, V322, P133, DOI 10.1016/j.ydbio.2008.07.019; Morris SA, 2010, P NATL ACAD SCI USA, V107, P6364, DOI 10.1073/pnas.0915063107; Ralston A, 2008, DEV BIOL, V313, P614, DOI 10.1016/j.ydbio.2007.10.054; JOHNSON MH, 1986, J EMBRYOL EXP MORPH, V93, P239; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; Hirate Y, 2013, CURR BIOL, V23, P1181, DOI 10.1016/j.cub.2013.05.014; JOHNSON MH, 1981, CELL, V24, P71, DOI 10.1016/0092-8674(81)90502-X; Alarcon VB, 2010, BIOL REPROD, V83, P347, DOI 10.1095/biolreprod.110.084400; Anani S, 2014, DEVELOPMENT, V141, P2813, DOI 10.1242/dev.107276; PEDERSEN RA, 1986, DEV BIOL, V117, P581, DOI 10.1016/0012-1606(86)90327-1; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Cockburn K, 2013, CURR BIOL, V23, P1195, DOI 10.1016/j.cub.2013.05.044; JOHNSON MH, 1981, J CELL BIOL, V91, P303, DOI 10.1083/jcb.91.1.303; Mana-Capelli S, 2014, MOL BIOL CELL, V25, P1676, DOI 10.1091/mbc.E13-11-0701; DUCIBELLA T, 1977, J CELL BIOL, V74, P153, DOI 10.1083/jcb.74.1.153; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Hirate Y, 2012, P NATL ACAD SCI USA, V109, pE3389, DOI 10.1073/pnas.1211810109; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Vinot S, 2005, DEV BIOL, V282, P307, DOI 10.1016/j.ydbio.2005.03.001; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; FLEMING TP, 1988, ANNU REV CELL BIOL, V4, P459, DOI 10.1146/annurev.cb.04.110188.002331; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; McDole K, 2011, DEV BIOL, V355, P239, DOI 10.1016/j.ydbio.2011.04.024; Johnson MH, 2004, SEMIN CELL DEV BIOL, V15, P583, DOI 10.1016/j.semcdb.2004.04.002; Yamanaka Y, 2006, DEV DYNAM, V235, P2301, DOI 10.1002/dvdy.20844; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Skamagki M, 2013, CELL REP, V3, P442, DOI 10.1016/j.celrep.2013.01.006; GRAHAM CF, 1978, J EMBRYOL EXP MORPH, V48, P53; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; FLEMING TP, 1987, DEV BIOL, V119, P520, DOI 10.1016/0012-1606(87)90055-8; Sasaki H, 2010, DEV GROWTH DIFFER, V52, P263, DOI 10.1111/j.1440-169X.2009.01158.x; Rayon T, 2014, DEV CELL, V30, P410, DOI 10.1016/j.devcel.2014.06.019; Yonemura S, 1999, J CELL BIOL, V145, P1497, DOI 10.1083/jcb.145.7.1497; REEVE WJD, 1981, J EMBRYOL EXP MORPH, V62, P339; CALARCO PG, 1973, DEV BIOL, V32, P208, DOI 10.1016/0012-1606(73)90233-9; Dard N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007117; Hirate Y, 2014, TISSUE BARRIERS, V2; Hogan B, 1994, MANIPULATING MOUSE E; Johnson MH, 1981, CELLULAR MOL ASPECTS, P55; Leung CY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3251; Nishioka N, 2008, MECH DEVELOP, V125, P270, DOI 10.1016/j.mod.2007.11.002; Piotrowska-Nitsche K, 2005, DEVELOPMENT, V132, P479, DOI 10.1242/dev.01602; Sasaki H, 2015, SEMIN CELL DEV BIOL, V47-48, P80, DOI 10.1016/j.semcdb.2015.05.003; TARKOWSK.AK, 1967, J EMBRYOL EXP MORPH, V18, P155; Wicklow E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004618	46	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1592	1440-169X		DEV GROWTH DIFFER	Dev. Growth Diff.	OCT	2015	57	8					544	556		10.1111/dgd.12235		13	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	CU3DK	WOS:000363403900002		
J	Otsuka, T; Tsukahara, T; Takeda, H				Otsuka, Takayoshi; Tsukahara, Tatsuya; Takeda, Hiroyuki			Development of the pancreas in medaka, Oryzias latipes, from embryo to adult	DEVELOPMENT GROWTH & DIFFERENTIATION			English	Article						islet; medaka; pancreas; pdx1; ptf1a	BETA-CELL FORMATION; ENDOCRINE PANCREAS; TRANSGENIC ZEBRAFISH; TRANSCRIPTION FACTOR; EXPRESSING CELLS; PROGENITOR CELLS; ISLET-CELL; GENE; EXOCRINE; PTF1A	To address conserved and unique features of fish pancreas development, we performed extensive analyses of pancreatic development in medaka embryos and adults using pdx1- and ptf1a-transgenic medaka, insitu hybridization and immunohistochemistry. The markers used in these analyses included pdx1, nkx6.1, nkx6.2, nkx2.2, Islet1, insulin, Somatostatin, glucagon, ptf1a, ela3l, trypsin, and amylase. The double transgenic (Tg) fish produced in the present study visualizes the development of endocrine (pdx1+) and exocrine (ptf1a+) parts simultaneously in living fishes. Like other vertebrates, the medaka pancreas develops as two (dorsal and ventral) buds in the anterior gut tube, which soon fuse into a single anlagen. The double Tg fish demonstrates that the differential property between the two buds is already established at the initial phase of bud development as indicated by strong pdx1 expression in the dorsal one. This Tg fish also allowed us to examine the gross morphology and the structure of adult pancreas and revealed unique characters of medaka pancreas such as broad and multiple connections with the gut tube along the anterior-posterior axis.	[Otsuka, Takayoshi; Tsukahara, Tatsuya; Takeda, Hiroyuki] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Takeda, Hiroyuki] JST, CREST, Kawaguchi, Saitama 3320012, Japan	Takeda, H (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan.	htakeda@bs.s.u-tokyo.ac.jp			CREST, JST;  [22127002];  [25291048]	We thank Dr. A. Shimada for critical reading of the manuscript. We are grateful to Ms. Y. Ozawa and Ms. Y. Yamagishi for fish care. This work was supported in part by Grant-in-Aid for Scientific Research Priority Area Genome Science and Scientific Research on Innovative Areas 'Logic of Biological Pattern Formation' [22127002], Grant-in-Aid for Scientific Research (B) [25291048] and CREST, JST.	Sussel L, 1998, DEVELOPMENT, V125, P2213; Field HA, 2003, DEV BIOL, V261, P197, DOI 10.1016/S0012-1606(03)00308-7; Takeda H, 2010, ANNU REV GENET, V44, P217, DOI 10.1146/annurev-genet-051710-151001; Takashima S, 2007, DEV DYNAM, V236, P2298, DOI 10.1002/dvdy.21245; Jensen J, 2004, DEV DYNAM, V229, P176, DOI 10.1002/dvdy.10460; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Loosli F, 2000, MECH DEVELOP, V97, P133, DOI 10.1016/S0925-4773(00)00406-8; Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Yesil P, 2008, HISTOL HISTOPATHOL, V23, P883; Dong PDS, 2008, GENE DEV, V22, P1445, DOI 10.1101/gad.1663208; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Ishikawa Y, 2000, BIOESSAYS, V22, P487, DOI 10.1002/(SICI)1521-1878(200005)22:5<487::AID-BIES11>3.3.CO;2-#; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Moriyama Y, 2012, CURR BIOL, V22, P601, DOI 10.1016/j.cub.2012.01.063; Pisharath H, 2007, MECH DEVELOP, V124, P218, DOI 10.1016/j.mod.2006.11.005; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; GUZ Y, 1995, DEVELOPMENT, V121, P11; Tehrani Z, 2011, CELL CYCLE, V10, P3466, DOI 10.4161/cc.10.20.17764; UPCHURCH BH, 1994, DEVELOPMENT, V120, P245; Yee NS, 2005, DEV BIOL, V284, P84, DOI 10.1016/j.ydbio.2005.04.035; KARLSSON O, 1990, NATURE, V344, P879, DOI 10.1038/344879a0; Offield MF, 1996, DEVELOPMENT, V122, P983; Moss JB, 2009, DIABETES, V58, P1844, DOI 10.2337/db08-0628; Argenton F, 1999, MECH DEVELOP, V87, P217, DOI 10.1016/S0925-4773(99)00151-3; Kimura T, 2004, MECH DEVELOP, V121, P915, DOI 10.1016/j.mod.2004.03.033; Burlison JS, 2008, DEV BIOL, V316, P74, DOI 10.1016/j.ydbio.2008.01.011; Assouline B, 2002, MECH DEVELOP, V117, P299, DOI 10.1016/S0925-4773(02)00190-9; Kim HJ, 2006, MOL ENDOCRINOL, V20, P194, DOI 10.1210/me.2005-0189; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Zecchin E, 2004, DEV BIOL, V268, P174, DOI 10.1016/j.ydbio.2003.12.016; Rembold M, 2006, NAT PROTOC, V1, P1133, DOI 10.1038/nprot.2006.165; Kelsh RN, 2004, MECH DEVELOP, V121, P841, DOI 10.1016/j.mod.2004.01.004; Wan HY, 2006, EXP CELL RES, V312, P1526, DOI 10.1016/j.yexcr.2006.01.016; Godinho L, 2005, DEVELOPMENT, V132, P5069, DOI 10.1242/dev.02075; SLACK JMW, 1995, DEVELOPMENT, V121, P1569; Wierup N, 2002, REGUL PEPTIDES, V107, P63, DOI 10.1016/S0167-0115(02)00067-8; Hoshino M, 2005, NEURON, V47, P201, DOI 10.1016/j.neuron.2005.06.007; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; Li Z, 2009, DIFFERENTIATION, V77, P128, DOI 10.1016/j.diff.2008.09.014; Hesselson D, 2011, CURR BIOL, V21, P712, DOI 10.1016/j.cub.2011.03.041; Binot AC, 2010, DEV BIOL, V340, P397, DOI 10.1016/j.ydbio.2010.01.025; Furutani-Seiki M, 2004, MECH DEVELOP, V121, P647, DOI 10.1016/j.mod.2004.04.016; Curado S, 2007, DEV DYNAM, V236, P1025, DOI 10.1002/dvdy.21100; Sander M, 2000, DEVELOPMENT, V127, P5533; Krapp A, 1998, GENE DEV, V12, P3752, DOI 10.1101/gad.12.23.3752; Du AP, 2009, DIABETES, V58, P2059, DOI 10.2337/db08-0987; Nakamura S, 2008, DEV GROWTH DIFFER, V50, P415, DOI [10.1111/j.1440-169X.2008.01027.x, 10.1111/j.1440-169x.2008.01027.x]; Castro LFC, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2669; Huang HG, 2001, MOL CELL ENDOCRINOL, V177, P117, DOI 10.1016/S0303-7207(01)00408-7; Tiso N, 2009, MOL CELL ENDOCRINOL, V312, P24, DOI 10.1016/j.mce.2009.04.018	51	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1592	1440-169X		DEV GROWTH DIFFER	Dev. Growth Diff.	OCT	2015	57	8					557	569		10.1111/dgd.12237		13	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	CU3DK	WOS:000363403900003		
J	Hirahara, N; Matsubara, T; Hayashi, H; Takai, K; Fujii, Y; Tajima, Y				Hirahara, N.; Matsubara, T.; Hayashi, H.; Takai, K.; Fujii, Y.; Tajima, Y.			Impact of inflammation-based prognostic score on survival after curative thoracoscopic esophagectomy for esophageal cancer	EJSO			English	Article						Esophageal cancer; Glasgow Prognostic Score; Neutrophil lymphocyte ratio; Prognosis	CELL LUNG-CANCER; C-REACTIVE PROTEIN; NEUTROPHIL-LYMPHOCYTE RATIO; PERFORMANCE STATUS ECOG; SYSTEMIC INFLAMMATION; COLORECTAL-CANCER; ENDOSCOPIC ULTRASONOGRAPHY; POOR-PROGNOSIS; GASTRIC-CANCER; WEIGHT-LOSS	Background: Despite recent improvements in early detection, progress in surgical techniques, and development of chemoradiation therapies, prognosis of esophageal cancer remains poor. The aim of the present study was to assess whether Glasgow Prognostic Score (GPS), an inflammation-based prognostic score, has prognostic value independent of conventional clinicopathological criteria in patients undergoing curative resection for esophageal cancer, even in elderly patients. Methods: We retrospectively reviewed the database of 141 consecutive patients with histologically verified esophageal squamous cell carcinoma who underwent potentially curative surgery in our institute, between January 2006 and December 2014. GPS and neutrophil lymphocyte ratio (NLR) were calculated. Results: On multivariate analysis, TNM stage (p < 0.0001) and GPS (p = 0.041) were independently associated with worse prognosis in overall patients with esophageal cancer. Multivariate analysis evaluated the prognostic factors in two different patient groups: patients younger than 70 years (non-elderly) and those aged 70 years or more (elderly). Multivariate analysis demonstrated that TNM stage (p = 0.0003) was an only independent risk factor for a worse prognosis among non-elderly group. Meanwhile, multivariate analysis demonstrated that TNM stage (p = 0.001) and GPS (p = 0.043) were the independent risk factor for a worse prognosis among elderly group. Conclusion: The present study demonstrated that GPS is associated with prognosis and can be considered as an independent prognostic marker in patients who underwent esophagectomy. Moreover, the GPS has the advantage of being simple to measure, routinely available and well standardized. But the present study failed to confirm the NLR as a significant predictor of survival following resection for esophageal cancer. (C) 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license.	[Hirahara, N.; Matsubara, T.; Hayashi, H.; Takai, K.; Fujii, Y.; Tajima, Y.] Shimane Univ, Fac Med, Dept Digest & Gen Surg, Izumo, Shimane 6938501, Japan	Hirahara, N (reprint author), Shimane Univ, Fac Med, Dept Digest & Gen Surg, 89-1 Enya Cho, Izumo, Shimane 6938501, Japan.	norinorihirahara@yahoo.co.jp					Brown DJF, 2007, J CLIN PATHOL, V60, P705, DOI 10.1136/jcp.2005.033217; Proctor MJ, 2013, CANCER-AM CANCER SOC, V119, P2325, DOI 10.1002/cncr.28018; Ramsey S, 2007, CANCER, V109, P205, DOI 10.1002/cncr.22400; McMillan DC, 2001, NUTR CANCER, V39, P210, DOI 10.1207/S15327914nc392_8; Proctor MJ, 2011, EUR J CANCER, V47, P2633, DOI 10.1016/j.ejca.2011.03.028; Saif MW, 2010, EJSO-EUR J SURG ONC, V36, P709, DOI 10.1016/j.ejso.2010.05.023; Forrest LM, 2005, BRIT J CANCER, V92, P1834, DOI 10.1038/sj.bjc.6602591; Walsh Sr, 2005, J SURG ONCOL, V91, P181, DOI 10.1002/jso.20329; Guthrie GJK, 2013, CRIT REV ONCOL HEMAT, V88, P218, DOI 10.1016/j.critrevonc.2013.03.010; Kao SCH, 2010, CLIN CANCER RES, V16, P5805, DOI 10.1158/1078-0432.CCR-10-2245; Koike Y, 2008, J SURG ONCOL, V98, P540, DOI 10.1002/jso.21154; Guillem P, 2005, DIS ESOPHAGUS, V18, P146, DOI 10.1111/j.1442-2050.2005.00474.x; Erlinger TP, 2004, JAMA-J AM MED ASSOC, V291, P585, DOI 10.1001/jama.291.5.585; MORGAN DB, 1980, AM J CLIN NUTR, V33, P2101; Gregory AD, 2011, CANCER RES, V71, P2411, DOI 10.1158/0008-5472.CAN-10-2583; Forrest LM, 2003, BRIT J CANCER, V89, P1028, DOI 10.1038/sj.bjc.6601242; McMillan DC, 2001, NUTR CANCER, V41, P64, DOI 10.1207/S15327914NC41-1&2_8; Forrest LM, 2004, BRIT J CANCER, V90, P1704, DOI 10.1038/sj.bjc.6601789; Proctor MJ, 2012, BRIT J CANCER, V107, P695, DOI 10.1038/bjc.2012.292; Glen P, 2006, PANCREATOLOGY, V6, P450, DOI 10.1159/000094562; McMillan DC, 2009, CURR OPIN CLIN NUTR, V12, P223, DOI 10.1097/MCO.0b013e32832a7902; Schumacher K, 2001, CANCER RES, V61, P3932; Azab B, 2012, ANN SURG ONCOL, V19, P217, DOI 10.1245/s10434-011-1814-0; Al-Shaiba R, 2004, BRIT J CANCER, V91, P205, DOI 10.1038/sj.bjc.6601886; Ahn HS, 2009, J SURG ONCOL, V99, P20, DOI 10.1002/jso.21170; Crumley ABC, 2008, J GASTROEN HEPATOL, V23, pE325, DOI 10.1111/j.1440-1746.2007.05105.x; Ando M, 2001, BRIT J CANCER, V85, P1634, DOI 10.1054/bjoc.2001.2162; Gabay C, 1999, NEW ENGL J MED, V340, P448; Roxburgh CSD, 2010, FUTURE ONCOL, V6, P149, DOI [10.2217/fon.09.136, 10.2217/FON.09.136]; Krzystek-Korpacka M, 2008, CLIN CHEM LAB MED, V46, P359, DOI 10.1515/CCLM.2008.089; Lee HH, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-190; ROWLAND ML, 1990, AM J CLIN NUTR, V52, P1125; Sobin LH, 2010, TNM CLASSIFICATION M	33	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0748-7983	1532-2157		EJSO-EUR J SURG ONC	EJSO	OCT	2015	41	10					1308	1315		10.1016/j.ejso.2015.07.008		8	Oncology; Surgery	Oncology; Surgery	CU2HW	WOS:000363345600006		
J	Yamashita, K; Ushiku, H; Katada, N; Hosoda, K; Moriya, H; Mieno, H; Kikuchi, S; Hoshi, K; Watanabe, M				Yamashita, K.; Ushiku, H.; Katada, N.; Hosoda, K.; Moriya, H.; Mieno, H.; Kikuchi, S.; Hoshi, K.; Watanabe, M.			Reduced preoperative serum albumin and absence of peritoneal dissemination may be predictive factors for long-term survival with advanced gastric cancer with positive cytology test	EJSO			English	Article						Gastric cancer; CY1; Prognosis; Albumin; Long-term postoperative therapy; Peritoneal dissemination; Propensity score	INTRAPERITONEAL PACLITAXEL; OVARIAN-CANCER; S-1; CELLS; CHEMOTHERAPY; CISPLATIN; VIABILITY; TRIAL	Background: Peritoneal lavage cytology cancer-positive (CY1) is a critical prognostic factor and is taken as representing stage IV in gastric cancer. There is no consensus treatment strategy for CY1-gastric cancer, and the detailed clinicopathological features remain obscure. Patients and methods: Among 790 gastric cancer patients between 2005 and 2009, 52 cases of CY1 were identified (6.6%). A multivariate prognostic model was applied to the univariate prognostic factors to identify independent prognostic factors and factors associated with long-term survival in CY1-gastric cancer. Results:(1) Five-year overall survival (OS) was 17.6% in CY1-gastric cancer as compared with 93.9% in CYX and 77.7% in CY0(77.7%), where tumors with pT2 or beyond were included in 11% of CYX, 73% of CY0, and 98% of CY1 cases. (2) On univariate analysis, factors associated with a negative prognosis were the presence of peritoneal dissemination (p = 0.029) and high preoperative serum albumin (p = 0.011) in CY1-gastric cancer. The multivariate Cox proportional hazards and logistic regression model using propensity score identified preoperative albumin as a critical independent prognostic indicator. (3) Long-term survivors were identified and, were often characterized by long-term postoperative adjuvant treatment. Conclusion: Reduced preoperative serum albumin and absence of peritoneal dissemination may be predictive factors for long-term survival in patients with advanced gastric cancer with positive cytology test. Long-term postoperative adjuvant therapy might improve survival of patients with CY1. (C) 2015 Elsevier Ltd. All rights reserved.	[Yamashita, K.; Ushiku, H.; Katada, N.; Hosoda, K.; Moriya, H.; Mieno, H.; Kikuchi, S.; Watanabe, M.] Kitasato Univ, Dept Surg, Sch Med, Sagamihara, Kanagawa 2520380, Japan; [Hoshi, K.] Kitasato Univ, Dept Hyg, Sch Med, Sagamihara, Kanagawa 2520380, Japan	Yamashita, K (reprint author), Kitasato Univ, Dept Surg, Sch Med, Minami Ku, Asamizodai 2-1-1, Sagamihara, Kanagawa 2520380, Japan.	keishi23@med.kitasato-u.ac.jp					Yamashita K, 2013, SURG TODAY, V43, P1013, DOI 10.1007/s00595-012-0388-1; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI [10.1016/S1470-2045(08)70035-4, 10.1016/S1470-204S(08)70035-4]; DEMETRAKOPOULOS GE, 1982, CANCER BIOCHEM BIOPH, V6, P65; Fukagawa T, 2010, WORLD J SURG, V34, P563, DOI 10.1007/s00268-009-0355-1; FRANCIS P, 1995, J CLIN ONCOL, V13, P2961; Boku N, 2009, LANCET ONCOL, V10, P1063, DOI 10.1016/S1470-2045(09)70259-1; Reutter M, 2013, INT J GYNECOL CANCER, V23, P34, DOI 10.1097/IGC.0b013e318275b028; Mezhir JJ, 2010, ANN SURG ONCOL, V17, P3173, DOI 10.1245/s10434-010-1183-0; Koizumi W, 2012, CANCER CHEMOTH PHARM, V69, P407, DOI 10.1007/s00280-011-1701-1; Yamaguchi H, 2013, CANCER-AM CANCER SOC, V119, P3354, DOI 10.1002/cncr.28204; Lee SD, 2012, BRIT J SURG, V99, P397, DOI 10.1002/bjs.7812; Yamashita K, 2008, GASTRIC CANCER, V11, P111, DOI 10.1007/s10120-008-0466-7; Kitayama J, 2014, ANN SURG ONCOL, V21, P539, DOI 10.1245/s10434-013-3208-y; Ishii T, 2004, CANCER LETT, V213, P99, DOI 10.1016/j.canlet.2004.03.022; Roviello F, 2013, EJSO-EUR J SURG ONC, V39, P1309, DOI 10.1016/j.ejso.2013.10.010; Yamashita K, 2007, ANTICANCER RES, V27, P4381; Okuyama T, 2012, SURG TODAY, V42, P734, DOI 10.1007/s00595-012-0129-5; Armstrong DK, 2006, NEW ENGL J MED, V354, P34, DOI 10.1056/NEJMoa052985; Association JGC, 2011, GASTRIC CANCER, V14, P113; Cancer IUA, 2009, TNM CLASSIFICATION M; International Agency for Research on Cancer WHO, 2012, GLOBOCAN 2012 EST CA; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Japanese Gastric Cancer Association, 1998, GASTRIC CANCER, V1, P10, DOI DOI 10.1007/PL00011681]; Kim MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009003; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252	25	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0748-7983	1532-2157		EJSO-EUR J SURG ONC	EJSO	OCT	2015	41	10					1324	1332		10.1016/j.ejso.2015.05.021		9	Oncology; Surgery	Oncology; Surgery	CU2HW	WOS:000363345600008		
J	Mine, S; Kurokawa, Y; Takeuchi, H; Kishi, K; Ito, Y; Ohi, M; Matsuda, T; Hamakawa, T; Hasegawa, S; Yoshikawa, T; Hiki, N				Mine, S.; Kurokawa, Y.; Takeuchi, H.; Kishi, K.; Ito, Y.; Ohi, M.; Matsuda, T.; Hamakawa, T.; Hasegawa, S.; Yoshikawa, T.; Hiki, N.			Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in Siewert type II tumors	EJSO			English	Article						Adenocarcinoma; Esophagogastric junction; Gastrectomy; Esophagectomy; Lymphadenectomy	GASTROESOPHAGEAL JUNCTION; GASTRIC-CANCER; CHANGING PATTERNS; ADENOCARCINOMA; ESOPHAGEAL; RESECTION; MARGIN; CLASSIFICATION; GASTRECTOMY; DISSECTION	Background: The optimal surgical approach for Siewert type II adenocarcinoma of the esophagogastric junction (AEG) has not yet been agreed. Here we investigated whether the distance from the esophagogastric junction (EGJ) to the distal end of the tumor was related to the distribution of involved abdominal lymph nodes in Siewert type II tumors. Methods: A total of 288 patients with pT2-4 AEG Siewert II, treated by R0 surgical resection at 7 institutions in Japan, were retrospectively investigated. The distribution of involved abdominal nodes was correlated with the distance from the EGJ to the distal end of the tumor. Results: In patients where the distance from the EGJ to the distal end of the tumor was <= 30 mm, the frequency of nodal involvement along the greater curvature or antrum was low (2.2%). In contrast, in patients where the distance was >50 mm, the incidence of this nodal involvement was 20.0%. In patients where the distance was 30-50 mm incidence was intermediate (8.0%). Multivariate analyses showed that the distance from the EGJ to the distal end of the tumor was significantly related to lymph node involvement along the greater curvature or antrum (odds ratio 3.7, 95% confidence interval 1.3-11, p = 0.006). Conclusions: When the distance from the EGJ to the distal end of the tumor is <= 30 mm for Siewert II AEG, esophagectomy or proximal gastrectomy is sufficient from the point of view of abdominal lymphadenectomy. However, a total gastrectomy should be considered for abdominal lymphadenectomy when this distance is > 50 mm. (C) 2015 Elsevier Ltd. All rights reserved.	[Mine, S.; Hiki, N.] Canc Inst Hosp Ariake, Dept Surg Gastroenterol, Tokyo, Japan; [Kurokawa, Y.; Hamakawa, T.] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Osaka, Japan; [Takeuchi, H.; Matsuda, T.] Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan; [Kishi, K.] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Osaka, Japan; [Ito, Y.] Aichi Canc Ctr Hosp, Dept Surg Gastroenterol, Nagoya, Aichi 464, Japan; [Ohi, M.] Mie Univ, Grad Sch Med, Dept Innovat Surg, Tsu, Mie, Japan; [Hasegawa, S.; Yoshikawa, T.] Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Yokohama, Kanagawa 2410815, Japan	Yoshikawa, T (reprint author), Kanagawa Canc Ctr, Dept Gastrointestinal Surg, 1-1-2 Nakao, Yokohama, Kanagawa 2410815, Japan.	yoshikawat@kcch.jp; naoki.hiki@jfcr.or.jp					YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Deans C, 2011, WORLD J SURG, V35, P617, DOI 10.1007/s00268-010-0935-0; Mariette C, 2003, EUR J SURG ONCOL, V29, P588, DOI 10.1016/S0748-7983(03)00109-4; Kakeji Y, 2012, SURG TODAY, V42, P351, DOI 10.1007/s00595-011-0114-4; Dolan K, 1999, BRIT J CANCER, V80, P834, DOI 10.1038/sj.bjc.6690429; Kusano C, 2008, J GASTROEN HEPATOL, V23, P1662, DOI 10.1111/j.1440-1746.2008.05572.x; Sasako M, 2006, LANCET ONCOL, V7, P644, DOI 10.1016/S1470-2045(06)70766-5; Mariette C, 2011, LANCET ONCOL, V12, P296, DOI 10.1016/S1470-2045(10)70125-X; Grotenhuis BA, 2013, WORLD J SURG, V37, P147, DOI 10.1007/s00268-012-1804-9; Butte JM, 2011, SURG TODAY, V41, P1319, DOI 10.1007/s00595-010-4412-z; Mine S, 2013, BRIT J SURG, V100, P261, DOI 10.1002/bjs.8967; Lerut T, 2010, RECENT RESULTS CANC, V182, P127, DOI 10.1007/978-3-540-70579-6_11; TERZ JJ, 1987, AM J SURG, V154, P42, DOI 10.1016/0002-9610(87)90287-X; Siewert JR, 1998, BRIT J SURG, V85, P1457; Schiesser M, 2010, RECENT RESULTS CANC, V182, P93, DOI 10.1007/978-3-540-70579-6_8; PAPACHRISTOU DN, 1980, AM J SURG, V139, P711, DOI 10.1016/0002-9610(80)90369-4; Mine S, 2013, BRIT J SURG, V100, P1050, DOI 10.1002/bjs.9170; Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.3.CO;2-U; DeMeester SR, 2006, ANN SURG ONCOL, V13, P12, DOI 10.1245/ASO.2005.12.025; Hulscher JBF, 2002, NEW ENGL J MED, V347, P1662, DOI 10.1056/NEJMoa022343; Barbour AP, 2007, ANN SURG, V246, P1, DOI 10.1097/01.sla.0000255563.65157.d2; Ito H, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-2; Japanese Gastric Cancer Association, 1998, GASTRIC CANCER, V1, P10, DOI DOI 10.1007/S101209800016]; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Sobin LH, 2009, TNM CLASSIFICATION M	25	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0748-7983	1532-2157		EJSO-EUR J SURG ONC	EJSO	OCT	2015	41	10					1348	1353		10.1016/j.ejso.2015.05.004		6	Oncology; Surgery	Oncology; Surgery	CU2HW	WOS:000363345600011		
J	Kinoshita, J; Fushida, S; Tsukada, T; Oyama, K; Okamoto, K; Makino, I; Nakamura, K; Miyashita, T; Tajima, H; Takamura, H; Ninomiya, I; Ohta, T				Kinoshita, J.; Fushida, S.; Tsukada, T.; Oyama, K.; Okamoto, K.; Makino, I.; Nakamura, K.; Miyashita, T.; Tajima, H.; Takamura, H.; Ninomiya, I.; Ohta, T.			Efficacy of conversion gastrectomy following docetaxel, cisplatin, and S-1 therapy in potentially resectable stage IV gastric cancer	EJSO			English	Article						Gastric cancer; Stage IV; Chemotherapy; Conversion gastrectomy	PHASE-III TRIAL; HEPATIC RESECTION; LIVER METASTASIS; NEOADJUVANT CHEMOTHERAPY; PLUS CISPLATIN; SURGERY; SURVIVAL; STOMACH	Background: Recent advances in gastric cancer chemotherapy have made macroscopic complete resection possible in some patients with stage IV disease. Methods: We retrospectively investigated the efficacy of multimodal therapy with combined docetaxel, cisplatin, and S-1 (DCS) and conversion gastrectomy in 57 patients with stage IV gastric cancer. Results: Of the 57 patients, 15 patients were categorized into potentially resectable case, which is defined as patients with single incurable factor including the upper abdominal para-aortic lymph node metastasis (16a2b1 PAN metastasis) or fewer than three peripheral liver metastases. The other 42 were categorized as initially unresectable. All of patients underwent DCS therapy, and then 34 patients underwent conversion gastrectomy. The 3-year overall survival (OS) rate among the patients who underwent conversion gastrectomy was 50.1% with MST of 29.9 months. They had significantly longer OS than patients who underwent DCS therapy alone (p < 0.01). Univariate analysis among the patents with conversion gastrectomy identified 16a2b1PAN metastasis, peritoneal metastasis, potential resectable case, R0 resection as significant prognostic factors. A 3-year OS in potential resectable cases was 92.9%. Multivariate analysis identified potential resectability as the only independent prognostic factor contributing to OS (HR 0.133, 95%CI 0.024-0. 744, p = 0.021). In contrast, clinical response was selected as the only independent prognostic factor in the subgroup of initially unresectable cases (HR 0.354, 95%CI 0.151-0.783, p = 0.021). Conclusion: Patients with potentially resectable disease had a remarkably good prognosis among stage IV gastric cancer patients, and might be ideal candidates for conversion gastrectomy following DCS therapy. (C) 2015 The Authors. Published by Elsevier Ltd.	[Kinoshita, J.; Fushida, S.; Tsukada, T.; Oyama, K.; Okamoto, K.; Makino, I.; Nakamura, K.; Miyashita, T.; Tajima, H.; Takamura, H.; Ninomiya, I.; Ohta, T.] Kanazawa Univ, Grad Sch Med Sci, Div Canc Med, Dept Surg Gastroenterol, Kanazawa, Ishikawa 9208641, Japan	Fushida, S (reprint author), Kanazawa Univ, Grad Sch Med Sci, Div Canc Med, Dept Surg Gastroenterol, 13-1 Takaramachi, Kanazawa, Ishikawa 9208641, Japan.	fushida@staff.kanazawa-u.ac.jp					Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI [10.1016/S1470-2045(08)70035-4, 10.1016/S1470-204S(08)70035-4]; Takemura N, 2012, LANGENBECK ARCH SURG, V397, P951, DOI 10.1007/s00423-012-0959-z; Okano K, 2002, ANN SURG, V235, P86, DOI 10.1097/00000658-200201000-00011; [Anonymous], 2011, JPN GASTRIC CANC ASS, V14, P101; Ohtsu A, 2003, J CLIN ONCOL, V21, P54, DOI 10.1200/JCO.2003.04.130; Shirabe K, 2003, HEPATO-GASTROENTEROL, V50, P1560; Boku N, 2009, LANCET ONCOL, V10, P1063, DOI 10.1016/S1470-2045(09)70259-1; Cheon SH, 2008, ANN ONCOL, V19, P1146, DOI 10.1093/annonc/mdn026; Chen L, 2013, WORLD J GASTROENTERO, V19, P2097, DOI 10.3748/wjg.v19.i13.2097; Tsuburaya A, 2014, BRIT J SURG, V101, P653, DOI 10.1002/bjs.9484; YONEMURA Y, 1994, SURG TODAY, V24, P488; Yano M, 2002, WORLD J SURG, V26, P1155, DOI 10.1007/s00268-002-6362-0; Fushida S, 2009, ANTI-CANCER DRUG, V20, P752, DOI 10.1097/CAD.0b013e32832ec02b; Sakamoto Y, 2007, J SURG ONCOL, V95, P534, DOI 10.1002/jso.20739; Kanda T, 2012, GASTRIC CANCER, V15, P235, DOI 10.1007/s10120-011-0100-y; Nakajima T, 1997, ANN SURG ONCOL, V4, P203, DOI 10.1007/BF02306611; Roh HR, 2005, AM SURGEON, V71, P95; Ambiru S, 2001, AM J SURG, V181, P279, DOI 10.1016/S0002-9610(01)00567-0; Ishigami S, 2008, J GASTROINTEST SURG, V12, P1370, DOI 10.1007/s11605-008-0539-2; Suzuki T, 2010, ONCOL LETT, V1, P743, DOI 10.3892/ol_00000130; Sato Y, 2010, CANCER CHEMOTH PHARM, V66, P721, DOI 10.1007/s00280-009-1215-2; Fukuchi M, 2015, ANN SURG ONCOL; Nakayama N, 2008, ONCOLOGY-BASEL, V75, P1, DOI 10.1159/000151613; Schlansky B, 2001, AM J GASTROENTEROL, V106, P1978; Shin Aesun, 2011, J Gastric Cancer, V11, P135, DOI 10.5230/jgc.2011.11.3.135; Yabusaki H, 2013, HEPATO-GASTROENTEROL, V60, P377, DOI 10.5754/hge12683	26	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0748-7983	1532-2157		EJSO-EUR J SURG ONC	EJSO	OCT	2015	41	10					1354	1360		10.1016/j.ejso.2015.04.021		7	Oncology; Surgery	Oncology; Surgery	CU2HW	WOS:000363345600012		
J	Wu, CF; Wang, QH; Xiang, J; Yu, M; Chang, Q; Gao, M; Sonomoto, K				Wu, Chuanfu; Wang, Qunhui; Xiang, Juan; Yu, Miao; Chang, Qiang; Gao, Ming; Sonomoto, Kenji			Enhanced Productions and Recoveries of Ethanol and Methane from Food Waste by a Three-Stage Process	ENERGY & FUELS			English	Article							2-STAGE FERMENTATION PROCESS; 2-PHASE ANAEROBIC-DIGESTION; KITCHEN WASTE; CO-DIGESTION; HYDROGEN; PERFORMANCE; SUBSTRATE; GARBAGE; REACTOR; INHIBITION	A three-stage process that consisted of saccharification, ethanol fermentation of the saccharified liquid, and anaerobic treatment of the saccharified residue to convert food waste (FW) to ethanol and CH4 was developed. Results revealed that high sugar recovery (i.e., 61.7%) from FIAT could be achieved after saccharification and 15.2% saccharified sugar was retained in saccharified residue after solid-liquid separation. A high ethanol yield was obtained during ethanol fermentation of the saccharified liquid. This high yield indicates the superiority of the system. The ethanol productivity in the ethanol fermentation stage was 0.9 g L-1 h(-1). A CH4 yield of 248.4 mL/g of volatile solid (VS) was achieved in the CH4 fermentation stage, whereas that in the single-stage fermentation system was 252.6 mL/g of VS. A comparison of the two fermentation systems based on material balance and energy outcome demonstrated that the three-stage process achieved a 27.5% increase in the FIAT decomposition rate, a 51.8% reduction in the energy requirement for system operation, and a 17.6% improvement in the total energy yield. Therefore, the three-stage process is more suitable for practical application in terms of a lower post-treatment cost for the digester residue, a higher organic carbon utilization rate, and a higher bioenergy recovery efficiency compared to the single-stage system.	[Wu, Chuanfu; Wang, Qunhui; Xiang, Juan; Yu, Miao; Chang, Qiang] Univ Sci & Technol Beijing, Sch Civil & Environm Engn, Dept Environm Engn, Beijing 10083, Peoples R China; [Wu, Chuanfu; Wang, Qunhui] Univ Sci & Technol Beijing, Beijing Key Lab Resource Oriented Treatment Ind P, Beijing 10083, Peoples R China; [Gao, Ming; Sonomoto, Kenji] Kyushu Univ, Fac Agr, Grad Sch, Dept Biosci & Biotechnol,Higashi Ku, Fukuoka 8128581, Japan	Wang, QH (reprint author), Univ Sci & Technol Beijing, Sch Civil & Environm Engn, Dept Environm Engn, 30 Xueyuan Rd, Beijing 10083, Peoples R China.	wangqh59@sina.com			National Key Technology RD Program [2014BAC24B01]; National Natural Science Foundation of China [51278050]	This study was supported by the National Key Technology R&D Program (2014BAC24B01) and the National Natural Science Foundation of China (Grant 51278050).	AGUILAR A, 1995, WATER RES, V29, P505, DOI 10.1016/0043-1354(94)00179-B; Lee DY, 2010, BIORESOURCE TECHNOL, V101, pS42, DOI 10.1016/j.biortech.2009.03.037; Nasr N, 2012, BIORESOURCE TECHNOL, V111, P122, DOI 10.1016/j.biortech.2012.02.019; Lin Y, 2006, APPL MICROBIOL BIOT, V69, P627, DOI 10.1007/s00253-005-0229-x; Lee YW, 2010, INT J HYDROGEN ENERG, V35, P11746, DOI 10.1016/j.ijhydene.2010.08.093; Liu DW, 2006, WATER RES, V40, P2230, DOI 10.1016/j.watres.2006.03.029; FOX P, 1994, WATER ENVIRON RES, V66, P716; VINAS M, 1993, ENVIRON TECHNOL, V14, P995; Wang QH, 2008, BIOCHEM ENG J, V39, P604, DOI 10.1016/j.bej.2007.12.018; Park JH, 2012, BIORESOURCE TECHNOL, V113, P78, DOI 10.1016/j.biortech.2011.12.123; Ma HZ, 2009, RENEW ENERG, V34, P1466, DOI 10.1016/j.renene.2008.10.020; Dearman B, 2007, WASTE MANAGE, V27, P1792, DOI 10.1016/j.wasman.2006.08.006; Kawai M, 2014, BIORESOURCE TECHNOL, V157, P174, DOI 10.1016/j.biortech.2014.01.018; Li YQ, 2013, ENERG FUEL, V27, P2085, DOI 10.1021/ef400117f; Ueno Y, 2007, ENVIRON SCI TECHNOL, V41, P1413, DOI 10.1021/es062127f; Demirel B, 2002, J CHEM TECHNOL BIOT, V77, P743, DOI 10.1002/jctb.630; Koike Y, 2009, J BIOSCI BIOENG, V108, P508, DOI 10.1016/j.jbiosc.2009.06.007; Youn JH, 2005, WASTE MANAGE RES, V23, P32, DOI 10.1177/0734242X05049766; Luo G, 2010, INT J HYDROGEN ENERG, V35, P11733, DOI 10.1016/j.ijhydene.2010.08.033; Kim DH, 2009, ENZYME MICROB TECH, V45, P181, DOI 10.1016/j.enzmictec.2009.06.013; Shin HS, 2001, WATER RES, V35, P3441, DOI 10.1016/S0043-1354(01)00041-0; Ozmihci S, 2007, BIORESOURCE TECHNOL, V98, P2978, DOI 10.1016/j.biortech.2006.10.005; Li RP, 2009, ENERG FUEL, V23, P2225, DOI 10.1021/ef8008772; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Kim DH, 2013, BIORESOURCE TECHNOL, V127, P267, DOI 10.1016/j.biortech.2012.09.088; BUCKEE GK, 1993, J I BREWING, V99, P381; Liu XY, 2013, BIORESOURCE TECHNOL, V146, P317, DOI 10.1016/j.biortech.2013.07.096; Neves L, 2004, PROCESS BIOCHEM, V39, P2019, DOI 10.1016/j.procbio.2003.10.002; Forster-Carneiro T, 2008, BIORESOURCE TECHNOL, V99, P6994, DOI 10.1016/j.biortech.2008.01.018; Tang YQ, 2008, BIOMASS BIOENERG, V32, P1037, DOI 10.1016/j.biombioe.2008.01.027; Lakaniemi AM, 2013, BIORESOURCE TECHNOL, V135, P222, DOI 10.1016/j.biortech.2012.08.096; Chen Y, 2008, BIORESOURCE TECHNOL, V99, P4044, DOI 10.1016/j.biortech.2007.01.057	32	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0887-0624	1520-5029		ENERG FUEL	Energy Fuels	OCT	2015	29	10					6494	6500		10.1021/acs.energyfuels.5b01507		7	Energy & Fuels; Engineering, Chemical	Energy & Fuels; Engineering	CT8LM	WOS:000363068100036		
J	Wu, SJ; Katayama, R; Uddin, MA; Sasaoka, E; Xie, ZM				Wu, Sheng-ji; Katayama, Risa; Uddin, Md. Azhar; Sasaoka, Eiji; Xie, Zheng-miao			Study on Reactivity of HgO over Activated Carbon with HCI and SO2 in the Presence of Moisture by Temperature-Programmed Decomposition Desorption Mass Spectrometry	ENERGY & FUELS			English	Article							COMBUSTION FLUE-GAS; ELEMENTAL MERCURY REMOVAL; COAL; ADSORPTION; SORBENTS; CHLORIDE; CAPTURE; ACID	Reactivities of mercury compounds over mercury sorbents with HCl and SO2 are very important to the design of a solid sorbent for mercury vapor removal from coal-derived flue gases. However, presently available data on the reactivity of mercury oxide over mercury sorbent is insufficient. This study investigated the reactivity of mercury oxide with HCl and SO2 using a temperature-programmed decomposition and desorption technique and a mass spectrometer (TPDD-mass) method. Mercury desorption from HgO over activated carbon (HgO/AC) was observed at the same temperature range as from HgO/SiO2, but the mercury desorption peak from the HgO/AC was observed at a higher temperature than from the HgO/SiO2, indicating that some of the HgO was stabilized by the AC surface. When the HgO/AC was pretreated with HCl-H2O, the formation of HgCl2 was suggested by the mass spectra of m/z = 272 and 270. The mercury desorption temperatures in the TPDD spectra were lower than those of nonpretreated samples. On the basis of the shape of the peak, it was conjectured that the mercury evolved from a single surface complex. The main mercury desorption peak was around 240 degrees C when HgO/AC was pretreated with SO2-H2O and occurred at the lowest temperature of the three pretreatments. However, multiple peaks, indicating the formation of multicomplexes, were observed during the pretreatment. A mercury desorption peak (HgO) was observed at the intermediate position between the other two samples pretreated with SO2 and HCl. The peak shape revealed that the mercury evolved from a single surface complex. It was also suggested that HCl suppressed the sulfuration of HgO by SO2 during the pretreatment.	[Wu, Sheng-ji; Xie, Zheng-miao] Hangzhou Dianzi Univ, Coll Mat & Environm Engn, Hangzhou 310018, Zhejiang, Peoples R China; [Katayama, Risa; Uddin, Md. Azhar; Sasaoka, Eiji] Okayama Univ, Grad Sch Environm & Life Sci, Okayama 7008530, Japan	Wu, SJ (reprint author), Hangzhou Dianzi Univ, Coll Mat & Environm Engn, Xiasha Univ Pk, Hangzhou 310018, Zhejiang, Peoples R China.	wushengji26@hdu.edu.cn			National Natural Science Foundation of China [21406044]; Zhejiang Province Natural Science Foundation of China [LY12E06001]; Science and Technology Planning Project of Zhejiang Province, China [2013C31016]	This work was financially supported by the National Natural Science Foundation of China (grant no. 21406044), the Zhejiang Province Natural Science Foundation of China (grant no. LY12E06001), and the Science and Technology Planning Project of Zhejiang Province, China (grant no. 2013C31016).	Hutson ND, 2007, ENVIRON SCI TECHNOL, V41, P1747, DOI 10.1021/es062121q; Vidic RD, 2001, CARBON, V39, P3, DOI 10.1016/S0008-6223(00)00081-6; Li YH, 2003, FUEL, V82, P451, DOI 10.1016/S0016-2361(02)00307-1; Liu W, 1998, ENVIRON SCI TECHNOL, V32, P531, DOI 10.1021/es970630+; Rodriguez-Perez J, 2013, J HAZARD MATER, V260, P869, DOI 10.1016/j.jhazmat.2013.06.026; Lee SF, 2004, ATMOS ENVIRON, V38, P4887, DOI 10.1016/j.atmosenv.2004.05.043; Morris EA, 2012, ENVIRON SCI TECHNOL, V46, P7905, DOI 10.1021/es301209t; Lopez-Anton MA, 2010, FUEL, V89, P629, DOI 10.1016/j.fuel.2009.08.034; Jurng J, 2002, CHEMOSPHERE, V47, P907, DOI 10.1016/S0045-6535(01)00329-0; Wang YJ, 2009, FUEL PROCESS TECHNOL, V90, P643, DOI 10.1016/j.fuproc.2008.10.013; Zhang B, 2015, CHEM ENG J, V263, P1, DOI 10.1016/j.cej.2014.10.090; Zeng HC, 2004, FUEL, V83, P143, DOI 10.1016/S0016-2361(03)00235-7; Li GL, 2015, FUEL, V145, P189, DOI 10.1016/j.fuel.2014.12.083; Uddin MA, 2008, ENERG FUEL, V22, P2284, DOI 10.1021/ef800134t; Luo GQ, 2011, P COMBUST INST, V33, P2763, DOI 10.1016/j.proci.2010.06.108; Shen BX, 2015, CHEM ENG J, V272, P28, DOI 10.1016/j.cej.2015.03.006; Wu SJ, 2011, ENERG FUEL, V25, P144, DOI 10.1021/ef1009499; Granite EJ, 2000, IND ENG CHEM RES, V39, P1020, DOI 10.1021/ie990758v; Zhou Q, 2015, FUEL PROCESS TECHNOL, V134, P325, DOI 10.1016/j.fuproc.2014.12.052; Schroeder WH, 1998, ATMOS ENVIRON, V32, P809, DOI 10.1016/S1352-2310(97)00293-8; Miller SJ, 2000, FUEL PROCESS TECHNOL, V65, P343, DOI 10.1016/S0378-3820(99)00103-4; [Anonymous], 1996, J ENV SCI TECHNOL; Ochiai R, 2009, ENERG FUEL, V23, P4734, DOI 10.1021/ef900057e; Murakami A, 2010, ENERG FUEL, V24, P4241, DOI 10.1021/ef100288f; Rumayor M, 2015, FUEL PROCESS TECHNOL, V132, P9, DOI 10.1016/j.fuproc.2014.12.032; Ghorishi SB, 2002, ENVIRON SCI TECHNOL, V36, P4454, DOI 10.1021/es0255608; Uddin MA, 2009, ENERG FUEL, V23, P4710, DOI 10.1021/ef801068z; Ma JF, 2015, APPL SURF SCI, V329, P292, DOI 10.1016/j.apsusc.2014.11.090; Feng XB, 2004, ANAL BIOANAL CHEM, V380, P683, DOI 10.1007/s00216-004-2803-y; Galbreath KC, 2000, FUEL PROCESS TECHNOL, V65, P289, DOI 10.1016/S0378-3820(99)00102-2; Bidstrup P. L., 1964, TOXICITY MERCURY ITS, P1; Ferens M. C., 1974, EPA660373022; Reis AT, 2015, GEODERMA, V237, P98, DOI 10.1016/j.geoderma.2014.08.019	33	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0887-0624	1520-5029		ENERG FUEL	Energy Fuels	OCT	2015	29	10					6598	6604		10.1021/acs.energyfuels.5b01283		7	Energy & Fuels; Engineering, Chemical	Energy & Fuels; Engineering	CT8LM	WOS:000363068100048		
J	Kitano, T; Tsuji, T; Kurose, R; Komori, S				Kitano, Tomoaki; Tsuji, Takafumi; Kurose, Ryoichi; Komori, Satoru			Effect of Pressure Oscillations on Flashback Characteristics in a Turbulent Channel Flow	ENERGY & FUELS			English	Article							PREMIXED FLAME; FUEL DROPLETS; COMBUSTION; HYDROGEN; EVAPORATION; MECHANISMS; SIMULATION	A flashback phenomenon is reproduced by a direct numerical simulation (DNS) of a premixed hydrogen-air flame in a turbulent channel flow, and effects of the pressure oscillation, is caused by a virtual combustion instability on the flashback characteristics, are investigated. In addition, the interaction between the flashback flame structure and the turbulent flow structure is examined in detail. For the hydrogen air reaction, a chemical reaction model, which considers 9 chemical species and 20 reactions, is employed. The results show that the pressure oscillation strongly affects the flashback characteristics, such as the flashback speed and heat flux on the wall, and is at risk for increasing the flashback speed, because the acceleration of the flashback speed by the pressure oscillation is greater than the deceleration of it. Independent of the pressure oscillation, the turbulent eddies passing through the flame tend to be suppressed and vanish by the acceleration of the streamwise flow caused by thermal expansion. However, other turbulent eddies are generated again in a form of longitudinal eddies behind the flame only at the cusps and center of the channel where the upper and lower flames meet, because of the strong fluid shear owing to the thermal expansion.	[Kurose, Ryoichi] Kyoto Univ, Dept Mech Engn & Sci, Nishikyo Ku, Kyoto 6158540, Japan; Kyoto Univ, Adv Res Inst Fluid Sci & Engn, Nishikyo Ku, Kyoto 6158540, Japan	Kurose, R (reprint author), Kyoto Univ, Dept Mech Engn & Sci, Nishikyo Ku, Kyoto 6158540, Japan.	kurose@mech.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [hp130018]	This research was supported by the "Strategic Programs for Innovative Research (SPIRE)-Field No. 4: Industrial Innovations" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) using the K computer at RIKEN Advanced Institute for Computational Science (Project hp130018).	Strohle J, 2007, INT J HYDROGEN ENERG, V32, P125, DOI 10.1016/j.ijhydene.2006.04.005; Gruber A, 2012, J FLUID MECH, V709, P516, DOI 10.1017/jfm.2012.345; Franzelli B, 2012, COMBUST FLAME, V159, P621, DOI 10.1016/j.combustflame.2011.08.004; Kitano T, 2013, J THERM SCI TECH-JPN, V8, P269, DOI 10.1299/jtst.8.269; Ni M, 2006, FUEL PROCESS TECHNOL, V87, P461, DOI 10.1016/j.fuproc.2005.11.003; Santoso WB, 2013, ENRGY PROCED, V32, P3, DOI 10.1016/j.egypro.2013.05.002; Eichler C, 2012, J ENG GAS TURB POWER, V134, DOI 10.1115/1.4004149; Gou XL, 2010, COMBUST FLAME, V157, P1111, DOI 10.1016/j.combustflame.2010.02.020; Rabenstein G, 2008, J POWER SOURCES, V185, P1293, DOI 10.1016/j.jpowsour.2008.08.010; Tanahashi M, 2000, P COMBUST INST, V28, P529; Sato K, 2009, PROCEEDINGS OF THE ASME TURBO EXPO 2009, VOL 2, P87; Moureau V, 2007, J COMPUT PHYS, V226, P1256, DOI 10.1016/j.jcp.2007.05.035; LEE ST, 1982, COMBUST FLAME, V48, P273, DOI 10.1016/0010-2180(82)90134-1; MILLER JA, 1989, PROG ENERG COMBUST, V15, P287, DOI 10.1016/0360-1285(89)90017-8; Mayer C, 2012, J ENG GAS TURB POWER, V134, DOI 10.1115/1.4004255; Kitano T, 2014, FUEL, V136, P219, DOI 10.1016/j.fuel.2014.07.045; Tachibana S, 2015, COMBUST FLAME, V162, P2621, DOI 10.1016/j.combustflame.2015.03.014; Gruber A, 2015, P COMBUST INST, V35, P1485, DOI 10.1016/j.proci.2014.06.073; Kitano T, 2014, COMBUST FLAME, V161, P551, DOI 10.1016/j.combustflame.2013.09.009; Pitsch H., FLAMEMASTER C COMPUT; Swaminathan N., 2011, TURBULENT PREMIXED F; Veynante D., 2005, THEORETICAL NUMERICA; Yenerdag B, 2015, P COMBUST INST, V35, P1277, DOI 10.1016/j.proci.2014.05.153	23	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0887-0624	1520-5029		ENERG FUEL	Energy Fuels	OCT	2015	29	10					6815	6822		10.1021/acs.energyfuels.5b01687		8	Energy & Fuels; Engineering, Chemical	Energy & Fuels; Engineering	CT8LM	WOS:000363068100070		
J	Kanemaru, Y; Suzuki, T; Niimi, N; Gruz, P; Matsumoto, K; Adachi, N; Honma, M; Nohmi, T				Kanemaru, Yuki; Suzuki, Tetsuya; Niimi, Naoko; Gruz, Petr; Matsumoto, Kyomu; Adachi, Noritaka; Honma, Masamitsu; Nohmi, Takehiko			Catalytic and non-catalytic roles of DNA polymerase kappa in the protection of human cells against genotoxic stresses	ENVIRONMENTAL AND MOLECULAR MUTAGENESIS			English	Article						translesion DNA synthesis; Nalm-6-MSH+; catalytically dead mutants	VERTEBRATE POL-KAPPA; ERROR-FREE BYPASS; IN-VIVO EVIDENCE; TRANSLESION SYNTHESIS; Y-FAMILY; LESION-BYPASS; MAMMALIAN-CELLS; XERODERMA-PIGMENTOSUM; REPLICATION FORKS; PHENYLALANINE 171	DNA polymerase (Pol ) is a specialized DNA polymerase involved in translesion DNA synthesis. Although its bypass activities across lesions are well characterized in biochemistry, its cellular protective roles against genotoxic insults are still elusive. To better understand the in vivo protective roles, we have established a human cell line deficient in the expression of Pol (KO) and another expressing catalytically dead Pol (CD), to examine the cytotoxic sensitivity to 11 genotoxins including ultraviolet C light (UV). These cell lines were established in a genetic background of Nalm-6-MSH+, a human lymphoblastic cell line that has high efficiency for gene targeting, and functional p53 and mismatch repair activities. We classified the genotoxins into four groups. Group 1 includes benzo[a]pyrene diolepoxide, mitomycin C, and bleomycin, where the sensitivity was equally higher in KO and CD than in the cell line expressing wild-type Pol (WT). Group 2 includes hydrogen peroxide and menadione, where hypersensitivity was observed only in KO. Group 3 includes methyl methanesulfonate and ethyl methanesulfonate, where hypersensitivity was observed only in CD. Group 4 includes UV and three chemicals, where the chemicals exhibited similar cytotoxicity to all three cell lines. The results suggest that Pol not only protects cells from genotoxic DNA lesions via DNA polymerase activities, but also contributes to genome integrity by acting as a non-catalytic protein against oxidative damage caused by hydrogen peroxide and menadione. The non-catalytic roles of Pol in protection against oxidative damage by hydrogen peroxide are discussed. Environ. Mol. Mutagen. 56:650-662, 2015. (c) 2015 Wiley Periodicals, Inc.	[Kanemaru, Yuki; Suzuki, Tetsuya; Niimi, Naoko; Gruz, Petr; Honma, Masamitsu; Nohmi, Takehiko] Natl Inst Hlth Sci, Div Genet & Mutagenesis, Setagaya Ku, Tokyo 1588501, Japan; [Kanemaru, Yuki] Showa Univ, Div Toxicol, Dept Pharmacol Toxicol & Therapeut, Sch Pharm,Shinagawa Ku, Tokyo 1420064, Japan; [Matsumoto, Kyomu] Inst Environm Toxicol, Toxicol Div, Ibaraki 3030043, Japan; [Adachi, Noritaka] Yokohama City Univ, Grad Sch Nanobiosci, Yokohama, Kanagawa 2360027, Japan	Nohmi, T (reprint author), Natl Inst Hlth Sci, Biol Safety Res Ctr, Tokyo 1588501, Japan.	nohmi@nihs.go.jp					Jaloszynski P, 2005, GENES CELLS, V10, P543, DOI 10.1111/j.1365-2443.2005.000858.x; Foti JJ, 2012, SCIENCE, V336, P315, DOI 10.1126/science.1219192; Zlatanou A, 2011, MOL CELL, V43, P649, DOI 10.1016/j.molcel.2011.06.023; Schmitt MW, 2009, BIOCHIMIE, V91, P1163, DOI 10.1016/j.biochi.2009.06.007; Adachi N, 2004, BIOCHEM BIOPH RES CO, V318, P856, DOI 10.1016/j.bbrc.2004.04.099; Okada T, 2002, J BIOL CHEM, V277, P48690, DOI 10.1074/jbc.M207957200; Choi JY, 2006, J BIOL CHEM, V281, P21062, DOI 10.1074/jbc.M602246200; Kanagaraj R, 2012, NUCLEIC ACIDS RES, V40, P8449, DOI 10.1093/nar/gks648; Sassa A, 2014, DNA REPAIR, V15, P21, DOI 10.1016/j.dnarep.2013.12.008; Adachi N, 2006, DNA CELL BIOL, V25, P19, DOI 10.1089/dna.2006.25.19; Fukuda H, 2009, J BIOL CHEM, V284, P25585, DOI 10.1074/jbc.M109.037259; Kamiya H, 2012, CHEM RES TOXICOL, V25, P1771, DOI 10.1021/tx300259x; Ohashi E, 2004, GENES CELLS, V9, P523, DOI 10.1111/j.1365-2443.2004.00747.x; Wojtaszek J, 2012, J BIOL CHEM, V287, P33836, DOI 10.1074/jbc.M112.394841; Masutani C, 1999, NATURE, V399, P700; Kawanishi S, 2006, TOXICOLOGY, V221, P172, DOI 10.1016/j.tox.2006.01.002; Iiizumi S, 2006, BIOTECHNIQUES, V41, P311, DOI 10.2144/000112233; McCulloch SD, 2008, CELL RES, V18, P148, DOI 10.1038/cr.2008.4; Gerlach VL, 1999, P NATL ACAD SCI USA, V96, P11922, DOI 10.1073/pnas.96.21.11922; Clements J, 2000, MUTAT RES-FUND MOL M, V455, P97, DOI 10.1016/S0027-5107(00)00066-X; Gruz P, 2001, J BIOL CHEM, V276, P47394, DOI 10.1074/jbc.M107213200; Wojtaszek J, 2012, J BIOL CHEM, V287, P26400, DOI 10.1074/jbc.M112.380998; Jones MJK, 2012, EMBO J, V31, P908, DOI 10.1038/emboj.2011.457; Chen JY, 2005, NAT REV CANCER, V5, P102, DOI 10.1038/nrc1547; Avkin S, 2004, J BIOL CHEM, V279, P53298, DOI 10.1074/jbc.M409155200; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Ogi T, 1999, GENES CELLS, V4, P607, DOI 10.1046/j.1365-2443.1999.00289.x; Wagner J, 1999, MOL CELL, V4, P281, DOI 10.1016/S1097-2765(00)80376-7; Yuan BF, 2011, J BIOL CHEM, V286, P17503, DOI 10.1074/jbc.M111.232835; Niimi N, 2009, BIOCHEMISTRY-US, V48, P4239, DOI 10.1021/bi900153t; Ogi T, 2010, MOL CELL, V37, P714, DOI 10.1016/j.molcel.2010.02.009; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; Nohmi T, 2006, ANNU REV MICROBIOL, V60, P231, DOI 10.1146/annurev.micro.60.080805.142238; Zhang XL, 2013, DNA REPAIR, V12, P377, DOI 10.1016/j.dnarep.2013.02.008; Huang XW, 2003, BIOCHEMISTRY-US, V42, P2456, DOI 10.1021/bi026912q; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Rajao MA, 2009, MOL MICROBIOL, V71, P185, DOI 10.1111/j.1365-2958.2008.06521.x; Lone S, 2007, MOL CELL, V25, P601, DOI 10.1016/j.molcel.2007.01.018; Povirk LF, 1996, MUTAT RES-FUND MOL M, V355, P71, DOI 10.1016/0027-5107(96)00023-1; Masutani C, 2000, EMBO J, V19, P3100, DOI 10.1093/emboj/19.12.3100; Petta TB, 2008, EMBO J, V27, P2883, DOI 10.1038/emboj.2008.210; Ulrich HD, 2013, CHROMOSOMA, V122, P259, DOI 10.1007/s00412-013-0410-4; Fischhaber PL, 2002, J BIOL CHEM, V277, P37604, DOI 10.1074/jbc.M206027200; Suzuki N, 2002, BIOCHEMISTRY-US, V41, P6100, DOI 10.1021/bi020049c; Ohashi E, 2009, GENES CELLS, V14, P101, DOI 10.1111/j.1365-2443.2008.01255.x; Yoon JH, 2010, P NATL ACAD SCI USA, V107, P14116, DOI 10.1073/pnas.1007795107; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4138, DOI 10.1093/nar/28.21.4138; Betous R, 2013, EMBO J, V32, P2172, DOI 10.1038/emboj.2013.148; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Ogi T, 2005, J CELL SCI, V118, P129, DOI 10.1242/jcs.01603; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Sassa A, 2011, MUTAT RES-GEN TOX EN, V718, P10, DOI 10.1016/j.mrgentox.2010.11.002; Minko IG, 2008, J BIOL CHEM, V283, P17075, DOI 10.1074/jbc.M801238200; Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Yoon JH, 2014, GENES CELLS, V19, P594, DOI 10.1111/gtc.12156; Bavoux C, 2005, CANCER RES, V65, P325; Lv LN, 2013, NUCLEIC ACIDS RES, V41, P10312, DOI 10.1093/nar/gkt793; Ogi T, 2002, P NATL ACAD SCI USA, V99, P15548, DOI 10.1073/pnas.222377899; Vermeulen C, 2007, RADIAT RES, V168, P683, DOI 10.1667/RR1057R.1; Friedberg EC, 2002, SCIENCE, V296, P1627, DOI 10.1126/science.1070236; Haracska L, 2002, P NATL ACAD SCI USA, V99, P16000, DOI 10.1073/pnas.252524999; Takenaka K, 2006, J BIOL CHEM, V281, P2000, DOI 10.1074/jbc.M506153200; Ogi T, 2006, NAT CELL BIOL, V8, P640, DOI 10.1038/ncb1417; Baptiste BA, 2012, ENVIRON MOL MUTAGEN, V53, P787, DOI 10.1002/em.21721; Sekiguchi M, 2002, ONCOGENE, V21, P8895, DOI 10.1038/sj.onc.1206023; Bebenek K, 2001, SCIENCE, V291, P2156, DOI 10.1126/science.1058386; Maddukuri L, NUCL ACIDS IN PRESS; Suzuki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061189; Takeiri A, 2014, DNA REPAIR, V24, P113, DOI 10.1016/j.dnarep.2014.09.002; Yoshimura Daisuke, 2003, Journal of Biological Chemistry, V278, P37965, DOI 10.1074/jbc.M306201200	71	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0893-6692	1098-2280		ENVIRON MOL MUTAGEN	Environ. Mol. Mutagen.	OCT	2015	56	8					650	662		10.1002/em.21961		13	Environmental Sciences; Genetics & Heredity; Toxicology	Environmental Sciences & Ecology; Genetics & Heredity; Toxicology	CU0LV	WOS:000363209100002		
J	Massana, R; Gobet, A; Audic, S; Bass, D; Bittner, L; Boutte, C; Chambouvet, A; Christen, R; Claverie, JM; Decelle, J; Dolan, JR; Dunthorn, M; Edvardsen, B; Forn, I; Forster, D; Guillou, L; Jaillon, O; Kooistra, WHCF; Logares, R; Mahe, F; Not, F; Ogata, H; Pawlowski, J; Pernice, MC; Probert, I; Romac, S; Richards, T; Santini, S; Shalchian-Tabrizi, K; Siano, R; Simon, N; Stoeck, T; Vaulot, D; Zingone, A; de Vargas, C				Massana, Ramon; Gobet, Angelique; Audic, Stephane; Bass, David; Bittner, Lucie; Boutte, Christophe; Chambouvet, Aurelie; Christen, Richard; Claverie, Jean-Michel; Decelle, Johan; Dolan, John R.; Dunthorn, Micah; Edvardsen, Bente; Forn, Irene; Forster, Dominik; Guillou, Laure; Jaillon, Olivier; Kooistra, Wiebe H. C. F.; Logares, Ramiro; Mahe, Frederic; Not, Fabrice; Ogata, Hiroyuki; Pawlowski, Jan; Pernice, Massimo C.; Probert, Ian; Romac, Sarah; Richards, Thomas; Santini, Sebastien; Shalchian-Tabrizi, Kamran; Siano, Raffaele; Simon, Nathalie; Stoeck, Thorsten; Vaulot, Daniel; Zingone, Adriana; de Vargas, Colomban			Marine protist diversity in European coastal waters and sediments as revealed by high-throughput sequencing	ENVIRONMENTAL MICROBIOLOGY			English	Article							RIBOSOMAL-RNA GENE; DEEP-SEA; EUKARYOTIC PICOPLANKTON; MICROBIAL EUKARYOTES; COMMUNITIES; PICOEUKARYOTES; PATTERNS; OCEANS; DNA; PHYTOPLANKTON	Although protists are critical components of marine ecosystems, they are still poorly characterized. Here we analysed the taxonomic diversity of planktonic and benthic protist communities collected in six distant European coastal sites. Environmental deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) from three size fractions (pico-, nano- and micro/mesoplankton), as well as from dissolved DNA and surface sediments were used as templates for tag pyrosequencing of the V4 region of the 18S ribosomal DNA. Beta-diversity analyses split the protist community structure into three main clusters: picoplankton-nanoplankton-dissolved DNA, micro/mesoplankton and sediments. Within each cluster, protist communities from the same site and time clustered together, while communities from the same site but different seasons were unrelated. Both DNA and RNA-based surveys provided similar relative abundances for most class-level taxonomic groups. Yet, particular groups were overrepresented in one of the two templates, such as marine alveolates (MALV)-I and MALV-II that were much more abundant in DNA surveys. Overall, the groups displaying the highest relative contribution were Dinophyceae, Diatomea, Ciliophora and Acantharia. Also, well represented were Mamiellophyceae, Cryptomonadales, marine alveolates and marine stramenopiles in the picoplankton, and Monadofilosa and basal Fungi in sediments. Our extensive and systematic sequencing of geographically separated sites provides the most comprehensive molecular description of coastal marine protist diversity to date.	[Massana, Ramon; Forn, Irene; Logares, Ramiro; Pernice, Massimo C.] CSIC, Inst Ciencias Mar, ES-08003 Barcelona, Catalonia, Spain; [Gobet, Angelique; Audic, Stephane; Bittner, Lucie; Boutte, Christophe; Decelle, Johan; Guillou, Laure; Not, Fabrice; Probert, Ian; Romac, Sarah; Simon, Nathalie; Vaulot, Daniel; de Vargas, Colomban] CNRS, Ecol Systemat Evolut, FR-29682 Roscoff, France; [Gobet, Angelique; Audic, Stephane; Bittner, Lucie; Boutte, Christophe; Decelle, Johan; Guillou, Laure; Not, Fabrice; Probert, Ian; Romac, Sarah; Simon, Nathalie; Vaulot, Daniel; de Vargas, Colomban] Univ Paris 06, Equipe EPPO Evolut Plancton & PaleoOceans, UMR7144, Roscoff, France; [Bass, David] Nat Hist Museum, London SW7 5BD, England; [Bass, David] Cefas, Weymouth DT4 8UB, Dorset, England; [Bittner, Lucie; Dunthorn, Micah; Forster, Dominik; Mahe, Frederic; Stoeck, Thorsten] Univ Kaiserslautern, D-67663 Kaiserslautern, Germany; [Chambouvet, Aurelie; Richards, Thomas] Univ Exeter, Biosci, Exeter EX4 4QD, Devon, England; [Christen, Richard] Univ Nice Sophia Antipolis, CNRS, UMR 7138, FR-06108 Nice, France; [Claverie, Jean-Michel; Santini, Sebastien] Aix Marseille Univ, CNRS, UMR 7256, FR-13288 Marseille, France; [Dolan, John R.] Univ Paris 06, CNRS, Lab Oceanog Villefranche, UMR 7093, FR-06230 Villefranche Sur Mer, France; [Edvardsen, Bente; Shalchian-Tabrizi, Kamran] Univ Oslo, Dept Biosci, N-0316 Oslo, Norway; [Jaillon, Olivier] CEA, Genoscope, FR-91000 Evry, France; [Kooistra, Wiebe H. C. F.; Zingone, Adriana] Stn Zool Anton Dohrn, I-80121 Naples, Italy; [Ogata, Hiroyuki] Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan; [Pawlowski, Jan] Univ Geneva, CH-1211 Geneva, Switzerland; [Siano, Raffaele] IFREMER, DYNECO Pelagos, Plouzane, France	Massana, R (reprint author), CSIC, Inst Ciencias Mar, ES-08003 Barcelona, Catalonia, Spain.	ramonm@icm.csic.es		Audic, Stephane/0000-0001-6193-4374; Kooistra, Wiebe/0000-0002-8641-9739	European project BioMarKs (ERA-net Biodiversa, EU) [2008-6530]; MICINN, Spain [CGL2010-16304]; OCEANOMICS (France) [ANR-11-BTBR-0008]; Swiss National Foundation [31003A-125372]; RCN (Norway) [190307]	Financial support has been provided by the European project BioMarKs (2008-6530, ERA-net Biodiversa, EU), and state-based projects FLAME (CGL2010-16304, MICINN, Spain) to RM, OCEANOMICS (ANR-11-BTBR-0008, France) to CdV, grant 31003A-125372 (Swiss National Foundation) to JP, and RCN grant 190307 (Norway) to BE.	C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; Corinaldesi C, 2011, MOL ECOL, V20, P642, DOI 10.1111/j.1365-294X.2010.04958.x; Stoeck T, 2010, MOL ECOL, V19, P21, DOI 10.1111/j.1365-294X.2009.04480.x; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Logares R, 2012, ISME J, V6, P1823, DOI 10.1038/ismej.2012.36; Bik HM, 2012, MOL ECOL, V21, P1048, DOI 10.1111/j.1365-294X.2011.05297.x; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Satta CT, 2010, DEEP-SEA RES PT II, V57, P256, DOI 10.1016/j.dsr2.2009.09.013; KARL DM, 1989, LIMNOL OCEANOGR, V34, P543; Guillou L, 2013, NUCLEIC ACIDS RES, V41, pD597, DOI 10.1093/nar/gks1160; Bates ST, 2013, ISME J, V7, P652, DOI 10.1038/ismej.2012.147; Sorensen N, 2013, MICROB ECOL, V65, P964, DOI 10.1007/s00248-012-0174-z; Pernice MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057170; Dolan JR, 2013, ISME J, V7, P1237, DOI 10.1038/ismej.2013.23; Nanjappa D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103810; Graham JM, 2004, MICROBIAL ECOL, V48, P528, DOI 10.1007/s00248-004-0223-3; Berney C, 2013, ISME J, V7, P2387, DOI 10.1038/ismej.2013.116; Egge ES, 2015, MOL ECOL, V24, P3026, DOI 10.1111/mec.13160; Kimoto K, 2011, ENV MICROBIOL REP, V3, P86, DOI 10.1111/j.1758-2229.2010.00191.x; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; Prosser JI, 2010, ENVIRON MICROBIOL, V12, P1806, DOI 10.1111/j.1462-2920.2010.02201.x; Robasky K, 2014, NAT REV GENET, V15, P56, DOI 10.1038/nrg3655; Massana R, 2004, APPL ENVIRON MICROB, V70, P3528, DOI 10.1128/AEM.70.6.3528-3534.2004; POULSEN LK, 1993, APPL ENVIRON MICROB, V59, P1354; Lee WJ, 1998, PROTIST, V149, P229; Edgcomb V, 2011, ISME J, V5, P1344, DOI 10.1038/ismej.2011.6; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Blazewicz SJ, 2013, ISME J, V7, P2061, DOI 10.1038/ismej.2013.102; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Logares R, 2014, CURR BIOL, V24, P813, DOI 10.1016/j.cub.2014.02.050; Massana R, 2011, ANNU REV MICROBIOL, V65, P91, DOI 10.1146/annurev-micro-090110-102903; Diez B, 2001, APPL ENVIRON MICROB, V67, P2932, DOI 10.1128/AEM.67.7.2932-2941.2001; Cheung MK, 2010, ISME J, V4, P1053, DOI 10.1038/ismej.2010.26; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Nolte V, 2010, MOL ECOL, V19, P2908, DOI 10.1111/j.1365-294X.2010.04669.x; Amato A, 2007, PROTIST, V158, P193, DOI 10.1016/j.protis.2006.10.001; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Olguin HF, 2006, J PLANKTON RES, V28, P1107, DOI 10.1093/plankt/fbl045; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006; Mangot JF, 2013, ENVIRON MICROBIOL, V15, P1745, DOI 10.1111/1462-2920.12065; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Pizay MD, 2009, PROTIST, V160, P565, DOI 10.1016/j.protis.2009.04.003; Lejzerowicz F, 2013, DEEP-SEA RES PT II, V86-87, P214, DOI 10.1016/j.dsr2.2012.08.008; He LM, 2014, MICROB ECOL, V67, P951, DOI 10.1007/s00248-014-0393-6; Sherr BF, 2007, OCEANOGRAPHY, V20, P130; Stoeck T, 2007, MICROB ECOL, V53, P328, DOI 10.1007/s00248-006-9166-1; Weinbauer MG, 2002, APPL ENVIRON MICROB, V68, P1082, DOI 10.1128/AEM.68.3.1082-1087.2002; Caron DA, 2009, ISME J, V3, P4, DOI 10.1038/ismej.2008.101; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; Burki F, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016147; Decelle J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104297; desVargas C, 2015, SCIENCE, V348; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; Guillou L, 2008, ENVIRON MICROBIOL, V10, P397; Massana R, 2014, ISME J, V8, P854, DOI 10.1038/ismej.2013.204; Not F, 2007, SCIENCE, V315, P252; Not F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007143; Oksanen J., 2008, VEGAN COMMUNITY ECOL; Pawlowski J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001419; Schaechter M, 2012, EUKARYOTIC MICROBES; Seenivasan R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059565; Siano R., 2010, BIOGEOSCI DISCUSS, V7, P7391; Weber AAT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056739	65	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1462-2912	1462-2920		ENVIRON MICROBIOL	Environ. Microbiol.	OCT	2015	17	10			SI		4035	4049		10.1111/1462-2920.12955		15	Microbiology	Microbiology	CU3TO	WOS:000363448500045		
J	Yanagisawa, K; Nakanishi, T; Kitagawa, Y; Seki, T; Akama, T; Kobayashi, M; Taketsugu, T; Ito, H; Fushimi, K; Hasegawa, Y				Yanagisawa, Kei; Nakanishi, Takayuki; Kitagawa, Yuichi; Seki, Tomohiro; Akama, Tomoko; Kobayashi, Masato; Taketsugu, Tetsuya; Ito, Hajime; Fushimi, Koji; Hasegawa, Yasuchika			Seven-Coordinate Luminophores: Brilliant Luminescence of Lanthanide Complexes with C-3v Geometrical Structures	EUROPEAN JOURNAL OF INORGANIC CHEMISTRY			English	Article						Lanthanides; Luminescence; O ligands; Structure elucidation; Density functional calculations	ENERGY-TRANSFER; EU(III) COMPLEX; EUROPIUM COMPLEXES; BETA-DIKETONATE; TO-METAL; EU-III; LIGAND; SENSITIZATION; EMISSION; EXCITATION	Enhanced luminescence properties of mononuclear lanthanide complexes with asymmetric seven-coordination structures are reported for the first time. The lanthanide complexes are composed of a lanthanide ion (Eu-III or Tb-III), three tetramethyl heptanedionato ligands, and one triphenylphosphine oxide ligand. The coordination geometries of the lanthanide complexes have been evaluated by using single-crystal X-ray analyses and shape-measurement calculations. The complexes are categorized to be seven-coordinate monocapped octahedral structures (point group C-3v). The seven-coordinate lanthanide complexes show high intrinsic emission quantum yields, extra-large radiative rate constants, and unexpected small nonradiative rate constants. The brilliant luminescence properties have been elucidated in terms of the asymmetric coordination geometry and small vibrational quanta related to thermal relaxation.	[Yanagisawa, Kei] Hokkaido Univ, Grad Sch Chem Sci & Engn, Sapporo, Hokkaido 0608628, Japan; [Nakanishi, Takayuki; Kitagawa, Yuichi; Seki, Tomohiro; Ito, Hajime; Fushimi, Koji; Hasegawa, Yasuchika] Hokkaido Univ, Fac Engn, Sapporo, Hokkaido 0608628, Japan; [Akama, Tomoko; Kobayashi, Masato; Taketsugu, Tetsuya] Hokkaido Univ, Fac Sci, Sapporo, Hokkaido 0600810, Japan	Hasegawa, Y (reprint author), Hokkaido Univ, Fac Engn, Kita 13 Jo,Nishi 8 Chome, Sapporo, Hokkaido 0608628, Japan.	hasegaway@eng.hokudai.ac.jp	Kobayashi, Masato/A-9230-2008	Kobayashi, Masato/0000-0002-4001-3581	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [2401]; Ministry of Education, Culture, Sports Science and Technology through a Program for Leading Graduate Schools (Hokkaido University "Ambitious Leader's Program")	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Area of "New Polymeric Materials Based on Element-Blocks" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (grant number 2401). K. Y. was supported by the Ministry of Education, Culture, Sports Science and Technology through a Program for Leading Graduate Schools (Hokkaido University "Ambitious Leader's Program").	DOLG M, 1993, J PHYS CHEM-US, V97, P5852, DOI 10.1021/j100124a012; Hasegawa Y, 2003, J PHYS CHEM A, V107, P1697, DOI 10.1021/jp022397u; Gao F, 2013, INORG CHEM, V52, P11164, DOI 10.1021/ic401421h; Goossens K, 2012, DALTON T, V41, P13271, DOI 10.1039/c2dt31870a; HAAS Y, 1974, J CHEM PHYS, V60, P258, DOI 10.1063/1.1680777; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Lima NBD, 2013, SCI REP-UK, V3, DOI 10.1038/srep02395; Divya V, 2011, DALTON T, V40, P3257, DOI 10.1039/c0dt01652g; Ke XS, 2014, CHEM-EUR J, V20, P4324, DOI 10.1002/chem.201303972; Kotova O, 2013, CHEM-EUR J, V19, P16181, DOI 10.1002/chem.201303660; PRODI L, 1991, INORG CHEM, V30, P3798, DOI 10.1021/ic00020a006; Freire RO, 2005, CHEM PHYS LETT, V405, P123, DOI 10.1016/j.cplett.2005.02.022; Miyata K, 2011, CHEM-EUR J, V17, P521, DOI 10.1002/chem.201001993; Ananias D, 2015, J AM CHEM SOC, V137, P3051, DOI 10.1021/ja512745y; Ahmed Z, 2013, J PHYS CHEM A, V117, P11183, DOI 10.1021/jp403668j; Eliseeva SV, 2008, J PHYS CHEM A, V112, P3614, DOI 10.1021/jp711305u; Zheng XL, 2007, ANGEW CHEM INT EDIT, V46, P7399, DOI 10.1002/anie.200702401; Biju S, 2014, INORG CHEM, V53, P8407, DOI 10.1021/ic500966z; Li CY, 2011, J AM CHEM SOC, V133, P11231, DOI 10.1021/ja202344c; Pavithran R, 2006, INORG CHEM, V45, P2184, DOI 10.1021/ic051781d; CARNALL WT, 1968, J CHEM PHYS, V49, P4450, DOI 10.1063/1.1669896; Miyata K, 2013, ANGEW CHEM INT EDIT, V52, P6413, DOI 10.1002/anie.201301448; Wong KMC, 2014, ADV MATER, V26, P5558, DOI 10.1002/adma.201306327; GORLLERWALRAND C, 1991, J CHEM PHYS, V95, P3099; Dogariu A, 1999, SYNTHETIC MET, V100, P95, DOI 10.1016/S0379-6779(98)00168-4; SATO S, 1970, B CHEM SOC JPN, V43, P1955, DOI 10.1246/bcsj.43.1955; Stoll T, 2014, ANGEW CHEM INT EDIT, V53, P1654, DOI 10.1002/anie.201308132; Jankolovits J, 2011, ANGEW CHEM INT EDIT, V50, P9660, DOI 10.1002/anie.201103851; Kang TS, 2003, ADV FUNCT MATER, V13, P205, DOI 10.1002/adfm.200390031; Trivedi ER, 2014, J AM CHEM SOC, V136, P1526, DOI 10.1021/ja4113337; Xu JD, 2000, INORG CHEM, V39, P4156, DOI 10.1021/ic000063i; Hasegawa Y, 1996, CHEM PHYS LETT, V248, P8, DOI 10.1016/0009-2614(95)01279-6; Scott AP, 1996, J PHYS CHEM-US, V100, P16502, DOI 10.1021/jp960976r; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; Liao ZY, 2015, CHEM COMMUN, V51, P2372, DOI 10.1039/c4cc09618e; Hasegawa Y, 1996, J PHYS CHEM-US, V100, P10201, DOI 10.1021/jp960290z; Kuriki K, 2002, CHEM REV, V102, P2347, DOI 10.1021/cr010309g; DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153; Foucault-Collet A, 2014, ANGEW CHEM INT EDIT, V53, P2927, DOI 10.1002/anie.201311028; Dutra JDL, 2011, J PHOTOCH PHOTOBIO A, V217, P389, DOI 10.1016/j.jphotochem.2010.11.011; Gao F, 2013, INORG CHEM, V52, P6407, DOI 10.1021/ic400245n; Werts MHV, 2002, PHYS CHEM CHEM PHYS, V4, P1542, DOI 10.1039/b107770h; Pacold JI, 2014, J AM CHEM SOC, V136, P4186, DOI 10.1021/ja407924m; Martins AF, 2014, CHEM-EUR J, V20, P14834, DOI 10.1002/chem.201403856; McGehee MD, 1999, ADV MATER, V11, P1349, DOI 10.1002/(SICI)1521-4095(199911)11:16<1349::AID-ADMA1349>3.0.CO;2-W; BAXTER I, 1995, INORG CHEM, V34, P1384, DOI 10.1021/ic00110a016; McMahon B, 2009, J AM CHEM SOC, V131, P17542, DOI 10.1021/ja908006r; Martin-Ramos P, 2015, J ALLOY COMPD, V619, P553, DOI 10.1016/j.jallcom.2014.09.090; Nakamura K, 2004, CHEM PHYS LETT, V398, P500, DOI 10.1016/j.cplett.2004.09.089; Bulter S. J., 2013, CHEM-EUR J, V19, P9511; de Battencourt-Dias A., 2012, J AM CHEM SOC, V134, P6987; Frisch M.J., 2009, GAUSSIAN 09; Ito H., 2015, CHEM COMMUN, V21, P3882; Miranda YC, 2015, EUR J INORG CHEM, P3019, DOI 10.1002/ejic.201500263; Miyata K., 2009, EUR J INORG CHEM, V32, P4777; Siesler H. W., 2008, NEAR INFRARED SPECTR, P16	56	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1434-1948	1099-0682		EUR J INORG CHEM	Eur. J. Inorg. Chem.	OCT	2015		28					4769	4774		10.1002/ejic.201500820		6	Chemistry, Inorganic & Nuclear	Chemistry	CT5CD	WOS:000362824100019		
J	Abe, A; Abe, S; Oya, S; Matsui, T				Abe, A.; Abe, S.; Oya, S.; Matsui, T.			Usefulness of Preoperative Dual-Phase thallium-201 SPECT and Imaging Fusion with SPECT and MRI in Predicting Histopathology of Meningiomas and Hemangioblastomas	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Abe, A.; Oya, S.; Matsui, T.] Saitama Med Univ, Kawagoe, Saitama, Japan; [Abe, S.] Mitsui Mem Hosp, Tokyo 101, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P555	S605	S605				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203058		
J	Akamatsu, G; Ikari, Y; Ohnishi, A; Nishio, T; Nishida, H; Aita, K; Yamamoto, Y; Sasaki, M; Sasaki, M; Senda, M				Akamatsu, G.; Ikari, Y.; Ohnishi, A.; Nishio, T.; Nishida, H.; Aita, K.; Yamamoto, Y.; Sasaki, M.; Sasaki, M.; Senda, M.			Automated PET-only quantification of amyloid deposition with adaptive template and amyloid-specific region-of-interest	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Akamatsu, G.; Ikari, Y.; Ohnishi, A.; Nishio, T.; Nishida, H.; Aita, K.; Sasaki, M.; Senda, M.] Inst Biomed Res & Innovat, Kobe, Hyogo, Japan; [Akamatsu, G.; Sasaki, M.] Kyushu Univ, Fukuoka 812, Japan; [Yamamoto, Y.] Kobe Univ, Kobe, Hyogo 657, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P486	S573	S573				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202654		
J	Alobthani, GS; Morita, T; Isohashi, K; Kato, H; Tatsumi, M; Shimosegawa, E; Hatazawa, J				Alobthani, G. S.; Morita, T.; Isohashi, K.; Kato, H.; Tatsumi, M.; Shimosegawa, E.; Hatazawa, J.			Prolonged effect of chemotherapy on FDG uptake of the noraml bone marrow in patients with malignant lymphoma	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Alobthani, G. S.; Morita, T.; Isohashi, K.; Kato, H.; Tatsumi, M.; Hatazawa, J.] Osaka Univ, Grad Sch Med, Dept Nucl Med & Tracer Kinet, Osaka, Japan; [Shimosegawa, E.] Osaka Univ, Grad Sch Med, Dept Molcular Imaging Med, Osaka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P734	S692	S693				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203236		
J	Arakawa, Y; Shidahara, M; Nai, Y; Furumoto, S; Seki, C; Okamura, N; Tashiro, M; Tashiro, M; Kudo, Y; Yanai, K; Gonda, K; Watabe, H				Arakawa, Y.; Shidahara, M.; Nai, Y.; Furumoto, S.; Seki, C.; Okamura, N.; Tashiro, M.; Tashiro, M.; Kudo, Y.; Yanai, K.; Gonda, K.; Watabe, H.			Biomathematical modeling approach to predict clinical SUVR in amyloid PET imaging towards efficient radioligand discovery and development	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med			BRAIN		[Arakawa, Y.; Shidahara, M.; Okamura, N.; Kudo, Y.; Yanai, K.; Gonda, K.] Tohoku Univ, Sch Med, Sendai, Miyagi 980, Japan; [Nai, Y.; Furumoto, S.; Tashiro, M.; Tashiro, M.; Watabe, H.] Tohoku Univ, CYRIC, Sendai, Miyagi 980, Japan; [Seki, C.] Natl Inst Radiol Sci, Chiba 260, Japan							[Anonymous], 2007, J MED CHEM, V50, P4606; [Anonymous], 2009, J NUCL MED, V50, P1715; [Anonymous], 2006, J PHARM EXP THER, V316, P1282	3	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP162	S70	S70				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201117		
J	Banno, Y; Onoguchi, M; Nakajima, K; Matsuo, S				Banno, Y.; Onoguchi, M.; Nakajima, K.; Matsuo, S.			Performance of image evaluation due to the difference in the acquisition time using multifocal collimator with 99mTc myocardial SPECT: Evidence from a phantom study	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Banno, Y.; Onoguchi, M.] Kanazawa Univ, Dept Quantum Med Technol, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan; [Nakajima, K.; Matsuo, S.] Kanazawa Univ Hosp, Dept Nucl Med, Kanazawa, Ishikawa, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		TP053	S835	S836				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203537		
J	Brendel, M; Jaworska, A; Probst, F; Overhoff, F; Carlsen, J; Lindner, S; Herms, J; Bartenstein, P; Okamura, N; Rominger, A				Brendel, M.; Jaworska, A.; Probst, F.; Overhoff, F.; Carlsen, J.; Lindner, S.; Herms, J.; Bartenstein, P.; Okamura, N.; Rominger, A.			PET Imaging of Tau Pathology in two Transgenic Mouse Models using [F-18]-THK-5117	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Brendel, M.; Probst, F.; Overhoff, F.; Carlsen, J.; Lindner, S.; Bartenstein, P.; Rominger, A.] Univ Munich, Munich, Germany; [Jaworska, A.; Herms, J.] DZNE, Munich, Germany; [Okamura, N.] Tohoku Univ, Sendai, Miyagi 980, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP051	S21	S21				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201025		
J	Endo, M; Asakura, K; Aramaki, T; Bekku, E; Sato, R; Yoza, K				Endo, M.; Asakura, K.; Aramaki, T.; Bekku, E.; Sato, R.; Yoza, K.			The evaluation of clinical usefulness of continuous bed motion scanning in positron emission tomography in diagnosis of patients with subsolid pulmonary nodule	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Endo, M.; Asakura, K.; Aramaki, T.; Bekku, E.; Sato, R.; Yoza, K.] Shizuoka Canc Ctr, Shizuoka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P636	S644	S645				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203139		
J	Fujiwara, K; Koyama, K; Suga, K; Takahashi, M; Kusano-Arai, O; Mitsui, K; Akiba, H; Iwanari, H; Tsumoto, K; Hamakubo, T; Momose, T				Fujiwara, K.; Koyama, K.; Suga, K.; Takahashi, M.; Kusano-Arai, O.; Mitsui, K.; Akiba, H.; Iwanari, H.; Tsumoto, K.; Hamakubo, T.; Momose, T.			Imaging of CDH17-positive gastric cancer xenografts with 64Cu-labeled anti-CDH17 IgG PET	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Fujiwara, K.; Koyama, K.; Takahashi, M.; Momose, T.] Univ Tokyo, Grad Sch Med, Dept Radiol, Tokyo, Japan; [Suga, K.] SANKYO LABO SERV Co Ltd, Tokyo, Japan; [Kusano-Arai, O.; Mitsui, K.; Iwanari, H.; Hamakubo, T.] Univ Tokyo, Res Ctr Adv Sci & Technol, Dept Quantitat Biol & Med, Tokyo, Japan; [Akiba, H.; Tsumoto, K.] Univ Tokyo, Sch Engn, Dept Bioengn, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P166	S420	S420				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202341		
J	Fukuda, Y; Yamamoto, Y; Yamamoto, H; Ishikawa, R; Akamoto, S; Toyohara, J; Nishiyama, Y				Fukuda, Y.; Yamamoto, Y.; Yamamoto, H.; Ishikawa, R.; Akamoto, S.; Toyohara, J.; Nishiyama, Y.			Detection of gastrointestinal cancer using 4 '-[methyl-11C] thiothymidine PET/CT for proliferation imaging: comparison with 18F-FDG PET/CT	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Fukuda, Y.; Yamamoto, Y.; Nishiyama, Y.] Kagawa Univ, Dept Radiol, Takamatsu, Kagawa 760, Japan; [Yamamoto, H.] Kagawa Univ, Dept Med Phys, Takamatsu, Kagawa 760, Japan; [Ishikawa, R.] Kagawa Univ, Dept Diag Pathol, Takamatsu, Kagawa 760, Japan; [Akamoto, S.] Kagawa Univ, Dept Gastroenterol Surg, Takamatsu, Kagawa 760, Japan; [Toyohara, J.] Tokyo Metropolitan Inst Gerontol, Res Team Neuroimaging, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P133	S404	S404				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202308		
J	Fukushima, K; Arias, P; Wakabayashi, H; Shinaji, T; Werner, R; Pelzer, H; Higuchi, T				Fukushima, K.; Arias, P.; Wakabayashi, H.; Shinaji, T.; Werner, R.; Pelzer, H.; Higuchi, T.			Myocardial Insulin Resistant under Hyperinsulinemic-Euglycemic Clamp in a Rat Model	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Fukushima, K.; Arias, P.; Wakabayashi, H.; Shinaji, T.; Werner, R.; Pelzer, H.; Higuchi, T.] Univ Wurzburg, D-97070 Wurzburg, Germany; [Fukushima, K.] Hyogo Coll Med, Nishinomiya, Hyogo, Japan; [Shinaji, T.; Werner, R.; Higuchi, T.] Comprehens Heart Failure Cener, Wurzburg, Germany								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P334	S502	S502				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202507		
J	Fukushima, Y; Kumita, S; Hashimoto, H; Sugihara, Y				Fukushima, Y.; Kumita, S.; Hashimoto, H.; Sugihara, Y.			Prognostic impact of deep-inspiratory breath-hold pulmonary perfusion SPECT-CT in patients with pulmonary thromboembolism	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Fukushima, Y.; Kumita, S.; Hashimoto, H.; Sugihara, Y.] Nippon Med Coll Hosp, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P985	S808	S809				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203481		
J	Fukuzawa, S; Okino, S; Maekawa, J; Ichikawa, S; Kuroiwa, N; Yamanaka, K; Igarashi, T; Inagaki, M				Fukuzawa, S.; Okino, S.; Maekawa, J.; Ichikawa, S.; Kuroiwa, N.; Yamanaka, K.; Igarashi, T.; Inagaki, M.			Nuclear Cardiac Imaging Versus Fractional Flow Reserve in Diagonal Side Branch Ostial Stenosis After Left Anterior Descending Crossover Stenting	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Fukuzawa, S.; Okino, S.; Maekawa, J.; Ichikawa, S.; Kuroiwa, N.; Yamanaka, K.; Igarashi, T.; Inagaki, M.] Funabashi Municipal Med Ctr, Funabashi, Chiba, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP170	S74	S74				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201125		
J	Hanaoka, K; Hosono, M; Otsuka, M; Asai, Y; Okumura, M; Ishii, K; Murakami, T				Hanaoka, K.; Hosono, M.; Otsuka, M.; Asai, Y.; Okumura, M.; Ishii, K.; Murakami, T.			Therapy planning and dose prescription in radioiodine-131 therapy for hyperthyroidism using radioiodine-123 SPECT/CT imaging	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Hanaoka, K.; Hosono, M.; Otsuka, M.; Asai, Y.; Okumura, M.; Ishii, K.; Murakami, T.] Kinki Univ, Sakai, Osaka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		TP074	S845	S846				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203558		
J	Hanaoka, K; Hosono, M; Inada, M; Sakaguchi, K; Shimomura, K; Tamura, M; Matsumoto, K; Monzen, H; Nishimura, Y				Hanaoka, K.; Hosono, M.; Inada, M.; Sakaguchi, K.; Shimomura, K.; Tamura, M.; Matsumoto, K.; Monzen, H.; Nishimura, Y.			Assessment of heart injury induced by radiation therapy for esophageal cancer using FDG-PET/CT	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Hanaoka, K.; Hosono, M.; Inada, M.; Sakaguchi, K.; Shimomura, K.; Tamura, M.; Matsumoto, K.; Monzen, H.; Nishimura, Y.] Kinki Univ, Sakai, Osaka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P142	S408	S408				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202317		
J	Hashimoto, H				Hashimoto, H.			Determining prognosis using lower limb perfusion SPECT-CT in patients with arteriosclerosis obliterans	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Hashimoto, H.] Nippon Med Sch, Dept Radiol, Tokyo 113, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P979	S806	S806				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203476		
J	Hayakawa, N; Nakamoto, Y; Ishimori, T; Togashi, K				Hayakawa, N.; Nakamoto, Y.; Ishimori, T.; Togashi, K.			Is diffuse increased FDG uptake in renal parenchyma associated with impaired renal disfunction?	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Hayakawa, N.; Nakamoto, Y.; Ishimori, T.; Togashi, K.] Kyoto Univ, Grad Sch Med, Kyoto, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P980	S806	S807				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203477		
J	Hayasaka, K; Nihashi, T; Inoue, H; Saitoh, T; Shiraishi, Y; Yoshimori, K; Gotoh, H				Hayasaka, K.; Nihashi, T.; Inoue, H.; Saitoh, T.; Shiraishi, Y.; Yoshimori, K.; Gotoh, H.			Dual-phase F-18 FDG PET diagnosis of pulmonary adenocarcinoma smaller than 3 cm	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Hayasaka, K.; Inoue, H.; Saitoh, T.; Shiraishi, Y.; Yoshimori, K.; Gotoh, H.] Fukujyuuji Hoaspital, Tokyo, Japan; [Nihashi, T.] Nagoya Grad Scholl Med, Nagoya, Aichi, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P612	S633	S633				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203115		
J	Hosono, M; Takahara, N; Yakushiji, Y; Sakaguchi, K; Yamada, Y; Hosokawa, C; Ishii, K				Hosono, M.; Takahara, N.; Yakushiji, Y.; Sakaguchi, K.; Yamada, Y.; Hosokawa, C.; Ishii, K.			Occupational radiation exposure of nursing staff in PET facility in association with performance status of patients	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Hosono, M.; Takahara, N.; Yakushiji, Y.; Sakaguchi, K.; Yamada, Y.; Hosokawa, C.; Ishii, K.] Kinki Univ, Fac Med, Osaka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		TP099	S856	S856				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203583		
J	Hosono, M; Tachibana, I; NIshimura, Y; Hanaoka, K; Kanamori, S; Nakamatsu, K; Ishikawa, K; Sakaguchi, K				Hosono, M.; Tachibana, I.; NIshimura, Y.; Hanaoka, K.; Kanamori, S.; Nakamatsu, K.; Ishikawa, K.; Sakaguchi, K.			Texture analysis for tumor hypoxia visualized by FMISO PET/CT during radiation therapy	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Hosono, M.; Tachibana, I.; NIshimura, Y.; Hanaoka, K.; Kanamori, S.; Nakamatsu, K.; Ishikawa, K.; Sakaguchi, K.] Kinki Univ, Fac Med, Osaka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P775	S712	S712				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203277		
J	Imabayashi, E; Baba, H; Matsuda, H; Kuji, I				Imabayashi, E.; Baba, H.; Matsuda, H.; Kuji, I.			Pilot data on 11C-PiB PET in major depressive disorder	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Imabayashi, E.; Matsuda, H.] Natl Ctr Neurol & Psychiat, Tokyo, Japan; [Baba, H.] Juntendo Univ, Tokyo, Japan; [Kuji, I.] Saitama Med Univ, Saitama Int Ctr, Saitama, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P445	S553	S554				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202614		
J	Inai, R; Takayoshi, S; Tanaka, T; Tsuboi, Y; Norikane, S; Kojima, K; Tada, A; Kunisada, T; Sato, S; Ozaki, T; Kanazawa, S				Inai, R.; Takayoshi, S.; Tanaka, T.; Tsuboi, Y.; Norikane, S.; Kojima, K.; Tada, A.; Kunisada, T.; Sato, S.; Ozaki, T.; Kanazawa, S.			Prominent thallium-201 uptake of giant cell tumor of bone : comparison with osteosarcoma	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Inai, R.; Tanaka, T.; Tsuboi, Y.; Norikane, S.; Kojima, K.; Tada, A.; Kunisada, T.; Sato, S.; Ozaki, T.; Kanazawa, S.] Okayama Univ Hosp, Okayama, Japan; [Takayoshi, S.] Tokushima Univ Hosp, Tokushima, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P930	S783	S784				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203429		
J	Inaki, A; Nakajima, K; Watanabe, S; Kinuya, S				Inaki, A.; Nakajima, K.; Watanabe, S.; Kinuya, S.			Diagnostic accuracy of quantitative bone scintigraphy with artificial neural network in patients with breast cancer	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Inaki, A.; Nakajima, K.; Watanabe, S.; Kinuya, S.] Kanazawa Univ Hosp, Kanazawa, Ishikawa, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P063	S371	S371				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202238		
J	Ishibashi, M; Tanabe, Y; Fujii, S; Ohta, Y; Ogawa, T				Ishibashi, M.; Tanabe, Y.; Fujii, S.; Ohta, Y.; Ogawa, T.			FDG-PET/CT in thymic epithelial tumors: correlation with the WHO classification and the tumor stage	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Ishibashi, M.; Tanabe, Y.; Fujii, S.; Ohta, Y.; Ogawa, T.] Tottori Univ, Fac Med, Dept Pathophysiol & Therapeut Sci, Div Radiol, Yonago, Tottori 683, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P634	S643	S644				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203137		
J	Ishiguchi, H; Ito, S; Sakurai, Y; Kawai, H; Kato, K; Naganawa, S; Hama, A; Muramatsu, H; Takahashi, Y; Kojima, S				Ishiguchi, H.; Ito, S.; Sakurai, Y.; Kawai, H.; Kato, K.; Naganawa, S.; Hama, A.; Muramatsu, H.; Takahashi, Y.; Kojima, S.			Comparison between FDG-PET and DWIBS in Diagnosing Neuroblastoma of Child	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Ishiguchi, H.; Ito, S.; Sakurai, Y.; Kawai, H.; Kato, K.; Naganawa, S.; Hama, A.; Muramatsu, H.; Takahashi, Y.; Kojima, S.] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan			Naganawa, Shinji/I-1572-2012	Naganawa, Shinji/0000-0002-0214-613X				0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P139	S407	S407				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202314		
J	Ishii, K; Takahashi, R; Wakabyashi, Y; Hosokawa, C; Kaida, H; Murakami, T				Ishii, K.; Takahashi, R.; Wakabyashi, Y.; Hosokawa, C.; Kaida, H.; Murakami, T.			Introducing the Glucose Metabolism to Amyloid Deposition Ratio Image	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Ishii, K.; Wakabyashi, Y.; Hosokawa, C.; Kaida, H.; Murakami, T.] Kinki Univ, Osakasayama, Japan; [Takahashi, R.] Hyogo Prefectural Rehabil Hosp Nishi Harima, Tatsuno, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P428	S546	S546				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202598		
J	Isohashi, K; Kato, H; Horitsugi, G; Naka, S; Mochida, I; Shimosegawa, E; Hatazawa, J				Isohashi, K.; Kato, H.; Horitsugi, G.; Naka, S.; Mochida, I.; Shimosegawa, E.; Hatazawa, J.			Dynamic whole body distribution of FBPA in humans studied with 3D PET/CT	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Isohashi, K.; Kato, H.; Horitsugi, G.; Naka, S.; Mochida, I.; Hatazawa, J.] Osaka Univ, Grad Sch Med, Nucl Med & Tracer Kinet, Suita, Osaka, Japan; [Shimosegawa, E.] Osaka Univ, Grad Sch Med, PET Mol Imaging Ctr, Suita, Osaka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P088	S382	S383				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202263		
J	Ito, S; Iwano, S; Kato, K; Naganawa, S				Ito, S.; Iwano, S.; Kato, K.; Naganawa, S.			Predictive factors for the outcome of I-131 1110MBq ablation therapy in the patients with differentiated thyroid cancer: urinary iodine, serum thyroglobulin, and uptake to thyroid bed	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Ito, S.; Iwano, S.; Naganawa, S.] Nagoya Univ, Grad Sch Med, Dept Radiol, Nagoya, Aichi 4648601, Japan; [Kato, K.] Nagoya Univ, Grad Sch Med, Dept Radiol & Med Lab Sci, Nagoya, Aichi 4648601, Japan			Naganawa, Shinji/I-1572-2012	Naganawa, Shinji/0000-0002-0214-613X				0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P545	S600	S601				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203048		
J	Itoh, K; Kitsukawa, T; Takahashi, H; Myoujin, M; Oishi, T; Takenouchi, T; Watanabe, S; Kanegae, K; Hosokawa, M				Itoh, K.; Kitsukawa, T.; Takahashi, H.; Myoujin, M.; Oishi, T.; Takenouchi, T.; Watanabe, S.; Kanegae, K.; Hosokawa, M.			Tumor FDG-Metabolic Values to Predict Pathological Response After Neoadjuvant Chemoradiotherapy in Patients with Resectable Locally Advanced Esophageal Cancer	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Itoh, K.; Watanabe, S.; Kanegae, K.] Keiyukai Sapporo Hosp, Radiol Imaging Ctr, Sapporo, Hokkaido, Japan; [Kitsukawa, T.; Hosokawa, M.] Keiyukai Sapporo Hosp, Dept Digest Surg, Sapporo, Hokkaido, Japan; [Takahashi, H.] Keiyukai Sapporo 2nd Hosp, Dept Internal Med, Sapporo, Hokkaido, Japan; [Myoujin, M.] Keiyukai Sapporo Hosp, Deparrtment Radiotherapy, Sapporo, Hokkaido, Japan; [Oishi, T.; Takenouchi, T.] Keiyukai Sapporo Hosp, Dept Clin Pathol, Sapporo, Hokkaido, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P773	S711	S712				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203275		
J	Jinguji, M; Nakajo, M; Nakajo, M; Nakabeppu, Y; Koriyama, C; Yoshiura, T				Jinguji, M.; Nakajo, M.; Nakajo, M.; Nakabeppu, Y.; Koriyama, C.; Yoshiura, T.			Thymic involution after radioiodine therapy for Graves' disease	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Jinguji, M.; Nakajo, M.; Nakajo, M.; Nakabeppu, Y.; Yoshiura, T.] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Radiol, Kagoshima 890, Japan; [Koriyama, C.] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Epidemiol & Prevent Med, Kagoshima 890, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P807	S727	S728				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203309		
J	Kaida, H; Azuma, K; Kawahara, A; Hattori, S; Takamori, S; Sadashima, E; Fujimoto, K; Kage, M; Kurata, S; Hirose, Y; Ishii, K; Murakami, T; Ishibashi, M				Kaida, H.; Azuma, K.; Kawahara, A.; Hattori, S.; Takamori, S.; Sadashima, E.; Fujimoto, K.; Kage, M.; Kurata, S.; Hirose, Y.; Ishii, K.; Murakami, T.; Ishibashi, M.			The correlation between 18F-FDG uptake and Glut-1, Stat-1 and Stat-3 in non-small cell lung cancer patients.	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Kaida, H.; Ishii, K.; Murakami, T.] Kinki Univ, Fac Med, Osakasayama City, Japan; [Azuma, K.; Kawahara, A.; Hattori, S.; Takamori, S.; Sadashima, E.; Fujimoto, K.; Kage, M.; Kurata, S.; Hirose, Y.] Kurume Univ, Sch Med, Kurume, Fukuoka 830, Japan; [Ishibashi, M.] Fukuoka Tokushukai Hosp, Kasuga, Fukuoka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		PW040	S298	S298				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202098		
J	Kamiya, Y; Okumiya, S; Takaki, A; Yamashita, K; Ito, S				Kamiya, Y.; Okumiya, S.; Takaki, A.; Yamashita, K.; Ito, S.			Development of a new quantification method using the I-123 MIBG myocardial single photon emission tomography	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Kamiya, Y.; Okumiya, S.; Ito, S.] Kumamoto Univ, Kumamoto, Japan; [Kamiya, Y.] Chibana Clin, Okinawa, Japan; [Takaki, A.; Yamashita, K.] Fujifilm RI Pharma Co Ltd, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		PW041	S298	S299				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202099		
J	Kasai, T; Aiga, M; Iwasaki, Y; Oshima, K; Sasaki, Y; Fujita, Y; Tanaka, N; Yamashina, A				Kasai, T.; Aiga, M.; Iwasaki, Y.; Oshima, K.; Sasaki, Y.; Fujita, Y.; Tanaka, N.; Yamashina, A.			Usefulness and safety of adenosine stress myocardial perfusion SPECT for patients with "inactive" bronchial asthma.	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Kasai, T.; Aiga, M.; Iwasaki, Y.; Oshima, K.; Sasaki, Y.; Fujita, Y.; Tanaka, N.] Tokyo Med Univ, Hachioji Med Ctr, Tokyo 1608402, Japan; [Yamashina, A.] Tokyo Med Univ, Tokyo 1608402, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P404	S534	S534				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202574		
J	Kasai, T; Aiga, M; Iwasaki, Y; Oshima, K; Fujita, Y; Sasaki, Y; Tanaka, N; Yamashina, A				Kasai, T.; Aiga, M.; Iwasaki, Y.; Oshima, K.; Fujita, Y.; Sasaki, Y.; Tanaka, N.; Yamashina, A.			Usefulness of simultaneous intermediate-level exercise for dobutamine stress myocardial perfusion imaging	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Kasai, T.; Aiga, M.; Oshima, K.; Fujita, Y.; Sasaki, Y.; Tanaka, N.] Tokyo Med Univ, Hachioji Med Ctr, Tokyo 1608402, Japan; [Iwasaki, Y.; Yamashina, A.] Tokyo Med Univ, Tokyo 1608402, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP187	S79	S79				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201134		
J	Kataoka, S; Momose, M; Fukushima, K; Serizawa, N; Suzuki, A; Kondo, C; Abe, K; Sakai, S; Hagiwara, N				Kataoka, S.; Momose, M.; Fukushima, K.; Serizawa, N.; Suzuki, A.; Kondo, C.; Abe, K.; Sakai, S.; Hagiwara, N.			Relationship between active inflammation and myocardial injury in patients with cardiac sarcoidosis as detected by non-invasive multi-modality imaging	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Kataoka, S.; Momose, M.; Fukushima, K.; Serizawa, N.; Suzuki, A.; Kondo, C.; Abe, K.; Sakai, S.; Hagiwara, N.] Tokyo Womens Med Univ, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP437	S179	S179				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201315		
J	Kato, H; Shimosegawa, E; Fujino, K; Hatazawa, J				Kato, H.; Shimosegawa, E.; Fujino, K.; Hatazawa, J.			Attenuation correction by CTcan improve detectability of lesions by voxel based statistical analysis of brain SPECT	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Kato, H.; Shimosegawa, E.; Hatazawa, J.] Osaka Univ, Grad Sch Med, Osaka, Japan; [Fujino, K.] Osaka Univ, Hosp Med, Osaka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P494	S576	S577				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202661		
J	Kato, K; Tsuchiya, S; Koshiba, Y; Odagawa, T; Abe, S; Kubota, T; Terasaki, H; Naganawa, S				Kato, K.; Tsuchiya, S.; Koshiba, Y.; Odagawa, T.; Abe, S.; Kubota, T.; Terasaki, H.; Naganawa, S.			Comparison of I-123-IMP SPECT, F-18-FDG PET, and F-18-FDOPA PET in Detection of Uveal Malignant Melanoma	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Kato, K.; Tsuchiya, S.; Koshiba, Y.; Odagawa, T.; Terasaki, H.; Naganawa, S.] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Abe, S.] Nagoya Univ Hosp, Nagoya, Aichi, Japan; [Kubota, T.] Nagoya Med Ctr, Natl Hosp Org, Nagoya, Aichi, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		PW088	S323	S323				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202146		
J	Kawabe, J; Higashiyama, S; Kotani, K; Yoshida, A; Shiomi, S				Kawabe, J.; Higashiyama, S.; Kotani, K.; Yoshida, A.; Shiomi, S.			Evaluation of ablation of thyroid remnants with 1850MBq iodine-131 in patients with thyroid cancer	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Kawabe, J.; Higashiyama, S.; Kotani, K.; Yoshida, A.; Shiomi, S.] Osaka City Univ, Grad Sch Med, Osaka 558, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P813	S730	S731				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203315		
J	Kawamura, K; Shimoda, Y; Yui, J; Zhang, Y; Yamasaki, T; Wakizaka, H; Fujinaga, M; Kumata, K; Xie, L; Hatori, A; Ogawa, M; Kurihara, Y; Nengaki, N; Zhang, M				Kawamura, K.; Shimoda, Y.; Yui, J.; Zhang, Y.; Yamasaki, T.; Wakizaka, H.; Fujinaga, M.; Kumata, K.; Xie, L.; Hatori, A.; Ogawa, M.; Kurihara, Y.; Nengaki, N.; Zhang, M.			PET imaging of a feeding center using [11C]BU99008 with ultra-high specific activity	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Kawamura, K.; Shimoda, Y.; Yui, J.; Zhang, Y.; Yamasaki, T.; Wakizaka, H.; Fujinaga, M.; Kumata, K.; Xie, L.; Ogawa, M.; Kurihara, Y.; Nengaki, N.; Zhang, M.] Natl Inst Radiol Sci, Chiba 260, Japan; [Ogawa, M.; Kurihara, Y.; Nengaki, N.] SHI Accelerator Serv, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		PW002	S278	S279				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202060		
J	Kawamura, K; Ogawa, M; Takei, M; Kumata, K; Furutsuka, K; Yamasaki, T; Yui, J; Xie, L; Hatori, A; Zhang, Y; Nengaki, N; Hirano, K; Zhang, MR				Kawamura, K.; Ogawa, M.; Takei, M.; Kumata, K.; Furutsuka, K.; Yamasaki, T.; Yui, J.; Xie, L.; Hatori, A.; Zhang, Y.; Nengaki, N.; Hirano, K.; Zhang, M. R.			Efficient synthesis of [18F]FEDAC, and evaluation of non-clinical safety and stability tests for clinical application.	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Kawamura, K.; Ogawa, M.; Takei, M.; Kumata, K.; Furutsuka, K.; Yamasaki, T.; Yui, J.; Xie, L.; Hatori, A.; Zhang, Y.; Nengaki, N.; Zhang, M. R.] Natl Inst Radiol Sci, Chiba 260, Japan; [Ogawa, M.; Furutsuka, K.; Nengaki, N.] SHI Accelerator Serv, Tokyo, Japan; [Hirano, K.] NMP Business Support Co, Chiba, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		PW010	S282	S283				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202068		
J	Kinjo, T; Nakatani, K; Yoshino, K; Kitaguchi, K; Koyama, T				Kinjo, T.; Nakatani, K.; Yoshino, K.; Kitaguchi, K.; Koyama, T.			FDG-PET/CT in intravascular large B-cell lymphoma: evaluation of diffuse splenic and bone marrow uptake as predictive factors of hemophagocytic syndrome	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Kinjo, T.; Nakatani, K.; Yoshino, K.; Kitaguchi, K.; Koyama, T.] Kurashiki Cent Hosp, Kurashiki, Okayama, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P723	S687	S687				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203225		
J	Kondo, C; Watanabe, E; Momose, M; Fukushima, K; Abe, K; Hagiwara, N; Sakai, S				Kondo, C.; Watanabe, E.; Momose, M.; Fukushima, K.; Abe, K.; Hagiwara, N.; Sakai, S.			In vivo validation of gated myocardial SPECT imaging for quantification of small hearts: comparison with cardiac MRI	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Kondo, C.; Watanabe, E.; Momose, M.; Fukushima, K.; Abe, K.; Hagiwara, N.; Sakai, S.] Tokyo Womens Med Univ, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP171	S74	S75				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201126		
J	Koshiba, Y; Abe, S; Tsuchiya, S; Fujita, N; Odagawa, T; Kato, K				Koshiba, Y.; Abe, S.; Tsuchiya, S.; Fujita, N.; Odagawa, T.; Kato, K.			Studies on measurement of thyroid uptake rate on I-131 scintigraphy images	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Koshiba, Y.; Tsuchiya, S.; Odagawa, T.; Kato, K.] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Abe, S.; Fujita, N.] Nagoya Univ Hosp, Nagoya, Aichi, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		TP008	S814	S814				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203492		
J	Koyama, K; Kubota, K; Mochiki, M; Ogura, T; Hoshizaki, H; Oshima, S; Higuchi, T; Tsushima, Y				Koyama, K.; Kubota, K.; Mochiki, M.; Ogura, T.; Hoshizaki, H.; Oshima, S.; Higuchi, T.; Tsushima, Y.			Quantification of left ventricular function using gated SPECT with two different automated software packages and cardiac MRI	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Koyama, K.; Kubota, K.; Mochiki, M.; Ogura, T.; Hoshizaki, H.; Oshima, S.] Gunma Prefectural Cardiovasc Ctr, Maebashi, Gumma, Japan; [Higuchi, T.; Tsushima, Y.] Gunma Facul Med, Maebashi, Gumma, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P223	S447	S448				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202396		
J	Koyama, K; Mitsumoto, T; Inoue, K; Tsuda, K; Kotaka, K; Yoshikawa, K; Hatano, K; Fukushi, M				Koyama, K.; Mitsumoto, T.; Inoue, K.; Tsuda, K.; Kotaka, K.; Yoshikawa, K.; Hatano, K.; Fukushi, M.			development of metabolic tumor volume measurement based on suvpeak	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Koyama, K.; Mitsumoto, T.; Kotaka, K.; Yoshikawa, K.; Hatano, K.] Tokyo Bay Adv Imaging & Radiat Oncol Clinic MAKUH, Chiba, Japan; [Koyama, K.; Inoue, K.; Fukushi, M.] Tokyo Metropolitan Univ, Tokyo 158, Japan; [Tsuda, K.] Tsukuba Int Univ, Ibaraki, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P074	S376	S376				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202249		
J	Kubota, K; Morooka, M; Okasaki, M; Kameyama, M; Miyata, Y; Minamimoto, R; Goda, Y; Yano, H				Kubota, K.; Morooka, M.; Okasaki, M.; Kameyama, M.; Miyata, Y.; Minamimoto, R.; Goda, Y.; Yano, H.			FDGPET/CT for Pseudomyxoma Peritonei (PMP) and other peritoneal malignancies: Diagnostic features and prognostic consideration	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Kubota, K.; Morooka, M.; Okasaki, M.; Kameyama, M.; Miyata, Y.; Minamimoto, R.; Goda, Y.; Yano, H.] Natl Ctr Global Hlth & Med, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P791	S720	S721				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203293		
J	Kudo, T; Ideguchi, R; Uetani, M; Nanashima, A; Nagayasu, T				Kudo, T.; Ideguchi, R.; Uetani, M.; Nanashima, A.; Nagayasu, T.			Delayed FDG image obtained 90 min after injection gives incremental information which correlates histopathological data; Analysis with surgically resected pancreatic cancer	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Kudo, T.; Ideguchi, R.; Uetani, M.; Nagayasu, T.] Nagasaki Univ, Nagasaki 852, Japan; [Nanashima, A.] Miyazaki Univ, Miyazaki, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P647	S650	S650				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203150		
J	Kudo, T; Ideguchi, R; Uetani, M; Koide, Y; Maemura, K				Kudo, T.; Ideguchi, R.; Uetani, M.; Koide, Y.; Maemura, K.			Interchangeability of cardiac volumetric and phase analysis parameters between two software (CardioRepo and Heart Function View)	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Kudo, T.; Ideguchi, R.; Uetani, M.; Koide, Y.; Maemura, K.] Nagasaki Univ, Nagasaki 852, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P345	S506	S506				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202516		
J	Kudomi, N; NIshiyama, A; Maeda, Y; Hatakeyama, T; Yamamoto, Y; Nishiyama, Y				Kudomi, N.; NIshiyama, A.; Maeda, Y.; Hatakeyama, T.; Yamamoto, Y.; Nishiyama, Y.			Fully Parametric Imaging for Reversible Tracer of FLT within Reasonable Time	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Kudomi, N.; NIshiyama, A.; Maeda, Y.; Hatakeyama, T.; Yamamoto, Y.; Nishiyama, Y.] Kagawa Univ, Faclty Med, Takamatsu, Kagawa 760, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P487	S573	S574				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202655		
J	Makino, A; Miyazaki, A; Tomoike, A; Kimura, H; Hirata, M; Ohmomo, Y; Ono, M; Okazawa, H; Kiyono, Y; Saji, H				Makino, A.; Miyazaki, A.; Tomoike, A.; Kimura, H.; Hirata, M.; Ohmomo, Y.; Ono, M.; Okazawa, H.; Kiyono, Y.; Saji, H.			PET probe detecting acquired drug resistance against EGFR targeted molecular therapy	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Makino, A.; Okazawa, H.; Kiyono, Y.] Univ Fukui, Eiheiji, Fukui, Japan; [Makino, A.; Miyazaki, A.; Tomoike, A.; Kimura, H.; Ono, M.; Saji, H.] Kyoto Univ, Kyoto, Japan; [Hirata, M.; Ohmomo, Y.] Osaka Univ Pharmaceut Sci, Takatsuki, Osaka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P147	S410	S411				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202322		
J	Mano, S; Tadokoro, M; Shirakawa, S; Ishiguro, M; Toyama, H				Mano, S.; Tadokoro, M.; Shirakawa, S.; Ishiguro, M.; Toyama, H.			Non-invasive quantification of the regional cerebral blood flow using I-123 IMP SPECT and phase contrast MRA; preliminary study of combination and revisit of the matured technologies.	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Mano, S.; Tadokoro, M.; Shirakawa, S.; Ishiguro, M.; Toyama, H.] Fujita Hlth Univ, Toyoake, Aichi, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		TP022	S820	S821				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203506		
J	Matsuda, H; Imabayashi, E; Rokicki, J; Maikusa, N				Matsuda, H.; Imabayashi, E.; Rokicki, J.; Maikusa, N.			Graph-theoretical analysis for comparison of functional brain networks between very early Alzheimer's disease and healthy volunteers	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Matsuda, H.; Imabayashi, E.; Rokicki, J.; Maikusa, N.] Natl Ctr Neurol & Psychiat, Kodaira, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P443	S553	S553				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202613		
J	Matsumoto, K; Takahashi, Y; Takaki, A; Murase, K; Wada, Y; Watanabe, Y; Endo, K				Matsumoto, K.; Takahashi, Y.; Takaki, A.; Murase, K.; Wada, Y.; Watanabe, Y.; Endo, K.			Development of advanced data acquisition methods for quantitative single photon emission computed tomography	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Matsumoto, K.; Endo, K.] Kyoto Coll Med Sci, Kyoto, Japan; [Matsumoto, K.; Takahashi, Y.; Murase, K.] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan; [Matsumoto, K.; Wada, Y.; Watanabe, Y.] RIKEN, Ctr Life Sci Technol, Kobe, Hyogo, Japan; [Takahashi, Y.] Gunma Prefectural Coll Hlth Sci, Maebashi, Gumma, Japan; [Takaki, A.] Fujifilm RI Pharma Co Ltd, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P038	S358	S359				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202213		
J	Matsunaga, K; Watabe, T; Nakae, A; Kang, H; Kanai, Y; Isohashi, K; Kato, H; Shimosegawa, E; Hatazawa, J				Matsunaga, K.; Watabe, T.; Nakae, A.; Kang, H.; Kanai, Y.; Isohashi, K.; Kato, H.; Shimosegawa, E.; Hatazawa, J.			Measurement of concentration-dependent effect of sevoflurane on myocardial oxygen consumption using 11C acetate PET in rats	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Matsunaga, K.; Watabe, T.; Isohashi, K.; Kato, H.; Shimosegawa, E.; Hatazawa, J.] Osaka Univ, Grad Sch Med, Dept Nucl Med & Tracer Kinet, Suita, Osaka, Japan; [Nakae, A.; Kang, H.] Osaka Univ, Grad Sch Med, Dept Anesthesiol & Intens Care, Suita, Osaka, Japan; [Kanai, Y.; Shimosegawa, E.] Osaka Univ, Grad Sch Med, Dept Mol Imaging Med, Suita, Osaka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P333	S502	S502				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202506		
J	Matsunari, I; Komatsu, J; Samuraki, M; Noguchi-Shinohara, M; Hamaguchi, T; Ono, K; Kuji, I; Yamada, M; Kinuya, S				Matsunari, I.; Komatsu, J.; Samuraki, M.; Noguchi-Shinohara, M.; Hamaguchi, T.; Ono, K.; Kuji, I.; Yamada, M.; Kinuya, S.			Agreement of brain amyloid PET interpretation between automated diagnosis using support vector machine and visual assessment by expert readers	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Matsunari, I.] Saitama Med Univ Hosp, Saitama, Japan; [Komatsu, J.; Samuraki, M.; Noguchi-Shinohara, M.; Hamaguchi, T.; Ono, K.; Yamada, M.; Kinuya, S.] Kanazawa Univ, Kanazawa, Ishikawa, Japan; [Kuji, I.] Saitama Med Univ, Int Med Ctr, Hidaka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP562	S238	S238				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201423		
J	Matsuo, S; Nakajima, K; Kinuya, S; Takahara, K				Matsuo, S.; Nakajima, K.; Kinuya, S.; Takahara, K.			Cardiac involvement in systemic sclerosis patients can be detected by dual single-photon emission computed tomography of thallium-201 and iodine-123-beta-methyl-p-iodophenyl-pentadecanoic acid scintigraphy	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Matsuo, S.; Nakajima, K.; Kinuya, S.; Takahara, K.] Kanazawa Univ Hosp, Kanazawa, Ishikawa, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP435	S178	S178				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201313		
J	Maya, Y; Werner, RA; Jahns, V; Wakabayashi, H; Nakajo, M; Fukushima, K; Yanagisawa, T; Jahns, R; Higuchi, T				Maya, Y.; Werner, R. A.; Jahns, V.; Wakabayashi, H.; Nakajo, M.; Fukushima, K.; Yanagisawa, T.; Jahns, R.; Higuchi, T.			Assessment of radiolabeled methionine for imaging myocardial inflammation in a rat model of autoimmune myocarditis: Comparison with18F-FDG and histological findings	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Maya, Y.; Werner, R. A.; Wakabayashi, H.; Nakajo, M.; Higuchi, T.] Univ Klinikum Wurzburg, Dept Nucl Med, Wurzburg, Germany; [Maya, Y.] Nihon Medi Phys Co Ltd, Res Ctr, Chiba, Japan; [Werner, R. A.; Higuchi, T.] Comprehens Heart Failure Ctr, Wurzburg, Germany; [Jahns, V.] Univ Klinikum Wurzburg, Dept Pharmacol, Wurzburg, Germany; [Fukushima, K.] Hyogo Coll Med, Nishinomiya, Hyogo, Japan; [Yanagisawa, T.] Kitazato Univ, Sch Med, Dept Cardioangiol, Sagamihara, Kanagawa, Japan; [Jahns, R.] Univ Wurzburg, Dept Internal Med 1, D-97070 Wurzburg, Germany								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP432	S176	S177				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201310		
J	Maya, Y; Werner, R; Wakabayashi, H; Nakajo, M; Fukushima, K; Lapa, C; Herrmann, K; Higuchi, T				Maya, Y.; Werner, R.; Wakabayashi, H.; Nakajo, M.; Fukushima, K.; Lapa, C.; Herrmann, K.; Higuchi, T.			Assessment of cardiac sympathetic nerve system in the rat heart using 11C-HED	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Maya, Y.; Werner, R.; Wakabayashi, H.; Nakajo, M.; Lapa, C.; Herrmann, K.; Higuchi, T.] Univ Klinikum Wurzburg, Dept Nucl Med, Wurzburg, Germany; [Maya, Y.] Nihon Med Phys Co Ltd, Res Ctr, Chiba, Japan; [Werner, R.; Higuchi, T.] Comprehens Heart Failure Ctr, Wurzburg, Germany; [Fukushima, K.] Hyogo Coll Med, Nishinomiya, Hyogo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP542	S227	S228				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201403		
J	Miyauchi, H; Iimori, T; Sawada, K; Kuwabara, Y; Sakao, S; Tatsumi, K; Kobayashi, Y				Miyauchi, H.; Iimori, T.; Sawada, K.; Kuwabara, Y.; Sakao, S.; Tatsumi, K.; Kobayashi, Y.			Assessment of Right Ventricular Myocardial Perfusion and Fatty Acid Metabolism Using Planar Imaging in Patients with Chronic Thromboembolic Pulmonary Hypertension	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Miyauchi, H.; Kuwabara, Y.; Sakao, S.; Tatsumi, K.; Kobayashi, Y.] Chiba Univ, Grad Sch Med, Chiba, Japan; [Iimori, T.; Sawada, K.] Chiba Univ Hosp, Chiba, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		PW016	S285	S286				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202074		
J	Mizutani, A; Matsunari, I; Kobayashi, M; Nishi, K; Fujita, W; Nekolla, SG; Kawai, K; Fukuchi, K				Mizutani, A.; Matsunari, I.; Kobayashi, M.; Nishi, K.; Fujita, W.; Nekolla, S. G.; Kawai, K.; Fukuchi, K.			Phase analysis using ECG-gated myocardial FDG PET in the rat in comparison with speckle tracking echocardiography	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Mizutani, A.; Fukuchi, K.] Osaka Univ, Osaka, Japan; [Matsunari, I.] Saitama Med Univ Hosp, Saitama, Japan; [Kobayashi, M.] Kanazawa Univ, Kanazawa, Ishikawa, Japan; [Nishi, K.] Nagasaki Univ, Nagasaki 852, Japan; [Fujita, W.] Kanazawa Med Univ, Kanazawa, Ishikawa, Japan; [Nekolla, S. G.] Tech Univ Munich, Munich, Japan; [Kawai, K.] Kanazawa Univ, Osaka Univ, Kanazawa, Ishikawa, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP224	S91	S92				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201156		
J	Mochida, I; Matsunaga, K; Watanabe, S; Isohashi, K; Watabe, T; Tatsumi, M; Kato, H; Shimosegawa, E; Hatazawa, J				Mochida, I.; Matsunaga, K.; Watanabe, S.; Isohashi, K.; Watabe, T.; Tatsumi, M.; Kato, H.; Shimosegawa, E.; Hatazawa, J.			Initial experience of the dopamine transporter SPECT in three pediatric patients with rare neurodegenerative disorder	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Mochida, I.; Matsunaga, K.; Watanabe, S.; Isohashi, K.; Watabe, T.; Tatsumi, M.; Kato, H.; Shimosegawa, E.; Hatazawa, J.] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P460	S559	S560				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202628		
J	Momose, M				Momose, M.			The comparison of I-123-ioflupane dopamine transporter imaging with I-123-MIBG cardiac imaging in Parkinson's disease and Lewy body disease	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Momose, M.] Matsumoto Med Ctr, Matsumoto, Nagano, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P457	S558	S559				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202625		
J	Momose, M; Fukushima, K; Kondo, C; Serizawa, N; Suzuki, A; Abe, K; Hagiwara, N; Sakai, S				Momose, M.; Fukushima, K.; Kondo, C.; Serizawa, N.; Suzuki, A.; Abe, K.; Hagiwara, N.; Sakai, S.			Large myocardial injury attenuates a response to steroid therapy in patients with cardiac sarcoidosis	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Momose, M.; Fukushima, K.; Kondo, C.; Abe, K.; Sakai, S.] Tokyo Womens Med Univ, Dept Diagnost Imaging & Nuclaer Med, Tokyo, Japan; [Serizawa, N.; Suzuki, A.; Hagiwara, N.] Tokyo Womens Med Univ, Dept Cardiol, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P349	S508	S508				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202520		
J	Morita, N; Shimizu, A; Terakawa, Y; Kajimoto, K; Uehara, T; Maruyama, D; Nakagawara, J; Iida, H				Morita, N.; Shimizu, A.; Terakawa, Y.; Kajimoto, K.; Uehara, T.; Maruyama, D.; Nakagawara, J.; Iida, H.			Comparison with cerebral blood volume on 15Ogas-PET/CT in patients with chronic cerebrovascular disease	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Morita, N.; Shimizu, A.; Terakawa, Y.; Kajimoto, K.; Uehara, T.; Maruyama, D.; Nakagawara, J.; Iida, H.] Natl Cerebral & Cardiovasc Ctr, Suita, Osaka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P488	S574	S574				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202656		
J	Morita, N; Shimizu, A; Terakawa, Y; Kajimoto, K; Uehara, T; Maruyama, D; Nakagawara, J; Iida, H				Morita, N.; Shimizu, A.; Terakawa, Y.; Kajimoto, K.; Uehara, T.; Maruyama, D.; Nakagawara, J.; Iida, H.			Evaluation of increasing cerebral blood volume on 15Ogas-PET/CT in patients with severe ischemic cerebrovascular disease	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Morita, N.; Shimizu, A.; Terakawa, Y.; Kajimoto, K.; Uehara, T.; Maruyama, D.; Nakagawara, J.; Iida, H.] Natl Cerebral & Cardiovasc Ctr, Suita, Osaka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P489	S574	S575				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202657		
J	Munechika, H; Saginoya, T; Miura, Y; Takekawa, S; Seto, K; Watanabe, K				Munechika, H.; Saginoya, T.; Miura, Y.; Takekawa, S.; Seto, K.; Watanabe, K.			FDG PET/CT and MRI in oral cavity carcinomas: anatomical considerations	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Munechika, H.; Saginoya, T.; Miura, Y.; Takekawa, S.; Seto, K.; Watanabe, K.] Southern Tohoku Gen Hosp, Koriyama, Fukushima, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P556	S605	S606				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203059		
J	Murakami, K; Nakahara, T; Ogata, Y; Iwabuchi, Y; Katagiri, M; Matsusaka, Y				Murakami, K.; Nakahara, T.; Ogata, Y.; Iwabuchi, Y.; Katagiri, M.; Matsusaka, Y.			Evaluation of image quality on PET/CTwith Flow motion technology -Does it keep quantitative performance and uniformity ? -	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Murakami, K.; Nakahara, T.; Ogata, Y.; Iwabuchi, Y.; Katagiri, M.; Matsusaka, Y.] Keio Univ, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P58	S368	S368				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202233		
J	Nagamachi, S; Onizuka, H; Nishii, R; Mizutani, Y; Hirai, T; Kitamura, K				Nagamachi, S.; Onizuka, H.; Nishii, R.; Mizutani, Y.; Hirai, T.; Kitamura, K.			Comparison of Phase analysis among three kinds of soft-ware (QGS, ETB and Heart function view) in diagnosing ischemic heart disease	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Nagamachi, S.; Nishii, R.; Mizutani, Y.; Hirai, T.] Miyazaki Univ, Dept Radiol, Miyazaki, Japan; [Onizuka, H.] Miyazaki Univ, Dept Internal Med 1, Miyazaki, Japan; [Kitamura, K.] Miyazaki Univ, Dept Intenal Med 1, Miyazaki, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P396	S531	S531				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202566		
J	Nagamachi, S; Nishii, R; Mizutani, Y; Umemura, Y; Ohkubo, R; Takashima, H; Hirai, T				Nagamachi, S.; Nishii, R.; Mizutani, Y.; Umemura, Y.; Ohkubo, R.; Takashima, H.; Hirai, T.			The effectiveness of dopamine transporter volume estimated by C-11 PE-2I PET in diagnosing Parkinsonism-Novel parameter for quantifying the total amount of dopamine transporter	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Nagamachi, S.; Nishii, R.; Mizutani, Y.; Hirai, T.] Miyazaki Univ, Miyazaki, Japan; [Umemura, Y.; Ohkubo, R.] Fujimoto Hayasuzu Hosp, Miyakonojou, Japan; [Takashima, H.] Kagoshima Univ, Kagoshima 890, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		TP089	S852	S852				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203573		
J	Nakagami, Y; Kano, D; Kusumoto, M				Nakagami, Y.; Kano, D.; Kusumoto, M.			Bone scintigraphy as a new imaging biomarker: the relationship between bone scan index and PSA in prostate cancer patients receiving radium-223 dichloride therapy.	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Nakagami, Y.; Kano, D.; Kusumoto, M.] Natl Canc Ctr, Chiba, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P747	S698	S699				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203249		
J	Nakagawa, K; Onodera, S; Uchida, T; Ozaki, Y; Henmi, H; Uchino, Y				Nakagawa, K.; Onodera, S.; Uchida, T.; Ozaki, Y.; Henmi, H.; Uchino, Y.			Value of ECG-gated study during dipyridamole stress in myocardial perfusion PET	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Nakagawa, K.] Tokyo Seaside Clin, Tokyo, Japan; [Onodera, S.; Uchida, T.; Ozaki, Y.; Henmi, H.; Uchino, Y.] Chiba Ryougo Ctr, Chiba, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P356	S511	S511				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202526		
J	Nakajima, K; Okuda, K; Matsuo, S; Nakata, T; Kinuya, S				Nakajima, K.; Okuda, K.; Matsuo, S.; Nakata, T.; Kinuya, S.			Effect of standardization of I-123 MIBG heart-to-mediastinum ratio on the prognostic threshold: application to multicenter database of chronic heart failure	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Nakajima, K.; Matsuo, S.; Kinuya, S.] Kanazawa Univ Hosp, Kanazawa, Ishikawa, Japan; [Okuda, K.] Kanazawa Med Univ, Uchinada, Ishikawa 92002, Japan; [Nakata, T.] Hakodate Gryoukaku Hosp, Hakodate, Hokkaido, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP065	S28	S28				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201039		
J	Nakajima, K; Matsuo, S; Okuda, K; Yokoyama, K; Bunko, H; Kinuya, S; Edenbrandt, L				Nakajima, K.; Matsuo, S.; Okuda, K.; Yokoyama, K.; Bunko, H.; Kinuya, S.; Edenbrandt, L.			Detection of myocardial ischemia using artificial neural network: different characteristics from conventional defect scoring methods	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Nakajima, K.; Matsuo, S.; Kinuya, S.] Kanazawa Univ Hosp, Kanazawa, Ishikawa, Japan; [Okuda, K.] Kanazawa Med Univ, Uchinada, Ishikawa 92002, Japan; [Yokoyama, K.] Matto Ishikawa Cent Hosp, Haku San, Japan; [Bunko, H.] Kanazawa Cardiovasc Hosp, Kanazawa, Ishikawa, Japan; [Edenbrandt, L.] Univ Gothenburg, Gothenburg, Sweden								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP169	S73	S74				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201124		
J	Nakajo, M; Kajiya, Y; Tani, A; Jinguji, M; Nakabeppu, Y; Nakajo, M; Shimaoka, S; Nihara, T; Tanaka, S; Yoshiura, T				Nakajo, M.; Kajiya, Y.; Tani, A.; Jinguji, M.; Nakabeppu, Y.; Nakajo, M.; Shimaoka, S.; Nihara, T.; Tanaka, S.; Yoshiura, T.			Diagnostic performance of 18F-fluorothymidine PET/CT for primary gastric cancer and its lymph node metastasis: Comparison with 18F-fluorodeoxyglucose PET/CT	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Nakajo, M.; Jinguji, M.; Nakabeppu, Y.; Yoshiura, T.] Kagoshima Univ, Dept Radiol, Grad Sch Med & Dent Sci, Kagoshima 890, Japan; [Kajiya, Y.; Tani, A.; Nakajo, M.] Nanpuh Hosp, Dept Radiol, Kagoshima, Japan; [Shimaoka, S.; Nihara, T.] Nanpuh Hosp, Dept Gastroentenol, Kagoshima, Japan; [Tanaka, S.] Nanpuh Hosp, Dept Pathol, Kagoshima, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP057	S24	S24				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201031		
J	Nakamoto, Y; Sano, K; Ishimori, T; Togashi, K				Nakamoto, Y.; Sano, K.; Ishimori, T.; Togashi, K.			Clinical efficacy of PET/CT using 68Ga-DOTATOC for restaging in renal cell carcinoma	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Nakamoto, Y.; Sano, K.; Ishimori, T.; Togashi, K.] Kyoto Univ, Grad Sch Med, Kyoto, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P693	S672	S673				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203196		
J	Nakayama, M; Okizaki, A; Ishitoya, S; Uno, T; Suzuki, T; Mikami, Y; Sato, J; Takahashi, K				Nakayama, M.; Okizaki, A.; Ishitoya, S.; Uno, T.; Suzuki, T.; Mikami, Y.; Sato, J.; Takahashi, K.			Effectiveness of aromatherapy on Physiology and Psychology in patients undergoing I-131 ablation with differentiated thyroid cancer.-Using Physiological and Sensory evaluation-	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Nakayama, M.; Okizaki, A.; Ishitoya, S.; Takahashi, K.] Asahikawa Med Univ, Asahikawa, Hokkaido, Japan; [Uno, T.; Suzuki, T.; Mikami, Y.; Sato, J.] Asahikawa Med Univ Hosp, Asahikawa, Hokkaido, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P530	S593	S594				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203033		
J	Nesterov, SV; Yoshinaga, K; Tomiyama, Y; Han, C; Sciagra, R; Berti, V; Knappen, P; Danad, I; Knuuti, JM				Nesterov, S. V.; Yoshinaga, K.; Tomiyama, Y.; Han, C.; Sciagra, R.; Berti, V.; Knappen, P.; Danad, I.; Knuuti, J. M.			AQUA-5: Four Software Tools for 15O-Water PET Myocardial Perfusion Quantification Exhibit Good Intraobserver Reproducibility	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Nesterov, S. V.; Han, C.; Knuuti, J. M.] Turku PET Ctr, Turku, Finland; [Nesterov, S. V.] RAS, Inst Evolutionary Biochem & Physiol, St Petersburg, Russia; [Yoshinaga, K.; Tomiyama, Y.] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan; [Sciagra, R.; Berti, V.] Univ Florence, Nucl Med Unit, Florence, Italy; [Knappen, P.; Danad, I.] Vrije Univ Amsterdam, Dept Nucl Med, Amsterdam, Netherlands; [Knappen, P.; Danad, I.] Vrije Univ Amsterdam, Dept PET Res, Amsterdam, Netherlands								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP126	S55	S55				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201088		
J	Niimi, T; Sugimoto, M; Nanasato, M; Maeda, H				Niimi, T.; Sugimoto, M.; Nanasato, M.; Maeda, H.			Evaluation of simultaneous Tc-99m and I-123 dual-isotope SPECT imaging using cardiac CZT camera	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Niimi, T.; Sugimoto, M.; Nanasato, M.] Nagoya Daini Red Cross Hosp, Nagoya, Aichi, Japan; [Maeda, H.] Nagoya Univ, Nagoya, Aichi 4648601, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P393	S529	S530				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202563		
J	Niimi, T; Nanasato, M; Maeda, H				Niimi, T.; Nanasato, M.; Maeda, H.			Contraction synchronicity and work measured in patients with coronary artery disease	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Niimi, T.; Nanasato, M.] Nagoya Daini Red Cross Hosp, Nagoya, Aichi, Japan; [Maeda, H.] Nagoya Univ, Nagoya, Aichi 4648601, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P405	S535	S535				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202575		
J	Niimi, T; Sugimoto, M; Nanasato, M; Maeda, H				Niimi, T.; Sugimoto, M.; Nanasato, M.; Maeda, H.			Evaluation of CZT-SPECT system for nuclear cardiology: comparison with conventional Anger SPECT	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Niimi, T.; Sugimoto, M.; Nanasato, M.] Nagoya Daini Red Cross Hosp, Nagoya, Aichi, Japan; [Maeda, H.] Nagoya Univ, Nagoya, Aichi 4648601, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		TP080	S848	S848				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203564		
J	Nogami, M; Iwasa, H; Miyatake, K; Kohsaki, S; Ohgi, K; Nishimori, M; Yamagami, T; Takenaka, D; Adachi, S				Nogami, M.; Iwasa, H.; Miyatake, K.; Kohsaki, S.; Ohgi, K.; Nishimori, M.; Yamagami, T.; Takenaka, D.; Adachi, S.			Diuretic FDG PET/CT and diffusion weighted MR imaging for urothelial carcinoma: capability for prediction of pathological characteristics and prognosis	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Nogami, M.; Takenaka, D.; Adachi, S.] Hyogo Canc Ctr, Akashi, Hyogo, Japan; [Iwasa, H.; Miyatake, K.; Kohsaki, S.; Ohgi, K.; Nishimori, M.; Yamagami, T.] Kochi Univ, Kochi Med Sch, Nankoku, Kochi, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P686	S668	S669				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203189		
J	Ogawa, K; Aitani, N; Hemuki, Y				Ogawa, K.; Aitani, N.; Hemuki, Y.			Quantitative Evaluation of Scattered Photons in a Myocardial Pinhole SPECT Imaging	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Ogawa, K.; Aitani, N.; Hemuki, Y.] Hosei Univ, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P066	S372	S372				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202241		
J	Ogushi, G; Kudo, S; Matsuda, R; Tomiguchi, S; Shiraishi, S; Yamashita, Y				Ogushi, G.; Kudo, S.; Matsuda, R.; Tomiguchi, S.; Shiraishi, S.; Yamashita, Y.			Appropriate time interval of dynamic 201Tl SPECT-MPI data acquisition for quantitative myocardial blood flow analysis on cardiac dedicated ultrafast SPECT camera	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Ogushi, G.; Kudo, S.; Matsuda, R.; Tomiguchi, S.; Shiraishi, S.; Yamashita, Y.] Kumamoto Univ, Kumamoto, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		TP096	S855	S855				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203580		
J	Ohno, K; Higashi, T; Okuyama, C; Nakamoto, Y; Endo, K				Ohno, K.; Higashi, T.; Okuyama, C.; Nakamoto, Y.; Endo, K.			Promotion of measures to counter radiation health concerns using the comic (manga)	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Ohno, K.; Endo, K.] Kyoto Coll Med Sci, Nantan, Japan; [Higashi, T.] Shiga Med Ctr Res Inst, Moriyama, Japan; [Okuyama, C.] Image Communiat Corp, Kyoto, Japan; [Nakamoto, Y.] Kyoto Univ, Grad Sch Med, Kyoto, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P027	S352	S353				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202202		
J	Okazawa, H; Ikawa, M; Tsujikawa, T; Mori, T; Makino, A; Kiyono, Y; Yoneda, M				Okazawa, H.; Ikawa, M.; Tsujikawa, T.; Mori, T.; Makino, A.; Kiyono, Y.; Yoneda, M.			Evaluation of nigrostriatal oxidative stress intensity in patients with Parkinson's disease using [Cu-62]ATSM PET and FP-CIT SPECT	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Okazawa, H.; Ikawa, M.; Tsujikawa, T.; Mori, T.; Makino, A.; Kiyono, Y.] Univ Fukui, Fukui 910, Japan; [Yoneda, M.] Fukui Prefectural Univ, Fukui, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP641	S273	S273				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202051		
J	Okumiya, S; Ofuji, A; Ito, S				Okumiya, S.; Ofuji, A.; Ito, S.			Development of a new quantification method of dopamine transporter density with 123I-ioflupane	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Okumiya, S.; Ofuji, A.; Ito, S.] Kumamoto Univ, Kumamoto, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		TP078	S847	S847				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203562		
J	Onishi, H; Nakamoto, K; Kenda, S; Kangai, Y; Yada, N; Saho, T; Sakai, T; Hasegawa, D; Fukunaga, M; Amijima, H				Onishi, H.; Nakamoto, K.; Kenda, S.; Kangai, Y.; Yada, N.; Saho, T.; Sakai, T.; Hasegawa, D.; Fukunaga, M.; Amijima, H.			Effects of mis-registration of CT attenuation-corrected on myocardial perfusion images acquired using multi-focus fan beam collimator SPECT/CT and conventional SPECT	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Onishi, H.; Kangai, Y.; Yada, N.; Saho, T.] Prefectural Univ Hiroshima, Grad Sch Comprehens Sci Res, Program Biol Syst Sci, Shobara, Hiroshima, Japan; [Nakamoto, K.] Hiroshima Prefectural Hosp, Dept Radiol, Hiroshima, Japan; [Kenda, S.; Sakai, T.; Hasegawa, D.; Fukunaga, M.] Prefectural Univ Hiroshima, Grad Sch Comprehens Sci Res, Program Hlth & Welfare Sci, Mihara, Hiroshima, Japan; [Amijima, H.] Hyogo Univ Hlth Sci, Grad Sch Nursing, Kobe, Hyogo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P039	S359	S359				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202214		
J	Otomi, Y; Otsuka, H; Shinya, T; Terazawa, K; Kubo, M; Harada, M				Otomi, Y.; Otsuka, H.; Shinya, T.; Terazawa, K.; Kubo, M.; Harada, M.			FDG-PET/CT of bone lesions	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Otomi, Y.; Shinya, T.; Terazawa, K.; Kubo, M.; Harada, M.] Tokushima Univ Hosp, Tokushima, Japan; [Otsuka, H.] Univ Tokushima, Tokushima 770, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P925	S781	S781				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203424		
J	Saga, T; Inubushi, M; Koizumi, M; Yoshikawa, K; Zhang, M; Obata, T; Harada, R; Uno, T				Saga, T.; Inubushi, M.; Koizumi, M.; Yoshikawa, K.; Zhang, M.; Obata, T.; Harada, R.; Uno, T.			Clinical Value of FAZA-PET/CT in Head and Neck Cancer Patients	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Saga, T.; Yoshikawa, K.; Zhang, M.; Obata, T.] Natl Inst Radiol Sci, Chiba 260, Japan; [Inubushi, M.] Kawasaki Med Univ, Kurashiki, Okayama, Japan; [Koizumi, M.] Canc Inst Hosp, Tokyo, Japan; [Harada, R.; Uno, T.] Chiba Univ, Grad Sch Med, Chiba, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		PW086	S322	S322				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202144		
J	Saito, H; Yamane, A; Imai, S; Orita, E; Hakozaki, K; Akiyama, K; Ishihara, K; Kumita, S				Saito, H.; Yamane, A.; Imai, S.; Orita, E.; Hakozaki, K.; Akiyama, K.; Ishihara, K.; Kumita, S.			Diagnostic performance of time-of-flight system to detect neck small lymph node using 18F-FDG PET/CT	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Saito, H.; Yamane, A.; Imai, S.; Orita, E.; Hakozaki, K.; Akiyama, K.; Ishihara, K.; Kumita, S.] Nippon Med Sch, Bunkyo Ku, Tokyo 113, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P559	S607	S607				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203062		
J	Sakamoto, F; Shiraishi, S; Tsuda, N; Yuki, H; Namimoto, T; Kitajima, M; Hashimoto, M; Tomiguchi, S; Ikeda, M; Yamashita, Y				Sakamoto, F.; Shiraishi, S.; Tsuda, N.; Yuki, H.; Namimoto, T.; Kitajima, M.; Hashimoto, M.; Tomiguchi, S.; Ikeda, M.; Yamashita, Y.			IMP and MIBG scintigraphy as an index comparable to the core symptoms for a diagnosis of dementia with Lewy bodies?	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Sakamoto, F.; Shiraishi, S.; Tsuda, N.; Yuki, H.; Namimoto, T.; Kitajima, M.] Kumamoto Univ, Grad Sch Life Sci, Diagnost Radiol, Kumamoto, Japan; [Hashimoto, M.; Ikeda, M.] Kumamoto Univ, Grad Sch Life Sci, Dept Neuropsychiat, Kumamoto, Japan; [Tomiguchi, S.] Kumamoto Univ, Sch Hlth, Dept Diagnost Med Imaging, Fac Life Sci, Kumamoto, Japan; [Yamashita, Y.] Kumamoto Univ, Grad Sch Life Sci, Dept Diagnost Radiol, Kumamoto, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P987	S809	S809				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203483		
J	Sekine, T; Barbosa, F; Kuhn, F; Burger, I; von Schulthess, G; Veit-Haibach, P; Huellner, M				Sekine, T.; Barbosa, F.; Kuhn, F.; Burger, I.; von Schulthess, G.; Veit-Haibach, P.; Huellner, M.			PET/MR versus PET/CT in the Initial Staging of Head and Neck Cancer	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Sekine, T.; Barbosa, F.; Kuhn, F.; Burger, I.; von Schulthess, G.; Veit-Haibach, P.; Huellner, M.] Univ Zurich Hosp, CH-8091 Zurich, Switzerland; [Sekine, T.] Nippon Med Sch, Tokyo 113, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP600	S253	S254				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202014		
J	Shimizu, K; Hino, M; Matsumoto, K; Yamamoto, S				Shimizu, K.; Hino, M.; Matsumoto, K.; Yamamoto, S.			Comparison of capability of diagnosis supporting system between two deifferent gamma cameras for bone scintigraphic images in diagnosing bone metastasis of cancer	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Shimizu, K.; Hino, M.] Kobe City Med Ctr, Gen Hosp, Kobe, Hyogo, Japan; [Matsumoto, K.] Kyoto Coll Med Sci, Nantan, Japan; [Yamamoto, S.] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		TP034	S826	S826				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203518		
J	Shinya, T; Otomi, Y; Tanaka, T; Inai, R; Kanazawa, S; Harada, M				Shinya, T.; Otomi, Y.; Tanaka, T.; Inai, R.; Kanazawa, S.; Harada, M.			The Evaluation of Dual-time-point F-18 FDG PET/CT and chest CT for the prediction of the WHO grade in thymic epithelial neoplasms	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Shinya, T.; Otomi, Y.; Harada, M.] Univ Tokushima, Grad Sch, Tokushima 770, Japan; [Tanaka, T.; Inai, R.; Kanazawa, S.] Okayama Univ Hosp, Okayama, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P789	S719	S720				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203291		
J	Shiraishi, S; Tsuda, N; Sakamoto, F; Yoshida, M; Tomiguchi, S; Yamashita, Y				Shiraishi, S.; Tsuda, N.; Sakamoto, F.; Yoshida, M.; Tomiguchi, S.; Yamashita, Y.			Prediction of occult coronary artery disease in patients with normal myocardial perfusion scintigraphy using myocardial perfusion reserve on dynamic thallium-201 single-photon emission computed tomography with a semiconductor gamma camera	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Shiraishi, S.; Tsuda, N.; Sakamoto, F.; Tomiguchi, S.; Yamashita, Y.] Kumamoto Univ, Kumamoto, Japan; [Yoshida, M.] Amakusa Med Ctr, Hondo City, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P348	S508	S508				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202519		
J	Shuke, N; Miyazaki, C; Ando, A; Onishi, T; Saito, K; Sato, J; Okizaki, A; Nishikawa, K				Shuke, N.; Miyazaki, C.; Ando, A.; Onishi, T.; Saito, K.; Sato, J.; Okizaki, A.; Nishikawa, K.			Proposal of a Method to Estimate Normal Threshold Values of Summed Z-scores in the Specified Regions for Z Sum Analysis for Diagnosing Alzheimer's Disease with Voxel-based Control Database of I-123 IMP SPECT	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Shuke, N.; Miyazaki, C.; Ando, A.; Onishi, T.; Saito, K.] Kushiro Kojinkai Mem Hosp, Kushiro, Japan; [Sato, J.; Okizaki, A.] Asahikawa Med Coll, Asahikawa, Hokkaido 078, Japan; [Nishikawa, K.] Nihon Medi Phys Co Ltd, Imaging Informat Technol Ctr, Osaka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P434	S549	S549				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202604		
J	Sone, Y; Abe, M; Arakawa, C; Kato, I; Sobajima, A; Kawachi, T; Takeda, I; Kumada, T				Sone, Y.; Abe, M.; Arakawa, C.; Kato, I.; Sobajima, A.; Kawachi, T.; Takeda, I.; Kumada, T.			Diagnostic value of 18F-FDG PET/CT in whole body cancer screening	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Sone, Y.; Abe, M.; Arakawa, C.] Ogaki Municipal Hosp, Dept Radiol, Ogaki, Japan; [Kato, I.; Sobajima, A.; Kawachi, T.] Ogaki Municipal Hosp, Dept Radiol Technol, Ogaki, Japan; [Takeda, I.; Kumada, T.] Ogaki Municipal Hosp, Hlth Management Ctr, Ogaki, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P784	S717	S717				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203286		
J	Sugihara, Y; Fukushima, Y; Kumita, S				Sugihara, Y.; Fukushima, Y.; Kumita, S.			Diagnostic accuracy of 123I-MIBG SPECT-CT using semi-quantitative analysis in patients with adrenal pheochromocytoma	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Sugihara, Y.; Fukushima, Y.; Kumita, S.] Nippon Med Coll Hosp, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P966	S800	S801				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203464		
J	Takanami, K; Umezawa, R; Kadoya, N; Arai, A; Jingu, K; Takase, K				Takanami, K.; Umezawa, R.; Kadoya, N.; Arai, A.; Jingu, K.; Takase, K.			Association between radiation dosimetry of the heart and the myocardial fatty acid metabolic impairment due to chemoradiation-therapy : Prospective study using I-123 BMIPP SPECT/CT	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Takanami, K.; Arai, A.; Takase, K.] Tohoku Univ Hosp, Dept Diagnost Radiol, Sendai, Miyagi, Japan; [Umezawa, R.; Kadoya, N.; Jingu, K.] Tohoku Univ Hosp, Dept Radiat Oncol, Sendai, Miyagi, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		PW014	S284	S285				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202072		
J	Takano, A; Stepanov, V; Nakao, R; Amini, N; Kimura, H; Halldin, C				Takano, A.; Stepanov, V.; Nakao, R.; Amini, N.; Kimura, H.; Halldin, C.			Comparative Evaluation of Two PET Radioligands for PDE10A, [11C]T-773 and [18F]FM-T-773-d2 in Nonhuman Primates	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Takano, A.; Stepanov, V.; Nakao, R.; Amini, N.; Halldin, C.] Karolinska Inst, Stockholm, Sweden; [Kimura, H.] Takeda Pharmaceut Co Ltd, Fujisawa, Kanagawa, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP287	S119	S120				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201207		
J	Tanaka, T; Sato, S; Inai, R; Tada, A; Kanazawa, S				Tanaka, T.; Sato, S.; Inai, R.; Tada, A.; Kanazawa, S.			Contralateral axillary sentinel lymph node in breast cancer patients: an uncommon lymphatic drainage	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Tanaka, T.; Sato, S.; Inai, R.; Tada, A.; Kanazawa, S.] Okayama Univ Hosp, Dept Radiol, Okayama, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P581	S617	S617				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203084		
J	Toubaru, S; Ohashi, S; Tachibana, Y; Hasebe, M; Tanimoto, K; Zhang, M; Yamamoto, N; Nakajima, M; Karube, M; Obata, T; Saga, T; Ando, Y; Yoshikawa, K; Kamada, T				Toubaru, S.; Ohashi, S.; Tachibana, Y.; Hasebe, M.; Tanimoto, K.; Zhang, M.; Yamamoto, N.; Nakajima, M.; Karube, M.; Obata, T.; Saga, T.; Ando, Y.; Yoshikawa, K.; Kamada, T.			Efficacy of SUVmax and SUVpeak to predict distant metastasis of non-small cell lung cancer before treatment	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Toubaru, S.; Ohashi, S.; Tachibana, Y.; Hasebe, M.; Tanimoto, K.; Zhang, M.; Yamamoto, N.; Nakajima, M.; Karube, M.; Obata, T.; Saga, T.; Ando, Y.; Kamada, T.] Natl Inst Radiol Sci, Chiba 260, Japan; [Yoshikawa, K.] Tokyo Bay Adv Imaging & Radiat Oncol Clin MAKUHAR, Chiba, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P637	S645	S645				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203140		
J	Toyohara, J; Okamoto, M; Aramaki, H; Zaitsu, Y; Shimizu, I; Hosokawa, S; Ishiwata, K				Toyohara, J.; Okamoto, M.; Aramaki, H.; Zaitsu, Y.; Shimizu, I.; Hosokawa, S.; Ishiwata, K.			Radiosynthesis and fundamental evaluation of (R)-[11C] mopamil as a novel tracer for imaging enhanced P-glycoprotein function in the brain	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Toyohara, J.; Okamoto, M.; Ishiwata, K.] Tokyo Metropolitan Inst Gerontol, Tokyo, Japan; [Okamoto, M.; Aramaki, H.; Zaitsu, Y.; Shimizu, I.; Hosokawa, S.] Waseda Univ, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP284	S117	S118				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201204		
J	Tsuchiya, S; Abe, S; Fujita, N; Sakuragi, Y; Koshiba, Y; Odagawa, T; Kato, K				Tsuchiya, S.; Abe, S.; Fujita, N.; Sakuragi, Y.; Koshiba, Y.; Odagawa, T.; Kato, K.			Comparative study on recovery coefficients of SPECT-CT	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Tsuchiya, S.; Koshiba, Y.; Odagawa, T.; Kato, K.] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Abe, S.; Fujita, N.; Sakuragi, Y.] Nagoya Univ Hosp, Nagoya, Aichi, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		TP020	S820	S820				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203504		
J	Tsukimoto, S				Tsukimoto, S.			A new amyloid imaging probe 125I-EISB in PET/SPECT imaging of amyloid was developed for both brain and whole body for clinical use	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Tsukimoto, S.] Kumamoto Univ, Kumamoto, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		TP027	S823	S823				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203511		
J	Uchino, Y				Uchino, Y.			Calorie consumption and brain glucose metabolism in the patients with chronic severe brain injury - A study using brain 18F-FDGPET -	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Uchino, Y.] Chiba Ryogo Ctr, Chiba, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P504	S581	S582				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203008		
J	Umeda, IO; Ito, K; Hamamichi, S; Asano, M; Iwata, M; Matsui, J; Hori, Y; Funahashi, Y; Fujii, H				Umeda, I. O.; Ito, K.; Hamamichi, S.; Asano, M.; Iwata, M.; Matsui, J.; Hori, Y.; Funahashi, Y.; Fujii, H.			SPECT/CT Imaging of Radionuclide-carrying Liposomes Predict Therapeutic Effects of Liposomal Anti-cancer Agents in Mouse Xenograft Models	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Umeda, I. O.; Hamamichi, S.; Fujii, H.] Natl Canc Ctr, Kashiwa, Chiba, Japan; [Ito, K.; Asano, M.; Iwata, M.; Matsui, J.; Hori, Y.; Funahashi, Y.] Eisai & Co Ltd, Tsukuba, Ibaraki, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P230	S450	S451				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202403		
J	Utsunomiya, K; Yasuda, K; Kono, Y; Ueno, Y; Hakawa, SK; Stundzia, A; Tanigawa, N				Utsunomiya, K.; Yasuda, K.; Kono, Y.; Ueno, Y.; Hakawa, S. K.; Stundzia, A.; Tanigawa, N.			The clinical efficacy of endometriosis diagnosis using I-123 MIBG SPECT and MRI image fusion	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Utsunomiya, K.] Kansai Med Univ, Takii Hosp, Dept Radiol, Moriguchi, Osaka 570, Japan; [Yasuda, K.] Kansai Med Univ, Takii Hosp, Dept Gynecol, Moriguchi, Osaka 570, Japan; [Kono, Y.; Ueno, Y.; Hakawa, S. K.; Tanigawa, N.] Kansai Med Univ, Dept Radiol, Hirakata, Osaka, Japan; [Stundzia, A.] Tomographix, Toronto, ON, Canada								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P196	S435	S435				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202370		
J	van den Berg, NS; KleinJan, GH; Miwa, M; Sato, T; Maeda, Y; Karakullukcu, B; Horenblas, S; van Leeuwen, FWB				van den Berg, N. S.; KleinJan, G. H.; Miwa, M.; Sato, T.; Maeda, Y.; Karakullukcu, B.; Horenblas, S.; van Leeuwen, F. W. B.			Intraoperative fluorescence guidance under ambient light conditions using a new modified fluorescence camera	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[van den Berg, N. S.; KleinJan, G. H.; van Leeuwen, F. W. B.] LUMC, Leiden, Netherlands; [van den Berg, N. S.; KleinJan, G. H.; Karakullukcu, B.; Horenblas, S.; van Leeuwen, F. W. B.] AVL NKI, Amsterdam, Netherlands; [Miwa, M.; Sato, T.; Maeda, Y.] Hamamatsu Photon KK, Hamamatsu, Shizuoka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P189	S431	S432				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202363		
J	Watanabe, S; Nakajima, K; Yaegashi, H; Mizokami, A; Noguchi, N; Kawashiri, S; Inokuchi, M; Kinuya, S				Watanabe, S.; Nakajima, K.; Yaegashi, H.; Mizokami, A.; Noguchi, N.; Kawashiri, S.; Inokuchi, M.; Kinuya, S.			Feasibility of bone scan index for the diagnosis and follow-up of medication-related osteonecrosis of the jaw	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Watanabe, S.; Nakajima, K.; Yaegashi, H.; Mizokami, A.; Noguchi, N.; Kawashiri, S.; Inokuchi, M.; Kinuya, S.] Kanazawa Univ Hosp, Kanazawa, Ishikawa, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P913	S775	S776				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203412		
J	Watanabe, S; Okamoto, S; Shiga, T; Inoue, T; Hirata, K; Magota, K; Nishijima, K; Kuge, Y; Shirato, H; Tamaki, N				Watanabe, S.; Okamoto, S.; Shiga, T.; Inoue, T.; Hirata, K.; Magota, K.; Nishijima, K.; Kuge, Y.; Shirato, H.; Tamaki, N.			Respiratory-gated FMISO-PET/CT detects tumor hypoxia with higher sensitivity in non-small cell lung cancer	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Watanabe, S.; Okamoto, S.; Shiga, T.; Hirata, K.; Magota, K.; Tamaki, N.] Hokkaido Univ, Grad Sch Med, Dept Nucl Med, Sapporo, Hokkaido, Japan; [Inoue, T.; Shirato, H.] Hokkaido Univ, Grad Sch Med, Dept Radiat Med, Sapporo, Hokkaido, Japan; [Nishijima, K.; Kuge, Y.] Hokkaido Univ, Cent Inst Isotope Sci, Sapporo, Hokkaido, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP144	S61	S61				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201099		
J	Watanabe, S; Kato, H; Shimosegawa, E; Hatazawa, J				Watanabe, S.; Kato, H.; Shimosegawa, E.; Hatazawa, J.		Osaka Twin Res Grp	Genetic influences in FDG uptake in precuneus and posterior cingulate cortex: a PET study in non-demented twins	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Watanabe, S.; Kato, H.; Hatazawa, J.] Osaka Univ, Grad Sch Med, Dept Nucl Med & Tracer Kinet, Suita, Osaka, Japan; [Shimosegawa, E.] Osaka Univ, Grad Sch Med, Dept Mol Imaging Med, Suita, Osaka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP515	S216	S216				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201383		
J	Werner, RA; Maya, Y; Jahns, V; Wakabayashi, H; Nakajo, M; Fukushima, K; Javadi, M; Yanagisawa, T; Jahns, R; Higuchi, T				Werner, R. A.; Maya, Y.; Jahns, V.; Wakabayashi, H.; Nakajo, M.; Fukushima, K.; Javadi, M.; Yanagisawa, T.; Jahns, R.; Higuchi, T.			FDG PET Imaging of a Rat Model of Autoimmune Myocarditis: Comparison with Histological Analysis	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Werner, R. A.; Maya, Y.; Wakabayashi, H.; Nakajo, M.; Higuchi, T.] Univ Klinikum Wurzburg, Dept Nucl Med, Wurzburg, Germany; [Werner, R. A.; Higuchi, T.] Comprehens Heart Failure Ctr, Wurzburg, Germany; [Maya, Y.] Nihon Medi Phys Co Ltd, Res Ctr, Chiba, Japan; [Jahns, V.] Univ Klinikum Wurzburg, Dept Pharmacol, Wurzburg, Germany; [Fukushima, K.] Hyogo Coll Med, Nishinomiya, Hyogo, Japan; [Javadi, M.] Johns Hopkins Univ, Div Nucl Med, Baltimore, MD 21218 USA; [Yanagisawa, T.] Kitazato Univ, Sch Med, Dept Cardioangiol, Tokyo, Japan; [Jahns, R.] Univ Wurzburg, Dept Internal Med 1, D-97070 Wurzburg, Germany								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP431	S176	S176				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201309		
J	Yamamoto, Y; Tanaka, K; Yamamoto, H; Kudomi, N; Hatakeyama, T; Toyohara, J; Nishiyama, Y				Yamamoto, Y.; Tanaka, K.; Yamamoto, H.; Kudomi, N.; Hatakeyama, T.; Toyohara, J.; Nishiyama, Y.			Correlation of 4 '-[Methyl-11C]-Thiothymidine Uptake with Ki-67 Immunohistochemistry in Patients with Newly Diagnosed and Recurrent Gliomas: Comparison with 11C-Methionine Uptake	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Yamamoto, Y.; Tanaka, K.; Yamamoto, H.; Kudomi, N.; Hatakeyama, T.; Nishiyama, Y.] Kagawa Univ, Takamatsu, Kagawa 760, Japan; [Toyohara, J.] Tokyo Metropolitan Inst Gerontol, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P549	S602	S602				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203052		
J	Yamane, T; Seto, A; Matsunari, I; Kuji, I				Yamane, T.; Seto, A.; Matsunari, I.; Kuji, I.			Role of F-18 FDG PET in the differential diagnosis between mediastinal malignant lymphoma and thymic epithelial tumors	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Yamane, T.; Seto, A.; Matsunari, I.; Kuji, I.] Saitama Med Univ, Saitama Int Medicial Ctr, Hidaka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P613	S633	S634				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203116		
J	Yokoyama, K; Imabayashi, E; Matsuda, H				Yokoyama, K.; Imabayashi, E.; Matsuda, H.			Application of CT based spatial normalization by DARTEL to quantitative assessment of 123I-FP-CIT SPECT.	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Yokoyama, K.; Imabayashi, E.; Matsuda, H.] Natl Ctr Neurol & Psychiat, Kodaira, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P465	S562	S562				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202633		
J	Yoshida, M; Shiraishi, S; Tsuda, N; Sakamoto, F; Tomiguchi, S; Beppu, T; Baba, H; Yamashita, Y				Yoshida, M.; Shiraishi, S.; Tsuda, N.; Sakamoto, F.; Tomiguchi, S.; Beppu, T.; Baba, H.; Yamashita, Y.			Evaluating the risk of postoperative liver failure using preoperative 99mTc-GSA SPECT/CT fused imaging	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Yoshida, M.] Amakusa Med Ctr, Amakusa, Japan; [Shiraishi, S.; Tsuda, N.; Sakamoto, F.; Yamashita, Y.] Kumamoto Univ, Grad Sch Life Sci, Dept Diagnost Radiol, Kumamoto, Japan; [Tomiguchi, S.] Kumamoto Univ, Sch Hlth, Dept Diagnost Med Imaging, Fac Life Sci, Kumamoto, Japan; [Beppu, T.; Baba, H.] Kumamoto Univ, Grad Sch Life Sci, Dept Gastroenterol Surg, Kumamoto, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		PW034	S295	S295				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202092		
J	Zhou, X; de Vries, E; Ishiwata, K; Dierckx, R; Nishiyama, S; Tsukada, H; Elsinga, P				Zhou, X.; de Vries, E.; Ishiwata, K.; Dierckx, R.; Nishiyama, S.; Tsukada, H.; Elsinga, P.			In vivo evaluation of [C-11]preladenant for imaging of adenosine A(2A) receptors in the conscious monkey	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Zhou, X.; de Vries, E.; Dierckx, R.; Elsinga, P.] Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Ishiwata, K.] Tokyo Metropolitan Inst Gerontol, Res Team Neuroimaging, Tokyo, Japan; [Nishiyama, S.; Tsukada, H.] Hamamatsu Photon KK, Cent Res Lab, Hamamatsu, Shizuoka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP048	S19	S20				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201022		
J	Morishita, S; Kaida, K; Yamauchi, S; Wakasugi, T; Ikegame, K; Kodama, N; Ogawa, H; Domen, K				Morishita, Shinichiro; Kaida, Katsuji; Yamauchi, Shinya; Wakasugi, Tatsushi; Ikegame, Kazuhiro; Kodama, Norihiko; Ogawa, Hiroyasu; Domen, Kazuhisa			Early-phase differences in health-related quality of life, psychological status, and physical function between human leucocyte antigen-haploidentical and other allogeneic haematopoietic stem cell transplantation recipients	EUROPEAN JOURNAL OF ONCOLOGY NURSING			English	Article						Allogeneic haematopoietic stem cell transplantation; HLA-haploidentical donor; Health-related QOL; Psychological status; Physical function; Oncology	ACUTE MYELOID-LEUKEMIA; BONE-MARROW-TRANSPLANTATION; MUSCLE STRENGTH MEASUREMENTS; HAND-HELD DYNAMOMETER; UMBILICAL-CORD BLOOD; UNRELATED DONOR; TRANSLATION; RELIABILITY; VALIDATION; SURVIVORS	Purpose: This study investigated the differences between allogeneic haematopoietic stem cell transplantation (allo-HSCT) patients receiving HSC from human leucocyte antigen (HLA)-haploidentical donors (HID) and other donors that included HLA-matched sibling, matched unrelated, and unrelated umbilical cord blood donors in the 6 weeks after HSCT with respect to quality of life (QOL), psychological status, and physical function. Methods: The study included 126 patients (HID group, n = 100; other donor group, n = 26) who underwent allo-HSCT between July 2007 and December 2012. Patients were evaluated for health-related QOL using the Medical Outcome Study 36-item Short Form Health Survey. Psychological status was measured by Hospital Anxiety and Depression Scale. Physical function was assessed using tests for handgrip strength, knee extensor strength, and the 6-min walk test. Results: After HSCT, the HID group showed significantly greater improvements in the general health subscale and Mental Component Summary (MCS) of QOL than the other donor group (P < 0.01). Multivariate analysis confirmed that complete remission and age were associated with changes in the general health subscale before and after HSCT (P < 0.05). With regard to physical function, the HID group showed significantly more decline than the other donor group with respect to handgrip strength and knee extensor muscle strength after HSCT (P < 0.05). Total corticosteroid dose was associated with decreased handgrip strength before and after HSCT (P < 0.05). Conclusions: The donor type affects QOL, psychological status, and physical function in allo-HSCT recipients; these findings may provide insights for customised rehabilitation strategies for HSCT recipients. (C) 2015 Elsevier Ltd. All rights reserved.	[Morishita, Shinichiro; Yamauchi, Shinya; Wakasugi, Tatsushi] Hyogo Coll Med Hosp, Dept Rehabil, Nishinomiya, Hyogo, Japan; [Kaida, Katsuji; Ikegame, Kazuhiro; Ogawa, Hiroyasu] Hyogo Coll Med, Dept Internal Med, Div Haematol, Nishinomiya, Hyogo 6638501, Japan; [Kodama, Norihiko; Domen, Kazuhisa] Hyogo Coll Med, Dept Rehabil Med, Nishinomiya, Hyogo 6638501, Japan	Morishita, S (reprint author), Hyogo Coll Med, Dept Rehabil, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	ptmorishin@yahoo.co.jp; kaidak@hyo-med.ac.jp; yamashin5577@yahoo.co.jp; waka.t2s920@gmail.com; kame@hyo-med.ac.jp; norihiko@hyo-med.ac.jp; ogawah@hyo-med.ac.jp; domen@aqu.bekkoame.ne.jp			Japan Society for the Promotion of Science [25862173]	This study was partly supported by a Grant-in-Aid for Young Scientists (B) and the Japan Society for the Promotion of Science (KAKENHI [25862173]).	Passweg JR, 2012, BONE MARROW TRANSPL, V47, P906, DOI 10.1038/bmt.2012.66; Morishita S, 2013, PSYCHO-ONCOLOGY, V22, P1159, DOI 10.1002/pon.3128; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Grulke N, 2012, BONE MARROW TRANSPL, V47, P473, DOI 10.1038/bmt.2011.107; Aversa F, 2012, SEMIN ONCOL, V39, P643, DOI 10.1053/j.seminoncol.2012.09.002; Syrjala KL, 2010, PSYCHO-ONCOLOGY, V19, P462, DOI 10.1002/pon.1572; Rischer J, 2009, BONE MARROW TRANSPL, V44, P121, DOI 10.1038/bmt.2008.430; Ballen KK, 2012, BLOOD, V119, P1972, DOI 10.1182/blood-2011-11-354563; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1045, DOI 10.1016/S0895-4356(98)00096-1; Sun CL, 2011, BLOOD, V118, P4723, DOI 10.1182/blood-2011-04-348730; Watson M, 2004, EUR J CANCER, V40, P971, DOI 10.1016/S0959-8049(03)00628-2; Mo XD, 2012, BONE MARROW TRANSPL, V47, P1201, DOI 10.1038/bmt.2011.250; Kugaya A, 1998, JPN J CLIN ONCOL, V28, P333, DOI 10.1093/jjco/28.5.333; Morishita S, 2013, SUPPORT CARE CANCER, V21, P2161, DOI 10.1007/s00520-013-1778-7; Yoshimi A, 2010, BONE MARROW TRANSPL, V45, P1682, DOI 10.1038/bmt.2010.34; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1037, DOI 10.1016/S0895-4356(98)00095-X; Lau AKL, 2002, BONE MARROW TRANSPL, V29, P41, DOI 10.1038/sj.bmt.1703313; Reisner Y, 2011, BLOOD, V118, P6006, DOI 10.1182/blood-2011-07-338822; Bevans M, 2011, PSYCHO-ONCOLOGY, V20, P615, DOI 10.1002/pon.1906; Morishita S, 2012, SUPPORT CARE CANCER, V20, P821, DOI 10.1007/s00520-011-1156-2; Morishita S, 2012, SUPPORT CARE CANCER, V20, P3161, DOI 10.1007/s00520-012-1460-5; Doorduijn J, 2005, EUR J HAEMATOL, V75, P116, DOI 10.1111/j.1600-0609.2005.00438.x; Katoh M, 2009, J PHYS THER SCI, V21, P37; Ogawa H, 2006, BIOL BLOOD MARROW TR, V12, P1073, DOI 10.1016/j.bbmt.2006.06.007; Bieri S, 2008, BONE MARROW TRANSPL, V42, P819, DOI 10.1038/bmt.2008.253; Ballen KK, 2011, BONE MARROW TRANSPL, V46, P323, DOI 10.1038/bmt.2010.260; Morishita S, 2013, EUR J CANCER CARE, V22, P289, DOI 10.1111/ecc.12027; Luznik L, 2012, SEMIN ONCOL, V39, P683, DOI 10.1053/j.seminoncol.2012.09.005; Alibhai SMH, 2009, CRIT REV ONCOL HEMAT, V69, P168, DOI 10.1016/j.critrevonc.2008.07.015; Okamoto S, 2002, INT J HEMATOL, V76, P310; Ruggeri A, 2010, BEST PRACT RES CL HA, V23, P207, DOI 10.1016/j.beha.2010.06.002; Wolschke C, 2014, BONE MARROW TRANSPL, V49, P126, DOI 10.1038/bmt.2013.143; Koh LP, 2008, BONE MARROW TRANSPL, V42, pS60, DOI 10.1038/bmt.2008.117; Sciurba F, 2003, AM J RESP CRIT CARE, V167, P1522, DOI 10.1164/rccm.200203-166OC; Katoh M, 2009, J PHYS THER SCI, V21, P239; Fukuhara S, 2004, MANUAL SF 36V2 JAPAN; Guimaraes FAB, 2008, REV LAT-AM ENFERM, V16, P856, DOI 10.1590/S0104-11692008000500010; Kanda J, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.85; Koreth J, 2009, JAMA-J AM MED ASSOC, V301, P2349, DOI 10.1001/jama.2009.813; Pidala J, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008818.pub2; Piper B F, 1998, Oncol Nurs Forum, V25, P677; Van Haren LE., 2013, PHYS THER, V93, P514; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	43	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1462-3889	1532-2122		EUR J ONCOL NURS	Eur. J. Oncol. Nurs.	OCT	2015	19	5					443	450		10.1016/j.ejon.2015.02.002		8	Oncology; Nursing	Oncology; Nursing	CU2IR	WOS:000363347700001		
J	Kotani, S; Sakamoto, M; Osakama, K; Nakajima, M				Kotani, Shunsuke; Sakamoto, Midori; Osakama, Kazuki; Nakajima, Makoto			A Sterically Congested -Cyanoamine as a Cyanating Reagent: Cyanation of Acetals and Orthoesters	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Synthetic methods; Nucleophilic addition; Cyanation; Acetals; Cyanides	ALPHA,BETA-UNSATURATED CARBONYL-COMPOUNDS; ASYMMETRIC CYANOHYDRIN SYNTHESIS; CHIRAL PHOSPHINE OXIDE; TRANSFER HYDROGENATION; ALDOL REACTION; TRICHLOROSILYL TRIFLATE; TRIMETHYLSILYL CYANIDE; CONJUGATE REDUCTION; HYDRIDE DONOR; LITHIUM DIISOPROPYLAMIDE	The cyanation of acetals and orthoesters by using a sterically congested -cyanoamine as a cyanating reagent was investigated. The -cyanoamine effectively facilitated cyanation in the presence of trichlorosilyl triflate to produce a variety of cyanated adducts in excellent yields. Analysis of the reaction mixture by H-1 NMR spectroscopy revealed that trichlorosilyl triflate produced an oxocarbenium cation species as an intermediate.	[Kotani, Shunsuke] Kumamoto Univ, Prior Org Innovat & Excellence, Chuo Ku, Kumamoto 8620973, Japan; [Kotani, Shunsuke; Sakamoto, Midori; Osakama, Kazuki; Nakajima, Makoto] Kumamoto Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Kumamoto 8620973, Japan	Kotani, S (reprint author), Kumamoto Univ, Prior Org Innovat & Excellence, Chuo Ku, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	skotani@gpo.kumamoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan through JSPS KAKENHI [25860008]	This work was partially supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, through JSPS KAKENHI grant number 25860008.	Zhou GH, 2010, CHEM COMMUN, V46, P6593, DOI 10.1039/c0cc01946a; Zhang C, 2009, J ORG CHEM, V74, P419, DOI 10.1021/jo802325x; North M, 2003, TETRAHEDRON-ASYMMETR, V14, P147, DOI 10.1016/S0957-4166(02)00825-X; Clerici A, 2004, TETRAHEDRON LETT, V45, P1825, DOI 10.1016/j.tetlet.2004.01.025; Kotani S, 2011, ORG LETT, V13, P3968, DOI 10.1021/ol2014895; MAJEWSKI M, 1988, TETRAHEDRON LETT, V29, P4057, DOI 10.1016/S0040-4039(00)80416-5; OLAH GA, 1968, J AM CHEM SOC, V90, P4323, DOI 10.1021/ja01018a023; MAYR H, 1995, J AM CHEM SOC, V117, P7862, DOI 10.1021/ja00135a002; CHIKASHITA H, 1986, B CHEM SOC JPN, V59, P1747, DOI 10.1246/bcsj.59.1747; SCHREIBER SL, 1980, TETRAHEDRON LETT, V21, P1027, DOI 10.1016/S0040-4039(00)78830-7; North M, 2008, CHEM REV, V108, P5146, DOI 10.1021/cr800255k; Aoki S, 2012, CHEM COMMUN, V48, P5524, DOI 10.1039/c2cc31543b; Okajima M, 2005, J AM CHEM SOC, V127, P6930, DOI 10.1021/ja050414y; Zhu C, 2009, ORG LETT, V11, P4180, DOI 10.1021/ol901762g; Brunel JM, 2004, ANGEW CHEM INT EDIT, V43, P2752, DOI 10.1002/anie.200300604; TORII S, 1987, B CHEM SOC JPN, V60, P2173, DOI 10.1246/bcsj.60.2173; Zhang YB, 2009, HETEROCYCLES, V78, P1541, DOI 10.3987/COM-08-11603; Murarka S, 2009, J AM CHEM SOC, V131, P13226, DOI 10.1021/ja905213f; Haibach MC, 2011, J AM CHEM SOC, V133, P2100, DOI 10.1021/ja110713k; Cho CS, 2009, B KOREAN CHEM SOC, V30, P1931; HIYAMA T, 1987, B CHEM SOC JPN, V60, P2139, DOI 10.1246/bcsj.60.2139; NISHIGUCHI T, 1975, J ORG CHEM, V40, P237, DOI 10.1021/jo00890a019; Hasegawa E, 2009, HETEROCYCLES, V77, P1147, DOI 10.3987/COM-08-S(F)94; Kotani S, 2011, TETRAHEDRON LETT, V52, P2834, DOI 10.1016/j.tetlet.2011.03.095; Mori K, 2009, CHEM LETT, V38, P524, DOI 10.1246/cl.2009.524; BABLER JH, 1987, TETRAHEDRON LETT, V28, P4657, DOI 10.1016/S0040-4039(00)96589-4; Murarka S, 2009, ORG LETT, V11, P129, DOI 10.1021/ol802519r; Rueping M, 2011, GREEN CHEM, V13, P1084, DOI 10.1039/c1gc15027h; KOWALSKI C, 1978, J ORG CHEM, V43, P2601, DOI 10.1021/jo00407a011; Connon SJ, 2007, ORG BIOMOL CHEM, V5, P3407, DOI 10.1039/b711499k; Kotani S, 2014, ORG LETT, V16, P4802, DOI 10.1021/ol502269w; Cao WD, 2011, ORG LETT, V13, P600, DOI 10.1021/ol1028282; UTIMOTO K, 1981, TETRAHEDRON LETT, V22, P4279, DOI 10.1016/S0040-4039(01)82933-6; You SL, 2007, CHEM-ASIAN J, V2, P820, DOI 10.1002/asia.200700081; Osakama K, 2012, TETRAHEDRON LETT, V53, P4199, DOI 10.1016/j.tetlet.2012.05.147; Gregory RJH, 1999, CHEM REV, V99, P3649, DOI 10.1021/cr9902906; BASSINDALE AR, 1984, J ORGANOMET CHEM, V271, pC1, DOI 10.1016/0022-328X(84)85193-1; Brunel J.-M., 2004, ANGEW CHEM, V116, P2810, DOI 10.1002/ange.200300604; Chen FX, 2005, SYNLETT, P892, DOI 10.1055/s-2005-864831; Chikashita H., 1987, J CHEM SOC PERK T, P699; CHIKASHITA H, 1984, SYNTHESIS-STUTTGART, P308; ITO Y, 1984, CHEM LETT, P937, DOI 10.1246/cl.1984.937; KANTLEHNER W, 1981, LIEBIGS ANN CHEM, P70; KIRCHMEYER S, 1983, SYNTHESIS-STUTTGART, P498; Kumamoto K, 2006, SYNLETT, P1968, DOI 10.1055/s-2006-947347; Ma L., 2013, J AM CHEM SOC, V134, P15305; Matyus P, 2006, SYNTHESIS-STUTTGART, P2625, DOI 10.1055/s-2006-942490; MIURA T, 1994, J CHEM SOC PERK T 1, P1659, DOI 10.1039/p19940001659; MIURA T, 1995, J CHEM SOC PERK T 1, P2155, DOI 10.1039/p19950002155; Moberg C, 2010, SYNLETT, P355, DOI 10.1055/s-0029-1219154; MUKAIYAMA T, 1989, CHEM LETT, P997, DOI 10.1246/cl.1989.997; NORTH M, 1993, SYNLETT, P807; Ohishi Y., 1999, ORG LETT, V1, P237; Ouellet SG, 2007, ACCOUNTS CHEM RES, V40, P1327, DOI 10.1021/ar7001864; SCOTT LT, 1978, TETRAHEDRON LETT, P4637; Tokuyama H, 2000, SYNTHESIS-STUTTGART, P1299; TORII S, 1984, CHEM LETT, P897, DOI 10.1246/cl.1984.897; WOO EP, 1974, TETRAHEDRON LETT, P4095	58	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	OCT	2015		30					6606	6609		10.1002/ejoc.201501084		4	Chemistry, Organic	Chemistry	CU2FR	WOS:000363339600004		
J	Nagata, C; Wada, K; Tsuji, M; Hayashi, M; Takeda, N; Yasuda, K				Nagata, Chisato; Wada, Keiko; Tsuji, Michiko; Hayashi, Makoto; Takeda, Noriyuki; Yasuda, Keigo			Association of hair dye use with circulating levels of sex hormones in premenopausal Japanese women	EUROPEAN JOURNAL OF PUBLIC HEALTH			English	Article							POSTMENOPAUSAL WOMEN; STEROID-HORMONES; CANCER; CARCINOGENICITY; TESTOSTERONE; NUTRITION; ALCOHOL; RISK; RATS	Background: Substances identified as animal carcinogens are no longer used as ingredients of hair dyes. However, hair dyes are diverse groups of chemicals, and certain compounds may affect endogenous sex hormone levels. We examined the association between hair dye use and sex hormone levels among premenopausal women. Methods: Study subjects were 431 premenopausal Japanese women who had regular menstrual cycles less than 40 days long. Information on the use of hair dyes or hair bleach, the type of hair coloring used, the duration of use and the frequency of application was collected using a self-administered questionnaire. Fasting plasma samples were obtained to measure estradiol, testosterone, dehydroepiandrosterone sulfate, sex hormone-binding globulin, follicle-stimulating hormone and luteinizing hormone. Results: After controlling for covariates, the mean plasma total testosterone level was about 14% higher in women who had used hair dyes for 10 or more years than that among women who had never used them (P for trend = 0.02). A similar association was observed when the type of hair dye was restricted to permanent hair dyes. A higher frequency of applying non-permanent hair dyes was marginally significantly associated with higher total and free estradiol levels. Conclusions: Data suggest that long-term use of hair dyes may be associated with an increase in circulating testosterone levels. As this is, to our knowledge, the first study examining the association between hair dye use and sex hormone levels, replication of the results is required.	[Nagata, Chisato; Wada, Keiko] Gifu Univ, Grad Sch Med, Dept Epidemiol & Prevent Med, Gifu 5011194, Japan; [Tsuji, Michiko] Japan Womens Univ, Dept Food & Nutr, Tokyo 112, Japan; [Hayashi, Makoto; Yasuda, Keigo] Matsunami Gen Hosp, Dept Internal Med, Gifu, Japan; [Takeda, Noriyuki] Asahi Univ, Murakami Mem Hosp, Dept Endocrinol & Metab, Gifu, Japan	Nagata, C (reprint author), Gifu Univ, Grad Sch Med, Dept Epidemiol & Prevent Med, 1-1 Yanagido, Gifu 5011194, Japan.	chisato@gifu-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [221S0001]	This work was supported in part by Grants-in-Aid for Scientific Research on Innovative Areas (No. 221S0001) from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Ames BN, 1975, P NATL ACAD SCI USA, V72, P423; SODERGARD R, 1982, J STEROID BIOCHEM, V16, P801, DOI 10.1016/0022-4731(82)90038-3; Woolcock JG, 2008, FERTIL STERIL, V90, P2269, DOI 10.1016/j.fertnstert.2007.10.060; Schmidt L, 2013, ANAL BIOANAL CHEM, V405, P2019, DOI 10.1007/s00216-012-6618-y; Nettleship JE, 2007, HORM METAB RES, V39, P366, DOI 10.1055/s-2007-976543; Verkasalo PK, 2001, CANCER CAUSE CONTROL, V12, P47, DOI 10.1023/A:1008929714862; Nagata C, 2009, BRIT J NUTR, V101, P1427, DOI 10.1017/S0007114508083566; Baan R, 2008, LANCET ONCOL, V9, P322, DOI 10.1016/S1470-2045(08)70089-5; Wang HX, 2013, ANAL BIOANAL CHEM, V405, P4313, DOI 10.1007/s00216-013-6779-3; Han Y, 2010, SCI TOTAL ENVIRON, V408, P768, DOI 10.1016/j.scitotenv.2009.11.021; Yazar K, 2009, CONTACT DERMATITIS, V61, P269, DOI 10.1111/j.1600-0536.2009.01612.x; Takkouche B, 2005, JAMA-J AM MED ASSOC, V293, P2516, DOI 10.1001/jama.293.20.2516; Rinaldi S, 2006, CANCER CAUSE CONTROL, V17, P1033, DOI 10.1007/s10552-006-0041-7; Boberg J, 2010, REPROD TOXICOL, V30, P301, DOI 10.1016/j.reprotox.2010.03.011; Nagata C, 2011, CANCER CAUSE CONTROL, V22, P581, DOI 10.1007/s10552-011-9731-x; van Meeuwen JA, 2008, TOXICOL APPL PHARM, V230, P372, DOI 10.1016/j.taap.2008.03.002; WEISBURGER EK, 1980, CARCINOGENESIS, V1, P495, DOI 10.1093/carcin/1.6.495; McFadden JP, 2011, CLIN DERMATOL, V29, P316, DOI 10.1016/j.clindermatol.2010.11.011; Zoeller RT, 2012, ENDOCRINOLOGY, V153, P4097, DOI 10.1210/en.2012-1422; Tsuji M, 2012, CANCER CAUSE CONTROL, V23, P683, DOI 10.1007/s10552-012-9935-8; Bezemer ID, 2005, CANCER CAUSE CONTROL, V16, P561, DOI 10.1007/s10552-004-7472-9; CARDY RH, 1979, J NATL CANCER I, V62, P1107; Endogenous H, 2013, LANCET ONCOL, V14, P1009, DOI [10.1016/S1470-2045(13)70301-2, DOI 10.1016/S1470-2045(13)70301-2]; International Agency For Research On Cancer (IARC), 2010, IARC MON EV CARC RIS, V99; Japan Soap and Detergent Association, 2002, JAPAN SOAP DETERGENT, V16, P3; Mileva Zh, 1988, Vutr Boles, V27, P29; Pardeshi SK, 2009, J HAZARD MATER, V163, P403, DOI 10.1016/j.jhazmat.2008.06.111; Yazar K, 2011, CONTACT DERMATITIS, V66, P27	28	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1101-1262	1464-360X		EUR J PUBLIC HEALTH	Eur. J. Public Health	OCT	2015	25	5					895	899		10.1093/eurpub/ckv020		5	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CT7DB	WOS:000362972700031		
J	Ishikawa, T; Abe, S; Kojima, Y; Horigome, R; Sano, T; Iwanaga, A; Seki, K; Honma, T; Yoshida, T				Ishikawa, Toru; Abe, Satoshi; Kojima, Yuichi; Horigome, Ryoko; Sano, Tomoe; Iwanaga, Akito; Seki, Keiichi; Honma, Terasu; Yoshida, Toshiaki			Telaprevir-based triple therapy following partial splenic arterial embolization for chronic hepatitis C with thrombocytopenia can reduce carcinogenesis and improve hepatic function reserve	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						partial splenic arterial embolization; telaprevir-based triple therapy; thrombocytopenia	OVERWHELMING POSTSPLENECTOMY INFECTION; CHRONIC HCV INFECTION; LIVER-CIRRHOSIS; RIBAVIRIN; PEGINTERFERON; HYPERSPLENISM; SPLENECTOMY; RETREATMENT; INTERFERON; PLATELETS	Thrombocytopenia in patients with chronic hepatitis C negatively impacts interferon (IFN)-based treatment. The aim of this study was to evaluate the efficacy and safety of telaprevir (TVR)-based triple therapy including IFN for patients who have undergone partial splenic arterial embolization (PSE). Ten patients with thrombocytopenia who were infected with hepatitis C virus (HCV) genotype 1b received 12 weeks of TVR in combination with 24 weeks of pegylated interferon (PEG-IFN)alpha 2b and ribavirin following PSE. A sustained virological response (SVR) was seen in 9 of the 10 patients who could be assessed. Early relapse was seen in 1 patient who had the IL-28B minor allele and a null response to pretreatment. The a-fetoprotein levels of the patients decreased from 17.94 +/- 7.30 ng/ml prior to PSE to 4.33 +/- 2.41 ng/ml at 6 months after triple therapy (P=0.08). Furthermore, serum albumin, levels improved significantly from 3.68 +/- 0.49 g/dl pre-PSE to 4.13 +/- 0.34 g/dl at 12 months after triple therapy (P=0.043). PSE contributed to the treatment success of triple therapy, particularly for patients who were either treatment-naive, had a history of relapse or the IL28B major allele. This strategy can reduce carcinogenesis and improve hepatic function reserve.	[Ishikawa, Toru; Abe, Satoshi; Kojima, Yuichi; Horigome, Ryoko; Sano, Tomoe; Iwanaga, Akito; Seki, Keiichi; Honma, Terasu; Yoshida, Toshiaki] Saiseikai Niigata Daini Hosp, Dept Gastroenterol & Hepatol, Niigata 9501104, Japan	Ishikawa, T (reprint author), Saiseikai Niigata Daini Hosp, Dept Gastroenterol & Hepatol, Niigata 9501104, Japan.	toruishi@ngt.saiseikai.or.jp					GOLDSTONE J, 1978, AM J SURG, V135, P385, DOI 10.1016/0002-9610(78)90071-5; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; ASTER RH, 1966, J CLIN INVEST, V45, P645, DOI 10.1172/JCI105380; Yoshida H, 2008, HEPATOL RES, V38, P225, DOI 10.1111/j.1872-034X.2007.00302.x; Amin MA, 2009, WORLD J SURG, V33, P1702, DOI 10.1007/s00268-009-0095-2; Nagamine T, 1996, J HEPATOL, V24, P135, DOI 10.1016/S0168-8278(96)80021-3; Okabayashi T, 2008, WORLD J GASTROENTERO, V14, P176, DOI 10.3748/wjg.14.176; Afdhal N, 2008, J HEPATOL, V48, P1000, DOI 10.1016/j.jhep.2008.03.009; Shimizu H, 2009, INTERNAL MED, V48, P747, DOI 10.2169/internalmedicine.48.1649; MADDISON FE, 1973, INVEST RADIOL, V8, P280, DOI 10.1097/00004424-197307000-00054; Ishikawa T, 1998, J GASTROEN HEPATOL, V13, P907, DOI 10.1111/j.1440-1746.1998.tb00760.x; Ikeda N, 2014, HEPATOL RES, V44, P829, DOI 10.1111/hepr.12184; Shiffman ML, 2007, GASTROENTEROLOGY, V132, P103, DOI 10.1053/j.gastro.2006.11.011; BUTLER JC, 1993, JAMA-J AM MED ASSOC, V270, P1826, DOI 10.1001/jama.270.15.1826; LINTON RR, 1947, SURG CLIN N AM, V27, P1162; McHutchison JG, 2010, NEW ENGL J MED, V362, P1292, DOI 10.1056/NEJMoa0908014; AOKI Y, 1993, EUR J NUCL MED, V20, P123; Ogawa E, 2013, J HEPATOL, V59, P667, DOI 10.1016/j.jhep.2013.05.017; Tahara H, 2011, J GASTROENTEROL, V46, P1010, DOI 10.1007/s00535-011-0407-9; Waghorn DJ, 1997, J INFECTION, V35, P289, DOI 10.1016/S0163-4453(97)93232-1; SPIGOS DG, 1979, AM J ROENTGENOL, V132, P777; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Miyake Y, 2008, HEPATOL RES, V38, P980, DOI 10.1111/j.1872-034X.2008.00357.x; Hayashi H, 2007, J GASTROEN HEPATOL, V22, P1638, DOI 10.1111/j.1440-1746.2007.05090.x; Hanafiah M, 2013, BMJ CASE REP; Ishikawa T, 2014, HEPATOL RES, V44, P1056, DOI 10.1111/hepr.12222; Shimizu H, 2014, INTERNAL MED, V53, P925, DOI 10.2169/internalmedicine.53.1842	28	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	OCT	2015	10	4					1334	1338		10.3892/etm.2015.2674		5	Medicine, Research & Experimental	Research & Experimental Medicine	CT7MS	WOS:000362999400016		
J	Furukawa, S; Kuwajima, Y; Chosa, N; Satoh, K; Ohtsuka, M; Miura, H; Kimura, M; Inoko, H; Ishisaki, A; Fujimura, A; Miura, H				Furukawa, Shinji; Kuwajima, Yukinori; Chosa, Naoyuki; Satoh, Kazuro; Ohtsuka, Masato; Miura, Hiromi; Kimura, Minoru; Inoko, Hidetoshi; Ishisaki, Akira; Fujimura, Akira; Miura, Hiroyuki			Establishment of immortalized mesenchymal stem cells derived from the submandibular glands of tdTomato transgenic mice	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						tdTomato transgenic mice; submandibular gland; mesenchymal stem cells; osteogenic differentiation; adipogenic differentiation	HUMAN SALIVARY-GLANDS; QUALITY-OF-LIFE; BONE-MARROW; T-ANTIGEN; ECTODERMAL DYSPLASIAS; PANCREATIC LINEAGES; PROGENITOR CELLS; SJOGREN SYNDROME; STROMAL CELLS; TRANSPLANTATION	Transgenic mice that overexpress the red fluorescent protein tdTomato (tdTomato mice) are well suited for use in regenerative medicine studies. Cultured cells from this murine model exhibit strong red fluorescence, enabling real-time in vivo imaging through the body surface of grafted animals. Mesenchymal stem cells (MSCs) have marked potential for use in cell therapy and regenerative medicine; however, the mechanisms that regulate their dynamics in vivo are poorly understood. In the present study, an MSC line was derived from the submandibular gland fibroblasts of tdTomato mice. The fluorescent signal from this cell line was observed in organs throughout the body, as well as in salivary glands. Primary culture cells derived from the submandibular gland were immortalized with SV40 large T antigen (GManSV cells); these cells exhibited increased migratory ability, as compared with those isolated from the sublingual gland. GManSV cells were tdTomato-positive and exhibited spindle-shaped fibroblastic morphology; they also robustly expressed mouse MSC markers: Stem cell antigen-1 (Sca-1), CD44, and CD90. This cell line retained multipotent stem cell characteristics, as evidenced by its ability to differentiate into both osteogenic and adipogenic lineages. These results indicate that Sca-1(+)/CD44(+)/CD90(+)-GManSV cells may be useful for kinetic studies of submandibular gland-derived MSCs in the context of in vitro co-culture with other types of salivary gland-derived cells. These cells may also be used for in vivo imaging studies, in order to identify novel cell therapy and regenerative medicine for the treatment of salivary gland diseases.	[Furukawa, Shinji; Kuwajima, Yukinori; Satoh, Kazuro; Miura, Hiroyuki] Iwate Med Univ, Sch Dent, Dept Dev Oral Hlth Sci, Div Orthodont, Morioka, Iwate 0208505, Japan; [Chosa, Naoyuki; Ishisaki, Akira] Iwate Med Univ, Dept Biochem, Div Cellular Biosignal Sci, Yahaba, Iwate 0283694, Japan; [Ohtsuka, Masato; Miura, Hiromi; Kimura, Minoru; Inoko, Hidetoshi] Tokai Univ, Sch Med, Dept Mol Life Sci, Div Basic Med Sci & Mol Med, Isehara, Kanagawa 2591193, Japan; [Fujimura, Akira] Iwate Med Univ, Dept Anat, Div Funct Morphol, Yahaba, Iwate 0283694, Japan	Chosa, N (reprint author), Iwate Med Univ, Dept Biochem, Div Cellular Biosignal Sci, 2-1-1 Nshitokuta, Yahaba, Iwate 0283694, Japan.	nchosa@iwate-med.ac.jp			JSPS KAKENHI [25463053, 23592896]; Ministry of Education, Culture, Sports, Science and Technology of Japan	The present study was supported in part by JSPS KAKENHI (grant no. 25463053 to Dr Naoyuki Chosa and grant no. 23592896 to Professor Akira Ishisaki); and a Grant-in-aid for Strategic Medical Science Research Centre from the Ministry of Education, Culture, Sports, Science and Technology of Japan, 2010-2014.	Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; PRIVES C, 1990, CELL, V61, P735, DOI 10.1016/0092-8674(90)90179-I; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Belema-Bedada F, 2008, CELL STEM CELL, V2, P566, DOI 10.1016/j.stem.2008.03.003; Kawakami M, 2013, HUM CELL, V26, P80, DOI 10.1007/s13577-013-0061-z; Sato A, 2007, CLONING STEM CELLS, V9, P191, DOI 10.1089/clo.2006.0054; Rotter N, 2008, STEM CELLS DEV, V17, P509, DOI 10.1089/scd.2007.0180; Kawamoto T, 2000, HISTOCHEM CELL BIOL, V113, P331; Labas YA, 2002, P NATL ACAD SCI USA, V99, P4256, DOI 10.1073/pnas.062552299; Carpenter GH, 2010, FRONT ORAL BIOL, V14, P107, DOI 10.1159/000313710; Jensen SB, 2010, SUPPORT CARE CANCER, V18, P1039, DOI 10.1007/s00520-010-0827-8; Ohtsuka M, 2012, CELL TISSUE RES, V350, P251, DOI 10.1007/s00441-012-1470-0; KAHN P, 1983, VIROLOGY, V126, P348, DOI 10.1016/0042-6822(83)90484-1; Taichman RS, 2010, STEM CELLS DEV, V19, P1557, DOI 10.1089/scd.2009.0445; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; KAWAMOTO T, 1990, J HISTOCHEM CYTOCHEM, V38, P1805; Nordgarden H, 2003, EUR J ORAL SCI, V111, P371, DOI 10.1034/j.1600-0722.2003.00058.x; Hisatomi Y, 2004, HEPATOLOGY, V39, P667, DOI 10.1002/hep.20063; Lin CY, 2011, J DENT RES, V90, P341, DOI 10.1177/0022034510386374; Clauss F, 2008, J DENT RES, V87, P1089; Xu JJ, 2012, BLOOD, V120, P3142, DOI 10.1182/blood-2011-11-391144; BOROWIEC JA, 1990, CELL, V60, P181, DOI 10.1016/0092-8674(90)90730-3; Weigert R, 2013, J CELL BIOL, V201, P969, DOI 10.1083/jcb.201212130; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Maria OM, 2012, ORAL DIS, V18, P162, DOI 10.1111/j.1601-0825.2011.01858.x; Okumura K, 2003, HEPATOLOGY, V38, P104, DOI 10.1053/jhep.2003.50259; Lim JY, 2015, TISSUE ENG PART C-ME, V21, P447, DOI [10.1089/ten.TEC.2014.0204, 10.1089/ten.tec.2014.0204]; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Scott J, 1999, J DENT RES, V78, P1711; Lim JY, 2013, ORAL ONCOL, V49, P136, DOI 10.1016/j.oraloncology.2012.08.010; HOWELL N, 1982, CYTOGENET CELL GENET, V34, P215, DOI 10.1159/000131809; Nelson J, 2013, ORAL DIS, V19, P236, DOI 10.1111/j.1601-0825.2012.01958.x; Coppes RP, 2011, ORAL DIS, V17, P143, DOI 10.1111/j.1601-0825.2010.01723.x; Pillemer SR, 2001, MAYO CLIN PROC, V76, P593; Matsumoto S, 2007, CLONING STEM CELLS, V9, P176, DOI 10.1089/clo.2006.0022; Day RN, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2939093; PINHEIRO M, 1994, AM J MED GENET, V53, P153, DOI 10.1002/ajmg.1320530207; Nitta M, 2001, GYNECOL ONCOL, V81, P10, DOI 10.1006/gyno.2000.6084; Berk L, 2008, EXPERT OPIN DRUG MET, V4, P1333, DOI [10.1517/17425255.4.10.1333 , 10.1517/17425250802404841]; Arlt VM, 2007, CARCINOGENESIS, V28, P2253, DOI 10.1093/carcin/bgm082; Pringle S, 2013, STEM CELLS, V31, P613, DOI 10.1002/stem.1327; Chen XD, 1999, J BONE MINER RES, V14, P362, DOI 10.1359/jbmr.1999.14.3.362; Sumita Y, 2011, INT J BIOCHEM CELL B, V43, P80, DOI [10.1016/j.biocel.2010.09.023, 10.1016/j.bioce1.2010.09.023]; GEE CJ, 1979, J CELL SCI, V36, P223; Aomatsu E, 2014, SCI REP-UK, V4, DOI 10.1038/srep03652; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; FRIEDENS.AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Holsinger FC, 2007, SALIVARY GLANDS DISO, V1, P1; Jeong J, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.121; Khalili S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038615; Lombaert IMA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002063; Ogawa M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3498; Ohtsuka M, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq860; Park YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112158; Sohni A., 2013, STEM CELLS INT, V2013; Thomson WM, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-86	56	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	OCT	2015	10	4					1380	1386		10.3892/etm.2015.2700		7	Medicine, Research & Experimental	Research & Experimental Medicine	CT7MS	WOS:000362999400022		
J	Tomizawa, M; Shinozaki, F; Fugo, K; Motoyoshi, Y; Sugiyama, T; Yamamoto, S; Kishimoto, T; Ishige, N				Tomizawa, Minoru; Shinozaki, Fuminobu; Fugo, Kazunori; Motoyoshi, Yasufumi; Sugiyama, Takao; Yamamoto, Shigenori; Kishimoto, Takashi; Ishige, Naoki			Anti-mitochondrial M2 antibody-positive autoimmune hepatitis	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						primary biliary cirrhosis; anti-nuclear antibody; anti-mitochondrial antibody; receiver operator characteristics; logistic regression model	PRIMARY BILIARY-CIRRHOSIS; CLINICAL-SIGNIFICANCE; SCORING SYSTEM; AUTOANTIBODIES; DIAGNOSIS; PROGNOSIS; PROGRESS; EPITOPE	Anti-mitochondrial M2 antibody (AMA-M2) is specific to primary biliary cirrhosis (PBC), but can also be found in certain patients with autoimmune hepatitis (AIH). Effective methods of differentiating between PBC and AIH are required, as their clinical course and management are different. Titers of AMA-M2 were analyzed before and after follow-up in patients with PBC or AIH. Patients who underwent liver biopsy and were diagnosed with either AIH (10 patients) or PBC (3 patients) were enrolled in the study. The AMA-M2 antibody titers of these patients were analyzed upon hospital admission. AMA-M2 reacted with the pyruvate dehydrogenase complex-E2, branched-chain 2-oxo acid dehydrogenase complex and 2-oxoglutaric acid dehydrogenase complex in the assay utilized for this study. The cut-off value for AMA-M2 was 5. Six AIH patients were AMA-M2(-) and 4 were AMA-M2(+). The titer for the AIH patients who were AMA-M2(+) was 24.8 +/- 14.8, compared with 324 174 in the patients with PBC (P=0.0138). Three AMA-M2(+) AIH patients were followed-up after liver biopsy. The AMA-M2 levels had decreased in all 3 patients, becoming undetectable in 2 of them. In conclusion, certain patients with AIH in this study were found to be AMA-M2(+), but the titers were significantly lower than those in the patients with PBC. At follow-up, the AIH patients exhibited decreased AMA-M2 titers.	[Tomizawa, Minoru] Shimoshizu Hosp, Natl Hosp Org, Dept Gastroenterol, Yotsukaido, Chiba 2840003, Japan; [Shinozaki, Fuminobu] Shimoshizu Hosp, Natl Hosp Org, Dept Radiol, Yotsukaido, Chiba 2840003, Japan; [Fugo, Kazunori; Kishimoto, Takashi] Chiba Univ, Grad Sch Med, Dept Mol Pathol, Chiba, Chiba 2608670, Japan; [Motoyoshi, Yasufumi] Shimoshizu Hosp, Natl Hosp Org, Dept Neurol, Yotsukaido, Chiba 2840003, Japan; [Sugiyama, Takao] Shimoshizu Hosp, Natl Hosp Org, Dept Rheumatol, Yotsukaido, Chiba 2840003, Japan; [Yamamoto, Shigenori] Shimoshizu Hosp, Natl Hosp Org, Dept Pediat, Yotsukaido, Chiba 2840003, Japan; [Ishige, Naoki] Shimoshizu Hosp, Natl Hosp Org, Dept Neurosurg, Yotsukaido, Chiba 2840003, Japan	Tomizawa, M (reprint author), Shimoshizu Hosp, Natl Hosp Org, Dept Gastroenterol, 934-5 Shikawatashi, Yotsukaido, Chiba 2840003, Japan.	nihminor-cib@umin.ac.jp					Alvarez F., 1999, Journal of Hepatology, V31, P929, DOI 10.1016/S0168-8278(99)80297-9; GERSHWIN ME, 1987, J IMMUNOL, V138, P3525; Oketani M, 2013, HEPATOL RES, V43, P97, DOI 10.1111/j.1872-034X.2012.01105.x; Suzuki A, 2011, HEPATOLOGY, V54, P931, DOI 10.1002/hep.24481; Kakuda Y, 2013, HUM PATHOL, V44, P1107, DOI 10.1016/j.humpath.2012.09.017; Liberal R, 2013, J AUTOIMMUN, V41, P126, DOI 10.1016/j.jaut.2012.11.002; Roda A, 2000, FRESEN J ANAL CHEM, V366, P752, DOI 10.1007/s002160051569; Liberal R, 2013, J AUTOIMMUN, V46, P17, DOI 10.1016/j.jaut.2013.08.001; LEUNG PSC, 1995, HEPATOLOGY, V22, P505, DOI 10.1016/0270-9139(95)90572-3; Bowlus CL, 2014, AUTOIMMUN REV, V13, P441, DOI 10.1016/j.autrev.2014.01.041; Czaja AJ, 2013, DIGEST DIS SCI, V58, P897, DOI 10.1007/s10620-012-2445-4; CZAJA AJ, 1993, GASTROENTEROLOGY, V104, P1755; Chazouilleres O, 1998, HEPATOLOGY, V28, P296, DOI 10.1002/hep.510280203; Chantran Y, 2013, CLIN RES HEPATOL GAS, V37, P431, DOI 10.1016/j.clinre.2013.05.002; O'Brien C, 2008, HEPATOLOGY, V48, P550, DOI 10.1002/hep.22380; Verslype C, 2005, ALIMENT PHARM THERAP, V21, P695, DOI 10.1111/j.1365-2036.2005.02403.x; Farias AQ, 2006, J GASTROEN HEPATOL, V21, P887, DOI 10.1111/1440-1746.2006.04130.x; Lindor KD, 2009, HEPATOLOGY, V50, P291, DOI 10.1002/hep.22906; Moteki S, 1996, HEPATOLOGY, V23, P436; Yamamoto K, 2003, J GASTROENTEROL, V38, P52, DOI 10.1007/s005350300006; Manns MP, 2010, HEPATOLOGY, V51, P2193, DOI 10.1002/hep.23584; Miyakawa H, 2000, HEPATOL RES, V18, P1, DOI 10.1016/S1386-6346(99)00079-0; Yoshizawa K, 2012, HEPATOLOGY, V56, P668, DOI 10.1002/hep.25658; Yamagiwa S, 2014, WORLD J GASTROENTERO, V20, P2606, DOI 10.3748/wjg.v20.i10.2606; Yanagawa T, 2003, HEPATOL RES, V26, P81, DOI 10.1016/S1386-6346(03)00014-7; Montano-Loza AJ, 2008, AM J GASTROENTEROL, V103, P1944, DOI 10.1111/j.1572-0241.2008.01922.x; Dellavance A, 2012, HEPATOL INT, V7, P775; Gershwin M E, 1992, Prog Liver Dis, V10, P47; Krawitt EL, 2006, NEW ENGL J MED, V354, P54, DOI 10.1056/NEJMra050408	29	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	OCT	2015	10	4					1419	1422		10.3892/etm.2015.2694		4	Medicine, Research & Experimental	Research & Experimental Medicine	CT7MS	WOS:000362999400028		
J	Nakamura, M; Haarmann-Stemmann, T; Krutmann, J				Nakamura, Motoki; Haarmann-Stemmann, Thomas; Krutmann, Jean			COX inhibition enhances inflammatory immune cell infiltration in UV-irradiated human skin: implications for the treatment of sunburn	EXPERIMENTAL DERMATOLOGY			English	Editorial Material						cyclooxygenase; lipoxygenase; non-steroidal anti-inflammatory drug; sunburn; ultraviolet radiation			[Nakamura, Motoki; Haarmann-Stemmann, Thomas; Krutmann, Jean] IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany; [Nakamura, Motoki] Nagoya City Univ, Dept Environm & Geriatr Dermatol, Nagoya, Aichi, Japan; [Krutmann, Jean] Univ Dusseldorf, Fac Med, Dusseldorf, Germany	Krutmann, J (reprint author), IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany.	jean.krutmann@iuf-duesseldorf.de					Rhodes LE, 2009, FASEB J, V23, P3947, DOI 10.1096/fj.09-136077; BLACK AK, 1978, BRIT J CLIN PHARMACO, V5, P431; Rhodes LE, 2001, J INVEST DERMATOL, V117, P880, DOI 10.1046/j.0022-202x.2001.01514.x; Krutmann J, 2012, J INVEST DERMATOL, V132, P976, DOI 10.1038/jid.2011.394; Gresham A, 1996, AM J PHYSIOL-CELL PH, V270, pC1037; GILCHREST BA, 1981, J AM ACAD DERMATOL, V5, P411, DOI 10.1016/S0190-9622(81)70103-8; CUNNINGHAM FM, 1987, PROSTAGLANDINS, V34, P71, DOI 10.1016/0090-6980(87)90264-4; Pilkington SM, 2015, EXP DERMATOL, V24, P790, DOI 10.1111/exd.12734; Rossaint J, 2012, CRIT CARE, V16, DOI 10.1186/cc11518	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0906-6705	1600-0625		EXP DERMATOL	Exp. Dermatol.	OCT	2015	24	10					734	735		10.1111/exd.12783		2	Dermatology	Dermatology	CT8FG	WOS:000363049800004		
J	Thandavarayan, RA; Garikipati, VNS; Joladarashi, D; Babu, SS; Jeyabal, P; Verma, SK; Mackie, AR; Khan, M; Arumugam, S; Watanabe, K; Kishore, R; Krishnamurthy, P				Thandavarayan, Rajarajan A.; Garikipati, Venkata Naga Srikanth; Joladarashi, Darukeshwara; Babu, Sahana Suresh; Jeyabal, Prince; Verma, Suresh K.; Mackie, Alexander R.; Khan, Mohsin; Arumugam, Somasundaram; Watanabe, Kenichi; Kishore, Raj; Krishnamurthy, Prasanna			Sirtuin-6 deficiency exacerbates diabetes-induced impairment of wound healing	EXPERIMENTAL DERMATOLOGY			English	Article						angiogenesis; diabetes; inflammation; sirtuin 6; wound healing	HISTONE DEACETYLASE SIRT6; LOWER-EXTREMITY ULCERS; OXIDATIVE STRESS; ENDOTHELIAL-CELLS; GENE-EXPRESSION; 14-3-3 PROTEIN; GROWTH-FACTOR; MICE; CARDIOMYOPATHY; DYSFUNCTION	Delayed wound healing is one of the major complications in diabetes and is characterized by chronic proinflammatory response, and abnormalities in angiogenesis and collagen deposition. Sirtuin family proteins regulate numerous pathophysiological processes, including those involved in promotion of longevity, DNA repair, glycolysis and inflammation. However, the role of sirtuin 6 (SIRT6), a NAD+-dependent nuclear deacetylase, in wound healing specifically under diabetic condition remains unclear. To analyse the role of SIRT6 in cutaneous wound healing, paired 6-mm stented wound was created in diabetic db/db mice and injected siRNA against SIRT6 in the wound margins (transfection agent alone and nonsense siRNA served as controls). Wound time to closure was assessed by digital planimetry, and wounds were harvested for histology, immunohistochemistry and Western blotting. SIRT6-siRNA-treated diabetic wound showed impaired healing, which was associated with reduced capillary density (CD31-staining vessels) when compared to control treatment. Interestingly, SIRT6 deficiency decreased vascular endothelial growth factor expression and proliferation markers in the wounds. Furthermore, SIRT6 ablation in diabetic wound promotes nuclear factor-kappa B (NF-kappa B) activation resulting in increased expression of proinflammatory markers (intercellular adhesion molecule-1, vascular cell adhesion molecule-1, tumor necrosis factor-alpha and interleukin-1 beta) and increased oxidative stress. Collectively, our findings demonstrate that loss of SIRT6 in cutaneous wound aggravates proinflammatory response by increasing NF-kappa B activation, oxidative stress and decrease in angiogenesis in the diabetic mice. Based on these findings, we speculate that the activation of SIRT6 signalling might be a potential therapeutic approach for promoting wound healing in diabetics.	[Thandavarayan, Rajarajan A.; Joladarashi, Darukeshwara; Babu, Sahana Suresh; Jeyabal, Prince; Krishnamurthy, Prasanna] Houston Methodist Res Inst, Dept Cardiovasc Sci, Ctr Cardiovasc Regenerat, Houston, TX 77030 USA; [Garikipati, Venkata Naga Srikanth; Verma, Suresh K.; Khan, Mohsin; Kishore, Raj] Temple Univ, Sch Med, Ctr Translat Med, Philadelphia, PA 19122 USA; [Mackie, Alexander R.] Northwestern Univ, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA; [Arumugam, Somasundaram; Watanabe, Kenichi] Niigata Univ Pharm & Appl Life Sci, Dept Clin Pharmacol, Niigata, Japan; [Krishnamurthy, Prasanna] Cornell Univ, Weill Cornell Med Coll, Dept Cardiothorac Surg, Cell & Dev Biol, New York, NY 10021 USA	Krishnamurthy, P (reprint author), Houston Methodist Res Inst, Dept Cardiovasc Sci, Houston, TX 77030 USA.	pkrishnamurthy@houstonmethodist.org			National Institutes of Health (NIH) [1R01HL116729, HL091983, HL053354, HL108795, HL108806]; American Heart Association National-The Davee Foundation SDG Grant [0530350N]; AHA post-doctoral fellowship [15POST25710392, 15POST22720022]	This work was supported, in part, by the National Institutes of Health (NIH) grants 1R01HL116729 (to P.K.), HL091983, HL053354, HL108795 and HL108806 (to R.K.); American Heart Association National-The Davee Foundation SDG Grant 0530350N (to P.K.), AHA post-doctoral fellowship 15POST25710392 (to R.A.T) and 15POST22720022 (V.N.S.G).	Rolo AP, 2006, TOXICOL APPL PHARM, V212, P167, DOI 10.1016/j.taap.2006.01.003; Michaels J, 2007, WOUND REPAIR REGEN, V15, P665, DOI 10.1111/j.1524-475X.2007.00273.x; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Watanabe K, 2009, ACTA PHYSIOL HUNG, V96, P277, DOI 10.1556/APhysiol.96.2009.3.3; Thandavarayan RA, 2008, BIOCHEM PHARMACOL, V75, P1797, DOI 10.1016/j.bcp.2008.02.003; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Chan JCN, 2014, DIABETES RES CLIN PR, V103, P244, DOI 10.1016/j.diabres.2013.11.012; Balestrieri ML, 2015, DIABETES, V64, P1395, DOI 10.2337/db14-1149; Bitar MS, 1996, J SURG RES, V61, P113, DOI 10.1006/jsre.1996.0090; Thandavarayan RA, 2009, AM J PHYSIOL-HEART C, V297, pH911, DOI 10.1152/ajpheart.00124.2009; Kanfi Y, 2010, AGING CELL, V9, P162, DOI 10.1111/j.1474-9726.2009.00544.x; Wang Y, 2013, INVEST OPHTH VIS SCI, V54, P3806, DOI 10.1167/iovs.13-12091; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Etchegaray JP, 2013, CURR TOP MED CHEM, V13, P2991; Reiber GE, 1999, DIABETES CARE, V22, P157, DOI 10.2337/diacare.22.1.157; Boulton AJM, 2005, LANCET, V366, P1719, DOI 10.1016/S0140-6736(05)67698-2; Li J, 2003, MICROSC RES TECHNIQ, V60, P107, DOI 10.1002/jemt.10249; Tie L, 2009, AM J PHYSIOL-ENDOC M, V296, pE1423, DOI 10.1152/ajpendo.00150.2009; Hansen SL, 2003, AM J PATHOL, V163, P2421, DOI 10.1016/S0002-9440(10)63597-3; Thanik VD, 2007, GENE THER, V14, P1305, DOI 10.1038/sj.gt.3302986; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Niebuhr M, 2008, EXP DERMATOL, V17, P1052, DOI 10.1111/j.1600-0625.2008.00750.x; Thandavarayan Rajarajan A., 2011, Cardiovascular & Hematological Agents in Medicinal Chemistry, V9, P225; Cardus A, 2013, CARDIOVASC RES, V97, P571, DOI 10.1093/cvr/cvs352; Martin A, 2003, MED RES REV, V23, P117, DOI 10.1002/med.10024; Thandavarayan RA, 2010, FREE RADICAL BIO MED, V49, P1422, DOI 10.1016/j.freeradbiomed.2010.08.005; Dasu MR, 2010, LAB INVEST, V90, P1628, DOI 10.1038/labinvest.2010.158; Lan CCE, 2013, DIABETES, V62, P2530, DOI 10.2337/db12-1714; Harrington C, 2000, DIABETES CARE, V23, P1333, DOI 10.2337/diacare.23.9.1333; Xu JW, 2012, DIABETES, V61, P2906, DOI 10.2337/db12-0145; Kitada M, 2011, DIABETES, V60, P634, DOI 10.2337/db10-0386; Diegelmann RF, 2004, FRONT BIOSCI, V9, P283, DOI 10.2741/1184; SCHWEIGERER L, 1987, NATURE, V325, P257, DOI 10.1038/325257a0; Thandavarayan RA, 2011, CELL PHYSIOL BIOCHEM, V28, P911, DOI 10.1159/000335805; Karuppagounder V, 2015, EXP DERMATOL, V24, P418, DOI 10.1111/exd.12685; Etchegaray JP, 2015, NAT CELL BIOL, V17, P545, DOI 10.1038/ncb3147; Chen Y, 2015, BIOMED RES INT, V2015; Lee Y H, 2012, EXP DIABETES RES, V2012, DOI [DOI 10.1155/2012/504693, 10.1155/2012/504693]; Lin YT, 2015, J INVEST DERMATOL, V135, P258, DOI 10.1038/jid.2014.288; Sreedhar R, 2015, CELL SIGNAL, V27, P770, DOI 10.1016/j.cellsig.2014.12.021; Watanabe Kenichi, 2010, Curr Cardiol Rev, V6, P280, DOI 10.2174/157340310793566145; Yu SS, 2013, BRIT J PHARMACOL, V168, P117, DOI 10.1111/j.1476-5381.2012.01903.x; YUE DK, 1986, DIABETIC MED, V3, P221	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0906-6705	1600-0625		EXP DERMATOL	Exp. Dermatol.	OCT	2015	24	10					773	778		10.1111/exd.12762		6	Dermatology	Dermatology	CT8FG	WOS:000363049800013		
J	Yokoyama, S; Hiramoto, K; Koyama, M; Ooi, K				Yokoyama, Satoshi; Hiramoto, Keiichi; Koyama, Mayu; Ooi, Kazuya			Impairment of skin barrier function via cholinergic signal transduction in a dextran sulphate sodium-induced colitis mouse model	EXPERIMENTAL DERMATOLOGY			English	Article						acetylcholine receptor; colitis; mast cell; skin hydration; transepidermal water loss	INFLAMMATORY-BOWEL-DISEASE; NECROSIS-FACTOR-ALPHA; MAST-CELL ACTIVATION; ATOPIC-DERMATITIS; NITRIC-OXIDE; INTESTINAL INFLAMMATION; STRATUM-CORNEUM; CROHNS-DISEASE; FACTOR TNF; MICE	Dry skin has been clinically associated with visceral diseases, including liver disease, as well as for our previously reported small intestinal injury mouse model, which have abnormalities in skin barrier function. To clarify this disease-induced skin disruption, we used a dextran sulphate sodium (DSS)-induced colitis mouse model. Following treatment with DSS, damage to the colon and skin was monitored using histological and protein analysis methods as well as the detection of inflammatory mediators in the plasma. Notably, transepidermal water loss was higher, and skin hydration was lower in DSS-treated mice compared to controls. Tumor necrosis factor-alpha (TNF-alpha), interleukin 6 and NO2-/NO3- levels were also upregulated in the plasma, and a decrease in body weight and colon length was observed in DSS-treated mice. However, when administered TNF-alpha antibody or an iNOS inhibitor, no change in skin condition was observed, indicating that another signalling mechanism is utilized. Interestingly, the number of tryptase-expressing mast cells, known for their role in immune function via cholinergic signal transduction, was elevated. To evaluate the function of cholinergic signalling in this context, atropine (a muscarinic cholinoceptor antagonist) or hexamethonium (a nicotinic cholinergic ganglion-blocking agent) was administered to DSS-treated mice. Our data indicate that muscarinic acetylcholine receptors (mAChRs) are the primary receptors functioning in colon-to-skin signal transduction, as DSS-induced skin disruption was suppressed by atropine. Thus, skin disruption is likely associated with DSS-induced colitis, and the activation of mast cells via mAChRs is critical to this association.	[Yokoyama, Satoshi; Hiramoto, Keiichi; Koyama, Mayu; Ooi, Kazuya] Suzuka Univ Med Sci, Fac Pharmaceut Sci, Suzuka, Mie, Japan	Ooi, K (reprint author), Suzuka Univ Med Sci, Fac Pharmaceut Sci, Minami Tamagakicho 3500-3, Suzuka, Mie, Japan.	zooi@suzuka-u.ac.jp					Holtmann MH, 2002, EUR J IMMUNOL, V32, P3142, DOI 10.1002/1521-4141(200211)32:11<3142::AID-IMMU3142>3.0.CO;2-4; Radosa J, 2011, EXP DERMATOL, V20, P677, DOI 10.1111/j.1600-0625.2011.01283.x; Sakai S, 2005, BRIT J DERMATOL, V153, P319, DOI 10.1111/j.1365-2133.2005.06756.x; Wulff BC, 2013, EXP DERMATOL, V22, P507, DOI 10.1111/exd.12169; Koarai A, 2012, EUR RESPIR J, V39, P698, DOI 10.1183/09031936.00136710; BREESE EJ, 1994, GASTROENTEROLOGY, V106, P1455; BLANDINA P, 1980, J PHYSIOL-LONDON, V301, P281; Mori L, 1996, J IMMUNOL, V157, P3178; Orita K, 2011, EXP DERMATOL, V20, P911, DOI 10.1111/j.1600-0625.2011.01360.x; Nishimura T, 2010, J CLIN BIOCHEM NUTR, V46, P105, DOI 10.3164/jcbn.09-72; BAREL AO, 1995, SKIN PHARMACOL, V8, P186; Kondo S, 1997, EUR J IMMUNOL, V27, P1713, DOI 10.1002/eji.1830270718; Niederau C, 2008, LIVER INT, V28, P659, DOI 10.1111/j.1478-3231.2008.01694.x; Imai A, 2001, EUR J PHARMACOL, V423, P63, DOI 10.1016/S0014-2999(01)01042-1; Kassiotis G, 2001, J EXP MED, V193, P427, DOI 10.1084/jem.193.4.427; Buchli R, 1999, J CELL BIOCHEM, V74, P264, DOI 10.1002/(SICI)1097-4644(19990801)74:2<264::AID-JCB11>3.0.CO;2-Z; Kurashima Y, 2014, IMMUNITY, V40, P530, DOI 10.1016/j.immuni.2014.01.014; Murthy SK, 2011, AM J GASTROENTEROL, V106, P713, DOI 10.1038/ajg.2011.53; Wajant H, 2009, RESULTS PROBL CELL D, V49, P1, DOI 10.1007/400_2008_26; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Krieglstein CF, 2001, J EXP MED, V194, P1207, DOI 10.1084/jem.194.9.1207; Taniuchi S, 2001, ALLERGY, V56, P693, DOI 10.1034/j.1398-9995.2001.00131.x; Ormerod AD, 1998, ARCH DERMATOL RES, V290, P3, DOI 10.1007/s004030050268; Yokoyama S, 2014, EXP DERMATOL, V23, P659, DOI 10.1111/exd.12499; Kim DW, 2006, INT J DERMATOL, V45, P698, DOI 10.1111/j.1365-4632.2005.02644.x; Tanaka S, 2010, EXPERT OPIN THER TAR, V14, P31, DOI 10.1517/14728220903473186; Reimund JM, 1996, GUT, V39, P684, DOI 10.1136/gut.39.5.684; Schottelius AJG, 2004, EXP DERMATOL, V13, P193, DOI 10.1111/j.0906-6705.2004.00205.x; Twig G, 2005, ANN NY ACAD SCI, V1051, P166, DOI 10.1196/annals.1361.058; Park TH, 1995, NEPHROL DIAL TRANSPL, V10, P2269; CUMMINGS JH, 1975, GUT, V16, P323, DOI 10.1136/gut.16.4.323; Mizoguchi E, 2002, GASTROENTEROLOGY, V122, P134, DOI 10.1053/gast.2002.30347; Grando SA, 2006, EXP DERMATOL, V15, P265, DOI 10.1111/j.0906-6705.2006.00410.x; Ito T, 2012, J IMMUNOL, V188, P5428, DOI 10.4049/jimmunol.1103366; Berardesca E, 1997, SKIN RES TECHNOL, V3, P126, DOI 10.1111/j.1600-0846.1997.tb00174.x; Fakhoury M, 2014, J INFLAMM RES, V23, P113; Huang BL, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00013; Norman Robert A, 2003, Dermatol Ther, V16, P254, DOI 10.1046/j.1529-8019.2003.01635.x; Schreiber O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071843; Tagami Hachiro, 2006, J Cosmet Dermatol, V5, P140, DOI 10.1111/j.1473-2165.2006.00241.x; Williams Horace, 2008, Curr Gastroenterol Rep, V10, P597, DOI 10.1007/s11894-008-0108-6	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0906-6705	1600-0625		EXP DERMATOL	Exp. Dermatol.	OCT	2015	24	10					779	784		10.1111/exd.12775		6	Dermatology	Dermatology	CT8FG	WOS:000363049800014		
J	Matsuda, M; Hamada, T; Numata, S; Teye, K; Ishii, N; Ohata, C; Furumura, M; Nakama, T; Hashimoto, T				Matsuda, Mitsuhiro; Hamada, Takahiro; Numata, Sanae; Teye, Kwesi; Ishii, Norito; Ohata, Chika; Furumura, Minao; Nakama, Takekuni; Hashimoto, Takashi			A three-dimensional in vitro culture model of Hailey-Hailey disease	EXPERIMENTAL DERMATOLOGY			English	Article						ATP2C1; Hailey-Hailey disease; SPCA1; 3D culture	ATP2C1 GENE; KERATINOCYTES; MUTATIONS; SPCA1		[Hashimoto, Takashi] Kurume Univ, Sch Med, Dept Dermatol, Kurume, Fukuoka 8300011, Japan; Kurume Univ, Inst Cutaneous Cell Biol, Kurume, Fukuoka 8300011, Japan	Hashimoto, T (reprint author), Kurume Univ, Sch Med, Dept Dermatol, 67 Asahimachi, Kurume, Fukuoka 8300011, Japan.	hashimot@med.kurume-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Health and Labour Sciences Research Grants; Ministry of Health, Labour and Welfare of Japan	We gratefully appreciate the technical assistance of Ms. Ayumi Suzuki, and Ms. Sachiko Sakaguchi, and the secretarial work of Ms. Tomoko Tashima and Ms. Mami Nishida. This study was supported by Grants-in-Aid for Scientific Research and Strategic Research Basis Formation Supporting Project from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by Health and Labour Sciences Research Grants and the grants for Research on Measures for Intractable Diseases from the Ministry of Health, Labour and Welfare of Japan.	Hakuno M, 2000, BRIT J DERMATOL, V142, P702, DOI 10.1046/j.1365-2133.2000.03415.x; Matsuda M, 2014, EXP DERMATOL, V23, P514, DOI 10.1111/exd.12410; Bernards M, 2000, J INVEST DERMATOL, V114, P1058, DOI 10.1046/j.1523-1747.2000.00960-2.x; Okunade GW, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703029200; Ikebe D, 2007, GENES CELLS, V12, P197, DOI 10.1111/j.1365-2443.2007.001043.x; Raiko L, 2012, EXP DERMATOL, V21, P586, DOI 10.1111/j.1600-0625.2012.01520.x; Cooley JE, 1996, J INVEST DERMATOL, V107, P877, DOI 10.1111/1523-1747.ep12331167; Hu ZL, 2000, NAT GENET, V24, P61, DOI 10.1038/71701; Dobson-Stone C, 2002, J INVEST DERMATOL, V118, P338, DOI 10.1046/j.0022-202x.2001.01675.x	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0906-6705	1600-0625		EXP DERMATOL	Exp. Dermatol.	OCT	2015	24	10					788	789		10.1111/exd.12777		2	Dermatology	Dermatology	CT8FG	WOS:000363049800016		
J	Fukuda, Y; Sone, T; Sakuraba, H; Araki, T; Ohshima, T; Shibata, T; Yoneda, K				Fukuda, Yudai; Sone, Takeki; Sakuraba, Haruhiko; Araki, Tomohiro; Ohshima, Toshihisa; Shibata, Takeshi; Yoneda, Kazunari			A novel NAD(P)H-dependent carbonyl reductase specifically expressed in the thyroidectomized chicken fatty liver: catalytic properties and crystal structure	FEBS JOURNAL			English	Article						crystal structure; enzyme kinetics; NAD(P)H-dependent carbonyl reductase; short-chain dehydrogenase; reductase family; thyroidectomized chicken fatty liver	PROTEIN; HYPOTHYROIDISM; DEHYDROGENASE; HYPERTHYRODISM; LIPOPROTEIN; BINDING; FAMILY	A gene encoding a functionally unknown protein that is specifically expressed in the thyroidectomized chicken fatty liver and has a predicted amino acid sequence similar to that of NAD(P)H-dependent carbonyl reductase was overexpressed in Escherichiacoli; its product was purified and characterized. The expressed enzyme was an NAD(P)H-dependent broad substrate specificity carbonyl reductase and was inhibited by arachidonic acid at 1.5m. Enzymological characterization indicated that the enzyme could be classified as a cytosolic-type carbonyl reductase. The enzyme's 3D structure was determined using the molecular replacement method at 1.98 angstrom resolution in the presence of NADPH and ethylene glycol. The asymmetric unit consisted of two subunits, and a noncrystallographic twofold axis generated the functional dimer. The structures of the subunits, A and B, differed from each other. In subunitA, the active site contained an ethylene glycol molecule absent in subunitB. Consequently, Tyr172 in subunitA rotated by 103.7 degrees in comparison with subunitB, which leads to active site closure in subunitA. In Y172A mutant, the K-m value for 9,10-phenanthrenequinone (model substrate) was 12.5times higher than that for the wild-type enzyme, indicating that Tyr172 plays a key role in substrate binding in this carbonyl reductase. Because the Tyr172-containing active site lid structure (Ile164-Gln174) is not conserved in all known carbonyl reductases, our results provide new insights into substrate binding of carbonyl reductase. The catalytic properties and crystal structure revealed that thyroidectomized chicken fatty liver carbonyl reductase is a novel enzyme.	[Fukuda, Yudai; Sone, Takeki; Araki, Tomohiro; Yoneda, Kazunari] Tokai Univ, Dept Biosci, Kumamoto 8691404, Japan; [Sakuraba, Haruhiko] Kagawa Univ, Dept Appl Biol Sci, Kagawa, Japan; [Ohshima, Toshihisa] Osaka Inst Technol, Dept Biomed Engn, Osaka 535, Japan; [Shibata, Takeshi] Tokai Univ, Dept Anim Sci, Kumamoto 8691404, Japan	Yoneda, K (reprint author), Tokai Univ, Sch Agr, Dept Biosci, Kumamoto 8691404, Japan.	kyoneda@agri.u-tokai.ac.jp			Tokai University Educational System	We are grateful to the staff of the Photon Factory for their assistance with data collection, which was approved by the Photon Factory Program Advisory Committee (Proposal no. 2014G502). This study was supported in part by the Tokai University Educational System (to KY) and a grant for Young Scientists (B) (to KY).	Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Tanaka N, 1996, STRUCTURE, V4, P33, DOI 10.1016/S0969-2126(96)00007-X; Yoneda K, 2012, ACTA CRYSTALLOGR F, V68, P1568, DOI 10.1107/S1744309112046453; GHOSH D, 1991, P NATL ACAD SCI USA, V88, P10064, DOI 10.1073/pnas.88.22.10064; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; Imamura Y, 1999, BIOL PHARM BULL, V22, P731; Tanaka N, 2008, STRUCTURE, V16, P388, DOI 10.1016/j.str.2007.12.022; LAKER ME, 1981, BIOCHEM J, V196, P247; MOORE GE, 1984, GEN COMP ENDOCR, V55, P195, DOI 10.1016/0016-6480(84)90101-1; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Tanaka N, 1996, BIOCHEMISTRY-US, V35, P7715, DOI 10.1021/bi951904d; Shibata T, 2003, POULTRY SCI, V82, P207; NISHINAKA T, 1992, ENZYME, V46, P221; NAKANISHI M, 1995, EUR J BIOCHEM, V228, P381, DOI 10.1111/j.1432-1033.1995.tb20274.x; Nakanishi M, 1997, ADV EXP MED BIOL, V414, P555; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; KING DB, 1976, GEN COMP ENDOCR, V29, P473, DOI 10.1016/0016-6480(76)90030-7; Tanaka M, 2005, PLOS BIOL, V3, P764, DOI 10.1371/journal.pbio.0030128; Sgraja T, 2004, J MOL BIOL, V342, P1613, DOI 10.1016/j.jmb.2004.08.020; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; SCOTTOLINI AG, 1980, CLIN CHEM, V26, P584; Kawabata T, 2003, NUCLEIC ACIDS RES, V31, P3367, DOI 10.1093/nar/gkg581; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; OHSHIMA T, 1978, J BIOL CHEM, V253, P5719; BENNER SA, 1982, EXPERIENTIA, V38, P633, DOI 10.1007/BF02327092; LITHELL H, 1981, EUR J CLIN INVEST, V11, P3, DOI 10.1111/j.1365-2362.1981.tb01758.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nikki Takahiro, 1994, Japanese Poultry Science, V31, P262; NIKKI T, 1989, Proceedings of School of Agriculture Kyushu Tokai University, V8, P47; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RAHEJA K L, 1970, Comparative Biochemistry and Physiology, V37, P555; Sturkie PD, 1976, AVIAN PHYSL, V3, P348; Wermuth B, 1985, ENZYMOLOGY CARBONYL, V2, P209	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	OCT	2015	282	20					3918	3928		10.1111/febs.13385		11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU0KE	WOS:000363204200005		
J	Uda, N; Matoba, Y; Oda, K; Kumagai, T; Sugiyama, M				Uda, Narutoshi; Matoba, Yasuyuki; Oda, Kosuke; Kumagai, Takanori; Sugiyama, Masanori			The structural and mutational analyses of O-ureido-l-serine synthase necessary for d-cycloserine biosynthesis	FEBS JOURNAL			English	Article						antibiotic; biosynthesis; crystal structure; d-cycloserine; Streptomyceslavendulae	ALANYL-D-ALANINE; ACETYLSERINE SULFHYDRYLASE; CYSTEINE SYNTHASE; ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; STREPTOMYCES-GARYPHALUS; SALMONELLA-TYPHIMURIUM; ENZYMATIC-SYNTHESIS; AMINO-ACIDS; CRYSTAL-STRUCTURES	We have recently been successful in cloning a gene cluster necessary for the biosynthesis of d-cycloserine (d-CS) from d-CS-producing StreptomyceslavendulaeATCC11924. Although dcsD, one of the ORFs located on the gene cluster, encodes a protein homologous to O-acetylserine sulfhydrylase that synthesizes l-cysteine using O-acetyl-l-serine together with sulfide, it functions to form O-ureido-l-serine as a d-CS biosynthetic intermediate, using O-acetyl-l-serine together with hydroxyurea (HU). In the present study, using crystallographic and mutational studies, three amino acid residues in DcsD that are important for the substrate preference toward HU were determined. We showed that two of the three residues are important for the binding of HU into the substrate-binding pocket. The other residue contributes to the formation of a loose hydrogen-bond network during the catalytic reaction. Information regarding the amino acid residues will be very useful in the design of a new catalyst for synthesizing the -substituted-l-alanine derivatives.	[Uda, Narutoshi; Matoba, Yasuyuki; Oda, Kosuke; Kumagai, Takanori; Sugiyama, Masanori] Hiroshima Univ, Dept Mol Microbiol & Biotechnol, Grad Sch Biomed & Hlth Sci, Hiroshima 7348551, Japan	Sugiyama, M (reprint author), Hiroshima Univ, Dept Mol Microbiol & Biotechnol, Grad Sch Biomed & Hlth Sci, Minami Ku, Kasumi 1-2-3, Hiroshima 7348551, Japan.	sugi@hiroshima-u.ac.jp			Japan Aerospace Exploration Agency (JAXA); Japan Society for the Promotion of Science [15K07997]; Institute for Fermentation, Osaka (IFO); Novozymes, Japan	DNA sequence determination was carried out at the Analysis Center of Life Science, Hiroshima University. We are grateful to the beamline staff at SPring-8, Japan, for their kind help with the X-ray data collection. We also thank the Japan Aerospace Exploration Agency (JAXA) for the crystallographic experiment and for financial support. This study was supported by a Grant-in-Aid for Scientific Research (15K07997 to YM) from the Japan Society for the Promotion of Science and by research funds from the Institute for Fermentation, Osaka (IFO) and Novozymes, Japan, given to YM.	LAMBERT MP, 1972, J BACTERIOL, V110, P978; Matsuo H, 2003, J ANTIBIOT, V56, P762; Bonner ER, 2005, J BIOL CHEM, V280, P38803, DOI 10.1074/jbc.M505313200; Rabeh WM, 2004, J BIOL CHEM, V279, P26803, DOI 10.1074/jbc.R400001200; WEAVER JD, 1974, J MED CHEM, V17, P1033, DOI 10.1021/jm00255a034; Kumagai T, 2012, ANTIMICROB AGENTS CH, V56, P3682, DOI 10.1128/AAC.00614-12; KREDICH NM, 1966, J BIOL CHEM, V241, P4955; Drauz K, 1997, CHIMIA, V51, P310; SVENSSON ML, 1982, ARCH MICROBIOL, V131, P129, DOI 10.1007/BF01053994; IKEGAMI F, 1990, PHYTOCHEMISTRY, V29, P3461, DOI 10.1016/0031-9422(90)85258-H; Pfyffer GE, 1999, J CLIN MICROBIOL, V37, P3179; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Chattopadhyay A, 2007, BIOCHEMISTRY-US, V46, P8315, DOI 10.1021/bi602603c; Maier THP, 2003, NAT BIOTECHNOL, V21, P422, DOI 10.1038/nbt807; IKEGAMI F, 1988, PHYTOCHEMISTRY, V27, P3379, DOI 10.1016/0031-9422(88)80735-0; Mozzarelli A, 2011, BBA-PROTEINS PROTEOM, V1814, P1497, DOI 10.1016/j.bbapap.2011.04.011; Claus MT, 2005, BIOCHEMISTRY-US, V44, P8620, DOI 10.1021/bi050485+; COOK PF, 1992, BIOCHEMISTRY-US, V31, P2298, DOI 10.1021/bi00123a013; Heine A, 2004, PROTEINS, V56, P387, DOI 10.1002/prot.20003; Schnell R, 2007, J BIOL CHEM, V282, P23473, DOI 10.1074/jbc.M703518200; LEESON PD, 1994, J MED CHEM, V37, P4053, DOI 10.1021/jm00050a001; SVENSSON ML, 1981, ARCH MICROBIOL, V129, P210, DOI 10.1007/BF00425252; Schneider G, 2000, STRUCT FOLD DES, V8, pR1, DOI 10.1016/S0969-2126(00)00085-X; HERBERG LJ, 1990, PHARMACOL BIOCHEM BE, V36, P735, DOI 10.1016/0091-3057(90)90069-T; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; IKEGAMI F, 1993, PHYTOCHEMISTRY, V32, P31, DOI 10.1016/0031-9422(92)80101-J; Zocher G, 2007, FEBS J, V274, P5382, DOI 10.1111/j.1742-4658.2007.06063.x; IKEGAMI F, 1988, PHYTOCHEMISTRY, V27, P697, DOI 10.1016/0031-9422(88)84078-0; Goff DC, 1999, ARCH GEN PSYCHIAT, V56, P21, DOI 10.1001/archpsyc.56.1.21; IKEGAMI F, 1992, PHYTOCHEMISTRY, V31, P1991, DOI 10.1016/0031-9422(92)80347-H; Burkhard P, 1999, J MOL BIOL, V291, P941, DOI 10.1006/jmbi.1999.3002; STAMMER CH, 1962, J ORG CHEM, V27, P2957, DOI 10.1021/jo01055a530; HIDY PH, 1955, J AM CHEM SOC, V77, P2345, DOI 10.1021/ja01613a106; Fenn TD, 2003, BIOCHEMISTRY-US, V42, P5775, DOI 10.1021/bi027022d; Bruning JB, 2011, ANTIMICROB AGENTS CH, V55, P291, DOI 10.1128/AAC.00558-10; NEUHAUS FC, 1964, BIOCHEMISTRY-US, V3, P471, DOI 10.1021/bi00892a001; Noda M, 2004, J BIOL CHEM, V279, P46143, DOI 10.1074/jbc.M404603200; Uda N, 2013, ANTIMICROB AGENTS CH, V57, P2603, DOI 10.1128/AAC.02291-12; ASWAD DW, 1984, ANAL BIOCHEM, V137, P405, DOI 10.1016/0003-2697(84)90106-4; MURAKOSHI I, 1985, PHYTOCHEMISTRY, V24, P1907, DOI 10.1016/S0031-9422(00)83090-3; Dietrich D, 2012, ORG BIOMOL CHEM, V10, P2248, DOI 10.1039/c2ob06864h; Oda K, 2013, J BACTERIOL, V195, P1741, DOI 10.1128/JB.02085-12; Kumagai T, 2010, ANTIMICROB AGENTS CH, V54, P1132, DOI 10.1128/AAC.01226-09; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Gren D, 2009, FEBS LETT, V583, P330; Haydel SE, 2010, PHARMACEUTICALS, V3, P2268, DOI DOI 10.3390/PH3072268; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; McRee D. E., 1992, J MOL GRAPHICS, V10, P44, DOI 10.1016/0263-7855(92)80022-6; IKEGAMI F, 1994, PHYTOCHEMISTRY, V35, P1089, DOI 10.1016/S0031-9422(00)94805-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sashikata K, 1969, J GEN APPL MICROBIOL, V9, P409	52	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	OCT	2015	282	20					3929	3944		10.1111/febs.13386		16	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU0KE	WOS:000363204200006		
J	Kumagai, Y; Yamashita, K; Tagami, T; Uraji, M; Wan, K; Okuyama, M; Yao, M; Kimura, A; Hatanaka, T				Kumagai, Yuya; Yamashita, Keitaro; Tagami, Takayoshi; Uraji, Misugi; Wan, Kun; Okuyama, Masayuki; Yao, Min; Kimura, Atsuo; Hatanaka, Tadashi			The loop structure of Actinomycete glycoside hydrolase family 5 mannanases governs substrate recognition	FEBS JOURNAL			English	Article						Actinomycete; chimeric enzyme; galactosylmannooligosaccharide; glycoside hydrolase family 5; mannanase	CARBOHYDRATE-BINDING MODULES; ALPHA-GALACTOSIDASE; THERMAL-STABILITY; BETA-MANNANASE; POLYSACCHARIDE RECOGNITION; CRYSTAL-STRUCTURE; SPECIFICITY; BIOFUELS; SITE; OLIGOSACCHARIDES	Endo--1,4-mannanases from Streptomyces thermolilacinus (StMan) and Thermobifida fusca (TfMan) demonstrated different substrate specificities. StMan hydrolyzed galactosylmannooligosaccharide (GGM5; 6(III),6(IV)--d-galactosyl mannopentaose) to GGM3 and M2, whereas TfMan hydrolyzed GGM5 to GGM4 and M1. To determine the region involved in the substrate specificity, we constructed chimeric enzymes of StMan and TfMan and evaluated their substrate specificities. Moreover, the crystal structure of the catalytic domain of StMan (StMandC) and the complex structure of the inactive mutant StE273AdC with M6 were solved at resolutions of 1.60 and 1.50 angstrom, respectively. Structural comparisons of StMandC and the catalytic domain of TfMan lead to the identification of a subsite around -1 in StMandC that could accommodate a galactose branch. These findings demonstrate that the two loops (loop7 and loop8) are responsible for substrate recognition in GH5 actinomycete mannanases. In particular, Trp281 in loop7 of StMan, which is located in a narrow and deep cleft, plays an important role in its affinity toward linear substrates. Asp310 in loop8 of StMan specifically bound to the galactosyl unit in the -1 subsite.	[Kumagai, Yuya; Uraji, Misugi; Wan, Kun; Hatanaka, Tadashi] Okayama Prefectural Technol Ctr Agr Forestry & Fi, Res Inst Biol Sci, Okayama, Okayama 7161241, Japan; [Kumagai, Yuya; Tagami, Takayoshi; Okuyama, Masayuki; Kimura, Atsuo] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido, Japan; [Yamashita, Keitaro; Yao, Min] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido, Japan; [Yao, Min] Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido, Japan	Hatanaka, T (reprint author), Okayama Prefectural Technol Ctr Agr Forestry & Fi, Res Inst Biol Sci, 7549-1 Kibichuo Cho, Okayama, Okayama 7161241, Japan.	hatanaka@bio-ribs.com	yao, min/F-5287-2011	yao, min/0000-0003-1687-5904			ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Hogg D, 2003, BIOCHEM J, V371, P1027, DOI 10.1042/BJ20021860; Clarke JH, 2000, APPL MICROBIOL BIOT, V53, P661; Puchart V, 2005, BBA-GEN SUBJECTS, V1726, P206, DOI 10.1016/j.bbagen.2005.07.015; Hilge M, 1998, STRUCT FOLD DES, V6, P1433, DOI 10.1016/S0969-2126(98)00142-7; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Demirbas MF, 2009, APPL ENERG, V86, pS151, DOI 10.1016/j.apenergy.2009.04.043; Kumagai Y, 2011, BBA-PROTEINS PROTEOM, V1814, P1127, DOI 10.1016/j.bbapap.2011.04.017; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Cartmell A, 2008, J BIOL CHEM, V283, P34403, DOI 10.1074/jbc.M804053200; Couturier M, 2013, J BIOL CHEM, V288, P14624, DOI 10.1074/jbc.M113.459438; PORZIO MA, 1977, BIOCHIM BIOPHYS ACTA, V490, P27, DOI 10.1016/0005-2795(77)90102-7; Peralta-Yahya PP, 2012, NATURE, V488, P320, DOI 10.1038/nature11478; BULPIN PV, 1990, CARBOHYD POLYM, V12, P155, DOI 10.1016/0144-8617(90)90016-L; Dias FMV, 2004, J BIOL CHEM, V279, P25517, DOI 10.1074/jbc.M401647200; Rinaudo M, 2004, BIOMACROMOLECULES, V5, P1155, DOI 10.1021/bm030077q; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Olsson L, 1996, ENZYME MICROB TECH, V18, P312, DOI 10.1016/0141-0229(95)00157-3; Tailford LE, 2009, BIOCHEMISTRY-US, V48, P7009, DOI 10.1021/bi900515d; Boraston AB, 2004, BIOCHEM J, V382, P769; Ardevol A, 2010, J AM CHEM SOC, V132, P16058, DOI 10.1021/ja105520h; Goncalves AMD, 2012, ACTA CRYSTALLOGR D, V68, P1468, DOI 10.1107/S0907444912034646; Kumagai Y, 2013, J MOL CATAL B-ENZYM, V94, P63, DOI 10.1016/j.molcatb.2013.05.001; Kim HW, 2011, BIOCHEM J, V437, P223, DOI 10.1042/BJ20110292; Daas PJH, 2000, CARBOHYD RES, V329, P609, DOI 10.1016/S0008-6215(00)00209-3; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Kumagai Y, 2012, BIOCHIMIE, V94, P2783, DOI 10.1016/j.biochi.2012.09.012; Kumagai Y, 2013, BBA-PROTEINS PROTEOM, V1834, P301, DOI 10.1016/j.bbapap.2012.08.011; Sticklen MB, 2008, NAT REV GENET, V9, P433, DOI 10.1038/nrg2336; Dhawan S, 2007, CRIT REV BIOTECHNOL, V27, P197, DOI 10.1080/07388550701775919; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Larsson AM, 2006, J MOL BIOL, V357, P1500, DOI 10.1016/j.jmb.2006.01.044; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Mori K, 2005, APPL ENVIRON MICROB, V71, P754, DOI 10.1128/AEM.71.2.754-760.2005; Zhang XY, 2014, J BIOL CHEM, V289, P2002, DOI 10.1074/jbc.M113.527770; Moreira LRS, 2008, APPL MICROBIOL BIOT, V79, P165, DOI 10.1007/s00253-008-1423-4; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Pauly M, 2008, PLANT J, V54, P559, DOI 10.1111/j.1365-313X.2008.03463.x; dasSilva VM, 2014, PLOS ONE, V9; Montanier C, 2009, PLOS BIOL, V7, P687, DOI 10.1371/journal.pbio.1000071; Santos CR, 2012, J STRUCT BIOL, V177, P469, DOI [10.1016/j.jsb.2011.11.021, DOI 10.1016/J.JSB.2011.11.021]; Takasuka TE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094166; WANG WT, 1984, ANAL BIOCHEM, V141, P366, DOI 10.1016/0003-2697(84)90057-5; Zhou P, 2014, ACTA CRYSTALLOGR D, V70, P2970, DOI 10.1107/S1399004714019762	49	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	OCT	2015	282	20					4001	4014		10.1111/febs.13401		14	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU0KE	WOS:000363204200011		
J	Machiyama, H; Yamaguchi, T; Sawada, Y; Watanabe, TM; Fujita, H				Machiyama, Hiroaki; Yamaguchi, Tomoyuki; Sawada, Yasuhiro; Watanabe, Tomonobu M.; Fujita, Hideaki			SH3 domain of c-Src governs its dynamics at focal adhesions and the cell membrane	FEBS JOURNAL			English	Article						focal adhesion; phosphorylation; SH3 domain; Src; TIRF microscopy	TYROSINE KINASE SRC; FAMILY KINASES; DASATINIB BMS-354825; SIGNAL-TRANSDUCTION; LIGAND-BINDING; LIVING CELLS; CANCER CELLS; V-SRC; PHOSPHORYLATION; INTEGRIN	We studied the role of the Src SH3 domain in its dynamics at the cell membrane using site-directed mutagenesis and live cell imaging. Physiologically, cell proliferation and migration require the expression of Src family kinases. Hyperactivation of Src molecules has been detected in various cancer cells. Although the activation mechanism of Src has been intensively studied, the dynamics of Src at the cell membrane are still unclear. Although Src molecules also exist at various cellular locations, we found that activated Src molecules are mainly localized at peripheral cell adhesion sites. Src phosphorylation status and subdomain conformations are thought to regulate Src activation and translocation. In this study, we analyzed the single-molecule dynamics of wild-type Src and SH2- and SH3-mutated Src at the cell membrane. Introducing mutations in the SH3 domain resulted in reduced Src motility at the cell membrane, both inside and outside of focal adhesions. Disruption of the actin cytoskeleton resulted in less diffusive Src movement at the cell membrane. We demonstrate that, inside focal adhesions, the SH3 domain enhanced dissociation of Src from the adhesion site and disruption of the SH3 domain altered the distribution of Src at the cell membrane. Inside focal adhesions, kinase activity of Src was essential for the Src mobility reduction by SH3 domain mutation, suggesting that rapid mobility of Src at focal adhesions mediated by the SH3 domain is catalytic-activity-dependent. These findings show that the SH3 domain of Src governs the dynamics of Src at the cell membrane and may be involved in rapid signal transduction in cells.	[Machiyama, Hiroaki; Yamaguchi, Tomoyuki; Watanabe, Tomonobu M.; Fujita, Hideaki] Osaka Univ, Immunol Frontier Res Ctr, Suita, Osaka 5650874, Japan; [Sawada, Yasuhiro] Natl Rehabil Ctr Persons Disabil, Res Inst, Saitama, Japan; [Watanabe, Tomonobu M.; Fujita, Hideaki] RIKEN, Quantitat Biol Ctr, Suita, Osaka, Japan	Fujita, H (reprint author), Osaka Univ, Immunol Frontier Res Ctr, OLABB, 6-2-3 Furuedai, Suita, Osaka 5650874, Japan.	fujita@ifrec.osaka-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [24570191]	We thank Kazuki Matsuda and Miwa Fukami for technical assistance. This work was supported by a grant from the Japanese Ministry of Education, Culture, Sports, Science and Technology to HF (#24570191).	Anbalagan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033017; Hossain MI, 2013, J BIOL CHEM, V288, P9696, DOI 10.1074/jbc.M112.419713; Martin DS, 2002, BIOPHYS J, V83, P2109; SNYDER MA, 1985, MOL CELL BIOL, V5, P1772; Chiang GG, 2000, J BIOL CHEM, V275, P6055, DOI 10.1074/jbc.275.9.6055; Cary LA, 2002, MOL CELL BIOL, V22, P2427, DOI 10.1128/MCB.22.8.2427-2440.2002; BUSS JE, 1986, J VIROL, V58, P468; Schwartzberg PL, 1997, GENE DEV, V11, P2835, DOI 10.1101/gad.11.21.2835; Staley CA, 1997, CELL GROWTH DIFFER, V8, P269; Chellappa K, 2012, P NATL ACAD SCI USA, V109, P2302, DOI 10.1073/pnas.1106799109; Johnson FM, 2005, CLIN CANCER RES, V11, P6924, DOI 10.1158/1078-0432.CCR-05-0757; Hauck CR, 2002, J BIOL CHEM, V277, P12487, DOI 10.1074/jbc.C100760200; Lele TP, 2006, J CELL PHYSIOL, V207, P187, DOI 10.1002/jcp.20550; Nam S, 2005, CANCER RES, V65, P9185, DOI 10.1158/0008-5472.CAN-05-17312; Machiyama H, 2014, J CELL SCI, V127, P3440, DOI 10.1242/jcs.143438; Gonzalez L, 2006, J BIOL CHEM, V281, P20851, DOI 10.1074/jbc.M601570200; Subach FV, 2009, NAT METHODS, V6, P153, DOI [10.1038/nmeth.1298, 10.1038/NMETH.1298]; Fincham VJ, 2000, MOL CELL BIOL, V20, P6518, DOI 10.1128/MCB.20.17.6518-6536.2000; Lutz MP, 1998, BIOCHEM BIOPH RES CO, V243, P503, DOI 10.1006/bbrc.1997.8043; Arndt KM, 1998, BIOCHEMISTRY-US, V37, P12918, DOI 10.1021/bi9810407; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Tugues S, 2013, J BIOL CHEM, V288, P19060, DOI 10.1074/jbc.M113.468199; Pan Q, 2011, CELL MOL LIFE SCI, V68, P3425, DOI 10.1007/s00018-011-0638-1; Felsenfeld DP, 1999, NAT CELL BIOL, V1, P200, DOI 10.1038/12021; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Li LM, 2002, MOL CELL BIOL, V22, P1203, DOI 10.1128/MCB.22.4.1203-1217.2002; Chatterjee SJ, 2004, J PATHOL, V203, P762, DOI 10.1002/path.1567; MORAN MF, 1990, P NATL ACAD SCI USA, V87, P8622, DOI 10.1073/pnas.87.21.8622; Spagnol ST, 2014, INTEGR BIOL-UK, V6, P523, DOI 10.1039/c3ib40226f; Guo M, 2014, CELL, V158, P822, DOI 10.1016/j.cell.2014.06.051; Timpson P, 2001, CURR BIOL, V11, P1836, DOI 10.1016/S0960-9822(01)00583-8; Evans JV, 2012, J CELL SCI, V125, P6185, DOI 10.1242/jcs.121046; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Summy JM, 2006, CLIN CANCER RES, V12, P1398, DOI 10.1158/1078-0432.CCR-05-2692; Watanabe TM, 2007, BIOPHYS J, V92, P4109, DOI 10.1529/biophysj.106.094649; CHANG JH, 1995, J CELL BIOL, V130, P355, DOI 10.1083/jcb.130.2.355; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Low-Nam ST, 2011, NAT STRUCT MOL BIOL, V18, P1244, DOI 10.1038/nsmb.2135; Tatosyan AG, 2000, BIOCHEMISTRY-MOSCOW+, V65, P49; ERPEL T, 1995, EMBO J, V14, P963; Kasahara K, 2007, J CELL PHYSIOL, V211, P220, DOI 10.1002/jcp.20931; Shvartsman DE, 2007, J CELL BIOL, V178, P675, DOI 10.1093/jcb.200701133; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Ferrando IM, 2012, MOL CELL PROTEOMICS, V11, P355, DOI 10.1074/mcp.M111.015750; Wolfenson H, 2011, J CELL SCI, V124, P1425, DOI 10.1242/jcs.077388; COOPER JA, 1986, SCIENCE, V231, P1431, DOI 10.1126/science.2420005; Liu F, 2002, FEBS LETT, V512, P101, DOI 10.1016/S0014-5793(02)02228-7; SMART JE, 1981, P NATL ACAD SCI-BIOL, V78, P6013, DOI 10.1073/pnas.78.10.6013; Machiyama H, 2009, BIOPHYS J, V97, P1048, DOI 10.1016/j.bpj.2009.05.021; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; CHACKALAPARAMPIL I, 1988, CELL, V52, P801, DOI 10.1016/0092-8674(88)90422-9; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; Wang WQ, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-49	54	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	OCT	2015	282	20					4034	4055		10.1111/febs.13404		22	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU0KE	WOS:000363204200013		
J	Reyes-Becerril, M; Ascencio-Valle, F; Alamillo, E; Hirono, I; Kondo, H; Jirapongpairoj, W; Angulo, C				Reyes-Becerril, Martha; Ascencio-Valle, Felipe; Alamillo, Erika; Hirono, Ikuo; Kondo, Hidehiro; Jirapongpairoj, Walissara; Angulo, Carlos			Molecular cloning and comparative responses of Toll-like receptor 22 following ligands stimulation and parasitic infection in yellowtail (Seriola lalandi)	FISH & SHELLFISH IMMUNOLOGY			English	Article						Yellowtail Seriola lalandi; TLR22; Expression modulation	ROHU LABEO-ROHITA; SPERMATOGONIAL CELLS; EXPRESSION ANALYSIS; SIGNALING PATHWAYS; GENE STRUCTURE; IDENTIFICATION; FAMILY; TLR22; FISH; CARP	TLR22 is exclusively present in teleosts and amphibians and is expected to play the distinctive role in innate immunity. In this study, we cloned the full-length cDNA sequence of yellowtail (Serbia lalandi) TLR22 (SlTLR22). The complete cDNA sequence of SlTLR22 was 4208 bp and encodes a polypeptide of 961 amino acids. Analysis of the deduced amino acid sequence indicated that SlTLR22 has typical structural features of proteins belonging to the TLR family. These included 17 LRR domains (residues 91-633) and one C-terminal LRR domain (LRR-CT, residues 693-744) in the extracellular region, and a TIR domain (residues 800-943) in the cytoplasmic region. Comparison with homologous proteins showed that the deduced SlTLR22 has the highest sequence identity to turbot TLR22 (76%). Quantitative real-time PCR (qPCR) analysis demonstrated the constitutive expression of SlTLR22 mRNA in all examined tissues with higher levels in the head kidney, intestine, skin and spleen. Further, SlTLR22 expression was significantly up-regulated following TLR ligands injection with lipopolysaccharide (LPS), CpG ODN2006 and polyinosinic: polycytidylic acid (poly I:C) in spleen and liver. Amyloodinium ocellatum infection also induced a high expression of SlTLR22 in spleen, intestine, muscle, skin and gill, with maximum increases ranging from 1000 to 100 fold upon different ligands and organs. Finally, histological examination in gill tissue confirmed infection by the parasite and histopathological lesion was observed also in spleen and skin. These findings suggest a possible role of SlTLR22 in the immune responses to the infections of a broad range of pathogens that include DNA and RNA viruses and parasites. (C) 2015 Elsevier Ltd. All rights reserved.	[Reyes-Becerril, Martha; Ascencio-Valle, Felipe; Alamillo, Erika; Angulo, Carlos] Inst Politecn Nacl, Ctr Invest Biol Noroeste CIBNOR, La Paz 23096, BCS, Mexico; [Hirono, Ikuo; Kondo, Hidehiro; Jirapongpairoj, Walissara] Tokyo Univ Marine Sci & Technol, Lab Genome Sci, Minato Ku, Tokyo 1088477, Japan	Angulo, C (reprint author), Inst Politecn Nacl, Ctr Invest Biol Noroeste CIBNOR, 195 Playa Palo de Santa Rita, La Paz 23096, BCS, Mexico.	eangulo@cibnor.mx			SEP-CONACYT grant [CB-2010/155381, CONACYT-INFR-2014-01/225924]	The juvenile yellowtail Serbia lalandi used in this study was generously provided by Dr. Juan Carlos Perez Urbiola. The project was funded under SEP-CONACYT grant CB-2010/155381 and CONACYT-INFR-2014-01/225924.	C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Xiao XQ, 2011, FISH SHELLFISH IMMUN, V30, P224, DOI 10.1016/j.fsi.2010.10.014; Oshiumi H, 2003, IMMUNOGENETICS, V54, P791, DOI 10.1007/s00251-002-0519-8; Munoz I, 2014, DEV COMP IMMUNOL, V44, P173, DOI 10.1016/j.dci.2013.12.003; Slack JL, 2000, J BIOL CHEM, V275, P4670, DOI 10.1074/jbc.275.7.4670; Ding X, 2012, FISH SHELLFISH IMMUN, V33, P494, DOI 10.1016/j.fsi.2012.05.034; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Saurabh S, 2011, VET PARASITOL, V175, P119, DOI 10.1016/j.vetpar.2010.10.001; Byadgi O, 2014, FISH SHELLFISH IMMUN, V36, P417, DOI 10.1016/j.fsi.2013.12.017; Hirono I, 2004, IMMUNOGENETICS, V56, P38, DOI 10.1007/s00251-004-0657-2; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Arancibia SA, 2007, BIOL RES, V40, P97, DOI 10.4067/S0716-97602007000200001; Samanta M, 2012, FISH SHELLFISH IMMUN, V32, P411, DOI 10.1016/j.fsi.2011.11.029; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Jault C, 2004, MOL IMMUNOL, V40, P759, DOI 10.1016/j.molimm.2003.10.001; Lv JJ, 2012, FISH SHELLFISH IMMUN, V32, P1022, DOI 10.1016/j.fsi.2012.02.024; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Rebl A, 2010, VET IMMUNOL IMMUNOP, V134, P139, DOI 10.1016/j.vetimm.2009.09.021; Hu GB, 2015, FISH SHELLFISH IMMUN, V44, P399, DOI 10.1016/j.fsi.2015.03.001; Rebl A, 2007, DEV COMP IMMUNOL, V31, P499, DOI 10.1016/j.dci.2006.08.007; Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Stafford JL, 2003, DEV COMP IMMUNOL, V27, P685, DOI 10.1016/S0145-305X(03)00041-7; Mohapatra C, 2010, MAR GENOM, V3, P157, DOI 10.1016/j.margen.2010.09.002; Levy MG, 2007, DIS AQUAT ORGAN, V73, P219, DOI 10.3354/dao073219; Mohapatra C, 2014, MOL BIOL REP, V41, P4123, DOI 10.1007/s11033-014-3283-6; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Matsuo A, 2008, J IMMUNOL, V181, P3474; Betancur-R R., 2013, PLOS CURRENTS TREE L, V1, P1, DOI DOI 10.1371/CURRENTS.TOL.53BA26640DF0CCAEE75BB165C8C26288; Noga E. J., 2006, FISH DIS DISORDERS, V1, P16; Panda RP, 2014, DEV COMP IMMUNOL, V47, P25, DOI 10.1016/j.dci.2014.06.016; Peter M., 2007, IMMUNOLOGY, V123, P118; Rodriguez-De la cruz M.C., 1994, ATLAS PEQUERO MAXICO, P234; Sharp N., FISH FARMING INT; Sharp N., 2000, P NZ MAR SCI SOC C; Takashi A., 2008, FISH BETHESDA, P263	36	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1050-4648	1095-9947		FISH SHELLFISH IMMUN	Fish Shellfish Immunol.	OCT	2015	46	2					323	333		10.1016/j.fsi.2015.06.020		11	Fisheries; Immunology; Marine & Freshwater Biology; Veterinary Sciences	Fisheries; Immunology; Marine & Freshwater Biology; Veterinary Sciences	CT8MR	WOS:000363071200020		
J	Sahashi, G; Morita, K; Ohnuki, T; Ohkuma, K				Sahashi, G.; Morita, K.; Ohnuki, T.; Ohkuma, K.			An evaluation of the contribution of hatchery stocking on population density and biomass: a lesson from masu salmon juveniles within a Japanese river system	FISHERIES MANAGEMENT AND ECOLOGY			English	Article						enhancement; replacement; salmonid fish; wild fish	TROUT ONCORHYNCHUS-MYKISS; NATURAL-POPULATIONS; ATLANTIC SALMON; REARED FISH; WILD FISH; SUPPLEMENTATION; PRODUCTIVITY; MANAGEMENT; PROGRAMS; HABITAT	Stocking is an important management tool for enhancing fisheries resources, but its actual contribution to fisheries resources is controversial, taking into consideration both the positive and negative effects. This study compared density and biomass of hatchery (otolith thermal marked) and wild masu salmon parr between stocked and unstocked rivers to evaluate the contribution of stocking with hatchery-reared fish. Density and biomass of all fish did not differ between stocked and unstocked rivers. Moreover, density and biomass of wild fish in the stocked rivers were lower than those of the unstocked rivers. Density and biomass of hatchery fish in a non-natural reproducing river were similar with those of all fish in natural reproducing rivers. These results indicate that hatchery stocking does not have positive effects on population density or biomass but replaces wild fish with hatchery fish and that non-natural reproducing areas are more suitable as stocking sites.	[Sahashi, G.] Hokkaido Univ, Grad Sch Environm Sci, Div Biosphere Sci, Hakodate, Hokkaido 0400051, Japan; [Morita, K.; Ohnuki, T.; Ohkuma, K.] Fisheries Res Agcy, Hokkaido Natl Fisheries Res Inst, Sapporo, Hokkaido, Japan	Sahashi, G (reprint author), Hokkaido Univ, Grad Sch Environm Sci, Div Biosphere Sci, 20-5 Benten Cho, Hakodate, Hokkaido 0400051, Japan.	genki.sahashi@gmail.com	Morita, Kentaro/G-2578-2015	Morita, Kentaro/0000-0002-7803-2438	JSPS KAKENHI [15J01925]	We thank K. Miyashita for his support and encouragement, T. Nomoto for obtaining the sampling permit issued by the Governor of Hokkaido and the staff of the Shari Field Station, Hokkaido National Fisheries Research Institute for thermally marking the salmon otoliths and providing the Shari River system hatchery stocking information. This work was supported by JSPS KAKENHI Grant Number 15J01925.	Griffiths AM, 2011, BIOL CONSERV, V144, P2733, DOI 10.1016/j.biocon.2011.07.017; Sweeting RM, 2003, N AM J FISH MANAGE, V23, P492, DOI 10.1577/1548-8675(2003)023<0492:ROWCSB>2.0.CO;2; Morita K, 2014, J ANIM ECOL, V83, P1268, DOI 10.1111/1365-2656.12240; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Lorenzen K, 2012, BIOL REV, V87, P639, DOI 10.1111/j.1469-185X.2011.00215.x; Pess GR, 2014, REV FISH BIOL FISHER, V24, P881, DOI 10.1007/s11160-013-9339-1; McLean JE, 2003, CAN J FISH AQUAT SCI, V60, P433, DOI 10.1139/F03-040; Pearsons TN, 2010, T AM FISH SOC, V139, P502, DOI 10.1577/T08-094.1; Shimoda Kazutaka, 2012, Scientific Reports of Hokkaido Fisheries Research Institutes, V82, P41; Hilborn R, 2000, T AM FISH SOC, V129, P333, DOI 10.1577/1548-8659(2000)129<0333:AROTHP>2.0.CO;2; Anderson JH, 2015, CAN J FISH AQUAT SCI, V72, P454, DOI 10.1139/cjfas-2014-0180; Araki H, 2010, AQUACULTURE, V308, pS2, DOI 10.1016/j.aquaculture.2010.05.036; Buhle ER, 2009, BIOL CONSERV, V142, P2449, DOI 10.1016/j.biocon.2009.05.013; Kitada S, 2006, FISH RES, V80, P101, DOI 10.1016/j.fishres.2006.03.019; Volk EC, 1999, FISH RES, V43, P205, DOI 10.1016/S0165-7836(99)00073-9; Temple GM, 2012, ENVIRON BIOL FISH, V94, P67, DOI 10.1007/s10641-011-9811-5; Morita K, 2010, CAN J FISH AQUAT SCI, V67, P955, DOI 10.1139/F10-028; Hill MS, 2006, CAN J FISH AQUAT SCI, V63, P1627, DOI 10.1139/F06-061; Shimoda Kazutaka, 2012, Scientific Reports of Hokkaido Fisheries Research Institutes, V81, P145; Chilcote MW, 2011, CAN J FISH AQUAT SCI, V68, P511, DOI 10.1139/F10-168; Ando D, 2002, NIPPON SUISAN GAKK, V68, P52; Levin PS, 2001, P ROY SOC B-BIOL SCI, V268, P1153, DOI 10.1098/rspb.2001.1634; Jonsson N, 2003, J APPL ECOL, V40, P900, DOI 10.1046/j.1365-2664.2003.00851.x; Chilcote MW, 2003, CAN J FISH AQUAT SCI, V60, P1057, DOI 10.1139/F03-092; Stottrup JG, 2002, FISH RES, V59, P161, DOI 10.1016/S0165-7836(01)00413-1; Aoyama T., 2014, SHIKEN KENKYU WA IMA; Burnham K.P., 1991, USERS GUIDE INTERACT; Kato F., 1991, PACIFIC SALMON LIFE, P448; Kawana M., 2002, NPAFC DOCUMENTS; Leber K.M., 2005, STOCK ENHANCEMENT SE, P1; Machidori S., 1984, INT N PAC FISH COMM, V43, P1; Obata Y., 2008, ENHANCEMENT CONSERVA, P66; Ohnuki T., 2012, NPAFC DOCUMENTS, V1387, P8; Sato S., 2011, NPAFC DOCUMENTS, V1312, P7; Shimoda K., 2014, SCI REPORT HOKKAIDO, V85, P41; Sugiwaka K., 1994, UOTOMIZU, V31, P171; Urabe H., 2013, SCI REPORT HOKKAIDO, V84, P34	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0969-997X	1365-2400		FISHERIES MANAG ECOL	Fisheries Manag. Ecol.	OCT	2015	22	5					371	378		10.1111/fme.12136		8	Fisheries	Fisheries	CT8GM	WOS:000363053000003		
J	Ueda, S; Ozawa, S; Mori, K; Asanuma, K; Yanagita, M; Uchida, S; Nakagawa, T				Ueda, Shuko; Ozawa, Shota; Mori, Kiyoshi; Asanuma, Katsuhiko; Yanagita, Motoko; Uchida, Shunya; Nakagawa, Takahiko			ENOS deficiency causes podocyte injury with mitochondrial abnormality	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						Endothelial; Oxidative stress; Nitric oxide; NO; Glomerular; Podocyte	NITRIC-OXIDE SYNTHASE; ADVANCED DIABETIC-NEPHROPATHY; ENDOTHELIAL GROWTH-FACTOR; OXIDATIVE STRESS; KNOCKOUT MICE; THROMBOTIC MICROANGIOPATHY; BLOOD-PRESSURE; RENAL INJURY; EXPRESSION; KIDNEY	The contribution of endothelial nitric oxide synthase (eNOS) to podocyte integrity remains unclear. This study therefore examined podocytes and mitochondrial abnormalities in eNOS deficient mice. Absence of eNOS caused glomerular hypertrophy, along with occasional glomerular sclerosis and mesangiolysis. While many glomeruli did not have such advanced lesions, ultrastructural analysis showed cellular hypertrophy, vacuolization, lysosomal enlargement, and microvillus formation in podocytes of eNOS knockout (KO) mice. Increased oxidative stress was associated with mitochondrial abnormalities, including an increase in number, coupled with a reduction in size, of mitochondria in podocytes of eN0S1(0 mice. While the levels of expression of several mitochondrial proteins were not altered, the D-17 mutation in mitochondrial DNA was significantly associated with the eNOS deficiency. Renal ATP level in the renal cortex and mitochondrial respiration in the primary podocytes were significantly lower in eN0S-K0 mice, suggesting that renal mitochondria may be functionally impaired. Podocytes cultured with endothelial conditioned medium lacking NO consistently showed a greater degree of mitochondrial fragmentation and an increase in mitochondrial oxidative stress, with these mitochondrial alterations rescued by an NO donor. In conclusion, eNOS may be necessary to maintain poclocyte integrity, especially mitochond rial function. (C) 2015 Published by Elsevier Inc.	[Ueda, Shuko; Ozawa, Shota; Mori, Kiyoshi; Asanuma, Katsuhiko; Yanagita, Motoko; Nakagawa, Takahiko] Kyoto Univ, TMK Project, Med Innovat Ctr, Kyoto 6068397, Japan; [Ueda, Shuko; Uchida, Shunya] Teikyo Univ, Sch Med, Dept Internal Med, Tokyo 173, Japan; [Ozawa, Shota] Mitsubishi Tanabe Pharma Corp, Pharmacol Res Labs 2, Saitama, Japan; [Yanagita, Motoko] Kyoto Univ, Grad Sch Med, Dept Nephrol, Kyoto, Japan	Nakagawa, T (reprint author), Kyoto Univ, TMK Project, Med Innovat Ctr, Sakyo Ku, 53 Shogoin,Kawahara Cho, Kyoto 6068397, Japan.	nakagawt@gmail.com			Mitsubishi Tanabe Pharma Corporation; Teikyo University; Uehara memorial foundation	This study was supported by a research fund from the Mitsubishi Tanabe Pharma Corporation, a financial support from Teikyo University, and a research grant from the Uehara memorial foundation.	Komers R, 2006, DIABETES, V55, P1651, DOI 10.2337/db05-1595; KANNER J, 1991, ARCH BIOCHEM BIOPHYS, V289, P130, DOI 10.1016/0003-9861(91)90452-O; Wallerath T, 2002, CIRCULATION, V106, P1652, DOI 10.1161/01.CIR.0000029925.18593.5C; Mbaya E, 2010, CELL DEATH DIFFER, V17, P1855, DOI 10.1038/cdd.2010.51; Wu LL, 2004, CLIN CHIM ACTA, V339, P1, DOI 10.1016/j.cccn.2003.09.010; Nakagawa T, 2006, J AM SOC NEPHROL, V17, P736, DOI 10.1681/ASN.2005070759; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; De Palma C, 2010, CELL DEATH DIFFER, V17, P1684, DOI 10.1038/cdd.2010.48; Li HG, 2006, J AM COLL CARDIOL, V47, P2536, DOI 10.1016/j.jacc.2006.01.071; Forbes MS, 2007, AM J PATHOL, V170, P87, DOI 10.2353/ajpath.2007.060610; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Iqbal S, 2014, AM J PHYSIOL-CELL PH, V306, pC1176, DOI 10.1152/ajpcell.00017.2014; Nisoli E, 2004, P NATL ACAD SCI USA, V101, P16507, DOI 10.1073/pnas.0405432101; Thomas SE, 1998, J AM SOC NEPHROL, V9, P231; Kume S, 2010, J CLIN INVEST, V120, P1043, DOI 10.1172/JCI41376; Yuen DA, 2012, J AM SOC NEPHROL, V23, P1810, DOI 10.1681/ASN.2011121170; Nakayama T, 2010, AM J PATHOL, V176, P2198, DOI 10.2353/ajpath.2010.090316; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; TANHAUSER SM, 1995, J BIOL CHEM, V270, P24769; Dugan LL, 2013, J CLIN INVEST, V123, P4888, DOI 10.1172/JCI66218; Tanabe K, 2012, AM J PHYSIOL-RENAL, V303, pF1264, DOI 10.1152/ajprenal.00227.2012; BACHMANN S, 1995, AM J PHYSIOL-RENAL, V268, pF885; Kosugi T, 2009, AM J PATHOL, V174, P1221, DOI 10.2353/ajpath.2009.080605; Le Gouill E, 2007, DIABETES, V56, P2690, DOI 10.2337/db06-1228; Herrera M, 2006, HYPERTENSION, V47, P95, DOI 10.1161/01.HYP.0000196274.78603.85; Heeringa P, 2000, AM J PATHOL, V156, P879, DOI 10.1016/S0002-9440(10)64957-7; van den Berg JG, 2004, KIDNEY INT, V66, P1901, DOI 10.1111/j.1523-1755.2004.00964.x; Nakagawa T, 2007, J AM SOC NEPHROL, V18, P539, DOI 10.1681/ASN.2006050459; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Tanabe K, 2012, AM J PHYSIOL-RENAL, V302, pF1151, DOI 10.1152/ajprenal.00596.2011; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; Wu SN, 2011, FEBS J, V278, P941, DOI 10.1111/j.1742-4658.2011.08010.x; Eremina V, 2006, J AM SOC NEPHROL, V17, P724, DOI 10.1681/ASN.2005080810; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Shenouda SM, 2011, CIRCULATION, V124, P444, DOI 10.1161/CIRCULATIONAHA.110.014506; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Faria AM, 2012, DIABETES, V61, P1838, DOI [10.2337/db11-1241, 10.2337/db11-1241/-/DC1]; Kanetsuna Y, 2007, AM J PATHOL, V170, P1473, DOI 10.2353/ajpath.2007.060481; Gilkeson GS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064650; Gu Xin, 2010, Int J Nephrol Renovasc Dis, V3, P11; Li Q., 2010, INVEST OPHTHALMOL VI; Nakayama T., 2009, AM J PHYSIOL-RENAL, V296, P317; Steinkamp-Fenske Katja, 2007, Atherosclerosis, V195, pe104, DOI 10.1016/j.atherosclerosis.2007.03.028	43	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	OCT	2015	87						181	192		10.1016/j.freeradbiomed.2015.06.028		12	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CU1JK	WOS:000363277100016		
J	Iida, R; Ueki, M; Yasuda, T				Iida, Reiko; Ueki, Misuzu; Yasuda, Toshihiro			Identification of interacting partners of Human Mpv17-like protein with a mitigating effect of mitochondrial dysfunction through mtDNA damage	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						Mitochondrial dysfunction; Mitochondrial DNA; Mpv17 family; Oxidative stress	ENDOPLASMIC-RETICULUM ER; PEROXISOMAL MEMBRANE; DNA-DAMAGE; REGULATES EXPRESSION; M-LP; GENE; S3; ORGANIZATION; REPLICATION; APOPTOSIS	Human Mpv17-like protein (M-LPH) has been suggested to participate in mitochondrial function. In this study, we investigated the proteins that interact with M-LPH, and identified four: H2A histone family, member X (H2AX), ribosomal protein S14 (RPS14), ribosomal protein 53 (RPS3) and B-cell receptor-associated protein 31 (Bap31). Immunofluorescence and subcellular fractionation studies revealed that M-LPH is localized predominantly in the nucleus, to some extent in a subset of mitochondria, and marginally in the cytosol. Mitochondrial M-LPH appeared as punctate foci, and these were co-localized with a subset of mitochonclrial transcription factor A (TFAM) and mtDNA, indicating that M-LPH is localized in or in close proximity to mitochonclrial nucleoids. RNAi-mecliatecl knockdown of M-LPH resulted in an increase of mtDNA damage and reduced the expression of mtDNA-encoded genes. A ROS inducer, antimycin A, caused an increase in both the number and size of the mitochonclrial M-LPH foci, and these foci were co-localized with two enzymes, DNA polymerase gamma (POLG) and DNA ligase Ill (LIG3), both involved in mtDNA repair. Furthermore, knockdown of M-LPH hampered mitochonclrial localization of these enzymes. Taken together, these observations suggest that M-LPI-1 is involved in the maintenance of mtDNA and protects cells from mitochondrial dysfunction. (C) 2015 Elsevier Inc. All rights reserved	[Iida, Reiko] Univ Fukui, Fac Med Sci, Div Life Sci, Fukui 9101193, Japan; [Iida, Reiko; Yasuda, Toshihiro] Univ Fukui, Fac Med Sci, Org Life Sci Adv Programs, Fukui 9101193, Japan; [Ueki, Misuzu; Yasuda, Toshihiro] Univ Fukui, Fac Med Sci, Div Med Genet & Biochem, Fukui 9101193, Japan	Iida, R (reprint author), Univ Fukui, Fac Med Sci, Div Life Sci, Fukui 9101193, Japan.	riida@u-fukui.ac.jp			Japan Society for the Promotion of Science [26293162, 24659335, 22249023]	This work was supported in part by Grants-in-Aid for scientific research from Japan Society for the Promotion of Science (26293162 and 24659335 to R.I., 22249023 to T.Y.),	Neumann F, 1997, EXP CELL RES, V230, P252, DOI 10.1006/excr.1996.3417; Zhou X, 2013, ONCOGENE, V32, P388, DOI 10.1038/onc.2012.63; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Krick S, 2008, P NATL ACAD SCI USA, V105, P14106, DOI 10.1073/pnas.0801146105; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Alexeyev M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012641; Barlow JL, 2010, NAT MED, V16, P59, DOI 10.1038/nm.2063; Rajala N, 2014, NUCLEIC ACIDS RES, V42, P952, DOI 10.1093/nar/gkt988; KIM J, 1995, J BIOL CHEM, V270, P13620; Iida R, 2000, MECH AGEING DEV, V113, P135, DOI 10.1016/S0047-6374(99)00104-9; Deutsch WA, 1997, J BIOL CHEM, V272, P32857, DOI 10.1074/jbc.272.52.32857; Iida R, 2012, FREE RADICAL BIO MED, V52, P1413, DOI 10.1016/j.freeradbiomed.2012.01.003; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Iwasawa R, 2011, EMBO J, V30, P556, DOI 10.1038/emboj.2010.346; ZIEMIECKI A, 1990, EMBO J, V9, P191; Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765; Duxin JP, 2009, MOL CELL BIOL, V29, P4274, DOI 10.1128/MCB.01834-08; Natter K, 2005, MOL CELL PROTEOMICS, V4, P662, DOI 10.1074/mcp.M400123-MCP200; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8; Yadavilli S, 2009, DNA REPAIR, V8, P1215, DOI 10.1016/j.dnarep.2009.07.003; Heath-Engel HM, 2012, BBA-MOL CELL RES, V1823, P335, DOI 10.1016/j.bbamcr.2011.11.020; Iida R, 2005, EXP CELL RES, V302, P22, DOI 10.1016/j.yexer.2004.08.027; Breckenridge DG, 2003, J CELL BIOL, V160, P1115, DOI 10.1083/jcb.200212059; Iida R, 2006, BIOCHEM BIOPH RES CO, V344, P948, DOI 10.1016/j.bbrc.2006.04.008; Lynes EM, 2011, BBA-MOL CELL RES, V1813, P1893, DOI 10.1016/j.bbamcr.2011.06.011; Muftuoglu M, 2014, MITOCHONDRION, V17, P164, DOI 10.1016/j.mito.2014.03.007; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Uusimaa J, 2014, EUR J HUM GENET, V22, P184, DOI 10.1038/ejhg.2013.112; Iida R, 2001, BIOCHEM BIOPH RES CO, V283, P292, DOI 10.1006/bbrc.2001.4769; Hegde V, 2004, DNA REPAIR, V3, P121, DOI 10.1016/j.dnarep.2003.10.004; ALBRING M, 1977, P NATL ACAD SCI USA, V74, P1348, DOI 10.1073/pnas.74.4.1348; Lisenbee CS, 2003, TRAFFIC, V4, P491, DOI 10.1034/j.1600-0854.2003.00107.x; Wakana Y, 2008, MOL BIOL CELL, V19, P1825, DOI 10.1091/mbc.E07-08-0781; Kim Y, 2013, BBA-MOL CELL RES, V1833, P2943, DOI 10.1016/j.bbamcr.2013.07.015; Blakely EL, 2012, NEUROMUSCULAR DISORD, V22, P587, DOI 10.1016/j.nmd.2012.03.006; Doudna JA, 2002, CELL, V109, P153, DOI 10.1016/S0092-8674(02)00725-0; Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405; Brosius U, 2002, J BIOL CHEM, V277, P774, DOI 10.1074/jbc.M108155200; Antonenkov VD, 2012, BBA-MOL BASIS DIS, V1822, P1374, DOI 10.1016/j.bbadis.2011.12.011; Iida R, 2003, J BIOL CHEM, V278, P6301, DOI 10.1074/jbc.M210886200; Naora H, 1999, IMMUNOL CELL BIOL, V77, P197, DOI 10.1046/j.1440-1711.1999.00816.x; Radyuk SN, 2006, FREE RADICAL BIO MED, V41, P757, DOI 10.1016/j.freeradbiomed.2006.05.021; Dalla Rosa I., 2014, NUCLEIC ACIDS RES, V42, P8500; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Firsanov Denis V, 2011, Clin Epigenetics, V2, P283, DOI 10.1007/s13148-011-0044-4; Helle SCJ, 2013, BBA-MOL CELL RES, V1833, P2526, DOI 10.1016/j.bbamcr.2013.01.028; Kang MA, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.134; lida R., 2013, OPEN ACCESS, V2, P440; Rokka A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005090; Zhou Xiang, 2012, Genes Cancer, V3, P298, DOI 10.1177/1947601912455200	52	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	OCT	2015	87						336	345		10.1016/j.freeradbiomed.2015.07.008		10	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CU1JK	WOS:000363277100029		
J	Noguchi, N; Urano, Y; Takabe, W; Saito, Y				Noguchi, Noriko; Urano, Yasuomi; Takabe, Wakako; Saito, Yoshiro			New aspects of 24(S)-hydroxycholesterol in modulating neuronal cell death	FREE RADICAL BIOLOGY AND MEDICINE			English	Review						24(S)-Hydroxycholesterol; CYP46A1; Cholesterol homeostasis; Cell death; Neurodegenerative disease; Free radicals	AMYLOID PRECURSOR PROTEIN; CENTRAL-NERVOUS-SYSTEM; HUMAN NEUROBLASTOMA-CELLS; BLOOD-BRAIN-BARRIER; DIFFERENTIATED PC12 CELLS; MIXED LINEAGE KINASE; ALZHEIMERS-DISEASE; CHOLESTEROL 24-HYDROXYLASE; LIPID-PEROXIDATION; OXIDATIVE STRESS	24(5)-Hydroxycholesterol (24S-OHC), which is enzymatically produced in the brain, has been known to play an important role in maintaining cholesterol homeostasis in the brain and has been proposed as a possible biomarker of neurodegenerative disease. Recent studies have revealed diverse functions of 24SOHC and gained increased attention. For example, 24S-OHC at sublethal concentrations has been found to induce an adaptive response via activation of the liver X receptor signaling pathway, thereby protecting neuronal cells against subsequent oxidative stress. It has also been found that physiological concentrations of 24S-OHC suppress amyloid-beta production via downregulation of amyloid precursor protein trafficking in neuronal cells. On the other hand, high concentrations of 24S-OHC have been found to induce a type of nonapoptotic programmed cell death in neuronal cells expressing little caspase-8. Because neuronal cell death induced by 24S-OHC has been found to proceed by a unique mechanism, which is different from but in some ways similar to necroptosis necroptosis being a type of programmed necrosis induced by tumor necrosis factor alpha neuronal cell death induced by 24S-OHC has been called "necroptosis-like" cell death. 24S-OHC-induced cell death is dependent on the formation of 24S-OHC esters but not on oxidative stress. This review article discusses newly reported aspects of 24S-OHC in neuronal cell death and sheds light on the possible importance of controlling 24S-OHC levels in the brain for preventing neuroclegenerative disease. (C) 2015 Elsevier Inc. All rights reserved.	[Noguchi, Noriko; Urano, Yasuomi; Takabe, Wakako; Saito, Yoshiro] Doshisha Univ, Fac Life & Med Sci, Dept Med Life Syst, Syst Life Sci Lab, Kyoto 6100394, Japan	Noguchi, N (reprint author), Doshisha Univ, Fac Life & Med Sci, Dept Med Life Syst, Syst Life Sci Lab, Kyoto 6100394, Japan.	nnoguchi@mail.doshisha.ac.jp			KAKENHI [25830041]; Adaptable and Seamless Technology Transfer Program through target-driven RD, JST; Foundation of Cosmetology Research; MEXT	We thank Gerry Peters (JTT K.K., Takatsuki, Japan) for his careful editing of the manuscript. This work was supported in part by KAKENHI Grant-in-Aid for Young Scientists (B) 25830041 to Y.U., the Adaptable and Seamless Technology Transfer Program through target-driven R&D, JST, to Y.U., the Foundation of Cosmetology Research to N.N,, and the MEXT-Supported Program for the Strategic Research Foundation at Private Universities in Japan for the years 2012-2016.	Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; Chang TY, 2009, AM J PHYSIOL-ENDOC M, V297, pE1, DOI 10.1152/ajpendo.90926.2008; Mitic T, 2013, BIOCHIMIE, V95, P548, DOI 10.1016/j.biochi.2012.08.007; Jang ER, 2011, NEUROCHEM INT, V58, P52, DOI 10.1016/j.neuint.2010.10.012; Saito Y, 2014, BIOCHEM BIOPH RES CO, V446, P741, DOI 10.1016/j.bbrc.2013.12.083; JUREVICS H, 1995, J NEUROCHEM, V64, P895; Gosselet F, 2014, BIOCHEM BIOPH RES CO, V446, P687, DOI 10.1016/j.bbrc.2013.11.059; Zwain IH, 1999, ENDOCRINOLOGY, V140, P3843, DOI 10.1210/en.140.8.3843; POIRIER J, 1993, NEUROSCIENCE, V55, P81, DOI 10.1016/0306-4522(93)90456-P; Rao ML, 1999, ANN NY ACAD SCI, V893, P379, DOI 10.1111/j.1749-6632.1999.tb07860.x; Kristofikova Z, 2008, NEUROCHEM RES, V33, P412, DOI 10.1007/s11064-007-9443-5; Estus S, 1997, J NEUROSCI, V17, P7736; Halford RW, 2009, P NATL ACAD SCI USA, V106, P3502, DOI 10.1073/pnas.0813349106; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Iuliano L, 2011, CHEM PHYS LIPIDS, V164, P457, DOI 10.1016/j.chemphyslip.2011.06.006; Bjorkhem I, 1997, J BIOL CHEM, V272, P30178, DOI 10.1074/jbc.272.48.30178; Gamba P, 2011, AGING CELL, V10, P403, DOI 10.1111/j.1474-9726.2011.00681.x; Chisari M, 2010, TRENDS NEUROSCI, V33, P299, DOI 10.1016/j.tins.2010.03.005; Noguchi N, 2014, BIOCHEM BIOPH RES CO, V446, P692, DOI 10.1016/j.bbrc.2014.02.010; Kolsch H, 2004, NEUROSCI LETT, V368, P303, DOI 10.1016/j.neulet.2004.07.031; Hubin E, 2014, CELL MOL LIFE SCI, V71, P3507, DOI 10.1007/s00018-014-1634-z; Do Rego JL, 2009, FRONT NEUROENDOCRIN, V30, P259, DOI 10.1016/j.yfrne.2009.05.006; Vejux A, 2008, BRAZ J MED BIOL RES, V41, P545, DOI 10.1590/S0100-879X2008000700001; Saito Y, 2007, J NEUROCHEM, V102, P1625, DOI 10.1111/j.1471-4159.2007.04701.x; Hudry E, 2010, MOL THER, V18, P44, DOI 10.1038/mt.2009.175; Popp J, 2012, J NEUROCHEM, V123, P310, DOI 10.1111/j.1471-4159.2012.07893.x; Nelson TJ, 2005, J BIOL CHEM, V280, P7377, DOI 10.1074/jbc.M409071200; Shafaati M, 2010, J LIPID RES, V51, P318, DOI [10.1194/jlr.M900174-JLR200, 10.1194/jlr.M900174]; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; LOO DT, 1993, P NATL ACAD SCI USA, V90, P7951, DOI 10.1073/pnas.90.17.7951; Mast N, 2010, J BIOL CHEM, V285, P31783, DOI 10.1074/jbc.M110.143313; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI [10.1194/jlr.r400004, 10.1194/jlr.r400004-JLR200]; Bjorkhem I, 2013, NEUROSCI LETT, V555, P102, DOI 10.1016/j.neulet.2013.09.003; Patte-Mensah C, 2008, BRAIN RES REV, V57, P454, DOI 10.1016/j.brainresrev.2007.05.007; Hughes TM, 2013, J ALZHEIMERS DIS, V33, P891, DOI 10.3233/JAD-2012-121585; Fourgeux C, 2014, BIOCHEM BIOPH RES CO, V446, P775, DOI 10.1016/j.bbrc.2014.01.118; Russell DW, 2009, ANNU REV BIOCHEM, V78, P1017, DOI 10.1146/annurev.biochem.78.072407.103859; Sottero B, 2009, CURR MED CHEM, V16, P685; Ferrera P, 2008, NEUROCHEM RES, V33, P1509, DOI 10.1007/s11064-008-9623-y; Kim J, 2005, J BIOL CHEM, V280, P7758, DOI 10.1074/jbc.M411091200; Fukumoto H, 2002, J BIOL CHEM, V277, P48508, DOI 10.1074/jbc.M209085200; Niki E, 2009, FREE RADICAL BIO MED, V47, P469, DOI 10.1016/j.freeradbiomed.2009.05.032; Lee CYJ, 2009, ANTIOXID REDOX SIGN, V11, P407, DOI 10.1089/ARS.2008.2179; Yamanaka K, 2012, RSC ADV, V2, P7894, DOI 10.1039/c2ra20816d; Wang QM, 2014, CURR PHARM DESIGN, V20, P1223; Kolsch H, 1999, BRAIN RES, V818, P171, DOI 10.1016/S0006-8993(98)01274-8; Bjorkhem I, 2006, J INTERN MED, V260, P493, DOI 10.1111/j.1365-2796.2006.01725.x; Jiang MR, 2008, BBA-MOL CELL RES, V1783, P1055, DOI 10.1016/j.bbamcr.2008.02.007; Leoni V, 2011, CHEM PHYS LIPIDS, V164, P515, DOI 10.1016/j.chemphyslip.2011.04.002; Urano Y, 2005, J LIPID RES, V46, P904, DOI 10.1194/jlr.M400333-JLR200; Kolsch H, 2001, J NEURAL TRANSM, V108, P475, DOI 10.1007/s007020170068; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Yamanaka K, 2011, J BIOL CHEM, V286, P24666, DOI 10.1074/jbc.M111.236273; Ramirez DMO, 2008, J COMP NEUROL, V507, P1676, DOI 10.1002/cne.21605; Saeed AA, 2014, J BIOL CHEM, V289, P23712, DOI 10.1074/jbc.M114.556159; Shafaati M, 2007, NEUROSCI LETT, V425, P78, DOI 10.1016/j.neulet.2007.08.014; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b; Bretillon L, 2000, NEUROSCI LETT, V293, P87, DOI 10.1016/S0304-3940(00)01466-X; Kolsch H, 2002, MOL PSYCHIATR, V7, P899, DOI 10.1038/sj.mp.4001109; He MX, 2013, CELL DEATH DIFFER, V20, P188, DOI 10.1038/cdd.2012.148; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Pfrieger FW, 2011, PROG LIPID RES, V50, P357, DOI 10.1016/j.plipres.2011.06.002; Vo DKH, 2015, STEROIDS, V99, P230, DOI 10.1016/j.steroids.2015.02.007; Bjorkhem I, 1999, CURR OPIN LIPIDOL, V10, P161, DOI 10.1097/00041433-199904000-00010; Lund EG, 2003, J BIOL CHEM, V278, P22980, DOI 10.1074/jbc.M303415200; Ohyama Y, 2006, J BIOL CHEM, V281, P3810, DOI 10.1074/jbc.M505179200; Gamba P, 2014, AGING CELL, V13, P561, DOI 10.1111/acel.12206; Ohtsuki S, 2007, J NEUROCHEM, V103, P1430, DOI 10.1111/j.1471-4159.2007.04901.x; Bjorkhem I, 2009, MOL ASPECTS MED, V30, P171, DOI 10.1016/j.mam.2009.02.001; Chen ZH, 2006, J BIOL CHEM, V281, P14440, DOI 10.1074/jbc.M600260200; Cavallucci V, 2012, MOL NEUROBIOL, V45, P366, DOI 10.1007/s12035-012-8251-3; Heverin M, 2004, J LIPID RES, V45, P186, DOI 10.1194/jlr.M300320-JLR200; Leoni V, 2013, NEUROBIOL DIS, V55, P37, DOI 10.1016/j.nbd.2013.03.013; Lutjohann D, 2000, J LIPID RES, V41, P195; Cai DM, 2003, J BIOL CHEM, V278, P3446, DOI 10.1074/jbc.M209065200; Kristofikova Z, 2012, NEUROCHEM RES, V37, P604, DOI 10.1007/s11064-011-0650-8; Kim DE, 2009, NEUROCHEM RES, V34, P1433, DOI 10.1007/s11064-009-9930-y; Bogdanovica N, 2001, NEUROSCI LETT, V314, P45, DOI 10.1016/S0304-3940(01)02277-7; Brown J., 2004, J BIOL CHEM, V279, P34674; Doodipala S. R., 2010, PROG BRAIN RES, V186, P113; Feoktistova M., 2011, MOL CELL, V43, P449; Huang Y, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-40; Marca V. L., 2014, J NEUROCHEM, V130, P97; Okabe Akishi, 2013, Redox Biol, V2, P28, DOI 10.1016/j.redox.2013.11.007; Poli G, 2013, REDOX BIOL, V1, P125, DOI 10.1016/j.redox.2012.12.001; Prasanthi JRP, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-1; Sun M. Y., 2015, NEUROSCIENTIST, P1; Urano Y, 2013, FASEB J, V27, P4305, DOI 10.1096/fj.13-231456; Yamanaka K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.524; Zuliani G, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-121	94	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	OCT	2015	87						366	372		10.1016/j.freeradbiomed.2015.06.036		7	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CU1JK	WOS:000363277100032		
J	Ferro, A; Gaio, E; Novello, L; Matsukawa, M; Shimada, K; Kawamata, Y; Takechi, M				Ferro, Alberto; Gaio, Elena; Novello, Luca; Matsukawa, Makoto; Shimada, Katsuhiro; Kawamata, Yoichi; Takechi, Manabu			Reference design of the power supply system for the resistive-wall-mode control in JT-60SA	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		JT-60SA; RWM; Sector coil; Power supply		The mission of JT-60SA, the satellite Tokamak under construction in Naka (Japan), includes the attainment of steady-state high-beta plasmas. For this purpose, an active control system based on 18 in-vessel sector coils (SC) is foreseen to suppress the resistive wall modes (RWM). Each coil will be independently fed by a dedicated converter, rated for 300A and 240V, which has to produce the required current/voltage following in real time the reference provided by the JT-60SA MHD Controller. To minimize the current rating, these converters shall be sufficiently fast to avoid an excessive growth of the RWM. This requires a very high dynamic performance, largely beyond that of standard industrial applications. This paper firstly reports the latest results of the studies on the requirements of the RWM active control system. Then, the reference design of the power supply system is presented, including the ac/dc conversion stage, the fast converters and the control section. The advantages of the proposed scheme are discussed and the main electrical parameters are presented. (C) 2015 Consorzio RFX. Published by Elsevier B.V. All rights reserved.	[Ferro, Alberto; Gaio, Elena] Consorzio RFX, I-35127 Padua, Italy; [Novello, Luca] Fus Energy, Broader Dev Fus Dept, D-85748 Garching, Germany; [Matsukawa, Makoto; Shimada, Katsuhiro; Kawamata, Yoichi; Takechi, Manabu] Japan Atom Energy Agcy, Naka Fus Inst, Naka, Ibaraki 3110193, Japan	Ferro, A (reprint author), Consorzio RFX, Cso Stari Uniti 4, I-35127 Padua, Italy.	alberto.ferro@igi.cnr.it					Ferro A, 2011, FUSION ENG DES, V86, P1527, DOI 10.1016/j.fusengdes.2010.12.009; Ferro A, 2013, FUSION ENG DES, V88, P1509, DOI 10.1016/j.fusengdes.2013.01.094; Toigo V, 2003, FUSION ENG DES, V66-68, P1143, DOI 10.1016/S0920-3796(03)00293-X; JT-60SA Research Unit, 2013, JT 60SA RES PLAN RES; Mohan N., 2003, POWER ELECT CONVERTE; Takechi M., 2010, 37 EPS C PLASM PHYS; Takechi M., 2010, 23 IAEA FUS EN C DAE	7	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1053	1057		10.1016/j.fusengdes.2015.06.116		5	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900004		
J	Hishinuma, Y; Kikuchi, A; Shimada, Y; Kashiwai, T; Hata, S; Yamada, S; Muroga, T; Sagara, A				Hishinuma, Yoshimitsu; Kikuchi, Akihiro; Shimada, Yusuke; Kashiwai, Taro; Hata, Satoshi; Yamada, Shuichi; Muroga, Takeo; Sagara, Akio			Development of MgB2 superconducting wire for the low activation superconducting magnet system operated around core D-T plasma	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		MgB2; Cu addition; Solenoid coil; Excitation test; B-11 boron isotope	FUSION-REACTOR; MICROSTRUCTURE	MgB2 is one of the "low activation superconductors", because the half-life of the induced radio-activity on the MgB2 is much shorter than that of Nb-based superconductors such as NbTi, Nb3Sn and Nb3Al. MgB2 wire would become an alternative material for Nb-Ti wire for the Poloidal Field and correction feedback coils, if the critical current density (J(c)) around the magnetic field of 4T could be improved. We found that addition of Cu using the compound Mg2Cu was an effective method to enhancek and succeed to fabricate 100 m length of MgB2 wire with Cu addition. Jc of the 100 m long MgB2 with Cu addition was comparable to that of a NbTi wire, and the small solenoid coil using Cu added MgB2 wire reached a central magnetic field of 2.62T. We found that MgB2 wire is an alternative material to commercial NbTi wires under the hard neutron irradiation in a fusion reactor. Furthermore, we also fabricated a Cu added MgB2 wire using isotope pure boron-11 (B-11) powder as the boron source to reduce the radioactivity. The critical temperature (T-c) of the MgB2 wire using B-11 powder was found to be 37K, and T-c was found to be changed by different boron materials. (C) 2015 Published by Elsevier B.V.	[Hishinuma, Yoshimitsu; Yamada, Shuichi; Muroga, Takeo; Sagara, Akio] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Kikuchi, Akihiro] Natl Inst Mat Sci, Tsukuba, Ibaraki, Japan; [Shimada, Yusuke] Kyushu Univ, HVEM Lab, Nishi Ku, Fukuoka 812, Japan; [Kashiwai, Taro; Hata, Satoshi] Kyushu Univ, Dept Mol & Mat Sci, Fukuoka 812, Japan	Hishinuma, Y (reprint author), Natl Inst Nat Sci, Natl Inst Fus Sci, 322-6 Oroshicho, Toki, Gifu 5095292, Japan.	hishinuma.yoshimitsu@nifs.ac.jp					Hishinuma Y, 2006, SUPERCOND SCI TECH, V19, P1269, DOI 10.1088/0953-2048/19/12/008; DeFouw JD, 2008, ACTA MATER, V56, P5751, DOI 10.1016/j.actamat.2008.07.049; Finnemore DK, 2001, PHYS REV LETT, V86, P2420, DOI 10.1103/PhysRevLett.86.2420; Noda T, 2004, J NUCL MATER, V329, P1590, DOI 10.1016/j.jnucmat.2004.04.164; Hishinuma Y, 2007, SUPERCOND SCI TECH, V20, P1178, DOI 10.1088/0953-2048/20/12/017; Hishinuma Y, 2007, IEEE T APPL SUPERCON, V17, P2798, DOI 10.1109/TASC.2007.897453; Hishinuma Y., 2006, FUSION ENG DES, V20-22, P2467; Hishinuma Y., 2012, PHYS PROCEDIA, V36, P1485	8	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1076	1080		10.1016/j.fusengdes.2015.05.005		5	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900009		
J	Kizu, K; Murakami, H; Natsume, K; Tsuchiya, K; Koide, Y; Yoshida, K; Obana, T; Hamaguchi, S; Takahata, K				Kizu, Kaname; Murakami, Haruyuki; Natsume, Kyohei; Tsuchiya, Katsuhiko; Koide, Yoshihiko; Yoshida, Kiyoshi; Obana, Tetsuhiro; Hamaguchi, Shinji; Takahata, Kazuya			Manufacturing design and development of the current feeders and coil terminal boxes for JT-60SA	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Coil terminal box; Current feeder; Electrical joint; JT-60SA; NbTi		Feeders and coil terminal boxes (CTBs) of the superconducting magnets for JT-60SA have been designed. A small tool which can connect soldering joint with vertical direction in the cryostat has been developed. The joint resistance of the sample showed 1.7 n Omega at 2T, 4.2 K, 20 kA which is within the requirement of <5 n Omega. A prototype feeder in CTB with crank shape was manufactured. The maximum dimensional error was 3 mm being within the requirement of +/- 10 mm. Feeder insulation samples showed a shear strength >60 MPa which is much higher than the requirement of 10 MPa as derived from analysis. Since all the manufacturing processes concerned have been proof-tested, the production of feeders and CTBs has been released. (C) 2015 Elsevier B.V. All rights reserved.	[Kizu, Kaname; Murakami, Haruyuki; Natsume, Kyohei; Tsuchiya, Katsuhiko; Koide, Yoshihiko; Yoshida, Kiyoshi] Japan Atom Energy Agcy, Naka, Ibaraki 3110193, Japan; [Obana, Tetsuhiro; Hamaguchi, Shinji; Takahata, Kazuya] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan	Kizu, K (reprint author), Japan Atom Energy Agcy, Naka, Ibaraki 3110193, Japan.	kizu.kaname@jaea.go.jp					Song Y, 2010, IEEE T APPL SUPERCON, V20, P1710, DOI 10.1109/TASC.2010.2044566; Obana T, 2010, IEEE T APPL SUPERCON, V20, P1471, DOI 10.1109/TASC.2009.2039637; Fietz WH, 2009, IEEE T APPL SUPERCON, V19, P2202, DOI 10.1109/TASC.2009.2019550; Yoshida K, 2012, IEEE T APPL SUPERCON, V22, DOI 10.1109/TASC.2011.2174545; Kizu K, 2011, FUSION ENG DES, V86, P1432, DOI 10.1016/j.fusengdes.2011.01.028; FAST RW, 1988, CRYOGENICS, V28, P7, DOI 10.1016/0011-2275(88)90223-8; KITAMURA K, 1994, IEEE T MAGN, V30, P1879, DOI 10.1109/20.305628; Yoshida K, 2013, FUSION ENG DES, V88, P1499, DOI 10.1016/j.fusengdes.2012.12.010; Zani L, 2013, FUSION ENG DES, V88, P555, DOI 10.1016/j.fusengdes.2012.12.032	9	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1094	1097		10.1016/j.fusengdes.2015.04.030		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900013		
J	Lampasi, A; Zito, P; Coletti, A; Novello, L; Matsukawa, M; Shimada, K; Burini, F; Fone, YK; Taddia, G; Tenconi, S				Lampasi, Alessandro; Zito, Pietro; Coletti, Alberto; Novello, Luca; Matsukawa, Makoto; Shimada, Katsuhiro; Burini, Filippo; Fone, Yannick Kuate; Taddia, Giuseppe; Tenconi, Sandro			First Switching Network Unit for the JT-60SA superconducting Central Solenoid	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		JT-60SA; Switching Network Unit (SNU); DC current interruption; Hybrid electromechanical-electronic switch; High current tests	DESIGN	This paper presents the main characteristics and test results of the first Switching Network Unit (SNU) of the Central Solenoid for plasma initiation in the international experiment JT-60SA. The SNU can interrupt a direct current up to 20 kA producing at its terminals a voltage up to 5 kV with a rise time shorter than 100 mu s. This is obtained by synchronizing the operation of a light electromechanical contactor with a static switch in order to combine the benefits of both devices. Even though the design was based on the JT-60SA specifications, the adopted solutions can be extended to many fusion and industrial applications. Due to the novelty of the developed solutions, an exhaustive set of tests were performed both on relevant single devices and on the complete SNU, even at full current, full voltage and full energy. The most relevant tests were performed using the Frascati Tokamak Upgrade (FTU) facilities reproducing the JT-60SA operating conditions. As the presented tests demonstrated the capabilities of the SNU to comply with the requirements, the manufacturing of the remaining three Central Solenoid SNUs can proceed and is expected to be completed by 2015. (C) 2015 Elsevier B.V. All rights reserved.	[Lampasi, Alessandro; Zito, Pietro] Natl Agcy New Technol Energy & Sustainable Econ D, Frascati, Italy; [Coletti, Alberto; Novello, Luca] Fus Energy F4E Broader Fus Dev Dept, Garching, Germany; [Matsukawa, Makoto; Shimada, Katsuhiro] Japan Atom Energy Agcy, Naka Fus Inst, Naka, Ibaraki 3110193, Japan; [Burini, Filippo; Fone, Yannick Kuate; Taddia, Giuseppe; Tenconi, Sandro] OCEM Energy Technol, Valsamoggia, Italy	Lampasi, A (reprint author), Natl Agcy New Technol Energy & Sustainable Econ D, Frascati, Italy.	alessandro.lampasi@enea.it		Lampasi, Alessandro/0000-0003-4395-3496			Lampasi A, 2014, FUSION ENG DES, V89, P342, DOI 10.1016/j.fusengdes.2014.02.080; Yamauchi K, 2013, PLASMA SCI TECHNOL, V15, P148, DOI 10.1088/1009-0630/15/2/14; Di Pietro E, 2014, FUSION ENG DES, V89, P2128, DOI 10.1016/j.fusengdes.2013.11.015; Roshal A, 2011, FUSION ENG DES, V86, P1450, DOI 10.1016/j.fusengdes.2011.01.032; Neumeyer C., 2013, 2013 IEEE 25 S FUS E, P1; Novello L, 2015, FUSION ENG DES, V98-99, P1122, DOI 10.1016/j.fusengdes.2015.06.014	6	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1098	1102		10.1016/j.fusengdes.2015.06.177		5	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900014		
J	Maistrello, A; Gaio, E; Novello, L; Matsukawa, M; Yamauchi, K				Maistrello, Alberto; Gaio, Elena; Novello, Luca; Matsukawa, Makoto; Yamauchi, Kunihito			Analyses of the impact of connections' layout on the coil transient voltage at the Quench Protection Circuit intervention in JT-60SA	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Quench Protection Circuit; dc current interruption; Layout optimization		The transient overvoltages associated to the interruption of high direct currents with high current derivative, at the base of the operation of a Quench Protection System for Superconducting Coils, have been studied, with particular reference to the JT-60SA project, which adopt edge technology solutions for current interruption: a Hybrid mechanical-static Circuit Breaker as main circuit breaker in series with a PyroBreaker as backup protection. The paper reports in particular on the analyses of the intervention of the backup circuit breaker in the final circuital conditions, considering the actual power connections that will be implemented on Site. The key elements which influence the peak value of the voltage and the relation existing among the different stray impedances of the circuit are identified, thus giving general guidelines for the design of the layout of the power connections. The specific case of JT-60SA is considered, but general criteria can be derived. (C) 2015 Elsevier B.V. All rights reserved.	[Maistrello, Alberto; Gaio, Elena] Consorzio RFX, Padua, Italy; [Novello, Luca] Fus Energy, Broader Dev Fus Dept, Garching, Germany; [Matsukawa, Makoto; Yamauchi, Kunihito] Japan Atom Energy Agcy, Naka Fus Inst, Naka, Ibaraki 3110193, Japan	Maistrello, A (reprint author), Consorzio RFX, Padua, Italy.	alberto.maistrello@igi.cnr.it					Gaio E, 2013, FUSION ENG DES, V88, P563, DOI 10.1016/j.fusengdes.2013.02.083; Gaio E, 2012, IEEE T PLASMA SCI, V40, P557, DOI 10.1109/TPS.2011.2171008; Manzuk M, 2013, FUSION ENG DES, V88, P1537, DOI 10.1016/j.fusengdes.2013.01.006; Maistrello, 2014, IEEE T APPL SUPERCON, V24	4	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1109	1112		10.1016/j.fusengdes.2015.06.020		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900016		
J	Matsunaga, G; Takechi, M; Sakurai, S; Suzuki, Y; Ide, S; Urano, H				Matsunaga, G.; Takechi, M.; Sakurai, S.; Suzuki, Y.; Ide, S.; Urano, H.			In-vessel coils for magnetic error field correction in JT-60SA	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		JT-60SA; Error field; Resonant magnetic perturbation	SYSTEM	We have designed in-vessel coils for a correction of magnetic error fields in JT-60SA. In order to design the in-vessel coils, namely, error field correction coils (EFCCs), error fields from several sources such as manufacturing and assembly errors of superconducting coils are calculated by Monte-Carlo approach. Required EFCC currents to correct error fields are evaluated by a least square method. Additionally, by the field line tracing, it is found that resonant magnetic perturbations (RMPs) by the EFCC enable to produce stochastic magnetic structures at the edge region, that is applicable to an ELM control. (C) 2015 Elsevier B.V. All rights reserved.	[Matsunaga, G.; Takechi, M.; Sakurai, S.; Ide, S.; Urano, H.] Japan Atom Energy Agcy, Naka, Ibaraki, Japan; [Suzuki, Y.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan	Matsunaga, G (reprint author), Japan Atom Energy Agcy, Naka, Ibaraki, Japan.	matsunaga.go@jaea.go.jp					Ikeda Y, 2007, FUSION ENG DES, V82, P791, DOI 10.1016/j.fusengdes.2007.05.077; Shimada M, 2007, NUCL FUSION, V47, pS1, DOI 10.1088/0029-5515/47/6/S01; Ishida S, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/9/094018; Park JK, 2008, NUCL FUSION, V48, DOI 10.1088/0029-5515/48/4/045006; Hender TC, 2007, NUCL FUSION, V47, pS128, DOI 10.1088/0029-5515/47/6/S03; Evans TE, 2005, NUCL FUSION, V45, P595, DOI 10.1088/0029-5515/45/7/007; Kamada Y, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/7/073011; Knaster J, 2011, FUSION ENG DES, V86, P1053, DOI 10.1016/j.fusengdes.2011.02.045; Suzuki Y., 2014, P 25 IAEA FUS EN C 1	9	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1113	1117		10.1016/j.fusengdes.2015.06.024		5	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900017		
J	Novello, L; Baulaigue, O; Coletti, A; Dumas, N; Ferro, A; Gaio, E; Lampasi, A; Maistrello, A; Matsukawa, M; Shimada, K; Yamauchi, K; Zito, P				Novello, Luca; Baulaigue, Olivier; Coletti, Alberto; Dumas, Nicolas; Ferro, Alberto; Gaio, Elena; Lampasi, Alessandro; Maistrello, Alberto; Matsukawa, Makoto; Shimada, Katsuhiro; Yamauchi, Kunihito; Zito, Pietro			Overview of the new Magnet Power Supply Systems of JT-60SA procured by EU	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		JT-60SA; Power Supply; ac-dc converter; dc current interruption; Inverter	DESIGN	JT-60SA, the superconducting tokamak under construction in Japan, will be equipped with a mix of new and reused Power Supply Systems. Most of the new Power Supply Systems are procured by European Voluntary Contributors under the framework of Broader Approach agreement between Europe and Japan. For the toroidal circuit, the 25.7 kA steady state ac/dc converter is procured by CEA. For the poloidal circuits, the procurement of 10 ac/dc converters, almost all rated +/- 20 kA and about +/- 1 kV is shared between CEA and ENEA. The two in-vessel coils for fast control of plasma position are supplied with two independent thyristor converters procured by ENEA, each one rated +/- 5 kA and +/- 1 kV. The operation of four Switching Network Units procured by ENEA inserts settable resistors in series to each Central Solenoid module, producing up to 5 kV at the nominal current of 20 kA and allowing stable plasma initiation. The protection of toroidal and poloidal superconducting magnets is assured by thirteen Quench Protection Circuits procured by Consorzio RFX, rated +/- 20 kA and +/- 3.8 kV for poloidal coils and 25.7 kA and 2.8 kV for toroidal ones, inserting a discharge resistor in the related circuit for fast dissipation of the magnetic energy stored in the coil. Finally, the suppression of Resistive Wall Modes is actively performed by 18 in-vessel coils, independently supplied by a corresponding number of fast inverters procured by Consorzio RFX, each one rated for 300A and 240V. The key aspects of the design of the aforementioned Power Supply Systems are described in the paper, informing also about the present status of the procurement: their design was completed and some systems were already manufactured, tested and delivered to Japan. (C) 2015 Elsevier B.V. All rights reserved.	[Novello, Luca; Coletti, Alberto] Fus Energy, Garching, Germany; [Baulaigue, Olivier; Dumas, Nicolas] CEA Cadarache, IRFM, F-13108 St Paul Les Durance, France; [Ferro, Alberto; Gaio, Elena; Maistrello, Alberto] Consorzio RFX, Padua, Italy; [Lampasi, Alessandro; Zito, Pietro] ENEA, Frascati, Italy; [Matsukawa, Makoto; Shimada, Katsuhiro; Yamauchi, Kunihito] JAEA, Naka, Ibaraki, Japan	Novello, L (reprint author), Fus Energy, Garching, Germany.	luca.novello@jt60sa.org		Lampasi, Alessandro/0000-0003-4395-3496			Lampasi A, 2014, FUSION ENG DES, V89, P342, DOI 10.1016/j.fusengdes.2014.02.080; Gaio E, 2013, FUSION ENG DES, V88, P563, DOI 10.1016/j.fusengdes.2013.02.083; Ferro A, 2013, FUSION ENG DES, V88, P1509, DOI 10.1016/j.fusengdes.2013.01.094; Coletti A, 2011, FUSION ENG DES, V86, P1373, DOI 10.1016/j.fusengdes.2011.02.042; Gaio E, 2012, IEEE T PLASMA SCI, V40, P557, DOI 10.1109/TPS.2011.2171008; Di Pietro E, 2014, FUSION ENG DES, V89, P2128, DOI 10.1016/j.fusengdes.2013.11.015; Benfatto I., 1995, 16 S FUS ENG SOFE; Ferro A., 2014, 28 S FUS TECHN SOFT; Lampasi A., 2014, 28 S FUS TECHN SOFT; Zito P., 2014, 28 S FUS TECHN SOFT	10	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1122	1126		10.1016/j.fusengdes.2015.06.014		5	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900019		
J	Zito, P; Lampasi, A; Coletti, A; Novello, L; Matsukawa, M; Shimada, K; Cinarelli, D; Portesine, M; Dorronsoro, A; Vian, D				Zito, P.; Lampasi, A.; Coletti, A.; Novello, L.; Matsukawa, M.; Shimada, K.; Cinarelli, D.; Portesine, M.; Dorronsoro, A.; Vian, D.			Design and realization of JT-60SA Fast Plasma Position Control Coils power supplies	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		JT-60SA; Power supply; AC/DC converter; In vessel coil		Fast Plasma Position Control Coils (FPPCC) PSs control the vertical position of the plasma during a plasma shot, to prevent Vertical Displacement Event (VDE), using FPPC coils installed in vacuum vessel for JT-60SA. For this task, the FPPCC PSs have to be very fast for reacting to plasma movements. Further, an open loop feed forward voltage control is adopted in order to achieve a fast control of FPPCC PSs. The main characteristics are: 4-quadrant AC/DC converter 12-pulse with circulating current, DC load voltage +/- 1000 V and DC load current +/- 5 kA. The overvoltage induced by FPPC coil during a plasma disruption can reach 10 kV and it is protected by a nonlinear resistor in parallel to the crowbar up to its intervention. All these technical characteristics have strongly influenced the design of the FPPCC converter and transformers which have been validated by simulation model of FPPCC PS. The outcomes of the simulation allowed to finalize the performances and dynamic behavior of voltage response. (C) 2015 Elsevier B.V. All rights reserved.	[Zito, P.; Lampasi, A.] Natl Agcy New Technol Energy & Sustainable Econ D, I-00044 Frascati, Italy; [Coletti, A.; Novello, L.] Fus Energy F4E Broader Fus Dev Dept, Garching, Germany; [Matsukawa, M.; Shimada, K.] Japan Atom Energy Agcy, Naka Fus Inst, Naka, Ibaraki 3110193, Japan; [Cinarelli, D.; Portesine, M.] POSEICO, I-16152 Genoa, Italy; [Dorronsoro, A.; Vian, D.] JEMA, Lasarte Oria Gipuzkoa 20160, Spain	Zito, P (reprint author), Natl Agcy New Technol Energy & Sustainable Econ D, Via E Fermi 45, I-00044 Frascati, Italy.	pietro.zito@enea.it		Lampasi, Alessandro/0000-0003-4395-3496			Shimada K, 2011, FUSION ENG DES, V86, P1427, DOI 10.1016/j.fusengdes.2011.02.097; Jin JK, 2013, IEEE T PLASMA SCI, V41, P1799, DOI 10.1109/TPS.2013.2263299; Huang H., 2013, IEEE T APPL SUPERCON, V23; Novello L., 2014, SOFT C; Novello L., 2011, FUSION ENG DES, V86; Song I., 2014, IEEE T APPL SUPERCON, V24	6	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1191	1196		10.1016/j.fusengdes.2015.05.069		6	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900033		
J	Ezato, K; Suzuki, S; Seki, Y; Mohri, K; Yokoyama, K; Escourbiac, F; Hirai, T; Kuznetcov, V				Ezato, K.; Suzuki, S.; Seki, Y.; Mohri, K.; Yokoyama, K.; Escourbiac, F.; Hirai, T.; Kuznetcov, V.			Progress of ITER full tungsten divertor technology qualification in Japan	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		ITER; Divertor; Outer target; Tungsten monoblock; High heat flux test		Japan Atomic Energy Agency (JAEA) is in progress for technology qualification toward full-tungsten (W) ITER divertor outer vertical target (OVT), especially, tungsten monoblock technology that needs to withstand the repetitive heat load as high as 20 MW/m(2). To demonstrate the armor heat sink bonding technology and heat removal capability, 6 small-scale W monoblock mock-ups manufactured by different bonding technologies using different W materials in addition to 4 full-scale prototype plasma-facing units (PFUs). After non-destructive test, the W components were tested under high heat flux (HHF) in ITER Divertor Test Facility (IDTF) at NIIEFA. Consequently, all of the W monoblocks endured the repetitive heat load at 20MW/m(2) for 1000 cycles (requirements 20 MW/m(2) for 300 cycles) without any failure. In addition to the armor to heat sink joints, the load carrying capability test on the W monoblock with a leg attachment was carried out. In uniaxial tensile test, all of the W monoblock attachments with different bonding technologies such as brazing and HIPping withstand the tensile load exceeding 20 kN that is the value more than twice the design value. The failures occurred at the leg attachments or the W monoblocks, rather than the bonding interface of the W monoblocks to the leg attachment. (C) 2015 Elsevier B.V. All rights reserved.	[Ezato, K.; Suzuki, S.; Seki, Y.; Mohri, K.; Yokoyama, K.] Japan Atom Energy Agcy, Naka, Ibaraki, Japan; [Escourbiac, F.; Hirai, T.] ITER Org, F-13067 St Paul Les Durance, France; [Kuznetcov, V.] DV Efremov Sci Res Inst Electrophys Apparatus, St Petersburg 196641, Russia	Ezato, K (reprint author), Japan Atom Energy Agcy, 801-1 Mukoyma, Naka, Ibaraki, Japan.	ezato.koichiro@jaea.go.jp					Hirai T, 2014, PHYS SCRIPTA, VT159, DOI 10.1088/0031-8949/2014/T159/014006; Hirai T, 2013, FUSION ENG DES, V88, P1798, DOI 10.1016/j.fusengdes.2013.05.010; Kuznetsov V, 2014, FUSION ENG DES, V89, P955, DOI 10.1016/j.fusengdes.2014.04.064; Pintuk G., CHARACTERIZATION ITE	4	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1281	1284		10.1016/j.fusengdes.2015.03.009		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900051		
J	Gwon, H; Matsuda, S; Kasada, R; Konishi, S				Gwon, Hyoseong; Matsuda, Shinzaburo; Kasada, Ryuta; Konishi, Satoshi			Evaluation of thermal structural behavior of divertor under ELM	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		ELM; Critical ELM energy flux; Thermal stress		In this study, a YAG laser was used to simulate the transient heat load like ELM for the tungsten target, and the experiment results were compared with the analysis results by using finite element method. Average of total heat flux, ELM energy flux, and pulse width of ELM was considered as parameters in the analysis. Based on the results the thermal structural behavior of tungsten target under ELM was evaluated. When approximately 0.25 MJ/m(2) of ELM energy flux was applied, crack, and plastic deformation occurred at the tungsten surface even though recrystallization was not confirmed. It implied that the tungsten target could be damaged by thermal stress even at below 0.5 MJ/m(2). In addition the crack propagation under ELM was also investigated in this study. (C) 2015 Elsevier B.V. All rights reserved.	[Gwon, Hyoseong; Matsuda, Shinzaburo; Kasada, Ryuta; Konishi, Satoshi] Kyoto Univ, Inst Adv Energy, Kyoto, Japan; [Matsuda, Shinzaburo] Tokyo Inst Technol, Tokyo 152, Japan	Gwon, H (reprint author), Kyoto Univ, Inst Adv Energy, Kyoto, Japan.	gwonhs0213@gmail.com					Pitts RA, 2011, J NUCL MATER, V415, pS957, DOI 10.1016/j.jnucmat.2011.01.114; Oyama N, 2007, PLASMA PHYS CONTR F, V49, P249, DOI 10.1088/0741-3335/49/3/005; Zhitlukhin A, 2007, J NUCL MATER, V363, P301, DOI 10.1016/j.jnucmat.2007.01.027; Eich T, 2013, J NUCL MATER, V438, pS72, DOI 10.1016/j.jnucmat.2013.01.011; Federici G., 2003, PLASMA PHYS CONTROL, V45; Gludovatz B., 2010, INT J REFRACT METALS, V28; Holman JP, 2011, HEAT TRANSFER; Kirk A., 2008, J PHYS C SER, V123; Linke J., 2011, NUCL FUSION, V51; Pleli I., 2006, ANN REPORT ASS FORSC; Raffray A. R., 1999, FUSION ENG DES, V45; Smid I., 1998, J NUCL MATER, V25, P258; Tada H., 1973, STRESS ANAL CRACKS H; van Eden G. G., 2014, NUCL FUSION, V54; Wirtz M., 2013, J NUCL MAT, V438; Zohm H, 1996, PLASMA PHYS CONTR F, V38, P105, DOI 10.1088/0741-3335/38/2/001	16	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1318	1322		10.1016/j.fusengdes.2015.02.015		5	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900059		
J	Uehara, K; Katayama, K; Date, H; Fukada, S				Uehara, Keiichiro; Katayama, Kazunari; Date, Hiroyuki; Fukada, Satoshi			Hydrogen gas driven permeation through tungsten deposition layer formed by hydrogen plasma sputtering	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		D-T fusion reactor; Tungsten deposition; Sputtering; Hydrogen permeation; Hydrogen isotope	DEUTERIUM; BEHAVIOR; ISOTOPES; NICKEL	It is important to evaluate the influence of deposition layers formed on plasma facing wall on tritium permeation and tritium retention in the vessel of a fusion reactor from a viewpoint of safety. In this work, tungsten deposition layers having different thickness and porosity were formed on circular nickel plates by hydrogen RF plasma sputtering. Hydrogen permeation experiment was carried out at the temperature range from 250 degrees C to 500 degrees C and at hydrogen pressure range from 1013 Pa to 101,300 Pa. The hydrogen permeation flux through the nickel plate with tungsten deposition layer was significantly smaller than that through a bare nickel plate. This indicates that a rate-controlling step in hydrogen permeation was not permeation through the nickel plate but permeation though the deposition layer. The pressure dependence on the permeation flux differed by temperature. Hydrogen permeation flux through tungsten deposition layer is larger than that through tungsten bulk. From analysis of the permeation curves, it was indicated that hydrogen diffusivity in tungsten deposition layer is smaller than that in tungsten bulk and the equilibrium hydrogen concentration in tungsten deposition layer is enormously larger than that in tungsten bulk at same hydrogen pressure. (C) 2015 Elsevier B.V. All rights reserved.	[Uehara, Keiichiro; Katayama, Kazunari; Date, Hiroyuki; Fukada, Satoshi] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 8168580, Japan	Katayama, K (reprint author), Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, 6-1 Kasuga Koen, Kasuga, Fukuoka 8168580, Japan.	kadzu@nucl.kyushu-u.ac.jp					Esteban GA, 2001, J NUCL MATER, V295, P49, DOI 10.1016/S0022-3115(01)00486-X; Katayama K, 2008, FUSION SCI TECHNOL, V54, P549; Nakamura H, 2001, J NUCL MATER, V297, P285, DOI 10.1016/S0022-3115(01)00635-3; Shiraishi T, 1998, J NUCL MATER, V254, P205, DOI 10.1016/S0022-3115(97)00362-0; Nemanic V, 2012, J NUCL MATER, V429, P92, DOI 10.1016/j.jnucmat.2012.05.031; Chikada T., 2011, NUCL FUSION, V9, P1; FRAUENFE.R, 1968, J CHEM PHYS, V48, P3955, DOI 10.1063/1.1669720; Ishikawa S, 2012, FUSION ENG DES, V87, P1390, DOI 10.1016/j.fusengdes.2012.03.021; Katayama K, 2013, J NUCL MATER, V438, pS1010, DOI 10.1016/j.jnucmat.2013.01.220; Nemanic V, 2014, J VAC SCI TECHNOL A, V32, DOI 10.1116/1.4898061; ROBERTSO.WM, 1973, Z METALLKD, V64, P436; Zakharov A.P., 1973, SOV MATER SCI, V9, P149	12	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1341	1344		10.1016/j.fusengdes.2015.01.027		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900064		
J	Tsuru, D; Sakurai, S; Nakamura, S; Ozaki, H; Seki, Y; Yokoyama, K; Suzuki, S				Tsuru, Daigo; Sakurai, Shinji; Nakamura, Shigetoshi; Ozaki, Hidetsugu; Seki, Yohji; Yokoyama, Kenji; Suzuki, Satoshi			Development of residual thermal stress-relieving structure of CFC monoblock target for JT-60SA divertor	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		CFC monoblock target; Vacuum brazing; Residual thermal stress; Numerical simulation; Infrared thermography inspection; High heat flux test		Carbon fibre-reinforced carbon composite (CFC) monoblock target for JT-60SA divertor is under development towards the mass-production. CFC monoblocks, WCu interlayers and a CuCrZr cooling tube at the centre of the monoblocks were bonded by vacuum brazing in a high temperature, to a target. If residual thermal stress due to difference of thermal expansions between CFC and CuCrZr exceeds the maximum allowable stress of the CFC after the bonding, cracks are generated in the CFC monoblock and heat removal capacity of the target degrades. In this paper, new structures of the targets were proposed, to reduce residual thermal stress and to mitigate the degradation of heat removal capacity of the targets. Some measures, including slitting of the CFC monoblock aside of the cooling tube, replacement of the interlayer material and shifting the position of the cooling tube, were implemented. The effectiveness of the measures was evaluated by numerical simulations. Target mock-ups with the proposed structures were manufactured. Infrared thermography inspection and high heat flux test were carried out on the mock-ups in order to evaluate the heat removal capacity. (C) 2015 Elsevier B.V. All rights reserved.	[Tsuru, Daigo; Sakurai, Shinji; Nakamura, Shigetoshi; Ozaki, Hidetsugu; Seki, Yohji; Yokoyama, Kenji; Suzuki, Satoshi] Japan Atom Energy Agcy, Tokyo, Japan	Tsuru, D (reprint author), Japan Atom Energy Agcy, Tokyo, Japan.	tsuru.daigo@jaea.go.jp					Nakamura S, 2014, FUSION ENG DES, V89, P1024, DOI 10.1016/j.fusengdes.2014.02.067; Masaki K, 2002, FUSION ENG DES, V61-62, P171, DOI 10.1016/S0920-3796(02)00115-1; Ishida S, 2010, FUSION ENG DES, V85, P2070, DOI 10.1016/j.fusengdes.2010.07.027; Seki Y, 2010, FUSION ENG DES, V85, P1451, DOI 10.1016/j.fusengdes.2010.04.010; Ezato K, 2012, FUSION ENG DES, V87, P1177, DOI 10.1016/j.fusengdes.2012.02.094; Sakurai S., 2010, P 23 INT C FUS EN	6	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1403	1406		10.1016/j.fusengdes.2015.02.052		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900078		
J	Kim, GH; Park, CK; Ahn, HJ; Kim, HS; Hong, KH; Jin, SW; Lee, HG; Fukanuma, H; Huang, R; Roh, BR; Kim, TS; Sung, HJ; Sa, JW; Choi, CH				Kim, G. H.; Park, C. K.; Ahn, H. J.; Kim, H. S.; Hong, K. H.; Jin, S. W.; Lee, H. G.; Fukanuma, H.; Huang, R.; Roh, B. R.; Kim, T. S.; Sung, H. J.; Sa, J. W.; Choi, C. H.			Fabrication feasibility study on copper cold spray in tokamak system	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Tokamak; Copper coating; Cold spray; Overlay welding; Plasma stabilization		To improve the plasma vertical stabilization during tokamak operation, partial pure copper layer could be considered on the inner shell of vacuum vessel which is large complex component made of stainless steel. The copper cladding has been a great challenge due to the complicated configuration and difficulty of dissimilar metal joining. From an engineering point of view, there are several candidates for the copper cladding such as cold spray, overlay welding and explosive welding. In this paper, fabrication feasibility study for copper cladding has been carried out by using cold spray method, and a set of full scale mock-up of in-vessel component has been conducted to demonstrate applicability of copper cold spray and to verify copper layer. The results of copper cold spray on test specimens and mock-up showed good properties and no defects on the thick copper layer. Optimum conditions of copper cold spray have been developed based on these results. Accordingly, it can be concluded that cold spray is a feasible and practical method to achieve thick copper cladding on tokamak component. (C) 2015 Elsevier B.V. All rights reserved.	[Kim, G. H.; Park, C. K.; Ahn, H. J.; Kim, H. S.; Hong, K. H.; Jin, S. W.; Lee, H. G.] ITER Korea, Natl Fus Res Inst, Daejeon 305333, South Korea; [Fukanuma, H.; Huang, R.] Plasma Giken Co Ltd, Saitama 3691214, Japan; [Roh, B. R.; Kim, T. S.; Sung, H. J.] Hyundai Heavy Ind Co Ltd, Ulsan 682792, South Korea; [Sa, J. W.; Choi, C. H.] ITER Org, F-13067 St Paul Les Durance, France	Park, CK (reprint author), ITER Korea, Natl Fus Res Inst, Daejeon 305333, South Korea.	ckpark@nfri.re.kr					Kim BC, 2013, FUSION ENG DES, V88, P1960, DOI 10.1016/j.fusengdes.2013.01.012; Karthikeyan J., 2013, ASM HDB, V5A, P54; loki K., 2009, FUS ENG DES, V84, P229; Portone A., COMMUNICATION	4	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1576	1579		10.1016/j.fusengdes.2015.06.134		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900116		
J	Shibama, Y; Okano, F; Yagyu, J; Kaminaga, A; Miyo, Y; Hayakawa, A; Sagawa, K; Mochida, T; Morimoto, T; Hamada, T; Minemura, T; Yoneta, D; Ogawa, H; Mizumaki, S; Okuyama, T; Nobuoka, Y; Asano, S; Masaki, K; Sakasai, A				Shibama, Yusuke; Okano, Fuminori; Yagyu, Junnichi; Kaminaga, Atsushi; Miyo, Yasuhiko; Hayakawa, Atsuro; Sagawa, Keiich; Mochida, Tsutomu; Morimoto, Tamotsu; Hamada, Takashi; Minemura, Toshiyuki; Yoneta, Daiki; Ogawa, Hiromichi; Mizumaki, Shoichi; Okuyama, Toshihisa; Nobuoka, Yoshishige; Asano, Shiro; Masaki, Kei; Sakasai, Akira			Welding technology on sector assembly of the JT-60SA vacuum vessel	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Vacuum vessel; Onsite assembly; Root gap; Linear misalignment; Plastic deformation; JT-60SA		Manufacturing of JT-60SA Vacuum Vessel (VV) is under the onsite sector assembly, where ten W sectors are to be welded together into a torus. The vessel is 6.6 m height and 5 m major radius and a double wall structure with the thickness of 18 mm and locally 30 mm, and total dimensional tolerance is designed to avoid any interference due to operational displacements. In this paper, two issues are focused: the onsite sector assembly concept and sector welding technology. The assembly concept is a contrivance to fulfil high precision as a large torus W and efficient procedure, and obtained with combination of the direct butt joint and splice plate joint. The welding technology is a method to realize the VV, and investigated on acceptable error sizes with the test pieces for the onsite manipulator welding. Correction method of sector edge is also confirmed by the mock-up. Moreover, application to the onsite sector assembly is discussed. The onsite assembly has been started by this concept with its welding technology. (C) 2015 Elsevier B.V. All rights reserved.	[Shibama, Yusuke; Okano, Fuminori; Yagyu, Junnichi; Kaminaga, Atsushi; Miyo, Yasuhiko; Masaki, Kei; Sakasai, Akira] Japan Atom Energy Agcy, Naka, Ibaraki, Japan; [Hayakawa, Atsuro; Sagawa, Keiich; Mochida, Tsutomu; Morimoto, Tamotsu; Hamada, Takashi; Minemura, Toshiyuki; Mizumaki, Shoichi; Okuyama, Toshihisa; Asano, Shiro] Toshiba Co Ltd, Isogo Ku, Yokohama, Kanagawa, Japan; [Yoneta, Daiki; Ogawa, Hiromichi; Nobuoka, Yoshishige] Toshiba Plant Syst & Serv Corp, Isogo Ku, Yokohama, Kanagawa, Japan	Shibama, Y (reprint author), Japan Atom Energy Agcy, Naka, Ibaraki, Japan.	shibama.yusuke@jaea.go.jp					Medrano M, 2013, FUSION ENG DES, V88, P711, DOI 10.1016/j.fusengdes.2013.01.028; Asano S, 2011, FUSION ENG DES, V86, P1816, DOI 10.1016/j.fusengdes.2011.03.024; Ishida S, 2010, FUSION ENG DES, V85, P2070, DOI 10.1016/j.fusengdes.2010.07.027; Shibanuma K, 2013, FUSION ENG DES, V88, P705, DOI 10.1016/j.fusengdes.2012.12.011; Di Pietro E, 2014, FUSION ENG DES, V89, P2128, DOI 10.1016/j.fusengdes.2013.11.015; Masaki K, 2012, FUSION ENG DES, V87, P742, DOI 10.1016/j.fusengdes.2012.02.014; Sakasai A., 2012, P 24 IAEA FUS EN C S	7	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1614	1619		10.1016/j.fusengdes.2015.06.072		6	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900125		
J	Tamura, H; Tanaka, T; Goto, T; Miyazawa, J; Masuzaki, S; Watanabe, T; Yanagi, N; Sagara, A; Ito, S; Hashizume, H				Tamura, Hitoshi; Tanaka, Teruya; Goto, Takuya; Miyazawa, Junich; Masuzaki, Suguru; Watanabe, Tsuguhiro; Yanagi, Nagato; Sagara, Akio; Ito, Satoshi; Hashizume, Hidetoshi			Novel divertor design to mitigate neutron irradiation in the helical reactor FFHR-d1	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Helical reactor; FFHR; Divertor; Irradiation; Superconducting magnet; Structural analysis	DEMO	The heat flux at the divertor in a fusion reactor is considered to have a peak of >10 MW/m(2). In a design study of the helical reactor FFHR-d1, the feasibility of employing a copper alloy for divertor cooling pipes was investigated; however, radiation in the divertor area would quickly damage the copper alloy. The neutron load on the divertor can be reduced by a blanket arrangement; nevertheless, in the present divertor structure, irradiation damage of materials on the inboard side of the torus remains relatively high. If the divertor could be moved to an area receiving much less radiation, then the lifetimes of divertor materials should increase. In this paper, a novel divertor structure is introduced in which the coil-support structure is modified to create a region receiving relatively low amounts of radiation without changing the geometry of the helical or vertical field coils. Using this proposed design would increase the lifetime of the copper alloy in divertor components to more than an estimated six years. In addition, the divertor could be accessed from either the upper or lower sides of the device, simplifying maintenance. (C) 2015 Elsevier B.V. All rights reserved.	[Tamura, Hitoshi; Tanaka, Teruya; Goto, Takuya; Miyazawa, Junich; Masuzaki, Suguru; Watanabe, Tsuguhiro; Yanagi, Nagato; Sagara, Akio] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Ito, Satoshi; Hashizume, Hidetoshi] Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 9808579, Japan	Tamura, H (reprint author), Natl Inst Nat Sci, Natl Inst Fus Sci, 322-6 Oroshicho, Toki, Gifu 5095292, Japan.	tamura@nifs.ac.jp					Tanaka T, 2014, FUSION ENG DES, V89, P1939, DOI 10.1016/j.fusengdes.2014.02.071; Sagara A, 2014, FUSION ENG DES, V89, P2114, DOI 10.1016/j.fusengdes.2014.02.076; Sagara A, 2012, FUSION ENG DES, V87, P594, DOI 10.1016/j.fusengdes.2012.01.030; Tamura H, 2014, FUSION ENG DES, V89, P2336, DOI 10.1016/j.fusengdes.2014.02.058; Yanagi N, 2014, IEEE T APPL SUPERCON, V24, DOI 10.1109/TASC.2013.2292775; EDWARDS DJ, 1992, J NUCL MATER, V191, P416; Yanagi N, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/10/103017; Chida Y, 2011, FUSION ENG DES, V86, P2900, DOI 10.1016/j.fusengdes.2011.06.004; Li-Puma A, 2013, FUSION ENG DES, V88, P1836, DOI 10.1016/j.fusengdes.2013.05.114; GOURDON C, 1971, NUCL FUSION, V11, P161; Ito S., 2014, APPL SUP C AUG 10 15; Yanagi N., 2012, 24 FUS EN C SAN DIEG	12	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1629	1633		10.1016/j.fusengdes.2015.01.025		5	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900128		
J	Tanigawa, H; Maruyama, T; Noguchi, Y; Takeda, N; Kakudate, S				Tanigawa, Hisashi; Maruyama, Takahito; Noguchi, Yuto; Takeda, Nobukazu; Kakudate, Satoshi			Laser welding to expand the allowable gap in bore welding for ITER blanket hydraulic connection	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Remote handling; Maintenance; Re-welding; Irradiated materials; Tool lifetime		For application to bore welding of hydraulic connection in the ITER blanket module, laser welding presents the following benefits: low weld heat input is preferred for re-welding of the irradiated material. Its contactless process can intrinsically avoid a failure mode of the tool sticking on the weld. The exact requirements for pipe alignment were assessed in comparison with the assembly tolerance. The groove geometry was modified to expand the allowable initial gap. The groove was machined to be partially thick to obviate the filler wire. First, plates with partially thick grooves were welded to elucidate the preferred groove geometry and welding conditions. With the modified groove, the plates were welded for the initial gap of 1.0 mm. Then the groove geometry and welding conditions were adjusted based on results of pipe welding tests. By application of the additional 0.5-mm-thick and 2.5-mm-wide metal in the groove, pipes with an initial gap of 0.7 mm were welded successfully. (C) 2015 Elsevier B.V. All rights reserved.	[Tanigawa, Hisashi; Maruyama, Takahito; Noguchi, Yuto; Takeda, Nobukazu; Kakudate, Satoshi] Japan Atom Energy Agcy, Naka, Ibaraki, Japan	Tanigawa, H (reprint author), Japan Atom Energy Agcy, 801-1 Mukoyama, Naka, Ibaraki, Japan.	tanigawa.hisashi@jaea.go.jp					Tanigawa H, 2012, FUSION ENG DES, V87, P999, DOI 10.1016/j.fusengdes.2012.02.055; Merola M, 2014, FUSION ENG DES, V89, P890, DOI 10.1016/j.fusengdes.2014.01.055	2	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1634	1637		10.1016/j.fusengdes.2015.06.155		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900129		
J	Utoh, H; Tobita, K; Someya, Y; Asakura, N; Sakamoto, Y; Hoshino, K; Nakamura, M				Utoh, Hiroyasu; Tobita, Kenji; Someya, Youji; Asakura, Nobuyuki; Sakamoto, Yoshiteru; Hoshino, Kazuo; Nakamura, Makoto			Comparative evaluation of remote maintenance schemes for fusion DEMO reactor	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Remote maintenance; DEMO; Segment; Sector transport; Fusion reactor	PLASMA VERTICAL POSITION; DESIGN	Maintenance schemes are one of the critical issues in DEMO design, significantly affecting the configuration of in-vessel components, the size of toroidal field (TF) coil, the arrangement of poloidal field (PF) coils, reactor building, hot cell and so forth. Therefore, the maintenance schemes should satisfy many design requirements and criteria to assure reliable and safe plant operation and to attain reasonable plant availability. The plant availability depends on reliability of remote maintenance scheme, inspection of pipe connection and plasma operation. In this paper, various remote maintenance schemes for DEMO were comparatively assessed based on requirements for DEMO remote maintenance. From the view points of the reliability of inspection on hot cell, TF coil size, stored energy of PF coil and portability of segment, the banana shape segment transport using all vertical maintenance ports would be more probable DEMO reactor maintenance scheme, and it has key engineering issues such as in-vessel transferring mechanism of segment, pipe connection and conducting shell design for plasma vertical stability. (C) 2015 Elsevier B.V. All rights reserved.	[Utoh, Hiroyasu; Tobita, Kenji; Someya, Youji; Asakura, Nobuyuki; Sakamoto, Yoshiteru; Hoshino, Kazuo; Nakamura, Makoto] Japan Atom Energy Agcy, Rokkasho, Japan	Utoh, H (reprint author), Japan Atom Energy Agcy, Rokkasho, Japan.	uto.hiroyasu@jaea.go.jp					Tobita K, 2011, FUSION ENG DES, V86, P2730, DOI 10.1016/j.fusengdes.2011.03.022; Maisonnier D, 2008, FUSION ENG DES, V83, P858, DOI 10.1016/j.fusengdes.2008.05.014; KASAI M, 1988, FUSION ENG DES, V5, P343; Ihli T, 2007, FUSION ENG DES, V82, P2705, DOI 10.1016/j.fusengdes.2007.02.034; NISHIO S, 1993, FUSION ENG DES, V23, P17, DOI 10.1016/0920-3796(93)90107-S; Utoh H, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/12/123005; KAMEARI A, 1985, NUCL ENG DES FUSION, V2, P365, DOI 10.1016/0167-899X(85)90024-2; Nagy D, 2008, FUSION ENG DES, V83, P1870, DOI 10.1016/j.fusengdes.2008.05.033; Tobita K, 2006, FUSION ENG DES, V81, P1151, DOI 10.1016/j.fusengdes.2005.08.058; Tobita K, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/7/075029	10	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1648	1651		10.1016/j.fusengdes.2015.06.139		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900132		
J	Hoshino, T				Hoshino, Tsuyoshi			Optimization of sintering conditions of advanced tritium breeder pebbles fabricated by the emulsion method	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Advanced tritium breeder; Pebble fabrication technique; Mass production; Li2TiO3; Li2TiO3 with excess Li	LI2TIO3; BLANKET; ITER	Demonstration power plant (DEMO) reactors require advanced tritium breeders with high thermal stability. Li2TiO3 with excess Li (Li2+x TiO3+y) has been developed as a material for an advanced tritium breeder. Considering the tritium release characteristics and the packing factor of the blanket, the optimum pebble diameter and grain size after sintering were determined to be 1 mm and <5 mu m, respectively. Therefore, optimum sintering conditions were surveyed in-the present study to obtain these target values. The predominant factor affecting grain growth is assumed to be the presence of binder in the gel particles. This remaining binder reacts with the excess Li in the Li2+x TiO3+y and Li2CO3 is generated, which promotes grain growth. To inhibit the generation of Li2CO3, calcined Li2+xTiO3+y pebbles were sintered under vacuum and subsequent 1% H-2-He atmosphere conditions. The diameter of the sintered Li2+xTiO3+y pebbles was 1.07 mm, and the average grain size on the surfaces and cross sections was <5 mu m. The results presented show that Li2+xTiO3+y, pebbles with optimum characteristics were successfully fabricated using the emulsion method. (C) 2015 Elsevier B.V. All rights reserved.	Japan Atom Energy Agcy, Breeding Funct Mat Dev Grp, Sector Fus Res & Dev, Rokkasho Fus Inst,Dept Blanket Syst Res, Rokkasho, Aomori 0393212, Japan	Hoshino, T (reprint author), Japan Atom Energy Agcy, Breeding Funct Mat Dev Grp, Sector Fus Res & Dev, Rokkasho Fus Inst,Dept Blanket Syst Res, 2-166 Obuch, Rokkasho, Aomori 0393212, Japan.	hoshino.tsuyoshi@jaea.go.jp					Kleykamp H, 2002, FUSION ENG DES, V61-62, P361, DOI 10.1016/S0920-3796(02)00120-5; Hoshino T, 2011, FUSION ENG DES, V86, P2172, DOI 10.1016/j.fusengdes.2011.01.065; Tanigawa H, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/5/055021; KOPASZ JP, 1994, J NUCL MATER, V212, P927, DOI 10.1016/0022-3115(94)90971-7; Giancarli L, 2007, J NUCL MATER, V367, P1271, DOI 10.1016/j.jnucmat.2007.03.234; Hoshino T, 2009, FUSION ENG DES, V84, P956, DOI 10.1016/j.fusengdes.2008.12.049; Hoshino T, 2007, FUSION ENG DES, V82, P2269, DOI 10.1016/j.fusengdes.2007.07.005; Hanada T, 2011, J NUCL MATER, V417, P735, DOI 10.1016/j.jnucmat.2010.12.130; Hoshino T, 2012, FUSION ENG DES, V87, P486, DOI 10.1016/j.fusengdes.2012.01.005; Roux N, 1998, FUSION ENG DES, V41, P31, DOI 10.1016/S0920-3796(97)00140-3; Roux N, 1996, J NUCL MATER, V233, P1431, DOI 10.1016/S0022-3115(96)00136-5; Hoshino T, 2002, FUSION ENG DES, V61-62, P353, DOI 10.1016/S0920-3796(02)00216-8; [Anonymous], 330831 PDF MAT DAT I	13	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1788	1791		10.1016/j.fusengdes.2015.04.023		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900164		
J	Isobe, K; Kawamura, Y; Iwai, Y; Oyaidzu, M; Nakamura, H; Suzuki, T; Yamada, M; Edao, Y; Kurata, R; Hayashi, T; Yamanishi, T				Isobe, Kanetsugu; Kawamura, Yoshinori; Iwai, Yasunori; Oyaidzu, Makoto; Nakamura, Hirofumi; Suzuki, Takumi; Yamada, Masayuki; Edao, Yuki; Kurata, Rie; Hayashi, Takumi; Yamanishi, Toshihiko			R&D activities of tritium technologies on Broader Approach in Phase 2-2	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Broader Approach; Tritium technology; Tritium accountancy; Tritium safety; Tritium durability	TRITIATED-WATER; PERMEATION; BEHAVIOR	Activities on Broader Approach (BA) were started in 2007. In Phase 2-2, many R&Ds, development of tritium accountancy technology, development of basic tritium safety research and tritium durability test, were implemented successfully by JAEA and Japanese Universities. In Phase 2-3, new collaborative study for tritium measurement and new R&D activities for JET ILW are started. R&D activities on BA have continued in Phase 2-3 (2014-2016). (C) 2015 Elsevier B.V. All rights reserved.	[Isobe, Kanetsugu; Kawamura, Yoshinori; Iwai, Yasunori; Oyaidzu, Makoto; Nakamura, Hirofumi; Suzuki, Takumi; Yamada, Masayuki; Edao, Yuki; Kurata, Rie; Hayashi, Takumi; Yamanishi, Toshihiko] Japan Atom Energy Agcy, Directorates Fus Energy Res, Tritium Technol Grp, Tokyo, Japan	Isobe, K (reprint author), Japan Atom Energy Agcy, Directorates Fus Energy Res, Tritium Technol Grp, Tokyo, Japan.	isobe.kanetsugu@jaea.go.jp					Iwai Y, 2013, FUSION ENG DES, V88, P2319, DOI 10.1016/j.fusengdes.2013.05.051; Nishitani T, 2011, J NUCL MATER, V417, P1331, DOI 10.1016/j.jnucmat.2010.12.304; Fukada S, 2013, FUSION SCI TECHNOL, V64, P636; Mao W, 2014, J NUCL MATER, V455, P360, DOI 10.1016/j.jnucmat.2014.06.063; Mao W, 2014, FUSION ENG DES, V89, P1294, DOI 10.1016/j.fusengdes.2014.03.019; Iwai Y, 2014, FUSION ENG DES, V89, P1534, DOI 10.1016/j.fusengdes.2014.02.018; WENDEL J, 1995, FUSION TECHNOL, V28, P1090; Oyaidzu M, 2013, ECS TRANSACTIONS, V50, P63, DOI 10.1149/05050.0063ecst; Oya M, 2015, J NUCL MATER, V463, P1037, DOI 10.1016/j.jnucmat.2014.11.124; Kawamura Y, 2013, FUSION ENG DES, V88, P2255, DOI 10.1016/j.fusengdes.2013.05.021; Oyaidzu M, 2015, FUSION SCI TECHNOL, V67, P519; Yamanishi T, 2013, FUSION ENG DES, V88, P2272, DOI 10.1016/j.fusengdes.2013.04.046; Engelmann U., 1997, P 4 INT S FUS NUCL T, P240; Hashizume K, 2013, J NUCL MATER, V442, pS880, DOI 10.1016/j.jnucmat.2013.05.038; Isobe K., 2013, J PLASMA FUSION RES, V10, P81; Otuka T., 2013, J NUCL MATER, V438, pS1048; Yamanishi T., 2008, FUSION SCI TECHNOL, V273, P45	17	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1792	1795		10.1016/j.fusengdes.2015.06.075		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900165		
J	Iwai, Y				Iwai, Yasunori			Upgrade in catalytic activity of hydrophobic platinum catalysts by irradiation with electron beams	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Tritium; Detritiation; Electron beams; Hydrophobic catalyst; Platinum; Reaction rate	OXIDATION; HYDROGEN; POLYMERS; OXYGEN	The development of hydrophobic platinum catalysts is important to realize the passive recombiner for fusion safety. The upgrade in catalytic activity of hydrophobic platinum catalysts is required since the catalysts generally decrease in catalytic activity with a decrease in temperature. To upgrade in catalytic activity of granular polymer supported hydrophobic platinum catalysts, application of irradiation with electron beams has demonstrated. After irradiation with electron beams, the catalytic activity was evaluated by means of assessing overall reaction rate constant for the oxidation of tritium. The overall reaction rate constant increased as increase in dose. The constant showed the peak value in the dose between 500 and 750 kGy. After the peak, the constant decreased as increase in dose. The overall reaction rate constant at the peak was 6 times larger than that evaluated with unirradiated. The mechanical strength of irradiated catalysts kept integrity until 1500 kGy. The irradiation is a promising method to the upgrading in catalytic activity of Pt/SDBC group catalysts. (C) 2015 Elsevier B.V. All rights reserved.	Japan Atom Energy Agcy, Tokai, Ibaraki 3191195, Japan	Iwai, Y (reprint author), Japan Atom Energy Agcy, Tokai, Ibaraki 3191195, Japan.	iwai.yasunori@jaea.go.jp					Oshima A, 1999, POLYM INT, V48, P996, DOI 10.1002/(SICI)1097-0126(199910)48:10<996::AID-PI260>3.0.CO;2-M; Uda T, 2012, FUSION ENG DES, V87, P900, DOI 10.1016/j.fusengdes.2012.02.040; SEGUCHI T, 1981, RADIAT PHYS CHEM, V17, P195, DOI 10.1016/0146-5724(81)90331-9; ARAKAWA K, 1983, J POLYM SCI POL CHEM, V21, P1173, DOI 10.1002/pol.1983.170210424; Iwai Y, 2011, J NUCL SCI TECHNOL, V48, P1184, DOI 10.3327/jnst.48.1184; NARUSE Y, 1990, FUSION ENG DES, V12, P293, DOI 10.1016/0920-3796(90)90003-O; Iwai Y, 2011, FUSION ENG DES, V86, P2164, DOI 10.1016/j.fusengdes.2011.04.028; Popescu I, 2005, FUSION SCI TECHNOL, V48, P108; Iwai Y, 2002, FUSION SCI TECHNOL, V41, P1126; Iwai Y, 2010, J PLASMA FUSION RES, V9, P332; Iwai Y., 2014, P 7 TOK C ADV CAT SC	11	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1796	1799		10.1016/j.fusengdes.2015.03.024		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900166		
J	Kasada, R; Kwon, S; Konishi, S; Sakamoto, Y; Yamanishi, T; Tobita, K				Kasada, Ryuta; Kwon, Saerom; Konishi, Satoshi; Sakamoto, Yoshiteru; Yamanishi, Toshihiko; Tobita, Kenji			A system dynamics model for stock and flow of tritium in fusion power plant	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Fusion reactor; Tritium; Fuel cycle; System dynamics	REACTORS	In order to analyze self-efficiency of tritium fuel cycle (TFC) and share the systems thinking of TFC among researchers and engineers in the vast area of fusion reactor technology, we develop a system dynamics (SD) TFC model using a commercial software STELLA. The SD-TFC model is illustrated as a pipe diagram which consists of tritium stocks, such as plasma, fuel clean up, isotope separation, fueling with storage and blanket, and pipes connecting among them. By using this model, we survey a possibility of D-D start-up without initial loading of tritium on two kinds of fusion plant having different plasma parameters. The D-D start-up scenario can reduce the necessity of initial loading of tritium through the production in plasma by D-D reaction and in breeding blanket by D-D neutron. The model is also used for considering operation scenario to avoid excess stock of tritium which must be produced at tritium breeding ratio over unity. (C) 2015 Elsevier B.V. All rights reserved.	[Kasada, Ryuta; Kwon, Saerom; Konishi, Satoshi] Kyoto Univ, Inst Adv Energy, Uji, Kyoto 6110011, Japan; [Kwon, Saerom] Japan Atom Energy Agcy, Tokai, Ibaraki 3191195, Japan; [Sakamoto, Yoshiteru; Yamanishi, Toshihiko; Tobita, Kenji] Japan Atom Energy Agcy, Rokkasho, Aomori 0393212, Japan	Kasada, R (reprint author), Kyoto Univ, Inst Adv Energy, Uji, Kyoto 6110011, Japan.	r-kasada@iae.kyoto-u.ac.jp					BOSCH HS, 1992, NUCL FUSION, V32, P611, DOI 10.1088/0029-5515/32/4/I07; El-Guebaly LA, 2009, FUSION ENG DES, V84, P2072, DOI 10.1016/j.fusengdes.2008.12.098; ABDOU MA, 1986, FUSION TECHNOL, V9, P250; Sakamoto Y, 2014, FUSION ENG DES, V89, P2440, DOI 10.1016/j.fusengdes.2014.04.032; Kuan W, 1999, FUSION TECHNOL, V35, P309; Tobita K, 2014, FUSION ENG DES, V89, P1870, DOI 10.1016/j.fusengdes.2014.02.077; Asaoka Y., 2000, 18 IAEA FUS EN C; Hiwatari R., 2010, IAEA FUS EN C DAEJ R, P446; Konishi S., 2000, J PLASMA FUSION RES, V76, P1309; Kwon S., 2013, 2013 IEEE 25 S FUS E; Tobita K, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/7/075029	11	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1804	1807		10.1016/j.fusengdes.2015.03.047		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900168		
J	Shimozori, M; Katayama, K; Hoshino, T; Ushida, H; Yamamoto, R; Fukada, S				Shimozori, Motoki; Katayama, Kazunari; Hoshino, Tsuyoshi; Ushida, Hiroki; Yamamoto, Ryotaro; Fukada, Satoshi			Water vapor concentration dependence and temperature dependence of Li mass loss from Li2TiO3 with excess Li and Li4SiO4	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		D-T fusion reactor; Tritium breeding ceramic; Li mass loss		In this study, weight reduction of Li2TiO3 with excess Li and Li4SiO4 at elevated temperatures under hydrogen atmosphere or water vapor atmosphere was investigated. The Li mass loss for the Li2TiO3 at 900 degrees C was 0.4 wt% under 1000 Pa H-2 atmosphere and 1.5 wt% under 50 Pa H2O atmosphere. The Li mass loss for the Li2TiO3 increased proportionally to the water vapor pressure in the range from 50 to 200 Pa at 900 degrees C and increased with increasing temperature from 700 to 900 degrees C although Li mass loss at 600 degrees C was significantly smaller than expected. It was found that water vapor concentration dependence and temperature dependence of Li mass loss for the Li2TiO3 and the Li4SiO4 used in this work were quite different. Water vapor is released from the ceramic breeder materials into the purge gas due to desorption of adsorbed water and water formation reaction. The released water vapor possibly promotes Li mass loss with the formation of LiOH on the surface. (C) 2015 Elsevier B.V. All rights reserved.	[Shimozori, Motoki; Katayama, Kazunari; Ushida, Hiroki; Yamamoto, Ryotaro; Fukada, Satoshi] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 8168580, Japan; [Hoshino, Tsuyoshi] Japan Atom Energy Agcy, Sect Fus Res & Dev, Breeding Funct Mat Dev Grp, Dept Blanket Syst Res,Rokkasho Fus Inst, Rokkasho, Aomori 0393212, Japan	Katayama, K (reprint author), Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, 6-1 Kasugakoen, Kasuga, Fukuoka 8168580, Japan.	kadzu@nucl.kyushu-u.ac.jp					TERAI T, 1991, J NUCL MATER, V179, P808, DOI 10.1016/0022-3115(91)90211-O; Katayama K, 2012, FUSION ENG DES, V87, P927, DOI 10.1016/j.fusengdes.2012.02.050; Kashimura H., 2013, J PLASMA FUSION RES, V10, P18; Kashimura H., 2013, FUSION ENG DES, V88, P2022	4	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1808	1811		10.1016/j.fusengdes.2015.03.015		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900169		
J	Kim, JH; Nakamichi, M				Kim, Jae-Hwan; Nakamichi, Masaru			Effect of titanium content on mechanical properties and reactivity of titanium beryllide pebbles	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Beryllide; Pebble; Crush strength; Oxidation resistance	ADVANCED NEUTRON MULTIPLIER; INTERMETALLIC COMPOUNDS	A combinational process for the fabrication of beryllide pebbles, consisting of a plasma-sintering method and the rotating electrode method for fabrication of electrode rods and pebbles, respectively, is proposed. To investigate the effect of Ti content in titanium beryllide pebbles on the pebbles' crush strength and oxidation resistance, beryllide pebbles with 3-10.5 at.% Ti were fabricated. Scanning electron microscopy (SEM) observations demonstrated that the surfaces of Be 3 and 5 at.% Ti pebbles contained a Be phase, whereas the surfaces of Be - 7-10.5 at.% Ti pebbles did not. Moreover, according to cross-sectional SEM images, the area fraction of the Be phase decreased with increasing Ti content in beryllide pebbles with 3-9 at.% Ti, whereas the pebble with 10.5 at.% Ti consisted primarily of the Be17Ti2 phase. With regard to the mechanical properties of the pebbles, their strength and elongation decreased with increasing Ti content because of the brittleness of the Be phase. The weight gain and the amount of H-2 generated by the pebbles under reaction with 1% H2O/Ar decreased with increasing Ti content, whereas the stability of the pebbles was strongly dependent on the presence of the Be phase on their surface. (C) 2015 Elsevier B.V. All rights reserved.	[Kim, Jae-Hwan; Nakamichi, Masaru] Japan Atom Energy Agcy, Sect Fus Res & Dev, Breeding Funct Mat Dev Grp, Rokkasho, Aomori 0393212, Japan	Kim, JH (reprint author), Japan Atom Energy Agcy, Sect Fus Res & Dev, Breeding Funct Mat Dev Grp, 2-166 Oaza Obuchi Aza Omotedate, Rokkasho, Aomori 0393212, Japan.	kim.jaehwan@jaea.go.jp					Nakamichi M, 2013, FUSION ENG DES, V88, P611, DOI 10.1016/j.fusengdes.2013.02.077; Nakamichi M, 2014, FUSION ENG DES, V89, P1304, DOI 10.1016/j.fusengdes.2014.02.081; Kim JH, 2013, J ALLOY COMPD, V577, P90, DOI 10.1016/j.jallcom.2013.04.185; Kim JH, 2013, J NUCL MATER, V442, pS461, DOI 10.1016/j.jnucmat.2012.10.013; Kim JH, 2013, J NUCL MATER, V438, P218, DOI 10.1016/j.jnucmat.2013.02.066; Kim JH, 2014, J ALLOY COMPD, V585, P63, DOI 10.1016/j.jallcom.2013.09.103	6	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1812	1816		10.1016/j.fusengdes.2015.06.170		5	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900170		
J	Nakamichi, M; Kim, JH				Nakamichi, Masaru; Kim, Jae-Hwan			Fabrication and hydrogen generation reaction with water vapor of prototypic pebbles of binary beryllides as advanced neutron multiplier	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Beryllide; Beryllium; Intermetallic compound; Neutron multiplier; Plasma sintering synthesis; Rotating electrode granulation		Advanced neutron multipliers such as beryllides with high stability at high temperatures are desired for demonstration power plant (DEMO) reactors. Prototypic pebbles 1 mm in diameter of single phase Be12Ti beryllide were successfully fabricated by a combination process involving plasma sintering, a rotating electrode method, and a homogenization treatment. Relative to the non-treated, multi-phase pebbles, the homogenized Be12Ti pebbles demonstrated an increased reactivity because the homogenization treatment caused an increase in the specific surface area of the treated pebbles. To prevent increased hydrogen generation, prototypic Be17Ti2 pebbles were successfully fabricated without homogenization. The Be17Ti2 prototypic pebbles where shown to have a good oxidation resistance. (C) 2015 Elsevier B.V. All rights reserved.	[Nakamichi, Masaru; Kim, Jae-Hwan] Japan Atom Energy Agcy, Fus Res & Dev Directorate, Breeding Funct Mat Grp, Tokyo, Japan	Nakamichi, M (reprint author), Japan Atom Energy Agcy, Fus Res & Dev Directorate, Breeding Funct Mat Grp, Tokyo, Japan.	nakamichi.masaru@jaea.go.jp					Nakamichi M, 2013, J NUCL MATER, V440, P530, DOI 10.1016/j.jnucmat.2013.02.070; Nakamichi M, 2011, J NUCL MATER, V417, P765, DOI 10.1016/j.jnucmat.2010.12.140; Nakamichi M, 2013, FUSION ENG DES, V88, P611, DOI 10.1016/j.fusengdes.2013.02.077; Nakamichi M, 2011, FUSION ENG DES, V86, P2262, DOI 10.1016/j.fusengdes.2011.03.009; Kim JH, 2013, J NUCL MATER, V438, P218, DOI 10.1016/j.jnucmat.2013.02.066	5	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1838	1842		10.1016/j.fusengdes.2015.04.026		5	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900176		
J	Ochiai, K; Edao, Y; Kawamura, Y; Hoshino, T; Ohta, M; Sato, S; Konno, C				Ochiai, Kentaro; Edao, Yuki; Kawamura, Yoshinori; Hoshino, Tsuyoshi; Ohta, Masayuki; Sato, Satoshi; Konno, Chikara			Experimental investigation on tritium release from lithium titanate pebble under high temperature of 1073 K	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Tritium release; DT neutron; Blanket; Lithium titanate; Temperature; Purge gas	NEUTRON-IRRADIATION; BLANKET; BED	The temperature of Li2TiO3 pebble breeder in a fusion DEMO blanket is assumed to be more than 1000 K. For the investigation of tritium release from a Li2TiO3 pebble breeder blanket at such a high temperature, we have carried out a tritium release experiment with the DT neutron source at the JAEA-FNS. The Li2TiO3 pebble (1.0-1.2 mm in diameter) of 70g was put into a stainless steel container and installed into an assembly stratified with beryllium and Li2TiO3 layers. During the DT neutron irradiation, the temperature was kept at 1073 K with wire heaters in the blanket container. Helium gas including 1% hydrogen gas (H-2/He) mainly flowed inside the container as the purge gas. Two chemical forms, HT and HTO, of extracted tritium were separately collected during the DT neutron irradiation by using water bubblers and CuO bed. The tritium activity in the water bubbler was measured by a liquid scintillation counter. To investigate the effect of moisture in the purge gas, we also performed the same experiments with H2O/He gas (H2O content: 1%) or pure helium gas. From our experiment at 1073K, in the case of the purge gas includes H-2, it is indicated that the increasing tendency of HT release is similar to that of the dry H-2/He. (C) 2015 Elsevier B.V. All rights reserved.	[Ochiai, Kentaro; Edao, Yuki; Kawamura, Yoshinori; Ohta, Masayuki; Sato, Satoshi; Konno, Chikara] Japan Atom Energy Agcy, Tokai, Ibaraki, Japan; [Hoshino, Tsuyoshi] Japan Atom Energy Agcy, Rokkasho, Aomori, Japan	Ochiai, K (reprint author), Japan Atom Energy Agcy, Tokai, Ibaraki, Japan.	howartre@onid.oregonstate.edu					Kawamura Y, 2012, FUSION ENG DES, V87, P1253, DOI 10.1016/j.fusengdes.2012.02.125; Ochiai K, 2014, FUSION ENG DES, V89, P1464, DOI 10.1016/j.fusengdes.2014.04.079; Batistoni P, 2007, FUSION ENG DES, V82, P2095, DOI 10.1016/j.fusengdes.2007.04.009; Tsuru D, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/6/065024; Kondo K, 2010, FUSION ENG DES, V85, P1229, DOI 10.1016/j.fusengdes.2010.03.009; Kinjyo T, 2007, FUSION ENG DES, V82, P2147, DOI 10.1016/j.fusengdes.2007.07.002; Sato S, 2003, NUCL FUSION, V43, P527, DOI 10.1088/0029-5515/43/7/303; Enoeda M, 2003, NUCL FUSION, V43, P1837, DOI 10.1088/0029-5515/43/12/026; Brown F.B., 2002, T AM NUCL SOC, V87; Kobayashi K., 2002, JENDLD99 JAP AT EN R; Lopez Al-dama D., 2004, INDCNDS467 INT AT EN	11	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1843	1846		10.1016/j.fusengdes.2015.07.003		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900177		
J	Ohta, M; Sato, S; Ochiai, K; Konno, C				Ohta, Masayuki; Sato, Satoshi; Ochiai, Kentaro; Konno, Chikara			Integral test of International Reactor Dosimetry and Fusion File on graphite assembly with DT neutron at JAEA/FNS	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Integral experiment; IRDFF; Graphite; DT neutron; Dosimetry reaction		We perform an integral test of a new library of dosimetry cross section data, International Reactor Dosimetry and Fusion File release 1.0 (IRDFF 1.0), which has been released from the International Atomic Energy Agency recently. A pseudo-cylindrical graphite assembly is used with a DT neutron source at the fusion neutronics source facility of Japan Atomic Energy Agency. A lot of foils for measurements of dosimetry reaction rates are placed in the small space along the central axis in the assembly. After the DT neutron irradiation, forty dosimetry reaction rates are measured and are compared with calculated values, which are obtained by using a Monte Carlo neutron transport code MCNP5-1.40 and a nuclear data library ENDF/B-VII.1 with the IRDFF-v.1.03 as the response functions for the dosimetry reactions. The calculated results generally show good agreements with the experimental ones. The cross section data of the Zn-68(n,np)Cu-67 and Zn-68(n,d)Cu-67 reactions and the In reaction, which are not included in IRDFF-v1.03, are needed for the analysis of the Zn-67(n,p)Cu-67 reaction and the In-113(n,gamma)In-114m reaction as the competitive reactions, respectively. (C) 2015 Elsevier B.V. All rights reserved.	[Ohta, Masayuki; Sato, Satoshi; Ochiai, Kentaro; Konno, Chikara] Japan Atom Energy Agcy, Tokai, Ibaraki, Japan	Ohta, M (reprint author), Japan Atom Energy Agcy, Tokai, Ibaraki, Japan.	ohta.masayuki@jaea.go.jp					[Anonymous], 2013, MCNP61MCNP5MCNPX; Bersillon O., 2006, IAEA TECHNICAL REPOR, V452; Kobayashi K., 2002, JENDLD99; MacFarlane R.E., 1994, LA12740M; Maekawa H., 1988, JAERIM88034; MCNP Team, 2005, LAUR058617 MCNP TEAM; Sublet J.-C., 2010, CCFER1005; Zsolnay E. M., 2012, INDCNDS0616 IAEA	8	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1847	1850		10.1016/j.fusengdes.2015.03.032		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900178		
J	Ogawa, S; Masuko, Y; Kato, H; Yuyama, H; Sakai, Y; Niwa, E; Hashimoto, T; Mukai, K; Hosino, T; Sasaki, K				Ogawa, Seiya; Masuko, Yuki; Kato, Hirokazu; Yuyama, Hayato; Sakai, Yutaro; Niwa, Eiki; Hashimoto, Takuya; Mukai, Keisuke; Hosino, Tsuyoshi; Sasaki, Kazuya			Li vaporization property of two-phase material of Li2TiO3 and Li2SiO3 for tritium breeder	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Tritium breeder; Two-phase material; Li2TiO3; Li2SiO3; Li vaporization; DEMO blanket	LITHIUM-ORTHOSILICATE PEBBLES; BLANKET	Li vaporization property of two-phase materials of Li2TiO3 and Li2SiO3 in a working condition for the solid tritium breeder used in the demonstration power plant of fusion reactor was investigated, and the suppression mechanism of the vaporization was considered. The Li vaporization rate from the specimen pellet was measured by gravimetric method, and the change of Li concentration distribution in the pellet was analyzed by time-of-flight secondary ion mass spectrometer. Li was vaporized only from the Li2SiO3 at the vicinity of the surface of the pellet. The remarkable vaporization of Li arose only in an early short time. The inhibition of the vaporization from the Li2SiO3 was successful by adding the small amount of the stable secondary phase of Li2TiO3. (C) 2015 Elsevier B.V. All rights reserved.	[Ogawa, Seiya; Sasaki, Kazuya] Tokai Univ, Grad Sch Engn, Course Mech Engn, Hiratsuka, Kanagawa 2591292, Japan; [Masuko, Yuki; Kato, Hirokazu; Yuyama, Hayato; Sakai, Yutaro; Sasaki, Kazuya] Tokai Univ, Sch Engn, Dept Prime Mover Engn, Hiratsuka, Kanagawa 2591292, Japan; [Sasaki, Kazuya] Tokai Univ, Grad Sch Sci & Technol, Course Mech Engn & Aeronaut & Astronaut, Hiratsuka, Kanagawa 2591292, Japan; [Niwa, Eiki; Hashimoto, Takuya] Nihon Univ, Coll Humanities & Sci, Dept Phys, Setagaya Ku, Tokyo 1568550, Japan; [Mukai, Keisuke] Univ Tokyo, Sch Engn, Dept Nucl Engn & Management, Bunkyo Ku, Tokyo 1138656, Japan; [Hosino, Tsuyoshi] Japan Atom Energy Agcy, Sect Fus Res & Dev, Rokkasho Fus Inst, Breeding Funct Mat Dev Grp,Dept Blanket Syst Res, Rokkasho, Aomori 0393212, Japan	Sasaki, K (reprint author), Tokai Univ, Sch Engn, Dept Prime Mover Engn, 4-1-1 Kitakaname, Hiratsuka, Kanagawa 2591292, Japan.	k_sasaki@tokai-u.jp					HESSE KF, 1977, ACTA CRYSTALLOGR B, V33, P901, DOI 10.1107/S0567740877004932; Hoshino T, 2009, FUSION ENG DES, V84, P956, DOI 10.1016/j.fusengdes.2008.12.049; Hoshino T, 2007, FUSION ENG DES, V82, P2269, DOI 10.1016/j.fusengdes.2007.07.005; Knitter R, 2009, J NUCL MATER, V386-88, P1071, DOI 10.1016/j.jnucmat.2008.12.284; Knitter R, 2007, J NUCL MATER, V361, P104, DOI 10.1016/j.jnucmat.2006.11.005; Roux N, 1996, J NUCL MATER, V233, P1431, DOI 10.1016/S0022-3115(96)00136-5; Knitter R, 2013, J NUCL MATER, V442, pS433, DOI 10.1016/j.jnucmat.2012.10.034; Enoeda M, 2003, NUCL FUSION, V43, P1837, DOI 10.1088/0029-5515/43/12/026; Ying A, 2012, FUSION ENG DES, V87, P1130, DOI 10.1016/j.fusengdes.2012.02.090; SCHUMACHER G, 1991, FUSION ENG DES, V17, P31, DOI 10.1016/0920-3796(91)90032-L; Claverie J., 1966, B SOC CHIM FR, V244-246	11	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1859	1863		10.1016/j.fusengdes.2015.01.042		5	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900181		
J	Satake, S; Aoyagi, Y; Unno, N; Yuki, K; Seki, Y; Enoeda, M				Satake, Shin-ichi; Aoyagi, Yusuke; Unno, Noriyuki; Yuki, Kazuhisa; Seki, Yohji; Enoeda, Mikio			Three-dimensional flow measurement of a water flow in a sphere-packed pipe by digital holographic PTV	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Digital hologram; Pebble; Refractive matching method		A water cooled ceramic breeder for ITER and DEMO of a nuclear fusion reactor plays a significant role in the design of a blanket module. Pebbles of a ceramic tritium breeder are packed in a container of the blanket. Investigation of the flow behavior is necessary in an actual environment of a facility where pressure drop takes place under a complex flow such as in case of the container for the pebble bed. For the development of a facility, it is necessary to be able to monitor fluid motion of a basic flow such as a sphere-packed pipe (SPP). In the present study, to discern the complex flow structures in SPP, digital holographic PTV visualization is carried out by a refractive index-matching method using a water employed as a working fluid. The water is chosen to be able to adjust its refractive index to match to that of the MEXFLON pebble with an index of 1.33. Hologram fringe images of particles behind the spheres can be observed, and the particles' positions can be reconstructed by a digital hologram. Consequently, 3-D velocity-fields around the spheres are obtained by the reconstructed particles' positions. The velocity between pebbles is found to be convergence and divergence regions in the SPP. (C) 2015 Elsevier B.V. All rights reserved.	[Satake, Shin-ichi; Aoyagi, Yusuke; Unno, Noriyuki] Tokyo Univ Sci, Katsushika Ku, Tokyo 1258585, Japan; [Unno, Noriyuki] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1020083, Japan; [Yuki, Kazuhisa] Tokyo Univ Sci, Dept Mech Engn, Sanyo Onoda, Yamaguchi 7560884, Japan; [Seki, Yohji; Enoeda, Mikio] Japan Atom Energy Agcy, Blanket Technol Grp, Naka, Ibaraki 3110193, Japan	Satake, S (reprint author), Tokyo Univ Sci, Katsushika Ku, 6-3-1 Niijuku, Tokyo 1258585, Japan.	satake@te.noda.tus.ac.jp					Yanagi Y, 2001, J NUCL SCI TECHNOL, V38, P1014; Satake SI, 2007, APPL OPTICS, V46, P538, DOI 10.1364/AO.46.000538; Someya S, 2010, APPL PHYS B-LASERS O, V99, P325, DOI 10.1007/s00340-010-3926-9; Yuki K, 2008, J THERMOPHYS HEAT TR, V22, P632, DOI 10.2514/1.30141; Satake S, 2014, FUSION ENG DES, V89, P1064, DOI 10.1016/j.fusengdes.2014.01.029; BUDWIG R, 1994, EXP FLUIDS, V17, P350, DOI 10.1007/BF01874416; Enoeda M., 2001, JAERI TECHNOL, P2001; Hendricks R. C., 1998, VIRTUAL EXPT VISUALI; Satake S., 2004, OPT REV, V11, pL162; Seki Y., 2007, S COD DEV INT SIM TR; Seki Y., 2011, JAEA TECHNOL, P2007	11	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1864	1867		10.1016/j.fusengdes.2015.03.023		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900182		
J	Someya, Y; Tobita, K; Utoh, H; Tokunaga, S; Hoshino, K; Asakura, N; Nakamura, M; Sakamoto, Y				Someya, Youji; Tobita, Kenji; Utoh, Hiroyasu; Tokunaga, Shinji; Hoshino, Kazuo; Asakura, Nobuyuki; Nakamura, Makoto; Sakamoto, Yoshiteru			Design study of blanket structure based on a water-cooled solid breeder for DEMO	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Breeding blanket; Water-cooled solid breeder; DEMO		Blanket concept with a simplified interior for mass production has been developed using a mixed bed of Li2TiO3 and Be12Ti pebbles, coolant conditions of 15.5 MPa and 290-325 degrees C and cooling pipes without any partitions. Considering the continuity with the ITER test blanket module option of Japan and the engineering feasibility in its fabrication, our design study focused on a water-cooled solid breeding blanket using the mixed pebbles bed. Herein, we propose blanket segmentation corresponding to the shape and dimension of the blanket and routing of the coolant flow. Moreover, we estimate the overall tritium breeding ratio (TBR) with a torus configuration, based on the segmentation using three-dimensional (3D) Monte Carlo N-particle calculations. As a result, the overall TBR is 1.15. Our 3D neutronics analysis for TBR ensures that the blanket concept can achieve a self-sufficient supply of tritium. (C) 2015 Elsevier B.V. All rights reserved.	[Someya, Youji; Tobita, Kenji; Utoh, Hiroyasu; Tokunaga, Shinji; Hoshino, Kazuo; Asakura, Nobuyuki; Nakamura, Makoto; Sakamoto, Yoshiteru] Japan Atom Energy Agcy, Rokkasho, Aomori, Japan	Someya, Y (reprint author), Japan Atom Energy Agcy, Rokkasho, Aomori, Japan.						Al-dama D. Lopez, 2004, INDCNDS46 IAEA; Someya Y, 2011, FUSION ENG DES, V86, P2269, DOI 10.1016/j.fusengdes.2011.01.141; Someya Y, 2013, PLASMA SCI TECHNOL, V15, P171, DOI 10.1088/1009-0630/15/2/19; Uchida M, 2003, FUSION ENG DES, V69, P499, DOI 10.1016/S0920-3796(03)00395-8; Billone M.C., 1993, ITER SOLID BREEDER B; Krikorian O. H., 1985, High Temperatures - High Pressures, V17; Utoh H., 2011, FUSION ENG DES, V9-11, P2378; X-5 Monte Carlo Team, 2005, LACP030245 LANL	8	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1872	1875		10.1016/j.fusengdes.2015.05.042		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900184		
J	Sugiyama, T; Takada, A; Morita, Y; Kotoh, K; Munakata, K; Taguchi, A; Kawano, T; Tanaka, M; Akata, N				Sugiyama, Takahiko; Takada, Akito; Morita, Youhei; Kotoh, Kenji; Munakata, Kenzo; Taguchi, Akira; Kawano, Takao; Tanaka, Masahiro; Akata, Naofumi			Dual temperature dual pressure water-hydrogen chemical exchange for water detritiation	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Tritium; Water detritiation; Isotope separation; Water-hydrogen chemical exchange; Separative analysis	CECE PROCESS; TRITIUM; PLANT	Experimental and analytical studies on hydrogen-tritium isotope separation by a dual temperature dual pressure catalytic exchange (DTDP-CE) with liquid phase chemical exchange columns were carried out in order to apply it to a part of the water detritiation system for DEMO fuel cycle. A prototype DTDP-CE apparatus was successfully operated and it was confirmed that tritium was separated by the apparatus as significantly distinguishable. A calculation code was developed based on the channeling stage model. The values of separation factors and the effects of some operating parameters were well predicted by the separative analyses with the code. (C) 2015 Elsevier B.V. All rights reserved.	[Sugiyama, Takahiko; Takada, Akito; Morita, Youhei] Nagoya Univ, Fac Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Kotoh, Kenji] Kyushu Univ, Grad Sch Engn, Nishi Ku, Fukuoka 8190395, Japan; [Munakata, Kenzo] Akita Univ, Fac Engn & Resource Sci, Akita 0108502, Japan; [Taguchi, Akira] Toyama Univ, Hydrogen Isotope Res Ctr, Toyama 9308555, Japan; [Kawano, Takao; Tanaka, Masahiro; Akata, Naofumi] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan	Sugiyama, T (reprint author), Nagoya Univ, Fac Engn, Chikusa Ku, Fro Cho 1, Nagoya, Aichi 4648603, Japan.	t-sugiyama@nucl.nagoya-u.ac.jp					Michling R, 2009, FUSION ENG DES, V84, P338, DOI 10.1016/j.fusengdes.2009.03.003; Miller JM, 2002, FUSION SCI TECHNOL, V41, P1077; Vasyanina TV, 2008, FUSION ENG DES, V83, P1451, DOI 10.1016/j.fusengdes.2008.07.027; Iwai Y, 2002, FUSION SCI TECHNOL, V41, P1126; Alekseev IA, 2003, FUSION ENG DES, V69, P33, DOI 10.1016/S0920-3796(03)00230-8; Sugiyama T, 2011, FUSION SCI TECHNOL, V60, P1323; Benedict M., 1987, NUCL CHEM ENG; Sugiyama T., 2000, J NUCL SCI TECHNOL, V37	8	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1876	1879		10.1016/j.fusengdes.2015.05.054		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900185		
J	Yagi, J; Sagara, A; Watanabe, T; Tanaka, T; Takayama, S; Muroga, T				Yagi, Juro; Sagara, Akio; Watanabe, Takashi; Tanaka, Teruya; Takayama, Sadatsugu; Muroga, Takeo			Hydrogen solubility in FLiNaK mixed with titanium powder	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Metal powder-mixed molten salt; FLiNaK; Hydrogen solubility; Vanadium alloy	HELICAL REACTOR	The hydrogen solubility in a FLiNaK molten salt mixed with Ti powder was investigated. A hydrogen-soluble metal powder mixed with a molten salt can increase the effective hydrogen solubility of the molten salt, which is currently a major disadvantage of molten salts. A significant increase in hydrogen solubility was observed, even with a mass fraction of Ti powder of only 0.1 wt%. The increase of hydrogen solubility was so large that a vanadium alloy would be compatible with the Ti powder/molten salt mixture, unlike typical molten salts that result in an unacceptably large tritium inventory in the vanadium alloy. In addition, contamination of the Ti powder by oxidation suppressed the hydrogen uptake and release capability. Controlling the purity of the molten salt was found to be one of the key issues for the metal powder mixture concept. (C) 2015 Elsevier B.V. All rights reserved.	[Yagi, Juro; Sagara, Akio; Tanaka, Teruya; Takayama, Sadatsugu; Muroga, Takeo] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Watanabe, Takashi] Shizuoka Univ, Shizuoka, Shizuoka 4228529, Japan	Yagi, J (reprint author), Natl Inst Nat Sci, Natl Inst Fus Sci, 322-6 Oroshicho, Toki, Gifu 5095292, Japan.	yagi.juro@LHD.nifs.ac.jp					Buxbaum RE, 2002, J NUCL MATER, V307, P576, DOI 10.1016/S0022-3115(02)01215-1; Sagara A, 2014, FUSION ENG DES, V89, P2114, DOI 10.1016/j.fusengdes.2014.02.076; Muroga T, 2014, J NUCL MATER, V455, P263, DOI 10.1016/j.jnucmat.2014.06.025; Tanaka T, 2005, FUSION SCI TECHNOL, V47, P530; MALINAUS.AP, 1974, IND ENG CHEM FUND, V13, P242, DOI 10.1021/i160051a015; San-Martin A., 1987, B ALLOY PHASE DIAGRA, V8, P30, DOI 10.1007/BF02868888	6	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1907	1910		10.1016/j.fusengdes.2015.06.124		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900192		
J	Chen, DS; Kimura, A; Han, WT; Je, H				Chen, Dongsheng; Kimura, Akihiko; Han, Wentuo; Je, Hwanil			Age-hardening susceptibility of high-Cr ODS ferritic steels and SUS430 ferritic steel	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Phase decomposition; Age-hardening; Cr precipitates; TEM; ODS steel; SUS430 steel	ALLOYS; IRON	The effect of aging on high-Cr ferritic steels was investigated with focusing on the role of oxide particles in alpha/alpha' phase decomposition behavior. 12Cr-oxide dispersion strengthened (ODS) steel, 15Cr-ODS steel and commercial SUS430 steel were isothermally aged at 475 degrees C for up to 10,000 h. Thermal aging caused a larger hardening in SUS430 than 15Cr-ODS, while 12Cr-ODS showed almost no hardening. A characteristic of the ODS steels is that the hardening was not accompanied by the significant loss of ductility that was observed in SUS430 steel. After aging for 2000 h, SUS430 steel shows a larger ductile-brittle transition temperature (DBTF) shift than 15Cr-ODS steel, which suggests that the age-hardening susceptibility is lower in 15Cr-ODS steel than in conventional SUS430 steel. Thermal aging leaded to a large number of Cr-rich alpha' precipitates, which were confirmed by transmission electron microscopy (TEM). Correlation of age-hardening and phase decomposition was interpreted by Orowan type strengthening model. Results indicate that oxide particles cannot only suppress ductility loss, but also may influence a/a' phase decomposition kinetics. (C) 2015 Elsevier B.V. All rights reserved.	[Chen, Dongsheng] Kyoto Univ, Grad Sch Energy Sci, Uji, Kyoto 6110011, Japan; [Kimura, Akihiko; Han, Wentuo; Je, Hwanil] Kyoto Univ, Inst Adv Energy, Uji, Kyoto 6110011, Japan	Chen, DS (reprint author), Kyoto Univ, Grad Sch Energy Sci, Uji, Kyoto 6110011, Japan.	chen.dongsheng85@gmail.com					Isselin J, 2011, J NUCL MATER, V417, P185, DOI 10.1016/j.jnucmat.2010.12.061; Cho HS, 2007, J NUCL MATER, V367, P1180, DOI 10.1016/j.jnucmat.2007.03.211; LUCAS GE, 1993, J NUCL MATER, V206, P287, DOI 10.1016/0022-3115(93)90129-M; Yoshitake T, 2002, J NUCL MATER, V307, P788, DOI 10.1016/S0022-3115(02)00947-9; Terentyev DA, 2008, ACTA MATER, V56, P3229, DOI 10.1016/j.actamat.2008.03.004; Haghighat SMH, 2014, ACTA MATER, V64, P24, DOI 10.1016/j.actamat.2013.11.037; Bonny G, 2009, J NUCL MATER, V385, P278, DOI 10.1016/j.jnucmat.2008.12.002; Chen DS, 2014, J NUCL MATER, V455, P436, DOI 10.1016/j.jnucmat.2014.07.069; Kimura A, 2011, J NUCL MATER, V417, P176, DOI 10.1016/j.jnucmat.2010.12.300; Ribis J, 2014, J NUCL MATER, V444, P314, DOI 10.1016/j.jnucmat.2013.10.010; Muroga T, 2014, FUSION ENG DES, V89, P1717, DOI 10.1016/j.fusengdes.2014.01.010; Okuda N, 2009, J NUCL MATER, V386-88, P974, DOI 10.1016/j.jnucmat.2008.12.265; Lee JS, 2007, J NUCL MATER, V367, P229, DOI 10.1016/j.jnucmat.2007.03.007; Cepdevila C., 2008, MAT SCI ENG A-STRUCT, V490, P277	14	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1945	1949		10.1016/j.fusengdes.2015.05.078		5	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900201		
J	Fu, HY; Nagasaka, T; Kometani, N; Muroga, T; Guan, WH; Nogami, S; Yabuuchi, K; Iwata, T; Hasegawa, A; Yamazaki, M; Kano, S; Satoh, Y; Abe, H; Tanigawa, H				Fu, Haiying; Nagasaka, Takuya; Kometani, Nobuyuki; Muroga, Takeo; Guan, Wenhai; Nogami, Shuhei; Yabuuchi, Kiyohiro; Iwata, Takuya; Hasegawa, Akira; Yamazaki, Masanori; Kano, Sho; Satoh, Yuhki; Abe, Hiroaki; Tanigawa, Hiroyasu			Effect of post-weld heat treatment and neutron irradiation on a dissimilar-metal joint between F82H steel and 316L stainless steel	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		F82H steel; 316L stainless steel; Electron beam welding; Post-weld heat treatment; Neutron irradiation	DESIGN	A dissimilar-metal joint between F82H steel and 316L stainless steel was fabricated by using electron beam welding (EBW). By microstructural analysis and hardness test, the heat-affected zone (HAZ) of F82H was classified into interlayer area, fine-grain area, and coarse-carbide area. Post-weld heat treatment (PWHT) was applied to control the hardness of HAZ. After PWHT at 680 degrees C for 1 h, neutron irradiation at 300 degrees C with a dose of 0.1 dpa was carried out for the joint in Belgian Reactor II (BR-II). Compared to the base metals (BMs) and weld metal (WM), significant irradiation hardening up to 450HV was found in the fine-grain HAZ of F82H. However, the impact property of F82H-HAZ specimens, which was machined with the root of the V-notch at HAZ of F82H, was not deteriorated obviously in spite of the significant irradiation hardening. (C) 2015 Elsevier B.V. All rights reserved.	[Fu, Haiying; Nagasaka, Takuya; Muroga, Takeo] SOKENDAI, Toki, Gifu, Japan; [Nagasaka, Takuya; Muroga, Takeo] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Kometani, Nobuyuki] Nagoya Univ, Nagoya, Aichi 4648601, Japan; [Guan, Wenhai; Nogami, Shuhei; Yabuuchi, Kiyohiro; Iwata, Takuya; Hasegawa, Akira] Tohoku Univ, Sendai, Miyagi 980, Japan; [Yamazaki, Masanori] Tohoku Univ, Inst Mat Res, Int Res Ctr Nucl Mat Sci, Sendai, Miyagi 980, Japan; [Kano, Sho; Satoh, Yuhki; Abe, Hiroaki] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 980, Japan; [Tanigawa, Hiroyasu] Japan Atom Energy Agcy, Rokkasho, Japan	Fu, HY (reprint author), SOKENDAI, Toki, Gifu, Japan.	haigirl1983@gmail.com					El-Guebaly LA, 2006, FUSION ENG DES, V80, P99, DOI 10.1016/j.fusengdes.2005.06.355; Tavassoli AAF, 2014, J NUCL MATER, V455, P269, DOI 10.1016/j.jnucmat.2014.06.017; Kalinin G, 1996, J NUCL MATER, V233, P9, DOI 10.1016/S0022-3115(96)00316-9; Nogami S, 2011, FUSION SCI TECHNOL, V60, P334; Hara N, 2009, FUSION SCI TECHNOL, V56, P318; Furuya K, 2009, J NUCL MATER, V386-88, P963, DOI 10.1016/j.jnucmat.2008.12.259; Asaoka Y, 2000, FUSION ENG DES, V48, P397, DOI 10.1016/S0920-3796(00)00149-6; Ansara I., 1985, 9657IEN EUR; Suri A.K., 2010, J PHYS C SER, V208; Takanori H., 2011, J PLASMA FUSION RES, V87, P172	10	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1968	1972		10.1016/j.fusengdes.2015.06.079		5	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900206		
J	Hirose, T; Sakasegawa, H; Nakajima, M; Tanigawa, H				Hirose, Takanori; Sakasegawa, Hideo; Nakajima, Motoki; Tanigawa, Hiroyasu			Mechanical properties of TIG and EB weld joints of F82H	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Reduced activation ferritic/martensitic steel; Welding; Post weld heat treatment; Mechanical property	MICROSTRUCTURE; STEEL	This work investigates mechanical properties of weld joints of a reduced activation ferritic/martensitic steel, F82H and effects of post weld heat treatment on the welds. Vickers hardness, tensile and Charpy impact tests were conducted on F82H weld joints prepared using tungsten-inert-gas and electron beam after various heat treatments. Although narrow groove tungsten-inert-gas welding reduced volume of weld bead, significant embrittlement was observed in a heat affected zone transformed due to heat input. Post weld heat treatment above 993 K successfully moderated the brittle transformed region. The hardness of the brittle region strongly depends on the heat treatment temperature. Meanwhile, strength of base metal was slightly reduced by the treatment at temperature ranging from 993 to 1053 K. Moreover, softening due to double welding was observed only in the weld metal, but negligible in base metal. (C) 2015 Elsevier B.V. All rights reserved.	[Hirose, Takanori; Sakasegawa, Hideo; Nakajima, Motoki; Tanigawa, Hiroyasu] Japan Atom Energy Agcy, Aomori, Japan	Hirose, T (reprint author), Japan Atom Energy Agcy, Aomori, Japan.	hirose.takanori@jaea.go.jp					Hirose T, 2014, FUSION ENG DES, V89, P1595, DOI 10.1016/j.fusengdes.2013.12.005; Hirose T, 2013, J NUCL MATER, V442, pS557, DOI 10.1016/j.jnucmat.2013.05.063; Tanigawa H, 2008, FUSION ENG DES, V83, P1471, DOI 10.1016/j.fusengdes.2008.07.024; Sawai T, 2000, J NUCL MATER, V283, P657, DOI 10.1016/S0022-3115(00)00089-1; [Anonymous], 2013, Z3121 JIS; Shiba K, 2012, FUSION SCI TECHNOL, V62, P145; Tanigawa H, 2003, FUSION SCI TECHNOL, V44, P219; Nakata T, 2012, FUSION ENG DES, V87, P589, DOI 10.1016/j.fusengdes.2012.01.048; Tanigawa H, 2011, FUSION ENG DES, V86, P2549, DOI 10.1016/j.fusengdes.2011.04.047; Hirose T, 2010, PROCEEDINGS OF THE ASME PRESSURE VESSELS AND PIPING CONFERENCE 2010, VOL 1: CODES AND STANDARDS, P263; Hollomon J H, 1947, FERROUS METALLURGICA, P245	11	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1982	1985		10.1016/j.fusengdes.2015.06.133		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900209		
J	Kanemura, T; Kondo, H; Furukawa, T; Hirakawa, Y; Hoashi, E; Yoshihashi, S; Horiike, H; Wakai, E				Kanemura, Takuji; Kondo, Hiroo; Furukawa, Tomohiro; Hirakawa, Yasushi; Hoashi, Eiji; Yoshihashi, Sachiko; Horiike, Hiroshi; Wakai, Eiichi			Measurement of Li target thickness in the EVEDA Li Test Loop	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		IFMIF; EVEDA; Liquid lithium; Wall jet; Vacuum; Flow diagnostics	JET	A high-speed (nominal: 15 m/s, range: 10-16 m/s) liquid lithium wall jet is planned to serve as the target for two 40 MeV and 125 mA deuteron beams in the International Fusion Materials Irradiation Facility (IFMIF). The design requirement of target thickness stability is 25 +/- 1 mm under a vacuum of 10(-3) Pa. This paper presents the results of the target thickness measurement conducted in the EVEDA Li Test Loop under a wide range of conditions including the IFMIF condition (target speed of 10, 15, and 20 m/s; vacuum pressure of 10(-3) Pa; and Li temperature of 250 degrees C). For measurement, we use a laser probe method that we developed in advance; this method generates statistical measurements method using a laser distance meter. The measurement results obtained under the IFMIF nominal condition (15 m/s, 10(-3) Pa, 250 degrees C) at the IFMIF beam center are as follows: average target thickness = 26.08 +/- 0.09 mm (2 sigma), mean wave amplitude = 0.26 +/- 0.01 mm (2 sigma), and maximum wave amplitude = 1.46 +/- 0.25 mm (2 sigma.). Of the total wave components, 99.7% are within the design requirement. The analytically predicted target thickness is in excellent agreement with the experimental data, resulting in successful characterization of the Li target thickness. (C) 2015 Elsevier B.V. All rights reserved.	[Kanemura, Takuji; Kondo, Hiroo; Furukawa, Tomohiro; Hirakawa, Yasushi; Wakai, Eiichi] Japan Atom Energy Agcy, Oarai, Ibaraki 3111393, Japan; [Hoashi, Eiji; Yoshihashi, Sachiko; Horiike, Hiroshi] Osaka Univ, Suita, Osaka 5650871, Japan	Kanemura, T (reprint author), Japan Atom Energy Agcy, 4002 Narita, Oarai, Ibaraki 3111393, Japan.	kanemura.takuji@jaea.go.jp					Ida M, 2002, FUSION ENG DES, V63-64, P333, DOI 10.1016/S0920-3796(02)00122-9; Kondo H, 2014, FUSION ENG DES, V89, P1688, DOI 10.1016/j.fusengdes.2014.02.022; Nakamura H, 1998, J NUCL MATER, V258, P440, DOI 10.1016/S0022-3115(98)00235-9; Knaster J, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/11/116001; Kanemura T, 2014, FUSION ENG DES, V89, P1642, DOI 10.1016/j.fusengdes.2014.03.037; Kondo H, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/12/123008; Francesco Saverio N., 2010, TERMOFLUIDODINAMICA; Holthuijsen L.H., 2007, WAVES OCEANIC COASTA; Kolowith R., 1985, 8429 HEDLTME; Kondo H., 2015, FUSION ENG DES; Rondo H., 2010, FUSION ENG DES, V85, P1102; The American Society of Mechanical Engineering Measurement Uncertainty, 1985, 1911985 ANSIASME P 1	12	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1991	1997		10.1016/j.fusengdes.2015.06.060		7	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900211		
J	Kondo, K; Arbeiter, F; Fischer, U; Lu, L; Qiu, YF; Tian, K				Kondo, Keitaro; Arbeiter, Frederik; Fischer, Ulrich; Lu, Lei; Qiu, Yuefeng; Tian, Kuo			Shielding performances analysis for the IFMIF test facility based on high-fidelity Monte Carlo neutronic calculations	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		IFMIF; Test cell; Neutronics; McDeLicious; McCad; Neutron streaming	REFERENCE TEST CELL	The IFMIF Test Cell (TC) design was developed and optimized in the EVEDA phase, and finally the reference TC design was proposed. The present study is devoted to further investigations of open issues on the reference TC design. In order to examine the neutron streaming effect caused by pipe penetrations and gaps around removable shielding plugs, a new geometry model for neutronic analyses has been prepared directly from engineering CAD data by utilizing the McCad conversion software. All removable shielding plugs are separately described in the model and a detailed description of pipes was incorporated into the model. The calculation result suggests that the streaming effect is mitigated if the pipe penetration is designed appropriately, while the gaps around the shielding plugs above the TC have large impact on the radiation dose in the access cell. The concept of the reference TC design has been basically validated from the neutronics point of view, although the streaming effect should be compensated by the shielding capability of the test cell cover plate so that occupational workers can access to the access cell during operation. (C) 2015 Karlsruhe Institute of Technology. Published by Elsevier B.V. All rights reserved.	[Kondo, Keitaro; Arbeiter, Frederik; Fischer, Ulrich; Lu, Lei; Qiu, Yuefeng; Tian, Kuo] KIT, Eggenstein Leopoldshafen, Germany	Kondo, K (reprint author), Japan Atom Energy Agcy, Rokkasho, Japan.	kondo.keitaro@jaea.go.jp					Kondo K, 2014, FUSION ENG DES, V89, P1758, DOI 10.1016/j.fusengdes.2013.12.008; Garin P, 2012, FUSION SCI TECHNOL, V62, P219; Qiu YF, 2014, FUSION ENG DES, V89, P1330, DOI 10.1016/j.fusengdes.2014.02.044; Simakov SP, 2012, FUSION SCI TECHNOL, V62, P233; Lu L, 2014, FUSION ENG DES, V89, P1885, DOI 10.1016/j.fusengdes.2014.05.015; Tian K, 2014, FUSION ENG DES, V89, P1694, DOI 10.1016/j.fusengdes.2014.02.008; Forrest R.A., 2012, INDCNDS0628 IAEA; Grage D., 2014, FUS ENG DES, V88, P2210; Tian K., 2014, FUS ENG DES, V88, P635; X-5 Monte Carlo Team, 2003, LAUR031987 LOS AL NA	10	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				1998	2002		10.1016/j.fusengdes.2015.01.019		5	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900212		
J	Kondo, M; Ishii, M; Muroga, T				Kondo, Masatoshi; Ishii, Masaorni; Muroga, Takeo			Corrosion of steels in molten gallium (Ga), tin (Sn) and tin lithium alloy (Sn-20Li)	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Liquid breeder; Lithium tin alloy; Tin; Gallium; Corrosion; Reduced activation ferritic martensitic steel	LIQUID GALLIUM; JLF-1	The compatibility of steels in liquid gallium (Ga), tin (Sn) and tin lithium alloy (Sn-20Li) was investigated by means of static corrosion tests. The corrosion tests were performed for reduced activation ferritic martensitic steel JLF-1 (JOYO-HEAT, Fe-9Cr-2W-0.1C) and austenitic steel SUS316 (Fe-18Cr-12Ni-2Mo). The test temperature was 873 K, and the exposure time was 250 and 750 h. The corrosion of these steels in liquid Ga, Sn and Sn-20Li alloy was commonly caused by the formation of a reaction layer and the dissolution of the steel elements into the melts. The reaction layer formed in liquid Ga was identified as Fe3Ga from the results of metallurgical analysis and the phase diagram. The growth rate of the reaction layer on the JLF-1 steel showed a parabolic rate law, and this trend indicated that the corrosion could be controlled by the diffusion process through the layer. The reaction layer formed in liquid Sn and Sn-20Li was identified as FeSn. The growth rate had a linear function with exposure time. The corrosion in Sn and Sn-20Li could be controlled by the interface reaction on the layer. The growth rate of the layer formed in liquid Sn and Sn-20Li was much slower than that in liquid Ga. The weight change of the JLF-1 specimen immersed in Sn-20Li for 750 h was measured after the removal of the adherent Sn-20Li in a Li pool. The weight loss was 1.42 x 10(3) g/m(3), and this value was 1500 times larger than that tested in liquid lead lithium alloy (Pb-17Li) at the same conditions in the previous studies. (C) 2015 Elsevier B.V. All rights reserved.	[Kondo, Masatoshi] Tokyo Inst Technol, Nucl Reactors Res Lab, Meguro Ku, Tokyo 1528550, Japan; [Ishii, Masaorni] Tokai Univ, Sch Engn, Dept Nucl Engn, Hiratsuka, Kanagawa 2591292, Japan; [Muroga, Takeo] Natl Inst Fus Sci, Dept Helical Plasma Res, Gifu 5025292, Japan	Kondo, M (reprint author), Tokyo Inst Technol, Nucl Reactors Res Lab, Meguro Ku, 2-12-1 O Okayama, Tokyo 1528550, Japan.	kondo.masatoshi@nr.titech.acjp					Futterer MA, 2000, J NUCL MATER, V283, P1375, DOI 10.1016/S0022-3115(00)00124-0; Kondo M, 2012, FUSION ENG DES, V87, P1777, DOI 10.1016/j.fusengdes.2011.12.013; [Anonymous], 2001, NIGENGOUKIN JOUTAIZU; Kondo M, 2013, FUSION ENG DES, V88, P2556, DOI 10.1016/j.fusengdes.2013.05.049; Natesan K, 2002, J NUCL MATER, V307, P743, DOI 10.1016/S0022-3115(02)01221-7; Shin SH, 2014, J NUCL MATER, V450, P314, DOI 10.1016/j.jnucmat.2013.08.006; Xu Q, 2009, J NUCL MATER, V394, P20, DOI 10.1016/j.jnucmat.2009.08.005; Barbier F, 1999, J MATER RES, V14, P737, DOI 10.1557/JMR.1999.0099; Ono H, 2004, J NUCL MATER, V329, P1117, DOI 10.1016/j.jnucmat.2004.04.034; Nakajima Y., 2015, FUSION ENG IN PRESS; Rondo M., 2013, PLASMA FUSION RES RE, V8; Yeliseyeva OI, 2002, J NUCL MATER, V307, P1400, DOI 10.1016/S0022-3115(02)00989-3	12	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				2003	2008		10.1016/j.fusengdes.2015.05.051		6	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900213		
J	Nakajima, Y; Kondo, M; Nozawa, T				Nakajima, Yuu; Kondo, Masatoshi; Nozawa, Takashi			Study on fabrication method of lithium alloys with metal grains	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Liquid breeder; Lithium; Lithium-lead alloy; Lithium-tin alloy; Fusion blanket		Fabrication methods of lead-lithium (Pb-Li) alloys and tin-lithium (Sn-Li) alloys were studied. The alloys at various Li concentration were fabricated by the melting and mixing of the small metal grains of Li, Pb and Sn. The concentration of Li in the fabricated alloy was evaluated by two methods, i.e. chemical analysis by ICP-AES and the evaluation of the melting point of the alloys with the phase diagram. The concentration of Li determined by these two methods agreed well each other. The Li concentration of the fabricated alloys was lower than that expected from the mass of the Li metal grains used. The depletion of Li metal was caused by the oxidation of Li with the oxides on the pure Pb or Sn grains in the fabrication process. The concentration of Li in the fabricated alloy was successfully adjusted by the addition of the Li alloy having different Li concentration. (C) 2015 Elsevier B.V. All rights reserved.	[Nakajima, Yuu] Tokai Univ, Dept Nucl Engn, Hiratsuka, Kanagawa 2591292, Japan; [Kondo, Masatoshi] Tokyo Inst Technol, Nucl Reactors Res Lab, Meguro Ku, Tokyo 1528550, Japan; [Nozawa, Takashi] Japan Atom Energy Agcy, Rokkasyo, Aomori 0393212, Japan	Kondo, M (reprint author), Tokyo Inst Technol, Tokyo, Japan.	kondo.masatoshi@nr.titech.ac.jp					NEUBERT A, 1979, J CHEM THERMODYN, V11, P971, DOI 10.1016/0021-9614(79)90046-6; Gasior W, 2001, J NUCL MATER, V294, P77, DOI 10.1016/S0022-3115(01)00440-8; BUXBAUM RE, 1984, J LESS-COMMON MET, V97, P27, DOI 10.1016/0022-5088(84)90005-5; Kondo M, 2013, FUSION ENG DES, V88, P2556, DOI 10.1016/j.fusengdes.2013.05.049; Natesan K, 2002, J NUCL MATER, V307, P743, DOI 10.1016/S0022-3115(02)01221-7; Conde E., 2013, FUSION ENG DES, V89, P1250; Jansen D.H., 1959, J NUCL MATER, V3, P249; Lyon R.N., 1952, LIQUID METALS HDB; Yokogawa H., 1993, NETSU BUSSEI, V7, P63	9	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				2009	2014		10.1016/j.fusengdes.2015.06.184		6	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900214		
J	Nagasaka, T; Sakasegawa, H; Tanigawa, H; Ando, M; Tanaka, T; Muroga, T; Sagara, A				Nagasaka, Takuya; Sakasegawa, Hideo; Tanigawa, Hiroyasu; Ando, Masami; Tanaka, Teruya; Muroga, Takeo; Sagara, Akio			Tensile properties of F82H steel after aging at 400-650 degrees C for 100,000h	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Fusion blankets; Reduced-activation ferritic/martensitic steels; Tensile tests; Aging effect	FERRITIC/MARTENSITIC STEELS; MECHANICAL-PROPERTIES; ACTIVATION	The present study investigated tensile properties of F82H steel after aging at 400-650 degrees C for 100,000 h (100 kh), and discusses the mechanisms for change in tensile properties due to the long-term aging. Tensile strength was degraded during the aging. The degradation of yield strength and ultimate tensile strength was 50 MPa or less at 550 degrees C and below in both room temperature and high temperature tests. Above 550 degrees C, yield strength and ultimate tensile strength decreased with increasing aging temperature. On the other hand, no degradation of ductility was detected after the aging. Most of the degradation of the tensile strength could be attributed to loss of solid solution hardening by W due to precipitation of Laves phase (Fe2W) at 550 degrees C. However, other mechanisms, such as coarsening of martensite structure and recovery of dislocations, should be taken into account to explain additional degradation above 550 degrees C. (C) 2015 Published by Elsevier B.V.	[Nagasaka, Takuya; Tanaka, Teruya; Muroga, Takeo; Sagara, Akio] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Sakasegawa, Hideo; Tanigawa, Hiroyasu; Ando, Masami] Japan Atom Energy Agcy, Rokkasho, Japan	Nagasaka, T (reprint author), Natl Inst Nat Sci, Natl Inst Fus Sci, 322-6 Oroshicho, Toki, Gifu 5095292, Japan.	nagasaka@nifs.ac.jp					Shiba K, 2006, FUSION ENG DES, V81, P1051, DOI 10.1016/j.fusengdes.2005.07.030; Nagasaka T, 2011, FUSION ENG DES, V86, P2581, DOI 10.1016/j.fusengdes.2010.11.006; Tavassoli AAF, 2014, J NUCL MATER, V455, P269, DOI 10.1016/j.jnucmat.2014.06.017; Tavassoli AAF, 2002, FUSION ENG DES, V61-62, P617, DOI 10.1016/S0920-3796(02)00255-7; Sasmal CS, 2013, PROCEDIA ENGINEER, V55, P277, DOI 10.1016/j.proeng.2013.03.254; Shiba K, 2011, FUSION ENG DES, V86, P2895, DOI 10.1016/j.fusengdes.2011.06.005; Jitsukawa S, 2004, J NUCL MATER, V329, P39, DOI [10.1016/j.jnucmat.2004.04.319, 10.1016/jnucmat.2004.04.319]; Nagasaka T, 2013, FUSION ENG DES, V88, P2565, DOI 10.1016/j.fusengdes.2013.05.037; Kohyama A, 1996, J NUCL MATER, V233, P138, DOI 10.1016/S0022-3115(96)00327-3; Shiba K., 1997, 97038 JAERI, P55; Tamura M, 2000, J NUCL MATER, V283, P667, DOI 10.1016/S0022-3115(00)00138-0; Tanigawa, 2011, J NUCL MAT, V417, P9	12	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				2046	2049		10.1016/j.fusengdes.2015.06.190		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900222		
J	Okita, T; Hoashi, E; Yoshihashi, S; Kondo, H; Kanemura, T; Yamaoka, N; Horiike, H				Okita, Takafumi; Hoashi, Eiji; Yoshihashi, Sachiko; Kondo, Hiroo; Kanemura, Takuji; Yamaoka, Nobuo; Horiike, Hiroshi			Certification of contact probe measurement of surface wave of Li jet for IFMIF	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		International fusion materials irradiation facility (IFMIF); Electra-contact probe; Liquid Li; Droplet; Accuracy; Surface tension	TARGET	The international fusion material irradiation facility (IFMIF) is a neutron source for developing fusion reactor materials. A liquid lithium (Li) jet with free surface is planned as a target to generate intense neutron field. It is important to obtain information on the surface wave characteristic for safety of the facility and efficient neutron generation. Surface wave characteristics experiment using the liquid Li circulation facility is carried out at Osaka University. In our studies, measurement using an electro-contact probe apparatus is conducted and many data about surface wave height were taken. In this experiment, a liquid Li droplet was observed on the probe. To see effect due to droplets on the probe needle, images near the surface of the Li jet including the Li droplet were taken by HSV camera synchronized with probe contact signals, and correlation between the behavior of the Li droplet and signals was evaluated. From the results, when the droplet on the probe contacts of the droplet with the surface, signals obviously different from the regular signal were observed. The influence on the result of frequency was estimated and is approximately <1%. Accuracy of measurement using probe could be increased by carefully deleting false signals. (C) 2015 Elsevier B.V. All rights reserved.	[Okita, Takafumi; Hoashi, Eiji; Yoshihashi, Sachiko; Yamaoka, Nobuo; Horiike, Hiroshi] Osaka Univ, Grad Sch Engn, Suita, Osaka, Japan; [Kondo, Hiroo; Kanemura, Takuji] Japan Atom Energy Agcy, Oarai, Ibaraki, Japan	Okita, T (reprint author), Osaka Univ, Grad Sch Engn, 2-1 Yamadaoka, Suita, Osaka, Japan.	okita@stu.nucl.eng.osaka-u.ac.jp					Knaster J, 2014, FUSION ENG DES, V89, P1709, DOI 10.1016/j.fusengdes.2014.01.011; Knaster J, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/11/116001; Ida M, 2004, FUSION ENG DES, V70, P95, DOI 10.1016/S0920-3796(03)00416-2; Sugiura H, 2011, FUSION ENG DES, V86, P2635, DOI 10.1016/j.fusengdes.2011.03.084; Okita T., 2013, P NURETH, P186; Yoshihashi-Suzuki S, 2012, FUSION ENG DES, V87, P1434, DOI 10.1016/j.fusengdes.2012.03.027	6	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				2050	2053		10.1016/j.fusengdes.2015.04.035		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900223		
J	Ozawa, K; Tanigawa, H; Morisada, Y; Fujii, H				Ozawa, Kazumi; Tanigawa, Hiroyasu; Morisada, Yoshiaki; Fujii, Hidetoshi			Impacts of friction stir processing on irradiation effects in vacuum-plasma-spray coated tungsten	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Tungsten; Vacuum plasma spray; Friction stir processing; Ion irradiation; Nano indentation	HARDNESS	In order to examine the impacts of friction stir processing (FSP) on irradiation effects in vacuum-plasmaspray (VPS) coated tungsten (W), nano indentation hardness was evaluated of three kinds of W materials after self-ion-irradiation to 5.0-5.4 dpa at 500 and 800 degrees C. The VPS-FSP clearly got grains refined and isotropic compared to bulk-W and the as-VPS-W. Nano indentation hardness remains unchanged for the as-VPS-W and VPS-FSP x 2-W irradiated to 5.4 dpa at 500 degrees C and it decreased from 1 dpa at 800 degrees C, while typical irradiation induced hardening was observed for the bulk-W irradiated at 500 degrees C. (C) 2015 Elsevier B.V. All rights reserved.	[Ozawa, Kazumi; Tanigawa, Hiroyasu] Japan Atom Energy Agcy, Fus Res & Dev Directorate, Aomori 0393212, Japan; [Morisada, Yoshiaki; Fujii, Hidetoshi] Osaka Univ, Joining & Welding Res Inst, Ibaraki, Osaka 5670047, Japan	Ozawa, K (reprint author), Japan Atom Energy Agcy, Fus Res & Dev Directorate, 2-166 Obuchi Omotedate, Aomori 0393212, Japan.	ozawa.kazumi@jaea.go.jp					Bolt H, 2004, J NUCL MATER, V329, P66, DOI 10.1016/j.jnucmat.2004.04.005; Fukuda M, 2013, J NUCL MATER, V442, pS273, DOI 10.1016/j.jnucmat.2013.03.058; Hirose T, 2006, FUSION ENG DES, V81, P645, DOI 10.1016/j.fusengdes.2005.07.015; Morisada Y, 2010, SURF COAT TECH, V204, P2459, DOI 10.1016/j.surfcoat.2010.01.021; Sasaki K, 2013, FUSION ENG DES, V88, P1735, DOI 10.1016/j.fusengdes.2013.05.052; Noh S, 2014, FUSION ENG DES, V89, P289, DOI 10.1016/j.fusengdes.2014.01.084; Tokunaga K, 2006, FUSION ENG DES, V81, P133, DOI 10.1016/j.fusengdes.2005.08.032; Zinkle SJ, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/10/104024; Nagasaka T, 2009, FUSION SCI TECHNOL, V56, P1053; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Tanigawa H, 2015, FUSION ENG DES, V98-99, P2080, DOI 10.1016/j.fusengdes.2015.04.059; Ziegler J.F., 1985, STOPPING RANGE IONS, P109	12	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				2054	2057		10.1016/j.fusengdes.2015.06.104		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900224		
J	Sakasegawa, H; Tanigawa, H; Kano, S; Abe, H				Sakasegawa, Hideo; Tanigawa, Hiroyasu; Kano, Sho; Abe, Hiroaki			Material properties of the F82H melted in an electric arc furnace	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Fusion DEMO reactor; Reduced activation ferritic/martensitic steel; Electric arc furnace; Mechanical property; Microstructure	STEEL; TOUGHNESS	Fusion DEMO reactor requires over 11,000 tons of reduced activation ferritic/martensitic steel. It is necessary to develop the manufacturing technology for fabricating such large-scale steel with appropriate mechanical properties. In this work, we focused fundamental mechanical properties and microstructures of F82H-BA12 heat which was melted using a 20 tons electric arc furnace followed by electroslag remelting process. Its raw material of iron was blast furnace iron, because the production volume of electrolytic iron which has been used in former heats, is limited. After melting and forging, this F82H-BA12 heat was heat-treated in four different conditions to consider their fluctuations and to optimize them, and tensile and Charpy impact tests were then performed. The result of these mechanical properties were comparable to those of former F82H heats less than 5 tons which were melted applying vacuum induction melting. (C) 2015 Elsevier B.V. All rights reserved.	[Sakasegawa, Hideo; Tanigawa, Hiroyasu] Japan Atom Energy Agcy, Aomori, Japan; [Kano, Sho; Abe, Hiroaki] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 980, Japan	Sakasegawa, H (reprint author), Japan Atom Energy Agcy, Aomori, Japan.	sakasegawa.hideo@jaea.go.jp					Kushima H, 1999, TETSU TO HAGANE, V85, P841; Tanigawa H, 2014, FUSION ENG DES, V89, P1573, DOI 10.1016/j.fusengdes.2014.02.052; Obara S, 2009, TETSU TO HAGANE, V95, P417; Sakasegawa H, 2014, FUSION ENG DES, V89, P1684, DOI 10.1016/j.fusengdes.2014.02.024; WILLIAMSON GK, 1953, ACTA METALL MATER, V1, P22, DOI 10.1016/0001-6160(53)90006-6; Shiba K, 2012, FUSION SCI TECHNOL, V62, P145; WILLIAMSON GK, 1956, PHILOS MAG, V1, P34, DOI 10.1080/14786435608238074; Sakasegawa H, 2011, FUSION ENG DES, V86, P2541, DOI 10.1016/j.fusengdes.2011.03.087; Tanigawa H, 2011, FUSION ENG DES, V86, P2549, DOI 10.1016/j.fusengdes.2011.04.047	9	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				2068	2071		10.1016/j.fusengdes.2015.06.103		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900227		
J	Sukegawa, AM; Murakami, H; Matsunaga, G; Sakurai, S; Takechi, M; Yoshida, K; Ikeda, Y				Sukegawa, Atsuhiko M.; Murakami, Haruyuki; Matsunaga, Go; Sakurai, Shinji; Takechi, Manabu; Yoshida, Kiyoshi; Ikeda, Yoshitaka			Estimation of the lifetime of resin insulators against baking temperature for JT-60SA in-vessel coils	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Bismaleimides resin; Cyanate ester resin; Cyanate ester epoxy resin; Thermal endurance; Lifetime; JT-605A in-vessel coils		In the present study, the thermal endurance of epoxy-based, bismaleimides, and cyanate ester resins for the current design of the in-vessel coils was measured by performing acceleration tests to assess their insulation properties using the thermal endurance defined by the International Electrotechnical Commission (IEC-60216 Partl -Part 6) for a minimum of 5,000h in the 180-240 degrees C temperature range. It was found that none of the resin insulators could tolerate the baking conditions of 40,000 h at 200 degrees C in the JT-60SA vacuum vessel. Therefore, the design of the in-vessel coils, including the error field correction coils (EFCC), was changed from the type without water cooling to with water cooling on JT-60SA. (C) 2015 Elsevier B.V. All rights reserved.	[Sukegawa, Atsuhiko M.; Murakami, Haruyuki; Matsunaga, Go; Sakurai, Shinji; Takechi, Manabu; Yoshida, Kiyoshi; Ikeda, Yoshitaka] Japan Atom Energy Agcy, Naka, Ibaraki, Japan	Sukegawa, AM (reprint author), Japan Atom Energy Agcy, Naka, Ibaraki, Japan.	morioka.atsuhiko@jaea.go.jp					Abernethy R, 2006, NEW WEIBULL HDB; Sukegawa AM, 2011, J NUCL MATER, V417, P850, DOI 10.1016/j.jnucmat.2010.12.291; Ishida S, 2010, FUSION ENG DES, V85, P2070, DOI 10.1016/j.fusengdes.2010.07.027; Sukegawa AM, 2007, FUSION ENG DES, V82, P2799, DOI 10.1016/j.fusengdes.2007.06.021; Ayano R, 1984, NETSUKOHKASEIJYUSHI, V5, P23; Delfa G.L., HIGH TEMPERATURE FLA; Matsunaga G., 2014, 28 SOFT 2014 S FUS T; Tavlet M., 1998, COMPILATION RAD DAMA; Weber H.W., 2013, IEEE T APPL SUPERCON	9	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				2076	2079		10.1016/j.fusengdes.2015.06.018		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900229		
J	Tanigawa, H; Ozawa, K; Morisada, Y; Noh, S; Fujii, H				Tanigawa, Hiroyasu; Ozawa, Kazumi; Morisada, Yoshiaki; Noh, Sanghoon; Fujii, Hidetoshi			Modification of vacuum plasma sprayed tungsten coating on reduced activation ferritic/martensitic steels by friction stir processing	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Tungsten; Vacuum plasma spray; Friction stir processing; Reduced activation ferritic/martensitic steel		Tungsten (W) is the primary candidate material as a plasma facing material in fusion devices, as for its high melting temperature, good thermal conductivity and low sputtering rate, and vacuum plasma spray (VPS) technique is preferred as it is applicable for large area without brittle interlayer, but the thermal conductivity of W layer is very poor, and easy to detach, mainly caused by its porous structure. W Friction stir processing (FSP) was applied on VPS-W to improve these poor properties, and it was suggested that FSP can contribute to significant improvement in both mechanical and thermal properties of the VPS-W coating. (C) 2015 Elsevier B.V. All rights reserved.	[Tanigawa, Hiroyasu; Ozawa, Kazumi; Noh, Sanghoon] Japan Atom Energy Agcy, Fus Res & Dev Directorate, Aomori, Japan; [Morisada, Yoshiaki; Fujii, Hidetoshi] Osaka Univ, Joining & Welding Res Inst, Ibaraki, Osaka, Japan; [Noh, Sanghoon] Korea Atom Energy Res Inst, Nucl Mat Dev Div, Daejeon, South Korea	Tanigawa, H (reprint author), Japan Atom Energy Agcy, Fus Res & Dev Directorate, Aomori, Japan.	tanigawa.hiroyasu@jaea.go.jp					Bolt H, 2004, J NUCL MATER, V329, P66, DOI 10.1016/j.jnucmat.2004.04.005; Hirose T, 2006, FUSION ENG DES, V81, P645, DOI 10.1016/j.fusengdes.2005.07.015; Morisada Y, 2010, SURF COAT TECH, V204, P2459, DOI 10.1016/j.surfcoat.2010.01.021; Tokunaga K, 2006, FUSION ENG DES, V81, P133, DOI 10.1016/j.fusengdes.2005.08.032; Nagasaka T, 2009, FUSION SCI TECHNOL, V56, P1053	5	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				2080	2084		10.1016/j.fusengdes.2015.04.059		5	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900230		
J	Tian, K; Abou-Sena, A; Arbeiter, F; Garcia, A; Gouat, P; Heidinger, R; Heinzel, V; Ibarra, A; Leysen, W; Mas, A; Mittwollen, M; Moslang, A; Theile, J; Yamamoto, M; Yokomine, T				Tian, Kuo; Abou-Sena, Ali; Arbeiter, Frederik; Garcia, Angela; Gouat, Philippe; Heidinger, Roland; Heinzel, Volker; Ibarra, Angel; Leysen, Willem; Mas, Avelino; Mittwollen, Martin; Moeslang, Anton; Theile, Juergen; Yamamoto, Michiyoshi; Yokomine, Takehiko			Overview of the IFMIF test facility design in IFMIF/EVEDA phase	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		IFMIF; Test facility; Test modules; Test cell; Neutron irradiation; Fusion material	BREEDER VALIDATION MODULE; REFERENCE TEST CELL; ENGINEERING DESIGN; KEY COMPONENTS; TARGET	The test facility (TF) is one of the three major facilities of the International Fusion Material Irradiation Facility (IFMIF). Engineering designs of TF main systems and key components have been initiated and developed in the IFMIF EVEDA (Engineering Validation and Engineering Design Activities) phase since 2007. The related work covers the designs of a test cell which is the meeting point of the TF and accelerator facility and lithium facility, a series of test modules for experiments under different irradiation conditions, an access cell to accommodate remote handling systems, four test module handling cells for test module processing and assembling, and test facility ancillary systems for engineering support on energy, media, and control infrastructure. This paper summarizes the principle functions, brief specifications, and the current design status of the above mentioned IFMIF TF systems and key components. (C) 2015 Karlsruhe Institute of Technology. Published by Elsevier B.V. All rights reserved.	[Tian, Kuo; Abou-Sena, Ali; Arbeiter, Frederik; Heinzel, Volker; Mittwollen, Martin; Moeslang, Anton] KIT, Karlsruhe, Germany; [Garcia, Angela; Ibarra, Angel; Mas, Avelino] CIEMAT, E-28040 Madrid, Spain; [Gouat, Philippe; Leysen, Willem] CEN SCK, B-2400 Mol, Belgium; [Heidinger, Roland] F4E BFD, Garching, Germany; [Theile, Juergen] CRPP EPFL, Villigen, Switzerland; [Yamamoto, Michiyoshi] IFMIF EVEDA Project Team, Rokkasho, Japan; [Yokomine, Takehiko] Kyoto Univ, Kyoto, Japan	Tian, K (reprint author), KIT, Karlsruhe, Germany.	kuo.tian@kit.edu					Kondo K, 2014, FUSION ENG DES, V89, P1758, DOI 10.1016/j.fusengdes.2013.12.008; Heidinger R, 2013, FUSION ENG DES, V88, P631, DOI 10.1016/j.fusengdes.2013.01.066; Wakai E, 2012, FUSION SCI TECHNOL, V62, P246; Arbeiter F, 2011, FUSION ENG DES, V86, P607, DOI 10.1016/j.fusengdes.2011.01.031; Mas A, 2014, FUSION ENG DES, V89, P1728, DOI 10.1016/j.fusengdes.2013.12.029; Gouat P, 2013, FUSION ENG DES, V88, P729, DOI 10.1016/j.fusengdes.2013.02.057; Tian K, 2010, FUSION ENG DES, V85, P2282, DOI 10.1016/j.fusengdes.2010.09.007; Tian K, 2013, FUSION ENG DES, V88, P635, DOI 10.1016/j.fusengdes.2013.03.055; Garin P, 2008, FUSION ENG DES, V83, P971, DOI 10.1016/j.fusengdes.2008.05.028; Casal N, 2013, FUSION ENG DES, V88, P863, DOI 10.1016/j.fusengdes.2013.03.057; Tian K, 2011, NUCL ENG DES, V241, P4818, DOI 10.1016/j.nucengdes.2011.03.037; Moeslang A, 2006, FUSION ENG DES, V81, P863, DOI 10.1016/j.fusengdes.2005.07.044; Tian K, 2014, FUSION ENG DES, V89, P1694, DOI 10.1016/j.fusengdes.2014.02.008; Yamamoto M, 2013, FUSION ENG DES, V88, P746, DOI 10.1016/j.fusengdes.2013.03.062; Abou-Sena A, 2013, FUSION ENG DES, V88, P818, DOI 10.1016/j.fusengdes.2013.02.041; IFMIF International Team, 2003, IFMIF COMPR DES REP; Leysen W., 2012, SOFT27; Tian K., 2013, ICONE, V21	18	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				2085	2088		10.1016/j.fusengdes.2015.05.041		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900231		
J	Wakai, E; Kikuchi, T; Kim, B; Kimura, A; Nogami, S; Hasegawa, A; Nishimura, A; Soldaini, M; Yamamoto, M; Knaster, J				Wakai, Eiichi; Kikuchi, Takayuki; Kim, Byung; Kimura, Akihiko; Nogami, Shuhei; Hasegawa, Akira; Nishimura, Arata; Soldaini, Michel; Yamamoto, Michiyoshi; Knaster, Juan			Overview on recent progress toward small specimen test technique	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Small specimen test technique; IFMIF; Master curve method; Ductile-brittle transition temperature; PIE	TEMPERED MARTENSITIC STEEL; MASTER-CURVE ANALYSIS; FERRITIC/MARTENSITIC STEEL; SWELLING BEHAVIOR; ION-BEAMS; F82H; IRRADIATION; HELIUM; EUROFER97; HYDROGEN	The present status of the small specimen test technique (SSTT) and the engineering design of the post irradiation examination (PIE) facility in the International Fusion Materials Irradiation Facility (IFMIF) were evaluated and summarized as parts of the IFMIF/engineering validation and engineering design activity (EVEDA). SSTT is very important to obtain data mainly for the design of fusion demonstration (DEMO) reactors using the high flux test module (HFTM) of IFMIF. The analysis of brittle-ductile transition behaviors of reduced-activation ferritic/martensitic (RAFM) steels is very important for evaluating the structural integrity of RAFM steels used in the fusion DEMO reactors, and it is necessary to develop new analyses combined with random inhomogeneity analysis and the modified master curve method. Further developed analysis and test equipment developing for small specimen tests are necessary in the establishment of SSTT. (C) 2015 Elsevier B.V. All rights reserved.	[Wakai, Eiichi; Kikuchi, Takayuki; Kim, Byung] JAEA, Tokai, Ibaraki, Japan; [Kimura, Akihiko] Kyoto Univ, Uji, Kyoto, Japan; [Nogami, Shuhei; Hasegawa, Akira] Tohoku Univ, Sendai, Miyagi 980, Japan; [Nishimura, Arata] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Soldaini, Michel] CEA, Paris, France; [Yamamoto, Michiyoshi; Knaster, Juan] IFMIF Project Team, Aomori, Japan	Wakai, E (reprint author), JAEA, Tokai, Ibaraki, Japan.	wakai.eiichi@jaea.go.jp					Kim BJ, 2013, J NUCL MATER, V442, pS38, DOI 10.1016/j.jnucmat.2013.03.079; Wakai E, 2011, FUSION ENG DES, V86, P712, DOI 10.1016/j.fusengdes.2011.04.061; Wakai E, 2003, J NUCL MATER, V318, P267, DOI 10.1016/S0022-3115(03)00122-3; Wakai E, 2004, MATER TRANS, V45, P2641, DOI 10.2320/matertrans.45.2641; Wakai E, 2006, J NUCL MATER, V356, P95, DOI 10.1016/j.jnucmat.2006.05.032; Wakai E, 2012, FUSION SCI TECHNOL, V62, P246; Nogami S, 2013, J NUCL MATER, V441, P125, DOI 10.1016/j.jnucmat.2013.05.051; Wakai E, 2002, J NUCL MATER, V307, P278, DOI 10.1016/S0022-3115(02)01076-0; Wakai E, 2005, J NUCL MATER, V343, P285, DOI 10.1016/j.jnucmat.2004.10.167; Wallin K, 2004, ENG FRACT MECH, V71, P2329, DOI [10.1016/j.engfracmech.2004.01.010, 10.1016/j.angfracmech.2004.01.010]; [Anonymous], 2004, IFMIF COMPR DES REP; Gaganidze E, 2011, J NUCL MATER, V417, P93, DOI 10.1016/j.jnucmat.2010.12.047; Wakai E, 2000, J NUCL MATER, V283, P799, DOI 10.1016/S0022-3115(00)00268-3; Knaster J, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/11/116001; Nogami S, 2011, J NUCL MATER, V417, P131, DOI 10.1016/j.jnucmat.2010.12.048; Tanaka T, 2004, J NUCL MATER, V329, P294, DOI 10.1016/j.jnucmat.2004.04.051; Morimura T, 1996, J NUCL MATER, V239, P118, DOI 10.1016/S0022-3115(96)00466-7; Wakai E, 2011, J NUCL MATER, V417, P1325, DOI 10.1016/j.jnucmat.2011.02.011; Spatig P, 2007, J NUCL MATER, V367, P527, DOI 10.1016/j.jnucmat.2007.03.038; Taguchi T, 2004, J NUCL MATER, V335, P508, DOI 10.1016/j.jnucmat.2004.08.014; Mueller P, 2009, J NUCL MATER, V386-88, P323, DOI 10.1016/j.jnucmat.2008.12.122; Kim BJ, 2011, FUSION ENG DES, V86, P2403, DOI 10.1016/j.fusengdes.2011.04.001; [Anonymous], 1995, IEA TECHN PLANN WORK; Bonade R, 2007, J NUCL MATER, V367, P581, DOI 10.1016/j.jnucmat.2007.03.031; IFMIF International Team, 2003, IFMIF KEP INT FUS MA; Ito Y., 2014, 1576 ASTM STP, P209; Ito Y., 2015, J PLASMA FUSION RES, V11, P73; Martone M., 1996, RTERGFUS9611 ENEA; Moeslang A., DEV REFERENCE TEST M; Sokojov MA, 2007, J NUCL MATER, V367, P587, DOI 10.1016/j.jnucmat.2007.03.105; Wakai E., 2015, INT C FUS REACT MAT; Wakai E., 2015, J PLASMA FUSION RES, V11, P104; Wakai E., 2012, 24 IAEA FUS EN C OCT, P7	33	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				2089	2093		10.1016/j.fusengdes.2015.06.068		5	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900232		
J	Zhang, ZX; Chen, DS; Han, WT; Kimura, A				Zhang, Z. X.; Chen, D. S.; Han, W. T.; Kimura, A.			Irradiation hardening in pure tungsten before and after recrystallization	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Tungsten; Recrystallization; Ion-irradiation; Nano-indentation; Hardening effect	ION-IRRADIATION; COOLED DIVERTOR; DAMAGE; DEMO	Ion-irradiation hardening of tungsten (W) before and after recrystallization was investigated in this paper. Three specimens were sampled from a rolled pure (99.95%) W plate. Two are from the as-received W and one was from the recrystallized W (annealed at 1400 degrees C for 1 h). Specimens were irradiated with 6.4 MeV Fe3+ at 300 degrees C, 700 degrees C and 1000 degrees C, respectively. The profile of displacement per atom (dpa) calculated by SRIM showed the average displacement damage is about 2 dpa at the depth of 600 nm. The hardness of irradiated area was measured by nano-indentation method with continuous stiffness measurement (CSM) and was calculated by Nix-Gao model for bulk-equivalent hardness. Irradiation hardening was defined as the difference between the hardness values of irradiated area and unirradiated area of a specimen. The result revealed that recrystallized specimens exhibited larger irradiation hardening than the as-received ones, and the amount of hardening was independent of irradiation temperature, while the hardening of as-received W increased with increasing irradiation temperature. There was no difference in the irradiation hardening between the specimens sampled from the different sides of the as-received W. (C) 2015 Elsevier B.V. All rights reserved.	[Zhang, Z. X.; Chen, D. S.] Kyoto Univ, Grad Sch Energy Sci, Uji, Kyoto, Japan; [Han, W. T.; Kimura, A.] Kyoto Univ, Inst Adv Energy, Uji, Kyoto, Japan	Zhang, ZX (reprint author), Kyoto Univ, Grad Sch Energy Sci, Uji, Kyoto, Japan.	zx-zhang@iae.kyoto-u.ac.jp					Alimov VK, 2011, PHYS SCRIPTA, VT145, DOI 10.1088/0031-8949/2011/T145/014037; Hasegawa A, 2013, MATER TRANS, V54, P466, DOI 10.2320/matertrans.MG201208; Cui MH, 2013, NUCL INSTRUM METH B, V307, P507, DOI 10.1016/j.nimb.2012.12.083; Rieth M, 2013, J NUCL MATER, V432, P482, DOI 10.1016/j.jnucmat.2012.08.018; Kasada R, 2011, FUSION ENG DES, V86, P2658, DOI 10.1016/j.fusengdes.2011.03.073; Nix WD, 1998, J MECH PHYS SOLIDS, V46, P411, DOI 10.1016/S0022-5096(97)00086-0; Xu Q, 2003, NUCL INSTRUM METH B, V206, P123, DOI 10.1016/S0168-583X(03)00697-9; Pharr GM, 2010, ANNU REV MATER RES, V40, P271, DOI 10.1146/annurev-matsci-070909-104456; [Anonymous], 2009, E521962009 ASTM; Armstrong DEJ, 2013, J NUCL MATER, V432, P428, DOI 10.1016/j.jnucmat.2012.07.044; Bolt H, 2002, J NUCL MATER, V307, P43, DOI 10.1016/S0022-3115(02)01175-3; Stoller RE, 2013, NUCL INSTRUM METH B, V310, P75, DOI 10.1016/j.nimb.2013.05.008; Yi X, 2013, PHILOS MAG, V93, P1715, DOI 10.1080/14786435.2012.754110; Hasegawa A, 2014, FUSION ENG DES, V89, P1568, DOI 10.1016/j.fusengdes.2014.04.035; Norajitra P, 2007, J NUCL MATER, V367, P1416, DOI 10.1016/j.jnucmat.2007.04.027; NORGETT MJ, 1975, NUCL ENG DES, V33, P50, DOI 10.1016/0029-5493(75)90035-7; Rieth M, 2011, J NUCL MATER, V417, P463, DOI 10.1016/j.jnucmat.2011.01.075; Himei Y, 2013, MATER TRANS, V54, P446, DOI 10.2320/matertrans.MG201212; Norajitra P, 2006, FUSION ENG DES, V81, P341, DOI 10.1016/j.fusengdes.2005.07.024; Wang HW, 2013, J NUCL MATER, V442, P189, DOI 10.1016/j.jnucmat.2013.08.036; Janeschitz G, 2006, FUSION ENG DES, V81, P2661, DOI 10.1016/j.fusengdes.2006.07.085; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; SCATTERGOOD RO, 1982, ACTA METALL MATER, V30, P1665, DOI 10.1016/0001-6160(82)90188-2	23	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				2103	2107		10.1016/j.fusengdes.2015.06.192		5	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900235		
J	Furukawa, T; Hirakawa, Y; Kondo, H; Kanemura, T; Wakai, E				Furukawa, Tomohiro; Hirakawa, Yasushi; Kondo, Hiroo; Kanemura, Takuji; Wakai, Eiichi			Chemical reaction of lithium with room temperature atmosphere of various humidities	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		IFMIF; EVEDA; Lithium; Safety handling; Chemical reaction		When replacing lithium target components in the International Fusion Materials Irradiation Facility, the lithium adhering on the surface of components will chemically react with the surrounding atmosphere. In this study, we investigate the chemical reaction of pure lithium in room temperature air, oxygen, nitrogen, and argon of various humidities. In air, oxygen, and argon, the weight gain increases with time and humidity, and no significant difference is observed in these gases. In nitrogen, except for the test with 75% relative humidity (RH), the weight gain accelerates with time, and the weight gain rate decreases with increasing RH. We attribute the weight gain increase observed in low humidity to the acceleration due to lithium nitride formation. Upon increasing the moisture content of the gas, the main lithium reaction becomes lithium hydroxide formation. (C) 2014 Elsevier B.V. All rights reserved.	[Furukawa, Tomohiro; Hirakawa, Yasushi; Kondo, Hiroo; Kanemura, Takuji; Wakai, Eiichi] Japan Atom Energy Agcy, Oarai, Ibaraki 3111393, Japan	Furukawa, T (reprint author), Japan Atom Energy Agcy, 4002 Narita, Oarai, Ibaraki 3111393, Japan.	furukawa.tomohiro@jaea.go.jp					Knaster J, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/11/116001; Kondo H, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/12/123008; Furukawa T, 2013, FUSION ENG DES, V88, P2502, DOI 10.1016/j.fusengdes.2013.04.036; Furukawa T, 2011, FUSION ENG DES, V86, P2433, DOI 10.1016/j.fusengdes.2010.12.037; Kondo H, 2012, FUSION ENG DES, V87, P418, DOI 10.1016/j.fusengdes.2011.11.011; Furukawa T., 2012, P 2012 20 INT C NUCL; Furukawa T., 2014, P 2014 22 INT C NUCL; Furukawa T., 2010, P 18 INT C NUCL ENG; Matsumoto T., 1992, NETSU SOKUTEI, V19, P170; Moeslang A., 2002, P 19 FUS EN C	10	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				2138	2141		10.1016/j.fusengdes.2014.11.019		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900243		
J	Namba, K; Kasada, R; Konishi, S; Yamamoto, Y				Namba, Kyosuke; Kasada, Ryuta; Konishi, Satoshi; Yamamoto, Yasushi			Evaluation of tritium transport in the biomass-fusion hybrid system and its environmental impact	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Tritium; Biomass; Fusion reactor; Fuel cell; Environmental safety; System dynamics	HIGH-TEMPERATURE; NEUTRONICS; REACTOR; BLANKET	The behavior of tritium contained, in the biofuel produced by the fusion energy is analyzed. Hydrogen product is contaminated with tritium from breeding blanket of fusion plant within the regulation limit and released to atmosphere when used for fuel cell vehicles. In the model city, Osaka, seven-compartment model describes the behavior of exhausted tritium by adapting the environment water flow and its migration was analyzed with STELLA system dynamics code. Tritium (HTO) with a concentration of 5000 Bq//m(3) exhausted from the running vehicle increases decades and reaches steady state after about 50 years, at around 40 Bq/m(3) in atmosphere and 4Bq/L in surface soil water that does not deserve health hazard, however causes contamination of large populated area. (C) 2015 Elsevier B.V. All rights reserved.	[Namba, Kyosuke] Kyoto Univ, Grad Sch Energy Sci, Kyoto, Japan; [Kasada, Ryuta; Konishi, Satoshi] Kyoto Univ, Inst Adv Energy, Kyoto, Japan; [Yamamoto, Yasushi] Kansai Univ, Fac Engn Sci, Osaka, Japan	Kasada, R (reprint author), Kyoto Univ, Inst Adv Energy, Kyoto, Japan.	r-kasada@iae.kyoto-u.ac.jp					[Anonymous], 2009, DAT PREC JAP; Demange D, 2014, FUSION ENG DES, V89, P1219, DOI 10.1016/j.fusengdes.2014.04.028; Kwon S, 2013, FUSION SCI TECHNOL, V64, P599; Ibano K, 2011, FUSION ENG DES, V86, P2779, DOI 10.1016/j.fusengdes.2010.12.011; Ibano K, 2013, FUSION ENG DES, V88, P2881, DOI 10.1016/j.fusengdes.2013.05.088; Yamamoto Y, 2014, FUSION ENG DES, V89, P1392, DOI 10.1016/j.fusengdes.2014.01.039; [Anonymous], 2012, WHIT PAP LAND INFR T; Hamon W.R., 1961, J HYDRAULICS DIVISIO, V87, P107; Marui A., 2010, REPORT AMOUNT AVAILA; Onaka H., 2010, INT SEM JHFC; Rascob W., 1990, 4605 KFK; Rascob W., 1990, 5364 KFK; Toshihiro S., 2009, 23 IEEE NPSS S 2009	13	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				2162	2165		10.1016/j.fusengdes.2015.07.009		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900248		
J	Konno, C; Ochiai, K; Sato, S; Ohta, M				Konno, Chikara; Ochiai, Kentaro; Sato, Satoshi; Ohta, Masayuki			Analyses of iron and concrete shielding experiments at JAEA/TIARA with JENDL/HE-2007, ENDF/B-VII.1 and FENDL-3.0	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	28th Symposium on Fusion Technology (SOFT)	SEP 29-OCT 03, 2014	San Sebastian, SPAIN	Spanish Res Ctr Energy Environm & Technol		Iron; Concrete; TIARA; JENDL/HE-2007; ENDF/B-VII.1; FENDL-3.0	NUCLEAR-SCIENCE; TECHNOLOGY; LIBRARY	IAEA released a new Fusion Evaluated Nuclear Data Library, FENDL-3.0, in 2012. FENDL-3.0 extends the neutron energy range from 20 MeV to greater than 60 MeV. Now there is increasing interest in nuclear data above 20 MeV. Thus we have analyzed the iron and concrete shielding experiments with the 40 and 65 MeV neutron sources at TIARA in Japan Atomic Energy Agency with the latest high-energy nuclear data libraries, JENDL/HE-2007, ENDF/B-VII.1 and FENDL-3.0. The Monte Carlo code MCNP-5 and ACE files of JENDL/HE-2007, ENDF/B-VII.1 and FENDL-3.0, which are supplied from JAEA, LANL and IAEA, respectively, were used for this analysis. The collimated neutron beam and test shields were modeled in the analysis. The measured source neutron data were adopted in the analysis. The followings are found out from the results; (1) Iron experiments: The calculation result with FENDL-3.0 agrees with the measured one best. That with JENDL/HE-2007 fairly agrees with the measured one. On the contrary that with ENDF/BVII.1 drastically overestimates the measured one. It is confirmed that this overestimation is due to the smaller non-elastic scattering data of Fe-56 in ENDF/B-VII.1. (2) Concrete experiments: The calculation result with ENDL/HE-2007 agrees with the measured one best, while those with FENDL-3.0 and ENDF/BVII.1 drastically overestimate the measured one. It is confirmed that this overestimation is due to both the larger elastic and smaller non-elastic scattering data of 160 in FENDL-3.0 and ENDF/B-VII.1. (C) 2015 Elsevier B.V. All rights reserved.	[Konno, Chikara; Ochiai, Kentaro; Sato, Satoshi; Ohta, Masayuki] Japan Atom Energy Agcy, Sect Fus Res & Dev, Tokai, Ibaraki 3191195, Japan	Konno, C (reprint author), Japan Atom Energy Agcy, Sect Fus Res & Dev, Tokai, Ibaraki 3191195, Japan.	konno.chikara@jaea.go.jp					Chadwick MB, 2011, NUCL DATA SHEETS, V112, P2887, DOI 10.1016/j.nds.2011.11.002; [Anonymous], 2013, RSICC CODE PACKAGE C; Watanabe Y, 2011, J KOREAN PHYS SOC, V59, P1040, DOI 10.3938/jkps.59.1040; Shibata K, 2011, J NUCL SCI TECHNOL, V48, P1, DOI 10.3327/jnst.48.1; Chadwick MB, 2006, NUCL DATA SHEETS, V107, P2931, DOI 10.1016/j.nds.2006.11.001; Chadwick M. B., 1999, LAUR991222; Forrest R.A, INDCNDS0628; Kondo K, 2014, PROG NUCL SCI TECHNO, V4, P322; MacFarlane R.E., 1994, LA12740M; Nakane Y., 1996, 96029 JAERIDATACODE; Santamarina A., 2009, 22 JEFF; Sasa T., 2008, 2008022 JAEADATACODE; X-5 Monte Carlo Team, 2005, LAUR031987	13	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	OCT	2015	98-99		B				2178	2181		10.1016/j.fusengdes.2014.12.034		4	Nuclear Science & Technology	Nuclear Science & Technology	CU2HP	WOS:000363344900251		
J	Yokota, SI; Konno, M; Fujiwara, SI; Toita, N; Takahashi, M; Yamamoto, S; Ogasawara, N; Shiraishi, T				Yokota, Shin-ichi; Konno, Mutsuko; Fujiwara, Shin-ichi; Toita, Nariaki; Takahashi, Michiko; Yamamoto, Soh; Ogasawara, Noriko; Shiraishi, Tsukasa			Intrafamilial, Preferentially Mother-to-Child and Intraspousal, Helicobacter pylori Infection in Japan Determined by Mutilocus Sequence Typing and Random Amplified Polymorphic DNA Fingerprinting	HELICOBACTER			English	Article						Intrafamilial infection; intraspousal infection; Helicobacter pylori; multilocus sequence typing; random amplified polymorphic DNA fingerprinting	MOLECULAR EPIDEMIOLOGY; FOLLOW-UP; TRANSMISSION; ERADICATION; POPULATION; PREVALENCE; FAMILIES; SPOUSES; CAMPYLOBACTER; REINFECTION	Background: The infection route of Helicobacter pylori has been recognized to be mainly intrafamilial, preferentially mother-to-child, especially in developed countries. To determine the transmission route, we examined whether multilocus sequence typing (MLST) was useful for analysis of intrafamilial infection. The possibility of intraspousal infection was also evaluated. Materials and Methods: Clonal relationships between strains derived from 35 index Japanese pediatric patients, and their family members were analyzed by two genetic typing procedures, MLST and random amplified polymorphic DNA (RAPD) fingerprinting. Results: Mostly coincident results were obtained by MLST and RAPD. By MLST, the allele of loci in the isolates mostly matched between the index child and both the father and mother for 9 (25.7%) of the 35 patients, between the index child and the mother for 25 (60.0%) of the 35 patients. Conclusions: MLST is useful for analyzing the infection route of H. pylori as a highly reproducible method. Intrafamilial, especially mother-to-children and sibling, infection is the dominant transmission route. Intraspousal infection is also thought to occur in about a quarter in the Japanese families.	[Yokota, Shin-ichi; Yamamoto, Soh; Ogasawara, Noriko; Shiraishi, Tsukasa] Sapporo Med Univ, Sch Med, Dept Microbiol, Sapporo, Hokkaido, Japan; [Konno, Mutsuko; Fujiwara, Shin-ichi; Toita, Nariaki; Takahashi, Michiko] Sapporo Kosei Gen Hosp, Dept Pediat, Sapporo, Hokkaido 0600033, Japan; [Ogasawara, Noriko] Sapporo Med Univ, Sch Med, Dept Otolaryngol, Sapporo, Hokkaido, Japan	Yokota, SI (reprint author), Sapporo Kosei Gen Hosp, Dept Pediat, Chuo Ku, North-3,East-8, Sapporo, Hokkaido 0600033, Japan.	mutsukon@ja-hokkaidoukouseiren.or.jp					Nomura H, 2000, J GASTROEN HEPATOL, V15, P1377, DOI 10.1046/j.1440-1746.2000.02228.x; Kamada T, 2007, DIGEST ENDOSC, V19, P32, DOI 10.1111/j.1443-1661.2007.00671.x; SCHUTZE K, 1995, GUT, V36, P831, DOI 10.1136/gut.36.6.831; Vale FF, 2010, INT J FOOD MICROBIOL, V138, P1, DOI 10.1016/j.ijfoodmicro.2010.01.016; Mourad-Baars P, 2010, HELICOBACTER, V15, P53, DOI 10.1111/j.1523-5378.2010.00776.x; Suzuki J, 1999, J CLIN MICROBIOL, V37, P4174; MIYAJI H, 1995, LANCET, V345, P464; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Toita N, 2013, GASTROENT RES PRACT, DOI 10.1155/2013/721306; Osaki T, 2013, J MED MICROBIOL, V62, P761, DOI 10.1099/jmm.0.053140-0; Breurec S, 2013, HELICOBACTER, V18, P249, DOI 10.1111/hel.12037; Konno M, 2008, PEDIATR INFECT DIS J, V27, P999, DOI 10.1097/INF.0b013e31817d756e; Kivi M, 2006, SCAND J INFECT DIS, V38, P407, DOI 10.1080/00365540600585131; Konno M, 2005, J CLIN MICROBIOL, V43, P2246, DOI 10.1128/JCM.43.5.2246; Take S, 2012, J GASTROENTEROL, V47, P641, DOI 10.1007/s00535-012-0536-9; Lee JYH, 2001, GUT, V49, pA31; Suzuki R, 2012, INFECT GENET EVOL, V12, P203, DOI 10.1016/j.meegid.2011.12.002; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Rowland M, 2006, GASTROENTEROLOGY, V130, P65, DOI 10.1053/j.gastro.2005.11.004; WEBB PM, 1994, BRIT MED J, V308, P750; Achtman M, 1999, MOL MICROBIOL, V32, P459, DOI 10.1046/j.1365-2958.1999.01382.x; Perez-Losada M, 2013, INFECT GENET EVOL, V16, P38, DOI 10.1016/j.meegid.2013.01.009; GOODMAN KJ, 1995, INT J EPIDEMIOL, V24, P875, DOI 10.1093/ije/24.5.875; Leal-Herrera Y, 2003, AM J GASTROENTEROL, V98, P2395, DOI 10.1016/S0002-9270(03)00714-7; POUNDER RE, 1995, ALIMENT PHARM THERAP, V9, P33; Kivi M, 2003, J CLIN MICROBIOL, V41, P5604, DOI 10.1128/JCM.41.12.5604-5608.2003; Blaser MJ, 1996, SCI AM, V274, P104; Luman W, 2002, EUR J GASTROEN HEPAT, V14, P521, DOI 10.1097/00042737-200205000-00009; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Fukase K, 2008, LANCET, V372, P392, DOI 10.1016/S0140-6736(08)61159-9; Kuo CH, 1999, J INFECT DIS, V180, P2064, DOI 10.1086/315130; Moodley Y, 2009, SCIENCE, V323, P527, DOI 10.1126/science.1166083; Kennemann L, 2011, P NATL ACAD SCI USA, V108, P5033, DOI 10.1073/pnas.1018444108; Yamaoka Y, 2009, CLIN MICROBIOL INFEC, V15, P829, DOI 10.1111/j.1469-0691.2009.02967.x; BAMFORD KB, 1993, GUT, V34, P1348, DOI 10.1136/gut.34.10.1348; Roma-Giannikou E, 2003, HELICOBACTER, V8, P15, DOI 10.1046/j.1523-5378.2003.00126.x; Han SR, 2000, J CLIN MICROBIOL, V38, P3646; Georgopoulos SD, 1996, GUT, V39, P634, DOI 10.1136/gut.39.5.634; MORRIS AJ, 1991, ANN INTERN MED, V114, P662; Devi SM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-191; GRAHAM DY, 1989, GASTROENTEROLOGY, V96, P615; Linz B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082187; MARSHALL BJ, 1985, MED J AUSTRALIA, V142, P436; Schwarz S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000180; Ueda J, 2014, HELICOBACTER, V19, P105, DOI 10.1111/hel.12110	45	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1083-4389	1523-5378		HELICOBACTER	Helicobacter	OCT	2015	20	5					334	342		10.1111/hel.12217		9	Gastroenterology & Hepatology; Microbiology	Gastroenterology & Hepatology; Microbiology	CT8KD	WOS:000363064100003		
J	Zaidi, SF; Refaat, A; Zhou, Y; Muhammad, JS; Shin, MS; Saiki, I; Sakurai, H; Sugiyama, T				Zaidi, Syed Faisal; Refaat, Alaa; Zhou, Yue; Muhammad, Jibran Sualeh; Shin, Myoung-Sook; Saiki, Ikuo; Sakurai, Hiroaki; Sugiyama, Toshiro			Helicobacter pylori Induces Serine Phosphorylation of EGFR via Novel TAK1-p38 Activation Pathway in an HB-EGF-Independent Manner	HELICOBACTER			English	Article						Epidermal growth factor receptor; HB-EGF; Helicobacter pylori; p38; TAK1; transactivation	GASTRIC EPITHELIAL-CELLS; GROWTH-FACTOR RECEPTOR; NF-KAPPA-B; VACUOLATING CYTOTOXIN; VIRULENCE FACTORS; INFECTION; CAGA; KINASE; TRANSACTIVATION; CANCER	Background: The interaction of Helicobacter pylori with gastric epithelial cells can result in the activation of transcription factor NF-kappa B via TGF-beta-activated kinase 1 (TAK1). In this study, we have demonstrated the role of H. pylori in the activation of EGFR via TAK1-mediated phosphorylation of p38. Materials and Methods: Gastric epithelial AGS or MKN-45 cells were co-cultured with wild-type or cagA(-) H. pylori strains. H. pylori was added to the cells, and the activation of EGFR, p65 (NF-kappa B) subunit, p38, ERK, and TAK1 was examined by Western blotting. Infected cells were pretreated with or without ligands, chemical inhibitors, anti-HB-EGF antibody, and siRNAs to evaluate the effects on phosphorylation of various EGFR residues. Fluorescence microscopy and flow cytometry were performed to detect the internalization of EGFR. Results: Incubating cells with wild-type and CagA(-) H. pylori strains resulted in the rapid and transient phosphorylation of serine residues of EGFR. RNAi experiments using siRNA against TAK1 and p38 pathways blocked the phosphorylation of serine residue. Immunofluorescence and flow cytometry revealed that EGFR was internalized in H. pylori-infected cells after EGFR phosphorylation in a p38-dependent manner. In contrast, pretreatment with gefitinib and anti-HB-EGF antibody did not block both the phosphorylation and internalization of EGFR. Conclusion: Helicobacter pylori induces internalization of EGFR via novel TAK1-p38-serine activation pathway which is independent of HB-EGF. The interaction between TAK1 and EGFR in H. pylori-infected cells might open new dimensions in understanding H. pylori-associated gastric carcinogenesis.	[Zaidi, Syed Faisal; Muhammad, Jibran Sualeh; Sugiyama, Toshiro] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Gastroenterol & Hematol, Toyama 9300194, Japan; [Zaidi, Syed Faisal] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, Dept Basic Med Sci, Jeddah, Saudi Arabia; [Zaidi, Syed Faisal] Aga Khan Univ, Fac Hlth Sci, Dept Biol & Biomed Sci, Karachi, Pakistan; [Refaat, Alaa; Shin, Myoung-Sook; Saiki, Ikuo] Toyama Univ, Inst Nat Med, Div Pathogen Biochem, Toyama 9300194, Japan; [Refaat, Alaa] Zewail City Sci & Technol, Ctr Aging & Associated Dis, Giza, Egypt; [Zhou, Yue; Sakurai, Hiroaki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Canc Cell Biol, Toyama 9300194, Japan	Sugiyama, T (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Gastroenterol, 2630 Sugitani, Toyama 9300194, Japan.	sfaisalhz@gmail.com; tsugi@med.u-toyama.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	The authors would like to thank Mrs. Toyomi Kozawa (Department of Gastroenterology, University of Toyama) for providing technical support in experiments. This work was supported in part by Grants-in-Aid for Scientific Research on Innovative Areas and the Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	TAYLOR DN, 1991, EPIDEMIOL REV, V13, P42; Morandell S, 2008, PROTEOMICS, V8, P4383, DOI 10.1002/pmic.200800204; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; TSUDA M, 1993, MICROBIOL IMMUNOL, V37, P85; Lamb A, 2009, EMBO REP, V10, P1242, DOI 10.1038/embor.2009.210; Schweitzer K, 2010, EMBO REP, V11, P10, DOI 10.1038/embor.2009.263; Bauer B, 2009, CELL MICROBIOL, V11, P156, DOI 10.1111/j.1462-5822.2008.01246.x; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Tegtmeyer N, 2009, CELL MICROBIOL, V11, P488, DOI 10.1111/j.1462-5822.2008.01269.x; Sunnarborg SW, 2002, J BIOL CHEM, V277, P12838, DOI 10.1074/jbc.M112050200; Sakurai H, 2012, TRENDS PHARMACOL SCI, V33, P522, DOI 10.1016/j.tips.2012.06.007; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; Ogura K, 2000, J EXP MED, V192, P1601, DOI 10.1084/jem.192.11.1601; Keates S, 1997, GASTROENTEROLOGY, V113, P1099, DOI 10.1053/gast.1997.v113.pm9322504; Dickson JH, 2006, CANCER RES, V66, P7524, DOI 10.1158/0008-5472-CAN-05-3246; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Keates S, 2007, J INFECT DIS, V196, P95, DOI 10.1086/518440; Keates S, 2001, J BIOL CHEM, V276, P48127, DOI 10.1074/jbc.M107630200; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Prenzel N, 1999, NATURE, V402, P884; Nishimura M, 2009, MOL CELL BIOL, V29, P5529, DOI 10.1128/MCB.00375-09; Gooz M, 2001, AM J PHYSIOL-GASTR L, V281, pG823; Cover TL, 1996, MOL MICROBIOL, V20, P241, DOI 10.1111/j.1365-2958.1996.tb02612.x; Peek RM, 2002, J GASTROENTEROL, V37, P10, DOI 10.1007/BF02990093; BLASER MJ, 1995, CANCER RES, V55, P2111; Hatakeyama M, 2005, CANCER SCI, V96, P835, DOI 10.1111/j.1349-7006.2005.00130.x; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Zaidi SFH, 2009, HELICOBACTER, V14, P588, DOI 10.1111/j.1523-5378.2009.00724.x; Yan F, 2009, GASTROENTEROLOGY, V136, P1297, DOI 10.1053/j.gastro.2008.12.059; Ashktorab H, 2007, AM J GASTROENTEROL, V102, P2135, DOI 10.1111/j.1572-0241.2007.01400.x; Marchildon PA, 2003, J CLIN MICROBIOL, V41, P1480, DOI 10.1128/JCM.41.4.1480-1485.2003; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Wallasch C, 2002, BIOCHEM BIOPH RES CO, V295, P695, DOI 10.1016/S0006-291X(02)00740-4; Keates S, 1999, J IMMUNOL, V163, P5552; CORREA P, 1992, CANCER RES, V52, P6735; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 1994, SCHIST LIV FLUK HEL; Nakakuki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001782; Schweitzer K, 2010, EMBO REP, V11, P11; Singhirunnusorn P, 2005, BIOL CHEM, V280, P7359; Sokolova O, 2014, BBA-MOL CELL RES, V1843, P715, DOI 10.1016/j.bbamcr.2014.01.006; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1083-4389	1523-5378		HELICOBACTER	Helicobacter	OCT	2015	20	5					381	389		10.1111/hel.12215		9	Gastroenterology & Hepatology; Microbiology	Gastroenterology & Hepatology; Microbiology	CT8KD	WOS:000363064100007		
J	Omata, M; Kanda, T; Yokosuka, O; Crawford, D; Al-Mahtab, M; Wei, L; Ibrahim, A; Lau, GKK; Sharma, BC; Hamid, SS; Chuang, WL; Dokmeci, AK				Omata, Masao; Kanda, Tatsuo; Yokosuka, Osamu; Crawford, Darrell; Al-Mahtab, Mamun; Wei, Lai; Ibrahim, Alaaeldin; Lau, George K. K.; Sharma, Barjesh C.; Hamid, Saeed S.; Chuang, Wan-Long; Dokmeci, A. Kadir			Features of hepatitis C virus infection, current therapies and ongoing clinical trials in ten Asian Pacific countries	HEPATOLOGY INTERNATIONAL			English	Review						Asian Pacific countries; HCV; IL28B; Direct-acting antivirals	SUSTAINED VIROLOGICAL RESPONSE; RANDOMIZED CONTROLLED-TRIAL; HEALTH-CARE WORKERS; INTERFERON-ALPHA-2B PLUS RIBAVIRIN; CHRONIC LIVER-DISEASES; CHRONIC-RENAL-FAILURE; LONG-TERM EFFICACY; CHRONIC GENOTYPE 2; BLOOD-DONORS; RISK-FACTORS	Estimated hepatitis C virus (HCV) infection rates in the general populations were 1.3, 0.9, 0.4-1.0, 14.7, 0.1-0.3, 0.9-1.9, 1.0-2.0, 5, 4.4-8.6 and 0.5-1.3 % in Australia, Bangladesh, Mainland China, Egypt, Hong Kong, India, Japan, Pakistan, Taiwan and Turkey, respectively. The main HCV genotypes (Gs) are G1, G3, G1b, G4, G1b, G3, G1b, G3, G1b and G2, and G1 in Australia, Bangladesh, Mainland China, Egypt, Hong Kong, India, Japan, Pakistan, Taiwan and Turkey, respectively. Of IL28B genotypes, favorable alleles are similar to 50 % in Australia and Turkey, but 60-70 % in most of the other Asian countries. Peginterferon plus ribavirin is available in all ten Asian Pasific countries. In addition, HCV NS3/4A protease inhibitors with peginterferon plus ribavirin are currently available in several countries. Clinical trials of interferon-free regimens for HCV are ongoing in most of the ten Asian Pacific countries.	[Omata, Masao] Yamanashi Hosp Cent & Kita Org, Kofu, Yamanashi 4008506, Japan; [Omata, Masao] Univ Tokyo, Bunkyo Ku, Tokyo 1138655, Japan; [Kanda, Tatsuo; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chuo Ku, Chiba 2608677, Japan; [Crawford, Darrell] Univ Queensland, Sch Med, Woolloongabba, Qld 4102, Australia; [Al-Mahtab, Mamun] Bangabandhu Sheikh Mujib Med Univ, Dept Hepatol, Dhaka 1000, Bangladesh; [Wei, Lai] Peking Univ, Peoples Hosp, Inst Hepatol, Beijing 100871, Peoples R China; [Ibrahim, Alaaeldin] Benha Univ, Dept Internal Med, GI Liver Div, Banha, Egypt; [Lau, George K. K.] 302 Hosp, Hong Kong SAR China Inst Translat Hepatol, Humanity & Hlth Med Ctr, Beijing, Peoples R China; [Lau, George K. K.] 302 Hosp, Ctr Liver Fibrosis Diag & Treatment Ctr, Beijing, Peoples R China; [Sharma, Barjesh C.] GB Pant Hosp, Dept Gastroenterol, New Delhi, India; [Hamid, Saeed S.] Aga Khan Univ & Hosp, Dept Med, Karachi 74800, Pakistan; [Chuang, Wan-Long] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Hepatobiliary Div, Dept Internal Med, Kaohsiung, Taiwan; [Dokmeci, A. Kadir] Ankara Univ, Sch Med, Dept Gastroenterol, TR-06100 Ankara, Turkey	Kanda, T (reprint author), Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chuo Ku, 1-8-1 Inohana, Chiba 2608677, Japan.	momata-tky@umin.ac.jp; kandat-cib@umin.ac.jp; yokosukao@faculty.chiba-u.jp; d.crawford@uq.edu.au; shwapnil@agni.com; weilai@pkuph.edu.cn; alaabkbs@yahoo.com; gkklau@vip.126.com; drbcsharma@hotmail.com; saeed.hamid@aku.edu; waloch@kmu.edu.tw; akdokmeci@hotmail.com			Chugai Pharmaceutical; MSD; Sumitomo Dainippon Pharma; Tanabe-Mitsubishi; Ajinomoto; Bristol-Myers Squibb; Daiichi-Sankyo; Janssen Pharmaceutical; Bayer; Abbvie; Gilead; GlaxoSmithKline	All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Declaration of Helsinki 1975, as revised in 2008 (5). Informed consent was obtained from all patients for being included in the study. This article does not contain any studies with animal subjects. Masao Omata, Mamun Al-Mahtab, Alaaeldin Ibrahim, George K.K. Lau, Barjesh C. Sharma, Saeed S. Hamid and A. Kadir Dokmeci declare that they have no conflict of interest. Tatsuo Kanda has research grants from Chugai Pharmaceutical, MSD, Sumitomo Dainippon Pharma and Bristol-Myers Squibb, and reports receiving lecture fees from Chugai Pharmaceutical, MSD, Tanabe-Mitsubishi, Ajinomoto, Bristol-Myers Squibb, Daiichi-Sankyo, Janssen Pharmaceutical and GlaxoSmithKline. Osamu Yokosuka has research grants from Chugai Pharmaceutical, Bayer, MSD, Daiichi-Sankyo, Tanabe-Mitsubishi, Bristol-Myers Squibb and Gilead. Darrell Crawford is a member of the national and international advisory board of Abbvie and a national advisory board member of Gilead and Jansen Cilag. Lai Wei has research grants from Bristol-Myers Squibb and reports receiving consulting fees from Abbvie and Gilead. Wan-Long Chuang is a member of the advisory boards of Abbvie, BI, Gilead, Novartis and Roche and is a speaker for BMS, Gilead, MSD and Roche.	Abraham Rachel, 2009, Indian J Gastroenterol, V28, P53, DOI 10.1007/s12664-009-0018-z; Aceijas C, 2006, SEX TRANSM INFECT S3, V82; Agarwal M B, 1993, J Assoc Physicians India, V41, P195; Agarwal S K, 1999, J Assoc Physicians India, V47, P1139; Aliberch MRM, 2010, GAC SANIT, V24, P288; Amarapurkar D N, 1992, Indian J Gastroenterol, V11, P80; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Khan A, 2009, J MED VIROL, V81, P1189, DOI 10.1002/jmv.21466; Hung CH, 2005, J GASTROEN HEPATOL, V20, P727, DOI 10.1111/j.1400-1746.2005.03791.x; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Yu ML, 2006, LIVER INT, V26, P73, DOI 10.1111/j.1478-3231.2005.01196.x; Yu ML, 2009, J GASTROEN HEPATOL, V24, P336, DOI 10.1111/j.1440-1746.2009.05789.x; Saha MK, 2000, INDIAN J MED RES, V111, P37; Amarapurkar D, 2001, J Assoc Physicians India, V49, P983; Lee PL, 2004, T ROY SOC TROP MED H, V98, P367, DOI 10.1016/j.trstmh.2003.10.013; Nishiguchi S, 2014, LIVER INT, V34, P78, DOI 10.1111/liv.12254; Senturk H, 2003, DIGEST DIS SCI, V48, P1124, DOI 10.1023/A:1023725014751; Ahmed B, 2013, HEPATOL INT, V7, P500, DOI 10.1007/s12072-012-9417-9; Seto WK, 2010, J HEPATOL, V53, P444, DOI 10.1016/j.jhep.2010.04.009; Bowden DS, 2006, FUTURE MICROBIOL, V1, P103, DOI 10.2217/17460913.1.1.103; TANAKA H, 1994, CANCER CAUSE CONTROL, V5, P409, DOI 10.1007/BF01694754; Pybus OG, 2003, MOL BIOL EVOL, V20, P381, DOI 10.1093/molbev/msg043; Lee SD, 2005, J VIRAL HEPATITIS, V12, P283, DOI 10.1111/j.1365-2893.2005.00590.x; BHATTACHARYA DK, 1991, INDIAN J MED RES-B, V94, P430; Fujiwara K, 2006, LIVER INT, V26, P520, DOI 10.1111/j.1478-3231.2006.01263.x; Roberts SK, 2009, HEPATOLOGY, V50, P1045, DOI 10.1002/hep.23130; Yu ML, 2000, J GASTROEN HEPATOL, V15, P1404, DOI 10.1046/j.1440-1746.2000.02359.x; Yu ML, 2011, HEPATOLOGY, V53, P7, DOI 10.1002/hep.23976; Singh S, 2004, INDIAN J MED RES, V119, P145; Yokosuka O, 2004, INTERVIROLOGY, V47, P328, DOI 10.1159/000080876; Wong HK, 2012, TRANSFUSION MED, V22, P133, DOI 10.1111/j.1365-3148.2011.01128.x; Chakravarti A, 2011, INDIAN J MED RES, V133, P326; Omata M, 2012, HEPATOL INT, V6, P409, DOI 10.1007/s12072-012-9342-y; Abdelwahab S, 2012, T ROY SOC TROP MED H, V106, P98, DOI 10.1016/j.trstmh.2011.10.003; Tanaka J, 2011, INTERVIROLOGY, V54, P185, DOI 10.1159/000324525; Bozdayi AM, 2004, ARCH VIROL, V149, P2115, DOI 10.1007/s00705-004-0363-2; Akhan SC, 2008, INFECTION, V36, P341, DOI 10.1007/s15010-008-7134-z; Janjua NZ, 2010, J VIRAL HEPATITIS, V17, P317, DOI 10.1111/j.1365-2893.2009.01230.x; Takano S, 1996, HEPATOLOGY, V23, P708, DOI 10.1002/hep.510230408; Simsek H, 2012, EUR J GASTROEN HEPAT, V24, P1113, DOI 10.1097/MEG.0b013e3283554c41; Karaca C, 2006, DIGEST DIS SCI, V51, P365, DOI 10.1007/s10620-006-3139-6; Waheed Y, 2009, WORLD J GASTROENTERO, V15, P5647, DOI 10.3748/wjg.15.5647; Fung J, 2008, J INFECT DIS, V198, P808, DOI 10.1086/591252; HWANG SJ, 1995, J INTERF CYTOK RES, V15, P611, DOI 10.1089/jir.1995.15.611; Akbar SMF, 1997, HEPATOL RES, V7, P113, DOI 10.1016/S0928-4346(97)00027-3; Mumtaz K, 2008, SAUDI MED J, V29, P1671; Kanda T, 2011, DIGEST DIS SCI, V56, P3335, DOI 10.1007/s10620-011-1750-7; Yang JF, 2010, KAOHSIUNG J MED SCI, V26, P461, DOI 10.1016/S1607-551X(10)70073-5; Kumar D, 2003, MED J AUSTRALIA, V178, P267; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Morikawa H, 2013, HEPATOL RES, V43, P1013, DOI 10.1111/hepr.12066; Gurol E, 2006, EUR J EPIDEMIOL, V21, P299, DOI 10.1007/s10654-006-0001-2; Ochi H, 2011, J GEN VIROL, V92, P1071, DOI 10.1099/vir.0.029124-0; Huang JF, 2001, EPIDEMIOL INFECT, V127, P485; Solomon SS, 2010, AIDS BEHAV, V14, P1001, DOI 10.1007/s10461-010-9711-2; Mukhopadhya A, 2008, J BIOSCIENCES, V33, P465, DOI 10.1007/s12038-008-0065-0; KHAN M, 1993, GASTROENTEROL JPN, V28, P28, DOI 10.1007/BF02989200; Rao HY, 2014, J GASTROEN HEPATOL, V29, P545, DOI 10.1111/jgh.12398; Razavi H, 2014, J VIRAL HEPATITIS, V21, P34, DOI 10.1111/jvh.12248; Izumi N, 2014, J GASTROENTEROL, V49, P941, DOI 10.1007/s00535-014-0949-8; Coban S, 2011, HEPATO-GASTROENTEROL, V58, P1301, DOI 10.5754/hge10625; Parthiban R, 2009, INT J INFECT DIS, V13, pE394, DOI 10.1016/j.ijid.2009.01.013; El-Ghitany EM, 2015, LIVER INT, V35, P489, DOI 10.1111/liv.12617; Kim DY, 2013, LIVER INT, V33, P586, DOI 10.1111/liv.12108; Chimparlee N, 2011, SE ASIAN J TROP MED, V42, P609; Lawitz E, 2013, J HEPATOL, V59, P11, DOI 10.1016/j.jhep.2013.02.008; Yu ML, 2004, ANTIVIR RES, V63, P25, DOI 10.1016/j.antiviral.2004.01.002; Huang CF, 2011, HEPATOLOGY, V53, P367, DOI 10.1002/hep.24049; Kanda T, 2010, HEPATOL INT, V4, P548, DOI 10.1007/s12072-010-9193-3; Akcam FZ, 2009, INT J INFECT DIS, V13, P274, DOI 10.1016/j.ijid.2008.07.005; Lai MY, 1996, GASTROENTEROLOGY, V111, P1307, DOI 10.1053/gast.1996.v111.pm8898645; Yu ML, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-27; Lu WP, 2012, J CLIN MICROBIOL, V50, P2142, DOI 10.1128/JCM.00273-12; Hissar SS, 2006, J MED VIROL, V78, P452, DOI 10.1002/jmv.20561; Liaw YF, 2012, HEPATOL INT, V6, P531, DOI 10.1007/s12072-012-9365-4; Yu ML, 2001, J MED VIROL, V65, P58; Fukuda Y, 1998, HAEMOPHILIA, V4, P595, DOI 10.1046/j.1365-2516.1998.440595.x; Westbrook RH, 2014, J HEPATOL, V61, pS58, DOI 10.1016/j.jhep.2014.07.012; Yu JW, 2007, J GASTROEN HEPATOL, V22, P832, DOI 10.1111/j.1440-1746.2007.04904.x; Yu ML, 2006, LIVER INT, V26, P1187, DOI 10.1111/j.1478-3231.2006.01358a.x; Murakami J, 2012, HEPATOL RES, V42, P648, DOI 10.1111/j.1872-034X.2012.00968.x; Jaiswal SB, 2002, DIALYSIS TRANSPLANT, V31, P234; Huang CF, 2008, T ROY SOC TROP MED H, V102, P929, DOI 10.1016/j.trstmh.2008.05.018; Khodabandehloo M, 2013, J RES MED SCI, V18, P674; Jazag A, 2012, KOREAN J INTERN MED, V27, P121, DOI 10.3904/kjim.2012.27.2.121; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Chen CH, 2007, J FORMOS MED ASSOC, V106, P148; Altuglu I, 2008, INT J INFECT DIS, V12, P239, DOI 10.1016/j.ijid.2007.07.003; Yu ML, 2008, HEPATOLOGY, V47, P1884, DOI 10.1002/hep.22319; Zhou YQ, 2011, J VIRAL HEPATITIS, V18, P595, DOI 10.1111/j.1365-2893.2010.01373.x; Chandra M, 2004, INTERVIROLOGY, V47, P374, DOI 10.1159/000080883; Rodriguez-Torres M, 2014, CLIN GASTROENTEROL H, V12, P1029, DOI 10.1016/j.cgh.2013.09.067; Senturk H, 1997, DIGEST DIS SCI, V42, P1438, DOI 10.1023/A:1018854424403; Guerra J, 2012, J VIRAL HEPATITIS, V19, P560, DOI 10.1111/j.1365-2893.2011.01576.x; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Zhao SH, 2009, INT J CLIN PRACT, V63, P1334, DOI 10.1111/j.1742-1241.2009.02082.x; Gupta AC, 2014, J MED VIROL, V86, P707, DOI 10.1002/jmv.23876; Uddin G, 2010, J VIRAL HEPATITIS, V17, P327, DOI 10.1111/j.1365-2893.2009.01240.x; Sievert W, 2011, LIVER INT, V31, P61, DOI 10.1111/j.1478-3231.2011.02540.x; Dore GJ, 2003, J CLIN VIROL, V26, P171, DOI 10.1016/S1386-6532(02)00116-6; Jindal N, 2006, INDIAN J MED RES, V123, P179; Shirin T, 2000, J HEALTH POPUL NUTR, V18, P145; Wong VWS, 2014, J GASTROEN HEPATOL, V29, P116, DOI 10.1111/jgh.12355; Chiou SS, 2006, DIGESTION, V74, P208, DOI 10.1159/000100506; MITA E, 1994, DIGEST DIS SCI, V39, P977, DOI 10.1007/BF02087547; Roberts SK, 2014, J GASTROEN HEPATOL, V29, P179, DOI 10.1111/jgh.12424; Khattab MA, 2011, J HEPATOL, V54, P1250, DOI 10.1016/j.jhep.2010.11.016; Kogure T, 2006, WORLD J GASTROENTERO, V12, P4757; Huang CF, 2013, J GASTROEN HEPATOL, V28, P1515, DOI 10.1111/jgh.12211; Chang JM, 2014, INT J MED SCI, V11, P436, DOI 10.7150/ijms.8265; Manns M, 2014, LANCET, V384, P1597, DOI 10.1016/S0140-6736(14)61059-X; Raghuraman S, 2003, J CLIN VIROL, V26, P61, DOI 10.1016/S1386-6532(02)00025-2; [Anonymous], CENS IND WEBS OFF RE; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Marx MA, 2003, CLIN INFECT DIS, V37, P514, DOI 10.1086/376639; SAITO I, 1990, P NATL ACAD SCI USA, V87, P6547, DOI 10.1073/pnas.87.17.6547; Abdelwahab SF, 2013, J CLIN VIROL, V57, P24, DOI 10.1016/j.jcv.2013.01.005; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Barua P, 2012, INDIAN J MED RES, V136, P30; Simsek H, 1996, J INT MED RES, V24, P132; Hayashi N, 2012, J VIRAL HEPATITIS, V19, pE134, DOI 10.1111/j.1365-2893.2011.01528.x; Kumada H, 2012, J HEPATOL, V56, P78, DOI 10.1016/j.jhep.2011.07.016; Liu CH, 2008, CLIN INFECT DIS, V47, P1260, DOI 10.1086/592579; Foster GR, 2011, GASTROENTEROLOGY, V141, P881, DOI 10.1053/j.gastro.2011.05.046; Sarkar K, 2003, LANCET, V361, P1301, DOI 10.1016/S0140-6736(03)13006-1; Kanda T, 2004, J GASTROEN HEPATOL, V19, P717, DOI 10.1111/j.1440-1746.2004.03399.x; Yu ML, 2007, GUT, V56, P553, DOI 10.1136/gut.2006.102558; Huang CF, 2012, J HEPATOL, V56, P34, DOI 10.1016/j.jhep.2011.03.029; Kuboki M, 2007, J GASTROEN HEPATOL, V22, P645, DOI 10.1111/j.1440-1746.2007.04834.x; Jain A, 1999, EUR J GASTROEN HEPAT, V11, P1231, DOI 10.1097/00042737-199911000-00008; Kumada H, 2014, HEPATOLOGY, V59, P2083, DOI 10.1002/hep.27113; Nakayama H, 2005, J MED VIROL, V75, P258, DOI 10.1002/jmv.20265; Narahari S, 2009, INFECT GENET EVOL, V9, P643, DOI 10.1016/j.meegid.2009.04.001; TAKANO S, 1994, DIGEST DIS SCI, V39, P28, DOI 10.1007/BF02090056; Ashraf H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-208; Chakrabarty P, 2014, Mymensingh Med J, V23, P235; Chen Yuan-sheng, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P888; Choudhry V. P., 1995, Indian Journal of Pediatrics, V62, P655, DOI 10.1007/BF02825110; Chuang Wang-Long, 2006, Intervirology, V49, P99, DOI 10.1159/000087271; Cuadros DF, 2014, HEPATOLOGY, V60, P1150, DOI 10.1002/hep.27248; Dai ZC, 1995, SEROPREVALENCE SURVE, P60; Das B R, 2002, Indian J Pathol Microbiol, V45, P323; Duseja A, 2002, Trop Gastroenterol, V23, P125; Esmat G, 2013, LIVER INT S, V33, P141; Ferenci P, 2015, J HEPA IN PRESS 0102; Fouad YM, 2012, TROP GASTROENTEROL, V33, P111; Galal IF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101264; Ganju Sunite A., 2000, Journal of Communicable Diseases, V32, P228; Gupta Nalini, 2004, Indian J Med Sci, V58, P255; Hassanein T, 2014, J HEPATOL, V60, pS472; Hayashi N, 2014, J GASTROENTEROL, V49, P138, DOI 10.1007/s00535-013-0875-1; Hezode C, 2014, J HEPATOL, V60, pS24; Hsieh MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094791; Huang CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058882; Islam ASM., 2014, THESIS BS MUJIB MED; IWAMURA K, 1988, Tokai Journal of Experimental and Clinical Medicine, V13, P191; John GT, 1999, TRANSPLANT REV, V13, P183; Kalaskar A, 2012, INT RES J MICROBIOL, V3, P10; Kapoor D, 2000, Indian J Gastroenterol, V19, P64; Li Quan-run, 2012, Zhonghua Gan Zang Bing Za Zhi, V20, P353, DOI 10.3760/cma.j.issn.1007-3418.2012.05.010; Mahtab MA, 2008, J GASTROEN HEPATOL, V23, P27; Mahtab MA, 2011, J CLIN EXP HEPATOL, V1, P13; Mahtab MA, 2008, HUNGARIAN MED J, V2, P577; Mittal Garima, 2013, J Clin Exp Hepatol, V3, P24, DOI 10.1016/j.jceh.2013.02.003; Mizokami M, 2014, HEPATOLOGY, V60, p1130A; Moatter Tariq, 2002, International Journal of Infectious Diseases, V6, P272, DOI 10.1016/S1201-9712(02)90160-8; Mohamoud YA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-288; Narhari S, 2009, INFECT GENET EVOL, V9, P643; Oi Y, HEPATITIS FREE GENER; Omata M, 2014, J VIRAL HEPATITIS, V21, P762, DOI 10.1111/jvh.12312; Pereira M, 2003, SEX TRANSM INFECT, V79, P424; Puri Pankaj, 2014, J Clin Exp Hepatol, V4, P106, DOI 10.1016/j.jceh.2014.05.006; Qureshi H, 2010, East Mediterr Health J, V16 Suppl, pS15; Rahman M Z, 2013, Bangladesh Med Res Counc Bull, V39, P11; Rahman M Z, 2014, Mymensingh Med J, V23, P335; Recker C, 2014, INT J INFECT DIS; Reddy A K, 2005, Indian J Med Microbiol, V23, P106; Ruane PJ, 2014, J HEPATOL, V60, pS503; Rudra S, 2010, Mymensingh Med J, V19, P515; Rudra S, 2011, Mymensingh Med J, V20, P183; Sereno Leandro, 2012, J Int Assoc Physicians AIDS Care (Chic), V11, P311, DOI 10.1177/1545109712453939; Sood Ajit, 2014, Indian J Gastroenterol, V33, P343, DOI 10.1007/s12664-014-0451-5; Sood Ajit, 2012, Indian J Gastroenterol, V31, P27, DOI 10.1007/s12664-012-0163-7; Suoglu OD, 2002, J PEDIATR GASTR NUTR, V34, P199, DOI 10.1097/00005176-200202000-00018; Tourism Commisson, TOUR PERF; Toyoda H, 2014, EPIDEMIOL INFECT, V5, P1; Waheed Y, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-211; Williams T N, 1992, Indian Pediatr, V29, P1119; Wu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073615; Yenice Necati, 2006, Turk J Gastroenterol, V17, P94; Yu ML, 2014, J HEPATOL, V60, P253, DOI 10.1016/j.jhep.2013.09.023	191	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1936-0533	1936-0541		HEPATOL INT	Hepatol. Int.	OCT	2015	9	4					486	507		10.1007/s12072-015-9630-4		22	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CT8DA	WOS:000363044000003		
J	Han, Y; Hazelett, DJ; Wiklund, F; Schumacher, FR; Stram, DO; Berndt, SI; Wang, ZM; Rand, KA; Hoover, RN; Machiela, MJ; Yeager, M; Burdette, L; Chung, CC; Hutchinson, A; Yu, K; Xu, JF; Travis, RC; Key, TJ; Siddiq, A; Canzian, F; Takahashi, A; Kubo, M; Stanford, JL; Kolb, S; Gapstur, SM; Diver, WR; Stevens, VL; Strom, SS; Pettaway, CA; Al Olama, AA; Kote-Jarai, Z; Eeles, RA; Yeboah, ED; Tettey, Y; Biritwum, RB; Adjei, AA; Tay, E; Truelove, A; Niwa, S; Chokkalingam, AP; Isaacs, WB; Chen, C; Lindstrom, S; Le Marchand, L; Giovannucci, EL; Pomerantz, M; Long, H; Li, FG; Ma, J; Stampfer, M; John, EM; Ingles, SA; Kittles, RA; Murphy, AB; Blot, WJ; Signorello, LB; Zheng, W; Albanes, D; Virtamo, J; Weinstein, S; Nemesure, B; Carpten, J; Leske, MC; Wu, SY; Hennis, AJM; Rybicki, BA; Neslund-Dudas, C; Hsing, AW; Chu, LS; Goodman, PJ; Klein, EA; Zheng, SL; Witte, JS; Casey, G; Riboli, E; Li, QY; Freedman, ML; Hunter, DJ; Gronberg, H; Cook, MB; Nakagawa, H; Kraft, P; Chanock, SJ; Easton, DF; Henderson, BE; Coetzee, GA; Conti, DV; Haiman, CA				Han, Ying; Hazelett, Dennis J.; Wiklund, Fredrik; Schumacher, Fredrick R.; Stram, Daniel O.; Berndt, Sonja I.; Wang, Zhaoming; Rand, Kristin A.; Hoover, Robert N.; Machiela, Mitchell J.; Yeager, Merideth; Burdette, Laurie; Chung, Charles C.; Hutchinson, Amy; Yu, Kai; Xu, Jianfeng; Travis, Ruth C.; Key, Timothy J.; Siddiq, Afshan; Canzian, Federico; Takahashi, Atsushi; Kubo, Michiaki; Stanford, Janet L.; Kolb, Suzanne; Gapstur, Susan M.; Diver, W. Ryan; Stevens, Victoria L.; Strom, Sara S.; Pettaway, Curtis A.; Al Olama, Ali Amin; Kote-Jarai, Zsofia; Eeles, Rosalind A.; Yeboah, Edward D.; Tettey, Yao; Biritwum, Richard B.; Adjei, Andrew A.; Tay, Evelyn; Truelove, Ann; Niwa, Shelley; Chokkalingam, Anand P.; Isaacs, William B.; Chen, Constance; Lindstrom, Sara; Le Marchand, Loic; Giovannucci, Edward L.; Pomerantz, Mark; Long, Henry; Li, Fugen; Ma, Jing; Stampfer, Meir; John, Esther M.; Ingles, Sue A.; Kittles, Rick A.; Murphy, Adam B.; Blot, William J.; Signorello, Lisa B.; Zheng, Wei; Albanes, Demetrius; Virtamo, Jarmo; Weinstein, Stephanie; Nemesure, Barbara; Carpten, John; Leske, M. Cristina; Wu, Suh-Yuh; Hennis, Anselm J. M.; Rybicki, Benjamin A.; Neslund-Dudas, Christine; Hsing, Ann W.; Chu, Lisa; Goodman, Phyllis J.; Klein, Eric A.; Zheng, S. Lilly; Witte, John S.; Casey, Graham; Riboli, Elio; Li, Qiyuan; Freedman, Matthew L.; Hunter, David J.; Gronberg, Henrik; Cook, Michael B.; Nakagawa, Hidewaki; Kraft, Peter; Chanock, Stephen J.; Easton, Douglas F.; Henderson, Brian E.; Coetzee, Gerhard A.; Conti, David V.; Haiman, Christopher A.			Integration of multiethnic fine-mapping and genomic annotation to prioritize candidate functional SNPs at prostate cancer susceptibility regions	HUMAN MOLECULAR GENETICS			English	Article							RISK-ASSOCIATED LOCI; WIDE ASSOCIATION; CAUSAL VARIANTS; TRANSETHNIC METAANALYSIS; SEQUENCE VARIANTS; GENE-EXPRESSION; ANALYSES REVEAL; COMMON VARIANT; MULTIPLE; IDENTIFICATION	Interpretation of biological mechanisms underlying genetic risk associations for prostate cancer is complicated by the relatively large number of risk variants (n = 100) and the thousands of surrogate SNPs in linkage disequilibrium. Here, we combined three distinct approaches: multiethnic fine-mapping, putative functional annotation (based upon epigenetic data and genome-encoded features), and expression quantitative trait loci (eQTL) analyses, in an attempt to reduce this complexity. We examined 67 risk regions using genotyping and imputation-based fine-mapping in populations of European (cases/controls: 8600/6946), African (cases/controls: 5327/5136), Japanese (cases/controls: 2563/4391) and Latino (cases/controls: 1034/1046) ancestry. Markers at 55 regions passed a region-specific significance threshold (P-value cutoff range: 3.9 x 10(-4)-5.6 x 10(-3)) and in 30 regions we identified markers that were more significantly associated with risk than the previously reported variants in the multiethnic sample. Novel secondary signals (P < 5.0 x 10(-6)) were also detected in two regions (rs13062436/3q21 and rs17181170/3p12). Among 666 variants in the 55 regions with P-values within one order of magnitude of the most-associated marker, 193 variants (29%) in 48 regions overlapped with epigenetic or other putative functional marks. In 11 of the 55 regions, cis-eQTLs were detected with nearby genes. For 12 of the 55 regions (22%), the most significant region-specific, prostate-cancer associated variant represented the strongest candidate functional variant based on our annotations; the number of regions increased to 20 (36%) and 27 (49%) when examining the 2 and 3 most significantly associated variants in each region, respectively. These results have prioritized subsets of candidate variants for downstream functional evaluation.	[Han, Ying; Hazelett, Dennis J.; Schumacher, Fredrick R.; Stram, Daniel O.; Rand, Kristin A.; Ingles, Sue A.; Casey, Graham; Henderson, Brian E.; Coetzee, Gerhard A.; Conti, David V.; Haiman, Christopher A.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Schumacher, Fredrick R.; Stram, Daniel O.; Ingles, Sue A.; Casey, Graham; Henderson, Brian E.; Coetzee, Gerhard A.; Conti, David V.; Haiman, Christopher A.] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Coetzee, Gerhard A.] Univ So Calif, Keck Sch Med, Dept Urol, Los Angeles, CA 90033 USA; [Wiklund, Fredrik; Gronberg, Henrik] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Berndt, Sonja I.; Wang, Zhaoming; Hoover, Robert N.; Machiela, Mitchell J.; Burdette, Laurie; Chung, Charles C.; Hutchinson, Amy; Yu, Kai; Albanes, Demetrius; Weinstein, Stephanie; Cook, Michael B.; Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Wang, Zhaoming; Yeager, Merideth; Burdette, Laurie; Hutchinson, Amy] SAIC Frederick Inc, NCI DCEG, Canc Genom Res Lab, Frederick, MD USA; [Xu, Jianfeng] NorthShore Univ HealthSyst, Program Personalized Canc Care, Evanston, IL USA; [Xu, Jianfeng] NorthShore Univ HealthSyst, Dept Surg, Evanston, IL USA; [Travis, Ruth C.; Key, Timothy J.] Univ Oxford, Nuffield Dept Populat Hlth, Canc Epidemiol Unit, Oxford, England; [Siddiq, Afshan] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Genom Common Dis, London, England; [Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Canzian, Federico] German Canc Res Ctr, Genom Epidemiol Grp, Heidelberg, Germany; [Takahashi, Atsushi] RIKEN Ctr Integrat Med Sci, Lab Stat Anal, Tokyo, Japan; [Kubo, Michiaki] RIKEN Ctr Integrat Med Sci, Lab Genotyping Dev, Tokyo, Japan; [Nakagawa, Hidewaki] RIKEN Ctr Integrat Med Sci, Lab Genome Sequencing Anal, Tokyo, Japan; [Stanford, Janet L.; Kolb, Suzanne] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Stanford, Janet L.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Gapstur, Susan M.; Diver, W. Ryan; Stevens, Victoria L.] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA; [Strom, Sara S.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Pettaway, Curtis A.] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA; [Al Olama, Ali Amin; Easton, Douglas F.] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England; [Kote-Jarai, Zsofia; Eeles, Rosalind A.] Inst Canc Res, London SW3 6JB, England; [Eeles, Rosalind A.] Royal Marsden Natl Hlth Serv NHS Fdn Trust, London, England; [Eeles, Rosalind A.] Royal Marsden Natl Hlth Serv NHS Fdn Trust, Sutton, Surrey, England; [Yeboah, Edward D.; Tettey, Yao; Biritwum, Richard B.; Adjei, Andrew A.; Tay, Evelyn] Korle Bu Teaching Hosp, Accra, Ghana; [Yeboah, Edward D.; Tettey, Yao; Biritwum, Richard B.; Adjei, Andrew A.; Tay, Evelyn] Univ Ghana, Sch Med, Accra, Ghana; [Truelove, Ann; Niwa, Shelley] WESTAT Corp, Rockville, MD 20850 USA; [Chokkalingam, Anand P.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Isaacs, William B.] Johns Hopkins Univ Hosp, James Buchanan Brady Urol Inst, Baltimore, MD 21287 USA; [Isaacs, William B.] Inst Med, Baltimore, MD USA; [Chen, Constance; Lindstrom, Sara; Hunter, David J.; Kraft, Peter] Harvard Univ, Sch Publ Hlth, Program Genet Epidemiol & Stat Genet, Dept Epidemiol, Boston, MA 02115 USA; [Giovannucci, Edward L.; Stampfer, Meir] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Giovannucci, Edward L.; Stampfer, Meir; Signorello, Lisa B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Le Marchand, Loic] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA; [Pomerantz, Mark; Freedman, Matthew L.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Long, Henry; Li, Fugen] Dana Farber Canc Inst, Dept Med Oncol, Ctr Funct Canc Epigenet, Boston, MA 02115 USA; [Ma, Jing] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Div Network Med,Dept Med, Boston, MA USA; [John, Esther M.; Hsing, Ann W.; Chu, Lisa] Canc Prevent Inst Calif, Fremont, CA USA; [John, Esther M.; Hsing, Ann W.; Chu, Lisa] Stanford Univ, Div Epidemiol, Dept Hlth Res & Policy, Sch Med, Stanford, CA 94305 USA; [John, Esther M.; Hsing, Ann W.; Chu, Lisa] Stanford Univ, Stanford Canc Inst, Sch Med, Stanford, CA 94305 USA; [Kittles, Rick A.] Univ Arizona, Coll Med, Tucson, AZ USA; [Kittles, Rick A.] Univ Arizona, Ctr Canc, Tucson, AZ USA; [Murphy, Adam B.] Northwestern Univ, Dept Urol, Chicago, IL 60611 USA; [Blot, William J.] Int Epidemiol Inst, Rockville, MD USA; [Blot, William J.; Zheng, Wei] Vanderbilt Univ, Sch Med, Vanderbilt Epidemiol Ctr, Div Epidemiol,Dept Med, Nashville, TN 37212 USA; [Virtamo, Jarmo] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Nemesure, Barbara; Leske, M. Cristina; Wu, Suh-Yuh; Hennis, Anselm J. M.] SUNY Stony Brook, Dept Prevent Med, Stony Brook, NY 11794 USA; [Carpten, John] Translat Genom Res Inst, Phoenix, AZ USA; [Hennis, Anselm J. M.] Univ W Indies, Chron Dis Res Ctr, Bridgetown, Barbados; [Hennis, Anselm J. M.] Univ W Indies, Fac Med Sci, Bridgetown, Barbados; [Rybicki, Benjamin A.; Neslund-Dudas, Christine] Henry Ford Hosp, Dept Publ Hlth Sci, Detroit, MI 48202 USA; [Goodman, Phyllis J.] Fred Hutchinson Canc Res Ctr, SWOG Stat Ctr, Seattle, WA 98104 USA; [Klein, Eric A.] Cleveland Clin, Glickman Urol & Kidney Inst, Dept Urol, Cleveland, OH 44106 USA; [Zheng, S. Lilly] Wake Forest Sch Med, Ctr Canc Genom, Winston Salem, NC USA; [Witte, John S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Witte, John S.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Li, Qiyuan] Xiamen Univ, Coll Med, Xiamen 361102, Peoples R China	Haiman, CA (reprint author), Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA.	haiman@usc.edu	Cook, Michael/A-5641-2009	Cook, Michael/0000-0002-0533-7302	National Institutes of Health (NIH), National Cancer Institute (NCI) GAME-ON U19 initiative for prostate cancer (ELLIPSE) [CA148537]; NIH/NCI [U01-CA98233, U01-CA98710, U01-CA98216, U01-CA98758]; NIH/National Cancer Institute, Division of Cancer Epidemiology and Genetics; NIH; NCI; U.S. Public Health Service from the NCI, Department of Health and Human Services [N01-CN-45165, N01-RC-45035, N01-RC-37004, HHSN261201000006C]; Cancer Risk Prediction Center (CRisP); Linneus Centre - Swedish Research Council [70867902, K2010-70X-20430-04-3]; Swedish Cancer Foundation [09-0677]; Hedlund Foundation; Soderberg Foundation; Enqvist Foundation; Stockholm County Council; Stiftelsen Johanna Hagstrand och Sigfrid Linner's Minne; Karlsson's Fund for urological and surgical research; NIH [CA63464, CA54281, CA1326792, CA148085, HG004726, CA056678, CA082664, CA092579, ES011126, S06GM08016, CA092447, CA098758]; Division of Cancer Epidemiology and Genetics, NCI, NIH; Cancer Research Fund [99-00524V-10258]; Department of Health Services Cancer Research Program [97-12013, 98-00924V]; NCI, NIH, Department of Health and Human Services [N01-PC-35139]; California Department of Health Services [103885]; Centers for Disease Control and Prevention [1U58DP000807-3]; Fred Hutchinson Cancer Research Center; National Human Genome Research Institute; DOD [W81XWH-07-1-0122, DAMD W81XWH-07-1-0203, DAMD W81XWH-06-1-0066, W81XWH-10-1-0532]; American Cancer Society; Public Health Service from the National Cancer Institute [CA37429, 5UM1CA182883]; National Program of Cancer Registries, Centers for Disease Control and Prevention (CDC); NIH/National Human Genome Research Institute [U01 HG004726-01]; Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government; Princess Takamatsu Cancer Research Fund; Takeda Science Foundation;  [CA136924];  [CA68578];  [ES007784];  [DAMD W81XWH-07-1-0645];  [CA140388];  [U01 HG004446];  [R01 CA136924];  [R01 GM107427]	This work was supported by the National Institutes of Health (NIH), National Cancer Institute (NCI) GAME-ON U19 initiative for prostate cancer (ELLIPSE, CA148537). The BPC3 was supported by NIH/NCI cooperative agreements U01-CA98233 to D.J.H., U01-CA98710 to S.M.G., U01-CA98216 to E.R., and U01-CA98758 to B.E.H., and Intramural Research Program of NIH/National Cancer Institute, Division of Cancer Epidemiology and Genetics). ATBC, PEGASUS/PLCO and the Ghana Prostate Study were supported in part by the Intramural Research Program of the NIH and NCI. Additionally, this research was supported by U.S. Public Health Service contracts N01-CN-45165, N01-RC-45035, N01-RC-37004 and HHSN261201000006C from the NCI, Department of Health and Human Services. CAPS was supported by the Cancer Risk Prediction Center (CRisP; www.crispcenter.org), a Linneus Centre (Contract ID 70867902) financed by the Swedish Research Council (grant no. K2010-70X-20430-04-3), the Swedish Cancer Foundation (grant no. 09-0677), the Hedlund Foundation, the Soderberg Foundation, the Enqvist Foundation, ALF funds from the Stockholm County Council. Stiftelsen Johanna Hagstrand och Sigfrid Linner's Minne, Karlsson's Fund for urological and surgical research. The AAPC studies were supported as follows: The MEC and the genotyping in AAPC were supported by NIH grants CA63464, CA54281, CA1326792, CA148085 and HG004726. Functional annotation was supported by grant CA136924. Genotyping of the PLCO samples was funded by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics, NCI, NIH. LAAPC was funded by grant 99-00524V-10258 from the Cancer Research Fund, under Interagency Agreement #97-12013 (University of California contract # 98-00924V) with the Department of Health Services Cancer Research Program. Cancer incidence data for the MEC and LAAPC studies have been collected by the Los Angeles Cancer Surveillance Program of the University of Southern California with Federal funds from the NCI, NIH, Department of Health and Human Services, under Contract No. N01-PC-35139, and the California Department of Health Services as part of the state-wide cancer reporting program mandated by California Health and Safety Code Section 103885, and grant number 1U58DP000807-3 from the Centers for Disease Control and Prevention. KCPCS was supported by NIH grants CA056678, CA082664 and CA092579, with additional support from the Fred Hutchinson Cancer Research Center and the Intramural Program of the National Human Genome Research Institute. MDA was support by grants, CA68578, ES007784, DAMD W81XWH-07-1-0645, and CA140388. GECAP was supported by NIH grant ES011126. CaP Genes was supported by CA88164 and CA127298. IPCG was support by DOD grant W81XWH-07-1-0122. DCPC was supported by NIH grant S06GM08016 and DOD grants DAMD W81XWH-07-1-0203, DAMD W81XWH-06-1-0066 and DOD W81XWH-10-1-0532. CPS-II is supported by the American Cancer Society. SELECT is funded by Public Health Service grants CA37429 and 5UM1CA182883 from the National Cancer Institute. SCCS is funded by NIH grant CA092447. SCCS sample preparation was conducted at the Epidemiology Biospecimen Core Lab that is supported in part by the Vanderbilt Ingram Cancer Center (CA68485).; Data on SCCS cancer cases used in this publication were provided by the Alabama Statewide Cancer Registry; Kentucky Cancer Registry; Tennessee Department of Health, Office of Cancer Surveillance; Florida Cancer Data System; North Carolina Central Cancer Registry, North Carolina Division of Public Health; Georgia Comprehensive Cancer Registry; Louisiana Tumor Registry; Mississippi Cancer Registry; South Carolina Central Cancer Registry; Virginia Department of Health, Virginia Cancer Registry; Arkansas Department of Health, Cancer Registry. The Arkansas Central Cancer Registry is fully funded by a grant from National Program of Cancer Registries, Centers for Disease Control and Prevention (CDC). Data on SCCS cancer cases from Mississippi were collected by the Mississippi Cancer Registry which participates in the National Program of Cancer Registries (NPCR) of the Centers for Disease Control and Prevention (CDC). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the CDC or the Mississippi Cancer Registry. JAPC and LAPC were supported by NIH grants CA63464, CA54281 and CA098758, the NIH/National Human Genome Research Institute by U01 HG004726-01 and the Genome Coordinating Center was supported by U01 HG004446. BBJ was supported by the Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government, and this study was supported in part by the Princess Takamatsu Cancer Research Fund and Takeda Science Foundation Award (to H.N.). G.A. Coetzee was supported by grant R01 CA136924 and M.L. Freedman was supported by grant R01 GM107427. We should like to thank all of the men who took part in these studies.	Al Olama A.A., 2014, NAT GENET IN PRESS; Al Olama A.A., 2012, HUM MOL GEN IN PRESS; Al Olama A.A., HUM MOL GENET, V24, P5589; Huang QL, 2014, NAT GENET, V46, P126, DOI 10.1038/ng.2862; Lou H, 2009, P NATL ACAD SCI USA, V106, P7933, DOI 10.1073/pnas.0902104106; Teo YY, 2010, GENET EPIDEMIOL, V34, P653, DOI 10.1002/gepi.20522; Zheng SL, 2009, CANCER EPIDEM BIOMAR, V18, P1815, DOI 10.1158/1055-9965.EPI-08-0983; Xu X, 2014, EUR J HUM GENET, V22, P558, DOI 10.1038/ejhg.2013.195; Liu CT, 2014, HUM MOL GENET, V23, P4738, DOI 10.1093/hmg/ddu183; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Cook MB, 2014, HUM GENET, V133, P509, DOI 10.1007/s00439-013-1387-z; Akamatsu S, 2010, HUM MOL GENET, V19, P4265, DOI 10.1093/hmg/ddq350; Kote-Jarai Z, 2011, HUM GENET, V129, P687, DOI 10.1007/s00439-011-0981-1; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Kote-Jarai Z, 2013, HUM MOL GENET, V22, P2520, DOI 10.1093/hmg/ddt086; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Schumacher FR, 2011, HUM MOL GENET, V20, P3867, DOI 10.1093/hmg/ddr295; Parikh H, 2011, HUM GENET, V129, P675, DOI 10.1007/s00439-011-0953-5; Ong RTH, 2012, EUR J HUM GENET, V20, P1300, DOI 10.1038/ejhg.2012.88; Brawley OW, 2012, WORLD J UROL, V30, P195, DOI 10.1007/s00345-012-0824-2; Jeggari A, 2012, BIOINFORMATICS, V28, P2062, DOI 10.1093/bioinformatics/bts344; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; Andreu-Vieyra C, 2011, MOL CELL BIOL, V31, P4648, DOI 10.1128/MCB.05934-11; Duggan D, 2007, J NATL CANCER I, V99, P1836, DOI 10.1093/jnci/djm250; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Zaitlen N, 2010, AM J HUM GENET, V86, P23, DOI 10.1016/j.ajhg.2009.11.016; Sharma NL, 2013, CANCER CELL, V23, P35, DOI 10.1016/j.ccr.2012.11.010; Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Kote-Jarai Z, 2011, NAT GENET, V43, P785, DOI 10.1038/ng.882; Xu JF, 2012, NAT GENET, V44, P1231, DOI 10.1038/ng.2424; Wakefield J, 2009, GENET EPIDEMIOL, V33, P79, DOI 10.1002/gepi.20359; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Tan PY, 2012, MOL CELL BIOL, V32, P399, DOI 10.1128/MCB.05958-11; Cheng I, 2012, CANCER EPIDEM BIOMAR, V21, P2048, DOI 10.1158/1055-9965.EPI-12-0598; Haiman CA, 2011, NAT GENET, V43, P570, DOI 10.1038/ng.839; Onengut-Gumuscu S, 2015, NAT GENET, V47, P381, DOI 10.1038/ng.3245; Takata R, 2010, NAT GENET, V42, P751, DOI 10.1038/ng.635; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Eeles RA, 2013, NAT GENET, V45, P385, DOI 10.1038/ng.2560; Morris AP, 2011, GENET EPIDEMIOL, V35, P809, DOI 10.1002/gepi.20630; Conti DV, 2003, AM J HUM GENET, V72, P351, DOI 10.1086/346117; Yeager M, 2009, NAT GENET, V41, P1055, DOI 10.1038/ng.444; Al Olama AA, 2009, NAT GENET, V41, P1058, DOI 10.1038/ng.452; Wakefield J, 2007, AM J HUM GENET, V81, P208, DOI 10.1086/519024; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Li QY, 2013, CELL, V152, P633, DOI 10.1016/j.cell.2012.12.034; Sun J, 2008, NAT GENET, V40, P1153, DOI 10.1038/ng.214; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Gudmundsson J, 2009, NAT GENET, V41, P1122, DOI 10.1038/ng.448; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Chung CC, 2011, HUM MOL GENET, V20, P2869, DOI 10.1093/hmg/ddr189; Coetzee GA, 2010, CELL CYCLE, V9, P256; Sun JL, 2009, CANCER RES, V69, P10, DOI 10.1158/0008-5472.CAN-08-3464; Chung CC, 2012, PROSTATE, V72, P476, DOI 10.1002/pros.21450; Gudmundsson J, 2008, NAT GENET, V40, P281, DOI 10.1038/ng.89; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Kote-Jarai Z, 2008, CANCER EPIDEM BIOMAR, V17, P2052, DOI 10.1158/1055-9965.EPI-08-0317; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Franceschini N, 2012, AM J HUM GENET, V91, P744, DOI 10.1016/j.ajhg.2012.08.021; Grisanzio C, 2012, P NATL ACAD SCI USA, V109, P11252, DOI 10.1073/pnas.1200853109; Berndt S.I., 2011, HUM MOL GEN IN PRESS; Coetzee SG, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks542; Haiman CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001387; Han Y., 2014, INT J CANC IN PRESS; Hazelett DJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004102; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jia L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000597; Li QY, 2014, HUM MOL GENET, V23, P5294, DOI 10.1093/hmg/ddu228; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Pomerantz MM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001204; Replication DIG, 2014, NAT GENET, V46, P234, DOI DOI 10.1038/NG.2897; Rhie SK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-331; Takayama K.I., 2014, CANC RES IN PRESS; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Westra HJ, 2014, BBA-MOL BASIS DIS, V1842, P1896, DOI 10.1016/j.bbadis.2014.04.024; Wu Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003379	78	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0964-6906	1460-2083		HUM MOL GENET	Hum. Mol. Genet.	OCT 1	2015	24	19					5603	5618		10.1093/hmg/ddv269		16	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CT7TT	WOS:000363018100018		
J	Dat, PT; Kanno, A; Yamamoto, N; Kawanishi, T				Pham Tien Dat; Kanno, Atsushi; Yamamoto, Naokatsu; Kawanishi, Testuya			WDM RoF-MMW and Linearly Located Distributed Antenna System for Future High-Speed Railway Communications	IEEE COMMUNICATIONS MAGAZINE			English	Article							USERS	In this article, we propose dual-hop network architecture capable of providing high-speed communications to high-speed trains (HSTs). The system uses a seamless fiber-millimeter-wave system for backhaul transmission from a central station to antennas on trains, and a highspeed in-train Wi-Fi network. The system can be combined with signal processing and network control technologies to compensate for interference and the Doppler effect, and to reduce the number of handovers. It can realize seamless connectivity between the inside and outside of trains to avoid penetration loss and help organize the in-train network optimally to increase coverage and data rate. We present and discuss the possible network architecture and technologies that can help realize the proposed network. We also present a proof-of-concept demonstration on a high-performance seamless fiber-MMW system that can be applied for applications in backhaul networks. The proposed network can be an attractive solution to provide broadband services such as video on demand and high-speed mobile signals to users on HSTs.	[Pham Tien Dat; Kanno, Atsushi; Yamamoto, Naokatsu; Kawanishi, Testuya] Natl Inst Informat & Commun Technol, Beijing, Peoples R China; [Kawanishi, Testuya] Waseda Univ, Tokyo, Japan	Dat, PT (reprint author), Natl Inst Informat & Commun Technol, Beijing, Peoples R China.	ptdat@nict.go.jp			Ministry of Internal Affairs and Communications (MIC), Japan	This work was conducted as a part of the "Research and development for expansion of radio wave resources," supported by the Ministry of Internal Affairs and Communications (MIC), Japan.	[Anonymous], 2012, 36836 3GPP TR; [Anonymous], 2014, APTASTAPREPT11; Ito H, 2002, ELECTRON LETT, V38, P1376, DOI 10.1049/el:20020951; Sui YT, 2013, IEEE COMMUN MAG, V51, P62; Kanno A, 2012, IEEE PHOTONICS J, V4, P2196, DOI 10.1109/JPHOT.2012.2228182; de Greve F, 2005, WIRELESS PERS COMMUN, V33, P281, DOI 10.1007/s11277-005-0573-2; [Anonymous], 2010, G9872 ITUT; Wang JZ, 2012, IEEE J SEL AREA COMM, V30, P675, DOI 10.1109/JSAC.2012.120502; Dat P. T., 2013, P IEEE OFC; Dat P. T., 2014, J LIGHTWAVE TECH, V32, P0733; Dat P. T., 2014, P IEEE IMS; Haruyyama S., 2011, P IEEE OFC; Kanno A., 2013, P IEEE GLOBECOM; Lannoo, 2007, IEEE COMMUN MAG, V45, P56; Thanh T. L., 2015, P IEEE ICC	15	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0163-6804	1558-1896		IEEE COMMUN MAG	IEEE Commun. Mag.	OCT	2015	53	10					86	94				9	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CU0YU	WOS:000363246200012		
J	Choi, JK; Nishida, S; Yokobiki, T; Kawaguchi, K				Choi, Jin-Kyu; Nishida, Shuhei; Yokobiki, Takashi; Kawaguchi, Katsuyoshi			Automated Cable-Laying System for Thin Optical-Fiber Submarine Cable Installation	IEEE JOURNAL OF OCEANIC ENGINEERING			English	Article						Automated cable-laying system; Dense Oceanfloor Network System for Earthquakes and Tsunamis (DONET); optical-fiber submarine cable; remotely operated vehicle (ROV)		We have installed the Dense Oceanfloor Network System for Earthquakes and Tsunamis (DONET) that includes 20 observatories at Kumanonada (called DONET1) for the purpose of monitoring the seismogenic zone around the Nankai Trough. During the construction of DONET1, a remotely operated vehicle (ROV) was successfully used to lay the optical-fiber submarine cables that connect the observatories with the science nodes; however, the cable-laying operation was onerous because it takes approximately 10 h and is manually performed by ROV operators. For this reason, the cable-laying operation is usually not performed on successive days, which makes it difficult to schedule the construction work. In this paper, we present an automated cable-laying system that can automatically pay out the optical-fiber submarine cable on the seafloor at a rate that keeps pace with the ground speed and also adjusts the cable tautness. The components and control strategies are first described, and the results of some experiments and the first mission are then presented. The experiments and the first mission demonstrate that the automated cable-laying system can reduce the physical and mental burdens on the ROV operator and speed up the installation of DONET2 in 31 observatories. DONET2 is planned to be deployed off the Kii Peninsula (on the western side of DONET1).	[Choi, Jin-Kyu; Nishida, Shuhei; Yokobiki, Takashi; Kawaguchi, Katsuyoshi] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Yokosuka, Kanagawa 2370061, Japan	Choi, JK (reprint author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Yokosuka, Kanagawa 2370061, Japan.	jk-choi@jamstec.go.jp; shuheinishida@jamstec.go.jp; yokobikit@jamstec.go.jp; kawak@jam-stec.go.jp					Andres J. M., 1993, P IEEE OCEANS C VICT, V2, pII413; Ferguson J, 1999, SEA TECHNOL, V40, P65; Kawaguchi K, 2002, IEEE J OCEANIC ENG, V27, P182, DOI 10.1109/JOE.2002.1002472; ZAJAC EE, 1957, AT&T TECH J, V36, P1129; Bird L. E., 2002, P MTS IEEE OCEANS C, DOI [10.1109/OCEANS.2002.1191947, DOI 10.1109/0CEANS.2002.1191947]; Butler B., 1993, P IEEE OCEANS C VICT, DOI [10.1109/OCEANS.1993.326046, DOI 10.1109/OCEANS.1993.326046]; Choi J.-K., 2013, P INT S UND TECHN TO, DOI [10.1109/UT.2013.6519810, DOI 10.1109/UT.2013.6519810]; Grewal M. S., 2001, KALMAN FILTERING THE; Hartley P., 1991, P INT S UNM UNT SUBM, P20; Japan Agency for Marine-Earth Science and Technology (JAMSTEC), DENS OC NETW SYST EA; Kaneda Y., 2013, P INT S UND TECHN TO, DOI [10.1109/UT.2013.6519904, DOI 10.1109/UT.2013.6519904]; Kawaguchi K., 2012, P MTS IEEE OCEANS YE, DOI [10.1109/OCEANS-Yeosu.2012.6263447, DOI 10.1109/OCEANS-YEOSU.2012.6263447]; Kawaguchi K., 2009, P IEEE OCEANS EUR C, DOI [10.1109/OCEANSE.2009.5278322, DOI 10.1109/0CEANSE.2009.5278322]; Kitada K., 2013, P INT S UND TECHN TO, DOI [10.1109/UT.2013.6519882, DOI 10.1109/UT.2013.6519882]; Kojima J., 1990, J SOC NAVAL ARCHITEC, V168, P309; Shepherd K., 2007, P MTS IEEE OCEANS C, DOI [10.1109/OCEANS.2007.4449275, DOI 10.1109/OCEANS.2007.4449275]	16	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0364-9059	1558-1691		IEEE J OCEANIC ENG	IEEE J. Ocean. Eng.	OCT	2015	40	4					981	992		10.1109/JOE.2014.2363785		12	Engineering, Civil; Engineering, Ocean; Engineering, Electrical & Electronic; Oceanography	Engineering; Oceanography	CT9XZ	WOS:000363171200021		
J	Wang, H; Kousai, S; Onizuka, K; Hu, S				Wang, Hua; Kousai, Shouhei; Onizuka, Kohei; Hu, Song			The Wireless Workhorse	IEEE MICROWAVE MAGAZINE			English	Article							CMOS POWER-AMPLIFIER; EFFICIENCY IMPROVEMENT; BACK-OFF; DIGITAL PREDISTORTION; ENVELOPE ELIMINATION; MOBILE PHONES; BULK CMOS; NM CMOS; TRANSMITTER; TRANSFORMER		[Wang, Hua; Hu, Song] Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30332 USA; [Kousai, Shouhei; Onizuka, Kohei] Toshiba Co Ltd, Ctr Semicond R&D, Tokyo, Japan	Wang, H (reprint author), Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30332 USA.	hua.wang@ece.gatech.edu; shouhei.kousai@toshiba.co.jp; kohei.onizuka@toshiba.co.jp; husong@gatech.edu					Choi J, 2009, IEEE T MICROW THEORY, V57, P1675, DOI 10.1109/TMTT.2009.2021880; Alavi MS, 2014, IEEE T MICROW THEORY, V62, P732, DOI 10.1109/TMTT.2014.2307876; Staszewski RB, 2005, IEEE J SOLID-ST CIRC, V40, P2469, DOI 10.1109/JSSC.2005.857417; Hu S, 2015, IEEE J SOLID-ST CIRC, V50, P1094, DOI 10.1109/JSSC.2015.2415494; Li CH, 2009, IEEE T ANTENN PROPAG, V57, P2763, DOI 10.1109/TAP.2009.2027081; Doherty WH, 1936, P IRE, V24, P1163, DOI 10.1109/JRPROC.1936.228468; Carrubba V, 2010, EUR MICROW INTEGRAT, P432; Boumaiza S, 2002, IEEE T MICROW THEORY, V50, P3016, DOI 10.1109/TMTT.2002.805139; Kwak M, 2012, IEEE T MICROW THEORY, V60, P1850, DOI 10.1109/TMTT.2012.2184128; Jager H, 2002, IEEE MTT-S, P1035, DOI 10.1109/MWSYM.2002.1011812; Zhao DX, 2012, IEEE J SOLID-ST CIRC, V47, P3172, DOI 10.1109/JSSC.2012.2216692; [Anonymous], 2008, IEEE J SOLID-ST CIRC; Kim D, 2011, IEEE T MICROW THEORY, V59, P1787, DOI 10.1109/TMTT.2011.2140124; Okazaki H, 2013, URSI INT SYM ELECT, P432; Morgan DR, 2006, IEEE T SIGNAL PROCES, V54, P3852, DOI 10.1109/TSP.2006.879264; Hassan M, 2012, IEEE T MICROW THEORY, V60, P1321, DOI 10.1109/TMTT.2012.2187537; Chowdhury D, 2011, IEEE J SOLID-ST CIRC, V46, P1796, DOI 10.1109/JSSC.2011.2155790; Chowdhury D, 2012, IEEE J SOLID-ST CIRC, V47, P1113, DOI 10.1109/JSSC.2012.2185555; SOKAL NO, 1975, IEEE J SOLID-ST CIRC, VSC10, P168, DOI 10.1109/JSSC.1975.1050582; [Anonymous], 2015, RADIO FREQUENCY DEVI; Staszewski RB, 2004, IEEE J SOLID-ST CIRC, V39, P2278, DOI 10.1109/JSSC.2004.836345; Yoo SM, 2011, IEEE J SOLID-ST CIRC, V46, P2977, DOI 10.1109/JSSC.2011.2163469; Dasgupta K, 2014, IEEE RAD FREQ INTEGR, P343, DOI 10.1109/RFIC.2014.6851737; Grebennikov A, 2012, P IEEE, V100, P3190, DOI 10.1109/JPROC.2012.2211091; [Anonymous], 2014, P IEEE RF INT CIRC S; Ye L, 2013, IEEE J SOLID-ST CIRC, V48, P3160, DOI 10.1109/JSSC.2013.2281142; Yoo SM, 2013, IEEE J SOLID-ST CIRC, V48, P1212, DOI 10.1109/JSSC.2013.2252754; Wang FP, 2006, IEEE T MICROW THEORY, V54, P4086, DOI 10.1109/TMTT.2006.885575; Chen CT, 2012, IEEE T MICROW THEORY, V60, P4117, DOI 10.1109/TMTT.2012.2223712; Kim N, 2009, IEEE J SOLID-ST CIRC, V44, P2126, DOI 10.1109/JSSC.2009.2022921; [Anonymous], 2014, P IEEE RFIC S JUN 20; Margomenos A, 2012, EUR MICROW INTEGRAT, P615; Hu S, 2015, ISSCC DIG TECH PAP I, V58, P44; Berretta G, 2006, IEEE RADIO WIRELESS, P523, DOI 10.1109/RWS.2006.1615209; Wang H, 2010, IEEE J SOLID-ST CIRC, V45, P2709, DOI 10.1109/JSSC.2010.2077171; Haldi P, 2006, ELECTRON LETT, V42, P1091, DOI 10.1049/el:20061585; Liu G, 2008, IEEE J SOLID-ST CIRC, V43, P600, DOI 10.1109/JSSC.2007.916585; Birafane A, 2004, IEEE T MICROW THEORY, V52, P1702, DOI 10.1109/TMTT.2004.830485; Walling JS, 2009, IEEE J SOLID-ST CIRC, V44, P2339, DOI 10.1109/JSSC.2009.2023191; Darraji R, 2012, IEEE T MICROW THEORY, V60, P2875, DOI 10.1109/TMTT.2012.2207910; Vasylyev A, 2005, ELECTRON LETT, V41, P1281, DOI 10.1049/el:20053261; Chen KL, 2012, IEEE T MICROW THEORY, V60, P4107, DOI 10.1109/TMTT.2012.2221142; Wu RL, 2013, IEEE J SOLID-ST CIRC, V48, P2030, DOI 10.1109/JSSC.2013.2265501; Kousai S, 2009, IEEE J SOLID-ST CIRC, V44, P3376, DOI 10.1109/JSSC.2009.2032271; Boyle KR, 2007, IEEE T ANTENN PROPAG, V55, P364, DOI 10.1109/TAP.2006.889834; Chakrabarti A, 2014, IEEE T MICROW THEORY, V62, P1686, DOI 10.1109/TMTT.2014.2327919; Reynaert P, 2005, IEEE J SOLID-ST CIRC, V40, P2598, DOI 10.1109/JSSC.2005.857425; Wang CZ, 2004, IEEE J SOLID-ST CIRC, V39, P1927, DOI 10.1109/JSSC.2004.835834; Bowers SM, 2013, IEEE T MICROW THEORY, V61, P1301, DOI 10.1109/TMTT.2013.2243750; Noh YS, 2004, IEEE J SOLID-ST CIRC, V39, P967, DOI 10.1109/JSSC.2004.827804; Pelosi M, 2010, IEEE ANTENN PROPAG M, V52, P15, DOI 10.1109/MAP.2010.5586570; Wang FP, 2005, IEEE MTT-S, P645; Aoki I, 2002, IEEE T MICROW THEORY, V50, P316, DOI 10.1109/22.981284; Sowlati T, 2004, IEEE J SOLID-ST CIRC, V39, P2179, DOI 10.1109/JSSC.2004.836335; Xu HT, 2011, IEEE J SOLID-ST CIRC, V46, P1596, DOI 10.1109/JSSC.2011.2143930; Agah A, 2014, IEEE J SOLID-ST CIRC, V49, P1148, DOI 10.1109/JSSC.2014.2308292; Tai W, 2012, IEEE J SOLID-ST CIRC, V47, P1646, DOI 10.1109/JSSC.2012.2191674; Hassan M, 2012, IEEE J SOLID-ST CIRC, V47, P1185, DOI 10.1109/JSSC.2012.2184639; Wang H, 2014, IEEE T CIRCUITS-I, V61, P1321, DOI 10.1109/TCSI.2014.2309811; Kousai S, 2012, IEEE J SOLID-ST CIRC, V47, P2964, DOI 10.1109/JSSC.2012.2217833; Bakalski W, 2003, BCTM PROC, P61; Chireix H, 1935, P IRE, V23, P1370, DOI 10.1109/JRPROC.1935.227299; Thian M, 2009, IEEE T MICROW THEORY, V57, P323, DOI 10.1109/TMTT.2008.2011164; Asbeck P., 2012, IEEE 12 TOP M SIRF, P1; Chen J., 2013, ISSCC, P232, DOI DOI 10.1109/ISSCC.2013.6487713; Chiriac V., 2004, P ASME IMECE T AN CA, P1; Chowdhury D, 2009, IEEE J SOLID-ST CIRC, V44, P3393, DOI 10.1109/JSSC.2009.2032277; COX DC, 1974, IEEE T COMMUN, VCO22, P1942, DOI 10.1109/TCOM.1974.1092141; Cripps S., 2006, RF POWER AMPLIFIERS; Cripps SC, 2002, ADV TECHNIQUES RF PO; Fan X., 2008, P IEEE 10 EL PACK TE, P1, DOI DOI 10.1109/PIMRC.2008.4699508; Gaber W., 2011, P ESSCIRC SEP, P139; Gaber W. M., 2012, P ESSCIRC, P341; Hau G., 2008, P IEEE RAD FREQ INT, P409; Hu S, 2015, IEEE T MICROW THEORY, V63, P580, DOI 10.1109/TMTT.2014.2385860; Ishihara H., 2010, IEEE INT SOL STAT CI, P66; Kousai S, 2014, IEEE J SOLID-ST CIRC, V49, P2902, DOI 10.1109/JSSC.2014.2361322; Lee T. H., 2003, DESIGN CMOS RADIO FR; Onizuka Kohei, 2012, Proceedings of the 2012 IEEE Asian Solid State Circuits Conference (A-SSCC); Onizuka K., 2013, P IEEE INT SOL STAT, P90; Pham A., 2006, P IEEE RAD FREQ INT, P4; RAAB FH, 1985, IEEE T COMMUN, V33, P1094, DOI 10.1109/TCOM.1985.1096219; Razavi B., 2011, RF MICROELECTRONICS; Schaumann R., 2009, DESIGN ANALOG FILTER; Song H., 2009, P IEEE INT SOL STAT, P384; Tuffy N., 2011, Proceedings 2011 European Microwave Integrated Circuit Conference (EuMIC 2011); Zhou J, 2014, IEEE J SOLID-ST CIRC, V49, P3046, DOI 10.1109/JSSC.2014.2359914	87	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1527-3342	1557-9581		IEEE MICROW MAG	IEEE Microw. Mag.	OCT	2015	16	9					36	63		10.1109/MMM.2015.2453872		28	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CU0WZ	WOS:000363241000005		
J	Farghal, AE; Shalaby, HMH; Kato, K; Pokharel, RK				Farghal, Ahmed E.; Shalaby, Hossam M. H.; Kato, Kazutoshi; Pokharel, Ramesh K.			Optical Code-Division Multiplexing (OCDM) Networks Adopting Code-Shift Keying/Overlapping PPM Signaling: Proposal and Performance Analysis	IEEE TRANSACTIONS ON COMMUNICATIONS			English	Article						Optical code division multiplexing (OCDM); APD noise; intersymbol interference (ISI); code-shift keying (CSK); overlapping pulse-position modulation (OPPM)	PULSE-POSITION MODULATION; ACCESS SYSTEMS; CDMA SYSTEMS; DISPERSION; SECURITY; SCHEMES; IMPACT; OPPM; TIME; APDS	Optical code-division multiplexing (OCDM) systems use short pulses compared with bit-duration to achieve high transmission rate. The use of short pulses poses several problems as a result of group velocity dispersion (GVD), intersymbol interference (ISI) (due to avalanche photodiode (APD) buildup time), and receivers limited bandwidth. In this paper, an OCDM system employing code-shift keying (CSK) and overlapping pulse-position modulation (OPPM) signaling is proposed and theoretically investigated. By using CSK while maintaining same data rate, the chip duration can be increased to counteract the GVD effect in 2D OCDM systems. Moreover, by increasing the chip duration, the chip rate is decreased and the stringent requirement on receiver bandwidth is relaxed. In addition, using overlapping property in OPPM allows for further chip duration increase. We consider using correlation receivers with hard-limiters and APDs at the receiver side. The bit error probability (BEP) of the proposed system is derived taking into account the impacts of APD noise, thermal noise, GVD, ISI, and multiple-access interference (MAI). A performance comparison between OOK-, PPM-, OPPM-OCDM and the proposed system is carried out. Our results reveal that the use of CSK/OPPM-OCDM with data rate constraint allows the reduction of MAI, GVD and ISI effects with improved spectral efficiency.	[Farghal, Ahmed E.; Shalaby, Hossam M. H.] Egypt Japan Univ Sci & Technol E JUST, Dept Elect & Commun Engn, Alexandria 21934, Egypt; [Kato, Kazutoshi; Pokharel, Ramesh K.] Kyushu Univ, Grad Sch Informat Sci & Elect Engn, Fukuoka 8190395, Japan	Farghal, AE (reprint author), Egypt Japan Univ Sci & Technol E JUST, Dept Elect & Commun Engn, Alexandria 21934, Egypt.	ahmed.farghal@ejust.edu.eg; shalaby@ieee.org; kato@ed.kyushu-u.ac.jp; pokharel@ed.kyushu-u.ac.jp			Egyptian Ministry of Higher Education	This work was supported by the Egyptian Ministry of Higher Education. The associate editor coordinating the review of this paper and approving it for publication was W. C. Kwong.	Agrawal G. P., 2001, NONLINEAR FIBER OPTI; Agrawal G. P., 2002, FIBER OPTIC COMMUNIC, P164; Sun P, 2006, J LIGHTWAVE TECHNOL, V24, P755, DOI 10.1109/JLT.2005.862436; Manzacca G, 2007, IEEE PHOTONIC TECH L, V19, P559, DOI 10.1109/LPT.2007.894261; [Anonymous], 2015, SUPP VIRT 7 FAM OV; Campbell JC, 2007, J LIGHTWAVE TECHNOL, V25, P109, DOI 10.1109/JLT.2006.888481; Ong DSG, 2009, J LIGHTWAVE TECHNOL, V27, P3294, DOI 10.1109/JLT.2009.2020303; Dang NT, 2010, J OPT COMMUN NETW, V2, P967, DOI 10.1364/JOCN.2.000967; Galli S, 2008, IEEE T COMMUN, V56, P2133, DOI 10.1109/TCOMM.2008.050640; Yang GC, 1997, IEEE T COMMUN, V45, P1426, DOI 10.1109/26.649764; Shalaby HMH, 1999, J LIGHTWAVE TECHNOL, V17, P1158, DOI 10.1109/50.774248; Tancevski L, 1996, IEE P-OPTOELECTRON, V143, P161, DOI 10.1049/ip-opt:19960318; Wang TC, 2009, J LIGHTWAVE TECHNOL, V27, P2612, DOI 10.1109/JLT.2009.2013367; Shake TH, 2005, J LIGHTWAVE TECHNOL, V23, P655, DOI 10.1109/JLT.2004.838844; Narimanov E, 2005, IEEE T COMMUN, V53, P2150, DOI 10.1109/TCOMM.2005.860041; Lu LJ, 2014, OPT LETT, V39, P1633, DOI 10.1364/OL.39.001633; Shalaby HMH, 2000, J LIGHTWAVE TECHNOL, V18, P905, DOI 10.1109/50.850734; Dang NT, 2011, ASIA-PAC CONF COMMUN, P96; Tancevski L, 1996, J LIGHTWAVE TECHNOL, V14, P2636, DOI 10.1109/50.545782; Majumder SP, 2005, IEEE PHOTONIC TECH L, V17, P1340, DOI 10.1109/LPT.2005.846924; Smith EDJ, 1998, IEEE T COMMUN, V46, P1176, DOI 10.1109/26.718559; PAPOULIS A, 1971, J APPL PROBAB, V8, P118, DOI 10.2307/3211842; Mashhadi S, 2006, IEEE T COMMUN, V54, P1457, DOI 10.1109/TCOMM.2006.878835; SHALABY HMH, 1995, J LIGHTWAVE TECHNOL, V13, P2121, DOI 10.1109/50.482031; Ng EKH, 2002, IEEE T COMMUN, V50, P1811, DOI 10.1109/TCOMM.2002.805262; El-Howayek G, 2014, IEEE PHOTONICS J, V6, DOI 10.1109/JPHOT.2014.2302792; Farghal AE, 2014, J LIGHTWAVE TECHNOL, V32, P2649, DOI 10.1109/JLT.2014.2331700; Gagliardi R., 1995, OPTICAL COMMUNICATIO; Kong W. C., 2005, IEEE T COMMUN, V53, P117; Kouketsu H., 2014, P OPT FIB COMM C SAN; Sabbagh AG, 2013, J LIGHTWAVE TECHNOL, V31, DOI 10.1109/JLT.2013.2271238; Sanches Anderson L, 2009, Journal of Lightwave Technology, V27, DOI 10.1109/JLT.2009.2030775; Shurong S., 2006, J LIGHTWAVE TECHNOL, V24, P1646	33	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0090-6778	1558-0857		IEEE T COMMUN	IEEE Trans. Commun.	OCT	2015	63	10					3779	3788		10.1109/TCOMM.2015.2467372		10	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CU1CP	WOS:000363257200026		
J	Asada, T; Baba, Y; Nagaoka, N; Ametani, A				Asada, Takashi; Baba, Yoshihiro; Nagaoka, Naoto; Ametani, Akihiro			Representation of a Straight Thin Wire in a Lossy Medium and an Oblique Thin Wire in Air for FDTD Simulations	IEEE TRANSACTIONS ON ELECTROMAGNETIC COMPATIBILITY			English	Article						Equivalent radius; finite-difference time-domain method; thin wire; transient	SURGE SIMULATION; BOUNDARY	An improved representation of a straight thin wire for a 3-D finite-difference time-domain simulation has been applied to the transient analysis of a straight thin wire in a lossy medium, and its validity has been shown. In this representation, a straight wire having a specified radius is simulated by a straight wire having the equivalent radius 0.199 Delta s, where Delta s is the lateral side length of cubic cells employed, embedded in an artificial parallelepiped medium having modified conductivity (only if it is in a lossy medium), modified relative permittivity, and modified relative permeability. Also, the equivalent radius of a staircase-approximated oblique wire in air has been evaluated, and its thin-wire representation has been discussed.	[Asada, Takashi; Baba, Yoshihiro; Nagaoka, Naoto; Ametani, Akihiro] Doshisha Univ, Dept Elect Engn, Kyoto 6100321, Japan	Asada, T (reprint author), Doshisha Univ, Dept Elect Engn, Kyoto 6100321, Japan.	dun0306@mail4.doshisha.ac.jp; ybaba@mail.doshisha.ac.jp; nnagaoka@mail.doshisha.ac.jp; aametani@mail.doshisha.ac.jp					Zhang G, 2007, IET MICROW ANTENNA P, V1, P381, DOI 10.1049/iet-map:20050305; Asada T, 2015, IEEE T ELECTROMAGN C, V57, P484, DOI 10.1109/TEMC.2014.2380815; Baba Y, 2014, IEEE T ELECTROMAGN C, V56, P1506, DOI 10.1109/TEMC.2014.2331323; Edelvik F, 2003, IEEE T ELECTROMAGN C, V45, P416, DOI 10.1109/TEMC.2003.811294; Noda T, 2002, IEEE T POWER DELIVER, V17, P840, DOI 10.1109/TPWRD.2002.1022813; Makinen RM, 2002, IEEE T MICROW THEORY, V50, P1245, DOI 10.1109/22.999136; Baba Y, 2005, IEEE T ELECTROMAGN C, V47, P54, DOI 10.1109/TEMC.2004.842115; Taniguchi Y, 2008, IEEE T ANTENN PROPAG, V56, P3248, DOI 10.1109/TAP.2008.929447; Railton CJ, 2006, IEEE T ELECTROMAGN C, V48, P654, DOI 10.1109/TEMC.2006.884452; Holland R., 1981, ELECTROMAGNETIC COMP, VEMC-23, P88; LIAO ZP, 1984, SCI SIN A-MATH P A T, V27, P1063; Noda T, 2004, IEEE T POWER DELIVER, V19, P1913, DOI 10.1109/TPWRD.2004.835396; UMASHANKAR KR, 1987, IEEE T ANTENN PROPAG, V35, P1248, DOI 10.1109/TAP.1987.1144000; YEE KS, 1966, IEEE T ANTENN PROPAG, VAP14, P302	14	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9375	1558-187X		IEEE T ELECTROMAGN C	IEEE Trans. Electromagn. Compat.	OCT	2015	57	5					1164	1167		10.1109/TEMC.2015.2424976		4	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CU0EQ	WOS:000363189200029		
J	Paoletti, U; Suga, T				Paoletti, Umberto; Suga, Takashi			The Printed Reverberation Board and the Extraction of IC Noise Models Above 1 GHz	IEEE TRANSACTIONS ON ELECTROMAGNETIC COMPATIBILITY			English	Article						Integrated circuit (IC) measurements; integrated circuit modeling; integrated circuit noise; power supplies	CHAOTIC MICROWAVE CAVITIES; SCATTERING MATRICES; IMPEDANCE; STATISTICS	A new approach to integrated circuit (IC) noise modeling using a single current source for the whole area below the IC on a printed circuit board (PCB) is proposed. This approach extends the frequency of application of similar models in the literature by focusing on the current and power injected into the region outside the IC perimeter. A new measurement equipment for IC electromagnetic compatibility tests above 1 GHz is proposed; the printed reverberation board (PRB). A statistical model for characterizing the PRB is presented and confirmed by measurement results. Limitations of the fabricated PRB prototype and possible improvements are discussed. Anew random IC model that includes the random properties of the IC noise is introduced. A methodology to extract the IC model by means of the PRB is presented. An active test PCB has been designed and fabricated to verify the feasibility of the modeling and measurement methods. Measurement results corroborated the validity of the new measurement and modeling approaches on one side, and on the other side showed that further studies are required.	[Paoletti, Umberto; Suga, Takashi] Hitachi Ltd, Yokohama Res Lab, Yokohama, Kanagawa 2440817, Japan	Paoletti, U (reprint author), Hitachi Ltd, Yokohama Res Lab, Yokohama, Kanagawa 2440817, Japan.	umberto.paoletti.ff@hitachi.com; takashi.suga.pt@hitachi.com					Wang ZL, 2005, IEEE T ELECTROMAGN C, V47, P2, DOI 10.1109/TEMC.2004.842205; Zhang YJ, 2010, IEEE T MICROW THEORY, V58, P3780, DOI 10.1109/TMTT.2010.2083870; Hemmady S, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056215; Zheng X, 2006, ELECTROMAGNETICS, V26, P37, DOI 10.1080/02726340500214902; Zheng X, 2006, ELECTROMAGNETICS, V26, P3, DOI 10.1080/02726340500214894; Li L, 2012, IEEE INT SYMP ELEC, P560; Gotoh K, 2005, IEICE T COMMUN, VE88B, P3235, DOI 10.1093/ietcom/e88-b.8.3235; Paoletti U, 2013, 2013 9TH INTERNATIONAL WORKSHOP ON ELECTROMAGNETIC COMPATIBILITY OF INTEGRATED CIRCUITS (EMC COMPO 2013), P21, DOI 10.1109/EMCCompo.2013.6735166; Hemmady S, 2012, IEEE T ELECTROMAGN C, V54, P758, DOI 10.1109/TEMC.2011.2177270; Hill DA, 1998, IEEE T ELECTROMAGN C, V40, P209, DOI 10.1109/15.709418; Fiori F, 2003, IEEE T INSTRUM MEAS, V52, P839, DOI 10.1109/TIM.2003.814685; [Anonymous], 2011, 624331 IEC; [Anonymous], 2002, 619671 IEC; Hart JA, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.041109; Antonini G., 2003, P C EL PERF EL PACK, P345; Chen RL, 2005, IEEE T ELECTROMAGN C, V47, P10, DOI 10.1109/TEMC.2004.842204; EMC, 2000, 61000421 IEC; Nakao T., 2012, P IEEE INT 3D SYST I, P1; Paoletti U., 2012, P EUR INT S EL COMP; Papoulis A., 2002, PROBABILITY RANDOM V; Wada O., 2006, P 17 INT ZUR S EL CO, P316	21	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9375	1558-187X		IEEE T ELECTROMAGN C	IEEE Trans. Electromagn. Compat.	OCT	2015	57	5					1206	1215		10.1109/TEMC.2015.2423314		10	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CU0EQ	WOS:000363189200034		
J	Mashimo, T				Mashimo, Tomoaki			Performance Evaluation of a Micro Ultrasonic Motor Using a One-Cubic-Millimeter Stator	IEEE TRANSACTIONS ON ULTRASONICS FERROELECTRICS AND FREQUENCY CONTROL			English	Article							TRANSDUCER; CONTACT	A piezoelectric ultrasonic motor has two significant advantages, high energy density and simple structure, and these advantages can help in the miniaturization of the motor. We build a prototype micro ultrasonic motor using a stator with a volume of approximately 1 cubic millimeter. To evaluate its representative performance values (torque, angular velocity, and energy efficiency), we built an experimental setup and operated the prototype motor by varying experimental conditions, such as the preload between the stator and rotor and the amplitude of voltages applied to motor. The performance values obtained at the millimeter to sub-millimeter scale are discussed analytically using the macro scale models of ultrasonic motors. Experimentally, the prototype motor has generated a torque of more than 10 mu Nm with a 1-cubic-millimeter stator. The motor described herein is now the smallest micro ultrasonic motor with a practical torque, although its efficiency is still low.	Toyohashi Univ Technol, Toyohashi, Aichi 4418580, Japan	Mashimo, T (reprint author), Toyohashi Univ Technol, Toyohashi, Aichi 4418580, Japan.	mashimo@eiiris.tut.ac.jp					Mashimo T, 2014, SENSOR ACTUAT A-PHYS, V213, P102, DOI 10.1016/j.sna.2014.03.018; Inoue A, 2006, MATER TRANS, V47, P1275, DOI 10.2320/matertrans.47.1275; HAGOOD NW, 1995, IEEE T ULTRASON FERR, V42, P210, DOI 10.1109/58.365235; Uchino K, 2004, J ELECTROCERAM, V13, P393, DOI 10.1007/s10832-004-5131-x; FAN LS, 1989, SENSOR ACTUATOR, V20, P41, DOI 10.1016/0250-6874(89)87100-8; Watson B, 2009, SENSOR ACTUAT A-PHYS, V152, P219, DOI 10.1016/j.sna.2009.04.001; Cagatay S, 2003, IEEE T ULTRASON FERR, V50, P782, DOI 10.1109/TUFFC.2003.1214498; NAKAMURA K, 1991, IEEE T ULTRASON FERR, V38, P481, DOI 10.1109/58.84293; NAKAMURA K, 1991, IEEE T ULTRASON FERR, V38, P188, DOI 10.1109/58.79602; Morita T, 2003, SENSOR ACTUAT A-PHYS, V103, P291, DOI 10.1016/S0924-4247(02)00405-3; KUROSAWA M, 1989, IEEE T ULTRASON FERR, V36, P517, DOI 10.1109/58.31795; [Anonymous], 2014, INT ULTR S, DOI DOI 10.1109/ULTSYM.2014.0213; Kanda T, 2006, SENSOR ACTUAT A-PHYS, V127, P131, DOI 10.1016/j.sna.2005.10.056; Wallaschek J, 1998, SMART MATER STRUCT, V7, P369, DOI 10.1088/0964-1726/7/3/011; GUCKEL H, 1993, MICRO ELECTRO MECHANICAL SYSTEMS, PROCEEDINGS, P7; Iino A, 2000, ULTRASONICS, V38, P54, DOI 10.1016/S0041-624X(99)00192-4; Jacobsen S. C., 1989, P IEEE INT C ROB AUT, V3, P1536; lino A., 2002, JPN J PREC ENG, V68, P641; Liu Daniel Kuang-Chen, 2010, Acoustical Science and Technology, V31, DOI 10.1250/ast.31.115; MAENO T, 1992, IEEE T ULTRASON FERR, V39, P675, DOI 10.1109/58.165550; Morita T, 2000, SENSOR ACTUAT A-PHYS, V83, P225, DOI 10.1016/S0924-4247(99)00388-X; TRIMMER WSN, 1989, SENSOR ACTUATOR, V19, P267, DOI 10.1016/0250-6874(89)87079-9; Watson B, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/2/022001; Watson B., 2009, IEEE INT C ROB AUT K, P2225	24	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0885-3010	1525-8955		IEEE T ULTRASON FERR	IEEE Trans. Ultrason. Ferroelectr. Freq. Control	OCT	2015	62	10					1819	1826		10.1109/TUFFC.2014.006834		8	Acoustics; Engineering, Electrical & Electronic	Acoustics; Engineering	CU0WW	WOS:000363240600009		
J	Sugiura, S; Hanzo, L				Sugiura, Shinya; Hanzo, Lajos			Single-RF Spatial Modulation Requires Single-Carrier Transmission: Frequency-Domain Turbo Equalization for Dispersive Channels	IEEE TRANSACTIONS ON VEHICULAR TECHNOLOGY			English	Article						Broadband transmissions; EXIT chart; frequency-domain equalization; iterative detection; minimum mean-square error; orthogonal frequency-division multiplexing; single-carrier transmission; space-shift keying; spatial modulation	PERFORMANCE ANALYSIS; INFORMATION; SYSTEMS; DESIGN; CODES; FDMA	In this paper, we propose a broadband single-carrier (SC) spatial modulation (SM)-based multiple-input-multiple-output (MIMO) architecture relying on a soft decision (SoD) frequency-domain equalization (FDE) receiver. We demonstrate that conventional orthogonal-frequency-division-multiplexing (OFDM)-based broadband transmissions are not readily suitable for the single-radio-frequency-assisted SM-MIMO schemes since this scheme exhibits no substantial performance advantage over single-antenna transmissions. To circumvent this limitation, a low-complexity SoD FDE algorithm based on the minimum mean square error (MMSE) criterion is invoked for our broadband SC-based SM-MIMO scheme, which is capable of operating in a strongly dispersive channel having a long channel impulse response at moderate decoding complexity. Furthermore, our SoD FDE attains a near-capacity performance with the aid of a three-stage concatenated SC-based SM architecture.	[Sugiura, Shinya] Tokyo Univ Agr & Technol, Dept Comp & Informat Sci, Tokyo 1848588, Japan; [Hanzo, Lajos] Univ Southampton, Sch Elect & Comp Sci, Southampton SO17 1BJ, Hants, England	Sugiura, S (reprint author), Tokyo Univ Agr & Technol, Dept Comp & Informat Sci, Tokyo 1848588, Japan.	sugiura@ieee.org; lh@ecs.soton.ac.uk	Sugiura, Shinya/A-5358-2013		Japan Society for the Promotion of Science [26709028]	This work was supported by the Japan Society for the Promotion of Science Grants-in Aid for Scientific Research (KAKENHI) under Grant 26709028. The review of this paper was coordinated by Dr. C. Cozzo.	Myung HG, 2006, IEEE VEH TECHNOL MAG, V1, P30, DOI 10.1109/MVT.2006.307304; Alrabadi ON, 2012, IEEE T ANTENN PROPAG, V60, P654, DOI 10.1109/TAP.2011.2173429; Mesleh RY, 2008, IEEE T VEH TECHNOL, V57, P2228, DOI [10.1109/TVT.2007.912136, 10.1109/TVT.2008.912136]; Som P, 2012, UEEE INT SYM PERS IN, P1962, DOI 10.1109/PIMRC.2012.6362674; Sugiura S, 2012, IEEE SIGNAL PROC LET, V19, P805, DOI 10.1109/LSP.2012.2221707; Jeganathan J, 2008, IEEE COMMUN LETT, V12, P545, DOI 10.1109/LCOMM.2008.080739; Kadir MI, 2013, IEEE T VEH TECHNOL, V62, P408, DOI 10.1109/TVT.2012.2220794; Di Renzo M, 2010, IEEE T COMMUN, V58, P2590, DOI 10.1109/TCOMM.2010.09.090565; ten Brink S, 2001, IEEE T COMMUN, V49, P1727, DOI 10.1109/26.957394; Di Renzo M, 2011, IEEE COMMUN MAG, V49, P182; Pancaldi F, 2008, IEEE SIGNAL PROC MAG, V25, P37, DOI 10.1109/MSP.2008.926657; Sugiura S, 2012, IEEE COMMUN SURV TUT, V14, P421, DOI 10.1109/SURV.2011.032511.00136; ten Brink S, 2004, IEEE T COMMUN, V52, P670, DOI 10.1109/TCOMM.2004.826370; Jeganathan J, 2009, IEEE T WIREL COMMUN, V8, P3692, DOI 10.1109/TWC.2009.080910; Rajashekar R, 2013, IEEE T COMMUN, V61, P2318, DOI 10.1109/TCOMM.2013.043013.130011; ten Brink S, 2000, AEU-INT J ELECTRON C, V54, P389; Sugiura S, 2012, IEEE COMMUN SURV TUT, V14, P401, DOI 10.1109/SURV.2011.041911.00105; Astely D, 2009, IEEE COMMUN MAG, V47, P44, DOI 10.1109/MCOM.2009.4907406; Sugiura S, 2010, IEEE T COMMUN, V58, P3219, DOI 10.1109/TCOMM.2010.093010.090730; Sugiura S, 2014, IEEE SIGNAL PROC LET, V21, P390, DOI 10.1109/LSP.2014.2303471; Di Renzo M, 2014, P IEEE, V102, P56, DOI 10.1109/JPROC.2013.2287851; Ganesan S., 2006, P 40 AS C SIGN SYST; Hanzo L., 2009, NEAR CAPACITY MULTIF; Hanzo L., 2011, TURBO CODING TURBO E; Hanzo L., 2003, OFDM MC CDMA BROADBA; Hanzo L., 2003, SINGLE MULTICARRIER; Ishibashi Koji, 2014, IEEE Wireless Communications Letters, V3, DOI 10.1109/LWC.2014.2315819; Kalis A, 2008, IEEE J SEL AREA COMM, V26, P972, DOI 10.1109/JSAC.2008.080813; Ngo H. A., 2011, IEEE SIGNAL PROCESS, V18, P177, DOI 10.1109/LSP.2011.2106773; Tuchler M, 2002, IEEE T SIGNAL PROCES, V50, P673, DOI 10.1109/78.984761	30	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9545	1939-9359		IEEE T VEH TECHNOL	IEEE Trans. Veh. Technol.	OCT	2015	64	10					4870	4875		10.1109/TVT.2014.2370679		6	Engineering, Electrical & Electronic; Telecommunications; Transportation Science & Technology	Engineering; Telecommunications; Transportation	CU0FI	WOS:000363191100043		
J	Yuhji, M; Kiho, T; Yasuo, I; Yoshifumi, U; Shinji, T				Yuhji, Marui; Kiho, Tanaka; Yasuo, Ishii; Yoshifumi, Ubara; Shinji, Tomikawa			IMPACT OF PRE-OPERATIVE TREATMENT FOR POLYCYSTIC KIDNEY IN RENAL TRANSPLANT RECIPIENTS FOR AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE	IMMUNOLOGY AND CELL BIOLOGY			English	Meeting Abstract	33rd Annual Scientific Meeting of the Transplantation-Society-of-Australia-and-New Zealand	JUN 21-23, 2015	ANU Campus, Canberra, AUSTRALIA	Transplantat Soc Australia & New Zealand	ANU Campus				[Yuhji, Marui; Kiho, Tanaka; Yasuo, Ishii; Shinji, Tomikawa] Toranomon Hosp Kajigya, Dept Renal Transplantat Surg, Tokyo, Japan; [Yoshifumi, Ubara] Toranomon Hosp Kajigya, Dept Nephrol, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0818-9641	1440-1711		IMMUNOL CELL BIOL	Immunol. Cell Biol.	OCT	2015	93	9					A27	A28				2	Cell Biology; Immunology	Cell Biology; Immunology	CU1ZE	WOS:000363320100069		
J	Rajalakshmy, AR; Malathi, J; Madhavan, HN; Samuel, JKA				Rajalakshmy, A. R.; Malathi, J.; Madhavan, H. N.; Samuel, J. K. A.			Mebiolgel, a thermoreversible polymer as a scaffold for three dimensional culture of Huh7 cell line with improved hepatocyte differentiation marker expression and HCV replication	INDIAN JOURNAL OF MEDICAL MICROBIOLOGY			English	Article						Hepatitis C virus; hepatocyte; Huh7; mebiolgel; three dimensional culture	HEPATITIS-C VIRUS; GELATION POLYMER; STEM-CELLS; SYSTEM; CULTIVATION; GENOME; LIVER	Purpose: A novel three dimensional (3D) culture system purely synthesised from co-polymer which is free from biological contamination for Huh7 cell cultivation and hepatitis C virus (HCV) replication has been attempted. Materials and Methods: Mebiolgel, a thermo-reversible gelation polymer was used as a 3D scaffold for culturing Huh7, a liver carcinoma cell line used in our study. The 3D culture of the cells were infected with cell culture derived HCV. Result: The scaffold supported the cell growth as 3D spheroids for up to 63 days. Moreover mebiolgel was found to be improving the hepatocyte differentiation of Huh7 cells at the transcript level. Three dimensional culture was susceptible for HCV infection, and this was confirmed by detecting the HCV replication intermediate viral core antigen. Conclusion: Mebiolgel based culture system was proven to be suited for 3D culture of Huh7 cells by improvising liver specific genotypic expression and was susceptible for HCV replication. Since mebiolgel based Huh 7 express better hepatocyte differentiation markers genotypically, this can be implemented as an alternate for primary hepatocytes in studies such as viral isolation from patient serum.	[Rajalakshmy, A. R.] Sankara Nethralaya, Chennai, Tamil Nadu, India; [Rajalakshmy, A. R.] SASTRA, CENTAB, Thanjavur, Tamil Nadu, India; [Rajalakshmy, A. R.] Sankara Nethralaya, Vis Res Fdn, Chennai, Tamil Nadu, India; [Malathi, J.; Madhavan, H. N.] Yamanashi Univ, Fac Med, Chuo, Yamanashi 4093898, Japan; [Samuel, J. K. A.] NCRM, Mary Yoshio Translat Hexagon, Chennai, Tamil Nadu, India	Madhavan, HN (reprint author), Sankara Nethralaya, Chennai, Tamil Nadu, India.	drhnm@snmail.org					Molina-Jimenez F, 2012, VIROLOGY, V425, P31, DOI 10.1016/j.virol.2011.12.021; Podevin P, 2010, GASTROENTEROLOGY, V139, P1355, DOI 10.1053/j.gastro.2010.06.058; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Tosh D, 2002, HEPATOLOGY, V36, P534, DOI 10.1053/jhep.2002.35060; Nagaya M, 2006, HEPATOLOGY, V43, P1053, DOI 10.1002/hep.21153; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Pilarek M, 2013, BIOTECHNOL LETT, V35, P1387, DOI 10.1007/s10529-013-1218-2; Wang ZY, 2010, FEBS J, V277, P4066, DOI 10.1111/j.1742-4658.2010.07802.x; Medina RJ, 2006, J CELL BIOCHEM, V98, P174, DOI 10.1002/jcb.20757; Matsuda Y, 2011, INT J ONCOL, V38, P1253, DOI 10.3892/ijo.2011.945; Yang XZ, 2009, TISSUE ENG PART C-ME, V15, P615, DOI 10.1089/ten.TEC.2008.0516; Shimizu S, 1996, ARTIF ORGANS, V20, P1232; Nagaya M, 2004, EUR SURG RES, V36, P95, DOI 10.1159/000076649; Sitalakshmi G, 2009, TISSUE ENG PT A, V15, P407, DOI 10.1089/ten.tea.2008.0041; Nakata K, 2006, DRUG METAB PHARMACOK, V21, P437, DOI 10.2133/dmpk.21.437; Sudha B, 2006, INDIAN J MED RES, V124, P655; Sainz B, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-103	17	0	0	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0255-0857	1998-3646		INDIAN J MED MICROBI	Indian J. Med. Microbiol.	OCT-DEC	2015	33	4					554	559		10.4103/0255-0857.167330		6	Immunology	Immunology	CU1KK	WOS:000363279900014		
J	Furihata, T; Fu, ZG; Suzuki, Y; Matsumoto, S; Morio, H; Tsubota, A; Matsumoto, S; Chiba, K				Furihata, Tomomi; Fu, Zhongguo; Suzuki, Yuki; Matsumoto, Shogo; Morio, Hanae; Tsubota, Akihito; Matsumoto, Sayaka; Chiba, Kan			Differential inhibition features of direct-acting anti-hepatitis C virus agents against human organic anion transporting polypeptide 2B1	INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS			English	Article						Direct-acting antivirals; Organic anion transporting polypeptide 2B1; Transporter; Drug drug interaction; Hepatitis C virus; Long-lasting inhibition	DRUG-DRUG INTERACTIONS; GRAPEFRUIT JUICE; PLASMA-CONCENTRATIONS; SUBSTRATE ALISKIREN; FRUIT JUICES; APPLE JUICE; PHARMACOKINETICS; TELAPREVIR; FEXOFENADINE; ABSORPTION	Simeprevir (SMV), asunaprevir (ASV), daclatasvir (DCV) and sofosbuvir (SOF), which are direct-acting antiviral (DAA) agents, are expected to become essential pharmaceutical tools in the fight against the hepatitis C virus (HCV). However, because DAAs are taken orally, there is a potential risk of drug-drug interactions (DDIs) at the absorption step with co-administered drugs in the small intestine. Since it is known that organic anion transporting polypeptide 2B1 (OATP2B1) is one of the key transporters contributing to intestinal drug absorption, it is important to thoroughly understand the inhibition profiles of various DAAs in relation to OATP2B1 function in order to avoid unexpected DDIs. Therefore, using a cell-based transport assay, this study aimed at clarifying such DAA inhibition characteristics towards OATP2B1 function. The results of co-incubation inhibition assays showed that SMV and ASV strongly inhibited estrone sulfate (5 nM) uptake by OATP2B1, with half maximal inhibitory concentrations of 0.49 +/- 0.12 mu M and 0.16 +/- 0.06 mu M, respectively. Furthermore, it was found that SMV and ASV imposed long-lasting pre-incubation inhibitory effects on OATP2B1 function that enhanced their co-incubation inhibition potencies. On the other hand, no (or much less significant) inhibitory effects were observed for SOF or DCV. To summarise, these results show that SMV and ASV are co-incubation, as well as long-lasting pre-incubation, inhibitors of OATP2B1 function and therefore these inhibitions may lead to clinically relevant DDIs when used with OATP2B1 substrates. (C) 2015 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.	[Furihata, Tomomi; Fu, Zhongguo; Suzuki, Yuki; Matsumoto, Shogo; Morio, Hanae; Matsumoto, Sayaka; Chiba, Kan] Chiba Univ, Grad Sch Pharmaceut Sci, Lab Pharmacol & Toxicol, Chuo Ku, Chiba, Chiba 2608675, Japan; [Tsubota, Akihito] Jikei Univ, Sch Med, Res Ctr Med Sci, Core Res Facil Basic Sci,Div Mol Cell Biol, Tokyo 1058461, Japan	Furihata, T (reprint author), Chiba Univ, Grad Sch Pharmaceut Sci, Lab Pharmacol & Toxicol, Chuo Ku, 1-8-1 Inohana, Chiba, Chiba 2608675, Japan.	tomomif@faculty.chiba-u.jp			Ministry of Health, Labor and Welfare, Japan	This work was funded by a Ministry of Health, Labor and Welfare Grant-in-Aid for Scientific Research (Emergency Research Project to Conquer Hepatitis), Japan.	Schiller C, 2005, ALIMENT PHARM THERAP, V22, P971, DOI 10.1111/j.1365-2036.2005.02683.x; Mougey EB, 2011, J CLIN PHARMACOL, V51, P751, DOI 10.1177/0091270010374472; Chu XY, 2013, DRUG METAB DISPOS, V41, P668, DOI 10.1124/dmd.112.049668; Kunze A, 2012, BIOCHEM PHARMACOL, V84, P1096, DOI 10.1016/j.bcp.2012.07.032; Suzuki K, 2012, J PHARM SCI-US, V101, P2606, DOI 10.1002/jps.23174; Tapaninen T, 2010, CLIN PHARMACOL THER, V88, P339, DOI 10.1038/clpt.2010.101; Kullak-Ublick GA, 2001, GASTROENTEROLOGY, V120, P525, DOI 10.1053/gast.2001.21176; Burger D, 2013, J HEPATOL, V58, P792, DOI 10.1016/j.jhep.2012.10.027; Karlgren M, 2012, J MED CHEM, V55, P4740, DOI 10.1021/jm300212s; Furihata T, 2014, ANTIMICROB AGENTS CH, V58, P4555, DOI 10.1128/AAC.02724-14; Imanaga J, 2011, PHARMACOGENET GENOM, V21, P84, DOI 10.1097/FPC.0b013e32834300cc; Tapaninen T, 2011, BRIT J CLIN PHARMACO, V71, P718, DOI 10.1111/j.1365-2125.2010.03898.x; Lee JE, 2011, ANTIMICROB AGENTS CH, V55, P4569, DOI 10.1128/AAC.00653-11; Dresser GK, 2002, CLIN PHARMACOL THER, V71, P11, DOI 10.1067/mcp.2002.121152; Garg V, 2012, J CLIN PHARMACOL, V52, P1566, DOI 10.1177/0091270011419850; Tweedie D, 2013, CLIN PHARMACOL THER, V94, P113, DOI 10.1038/clpt.2013.77; Tamai I, 2012, ADV DRUG DELIVER REV, V64, P508, DOI 10.1016/j.addr.2011.07.007; Dolton MJ, 2012, CLIN PHARMACOL THER, V92, P622, DOI 10.1038/clpt.2012.159; Kiser JJ, 2013, NAT REV GASTRO HEPAT, V10, P596, DOI 10.1038/nrgastro.2013.106; Shitara Y, 2012, DRUG METAB PHARMACOK, V27, P368, DOI 10.2133/dmpk.DMPK-11-RG-096; Garg V, 2011, HEPATOLOGY, V54, P20, DOI 10.1002/hep.24443; Shah N, 2013, EXPERT OPIN INV DRUG, V22, P1107, DOI 10.1517/13543784.2013.806482; Shirasaka Y, 2012, DRUG METAB PHARMACOK, V27, P360, DOI 10.2133/dmpk.DMPK-11-SH-080; Lilja JJ, 1999, CLIN PHARMACOL THER, V66, P118, DOI 10.1053/cp.1999.v66.100453001; Shirasaka Y, 2013, DRUG METAB DISPOS, V41, P615, DOI 10.1124/dmd.112.049635; Shirasaka Y, 2014, PHARM RES-DORDR, V31, P2035, DOI 10.1007/s11095-014-1305-7; Tamai I, 2013, CURR OPIN PHARMACOL, V13, P859, DOI 10.1016/j.coph.2013.09.001; Eley T, 2014, CLIN DRUG INVEST, V34, P661, DOI 10.1007/s40261-014-0219-9; Eley T, 2015, CLIN PHARMACOL THER, V97, P159, DOI 10.1002/cpt.4; Tsubota A, 2013, CLIN INVESTIGATOR, V3, P1	30	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0924-8579	1872-7913		INT J ANTIMICROB AG	Int. J. Antimicrob. Agents	OCT	2015	46	4					381	388		10.1016/j.ijantimicag.2015.05.013		8	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	CU4IN	WOS:000363491200005		
J	Kumagai, Y; Murakawa, Y; Hasunuma, T; Aso, M; Yuji, W; Sakurai, T; Noto, M; Oe, T; Kaneko, A				Kumagai, Yuji; Murakawa, Yuji; Hasunuma, Tomoko; Aso, Masako; Yuji, Wakako; Sakurai, Tsutomu; Noto, Masahiko; Oe, Tetsuya; Kaneko, Akiko			Lack of effect of favipiravir, a novel antiviral agent, on the QT interval in healthy Japanese adults	INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS			English	Article						favipiravir; thorough QT study; crossover; Japanese subjects; Ebola viruses	CARDIAC REPOLARIZATION; THOROUGH QT; MOXIFLOXACIN; T-705	Objective: A thorough QT study of favipiravir, a novel antiviral agent, was conducted using a randomized, double-blind, 4-group, 4-period crossover, placebo and positive-controlled (open-label moxifloxacin) design. Materials and methods: 56 healthy Japanese adults of both sexes received single oral doses of favipiravir 1,200 and 2,400 mg (Avigan (R) Tablets, Toyama Chemical Co., Ltd.), moxifloxacin 400 mg, and a placebo. QT intervals after these treatments were measured under blinded conditions. The primary endpoint was the time-matched, placebo-adjusted change in corrected QT intervals using the Fridericia method (QTcF) from predose for favipiravir or moxifloxacin (Delta Delta QTcF). Results: Lower bounds of the two-sided 90% confidence interval of Delta Delta QTcF values for moxifloxacin exceeded 3 msec at all time points, and the maximum value was 14.0 (11.8 - 16.1, 90% confidence interval) msec at 3 hours after administration. Similarly, maximum Delta Delta QTcF values for favipiravir were 0.833 (-1.33 - 3.00) msec at 3 hours after administration of 1,200 mg, and 0.500 (-1.88 - 2.88) msec at 6 hours after administration of 2,400 mg. Calculation of the sample size using the Delta Delta QTcF value of moxifloxacin indicated that 25 subjects would be sufficient for detection at a power of 90% or higher, which meets the criteria for assuring assay sensitivity. Conclusions: It is possible to use a smaller number of subjects in thorough QT studies in Japan than in Europe and the US utilizing moxifloxacin as a positive control. There were no detectable effects of favipiravir on the QT/QTc interval.	[Kumagai, Yuji; Aso, Masako] Kitasato Univ Hosp, Clin Trial Ctr, Sagamihara, Kanagawa 2520375, Japan; [Murakawa, Yuji] Teikyo Univ, Sch Med, Mizonokuchi Hosp, Dept Internal Med 4, Yokohama, Kanagawa, Japan; [Hasunuma, Tomoko] Oita Univ Hosp, Clin Pharmacol Ctr, Oita, Japan; [Yuji, Wakako] Kitasato Inst Hosp, Biomed Res Ctr, Tokyo, Japan; [Sakurai, Tsutomu; Noto, Masahiko; Oe, Tetsuya] Toyama Chem Co Ltd, Clin Res Dept, Tokyo, Japan; [Kaneko, Akiko] Toyama Chem Co Ltd, Data Sci & Adm Dept, Tokyo, Japan	Kumagai, Y (reprint author), Kitasato Univ Hosp, Clin Trial Ctr, Minami Ku, 15-1 Kitazato,1 Chome, Sagamihara, Kanagawa 2520375, Japan.	kuma-guy@za2.so-net.ne.jp			Toyama Chemical Co., Ltd	Financial support was provided by Toyama Chemical Co., Ltd. Dr. Kumagai and Dr. Murakawa received honorarium from Toyama Chemical Co., Ltd. However, Dr. Kumagai, Dr. Murakawa, Dr. Hasunuma, Dr. Aso and Dr. Yuji have no employment relationship with Toyama Chemical Co., Ltd. Dr. Kumagai is an advisor for evaluation of QT/QTc, Dr. Murakawa is a medical expert of thorough QT study. Dr. Hasunuma is a principal investigator of thorough QT study, Dr. Aso and Dr. Yuji are sub-investigators of thorough QT study.	Oestereich L, 2014, ANTIVIR RES, V105, P17, DOI 10.1016/j.antiviral.2014.02.014; Morganroth J, 2004, AM J CARDIOL, V93, P1378, DOI 10.1016/j.amjcard.2004.02.034; Garnett CE, 2008, J CLIN PHARMACOL, V48, P13, DOI 10.1177/0091270007307881; Chen SG, 2012, PHARMACOTHERAPY, V32, P333, DOI 10.1002/j.1875-9114.2012.01033.x; Boni JP, 2012, CANCER CHEMOTH PHARM, V69, P1433, DOI 10.1007/s00280-012-1845-7; Linnebjerg H, 2011, INT J CLIN PHARM TH, V49, P594, DOI 10.5414/CP201462; [Anonymous], 2005, GUID IND E14 CLIN EV; Whellan DJ, 2009, CLIN PHARMACOL THER, V86, P101, DOI 10.1038/clpt.2009.70; Damle B, 2011, ANTIMICROB AGENTS CH, V55, P4302, DOI 10.1128/AAC.01723-10; Sidwell RW, 2007, ANTIMICROB AGENTS CH, V51, P845, DOI 10.1128/AAC.01051-06; Demolis JL, 2000, CLIN PHARMACOL THER, V68, P658, DOI 10.1067/mcp.2000.111482; Bloomfield DM, 2008, CLIN PHARMACOL THER, V84, P475, DOI 10.1038/clpt.2008.33; Furuta Y, 2002, ANTIMICROB AGENTS CH, V46, P977, DOI 10.1128/AAC.46.4.977-981.2002; Mansbach RS, 2011, CLIN THER, V33, P851, DOI 10.1016/j.clinthera.2011.05.092; del Corral A, 2012, CANCER CHEMOTH PHARM, V69, P1255, DOI 10.1007/s00280-012-1825-y; Dmitrienko A, 20080429 BIOPH NETW; Ebana R, 2007, JPN J CLIN PHARM THE, V38, P97; European Medicines Agency, 2005, ICH TOP E14 CLIN EV; Food and Drug Administration, 2005, INT C HARM GUID E14; Hayashi T, 2008, 9 WORLD C CLIN PHARM; Mendzelevski B, 2011, BR J CLIN PHARM, V73, P203; Ministry of Health Labor and Welfare, 2009, CLIN EV QT QTC INT P; Nakano M, 2013, JMAJ, V56, P115; Ohnishi A, 2005, JPN PHARMACOL THER, V33, P1029	24	0	0	DUSTRI-VERLAG DR KARL FEISTLE	DEISENHOFEN-MUENCHEN	BAHNHOFSTRASSE 9 POSTFACH 49, D-82032 DEISENHOFEN-MUENCHEN, GERMANY	0946-1965			INT J CLIN PHARM TH	Int. J. Clin. Pharmacol. Ther.	OCT	2015	53	10					866	874		10.5414/CP202388		9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CU3PH	WOS:000363436800009		
J	Takahashi, N; Noda, S; Taniguchi, T; Adachi, M				Takahashi, Naomi; Noda, Shinji; Taniguchi, Takashi; Adachi, Makoto			Efficacy comparison of ustekinumab between anti-tumor necrosis factor-alpha drug-naiive and anti-tumor necrosis factor-alpha drug-resistant Japanese psoriasis cases	INTERNATIONAL JOURNAL OF DERMATOLOGY			English	Article							TO-SEVERE PSORIASIS; ARTHRITIS; TUBERCULOSIS; INHIBITORS; GUIDELINES; MANAGEMENT; SAFETY; CARE	Ustekinumab is highly efficacious for psoriasis; however, it has not been fully clarified whether previous failure in anti-tumor necrosis factor-alpha (TNF-alpha) therapy affects the treatment response with ustekinumab. Therefore, we evaluated the efficacy of ustekinumab in anti-TNF-alpha-naive and anti-TNF-alpha-resistant cases and compared the clinical efficacies of adalimumab and ustekinumab in biologic naive cases. Thirty-five patients with plaque psoriasis who showed resistance to conventional therapies were enrolled; 26 patients, who had never been treated with biologics, were allocated to ustekinumab or adalimumab; nine patients who failed to achieve psoriasis area and severity index (PASI) 50 at week 16 with one or two TNF-alpha antagonists were switched to ustekinumab. The end of the study was defined as 52 weeks after starting the first biologic for anti-TNF-alpha-naive patients and after switching to ustekinumab for anti-TNF-alpha-resistant patients. The primary outcome measurement was the percentage of patients achieving PASI75 at week 16. In patients treated with ustekinumab, 87.5% of anti-TNF-alpha-naive and 77.8% of anti-TNF-alpha-resistant cases achieved a PASI75 response at week 16, and no statistically significant difference was found between the treatment response rates (P = 0.60). When comparing the treatment efficacy of ustekinumab and adalimumab among anti-TNF-alpha-naive patients, there was also no statistically significant difference in PASI75 achievement rates (87.5 vs. 83.3%, P = 0.79). Our study suggests that ustekinumab can be considered as a first-line biologic for psoriasis and a rescue therapy for anti-TNF-alpha-resistant cases.	[Takahashi, Naomi; Noda, Shinji; Taniguchi, Takashi; Adachi, Makoto] Kanto Rosai Hosp, Dept Dermatol, Kawasaki, Kanagawa 2118510, Japan	Noda, S (reprint author), Kanto Rosai Hosp, Dept Dermatol, Nakahara Ku, 1-1 Kizukisumiyoshi Cho, Kawasaki, Kanagawa 2118510, Japan.	m31071@gmail.com					Piaserico S, 2014, J AM ACAD DERMATOL, V70, P257, DOI 10.1016/j.jaad.2013.10.019; Hernandez C, 2008, J AM ACAD DERMATOL, V59, P363, DOI 10.1016/j.jaad.2008.05.033; Papp KA, 2008, LANCET, V371, P1675, DOI 10.1016/S0140-6736(08)60726-6; Clemmensen A, 2011, J EUR ACAD DERMATOL, V25, P1037, DOI 10.1111/j.1468-3083.2010.03914.x; Griffiths CEM, 2010, NEW ENGL J MED, V362, P118, DOI 10.1056/NEJMoa0810652; Fagerli KM, 2013, ANN RHEUM DIS, V72, P1840, DOI 10.1136/annrheumdis-2012-203018; Menter A, 2011, J AM ACAD DERMATOL, V65, P137, DOI 10.1016/j.jaad.2010.11.055; Tsai TF, 2012, BRIT J DERMATOL, V167, P1145, DOI 10.1111/j.1365-2133.2012.11142.x; Gottlieb A, 2008, J AM ACAD DERMATOL, V58, P851, DOI 10.1016/j.jaad.2008.02.040; Hernandez C, 2008, J AM ACAD DERMATOL, V59, P82	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0011-9059	1365-4632		INT J DERMATOL	Int. J. Dermatol.	OCT	2015	54	10					1194	1198		10.1111/ijd.12859		5	Dermatology	Dermatology	CU3CQ	WOS:000363401700034		
J	Nakai, K; Yoneda, K; Moriue, J; Moriue, T; Koura, A; Yokoi, I; Ishikawa, E; Kubota, Y; Haba, R; Kushida, Y; Katsuki, N; Inoue, S				Nakai, Kozo; Yoneda, Kozo; Moriue, Junko; Moriue, Tetsuya; Koura, Ayako; Yokoi, Ikumi; Ishikawa, Emiko; Kubota, Yasuo; Haba, Reiji; Kushida, Yoshio; Katsuki, Naomi; Inoue, Shigeaki			beta Klotho expression is reduced in human non-melanoma skin cancer	INTERNATIONAL JOURNAL OF DERMATOLOGY			English	Letter							GROWTH-FACTOR RECEPTORS		[Nakai, Kozo; Yoneda, Kozo; Moriue, Junko; Moriue, Tetsuya; Koura, Ayako; Yokoi, Ikumi; Ishikawa, Emiko; Kubota, Yasuo] Kagawa Univ, Fac Med, Dept Dermatol, Takamatsu, Kagawa 760, Japan; [Haba, Reiji; Kushida, Yoshio; Katsuki, Naomi] Kagawa Univ, Fac Med, Dept Diagnost Pathol, Takamatsu, Kagawa 760, Japan; [Inoue, Shigeaki] Tokai Univ, Inst Innovat Sci & Technol, Hiratsuka, Kanagawa 25912, Japan	Nakai, K (reprint author), Kagawa Univ, Fac Med, Dept Dermatol, Takamatsu, Kagawa 760, Japan.	kozo@kms.ac.jp					Takenaka H, 2002, ARCH DERMATOL RES, V294, P331, DOI 10.1007/s00403-002-0333-z; Groesser L, 2012, NAT GENET, V44, P783, DOI 10.1038/ng.2316; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Nakai K, 2013, EXP DERMATOL, V22, P772, DOI 10.1111/exd.12258; Yang JX, 2010, J CELL BIOL, V188, P935, DOI 10.1083/jcb.200910126; Meyer M, 2012, J CELL SCI, V125, P5690, DOI 10.1242/jcs.108167; Kuro-o Makoto, 2011, Korean Journal of Internal Medicine, V26, P113, DOI 10.3904/kjim.2011.26.2.113; Nakai K, 2014, J DERMATOL, V41, P171, DOI 10.1111/1346-8138.12371; Ye XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055615	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0011-9059	1365-4632		INT J DERMATOL	Int. J. Dermatol.	OCT	2015	54	10					E431	E433		10.1111/ijd.12924		4	Dermatology	Dermatology	CU3CQ	WOS:000363401700010		
J	Nakata, Y; Watanabe, Y; Otake, H; Nakamura, T; Oiso, G; Sawa, T				Nakata, Yoshinori; Watanabe, Yuichi; Otake, Hiroshi; Nakamura, Toshihito; Oiso, Giichiro; Sawa, Tomohiro			The Japanese Surgical Reimbursement System Fails to Reflect Resource Utilization	INTERNATIONAL JOURNAL OF HEALTH SERVICES			English	Article						efficiency; data envelopment analysis; surgical reimbursement system		The goal of this study was to examine the current Japanese surgical payment system from the viewpoint of resource utilization. We collected data from surgical records in Teikyo University's electronic medical record system from April 1 through September 30, 2013. We defined the decision-making unit as a surgeon with the highest academic rank in the surgery. Inputs were defined as: 1) the number of medical doctors who assisted surgery and 2) the time of operation from skin incision to closure. An output was defined as the surgical fee. We calculated each surgeon's efficiency score using the output-oriented Banker-Charnes-Cooper model of data envelopment analysis. We compared the efficiency scores of each surgical specialty using the Kruskal-Wallis and Steel methods. We analyzed 2,825 surgical procedures performed by 103 surgeons. The difference in efficiency scores was significant (P=0.0001). The thoracic surgeons were the most efficient and were more efficient than plastic, obstetric and gynecologic, urologic, otorhinolaryngologic, orthopedic, general, and emergency surgeons (P<0.05). We demonstrated that surgeons' efficiency in operating rooms was significantly different among surgical specialties. This suggests that the Japanese surgical reimbursement scales fails to reflect resource utilization.	[Nakata, Yoshinori; Watanabe, Yuichi] Teikyo Univ, Grad Sch Publ Hlth, Tokyo 1738605, Japan; [Nakata, Yoshinori; Sawa, Tomohiro] Teikyo Univ, Med Informat & Syst Res Ctr, Tokyo 1738605, Japan; [Otake, Hiroshi] Showa Univ, Sch Med, Dept Anesthesia, Tokyo 142, Japan; [Nakamura, Toshihito] Chiba Univ Hosp, Dept Hlth Policy Aged Soc, Chiba, Japan; [Oiso, Giichiro] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka 4313192, Japan	Nakata, Y (reprint author), Teikyo Univ, Grad Sch Publ Hlth, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	ynakata@med.teikyo-u.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [25670337]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant No. 25670337 to Dr Yoshinori Nakata.	American Medical Association, 2013, MED RBRVS 2013 PHYS; Ikegami N, 2011, LANCET, V378, P1106, DOI 10.1016/S0140-6736(11)60828-3; Hayashida K, 2005, HEALTH POLICY, V74, P24, DOI 10.1016/j.healthpol.2004.12.005; Macario A, 2010, J CLIN ANESTH, V22, P233, DOI 10.1016/j.jclinane.2010.02.003; Cooper W W, 2007, DATA ENVELOPMENT ANA; FARRELL MJ, 1957, J R STAT SOC SER A-G, V120, P253, DOI 10.2307/2343100; Hollingsworth B, 2008, ROUT INT STUD HEALTH, P1, DOI 10.4324/9780203486566; Japanese Joint Committee of Social Insurance by the Multidisciplinary Group of Surgical Associations (GAIHOREN), 2012, PROP SURG PAYM SYST; Ozcan Y. A., 2008, HLTH CARE BENCHMARKI; Social Insurance Institute (Shakaihoken Kenkyuusho), 2012, INT MED REIMB SCAL A, P622; Thanassoulis E., 2008, MEASUREMENT PRODUCTI, P251	11	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0020-7314	1541-4469		INT J HEALTH SERV	Int. J. Health Serv.	OCT	2015	45	4					801	809		10.1177/0020731415585989		9	Health Care Sciences & Services; Health Policy & Services	Health Care Sciences & Services	CU1KD	WOS:000363279200013		
J	Kawakita, M				Kawakita, Masayuki			A connectedness theorem over the spectrum of a formal power series ring	INTERNATIONAL JOURNAL OF MATHEMATICS			English	Article						Connectedness lemma; formal power series ring; minimal log discrepancy	MINIMAL LOG DISCREPANCIES; ADIC SEMI-CONTINUITY; CANONICAL THRESHOLDS; CHARACTERISTIC ZERO; ALGEBRAIC VARIETY; IDEAL; DESINGULARIZATION; SINGULARITIES; RESOLUTION; TOPOLOGY	We study the connectedness of the non-klt locus over the spectrum of a formal power series ring. In dimension 3, we prove the existence and normality of the smallest lc center, and apply it to the ACC for minimal log discrepancies greater than 1 on smooth 3-folds.	Kyoto Univ, Math Sci Res Inst, Kyoto 6068502, Japan	Kawakita, M (reprint author), Kyoto Univ, Math Sci Res Inst, Kyoto 6068502, Japan.	masayuki@kurims.kyoto-u.ac.jp			JSPS [24684003]	I would like to thank Professors O. Fujino, Y. Gongyo, H. Kawanoue, J. Kollar, M. Mustata and N. Nakayama for discussions. The research was partially supported by JSPS Grant-in-Aid for Young Scientists (A) 24684003.	Abhyankar S., 1998, SPRINGER MONOGRAPHS; Kawakita M, 2013, MICH MATH J, V62, P443; VERMA JK, 1988, J ALGEBRA, V112, P416, DOI 10.1016/0021-8693(88)90099-3; Fujino O, 2011, PUBL RES I MATH SCI, V47, P727, DOI 10.2977/PRIMS/50; Ambro F, 1999, MATH RES LETT, V6, P573; COHEN IS, 1946, T AM MATH SOC, V59, P54; de Fernex T, 2010, DUKE MATH J, V152, P93, DOI 10.1215/00127094-2010-008; Kawakita M, 2007, INVENT MATH, V167, P129, DOI 10.1007/s00222-006-0008-z; KODAIRA K, 1953, P NATL ACAD SCI USA, V39, P1268, DOI 10.1073/pnas.39.12.1268; ALEXEEV V, 1993, DUKE MATH J, V69, P527, DOI 10.1215/S0012-7094-93-06922-0; LIPMAN J, 1978, ANN MATH, V107, P151, DOI 10.2307/1971141; RAYNAUD M, 1971, INVENT MATH, V13, P1, DOI 10.1007/BF01390094; KAWAMATA Y, 1982, MATH ANN, V261, P43, DOI 10.1007/BF01456407; VIEHWEG E, 1982, J REINE ANGEW MATH, V335, P1; Temkin M, 2008, ADV MATH, V219, P488, DOI 10.1016/j.aim.2008.05.006; SCHENZEL P, 1985, P AM MATH SOC, V93, P15, DOI 10.2307/2044544; de Fernex T, 2009, ANN SCI ECOLE NORM S, V42, P491; Kawakita M, 2013, MATH ANN, V356, P1359, DOI 10.1007/s00208-012-0885-y; Chatzistamatiou A, 2015, COMPOS MATH, V151, P2131, DOI 10.1112/S0010437X15007435; Fernex T. de, 2011, EMS SER C REP, P221; Grothendieck A., 1965, PUBL MATH-PARIS, V24, P231; Grothendieck A., 1966, PUBL MATH-PARIS, V28, P255; Grothendieck A., 1961, PUBL MATH-PARIS, V11, P167; Hartshorne R., 1977, GRADUATE TEXTS MATH, V52; HIRONAKA H, 1964, ANN MATH, V79, P109, DOI 10.2307/1970486; Kawakita M, 2014, J ALGEBRAIC GEOM, V23, P765; Kollar J., 2008, ARXIV08050756; Kollar J., 2013, CAMBRIDGE TRACTS MAT, V200; Kollar J., 1992, ASTERISQUE, V211; Liu Q., 2002, OXFORD GRADUATE TEXT, V6; McKernan J., 2013, MSRI WORKSH 6 MAY; Nakamura Y., J REINE ANG IN PRESS, DOI [10.1515/Crelle-2013-0112, DOI 10.1515/CRELLE-2013-0112]; Shokurov V., 1992, IZV MATH+, V56, P105; Shokurov V. V., 2004, P STEKLOV I MATH, V246, P315; Shokurov V. V., 1988, BIRATIONAL GEOMETRY, P30; Shokurov V.V., 1996, J MATH SCI, V81, P2667, DOI 10.1007/BF02362335; Temkin M., 2009, ARXIV09122570; Zariski O., 1951, MEMORIES AM MATH SOC, V5	38	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0129-167X	1793-6519		INT J MATH	Int. J. Math.	OCT	2015	26	11							1550088	10.1142/S0129167X15500883		27	Mathematics	Mathematics	CU3IZ	WOS:000363419500002		
J	Sasaki, H; Maeda, T; Hara, Y; Osa, M; Imai, K; Moriguchi, K; Mikita, K; Fujikura, Y; Kaida, K; Kawana, A				Sasaki, Hiroaki; Maeda, Takuya; Hara, Yu; Osa, Morichika; Imai, Kazuo; Moriguchi, Kota; Mikita, Kei; Fujikura, Yuji; Kaida, Kenichi; Kawana, Akihiko			Human herpes virus-8-associated multicentric Castleman's disease in an HIV-positive patient presenting with relapsing and remitting hyponatraemia	INTERNATIONAL JOURNAL OF STD & AIDS			English	Article						Multicentric Castleman disease; HIV; AIDS; human herpes virus-8; interleukin-6; hyponatraemia; sodium; central pontine myelinolysis; antidiuretic hormone	CENTRAL PONTINE MYELINOLYSIS; KAPOSIS-SARCOMA; INTERLEUKIN-6; AIDS	We report a case of human herpes virus-8-associated multicentric Castleman's disease in an HIV-positive patient with hyponatraemia. A 65-year-old man was admitted with relapsing and remitting fever, scattered skin eruptions and hepatosplenomegaly following combination antiretroviral therapy for his HIV infection. Based on histopathological findings, he was diagnosed as having human herpes virus-8-associated multicentric Castleman's disease and was treated with four-weekly infusions of rituximab. Prior to receiving chemotherapy, we observed several suspected biomarkers of disease activity, positive correlations between plasma human herpes virus-8 viral load and the levels of plasma interleukin-6, C-reactive protein and soluble interleukin-2 receptor, and negative correlations between platelet count, albumin levels and especially serum sodium levels. We hypothesize that non-osmotic release of plasma antidiuretic hormone is a cause of hyponatraemia in human herpes virus-8-associated multicentric Castleman's disease and that relapsing and remitting hyponatraemia could be correlated with plasma human herpes virus-8 viral load.	[Sasaki, Hiroaki; Maeda, Takuya; Hara, Yu; Osa, Morichika; Imai, Kazuo; Mikita, Kei; Fujikura, Yuji; Kawana, Akihiko] Natl Def Med Coll, Dept Internal Med, Div Infect Dis & Pulm Med, Saitama 3598513, Japan; [Moriguchi, Kota; Kaida, Kenichi] Natl Def Med Coll, Dept Internal Med, Div Neurol, Saitama 3598513, Japan	Maeda, T (reprint author), Natl Def Med Coll, Dept Infect Dis & Pulm Med, Saitama 3598513, Japan.	tmaeda@ndmc.ac.jp					Katchanov J, 2013, INT J STD AIDS, V24, P583, DOI 10.1177/0956462413477557; YOSHIZAKI K, 1989, BLOOD, V74, P1360; Apoola A, 2003, SEX TRANSM INFECT, V79, P179, DOI 10.1136/sti.79.3.179; Du MQ, 2001, BLOOD, V97, P2130, DOI 10.1182/blood.V97.7.2130; Swart RM, 2011, NEPHRON PHYSIOL, V118, P45, DOI 10.1159/000322238; Bower M, 2010, BLOOD, V116, P4415, DOI 10.1182/blood-2010-07-290213; Oksenhendler E, 2000, BLOOD, V96, P2069; Mori Y, 2000, J MED VIROL, V61, P332, DOI 10.1002/1096-9071(200007)61:3<332::AID-JMV8>3.0.CO;2-3; Stebbing J, 2011, BLOOD, V118, P271, DOI 10.1182/blood-2011-02-335620; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879	10	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0956-4624	1758-1052		INT J STD AIDS	Int. J. STD AIDS	OCT	2015	26	12					909	911		10.1177/0956462414562050		3	Immunology; Infectious Diseases	Immunology; Infectious Diseases	CU0PD	WOS:000363218600011		
J	Sacco, RL; Sandercock, P; Endres, M; Feigin, V; Pandian, J; Shinohara, Y; Spence, JD				Sacco, Ralph L.; Sandercock, Peter; Endres, Matthias; Feigin, Valery; Pandian, Jeyaraj; Shinohara, Yukito; Spence, J. David			Review and prioritization of stroke research recommendations to address the mission of the World Stroke Organization: a call to action from the WSO Research Committee	INTERNATIONAL JOURNAL OF STROKE			English	Editorial Material							SCIENCE WORKSHOP		[Sacco, Ralph L.] Univ Miami, Miller Sch Med, Dept Neurol, Evelyn McKnight Brain Inst, Miami, FL 33136 USA; [Sandercock, Peter] Univ Edinburgh, Western Gen Hosp, DCN, Edinburgh, Midlothian, Scotland; [Endres, Matthias] Charite, Klin & Hcsh Ambulanz Neurol, D-13353 Berlin, Germany; [Feigin, Valery] AUT Univ, Fac Hlth & Environm Sci, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Pandian, Jeyaraj] Christian Med Coll & Hosp, Dept Neurol, Ludhiana, Punjab, India; [Shinohara, Yukito] Tachikawa Hosp, Federat Natl Publ Serv Personnel Mutual Aid Assoc, Tokyo, Japan; [Spence, J. David] Robarts Res Inst, Stroke Prevent & Atherosclerosis Res Ctr, London, ON N6A 5C1, Canada	Sacco, RL (reprint author), Univ Miami, Miller Sch Med, Dept Neurol, Evelyn McKnight Brain Inst, Miami, FL 33136 USA.						Rankin G, 2012, PHYSIOTHERAPY, V98, P260, DOI 10.1016/j.physio.2012.03.002; Hachinski V, 2010, INT J STROKE, V5, P238, DOI 10.1111/j.1747-4949.2010.00442.x; Mattle HP, 2012, CEREBROVASC DIS, V34, P95, DOI 10.1159/000341728; Pollock A, 2012, LANCET NEUROL, V11, P209, DOI 10.1016/S1474-4422(12)70029-7; Mattle HP, 2014, STROKE, V45, pE113, DOI 10.1161/STROKEAHA.114.005583; Lahiff-Jenkins C, 2014, WE INVITE YOU COMMEN; Pollock A, 2012, INT J STROKE	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1747-4930	1747-4949		INT J STROKE	Int. J. Stroke	OCT	2015	10			A100	SI		4	9		10.1111/ijs.12625		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CU6QW	WOS:000363658700003		
J	Fukuhara, K; Ogata, T; Ouma, S; Tsugawa, J; Matsumoto, J; Abe, H; Higashi, T; Inoue, T; Tsuboi, Y				Fukuhara, Kousuke; Ogata, Toshiyasu; Ouma, Shinji; Tsugawa, Jun; Matsumoto, Juntaro; Abe, Hiroshi; Higashi, Toshio; Inoue, Tooru; Tsuboi, Yoshio			Impact of initial symptom for accurate diagnosis of vertebral artery dissection	INTERNATIONAL JOURNAL OF STROKE			English	Article						symptoms; unilateral headaches; vertebral artery dissection; vertigo	HEADACHE; PAIN	BackgroundIt has been recognized that spontaneous vertebral artery dissection without neurological symptoms is not rare and easily misdiagnosed. Clinical clue for diagnosis of vertebral artery dissection includes initial symptoms such as headache, neck pain, or dizziness. AimTo assess the role of initial symptoms for diagnosis of spontaneous vertebral artery dissection. MethodsBetween September 2007 and January 2014, we retrospectively reviewed clinical records of 83 patients with unilateral vertebral artery dissection without consciousness disturbance at admission. Based on the diagnostic criteria of the Spontaneous Cervicocephalic Arterial Dissections Study, the patients were divided into three groups: possible, probable, and definite cases of vertebral artery dissection. Initial symptoms were collected at the time of diagnosis from medical record for the presence or absence of headache, neck pain, tinnitus and vertigo, as well as the area of pain and its characteristics. ResultsThe numbers of definite, probable, and possible vertebral artery dissection were 39, 26, and 18, respectively. Out of 83 cases, unilateral or bilateral headache was the most commonly seen (in 60 cases), followed by neck pain (in 41 cases) and vertigo (in 20 cases). Statistically, unilateral headache and/or neck pain was more common in cases with definite vertebral artery dissection group compared with other classification of the Spontaneous Cervicocephalic Arterial Dissections Study (P=0040). Vertigo was also associated with the stratification of Spontaneous Cervicocephalic Arterial Dissections Study criteria (P=0012). ConclusionsIn our study, headache and/or neck pain, especially unilateral presentation, and vertigo were symptoms associated with the stratification of Spontaneous Cervicocephalic Arterial Dissections Study criteria. Physicians should carefully obtain clinical history for the presence of a unilateral headache and/or neck pain and vertigo when vertebral artery dissection is suspected in patients with or without objective neurological signs.	[Fukuhara, Kousuke; Ogata, Toshiyasu; Ouma, Shinji; Tsugawa, Jun; Tsuboi, Yoshio] Fukuoka Univ, Fac Med, Dept Neurol, Fukuoka 8140180, Japan; [Matsumoto, Juntaro; Abe, Hiroshi; Higashi, Toshio; Inoue, Tooru] Fukuoka Univ, Fac Med, Dept Neurosurg, Fukuoka 8140180, Japan	Tsuboi, Y (reprint author), Fukuoka Univ, Dept Neurol, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	tsuboi@cis.fukuoka-u.ac.jp			Clinical Research Foundation in Japan	This study was partly supported by the Clinical Research Foundation in Japan.	Maruyama H, 2012, J HEADACHE PAIN, V13, P247, DOI 10.1007/s10194-012-0420-2; Gottesman RF, 2012, NEUROLOGIST, V18, P245, DOI 10.1097/NRL.0b013e31826754e1; SILBERT PL, 1995, NEUROLOGY, V45, P1517; Arnold M, 2006, STROKE, V37, P2499, DOI 10.1161/01.STR.0000240493.88473.39; Arnold M, 2006, J NEUROL NEUROSUR PS, V77, P1021, DOI 10.1136/jnnp.2006.094359; Matsumoto J, 2014, J STROKE CEREBROVASC, V23, P2857, DOI 10.1016/j.jstrokecerebrovasdis.2014.07.013; Takemoto K, 2011, ACTA NEUROCHIR SUPPL, V112, P59, DOI 10.1007/978-3-7091-0661-7_11; NICHOLS FT, 1993, HEADACHE, V33, P87, DOI 10.1111/j.1526-4610.1993.hed3302087.x; Tsukahara T, 2010, ACT NEUR S, V107, P35, DOI 10.1007/978-3-211-99373-6_5; Echigo Tadashi, 2013, No Shinkei Geka, V41, P305; Saeed Abdullah Bin, 2000, Canadian Journal of Neurological Sciences, V27, P292	11	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1747-4930	1747-4949		INT J STROKE	Int. J. Stroke	OCT	2015	10			A100	SI		30	33		10.1111/ijs.12546		4	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CU6QW	WOS:000363658700007		
J	Matsumoto, K; Ehara, S; Hasegawa, T; Sakaguchi, M; Otsuka, K; Yoshikawa, J; Shimada, K				Matsumoto, Kenji; Ehara, Shoichi; Hasegawa, Takao; Sakaguchi, Mikumo; Otsuka, Kenichiro; Yoshikawa, Junichi; Shimada, Kenei			Localization of Coronary High-Intensity Signals on T1-Weighted MR Imaging Relation to Plaque Morphology and Clinical Severity of Angina Pectoris	JACC-CARDIOVASCULAR IMAGING			English	Article						angina pectoris; atherosclerosis; intraplaque hemorrhage; magnetic resonance imaging; optical coherence tomography; thrombosis	OPTICAL COHERENCE TOMOGRAPHY; MAGNETIC-RESONANCE; INTRAPLAQUE HEMORRHAGE; ATHEROSCLEROTIC PLAQUES; INTRACORONARY THROMBUS; HYPERINTENSE PLAQUE; ARTERY-DISEASE; PROGRESSION; PATHOGENESIS; MECHANISMS	OBJECTIVES This study sought to investigate the relationship between Localization of high-intensity signals (HISs) on T1-weighted imaging (T1WI) with the noncontrast magnetic resonance technique and plaque morphology detected on optical coherence tomography, and the clinical severity of angina pectoris. BACKGROUND Since the introduction of the T1WI noncontrast magnetic resonance technique for plaque imaging, some groups have reported that HISs in the coronary artery on T1WI are associated with a vulnerable morphology and future cardiac events. However, the association between the localization of HISs, such as coronary intrawall or intraluminal, and plaque morphology has not been investigated. METHODS One hundred Lesions with either stable or unstable angina were included and divided into 3 groups according to the following criteria using T1WI. First, the plaques with the ratio between the signal intensities of coronary plaque and cardiac muscle <= 1.0 were classified as non-HISs (n = 39). Then, HISs with the ratio between the signal intensities of coronary plaque and cardiac muscle >1.0 were classified into 2 types by using cross-sectional T1WI. Those Localized within the coronary wall when the Lumen was identified were defined as intrawall HISs (n = 37), whereas those occupying the lumen when the Lumen was not, or even if only partly, identified, were defined as intraluminal HISs (n = 24). RESULTS Multivariate analysis revealed that intrawall HISs were associated with macrophage accumulation and the absence of calcification assessed by using optical coherence tomography. In contrast, thrombus and intimal vasculature were independent factors associated with intraluminal HISS. Furthermore, 50% of patients with intraluminal HISs experienced rest angina, such as Braunwald class II or III. CONCLUSIONS This study shows that intrawall and intraluminal HISs on T1WI in patients with angina are related to the different types of vulnerable plaque morphology and the clinical severity. (C) 2015 by the American College of Cardiology Foundation.	[Matsumoto, Kenji; Ehara, Shoichi; Hasegawa, Takao; Sakaguchi, Mikumo; Otsuka, Kenichiro; Shimada, Kenei] Osaka City Univ, Grad Sch Med, Dept Cardiovasc Med, Osaka 5458585, Japan; [Yoshikawa, Junichi] Nishinomiya Watanabe Cardiovasc Ctr, Nishinomiya, Hyogo, Japan	Ehara, S (reprint author), Osaka City Univ, Grad Sch Med, Dept Cardiovasc Med, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	ehara@med.osaka-cu.ac.jp			JSPS KAKENHI [23591057]	This work was supported by JSPS KAKENHI (23591057). All authors have reported that they have no relationships relevant to the contents of this paper to disclose.	Sun J, 2012, JACC-CARDIOVASC IMAG, V5, P798, DOI 10.1016/j.jcmg.2012.03.014; Ehara S, 2012, EUR HEART J-CARD IMG, V13, P394, DOI 10.1093/ehjci/jer305; Kawasaki T, 2009, JACC-CARDIOVASC IMAG, V2, P720, DOI 10.1016/j.jcmg.2009.01.016; Tearney GJ, 2003, CIRCULATION, V107, P113, DOI 10.1161/01.CIR.0000044384.41037.43; Noguchi T, 2014, J AM COLL CARDIOL, V63, P989, DOI 10.1016/j.jacc.2013.11.034; Takaya N, 2005, CIRCULATION, V111, P2768, DOI 10.1161/CIRCULATIONAHA.104.504167; Jansen CHP, 2011, CIRCULATION, V124, P416, DOI 10.1161/CIRCULATIONAHA.110.965442; Rupprecht HJ, 1995, EUR HEART J, V16, P1526; Michel JB, 2011, EUR HEART J, V32, P1977, DOI 10.1093/eurheartj/ehr054; Yabushita H, 2002, CIRCULATION, V106, P1640, DOI 10.1161/01.CIR.0000029927.92825.F6; Moody AR, 2003, CIRCULATION, V107, P3047, DOI 10.1161/01.CIR.0000074222.61572.44; Prati F, 2010, EUR HEART J, V31, P401, DOI 10.1093/eurheartj/ehp433; Kolodgie FD, 2003, NEW ENGL J MED, V349, P2316, DOI 10.1056/NEJMoa035655; Kume T, 2006, AM J CARDIOL, V97, P1713, DOI 10.1016/j.amjcard.2006.01.031; FUSTER V, 1992, NEW ENGL J MED, V326, P242; FUSTER V, 1992, NEW ENGL J MED, V326, P310; Habs M, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-76; Virmani R, 2000, THROMB VASC BIOL, V20, P1262, DOI DOI 10.1161/01.ATV.20.5.1262	18	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1936-878X	1876-7591		JACC-CARDIOVASC IMAG	JACC-Cardiovasc. Imag.	OCT	2015	8	10					1143	1152		10.1016/j.jcmg.2015.06.013		10	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CT8VX	WOS:000363096100005		
J	Choi, G; Lee, JM; Kim, HJ; Park, JB; Sankaran, S; Otake, H; Doh, JH; Nam, CW; Shin, ES; Taylor, CA; Koo, BK				Choi, Gilwoo; Lee, Joo Myung; Kim, Hyun-Jin; Park, Jun-Bean; Sankaran, Sethuraman; Otake, Hiromasa; Doh, Joon-Hyung; Nam, Chang-Wook; Shin, Eun-Seok; Taylor, Charles A.; Koo, Bon-Kwon			Coronary Artery Axial Plaque Stress and its Relationship With Lesion Geometry Application of Computational Fluid Dynamics to Coronary CT Angiography	JACC-CARDIOVASCULAR IMAGING			English	Article						axial plaque stress; computational fluid dynamics; coronary artery disease; coronary computed tomography angiography; coronary plaque; pressure; walt shear stress	3-DIMENSIONAL INTRAVASCULAR ULTRASOUND; CARDIAC COMPUTED-TOMOGRAPHY; WALL SHEAR-STRESS; LOCALIZED ELEVATION; FLOW; MORPHOLOGY; RUPTURE; DISEASE; ATHEROSCLEROSIS	OBJECTIVES The purpose of this study was to characterize the hemodynamic force acting on plaque and to investigate its relationship with Lesion geometry. BACKGROUND Coronary plaque rupture occurs when plaque stress exceeds plaque strength. METHODS Computational fluid dynamics was applied to 114 Lesions (81 patients) from coronary computed tomography angiography. The axial plaque stress (APS) was computed by extracting the axial component of hemodynamic stress acting on stenotic lesions, and the axial Lesion asymmetry was assessed by the Luminal radius change over length (radius gradient ERG]). Lesions were divided into upstream-dominant (upstream RG > downstream RG) and downstream-dominant lesions (upstream RG < downstream RG) according to the RG. RESULTS Thirty-three Lesions (28.9%) showed net retrograde axial plaque force. Upstream APS Linearly increased as lesion severity increased, whereas downstream APS exhibited a concave function for lesion severity. There was a negative correlation (r = -0.274, p = 0.003) between APS and lesion Length. The pressure gradient, computed tomography-derived fractional flow reserve (FFRCT), and wall shear stress were consistently higher in upstream segments, regardless of the lesion asymmetry. However, APS was higher in the upstream segment of upstream-dominant lesions (11,371.96 +/- 5,575.14 dyne/cm(2) vs. 6,878.14 +/- 4,319.51 dyne/cm(2), p < 0.001), and in the downstream segment of downstream-dominant lesions (7,681.12 +/- 4,556.99 dyne/cm(2) vs. 11,990.55 +/- 5,556.64 dyne/cm(2), p < 0.001). Although there were no differences in FFRCT, % diameter stenosis, and wall shear stress pattern, the distribution of APS was different between upstream- and downstream-dominant Lesions. CONCLUSIONS APS uniquely characterizes the stenotic segment and has a strong relationship with Lesion geometry. Clinical application of these hemodynamic and geometric indices may be helpful to assess the future risk of plaque rupture and to determine treatment strategy for patients with coronary artery disease. (Evaluation of FFR, WSS, and TPF Using CCTA; NCT01857687) (C) 2015 by the American College of Cardiology Foundation.	[Choi, Gilwoo; Kim, Hyun-Jin; Sankaran, Sethuraman; Taylor, Charles A.] HeartFlow, Redwood City, CA USA; [Choi, Gilwoo] Stanford Univ, Med Ctr, Dept Surg, Stanford, CA 94305 USA; [Lee, Joo Myung; Park, Jun-Bean; Koo, Bon-Kwon] Seoul Natl Univ Hosp, Dept Med, Seoul 110744, South Korea; [Otake, Hiromasa] Kobe Univ, Grad Sch Med, Dept Med, Kobe, Hyogo 657, Japan; [Doh, Joon-Hyung] Inje Univ, Dept Med, Ilsan Paik Hosp, Goyang, South Korea; [Nam, Chang-Wook] Keimyung Univ, Dept Med, Dongsan Med Ctr, Daegu, South Korea; [Shin, Eun-Seok] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Cardiol, Ulsan 680749, South Korea; [Taylor, Charles A.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Koo, Bon-Kwon] Seoul Natl Univ, Inst Aging, Seoul, South Korea	Koo, BK (reprint author), Seoul Natl Univ Hosp, Dept Internal Med, 101 Daehang Ro, Seoul 110744, South Korea.	bkkoo@snu.ac.kr			HeartFlow; St. Jude Medical	This study was funded by HeartFlow. Drs. Choi, Kim, Sankaran, and Taylor are employees and shareholders of HeartFlow, which provided the FFR<INF>CT</INF> service. Dr. Koo has received an institutional research grant from St. Jude Medical. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. The first 2 authors contributed equally to this work.	[Anonymous], 2008, EUR HEART J, V29, P38; Li ZY, 2008, J AM COLL CARDIOL, V52, P1106, DOI 10.1016/j.jacc.2008.08.004; Samady H, 2011, CIRCULATION, V124, P779, DOI 10.1161/CIRCULATIONAHA.111.021824; Li ZY, 2006, STROKE, V37, P1195, DOI 10.1161/01.STR.0000217331.61083.3b; Taylor AJ, 2010, J AM COLL CARDIOL, V56, P1864, DOI 10.1016/j.jacc.2010.07.005; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Tanaka A, 2008, CIRCULATION, V118, P2368, DOI 10.1161/CIRCULATIONAHA.108.782540; Otsuka F, 2014, NAT REV CARDIOL, V11, P379, DOI 10.1038/nrcardio.2014.62; De Bruyne B, 2014, NEW ENGL J MED, V371, P1208, DOI 10.1056/NEJMoa1408758; Taylor CA, 2013, J AM COLL CARDIOL, V61, P2233, DOI 10.1016/j.jacc.2012.11.083; Dolan JM, 2013, ANN BIOMED ENG, V41, P1411, DOI 10.1007/s10439-012-0695-0; Fukumoto Y, 2008, J AM COLL CARDIOL, V51, P645, DOI 10.1016/j.jacc.2007.10.030; De Bruyne B, 2014, NEW ENGL J MED, V371, P1465; Doriot PA, 2003, PHYS MED BIOL, V48, P127, DOI 10.1088/0031-9155/48/1/309; Kwak BR, 2014, EUR HEART J, V35, P3013, DOI 10.1093/eurheartj/ehu353	15	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1936-878X	1876-7591		JACC-CARDIOVASC IMAG	JACC-Cardiovasc. Imag.	OCT	2015	8	10					1156	1166		10.1016/j.jcmg.2015.04.024		11	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CT8VX	WOS:000363096100007		
J	Kubo, T; Shimamura, K; Ino, Y; Yamaguchi, T; Matsuo, Y; Shiono, Y; Taruya, A; Nishiguchi, T; Shimokado, A; Teraguchi, I; Orii, M; Yamano, T; Tanimoto, T; Kitabata, H; Hirata, K; Tanaka, A; Akasaka, T				Kubo, Takashi; Shimamura, Kunihiro; Ino, Yasushi; Yamaguchi, Tomoyuki; Matsuo, Yoshiki; Shiono, Yasutsugu; Taruya, Akira; Nishiguchi, Tsuyoshi; Shimokado, Aiko; Teraguchi, Ikuko; Orii, Makoto; Yamano, Takashi; Tanimoto, Takashi; Kitabata, Hironori; Hirata, Kumiko; Tanaka, Atsushi; Akasaka, Takashi			Superficial Calcium Fracture After PCI as Assessed by OCT	JACC-CARDIOVASCULAR IMAGING			English	Letter							CALCIFICATION; LESIONS		[Kubo, Takashi; Shimamura, Kunihiro; Ino, Yasushi; Yamaguchi, Tomoyuki; Matsuo, Yoshiki; Shiono, Yasutsugu; Taruya, Akira; Nishiguchi, Tsuyoshi; Shimokado, Aiko; Teraguchi, Ikuko; Orii, Makoto; Yamano, Takashi; Tanimoto, Takashi; Kitabata, Hironori; Hirata, Kumiko; Tanaka, Atsushi; Akasaka, Takashi] Wakayama Med Univ, Dept Cardiovasc Med, Wakayama 6418509, Japan	Kubo, T (reprint author), Wakayama Med Univ, Dept Cardiovasc Med, 811-1 Kimiidera, Wakayama 6418509, Japan.	takakubo@wakayama-med.ac.jp					Kobayashi Y, 2014, CIRC J, V78, P2209, DOI 10.1253/circj.CJ-14-0108; MINTZ GS, 1995, CIRCULATION, V91, P1959; Vaquerizo B, 2010, J INTERV CARDIOL, V23, P240, DOI 10.1111/j.1540-8183.2010.00547.x; Madhavan MV, 2014, J AM COLL CARDIOL, V63, P1703, DOI 10.1016/j.jacc.2014.01.017	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1936-878X	1876-7591		JACC-CARDIOVASC IMAG	JACC-Cardiovasc. Imag.	OCT	2015	8	10					1228	1229		10.1016/j.jcmg.2014.11.012		2	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CT8VX	WOS:000363096100016		
J	Barbanti, M; Gulino, S; Capranzano, P; Imme, S; Sgroi, C; Tamburino, C; Ohno, Y; Attizzani, GF; Patane, M; Sicuso, R; Pilato, G; Di Landro, A; Todaro, D; Di Simone, E; Picci, A; Giannetto, G; Costa, G; Deste, W; Giannazzo, D; Grasso, C; Capodanno, D; Tamburino, C				Barbanti, Marco; Gulino, Simona; Capranzano, Piera; Imme, Sebastiano; Sgroi, Carmelo; Tamburino, Claudia; Ohno, Yohei; Attizzani, Guilherme F.; Patane, Martina; Sicuso, Rita; Pilato, Gerlando; Di Landro, Alessio; Todaro, Denise; Di Simone, Emanuela; Picci, Andrea; Giannetto, Giuliana; Costa, Giuliano; Deste, Wanda; Giannazzo, Daniela; Grasso, Carmelo; Capodanno, Davide; Tamburino, Corrado			Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation)	JACC-CARDIOVASCULAR INTERVENTIONS			English	Article						AKI; RenalGuard; TAVR	CONTRAST-INDUCED NEPHROPATHY; ACADEMIC RESEARCH CONSORTIUM; PERCUTANEOUS CORONARY INTERVENTION; CLINICAL-OUTCOMES; SALINE HYDRATION; METAANALYSIS; FAILURE; RISK; INSUFFICIENCY; DEFINITIONS	OBJECTIVES The purpose of this study was to investigate the effect of the RenalGuard System (PLC Medical Systems, Milford, Massachusetts) on prevention of acute kidney injury (AKI) in patients undergoing transcatheter aortic valve replacement (TAVR). BACKGROUND TAVR is associated with varying degrees of post-procedural AKI. The RenalGuard System is a dedicated device designed for contrast-induced AKI prevention. Whether this device is also effective in patients with severe aortic stenosis undergoing TAVR is unexplored. METHODS The present is an investigator-driven, single-center, prospective, open-label, registry-based randomized study that used the TAVR institutional registry of the Ferrarotto Hospital in Catania, Italy, as the platform for randomization, data collection, and follow-up assessment. A total of 112 consecutive patients undergoing TAVR were randomly assigned to hydration with normal saline solution controlled by the RenalGuard system and furosemide (RenalGuard group) or normal saline solution (control group). The primary endpoint was the incidence of Valve Academic Research Consortium-defined AKI in the first 72 h after the procedure. RESULTS The AKI rate was lower in the RenalGuard group than in the control group (n = 3 [5.4%] vs. n = 14 [25.0%], respectively, p = 0.014). The majority of patients (5.4% vs. 23.2%) developed a mild AKI (stage 1); severe damage (stage 3) occurred only in 1 patient in the control group (0.0% vs. 1.8%). No case of in-hospital renal failure requiring dialysis was reported. No significant differences in terms of mortality, cerebrovascular events, bleeding, and hospitalization for heart failure were noted in both groups at 30 days. CONCLUSIONS Furosemide-induced diuresis with matched isotonic intravenous hydration using the RenalGuard system is an effective therapeutic tool to reduce the occurrence of AKI in patients undergoing TAVR. (C) 2015 by the American College of Cardiology Foundation.	[Barbanti, Marco; Gulino, Simona; Capranzano, Piera; Imme, Sebastiano; Sgroi, Carmelo; Tamburino, Claudia; Ohno, Yohei; Attizzani, Guilherme F.; Patane, Martina; Sicuso, Rita; Pilato, Gerlando; Di Landro, Alessio; Todaro, Denise; Di Simone, Emanuela; Picci, Andrea; Giannetto, Giuliana; Costa, Giuliano; Deste, Wanda; Giannazzo, Daniela; Grasso, Carmelo; Capodanno, Davide; Tamburino, Corrado] Univ Catania, Div Cardiol, Ferrarotto Hosp, Catania, Italy; [Ohno, Yohei] Tokai Univ, Sch Med, Dept Cardiol, Isehara, Kanagawa 25911, Japan; [Attizzani, Guilherme F.] Univ Hosp Cleveland, Valve & Struct Heart Dis Intervent Ctr, Harrington Heart & Vasc Inst, Case Med Ctr, Cleveland, OH 44106 USA; [Tamburino, Corrado] ETNA Fdn, Catania, Italy	Barbanti, M (reprint author), Univ Catania, Div Cardiol, Ferrarotto Hosp, Catania, Italy.	mbarbanti83@gmail.com					Barbash IM, 2012, AM HEART J, V163, P1031, DOI 10.1016/j.ahj.2012.01.009; Mueller C, 2002, ARCH INTERN MED, V162, P329, DOI 10.1001/archinte.162.3.329; Bagur R, 2010, EUR HEART J, V31, P865, DOI 10.1093/eurheartj/ehp552; Genereux P, 2012, J AM COLL CARDIOL, V59, P2317, DOI 10.1016/j.jacc.2012.02.022; Briguori C, 2011, CIRCULATION, V124, P1260, DOI 10.1161/CIRCULATIONAHA.111.030759; Trivedi HS, 2003, NEPHRON CLIN PRACT, V93, pC29, DOI 10.1159/000066641; Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068; Leon MB, 2011, J AM COLL CARDIOL, V57, P253, DOI 10.1016/j.jacc.2010.12.005; Nuis RJ, 2012, CIRC-CARDIOVASC INTE, V5, P680, DOI 10.1161/CIRCINTERVENTIONS.112.971291; Genereux P, 2013, AM J CARDIOL, V111, P100, DOI [10.1016/j.amjcard.2012.08.057, 10.1016/j.amjcard.2012.08:057]; Marenzi G, 2012, JACC-CARDIOVASC INTE, V5, P90, DOI 10.1016/j.jcin.2011.08.017; Gargiulo G, 2015, CATHETER CARDIO INTE, V86, P518, DOI 10.1002/ccd.25867; SOLOMON R, 1994, NEW ENGL J MED, V331, P1416, DOI 10.1056/NEJM199411243312104; Zagler A, 2006, AM HEART J, V151, P140, DOI 10.1016/j.ahj.2005.01.055; Rihal CS, 2002, CIRCULATION, V105, P2259, DOI 10.1161/01.CIR.0000016043.87291.33; Khawaja MZ, 2012, EUROINTERVENTION, V8, P563, DOI 10.4244/EIJV8I5A87; WEINSTEIN JM, 1992, NEPHRON, V62, P413; DIKSHIT K, 1973, NEW ENGL J MED, V288, P1087, DOI 10.1056/NEJM197305242882102; Best PJM, 2002, J AM COLL CARDIOL, V39, P1113, DOI 10.1016/S0735-1097(02)01745-X; Barbanti M, 2014, EUROINTERVENTION, V10, P133, DOI 10.4244/EIJV10I1A20; Nuis RJM, 2011, CATHETER CARDIO INTE, V77, P881, DOI 10.1002/ccd.22874; Dussol B, 2006, NEPHROL DIAL TRANSPL, V21, P2120, DOI 10.1093/ndt/gfl133; Resnic FS, 2009, J AM COLL CARDIOL, V53, pA36; Stevens Melissa A., 1999, Journal of the American College of Cardiology, V33, P403, DOI 10.1016/S0735-1097(98)00574-9	24	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1936-8798	1876-7605		JACC-CARDIOVASC INTE	JACC-Cardiovasc. Interv.	OCT	2015	8	12					1595	1604		10.1016/j.jcin.2015.07.012		10	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CU1GN	WOS:000363268600016		
J	Yamamoto, M; Kawarada, O; Sakamoto, S; Harada, K; Noguchi, T; Yasuda, S; Ogawa, H				Yamamoto, Masahiro; Kawarada, Osami; Sakamoto, Shingo; Harada, Koichiro; Noguchi, Teruo; Yasuda, Satoshi; Ogawa, Hisao			Hybrid Therapy Consisting of Balloon Maceration and Subsequent Fogarty Thrombectomy for Subacute Lower Limb Ischemia	JACC-CARDIOVASCULAR INTERVENTIONS			English	Editorial Material						endovascular therapy; peripheral artery disease; subacute ischemia; surgery; thrombus			[Yamamoto, Masahiro; Kawarada, Osami; Sakamoto, Shingo; Harada, Koichiro; Noguchi, Teruo; Yasuda, Satoshi; Ogawa, Hisao] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Suita, Osaka 5658565, Japan; [Ogawa, Hisao] Kumamoto Univ, Dept Cardiovasc Med, Grad Sch Med Sci, Kumamoto, Japan	Kawarada, O (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	kawarada.osami.hp@ncvc.go.jp					Dosluoglu HH, 2008, SEMIN VASC SURG, V21, P167, DOI 10.1053/j.semvascsurg.2008.11.002	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1936-8798	1876-7605		JACC-CARDIOVASC INTE	JACC-Cardiovasc. Interv.	OCT	2015	8	12					1633	1634		10.1016/j.jcin.2015.05.025		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CU1GN	WOS:000363268600022		
J	Maekawa, Y; Akita, K; Tsuruta, H; Yashima, F; Kimura, M; Yamada, Y; Kawakami, T; Kanazawa, H; Hayashida, K; Yuasa, S; Murata, M; Jinzaki, M; Fukuda, K				Maekawa, Yuichiro; Akita, Keitaro; Tsuruta, Hikaru; Yashima, Fumiaki; Kimura, Mai; Yamada, Yoshitake; Kawakami, Takashi; Kanazawa, Hideaki; Hayashida, Kentaro; Yuasa, Shinsuke; Murata, Mitsushige; Jinzaki, Masahiro; Fukuda, Keiichi			"Protruding Myocardium" as a Target for Percutaneous Transluminal Septal Myocardial Ablation in a Case of Hypertrophic Obstructive Cardiomyopathy	JACC-CARDIOVASCULAR INTERVENTIONS			English	Editorial Material						heart failure; hypertrophic obstructive cardiomyopathy; percutaneous transluminal septal myocardial ablation			[Maekawa, Yuichiro; Akita, Keitaro; Tsuruta, Hikaru; Yashima, Fumiaki; Kimura, Mai; Kawakami, Takashi; Kanazawa, Hideaki; Hayashida, Kentaro; Yuasa, Shinsuke; Murata, Mitsushige; Fukuda, Keiichi] Keio Univ, Dept Cardiol, Sch Med, Tokyo 1608582, Japan; [Yamada, Yoshitake; Jinzaki, Masahiro] Keio Univ, Dept Diagnost Radiol, Sch Med, Tokyo 1608582, Japan	Maekawa, Y (reprint author), Keio Univ, Dept Cardiol, Sch Med, Shinjuku Ku, Shinanomachi 35, Tokyo 1608582, Japan.	ymaekawa@a5.keio.jp					Maekawa Y, 2014, INT J CARDIOL, V176, pE131, DOI 10.1016/j.ijcard.2014.07.211	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1936-8798	1876-7605		JACC-CARDIOVASC INTE	JACC-Cardiovasc. Interv.	OCT	2015	8	12					E201	E202		10.1016/j.jcin.2015.05.029		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CU1GN	WOS:000363268600004		
J	Yoshida, K; Hayashida, N; Fukushima, Y; Ohtsuru, A; Ohba, T; Hasegawa, A; Sato, H; Shishido, F; Yasui, K; Kumagai, A; Yusa, T; Kudo, T; Yamashita, S; Takamura, N				Yoshida, Koji; Hayashida, Naomi; Fukushima, Yoshiko; Ohtsuru, Akira; Ohba, Takashi; Hasegawa, Arifumi; Sato, Hisashi; Shishido, Fumio; Yasui, Kiyotaka; Kumagai, Atsushi; Yusa, Takeshi; Kudo, Takashi; Yamashita, Shunichi; Takamura, Noboru			Changes in radiological imaging frequencies in children before and after the accident at the Fukushima Daiichi Nuclear Power Plant in Fukushima Prefecture, Japan	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Radiological examination; Radiation exposure; Fukushima Daiichi Nuclear Power Plant accident; Fukushima Prefecture; Children	COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE; CANCER INCIDENCE; SUBSEQUENT RISK; PEDIATRIC CT; COHORT; CHILDHOOD; SCANS	The accident at the Fukushima Daiichi Nuclear Power Plant has raised concerns about radiation exposure, including medical radiation exposure such as X-ray and CT, in residents of Fukushima. We compared the numbers and the ratio of outpatients less than 10 years old who underwent imaging examinations [e.g., CT, X-ray, MRI, ultrasonography (US), etc.] at Fukushima Medical University hospital in Fukushima, Japan before (April 1, 2008-March 31, 2011) and after (April 1, 2011-March 31, 2014) the accident. The number of outpatients less than 10 years old decreased after the accident. The number of outpatients less than 10 years old who underwent CT and X-ray examinations also significantly decreased after the accident (p < 0.001, p < 0.01, respectively). Our results suggest that the number of pediatric radiological examinations decreased after the accident in Fukushima. We should continue to communicate with patients and their families to ensure that they understand the risks and benefits of radiological imaging in order to overcome their concerns about the nuclear disaster.	[Yoshida, Koji] Nagasaki Univ, Dept Global Hlth Med & Welf, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Hayashida, Naomi] Nagasaki Univ, Atom Bomb Dis Inst, Div Promot Collaborat Res Radiat & Environm Hlth, Nagasaki 852, Japan; [Fukushima, Yoshiko] Natl Inst Radiol Sci, Chiba 260, Japan; [Ohtsuru, Akira; Ohba, Takashi] Fukushima Med Univ, Dept Radiat Hlth Management, Sch Med, Fukushima, Japan; [Hasegawa, Arifumi] Fukushima Med Univ, Dept Radiat Disaster Med, Sch Med, Fukushima, Japan; [Sato, Hisashi] Fukushima Med Univ, Dept Radiat Oncol, Sch Med, Fukushima, Japan; [Shishido, Fumio] Fukushima Med Univ, Dept Radiol, Sch Med, Fukushima, Japan; [Yoshida, Koji; Yasui, Kiyotaka; Kumagai, Atsushi] Fukushima Med Univ, Educ Ctr Disaster Med, Fukushima, Japan; [Yusa, Takeshi] Fukushima Med Univ Hosp, Dept Radiol Technol, Fukushima, Japan; [Kudo, Takashi] Nagasaki Univ, Atom Bomb Dis Inst, Dept Radioisotope Med, Nagasaki 852, Japan; [Yamashita, Shunichi] Nagasaki Univ, Atom Bomb Dis Inst, Dept Radiat Med Sci, Nagasaki 852, Japan; [Takamura, Noboru] Nagasaki Univ, Dept Global Hlth Med & Welf, Atom Bomb Dis Inst, Nagasaki 852, Japan	Takamura, N (reprint author), Nagasaki Univ, Dept Global Hlth Med & Welf, Atom Bomb Dis Inst, Nagasaki 852, Japan.	takamura@nagasaki-u.ac.jp					Huang WY, 2014, BRIT J CANCER, V110, P2354, DOI 10.1038/bjc.2014.103; Yabe Hirooki, 2014, Fukushima J Med Sci, V60, P57, DOI 10.5387/fms.2014-1; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Yasumura S, 2012, J EPIDEMIOL, V22, P375, DOI 10.2188/jea.JE20120105; Mettler FA, 2008, HEALTH PHYS, V95, P502, DOI 10.1097/01.HP.0000326333.42287.a2; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Orita M, 2013, RADIAT PROT DOSIM, V156, P383, DOI 10.1093/rpd/nct082; Smith-Bindman R, 2012, JAMA-J AM MED ASSOC, V307, P2400, DOI 10.1001/jama.2012.5960; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Hammer GP, 2009, RADIAT RES, V171, P504, DOI 10.1667/RR1575.1; Townsend BA, 2010, AM J ROENTGENOL, V194, P1194, DOI 10.2214/AJR.09.3682; Nagataki S, 2013, RADIAT RES, V180, P439, DOI 10.1667/RR13351.1; Nagataki S, 2014, CURR OPIN ENDOCRINOL, V21, P384, DOI 10.1097/MED.0000000000000098; Berrington de Gonzales A, 2004, LANCET, V363, P345, DOI DOI 10.1016/S0140-6736; Berrington de Gonzalez A, 2007, ARCH INTERN MED, V169, P2071; Fukushima Prefecture, REP AG 5 YEARS OLD R; Journy N, 2014, RADIAT ENVIRON BIOPH, V53, P39, DOI 10.1007/s00411-013-0491-8; Krille L, 2015, RADIAT ENVIRON BIOPH, V54, P1, DOI 10.1007/s00411-014-0580-3; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Miyazaki O., 2015, PEDIATR RADIOL, P1; Nuclear Emergency Response Headquarters of Japanese Government, ADD REP JAP GOV IAEA; Nuclear Emergency Response Headquarters of Japanese Government, JAP GOV IAEA MIN C N; Pearce MS, 2012, RADIOL RES PRACT; United Nations Scientific Committee on the Effects of Atomic Radiation, 2010, UNSCEAR 2008 REP GEN; United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), UNSCEAR 2013 REP, VI	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	OCT	2015	33	10					619	626		10.1007/s11604-015-0464-8		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT8KN	WOS:000363065400002		
J	Nakamura, Y; Kimura, T; Higaki, T; Honda, Y; Komoto, D; Yamagami, T; Iida, M; Nagata, Y; Honda, Y; Aikata, H; Chayama, K; Awai, K				Nakamura, Yuko; Kimura, Tomoki; Higaki, Toru; Honda, Yukiko; Komoto, Daisuke; Yamagami, Takuji; Iida, Makoto; Nagata, Yasushi; Honda, Yohji; Aikata, Hiroshi; Chayama, Kazuaki; Awai, Kazuo			Clinical utility of gadoxetate disodium-enhanced hepatic MRI for stereotactic body radiotherapy of hepatocellular carcinoma	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Hepatocellular carcinoma; Stereotactic body radiotherapy; Gadoxetate disodium; Magnetic resonance imaging	FOCAL LIVER REACTION; GD-EOB-DTPA; RADIATION-THERAPY; TRANSARTERIAL CHEMOEMBOLIZATION; TUMOR RESPONSE; PHASE-III; IMAGES; CT; CIRRHOSIS; IRRADIATION	To investigate the utility of gadoxetate disodium-enhanced hepatic MRI (EOB-MRI) for stereotactic body radiotherapy (SBRT) to treat hepatocellular carcinoma (HCC). We divided 30 HCC patients who underwent SBRT into group A (no change in their Child-Pugh score 6 months post-SBRT) and group B (increased score 6 months post-SBRT). EOB-MRI was performed before and 6 months after SBRT. We calculated the liver-spleen contrast (LSC) ratio for each radiation dose area on hepatobiliary phase scans (LSCbefore using images obtained before SBRT and LSCafter using images acquired after SBRT) and the weighted LSC (W-LSC) as: [(mean LSCbefore (0-30 Gy) x liver volume (0-30 Gy) + mean LSCbefore (30 Gy-) x liver volume (30 Gy-))/total liver volume]. Then we compared the W-LSC, percentage of the liver volume exposed to > 20 Gy (V20), and mean liver dose in the two groups. The LSCafter at 48, 40, and 30 Gy to the liver was statistically lower than the unirradiated area of the liver (p < 0.01). Univariate analysis showed that only W-LSC was significantly associated with group B (p = 0.02). W-LSC was a useful parameter for predicting changes in hepatic function after SBRT.	[Nakamura, Yuko; Higaki, Toru; Honda, Yukiko; Komoto, Daisuke; Iida, Makoto; Awai, Kazuo] Hiroshima Univ, Diagnost Radiol, Minami Ku, Hiroshima 7348551, Japan; [Kimura, Tomoki; Nagata, Yasushi] Hiroshima Univ, Radiat Oncol, Hiroshima, Japan; [Honda, Yohji; Aikata, Hiroshi; Chayama, Kazuaki] Hiroshima Univ, Dept Med & Mol Sci, Hiroshima, Japan; [Honda, Yohji; Aikata, Hiroshi; Chayama, Kazuaki] Hiroshima Liver Res Project Ctr, Hiroshima, Japan	Nakamura, Y (reprint author), Hiroshima Univ, Diagnost Radiol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	yukon@hiroshima-u.ac.jp; tkkimura@hiroshima-u.ac.jp; higaki@hiroshima-u.ac.jp; honday@hiroshima-u.ac.jp; komoto@hiroshima-u.ac.jp; yamagami@kouchi-u.ac.jp; edamako@hiroshima-u.ac.jp; nagat@hiroshima-u.ac.jp; hyohji@hiroshima-u.ac.jp; aikata@hiroshima-u.ac.jp; chayama@hiroshima-u.ac.jp; awai@hiroshima-u.ac.jp			Toshiba Medical Systems Co., Ltd	Kazuo Awai received a research grant from Toshiba Medical Systems Co., Ltd. The other authors declare that they have no conflict of interest.	Takeda A, 2008, HEPATOL RES, V38, P60, DOI 10.1111/j.1872-034X.2007.00084.x; Shinagawa Y, 2012, AM J ROENTGENOL, V199, P1010, DOI 10.2214/AJR.11.8204; Huppertz A, 2004, RADIOLOGY, V230, P266, DOI 10.1148/radiol.2301020269; Ikai I, 2010, HEPATOL RES, V40, P1043, DOI 10.1111/j.1872-034X.2010.00731.x; Pan CC, 2010, INT J RADIAT ONCOL, V76, pS94, DOI 10.1016/j.ijrobp.2009.06.092; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Ichikawa T, 2010, INVEST RADIOL, V45, P133, DOI 10.1097/RLI.0b013e3181caea5b; Kimura T, 2013, HEPATOL RES, V43, P717, DOI 10.1111/hepr.12007; Kim SH, 2009, AM J ROENTGENOL, V192, P1675, DOI 10.2214/AJR.08.1262; Motosugi U, 2009, J MAGN RESON IMAGING, V30, P1042, DOI 10.1002/jmri.21956; Di Martino M, 2010, RADIOLOGY, V256, P806, DOI 10.1148/radiol.10091334; Sanuki N, 2013, AM J ROENTGENOL, V201, pW812, DOI 10.2214/AJR.12.10169; Dawson LA, 2001, SEMIN RADIAT ONCOL, V11, P240, DOI 10.1053/srao.2001.23485; Liang SX, 2006, INT J RADIAT ONCOL, V65, P426, DOI 10.1016/j.ijrobp.2005.12.031; Takeda A, 2012, RADIOTHER ONCOL, V104, P374, DOI 10.1016/j.radonc.2011.12.008; Bluemke DA, 2005, RADIOLOGY, V237, P89, DOI 10.1148/radiol.2371031842; Morita K, 2011, MAGN RESON MED, V66, P213, DOI 10.1002/mrm.22770; Okamoto D, 2014, MAGN RESON IMAGING, V32, P660, DOI 10.1016/j.mri.2014.02.019; Takeda A, 2014, J GASTROEN HEPATOL, V29, P372, DOI 10.1111/jgh.12350; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; MATSUMATA T, 1987, WORLD J SURG, V11, P678; Thomas MB, 2010, J CLIN ONCOL, V28, P3994, DOI 10.1200/JCO.2010.28.7805; Lau H, 1997, BRIT J SURG, V84, P1255; Ryder S. D., 2003, Gut, V52, P1; Sanuki N, 2014, INT J RADIAT ONCOL, V88, P306, DOI 10.1016/j.ijrobp.2013.10.045; Sanuki-Fujimoto N, 2010, BRIT J RADIOL, V83, P1063, DOI 10.1259/bjr/74105551	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	OCT	2015	33	10					627	635		10.1007/s11604-015-0465-7		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT8KN	WOS:000363065400003		
J	Itoh, T; Saito, M; Marugami, N; Hirai, T; Marugami, A; Takahama, J; Tanaka, T; Kichikawa, K				Itoh, Takahiro; Saito, Miho; Marugami, Nagaaki; Hirai, Toshiko; Marugami, Aki; Takahama, Junko; Tanaka, Toshihiro; Kichikawa, Kimihiko			Correlation between the ABC classification and radiological findings for assessing gastric cancer risk	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Helicobacter pylori; ABC classification; Gastric cancer; Radiological finding	HELICOBACTER-PYLORI INFECTION; CHRONIC ACTIVE GASTRITIS; PEPSINOGEN; ANTIBODY	To investigate the correlation between ABC risk assessment and radiological findings of gastric mucosa and to propose an improved method for gastric cancer screening. We evaluated 318 participants with Helicobacter pylori (Hp) antibody titers, serum pepsinogen (PG) and upper GI radiography and then classified them into three groups: A, double-negative; B, Hp-positive, PG-negative; C, PG-positive. Group A was subclassified as: A-1, Hp antibody titer < 3.0 U/ml; A-2, Hp antibody titer a parts per thousand yen3.0 U/ml. Results for group A and non-A (B or C) participants and radiological findings of gastric mucosa (fold and area gastricae) were analyzed retrospectively. Radiological findings differed significantly between the 207 A-1 and 98 non-A group. Odds ratios were 17.72 for fold distribution, 10.63 for fold thickness, 6.10 for fold characteristics, and 10.62 for area gastricae. Presence of a parts per thousand yen2 risk factors offered 90.3 % sensitivity, 94.7 % specificity, and 93.3 % accuracy. Nine (69.2 %) of the 13 A-2 group participants and 11 (5.3 %) A-1 group participants had a risk for gastric cancer according to radiological findings. A good correlation exists between ABC classifications and radiological findings for gastric cancer risk, but some discrepant cases exist. We recommend both methods as screening for gastric cancer.	[Itoh, Takahiro; Marugami, Aki; Takahama, Junko; Tanaka, Toshihiro; Kichikawa, Kimihiko] Nara Med Univ, Dept Radiol, Kashihara, Nara 6348521, Japan; [Saito, Miho; Marugami, Nagaaki; Hirai, Toshiko] Nara Med Univ, Dept Endoscopy & Ultrasound, Kashihara, Nara 6348521, Japan	Itoh, T (reprint author), Nara Med Univ, Dept Radiol, 840 Shijocho, Kashihara, Nara 6348521, Japan.	titoh@naramed-u.ac.jp					Wang CC, 2007, AM J GASTROENTEROL, V102, P1789, DOI 10.1111/j.1572-0241.2007.01335.x; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Watabe H, 2005, GUT, V54, P764, DOI 10.1136/gut.2004.055400; Ohata H, 2004, INT J CANCER, V109, P138, DOI 10.1002/ijc.11680; SOHN J, 1995, RADIOLOGY, V195, P763; Hamashima C, 2008, JPN J CLIN ONCOL, V38, P259, DOI 10.1093/jjco/hyn017; OSHIMA A, 1986, INT J CANCER, V38, P829, DOI 10.1002/ijc.2910380608; FUKAO A, 1995, INT J CANCER, V60, P45, DOI 10.1002/ijc.2910600106; CROCKER JD, 1995, INVEST RADIOL, V30, P480, DOI 10.1097/00004424-199508000-00005; Dheer S, 2002, BRIT J RADIOL, V75, P805; Mizuno S, 2010, DIGEST DIS SCI, V55, P3132, DOI 10.1007/s10620-010-1154-0; Miki K, 2011, P JPN ACAD B-PHYS, V87, P405, DOI 10.2183/pjab.87.405; Kudo T, 2011, WORLD J GASTROENTERO, V17, P4793, DOI 10.3748/wjg.v17.i43.4793; Goto H, 2012, J GASTROINTEST CANC, V50, P429; Itoh T, 2011, J GASTROINTEST CANC, V49, P493; Miyamoto A, 2009, J GASTROENTEROLOGICA, V47, P55; Mochizuki N, 2014, J GASTROINTEST CANC, V52, P545; Nakajima S, 2006, STOMACH INTESTINE, V41, P1001; Nakajima S, 2013, CLIN GASTROENTEROL, V28, P1137; Okuda J, 2002, HLTH EVALUATION PROM, V29, P894; Saito Y, 2014, J GASTROINTEST CANC, V52, P46; Yamamichi N, 2014, PLOS ONE, V9, DOI [10.1371/journal(Pone.0111359.eCollection2014), DOI 10.1371/JOURNAL(PONE.0111359.ECOLLECTION2014)]; Yasuda M, 2010, J GASTROINTEST CANC, V48, P344; Yoshida T, 2014, INT J CANCER, V134, P1445, DOI 10.1002/ijc.28470	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	OCT	2015	33	10					636	644		10.1007/s11604-015-0469-3		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT8KN	WOS:000363065400004		
J	Kiguchi, T; Higuchi, T; Takahashi, N; Shimokoshi, T; Yamazaki, M; Yoshimura, N; Aoyama, H				Kiguchi, Takao; Higuchi, Takeshi; Takahashi, Naoya; Shimokoshi, Toshikazu; Yamazaki, Motohiko; Yoshimura, Norihiko; Aoyama, Hidefumi			CT measurement of splenic volume changes as a result of hypovolemic shock	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Spleen; Hypovolemic shock; Multidetector computed tomography; Emergencies	SPLEEN; STIMULATION; RESPONSES	To evaluate the changes in splenic volume during hypovolemic shock and after recovery by use of multidetector computed tomography (MDCT). We investigated 22 cases who underwent MDCT during hypovolemic shock up to 3 h after presentation, compared the splenic volume with that after recovery, and evaluated the volume difference. We compared the volume ratio (recovery/shock) for two age groups: under 60 years (n = 10) and 60 years and over (n = 12). For cases (n = 10) undergoing CT examination twice after treatment, we compared the volume ratios by using the initial recovery CT and the second CT images. The average spleen volume in shock was 63 cm(3); under normal conditions it was 132 cm(3) (P < 0.001). The average volume ratio for groups under 60 years old was 2.34; for groups 60 years and over it was 2.05 (P = 0.051). The average volume ratio obtained by use of the initial post-recovery CT was 2.11; the ratio obtained by use of the second post-recovery CT was 2.16 (P = 0.386). Our results revealed that splenic volume was reduced during hypovolemic shock and rapidly increased after recovery. Splenic contraction is an important CT finding in shock.	[Kiguchi, Takao; Higuchi, Takeshi; Shimokoshi, Toshikazu] Niigata City Gen Hosp, Dept Diagnost Radiol, Chuo Ku, Niigata 9501197, Japan; [Takahashi, Naoya] Niigata Univ, Dept Radiol Technol, Grad Sch Hlth Sci, Niigata, Japan; [Yamazaki, Motohiko; Yoshimura, Norihiko; Aoyama, Hidefumi] Niigata Univ, Dept Radiol, Grad Sch Med & Dent Sci, Niigata, Japan	Kiguchi, T (reprint author), Niigata City Gen Hosp, Dept Diagnost Radiol, Chuo Ku, 463-7 Shumoku, Niigata 9501197, Japan.	takakig+jo@gmail.com					Silagy C, 1998, LANCET, V352, P710, DOI 10.1016/S0140-6736(05)60828-8; GUNTHEROTH WG, 1963, AM J PHYSIOL, V204, P35; AYERS AB, 1972, BRIT J PHARMACOL, V44, P17; KNECHT H, 1988, EUR J HAEMATOL, V41, P382; Kanki A, 2011, AM J ROENTGENOL, V197, pW980, DOI 10.2214/AJR.10.5736; FISHER BM, 1990, CLIN SCI, V78, P469; Tarrant AM, 2008, BRIT J RADIOL, V81, P252, DOI 10.1259/bjr/40962054; HAFFNER HT, 1994, FORENSIC SCI INT, V66, P95, DOI 10.1016/0379-0738(94)90333-6; Kaufman MJ, 1998, J APPL PHYSIOL, V85, P1877; Borley NR, 2008, GRAYS ANATOMY, P1191; Corradi F, 2012, SHOCK, V38, P46; de Moya MA, 2013, SHOCK MERCK MANUALS; Goodman R, 1990, RADIOLOGY, V176, P629; Stewart IB, 2002, THESIS U BRIT COLUMB	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	OCT	2015	33	10					645	649		10.1007/s11604-015-0470-x		5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT8KN	WOS:000363065400005		
J	Hirata, K; Utsunomiya, D; Oda, S; Kidoh, M; Funama, Y; Yuki, H; Yoshida, M; Yamashita, Y				Hirata, Kenichiro; Utsunomiya, Daisuke; Oda, Seitaro; Kidoh, Masafumi; Funama, Yoshinori; Yuki, Hideaki; Yoshida, Morikatsu; Yamashita, Yasuyuki			Added value of a single-energy projection-based metal-artifact reduction algorithm for the computed tomography evaluation of oral cavity cancers	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Head/neck; CT; Adults; Technology assessment	SQUAMOUS-CELL CARCINOMA; DENTAL ARTIFACTS; F-18-FDG PET/CT; IMAGE QUALITY; CT; ANGIOGRAPHY; IMPACT; MRI	The purpose of our study was to investigate the added value of the single-energy projection-based metallic artifact reduction (SEMAR) technique on the visualization and diagnostic confidence of oral cavity cancers. Contrast-enhanced CT was performed on 40 patients with dental metalwork. Of these, 18 patients had pathologically confirmed oral cavity cancer, and the other 22 patients had no lesions. CT attenuation and noise in the oral cavity were compared between the conventional and SEMAR images. Two radiologists visually graded the diagnostic confidence on a 5-point scale from 1 (definitely absent) to 5 (definitely present). The value of the SEMAR was assessed in a receiver-operating characteristic curve analysis. The artifact of the SEMAR images was significantly lower than that of the conventional images (38.4 +/- A 18.0 HU vs. 187.7 +/- A 162.7 HU; P < 0.01). Reviewers 1 and 2 detected 10 and 7 more lesions with the SEMAR, respectively. Areas under the curve for the conventional and SEMAR reconstruction were 0.761 and 0.942, respectively, for reviewer 1 and 0.701 and 0.864, respectively, for reviewer 2. The SEMAR significantly improved the oral cavity cancer visualization and diagnostic confidence.	[Hirata, Kenichiro; Utsunomiya, Daisuke; Oda, Seitaro; Kidoh, Masafumi; Yuki, Hideaki; Yoshida, Morikatsu; Yamashita, Yasuyuki] Kumamoto Univ, Diagnost Radiol, Fac Life Sci, Chuo Ku, Kumamoto 8608556, Japan; [Funama, Yoshinori] Kumamoto Univ, Med Phys, Fac Life Sci, Chuo Ku, Kumamoto 8620976, Japan	Utsunomiya, D (reprint author), Kumamoto Univ, Diagnost Radiol, Fac Life Sci, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	utsunomi@kumamoto-u.ac.jp					Baek CH, 2008, J NUCL MED, V49, P1422, DOI 10.2967/jnumed.108.051649; Pessis E, 2013, RADIOGRAPHICS, V33, P573, DOI 10.1148/rg.332125124; Kidoh M, 2014, CLIN RADIOL, V69, pE11, DOI 10.1016/j.crad.2013.08.008; Moon SG, 2008, J COMPUT ASSIST TOMO, V32, P630, DOI 10.1097/RCT.0b013e3181568b27; Leslie A, 1999, J COMPUT ASSIST TOMO, V23, P43, DOI 10.1097/00004728-199901000-00010; Yu HY, 2007, ACAD RADIOL, V14, P495, DOI 10.1016/j.acra.2006.12.015; Chung NN, 2004, HEAD NECK-J SCI SPEC, V26, P241, DOI 10.1002/hed.10378; Arya S, 2014, CLIN RADIOL, V69, P916, DOI 10.1016/j.crad.2014.04.013; Li H, 2012, MED PHYS, V39, P7507, DOI 10.1118/1.4762814; Yu LF, 2011, MED PHYS, V38, P6371, DOI 10.1118/1.3658568; Shinohara Y, 2014, ACTA RADIOL, V55, P1015, DOI 10.1177/0284185113510492; Joemai RMS, 2013, AM J ROENTGENOL, V201, P1291, DOI 10.2214/AJR.12.9780; Morsbach F, 2013, EUR RADIOL, V23, P2687, DOI 10.1007/s00330-013-2885-z; Lell MM, 2012, INVEST RADIOL, V47, P415, DOI 10.1097/RLI.0b013e3182532f17; Teixeira PAG, 2014, SKELETAL RADIOL, V43, P1237, DOI 10.1007/s00256-014-1923-5; Dong J, 2013, OR SURG OR MED OR PA, V115, pE63, DOI 10.1016/j.oooo.2012.07.436; Funama Y, 2015, PHYS MEDICA, V31, P66, DOI 10.1016/j.ejmp.2014.10.003; Hong HR, 2014, J SURG ONCOL, V110, P696, DOI 10.1002/jso.23691; Pickering CR, 2013, AM J NEURORADIOL, V34, P1818, DOI 10.3174/ajnr.A3635; Winklhofer S, 2014, Clin Radiol, V69, pe199, DOI 10.1016/j.crad.2013.12.011	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	OCT	2015	33	10					650	656		10.1007/s11604-015-0471-9		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT8KN	WOS:000363065400006		
J	Miyazawa, R; Morita, Y; Okajima, Y; Matsusako, M; Kurihara, Y				Miyazawa, Ryo; Morita, Yuka; Okajima, Yuka; Matsusako, Masaki; Kurihara, Yasuyuki			Marathon-induced pulmonary edema of a patient with transient dyspnea	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Pulmonary edema; Marathon-induced pulmonary edema; Exercise-induced pulmonary edema; Endurance sports; Chest CT	EXERCISE	We report a case of a 31-year-old healthy man with marathon-induced pulmonary edema. Chest radiograph revealed pulmonary edema without cardiomegaly. Contrast-enhanced chest computed tomography (CT) revealed transient pulmonary edema without filling-defect in pulmonary arteries. As marathon running increases in popularity, radiologists and emergency physicians should be familiar with diagnosis of this entity on chest radiograph, avoiding unnecessary CT examination without additional clinical information.	[Miyazawa, Ryo; Morita, Yuka; Okajima, Yuka; Matsusako, Masaki; Kurihara, Yasuyuki] St Lukes Int Hosp, Dept Radiol, Chuo Ku, Tokyo 1048560, Japan	Miyazawa, R (reprint author), St Lukes Int Hosp, Dept Radiol, Chuo Ku, 9-1 Akashi Cho, Tokyo 1048560, Japan.	miyaryo@luke.ac.jp					Zavorsky GS, 2014, RESP PHYSIOL NEUROBI, V190, P137, DOI 10.1016/j.resp.2013.10.007; IRVING MH, 1974, NATURE, V248, P531, DOI 10.1038/248531a0; YOUNG M, 1987, AM REV RESPIR DIS, V136, P737; MCKECHNIE JK, 1979, S AFR MED J, V56, P261; OHHASHI T, 1978, PFLUG ARCH EUR J PHY, V375, P183, DOI 10.1007/BF00584242; Bates ML, 2011, PULM MED, DOI [10.1155/2011/361931., DOI 10.1155/2011/361931]; Cadez-Schmidt A, 2014, IDEA FIT J, V11, P16; Claire MH, 2013, CIRCULATION, V128, pe469; Ma JLG, 2013, EMERG MED AUSTRALAS, V25, P368, DOI 10.1111/1742-6723.12101; Shirakawa T, 2013, ANN REP HLTH PHYS ED, V32, P127; Zavorsky GS, 2014, PHYSL REP, DOI 10.14814/phy2.12056.	11	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	OCT	2015	33	10					675	677		10.1007/s11604-015-0474-6		3	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT8KN	WOS:000363065400011		
J	Asai, T				Asai, Takashi			Are video laryngoscopes useful for paramedics during cardiopulmonary resuscitation?	JOURNAL OF ANESTHESIA			English	Editorial Material							HOSPITAL CARDIAC-ARREST; CERVICAL-SPINE IMMOBILIZATION; MACINTOSH LARYNGOSCOPE; DIFFICULT-AIRWAYS; NASOTRACHEAL INTUBATION; TRACHEAL INTUBATION; ENDOTRACHEAL-TUBES; VIDEOLARYNGOSCOPES; SCOPE; METAANALYSIS		Dokkyo Med Univ, Koshigaya Hosp, Dept Anaesthesiol, Koshigaya, Saitama 3438555, Japan	Asai, T (reprint author), Dokkyo Med Univ, Koshigaya Hosp, Dept Anaesthesiol, 2-1-50 Minamikoshigaya, Koshigaya, Saitama 3438555, Japan.	asaita@dokkyomed.ac.jp					Jemmett ME, 2003, ACAD EMERG MED, V10, P961, DOI 10.1197/S1069-6563(03)00315-4; Arima T, 2014, AM J EMERG MED, V32, P40, DOI 10.1016/j.ajem.2013.09.026; Enomoto Y, 2008, BRIT J ANAESTH, V100, P544, DOI 10.1093/bja/aen002; Konrad C, 1998, ANESTH ANALG, V86, P635; Liu EHC, 2009, BRIT J ANAESTH, V103, P446, DOI 10.1093/bja/aep164; Saito T, 2012, J ANESTH, V26, P617, DOI 10.1007/s00540-012-1380-z; Gupta N, 2013, J ANESTH, V27, P663, DOI 10.1007/s00540-013-1588-6; Katz SH, 2001, ANN EMERG MED, V37, P32, DOI 10.1067/mem.2001.112098; Asai T, 2009, ANESTHESIOLOGY, V110, P898, DOI 10.1097/ALN.0b013e31819c45e5; Hasegawa K, 2013, JAMA-J AM MED ASSOC, V309, P257, DOI 10.1001/jama.2012.187612; Asai T, 2012, ANESTHESIOLOGY, V116, P515, DOI 10.1097/ALN.0b013e318246e866; Aziz MF, 2012, ANESTHESIOLOGY, V116, P629, DOI 10.1097/ALN.0b013e318246ea34; Kim J, 2014, RESUSCITATION, V85, P623, DOI 10.1016/j.resuscitation.2014.01.017; Asai T, 2014, J ANESTH, V28, P87, DOI 10.1007/s00540-013-1672-y; Fouche PF, 2014, PREHOSP EMERG CARE, V18, P244, DOI 10.3109/10903127.2013.831509; Shiga T, 2005, ANESTHESIOLOGY, V103, P429, DOI 10.1097/00000542-200508000-00027; Asai T, 2014, J ANESTH, V28, P647, DOI 10.1007/s00540-014-1808-8; Okazaki Yumiko, 2011, Masui, V60, P757; Ono K, 2014, J ANESTH, V28, P650, DOI 10.1007/s00540-013-1778-2; Ota K, 2014, J ANESTH, DOI [10.1007/s00540-014-1960-1, DOI 10.1007/S00540-014-1960-1]; Satoh Masaaki, 2008, Masui, V57, P1283	21	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	OCT	2015	29	5					651	653		10.1007/s00540-015-1978-z		3	Anesthesiology	Anesthesiology	CT7YV	WOS:000363032600001		
J	Miyazaki, Y; Komasawa, N; Matsunami, S; Kusaka, Y; Minami, T				Miyazaki, Yu; Komasawa, Nobuyasu; Matsunami, Sayuri; Kusaka, Yusuke; Minami, Toshiaki			Laryngoscopy facilitates successful i-gel insertion by novice doctors: a prospective randomized controlled trial	JOURNAL OF ANESTHESIA			English	Article						i-gel (R); Laryngoscopy; Novice doctors; Insertion efficacy; Randomized controlled trial	LARYNGEAL MASK AIRWAY; SUPRAGLOTTIC AIRWAY; CARDIOPULMONARY-RESUSCITATION; PEDIATRIC-PATIENTS; ENDOTRACHEAL-TUBE; EFFICACY; PLACEMENT; PRESSURE; DEVICES	This study investigated the hypothesis that the efficacy of insertion of the supraglottic device i-gel(A (R)) (i-gel) can be improved by laryngoscopy and can provide better sealing pressure in anesthetized patients by novice doctors. Eighty-four adult patients were assigned to the laryngoscopy group (L group, 42 patients) or control group (i.e., conventional blind insertion; C group, 42 patients). Anesthesia was induced with propofol and remifentanil, and rocuronium 0.6-0.9 mg/kg was administered. The number of attempts until successful insertion, sealing pressure, vital sign changes upon insertion, and subjective difficulty of insertion by novice doctors were compared between the groups. The total number of insertion attempts was one (L group 36 cases, C group 23 cases), two (L group 6 cases, C group 18 cases), and three (L group 0 case, C group 1 case), with significant differences between groups (P = 0.007). The sealing pressure was significantly higher in the L group than in the C group (L group 22.3 +/- A 2.6 cmH(2)O, C group 19.5 +/- A 2.7 cmH(2)O, P < 0.001). Vital sign changes (heart rate and blood pressure) did not differ between the two groups. The subjective difficulty of insertion was significantly lower in the L group than in the C group (L group 26.8 +/- A 11.8 mm, C group 47.0 +/- A 15.1 mm, P < 0.001). The incidence of postoperative pharyngeal pain was significantly lower in the L group than in the C group (P < 0.001), while the incidence of hoarseness did not differ between the two groups (P = 1.00). Our results suggest that laryngoscopy facilitates i-gel insertion by novice doctors, as reflected in the rate of successful insertions, higher sealing pressure, and lower subjective difficulty of insertion in anesthetized patients.	[Miyazaki, Yu; Komasawa, Nobuyasu; Matsunami, Sayuri; Kusaka, Yusuke; Minami, Toshiaki] Osaka Med Coll, Dept Anesthesiol, Takatsuki, Osaka 5698686, Japan	Komasawa, N (reprint author), Osaka Med Coll, Dept Anesthesiol, Daigaku Machi 2-7, Takatsuki, Osaka 5698686, Japan.	ane078@poh.osaka-med.ac.jp					Hashimoto Y, 2014, ANAESTHESIA, V69, P878, DOI 10.1111/anae.12731; Haske D, 2013, RESUSCITATION, V84, P1229, DOI 10.1016/j.resuscitation.2013.04.025; Theiler L, 2012, BRIT J ANAESTH, V109, P990, DOI 10.1093/bja/aes309; Yih PSW, 1999, CAN J ANAESTH, V46, P617; Kim HC, 2014, ANAESTHESIA, V69, P729, DOI 10.1111/anae.12680; Elwood T, 1996, CAN J ANAESTH, V43, P435; Kohama H, 2011, J ANESTH, V25, P98, DOI 10.1007/s00540-010-1054-7; Ismail SA, 2011, EUR J ANAESTH, V28, P443, DOI 10.1097/EJA.0b013e328345a413; Komasawa N, 2011, J ANESTH, V25, P535, DOI 10.1007/s00540-011-1145-0; REINHART DJ, 1994, ANN EMERG MED, V24, P260, DOI 10.1016/S0196-0644(94)70139-3; Abukawa Y, 2012, J ANESTH, V26, P357, DOI 10.1007/s00540-011-1322-1; Gabbott DA, 2007, RESUSCITATION, V73, P161, DOI 10.1016/j.resuscitation.2006.10.026; Asai T, 2009, ANESTHESIOLOGY, V110, P898, DOI 10.1097/ALN.0b013e31819c45e5; Asai T, 2002, RESUSCITATION, V55, P171, DOI 10.1016/S0300-9572(02)00170-3; Neumar RW, 2010, CIRCULATION, V122, pS729, DOI 10.1161/CIRCULATIONAHA.110.970988; Fujiwara A, 2015, J ANESTH, V29, P580, DOI 10.1007/s00540-015-1982-3; Wharton NM, 2008, ANAESTHESIA, V63, P991, DOI 10.1111/j.1365-2044.2008.05542.x; Janakiraman C, 2009, ANAESTHESIA, V64, P674, DOI 10.1111/j.1365-2044.2009.05898.x; Sanuki T, 2011, EUR J ANAESTH, V28, P597, DOI 10.1097/EJA.0b013e32834698f4; Apfelbaum Jeffrey L, 2013, Anesthesiology, V118, P251, DOI 10.1097/ALN.0b013e31827773b2; Asai T, 2002, ANAESTHESIA, V57, P918, DOI 10.1046/j.1365-2044.2002.02783.x; de Montblanc J, 2014, ANAESTHESIA, V69, P1151, DOI 10.1111/anae.12772; Japanese Society of Anesthesiologists, 2014, J ANESTH, V28, P482; Komasawa N, 2014, J ANESTH, V28, P676, DOI 10.1007/s00540-014-1802-1; Komasawa N, 2014, J CLIN ANESTH, V26, P663, DOI 10.1016/j.jclinane.2014.08.009; Russo SG, 2012, BRIT J ANAESTH, V109, P996, DOI 10.1093/bja/aes314	26	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	OCT	2015	29	5					654	659		10.1007/s00540-015-2016-x		6	Anesthesiology	Anesthesiology	CT7YV	WOS:000363032600002		
J	Ota, K; Sadamori, T; Kusunoki, S; Otani, T; Tamura, T; Une, K; Kida, Y; Itai, J; Iwasaki, Y; Hirohashi, N; Nakao, M; Tanigawa, K				Ota, Kohei; Sadamori, Takuma; Kusunoki, Shinji; Otani, Tadatsugu; Tamura, Tomoko; Une, Kazunobu; Kida, Yoshiko; Itai, Junji; Iwasaki, Yasumasa; Hirohashi, Nobuyuki; Nakao, Masakazu; Tanigawa, Koichi			Influence of clinical experience of the Macintosh laryngoscope on performance with the Pentax-AWS Airway Scope(A (R)), a rigid video-laryngoscope, by paramedics in Japan	JOURNAL OF ANESTHESIA			English	Article						Rigid video-laryngoscope; Endotracheal intubation; Paramedic	INTUBATION SUCCESS RATES; TRACHEAL INTUBATION; SCOPE; MANNEQUIN; AIRTRAQ(R); PERSONNEL	We sought to establish the clinical utility of the Pentax-AWS Airway Scope(A (R)) (AWS) when used by paramedics to intubate the trachea, and to evaluate whether their performance was influenced by previous clinical experience with the Macintosh laryngoscope (ML). Twenty paramedics attempted tracheal intubation using the AWS in five patients each in the operating room. We recorded the success rate, the number of intubation attempts, and the time for intubation and adverse events, and compared these based on the paramedics' previous clinical experience with the ML. Ten paramedics had no prior clinical experience of the ML (group A) and 10 had used it on more than 30 occasions (group B). The intubation success rate was 99 % (99/100). Notably, 96 % (47/49) of intubations were achieved on the first attempt by the inexperienced paramedics in group A, compared with 64 % (32/50) by the experienced paramedics in group B (p = 0.0001). The time to intubation (mean +/- A SD) was significantly shorter in group A than in group B (37 +/- A 24 vs. 48 +/- A 21 s, p = 0.002). There were marked variations in the times taken to intubate, but no apparent improvement as the intubators gained experience between their first and fifth cases. No complications were encountered in either group. We found that paramedics could achieve a high tracheal intubation success rate using the AWS independent of previous airway management experience. Better intubation performance with the AWS was observed in paramedics without clinical experience with the ML.	[Ota, Kohei; Sadamori, Takuma; Otani, Tadatsugu; Tamura, Tomoko; Une, Kazunobu; Kida, Yoshiko; Itai, Junji; Iwasaki, Yasumasa; Hirohashi, Nobuyuki; Tanigawa, Koichi] Hiroshima Univ, Grad Sch Biomed Sci, Dept Emergency & Crit Care Med, Minami Ku, Hiroshima 7348551, Japan; [Kusunoki, Shinji] Hiroshima Prefectural Hosp, Ctr Emergency Med, Hiroshima, Japan; [Nakao, Masakazu] Hiroshima Gen Hosp, Dept Anesthesiol, Hiroshima, Japan	Ota, K (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Emergency & Crit Care Med, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	kota@hiroshima-u.ac.jp			Science and Technology Promotion Grant of the Fire and Disaster Management Agency, Japan	The authors give special thanks to Drs. Masashi Kawamoto and Hideki Fukuda at Hiroshima University Hospital, Keiichi Tada at Hiroshima City Hospital, Miwako Nakao at Hiroshima Prefectural Hospital, and Masaki Senami at Onomichi General Hospital for their assistance with data collection. This study was supported by a Science and Technology Promotion Grant 2010 of the Fire and Disaster Management Agency, Japan. A portion of our findings was presented in the report of the Emergency Medical Activities Development promoting panel (Kyukyugyoumu Koudoka Suishin Kentoukai) meeting in 2011 [21].	Enomoto Y, 2008, BRIT J ANAESTH, V100, P544, DOI 10.1093/bja/aen002; Sadamori T, 2008, RESUSCITATION, V77, P155, DOI 10.1016/j.resuscitation.2007.11.014; Sakles JC, 2008, INTERN EMERG MED, V3, P139, DOI 10.1007/s11739-008-0101-y; Sadamori Takuma, 2008, Hiroshima Journal of Medical Sciences, V57, P99; Liu LJ, 2010, ANESTH ANALG, V110, P1049, DOI 10.1213/ANE.0b013e3181d2aad7; Hirabayashi Y, 2009, J CLIN ANESTH, V21, P268, DOI 10.1016/j.jclinane.2008.08.024; Hirabayashi Y, 2008, J ANESTH, V22, P81, DOI 10.1007/s00540-007-0580-4; Suzuki A, 2008, ANAESTHESIA, V63, P641, DOI 10.1111/j.1365-2044.2008.05452.x; Koyama JI, 2006, J NEUROSURG ANESTH, V18, P247, DOI 10.1097/00008506-200610000-00005; STEWART RD, 1984, ANN EMERG MED, V13, P1032, DOI 10.1016/S0196-0644(84)80064-5; Maharaj CH, 2006, ANAESTHESIA, V61, P671, DOI 10.1111/j.1365-2044.2006.04653.x; Miki T, 2007, ACTA ANAESTH SCAND, V51, P1378, DOI 10.1111/j.1399-6576.2007.01450.x; Garza AG, 2003, J EMERG MED, V25, P251, DOI 10.1016/S0736-4679(03)00198-7; Maharaj CH, 2006, ANAESTHESIA, V61, P469, DOI 10.1111/j.1365-2044.2006.04547.x; Morrison LJ, 2010, CIRCULATION, V122, P8345, DOI 10.1161/CIRCULATIONAHA.110.971051; Nasim Sajid, 2009, BMC Emerg Med, V9, P9, DOI 10.1186/1471-227X-9-9; Okazaki Yumiko, 2011, Masui, V60, P757; The Fire and Disaster Management Agency and the Ministry of Health, 2011, STRENGTH MED CONTR S; The Ministry of Health, PRECL CLIN TRAIN PAR	19	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	OCT	2015	29	5					672	677		10.1007/s00540-014-1960-1		6	Anesthesiology	Anesthesiology	CT7YV	WOS:000363032600005		
J	Ono, Y; Kikuchi, H; Hashimoto, K; Sasaki, T; Ishii, J; Tase, C; Shinohara, K				Ono, Yuko; Kikuchi, Hiroaki; Hashimoto, Katsuhiko; Sasaki, Tetsu; Ishii, Jyunya; Tase, Choichiro; Shinohara, Kazuaki			Emergency endotracheal intubation-related adverse events in bronchial asthma exacerbation: can anesthesiologists attenuate the risk?	JOURNAL OF ANESTHESIA			English	Article						Airway management; Status asthmaticus; Mechanical ventilation; Fatal asthma	INTENSIVE-CARE-UNIT; CEREBRAL-BLOOD-FLOW; TRACHEAL INTUBATION; AIRWAY MANAGEMENT; RESPIRATORY RESISTANCE; MECHANICAL VENTILATION; PROPOFOL; MEDICINE; KETAMINE; COMPLICATIONS	Airway management in severe bronchial asthma exacerbation (BAE) carries very high risk and should be performed by experienced providers. However, no objective data are available on the association between the laryngoscopist's specialty and endotracheal intubation (ETI)-related adverse events in patients with severe bronchial asthma. In this paper, we compare emergency ETI-related adverse events in patients with severe BAE between anesthesiologists and other specialists. This historical cohort study was conducted at a Japanese teaching hospital. We analyzed all BAE patients who underwent ETI in our emergency department from January 2002 to January 2014. Primary exposure was the specialty of the first laryngoscopist (anesthesiologist vs. other specialist). The primary outcome measure was the occurrence of an ETI-related adverse event, including severe bronchospasm after laryngoscopy, hypoxemia, regurgitation, unrecognized esophageal intubation, and ventricular tachycardia. Of 39 patients, 21 (53.8 %) were intubated by an anesthesiologist and 18 (46.2 %) by other specialists. Crude analysis revealed that ETI performed by an anesthesiologist was significantly associated with attenuated risk of ETI-related adverse events [odds ratio (OR) 0.090, 95 % confidence interval (CI) 0.020-0.41, p = 0.001]. The benefit of attenuated risk remained significant after adjusting for potential confounders, including Glasgow Coma Score, age, and use of a neuromuscular blocking agent (OR 0.058, 95 % CI 0.010-0.35, p = 0.0020). Anesthesiologist as first exposure was independently associated with attenuated risk of ETI-related adverse events in patients with severe BAE. The skill and knowledge of anesthesiologists should be applied to high-risk airway management whenever possible.	[Ono, Yuko; Kikuchi, Hiroaki; Hashimoto, Katsuhiko; Sasaki, Tetsu; Ishii, Jyunya; Shinohara, Kazuaki] Ohta Gen Hosp Fdn, Ohta Nishinouchi Hosp, Dept Anesthesiol, Koriyama, Fukushima 9638558, Japan; [Ono, Yuko; Tase, Choichiro] Fukushima Med Univ Hosp, Emergency & Crit Care Med Ctr, Fukushima, Japan	Ono, Y (reprint author), Ohta Gen Hosp Fdn, Ohta Nishinouchi Hosp, Dept Anesthesiol, 2-5-20 Nishinouchi, Koriyama, Fukushima 9638558, Japan.	windmill@fmu.ac.jp					CONTI G, 1993, INTENS CARE MED, V19, P305, DOI 10.1007/BF01690555; Brown RH, 1999, ANESTHESIOLOGY, V90, P822, DOI 10.1097/00000542-199903000-00025; Hasegawa K, 2012, RESUSCITATION, V83, P428, DOI 10.1016/j.resuscitation.2011.11.027; Langeron O, 2000, ANESTHESIOLOGY, V92, P1229, DOI 10.1097/00000542-200005000-00009; Kaisti KK, 2003, ANESTHESIOLOGY, V99, P603, DOI 10.1097/00000542-200309000-00015; Combes X, 2007, BRIT J ANAESTH, V99, P276, DOI 10.1093/bja/aem147; [Anonymous], 2001, CHEST; Barnett SBL, 2011, J ALLERGY CLIN IMMUN, V127, P145, DOI 10.1016/j.jaci.2010.10.020; Hasegawa K, 2012, ANN EMERG MED, V60, P749, DOI 10.1016/j.annemergmed.2012.04.005; Tayal VS, 1999, ACAD EMERG MED, V6, P31, DOI 10.1111/j.1553-2712.1999.tb00091.x; Mort TC, 2004, ANESTH ANALG, V99, P607, DOI 10.1213/01.ANE.0000122825.04923.15; ZIMMERMAN JL, 1993, CRIT CARE MED, V21, P1727, DOI 10.1097/00003246-199311000-00023; Walls RM, 2011, J EMERG MED, V41, P347, DOI 10.1016/j.jemermed.2010.02.024; Eames WO, 1996, ANESTHESIOLOGY, V84, P1307, DOI 10.1097/00000542-199606000-00005; Oshima T, 2002, ACTA ANAESTH SCAND, V46, P831, DOI 10.1034/j.1399-6576.2002.460713.x; Phipps P, 2003, THORAX, V58, P81, DOI 10.1136/thorax.58.1.81; Sagarin MJ, 2005, ANN EMERG MED, V46, P328, DOI 10.1016/j.annemergmed.2005.01.009; Petrillo TM, 2001, J ASTHMA, V38, P657; Breckwoldt J, 2012, RESUSCITATION, V83, P434, DOI 10.1016/j.resuscitation.2011.10.011; O'Malley RN, 2001, ANN EMERG MED, V38, P441, DOI 10.1067/mem.2001.118018; Pendergraft TB, 2004, ANN ALLERG ASTHMA IM, V93, P29; Papiris S, 2002, CRIT CARE, V6, P30; LHOMMEDIEU CS, 1987, ANN EMERG MED, V16, P568, DOI 10.1016/S0196-0644(87)80688-1; Li J, 1999, AM J EMERG MED, V17, P141, DOI 10.1016/S0735-6757(99)90046-3; Yanagawa Y, 2005, AM J EMERG MED, V23, P182, DOI 10.1016/j.ajem.2004.10.009; Wu RSC, 1996, BRIT J ANAESTH, V77, P735; HEMMINGSEN C, 1994, AM J EMERG MED, V12, P417, DOI 10.1016/0735-6757(94)90051-5; Hasegawa Kohei, 2013, Int J Emerg Med, V6, P12, DOI 10.1186/1865-1380-6-12; Moorman JE, 2012, VITAL HLTH STAT, V3, P1; Vandesteene A, 1988, Anaesthesia, V43 Suppl, P42, DOI 10.1111/j.1365-2044.1988.tb09067.x	30	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	OCT	2015	29	5					678	685		10.1007/s00540-015-2003-2		8	Anesthesiology	Anesthesiology	CT7YV	WOS:000363032600006		
J	Sugimoto, E; Kuroda, T; Fujita, Y; Namba, Y; Mitani, S				Sugimoto, Etsuko; Kuroda, Takayuki; Fujita, Yoshihisa; Namba, Yoshifumi; Mitani, Shigeru			D-dimer testing cannot rule out thromboembolism after major lower extremity arthroplasties and thromboprophylaxis treatment	JOURNAL OF ANESTHESIA			English	Article						D-dimer; Pulmonary embolism; Total hip arthroplasty; Total knee arthroplasty; Multidetector computed tomography	COMPUTED-TOMOGRAPHY	Our previous study showed, for the first time, that a guideline-recommended thromboprophylactic strategy reduced the prevalence of venous thromboembolism (VTE) including venous thromboembolism and pulmonary embolism after arthroplasties of the major lower extremities, such as total hip arthroplasty (THA) or total or partial knee arthroplasty (TPKA), to 4.4 %. In this retrospective study, we examined the diagnostic value of D-dimer for VTE and try to confirm the low prevalence of VTE after THA or TPKA. This was a retrospective study including 380 procedures of 361 patients who underwent elective 129 TPKA or 251 THA, as well as multidetector computed tomography (MDCT) on postoperative day 7 with D-timer testing to screen for VTE. In 303 of 380 procedures, D-timer testing was performed on the same day as MDCT. The antithrombotic prophylaxes included medical and mechanical therapy and early ambulation. The prevalence of VTE was 4.5 % (17 cases) (95 % confidence interval 2.4-6.6 %). The D-dimer level was significantly greater in patients with VTE than in those without (13.4 +/- A 11.1 vs 10.1 +/- A 6.5 mu g/mL). At the lowest cut-off value of 4.0 mu g/mL, D-dimer testing ruled out VTE in only 26 of 303 cases with 1 (6 %) false negative result. The low incidence of postoperative VTE with the strict anticoagulation strategy was confirmed in this validation study. D-dimer testing is not useful for excluding VTE postoperatively in patients who undergo THA or TPKA.	[Sugimoto, Etsuko; Fujita, Yoshihisa] Kawasaki Med Univ, Dept Anestheisol, Kurashiki, Okayama 7010192, Japan; [Sugimoto, Etsuko; Fujita, Yoshihisa] Kawasaki Med Univ, Dept ICM, Kurashiki, Okayama 7010192, Japan; [Kuroda, Takayuki; Namba, Yoshifumi; Mitani, Shigeru] Kawasaki Med Univ, Dept Orthoped, Kurashiki, Okayama 7010192, Japan	Fujita, Y (reprint author), Kawasaki Med Univ, Dept Anestheisol, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	fujitay@med.kawasaki-m.ac.jp					Watanabe H, 2011, J ARTHROPLASTY, V26, P1488, DOI 10.1016/j.arth.2011.01.001; Perrier A, 2005, NEW ENGL J MED, V352, P1760, DOI 10.1056/NEJMoa042905; Bytniewski P, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/s13018-014-0089-0; Fujita Y, 2014, EUR J ANAESTH, V31, P93; Fujita Y, 2014, J ANESTH IN PRESS; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Shiota Naofumi, 2002, J Orthop Sci, V7, P444, DOI 10.1007/s007760200077	7	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	OCT	2015	29	5					686	689		10.1007/s00540-015-2020-1		4	Anesthesiology	Anesthesiology	CT7YV	WOS:000363032600007		
J	Miyaji, T; Fukakura, Y; Usuda, Y; Maruyama, K; Hirabayashi, G; Yamada, R; Akihisa, Y; Nishioka, H; Andoh, T				Miyaji, Tetsuya; Fukakura, Yoshimasa; Usuda, Yutaka; Maruyama, Koichi; Hirabayashi, Go; Yamada, Rieko; Akihisa, Yuki; Nishioka, Hiroko; Andoh, Tomio			Effects of gas composition on the delivered tidal volume of the Avance Carestation	JOURNAL OF ANESTHESIA			English	Article						Anesthesia machine; Flowmeter; Gas density; Ventilation		Measurements with various flowmeters are affected by changes in gas mixture density. The Avance Carestation incorporates ventilator feedback controlled by a built-in flowmeter with a variable orifice sensor. We hypothesised that changes in the composition of delivered gas may cause changes in the delivered tidal volume by affecting the flow measurement unless appropriate corrections are made. We used 100 % O-2, 40 % O-2 in N-2 and 40 % O-2 in N2O as carrier gases with/without sevoflurane and desflurane. We measured delivered tidal volume using the FlowAnalyzer (TM) PF 300 calibrated with the corresponding gas mixtures during volume control ventilation with 500-ml tidal volume using the Avance Carestation connected to a test lung. Change of carrier gas and addition of sevoflurane and desflurane significantly altered delivered tidal volume. Desflurane 6 % reduced delivered tidal volume by 7.6, 3.6 and 16 % of the pre-set volume at 100 % O-2, 40 % O-2 in N-2 and 40 % O-2 in N2O, respectively. Importantly, the Carestation panel indicator did not register these changes in measured expired tidal volume. Ratios of delivered tidal volume to 500 ml correlated inversely with the square root of the delivered gas density. These results support our hypothesis and suggest that changing gas composition may alter delivered tidal volume of anesthesia machines with built-in ventilators that are feedback-controlled by uncorrected flowmeters due to changes in gas mixture density.	[Miyaji, Tetsuya; Fukakura, Yoshimasa] Teikyo Univ, Sch Med, Mizonokuchi Hosp, Div Med Engn, Kawasaki, Kanagawa 2138507, Japan; [Usuda, Yutaka] Saitama Int Med Ctr, Saitama Med Sch, Dept Anesthesiol, Saitama, Japan; [Maruyama, Koichi; Hirabayashi, Go; Yamada, Rieko; Akihisa, Yuki; Nishioka, Hiroko; Andoh, Tomio] Teikyo Univ, Sch Med, Mizonokuchi Hosp, Dept Anesthesiol,Takatsu Ku, Kawasaki, Kanagawa 2138507, Japan	Andoh, T (reprint author), Teikyo Univ, Sch Med, Mizonokuchi Hosp, Dept Anesthesiol,Takatsu Ku, 3-8-3 Mizonokuchi, Kawasaki, Kanagawa 2138507, Japan.	psdelico06@yahoo.co.jp					ELLIOTT SE, 1977, J APPL PHYSIOL, V42, P456; OSBORN JJ, 1978, CRIT CARE MED, V6, P349, DOI 10.1097/00003246-197809000-00013; Habre W, 2001, BRIT J ANAESTH, V87, P602, DOI 10.1093/bja/87.4.602; Goto T, 1999, ANESTHESIOLOGY, V90, P555, DOI 10.1097/00000542-199902000-00032; Hess DR, 2006, RESPIR CARE, V51, P608; [Anonymous], 2011, RIKA NENPYO CHRONOLO, P388; [Anonymous], 2006, MERCK INDEX ENCY CHE, P6655; Cotes JE, 2006, LUNG FUNCTION PHYSL, P61; Schena E, 2015, MED ENG PHYS, V37, P257, DOI 10.1016/j.medengphy.2015.01.010	9	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	OCT	2015	29	5					690	695		10.1007/s00540-015-2018-8		6	Anesthesiology	Anesthesiology	CT7YV	WOS:000363032600008		
J	Soga, T; Kume, K; Kakuta, N; Hamaguchi, E; Tsutsumi, R; Kawanishi, R; Fukuta, K; Tanaka, K; Tsutsumi, YM				Soga, Tomohiro; Kume, Katsuyoshi; Kakuta, Nami; Hamaguchi, Eisuke; Tsutsumi, Rie; Kawanishi, Ryosuke; Fukuta, Kohei; Tanaka, Katsuya; Tsutsumi, Yasuo M.			Fosaprepitant versus ondansetron for the prevention of postoperative nausea and vomiting in patients who undergo gynecologic abdominal surgery with patient-controlled epidural analgesia: a prospective, randomized, double-blind study	JOURNAL OF ANESTHESIA			English	Article						Fosaprepitant; Gynecologic abdominal surgery; Ondansetron; Patient-controlled epidural analgesia; Postoperative nausea and vomiting	RECEPTOR ANTAGONIST; APREPITANT; EFFICACY; EMESIS; SAFETY; TRIAL	Postoperative nausea and vomiting (PONV) is the most common postoperative complication. The postoperative use of opioids is known to increase the incidence. We compared fosaprepitant, a neurokinin-1 (NK1) receptor antagonist, and ondansetron for their preventive effects on PONV in patients who underwent gynecologic abdominal surgery with patient-controlled epidural analgesia. This prospective, double-blind, randomized study comprised 44 patients who underwent gynecologic abdominal surgery. They were randomly allocated to receive 150 mg intravenous fosaprepitant (n = 24; NKI group) or 4 mg ondansetron (n = 20; ONS group) before anesthesia, which was maintained with volatile anesthetics, remifentanil, fentanyl, and rocuronium. All patients received postoperative fentanyl by patient-controlled epidural anesthesia. The incidence of nausea and vomiting, complete response rate (i.e., no vomiting and no rescue antiemetic use), rescue antiemetic use, nausea score (0-3), and visual analog scale score (VAS 0-10) for pain were recorded at 2, 24, 48, and 72 h after surgery. No (0 %) patient in the NKI group experienced vomiting after surgery; however, 4-6 (20-30 %) of 20 patients in the ONS group experienced vomiting. This difference was significant at 0-24, 0-48, and 0-72 h. During the study period, no significant differences existed between the NK1 and ONS groups in the incidence of PONV, complete response rate, rescue antiemetic use, nausea score, and VAS score for pain. Compared to ondansetron, fosaprepitant more effectively decreased the incidence of vomiting in patients who underwent gynecologic abdominal surgery with patient-controlled epidural analgesia.	[Soga, Tomohiro; Kume, Katsuyoshi; Kakuta, Nami; Hamaguchi, Eisuke; Kawanishi, Ryosuke; Fukuta, Kohei; Tanaka, Katsuya; Tsutsumi, Yasuo M.] Univ Tokushima, Grad Sch, Dept Anesthesiol, Tokushima 7708503, Japan; [Tsutsumi, Rie] Univ Tokushima, Grad Sch, Dept Nutr, Tokushima 7708503, Japan	Tsutsumi, YM (reprint author), Univ Tokushima, Grad Sch, Dept Anesthesiol, 3-18-15 Kuramoto, Tokushima 7708503, Japan.	tsutsumi@tokushima-u.ac.jp			JSPS KAKENHI from Japan Society for the Promotion of Science, Tokyo [25861378]	Supported by JSPS KAKENHI Number 25861378 from Japan Society for the Promotion of Science, Tokyo.	Jung WS, 2013, J ANESTH, V27, P396, DOI 10.1007/s00540-012-1529-9; Marbury TC, 2011, J CLIN PHARMACOL, V51, P1712, DOI 10.1177/0091270010387792; Scuderi PE, 2011, ANESTH ANALG, V112, P750, DOI 10.1213/ANE.0b013e31820d979c; Sinclair DR, 1999, ANESTHESIOLOGY, V91, P109, DOI 10.1097/00000542-199907000-00018; Tramer MR, 1997, ANESTHESIOLOGY, V87, P1277, DOI 10.1097/00000542-199712000-00004; Grunberg S, 2011, J CLIN ONCOL, V29, P1495, DOI 10.1200/JCO.2010.31.7859; TATTERSALL FD, 1994, NEUROPHARMACOLOGY, V33, P259, DOI 10.1016/0028-3908(94)90018-3; Gan TJ, 2014, ANESTH ANALG, V118, P85, DOI 10.1213/ANE.0000000000000002; Lasseter KC, 2007, J CLIN PHARMACOL, V47, P834, DOI 10.1177/0091270007301800; Koivuranta M, 1997, ANAESTHESIA, V52, P443, DOI 10.1111/j.1365-2044.1997.117-az0113.x; RUST M, 1994, ANAESTHESIA, V49, P16, DOI 10.1111/j.1365-2044.1994.tb03578.x; Saito H, 2013, ANN ONCOL, V24, P1067, DOI 10.1093/annonc/mds541; Gonsalves S, 1996, EUR J PHARMACOL, V305, P181, DOI 10.1016/0014-2999(96)00216-6; Behera BK, 2008, J POSTGRAD MED, V54, P86; Gan TJ, 2007, ANESTH ANALG, V104, P1082, DOI 10.1213/01.ane.0000263277.35140.a3; Gan TJ, 1996, ANESTHESIOLOGY, V85, P1036, DOI 10.1097/00000542-199611000-00011; Apfel CC, 1999, ANESTHESIOLOGY, V91, P693, DOI 10.1097/00000542-199909000-00022; Tsutsumi YM, 2014, BIOMED RES INT, DOI 10.1155/2014/307025; Diemunsch P, 2007, BRIT J ANAESTH, V99, P202, DOI 10.1093/bja/aem133; Diemunsch Pierre, 2007, Curr Med Res Opin, V23, P2559, DOI 10.1185/030079907X233115; Kakuta Nami, 2011, J Med Invest, V58, P246; Kawano H, 2014, MINERVA ANE IN PRESS	22	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	OCT	2015	29	5					696	701		10.1007/s00540-015-2006-z		6	Anesthesiology	Anesthesiology	CT7YV	WOS:000363032600009		
J	Zhang, EQ; Maruyama, J; Yokochi, A; Mitani, Y; Sawada, H; Nishikawa, M; Ma, N; Maruyama, K				Zhang, Erquan; Maruyama, Junko; Yokochi, Ayumu; Mitani, Yoshihide; Sawada, Hirofumi; Nishikawa, Masakatsu; Ma, Ning; Maruyama, Kazuo			Sarpogrelate hydrochloride, a serotonin 5HT2A receptor antagonist, ameliorates the development of chronic hypoxic pulmonary hypertension in rats	JOURNAL OF ANESTHESIA			English	Article						Pulmonary hypertension; Hypoxia; Nitric oxide; Sarpogrelate hydrochloride; Serotonin 2A receptor	ARTERIAL-HYPERTENSION; PLASMA SEROTONIN; CORONARY-ARTERY; MICE; DISEASE; CIRCULATION; INHALATION; RECOVERY; EFFICACY; IMPROVES	The purpose of the present study was to determine if sarpogrelate hydrochloride (SPG), a serotonin 5HT2A receptor antagonist, prevented the development of chronic hypoxia-induced pulmonary hypertension (PH) and hypertensive pulmonary vascular remodeling. Forty-one male Sprague-Dawley rats were exposed to hypobaric hypoxia (380 mmHg, 10 % oxygen) or room air and administered 50 mg/kg SPG or vehicle by gavage once daily from day -2 to day 14. The mean pulmonary artery pressure (PAP) and right ventricular hypertrophy (RVH) were measured. Hypertensive pulmonary vascular remodelings were assessed morphometrically by light microscopy. Serotonin-induced contraction was determined in isolated pulmonary artery rings from 24 rats. In another set of rats, Western blotting, real-time polymerase chain reaction and immunofluorescent staining (n = 9) for lung tissue were performed. Chronic hypoxia induced a rise in mean PAP and RVH, increased the percentage of muscularized arteries in peripheral pulmonary arteries and medial wall thickness in small muscular arteries, and potentiated serotonin-induced contraction, each of which was significantly (p < 0.05) ameliorated by SPG. Chronic hypoxia significantly increased the expression of endothelial nitric oxide synthase (eNOS) and phosphorylated eNOS (peNOS) protein levels, cyclic guanosine monophosphate, and matrix metalloproteinase-13 (MMP-13) mRNA levels in whole lung tissues. SPG increased peNOS expression in the immunofluorescent staining of peripheral pulmonary arteries from chronic hypoxic rats and decreased the MMP-13 mRNA in lung tissue in chronic hypoxic rats. The administration of SPG ameliorated the development of chronic hypoxic PH and hypertensive pulmonary vascular changes.	[Zhang, Erquan; Maruyama, Junko; Yokochi, Ayumu; Sawada, Hirofumi; Maruyama, Kazuo] Mie Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Tsu, Mie 5148507, Japan; [Mitani, Yoshihide; Sawada, Hirofumi] Mie Univ, Sch Med, Dept Pediat, Tsu, Mie 5148507, Japan; [Nishikawa, Masakatsu] Mie Univ, Sch Med, Dept Inst Human Res Promot & Drug Dev, Tsu, Mie 5148507, Japan; [Maruyama, Junko] Suzuka Univ Med Sci, Fac Med Engn, Suzuka, Mie 5100293, Japan; [Ma, Ning] Suzuka Univ Med Sci, Fac Hlth Sci, Suzuka, Mie 5100293, Japan	Maruyama, K (reprint author), Mie Univ, Sch Med, Dept Anesthesiol & Crit Care Med, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	k-maru@clin.medic.mie-u.ac.jp			Japanese Association for the Promotion of Science	This study was supported in part by Grants-In-Aid for Scientific Research from the Japanese Association for the Promotion of Science. The authors thank Ms. A Okada and N Hiramtsu for the technical and secretarial assistance.	RABINOVITCH M, 1979, AM J PHYSIOL, V236, pH818; Rashid M, 2002, JPN J PHARMACOL, V89, P405, DOI 10.1254/jjp.89.405; Maruyama J, 1997, AM J PHYSIOL-HEART C, V272, pH517; Mitani Y, 1997, CIRCULATION, V96, P689; Keegan A, 2001, CIRC RES, V89, P1231, DOI 10.1161/hh2401.100426; MacLean MR, 1999, TRENDS PHARMACOL SCI, V20, P490, DOI 10.1016/S0165-6147(99)01389-9; MARUYAMA K, 1995, ANESTH ANALG, V80, P786, DOI 10.1097/00000539-199504000-00024; Zhang EQ, 2010, CIRC J, V74, P1696, DOI 10.1253/circj.CJ-10-0097; Shinohara Y, 2008, STROKE, V39, P1827, DOI 10.1161/STROKEAHA.107.505131; Iwabayashi M, 2012, ATHEROSCLEROSIS, V220, P337, DOI 10.1016/j.atherosclerosis.2011.10.042; Archer SL, 2010, CIRCULATION, V121, P2045, DOI 10.1161/CIRCULATIONAHA.108.847707; MEYRICK B, 1978, LAB INVEST, V38, P188; Vajner L, 2006, INT J EXP PATHOL, V87, P383, DOI 10.1111/j.1365-2613.2006.00493.x; Li M, 2011, J IMMUNOL, V187, P2711, DOI 10.4049/jimmunol.1100479; ROSENBERG HC, 1988, AM J PHYSIOL, V255, pH1484; HERVE P, 1995, AM J MED, V99, P249, DOI 10.1016/S0002-9343(99)80156-9; Satomura K, 2002, CLIN CARDIOL, V25, P28, DOI 10.1002/clc.4950250108; Israilova M, 2002, PHARMACOLOGY, V65, P69, DOI 10.1159/000056189; Hironaka E, 2003, CARDIOVASC RES, V60, P692, DOI 10.1016/j.cardiores.2003.09.023; Marcos E, 2003, AM J RESP CRIT CARE, V168, P487, DOI 10.1164/rccm.200210-1212OC; Miyata M, 2001, CHEST, V119, P554, DOI 10.1378/chest.119.2.554; Miyazaki M, 2007, J CARDIOVASC PHARM, V49, P221, DOI 10.1097/FJC.0b013e3180325af3; Miyata M, 2000, LUNG, V178, P63, DOI 10.1007/s004080000009; Kato S, 2000, J INT MED RES, V28, P258; Zhao YDD, 2005, CIRC RES, V96, P442, DOI 10.1161/01.RES.0000157572.70560.7b; MARUYAMA J, 1994, AM J PHYSIOL, V266, pH2476; Mitani Y, 2008, J THORAC CARDIOV SUR, V136, P142, DOI 10.1016/j.jtcvs.2007.10.061; MARUYAMA K, 1991, AM J PHYSIOL, V261, pH1716; Rabinovitch M, 2008, J CLIN INVEST, V118, P2372, DOI 10.1172/JCI33452; Campbell AIM, 1999, AM J RESP CELL MOL, V21, P567; RABINOVITCH M, 1983, CIRC RES, V52, P432; Launay JM, 2002, NAT MED, V8, P1129, DOI 10.1038/nm764; Callebert J, 2006, J PHARMACOL EXP THER, V317, P724, DOI 10.1124/jpet.105.098269; Golembeski SA, 2005, CHEST, V128, p572S, DOI 10.1378/chest.128.6_suppl.572S-a; Igarashi M, 2000, J Dermatol, V27, P643; ILKIW R, 1989, CIRC RES, V64, P814; KOUYOUMDJIAN C, 1994, J CLIN INVEST, V94, P578, DOI 10.1172/JCI117372	37	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	OCT	2015	29	5					715	723		10.1007/s00540-015-2015-y		9	Anesthesiology	Anesthesiology	CT7YV	WOS:000363032600012		
J	Utada, K; Ishida, K; Tohyama, S; Urushima, Y; Mizukami, Y; Yamashita, A; Uchida, M; Matsumoto, M				Utada, Kohji; Ishida, Kazuyoshi; Tohyama, Suguru; Urushima, Yutaka; Mizukami, Yoichi; Yamashita, Atsuo; Uchida, Masato; Matsumoto, Mishiya			The combination of insulin-like growth factor 1 and erythropoietin protects against ischemic spinal cord injury in rabbits	JOURNAL OF ANESTHESIA			English	Article						Spinal cord ischemia; Insulin-like growth factor 1; Erythropoietin; Rabbit	BLOOD-BRAIN-BARRIER; TYROSINE KINASE; FACTOR-I; RECEPTOR; NEURONS; VIVO	Insulin-like growth factor 1 (IGF-1) and erythropoietin (EPO) have been reported to independently protect against ischemic spinal cord injury in rabbits. In the present study, we investigated whether the combination of IGF-1 and EPO protects against ischemic spinal cord injury in rabbits. Animals were assigned to 1 of 4 groups (n = 6 in each): a control group (saline), an IGF-1 group (IGF-1 0.3 mg/kg), an EPO group (EPO 800 U/kg), or an IGF-1 + EPO group (IGF-1 0.3 mg/kg + EPO 800 U/kg). Spinal cord ischemia was produced by occluding the abdominal aorta for 15 min. Saline, IGF-1, and EPO were administered intravenously just after the start of reperfusion. Hindlimb motor function was assessed daily for 7 days, after which histopathological evaluation was performed. To analyze phosphorylation of signal transduction molecules, animals were assigned to 1 of the 4 groups (n = 8 in each). Spinal cord ischemia and the treatment were the same as those described above. The spinal cords were removed at 15 or 30 min after reperfusion and used to analyze phosphorylation of signal transduction molecules. Four animals served as the preischemic control, and the spinal cord was removed just before the start of ischemia. In the IGF-1 + EPO group, both neurological and histopathological outcomes were significantly improved as compared to the control group, which was consistent with the increase of Janus kinase-2 (JAK2) phosphorylation. The combination of IGF-1 and EPO protects against ischemic spinal cord injury in rabbits. JAK2 might contribute to the protective effect.	[Utada, Kohji; Ishida, Kazuyoshi; Tohyama, Suguru; Urushima, Yutaka; Mizukami, Yoichi; Yamashita, Atsuo; Uchida, Masato; Matsumoto, Mishiya] Yamaguchi Univ, Dept Anesthesiol, Grad Sch Med, Ube, Yamaguchi 7558505, Japan	Matsumoto, M (reprint author), Yamaguchi Univ, Dept Anesthesiol, Grad Sch Med, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	utada@yamaguchi-u.ac.jp; ishid002@yamaguchi-u.ac.jp; sugurutohyama@yahoo.co.jp; t003uf@yamaguchi-u.ac.jp; mizukami@yamaguchi-u.ac.jp; ymst2699@yamaguchi-u.ac.jp; uch0809@yamaguchi-u.ac.jp; mishiya@yamaguchi-u.ac.jp			Japan Society for the Promotion of Science [21591974]	This study was supported by a Grant-in-Aid for Scientific Research (C) (No. 21591974) from the Japan Society for the Promotion of Science.	Shirasawa Y, 2009, J ANESTH, V23, P242, DOI 10.1007/s00540-009-0741-8; Mizukami Y, 2004, J BIOL CHEM, V279, P50120, DOI 10.1074/jbc.M402299200; Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799; DRUMMOND JC, 1989, ANESTHESIOLOGY, V70, P64, DOI 10.1097/00000542-198901000-00014; KIRKEN RA, 1994, J BIOL CHEM, V269, P19136; Digicaylioglu M, 2004, P NATL ACAD SCI USA, V101, P9855, DOI 10.1073/pnas.0403172101; Nagamizo D, 2007, ANESTH ANALG, V105, P1397, DOI 10.1213/01.ane.0000281146.33391.69; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Matsumoto M, 1997, ANESTHESIOLOGY, V86, P1120, DOI 10.1097/00000542-199705000-00016; Nakao Y, 2001, J THORAC CARDIOV SUR, V122, P136, DOI 10.1067/mtc.2001.114101; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; REINHARDT RR, 1994, ENDOCRINOLOGY, V135, P1753, DOI 10.1210/en.135.5.1753; Smith PD, 2011, J THORAC CARDIOV SUR, V141, P256, DOI 10.1016/j.jtcvs.2010.09.017; MIURA O, 1994, BLOOD, V84, P1501; Ehrenreich H, 2002, MOL MED, V8, P495; GLUCKMAN P, 1992, BIOCHEM BIOPH RES CO, V182, P593, DOI 10.1016/0006-291X(92)91774-K; Zong CS, 2000, J BIOL CHEM, V275, P15099, DOI 10.1074/jbc.M000089200; Yadav A, 2005, J BIOL CHEM, V280, P31830, DOI 10.1074/jbc.M501316200	18	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	OCT	2015	29	5					741	748		10.1007/s00540-015-2031-y		8	Anesthesiology	Anesthesiology	CT7YV	WOS:000363032600016		
J	Tobe, M; Saito, S				Tobe, Masaru; Saito, Shigeru			History of T-cain: a local anesthetic developed and manufactured in Japan	JOURNAL OF ANESTHESIA			English	Article						Local anesthetic; T-cain; Dibucaine; Spinal anesthesia; Topical anesthesia		In many anesthesia textbooks written in English, lidocaine, tetracaine, bupivacaine, ropivacaine, and chloroprocaine are listed as useful local anesthetics for spinal anesthesia. In contrast, T-cain is not included in these lists, even though it has been reported to be suitable for spinal anesthesia in Japan. T-cain was developed as a local anesthetic in the early 1940s by Teikoku Kagaku Sangyo Inc. in Itami, Japan, by replacing a methyl group on tetracaine (Pantocaine(A (R))) with an ethyl group. T-cain was clinically approved for topical use in Japan in November 1949, and a mixture of dibucaine and T-cain (Neo-Percamin S-A (R)) was approved for spinal use in May 1950. Simply because of a lack of foreign marketing strategy, T-cain has never attracted global attention as a local anesthetic. However, in Japan, T-cain has been used topically or intrathecally (as Neo-Percamin S-A (R)) for more than 60 years. Other than the side effects generally known for all local anesthetics, serious side effects have not been reported for T-cain. In fact, several articles have reported that T-cain decreases the neurotoxicity of dibucaine. In this historical review, the characteristics of T-cain and its rise to become a major spinal anesthetic in Japan are discussed.	[Tobe, Masaru] Gunma Univ Hosp, Intens Care Unit, Maebashi, Gunma 3718511, Japan; [Saito, Shigeru] Gunma Univ, Grad Sch Med, Dept Anesthesiol, Maebashi, Gumma 371, Japan	Tobe, M (reprint author), Gunma Univ Hosp, Intens Care Unit, 3-39-22 Showa, Maebashi, Gunma 3718511, Japan.	to-be@f3.dion.ne.jp			Nagase Medicals Inc.	We express our sincere appreciation to Nagase Medicals Inc. for their support of the preparation of this manuscript.	SAKLAD M, 1947, ANESTHESIOLOGY, V8, P270, DOI 10.1097/00000542-194705000-00006; Whiteside JB, 2001, BRIT J ANAESTH, V87, P27, DOI 10.1093/bja/87.1.27; Fujita T, 1987, NIPPON MASUIKAGAKUSH; Fukui M., 1970, LEGAL MED, V24, P136; Goto S, 1943, CHIRYOU SHOHOU, V24, P697; Hirabayashi Y, 1993, Masui, V42, P1274; Honda K, 1952, MASUI, V1, P104; Ishiyama F, CLIN STUDY JAPAN MAD, P1; Japanese Society of Hospital Pharmacists, 2013, BYOIN YAKK JIR; Kan B, 1944, JICCHIIKARINSHO, V21, P115; Kaneko R., 1957, JPN REV CLIN OPTHALM, V51, P743; Kato T., 1954, RINSHO FUJINKA SANKA, V8, P43; Kitahara T, 1955, SHUJYUTSU, V9, P42; Koshinaga J, 1959, NIPPON DAIGAKU IGAKU, V18, P1250; Matsuki A., 1999, SPINAL ANESTHESIA RE; McLure H A, 2005, Minerva Anestesiol, V71, P59; Mori S., 1956, MASUI, V5, P273; Nishioka K., 1973, JPN REV CLIN OPTHALM, V67, P249; Otsuka M, 1975, PHARMACOMETRICS, V9, P413; Ruetsch Yvan A., 2001, Current Topics in Medicinal Chemistry, V1, P175, DOI 10.2174/1568026013395335; Saeki S, 1997, SHINYAKU TO RINSHOU, V46, P1721; Saito M., 1942, J JPN SURG SOC, V43, P773; Sakai T, 1962, MASUI, V11, P477; Strichartz GR, 2005, MILLERS ANESTHESIA, P573; Yuasa Y., 1955, J YONAGO MED ASSOC, V6, P135	25	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	OCT	2015	29	5					763	768		10.1007/s00540-015-2066-0		6	Anesthesiology	Anesthesiology	CT7YV	WOS:000363032600019		
J	Yatabe, T; Yamashita, K; Yokoyama, M				Yatabe, Tomoaki; Yamashita, Koichi; Yokoyama, Masataka			Drug fever caused by propofol in the intensive care unit	JOURNAL OF ANESTHESIA			English	Article						Drug fever; Remittent fever; Propofol; Dexmedetomidine; Type I glycogen storage disease	GLYCOGEN-STORAGE-DISEASE; ANESTHESIA; HYPERTHERMIA; CHILD	Few studies have reported that fever is caused by intravenous sedative drugs even though these agents are widely used. We present a case of propofol-induced drug fever. A 57-year-old woman underwent hepatic segmentectomy. Although she was diagnosed with type I glycogen storage disease when in her twenties, her liver function was normal. As the operative hemorrhage was high, the patient was transferred to the intensive care unit (ICU). Her temperature at ICU admission was 35.8 A degrees C, and sedation with propofol and dexmedetomidine was initiated. Two hours after admission to the ICU, the patient had a fever of 38-39.5 A degrees C. Remittent fever persisted until day 5 after surgery. Because of her persistent fever, pneumonia was suspected and antibiotics were initiated on day 4 after surgery. As the fever persisted after the initiation of antibiotics, drug fever was suspected. On day 5 after surgery, propofol infusion was discontinued and the patient was extubated. Her temperature of 37.7 A degrees C at the discontinuation of propofol infusion, and rapidly decreased to 36.1 A degrees C in the following 3 h. Propofol-induced drug fever must be considered in cases of fever of unknown origin when patients receive propofol and appear inappropriately well for the degree of fever that they have.	[Yatabe, Tomoaki; Yamashita, Koichi; Yokoyama, Masataka] Kochi Med Sch, Dept Anesthesiol & Intens Care Med, Nankoku, Kochi 7838505, Japan	Yatabe, T (reprint author), Kochi Med Sch, Dept Anesthesiol & Intens Care Med, Oko Cho, Nankoku, Kochi 7838505, Japan.	yatabe@kochi-u.ac.jp					Wang LYJ, 2007, PEDIATR ANESTH, V17, P738, DOI 10.1111/j.1460-9592.2007.02215.x; EDELSTEIN G, 1980, ANESTHESIOLOGY, V52, P90, DOI 10.1097/00000542-198001000-00025; Circiumaru B, 1999, INTENS CARE MED, V25, P668, DOI 10.1007/s001340050928; Bustamante SE, 2006, PEDIATR ANESTH, V16, P680, DOI 10.1111/j.1460-9592.2005.01833.x; Okabe T, 2009, ANESTH ANALG, V108, P1589, DOI 10.1213/ane.0b013e31819f1985; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Vodovar D, 2012, DRUG SAFETY, V35, P759, DOI 10.2165/11630640-000000000-00000; Bollig G, 2005, ACTA ANAESTH SCAND, V49, P1077, DOI 10.1111/j.1399-6576.2005.00755.x; Lee Hyun Kyu, 2011, Korean J Anesthesiol, V61, P112, DOI 10.4097/kjae.2011.61.2.112; Patel RA, 2010, PHARMACOTHERAPY, V30, P57, DOI 10.1592/phco.30.1.57; Rehman T, 2014, CHEST, V145, P158, DOI 10.1378/chest.12-2843	11	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	OCT	2015	29	5					786	789		10.1007/s00540-015-2007-y		4	Anesthesiology	Anesthesiology	CT7YV	WOS:000363032600021		
J	Fujita, Y; Moriyama, S; Aoki, S; Yoshizawa, S; Tomita, M; Kojima, T; Mori, Y; Takeuchi, N; So, MH; Yano, M; Sobue, K				Fujita, Yoshihito; Moriyama, Satoru; Aoki, Satoshi; Yoshizawa, Saya; Tomita, Maiko; Kojima, Taiki; Mori, Yukiko; Takeuchi, Naoko; So, Min-Hye; Yano, Motoki; Sobue, Kazuya			Estimation of the success rate of anesthetic management for thymectomy in patients with myasthenia gravis treated without muscle relaxants: a retrospective observational cohort study	JOURNAL OF ANESTHESIA			English	Article						Myasthenia gravis; MG; Thymectomy; Muscle relaxant	SUGAMMADEX; PROPOFOL	Although maintaining anesthesia for myasthenia gravis (MG) with minimal muscle relaxants (MR) is common, the success rate of anesthetic management for MG without MR is not clear. We therefore retrospectively examined the success rate of anesthetic management for MG without MR among 66 consecutive cases of thymectomy for MG performed at our hospital between January 2004 and April 2010, before approval of using sugammadex. A total of 60 patients (90.9 %) were treated without MR (N group). Among the 60 cases, 17 (28.3 %) patients were not extubated in the operating room due to postoperative respiratory depression or other reasons. Therefore, the success rate of anesthetic management for thymectomy in patients with MG without treating MR was 71.7 % (43/60) [95 % confident interval (CI): 65.9-77.5 %]. The reasons for using MR included coughing at intubation in one case, bucking during surgery in two cases, and MR was considered to be safer by the attending anesthesiologist in three cases. The number of cases of impossible extubation requiring ventilation on that day was three in the N group and none in the R group. Finally, the success rate of anesthetic management for MG without MR was estimated to be 71.1 % (95 % CI: 65.9-77.5 %).	[Fujita, Yoshihito] Aichi Med Univ, Dept Anesthesiol, Sch Med, Nagakute, Aichi 4801195, Japan; [Moriyama, Satoru; Yano, Motoki] Nagoya City Univ, Grad Sch Med Sci, Dept Oncol Immunol & Surg, Nagoya, Aichi, Japan; [Aoki, Satoshi; Yoshizawa, Saya; Tomita, Maiko; Kojima, Taiki; Mori, Yukiko; Takeuchi, Naoko; So, Min-Hye; Sobue, Kazuya] Nagoya City Univ, Grad Sch Med Sci, Dept Anesthesiol & Med Crisis Management, Nagoya, Aichi, Japan	Fujita, Y (reprint author), Aichi Med Univ, Dept Anesthesiol, Sch Med, 1-1 Karimata, Nagakute, Aichi 4801195, Japan.	fujita.yoshihito.823@mail.aichi-med-u.ac.jp					Della Rocca G, 2003, CAN J ANAESTH, V50, P547; Combes X, 2007, BRIT J ANAESTH, V99, P276, DOI 10.1093/bja/aem147; Bouvet L, 2008, CAN J ANAESTH, V55, P674, DOI 10.1007/BF03017743; EISENKRAFT JB, 1990, CAN J ANAESTH, V37, P301; Bouaggad A, 2005, EUR J ANAESTH, V22, P393, DOI 10.1017/S0265021505220677; Unterbuchner C, 2010, ANAESTHESIA, V65, P302, DOI 10.1111/j.1365-2044.2009.06236.x; Sanfilippo M, 1997, ACTA ANAESTH SCAND, V41, P1365; Chevalley C, 2001, CAN J ANAESTH, V48, P446; Le Corre F, 2011, CAN J ANESTH, V58, P944, DOI 10.1007/s12630-011-9554-y	9	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	OCT	2015	29	5					794	797		10.1007/s00540-015-1999-7		4	Anesthesiology	Anesthesiology	CT7YV	WOS:000363032600023		
J	Iwata, K; Iida, H; Iida, M; Fukuoka, N; Kito, K; Tanabe, K				Iwata, Kenji; Iida, Hiroki; Iida, Mami; Fukuoka, Naokazu; Kito, Kazuhiro; Tanabe, Kumiko			Effects of topical and intravenous JM-1232(-) infusion on cerebrovascular reactivity in rats	JOURNAL OF ANESTHESIA			English	Article						JM-1232(-); Cerebrovascular reactivity; Cranial window	CEREBRAL VASOMOTOR RESPONSIVENESS; CARBON-DIOXIDE; PROPOFOL; MIDAZOLAM; ISOFLURANE; VESSELS; HUMANS	A novel short-acting benzodiazepine receptor agonist, JM-1232(-), has been shown to have a sedative/hypnotic effect and wide safety margin. However, its effect on cerebral vessels is not well known. Therefore, we investigated the cerebrovascular reactivity to topical and intravenous JM-1232(-) and during hypotension or hypercapnia with intravenous administration of JM-1232(-). We used a closed cranial window preparation to measure the changes of cerebral pial arteriolar diameters in isoflurane-anesthetized Sprague-Dawley rats. We first measured the direct effect of topical JM-1232(-). We then determined the effect of intravenous JM-1232(-) and then we measured the response to hypercapnia before and after JM-1232(-) infusion. Finally, we measured the reaction to stepwise induction of hypotension before and after JM-1232(-) infusion. Topical infusion of JM-1232(-) dilated pial arterioles. Intravenous infusion of JM-1232(-) changed pial arterioles by 4.5 +/- A 2.7 %, 5.0 +/- A 3.9 %, and -2.8 +/- A 2.6 % (at 0.1, 0.3, and 1.0 mg/kg/min, respectively). Hypercapnia dilated pial arterioles before and after JM-1232(-) infusion. The diameters of pial arterioles did not change during hypotension before or after intravenous JM-1232(-) infusion. These results indicate that topical JM-1232(-) has a dilative effect on pial arterioles and that intravenous administration of JM-1232(-) may not affect cerebrovascular reactivity to hypotension or hypercapnia.	[Iwata, Kenji; Iida, Hiroki; Fukuoka, Naokazu; Kito, Kazuhiro; Tanabe, Kumiko] Gifu Univ, Dept Anesthesiol & Pain Med, Grad Sch Med, Gifu, Gifu 5011194, Japan; [Iida, Mami] Gifu Prefectural Gen Med Ctr, Div Internal Med & Cardiol, Gifu, Japan	Iida, H (reprint author), Gifu Univ, Dept Anesthesiol & Pain Med, Grad Sch Med, 1-1 Yanagido, Gifu, Gifu 5011194, Japan.	iida@gifu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [21591970, 24592294]	This research was supported by Grant-in-Aid for Scientific Research No. 21591970 and 24592294 from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The authors would like to thank Enago (www.enago.jp) for the English language review.	Kanamitsu N, 2007, CHEM PHARM BULL, V55, P1682, DOI 10.1248/cpb.55.1682; KUMANO H, 1993, ACTA ANAESTH SCAND, V37, P567; Shibuya K, 2009, J NEUROSURG ANESTH, V21, P40, DOI 10.1097/ANA.0b013e31818b22d5; Iida H, 1998, ANESTHESIOLOGY, V89, P954, DOI 10.1097/00000542-199810000-00020; Iida M, 2012, J ANESTH, V26, P928, DOI 10.1007/s00540-012-1433-3; MATTA BF, 1995, ANESTHESIOLOGY, V83, P980, DOI 10.1097/00000542-199511000-00011; Sneyd JR, 2012, ANESTHESIOLOGY, V116, P385, DOI 10.1097/ALN.0b013e318242b2af; PARK WK, 1992, ANESTHESIOLOGY, V77, P956, DOI 10.1097/00000542-199211000-00019; Moriyama T, 2011, J CARDIOTHOR VASC AN, V25, P72, DOI 10.1053/j.jvca.2010.03.013; STREBEL S, 1994, ANESTH ANALG, V78, P884; FORSTER A, 1983, J CEREBR BLOOD F MET, V3, P246; Iida H, 2010, J THROMB THROMBOLYS, V29, P483, DOI 10.1007/s11239-009-0382-7	12	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	OCT	2015	29	5					798	802		10.1007/s00540-015-2017-9		5	Anesthesiology	Anesthesiology	CT7YV	WOS:000363032600024		
J	Ueshima, H; Kitamura, A				Ueshima, Hironobu; Kitamura, Akira			The use of a needle guide kit improves the stability of ultrasound-guided techniques	JOURNAL OF ANESTHESIA			English	Article						Needle guide kit; Ultrasound-guided techniques; Stability	BLOCK	A needle guide kit will be able to improve visibility on ultrasonic images. We examined the degree of stability using a SIVA guide. The SIVA guide is a needle guide kit in which the angle is not restricted, allowing the puncture to be made at any angle. We punctured the Blue Phantom (TM) with a high-frequency linear probe with a SIVA guide and measured the intensities of the needle at depths of 0.5, 1.0, 1.5, and 2.0 cm on the ultrasound image with Image J software. We set all punctures angles at 45 degrees from the Blue Phantom (TM). Six anesthesiologists with > 7 years experience performed two punctures-one case was punctured with a SIVA guide and the other was punctured without a SIVA guide. Some significant differences were noted in the results between the two punctures at depths of 1.0, 1.5, and 2.0 cm. We were able to prove that the use of a needle guide kit could improve visibility on ultrasonic images.	[Ueshima, Hironobu; Kitamura, Akira] Saitama Med Univ, Int Med Ctr, Dept Anesthesiol, Saitama, Japan	Ueshima, H (reprint author), Saitama Med Univ, Int Med Ctr, Dept Anesthesiol, Yamane 1397-1, Saitama, Japan.	ueshimhi@yahoo.co.jp					Barrington MJ, 2013, REGION ANESTH PAIN M, V38, P289, DOI 10.1097/AAP.0b013e318292669b; Jacob AK, 2011, ANESTHESIOLOGY, V115, P1172, DOI 10.1097/ALN.0b013e3182326c20; MacLennan N, 2014, EUR J ANAESTH, V31, P244, DOI 10.1097/EJA.0000000000000021; Yoshida H, 2010, J ANESTH, V24, P653, DOI 10.1007/s00540-010-0957-7; Schafhalter-Zoppoth I, 2004, REGION ANESTH PAIN M, V29, P480, DOI 10.1016/j.rapm.2004.07.001; Tadokoro T, 2015, J ANESTH, V29, P131, DOI 10.1007/s00540-014-1869-8	6	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	OCT	2015	29	5					803	804		10.1007/s00540-015-2021-0		2	Anesthesiology	Anesthesiology	CT7YV	WOS:000363032600025		
J	Nishiwada, T; Kawaraguchi, Y; Uemura, K; Sugimoto, H; Kawaguchi, M				Nishiwada, Tadashi; Kawaraguchi, Yoshitaka; Uemura, Keiko; Sugimoto, Hiroshi; Kawaguchi, Masahiko			Effect of sevoflurane on human hepatocellular carcinoma HepG2 cells under conditions of high glucose and insulin	JOURNAL OF ANESTHESIA			English	Article						Sevoflurane; Hepatocellular carcinoma; Diabetes; Proliferation	VOLATILE ANESTHETICS; IN-VITRO; PROPOFOL ANESTHESIA; DIABETES-MELLITUS; APOPTOSIS; MODULATION; MECHANISMS; ISOFLURANE; RISK; RATS	Diabetes mellitus is associated with morbidity and progression of some cancers, such as hepatocellular carcinoma. It has been reported that sevoflurane, a volatile anesthetic agent commonly used in cancer surgery, can lead to lower overall survival rates than those observed when propofol is used to treat cancer patients, and sevoflurane increases cancer cell proliferation in in vitro studies. It has been also reported that glucose levels in rats anesthetized with sevoflurane were higher than those in rats anesthetized with propofol. We investigated the effect of sevoflurane, under conditions of high glucose and insulin, on cell proliferation in the human hepatocellular carcinoma cell line, HepG2. First, we exposed HepG2 cells to sevoflurane at 1 or 2 % concentration for 6 h in various glucose concentrations and then evaluated cell proliferation using the MTT assay. Subsequently, to mimic diabetic conditions observed during surgery, HepG2 cells were exposed to sevoflurane at 1 or 2 % concentration in high glucose concentrations at various concentrations of insulin for 6 h. One-percent sevoflurane exposure enhanced cell proliferation under conditions of high glucose, treated with 0.05 mg/l insulin. Our study implies that sevoflurane may affect cell proliferation in human hepatocellular carcinoma cells in a physiological situation mimicking that of diabetes.	[Nishiwada, Tadashi; Kawaraguchi, Yoshitaka; Uemura, Keiko; Sugimoto, Hiroshi; Kawaguchi, Masahiko] Nara Med Univ, Dept Anesthesiol, Kashihara, Nara 634, Japan	Nishiwada, T (reprint author), Nara Med Univ, Dept Anesthesiol, 840 Shijo Cho, Kashihara, Nara 634, Japan.	t-nishiwada@naramed-u.ac.jp					Kitamura T, 2012, ANESTH ANALG, V114, P110, DOI 10.1213/ANE.0b013e3182373552; WOODS GM, 1986, BRIT J ANAESTH, V58, P535, DOI 10.1093/bja/58.5.535; Benzonana LL, 2013, ANESTHESIOLOGY, V119, P593, DOI 10.1097/ALN.0b013e31829e47fd; Enlund M, 2014, UPSALA J MED SCI, V119, P251, DOI 10.3109/03009734.2014.922649; Melamed R, 2003, ANESTH ANALG, V97, P1331, DOI 10.1213/01.ANE.0000082995.44040.07; Kawaraguchi Y, 2011, ANESTHESIOLOGY, V115, P499, DOI 10.1097/ALN.0b013e3182276d42; Kotani N, 1998, ANESTHESIOLOGY, V89, P1125, DOI 10.1097/00000542-199811000-00012; Matsuoka H, 2001, ANESTHESIOLOGY, V95, P1467, DOI 10.1097/00000542-200112000-00028; Feng YH, 2011, MED ONCOL, V28, P1080, DOI 10.1007/s12032-010-9650-9; PETERSON PK, 1993, BIOCHEM PHARMACOL, V46, P343, DOI 10.1016/0006-2952(93)90508-T; Wang CG, 2012, INT J CANCER, V130, P1639, DOI 10.1002/ijc.26165; Eisenstein TK, 1998, J NEUROIMMUNOL, V83, P36, DOI 10.1016/S0165-5728(97)00219-1; Loop T, 2005, ANESTHESIOLOGY, V102, P1147, DOI 10.1097/00000542-200506000-00014; Lucchinetti E, 2009, ANESTH ANALG, V109, P1117, DOI 10.1213/ANE.0b013e3181b5a277; Sato K, 2013, ANESTH ANALG, V117, P627, DOI 10.1213/ANE.0b013e31829e4028; Sacerdote P, 1997, BRIT J PHARMACOL, V121, P834, DOI 10.1038/sj.bjp.0701138; Kudoh A, 2002, ANESTH ANALG, V95, P123, DOI 10.1097/00000539-200207000-00022; Ecimovic P, 2013, ANTICANCER RES, V33, P4255; Ben Q, 2011, EUR J CANCER, V47, P1928, DOI [10.1016/j.ejca.2011.03.003, DOI 10.1016/J.EJCA.2011.03.003]; Tanaka K, 2014, JPN J CLIN ONCOL, V44, P986, DOI 10.1093/jjco/hyu108	20	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	OCT	2015	29	5					805	808		10.1007/s00540-015-2025-9		4	Anesthesiology	Anesthesiology	CT7YV	WOS:000363032600026		
J	Hamaguchi, S; Tezuka, N; Nagao, M				Hamaguchi, Shinsuke; Tezuka, Nobuko; Nagao, Masaru			Rocuronium and sugammadex under TOF monitoring on mECT	JOURNAL OF ANESTHESIA			English	Letter							SUXAMETHONIUM		[Hamaguchi, Shinsuke; Tezuka, Nobuko; Nagao, Masaru] Dokkyo Univ, Sch Med, Dept Anesthesia & Pain Med, Mibu, Tochigi 3210293, Japan	Hamaguchi, S (reprint author), Dokkyo Univ, Sch Med, Dept Anesthesia & Pain Med, 880 Kitakobayashi, Mibu, Tochigi 3210293, Japan.	s-hama@dokkyomed.ac.jp		Hamaguchi, Shinsuke/0000-0001-5872-4421			Hoshi H, 2011, J ANESTH, V25, P286, DOI 10.1007/s00540-011-1095-6; Isono S, 2008, J ANESTH, V22, P337, DOI 10.1007/s00540-008-0630-6; VALDRIGHI JB, 1994, BRIT J ANAESTH, V72, P237, DOI 10.1093/bja/72.2.237	3	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	OCT	2015	29	5					815	815		10.1007/s00540-015-2009-9		1	Anesthesiology	Anesthesiology	CT7YV	WOS:000363032600030		
J	Hiraki, T; Ito, A; Ushijima, K				Hiraki, Teruyuki; Ito, Asuka; Ushijima, Kazuo			Corneal depression immediately after cardiac surgery	JOURNAL OF ANESTHESIA			English	Letter									[Hiraki, Teruyuki; Ito, Asuka; Ushijima, Kazuo] Kurume Univ, Sch Med, Dept Anesthesiol, Kurume, Fukuoka 8300011, Japan	Hiraki, T (reprint author), Kurume Univ, Sch Med, Dept Anesthesiol, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	hiraki_teruyuki@kurume-u.ac.jp					BAVBEK T, 1991, THORAC CARDIOV SURG, V39, P29, DOI 10.1055/s-2007-1013925; Donlon Jr JV, 2005, MILLERS ANESTHESIA, P2527	2	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	OCT	2015	29	5					816	816		10.1007/s00540-015-2022-z		1	Anesthesiology	Anesthesiology	CT7YV	WOS:000363032600031		
J	Seki, T; Kimura, K; Reid, ME; Miyazaki, A; Banno, H; Jin, W; Wachino, J; Yamada, K; Arakawa, Y				Seki, Tomomi; Kimura, Kouji; Reid, Megan E.; Miyazaki, Akira; Banno, Hirotsugu; Jin, Wanchun; Wachino, Jun-ichi; Yamada, Keiko; Arakawa, Yoshichika			High isolation rate of MDR group B streptococci with reduced penicillin susceptibility in Japan	JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY			English	Article							RESISTANCE; PBP2X; PRGBS	Objectives: In Japan, the isolation rate of group B Streptococcus (GBS) with reduced penicillin susceptibility (PRGBS) was 2.3% between 2005 and 2006. However, no data on this have been available since then; moreover, the isolation rate of MDR-PRGBS has never been reported. The aim of this study was to obtain recent data on the PRGBS isolation rate and to investigate, for the first time, the isolation rate of MDR-PRGBS. Methods: We collected 306 clinical GBS isolates from various regions in Japan between January 2012 and July 2013. The MICs of penicillin G, oxacillin, ceftizoxime and ceftibuten for all GBS isolates and the MICs of erythromycin and levofloxacin for PRGBS isolates were determined by the agar dilution method. The mutations in the genes involved in antibiotic resistance and antibiotic resistance geneswere analysed by PCR and DNA sequencing. Results: We detected 45 clinical PRGBS isolates, with a PRGBS isolation rate among GBS of 14.7% (45/306). Among the PRGBS isolates, 32 (32/45, 71.1%) and 43 (43/45, 95.6%) were resistant/non-susceptible to erythromycin and levofloxacin, respectively. Furthermore, 31 PRGBS isolates, which constituted 68.9% of the PRGBS (31/45) and 10.1% of the GBS (31/306), respectively, were resistant/non-susceptible to both macrolides and fluoroquinolones, indicating multidrug resistance. Conclusions: These results suggest that the number of clinical PRGBS isolates with a tendency to multidrug resistance increased rapidly between 2005-06 and 2012-13 in Japan.	[Seki, Tomomi; Kimura, Kouji; Reid, Megan E.; Miyazaki, Akira; Banno, Hirotsugu; Jin, Wanchun; Wachino, Jun-ichi; Yamada, Keiko; Arakawa, Yoshichika] Nagoya Univ, Grad Sch Med, Dept Bacteriol, Showa Ku, Nagoya, Aichi 4668550, Japan	Kimura, K (reprint author), Nagoya Univ, Grad Sch Med, Dept Bacteriol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	koujikim@med.nagoya-u.ac.jp	Kimura, Kouji/C-1847-2015; Arakawa, Yoshichika/P-5997-2015		Ministry of Health, Labour and Welfare of Japan [H24-Shinkou-Ippan-010]	This work was supported by grant H24-Shinkou-Ippan-010 from the Ministry of Health, Labour and Welfare of Japan. The grant covered the cost of editing by Editage (see the Transparency declarations below).	Kimura K, 2013, JPN J INFECT DIS, V66, P158; Kimura K, 2009, J CLIN MICROBIOL, V47, P4154, DOI 10.1128/JCM.02063-08; Banno H, 2014, J CLIN MICROBIOL, V52, P2169, DOI 10.1128/JCM.00226-14; Kimura K, 2013, J ANTIMICROB CHEMOTH, V68, P539, DOI 10.1093/jac/dks423; Kimura K, 2008, ANTIMICROB AGENTS CH, V52, P2890, DOI 10.1128/AAC.00185-08; Dahesh S, 2008, ANTIMICROB AGENTS CH, V52, P2915, DOI 10.1128/AAC.00461-08; Nagano N, 2008, ANTIMICROB AGENTS CH, V52, P4258, DOI 10.1128/AAC.00596-08; Kimura K, 2013, J ANTIMICROB CHEMOTH, V68, P1533, DOI 10.1093/jac/dkt060; Kimura K, 2013, J ANTIMICROB CHEMOTH, V68, P1442, DOI 10.1093/jac/dkt008; Kamiya C, 2015, DIAGN MICR INFEC DIS, V82, P269, DOI 10.1016/j.diagmicrobio.2015.04.010; Longtin J, 2011, ANTIMICROB AGENTS CH, V55, P2983, DOI 10.1128/AAC.01243-10; Murayama SY, 2009, ANTIMICROB AGENTS CH, V53, P2650, DOI 10.1128/AAC.01716-08; Nagano N, 2012, J ANTIMICROB CHEMOTH, V67, P849, DOI 10.1093/jac/dkr546; Baker CJ, 2000, STREPTOCOCCAL INFECT, P222; Clinical and Laboratory Standards Institute, 2010, M100S20 CLSI; Gaudreau C, 2009, J ANTIMICROB CHEMOTH, V65, P594; Japan Nosocomial Infections Surveillance (JANIS), OP REP APR 2014 JUN; Kimura K, 2006, 46 INT C ANT AG CHEM, P128; Okike IO, 2014, CLIN INFECT DIS, V59, pE150, DOI 10.1093/cid/ciu514; Schrag Stephanie, 2002, MMWR Recomm Rep, V51, P1	20	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-7453	1460-2091		J ANTIMICROB CHEMOTH	J. Antimicrob. Chemother.	OCT	2015	70	10					2725	2728		10.1093/jac/dkv203		4	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	CU0ZZ	WOS:000363249800006		
J	Morinaka, A; Tsutsumi, Y; Yamada, M; Suzuki, K; Watanabe, T; Abe, T; Furuuchi, T; Inamura, S; Sakamaki, Y; Mitsuhashi, N; Ida, T; Livermore, DM				Morinaka, Akihiro; Tsutsumi, Yuko; Yamada, Mototsugu; Suzuki, Kenji; Watanabe, Takashi; Abe, Takao; Furuuchi, Takeshi; Inamura, Seiichi; Sakamaki, Yoshiaki; Mitsuhashi, Nakako; Ida, Takashi; Livermore, David M.			OP0595, a new diazabicyclooctane: mode of action as a serine beta-lactamase inhibitor, antibiotic and beta-lactam 'enhancer'	JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY			English	Article							GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; AMDINOCILLIN MECILLINAM; PSEUDOMONAS-AERUGINOSA; AVIBACTAM; ENTEROBACTERIACEAE; COMBINATION; RESISTANCE; PENICILLIN; CARBAPENEMASES	Objectives: The production of a growing diversity of beta-lactamases by Gram-negative bacteria challenges antimicrobial chemotherapy. OP0595, discovered separately by each of Meiji Seika Pharma and Fedora Pharmaceuticals, is a new diazabicyclooctane serine beta-lactamase inhibitor that also acts as an antibiotic and as a beta-lactamase-independent beta-lactam 'enhancer'. Methods: Inhibitory activity against serine beta-lactamases and affinity for PBPs were determined using nitrocefin and Bocillin FL, respectively. MICs alone and in combination with beta-lactam agents were measured according to CLSI recommendations. Morphological changes in Escherichia coli were examined by phase-contrast microscopy. Results: IC(50)s of OP0595 for class A and C beta-lactamases were <1000 nM, with covalent binding demonstrated to the active-site serine of CTX-M-44 and AmpC enzymes. OP0595 also had direct antibiotic activity against many Enterobacteriaceae, associated with inhibition of PBP2 and conversion of the bacteria into spherical forms. Synergy between OP0595 and beta-lactam agents was seen against strains producing class A and C beta-lactamases vulnerable to inhibition. Lastly, OP0595 lowered the MICs of PBP3-targeted partner beta-lactam agents for a non-beta-lactamase-producing E. coli mutant that was resistant to OP0595 itself, indicating beta-lactamase-independent 'enhancer'-based synergy. Conclusions: OP0595 acts in three ways: (i) as an inhibitor of class A and C beta-lactamases, covalently binding at their active sites; (ii) as an antibacterial, by inhibiting PBP2 of several Enterobacteriaceae; and (iii) as an 'enhancer' of beta-lactam agents that bind to other PBPs besides PBP2 for several Enterobacteriaceae. OP0595 has considerable potential to overcome resistance when it is combined with various beta-lactam agents.	[Morinaka, Akihiro; Tsutsumi, Yuko; Yamada, Mototsugu; Suzuki, Kenji; Watanabe, Takashi; Abe, Takao; Furuuchi, Takeshi; Inamura, Seiichi; Sakamaki, Yoshiaki; Mitsuhashi, Nakako; Ida, Takashi] Meiji Seika Pharma Co Ltd, Yokohama, Kanagawa, Japan; [Livermore, David M.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England	Morinaka, A (reprint author), Meiji Seika Pharma Co Ltd, Yokohama, Kanagawa, Japan.	akihiro.morinaka@meiji.com					Abe T, Meiji Seika Pharma, Patent No. [WO2013180197, 2013180197]; Livermore DM, 2013, J ANTIMICROB CHEMOTH, V68, P2286, DOI 10.1093/jac/dkt178; Munoz-Price LS, 2013, LANCET INFECT DIS, V13, P785, DOI 10.1016/S1473-3099(13)70190-7; Ehmann DE, 2013, J BIOL CHEM, V288, P27960, DOI 10.1074/jbc.M113.485979; Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202; Dalhoff A, 2003, CHEMOTHERAPY, V49, P172, DOI 10.1159/000071141; Hirsch EB, 2012, ANTIMICROB AGENTS CH, V56, P3753, DOI 10.1128/AAC.05927-11; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; CURTIS NAC, 1985, J ANTIMICROB CHEMOTH, V16, P287, DOI 10.1093/jac/16.3.287; Lahiri SD, 2013, ANTIMICROB AGENTS CH, V57, P2496, DOI 10.1128/AAC.02247-12; VERBIST L, 1985, J ANTIMICROB CHEMOTH, V16, P719; JOSELEAUPETIT D, 1994, MOL MICROBIOL, V13, P911, DOI 10.1111/j.1365-2958.1994.tb00482.x; GUTMANN L, 1986, ANTIMICROB AGENTS CH, V30, P906; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Young KD, 2008, J BACTERIOL, V190, P1497, DOI 10.1128/JB.01975-07; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Zhanel GG, 2013, DRUGS, V73, P159, DOI 10.1007/s40265-013-0013-7; Tumbarello M, 2012, CLIN INFECT DIS, V55, P943, DOI 10.1093/cid/cis588; IIDA K, 1978, ANTIMICROB AGENTS CH, V14, P257; Laubacher ME, 2008, J BACTERIOL, V190, P2065, DOI 10.1128/JB.01740-07; Livermore DM, 2013, J ANTIMICROB CHEMOTH, V68, P153, DOI 10.1093/jac/dks350; Bush K, 2013, ANN NY ACAD SCI, V1277, P84, DOI 10.1111/nyas.12023; Clinical and Laboratory Standards Institute, 2015, M7A10 CLSI; Clinical and Laboratory Standards Institute, 2015, M100S25 CLSI; ISENBERG HD, 1982, CRC CR REV MICROBIOL, V10, P1, DOI 10.3109/10408418209113505; Kano A, 2015, 25 EUR C CLIN MICR I; Lahiri SD, 2014, ANTIMICROB AGENTS CH, V58, P5704, DOI 10.1128/AAC.03057-14; McRee DE, 1993, PRACTICAL PROTEIN CR; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Thulin E, 2015, ANTIMICROB AGENTS CH, V59, P1723, DOI 10.1128/AAC.04819-14; Watkins R. R., 2013, FRONT MICROBIOL, V4, P1	31	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-7453	1460-2091		J ANTIMICROB CHEMOTH	J. Antimicrob. Chemother.	OCT	2015	70	10					2779	2786		10.1093/jac/dkv166		8	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	CU0ZZ	WOS:000363249800015		
J	Sriwilaijaroen, N; Suzuki, K; Takashita, E; Hiramatsu, H; Kanie, O; Suzuki, Y				Sriwilaijaroen, Nongluk; Suzuki, Katsuhiko; Takashita, Emi; Hiramatsu, Hiroaki; Kanie, Osamu; Suzuki, Yasuo			6SLN-lipo PGA specifically catches (coats) human influenza virus and synergizes neuraminidase-targeting drugs for human influenza therapeutic potential	JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY			English	Article							HUMAN AIRWAY; SIALIC-ACID; MDCK CELLS; A VIRUSES; HEMAGGLUTININ; INHIBITORS; INFECTION; OLIGOSACCHARIDES; DERIVATIVES; ANTAGONISM	Objectives: The purpose of this study was to develop a new compound to overcome influenza epidemics and pandemics as well as drug resistance. Methods: We synthesized a new compound carrying: (i) Neu5Ac alpha 2-6Gal beta 1-4GlcNAc (6SLN) for targeting immutable haemagglutinins (HAs) unless switched from human-type receptor preference; (ii) an acyl chain (lipo) for locking the compound with the viral HA via hydrophobic interactions; and (iii) a flexible poly-alpha-L-glutamic acid (PGA) for enhancing the compound solubility and for coating the viral surface, precluding accessibility of the PGA-coated virus to the negatively charged sialic acid on the host cell surface. Results: 6SLN-lipo PGA appears to subvert binding of pandemic H1 and seasonal H3 HAs to receptors, as assessed by using guinea pig erythrocytes, which is critical for virus entry into host cells for multiplication. It shows high potency with IC50 values in the range of 300-500 nM against multiplication of both influenza pandemic H1N1/2009 and seasonal H3N2/2004 viruses in cell culture. It acts in synergism with either of the two FDA-approved neuraminidase inhibitor (NAI) clinical drugs, zanamivir (Relenza(R)) and oseltamivir carboxylate (active form of Tamiflu(R)), and it has the potential to aid NAI drugs to achieve complete clearance of the virus from the culture. Conclusions: 6SLN-lipo PGA is a new potential candidate drug for influenza control and is an attractive candidate for use in combination with an NAI drug for minimized toxicity, delayed development of resistance, prevention and treatment with the potential for eradication of human influenza.	[Sriwilaijaroen, Nongluk] Thammasat Univ, Fac Med, Dept Preclin Sci, Pathum Thani 12120, Thailand; [Sriwilaijaroen, Nongluk; Hiramatsu, Hiroaki; Suzuki, Yasuo] Chubu Univ, Coll Life & Hlth Sci, Chubu, Aichi 4878501, Japan; [Suzuki, Katsuhiko] RIKEN, Synthet Cellular Chem Lab, Wako, Saitama 3510198, Japan; [Takashita, Emi] Natl Inst Infect Dis, Influenza Virus Res Ctr, Tokyo 2080011, Japan; [Kanie, Osamu] Tokai Univ, Inst Glycosci, Isehara, Kanagawa 2591292, Japan	Sriwilaijaroen, N (reprint author), Thammasat Univ, Fac Med, Dept Preclin Sci, Rangsit Campus, Pathum Thani 12120, Thailand.	snongluk@hotmail.com			A-STEP (Adaptative and Seamless Technology transfer Program through Target driven RD, JST) project; MEXT COE project for private universities from the Ministry of Education, Culture, Sports, Science and Technology and Chubu University [S0801055]	Research in Y. S.'s lab is supported by the A-STEP (Adaptative and Seamless Technology transfer Program through Target driven R&D, JST) project and by the MEXT COE project for private universities from the Ministry of Education, Culture, Sports, Science and Technology and Chubu University (No. S0801055).	Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; BURNET FM, 1948, AUST J EXP BIOL MED, V26, P381, DOI 10.1038/icb.1948.39; Sriwilaijaroen N, 2012, ANTIVIR RES, V94, P139, DOI [/10.1016/j.antiviral.2012.02.013, 10.1016/j.antiviral.2012.02.013]; Mochalova L, 2003, VIROLOGY, V313, P473, DOI 10.1016/S0042-6822(03)00377-5; Lackenby A, 2008, CURR OPIN INFECT DIS, V21, P626, DOI 10.1097/QCO.0b013e3283199797; HUANG RTC, 1980, VIROLOGY, V107, P313, DOI 10.1016/0042-6822(80)90299-8; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Sriwilaijaroen Nongluk, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P607; Gubareva LV, 1996, J VIROL, V70, P1818; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Matrosovich MN, 2004, J VIROL, V78, P12665, DOI 10.1128/JVI.78.22.12665-12667.2004; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; SHIBUYA N, 1987, ARCH BIOCHEM BIOPHYS, V254, P1, DOI 10.1016/0003-9861(87)90074-9; Li C, 2002, ADV DRUG DELIVER REV, V54, P695, DOI 10.1016/S0169-409X(02)00045-5; Kobasa D, 1999, J VIROL, V73, P6743; Fivelman QL, 2004, ANTIMICROB AGENTS CH, V48, P4097, DOI 10.1128/AAC.48.11.4097-4102.2004; Suzuki Y, 2000, J VIROL, V74, P11825, DOI 10.1128/JVI.74.24.11825-11831.2000; Sriwilaijaroen N, 2011, FOOD CHEM, V127, P1, DOI 10.1016/j.foodchem.2010.12.031; [Anonymous], 2007, NAT REV MICROBIOL, V5, P2; MAMMEN M, 1995, J MED CHEM, V38, P4179, DOI 10.1021/jm00021a007; Wheeler AH, 1942, SCIENCE, V96, P92, DOI 10.1126/science.96.2482.92; Magesh Sadagopan, 2010, Anti-Infective Agents in Medicinal Chemistry, V9, P198; Kamitakahara H, 1998, ANGEW CHEM INT EDIT, V37, P1524; Ohuchi M, 2006, MICROBES INFECT, V8, P1287, DOI 10.1016/j.micinf.2005.12.008; Hayden FG, 2011, J INFECT DIS, V203, P6, DOI [10.1093/infdis/jiq012, 10.1093/infdis/jig012]; LAVER WG, 1969, VIROLOGY, V38, P105, DOI 10.1016/0042-6822(69)90132-9; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; BAENZIGER JU, 1979, J BIOL CHEM, V254, P789; LIS H, 1986, ANNU REV BIOCHEM, V55, P35, DOI 10.1146/annurev.biochem.55.1.35; Seko A, 1997, BBA-GEN SUBJECTS, V1335, P23, DOI 10.1016/S0304-4165(96)00118-3; LoGuidice JM, 1997, BIOCHEM J, V326, P431; Baum L G, 1990, Acta Histochem Suppl, V40, P35; CDC, 2013 2014 INFL SEAS; CDC, ANT DRUG RES INFL VI; CDC, INFL ANT DRUG RES; FDA, FDA APPR RAP TREAT F; Hatakeyama S, 2005, J CLIN MICROBIOL, V43, P4139, DOI 10.1128/JCM.43.8.4139-4146.2005; Meijer A, 2014, ANTIVIR RES, V110, P31, DOI 10.1016/j.antiviral.2014.07.001; Nielsen E, 2008, TOXICOLOGICAL RISK A, P371; PLACKETT RL, 1952, J ROY STAT SOC B, V14, P141; Sriwilaijaroen N, 2012, P JPN ACAD B-PHYS, V88, P226, DOI 10.2183/pjab.88.226; Sriwilaijaroen N, 2014, METHODS MOL BIOL, V1200, P107, DOI 10.1007/978-1-4939-1292-6_10; Sriwilaijaroen N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-124; Su B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008495; Vavricka CJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2487; von Itzstein M., 2012, INFLUENZA VIRUS SIAL; WHO, LAB METH TEST ANT SU; WHO, INFL SEAS	48	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-7453	1460-2091		J ANTIMICROB CHEMOTH	J. Antimicrob. Chemother.	OCT	2015	70	10					2797	2809		10.1093/jac/dkv193		13	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	CU0ZZ	WOS:000363249800017		
J	Hasegawa, T; Otani, T; Takeda, K; Matsumoto, H; Harato, K; Toyama, Y; Nagura, T				Hasegawa, Takayuki; Otani, Toshiro; Takeda, Kentaro; Matsumoto, Hideo; Harato, Kengo; Toyama, Yoshiaki; Nagura, Takeo			Anterior Cruciate Ligament Reconstruction Does Not Fully Restore Normal 3D Knee Kinematics at 12 Months During Walking and Walk-Pivoting: A Longitudinal Gait Analysis Study	JOURNAL OF APPLIED BIOMECHANICS			English	Article						ACL; motion analysis; biomechanics	EXCESSIVE TIBIAL ROTATION; ACL RECONSTRUCTION; DEFICIENT KNEE; JOINT; CARTILAGE; SURGERY; MOTION; OSTEOARTHRITIS; INSTABILITY; STRENGTH	The purpose of the current study was to longitudinally evaluate how preoperative knee kinematics change after ACL reconstruction. Three-dimensional gait analysis using the point cluster method was undertaken on the same subjects preoperatively and at 3, 6, and 12 months after ACL reconstructive surgery. Thirteen subjects (7 males, 6 females) were examined while performing 2 different activities at self-selected speeds: walking and walk-pivoting (walking, pivoting toward the landed limb side and walking away). The contralateral knees of subjects at 12 months postoperatively were selected as control knees. Flexion range in the stance phase increased with time after surgery, but remained lower than in the contralateral knee, even at 12 months postoperatively (P < .05) during walking and walk-pivoting. The rotation pattern during walking and walk-pivoting showed an offset toward external rotation by 6 months postoperatively compared with control knees, while at 12 months postoperatively the offset had nearly disappeared and the movement pattern resembled that in control knees. These findings suggest that a return to sport participation by 6 months after ACL reconstruction requires careful consideration. Depending on the type of sport, activity restriction even after 12 months may need to be considered to allow complete kinematic restoration.	[Hasegawa, Takayuki; Takeda, Kentaro; Harato, Kengo; Toyama, Yoshiaki; Nagura, Takeo] Keio Univ, Dept Orthopaed Surg, Tokyo, Japan; [Otani, Toshiro] Keio Univ, Fac Nursing & Med Care, Tokyo, Japan; [Matsumoto, Hideo] Keio Univ, Inst Integrated Sports Med, Tokyo, Japan; [Nagura, Takeo] Keio Univ, Dept Clin Biomech, Tokyo, Japan	Hasegawa, T (reprint author), Keio Univ, Dept Orthopaed Surg, Tokyo, Japan.	t.hasegawa@jasinine.ocn.ne.jp					Gokeler A, 2003, KNEE SURG SPORT TR A, V11, P372, DOI 10.1007/s00167-003-0432-1; Keays SL, 2001, KNEE, V8, P229, DOI 10.1016/S0968-0160(01)00099-0; Andriacchi TP, 2004, ANN BIOMED ENG, V32, P447, DOI 10.1023/B:ABME.0000017541.82498.37; Andriacchi TP, 2006, CLIN ORTHOP RELAT R, P39, DOI 10.1097/01.blo.0000197079.26600.09; Chaudhari AMW, 2008, MED SCI SPORT EXER, V40, P215, DOI 10.1249/mss.0b013e31815cbb0e; Hurd WI, 2007, J ORTHOP RES, V25, P1369, DOI 10.1002/jor.20440; Beynnon BD, 2002, J ORTHOPAED RES, V20, P332, DOI 10.1016/S0736-0266(01)00115-2; Asano H, 2004, ARTHROSCOPY, V20, P474, DOI 10.1016/j.arthro.2004.03.006; Andriacchi TP, 1998, J BIOMECH ENG-T ASME, V120, P743, DOI 10.1115/1.2834888; Brandsson S, 2002, AM J SPORT MED, V30, P361; Gao B, 2010, CLIN BIOMECH, V25, P222, DOI 10.1016/j.clinbiomech.2009.11.006; Patel RR, 2003, AM J SPORT MED, V31, P68; Ristanis S, 2006, CLIN J SPORT MED, V16, P111, DOI 10.1097/00042752-200603000-00005; Takeda K, 2014, J BIOMECH, V47, P2526, DOI 10.1016/j.jbiomech.2014.03.027; Okazaki K, 2007, AM J SPORT MED, V35, P1091, DOI 10.1177/0363546507299530; Kozanek M, 2008, AM J SPORT MED, V36, P2151, DOI 10.1177/0363546508319051; Ristanis S, 2005, ARTHROSCOPY, V21, P1323, DOI 10.1016/j.arthro.2005.08.032; Majewski M, 2006, KNEE, V13, P184, DOI 10.1016/j.knee.2006.01.005; Webster KE, 2012, GAIT POSTURE, V36, P167, DOI 10.1016/j.gaitpost.2012.02.004; Scanlan SF, 2010, J BIOMECH, V43, P1817, DOI 10.1016/j.jbiomech.2010.02.010; Papannagari R, 2006, AM J SPORT MED, V34, P2006, DOI 10.1177/0363546506290403; Almekinders LC, 2004, J BONE JOINT SURG AM, V86A, P983; BERCHUCK M, 1990, J BONE JOINT SURG AM, V72A, P871; DANIEL DM, 1994, AM J SPORT MED, V22, P632, DOI 10.1177/036354659402200511; Georgoalis AD, 2007, CLIN ORTHOP RELAT R, P89, DOI 10.1097/BLO.0b013e31802b4a0a; Knoll Z, 2004, J ELECTROMYOGR KINES, V14, P287, DOI 10.1016/j.jelekin.2003.12.005; LAFORTUNE MA, 1992, J BIOMECH, V25, P347, DOI 10.1016/0021-9290(92)90254-X; Maclntosh DL, 1980, CLIN ORTHOPAEDICS, P45; Reinschmidt C, 1997, GAIT POSTURE, V6, P98, DOI 10.1016/S0966-6362(97)01110-7	29	0	0	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1065-8483	1543-2688		J APPL BIOMECH	J. Appl. Biomech.	OCT	2015	31	5					330	339		10.1123/jab.2014-0175		10	Engineering, Biomedical; Sport Sciences	Engineering; Sport Sciences	CU5VN	WOS:000363600200006		
J	Wada, I; Shimada, Y; Ikeda, M; Sadr, A; Nakashima, S; Tagami, J; Sumi, Y				Wada, Ikumi; Shimada, Yasushi; Ikeda, Masaomi; Sadr, Alireza; Nakashima, Syozi; Tagami, Junji; Sumi, Yasunori			Clinical assessment of non carious cervical lesion using swept-source optical coherence tomography	JOURNAL OF BIOPHOTONICS			English	Article						NCCL; SS-OCT; TMR; demineralization; attenuation coefficient; in vivo	IN-VITRO; REFRACTIVE-INDEX; ABRASION; ENAMEL; DENTIN; EROSION; REMINERALIZATION; VALIDATION; ABFRACTION; MICROSCOPY	Non-carious cervical lesions (NCCLs) involve various forms of tooth loss with different etiologies. This study aimed to utilize swept-source optical coherence tomography (SS-OCT) at 1300 nm wavelength range in vitro and in vivo to evaluate and clarify the mechanism of NCCLs. In the in vitro phase, a dentin attenuation coefficient (mu(t)) derived from the SS-OCT signal at NCCL was compared with mineral loss obtained from transverse microradiography (TMR) to determine a mu(t) threshold to discriminate demineralization of cervical dentin in vivo. In the clinical study, 242 buccal surfaces were investigated in 35 subjects. Presence and dimensions of NCCLs, cervical cracking and the degree of demineralization at the exposed cervical dentin were determined using SS-OCT. Dentin demineralization was observed in 69% of NCCLs. SS-OCT results confirm that dentin mineral loss and occlusal attrition were associated with larger NCCLs, and can be considered as an etiological factor in formation and progress of these lesions.	[Wada, Ikumi; Shimada, Yasushi; Nakashima, Syozi; Tagami, Junji] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cariol & Operat Dent, Tokyo, Japan; [Ikeda, Masaomi; Tagami, Junji] Tokyo Med & Dent Univ, Fac Dent, Dept Oral Hlth Care Sci, Clin Oral Sci, Tokyo, Japan; [Sadr, Alireza] Tokyo Med & Dent Univ, Int Exchange Ctr, Tokyo, Japan; [Sumi, Yasunori] Natl Hosp Geriatr Med, Natl Ctr Geriatr & Gerontol, Dept Adv Med, Obu, Aichi, Japan	Shimada, Y (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cariol & Operat Dent, Tokyo, Japan.	shimada.ope@tmd.ac.jp			Japan Society for the Promotion of Science (JSPS) [24592861]; Research Grant for Longevity Sciences from Ministry of Health, Labor and Welfare [21A-8]	This work was supported by a Grant-in-Aid for Scientific Research (No. 24592861) from the Japan Society for the Promotion of Science (JSPS); and a Research Grant for Longevity Sciences (21A-8) from the Ministry of Health, Labor and Welfare.	Nakagawa H, 2013, J DENT, V41, P80, DOI 10.1016/j.jdent.2012.10.007; Zucchelli G, 2011, J PERIODONTOL, V82, P1713, DOI 10.1902/jop.2011.110080; Aw TC, 2002, J AM DENT ASSOC, V133, P725; Shimada Y, 2010, J DENT, V38, P655, DOI 10.1016/j.jdent.2010.05.004; Hariri I, 2012, J DENT, V40, P387, DOI 10.1016/j.jdent.2012.01.017; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Le MH, 2010, LASER SURG MED, V42, P62, DOI 10.1002/lsm.20862; Jaeggi T, 1999, CARIES RES, V33, P455, DOI 10.1159/000016551; Brandini DA, 2011, OPER DENT, V36, P581, DOI 10.2341/10-152-S; Piotrowski BT, 2001, J AM DENT ASSOC, V132, P1694; Nazari A, 2013, J BIOPHOTONICS, V6, P171, DOI 10.1002/jbio.201200012; Knuttel A, 2004, J BIOMED OPT, V9, P265, DOI [10.1117/1.1647544, 10.1117/1.16475441]; Bakhsh TA, 2011, DENT MATER, V27, P915, DOI 10.1016/j.dental.2011.05.003; Meng Z, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3130322; Azzopardi A, 2004, BRIT DENT J, V196, P351, DOI 10.1038/sj.bdj.4811083; Bartlett DW, 2006, J DENT RES, V85, P306; Fujimoto JG, 2003, NAT BIOTECHNOL, V21, P1361, DOI 10.1038/nbt892; BRADY JM, 1977, J AM DENT ASSOC, V94, P726; ARENDS J, 1989, CARIES RES, V23, P36; Heilman JR, 1997, CARIES RES, V31, P423; Imai K, 2012, J ENDODONT, V38, P1269, DOI 10.1016/j.joen.2012.05.008; Senna P, 2012, J ORAL REHABIL, V39, P450, DOI 10.1111/j.1365-2842.2012.02290.x; Natsume Y, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3600448; Grippo JO, 2012, J ESTHET RESTOR DENT, V24, P10, DOI 10.1111/j.1708-8240.2011.00487.x; Jones RS, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2161192; Fried D, 2013, P SOC PHOTO-OPT INST, P8566; Fried W. A., 2014, P SOC PHOTOOPTICAL I, V8929; Mandurah M. M., 2014, LASERS MED SCI; Mandurah MM, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.4.046006; Meyers Ian A, 2008, Ann R Australas Coll Dent Surg, V19, P27; Popescu DP, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2992129	31	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1864-063X	1864-0648		J BIOPHOTONICS	J. Biophotonics	OCT	2015	8	10					846	854		10.1002/jbio.201400113		9	Biochemical Research Methods; Biophysics; Optics	Biochemistry & Molecular Biology; Biophysics; Optics	CU4ES	WOS:000363480400008		
J	Koide, H; Holmbeck, K; Lui, JC; Guo, XXC; Driggers, P; Chu, T; Tatsuno, I; Quaglieri, C; Kino, T; Baron, J; Young, MF; Robey, PG; Segars, JH				Koide, Hisashi; Holmbeck, Kenn; Lui, Julian C.; Guo, Xiaoxiao C.; Driggers, Paul; Chu, Tiffany; Tatsuno, Ichiro; Quaglieri, Caroline; Kino, Tomoshige; Baron, Jeffrey; Young, Marian F.; Robey, Pamela G.; Segars, James H.			Mice Deficient in AKAP13 (BRX) Are Osteoporotic and Have Impaired Osteogenesis	JOURNAL OF BONE AND MINERAL RESEARCH			English	Article						OSTEOPOROSIS; BRX; RHO-GEF; OSTEOGENESIS; RUNX2	NUCLEOTIDE-EXCHANGE FACTORS; MARROW STROMAL CELLS; OSTEOBLAST DIFFERENTIATION; GENE-EXPRESSION; RHO-GTPASES; PROTEIN; ACTIVATION; KINASE; LBC; CBFA1	Mechanical stimulation is crucial to bone growth and triggers osteogenic differentiation through a process involving Rho and protein kinase A. We previously cloned a gene (AKAP13, aka BRX) encoding a protein kinase A-anchoring protein in the N-terminus, a guanine nucleotide-exchange factor for RhoA in the mid-section, coupled to a carboxyl region that binds to estrogen and glucocorticoid nuclear receptors. Because of the critical role of Rho, estrogen, and glucocorticoids in bone remodeling, we examined the multifunctional role of Akap13. Akap13 was expressed in bone, and mice haploinsufficient for Akap13 (Akap13(+/-)) displayed reduced bone mineral density, reduced bone volume/total volume, and trabecular number, and increased trabecular spacing; resembling the changes observed in osteoporotic bone. Consistent with the osteoporotic phenotype, Colony forming unit-fibroblast numbers were diminished in Akap13(+/-) mice, as were osteoblast numbers and extracellular matrix production when compared to control littermates. Transcripts of Runx2, an essential transcription factor for the osteogenic lineage, and alkaline phosphatase (Alp), an indicator of osteogenic commitment, were both reduced in femora of Akap13(+/-) mice. Knockdown of Akap13 reduced levels of Runx2 and Alp transcripts in immortalized bone marrow stem cells. These findings suggest that Akap13 haploinsufficient mice have a deficiency in early osteogenesis with a corresponding reduction in osteoblast number, but no impairment of mature osteoblast activity. (C) 2015 American Society for Bone and Mineral Research.	[Koide, Hisashi; Guo, Xiaoxiao C.; Driggers, Paul; Chu, Tiffany; Quaglieri, Caroline; Kino, Tomoshige; Segars, James H.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Unit Reprod Endocrinol, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD USA; [Holmbeck, Kenn; Young, Marian F.; Robey, Pamela G.] Natl Inst Dent & Craniofacial Res, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD USA; [Lui, Julian C.; Baron, Jeffrey] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Dev Endocrinol & Genet, NIH, Bethesda, MD USA; [Tatsuno, Ichiro] Toho Univ, Sakura Med Ctr, Ctr Diabet Metab & Endocrinol, Chiba 2748510, Japan	Segars, JH (reprint author), Dept Gynecol & Obstet, Div Reprod Sci & Womens Hlth Res, 720 Rutland Ave,Room 624 Ross Bldg, Baltimore, MD 21205 USA.	jsegars2@jhmi.edu	Lui, Chun Kin Julian/E-2253-2012				Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Kaback LA, 2008, J CELL PHYSIOL, V214, P173, DOI 10.1002/jcp.21176; Driggers PH, 2001, J BIOL CHEM, V276, P46792, DOI 10.1074/jbc.M106927200; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Ohnaka K, 2001, BIOCHEM BIOPH RES CO, V287, P337, DOI 10.1006/bbrc.2001.5597; Ishizaki T, 1996, EMBO J, V15, P1885; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Satomura K, 2000, J CELL BIOCHEM, V78, P391; Kino T, 2006, J BIOL CHEM, V281, P9118, DOI 10.1074/jbc.M509339200; Lazarus JE, 2007, BONE, V40, P577, DOI 10.1016/j.bone.2006.10.013; Sterpetti P, 1999, MOL CELL BIOL, V19, P1334; TOKSOZ D, 1994, ONCOGENE, V9, P621; Harada H, 1999, J BIOL CHEM, V274, P6972, DOI 10.1074/jbc.274.11.6972; Holroyd C, 2008, BEST PRACT RES CL EN, V22, P671, DOI 10.1016/j.beem.2008.06.001; Ren JQ, 2011, CYTOTHERAPY, V13, P661, DOI 10.3109/14653249.2010.548379; Xu XH, 2010, ENDOCR REV, V31, P447, DOI 10.1210/er.2009-0032; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Gopalakrishnan R, 2005, CELLS TISSUES ORGANS, V181, P166, DOI 10.1159/000091378; Chen XD, 2002, J BONE MINER RES, V17, P331, DOI 10.1359/jbmr.2002.17.2.331; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Khatiwala CB, 2009, J BONE MINER RES, V24, P886, DOI [10.1359/jbmr.081240, 10.1359/JBMR.081240]; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Yuan JZ, 2001, J BIOL CHEM, V276, P38619, DOI 10.1074/jbc.M105530200; Bandyopadhyay A, 2008, DEV BIOL, V321, P162, DOI 10.1016/j.ydbio.2008.06.012; Bear MD, 2010, J BIOL CHEM, V285, P32919, DOI 10.1074/jbc.M109.062513; Ducy P, 2000, DEV DYNAM, V219, P461, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1074>3.0.CO;2-C; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9; Mayers CM, 2010, J BIOL CHEM, V285, P12344, DOI 10.1074/jbc.M110.106856; Dutt P, 2002, FEBS LETT, V531, P565, DOI 10.1016/S0014-5793(02)03625-6; Diviani D, 2006, EUR J CELL BIOL, V85, P603, DOI 10.1016/j.ejcb.2006.01.001; Negishi-Koga T, 2011, NAT MED, V17, P1473, DOI 10.1038/nm.2489; Rubino D, 1998, ONCOGENE, V16, P2513, DOI 10.1038/sj.onc.1201783; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Arnsdorf EJ, 2009, J CELL SCI, V122, P546, DOI 10.1242/jcs.036293; Cohen MM, 2006, AM J MED GENET A, V140A, P2646, DOI 10.1002/ajmg.a.31368; Klein EA, 2008, J CELL SCI, V121, P3853, DOI 10.1242/jcs.039131; Park B, 2002, J BIOL CHEM, V277, P45361, DOI 10.1074/jbc.M202447200; Welsh CF, 2001, NAT CELL BIOL, V3, P950, DOI 10.1038/ncb1101-950; COX KH, 1984, DEV BIOL, V101, P485, DOI 10.1016/0012-1606(84)90162-3; Kim JM, 2013, J CELL PHYSIOL, V228, P617, DOI 10.1002/jcp.24171; Yamaguchi A, 2000, ENDOCR REV, V21, P393, DOI 10.1210/er.21.4.393; PARFITT AM, 1987, J BONE MINER RES, V2, P595; Krum SA, 2011, J CELL BIOCHEM, V112, P401, DOI 10.1002/jcb.22970; Banerjee C, 1997, J CELL BIOCHEM, V66, P1, DOI 10.1002/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO;2-V; Krebsbach PH, 1999, CRIT REV ORAL BIOL M, V10, P165; Kino T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000081; Kino T, 2010, EXPERT REV ENDOCRINO, V5, P603, DOI 10.1586/eem.10.3; Rangaswami H, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001423; Roshandel D, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-19	53	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0884-0431	1523-4681		J BONE MINER RES	J. Bone Miner. Res.	OCT	2015	30	10					1887	1895		10.1002/jbmr.2534		9	Endocrinology & Metabolism	Endocrinology & Metabolism	CU1MR	WOS:000363286500017		
J	Miyazaki, S; Taniguchi, H; Nakamura, H; Hachiya, H; Ichihara, N; Araki, M; Kuroi, A; Takagi, T; Iwasawa, J; Hirao, K; Iesaka, Y				Miyazaki, Shinsuke; Taniguchi, Hiroshi; Nakamura, Hiroaki; Hachiya, Hitoshi; Ichihara, Noboru; Araki, Makoto; Kuroi, Akio; Takagi, Takamitsu; Iwasawa, Jin; Hirao, Kenzo; Iesaka, Yoshito			Adenosine Triphosphate Test After Cryothermal Pulmonary Vein Isolation: Creating Contiguous Lesions Is Essential for Eliminating Dormant Conduction	JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY			English	Article						adenosine; atrial fibrillation; cryoablation; dormant conduction; pulmonary vein isolation	RADIOFREQUENCY CATHETER ABLATION; ATRIAL-FIBRILLATION; 2ND-GENERATION CRYOBALLOON; CAVOTRICUSPID ISTHMUS; EFFICACY; SAFETY; CRYOABLATION; FLUTTER; BALLOON	Dormant Conduction After Cryothermal PVI BackgroundAdenosine triphosphate (ATP) testing reveals dormant pulmonary vein (PV) conduction after electrical PV isolation (PVI). This study aimed to evaluate the incidence of latent PV conduction after cryothermal PVI. MethodsFifty-four consecutive paroxysmal atrial fibrillation patients undergoing cryothermal PVI were prospectively enrolled. PVI was performed with one 28-mm second-generation balloon using a 3-minute freeze technique, and touch-up lesions were created by focal cryothermal applications. ATP testing was performed following PVI with a 20-mm circular mapping catheter placed in each PV. ResultsOf 217 PVs, 205 (94.5%) were isolated using a cryoballoon, and 12 required additional focal ablation. ATP testing was performed in 46 patients for 173 and 8 PVs, which were isolated by cryoballoons and focal ablation, respectively. No dormant PV conduction was provoked in any PVs, which were isolated by cryoballoons, whereas 4 (50.0%) out of 8 PVs requiring focal ablation had transient ATP-provoked reconnections (0 vs. 50.0%, P < 0.0001) with a median duration of 11.3 (10.7-17.1) seconds. The latent PV conduction site was identical to the residual conduction gap site after cryoballoon ablation in all. All latent conduction was successfully eliminated by 2 (2.0-9.5) additional focal applications. At a mean follow-up of 7.7 1.6 months, 81.5% of the patients were arrhythmia free after a single procedure. ConclusionsNo dormant PV conduction was provoked in PVs, which were isolated by 28-mm second-generation cryoballoons, but was provoked in 50% of PVs, which were isolated by focal cryoablation. These findings suggest that creating contiguous lesions is essential for eliminating dormant conduction in cryothermal ablation.	[Miyazaki, Shinsuke; Taniguchi, Hiroshi; Nakamura, Hiroaki; Hachiya, Hitoshi; Ichihara, Noboru; Araki, Makoto; Kuroi, Akio; Takagi, Takamitsu; Iwasawa, Jin; Iesaka, Yoshito] Tsuchiura Kyodo Gen Hosp, Cardiovasc Ctr, Tsuchiura, Ibaraki 3000053, Japan; [Hirao, Kenzo] Tokyo Med & Dent Univ, Heart Rhythm Ctr, Tokyo, Japan	Miyazaki, S (reprint author), Tsuchiura Kyodo Gen Hosp, Cardiovasc Ctr, Div Cardiol, 11-7 Manabeshin Machi, Tsuchiura, Ibaraki 3000053, Japan.	mshinsuke@k3.dion.ne.jp					Macle L, 2012, CAN J CARDIOL, V28, P184, DOI 10.1016/j.cjca.2011.10.008; Miller MA, 2012, EUROPACE, V14, P653, DOI 10.1093/europace/eus048; Lehrmann H, 2012, HEART RHYTHM, V9, P1942, DOI 10.1016/j.hrthm.2012.08.020; Manusama R, 2004, CIRCULATION, V109, P1636, DOI 10.1161/01.CIR.0000124478.98343.00; Khairy P, 2008, J CARDIOVASC ELECTR, V19, P1203, DOI 10.1111/j.1540-8167.2008.01224.x; Khairy P, 2003, CIRCULATION, V107, P2045, DOI 10.1161/01.CIR.0000058706.82623.A1; Haissaguerre M, 2000, CIRCULATION, V102, P2463; Liu XP, 2006, J CARDIOVASC ELECTR, V17, P1263, DOI 10.1111/j.1540-8167.2006.00621.x; Andrade JG, 2013, J CARDIOVASC ELECTR, V24, P692, DOI 10.1111/jce.12114; Gula LJ, 2011, J CARDIOVASC ELECTR, V22, P982, DOI 10.1111/j.1540-8167.2011.02037.x; Franceschi F, 2011, HEART RHYTHM, V8, P1068, DOI 10.1016/j.hrthm.2011.01.047; Sarabanda AV, 2005, J AM COLL CARDIOL, V46, P1902, DOI 10.1016/j.jacc.2005.07.046; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Datino T, 2010, CIRCULATION, V121, P963, DOI 10.1161/CIRCULATIONAHA.109.893107; Kojodjojo P, 2010, HEART, V96, P1379, DOI 10.1136/hrt.2009.192419; Arentz T, 2004, J CARDIOVASC ELECTR, V15, P1041, DOI 10.1046/j.1540-8167.2004.04031.x; Nault I, 2010, EUR HEART J, V31, P1046, DOI 10.1093/eurheartj/ehq079; Tritto M, 2004, EUR HEART J, V25, P2155, DOI 10.1016/j.ehj.2004.08.023; Chierchia GB, 2009, EUROPACE, V11, P1606, DOI 10.1093/europace/eup339; Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016; Sacher F, 2006, J AM COLL CARDIOL, V47, P2498, DOI 10.1016/j.jacc.2006.02.050; Feld GK, 2008, HEART RHYTHM, V5, P1009, DOI 10.1016/j.hrthm.2008.03.019; Ciconte G, 2014, HEART RHYTHM, V12, P673; Hachiya H, 2007, J CARDIOVASC ELECTR, V18, P1; Macle L, 2014, HEART RHYTHM, V01-02; Martins RP, 2014, HEART RHYTHM, V11, P386, DOI 10.1016/j.hrthm.2014.01.002; Miyazaki S, 2014, J CARDIOVASC ELECTR, V26, P260; VansBelle YL, 2012, NETH HEART J, V20, P447	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1045-3873	1540-8167		J CARDIOVASC ELECTR	J. Cardiovasc. Electrophysiol.	OCT	2015	26	10					1069	1074		10.1111/jce.12726		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CU0MR	WOS:000363211600011		
J	Konno, T; Hayashi, K; Fujino, N; Oka, R; Nomura, A; Nagata, Y; Hodatsu, A; Sakata, K; Furusho, H; Takamura, M; Nakamura, H; Kawashiri, MA; Yamagishi, M				Konno, Tetsuo; Hayashi, Kenshi; Fujino, Noboru; Oka, Rie; Nomura, Akihiro; Nagata, Yoji; Hodatsu, Akihiko; Sakata, Kenji; Furusho, Hiroshi; Takamura, Masayuki; Nakamura, Hiroyuki; Kawashiri, Masa-Aki; Yamagishi, Masakazu			Electrocardiographic QRS Fragmentation as a Marker for Myocardial Fibrosis in Hypertrophic Cardiomyopathy	JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY			English	Article						cardiac magnetic resonance; fragmented QRS; fibrosis; hypertrophic cardiomyopathy; pathological Q waves	CARDIOVASCULAR MAGNETIC-RESONANCE; QUANTIFICATION; DISEASE; EVENTS; BRANCH; DEATH; WAVES; SCAR; CMR	fQRS Predicts Myocardial Fibrosis in HCM IntroductionMyocardial fibrosis in patients with hypertrophic cardiomyopathy (HCM) usually shows a patchy distribution, which may not be detected by pathological Q waves on 12-lead ECGs. Fragmented QRS complexes (fQRS) reflect intraventricular conduction delay and can be a marker of myocardial fibrosis. We assessed whether fQRS show better correlation with myocardial fibrosis than pathological Qwaves in HCM. Methods and ResultsThis cross-sectional study included 108 patients with HCM who underwent 12-lead ECG and cardiac magnetic resonance imaging with late gadolinium enhancement (LGE-CMR). The number of leads with pathological Q waves was not correlated with the extent of LGE measured at any different standard deviations (SDs) (2, 4, 6, 8, and 10 SD), whereas the number of leads with fQRS showed the best correlation with LGE at 6 SD (r = 0.32, P = 0.0008). Further, the number of leads with fQRS was an independent predictor for the extent of LGE at 6 SD. fQRS showed higher accuracy for detecting myocardial fibrosis defined by LGE at 6 SD than pathological Q waves; the overall sensitivity, specificity, and accuracy of fQRS were 40%, 80%, and 64%, respectively, whereas those of pathological Q waves were 7%, 97%, and 60%, respectively. fQRS in lateral leads showed the highest accuracy (75%), followed by inferior leads (59%) and anterior leads (57%), for detecting LGE at 6 SD in the corresponding left ventricular segment. ConclusionsThese findings suggest that fQRS may have a substantially higher sensitivity and diagnostic accuracy compared with pathological Q waves for detecting myocardial fibrosis in HCM.	[Konno, Tetsuo; Hayashi, Kenshi; Fujino, Noboru; Nomura, Akihiro; Nagata, Yoji; Hodatsu, Akihiko; Sakata, Kenji; Furusho, Hiroshi; Takamura, Masayuki; Kawashiri, Masa-Aki; Yamagishi, Masakazu] Kanazawa Univ, Div Cardiovasc Med, Grad Sch Med, Kanazawa, Ishikawa 9208640, Japan; [Konno, Tetsuo; Nakamura, Hiroyuki; Yamagishi, Masakazu] Kanazawa Univ, Res & Educ Ctr Innovat & Prevent Med, Kanazawa, Ishikawa 9208640, Japan; [Oka, Rie] Hokuriku Cent Hosp, Dept Internal Med, Oyabe, Japan; [Nakamura, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Publ Hlth, Kanazawa, Ishikawa 9208640, Japan	Konno, T (reprint author), Kanazawa Univ, Res & Educ Ctr Innovat & Prevent Med, 13-1 Takara Machi, Kanazawa, Ishikawa 9208640, Japan.	konnokontetsu@staff.kanazawa-u.ac.jp			Ministry of Education, Science and Culture of Japan [24790748, 26461105]	Tetsuo Konno was funded by a grant from the Ministry of Education, Science and Culture of Japan (Research Project Number: 24790748). Masakazu Yamagishi was funded by a grant from the Ministry of Education, Science and Culture of Japan (Research Project Number: 26461105).	Konno T, 2004, EUR HEART J, V25, P246, DOI 10.1016/j.ehj.2003.10.031; Debonnaire P, 2015, J CARDIOVASC ELECTR, V26, P547, DOI 10.1111/jce.12629; [Anonymous], 2011, J AM COLL CARDIOL, V58, pe212; Todiere G, 2012, J AM COLL CARDIOL, V60, P922, DOI 10.1016/j.jacc.2012.03.076; Konno T, 2010, P NATL ACAD SCI USA, V107, P18097, DOI 10.1073/pnas.1012826107; Kang KW, 2014, HEART RHYTHM, V11, P1433, DOI 10.1016/j.hrthm.2014.05.002; Mewton N, 2011, J AM COLL CARDIOL, V57, P891, DOI 10.1016/j.jacc.2010.11.013; Flett AS, 2011, JACC-CARDIOVASC IMAG, V4, P150, DOI 10.1016/j.jcmg.2010.11.015; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Harimoto K, 2014, J ELECTROCARDIOL, V47, P636, DOI 10.1016/j.jelectrocard.2014.06.010; Chen XY, 2014, EUR J RADIOL, V83, P297, DOI 10.1016/j.ejrad.2013.10.025; Das MK, 2006, CIRCULATION, V113, P2495, DOI 10.1161/CIRCULATIONHA.105.595892; Moon J, 2013, CIRC J, V77, P1742, DOI 10.1253/circj.CJ-12-1378; Hayashi T, 2013, CIRC J, V77, P2889, DOI 10.1253/circj.CJ-13-0335; Maron BJ, 2013, LANCET, V381, P242, DOI 10.1016/S0140-6736(12)60397-3; Das MK, 2008, CIRC-ARRHYTHMIA ELEC, V1, P258, DOI 10.1161/CIRCEP.107.763284; FLOWERS NC, 1969, CIRCULATION, V39, P531; Kosuge M, 2012, CIRC J, V76, P462, DOI 10.1253/circj.CJ-11-1036; Femenia F, 2013, J INTERV CARD ELECTR, V38, P159, DOI 10.1007/s10840-013-9829-z; Moravsky G, 2013, JACC-CARDIOVASC IMAG, V6, P587, DOI 10.1016/j.jcmg.2012.09.018; Nagata Y, 2015, CAN J CARDIOL, V31, P702, DOI 10.1016/j.cjca.2014.12.036; Chen XY, 2014, INT J CARDIOVAS IMAG, V30, P55, DOI 10.1007/s10554-014-0416-x; Das MK, 2009, HEART RHYTHM S, V6, pS8; Kawasaki T, 2015, CIRC J, V79, P847, DOI 10.1253/circj.CJ-14-1109; Konno T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101465; Nomura A, 2015, CIRC J, V79, P136, DOI 10.1253/circj.CJ-14-0822; Spiewak M, 2010, EUR J RADIOL, V74, pE150, DOI 10.1016/j.ejrad.2009.05.035; Suwa K, 2014, OPEN HEART, V1	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1045-3873	1540-8167		J CARDIOVASC ELECTR	J. Cardiovasc. Electrophysiol.	OCT	2015	26	10					1081	1087		10.1111/jce.12742		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CU0MR	WOS:000363211600013		
J	Toyama, M; Kishimoto, H; Mishiro, K; Nakano, R; Ihara, F				Toyama, Masatoshi; Kishimoto, Hidenari; Mishiro, Koji; Nakano, Ryo; Ihara, Fumio			Sticky Traps Baited with Synthetic Aggregation Pheromone Predict Fruit Orchard Infestations of Plautia stali (Hemiptera: Pentatomidae)	JOURNAL OF ECONOMIC ENTOMOLOGY			English	Article						Plautia stali; prediction method; sticky trap; aggregation pheromone; Chamaecyparis obtusa	WINGED GREEN BUG; SCOTT HETEROPTERA	The brown-winged green bug, Plautia stali Scott, mainly reproduces on Japanese cedar or cypress cones in Japanese plantation forests during summer and autumn. It often depletes its food sources in forest habitats and moves to cultivated crops in large numbers. To establish an easy method for assessing the risk of fruit orchard infestation by P. stali, we conducted a 3-yr field survey that monitored the attraction of bugs to the synthetic P. stali aggregation pheromone using a sticky trap. We used a morphological indicator, variable body size depending on food intake, to estimate the nutritional status in nymphs, which showed that nymphs attracted to the synthetic pheromone were starving. Comparisons between increasing changes in the number of stylet sheaths left on the cones by P. stali and the number of trapped nymphs show that monitoring nymphs with the pheromone-baited sticky trap is useful for inferring conditions regarding food resources in forest habitats. The trend toward trapping second instars can provide a timely overview of resource competition for cones. Trapping middle-to-late (third-fifth) instars is a warning that the cones are finally depleted and that there is a high probability that adults will leave the forests and invade the orchards. In addition, trends in trapping adults suggest that there is a potential risk of orchard infestation by the pest and predict the intensity and period of the invasion. The pheromone-baited sticky trap is an easy but useful survey tool for predicting P. stali orchard infestations.	[Toyama, Masatoshi; Mishiro, Koji; Nakano, Ryo; Ihara, Fumio] NARO, Inst Fruit Tree Sci, Tsukuba, Ibaraki 3058605, Japan; [Kishimoto, Hidenari] NARO, Inst Fruit Tree Sci, Apple Res Stn, Morioka, Iwate 0200123, Japan	Toyama, M (reprint author), NARO, Inst Fruit Tree Sci, Grape & Persimmon Res Stn, 301-2 Akitsu, Higashihiroshima, Hiroshima 7392494, Japan.	tym@affrc.go.jp			Ministry of Agriculture, Forestry, and Fisheries, Japan	We thank Mitsue Fukuda and Nana Yanagita for their excellent technical assistance in measuring morphological characters and Enago (www.enago.jp) for the English language review. This work was financially supported by the Ministry of Agriculture, Forestry, and Fisheries, Japan, through a project entitled "Revision of forecasting systems for crop pests and diseases."	Sugie H, 1996, APPL ENTOMOL ZOOL, V31, P427; Adachi I, 2007, APPL ENTOMOL ZOOL, V42, P425, DOI 10.1303/aez.2007.425; MORIYA S, 1984, APPL ENTOMOL ZOOL, V19, P317; Morishita M, 2007, JPN J APPL ENTOMOL Z, V51, P21, DOI 10.1303/jjaez.2007.21; BOWLING CC, 1979, J ECON ENTOMOL, V72, P259; Ide Y., 1997, PLANT PROTECT, V51, P155; Inoue K., 1986, PLANT PROT, V40, P289; Katase M., 2005, B CHIBA AGR RES CTR, V4, P135; Moriya S, 1995, B OKINAWA AGR EXP ST, V5, P1; Noda M., 1985, B FUKUOKA AGR RES B, V4, P17; Ohira Y., 2002, P ASS PLANT PROT KYU, V48, P76; Sato R., 1997, PLANT PROT, V51, P158; Shiga M., 1980, PRANT PROTECT, V34, P303; Shiga M., 1984, B FRUIT TREE RES STN, V11, P107; Shiga M, 1989, B FRUIT TREE RES S A, V16, P133; Takagi K., 1997, PLANT PROT, V51, P150; Toyama M., 2015, B NARO I FRUIT TREE, V19, P23; Tsutsumi T, 2001, PLANT PROT, V55, P560; Umeya K., 1976, PLANT PROTECT, V30, P133; Umeya K., 1974, PLANT PROT, V28, P279; Yanase N., 1997, PLANT PROT, V51, P160	21	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-0493	1938-291X		J ECON ENTOMOL	J. Econ. Entomol.	OCT	2015	108	5					2366	2372		10.1093/jee/tov198		7	Entomology	Entomology	CT5DQ	WOS:000362828300024		
J	Kera, S; Ueno, N				Kera, Satoshi; Ueno, Nobuo			Photoelectron spectroscopy on the charge reorganization energy and small polaron binding energy of molecular film	JOURNAL OF ELECTRON SPECTROSCOPY AND RELATED PHENOMENA			English	Review						Hopping mobility; Electron-phonon coupling; Hole-vibration coupling; Vibronic satellite; HOMO fine feature; Polaron; Reorganization energy; Relaxation energy; Ultraviolet photoelectron spectroscopy; Organic semiconductor; Pentacene, Perfluoropentacene	PHTHALOCYANINE ULTRATHIN-FILM; HIGHEST OCCUPIED BAND; ORGANIC THIN-FILMS; POSTCOLLISION INTERACTION; ELECTRONIC-STRUCTURE; OTI-PHTHALOCYANINE; FINE-STRUCTURES; MONOLAYER; TRANSPORT; IONIZATION	Understanding of electron-phonon coupling as well as intermolecular interaction is required to discuss the mobility of charge carrier in functional molecular solids. This article summarizes recent progress in direct measurements of valence hole-vibration coupling in ultrathin films of organic semiconductors by using ultraviolet photoelectron spectroscopy (UPS). The experimental study of hole-vibration coupling of the highest occupied molecular orbital (HOMO) state in ordered monolayer film by UPS is essential to comprehend hole-hopping transport and small-polaron related transport in organic semiconductors. Only careful measurements can attain the high-resolution spectra and provide key parameters in holetransport dynamics, namely the charge reorganization energy and small polaron binding energy. Analyses methods of the UPS HOMO fine feature and resulting charge reorganization energy and small polaron binding energy are described for pentacene and perfluoropentacene films. Difference between thin-film and gas-phase results is discussed by using newly measured high-quality gas-phase spectra of pentacene. Methodology for achieving high-resolution UPS measurements for molecular films is also described. (C) 2015 The Authors. Published by Elsevier B.V.	[Kera, Satoshi] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448585, Japan; [Kera, Satoshi; Ueno, Nobuo] Chiba Univ, Grad Sch Adv Integrat Sci, Dept Nanomat Sci, Inage Ku, Chiba 2638522, Japan	Kera, S (reprint author), Natl Inst Nat Sci, Inst Mol Sci, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	kera@ims.ac.jp	Ueno, Nobuo/F-4358-2014	Ueno, Nobuo/0000-0003-2051-1492	JSPS [24245034, 20245039, 20685014, 20656002, 17685019]; MEXT	The authors are very grateful to Prof. V. Coropceanu, Prof. S. Duhm, Dr. H. Yamane, Dr. H. Fukagawa, and Dr. S. Nagamatsu for stimulating discussions on the computation as well as many students in the Graduate School of Chiba University for doing experiments. The study is partly supported by JSPS KAKENHI (24245034, 20245039, 20685014, 20656002, 17685019), 21st Century CUE program (MEXT) and Global CUE program (MEXT).	CAPEK V, 1995, CHEM PHYS, V200, P309, DOI 10.1016/0301-0104(95)00290-1; Sakamoto Y, 2004, J AM CHEM SOC, V126, P8138, DOI 10.1021/ja0476258; Heimel G, 2013, NAT CHEM, V5, P187, DOI [10.1038/nchem.1572, 10.1038/NCHEM.1572]; Fukagawa H, 2005, J ELECTRON SPECTROSC, V144, P475, DOI 10.1016/j.elspec.2005.01.083; Yamane H, 2005, SYNTHETIC MET, V152, P297, DOI 10.1016/j.synthmet.2005.07.334; Koch N, 2007, ADV MATER, V19, P112, DOI 10.1002/adma.200601825; Yamamoto I, 2008, SURF SCI, V602, P2232, DOI 10.1016/j.susc.2008.04.037; Wang JZ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/9/095704; Yamane H, 2004, J ELECTRON SPECTROSC, V137, P223, DOI 10.1016/j.elspec.02.054; SCHMIDT V, 1981, PHYS REV A, V24, P1803, DOI 10.1103/PhysRevA.24.1803; Matzdorf R, 1998, SURF SCI REP, V30, P153, DOI 10.1016/S0167-5729(97)00013-7; Chong DP, 2002, J CHEM PHYS, V116, P1760, DOI 10.1063/1.1430255; Yamane H, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.086602; Stadtmuller B, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.106103; Scholl A, 2010, SCIENCE, V329, P303, DOI 10.1126/science.1189106; Bredas JL, 2004, CHEM REV, V104, P4971, DOI 10.1021/cr040084k; Duhm S, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.045418; Coropceanu V, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.275503; SALANECK WR, 1978, PHYS REV LETT, V40, P60, DOI 10.1103/PhysRevLett.40.60; Yamane H, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.153412; Tanaka A, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.033101; Troisi A, 2011, CHEM SOC REV, V40, P2347, DOI 10.1039/c0cs00198h; Yoshida H, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.235205; Koch N, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.156803; Inokuchi H, 2006, ORG ELECTRON, V7, P62, DOI 10.1016/j.orgel.2005.12.007; MILLER T, 1984, PHYS REV B, V29, P1121, DOI 10.1103/PhysRevB.29.1121; SALANECK WR, 1980, PHYS REV LETT, V45, P280, DOI 10.1103/PhysRevLett.45.280; Kakuta H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.247601; Ueno N, 2008, PROG SURF SCI, V83, P490, DOI 10.1016/j.progsurf.2008.10.002; Ortmann F, 2015, ADV FUNCT MATER, V25, P1933, DOI 10.1002/adfm.201402334; Shionoiri M, 2007, JPN J APPL PHYS 1, V46, P1625, DOI 10.1143/JJAP.46.1625; Sugiyama T, 2007, CHEM PHYS LETT, V449, P319, DOI 10.1016/j.cplett.2007.10.088; Willenbockel M, 2015, PHYS CHEM CHEM PHYS, V17, P1530, DOI 10.1039/c4cp04595e; Kera S, 2009, PROG SURF SCI, V84, P135, DOI 10.1016/j.progsurf.2009.03.002; Ohtomo M, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3232205; Kera S, 2013, J PHYS CHEM C, V117, P22428, DOI 10.1021/jp4032089; Delgado MCR, 2009, J AM CHEM SOC, V131, P1502, DOI 10.1021/ja807528w; Hovel H, 1998, PHYS REV LETT, V81, P4608, DOI 10.1103/PhysRevLett.81.4608; Kera S, 2004, SURF SCI, V566, P571, DOI 10.1016/j.susc.2004.05.110; Kera S, 2002, CHEM PHYS LETT, V364, P93, DOI 10.1016/S0009-2614(02)01302-7; Kataoka T, 2008, CHEM PHYS LETT, V451, P43, DOI 10.1016/j.cplett.2007.11.072; Duhm S, 2012, ADV MATER, V24, P901, DOI 10.1002/adma.201103262; Sugiyama T, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2388922; Machida S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.156401; Fukagawa H, 2007, ADV MATER, V19, P665, DOI 10.1002/adma.200601678; Coropceanu V, 2007, CHEM REV, V107, P926, DOI 10.1021/cr050140x; Puschnig P, 2009, SCIENCE, V326, P702, DOI 10.1126/science.1176105; SEKI K, 1974, B CHEM SOC JPN, V47, P1608, DOI 10.1246/bcsj.47.1608; Capek V., 1994, ORGANIC MOL CRYSTALS; Dauth M, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/10/103005; Feyer V., J ELECT SPE IN PRESS; Fujii K., 2007, J ELECTRON SPECTROSC, V174, P65; Fujii K., 2009, SURF SCI, V601, P3765; Fukagawa H, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.245310; Fukagawa H, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.041302; Fukagawa H, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.085304; Ishii H., 2015, SPRINGER SERIES MAT, V209; Kera S, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.121305; Kosugi N., J ELECT SPE IN PRESS; Nakayama Y, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.01AD03; Offenbacher H., J ELECT SPE IN PRESS; Paramonov PB, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.041403; Stadtmuller B., J ELECT SPE IN PRESS; Takeya J, 2005, JPN J APPL PHYS 2, V44, pL1393, DOI 10.1143/JJAP.44.L1393; Ueno N., 1976, THESIS TOHOKU U; Ueno N, 2008, APPL PHYS A-MATER, V92, P495, DOI 10.1007/s00339-008-4553-8; Ueno N., 2015, PROG SURF SCI, V209, pChapl	67	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0368-2048	1873-2526		J ELECTRON SPECTROSC	J. Electron Spectrosc. Relat. Phenom.	OCT 1	2015	204		A		SI		2	11		10.1016/j.elspec.2015.07.007		10	Spectroscopy	Spectroscopy	CT8PL	WOS:000363078400002		
J	Bussolotti, F				Bussolotti, Fabio			High-sensitivity ultraviolet photoemission spectroscopy technique for direct detection of gap states in organic thin films	JOURNAL OF ELECTRON SPECTROSCOPY AND RELATED PHENOMENA			English	Review						Photoemission spectroscopy; Gap states; Organic molecules; Organic/inorganic interface; Organic/organic interface	COPPER PHTHALOCYANINE; INTERFACE; ELECTRONS; ENERGY; CUPC	We developed ultrahigh sensitivity, low-background ultraviolet photoemission spectroscopy (UPS) technique which does not introduce detectable radiation damages into organic materials. The UPS allows to detect density of states of the order of similar to 10(16) states eV(-1) cm(-3) even for radiation-sensitive organic films, this results being comparable to electrical measurements of charge trapping centers. In this review we introduce the method of ultrahigh sensitivity photoemission measurement and we present some results on the energy distribution of gap states in pentacene (Pn) films deposited on SiO2 and Au(1 1 1) substrate. For Pn/SiO2 thin film the results show that exposure to inert gas (N-2 and Ar) atmosphere produces a sharp rise in gap states from 10(16) to 10(18) states eV(-1) cm(-3) and pushes the Fermi level closer to the valence band (0.15-0.17 eV), as does exposure to O-2 (0.20 eV), while no such gas-induced effects are observed for Pn/Au(1 1 1) system. The results demonstrate that these gap states originate from small imperfections in the Pn packing structure, which are induced by gas penetration into the film through the Pn crystal grain boundaries. Similar results were obtained for CuPc/F16CuPc thin films, a prototypical example of donor/acceptor interface for photovoltaic application. (C) 2015 Elsevier B.V. All rights reserved.	[Bussolotti, Fabio] Chiba Univ, Grad Sch Adv Integrat Sci, Dept Nanomat Sci, Chiba 2638522, Japan	Bussolotti, F (reprint author), Natl Inst Nat Sci, Inst Mol Sci, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	fabio@ims.ac.jp			MEXT	The ultrahigh sensitivity UPS project is supported by 21st Century COE program (MEXT) and 388 Global COE program (MEXT).	Heimel G, 2013, NAT CHEM, V5, P187, DOI [10.1038/nchem.1572, 10.1038/NCHEM.1572]; VOS M, 1989, PHYS REV B, V39, P3274, DOI 10.1103/PhysRevB.39.3274; Hosokai T, 2012, CHEM PHYS LETT, V544, P34, DOI 10.1016/j.cplett.2012.07.006; Kajiro H, 2010, INT J MOL SCI, V11, P3803, DOI 10.3390/ijms11103803; Hoshino A, 2003, ACTA CRYSTALLOGR B, V59, P393, DOI 10.1107/S010876810300942X; Koch N, 2007, ADV MATER, V19, P112, DOI 10.1002/adma.200601825; Kera S, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.085304; Schwieger T, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.155207; Mao HY, 2011, ORG ELECTRON, V12, P534, DOI 10.1016/j.orgel.2011.01.003; Amy F, 2005, ORG ELECTRON, V6, P85, DOI 10.1016/j.orgel.2005.03.003; Ye RB, 2008, APPL SURF SCI, V254, P7885, DOI 10.1016/j.apsusc.2008.03.048; Boudaiffa B, 2000, SCIENCE, V287, P1658, DOI 10.1126/science.287.5458.1658; Yoshida H, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.235205; Duhm S, 2008, NAT MATER, V7, P326, DOI 10.1038/nmat2119; Bussolotti F, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.155120; Hwang J, 2007, J PHYS CHEM C, V111, P1378, DOI 10.1021/jp067004w; Chen W, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2857460; Kalb WL, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.155315; Bussolotti F, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.115319; Bussolotti F, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.267602; De Angelis F., 2006, APPL PHYS LETT, V88; Fahlman M., 2007, J PHYS CONDENS MATT, V19; Fukagawa H, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.245310; Fukagawa H., 2007, ADV MATER, V19, P668; Hinderhofer A, 2011, THESIS U TUBINGEN GE; Hosokai T., 2010, APPL PHYS LETT, V97; Kafer D., 2007, PHYS REV B, V75, P1; Kafer D, 2009, APPL PHYS A-MATER, V95, P273, DOI 10.1007/s00339-008-5011-3; Kang J.H., 2005, APPL PHYS LETT, V86; Lang DV, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.086802; Ono M., 2006, MOL CRYST LIQ CRYST, V455, P241; Salzmann I, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2767972; Sueyoshi T., 2009, APPL PHYS LETT, V95; Sueyoshi T., 2010, APPL PHYS LETT, V96	34	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0368-2048	1873-2526		J ELECTRON SPECTROSC	J. Electron Spectrosc. Relat. Phenom.	OCT 1	2015	204		A		SI		29	38		10.1016/j.elspec.2015.04.002		10	Spectroscopy	Spectroscopy	CT8PL	WOS:000363078400005		
J	Yamane, H; Kosugi, N				Yamane, Hiroyuki; Kosugi, Nobuhiro			Systematic study on intermolecular valence-band dispersion in molecular crystalline films	JOURNAL OF ELECTRON SPECTROSCOPY AND RELATED PHENOMENA			English	Review						Organic semiconductor; Phthalocyanine; Intermolecular interaction; Valence band dispersion; Angle-resolved photoemission spectroscopy; Synchrotron radiation	ULTRAVIOLET PHOTOELECTRON-SPECTROSCOPY; ENERGY-LEVEL ALIGNMENT; ORGANIC MONOLAYER FILM; ORIENTED THIN-FILMS; ELECTRONIC-STRUCTURE; CHARGE-TRANSPORT; PHTHALOCYANINE; PHOTOEMISSION; STATES; SEMICONDUCTORS	Functionalities of organic semiconductors are governed not only by individual properties of constituent molecules but also by solid-state electronic states near the Fermi level such as frontier molecular orbitals, depending on weak intermolecular interactions in various conformations. The individual molecular property has been widely investigated in detail; on the other hand, the weak intermolecular interaction is difficult to investigate precisely due to the presence of the structural and thermal energy broadenings in organic solids. Here we show quite small but essential intermolecular valence band dispersions and their temperature dependence of sub-0.1-eV scale in crystalline films of metal phthalocyanines (H2Pc, ZnPc, CoPc, MnPc, and F16ZnPc) by using angle-resolved photoemission spectroscopy (ARPES) with synchrotron radiation. The observed bands show intermolecular and site dependent dispersion widths, phases, and periodicities, for different chemical substitution of terminal groups and central metals in the phthalocyanine molecule. The precise and systematic band-dispersion measurement would be a credible approach toward the comprehensive understanding of intermolecular interactions and resultant charge transport properties as well as their tuning by substituents in organic molecular systems. (C) 2015 Elsevier B.V. All rights reserved.	[Yamane, Hiroyuki; Kosugi, Nobuhiro] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448585, Japan; [Yamane, Hiroyuki; Kosugi, Nobuhiro] SOKENDAI, Okazaki, Aichi 4448585, Japan	Yamane, H (reprint author), Natl Inst Nat Sci, Inst Mol Sci, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	yamane@ims.ac.jp			Japan Society for the Promotion of Science [23245007, 24685032]	The authors would like to thank the staff of the UVSOR Synchrotron for their kind supports, in particular, Toshio Horigome in the development of the ARPES system at BL6U. We also thank Dr. Toshihiko Kaji and Prof. Masahiro Hiramoto (Department of Materials Molecular Science, IMS) for their fruitful assistance of the purification of CoPc. HY would like to offer sincere thanks to Prof. Nobuo Ueno for initiating the ARPES work on organic systems during the Ph.D. study and for continuous encouragements until now. This work was partly supported by Grant-in-Aid for Scientific Research (A) (no. 23245007) and Grant-in-Aid for Young Scientists (A) (no. 24685032) from Japan Society for the Promotion of Science.	Yoshimura D, 1999, PHYS REV B, V60, P9046, DOI 10.1103/PhysRevB.60.9046; DAY P, 1963, NATURE, V197, P589, DOI 10.1038/197589b0; Kera S, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2212406; Kanai K, 2009, THIN SOLID FILMS, V517, P3276, DOI 10.1016/j.tsf.2008.12.012; Bussolotti F, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3643717; Kera S, 2006, CHEM PHYS, V325, P113, DOI 10.1016/j.chemphys.2005.10.023; Taguchi Y, 1997, J PHYS-CONDENS MAT, V9, P6761, DOI 10.1088/0953-8984/9/31/025; Witte G, 2004, J MATER RES, V19, P1889, DOI 10.1557/JMR.2004.0251; Kahn A, 2003, J POLYM SCI POL PHYS, V41, P2529, DOI 10.1002/polb.10642; Ziroff J, 2009, SURF SCI, V603, P354, DOI 10.1016/j.susc.2008.11.019; Schwalb CH, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.146801; Xin Q, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.226401; Yamane H, 2008, PHYS STATUS SOLIDI B, V245, P793, DOI 10.1002/pssb.200743448; Koller G, 2007, SCIENCE, V317, P351, DOI 10.1126/science.1143239; Annese E, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.205417; Yamane H, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4902912; HASEGAWA S, 1994, J CHEM PHYS, V100, P6969, DOI 10.1063/1.467013; Yamane H, 2009, J ELECTRON SPECTROSC, V174, P28, DOI 10.1016/j.elspec.2009.03.002; Yamane H, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.086602; Annese E, 2011, J PHYS CHEM C, V115, P17409, DOI 10.1021/jp203200s; Ueno N, 1997, J CHEM PHYS, V107, P2079, DOI 10.1063/1.474558; AKAMATU H, 1950, J CHEM PHYS, V18, P810, DOI 10.1063/1.1747780; Suemori K, 2004, JPN J APPL PHYS 2, V43, pL1014, DOI 10.1143/JJAP.43.L1014; SAITO T, 1994, J PHYS CHEM-US, V98, P2726, DOI 10.1021/j100062a003; Tamai A, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.075134; Yamane H, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.153412; Petraki F, 2011, J PHYS CHEM C, V115, P21334, DOI 10.1021/jp207568q; Yamane H, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.033102; FROHLICH H, 1959, P PHYS SOC LOND, V74, P643, DOI 10.1088/0370-1328/74/5/420; Yoshida H, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.235205; Yamane H, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.165436; Koch N, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.156803; Ishii H, 1999, ADV MATER, V11, P605, DOI 10.1002/(SICI)1521-4095(199906)11:8<605::AID-ADMA605>3.0.CO;2-Q; SEKI K, 1984, CHEM PHYS, V91, P459, DOI 10.1016/0301-0104(84)80078-6; Kakuta H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.247601; Ueno N, 2008, PROG SURF SCI, V83, P490, DOI 10.1016/j.progsurf.2008.10.002; Kera S, 2009, PROG SURF SCI, V84, P135, DOI 10.1016/j.progsurf.2009.03.002; Ohtomo M, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3232205; Giovannetti G, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.035133; Beernink G, 2004, APPL PHYS LETT, V85, P398, DOI 10.1063/1.1775040; Bussolotti F, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.153402; Kera S, 2002, CHEM PHYS LETT, V364, P93, DOI 10.1016/S0009-2614(02)01302-7; Huang YL, 2010, LANGMUIR, V26, P3329, DOI 10.1021/la9030798; Betti MG, 2010, J PHYS CHEM C, V114, P21638, DOI 10.1021/jp108734u; Berkebile S, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.115312; Friedlein R, 2010, J AM CHEM SOC, V132, P12808, DOI 10.1021/ja104839d; Ding HJ, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3446849; Braun S, 2009, ADV MATER, V21, P1450, DOI 10.1002/adma.200802893; Li Y, 2012, J PHYS CHEM LETT, V3, P3325, DOI 10.1021/jz301575u; Temirov R, 2006, NATURE, V444, P350, DOI 10.1038/nature05270; Scheybal A, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.115406; Machida S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.156401; Ciuchi S, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.256401; Okajima T, 2002, SURF REV LETT, V9, P441, DOI 10.1142/S0218625X0200252X; Coropceanu V, 2007, CHEM REV, V107, P926, DOI 10.1021/cr050140x; Puschnig P, 2009, SCIENCE, V326, P702, DOI 10.1126/science.1176105; Annese E, 2007, SURF SCI, V601, P4242, DOI [10.1016/j.susc.2007.04.131, 10.1016/j.suse.2007.04.131]; Yamane H, 2006, J APPL PHYS, V99, DOI 10.1063/1.2192978; Peisert H, 2010, CHEM PHYS LETT, V493, P126, DOI 10.1016/j.cplett.2010.05.020; Salzmann I, 2012, ACS NANO, V6, P10874, DOI 10.1021/nn3042607; Vollmer A, 2012, J ELECTRON SPECTROSC, V185, P55, DOI 10.1016/j.elspec.2012.01.003; Wang Y, 2011, CHEM COMMUN, V47, P12349, DOI 10.1039/c1cc14942c; Fukagawa H, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.245310; Stadtmuller B, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.085416; Stohr J., 1992, NEXAFS SPECTROSCOPY; Ueno N., 1985, Journal of Molecular Electronics, V1; UENO N, 1991, PHYS REV B, V44, P6472, DOI 10.1103/PhysRevB.44.6472; Ules T, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.155430; Wiessner M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2522; Wiessner M, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.075437; Yanagisawa S, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.245141	71	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0368-2048	1873-2526		J ELECTRON SPECTROSC	J. Electron Spectrosc. Relat. Phenom.	OCT 1	2015	204		A		SI		61	67		10.1016/j.elspec.2015.04.014		7	Spectroscopy	Spectroscopy	CT8PL	WOS:000363078400008		
J	Aoki, M; Masuda, S				Aoki, M.; Masuda, S.			Local electronic structure at organic-metal interface studied by UPS, MAES, and first-principles calculation	JOURNAL OF ELECTRON SPECTROSCOPY AND RELATED PHENOMENA			English	Review						Organic-metal interface; Valence electronic state; Ultraviolet photoemission spectroscopy; Metastable atom electron spectroscopy; First-principles calculation	ENERGY-LEVEL ALIGNMENT; SOLID-SURFACES; WORK FUNCTION; GAP STATES; THIN-FILMS; SPECTROSCOPY; PT(111); TRANSPORT; ALKANETHIOLS; ADSORPTION	Understanding and controlling local electronic structures at organic-metal interfaces are crucial for fabricating novel organic-based electronics, as in the case of heterojunctions in semiconductor devices. Here, we report recent studies of valence electronic states at organic-metal interfaces (especially those near the Fermi level of a metal substrate) by the combined analysis of ultraviolet photoemission spectroscopy (UPS), metastable atom electron spectroscopy (MAES), and first-principles calculations. New electronic states in the HOMO (highest occupied molecular orbital)-LUMO (lowest unoccupied molecular orbital) gap formed at an organic-metal interface are classified as a chemisorption-induced gap state (CIGS) and a complex-based gap state (CBGS). The CIGS is further characterized by an asymptotic feature of the metal wave function in the chemisorbed species. The CIGSs in alkanethiolates on Pt(1 1 1) and C-60 on Pt(1 1 1) can be regarded as damping and propagating types, respectively. The CBGSs in K-doped dibenzopentacene (DBP) are composed of DBP-derived MOs and K sp states and distributed over the complex film. No metallic structures were found in the K1DBP and K3DBP phases, suggesting that they are Mott-Hubbard insulators due to strong electron correlation. The local electronic structures of a pentacene film bridged by Au electrodes under bias voltages were examined by an FET-like specimen. The pentacene-derived bands were steeply shifted at the positively biased electrode, reflecting the p-type character of the film. (C) 2015 Elsevier B.V. All rights reserved.	[Aoki, M.; Masuda, S.] Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Meguro Ku, Tokyo 1538902, Japan	Aoki, M (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.	cmaoki@mail.ecu.u-tokyo.ac.jp			JSPS [26390044]	This study was financially supported by JSPS KAKENHI Grant Number 26390044.	Lee YM, 2011, CURR APPL PHYS, V11, P1168, DOI 10.1016/j.cap.2011.02.013; Ruff A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.216403; Koch N, 2007, CHEMPHYSCHEM, V8, P1438, DOI 10.1002/cphc.200700177; Masuda S, 2010, PHYS CHEM CHEM PHYS, V12, P10914, DOI 10.1039/c001016b; Flores F, 2009, PHYS CHEM CHEM PHYS, V11, P8658, DOI 10.1039/b902492c; HARADA Y, 1984, PHYS REV LETT, V52, P2269, DOI 10.1103/PhysRevLett.52.2269; Aoki M, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1899148; Engelkes VB, 2004, J AM CHEM SOC, V126, P14287, DOI 10.1021/ja046274u; WEAVER JH, 1991, PHYS REV LETT, V66, P1741, DOI 10.1103/PhysRevLett.66.1741; Kim DH, 2008, ADV FUNCT MATER, V18, P1363, DOI 10.1002/adfm.200701019; Aoki M, 2012, PHYS CHEM CHEM PHYS, V14, P4101, DOI 10.1039/c2cp23206e; MORIKAWA Y, 1995, PHYS REV B, V51, P14802, DOI 10.1103/PhysRevB.51.14802; Masuda S, 2010, APPL SURF SCI, V256, P4054, DOI 10.1016/j.apsusc.2010.01.063; Yoshinobu J, 1997, PHYS REV LETT, V79, P3942, DOI 10.1103/PhysRevLett.79.3942; Ishii H, 1999, ADV MATER, V11, P605, DOI 10.1002/(SICI)1521-4095(199906)11:8<605::AID-ADMA605>3.0.CO;2-Q; Ueno N, 2008, PROG SURF SCI, V83, P490, DOI 10.1016/j.progsurf.2008.10.002; Braun S, 2007, ORG ELECTRON, V8, P14, DOI 10.1016/j.orgel.2006.10.006; Aoki M, 2001, J ELECTRON SPECTROSC, V114, P507, DOI 10.1016/S0368-2048(00)00331-5; HARADA Y, 1983, J CHEM PHYS, V79, P3251, DOI 10.1063/1.446218; Gao WY, 2003, J APPL PHYS, V94, P359, DOI 10.1063/1.1577400; Harada Y, 1997, CHEM REV, V97, P1897, DOI 10.1021/cr940315v; Bussolotti F, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.155120; Lin TH, 2005, J PHYS CHEM B, V109, P14079, DOI 10.1021/jp058084r; Kim SS, 1998, J CHEM PHYS, V109, P9574, DOI 10.1063/1.477619; Sogo M, 2010, J PHYS CHEM C, V114, P3504, DOI 10.1021/jp9044836; Sogo M, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3482849; Aoki M, 2009, J APPL PHYS, V106, DOI 10.1063/1.3204663; Aoki M, 2007, J ELECTRON SPECTROSC, V156, P383, DOI 10.1016/j.elspec.2006.12.044; MERKEL M, 1993, PHYS REV B, V47, P11470, DOI 10.1103/PhysRevB.47.11470; Masuda S, 2007, J PHYS CHEM C, V111, P11747, DOI 10.1021/jp074101w; Aoki M., IN PRESS; Kiguchi M, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3204466; Masuda S., 2014, TUN JAP S R D EN MAT, P28; Morgner H, 2000, ADV ATOM MOL OPT PHY, V42, P387, DOI 10.1016/S1049-250X(08)60191-3; Roth F, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2012-30247-3; Salaneck W.R., 2001, CONJUGATED POLYM MOL; Sato H., 2014, AVS 61 INT S EXH BAL; Sato H., 2012, PHYS CHEM CHEM PHYS, V14, P15229; Suzuki R., 2002, Physical Review B (Condensed Matter and Materials Physics), V65, DOI 10.1103/PhysRevB.65.035416; Toyoshima S., 2008, JPN J APPL PHYS, V47, P1397; Xue MQ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00389	41	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0368-2048	1873-2526		J ELECTRON SPECTROSC	J. Electron Spectrosc. Relat. Phenom.	OCT 1	2015	204		A		SI		68	74		10.1016/j.elspec.2015.04.005		7	Spectroscopy	Spectroscopy	CT8PL	WOS:000363078400009		
J	Yoshida, H				Yoshida, Hiroyuki			Principle and application of low energy inverse photoemission spectroscopy: A new method for measuring unoccupied states of organic semiconductors	JOURNAL OF ELECTRON SPECTROSCOPY AND RELATED PHENOMENA			English	Review						Low-energy inverse photoemission spectroscopy; Unoccupied state; Electron affinity; Organic semiconductor	INCIDENCE GRATING SPECTROMETER; VUV ISOCHROMAT SPECTROSCOPY; ULTRAVIOLET PHOTON DETECTOR; ELECTRONIC-STRUCTURE; THIN-FILM; MOLECULAR SEMICONDUCTOR; IMPROVED RESOLUTION; PHOTOVOLTAIC CELLS; VACUUM-ULTRAVIOLET; LEVEL ALIGNMENT	Information about the unoccupied states is crucial to both fundamental and applied physics of organic semiconductors. However, there were no available experimental methods that meet the requirement of such research. In this review, we describe a new experimental method to examine the unoccupied states, called low-energy inverse photoemission spectroscopy (LEIPS). An electron having the kinetic energy lower than the damage threshold of organic molecules is introduced to a sample film, and an emitted photon in the near-ultraviolet range is detected with high resolution and sensitivity. Unlike the previous inverse photoemission spectroscopy, the sample damage is negligible and the overall resolution is a factor of two improved to 0.25 eV. Using LEIPS, electron affinity of organic semiconductor can be determined with the same precision as photoemission spectroscopy for ionization energy. The instruments including an electron source and photon detectors as well as application to organic semiconductors are presented. (C) 2015 Published by Elsevier B.V.	Chiba Univ, Grad Sch Adv Integrat Sci, Inage Ku, Chiba 2638522, Japan	Yoshida, H (reprint author), Chiba Univ, Grad Sch Adv Integrat Sci, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan.	hyoshida@chiba-u.jp			JST PRESTO; JST A-STEP; JST ALCA; JSPS KAKENHI [26288007]	The author thanks Mr. Yamada, Dr. Richard Murdey, and Professor Naoki Sato of Kyoto University for helpful discussion. This work is supported by JST PRESTO, JST A-STEP, JST ALCA and JSPS KAKENHI (Grant number 26288007).	Kim SH, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2773941; Djurovich PI, 2009, ORG ELECTRON, V10, P515, DOI 10.1016/j.orgel.2008.12.011; Krause S, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/8/085001; Nishi T, 2008, CHEM PHYS LETT, V455, P213, DOI 10.1016/j.cplett.2008.01.049; GAO Y, 1988, J PHYS E SCI INSTRUM, V21, P489, DOI 10.1088/0022-3735/21/5/014; FRANK KH, 1986, CHEM PHYS LETT, V132, P83, DOI 10.1016/0009-2614(86)80700-X; JOHNSON PD, 1986, REV SCI INSTRUM, V57, P1324, DOI 10.1063/1.1138596; Kahn A, 2003, J POLYM SCI POL PHYS, V41, P2529, DOI 10.1002/polb.10642; Zhou NJ, 2015, P NATL ACAD SCI USA, V112, P7897, DOI 10.1073/pnas.1508578112; DOSE V, 1977, APPL PHYS, V14, P117, DOI 10.1007/BF00882639; OLLONQVIST TE, 1995, VACUUM, V46, P1177, DOI 10.1016/0042-207X(95)00135-2; STOFFEL NG, 1985, NUCL INSTRUM METH A, V234, P230, DOI 10.1016/0168-9002(85)90910-6; Maniraj M, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3630948; Yoshida H, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4822119; Sato N, 1998, J ELECTRON SPECTROSC, V88, P861, DOI 10.1016/S0368-2048(97)00171-0; Han WN, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4821445; BABBE N, 1985, J PHYS E SCI INSTRUM, V18, P158, DOI 10.1088/0022-3735/18/2/014; CHAUVET G, 1981, J ELECTRON SPECTROSC, V24, P255, DOI 10.1016/0368-2048(81)80012-6; FRANK KH, 1988, J CHEM PHYS, V89, P7569, DOI 10.1063/1.455720; Lipton-Duffin JA, 2002, REV SCI INSTRUM, V73, P3149, DOI 10.1063/1.1499536; LANG JK, 1979, REV SCI INSTRUM, V50, P221, DOI 10.1063/1.1135791; ERDMAN PW, 1982, REV SCI INSTRUM, V53, P225, DOI 10.1063/1.1136932; Gao WY, 2001, APPL PHYS LETT, V79, P4040, DOI 10.1063/1.1424067; Geng YF, 2011, CHEM MATER, V23, P4257, DOI 10.1021/cm2018423; Han WN, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4850531; Yoshida H, 2001, J ELECTRON SPECTROSC, V121, P83, DOI 10.1016/S0368-2048(01)00328-0; Boudaiffa B, 2000, SCIENCE, V287, P1658, DOI 10.1126/science.287.5458.1658; PENDRY JB, 1980, PHYS REV LETT, V45, P1356, DOI 10.1103/PhysRevLett.45.1356; Gorgoi M, 2004, APPL SURF SCI, V234, P138, DOI 10.1016/j.apsusc.2004.05.065; Lipton-Duffin JA, 2004, REV SCI INSTRUM, V75, P445, DOI 10.1063/1.1637435; Stiepel R, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1928192; Ishii H, 1999, ADV MATER, V11, P605, DOI 10.1002/(SICI)1521-4095(199906)11:8<605::AID-ADMA605>3.0.CO;2-Q; Hirose Y, 1997, APPL SURF SCI, V113, P291, DOI 10.1016/S0169-4332(96)00886-0; Schedin F, 1997, REV SCI INSTRUM, V68, P41, DOI 10.1063/1.1147844; Ueno N, 2008, PROG SURF SCI, V83, P490, DOI 10.1016/j.progsurf.2008.10.002; Li Z, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4862327; Yoshida H, 2012, CHEM PHYS LETT, V539, P180, DOI 10.1016/j.cplett.2012.04.058; DUDDE R, 1992, CHEM PHYS LETT, V196, P91, DOI 10.1016/0009-2614(92)85934-3; JOST MB, 1991, CHEM PHYS LETT, V184, P423, DOI 10.1016/0009-2614(91)80012-M; Duhm S, 2008, NAT MATER, V7, P326, DOI 10.1038/nmat2119; FAUSTER T, 1985, REV SCI INSTRUM, V56, P1212, DOI 10.1063/1.1137977; DOSE V, 1986, APPL PHYS A-MATER, V40, P203, DOI 10.1007/BF00616595; Adachi C, 2001, ORG ELECTRON, V2, P37, DOI 10.1016/S1566-1199(01)00010-6; Wu CI, 1997, CHEM PHYS LETT, V272, P43, DOI 10.1016/S0009-2614(97)00481-8; FUNNEMANN D, 1986, J PHYS E SCI INSTRUM, V19, P554, DOI 10.1088/0022-3735/19/7/011; Tsutsumi K, 2002, CHEM PHYS LETT, V361, P367, DOI 10.1016/S0009-2614(02)00990-9; Zhong YF, 2015, J PHYS CHEM C, V119, P23, DOI 10.1021/jp506296j; YANNOULIS P, 1991, SURF SCI, V241, P325, DOI 10.1016/0039-6028(91)90092-7; Brabec CJ, 2001, ADV FUNCT MATER, V11, P374, DOI 10.1002/1616-3028(200110)11:5<374::AID-ADFM374>3.3.CO;2-N; Wei QS, 2009, J AM CHEM SOC, V131, P17597, DOI 10.1021/ja9057053; Zahn DRT, 2006, CHEM PHYS, V325, P99, DOI 10.1016/j.chemphys.2006.02.003; Yoshida H, 2014, J PHYS CHEM C, V118, P24377, DOI 10.1021/jp509141y; DENNINGER G, 1979, APPL PHYS, V18, P375, DOI 10.1007/BF00899691; OTTO A, 1985, SURF SCI, V163, P140, DOI 10.1016/0039-6028(85)90854-4; ANDREWS PT, 1988, VACUUM, V38, P257, DOI 10.1016/0042-207X(88)90056-5; Braun S, 2009, ADV MATER, V21, P1450, DOI 10.1002/adma.200802893; Hwang J, 2009, MAT SCI ENG R, V64, P1, DOI 10.1016/j.mser.2008.12.001; Seki K, 2006, MOL CRYST LIQ CRYST, V455, P145, DOI 10.1080/15421400600803713; SANCROTTI M, 1991, REV SCI INSTRUM, V62, P639, DOI 10.1063/1.1142062; Kipp L, 1997, REV SCI INSTRUM, V68, P2144, DOI 10.1063/1.1148077; JOST MB, 1991, PHYS REV B, V44, P1966, DOI 10.1103/PhysRevB.44.1966; Yoshida H, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4860055; Murdey R, 2006, MOL CRYST LIQ CRYST, V455, P211, DOI 10.1080/15421400600698469; Ie Y, 2014, CHEM COMMUN, V50, P4123, DOI 10.1039/c4cc00940a; Namatame H, 1996, J ELECTRON SPECTROSC, V80, P393, DOI 10.1016/0368-2048(96)03000-9; Yoshida H, 2014, ANAL BIOANAL CHEM, V406, P2231, DOI 10.1007/s00216-014-7659-1; Budke M, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2771096; FAUSTER T, 1983, REV SCI INSTRUM, V54, P68, DOI 10.1063/1.1137218; Hawkes P.W., 1997, SPRINGER SERIES OPTI; SATO N, 1981, J CHEM SOC FARAD T 2, V77, P1621, DOI 10.1039/f29817701621; Yamada K., 2015, METHOD EVALUAT UNPUB; Yamada K., 2015, THESIS KYOTO U KYOTO; Yoshida H., PHYS REV B IN PRESS; Yoshida H, 2015, ORG ELECTRON, V20, P24, DOI 10.1016/j.orgel.2015.01.037	74	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0368-2048	1873-2526		J ELECTRON SPECTROSC	J. Electron Spectrosc. Relat. Phenom.	OCT 1	2015	204		A		SI		116	124		10.1016/j.elspec.2015.07.003		9	Spectroscopy	Spectroscopy	CT8PL	WOS:000363078400014		
J	Yamada, T; Yamamoto, R; Munakata, T				Yamada, T.; Yamamoto, R.; Munakata, T.			Microspot two-photon photoemission spectroscopy for CuPc film on HOPG	JOURNAL OF ELECTRON SPECTROSCOPY AND RELATED PHENOMENA			English	Article						Microspectroscopy; Two-photon photoemission; CuPc; Unoccupied states; Image potential states; Charge transfer exciton	SCANNING-TUNNELING-MICROSCOPY; LEAD PHTHALOCYANINE FILM; IMAGE POTENTIAL STATES; COPPER-PHTHALOCYANINE; GRAPHITE; NAPHTHALENE; CU(111)	Microspot two-photon photoemission (micro-2PPE) spectroscopy has been applied to measure the lateral distribution of unoccupied levels on copper phthalocyanine (CuPc) film on HOPG. In addition to the LUMO-derived level and the image potential state (IPS) on the film, we identified the modified IPS which is stabilized by the hole localized in a molecule. We show that modified IPS is observed only on bilayer area, reflecting the localization of the hole in a molecule. The modified IPS is absent on monolayer area, because the hole strongly interacts with substrate. (C) 2015 Elsevier B.V. All rights reserved.	[Yamada, T.; Yamamoto, R.; Munakata, T.] Osaka Univ, Grad Sch Sci, Dept Chem, Toyonaka, Osaka 5600043, Japan	Munakata, T (reprint author), Osaka Univ, Grad Sch Sci, Dept Chem, 1-1 Machikaneyama, Toyonaka, Osaka 5600043, Japan.	munakata@chem.sci.osaka-u.ac.jp			MEXT [24685004, 24656036, 25600004]	This work was supported by a Grant-in-Aid for Young Scientists (A) from MEXT Grant no. 24685004, Grant-in-Aids for Challenging Exploratory Research from MEXT Grant nos. 24656036 and 25600004.	Dougherty DB, 2006, CHEM PHYS LETT, V431, P303, DOI 10.1016/j.cplett.2006.09.104; Munakata T, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.165404; Yamamoto I, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.115404; Yang QX, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.115214; Yamada T, 2014, J PHYS CHEM C, V118, P1035, DOI 10.1021/jp4097875; DAVIDSON AT, 1982, J CHEM PHYS, V77, P168, DOI 10.1063/1.443636; Park J, 2012, J PHYS CHEM C, V116, P5821, DOI 10.1021/jp211938h; Yamada T, 2010, J PHYS CHEM C, V114, P13334, DOI 10.1021/jp1045194; Yamamoto R, 2011, SURF SCI, V605, P982, DOI 10.1016/j.susc.2011.02.018; Muntwiler M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.196403; Ueno N, 2008, PROG SURF SCI, V83, P490, DOI 10.1016/j.progsurf.2008.10.002; Kera S, 2009, PROG SURF SCI, V84, P135, DOI 10.1016/j.progsurf.2009.03.002; Yamamoto R, 2012, PHYS CHEM CHEM PHYS, V14, P9601, DOI 10.1039/c2cp40922d; Kera S, 2002, CHEM PHYS LETT, V364, P93, DOI 10.1016/S0009-2614(02)01302-7; Shibuta M, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.115426; Sugiyama T, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2388922; Munakata T, 2002, SURF SCI, V507, P434, DOI 10.1016/S0039-6028(02)01282-7; Shibuta M, 2011, J PHYS CHEM C, V115, P19269, DOI 10.1021/jp205922q; LUDWIG C, 1994, J VAC SCI TECHNOL B, V12, P1963, DOI 10.1116/1.587680; Bovensiepen U., 2010, DYNAMICS SOLID STATE, V1; Chen J., 2008, INTRO SCANNING TUNNE; Fukagawa H, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.085304; Hufner S., 2003, PHOTOELECTRON SPECTR	23	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0368-2048	1873-2526		J ELECTRON SPECTROSC	J. Electron Spectrosc. Relat. Phenom.	OCT 1	2015	204		A		SI		145	148		10.1016/j.elspec.2015.04.020		4	Spectroscopy	Spectroscopy	CT8PL	WOS:000363078400018		
J	Yanagisawa, S; Okuma, K; Inaoka, T; Hamada, I				Yanagisawa, Susumu; Okuma, Koji; Inaoka, Takeshi; Hamada, Ikutaro			Recent progress in predicting structural and electronic properties of organic solids with the van der Waals density functional	JOURNAL OF ELECTRON SPECTROSCOPY AND RELATED PHENOMENA			English	Review						van der Waals interaction; Organic solids; First-principles method; Density functional; Cohesive property; Band structure	GENERALIZED GRADIENT APPROXIMATION; THIN-FILM TRANSISTORS; AUGMENTED-WAVE METHOD; CRYSTAL-STRUCTURE; EXCHANGE-ENERGY; DISPERSION INTERACTIONS; POWDER DIFFRACTION; CHARGE-TRANSPORT; SOLAR-CELLS; BASIS-SET	We review recent studies on electronic properties of the organic solids with the first-principles electronic structure methods, with the emphasis on the roles of the intermolecular van der Waals (vdW) interaction in electronic properties of the organic semiconductors. After a brief summary of the recent vdW inclusive first-principle theoretical methods, we discuss their performance in predicting cohesive properties of oligoacene crystals as examples of organic crystals. We show that a variant of the van der Waals density functional describes structure and energetics of organic crystals accurately. In addition, we review our recent study on the zinc phthalocyanine crystal and discuss the importance of the intermolecular distance and orientational angle in the band dispersion. Finally, we draw some general conclusions and the future perspectives. (C) 2015 Elsevier B.V. All rights reserved.	[Yanagisawa, Susumu; Okuma, Koji; Inaoka, Takeshi] Univ Ryukyus, Fac Sci, Dept Phys & Earth Sci, Nishihara, Okinawa 9030213, Japan; [Hamada, Ikutaro] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton MANA, Tsukuba, Ibaraki 3050044, Japan	Yanagisawa, S (reprint author), Univ Ryukyus, Fac Sci, Dept Phys & Earth Sci, 1 Senbaru, Nishihara, Okinawa 9030213, Japan.	shou@sci.u-ryukyu.ac.jp; Hamada.Ikutaro@nims.go.jp	Hamada, Ikutaro/E-8040-2010	Hamada, Ikutaro/0000-0001-5112-2452	Japan Society for the Promotion of Science [22540332, 26810009, 26105011]; Cooperative Research Program of Network Joint Research Center for Materials and Devices in ISIR, Osaka University	This work was partly supported by the Grants-in-Aid for Scientific Research (C) (No. 22540332), for Young Scientists (B) (No. 26810009), and for Scientific Research on Innovative Areas "3D Active-Site Science" (No. 26105011) from Japan Society for the Promotion of Science, and by Cooperative Research Program of Network Joint Research Center for Materials and Devices in ISIR, Osaka University. The numerical calculations were carried out at the Institute for Solid State Physics at the University of Tokyo.	ALT HC, 1982, ACTA CRYSTALLOGR B, V38, P2595, DOI 10.1107/S056774088200942X; Andersson Y, 1996, PHYS REV LETT, V76, P102, DOI 10.1103/PhysRevLett.76.102; PERDEW JP, 1986, PHYS REV B, V33, P8800, DOI 10.1103/PhysRevB.33.8800; Grimme S, 2010, ANGEW CHEM INT EDIT, V49, P1402, DOI 10.1002/anie.200905484; Grimme S, 2011, WIRES COMPUT MOL SCI, V1, P211, DOI 10.1002/wcms.30; Vydrov OA, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.063004; Toyoda K, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3373389; Bussolotti F, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3643717; Tanaka Y, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.073408; Lin YY, 1997, IEEE ELECTR DEVICE L, V18, P606, DOI 10.1109/55.644085; Kannemann FO, 2009, J CHEM THEORY COMPUT, V5, P719, DOI 10.1021/ct800522r; Dobson JF, 1996, PHYS REV LETT, V76, P1780, DOI 10.1103/PhysRevLett.76.1780; Hoshino A, 2003, ACTA CRYSTALLOGR B, V59, P393, DOI 10.1107/S010876810300942X; Holmes D, 1999, CHEM-EUR J, V5, P3399, DOI 10.1002/(SICI)1521-3765(19991105)5:11<3399::AID-CHEM3399>3.0.CO;2-V; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Bredas JL, 2002, P NATL ACAD SCI USA, V99, P5804, DOI 10.1073/pnas.092143399; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Haruyama J, 2014, J PHYS CHEM LETT, V5, P2903, DOI 10.1021/jz501510v; Sato T, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3503040; Klimes J, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.195131; Xin Q, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.226401; Bucko T, 2013, J CHEM THEORY COMPUT, V9, P4293, DOI 10.1021/ct400694h; Koller G, 2007, SCIENCE, V317, P351, DOI 10.1126/science.1143239; Puschnig P, 1999, PHYS REV B, V60, P7891, DOI 10.1103/PhysRevB.60.7891; Vydrov OA, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3398840; SCHEIDT WR, 1977, J AM CHEM SOC, V99, P1101, DOI 10.1021/ja00446a021; Ruiz VG, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.146103; Stradi D, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.186102; Wen SH, 2009, J PHYS CHEM B, V113, P8813, DOI 10.1021/jp900512s; Hummer K, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.205205; Schatschneider B, 2013, J PHYS CHEM A, V117, P8323, DOI 10.1021/jp406573n; DAVID WIF, 1992, PHYSICA B, V180, P597, DOI 10.1016/0921-4526(92)90406-I; Silvestrelli PL, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4816964; Dimitrakopoulos CD, 2002, ADV MATER, V14, P99, DOI 10.1002/1521-4095(20020116)14:2<99::AID-ADMA99>3.0.CO;2-9; WOHRLE D, 1991, ADV MATER, V3, P129, DOI 10.1002/adma.19910030303; SCHEIN LB, 1977, PHYS REV B, V15, P1024, DOI 10.1103/PhysRevB.15.1024; ROBERTSON J, 1961, ACTA CRYSTALLOGR, V14, P697, DOI 10.1107/S0365110X61002151; Grimme S, 2006, J COMPUT CHEM, V27, P1787, DOI 10.1002/jcc.20495; Dion M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.246401; Yamane H, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.086602; Siegrist T, 2001, ANGEW CHEM INT EDIT, V40, P1732, DOI 10.1002/1521-3773(20010504)40:9<1732::AID-ANIE17320>3.0.CO;2-7; Brede J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.047204; Bultinck P, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2715563; LACKS DJ, 1993, PHYS REV A, V47, P4681, DOI 10.1103/PhysRevA.47.4681; Schiefer S, 2007, J AM CHEM SOC, V129, P10316, DOI 10.1021/ja0730516; Tamura H, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.035208; Tiago ML, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.115212; Tkatchenko A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.236402; Johnson ER, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2190220; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; MASON R, 1964, ACTA CRYSTALLOGR, V17, P547, DOI 10.1107/S0365110X64001281; Troisi A, 2011, CHEM SOC REV, V40, P2347, DOI 10.1039/c0cs00198h; Yoshida H, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.235205; Marom N, 2010, J CHEM THEORY COMPUT, V6, P81, DOI 10.1021/ct900410j; Mattheus CC, 2003, SYNTHETIC MET, V138, P475, DOI 10.1016/S0379-6779(02)00467-8; Tonigold K, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3439691; Bucko T, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.064110; Kakuta H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.247601; Cooper VR, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.161104; Mercurio G, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.036102; Zhang YK, 1997, J CHEM PHYS, V107, P7921, DOI 10.1063/1.475105; Takeya J, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2711393; Grimme S, 2008, ANGEW CHEM INT EDIT, V47, P3430, DOI 10.1002/anie.200705157; BECKE AD, 1986, J CHEM PHYS, V85, P7184, DOI 10.1063/1.451353; Lee K, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.081101; Bjorkman T, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4893329; Wu J, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4727850; CAMPBELL RB, 1962, ACTA CRYSTALLOGR, V15, P289, DOI 10.1107/S0365110X62000699; Murray ED, 2009, J CHEM THEORY COMPUT, V5, P2754, DOI 10.1021/ct900365q; Toyoda K, 2011, J PHYS CHEM C, V115, P5767, DOI 10.1021/jp1107262; Siegrist T, 2007, ADV MATER, V19, P2079, DOI 10.1002/adma.200602072; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; Nan GJ, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.115203; Berkebile S, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.115312; Kruse H, 2012, J ORG CHEM, V77, P10824, DOI 10.1021/jo302156p; Hamada I, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.121103; Ding HJ, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3446849; Ortmann F, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.205101; Atodiresei N, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.136809; Becke AD, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1884601; McNellis ER, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.205414; Sabatini R, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.041108; Toyoda K, 2011, ORG ELECTRON, V12, P295, DOI 10.1016/j.orgel.2010.11.010; Wu Q, 2002, J CHEM PHYS, V116, P515, DOI 10.1063/1.1424928; HEDIN L, 1965, PHYS REV, V139, pA796, DOI 10.1103/PhysRev.139.A796; Langreth DC, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/8/084203; Machida S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.156401; Ciuchi S, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.256401; Coropceanu V, 2007, CHEM REV, V107, P926, DOI 10.1021/cr050140x; Silvestrelli PL, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.053002; Wellendorff J, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.235149; Okamoto H, 2008, J AM CHEM SOC, V130, P10470, DOI 10.1021/ja803291a; Sato T, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3269802; Marom N, 2013, ANGEW CHEM INT EDIT, V52, P6629, DOI 10.1002/anie.201301938; Klimes J, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/2/022201; Yanagisawa S, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.115438; Adamo C, 1999, J CHEM PHYS, V110, P6158, DOI 10.1063/1.478522; Marzari N, 1997, PHYS REV B, V56, P12847, DOI 10.1103/PhysRevB.56.12847; Ortmann F, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.186101; Ambrosch-Draxl C, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/12/125010; Johnson ER, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1949201; Becke AD, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2768530; Becke AD, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2795701; Becke AD, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2139668; Berland K, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.035412; Berland K, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4871731; Bjork J, 2014, CHEMPHYSCHEM, V15, P2851, DOI 10.1002/cphc.201402063; Bjorkman T, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.165109; Bucko T, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4890003; Grimme S, 2004, J COMPUT CHEM, V25, P1463, DOI 10.1002/jcc.20078; Gulans A, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.201105; Hamada I, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.153412; Ishii H, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.245206; Otero-de-la-Roza A, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4738961; Jurecka P, 2006, PHYS CHEM CHEM PHYS, V8, P1985, DOI 10.1039/b600027d; Kawasaki N, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3076124; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Liu W, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.245405; Loncaric I, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.075414; Mattheus CC, 2001, ACTA CRYSTALLOGR C, V57, P939, DOI 10.1107/S010827010100703X; Morisaki H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6400; Puschnig P, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.235321; Reilly AM, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.055701; Reilly AM, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4812819; Roman-Perez G, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.096102; Rydberg H, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.126402; Schatschneider B, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.060104; Schunemann C, 2011, THIN SOLID FILMS, V519, P3939, DOI 10.1016/j.tsf.2011.01.356; Yanagisawa S, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.245141; Yanagisawa S, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.05FY02; Yoshida H, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2349307	131	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0368-2048	1873-2526		J ELECTRON SPECTROSC	J. Electron Spectrosc. Relat. Phenom.	OCT 1	2015	204		A		SI		159	167		10.1016/j.elspec.2015.04.007		9	Spectroscopy	Spectroscopy	CT8PL	WOS:000363078400020		
J	Fujikawa, T; Niki, K; Sakuma, H				Fujikawa, Takashi; Niki, Kaori; Sakuma, Hiroto			Theory of photoelectron spectroscopy for organic molecules and their crystals	JOURNAL OF ELECTRON SPECTROSCOPY AND RELATED PHENOMENA			English	Review						Photoemission; Keldysh Green's function; Organic solids; Electron-phonon interaction	X-RAY PHOTOEMISSION; CORE-LEVEL PHOTOEMISSION; DEBYE-WALLER; XAFS SPECTRA; THIN-FILMS; SOLIDS; STATE; XPS	In this short review we discuss recent progress in photoemission theory for organic molecules and their crystals. We discuss some important features in Keldysh Green's function theory for the photoemission. We briefly discuss many-body aspects in photoemission from core and extended levels. In particular phonon effects are investigated in more detail since organic solids are typically soft where electron-phonon interaction is important. Debye-Waller factor suppresses the interference effects of photoelectron waves which makes ARPES analyses useless, particularly in high energy region. (C) 2015 Elsevier B.V. All rights reserved.	[Fujikawa, Takashi; Niki, Kaori; Sakuma, Hiroto] Chiba Univ, Grad Sch Adv Integrat Sci, Inage Ku, Chiba, Japan	Fujikawa, T (reprint author), Chiba Univ, Grad Sch Adv Integrat Sci, Inage Ku, Yayoi Cho 1-33, Chiba, Japan.	tfujikawa@faculty.chiba-u.jp			Career-Support Program for Woman Scientist at Chiba University; Ministry of Education, Science and Culture of Japan [25246041]	This paper is dedicated to Professor Nobuo Ueno for his mandatory retirement at Chiba University, and for his great contribution to progress in organic solid science. One of the authors (KN) is grateful to the financial support by the Career-Support Program for Woman Scientist at Chiba University. TF is grateful to the financial support from a Grant-in-Aid for Scientific Research from Ministry of Education, Science and Culture of Japan, Project No. 25246041.	ALMBLADH CO, 1983, HDB SYNCHROTRON RAD, V1, P607; CAROLI C, 1973, PHYS REV B, V8, P4552, DOI 10.1103/PhysRevB.8.4552; Moritz B, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.165112; Fujikawa T, 2005, J ELECTRON SPECTROSC, V149, P61, DOI 10.1016/j.elspec.2005.07.003; FUJIKAWA T, 1981, J PHYS SOC JPN, V50, P1321, DOI 10.1143/JPSJ.50.1321; Kazama M, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.063417; Fujikawa T, 2002, J ELECTRON SPECTROSC, V123, P19, DOI 10.1016/S0368-2048(01)00370-X; BARDYSZEWSKI W, 1985, PHYS SCRIPTA, V32, P439, DOI 10.1088/0031-8949/32/4/033; Niki K, 2014, SURF INTERFACE ANAL, V46, P924, DOI 10.1002/sia.5504; Kuleff AI, 2014, J PHYS B-AT MOL OPT, V47, DOI 10.1088/0953-4075/47/12/124002; Hedin L, 1998, PHYS REV B, V58, P15565, DOI 10.1103/PhysRevB.58.15565; Suga S, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.035146; Fujikawa T, 2003, CHEM PHYS LETT, V368, P147, DOI 10.1016/S0009-2614(02)01814-6; Rehr JJ, 2000, REV MOD PHYS, V72, P621, DOI 10.1103/RevModPhys.72.621; Yamane H, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.153412; Arai H, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.075102; Kazama M, 2010, CHEM PHYS, V373, P261, DOI 10.1016/j.chemphys.2010.04.038; IGARASHI J, 1994, PHYS REV B, V50, P17820, DOI 10.1103/PhysRevB.50.17820; Cuk T, 2005, PHYS STATUS SOLIDI B, V242, P11, DOI 10.1002/pssb.200404959; Kakuta H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.247601; Ueno N, 2008, PROG SURF SCI, V83, P490, DOI 10.1016/j.progsurf.2008.10.002; Hatch RC, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.047601; Fujikawa T, 2009, J ELECTRON SPECTROSC, V174, P85, DOI 10.1016/j.elspec.2009.07.007; Shang MH, 2013, ANAL CHEM, V85, P3739, DOI 10.1021/ac4000865; Fujikawa T, 2008, J ELECTRON SPECTROSC, V162, P146, DOI 10.1016/j.elspec.2008.01.001; FUJIKAWA T, 1985, J PHYS SOC JPN, V54, P2747, DOI 10.1143/JPSJ.54.2747; FUJIKAWA T, 1982, J PHYS SOC JPN, V51, P251, DOI 10.1143/JPSJ.51.251; MERMIN ND, 1966, J MATH PHYS, V7, P1038, DOI 10.1063/1.1704995; Machida S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.156401; Ciuchi S, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.256401; Puschnig P, 2009, SCIENCE, V326, P702, DOI 10.1126/science.1176105; Fujikawa T, 2000, PHYS REV B, V62, P5387, DOI 10.1103/PhysRevB.62.5387; GELIUS U, 1972, FARADAY DISCUSS, V54, P257, DOI 10.1039/dc9725400257; Sebilleau D, 2006, LECT NOTES PHYS, V697, P15; BAYM G, 1961, ANN PHYS-NEW YORK, V14, P1, DOI 10.1016/0003-4916(61)90050-1; Braun J, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.205409; Dauth M, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/10/103005; DuBois D. F., 1967, LECTURES THEORETICAL, P469; Fadley C.S., 1992, SYNCHROTRON RAD RES, V1, P421; Freericks J.K., 2009, PHYS REV LETT, V102, P13640; Fujikawa T., 2008, E J SURF SCI NANOTEC, V6, P263, DOI 10.1380/ejssnt.2008.263; Fujikawa T, 1996, J ELECTRON SPECTROSC, V79, P25, DOI 10.1016/0368-2048(96)02793-4; Fujikawa T, 2009, J ELECTRON SPECTROSC, V173, P51, DOI 10.1016/j.elspec.2009.04.011; Fujikawa T, 2004, J ELECTRON SPECTROSC, V136, P85, DOI 10.1016/j.elspec.2004.02.135; Fujikawa T., 2006, Journal of Electron Spectroscopy and Related Phenomena, V151, DOI 10.1016/j.elspec.2005.11.011; Hedin L., 1969, SOLID STATE PHYS, V23, P1; Hedin L, 2003, SOLID STATE PHOTOEMI, P116, DOI 10.1002/9783527602506.ch3; Kazama M, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.045110; Kazama M, 2009, J PHYS CONF SER, V190, DOI 10.1088/1742-6596/190/1/012048; Langreth D. C., 1976, LINEAR NONLINEAR ELE, P3; Perveaux A, 2014, J PHYS B-AT MOL OPT, V47, DOI 10.1088/0953-4075/47/12/124010; Puschnig P., 2013, SMALL ORGANIC MOL SU, P3; Schattke W., 2003, SOLID STATE PHOTOEMI, P50, DOI 10.1002/9783527602506.ch2; Shang MH, 2011, J ELECTRON SPECTROSC, V184, P261, DOI 10.1016/j.elspec.2010.10.006; Shang M., 2012, E J SURF SCI NANOTEC, V10, P128; Shinotsuka H, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.085404; Shinotsuka H., 2008, J SURF ANAL, V14, P332; Suzuki R., 2005, E J SURF SCI NANOTEC, V3, P373, DOI 10.1380/ejssnt.2005.373	58	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0368-2048	1873-2526		J ELECTRON SPECTROSC	J. Electron Spectrosc. Relat. Phenom.	OCT 1	2015	204		A		SI		168	176		10.1016/j.elspec.2015.07.001		9	Spectroscopy	Spectroscopy	CT8PL	WOS:000363078400021		
J	Sato, F; Omura, T; Ishimaru, M; Endo, Y; Murase, H; Yamashita, E				Sato, Fumio; Omura, Takaya; Ishimaru, Mutsuki; Endo, Yoshiro; Murase, Harutaka; Yamashita, Eiji			Effects of Daily Astaxanthin and L-Carnitine Supplementation for Exercise-Induced Muscle Damage in Training Thoroughbred Horses	JOURNAL OF EQUINE VETERINARY SCIENCE			English	Article						Equine; Astaxanthin; L-carnitine; Supplement	L-TARTRATE SUPPLEMENTATION; OXIDATIVE STRESS MARKERS; EXERTIONAL RHABDOMYOLYSIS; EQUINE RHABDOMYOLYSIS; SKELETAL-MUSCLE; CREATINE-KINASE; UNITED-KINGDOM; VITAMIN-E; TYING-UP; RESPONSES	The effects of dietary supplementation with astaxanthin and L-carnitine on serum markers and clinical incidence rate of exercise-induced muscle damage were studied in training horses. Sixty-three healthy Thoroughbred horses were randomly assigned to two groups and received the same base diet and exercise training throughout this study. The supplement (supp.) group (n = 31) received daily supplementation with astaxanthin (75 mg) and L-carnitine (3,000 mg) for 8 weeks, and the control (cont.) group (n = 32) received no supplementation. Blood samples were collected after high-intensity exercise training at 5 weeks before supplementation, 3 days (3d), and 8 weeks (8w) after the start of the supplementation. The blood samples were analyzed for creatine kinase (CK) activity and lactate dehydrogenase isoenzyme-5 (LDH-5), and a retrospective study was carried out by analyzing medical records for symptoms of exercise-induced muscle damage in both groups. Five horses (two of supp. group and three of cont. group) were excluded from this study for other disease. In the cont. group, CK activity at 8w was significantly increased compared with 3d, whereas the supp. group showed no significant change. After 8w, the CK activity of the supp. group was significantly lower than that of the cont. group. Additionally, the LDH-5 concentration of the supp. group also tended to be lower as compared with that of the cont. group. The incidence rate of exercise-induced muscle damage was significantly lower in the supp. group compared with the cont. group. These results suggest that continuous dietary administration of astaxanthin and L-carnitine attenuates exercise-induced muscle damage in horses. (C) 2015 Elsevier Inc. All rights reserved.	[Sato, Fumio; Omura, Takaya; Ishimaru, Mutsuki; Endo, Yoshiro; Murase, Harutaka] Japan Racing Assoc, Hidaka Training & Res Ctr, Equine Breeding Sci Div, Urakawa, Hokkaido 0570171, Japan; [Yamashita, Eiji] AstaReal Co Ltd, Dept Res & Dev, Med Nutr Div, Osaka, Japan	Sato, F (reprint author), Japan Racing Assoc, Hidaka Training & Res Ctr, Equine Breeding Sci Div, 535-13 Nishicha, Urakawa, Hokkaido 0570171, Japan.	Fumio_Sato@jra.go.jp					DUARTE JA, 1994, EUR J APPL PHYSIOL O, V68, P48, DOI 10.1007/BF00599241; Ikeuchi M, 2006, BIOL PHARM BULL, V29, P2106, DOI 10.1248/bpb.29.2106; McKenzie EC, 2009, VET CLIN N AM-EQUINE, V25, P121, DOI 10.1016/j.cveq.2008.12.001; Valberg SJ, 1999, EQUINE VET J, V31, P43; Stewart JS, 2008, FOOD CHEM TOXICOL, V46, P3030, DOI 10.1016/j.fct.2008.05.038; Fukuzawa K, 1998, BIOFACTORS, V7, P31, DOI 10.1002/biof.5520070106; McKenzie EC, 2003, J VET INTERN MED, V17, P693, DOI 10.1892/0891-6640(2003)017<0693:EODSFA>2.3.CO;2; El-Deeb WM, 2010, VET RES COMMUN, V34, P677, DOI 10.1007/s11259-010-9439-5; Brass EP, 1998, J AM COLL NUTR, V17, P207; Maoka T, 2011, MAR DRUGS, V9, P278, DOI 10.3390/md9020278; McGowan CM, 2002, VET REC, V151, P623; DAVIES KJA, 1982, BIOCHEM BIOPH RES CO, V107, P1198, DOI 10.1016/S0006-291X(82)80124-1; Aoi W, 2004, FREE RADICAL BIO MED, V37, P480, DOI 10.1016/j.freeradbiomed.2004.05.008; Djordjevic B, 2012, J SPORT MED PHYS FIT, V52, P382; Oyanagi E, 2011, BIOCHEM BIOPH RES CO, V412, P61, DOI 10.1016/j.bbrc.2011.07.039; Bacurau RFP, 2003, NUTRITION, V19, P337, DOI 10.1016/S0899-9007(02)01015-8; Aoi W, 2003, ANTIOXID REDOX SIGN, V5, P139, DOI 10.1089/152308603321223630; Aoi W, 2008, BIOCHEM BIOPH RES CO, V366, P892, DOI 10.1016/j.bbrc.2007.12.019; Goto S, 2001, BBA-BIOMEMBRANES, V1512, P251, DOI 10.1016/S0005-2736(01)00326-1; Miyawaki H, 2008, J CLIN BIOCHEM NUTR, V43, P69, DOI 10.3164/jcbn.2008048; MacLeay JM, 1999, AM J VET RES, V60, P1562; Spiering BA, 2008, J STRENGTH COND RES, V22, P1130, DOI 10.1519/JSC.0b013e31817d48d9; [Anonymous], 2007, NUTR REQUIREMENTS HO; Williams CA, 2004, J ANIM SCI, V82, P588; Earnest CP, 2011, INT J SPORTS MED, V32, P882, DOI 10.1055/s-0031-1280779; Siciliano PD, 1997, J ANIM SCI, V75, P1553; Tozaki T, 2010, ANIM GENET, V41, P80, DOI 10.1111/j.1365-2052.2010.02112.x; Martin HD, 1999, PURE APPL CHEM, V71, P2253, DOI 10.1351/pac199971122253; Zeyner A, 1999, ARCH ANIM NUTR, V52, P115; White A, 2001, COMP BIOCHEM PHYS A, V128, P99, DOI 10.1016/S1095-6433(00)00286-5; Wall BT, 2011, J PHYSIOL-LONDON, V589, P963, DOI 10.1113/jphysiol.2010.201343; Tominaga K, 2012, ACTA BIOCHIM POL, V59, P43; THORNTON JR, 1979, EQUINE VET J, V11, P235; Avellini L, 1999, COMP BIOCHEM PHYS B, V123, P147, DOI 10.1016/S0305-0491(99)00045-0; Volek JS, 2002, AM J PHYSIOL-ENDOC M, V282, pE474; Brass EP, 2000, AM J CLIN NUTR, V72, P618; HARRIS PA, 1991, BRIT VET J, V147, P373; McKenzie EC, 2003, CURRENT THERAPY EQUI, P727, DOI 10.1016/B978-0-7216-9540-2.50197-3; Miki W., 1991, PURE APPL CHEM, V63, P144; Nishida Y., 2007, CAROTENOID SCI, V11, P16; Notin C, 2010, EQUINE VET J S, V38, P375; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Rivero JL, 2002, EQUINE VET J S, V34, P269; Sato F, 2012, CAROTENOID SCI, V17, P16; Sawaki H, 2002, RINSHO IYAKU, V10, P1085	45	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0737-0806	1542-7412		J EQUINE VET SCI	J. Equine Vet. Sci.	OCT	2015	35	10					836	842		10.1016/j.jevs.2015.08.003		7	Veterinary Sciences	Veterinary Sciences	CU2MP	WOS:000363357900008		
J	Ogawa, T; Kawashima, N; Obata, H; Kanosue, K; Nakazawa, K				Ogawa, Tetsuya; Kawashima, Noritaka; Obata, Hiroki; Kanosue, Kazuyuki; Nakazawa, Kimitaka			Mode-dependent control of human walking and running as revealed by split-belt locomotor adaptation	JOURNAL OF EXPERIMENTAL BIOLOGY			English	Article						Walk; Run; Adaptation; Split belt; Transfer	GAIT TRANSITIONS; REDUCED GRAVITY; RUN TRANSITION; SPEED; NETWORKS	Here, we investigate the association of neural control between walking and running, and in particular, how these two gait modes at different velocities are controlled by the central nervous system. The subjects were fully adapted by acquiring modified motor patterns to either walk or run on a split-belt treadmill driven in split mode (asymmetry in the velocities of two belts at 1.0 and 2.0 m s(-1)). Subsequently, we tested how the adaptation affected walking and running at three different velocities in the tied mode (equal belt velocities). At 0.75 m s(-1), we found a preference to walk, at 1.50 m s(-1), there was a preference to both walk and run, and at a velocity of 2.25 m s(-1) there was a preference to run. Both walking and running on the split belt resulted in the emergence of a significant aftereffect (asymmetrical movement) at all of the velocities tested when walking after adapting to walk and running after adapting to run. However, for contrasting modes (i.e. running after adapting to walk and walking after adapting to run), such aftereffects were far less evident at all velocities; thus showing only limited transfer across gait modes. The results demonstrate a clear mode dependency in the neural control of human walking and running. In addition, only for walking, was there a degree of velocity dependency.	[Ogawa, Tetsuya; Kanosue, Kazuyuki] Waseda Univ, Fac Sports Sci, Tokorozawa, Saitama 3591192, Japan; [Ogawa, Tetsuya] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1020083, Japan; [Ogawa, Tetsuya; Obata, Hiroki; Nakazawa, Kimitaka] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo 1538902, Japan; [Kawashima, Noritaka] Natl Rehabil Ctr Persons Disabil, Res Inst, Dept Rehabil Movement Funct, Tokorozawa, Saitama 3598555, Japan	Ogawa, T (reprint author), Waseda Univ, Fac Sports Sci, 2-579-15 Mikajima, Tokorozawa, Saitama 3591192, Japan.	ogawa@idaten.c.u-tokyo.ac.jp			 [14J08094]	This work was supported by Grant-in-Aid for Japan Society for the Promotion of Science Fellows [14J08094 to T.O.].	HRELJAC A, 1993, GAIT POSTURE, V1, P217, DOI 10.1016/0966-6362(93)90049-7; THORSTENSSON A, 1987, ACTA PHYSIOL SCAND, V131, P211, DOI 10.1111/j.1748-1716.1987.tb08228.x; Vasudevan EVL, 2010, J NEUROPHYSIOL, V103, P183, DOI 10.1152/jn.00501.2009; McLean DL, 2008, NAT NEUROSCI, V11, P1419, DOI 10.1038/nn.2225; Reisman DS, 2005, J NEUROPHYSIOL, V94, P2403, DOI 10.1152/jn.00089.2005; Cappellini G, 2006, J NEUROPHYSIOL, V95, P3426, DOI 10.1152/jn.00081.2006; GRILLNER S, 1979, BRAIN RES, V165, P177, DOI 10.1016/0006-8993(79)90059-3; Budick SA, 2000, J EXP BIOL, V203, P2565; Ivanenko YP, 2011, J APPL PHYSIOL, V110, P781, DOI 10.1152/japplphysiol.00799.2010; Choi JT, 2007, NAT NEUROSCI, V10, P1055, DOI 10.1038/nn1930; Ivanenko YP, 2008, EUR J NEUROSCI, V27, P3351, DOI 10.1111/j.1460-9568.2008.06289.x; Talpalar AE, 2013, NATURE, V500, P85, DOI 10.1038/nature12286; DIEDRICH FJ, 1995, J EXP PSYCHOL HUMAN, V21, P183, DOI 10.1037//0096-1523.21.1.183; Hagio Shota, 2015, Front Hum Neurosci, V9, P48, DOI 10.3389/fnhum.2015.00048; Ivanenko YP, 2007, J NEUROSCI, V27, P11149, DOI 10.1523/JNEUROSCI.2644-07.2007; Kram R, 1997, J EXP BIOL, V200, P821; Ogawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046349	17	0	0	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0022-0949	1477-9145		J EXP BIOL	J. Exp. Biol.	OCT	2015	218	20					3192	3198		10.1242/jeb.120865		7	Biology	Life Sciences & Biomedicine - Other Topics	CU3UO	WOS:000363451300008		
J	Bessho, Y; Nakamura, T; Nagura, T; Nishiwaki, M; Sato, K; Toyama, Y				Bessho, Y.; Nakamura, T.; Nagura, T.; Nishiwaki, M.; Sato, K.; Toyama, Y.			Effect of volar angulation of extra-articular distal radius fractures on distal radioulnar joint stability: a biomechanical study	JOURNAL OF HAND SURGERY-EUROPEAN VOLUME			English	Article						Distal radioulnar joint; distal radius fracture; volar angulation; stability; triangular fibrocartilage complex	TRIANGULAR FIBROCARTILAGE COMPLEX; CORRECTIVE OSTEOTOMY; FOREARM ROTATION; INSTABILITY; DEFORMITY; WRIST; ANATOMY; ADULTS	The relationship between increased volar tilt of the distal radius and distal radioulnar joint stability was examined. Distal radioulnar joint stiffness was recorded at 10 degrees intervals from 10 degrees dorsal angulation to 20 degrees of volar angulation from the anatomical position of the radius. Tests were performed with the intact radioulnar ligament and repeated after partial and then complete sectioning of the radioulnar ligament at the ulnar fovea. With the intact radioulnar ligament, distal radioulnar joint stiffness increased significantly at 10 degrees and 20 degrees of volar angulation. Partial sectioning of the radioulnar ligament resulted in an approximate 10% decrease of distal radioulnar joint stiffness compared with the intact state, but distal radioulnar joint stiffness still increased significantly with greater volar tilt. Complete sectioning of the radioulnar ligament significantly decreased distal radioulnar joint stiffness, and increasing the volar tilt did not result in increased distal radioulnar joint stiffness. These results suggest that volar angulation deformities of the distal radius should be corrected to 10 degrees of volar tilt when the triangular fibrocartilage complex is intact.	[Bessho, Y.; Nagura, T.; Nishiwaki, M.; Sato, K.; Toyama, Y.] Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan; [Nakamura, T.] Int Univ Hlth & Welf, Clin Res Ctr, Tokyo 1070052, Japan	Nakamura, T (reprint author), Int Univ Hlth & Welf, Sanno Hosp, Dept Orthopaed Surg, Clin Res Ctr, 8-10-16 Akasaka, Tokyo 1070052, Japan.	toshiyasu@ae.em-net.ne.jp					Adams BD, 2010, GREENS OPERATIVE HAN, P523; Szabo RM, 2006, J BONE JOINT SURG AM, V88A, P884; Nishiwaki M, 2008, J HAND SURG-AM, V33A, P198, DOI 10.1016/j.jhsa.2007.11.024; Gordon KD, 2003, J HAND SURG-AM, V28A, P943, DOI 10.1016/S0363-5023(03)00487-8; Kramer S, 2013, J HAND SURG-EUR VOL, V38, P710, DOI 10.1177/1753193412469582; Kihara H, 1996, J HAND SURG-AM, V21A, P40, DOI 10.1016/S0363-5023(96)80152-3; AFEKENSTAM F, 1985, SCAND J PLAST RECONS, V19, P175; Stoffelen D, 1998, J HAND SURG-BRIT EUR, V23B, P507, DOI 10.1016/S0266-7681(98)80134-4; Scheer JH, 2011, J HAND SURG-EUR VOL, V36E, P503, DOI 10.1177/1753193411403690; Fraser GS, 2009, J HAND SURG-AM, V34A, P838, DOI 10.1016/j.jhsa.2009.02.011; Haugstvedt JR, 2006, J HAND SURG-AM, V31A, P445, DOI 10.1016/j.jhsa.2005.11.008; Sato K, 2009, J HAND SURG-AM, V34A, P27, DOI 10.1016/j.jhsa.2008.09.018; PALMER AK, 1981, J HAND SURG-AM, V6, P153; Nakamura T, 2001, J HAND SURG-BRIT EUR, V26, P446, DOI 10.1054/jhsb.2001.0562; MCQUEEN M, 1988, J BONE JOINT SURG BR, V70, P649; Miyake J, 2012, J HAND SURG-EUR VOL, V37E, P506, DOI 10.1177/1753193412443644; Nakamura T, 1996, J HAND SURG-BRIT EUR, V21B, P581, DOI 10.1016/S0266-7681(96)80135-5; Lindau T, 2000, CLIN ORTHOP RELAT R, P229; COONEY WP, 1980, J BONE JOINT SURG AM, V62, P613; Nishiwaki M, 2005, J HAND SURG-AM, V30A, P719, DOI 10.1016/j.jhsa.2005.04.015; Nishiwaki M, 2014, J HAND SURG-AM, V39, P656, DOI 10.1016/j.jhsa.2014.01.013; Nakamura T, 2011, HAND CLIN, V27, P281, DOI 10.1016/j.hcl.2011.05.002; Hirahara H, 2003, J HAND SURG-AM, V28A, P614, DOI 10.1016/S0363-5023(03)00249-1; ADAMS BD, 1993, J HAND SURG-AM, V18A, P492, DOI 10.1016/0363-5023(93)90098-N; Gliatis JD, 2000, J HAND SURG-BRIT EUR, V25B, P535, DOI 10.1054/jhsb.2000.0373; Saito T, 2013, J HAND SURG-EUR VOL, V38, P739, DOI 10.1177/1753193412473036; Ellis J, 1965, J Bone Joint Surg Br, V47, P724; FERNANDEZ DL, 1982, J BONE JOINT SURG AM, V64, P1164; Gofton WT, 2004, J HAND SURG-AM, V29A, P423, DOI 10.1016/j.jhsa.2004.01.020; Wolfe SW, 2010, GREENS OPERATIVE HAN, P561; Zimmerman RM, 2014, J HAND SURG-EUR VOL, V39, P727, DOI 10.1177/1753193414527052	31	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1753-1934	2043-6289		J HAND SURG-EUR VOL	J. Hand Surg.-Eur. Vol.	OCT	2015	40	8					775	782		10.1177/1753193415584716		8	Orthopedics; Surgery	Orthopedics; Surgery	CU3ZD	WOS:000363464400002		
J	Kurahashi, T; Shinohara, T; Hirata, H				Kurahashi, T.; Shinohara, T.; Hirata, H.			Modified dorsal percutaneous screw fixation through a transtrapezial approach for scaphoid fractures	JOURNAL OF HAND SURGERY-EUROPEAN VOLUME			English	Letter									[Kurahashi, T.; Hirata, H.] Nagoya Univ, Grad Sch Med, Dept Hand Surg, Nagoya, Aichi 4648601, Japan; [Shinohara, T.] Chunichi Hosp, Nagoya Hand Surg Ctr, Nagoya, Aichi, Japan	Kurahashi, T (reprint author), Nagoya Univ, Grad Sch Med, Dept Hand Surg, Nagoya, Aichi 4648601, Japan.	t-kurahashi@med.nagoya-u.ac.jp					Suzuki M, 2010, J BONE JOINT SURG BR, V92B, P963, DOI 10.1302/0301-620X.92B7.23410; Jeon IH, 2009, J HAND SURG-AM, V34A, P228, DOI 10.1016/j.jhsa.2008.10.016; Meermans G, 2008, J HAND SURG-EUR VOL, V33E, P791, DOI 10.1177/1753193408092785; HERBERT TJ, 1984, J BONE JOINT SURG BR, V66, P114	4	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1753-1934	2043-6289		J HAND SURG-EUR VOL	J. Hand Surg.-Eur. Vol.	OCT	2015	40	8					868	869		10.1177/1753193414566553		3	Orthopedics; Surgery	Orthopedics; Surgery	CU3ZD	WOS:000363464400019		
J	Schandl, H; Muller, DB; Moriguchi, Y				Schandl, Heinz; Muller, Daniel B.; Moriguchi, Yuichi			Socioeconomic Metabolism Takes the Stage in the International Environmental Policy Debate: A Special Issue to Review Research Progress and Policy Impacts	JOURNAL OF INDUSTRIAL ECOLOGY			English	Editorial Material							MATERIAL FLOW-ANALYSIS; STOCK DYNAMICS; CYCLE; CONSUMPTION; RESOURCES; PATTERNS; BIOMASS		[Schandl, Heinz] CSIRO, Canberra, ACT 2601, Australia; [Schandl, Heinz] Australian Natl Univ, Sch Sociol, Canberra, ACT, Australia; [Schandl, Heinz] Nagoya Univ, Grad Sch Environm Studies, Nagoya, Aichi 4648601, Japan; [Schandl, Heinz; Moriguchi, Yuichi] United Nations Environm Programme, Int Resource Panel, Nairobi, Kenya; [Muller, Daniel B.] Norwegian Univ Sci & Technol, Ind Ecol Programme, Dept Energy & Proc Engn, N-7034 Trondheim, Norway; [Moriguchi, Yuichi] Univ Tokyo, Urban Engn, Tokyo, Japan; [Moriguchi, Yuichi] Natl Inst Environm Studies, Tsukuba, Ibaraki, Japan	Schandl, H (reprint author), CSIRO, Black Mt Labs, Clunies Ross St,Acton GPO Box 1700, Canberra, ACT 2601, Australia.	Heinz.Schandl@csiro.au					Allesch A., 2015, J IND ECOL, DOI [10.1111/jiec12354, DOI 10.1111/JIEC12354]; Hashimoto S, 2012, J IND ECOL, V16, P459, DOI 10.1111/j.1530-9290.2012.00522.x; Krausmann F, 2008, ECOL ECON, V65, P471, DOI 10.1016/j.ecolecon.2007.07.012; Liu G, 2013, NAT CLIM CHANGE, V3, P338, DOI 10.1038/NCLIMATE1698; Shove E, 2010, ENVIRON PLANN A, V42, P1273, DOI 10.1068/a42282; Kennedy C, 2012, J IND ECOL, V16, P780, DOI 10.1111/j.1530-9290.2012.00548.x; Bringezu S, 2012, LAND USE POLICY, V29, P224, DOI 10.1016/j.landusepol.2011.06.010; Steger S, 2011, J CLEAN PROD, V19, P816, DOI 10.1016/j.jclepro.2010.08.016; Graedel TE, 2004, ENVIRON SCI TECHNOL, V38, P1242, DOI 10.1021/es030433c; Weisz H, 2008, J IND ECOL, V12, P629, DOI 10.1111/j.1530-9290.2008.00097.x; Moriguchi Y, 2007, J MATER CYCLES WASTE, V9, P112, DOI 10.1007/s10163-007-0182-0; Giljum S, 2008, ENVIRON SCI POLICY, V11, P204, DOI 10.1016/j.envsci.2007.07.005; Takiguchi H, 2008, J IND ECOL, V12, P792, DOI 10.1111/j.1530-9290.2008.00093.x; Behrens A, 2007, ECOL ECON, V64, P444, DOI 10.1016/j.ecolecon.2007.02.034; Weisz H, 2010, CURR OPIN SUST, V2, P185, DOI 10.1016/j.cosust.2010.05.010; Muller DB, 2006, ECOL ECON, V59, P142, DOI 10.1016/j.ecolecon.2005.09.025; Kharrazi A, 2015, J IND ECOL, V19, P805, DOI 10.1111/jiec.12328; Schandl H, 2010, GLOBAL ENVIRON CHANG, V20, P636, DOI 10.1016/j.gloenvcha.2010.06.003; Lifset R, 2009, J IND ECOL, V13, P837, DOI 10.1111/j.1530-9290.2009.00189.x; Pauliuk S, 2015, J IND ECOL, V19, P728, DOI 10.1111/jiec.12306; Muller DB, 2013, ENVIRON SCI TECHNOL, V47, P11739, DOI 10.1021/es402618m; Fischer-Kowalski M, 1999, ADVAN HUMAN ECOL, V8, P215; Binder CR, 2009, J IND ECOL, V13, P643, DOI 10.1111/j.1530-9290.2009.00182.x; Commission European, 2011, RES EFF EUR FLAGSH I; Di Donato M., 2015, J IND ECOL, DOI [10.1111/jiec12356, DOI 10.1111/JIEC12356]; Fischer-Kowalski M., 1999, J IND ECOL, V2, P107; Fischer-Kowalski M., 1997, INT HDB ENV SOCIOLOG; Giljum S, 2015, J IND ECOL, V19, P792, DOI 10.1111/jiec.12214; Haas W, 2015, J IND ECOL, V19, P765, DOI 10.1111/jiec.12244; Infante-Amate J, 2015, J IND ECOL, V19, P866, DOI 10.1111/jiec.12261; Kastner T, 2015, J IND ECOL, V19, P825, DOI 10.1111/jiec.12238; Lederer J, 2015, J IND ECOL, V19, P695, DOI 10.1111/jiec.12320; Licht C, 2015, J IND ECOL, V19, P890, DOI 10.1111/jiec.12287; Madrid-Lopez C, 2015, J IND ECOL, V19, P853, DOI 10.1111/jiec.12340; Patricio J, 2015, J IND ECOL, V19, P837, DOI 10.1111/jiec.12336; Schaffartzik A, 2015, J IND ECOL, V19, P703, DOI 10.1111/jiec.12258; Schandl H., 2015, J CLEAN PROD, DOI [10.1016/j.jclepro.2015.06.100, DOI 10.1016/J.JCLEPRO.2015.06.100]; Shahrokni H, 2015, J IND ECOL, V19, P917, DOI 10.1111/jiec.12308; Tanikawa H, 2015, J IND ECOL, V19, P778, DOI 10.1111/jiec.12284; UN, 2014, OP WORK GROUP PROP S; UNEP (United Nations Environment Programme), 2015, CHAIRS SUMM 1 MIN EN; UNEP (United Nations Environment Programme), 2015, IND RES EFF GREEN AS; Wallsten B, 2015, J IND ECOL, V19, P742, DOI 10.1111/jiec.12361; Wang T, 2015, J IND ECOL, V19, P877, DOI 10.1111/jiec.12319; Wassenaar T, 2015, J IND ECOL, V19, P715, DOI 10.1111/jiec.12349; Wenzlik M, 2015, J IND ECOL, V19, P814, DOI 10.1111/jiec.12341	46	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1088-1980	1530-9290		J IND ECOL	J. Ind. Ecol.	OCT	2015	19	5			SI		689	694		10.1111/jiec.12357		6	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CU1GG	WOS:000363267800001		
J	Tanikawa, H; Fishman, T; Okuoka, K; Sugimoto, K				Tanikawa, Hiroki; Fishman, Tomer; Okuoka, Keijiro; Sugimoto, Kenji			The Weight of Society Over Time and Space: A Comprehensive Account of the Construction Material Stock of Japan, 1945-2010	JOURNAL OF INDUSTRIAL ECOLOGY			English	Article						bottom-up accounts; construction materials; database compilation; geographic information systems (GIS); material stocks; socieconomic metabolism	MATERIAL FLOW-ANALYSIS; IN-USE STOCKS; NIGHTTIME LIGHTS; METAL STOCKS; STEEL STOCK; BUILDINGS; IRON; EVOLUTION; DYNAMICS; COPPER	In order to fully comprehend the socioeconomic metabolic (SEM) dynamics and material balance of nations, long-term accounting of economy-wide material stock is necessary in parallel to material flow accounts. Nevertheless, material stock accounts have been scarce, isolated, and mostly focused either on single materials, short time spans, or small regions. This study has two objectives: (1) review the state of the art of material stock research in the SEM discourse and (2) present a project to map, in a high level of detail, the in-use construction material stocks of Japan and its 47 prefectures from the 1940s until the present era. This project documents the two major depositories of material stock: buildings and infrastructure. We describe the challenges and benefits of utilizing a bottom-up approach, in order to promote its usage in material stock studies. The resulting database presents the accumulation of stock over time, as well as visually displaying the spatial distribution of the stock using geographical information systems (GIS), which, we argue, is an essential aspect of material stock analysis in the context of socioeconomic metabolism research.	[Tanikawa, Hiroki] Nagoya Univ, Grad Sch Environm Studies, Environm Syst Res, Nagoya, Aichi 4648601, Japan; [Fishman, Tomer; Okuoka, Keijiro; Sugimoto, Kenji] Nagoya Univ, Grad Sch Environm Studies, Nagoya, Aichi 4648601, Japan	Fishman, T (reprint author), Nagoya Univ, Grad Sch Environm Studies, Chikusa Ku, D2-1 510 Furo Cho, Nagoya, Aichi 4648601, Japan.	tomer.fishman@nagoya-u.jp	Fishman, Tomer/C-9772-2015	Fishman, Tomer/0000-0003-4405-2382	Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [1-1402]	This research was financially supported by the Environment Research and Technology Development Fund (1-1402) of the Ministry of the Environment, Japan. The authors thank Keisuke Tanaka, Takayuki Hirakawa, and Yohei Hayakawa for their contributions to the compilation of the database.	ADRIAANSE A., 1997, RESOURCE FLOWS MAT B; Hsu FC, 2013, INT J REMOTE SENS, V34, P490, DOI 10.1080/01431161.2012.712232; Kovanda J, 2007, J IND ECOL, V11, P140, DOI 10.1162/jiec.2007.1155; Huang T, 2013, RESOUR CONSERV RECY, V72, P91, DOI 10.1016/j.resconrec.2012.12.013; Fischer-Kowalski M, 2011, J IND ECOL, V15, P855, DOI 10.1111/j.1530-9290.2011.00366.x; Gerst MD, 2009, ENVIRON SCI TECHNOL, V43, P6320, DOI 10.1021/es900845v; Hatayama H, 2010, ENVIRON SCI TECHNOL, V44, P6457, DOI 10.1021/es100044n; Muller DB, 2006, P NATL ACAD SCI USA, V103, P16111, DOI 10.1073/pnas.0603375103; Muller E, 2014, ENVIRON SCI TECHNOL, V48, P2102, DOI 10.1021/es403506a; [Anonymous], 1974, HDB SEAP AIRP DES WO; Hashimoto S, 2009, WASTE MANAGE, V29, P2859, DOI 10.1016/j.wasman.2009.06.011; Fishman T, 2015, ECOL ECON, V113, P76, DOI 10.1016/j.ecolecon.2015.03.001; Daigo I, 2007, ISIJ INT, V47, P1065, DOI 10.2355/isijinternational.47.1065; Han J, 2013, SUSTAIN SCI, V8, P553, DOI 10.1007/s11625-012-0196-y; Liang HW, 2014, REMOTE SENS-BASEL, V6, P4780, DOI 10.3390/rs6064780; Krausmann F, 2014, J IND ECOL, V18, P294, DOI 10.1111/jiec.12100; Krausmann F, 2011, J IND ECOL, V15, P877, DOI 10.1111/j.1530-9290.2011.00376.x; Muller DB, 2006, ECOL ECON, V59, P142, DOI 10.1016/j.ecolecon.2005.09.025; Laner D, 2014, J IND ECOL, V18, P859, DOI 10.1111/jiec.12143; Hashimoto S, 2007, WASTE MANAGE, V27, P1725, DOI 10.1016/j.wasman.2006.10.009; Rechberger H, 2014, J IND ECOL, V18, P159, DOI 10.1111/jiec.12087; Takahashi KI, 2009, MATER TRANS, V50, P1871, DOI 10.2320/matertrans.M2009030; Lauk C, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034023; Bergsdal H, 2007, BUILD RES INF, V35, P557, DOI 10.1080/09613210701287588; Rauch JN, 2009, P NATL ACAD SCI USA, V106, P18920, DOI 10.1073/pnas.0900658106; Pauliuk S, 2014, GLOBAL ENVIRON CHANG, V24, P132, DOI 10.1016/j.gloenvcha.2013.11.006; Fishman T, 2014, J IND ECOL, V18, P407, DOI 10.1111/jiec.12114; Tanikawa H, 2014, J IND ECOL, V18, P421, DOI 10.1111/jiec.12126; Schandl H, 2012, J IND ECOL, V16, P352, DOI 10.1111/j.1530-9290.2011.00420.x; Hu MM, 2010, RESOUR CONSERV RECY, V54, P591, DOI 10.1016/j.resconrec.2009.10.016; Tanikawa H, 2009, BUILD RES INF, V37, P483, DOI 10.1080/09613210903169394; West J, 2013, ECOL ECON, V94, P19, DOI 10.1016/j.ecolecon.2013.06.015; Muller DB, 2011, ENVIRON SCI TECHNOL, V45, P182, DOI 10.1021/es102273t; Gordon RB, 2006, P NATL ACAD SCI USA, V103, P1209, DOI 10.1073/pnas.0509498103; Gierlinger S, 2012, J IND ECOL, V16, P365, DOI 10.1111/j.1530-9290.2011.00404.x; Pauliuk S, 2013, RESOUR CONSERV RECY, V71, P22, DOI 10.1016/j.resconrec.2012.11.008; Liu G, 2013, ENVIRON SCI TECHNOL, V47, P4882, DOI 10.1021/es305108p; Pauliuk S, 2014, URBAN WATER J, V11, P274, DOI 10.1080/1573062X.2013.795234; Eurostat, 2013, EC WID MAT FLOW ACC; Eurostat, 2001, EC WID MAT FLOW ACC; Hayakawa Y, 2013, THESIS NAGOYA U NAGO; Hirakawa T., 2012, THESIS NAGOYA U NAGO; Inazu R., 2009, PAPERS ENV INFORM SC, V23, P89; Infrastructure Construction Editorial Board, 1968, CAS STUD INFR CONSTR, V7; Japan Dam Foundation, 2012, YB DAMS; Japan Industrial Standards Committee, 2012, JIS STAND DAT; Japan Sewage Works Association, 1977, SEW STAT; Komatsu Y, 2008, J ARCHITECTURE PLANN, V73, P2197; Komatsu Y., 1992, J ARCHIT PLANN ENV E, V439, P101; Lichtensteiger T., 2008, ENV ENG MANAGEMENT, V18, P41; Matthews E., 2000, WEIGHT NATIONS MAT O; Ministry of Land Infrastructure Transport and Tourism, 1965, YB RAILW STAT; Ministry of Land Infrastructure Transport and Tourism, 1965, YB ROAD STAT; Ministry of Land Infrastructure Transport and Tourism, 2012, NAT LAND NUM INF DOW; Ministry of Land Infrastructure Transport and Tourism, 2010, BUILD STOCK STAT; Ministry of Land Infrastructure Transport and Tourism, 1970, YB BUILD STAT; Ministry of Land Infrastructure Transport and Tourism, 2011, 2011 WHIT PAP LAND I; Ministry of Land Infrastructure Transport and Tourism, 2011, SURV DEM CONSTR MAT; Ministry of Land Infrastructure Transport and Tourism Chubu Branch, 2012, GUID ROAD CONSTR DES; Ministry of the Environment, 2009, MAT FLOW JAP 2006; Nagaoka K., 2009, SELECTED PAPERS ENV, V37, P213; Tanaka K., 2014, THESIS NAGOYA U NAGO; Zenrin Co. Ltd, 2011, ZMAP TOWNII 2003 200	63	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1088-1980	1530-9290		J IND ECOL	J. Ind. Ecol.	OCT	2015	19	5			SI		778	791		10.1111/jiec.12284		14	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CU1GG	WOS:000363267800009		
J	Kharrazi, A; Kraines, S; Rovenskaya, E; Avtar, R; Iwata, S; Yarime, M				Kharrazi, Ali; Kraines, Steven; Rovenskaya, Elena; Avtar, Ram; Iwata, Shuichi; Yarime, Masaru			Examining the Ecology of Commodity Trade Networks Using an Ecological Information-Based Approach: Toward Strategic Assessment of Resilience	JOURNAL OF INDUSTRIAL ECOLOGY			English	Article						ecological information-based approach; ecology of commodity trade networks; industrial ecology; resilience; strategic risk management; sustainability	INDUSTRIAL ECOLOGY; TROPICAL FOREST; SUSTAINABILITY; INDICATORS; ECOSYSTEM; FLOWS	Commodity trade networks exhibit certain patterns in the configuration of material flows that are similar to natural ecological networks. This article develops and explores an ecological information-based approach to examine the ecology of commodity trade networks. We demonstrate that commodity trade networks show a pattern of commonality when viewed through the introduced ecological information-based metrics. Specifically, we show how the network metrics of effective connectivity and effective number of roles can convey boundaries where commodity trade networks are robust. Further, the temporal trends of these metrics suggest the existence of multiple basins of attractions and provide clues on the dynamics of resilience of these networks over time.	[Kharrazi, Ali] Univ Tokyo, Grad Sch Publ Policy, Tokyo 1130033, Japan; [Kharrazi, Ali; Rovenskaya, Elena] Int Inst Appl Syst Anal, Adv Syst Anal Program, Laxenburg, Austria; [Kraines, Steven] Tokyo City Univ, Tokyo, Japan; [Rovenskaya, Elena] Lomonosov Moscow State Univ MSU, Fac Computat Math & Cybernet, Moscow, Russia; [Avtar, Ram] UN Univ, Inst Adv Study Sustainabil, Tokyo, Japan; [Iwata, Shuichi] Grad Sch Project Design, Tokyo, Japan; [Iwata, Shuichi] Univ Tokyo, Tokyo 1130033, Japan; [Yarime, Masaru] Univ Tokyo, Grad Sch Publ Policy, Sci Technol & Innovat Governance, Tokyo 1130033, Japan; [Yarime, Masaru] UCL, Dept Sci Technol Engn & Publ Policy STEaPP, London WC1E 6BT, England	Kharrazi, A (reprint author), Univ Tokyo, Grad Sch Publ Policy, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	ali@pp.u-tokyo.ac.jp			Japan's Ministry of Environment	The authors thank Japan's Ministry of Environment for financial support to conduct this research.	Allenby B., 1995, IND ECOLOGY; Ulanowicz RE, 2009, ECOL MODEL, V220, P1886, DOI 10.1016/j.ecolmodel.2009.04.015; Lifset R, 2005, J IND ECOL, V9, P1, DOI 10.1162/1088198054821717; Linkov I, 2014, NAT CLIM CHANGE, V4, P407; Fischer-Kowalski M, 2011, J IND ECOL, V15, P855, DOI 10.1111/j.1530-9290.2011.00366.x; Vandermeer J, 2004, ECOLOGY, V85, P575, DOI 10.1890/02-3140; Hirota M, 2011, SCIENCE, V334, P232, DOI 10.1126/science.1210657; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; Chen ZZ, 2011, OCEAN COAST MANAGE, V54, P601, DOI 10.1016/j.ocecoaman.2011.06.003; Clark WC, 2003, P NATL ACAD SCI USA, V100, P8059, DOI 10.1073/pnas.1231333100; KAUFFMAN SA, 1991, SCI AM, V265, P78; Ulanowicz RE, 2009, ECOL COMPLEX, V6, P27, DOI 10.1016/j.ecocom.2008.10.005; Kharrazi A, 2013, ECOL ECON, V90, P177, DOI 10.1016/j.ecolecon.2013.03.018; Levermann A, 2014, NATURE, V506, P27, DOI 10.1038/506027a; Kraines S, 2005, J IND ECOL, V9, P31, DOI 10.1162/1088198054821690; FINN JT, 1976, J THEOR BIOL, V56, P363, DOI 10.1016/S0022-5193(76)80080-X; Bodini A, 2012, ECOL INDIC, V15, P140, DOI 10.1016/j.ecolind.2011.09.032; Goerner SJ, 2009, ECOL ECON, V69, P76, DOI 10.1016/j.ecolecon.2009.07.018; PIMM SL, 1977, NATURE, V268, P329, DOI 10.1038/268329a0; Davis C, 2010, J IND ECOL, V14, P707, DOI 10.1111/j.1530-9290.2010.00281.x; RUTLEDGE RW, 1976, J THEOR BIOL, V57, P355, DOI 10.1016/0022-5193(76)90007-2; Beisner BE, 2003, FRONT ECOL ENVIRON, V1, P376, DOI 10.2307/3868190; Kharrazi A, 2014, ECOL INDIC, V37, P81, DOI 10.1016/j.ecolind.2013.10.003; Fath BD, 2015, OCEAN COAST MANAGE, V108, P13, DOI 10.1016/j.ocecoaman.2014.06.020; Fiscus Daniel A, 2001, B ECOL SOC AM, V82.4, P248; Haydon D., 1994, AM NAT, V144, P1; Hey A.J.G., 2009, 4 PARADIGM DATA INTE; Holling C, 2002, PANARCHY UNDERSTANDI; Huang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100923; Tilley David Rogers, 2003, Journal of Industrial Ecology, V7, P13, DOI 10.1162/108819803322564325; Ulanowicz Robert E., 1997, ECOLOGY ASCENDENT PE; Walker B, 2004, ECOL SOC, V19, P2; Zorach A. C., 2003, Complexity, V8, DOI 10.1002/cplx.10075	34	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1088-1980	1530-9290		J IND ECOL	J. Ind. Ecol.	OCT	2015	19	5			SI		805	813		10.1111/jiec.12328		9	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CU1GG	WOS:000363267800011		
J	Wang, T; Muller, DB; Hashimoto, S				Wang, Tao; Muller, Daniel B.; Hashimoto, Seiji			The Ferrous Find: Counting Iron and Steel Stocks in China's Economy	JOURNAL OF INDUSTRIAL ECOLOGY			English	Article						industrial ecology; iron and steel stocks; material stock accounting; recycling potential; sampling; steel intensity	MATERIAL FLOW-ANALYSIS; IN-USE STOCKS; CARBON EMISSIONS; LIFE-SPAN; CYCLE; COMMODITIES; EVOLUTION; DYNAMICS; INTERNET; ELEMENTS	A detailed understanding of material stocks in use is essential for anticipating future scrap availability, identifying critical drivers for material use, and developing strategies for resource efficiency. Here, we present a bottom-up assessment of iron and steel stocks in use in urban and rural China for the years 2000 and 2010, including >250 subcategories of products and components, and grouping them into five main end-use categories (i.e., buildings, infrastructure, domestic appliances, machinery, and transport equipment). The uncertainty range of the steel content per type of stock, a determinant of the accuracy and usefulness of the stock accounting, is probed by multiple means, including sample analysis. Important findings are that (1) iron and steel stocks in China have climbed to 2.4 tonnes/capita (t/cap) in 2010, up from 0.9 t/cap in 2000. The use of reinforced concrete in construction of the urban built environment was the major driver for stock growth; (2) a rural-urban difference was uncovered, with rural iron and steel stocks of approximately 1.1 t/cap and the urban iron and steel stocks of approximately 3.7 t/cap in 2010. Both are, nevertheless, far below the level of 10 to 16 t/cap observed in highly industrialized and urbanized countries. For this reason, further stock increase is foreseeable as urbanization and industrialization proceeds and quality of life improves; (3) nearly half of the steel stocks were embedded in concrete structures, and 23% were located in the countryside. Only a fraction of these stocks are currently recovered at end of life.	[Wang, Tao] Ritsumeikan Univ, Global Innovat Res Org, Kyoto, Japan; [Wang, Tao] Norwegian Univ Sci & Technol NTNU, Trondheim, Norway; [Muller, Daniel B.] NTNU, Ind Ecol Programme, Trondheim, Norway; [Muller, Daniel B.] NTNU, Dept Energy & Proc Engn, Trondheim, Norway; [Hashimoto, Seiji] Ritsumeikan Univ, Coll Sci & Engn, Dept Environm Syst Engn, Kusatsu, Shiga 5258577, Japan	Wang, T (reprint author), Ritsumeikan Univ, Global Innovat Res Org, 1-1-1 Noji Higashi, Kusatsu, Shiga 5258577, Japan.	a.t.wang@gmail.com			Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [S-6-4]	This research was supported by the Environment Research and Technology Development Fund (S-6-4) of the Ministry of the Environment, Japan. Part of the research was instructed by Dr. T.E. Graedel at Yale University. The authors sincerely thank many experts from the industries and academia for their data provision and advice.	Hvistendahl M, 2012, SCIENCE, V336, P1223, DOI 10.1126/science.336.6086.1223; Yuan HP, 2013, PROJ MANAG J, V44, P101, DOI 10.1002/pmj.21349; Hu D, 2010, RESOUR CONSERV RECY, V54, P1177, DOI 10.1016/j.resconrec.2010.03.011; Gerst MD, 2008, ENVIRON SCI TECHNOL, V42, P7038, DOI 10.1021/es800420p; Gubbi J, 2013, FUTURE GENER COMP SY, V29, P1645, DOI 10.1016/j.future.2013.01.010; Hatayama H, 2010, ENVIRON SCI TECHNOL, V44, P6457, DOI 10.1021/es100044n; Murakami S, 2010, J IND ECOL, V14, P598, DOI 10.1111/j.1530-9290.2010.00250.x; Pauliuk S, 2013, ENVIRON SCI TECHNOL, V47, P3448, DOI 10.1021/es303149z; Muller DB, 2006, P NATL ACAD SCI USA, V103, P16111, DOI 10.1073/pnas.0603375103; Muller E, 2014, ENVIRON SCI TECHNOL, V48, P2102, DOI 10.1021/es403506a; Hashimoto S, 2009, WASTE MANAGE, V29, P2859, DOI 10.1016/j.wasman.2009.06.011; Oguchi M, 2010, J IND ECOL, V14, P613, DOI 10.1111/j.1530-9290.2010.00251.x; Yang W, 2008, BUILD RES INF, V36, P1, DOI 10.1080/09613210701702883; Wang T, 2007, ENVIRON SCI TECHNOL, V41, P5120, DOI 10.1021/es062761t; [Anonymous], 2013, COMMUNICATION; Pauliuk S, 2012, ENVIRON SCI TECHNOL, V46, P148, DOI 10.1021/es201904c; Muller DB, 2006, ECOL ECON, V59, P142, DOI 10.1016/j.ecolecon.2005.09.025; Hashimoto S, 2007, WASTE MANAGE, V27, P1725, DOI 10.1016/j.wasman.2006.10.009; Milford RL, 2013, ENVIRON SCI TECHNOL, V47, P3455, DOI 10.1021/es3031424; Allwood JM, 2010, ENVIRON SCI TECHNOL, V44, P1888, DOI 10.1021/es902909k; Muller DB, 2011, ENVIRON SCI TECHNOL, V45, P182, DOI 10.1021/es102273t; Chen WQ, 2012, ENVIRON SCI TECHNOL, V46, P8574, DOI 10.1021/es3010333; Muller DB, 2013, ENVIRON SCI TECHNOL, V47, P11739, DOI 10.1021/es402618m; Pauliuk S, 2013, RESOUR CONSERV RECY, V71, P22, DOI 10.1016/j.resconrec.2012.11.008; [Anonymous], 2002, CHIN STAT YB 2002; Li JR, 2013, RESOUR CONSERV RECY, V74, P20, DOI 10.1016/j.resconrec.2013.02.015; Brunner P, 2004, PRACTICAL HDB MAT FL; CATRC (China Automotive Technology and Research Center), 2012, CHIN AUT IND YB 2011; CEC (China Electricity Council), 2012, CHIN EL YB 2011; CEC (China Electricity Council), 2002, CHIN EL POW YB 2001; Chen X., 2005, RAIL TRACK ENG; CISA (China Iron and Steel Association), 2006, CHIN STEEL YB 2005; CISA (China Iron and Steel Association), 2007, CHIN STEEL YB 2006; CNPC (China National Petroleum Corporation), 2011, CNPC ANN REP 2010; CNPC (China National Petroleum Corporation), 2011, CNPC YB 2010; CSCS (China Steel Construction Society), 2006, CHIN STEEL CONSTR YB; DRCSCC (Development Research Center of the State Council of China), 2005, FOR REP STEEL CONS C; Gartner, 2013, GARTN HYP CYCL SPEC; Gu Z., 2012, COMMUNICATION; Han Y., 2012, COMMUNICATION; Hashimoto S., 2008, P 8 INT C ECOBALANCE; He W., 2012, COMMUNICATION; IMF, 2013, WOR ECON OUTLOOK, P1; Kumrajva, 2007, DIAM TRA; Li MS, 2012, INT ADV EDU-GLOB, P103; Li Z., 1985, RURAL BUILDING ARCHI; Maddison A., 2006, WORLD EC; Manyika J., 2011, BIG DATA NEXT FRONTI; MOAC (Ministry of Agriculture of China), 2001, CHIN AGR STAT REP 20; MOAC (Ministry of Agriculture of China), 2011, CHIN AGR STAT REP 20; MOHURD (Ministry of Housing and Urban-Rural Development of China), 2007, STAT B URB RUR CONST; MORC (Ministry of Railways of China), 2011, CHIN RAILW YB 2010; MORC (Ministry of Railways of China), 2001, CHIN RAILW YB 2000; MOTC (Ministry of Transportation of China), 2011, STAT B HIGHW WAT TRA; NBSC, 2012, CHIN STAT YB 2012; NBSC (National Bureau of Statistics of China), 2012, TAB 2010 POP CENS PE; NBSC (National Bureau of Statistics of China), 2002, TAB 2000 POP CENS PE; NBSC (National Bureau of Statistics of China), 2014, CHIN STAT YB 2013; NBSC (National Bureau of Statistics of China), 1997, DAT COLL IND CENS PE; NBSC (National Bureau of Statistics of China), 2001, CHIN STAT YB 2001; NBSC (National Bureau of Statistics of China), 2011, CHIN STAT YB 2011; Niu L., 2006, WISCO TECHNOLOGY, V44, P48; Qin L., 2012, COMMUNICATION; SAC (Standardization Administration of China), 1999, 971121999 SAC GBT; SAC (Standardization Administration of China), 2000, 1772000 SAC YBT; Schmandt-Besserat Denise, 1996, WRITING CAME; Song Y., 2012, COMMUNICATION; SRI (Steel Recycling Institute), 2012, 2010 STEEL REC RAT; [谭泽先 Tan Zexian], 2007, [建筑结构, Building Structure], V37, P17; UNEP (United Nations Environment Programme) International Panel for Sustainable Resource Management, 2010, MET STOCK SOC SCI SY; Wang D., 1996, MANUAL COSTING BUILD; WardsAuto, 2011, WARDS MOT VEH FACTS; Yang W., 2010, MODELING EVOLUTION C; Zhong Q., 2012, COMMUNICATION; Zhou J., 2012, COMMUNICATION	75	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1088-1980	1530-9290		J IND ECOL	J. Ind. Ecol.	OCT	2015	19	5			SI		877	889		10.1111/jiec.12319		13	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CU1GG	WOS:000363267800017		
J	Kawamura, Y; Nakayama, A; Kato, T; Miura, H; Ishihara, N; Ihira, M; Takahashi, Y; Matsuda, K; Yoshikawa, T				Kawamura, Yoshiki; Nakayama, Ai; Kato, Taichi; Miura, Hiroki; Ishihara, Naoko; Ihira, Masaru; Takahashi, Yukitoshi; Matsuda, Kazumi; Yoshikawa, Tetsushi			Pathogenic Role of Human Herpesvirus 6B Infection in Mesial Temporal Lobe Epilepsy	JOURNAL OF INFECTIOUS DISEASES			English	Article						human herpesvirus 6; lobe; mesial temporal sclerosis	MONOCYTE CHEMOATTRACTANT PROTEIN-1; REAL-TIME PCR; EXANTHEM-SUBITUM; QUANTITATIVE-ANALYSIS; MESSENGER-RNA; VIRAL LOAD; RAT-BRAIN; ENCEPHALITIS; EXPRESSION; HUMAN-HERPESVIRUS-6	Background. Human herpesvirus 6B (HHV-6B) is the causative agent for exanthem subitum. HHV-6B was associated with mesial temporal sclerosis (MTS), leading to mesial temporal lobe epilepsy (MTLE). In this study, we sought to elucidate the pathogenic role of HHV-6B in patients with MTLE. Methods. Seventy-five intractable MTLE patients, including 52 MTS patients and 23 non-MTS patients, were enrolled in this study. Resected hippocampus, amygdala, and mixed samples of amygdala and uncus samples were examined by real-time polymerase chain reaction (PCR) and reverse-transcriptase PCR to detect viral DNA and messenger RNA (mRNA), respectively. Host gene expressions, including neural markers, were measured using the TaqMan Gene Expression Assay. Results. Detection of HHV-6 DNA was higher in MTS patients than non-MTS patients (median/interquartile range: 19.1/0-89.2 vs 0.0/0.0-0.0 copies/mu g DNA; P = .004). HHV-6B viral DNA was determined in 12/27 HHV-6 DNA-positive samples, and no HHV-6B mRNA were detected in all samples. In MTS patients, expression of monocyte chemotactic protein-1 (P = .029) and glial fibrillary acidic protein (P = .043) were significantly higher in the amygdala samples with HHV-6 DNA than those without viral DNA. Conclusions. This study suggests that HHV-6B may play an important role in the pathogenesis of MTS via modification of host gene expression.	[Kawamura, Yoshiki; Nakayama, Ai; Kato, Taichi; Miura, Hiroki; Ishihara, Naoko; Yoshikawa, Tetsushi] Fujita Hlth Univ, Sch Med, Dept Pediat, Toyoake, Aichi 4701192, Japan; [Ihira, Masaru] Fujita Hlth Univ, Fac Clin Engn, Sch Hlth Sci, Toyoake, Aichi 4701192, Japan; [Takahashi, Yukitoshi; Matsuda, Kazumi] Shizuoka Inst Epilepsy & Neurol Disorder, Natl Epilepsy Ctr, Shizuoka, Japan	Yoshikawa, T (reprint author), Fujita Hlth Univ, Sch Med, Dept Pediat, 1-98 Deagakugakubo,Kutsukake Cho, Toyoake, Aichi 4701192, Japan.	tetsushi@fujita-hu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25461610, 25860888]; Japan Society for the Promotion of Science [H25-Jisedai-003, H25-Shinko-003]	This work was supported in part by a Grant-in-Aid for Scientific Research(C) (No. 25461610) and Young Scientist(B) (No. 25860888) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and grants from the Japan Society for the Promotion of Science (H25-Jisedai-003 and H25-Shinko-003).	Tanaka N, 2000, BONE MARROW TRANSPL, V26, P1193, DOI 10.1038/sj.bmt.1702710; Karatas H, 2008, J NEUROL SCI, V264, P151, DOI 10.1016/j.jns.2007.08.010; Auer T, 2008, EPILEPSIA, V49, P1562, DOI 10.1111/j.1528-1167.2008.01679.x; Caserta MT, 1998, J PEDIATR-US, V133, P386, DOI 10.1016/S0022-3476(98)70275-6; Little AR, 2002, NEUROSCIENCE, V115, P307, DOI 10.1016/S0306-4522(02)00359-7; Donati D, 2003, NEUROLOGY, V61, P1405; Suga S, 2000, ARCH DIS CHILD, V82, P62, DOI 10.1136/adc.82.1.62; Xu ZC, 2011, NEUROCHEM RES, V36, P2208, DOI 10.1007/s11064-011-0576-1; STEWARD O, 1990, J NEUROSCI, V10, P2373; Kawamura Y, 2011, J CLIN VIROL, V51, P12, DOI 10.1016/j.jcv.2011.02.002; Blumcke I, 2002, BRAIN PATHOL, V12, P199; Torigoe S, 1996, J PEDIATR-US, V129, P301, DOI 10.1016/S0022-3476(96)70259-7; Ihira M, 2012, J MED VIROL, V84, P1388, DOI 10.1002/jmv.23350; Galasso JM, 2000, EXP NEUROL, V165, P295, DOI 10.1006/exnr.2000.7466; HALL CB, 1994, NEW ENGL J MED, V331, P432, DOI 10.1056/NEJM199408183310703; Li YQ, 2009, NEUROCHEM RES, V34, P1594, DOI 10.1007/s11064-009-9948-1; Yoshikawa T, 2002, J MED VIROL, V66, P497, DOI 10.1002/jmv.2172; YOSHIKAWA T, 1992, PEDIATRICS, V89, P888; Pevenstein SR, 1999, J VIROL, V73, P10514; Yoshikawa T, 2009, PEDIATR NEUROL, V41, P353, DOI 10.1016/j.pediatrneurol.2009.05.012; SAITO Y, 1995, J NEUROVIROL, V1, P30, DOI 10.3109/13550289509111008; Glabinski AR, 1996, J IMMUNOL, V156, P4363; ABLASHI DV, 1988, INT J CANCER, V42, P787, DOI 10.1002/ijc.2910420526; YAMANISHI K, 1988, LANCET, V1, P1065; Ward KN, 2005, CURR OPIN INFECT DIS, V18, P247, DOI 10.1097/01.qco.0000168386.16519.93; Fellin T, 2005, TRENDS MOL MED, V11, P530, DOI 10.1016/j.molmed.2005.10.007; TanakaTaya K, 1996, J MED VIROL, V48, P88, DOI 10.1002/(SICI)1096-9071(199601)48:1<88::AID-JMV14>3.0.CO;2-2; KIM JS, 1995, J NEUROIMMUNOL, V56, P127, DOI 10.1016/0165-5728(94)00138-E; He J, 1996, J VIROL, V70, P1296; Seeley WW, 2007, NEUROLOGY, V69, P156, DOI 10.1212/01.wnl.0000265591.10200.d7; Engel J, 2001, NEUROSCIENTIST, V7, P340; Kimura H, 1999, J CLIN MICROBIOL, V37, P132; KONDO K, 1991, J GEN VIROL, V72, P1401, DOI 10.1099/0022-1317-72-6-1401; Chan PKS, 2001, J MED VIROL, V64, P42, DOI 10.1002/jmv.1015; Ogata M, 2010, BONE MARROW TRANSPL, V45, P129, DOI 10.1038/bmt.2009.116; Lallemand F, 2000, J CLIN MICROBIOL, V38, P1404; McManus C, 1998, J NEUROIMMUNOL, V86, P20, DOI 10.1016/S0165-5728(98)00002-2; ASANO Y, 1992, ARCH DIS CHILD, V67, P1484; Gourmala NG, 1997, J NEUROIMMUNOL, V74, P35, DOI 10.1016/S0165-5728(96)00203-2; Caruso A, 2003, J MED VIROL, V70, P451, DOI 10.1002/jmv.10416; Cuomo L, 2001, J MED VIROL, V63, P45, DOI 10.1002/1096-9071(200101)63:1<45::AID-JMV1006>3.0.CO;2-K; SUGA S, 1993, ANN NEUROL, V33, P597, DOI 10.1002/ana.410330607; ABLASHI DV, 1991, VIROLOGY, V184, P545, DOI 10.1016/0042-6822(91)90424-A; Bhanushali MJ, 2013, NEUROLOGY, V80, P1494, DOI 10.1212/WNL.0b013e31828cf8a2; Fotheringham J, 2007, PLOS MED, V4, P848, DOI 10.1371/journal.pmed.0040180	45	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-1899	1537-6613		J INFECT DIS	J. Infect. Dis.	OCT 1	2015	212	7					1014	1021		10.1093/infdis/jiv160		8	Immunology; Infectious Diseases; Microbiology	Immunology; Infectious Diseases; Microbiology	CU0FK	WOS:000363191300002		
J	Iwanaga, N; Nakamura, S; Oshima, K; Kajihara, T; Takazono, T; Miyazaki, T; Izumikawa, K; Yanagihara, K; Sugawara, A; Sunazuka, T; Omura, S; Kohno, S				Iwanaga, Naoki; Nakamura, Shigeki; Oshima, Kazuhiro; Kajihara, Toshiki; Takazono, Takahiro; Miyazaki, Taiga; Izumikawa, Koichi; Yanagihara, Katsunori; Sugawara, Akihiro; Sunazuka, Toshiaki; Omura, Satoshi; Kohno, Shigeru			Macrolides Promote CCL2-Mediated Macrophage Recruitment and Clearance of Nasopharyngeal Pneumococcal Colonization in Mice	JOURNAL OF INFECTIOUS DISEASES			English	Article						Streptococcus pneumoniae; macrolides; colonization; CCL2; macrophage	STREPTOCOCCUS-PNEUMONIAE COLONIZATION; AZITHROMYCIN; ROXITHROMYCIN; ERYTHROMYCIN; ANTIBIOTICS; EXPRESSION; INFECTION; RECEPTOR; DISEASE; CELLS	Background. Streptococcus pneumoniae (pneumococcus) colonizes mucosal surfaces of the upper respiratory tract (URT), resulting in invasive disease. Macrolides are known for their immunomodulatory effects. We investigated the potency of macrolides to reduce pneumococcal colonization by activating host innate immunity. Methods. The kinetics of colonization, cellular response, and inflammatory cytokine levels in the URT were assessed after nasal inoculation of pneumococci. EM900 (a novel 12-membered nonantibiotic macrolide with an immunomodulatory effect) was orally administered throughout the experiment. Survival was evaluated for 10 days. Macrolide-mediated CCL2 production from peritoneal macrophages was determined by enzyme-linked immuosorbent assay. The cell-signaling pathway was analyzed by means of Western blotting and gene silencing assays. Results. Streptococcus pneumoniae was significantly reduced from EM900-treated mice 14 days after pneumococcal inoculation. Macrophage recruitment and Ccl2 messenger RNA expression were promoted. CCL2 production from peritoneal macrophages was significantly induced by macrolides and was dependent on NF-kappa B phosphorylation through the myeloid differentiation primary-response gene 88- or TIR domain-containing adapter-inducing interferon-beta-mediated pathway. Mortality of mice with invasive pneumococcal disease was improved by pretreatment with EM900. Conclusions. Macrolides may inhibit invasive pneumococcal infections by accelerating the clearance of pneumococcal nasopharyngeal colonization via promotion of macrophage-mediated innate immunity.	[Iwanaga, Naoki; Nakamura, Shigeki; Oshima, Kazuhiro; Kajihara, Toshiki; Takazono, Takahiro; Miyazaki, Taiga; Izumikawa, Koichi; Kohno, Shigeru] Nagasaki Univ, Grad Sch Biomed Sci, Dept Resp Dis, Nagasaki 8528501, Japan; [Nakamura, Shigeki; Izumikawa, Koichi] Nagasaki Univ, Grad Sch Biomed Sci, Unit Mol Microbiol & Immunol, Nagasaki 8528501, Japan; [Yanagihara, Katsunori] Kitasato Univ, Dept Lab Med, Nagasaki Univ Hosp, Tokyo, Japan; [Sugawara, Akihiro; Sunazuka, Toshiaki; Omura, Satoshi] Kitasato Univ, Kitasato Inst Life Sci, Tokyo, Japan	Nakamura, S (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Resp Dis, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	moju516@nagasaki-u.ac.jp					MARRIE TJ, 1989, REV INFECT DIS, V11, P586; ANDERSON R, 1989, J INFECT DIS, V159, P966; Sunazuka T, 2003, J ANTIBIOT, V56, P721; Vrancic M, 2012, BRIT J PHARMACOL, V165, P1348, DOI 10.1111/j.1476-5381.2011.01576.x; Davis KM, 2011, J CLIN INVEST, V121, P3666, DOI 10.1172/JCI57761; Yanagihara K, 1997, AM J RESP CRIT CARE, V155, P337; Albert RK, 2011, NEW ENGL J MED, V365, P689, DOI 10.1056/NEJMoa1104623; Kim JO, 1998, J INFECT DIS, V177, P368; KONNO S, 1992, LIFE SCI, V51, pPL107; Hodge S, 2008, AM J RESP CRIT CARE, V178, P139, DOI 10.1164/rccm.200711-1666OC; Otsu K, 2011, PHARMACOLOGY, V88, P327, DOI 10.1159/000334339; McCool TL, 2004, INFECT IMMUN, V72, P5807, DOI 10.1128/IAI.72.10.5807-5813.2004; Sugawara A, 2011, BIOORG MED CHEM LETT, V21, P3373, DOI 10.1016/j.bmcl.2011.04.004; Koppe U, 2012, CELL MICROBIOL, V14, P460, DOI 10.1111/j.1462-5822.2011.01746.x; Tanaka A, 2011, LETT APPL MICROBIOL, V53, P35, DOI 10.1111/j.1472-765X.2011.03079.x; Nakamura S, 2011, J CLIN INVEST, V121, P3657, DOI 10.1172/JCI57762; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; McCool TL, 2002, J EXP MED, V195, P359, DOI 10.1084/jem.20011576; Beisswenger C, 2009, INFECT IMMUN, V77, P2212, DOI 10.1128/IAI.01224-08; Zhang Z, 2009, J CLIN INVEST, V119, P1899, DOI 10.1172/JCI36731; Gavilanes X, 2009, J CYST FIBROS, V8, P203, DOI 10.1016/j.jcf.2009.03.003; Bergner PM, 2006, J IMMUNOL, V176, P2366; Culic O, 2001, EUR J PHARMACOL, V429, P209, DOI 10.1016/S0014-2999(01)01321-8; GRAY BM, 1986, PEDIATR INFECT DIS J, V5, P201, DOI 10.1097/00006454-198603000-00009; Shinkai M, 2006, AM J PHYSIOL-LUNG C, V290, pL75, DOI 10.1152/ajplung.00093.2005	25	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-1899	1537-6613		J INFECT DIS	J. Infect. Dis.	OCT 1	2015	212	7					1150	1159		10.1093/infdis/jiv157		10	Immunology; Infectious Diseases; Microbiology	Immunology; Infectious Diseases; Microbiology	CU0FK	WOS:000363191300016		
J	Hill-Batorski, L; Halfmann, P; Marzi, A; Lopes, TJS; Neumann, G; Feldmann, H; Kawaoka, Y				Hill-Batorski, Lindsay; Halfmann, Peter; Marzi, Andrea; Lopes, Tiago J. S.; Neumann, Gabriele; Feldmann, Heinz; Kawaoka, Yoshihiro			Loss of Interleukin 1 Receptor Antagonist Enhances Susceptibility to Ebola Virus Infection	JOURNAL OF INFECTIOUS DISEASES			English	Article						Ebola virus; interleukin 1 receptor antagonist; Il1rn; IL-1Ra	COLONY-STIMULATING FACTOR; HEMORRHAGIC-FEVER; NEUTROPHIL RECRUITMENT; INFLAMMATORY RESPONSE; MOUSE MODEL; GENE; MICE; PATHOGENESIS; EXPRESSION; IL-1-BETA	The current outbreak of Ebola virus (EBOV) infection in West Africa is unprecedented, with nearly 26 000 confirmed cases and >10 000 deaths. Comprehensive data on the pathogenesis of EBOV infection are lacking; however, recent studies suggested that fatal EBOV infections are characterized by dysregulation of the innate immune response and a subsequent cytokine storm. Specifically, several studies suggested that hypersecretion of interleukin 1 receptor antagonist (IL-1Ra) correlates with lethal EBOV infections. To examine the significance of IL-1Ra in EBOV infections, we infected mice that lack the gene encoding IL-1Ra, Il1rn (IL-1RNKO), and mice with wild-type Il1rn (IL-1RN-WT) with a mouse-adapted EBOV (MA-EBOV). Infected IL-1RN-KO mice lost more weight and had a lower survival rate than IL-1RN-WT mice infected with MA-EBOV. In addition, IL-1RN-KO mice infected with wild-type EBOV, which does not cause lethal infection in adult immunocompetent mice, such as C57BL/6 mice, experienced greater weight loss than IL-1RN-WT mice infected with wild-type EBOV. Further studies revealed that the levels of 6 cytokines in spleens-IL-1 alpha, IL-1 beta, interleukin 12p40, interleukin 17, granulocyte colony-stimulating factor, and regulated on activation, normal T-cell expressed and secreted-were significantly different between IL-1RN-KO mice and IL-1RN-WT mice infected with MA-EBOV. Collectively, our data suggest that IL-1Ra may have a protective effect upon EBOV infection, likely by damping an overactive proinflammatory immune response.	[Hill-Batorski, Lindsay; Halfmann, Peter; Lopes, Tiago J. S.; Neumann, Gabriele; Kawaoka, Yoshihiro] Univ Wisconsin, Influenza Res Inst, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; [Marzi, Andrea; Feldmann, Heinz] NIAID, Div Intramural Res, Virol Lab, NIH, Hamilton, MT USA; [Lopes, Tiago J. S.; Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Microbiol & Immunol,Div Virol, Tokyo 1138654, Japan; [Kawaoka, Yoshihiro] Japan Sci & Technol Agcy, ERATO Infect Induced Host Responses Project, Saitama, Japan	Kawaoka, Y (reprint author), 575 Sci Dr, Madison, WI 53711 USA.	kawaokay@svm.vetmed.wisc.edu			National Institutes of Health (NIH) [5 U19 AI106772-02]; National Institute of Allergy and Infectious Diseases, NIH	This work was supported by the National Institutes of Health (NIH; project5 U19 AI106772-02) and by the intramural research program of the National Institute of Allergy and Infectious Diseases, NIH.	Connolly BM, 1999, J INFECT DIS, V179, pS203, DOI 10.1086/514305; GINSBURG I, 1995, FREE RADICAL RES, V22, P489, DOI 10.3109/10715769509150323; Formenty P, 1999, J INFECT DIS, V179, pS48, DOI 10.1086/514285; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Baize S, 1999, NAT MED, V5, P423, DOI 10.1038/7422; Pan ZZ, 2000, AM J PHYSIOL-LUNG C, V279, pL658; Sanchez A, 2004, J VIROL, V78, P10370, DOI 10.1128/JVI.78.19.10370-10377.2004; Silva MT, 2008, APOPTOSIS, V13, P463, DOI 10.1007/s10495-008-0187-8; Raymond J, 2011, J INFECT DIS, V204, pS986, DOI 10.1093/infdis/jir335; GRANOWITZ EV, 1991, LANCET, V338, P1423, DOI 10.1016/0140-6736(91)92725-H; Ebihara H, 2011, J INFECT DIS, V204, pS991, DOI 10.1093/infdis/jir336; Sergejeva S, 2005, AM J RESP CELL MOL, V33, P248, DOI 10.1165/rcmb.2004-0213OC; Arnalich F, 2002, CLIN EXP IMMUNOL, V127, P331, DOI 10.1046/j.1365-2249.2002.01743.x; Cilloniz C, 2011, J VIROL, V85, P9060, DOI 10.1128/JVI.00659-11; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Sullivan N, 2003, J VIROL, V77, P9733, DOI 10.1128/JVI.77.18.9733-9737.2003; Kreuzer KA, 1997, CLIN EXP IMMUNOL, V109, P54, DOI 10.1046/j.1365-2249.1997.4181315.x; Basu S, 2002, BLOOD, V100, P854, DOI 10.1182/blood.V100.3.854; Leroy EM, 2001, CLIN EXP IMMUNOL, V124, P453, DOI 10.1046/j.1365-2249.2001.01517.x; Baize S, 2002, CLIN EXP IMMUNOL, V128, P163, DOI 10.1046/j.1365-2249.2002.01800.x; Kafka D, 2008, INT IMMUNOL, V20, P1139, DOI 10.1093/intimm/dxn071; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Hirsch E, 1996, P NATL ACAD SCI USA, V93, P11008, DOI 10.1073/pnas.93.20.11008; FISHERHOCH SP, 1983, LANCET, V2, P1055; Bray M, 1998, J INFECT DIS, V178, P651; Aksentijevich I, 2009, NEW ENGL J MED, V360, P2426, DOI 10.1056/NEJMoa0807865; Endo S, 1996, J MED, V27, P57; McElroy AK, 2014, J INFECT DIS, V210, P558, DOI 10.1093/infdis/jiu088; VANDERGROEN G, 1979, J MED VIROL, V4, P239, DOI 10.1002/jmv.1890040309; Miller LS, 2007, J IMMUNOL, V179, P6933; Fragoso JM, 2010, IMMUNOL LETT, V133, P106, DOI 10.1016/j.imlet.2010.08.003; Geisbert Thomas W., 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404008300; Wauquier N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000837; Rider P, 2011, J IMMUNOL, V187, P4835, DOI 10.4049/jimmunol.1102048; Gibb TR, 2001, J COMP PATHOL, V125, P233, DOI 10.1053/jcpa.2001.0502; Bray M, 1999, J INFECT DIS, V179, pS248, DOI 10.1086/514292; Lind H, 2005, LUNG CANCER-J IASLC, V50, P285, DOI 10.1016/j.lungcan.2005.07.003; Ebihara H, 2013, J INFECT DIS, V207, P306, DOI 10.1093/infdis/jis626; Gabay C, 1997, J CLIN INVEST, V99, P2930, DOI 10.1172/JCI119488; Thea DM, 1996, ANN INTERN MED, V124, P757; Reiner AP, 2008, ARTERIOSCL THROM VAS, V28, P1407, DOI 10.1161/ATVBAHA.108.167437; Centers for Disease Control and Prevention, 2015, OUTBR CHRON EB HEM F; de-Oliveira-Pinto LM, 2012, MEM I OSWALDO CRUZ, V107, P48, DOI 10.1590/S0074-02762012000100007; Ebihara H, 2006, PLOS PATHOG, V2, P705, DOI 10.1371/journal.ppat.0020073; Fisher-Hoch S., 1985, J INFECT DIS, V5, P887; Lehr HA, 1994, OPIN HEMATOL, V1, P92; Leroy EM, 2000, LANCET, V355, P2210, DOI 10.1016/S0140-6736(00)02405-3; Meyer NJ, 2014, AM J RESP CRIT CARE, V190, P656, DOI 10.1164/rccm.201403-0586OC	48	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-1899	1537-6613		J INFECT DIS	J. Infect. Dis.	OCT 1	2015	212			2			S329	S335		10.1093/infdis/jiv335		7	Immunology; Infectious Diseases; Microbiology	Immunology; Infectious Diseases; Microbiology	CU0EP	WOS:000363189100033		
J	Ogawa, H; Miyamoto, H; Nakayama, E; Yoshida, R; Nakamura, I; Sawa, H; Ishii, A; Thomas, Y; Nakagawa, E; Matsuno, K; Kajihara, M; Maruyama, J; Nao, N; Muramatsu, M; Kuroda, M; Simulundu, E; Changula, K; Hang'ombe, B; Namangala, B; Nambota, A; Katampi, J; Igarashi, M; Ito, K; Feldmann, H; Sugimoto, C; Moonga, L; Mweene, A; Takada, A				Ogawa, Hirohito; Miyamoto, Hiroko; Nakayama, Eri; Yoshida, Reiko; Nakamura, Ichiro; Sawa, Hirofumi; Ishii, Akihiro; Thomas, Yuka; Nakagawa, Emiko; Matsuno, Keita; Kajihara, Masahiro; Maruyama, Junki; Nao, Naganori; Muramatsu, Mieko; Kuroda, Makoto; Simulundu, Edgar; Changula, Katendi; Hang'ombe, Bernard; Namangala, Boniface; Nambota, Andrew; Katampi, Jackson; Igarashi, Manabu; Ito, Kimihito; Feldmann, Heinz; Sugimoto, Chihiro; Moonga, Ladslav; Mweene, Aaron; Takada, Ayato			Seroepidemiological Prevalence of Multiple Species of Filoviruses in Fruit Bats (Eidolon helvum) Migrating in Africa	JOURNAL OF INFECTIOUS DISEASES			English	Article						Ebola virus; Marburg virus; filovirus; specific antibody; fruit bat; Zambia	EBOLA-VIRUS; ANTIBODY PREVALENCE; GLYCOPROTEIN	Fruit bats are suspected to be a natural reservoir of filoviruses, including Ebola and Marburg viruses. Using an enzyme-linked immunosorbent assay based on the viral glycoprotein antigens, we detected filovirus-specific immunoglobulin G antibodies in 71 of 748 serum samples collected from migratory fruit bats (Eidolon helvum) in Zambia during 2006-2013. Although antibodies to African filoviruses (eg, Zaire ebolavirus) were most prevalent, some serum samples showed distinct specificity for Reston ebolavirus, which that has thus far been found only in Asia. Interestingly, the transition of filovirus species causing outbreaks in Central and West Africa during 2005-2014 seemed to be synchronized with the change of the serologically dominant virus species in these bats. These data suggest the introduction of multiple species of filoviruses in the migratory bat population and point to the need for continued surveillance of filovirus infection of wild animals in sub-Saharan Africa, including hitherto nonendemic countries.	[Ogawa, Hirohito; Ishii, Akihiro; Thomas, Yuka; Nakagawa, Emiko; Moonga, Ladslav] Hokudai Ctr Zoonosis Control, Lusaka, Zambia; [Ogawa, Hirohito; Nakamura, Ichiro; Sawa, Hirofumi; Ishii, Akihiro; Thomas, Yuka; Nakagawa, Emiko; Simulundu, Edgar; Nambota, Andrew; Sugimoto, Chihiro; Mweene, Aaron; Takada, Ayato] Univ Zambia, Sch Vet Med, Dept Dis Control, Lusaka, Zambia; [Changula, Katendi; Hang'ombe, Bernard; Namangala, Boniface; Moonga, Ladslav] Univ Zambia, Sch Vet Med, Dept Paraclin Studies, Lusaka, Zambia; [Katampi, Jackson] Zambia Wildlife Author, Chilanga, Zambia; [Miyamoto, Hiroko; Nakayama, Eri; Yoshida, Reiko; Matsuno, Keita; Kajihara, Masahiro; Maruyama, Junki; Nao, Naganori; Muramatsu, Mieko; Kuroda, Makoto; Igarashi, Manabu; Takada, Ayato] Hokkaido Univ, Res Ctr Zoonosis Control, Div Global Epidemiol, Sapporo, Hokkaido 0010020, Japan; [Nakamura, Ichiro; Sugimoto, Chihiro] Hokkaido Univ, Res Ctr Zoonosis Control, Div Collaborat & Educ, Sapporo, Hokkaido 0010020, Japan; [Sawa, Hirofumi] Hokkaido Univ, Res Ctr Zoonosis Control, Div Mol Pathobiol, Sapporo, Hokkaido 0010020, Japan; [Ito, Kimihito] Hokkaido Univ, Res Ctr Zoonosis Control, Div Bioinformat, Sapporo, Hokkaido 0010020, Japan; [Sawa, Hirofumi; Matsuno, Keita; Igarashi, Manabu; Ito, Kimihito; Sugimoto, Chihiro; Takada, Ayato] Hokkaido Univ, Global Inst Collaborat Res & Educ, Global Stn Zoonosis Control, Sapporo, Hokkaido 0010020, Japan; [Hang'ombe, Bernard; Mweene, Aaron] Southern African Ctr Infect Dis Surveillance, Morogoro, Tanzania; [Feldmann, Heinz] NIAID, Virol Lab, Div Intramural Res, NIH, Hamilton, MT USA	Takada, A (reprint author), Hokkaido Univ, Res Ctr Zoonosis Control, Div Global Epidemiol, Kita Ku, Kita 20,Nishi 10, Sapporo, Hokkaido 0010020, Japan.	atakada@czc.hokudai.ac.jp	Maruyama, Junki/H-7993-2013; Ogawa, Hirohito/F-6918-2012		Japan Initiative for Global Research Network on Infectious Diseases; Japan Science and Technology Agency; Japan International Cooperation Agency; Global Center Of Excellence Program "Establishment of International Collaboration Centers for Zoonosis Control" from Ministry of Education, Culture, Sports, Science and Technology, Japan [F-001]; Science and Technology Research Partnership for Sustainable Development	This work was supported by the Japan Initiative for Global Research Network on Infectious Diseases, the Japan Science and Technology Agency, and the Japan International Cooperation Agency within the framework of the Science and Technology Research Partnership for Sustainable Development. Funding was also provided by the Global Center Of Excellence Program "Establishment of International Collaboration Centers for Zoonosis Control" (grant F-001) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Amman BR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002877; Richter HV, 2008, J ZOOL, V275, P172, DOI 10.1111/j.1469-7998.2008.00425.x; Manicassamy B, 2007, VIROLOGY, V358, P79, DOI 10.1016/j.virol.2006.06.041; Nakayama E, 2010, CLIN VACCINE IMMUNOL, V17, P1723, DOI 10.1128/CVI.00170-10; Allela L, 2005, EMERG INFECT DIS, V11, P385; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Olival KJ, 2013, EMERG INFECT DIS, V19, P270, DOI 10.3201/eid1902.120524; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; de Jong Carol, 2011, FAO Animal Production and Health Manual, V12, P1; Pourrut X, 2007, J INFECT DIS, V196, pS176, DOI 10.1086/520541; Pan YY, 2014, ARCH VIROL, V159, P1129, DOI 10.1007/s00705-012-1477-6; Kuhn JH, 2014, ARCH VIROL, V159, P1229, DOI 10.1007/s00705-013-1877-2; Barrette RW, 2009, SCIENCE, V325, P204, DOI 10.1126/science.1172705; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Ogawa H, 2011, J VIROL METHODS, V171, P310, DOI 10.1016/j.jviromet.2010.11.010; Swanepoel R, 1996, EMERG INFECT DIS, V2, P321; Centers for Disease Control and Prevention, OUTBR; DeFrees SL, 1988, MAMMAL SPECIES, V312, P1, DOI DOI 10.2307/3504095; Hayman DTS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011978; Negredo A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002304; Nidom CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040740; Pourrut X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-159; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; World Health Organization, GLOB AL RESP	25	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-1899	1537-6613		J INFECT DIS	J. Infect. Dis.	OCT 1	2015	212			2			S101	S108		10.1093/infdis/jiv063		8	Immunology; Infectious Diseases; Microbiology	Immunology; Infectious Diseases; Microbiology	CU0EP	WOS:000363189100005		
J	Tsuda, Y; Hoenen, T; Banadyga, L; Weisend, C; Ricklefs, SM; Porcella, SF; Ebihara, H				Tsuda, Yoshimi; Hoenen, Thomas; Banadyga, Logan; Weisend, Carla; Ricklefs, Stacy M.; Porcella, Stephen F.; Ebihara, Hideki			An Improved Reverse Genetics System to Overcome Cell-Type-Dependent Ebola Virus Genome Plasticity	JOURNAL OF INFECTIOUS DISEASES			English	Article						Ebola virus; reverse genetics system; mutation; RNA editing site	REPLICATION; RNA; TRANSCRIPTION; GLYCOPROTEIN; POLYMERASE; PARTICLES; RECOVERY; CULTURE	Reverse genetics systems represent a key technique for studying replication and pathogenesis of viruses, including Ebola virus (EBOV). During the rescue of recombinant EBOV from Vero cells, a high frequency of mutations was observed throughout the genomes of rescued viruses, including at the RNA editing site of the glycoprotein gene. The influence that such genomic instability could have on downstream uses of rescued virus may be detrimental, and we therefore sought to improve the rescue system. Here we report an improved EBOV rescue system with higher efficiency and genome stability, using a modified full-length EBOV clone in Huh7 cells. Moreover, by evaluating a variety of cells lines, we revealed that EBOV genome instability is cell-type dependent, a fact that has significant implications for the preparation of standard virus stocks. Thus, our improved rescue system will have an impact on both basic and translational research in the filovirus field.	[Tsuda, Yoshimi; Banadyga, Logan; Weisend, Carla; Ebihara, Hideki] NIAID, Mol Virol & Host Pathogen Interact Unit, NIH, Hamilton, MT 59840 USA; [Hoenen, Thomas] NIAID, Dis Modeling & Transmiss Sect, Virol Lab, NIH, Hamilton, MT 59840 USA; [Ricklefs, Stacy M.; Porcella, Stephen F.] NIAID, Genom Unit, Res Technol Sect, Div Intramural Res,NIH, Hamilton, MT 59840 USA; [Tsuda, Yoshimi] Hokkaido Univ, Grad Sch Med, Dept Microbiol, Sapporo, Hokkaido, Japan	Ebihara, H (reprint author), NIAID, Rocky Mt Labs, 903 S 4th St, Hamilton, MT 59840 USA.	ebiharah@niaid.nih.gov			Intramural Research Program, NIH	This work was supported by the Intramural Research Program, NIH.	Yanai H, 2006, MICROBES INFECT, V8, P1522, DOI 10.1016/j.micinf.2006.01.010; Volchkov VE, 2001, SCIENCE, V291, P1965, DOI 10.1126/science.1057269; Hoenen T, 2010, VIROLOGY, V403, P56, DOI 10.1016/j.virol.2010.04.002; Keskinen P, 1999, VIROLOGY, V263, P364, DOI 10.1006/viro.1999.9983; Muhlberger E, 1999, J VIROL, V73, P2333; Pourrut X, 2005, MICROBES INFECT, V7, P1005, DOI 10.1016/j.micinf.2005.04.006; Neumann G, 2002, J VIROL, V76, P406, DOI 10.1128/JVI.76.1.406-410.2002; Sanchez A, 1996, P NATL ACAD SCI USA, V93, P3602, DOI 10.1073/pnas.93.8.3602; Mehedi M, 2011, J VIROL, V85, P5406, DOI 10.1128/JVI.02190-10; Ksiazek TG, 1999, J INFECT DIS, V179, pS177, DOI 10.1086/514321; Hoenen T, 2011, ANTIVIR RES, V91, P195, DOI 10.1016/j.antiviral.2011.06.003; Ebihara H, 2000, J VIROL, V74, P9245, DOI 10.1128/JVI.74.19.9245-9255.2000; Martinez MJ, 2011, J INFECT DIS, V204, pS934, DOI 10.1093/infdis/jir320; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Hoenen T, 2012, J VIROL, V86, P11779, DOI 10.1128/JVI.01525-12; Ebihara H, 2005, THROMB HAEMOSTASIS, V94, P240, DOI 10.1160/TH05-05-0335; Ito N, 2003, MICROBIOL IMMUNOL, V47, P613; Wahl-Jensen V, 2005, J VIROL, V79, P2413, DOI 10.1128/JVI79.4.2413-2419.2005; Volchkov VE, 1995, VIROLOGY, V214, P421, DOI 10.1006/viro.1995.0052; Conzelmann KK, 2004, CURR TOP MICROBIOL, V283, P1; Volchkova VA, 2011, J INFECT DIS, V204, pS941, DOI 10.1093/infdis/jir321; Ebihara H, 2006, PLOS PATHOG, V2, P705, DOI 10.1371/journal.ppat.0020073; Feldmann H, 2013, FIELDS VIROLOGY, P923; Kugelman JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050316; Mehedi M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003677	25	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-1899	1537-6613		J INFECT DIS	J. Infect. Dis.	OCT 1	2015	212			2			S129	S137		10.1093/infdis/jiu681		9	Immunology; Infectious Diseases; Microbiology	Immunology; Infectious Diseases; Microbiology	CU0EP	WOS:000363189100008		
J	Wrensch, F; Karsten, CB; Gnirss, K; Hoffmann, M; Lu, K; Takada, A; Winkler, M; Simmons, G; Pohlmann, S				Wrensch, Florian; Karsten, Christina B.; Gnirss, Kerstin; Hoffmann, Markus; Lu, Kai; Takada, Ayato; Winkler, Michael; Simmons, Graham; Poehlmann, Stefan			Interferon-Induced Transmembrane Protein-Mediated Inhibition of Host Cell Entry of Ebolaviruses	JOURNAL OF INFECTIOUS DISEASES			English	Article						Ebola; glycoprotein; entry; IFITM; interferon	INFLUENZA-A VIRUS; EBOLA-VIRUS; MARBURG VIRUS; ENVELOPE GLYCOPROTEIN; HEMORRHAGIC-FEVER; RESTON-EBOLAVIRUS; DENGUE VIRUS; DC-SIGN; INFECTION; CORONAVIRUS	Ebolaviruses are highly pathogenic in humans and nonhuman primates and pose a severe threat to public health. The interferon-induced transmembrane (IFITM) proteins can restrict entry of ebolaviruses, influenza A viruses, and other enveloped viruses. However, the breadth and mechanism of the antiviral activity of IFITM proteins are incompletely understood. Here, we employed ebolavirus glycoprotein-pseudotyped vectors and ebolavirus-like particles to address this question. We show that IFITM proteins inhibit the cellular entry of diverse ebolaviruses and demonstrate that type I interferon induces IFITM protein expression in macrophages, major viral targets. Moreover, we show that IFITM proteins block entry of influenza A viruses and ebolaviruses by different mechanisms and provide evidence that antibodies and IFITM proteins can synergistically inhibit cellular entry of ebolaviruses. These results provide insights into the role of IFITM proteins in infection by ebolaviruses and suggest a mechanism by which antibodies, though poorly neutralizing in vitro, might contribute to viral control in vivo.	[Wrensch, Florian; Karsten, Christina B.; Gnirss, Kerstin; Hoffmann, Markus; Winkler, Michael; Poehlmann, Stefan] German Primate Ctr, Infect Biol Unit, D-37077 Gottingen, Germany; [Karsten, Christina B.] Hannover Med Sch, Inst Cellular Chem, Hannover, Germany; [Lu, Kai; Simmons, Graham] Blood Syst Res Inst, San Francisco, CA USA; [Takada, Ayato] Hokkaido Univ, Res Ctr Zoonosis Control, Div Global Epidemiol, Sapporo, Hokkaido, Japan	Pohlmann, S (reprint author), German Primate Ctr, Infect Biol Unit, Kellnerweg 4, D-37077 Gottingen, Germany.	spoehlmann@dpz.eu			German Research Foundation [PO 716/8-1]; German Ministry for Research and Education (subproject within EBOCON); National Institute of Allergy and Infectious Diseases [R21AI107165]; Leibniz Graduate School Emerging Infectious Diseases; Leibniz Foundation	This work was supported by the German Research Foundation (grant PO 716/8-1 to S. P.), the German Ministry for Research and Education (subproject within EBOCON [S. P.]), Leibniz Graduate School Emerging Infectious Diseases (S. P.), the Leibniz Foundation, and the National Institute of Allergy and Infectious Diseases (grant R21AI107165 to G. S.).	Agua-Agum J, 2015, NEW ENGL J MED, V372, P584, DOI DOI 10.1056/NEJMC1414992; Amini-Bavil-Olyaee S, 2013, CELL HOST MICROBE, V13, P452; Saphire EO, 2013, IMMUNOTHERAPY-UK, V5, P1221, DOI [10.2217/imt.13.124, 10.2217/IMT.13.124]; Marzi A, 2004, J VIROL, V78, P12090, DOI 10.1128/JVI.21.12090-12095.2004; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Kuhl A, 2012, ZOONOSES PUBLIC HLTH, V59, P116, DOI 10.1111/j.1863-2378.2012.01454.x; Zhao XS, 2014, P NATL ACAD SCI USA, V111, P6756, DOI 10.1073/pnas.1320856111; Bertram S, 2013, J VIROL, V87, P6150, DOI 10.1128/JVI.03372-12; Miranda MEG, 2011, J INFECT DIS, V204, pS757, DOI 10.1093/infdis/jir296; Mills TC, 2014, J INFECT DIS, V209, P1028, DOI 10.1093/infdis/jit468; Villinger F, 1999, J INFECT DIS, V179, pS188, DOI 10.1086/514283; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Martinez O, 2012, ANTIVIR RES, V93, P416, DOI 10.1016/j.antiviral.2012.01.011; Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10; Perreira JM, 2013, J MOL BIOL, V425, P4937, DOI 10.1016/j.jmb.2013.09.024; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; John SP, 2013, J VIROL, V87, P7837, DOI 10.1128/JVI.00481-13; Maruyama J, 2014, J VIROL, V88, P99, DOI 10.1128/JVI.02265-13; Kajihara M, 2012, J VIROL, V86, P13467, DOI 10.1128/JVI.01896-12; Hutchinson KL, 2007, J INFECT DIS, V196, pS357, DOI 10.1086/520611; Geisbert TW, 2003, AM J PATHOL, V163, P2347, DOI 10.1016/S0002-9440(10)63591-2; Simmons G, 2003, VIROLOGY, V305, P115, DOI 10.1006/viro.2002.1730; Kuhn JH, 2010, ARCH VIROL, V155, P2083, DOI 10.1007/s00705-010-0814-x; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Lin TY, 2013, CELL REP, V5, P895, DOI 10.1016/j.celrep.2013.10.033; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; Taniguchi S, 2011, EMERG INFECT DIS, V17, P1559, DOI 10.3201/eid1708.101693; Ng M, 2014, VIROLOGY, V468, P637, DOI 10.1016/j.virol.2014.08.019; Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909; Compton AA, 2014, CELL HOST MICROBE, V16, P736, DOI 10.1016/j.chom.2014.11.001; Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124; Misasi J, 2014, CELL, V159, P477, DOI 10.1016/j.cell.2014.10.006; Nakayama E, 2011, J INFECT DIS, V204, pS978, DOI 10.1093/infdis/jir334; Negredo A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002304; Qian J, 2015, VIROLOGY, V474, P10, DOI 10.1016/j.virol.2014.10.015; Williams DEJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110096; World Health Organization (WHO), EB RESP ROADM SIT RE; Wrensch F, 2014, VIRUSES-BASEL, V6, P3683, DOI 10.3390/v6093683; Zhang YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2433; Zhang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049265	44	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-1899	1537-6613		J INFECT DIS	J. Infect. Dis.	OCT 1	2015	212			2			S210	S218		10.1093/infdis/jiv255		9	Immunology; Infectious Diseases; Microbiology	Immunology; Infectious Diseases; Microbiology	CU0EP	WOS:000363189100019		
J	Carrasco, N; Green, T; Itoh, N				Carrasco, Noelia; Green, Timothy; Itoh, Naoki			Marteilia spp. parasites in bivalves: A revision of recent studies	JOURNAL OF INVERTEBRATE PATHOLOGY			English	Article						Marteilia sp.; M. refringens; M. sydneyi; M. cochillia; M. granula; M. chungmuensis	OYSTER CRASSOSTREA-GIGAS; SYDNEY ROCK OYSTERS; COCKLE CERASTODERMA-EDULE; IN-SITU HYBRIDIZATION; MUSSELS MYTILUS-GALLOPROVINCIALIS; GALICIA NW SPAIN; SPANISH MEDITERRANEAN COAST; SACCOSTREA-GLOMERATA GOULD; COPEPOD PARACARTIA-GRANI; INITIAL INFECTIVE STAGES	Marteilia spp. parasites are Paramyxean organisms that affect several commercial species of molluscs, and thus have a socio-economical impact. These parasites also have an ecological impact on the biodiversity and population dynamics of natural mollusc beds. It has been over forty years since the first description of Marteilia refringens, the first Marteilia species described. Despite four decades of research, the biology, cellular development, as well as the life cycle of Marteilia parasites are not fully understood. In recent years, new studies have reported advances in knowledge of the life cycle, the description of new species, the development of new molecular detection/discrimination tools, new data on biotype geographical distribution, as well as new information on host response and defence mechanisms. Such information is summarized, reported and discussed in the present review in order to facilitate a new overview of the subject. However, numerous knowledge gaps are still unresolved and need to be prioritized in the research and funding institution agendas. (C) 2015 Elsevier Inc. All rights reserved.	[Carrasco, Noelia] IRTA St Carles Rapita, Tarragona 43540, Spain; [Green, Timothy] Macquarie Univ, Dept Biol Sci, N Ryde, NSW 2109, Australia; [Itoh, Naoki] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Fish Dis, Tokyo 1138657, Japan	Carrasco, N (reprint author), IRTA, Ctra Poblenou Km 5,AP 200, Tarragona 43540, Spain.	noelia.carrasco@irta.es			Macquarie University Postdoctoral Research Scheme [9201300681]	NC, would like to thank the INIA postdoctoral contract (Spanish Government) that has partially covered her professional life between 2009 and early 2015. Thanks also to the INIA Complementary Action project 2014/2015, which supported the 1st Paramyxean Working Group meeting in February 2015. The authors acknowledge funding provided to TG by Macquarie University Postdoctoral Research Scheme (Grant: 9201300681).	Adlard R. D., 1995, Bulletin of the European Association of Fish Pathologists, V15, P119; Adlard R.D., 2005, AQUATIC ANIMAL HLTH, P1; Anderson R.S., 1994, AUST J MAR FRESHW RE, V45, P1285; Segarra A, 2010, VIRUS RES, V153, P92, DOI 10.1016/j.virusres.2010.07.011; Kleeman SN, 2002, PARASITOLOGY, V125, P131, DOI 10.1017/S0031182002001919; Kleeman SN, 2000, DIS AQUAT ORGAN, V40, P137, DOI 10.3354/dao040137; Carrasco N, 2011, AQUACULTURE, V321, P197, DOI 10.1016/j.aquaculture.2011.09.018; HUTCHINGS P, 1979, J NAT HIST, V13, P745, DOI 10.1080/00222937900770561; Renault T, 1995, DIS AQUAT ORGAN, V23, P161, DOI 10.3354/dao023161; Novoa B, 2005, J FISH DIS, V28, P331, DOI 10.1111/j.1365-2761.2005.00634.x; Green TJ, 2010, MAR ECOL PROG SER, V402, P161, DOI 10.3354/meps08430; Boyer S, 2013, INT J PARASITOL, V43, P1089, DOI 10.1016/j.ijpara.2013.07.008; Carrasco N, 2008, J FISH DIS, V31, P153, DOI 10.1111/j.1365-2761.2007.00865.x; Balseiro P, 2007, B EUR ASSOC FISH PAT, V27, P148; Itoh N, 2003, DIS AQUAT ORGAN, V54, P163, DOI 10.3354/dao054163; Choi HJ, 2012, J INVERTEBR PATHOL, V111, P27, DOI 10.1016/j.jip.2012.05.004; Berthe FCJ, 1998, DIS AQUAT ORGAN, V34, P135, DOI 10.3354/dao034135; Kleeman SN, 2004, MOL CELL PROBE, V18, P133, DOI 10.1016/j.mcp.2003.11.002; Longshaw M, 2001, DIS AQUAT ORGAN, V44, P137, DOI 10.3354/dao044137; Carrasco N, 2012, AQUACULTURE, V324, P20, DOI 10.1016/j.aquaculture.2011.10.017; FRANC A, 1980, CAH BIOL MAR, V21, P99; Peters R, 2003, AQUACULTURE, V223, P29, DOI 10.1016/S0044-8486(03)00169-8; Lopez-Flores I, 2008, MOL CELL PROBE, V22, P151, DOI 10.1016/j.mcp.2008.01.002; Audemard C, 2002, PARASITOLOGY, V124, P315, DOI 10.1017/S0031182001001111; AUFFRET M, 1987, AQUACULTURE, V67, P255, DOI 10.1016/0044-8486(87)90048-2; Audemard C, 2001, J EXP MAR BIOL ECOL, V257, P87, DOI 10.1016/S0022-0981(00)00330-0; Carrasco N, 2008, J FISH DIS, V31, P497, DOI 10.1111/j.1365-2761.2008.00910.x; Itoh N, 2002, FISH PATHOL, V37, P23; Itoh N, 2004, INT J PARASITOL, V34, P1129, DOI 10.1016/j.ijpara.2004.06.001; Arzul I, 2014, PARASITOLOGY, V141, P227, DOI 10.1017/S0031182013001418; Dove MC, 2013, AQUAC RES, V44, P1791, DOI 10.1111/are.12012; Villalba A, 2014, DIS AQUAT ORGAN, V109, P55, DOI 10.3354/dao02723; NORTON JH, 1993, J INVERTEBR PATHOL, V61, P328, DOI 10.1006/jipa.1993.1063; Itoh N, 2004, J FISH DIS, V27, P311, DOI 10.1111/j.1365-2761.2004.00540.x; Kleeman SN, 2002, INT J PARASITOL, V32, P767, DOI 10.1016/S0020-7519(02)00025-5; Feist SW, 2009, FOLIA PARASIT, V56, P73; Simonian M, 2009, J FISH DIS, V32, P367, DOI 10.1111/j.1365-2761.2009.01022.x; Itoh N, 2003, FISH PATHOL, V38, P163; ROBLEDO JAF, 1994, DIS AQUAT ORGAN, V18, P211, DOI 10.3354/dao018211; Lopez C, 2006, J INVERTEBR PATHOL, V92, P109, DOI 10.1016/j.jip.2006.03.002; Wang ZW, 2012, J AQUAT ANIM HEALTH, V24, P161, DOI 10.1080/08997659.2012.675926; Lopez-Flores I, 2004, PARASITOLOGY, V129, P411, DOI 10.1017/S0031182004005827; Lee MK, 2001, AQUACULTURE, V201, P199, DOI 10.1016/S0044-8486(01)00648-2; Itoh N, 2005, J INVERTEBR PATHOL, V88, P201, DOI 10.1016/j.jip.2004.12.001; MOYER MA, 1993, J SHELLFISH RES, V12, P305; Lopez-Flores I, 2008, DIS AQUAT ORGAN, V82, P79, DOI 10.3354/dao01966; ROUBAL FR, 1989, AUST J MAR FRESH RES, V40, P155; Le Roux F, 1999, MAR BIOTECHNOL, V1, P588, DOI 10.1007/PL00011814; Carrasco N, 2013, AQUACULTURE, V412, P223, DOI 10.1016/j.aquaculture.2013.07.027; COMPS M, 1975, CR ACAD SCI D NAT, V281, P179; Butt D, 2007, MAR FRESHWATER RES, V58, P213, DOI 10.1071/MF06080; Wesche SJ, 1999, DIS AQUAT ORGAN, V36, P221, DOI 10.3354/dao036221; Diggles BK, 2013, NEW ZEAL J MAR FRESH, V47, P561, DOI 10.1080/00288330.2013.781511; Carrasco N, 2007, PARASITOLOGY, V134, P1541, DOI 10.1017/S0031182007003009; Green TJ, 2011, J SHELLFISH RES, V30, P47, DOI 10.2983/035.030.0108; VANBANNING P, 1979, MAR FISH REV, V41, P8; Tun KL, 2008, DIS AQUAT ORGAN, V80, P157, DOI 10.3354/dao01924; Kuchel RP, 2010, J INVERTEBR PATHOL, V104, P97, DOI 10.1016/j.jip.2010.02.001; Camacho AP, 1997, J SHELLFISH RES, V16, P77; Adlard RD, 2015, INT J PARASITOL, V45, P419, DOI 10.1016/j.ijpara.2015.02.002; Imanaka S, 2001, FISH PATHOL, V36, P83; Cavalier-Smith T, 2003, PROTIST, V154, P341, DOI 10.1078/143446103322454112; Ngo TTT, 2003, DIS AQUAT ORGAN, V56, P259, DOI 10.3354/dao056259; ANDERSON TJ, 1992, J PROTOZOOL, V39, P502, DOI 10.1111/j.1550-7408.1992.tb04839.x; Elgharsalli R, 2013, J INVERTEBR PATHOL, V112, P175, DOI 10.1016/j.jip.2012.11.004; BALOUET G, 1979, MAR FISH REV, V41, P64; Green TJ, 2009, FISH SHELLFISH IMMUN, V26, P799, DOI 10.1016/j.fsi.2009.03.003; Hine PM, 2000, DIS AQUAT ORGAN, V40, P67, DOI 10.3354/dao040067; Tun KL, 2008, INT J PARASITOL, V38, P211, DOI 10.1016/j.ijpara.2007.07.002; BOUGRIER S, 1986, AQUACULTURE, V58, P151, DOI 10.1016/0044-8486(86)90165-1; Butt D, 2006, AQUACULTURE, V251, P159, DOI 10.1016/j.aquaculture.2005.05.045; CAHOUR A, 1979, MAR FISH REV, V41, P19; Paul-Pont I, 2014, AQUACULTURE, V422, P146, DOI 10.1016/j.aquaculture.2013.12.009; Le Roux F, 2001, J EUKARYOT MICROBIOL, V48, P449, DOI 10.1111/j.1550-7408.2001.tb00178.x; Robert R, 1991, AQUAT LIVING RESOUR, V4, P265, DOI 10.1051/alr:1991028; Jenkins C, 2013, DIS AQUAT ORGAN, V105, P109, DOI 10.3354/dao02623; ALDERMAN DJ, 1979, MAR FISH REV, V41, P67; PERKINS FO, 1976, J PARASITOL, V62, P528, DOI 10.2307/3279407; O'Connor WA, 2009, J SHELLFISH RES, V28, P803, DOI 10.2983/035.028.0409; Anderson TJ, 1995, J FISH DIS, V18, P507, DOI 10.1111/j.1365-2761.1995.tb00354.x; Berthe FCJ, 2004, AQUAT LIVING RESOUR, V17, P433, DOI 10.1051/alr:2004051; Gombac M, 2014, J FISH DIS, V37, P805, DOI 10.1111/jfd.12174; Balouet G, 1977, HAPL HAPL LIK DIS SH, V41, P64; Carrasco N., 2013, 16 INT C EUR ASS FIS, P226; Cavalier-Smith T, 1998, BIOL REV, V73, P203, DOI 10.1017/S0006323198005167; Ceschia G., 1992, B SOC ITAL PATOL ITT, P24; Ceschia G., 2001, B SOC ITAL PATOL ITT, V13, P20; Chatton E., 1911, CR HEBD ACAD SCI, V152, P631; Comps M., 1985, Revue des Travaux de l'Institut des Peches Maritimes, V47, P99; Comps M., 1982, PARASITIC DIS DUE MA, P3; Comps M., 1980, SCI PECHE, P19; Comps M., 1970, Revue Trav. Inst. Pech. marit., V34, P317; COMPS M, 1986, Protistologica, V22, P279; Fuentes J., 2002, AQUACULTURE, V213, P1; Garcia C., 2009, 101 ANN M NAT SHELLF; Grizel H., 1974, SCI PECHE, V240-241, P1; Grizel H., 1983, Revue des Travaux de l'Institut des Peches Maritimes, V46, P209; Grizel H., 1985, THESIS U SCI TECHNIQ; Hegaret H., 2005, J SHELLFISH RES, V24, P1263; Herrbach B., 1971, REV TRAV I PECHES, V35, P79; Hine, 1997, DIS AQUAT ORGAN, V29, P197; Itoh N, 2014, FISH PATHOL, V49, P181; Jones B.J., 2006, J SHELLFISH RES, V25, P233; Kapllan S., 2006, ITTIOPATOLOGIA, V3, P47; Lester R.J.G., 1986, P33; Limpanont Yanin, 2013, J Invertebr Pathol, V114, P277, DOI 10.1016/j.jip.2013.08.008; Montes J., 1998, Bulletin of the European Association of Fish Pathologists, V18, P124; Nell J.A., 2001, MAR FISH REV, V63, P14; Park M.S., 1986, J FISH PATHOL, V2, P53; Pascual M., 1991, TESTING ARGENTINA OY; Pasqual S., 2010, BIOL INVASIONS, V12, P2091; Poder M., 1983, C BAS BIOL AQ DEC 12, P125; ROBLEDO JAF, 1995, J PARASITOL, V81, P354, DOI 10.2307/3283816; Roy M.A., 1978, J ANIM ECOL, V47, P219; Ruano F, 1994, SEMINARIO RECURSOS H, V1, P195; Siihnel S., 2014, DIS AQUAT ORGAN, V109, P241; Taveekijakarn P., 2008, DIS ASIAN AQUACULTUR, VVI, P335; Taveekijakarn P., 2002, AAHRI NEWS, V11, P1; Tige G., 1976, CIEM CM K, V21, P1; Tiscar P.G., 1993, B SOC ITAL PATOL ITT, V5, P40; Villalba A., 1992, CUAD AREA CIENC MAR, P201; VILLALBA A, 1993, DIS AQUAT ORGAN, V17, P205, DOI 10.3354/dao017205; Villalba A., 1993, ACT 4 C NAC AC, P551; Virilis C., 2006, AQUACULTURE, V259, P1; Wesche S.J., 1995, Bulletin of the European Association of Fish Pathologists, V15, P23; Zrnicic S., 2001, DIS AQUAT ORGAN, V44, P143	126	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-2011	1096-0805		J INVERTEBR PATHOL	J. Invertebr. Pathol.	OCT	2015	131						43	57		10.1016/j.jip.2015.07.016		15	Zoology	Zoology	CT8PA	WOS:000363077300005		
J	Schaller, M; Ito, T; Allen, RM; Kroetz, D; Kittan, N; Ptaschinski, C; Cavassani, K; Carson, WF; Godessart, N; Grembecka, J; Cierpicki, T; Dou, YL; Kunkel, SL				Schaller, Matthew; Ito, Toshihiro; Allen, Ronald M.; Kroetz, Danielle; Kittan, Nicolai; Ptaschinski, Catherine; Cavassani, Karen; Carson, William F.; Godessart, Nuria; Grembecka, Jolanta; Cierpicki, Tomasz; Dou, Yali; Kunkel, Steven L.			Epigenetic regulation of IL-12-dependent T cell proliferation	JOURNAL OF LEUKOCYTE BIOLOGY			English	Article						trithorax; Th1 differentiation; histone methylation; STAT4	MIXED-LINEAGE LEUKEMIA; TRANSCRIPTION FACTOR; GENE-EXPRESSION; TARGET GENES; IFN-GAMMA; TH2 CELLS; CYCLIN D3; IN-VIVO; MLL; RESPONSES	It is well established that the cytokine IL-12 and the transcription factor STAT4, an essential part of the IL-12 signaling pathway, are critical components of the Th1 differentiation process in T cells. In response to pathogenic stimuli, this process causes T cells to proliferate rapidly and secrete high amounts of the cytokine IFN-gamma, leading to the Th1 proinflammatory phenotype. However, there are still unknown components of this differentiation pathway. We here demonstrated that the expression of the histone methyltransferase Mll1 is driven by IL-12 signaling through STAT4 in humans and mice and is critical for the proper differentiation of a naive T cell to a Th1 cell. Once MLL1 is upregulated by IL-12, it regulates the proliferation of Th1 cells. As evidence of this, we show that Th1 cells from Mll1(+/-) mice are unable to proliferate rapidly in a Th1 environment in vitro and in vivo. Additionally, upon restimulation with cognate antigen Mll1(+/-), T cells do not convert to a Th1 phenotype, as characterized by IFN-gamma output. Furthermore, we observed a reduction in IFN-gamma production and proliferation in human peripheral blood stimulated with tetanus toxoid by use of a specific inhibitor of the MLL1/menin complex. Together, our results demonstrate that the MLL1 gene plays a previously unrecognized but essential role in Th1 cell biology and furthermore, describes a novel pathway through which Mll1 expression is regulated.	[Schaller, Matthew; Allen, Ronald M.; Kroetz, Danielle; Kittan, Nicolai; Ptaschinski, Catherine; Cavassani, Karen; Carson, William F.; Grembecka, Jolanta; Cierpicki, Tomasz; Dou, Yali; Kunkel, Steven L.] Univ Michigan, Dept Pathol, Sch Med, Ann Arbor, MI 48109 USA; [Ito, Toshihiro] Nara Med Univ, Dept Immunol, Nara, Japan; [Godessart, Nuria] Almirall SA, Dermatol Res, Sant Feliu de Llobregat, Spain	Schaller, M (reprint author), Univ Michigan, 109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	mschalle@umich.edu			U.S. National Institutes of Health National Heart, Lung, and Blood Institute [HL112897, HL31237, HL89216]	Funding for this research was provided by U.S. National Institutes of Health National Heart, Lung, and Blood Institute Grants HL112897, HL31237, and HL89216. The authors thank the Pathology Flow Cytometry Core for its help and support, Lisa Johnson for preparation of histological samples, and Dr. Judith Connett for her critical reading of the manuscript.	Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Elo LL, 2010, IMMUNITY, V32, P852, DOI 10.1016/j.immuni.2010.06.011; Hess JL, 1997, BLOOD, V90, P1799; DOMER PH, 1993, P NATL ACAD SCI USA, V90, P7884, DOI 10.1073/pnas.90.16.7884; Matsumura I, 1999, EMBO J, V18, P1367, DOI 10.1093/emboj/18.5.1367; O'Sullivan A, 2004, J BIOL CHEM, V279, P7339, DOI 10.1074/jbc.M309979200; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003; Kaech SM, 2001, NAT IMMUNOL, V2, P415; AJCHENBAUM F, 1993, J BIOL CHEM, V268, P4113; Li QS, 2006, J IMMUNOL, V177, P7618; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Shi AB, 2012, BLOOD, V120, P4461, DOI 10.1182/blood-2012-05-429274; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Schuettengruber B, 2011, NAT REV MOL CELL BIO, V12, P799, DOI 10.1038/nrm3230; Finkelman FD, 2000, J IMMUNOL, V164, P2303; Pepper M, 2011, NAT IMMUNOL, V12, P467, DOI 10.1038/ni.2038; Good SR, 2009, J IMMUNOL, V183, P3839, DOI 10.4049/jimmunol.0901411; Usui T, 2006, J EXP MED, V203, P755, DOI 10.1084/jem.20052165; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Nishikomori R, 2002, J IMMUNOL, V169, P4388; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Lund RJ, 2004, J IMMUNOL, V172, P6775; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; de Bruin AM, 2012, BLOOD, V119, P1543, DOI 10.1182/blood-2011-07-367706; McMahon KA, 2007, CELL STEM CELL, V1, P338, DOI 10.1016/j.stem.2007.07.002; Yagi H, 1998, BLOOD, V92, P108; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Kanno Y, 2012, ANNU REV IMMUNOL, V30, P707, DOI 10.1146/annurev-immunol-020711-075058; Muntean AG, 2012, ANNU REV PATHOL-MECH, V7, P283, DOI 10.1146/annurev-pathol-011811-132434; Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Weng AP, 2003, CANCER CELL, V4, P417, DOI 10.1016/S1535-6108(03)00305-2; Pakpour N, 2008, J IMMUNOL, V180, P8299; Calo V, 2003, J CELL PHYSIOL, V197, P157, DOI 10.1002/jcp.10364; Liu H, 2007, GENE DEV, V21, P2385, DOI 10.1101/gad.1574507; Thieu VT, 2008, IMMUNITY, V29, P679, DOI 10.1016/j.immuni.2008.08.017; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Miyatake S, 1997, EUR J IMMUNOL, V27, P1816, DOI 10.1002/eji.1830270733; Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Onodera A, 2010, J EXP MED, V207, P2493, DOI 10.1084/jem.20100760; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Sicinska E, 2003, CANCER CELL, V4, P451, DOI 10.1016/S1535-6108(03)00301-5; Yoo JK, 2002, J IMMUNOL, V169, P3637; Martino A, 2001, J IMMUNOL, V166, P1723; Takeda S, 2006, GENE DEV, V20, P2397, DOI 10.1101/gad.1449406; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Allan RS, 2012, NATURE, V487, P249, DOI 10.1038/nature11173; Yamashita M, 2006, IMMUNITY, V24, P611, DOI 10.1016/j.immuni.2006.03.017; CHENSUE SW, 1994, AM J PATHOL, V145, P1105; Kock J, 2014, J BIOL CHEM, V289, P26752, DOI 10.1074/jbc.M114.587865; Savarin C, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-104; Warner J. D., 2011, J IMMUNOL, V186, P4234	56	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0741-5400	1938-3673		J LEUKOCYTE BIOL	J. Leukoc. Biol.	OCT	2015	98	4					601	613		10.1189/jlb.1A0814-375RR		13	Cell Biology; Hematology; Immunology	Cell Biology; Hematology; Immunology	CT5FA	WOS:000362832700018		
J	Bsat, M; Chapuy, L; Baba, N; Rubio, M; Panzini, B; Wassef, R; Richard, C; Soucy, G; Mehta, H; Sarfati, M				Bsat, Marwa; Chapuy, Laurence; Baba, Nobuyasu; Rubio, Manuel; Panzini, Benoit; Wassef, Ramses; Richard, Carole; Soucy, Genevieve; Mehta, Heena; Sarfati, Marika			Differential accumulation and function of proinflammatory 6-sulfo LacNAc dendritic cells in lymph node and colon of Crohn's versus ulcerative colitis patients	JOURNAL OF LEUKOCYTE BIOLOGY			English	Article						inflammatory bowel diseases; human; CD172; CD47; cytokines	INFLAMMATORY-BOWEL-DISEASE; CD47; HOMEOSTASIS; EXPRESSION; SUBSET; TISSUE; TNF	Human Slan DCs have been studied in patients with psoriasis, rheumatoid arthritis, cancer, and autoimmune diseases. In this study, we investigated the frequency, phenotype, and function of Slan DCs in blood, colon, as well as mLNs of patients with IBD. We first show that the frequency of circulating CD14(dull)Slan DCs was reduced in CD patients refractory to immunosuppressive drugs or TNF-alpha blockers relative to untreated CD, UC, and healthy subjects. In blood of CD patients, Slan DCs expressed CD172a, as detected by CD47 fusion protein binding, when compared with its lack of expression in control subjects. Next, we demonstrate that CD172a(+)Slan DCs that produced IL-1 beta and TNF-alpha accumulated in mLNs and colons of CD patients. The CD172a(+)Slan DCs upregulated their expression of CD14 in CD tissues and the proinflammatory cytokines were produced in CD14(bright)CD172a(+)Slan DCs. By contrast, no difference was noted in the frequency of Slan DCs between inflamed, noninflamed colonic mucosa of UC patients and control, non-IBD donors. Finally, the percentage of cytokine-producing Slan DCs also augmented in response to TLR2 and NOD2 in in vitro stimulation in PBMCs of CD, but not UC, patients. In conclusion, we propose that proinflammatory CD14(bright)CD172a(+)Slan DCs are a distinguishing feature between CD and UC, as these cells accumulate uniquely in mLNs and colonic mucosa of CD patients. Thus, Slan DCs may contribute to CD immunopathogenesis.	[Bsat, Marwa; Chapuy, Laurence; Rubio, Manuel; Mehta, Heena; Sarfati, Marika] CRCHUM, Immunoregulat Lab, Montreal, PQ H2X 0A9, Canada; [Baba, Nobuyasu] Kochi Univ, Sch Med, Ctr Innovat & Translat Med, Kochi 780, Japan; [Panzini, Benoit] Ctr Hosp Univ Montreal, Dept Gastroenterol, Montreal, PQ, Canada; [Wassef, Ramses; Richard, Carole] Ctr Hosp Univ Montreal, Dept Digest Tract Surg, Montreal, PQ, Canada; [Soucy, Genevieve] Ctr Hosp Univ Montreal, Dept Pathol, Montreal, PQ, Canada	Sarfati, M (reprint author), CRCHUM, Immunoregulat Lab, Tour Viger R-12-424-204,900 St Denis St East, Montreal, PQ H2X 0A9, Canada.	m.sarfati@umontreal.ca			Canadian Institutes for Health and Research (CIHR); Faculte des Etudes Superieures de l'Universite de Montreal	This work has been supported by grants from Canadian Institutes for Health and Research (CIHR) and Faculte des Etudes Superieures de l'Universite de Montreal. The authors thank Carole Bergeron, R.N., for her help in obtaining the surgical samples and the Histology Department in the Centre de Recherche du Centre Hospitalier de l'Universite de Montreal for its technical assistance with the IHC studies.	Randolph GJ, 2002, J EXP MED, V196, P517, DOI 10.1084/jem.20011608; Fortin G, 2009, J EXP MED, V206, P1995, DOI 10.1084/jem.20082805; de Baey A, 2003, J IMMUNOL, V170, P5089; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Schakel K, 2002, IMMUNITY, V17, P289, DOI 10.1016/S1074-7613(02)00393-X; Baba N, 2013, J EXP MED, V210, P1251, DOI 10.1084/jem.20122037; Gunther C, 2013, EXP DERMATOL, V22, P535, DOI 10.1111/exd.12190; Costantini C, 2011, BLOOD, V117, P1677, DOI 10.1182/blood-2010-06-287243; Schakel K, 2006, IMMUNITY, V24, P767, DOI 10.1016/j.immuni.2006.03.020; Gunther C, 2012, CLIN EXP DERMATOL, V37, P169, DOI 10.1111/j.1365-2230.2011.04213.x; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Brain O, 2013, IMMUNITY, V39, P521, DOI 10.1016/j.immuni.2013.08.035; Brunner PM, 2013, J ALLERGY CLIN IMMUN, V132, P1184, DOI 10.1016/j.jaci.2013.05.036; Ogino T, 2013, GASTROENTEROLOGY, V145, P1380, DOI 10.1053/j.gastro.2013.08.049; Van VQ, 2006, EMBO J, V25, P5560, DOI 10.1038/sj.emboj.7601415; Dobel T, 2013, BLOOD, V121, P3609, DOI 10.1182/blood-2012-08-447045; Hansel A, 2013, J AUTOIMMUN, V40, P1, DOI 10.1016/j.jaut.2012.07.005; MacDonald TT, 2011, GASTROENTEROLOGY, V140, P1768, DOI 10.1053/j.gastro.2011.02.047; Watchmaker PB, 2014, NAT IMMUNOL, V15, P98, DOI 10.1038/ni.2768; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Clatworthy MR, 2014, NAT MED, V20, P1458, DOI 10.1038/nm.3709; Hansel A, 2011, J ALLERGY CLIN IMMUN, V127, P787, DOI 10.1016/j.jaci.2010.12.009; Thomas Katja, 2014, Neurol Neuroimmunol Neuroinflamm, V1, pe33, DOI 10.1212/NXI.0000000000000033; Vermi W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4029	24	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0741-5400	1938-3673		J LEUKOCYTE BIOL	J. Leukoc. Biol.	OCT	2015	98	4					671	681		10.1189/jlb.5A1014-509RR		11	Cell Biology; Hematology; Immunology	Cell Biology; Hematology; Immunology	CT5FA	WOS:000362832700025		
J	Nakamura, T; Tamada, D; Yanagi, Y; Itoh, Y; Nemoto, T; Utumi, H; Kose, K				Nakamura, Takashi; Tamada, Daiki; Yanagi, Yousuke; Itoh, Yoshitaka; Nemoto, Takahiro; Utumi, Hiroaki; Kose, Katsumi			Development of a superconducting bulk magnet for NMR and MRI	JOURNAL OF MAGNETIC RESONANCE			English	Article						NMR; MRI; Superconducting bulk magnet; High temperature superconducting material; Shim coil	COIL DESIGN; MAGNETIZATION; SYSTEMS	A superconducting bulk magnet composed of six vertically stacked annular single-domain c-axis-oriented Eu-Ba-Cu-O crystals was energized to 4.74 T using a conventional superconducting magnet for high-resolution NMR spectroscopy. Shim coils, gradient coils, and radio frequency coils for high resolution NMR and MRI were installed in the 23 mm-diameter room-temperature bore of the bulk magnet. A 6.9 ppm peak-to-peak homogeneous region suitable for MRI was achieved in the central cylindrical region (6.2 mm diameter, 9.1 mm length) of the bulk magnet by using a single layer shim coil. A 21 Hz spectral resolution that can be used for high resolution NMR spectroscopy was obtained in the central cylindrical region (1.3 mm diameter, 4 mm length) of the bulk magnet by using a multichannel shim coil. A clear 3D MR image dataset of a chemically fixed mouse fetus with (50 mu m)(3) voxel resolution was obtained in 5.5 h. We therefore concluded that the cryogen-free superconducting bulk magnet developed in this study is useful for high-resolution desktop NMR, MRI and mobile NMR device. (C) 2015 Elsevier Inc. All rights reserved.	[Nakamura, Takashi] RIKEN, Wako, Saitama 3510198, Japan; [Tamada, Daiki; Kose, Katsumi] Univ Tsukuba, Inst Appl Phys, Tsukuba, Ibaraki 3058573, Japan; [Yanagi, Yousuke; Itoh, Yoshitaka] IMRA Mat R&D Co Ltd, Kariya, Aichi 4480021, Japan; [Nemoto, Takahiro; Utumi, Hiroaki] JEOL Resonance, Akishima, Tokyo 1968558, Japan	Kose, K (reprint author), Univ Tsukuba, Inst Appl Phys, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058573, Japan.	kose@bk.tsukuba.ac.jp			Development of Systems and Technologies for Advanced Measurement and Analysis project by Japan Science and Technology Agency	This study was supported by a Development of Systems and Technologies for Advanced Measurement and Analysis project by Japan Science and Technology Agency.	Hashi K, 2015, J MAGN RESON, V256, P30, DOI 10.1016/j.jmr.2015.04.009; Zalesskiy SS, 2014, CHEM REV, V114, P5641, DOI 10.1021/cr400063g; BEAN CP, 1962, PHYS REV LETT, V8, P250, DOI 10.1103/PhysRevLett.8.250; Parkinson BJ, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2012.2235893; Terao Y, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2013.2239342; Razeti M, 2008, IEEE T APPL SUPERCON, V18, P882, DOI 10.1109/TASC.2008.920661; Tamada D, 2013, PHYSICA C, V492, P174, DOI 10.1016/j.physc.2013.06.016; Tomita M, 2003, NATURE, V421, P517, DOI 10.1038/nature01350; Tamada D, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.056701; TURNER R, 1993, MAGN RESON IMAGING, V11, P903, DOI 10.1016/0730-725X(93)90209-V; Tamada D, 2015, SUPERCOND SCI TECH, V28, DOI 10.1088/0953-2048/28/9/095010; Nariki S, 2008, PHYSICA C, V468, P1451, DOI 10.1016/j.physc.2008.05.256; Nakamura T, 2007, CONCEPT MAGN RESON B, V31B, P65, DOI 10.1002/cmr.b.20083; Nariki S, 2002, SUPERCOND SCI TECH, V15, P648, DOI 10.1088/0953-2048/15/5/302; Maeda H, 2014, IEEE T APPL SUPERCON, V24, DOI 10.1109/TASC.2013.2287707; Ogawa K, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3598440; Bliimich B., 2009, CHEM PHYS LETT, V477, P231; Haishi T., 2005, P INT SOC MAGN RESON, V13, P869; Kose K., 2006, NMR IMAGING CHEM ENG, P77; Mitchell J, 2014, PROG NUCL MAG RES SP, V76, P1, DOI 10.1016/j.pnmrs.2013.09.001; Nakamura T., 2011, TEION KOGAKU, V48, P139; ROMEO F, 1984, MAGNET RESON MED, V1, P44, DOI 10.1002/mrm.1910010107; Sakai Naomichi, 2011, Teion Kogaku (Journal of the Cryogenic Society of Japan), V46, DOI 10.2221/jcsj.46.131; Shigeki R., 2010, P INT SOC MAGN RESON, V19, P1542; Slade R A, 2014, IEEE T APPL SUPERCON, V24, P1	25	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1090-7807	1096-0856		J MAGN RESON	J. Magn. Reson.	OCT	2015	259						68	75		10.1016/j.jmr.2015.07.012		8	Biochemical Research Methods; Physics, Atomic, Molecular & Chemical; Spectroscopy	Biochemistry & Molecular Biology; Physics; Spectroscopy	CU2MY	WOS:000363358800008		
J	Matsuki, Y; Nakamura, S; Fukui, S; Suematsu, H; Fujiwara, T				Matsuki, Yoh; Nakamura, Shinji; Fukui, Shigeo; Suematsu, Hiroto; Fujiwara, Toshimichi			Closed-cycle cold helium magic-angle spinning for sensitivity-enhanced multi-dimensional solid-state NMR	JOURNAL OF MAGNETIC RESONANCE			English	Article						Cryogenic magic-angle spinning; Closed-loop helium circulation; Solid-state NMR; Sensitivity enhancement	DYNAMIC NUCLEAR-POLARIZATION; SPECTROSCOPY; TEMPERATURES; RESOLUTION	Magic-angle spinning (MAS) NMR is a powerful tool for studying molecular structure and dynamics, but suffers from its low sensitivity. Here, we developed a novel helium-cooling MAS NMR probe system adopting a closed-loop gas recirculation mechanism. In addition to the sensitivity gain due to low temperature, the present system has enabled highly stable MAS (v(R) = 4-12 kHz) at cryogenic temperatures (T= 35-120 K) for over a week without consuming helium at a cost for electricity of 16 kW/h. High-resolution 1D and 2D data were recorded for a crystalline tri-peptide sample at T=40 K and B-0 = 16.4 T, where an order of magnitude of sensitivity gain was demonstrated versus room temperature measurement. The low-cost and long-term stable MAS strongly promotes broader application of the brute-force sensitivity-enhanced multi-dimensional MAS NMR, as well as dynamic nuclear polarization (DNP)-enhanced NMR in a temperature range lower than 100 K. (C) 2015 The Authors. Published by Elsevier Inc.	[Matsuki, Yoh; Fujiwara, Toshimichi] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Nakamura, Shinji; Suematsu, Hiroto] JEOL RESONANCE Inc, Akishima, Tokyo 1968558, Japan; [Fukui, Shigeo] Cryovac Corp, Nishi Yodogawa, Osaka 5550013, Japan	Fujiwara, T (reprint author), Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	tfjwr@protein.osaka-u.ac.jp			SENTAN, JST; NMR Platform, MEXT	This research was partly supported by SENTAN, JST and the NMR Platform, MEXT.	Beduz C, 2012, P NATL ACAD SCI USA, V109, P12894, DOI 10.1073/pnas.1210790109; Wickramasinghe NP, 2009, NAT METHODS, V6, P215, DOI [10.1038/nmeth.1300, 10.1038/NMETH.1300]; Li SH, 2013, ANNU REP NMR SPECTRO, V78, P1, DOI 10.1016/B978-0-12-404716-7.00001-8; Mizuno T, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3263908; Bajaj VS, 2009, J AM CHEM SOC, V131, P118, DOI 10.1021/ja8045926; Matsuki Y, 2010, ANGEW CHEM INT EDIT, V49, P9215, DOI 10.1002/anie.201003329; TYCKO R, 1995, SCIENCE, V268, P1460, DOI 10.1126/science.7539550; Matsuki Y, 2012, J MAGN RESON, V225, P1, DOI 10.1016/j.jmr.2012.09.008; Thurber KR, 2008, J MAGN RESON, V195, P179, DOI 10.1016/j.jmr.2008.09.015; MACHO V, 1983, J MAGN RESON, V52, P450, DOI 10.1016/0022-2364(83)90170-1; Yan S, 2013, ACCOUNTS CHEM RES, V46, P2047, DOI 10.1021/ar300309s; Beckett P, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4751476; BECERRA LR, 1993, PHYS REV LETT, V71, P3561, DOI 10.1103/PhysRevLett.71.3561; Bajaj VS, 2009, P NATL ACAD SCI USA, V106, P9244, DOI 10.1073/pnas.0900908106; DOTY FD, 1981, REV SCI INSTRUM, V52, P1868, DOI 10.1063/1.1136530; STYLES P, 1984, J MAGN RESON, V60, P397, DOI 10.1016/0022-2364(84)90050-7; Lipton AS, 2001, J MAGN RESON, V151, P48, DOI 10.1006/jmre.2001.2353; Concistre M, 2013, ACCOUNTS CHEM RES, V46, P1914, DOI 10.1021/ar300323c; Barnes AB, 2010, PHYS CHEM CHEM PHYS, V12, P5861, DOI 10.1039/c003763j; Hansen MR, 2013, ACCOUNTS CHEM RES, V46, P1996, DOI 10.1021/ar300338b; Koers EJ, 2014, J BIOMOL NMR, V60, P157, DOI 10.1007/s10858-014-9865-8; Mito T., 2004, J CRYOGENICS SUPERCO, V39, P182; Tycko R, 2013, ACCOUNTS CHEM RES, V46, P1923, DOI 10.1021/ar300358z	23	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1090-7807	1096-0856		J MAGN RESON	J. Magn. Reson.	OCT	2015	259						76	81		10.1016/j.jmr.2015.08.003		6	Biochemical Research Methods; Physics, Atomic, Molecular & Chemical; Spectroscopy	Biochemistry & Molecular Biology; Physics; Spectroscopy	CU2MY	WOS:000363358800009		
J	Suzuki, T				Suzuki, Takayuki			Perturbative harmonic modulation of longitudinal electron-spin magnetization for short T-1 determination	JOURNAL OF MAGNETIC RESONANCE			English	Article						Electron spin resonance (ESR); Spin-lattice relaxation; Longitudinal detection (LOD); LOD-T-1; Perturbative harmonic modulation	PULSED EPR SPECTROMETER; RELAXATION; SPECTROSCOPY; RESONANCE; NMR	Longitudinally detected T-1 measurement scheme (LOD-T-1) is studied in detail. In contrast to the original work on LOD-T-1, using high power microwave pulses, this work deals with general and practically frequent cases in which perfect inversion of the electron-spin magnetization is not feasible due to the effect of relaxation during microwave pulses. Theoretical studies, numerical simulations, and experiments reveal a pair of separate contributions of the dynamics of the longitudinal magnetization to the LOD signal, namely, the periodic modulation and the relaxation contributions. The latter alone which is of interest can be extracted to give relaxation curves. In addition, it is shown that T-1 information can be obtained even when the available microwave power is so low that the electron magnetization can only be perturbatively modulated, at the cost of reduced sensitivity. To overcome this, a modified pulse sequence is proposed. In this new method, the pulse excitations are repeated during half a period of the resonance of the longitudinal detection circuit. The method is called the perturbative harmonic modulation method for longitudinally detected T-1 measurement (HM-LOD-T-1). HM-LOD-T-1 experiments are demonstrated in 2,2-diphenyl-1-picrylhydrazyl (DPPH). (C) 2015 Elsevier Inc. All rights reserved.	JEOL RESONANCE Inc, Akishima, Tokyo 1968558, Japan	Suzuki, T (reprint author), JEOL RESONANCE Inc, Akishima, Tokyo 1968558, Japan.	taksuzuk@jeol.co.jp					Granwehr J, 2001, APPL MAGN RESON, V20, P137, DOI 10.1007/BF03162315; BRANDLE R, 1970, Z NATURFORSCH PT A, VA 25, P1; BLOEMBERGEN N, 1954, PHYS REV, V93, P72, DOI 10.1103/PhysRev.93.72; Cernescu A, 2008, J MAGN RESON, V192, P78, DOI 10.1016/j.jmr.2008.02.018; Panagiotelis I, 2001, J MAGN RESON, V149, P74, DOI 10.1006/jmre.2000.2282; PERCIVAL PW, 1975, REV SCI INSTRUM, V46, P1522, DOI 10.1063/1.1134096; SCHWEIGER A, 1988, J MAGN RESON, V77, P512, DOI 10.1016/0022-2364(88)90009-1; HUISJEN M, 1974, REV SCI INSTRUM, V45, P669, DOI 10.1063/1.1686710; Takeda K, 2011, ANNU REP NMR SPECTRO, V74, P355, DOI 10.1016/B978-0-08-097072-1.00007-8; Takeda K, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2712940; Takeda K, 2008, J MAGN RESON, V192, P218, DOI 10.1016/j.jmr.2008.02.019; Colligiani A, 1992, APPL MAGN RESON, V3, P107; Brunner W., 1971, Experimentelle Technik der Physik, V19; Eaton G. R., 1998, FDN MODERN EPR; Jeschke G., 2001, PRINCIPLES PULSE ELE	15	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1090-7807	1096-0856		J MAGN RESON	J. Magn. Reson.	OCT	2015	259						95	101		10.1016/j.jmr.2015.08.006		7	Biochemical Research Methods; Physics, Atomic, Molecular & Chemical; Spectroscopy	Biochemistry & Molecular Biology; Physics; Spectroscopy	CU2MY	WOS:000363358800012		
J	Sakurai, T; Fujimoto, K; Matsui, R; Kawasaki, K; Okubo, S; Ohta, H; Matsubayashi, K; Uwatoko, Y; Tanaka, H				Sakurai, T.; Fujimoto, K.; Matsui, R.; Kawasaki, K.; Okubo, S.; Ohta, H.; Matsubayashi, K.; Uwatoko, Y.; Tanaka, H.			Development of multi-frequency ESR system for high-pressure measurements up to 2.5 GPa	JOURNAL OF MAGNETIC RESONANCE			English	Article						High-pressure ESR; Hybrid-type pressure cell; ZrO2-based ceramic; NiSnCl6 center dot 6H(2)O; CsCuCl3	DIAMOND-ANVIL CELL; HIGH-FIELD; SUPERCONDUCTIVITY; NISNCL6.6H2O	A new piston-cylinder pressure cell for electron spin resonance (ESR) has been developed. The pressure cell consists of a double-layer hybrid-type cylinder with internal components made of the ZrO2-based ceramics. It can generate a pressure of 2 GPa repeatedly and reaches a maximum pressure of around 2.5 GPa. A high-pressure ESR system using a cryogen-free superconducting magnet up 10T has also been developed for this hybrid-type pressure cell. The frequency region is from 50 GHz to 400 GHz. This is the first time a pressure above 2 GPa has been achieved in multi-frequency ESR system using a piston-cylinder pressure cell. We demonstrate its potential by showing the results of the high-pressure ESR of the S = 1 system with the single ion anisotropy NiSnCl6 center dot 6H(2)O and the S = 1/2 quantum spin system CsCuCl3. We performed ESR measurements of these systems above 2 GPa successfully. (C) 2015 Elsevier Inc. All rights reserved.	[Sakurai, T.] Kobe Univ, Ctr Supports Res & Educ Act, Nada Ku, Kobe, Hyogo 6578501, Japan; [Fujimoto, K.; Matsui, R.; Kawasaki, K.; Ohta, H.] Kobe Univ, Grad Sch Sci, Nada Ku, Kobe, Hyogo 6578501, Japan; [Okubo, S.; Ohta, H.] Kobe Univ, Mol Photosci Res Ctr, Nada Ku, Kobe, Hyogo 6578501, Japan; [Matsubayashi, K.; Uwatoko, Y.] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan; [Tanaka, H.] Tokyo Inst Technol, Dept Phys, Meguro Ku, Tokyo 1528550, Japan	Sakurai, T (reprint author), Kobe Univ, Ctr Supports Res & Educ Act, Nada Ku, Kobe, Hyogo 6578501, Japan.	tsakurai@kobe-u.ac.jp			Japan Society for the Promotion of Science [25400341]	This research was partially supported by a Grant-in-Aid for Scientific Research (C) (No. 25400341) from the Japan Society for the Promotion of Science.	Mirebeau I, 2002, NATURE, V420, P54, DOI 10.1038/nature01157; BARNETT JD, 1978, REV SCI INSTRUM, V49, P348, DOI 10.1063/1.1135405; SMITH TF, 1967, PHYS REV, V159, P353, DOI 10.1103/PhysRev.159.353; Sakurai T, 2012, J MAGN RESON, V223, P41, DOI 10.1016/j.jmr.2012.07.020; BIRECKOVEN B, 1988, J PHYS E SCI INSTRUM, V21, P841, DOI 10.1088/0022-3735/21/9/004; Sakurai T, 2006, J PHYS CONF SER, V51, P565, DOI 10.1088/1742-6596/51/1/128; MYERS BE, 1972, PHYS REV B, V6, P3488, DOI 10.1103/PhysRevB.6.3488; Sakurai T, 2010, J PHYS CONF SER, V215, DOI 10.1088/1742-6596/215/1/012184; TANAKA H, 1992, J PHYS SOC JPN, V61, P1344, DOI 10.1143/JPSJ.61.1344; Uwatoko Y, 2003, PHYSICA B, V329, P1658, DOI 10.1016/S0921-4526(02)02449-3; AJIRO Y, 1975, PHYS REV B, V12, P39, DOI 10.1103/PhysRevB.12.39; Ono T, 2001, PHYS REV B, V63; Merchant P, 2014, NAT PHYS, V10, P373, DOI [10.1038/nphys2902, 10.1038/NPHYS2902]; SAKAI N, 1985, REV SCI INSTRUM, V56, P726, DOI 10.1063/1.1138215; Matsumoto M, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.073709; Nafradi B, 2008, J MAGN RESON, V195, P206, DOI 10.1016/j.jmr.2008.09.014; CHRISTY AG, 1994, J PHYS-CONDENS MAT, V6, P3125, DOI 10.1088/0953-8984/6/17/005; Fujiwara N., 2007, REV SCI INSTRUM, V78; Goto K., 2007, J PHYS SOC JPN, V76; Hong T, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.184424; Hong T, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.224409; Kawasaki K., APPL MAGN RESON; Kozlenko DP, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.187207; Ruegg C, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.205701; Sakurai T., 2003, J PHYS SOC JPN, V72, P156; Sakurai T, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2746818; Sakurai T, 2009, J PHYS CONF SER, V150, DOI 10.1088/1742-6596/150/4/042171; Tajiri T., 2006, J PHYS SOC JPN, V75; Thede M, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.087204; Waki T, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.073710	30	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1090-7807	1096-0856		J MAGN RESON	J. Magn. Reson.	OCT	2015	259						108	113		10.1016/j.jmr.2015.08.005		6	Biochemical Research Methods; Physics, Atomic, Molecular & Chemical; Spectroscopy	Biochemistry & Molecular Biology; Physics; Spectroscopy	CU2MY	WOS:000363358800014		
J	Blondelle, J; Ohno, Y; Gache, V; Guyot, S; Storck, S; Blanchard-Gutton, N; Barthelemy, I; Walmsley, G; Rahier, A; Gadin, S; Maurer, M; Guillaud, L; Prola, A; Ferry, A; Aubin-Houzelstein, G; Demarquoy, J; Relaix, F; Piercy, RJ; Blot, S; Kihara, A; Tiret, L; Pilot-Storck, F				Blondelle, Jordan; Ohno, Yusuke; Gache, Vincent; Guyot, Stephane; Storck, Sebastien; Blanchard-Gutton, Nicolas; Barthelemy, Ines; Walmsley, Gemma; Rahier, Anaelle; Gadin, Stephanie; Maurer, Marie; Guillaud, Laurent; Prola, Alexandre; Ferry, Arnaud; Aubin-Houzelstein, Genevieve; Demarquoy, Jean; Relaix, Frederic; Piercy, Richard J.; Blot, Stephane; Kihara, Akio; Tiret, Laurent; Pilot-Storck, Fanny			HACD1, a regulator of membrane composition and fluidity, promotes myoblast fusion and skeletal muscle growth	JOURNAL OF MOLECULAR CELL BIOLOGY			English	Article						centronuclear myopathy; LPC; MUFA; PTPLA; VLCFA	CONGENITAL MYOPATHIES; CENTRONUCLEAR MYOPATHY; SPHINGOLIPID SYNTHESIS; MYOTUBULAR MYOPATHY; FATTY-ACIDS; CELLS; DIFFERENTIATION; REGENERATION; LYSOPHOSPHATIDYLCHOLINE; IDENTIFICATION	The reduced diameter of skeletal myofibres is a hallmark of several congenital myopathies, yet the underlying cellular and molecular mechanisms remain elusive. In this study, we investigate the role of HACD1/PTPLA, which is involved in the elongation of the very long chain fatty acids, in muscle fibre formation. In humans and dogs, HACD1 deficiency leads to a congenital myopathy with fibre size disproportion associated with a generalized muscle weakness. Through analysis of HACD1-deficient Labradors, Hacd1-knockout mice, and Hacd1-deficient myoblasts, we provide evidence that HACD1 promotes myoblast fusion during muscle development and regeneration. We further demonstrate that in normal differentiating myoblasts, expression of the catalytically active HACD1 isoform, which is encoded by a muscle-enriched splice variant, yields decreased lysophosphatidylcholine content, a potent inhibitor of myoblast fusion, and increased concentrations of >= C18 and monounsaturated fatty acids of phospholipids. These lipid modifications correlate with a reduction in plasma membrane rigidity. In conclusion, we propose that fusion impairment constitutes a novel, non-exclusive pathological mechanism operating in congenital myopathies and reveal that HACD1 is a key regulator of a lipid-dependent muscle fibre growth mechanism.	[Blondelle, Jordan; Gache, Vincent; Blanchard-Gutton, Nicolas; Barthelemy, Ines; Rahier, Anaelle; Gadin, Stephanie; Maurer, Marie; Guillaud, Laurent; Prola, Alexandre; Aubin-Houzelstein, Genevieve; Relaix, Frederic; Blot, Stephane; Tiret, Laurent; Pilot-Storck, Fanny] INSERM, IMRB U955 E10, F-94000 Creteil, France; [Blondelle, Jordan; Gache, Vincent; Blanchard-Gutton, Nicolas; Barthelemy, Ines; Rahier, Anaelle; Gadin, Stephanie; Maurer, Marie; Guillaud, Laurent; Prola, Alexandre; Aubin-Houzelstein, Genevieve; Relaix, Frederic; Blot, Stephane; Tiret, Laurent; Pilot-Storck, Fanny] Univ Paris Est, Ecole Natl Vet Alfort, F-94700 Maisons Alfort, France; [Blondelle, Jordan; Gache, Vincent; Blanchard-Gutton, Nicolas; Barthelemy, Ines; Rahier, Anaelle; Gadin, Stephanie; Maurer, Marie; Guillaud, Laurent; Prola, Alexandre; Aubin-Houzelstein, Genevieve; Relaix, Frederic; Blot, Stephane; Tiret, Laurent; Pilot-Storck, Fanny] Univ Paris Est Creteil, Fac Med, F-94000 Creteil, France; [Ohno, Yusuke; Kihara, Akio] Hokkaido Univ, Biochem Lab, Fac Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan; [Guyot, Stephane] Univ Bourgogne, UMR PAM EPMB A 02 102, AgroSup Dijon, F-21000 Dijon, France; [Storck, Sebastien] Univ Paris 05, Sorbonne Paris Cite, Inst Necker Enfants Malad, INSERM,U1151,CNRS UMR 8253,Fac Med, F-75015 Paris, France; [Walmsley, Gemma; Piercy, Richard J.] Univ London Royal Vet Coll, Dept Clin Sci & Serv, Comparat Neuromuscular Dis Lab, London NW1 0TU, England; [Ferry, Arnaud] Univ Paris 06, Univ Paris Descartes, Therapie Malad Muscle Strie INSERM, Inst Myol,U974,CNRS UMR7215,UPMC UM76, F-75000 Paris, France; [Demarquoy, Jean] Univ Bourgogne, Fac Sci Gabriel, BioperoxIL, F-21000 Dijon, France	Pilot-Storck, F (reprint author), INSERM, IMRB U955 E10, F-94000 Creteil, France.	ltiret@vet-alfort.fr; fstorck@vet-alfort.fr	GACHE, Vincent/M-9556-2015; KIHARA, AKIO/A-3802-2012	GACHE, Vincent/0000-0002-2928-791X; KIHARA, AKIO/0000-0001-5889-0788	Agence Nationale de la Recherche [ANR-12-JSV1-0005]; Association Francaise contre les Myopathies [14577, 15882, 16143]; CNM Project; Alliance program [22866ZM]; Myotubular Trust; Japan Society for the Promotion of Science [23370057]; French Ministry of Research and Technologies; Universite Paris 6 (Paris); ANR; AFM; BBSRC CASE	This work was supported by the Agence Nationale de la Recherche (ANR-12-JSV1-0005), the Association Francaise contre les Myopathies (14577, 15882, and 16143), the CNM Project (www.labradorcnm.com), the Alliance program (22866ZM), the Myotubular Trust and Grants-in-Aid for Scientific Research (B) to A.K. from Japan Society for the Promotion of Science (23370057). J.B. was supported by the French Ministry of Research and Technologies and the Universite Paris 6 (Paris), V.G., A.P., and A.R. were supported by the ANR, N.B-G. and I. B. were supported by the AFM, and G.W. was supported by the BBSRC CASE and the Myotubular Trust.	Miller JP, 2005, P NATL ACAD SCI USA, V102, P12123, DOI 10.1073/pnas.0505482102; Lenhart KC, 2014, DEV BIOL, V393, P298, DOI 10.1016/j.ydbio.2014.06.025; Lee JH, 2009, LIFE SCI, V84, P415, DOI 10.1016/j.lfs.2009.01.004; Aguilar PS, 2013, TRENDS GENET, V29, P427, DOI 10.1016/j.tig.2013.01.011; North K, 2008, NEUROMUSCULAR DISORD, V18, P433, DOI 10.1016/j.nmd.2008.04.002; CHERNOMORDIK LV, 1993, FEBS LETT, V318, P71, DOI 10.1016/0014-5793(93)81330-3; YEAGLE PL, 1994, BIOCHEMISTRY-US, V33, P1820, DOI 10.1021/bi00173a027; Millay DP, 2013, NATURE, V499, P301, DOI 10.1038/nature12343; Nance JR, 2012, CURR NEUROL NEUROSCI, V12, P165, DOI 10.1007/s11910-012-0255-x; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P18439, DOI 10.1073/pnas.1005572107; Ciechonska M, 2014, J VIROL, V88, P6528, DOI 10.1128/JVI.00314-14; Romero NB, 2010, NEUROMUSCULAR DISORD, V20, P223, DOI 10.1016/j.nmd.2010.01.014; Tiret L, 2003, HUM GENET, V113, P297, DOI 10.1007/s00439-003-0984-7; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Schmitz G, 2010, ATHEROSCLEROSIS, V208, P10, DOI 10.1016/j.atherosclerosis.2009.05.029; Kihara A, 2012, J BIOCHEM, V152, P387, DOI 10.1093/jb/mvs105; Millay DP, 2014, GENE DEV, V28, P1641, DOI 10.1101/gad.247205.114; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Nakanishi M, 2001, CELL BIOL INT, V25, P971, DOI 10.1006/cbir.2001.0750; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Georgiadis V, 2007, DEV DYNAM, V236, P1014, DOI 10.1002/dvdy.21123; Kihara A, 2008, J BIOL CHEM, V283, P11199, DOI 10.1074/jbc.M708993200; Chernomordik LV, 2005, CELL, V123, P375, DOI 10.1016/j.cell.2005.10.015; Leikina E, 2013, J CELL BIOL, V200, P109, DOI 10.1083/jcb.201207012; Gotoh M, 2012, BIOCHEM SOC T, V40, P31, DOI 10.1042/BST20110608; PRIVES J, 1977, NATURE, V268, P761, DOI 10.1038/268761a0; Laurin M, 2008, P NATL ACAD SCI USA, V105, P15446, DOI 10.1073/pnas.0805546105; Briolay A, 2013, BBA-BIOMEMBRANES, V1828, P602, DOI 10.1016/j.bbamem.2012.10.006; Molino D, 2014, BBA-MOL CELL BIOL L, V1841, P1422, DOI 10.1016/j.bbalip.2014.06.014; REPORTER M, 1973, SCIENCE, V181, P863, DOI 10.1126/science.181.4102.863; Abmayr SM, 2012, DEVELOPMENT, V139, P641, DOI 10.1242/dev.068353; Ikeda M, 2008, FEBS LETT, V582, P2435, DOI 10.1016/j.febslet.2008.06.007; Schneiter R, 2004, BIOCHEM J, V381, P941, DOI 10.1042/BJ20040320; Horsley V, 2001, J CELL BIOL, V153, P329, DOI 10.1083/jcb.153.2.329; Pierson CR, 2007, NEUROMUSCULAR DISORD, V17, P562, DOI 10.1016/j.nmd.2007.03.010; Muhammad E, 2013, HUM MOL GENET, V22, P5229, DOI 10.1093/hmg/ddt380; Doherty KR, 2005, DEVELOPMENT, V132, P5565, DOI 10.1242/dev.02155; Pele M, 2005, HUM MOL GENET, V14, P1417, DOI 10.1093/hmg/ddi151; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Lin X, 2012, MOL CELL BIOL, V32, P297, DOI 10.1128/MCB.05484-11; Hochreiter-Hufford AE, 2013, NATURE, V497, P263, DOI 10.1038/nature12135; Jungbluth H, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-26; Maurer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046408; Ravenscroft G, 2015, BRAIN, V138, P246, DOI 10.1093/brain/awu368; Teng SZ, 2015, MOL BIOL CELL, V26, P506, DOI 10.1091/mbc.E14-03-0802	45	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1674-2788	1759-4685		J MOL CELL BIOL	J. Mol. Cell Biol.	OCT	2015	7	5					429	440		10.1093/jmcb/mjv049		12	Cell Biology	Cell Biology	CU0JJ	WOS:000363201800005		
J	Tamura, K				Tamura, Koji			Beyond the Frozen Accident: Glycine Assignment in the Genetic Code	JOURNAL OF MOLECULAR EVOLUTION			English	Article						Origin; Genetic code; Glycine; tRNA; CCA	TRANSFER-RNA SYNTHETASES; CHIRAL-SELECTIVE AMINOACYLATION; THERMUS-THERMOPHILUS; PROTEIN-SYNTHESIS; ACCEPTOR STEM; AMINO-ACIDS; ORIGIN; STABILITY; EVOLUTION; RECOGNITION	tRNA with a terminal UCCA-3' forms a structure in which the 3'-sequence folds back. The adenine of glycyl-AMP can base-pair with the uridine of the UCCA-3' region, which places the glycine residue in close proximity to the 3'-terminal adenosine of tRNA, possibly enabling the transfer of glycine from glycyl-AMP to tRNA. Thus, the UCCA-3'-containing tRNA (as seen in eubacterial tRNA(Gly)s) would possess an intrinsic property of glycylation by glycyl-AMP. This model provides a new perspective on the origins of the glycine assignment in the genetic code, beyond the "frozen accident" hypothesis.	[Tamura, Koji] Tokyo Univ Sci, Dept Biol Sci & Technol, Katsushika Ku, Tokyo 1258585, Japan; [Tamura, Koji] Tokyo Univ Sci, Res Inst Sci & Technol, Noda, Chiba 2788510, Japan	Tamura, K (reprint author), Tokyo Univ Sci, Dept Biol Sci & Technol, Katsushika Ku, 6-3-1 Niijuku, Tokyo 1258585, Japan.	koji@rs.tus.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [25291082]	The author thanks Drs. Chien-Chia Wang, Tetsuo Kushiro, Shin-ichi Yokobori, and Nobukazu Nameki for helpful discussions. This work was supported by the Grants-in Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (Grant No. 25291082).	JURKA J, 1987, J MOL EVOL, V25, P15, DOI 10.1007/BF02100036; Yarus M, 1998, J MOL EVOL, V47, P109, DOI 10.1007/PL00006357; Ohnuma M, 2011, J MOL BIOL, V408, P971, DOI 10.1016/j.jmb.2011.03.025; Osawa K, 2005, ORIGINS LIFE EVOL B, V35, P213, DOI 10.1007/s11084-005-2405-5; Tamura K, 2004, SCIENCE, V305, P1253, DOI 10.1126/science.1099141; PUGLISI EV, 1994, P NATL ACAD SCI USA, V91, P11467, DOI 10.1073/pnas.91.24.11467; WONG JTF, 1975, P NATL ACAD SCI USA, V72, P1909, DOI 10.1073/pnas.72.5.1909; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Tamura K, 2006, P NATL ACAD SCI USA, V103, P13750, DOI 10.1073/pnas.0606070103; CARPENTER FH, 1960, J AM CHEM SOC, V82, P1111, DOI 10.1021/ja01490a024; Bernhardt HS, 2014, J MOL EVOL, V78, P307, DOI 10.1007/s00239-014-9627-y; Mazauric MH, 1996, EUR J BIOCHEM, V241, P814, DOI 10.1111/j.1432-1033.1996.00814.x; Calderone CT, 2004, CURR OPIN CHEM BIOL, V8, P645, DOI 10.1016/j.cbpa.2004.09.003; EIGEN M, 1977, NATURWISSENSCHAFTEN, V64, P541, DOI 10.1007/BF00450633; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; SHIMIZU M, 1982, J MOL EVOL, V18, P297, DOI 10.1007/BF01733895; KAGAWA Y, 1984, J BIOL CHEM, V259, P2956; Komatsu R, 2014, J MOL EVOL, V78, P310, DOI 10.1007/s00239-014-9629-9; Jaenicke R, 1998, CURR OPIN STRUC BIOL, V8, P738, DOI 10.1016/S0959-440X(98)80094-8; Nameki N, 1997, J MOL BIOL, V268, P640, DOI 10.1006/jmbi.1997.0993; WILMOT CM, 1988, J MOL BIOL, V203, P221, DOI 10.1016/0022-2836(88)90103-9; LIMMER S, 1993, P NATL ACAD SCI USA, V90, P6199, DOI 10.1073/pnas.90.13.6199; SCHIMMEL P, 1987, ANNU REV BIOCHEM, V56, P125, DOI 10.1146/annurev.biochem.56.1.125; MILLER SL, 1953, SCIENCE, V117, P528, DOI 10.1126/science.117.3046.528; Schimmel P, 1996, P NATL ACAD SCI USA, V93, P4521, DOI 10.1073/pnas.93.10.4521; LACEY JC, 1983, ORIGINS LIFE EVOL B, V13, P3, DOI 10.1007/BF00928761; Kool ET, 2001, ANNU REV BIOPH BIOM, V30, P1, DOI 10.1146/annurev.biophys.30.1.1; Bernhardt HS, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-16; Bernhardt HS, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-53; Chien CI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094659; Fontecilla-Camps Juan C., 2014, Life-Basel, V4, P1013, DOI 10.3390/life4041013; KVENVOLD.K, 1970, NATURE, V228, P923, DOI 10.1038/228923a0; Orgel LE, 1976, ORG EXPRESSION EUKAR, P499; PAECHTHO.M, 1973, J MOL EVOL, V2, P91, DOI 10.1007/BF01653989	34	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0022-2844	1432-1432		J MOL EVOL	J. Mol. Evol.	OCT	2015	81	3-4					69	71		10.1007/s00239-015-9694-8		3	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	CT8IR	WOS:000363059500001		
J	Murakami, H				Murakami, Hiroshi			Terahertz dynamics of water before and after water shedding from reverse micelles	JOURNAL OF MOLECULAR LIQUIDS			English	Article						Water; Reverse micelle; Confinement effect; Terahertz spectroscopy; Temperature dependence; Water shedding	TIME-DOMAIN SPECTROSCOPY; STRUCTURAL PARAMETERS; DIELECTRIC-PROPERTIES; LIQUID; PROTEIN; SIZE; PROBES; MODEL	Picosecond relaxation dynamics of water before and after water shedding from reverse micelles are studied using temperature-dependent terahertz time-domain spectroscopy measurements to clarify the confinement effect of the reverse micelle on the dynamics of water. Before water shedding, the relaxation process due to the collective motion of bulk-like water in the core of the reverse micelle exhibits a considerable slowing down in comparison with that in liquid water as the temperature decreases. This is attributed to the confinement effect of reverse micelles. Moreover, the time constant abruptly drops at the water shedding, and its temperature behavior is similar to that of liquid water afterwards. These results demonstrate that the water extracted from the reverse micelle attains the property of liquid water by reduction in the confinement imposed on the motion of the water. (C) 2015 Elsevier B.V. All rights reserved.	Japan Atom Energy Agcy, Kansai Photon Sci Inst, Kizu, Kyoto 6190215, Japan	Murakami, H (reprint author), Japan Atom Energy Agcy, Kansai Photon Sci Inst, 8-1 Umemidai, Kizu, Kyoto 6190215, Japan.	murakami.hiroshi@jaea.go.jp			 [23654139];  [22310038]	The author thanks Dr. M. Kado, Dr. N. Shikazono, and Dr. A. Tanaka for fruitful discussions, and Dr. K. Akamatsu for his assistance with the DLS experiment. This study was partly supported by Grants-in-Aid for Scientific Research (23654139 and 22310038).	DU Q, 1994, SCIENCE, V264, P826, DOI 10.1126/science.264.5160.826; Stiopkin IV, 2011, NATURE, V474, P192, DOI 10.1038/nature10173; Piletic IR, 2006, J PHYS CHEM A, V110, P4985, DOI 10.1021/jp061065c; Boyd JE, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.147401; Stanley HE, 2011, J NON-CRYST SOLIDS, V357, P629, DOI 10.1016/j.jnoncrysol.2010.07.029; ZAMPIERI GG, 1986, J PHYS CHEM-US, V90, P1849, DOI 10.1021/j100400a023; Amararene A, 2000, PHYS REV E, V61, P682, DOI 10.1103/PhysRevE.61.682; Scatena LF, 2001, SCIENCE, V292, P908, DOI 10.1126/science.1059514; Mishima O, 1998, NATURE, V396, P329; Riter RE, 1998, J PHYS CHEM B, V102, P2705, DOI 10.1021/jp973330n; Cringus D, 2007, J PHYS CHEM B, V111, P14193, DOI 10.1021/jp0723158; Dokter AM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.178301; Dutt GB, 2008, J PHYS CHEM B, V112, P7220, DOI 10.1021/jp711633u; Spehr T, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.031404; Murakami H, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.052304; Hedstrom J, 2007, EUR PHYS J-SPEC TOP, V141, P53, DOI 10.1141/epjst/e2007-00010-6; Moilanen DE, 2009, J PHYS CHEM B, V113, P8560, DOI 10.1021/jp902004r; Liu L, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.117802; ANGELL CA, 1983, ANNU REV PHYS CHEM, V34, P593, DOI 10.1146/annurev.pc.34.100183.003113; SCHOEMAN BJ, 1994, ZEOLITES, V14, P110, DOI 10.1016/0144-2449(94)90004-3; Yoshida K, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/6/064101; Gallo P, 2010, J PHYS CHEM LETT, V1, P729, DOI 10.1021/jz9003125; Arikawa T, 2008, CHEM PHYS LETT, V457, P12, DOI 10.1016/j.cplett.2008.03.062; MASHIMO S, 1989, J PHYS CHEM-US, V93, P4963, DOI 10.1021/j100349a057; GRISCHKOWSKY D, 1990, J OPT SOC AM B, V7, P2006, DOI 10.1364/JOSAB.7.002006; Keiding SR, 1997, J PHYS CHEM A, V101, P5250, DOI 10.1021/jp970605q; ONORI G, 1993, J PHYS CHEM-US, V97, P5430, DOI 10.1021/j100122a040; Munson CA, 2004, LANGMUIR, V20, P1551, DOI 10.1021/la0302753; KOTLARCHYK M, 1985, J PHYS CHEM-US, V89, P4382, DOI 10.1021/j100266a046; Mittleman DM, 1997, CHEM PHYS LETT, V275, P332, DOI 10.1016/S0009-2614(97)00760-4; BARTHEL J, 1990, CHEM PHYS LETT, V165, P369, DOI 10.1016/0009-2614(90)87204-5; CHRIST S, 1994, J PHYS CHEM-US, V98, P12708, DOI 10.1021/j100099a039; Simorellis AK, 2006, J AM CHEM SOC, V128, P5082, DOI 10.1021/ja0568401; Murakami H, 2011, J PHYS CHEM B, V115, P5877, DOI 10.1021/jp111852s; KAATZE U, 1981, Z PHYS CHEM NEUE FOL, V126, P151; BECK JS, 1992, J AM CHEM SOC, V114, P10834, DOI 10.1021/ja00053a020; Berne B.J., 2000, DYNAMIC LIGHT SCATTE; Franks F., 1982, WATER COMPREHENSIVE, V7, P1; Gordon R.G., 1968, ADV MAGN RESON, V3, P1, DOI DOI 10.1103/PHYSREVB.75.155119; Kato A., 2012, SCI REP, V2; Kindt JT, 1996, J PHYS CHEM-US, V100, P10373, DOI 10.1021/jp960141g; Lee Y.-S., 2009, PRINCIPLES TERAHERTZ; Luisi P.L., 1984, REVERSE MICELLES; Murakami H., 2012, CHEM PHYS LETT, P519; Murakami H, 2013, ADV PROTEIN CHEM STR, V93, P183, DOI 10.1016/B978-0-12-416596-0.00006-3; Pileni M P, 1989, STRUCTURE REACTIVITY; Ronne C, 2002, J MOL LIQ, V101, P199, DOI 10.1016/S0167-7322(02)00093-4; van de Hulst H C, 1981, LIGHT SCATTERING SMA	48	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7322	1873-3166		J MOL LIQ	J. Mol. Liq.	OCT	2015	210		A		SI		37	43		10.1016/j.molliq.2015.03.015		7	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CU2IH	WOS:000363346700006		
J	Kofu, M; Inamura, Y; Moriya, Y; Podlesnyak, A; Ehlers, G; Yamamuro, O				Kofu, Maiko; Inamura, Yasuhiro; Moriya, Yosuke; Podlesnyak, Andrey; Ehlers, Georg; Yamamuro, Osamu			Inelastic neutron scattering study on boson peaks of imidazolium-based ionic liquids	JOURNAL OF MOLECULAR LIQUIDS			English	Article						Ionic liquid; Inelastic neutron scattering; Boson peak; Glass	LOW-ENERGY EXCITATIONS; THERMODYNAMIC PROPERTIES; VITREOUS SILICA; PHYSICOCHEMICAL PROPERTIES; AMORPHOUS SILICATES; MOLECULAR GLASSES; FLOPPY MODES; CRYSTALLINE; DYNAMICS; PHONONS	Low energy excitations of 1-alkyl-3-methylimidazolium ionic liquids (ILs) have been investigated by means of neutron spectroscopy. In the spectra of inelastic scattering, a broad excitation peak referred to as a "boson peak" appeared at 1-3 meV in all of the ILs measured. The intensity of the boson peak was enhanced at the Q positions corresponding to the diffraction peaks, reflecting the in-phase vibrational nature of the boson peak. Furthermore the boson peak energy (E-BP) was insensitive to the length of the alkyl-chain but changed depending on the radius of the anion. From the correlation among E-BP, the anion radius, and the glass transition temperature T-g, we conclude that both E-BP and T-g in ILs are predominantly governed by the inter-ionic Coulomb interaction which is less influenced by the alkyl-chain length. We also found that the E-BP is proportional to the inverse square root of the molecular weight as observed in molecular glasses. (C) 2015 Elsevier B.V. All rights reserved.	[Kofu, Maiko; Inamura, Yasuhiro; Moriya, Yosuke; Yamamuro, Osamu] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan; [Podlesnyak, Andrey; Ehlers, Georg] Oak Ridge Natl Lab, Quantum Condensed Matter Div, Oak Ridge, TN 37831 USA	Yamamuro, O (reprint author), Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan.	yamamuro@issp.u-tokyo.ac.jp		Podlesnyak, Andrey/0000-0001-9366-6319	Scientific User Facilities Division, Office of Basic Energy Sciences, U.S. Department of Energy; US-Japan Cooperative Program on Neutron Scattering	We thank Prof. M. Nakakoshi, Dr. T. Ueki, and Prof. M. Watanabe in Yokohama National University for the synthesis of the samples. We are deeply grateful to the Oak Ridge National Laboratory for giving us the opportunity to carry out our experiments when the Japan Proton Accelerator Research Complex (J-PARC) was closed due to the earthquake in 2011. Research at ORNL's Spallation Neutron Source was sponsored by the Scientific User Facilities Division, Office of Basic Energy Sciences, U.S. Department of Energy. This work is financially supported by the US-Japan Cooperative Program on Neutron Scattering.	BUCHENAU U, 1984, PHYS REV LETT, V53, P2316, DOI 10.1103/PhysRevLett.53.2316; Ribeiro MCC, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3462962; Yamamuro O, 2002, PHYSICA B, V311, P84, DOI 10.1016/S0921-4526(01)01060-2; POCSIK I, 1990, SOLID STATE COMMUN, V74, P1253, DOI 10.1016/0038-1098(90)90986-L; Arai M, 1999, PHYSICA B, V263, P268, DOI 10.1016/S0921-4526(98)01354-4; MALINOVSKY VK, 1991, PHYS LETT A, V153, P63, DOI 10.1016/0375-9601(91)90363-D; Paulechka YU, 2007, J CHEM THERMODYN, V39, P158, DOI 10.1016/j.jct.2006.05.008; Chun S, 2001, ANAL CHEM, V73, P3737, DOI 10.1021/ac010061v; Chumakov AI, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.225501; Ehlers G, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3626935; Ruocco G, 2001, J PHYS-CONDENS MAT, V13, P9141, DOI 10.1088/0953-8984/13/41/307; Yamamuro O, 2006, AIP CONF PROC, V832, P73; FRICK B, 1995, PHYSICA B, V213, P506, DOI 10.1016/0921-4526(95)00194-E; Shintani H, 2008, NAT MATER, V7, P870, DOI 10.1038/nmat2293; Penna TC, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4793760; Nakamura M, 2001, J NON-CRYST SOLIDS, V293, P377, DOI 10.1016/S0022-3093(01)00688-3; Dove MT, 1997, PHYS REV LETT, V78, P1070, DOI 10.1103/PhysRevLett.78.1070; KAJITANI T, 1995, PHYSICA B, V213, P872, DOI 10.1016/0921-4526(95)00308-V; Yamamuro O, 1997, J CHEM PHYS, V106, P2997, DOI 10.1063/1.473045; Harris MJ, 2000, MINERAL MAG, V64, P435, DOI 10.1180/002646100549490; Tokuda H, 2006, J PHYS CHEM B, V110, P19593, DOI 10.1021/jp064159v; BUCHENAU U, 1986, PHYS REV B, V34, P5665, DOI 10.1103/PhysRevB.34.5665; Nemoto F, 2015, J PHYS CHEM B, V119, P5028, DOI 10.1021/acs.jpcb.5b01080; Hong L, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.134201; WUTTKE J, 1993, Z PHYS B CON MAT, V91, P357, DOI 10.1007/BF01344065; Ruocco G, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.079601; Paulechka YU, 2007, J CHEM THERMODYN, V39, P866, DOI 10.1016/j.jct.2006.11.006; Kofu M, 2013, J PHYS CHEM B, V117, P2773, DOI 10.1021/jp312608r; Ruffle B, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.045502; Zhang SJ, 2006, J PHYS CHEM REF DATA, V35, P1475, DOI 10.1063/1.2204959; Blokhin AV, 2008, J PHYS CHEM B, V112, P4357, DOI 10.1021/jp710872s; Derlet PM, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2012-20902-0; Harris MJ, 1999, PHYSICA B, V263, P357, DOI 10.1016/S0921-4526(98)01379-9; Kabo GJ, 2004, J CHEM ENG DATA, V49, P453, DOI 10.1021/je034102r; Matsuda Y, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.033801; Monaco A., 2009, P NATL ACAD SCI USA, V106, P3659; Ribeiro MCC, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3604533; Ue M, 2002, J ELECTROCHEM SOC, V149, pA1385, DOI 10.1149/1.1507593; Yamamuro O, 2006, CHEM PHYS LETT, V423, P371, DOI 10.1016/j.cplett.2006.03.074; Yamamuro O., UNPUB; Yamamuro O, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3622598; Yamamuro O, 1997, PROG THEOR PHYS SUPP, P93	42	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7322	1873-3166		J MOL LIQ	J. Mol. Liq.	OCT	2015	210		B		SI		164	168		10.1016/j.molliq.2015.07.021		5	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CU2II	WOS:000363346800002		
J	Abe, H; Takekiyo, T; Aono, M; Kishimura, H; Yoshimura, Y; Hamaya, N				Abe, Hiroshi; Takekiyo, Takahiro; Aono, Masami; Kishimura, Hiroaki; Yoshimura, Yukihiro; Hamaya, Nozomu			Polymorphs in room-temperature ionic liquids: Hierarchical structure, confined water and pressure-induced frustration	JOURNAL OF MOLECULAR LIQUIDS			English	Article						Room temperature ionic liquids; Nearly-free hydrogen bonding; Hierarchical structure; Confined water; H/D effect; Nanoheterogeneity engineering; 'Conformation glass'; High pressure crystal polymorph	N,N-DIETHYL-N-METHYL-N-(2-METHOXYETHYL) AMMONIUM TETRAFLUOROBORATE; DENSITY AMORPHOUS ICE; ANGLE NEUTRON-SCATTERING; IN-SITU CRYSTALLIZATION; RAMAN SPECTRAL CHANGES; 1-BUTYL-3-METHYLIMIDAZOLIUM HEXAFLUOROPHOSPHATE; 1-ETHYL-3-METHYLIMIDAZOLIUM TETRAFLUOROBORATE; PHASE-TRANSITION; HYDROGEN-BONDS; X-RAY	Room-temperature ionic liquids (RTILs) can extract hidden information about water. Various types of hydrogen bonds of water are detected clearly in the liquid, glass, and crystal states. In addition to hydrogen bonding in water, balancing among charge (scalar), dipole (vector), and coordination number (topology) contribute to heterogeneous structure on the multiple scales in RTILs-water systems. The water-mediated hierarchical structure in the liquid is connected to macroscopic properties such as AC impedance, pH oscillations, density, and differential scanning calorimetry trace as a function of water concentration. Nanoscale water confinement was observed inside the RTILs, and the size and distribution of confined water were tuned by water concentration and temperature. The loosely packed confinement plays an important role in the engineering of next generation novel nanoheterogeneous materials. High-pressure crystal polymorphs were identified in pure RTILs by X-ray diffraction and Raman spectroscopy. By further compression, amorphous appeared partially in the deformed crystalline. (C) 2015 Elsevier B.V. All rights reserved.	[Abe, Hiroshi; Aono, Masami; Kishimura, Hiroaki] Natl Def Acad, Dept Mat Sci & Engn, Yokosuka, Kanagawa 2398686, Japan; [Takekiyo, Takahiro; Yoshimura, Yukihiro] Natl Def Acad, Dept Appl Chem, Yokosuka, Kanagawa 2398686, Japan; [Hamaya, Nozomu] Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, Tokyo 1128610, Japan	Abe, H (reprint author), Natl Def Acad, Dept Mat Sci & Engn, 1-10-20 Hashirimizu, Yokosuka, Kanagawa 2398686, Japan.				J-PARC [2012B0001]; Photon Factory [2010G546, 2013G017]	We appreciate Dr. Y. Imai, Mr. N. Hatano, Mr. T. Goto, Ms. M. Shigemi of the National Defense Academy for experimental supports. We also thank Prof. A. Shimizu of Soka University and Prof. T. Hanasaki of Ritsumeikan University for helpful discussions. We acknowledge the supports of J-PARC (Proposal No. 2012B0001) and Photon Factory (Proposal Nos. 2010G546, 2013G017).	Abe H., 2013, OPEN J PHYS CHEM, V3, P14; Abe H., 2012, J CHEM CHEM ENG, V6, P383; Abe H., 2014, IOP C SER MAT SCI EN, V54; Abe H., 2012, J THERMODYN; Abe H., 2007, J PHYS SOC JPN, V76; Abe H, 2014, J SOLUTION CHEM, V43, P1791, DOI 10.1007/s10953-014-0241-9; Abe H., 2015, J PHYS SOC IN PRESS; Abe H., 2015, HIGH PRESSURE UNPUB; Tsuzuki S, 2008, J PHYS CHEM B, V112, P9914, DOI 10.1021/jp803866u; Li HN, 2014, J PHYS CHEM B, V118, P8684, DOI 10.1021/jp500866z; Endo T, 2013, CRYST GROWTH DES, V13, P5383, DOI 10.1021/cg401293g; Palmer JC, 2014, NATURE, V510, P385, DOI 10.1038/nature13405; Otto KE, 2014, PHYS CHEM CHEM PHYS, V16, P9849, DOI 10.1039/c3cp54272f; EMSLEY J, 1980, CHEM SOC REV, V9, P91, DOI 10.1039/cs9800900091; Loerting T, 2001, PHYS CHEM CHEM PHYS, V3, P5355, DOI 10.1039/b108676f; Saouane S, 2013, CHEM SCI, V4, P1270, DOI 10.1039/c2sc21959j; Yoshimura Y, 2013, J PHYS CHEM B, V117, P3264, DOI 10.1021/jp400341r; Favre-Nicolin V, 2002, J APPL CRYSTALLOGR, V35, P734, DOI 10.1107/S0021889802015236; Pallares G, 2014, P NATL ACAD SCI USA, V111, P7936, DOI 10.1073/pnas.1323366111; Abe H, 2010, J PHYS CHEM B, V114, P2834, DOI 10.1021/jp910947z; Yoshimura Y, 2009, J PHYS CHEM B, V113, P8091, DOI 10.1021/jp902125f; Sato T, 2004, ELECTROCHIM ACTA, V49, P3603, DOI 10.1016/j.electacta.2004.03.030; MISHIMA O, 1985, NATURE, V314, P76, DOI 10.1038/314076a0; Bai JI, 2012, P NATL ACAD SCI USA, V109, P21240, DOI 10.1073/pnas.1213342110; Perrin CL, 1997, ANNU REV PHYS CHEM, V48, P511, DOI 10.1146/annurev.physchem.48.1.511; Scatena LF, 2001, SCIENCE, V292, P908, DOI 10.1126/science.1059514; Mishima O, 1998, NATURE, V396, P329; Aono M, 2014, CHEM PHYS LETT, V598, P65, DOI 10.1016/j.cplett.2014.02.058; Takekiyo T, 2012, J PHYS CHEM B, V116, P11092, DOI 10.1021/jp3057064; Abe H, 2011, CHEM PHYS LETT, V512, P204, DOI 10.1016/j.cplett.2011.07.022; Mishima O, 1996, NATURE, V384, P546, DOI 10.1038/384546a0; Smallenburg F, 2014, NAT PHYS, V10, P653, DOI [10.1038/nphys3030, 10.1038/NPHYS3030]; Takekiyo T, 2012, HIGH PRESSURE RES, V32, P150, DOI 10.1080/08957959.2011.637036; Bahadur I, 2012, J CHEM THERMODYN, V49, P24, DOI 10.1016/j.jct.2012.01.002; Yoshimura Y, 2013, J PHYS CHEM B, V117, P12296, DOI 10.1021/jp4055507; Lopes JNAC, 2006, J PHYS CHEM B, V110, P3330, DOI 10.1021/jp056006y; Bulavin LA, 2002, APPL PHYS A-MATER, V74, pS546, DOI [10.1007/s003390201545, 10.1007/s03390201545]; Endo T, 2013, J PHYS CHEM B, V117, P326, DOI 10.1021/jp310947c; Takekiyo T, 2013, J PHYS CHEM B, V117, P10142, DOI 10.1021/jp405834n; Abe H, 1997, J PHYS SOC JPN, V66, P1860, DOI 10.1143/JPSJ.66.1860; Abe H, 2014, J PHYS CHEM LETT, V5, P1175, DOI 10.1021/jz500299z; Takekiyo T, 2011, HIGH PRESSURE RES, V31, P35, DOI 10.1080/08957959.2010.521501; Su L, 2012, J PHYS CHEM B, V116, P2216, DOI 10.1021/jp2108939; Strechan AA, 2008, THERMOCHIM ACTA, V474, P25, DOI 10.1016/j.tca.2008.05.002; Imai Y, 2009, HIGH PRESSURE RES, V29, P536, DOI 10.1080/08957950903392084; Jiang W, 2007, J PHYS CHEM B, V111, P4812, DOI 10.1021/jp0671421; Takekiyo T, 2011, CHEM PHYS LETT, V511, P241, DOI 10.1016/j.cplett.2011.06.022; Takekiyo T, 2014, CHEM PHYS LETT, V602, P22, DOI 10.1016/j.cplett.2014.03.089; FULLER J, 1994, J CHEM SOC CHEM COMM, P299, DOI 10.1039/c39940000299; Heimer NE, 2006, J MOL LIQ, V124, P84, DOI 10.1016/j.molliq.2005.08.004; Angell CA, 2014, NAT MATER, V13, P673, DOI 10.1038/nmat4022; Loerting T, 2006, PHYS CHEM CHEM PHYS, V8, P2810, DOI 10.1039/b603159e; Choudhury AR, 2005, J AM CHEM SOC, V127, P16792, DOI 10.1021/ja055956u; ABE H, 1995, MATER T JIM, V36, P1200; Endo T, 2012, J PHYS CHEM B, V116, P3780, DOI 10.1021/jp300636s; Imai Y, 2008, CHEM PHYS, V352, P224, DOI 10.1016/j.chemphys.2008.06.003; Russina O, 2011, PHYS CHEM CHEM PHYS, V13, P12067, DOI 10.1039/c0cp02684k; Matsumoto K, 2006, SOLID STATE SCI, V8, P1250, DOI 10.1016/j.solidstatesciences.2005.12.018; Imai Y, 2010, CHEM PHYS LETT, V486, P37, DOI 10.1016/j.cplett.2009.12.084; Aono M, 2012, THERMOCHIM ACTA, V532, P179, DOI 10.1016/j.tca.2011.06.011; Aono M, 2012, CHEM LETT, V41, P1532, DOI 10.1246/cl.2012.1532; Abe H, 2009, J MOL LIQ, V150, P16, DOI 10.1016/j.molliq.2009.09.004; Kuhne TD, 2014, J AM CHEM SOC, V136, P3395, DOI 10.1021/ja411161a; Russo J, 2014, NAT MATER, V13, P733, DOI [10.1038/nmat3977, 10.1038/NMAT3977]; Wang YT, 2006, J PHYS CHEM B, V110, P18601, DOI 10.1021/jp063199w; Yoshimura Y, 2015, J MOL LIQ, V206, P89, DOI 10.1016/j.molliq.2015.02.010; Triolo A, 2007, J PHYS CHEM B, V111, P4641, DOI 10.1021/jp067705t; MISHIMA O, 1984, NATURE, V310, P393, DOI 10.1038/310393a0; Yoshimura Y, 2013, J RAMAN SPECTROSC, V44, P475, DOI 10.1002/jrs.4197; Abe H, 2014, J PHYS CHEM B, V118, P1138, DOI 10.1021/jp409924h; Shigemi M, 2013, HIGH PRESSURE RES, V33, P229, DOI 10.1080/08957959.2013.774390; Aono M, 2011, METALL MATER TRANS A, V42A, P37, DOI 10.1007/s11661-010-0311-6; Chen JY, 2011, P NATL ACAD SCI USA, V108, P7685, DOI 10.1073/pnas.1100752108; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Wen XD, 2011, J AM CHEM SOC, V133, P9023, DOI 10.1021/ja201786y; Bernardes CES, 2011, J PHYS CHEM B, V115, P2067, DOI 10.1021/jp1113202; Imai Y, 2011, HIGH PRESSURE RES, V31, P53, DOI 10.1080/08957959.2010.521731; Shinohara T, 2009, NUCL INSTRUM METH A, V600, P111, DOI 10.1016/j.nima.2008.11.074; Dibrov SM, 2006, ACTA CRYSTALLOGR C, V62, pO19, DOI 10.1107/S0108270105037200; Engelsman JD, 2011, PHARM RES, V28, P920; Giovambattista N., 2012, SCI REP, V2, P1; Holbrey J.D., 1999, CLEAN PRODUCTS PROCE, V1, P223, DOI DOI 10.1007/S100980050036; Imai Y., 2010, J PHYS C SER, V215; Mishima O, 1998, NATURE, V392, P164, DOI 10.1038/32386; Russina O., 2009, J PHYS CONDENS MATT, V21; Schroder C., 2007, J CHEM PHYS, V127; Shigemi M, 2014, J SOLUTION CHEM, V43, P1614, DOI 10.1007/s10953-014-0233-9; SHIMOMURA O, 1992, REV SCI INSTRUM, V63, P967, DOI 10.1063/1.1143793; Stanley H.F., 1971, INTRO PHASE TRANSITI; Takekiyo T., 2012, ADV PHYS CHEM; Takekiyo T, 2014, J SOLUTION CHEM, V43, P1701, DOI 10.1007/s10953-014-0226-8; WILKES JS, 1992, J CHEM SOC CHEM COMM, P965, DOI 10.1039/c39920000965; Yamaguchi E., 2014, CRYOBIOL CRYOTECHNOL, V60, P127; Yoshimura Y, 2014, J SOLUTION CHEM, V43, P1509, DOI 10.1007/s10953-014-0181-4	94	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7322	1873-3166		J MOL LIQ	J. Mol. Liq.	OCT	2015	210		B		SI		200	214		10.1016/j.molliq.2015.05.057		15	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CU2II	WOS:000363346800006		
J	Marekha, BA; Bria, M; Moreau, M; De Waele, I; Miannay, FA; Smortsova, Y; Takamuku, T; Kalugin, ON; Kiselev, M; Idrissi, A				Marekha, Bogdan A.; Bria, Marc; Moreau, Myriam; De Waele, Isabelle; Miannay, Francois-Alexandre; Smortsova, Yevheniia; Takamuku, Toshiyuki; Kalugin, Oleg N.; Kiselev, Mikael; Idrissi, Abdenacer			Intermolecular interactions in mixtures of 1-n-butyl-3-methylimidazolium acetate and water: Insights from IR, Raman, NMR spectroscopy and quantum chemistry calculations	JOURNAL OF MOLECULAR LIQUIDS			English	Article						Ionic liquids; Acetate hydration; Intermolecular interactions	TEMPERATURE IONIC LIQUID; MOLECULAR-DYNAMICS SIMULATIONS; HYDROGEN-BONDED COMPLEXES; CENTER-DOT-O; NONCOVALENT INTERACTIONS; INFRARED-SPECTRA; CHEMICAL-SHIFTS; DFT CALCULATIONS; 1-ETHYL-3-METHYLIMIDAZOLIUM ACETATE; VIBRATIONAL SPECTROSCOPY	The intermolecular interactions in 1-n-butyl-3-methylimidazolium acetate (BmimAc)/water mixture were studied by examining the mole fraction dependence of the vibrational modes measured with infrared and Raman spectroscopy, as well as of the H-1, C-13, N-15 and O-17 NMR chemical shifts. Quantum chemistry calculations were carried out to assign as clearly as possible the vibrational modes of the cation and anion as well as to get information on the expected effect of the mixture composition on the vibrational modes and charge distribution in BmimAc. The behavior of the obtained spectroscopic data is consistent with the physical picture that when water is added to BmimAc, the interactions between cation-anion are weakened in favor of those between water and anion. The clear spectral signature is associated with the strong blue/red shift of the stretching and bending modes of the C-(2)-H, respectively. Consistently with this spectral behavior, the corresponding H-1 and C-13 chemical shifts decrease when adding water to BmimAc. The strengthening of the water-anion interactions is also traced back to both the blue shift of the nu(COO-) at around 1380 cm(-1) and nu(C-C) of acetate at around 920 cm(-1) as well as the blue shift of the delta(COO-) at around 637 cm(-1) and omega(COO-) at 615 cm(-1). The H-1, C-13 and O-17 chemical shifts of COO- are consistent with the corresponding spectral behavior. (C) 2015 Elsevier B.V. All rights reserved.	[Marekha, Bogdan A.; Moreau, Myriam; De Waele, Isabelle; Miannay, Francois-Alexandre; Smortsova, Yevheniia; Idrissi, Abdenacer] Univ Lille Sci & Technol, Lab Spectrochim Infrarouge & Raman, UMR CNRS 8516, F-59655 Villeneuve, France; [Bria, Marc] Univ Lille Sci & Technol, CCM RMN, F-59655 Villeneuve, France; [Smortsova, Yevheniia; Kalugin, Oleg N.] Kharkov Natl Univ, Dept Inorgan Chem, UA-61022 Kharkov, Ukraine; [Takamuku, Toshiyuki] Saga Univ, Grad Sch Sci & Engn, Dept Chem & Appl Chem, Honjo, Saga 8408502, Japan; [Kiselev, Mikael] RAS, Inst Solut Chem, Ivanovo 153045, Russia	Idrissi, A (reprint author), Univ Lille Sci & Technol, Lab Spectrochim Infrarouge & Raman, UMR CNRS 8516, Bat C5, F-59655 Villeneuve, France.	nacer.idrissi@univ-lille1.fr			Marie Curie program IRSES (International Research Staff Exchange Scheme) [247500]	This project was supported by the Marie Curie program IRSES (International Research Staff Exchange Scheme, GANo247500). The Centre de Ressources Informatiques (CRI) de l'Universite de Lille is thankfully acknowledged for the CPU time allocation.	Radhi A, 2015, J PHYS CHEM B, V119, P1633, DOI 10.1021/jp5112108; Bowers J, 2004, LANGMUIR, V20, P2191, DOI 10.1021/la035940m; Zhang LQ, 2008, J PHYS CHEM B, V112, P6411, DOI 10.1021/jp8001349; Chen Y, 2014, J MOL STRUCT, V1058, P244, DOI 10.1016/j.molstruc.2013.11.010; van der Rest G, 1999, J MOL SPECTROSC, V196, P146, DOI 10.1006/jmsp.1999.7856; Kiefer J, 2010, J PHYS CHEM A, V114, P6713, DOI 10.1021/jp1031527; Noack K, 2010, PHYS CHEM CHEM PHYS, V12, P14153, DOI 10.1039/c0cp00486c; Ding ZD, 2012, J MOL STRUCT, V1015, P147, DOI 10.1016/j.molstruc.2012.02.020; Jeon Y, 2008, J PHYS CHEM B, V112, P923, DOI 10.1021/jp0746650; Walker AJ, 2004, CHEM COMMUN, P2570, DOI 10.1039/b410467f; Rudolph WW, 2014, DALTON T, V43, P3174, DOI 10.1039/c3dt52580e; Moreno M, 2008, J PHYS CHEM B, V112, P7826, DOI 10.1021/jp800383g; Izgorodina EI, 2014, PHYS CHEM CHEM PHYS, V16, P7209, DOI 10.1039/c3cp53035c; Cammarata L, 2001, PHYS CHEM CHEM PHYS, V3, P5192, DOI 10.1039/b106900d; Kempter V, 2010, J MOL STRUCT, V972, P22, DOI 10.1016/j.molstruc.2010.02.003; Chen Y, 2014, J PHYS CHEM B, V118, P6896, DOI 10.1021/jp502995k; Noack K, 2012, J MOL STRUCT, V1018, P45, DOI 10.1016/j.molstruc.2012.02.031; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x; Wu TY, 2010, J TAIWAN INST CHEM E, V41, P315, DOI 10.1016/j.jtice.2009.10.003; Chen S, 2013, J PHYS CHEM B, V117, P3186, DOI 10.1021/jp310267x; GARFINKEL D, 1958, J AM CHEM SOC, V80, P3807, DOI 10.1021/ja01548a001; Chen Y, 2014, CHEM ENG TECHNOL, V37, P527, DOI 10.1002/ceat.201300583; Rodrigues F, 2010, VIB SPECTROSC, V54, P123, DOI 10.1016/j.vibspec.2010.06.009; Jeon Y, 2008, J PHYS CHEM B, V112, P4735, DOI 10.1021/jp7120752; Feng S, 2010, FLUID PHASE EQUILIBR, V294, P148, DOI 10.1016/j.fluid.2010.02.034; Addicoat MA, 2013, J COMPUT CHEM, V34, P2591, DOI 10.1002/jcc.23420; LEGRAND N, 1995, FEBS LETT, V364, P152, DOI 10.1016/0014-5793(95)00377-L; Tran CD, 2003, APPL SPECTROSC, V57, P152, DOI 10.1366/000370203321535051; Zakrzewska ME, 2010, ENERG FUEL, V24, P737, DOI 10.1021/ef901215m; Goerigk L, 2011, PHYS CHEM CHEM PHYS, V13, P6670, DOI 10.1039/c0cp02984j; KAKIHANA M, 1983, J PHYS CHEM-US, V87, P2526, DOI 10.1021/j100237a016; Fumino K, 2008, ANGEW CHEM INT EDIT, V47, P8731, DOI 10.1002/anie.200803446; Endo T, 2010, J PHYS CHEM B, V114, P9201, DOI 10.1021/jp104123v; Yokozeki A, 2007, PHYS CHEM CHEM PHYS, V9, P5018, DOI 10.1039/b706497g; Goerigk L, 2011, CHEMPHYSCHEM, V12, P3421, DOI 10.1002/cphc.201100826; Masaki T, 2010, J PHYS CHEM B, V114, P6323, DOI 10.1021/jp1017967; Akai N, 2010, J PHYS CHEM A, V114, P12662, DOI 10.1021/jp108209q; Takamuku T, 2009, J PHYS CHEM B, V113, P10817, DOI 10.1021/jp9042667; Zhao Y, 2008, ACCOUNTS CHEM RES, V41, P157, DOI 10.1021/ar700111a; Mendez-Morales T, 2011, J PHYS CHEM B, V115, P6995, DOI 10.1021/jp202692g; Li A, 2014, J CHEM THEORY COMPUT, V10, P1563, DOI 10.1021/ct401111c; Hanke CG, 2003, J PHYS CHEM B, V107, P10873, DOI 10.1021/jp034221d; Zvereva EE, 2009, RUSS CHEM B+, V58, P1812; Chen Y, 2014, J MOL LIQ, V190, P151, DOI 10.1016/j.molliq.2013.11.010; Hall CA, 2012, J PHYS CHEM B, V116, P12810, DOI 10.1021/jp306829c; KAKIHANA M, 1982, J PHYS CHEM-US, V86, P4385, DOI 10.1021/j100219a022; Zhang QG, 2010, J PHYS CHEM B, V114, P4747, DOI 10.1021/jp1009498; Singh T, 2011, VIB SPECTROSC, V55, P119, DOI 10.1016/j.vibspec.2010.09.009; Jiang W, 2007, J PHYS CHEM B, V111, P4812, DOI 10.1021/jp0671421; Hatano N, 2012, J PHYS CHEM A, V116, P1208, DOI 10.1021/jp2097873; Zhu Q, 2007, J ELECTROANAL CHEM, V601, P229, DOI 10.1016/j.jelechem.2006.11.016; Annapureddy HVR, 2008, J PHYS CHEM B, V112, P1770, DOI 10.1021/jp077623k; Chapman K, 2001, J PHYS CHEM A, V105, P5442, DOI 10.1021/jp004409m; WILMSHURST KJ, 1955, J CHEM PHYS, V23, P2463, DOI 10.1063/1.1741932; Katayanagi H, 2004, J PHYS CHEM B, V108, P19451, DOI 10.1021/jp0477607; Mizuno K, 1998, J CHEM PHYS, V109, P9502, DOI 10.1063/1.477612; Li WJ, 2007, J PHYS CHEM B, V111, P6452, DOI 10.1021/jp071051m; Izgorodina EI, 2011, J PHYS CHEM B, V115, P14659, DOI 10.1021/jp208150b; Danten Y, 2010, J MOL LIQ, V153, P57, DOI 10.1016/j.molliq.2009.07.001; Cha S, 2014, PHYS CHEM CHEM PHYS, V16, P9591, DOI 10.1039/c4cp00589a; Cabaco MI, 2012, J PHYS CHEM A, V116, P1605, DOI 10.1021/jp211211n; Izgorodina EI, 2012, CHEM COMMUN, V48, P1493, DOI 10.1039/c1cc15056a; Zhang QG, 2011, J PHYS CHEM B, V115, P11127, DOI 10.1021/jp204305g; Mele A, 2003, ANGEW CHEM INT EDIT, V42, P4364, DOI 10.1002/anie.200351783; Gao Y, 2010, J PHYS CHEM B, V114, P2828, DOI 10.1021/jp910528m; Fong-Padron C, 2014, CHEM PHYS LETT, V593, P181, DOI 10.1016/j.cplett.2014.01.013; Zahn S, 2008, ANGEW CHEM INT EDIT, V47, P3639, DOI 10.1002/anie.200705526; Wu B, 2009, CHEM-EUR J, V15, P6889, DOI 10.1002/chem.200802742; Angenendt K, 2010, J PHYS CHEM C, V114, P20577, DOI 10.1021/jp104961r; Dominguez-Vidal A, 2007, J PHYS CHEM B, V111, P4446, DOI 10.1021/jp068777n; Hohenstein EG, 2008, J CHEM THEORY COMPUT, V4, P1996, DOI 10.1021/ct800308k; Fazio B, 2008, J RAMAN SPECTROSC, V39, P233, DOI 10.1002/jrs.1825; Katsyuba SA, 2004, HELV CHIM ACTA, V87, P2556, DOI 10.1002/hlca.200490228; Dhumal NR, 2009, J PHYS CHEM A, V113, P10397, DOI 10.1021/jp907394v; Devlin JP, 2001, J PHYS CHEM A, V105, P974, DOI 10.1021/jp003455j; Zarrougui R, 2010, J SOLUTION CHEM, V39, P1531, DOI 10.1007/s10953-010-9600-3; Stangret J, 2002, J PHYS CHEM A, V106, P5393, DOI 10.1021/jp014063v; Mizuno K, 2000, J MOL LIQ, V85, P139, DOI 10.1016/S0167-7322(99)00170-1; Oomens J, 2008, J PHYS CHEM A, V112, P3281, DOI 10.1021/jp801806e; Zhang R, 2005, J PHYS CHEM B, V109, P7482, DOI 10.1021/jp044566b; GEROTHANASSIS IP, 1994, J ORG CHEM, V59, P2341, DOI 10.1021/jo00088a013; Bowron DT, 2010, J PHYS CHEM B, V114, P7760, DOI 10.1021/jp102180q; Xiao D, 2010, CHEM PHYS LETT, V497, P37, DOI 10.1016/j.cplett.2010.07.085; Castner J.E.W., 2010, J CHEM PHYS, V132; Chen Y, 2014, J PHYS CHEM B, V118, P11523, DOI 10.1021/jp5091075; Danten Y, 2009, J PHYS CHEM A, V113, P2873, DOI 10.1021/jp8108368; Falk M., 1984, ACTA, V40, P43; Grondin J., 2010, J RAMAN SPECTROSC, V42, P733; Jorgensen W.L, 1992, BOSS VERSION 3 3; Nagaraju M., 2010, J MOL MODEL, V17, P1801; Paulechka YU, 2003, J CHEM ENG DATA, V48, P457, DOI 10.1021/je025591i; Vreven J.A.J., 2013, GAUSSIAN 09 REVISION; YingJie X., 2010, SCI CHINA CHEM, V53, P1561; Yuan XX, 2010, CHEM CENT J, V4, DOI 10.1186/1752-153X-4-6; Zheng J., 2014, DATABASE FREQUENCY S	95	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7322	1873-3166		J MOL LIQ	J. Mol. Liq.	OCT	2015	210		B		SI		227	237		10.1016/j.molliq.2015.05.015		11	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CU2II	WOS:000363346800009		
J	Wu, YQ; Kazumura, K; Maruyama, W; Osawa, T; Naoi, M				Wu, Yuqiu; Kazumura, Kimiko; Maruyama, Wakako; Osawa, Toshihiko; Naoi, Makoto			Rasagiline and selegiline suppress calcium efflux from mitochondria by PK11195-induced opening of mitochondrial permeability transition pore: a novel anti-apoptotic function for neuroprotection	JOURNAL OF NEURAL TRANSMISSION			English	Article						Calcium; Apoptosis; Mitochondria; Rasagiline; Selegiline; Neuroprotection; Membrane permeability transition pore; PK11195; Outer membrane translocator protein 18 kDa	ADENINE-NUCLEOTIDE TRANSLOCASE; MONOAMINE-OXIDASE INHIBITORS; CELL-DEATH; NEURODEGENERATIVE DISORDERS; MEMBRANE PERMEABILIZATION; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; CYTOCHROME-C; CA2+; INDUCTION	Rasagiline and selegiline, inhibitors of type B monoamine oxidase (MAO-B), protect neurons from cell death in cellular and animal models. Suppression of mitochondrial membrane permeabilization and subsequent activation of apoptosis cascade, and induction of antiapoptotic, pro-survival genes are proposed to contribute the anti-apoptotic function. Rasagiline suppresses neurotoxin- and oxidative stress-induced membrane permeabilization in isolated mitochondria, but the mechanism has been not fully clarified. In this paper, regulation of the mitochondrial permeability transition pore by rasagiline and selegiline was examined in apoptosis induced by PK11195, a ligand of the outer membrane translocator protein 18 kDa (TSPO) in SH-SY5Y cells. The pore opening was quantitatively measured using a simultaneous monitoring system for calcium (Ca2+) and superoxide (O-2(-)) (Ishibashi et al. in Biochem Biophys Res Commun 344:571-580, 2006). The association of the pore opening with Ca2+ efflux and ROS increase was proved by the inhibition of Bcl-2 overexpression and cyclosporine A treatment. Potency to release Ca2+ was correlated with the cytotoxicity of TSPO antagonists, PK11195, FGIN-1-27 and protoporphyrin IX, whereas a TSPO agonist, 4-chloro-diazepamine, did not significantly increase Ca2+ or cause cell death. Rasagiline and selegiline inhibited mitochondrial Ca2+ efflux through the mitochondrial permeability transition pore dose dependently. Ca2+ efflux was confirmed as the initial signal in mitochondrial apoptotic cascade, and the suppression of Ca2+ efflux may account for the neuroprotective function of rasagiline and selegiline. The quantitative measurement of Ca2+ efflux can be applied to determine anti-apoptotic activity of neuroprotective compounds. The role of mitochondrial Ca2+ release in neuronal death and also in neuroprotection by MAO-B inhibitors is discussed.	[Wu, Yuqiu; Osawa, Toshihiko; Naoi, Makoto] Aichi Gakuin Univ, Dept Hlth & Nutr, Fac Psychol & Phys Sci, Nisshin, Aichi 4700195, Japan; [Kazumura, Kimiko] Hamamatsu Photon KK, Cent Res Lab, Hamamatsu, Shizuoka, Japan; [Maruyama, Wakako] Natl Res Ctr Geriatr & Gerontol, Dept Cognit Brain Sci, Obu, Aichi, Japan	Naoi, M (reprint author), Aichi Gakuin Univ, Dept Hlth & Nutr, Fac Psychol & Phys Sci, 12 Araike,Iwasaki Cho, Nisshin, Aichi 4700195, Japan.	mnaoi@dpc.agu.ac.jp			Ministry of Health, Labour and Welfare, Japan [21A-13]	This work was supported by the Research Grant for Longevity Science (21A-13) from the Ministry of Health, Labour and Welfare, Japan (W. M., M. N., Y. W.).	Inaba-Hasegawa K, 2012, J NEURAL TRANSM, V119, P405, DOI 10.1007/s00702-011-0730-6; De Marchi U, 2003, BIOCHEM PHARMACOL, V66, P1749, DOI 10.1016/S0006-2952(03)00474-X; Costantini P, 1998, BBA-BIOENERGETICS, V1365, P385, DOI 10.1016/S0005-2728(98)00090-5; Halestrap AP, 2003, CURR MED CHEM, V10, P1507, DOI 10.2174/0929867033457278; Ishibashi K, 2006, BIOCHEM BIOPH RES CO, V344, P571, DOI 10.1016/j.bbrc.2006.02.173; Giacomello M, 2013, PRION, V7, P76, DOI 10.4161/pri.23581; Vaarmann A, 2010, J BIOL CHEM, V285, P25018, DOI 10.1074/jbc.M110.111450; Striessnig J, 2006, BIOCHEM SOC T, V34, P903; Maruyama W, 2001, J NEUROCHEM, V78, P727, DOI 10.1046/j.1471-4159.2001.00448.x; Bonora M, 2013, CELL CYCLE, V12, P674, DOI 10.4161/cc.23599; Akao Y, 2002, J NEUROCHEM, V82, P913, DOI 10.1046/j.1471-4159.2002.01047.x; Maruyama W, 2013, J NEURAL TRANSM, V120, P83, DOI 10.1007/s00702-012-0876-x; Kazumura K, 2013, J PHARMACEUT BIOMED, V84, P90, DOI 10.1016/j.jpba.2013.05.048; Naoi M, 2013, EXPERT REV NEUROTHER, V13, P671, DOI [10.1586/ern.13.60, 10.1586/ERN.13.60]; Naoi M, 2006, J NEURAL TRANSM-SUPP, P67; Kwong JQ, 2014, CELL DEATH DIFFER, V21, P1209, DOI 10.1038/cdd.2014.36; Leung AWC, 2008, J BIOL CHEM, V283, P26312, DOI 10.1074/jbc.M805235200; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Friberg H, 2002, BIOCHIMIE, V84, P241, DOI 10.1016/S0300-9084(02)01381-0; Tatton WG, 2002, J PHARMACOL EXP THER, V301, P753, DOI 10.1124/jpet.301.2.753; Eriksson O, 1997, FEBS LETT, V409, P361, DOI 10.1016/S0014-5793(97)00549-8; Chan CS, 2009, TRENDS NEUROSCI, V32, P249, DOI 10.1016/j.tins.2009.01.006; Fedrizzi L, 2011, BIOFACTORS, V37, P189, DOI 10.1002/biof.157; COSTANTINI P, 1995, FEBS LETT, V362, P239, DOI 10.1016/0014-5793(95)00256-9; Giorgi C, 2012, CELL CALCIUM, V52, P36, DOI 10.1016/j.ceca.2012.02.008; Czerniczyniec A, 2007, NEUROSCIENCE, V144, P685, DOI 10.1016/j.neuroscience.2006.09.050; Youdim MBH, 2006, NAT REV NEUROSCI, V7, P295, DOI 10.1038/nrn1883; Naoi M, 2009, EXPERT REV NEUROTHER, V9, P1233, DOI [10.1586/ern.09.68, 10.1586/ERN.09.68]; Baumgartner HK, 2009, J BIOL CHEM, V284, P20796, DOI 10.1074/jbc.M109.025353; Riederer P, 2004, CURR MED CHEM, V11, P2033; Naoi M, 2010, CURR PHARM DESIGN, V16, P2799; Weinreb O, 2006, J NEURAL TRANSM-SUPP, P457; Naoi M, 2013, J NEURAL TRANSM, V120, P1539, DOI 10.1007/s00702-013-1033-x; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Wadia JS, 1998, J NEUROSCI, V18, P932; Ebadi M, 2006, CURR DRUG TARGETS, V7, P1513; Czerniczyniec A, 2006, NEUROCHEM INT, V48, P235, DOI 10.1016/j.neuint.2005.09.006; Vay L, 2009, CELL CALCIUM, V45, P243, DOI 10.1016/j.ceca.2008.10.007; Bernardi P, 2012, CELL CALCIUM, V52, P22, DOI 10.1016/j.ceca.2012.03.004; Azarashvili T, 2007, CELL CALCIUM, V42, P27, DOI 10.1016/j.ceca.2006.11.004; Martin LJ, 2011, J NEUROSCI, V31, P359, DOI 10.1523/JNEUROSCI.2225-10.2011; Kaludercic N, 2011, BBA-MOL CELL RES, V1813, P1323, DOI 10.1016/j.bbamcr.2010.09.010; Galluzzi L, 2007, APOPTOSIS, V12, P803, DOI 10.1007/s10495-007-0720-1; Magyar K, 2011, INT REV NEUROBIOL, V100, P65, DOI 10.1016/B978-0-12-386467-3.00004-2; Duchen MR, 2012, PFLUG ARCH EUR J PHY, V464, P111, DOI 10.1007/s00424-012-1112-0; Cassarino DS, 1999, BBA-MOL BASIS DIS, V1453, P49, DOI 10.1016/S0925-4439(98)00083-0; Bernardi P, 1996, BBA-BIOENERGETICS, V1275, P5, DOI 10.1016/0005-2728(96)00041-2; Brenner C, 2012, CIRC RES, V111, P1222; Burke Robert E, 2007, Handb Clin Neurol, V83, P591, DOI 10.1016/S0072-9752(07)83029-6; Park D, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-11; Sorato E, 2014, FREE RADICAL BIO MED, V75, P40, DOI 10.1016/j.freeradbiomed.2014.07.006; Vila M, 2003, NAT REV NEUROSCI, V4, P1; Wu Y, 2015, ANTIAPOPTOT IN PRESS	55	1	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0300-9564	1435-1463		J NEURAL TRANSM	J. Neural Transm.	OCT	2015	122	10					1399	1407		10.1007/s00702-015-1398-0		9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CU1IH	WOS:000363273700006		
J	Wada, A; Kawakami, M; Liu, MG; Otaka, E; Nishimura, A; Liu, FM; Otsuka, T				Wada, Ayako; Kawakami, Michiyuki; Liu, Meigen; Otaka, Eri; Nishimura, Atsuko; Liu, Fumio; Otsuka, Tomoyoshi			Development of a new scale for dysphagia in patients with progressive neuromuscular diseases: the Neuromuscular Disease Swallowing Status Scale (NdSSS)	JOURNAL OF NEUROLOGY			English	Article						Muscular dystrophy; Amyotrophic lateral sclerosis; Swallowing disorders; Instrument; Psychometric properties	DUCHENNE MUSCULAR-DYSTROPHY; AMYOTROPHIC-LATERAL-SCLEROSIS; STROKE	Dysphagia is one of the most critical problems in patients with progressive neuromuscular diseases. However, clinically useful and practical scales to evaluate dysphagia are limited. Therefore, the aim of this study was to develop such a scale. An 8-stage Neuromuscular Disease Swallowing Status Scale (NdSSS) was developed and tested for its inter- and intrarater reliabilities, concurrent validity, and responsiveness. The NdSSS was used to evaluate 134 patients with Duchenne muscular dystrophy (DMD) and 84 patients with amyotrophic lateral sclerosis (ALS). Inter- and intrarater reliabilities were examined with weighted kappa statistics. Concurrent validity was assessed by correlating the NdSSS with the existing scales [Functional Oral Intake Scale (FOIS), Functional Intake LEVEL Scales (FILS), and ALS Functional Rating Scale-Revised Swallow (ALSFRS-R Sw)], using Spearman's correlation coefficients. Responsiveness was determined with the standardized response mean (SRM). For inter- and intrarater reliabilities, the weighted kappas were 0.95 and 1.00, respectively, for DMD; and 0.98 and 0.98, respectively, for ALS. The NdSSS showed strong correlations with the FOIS (rs = 0.87 for DMD, rs = 0.93 for ALS, p < 0.001), FILS (rs = 0.89 for DMD, rs = 0.92 for ALS, p < 0.001), and ALSFRS-R SW (rs = 0.93, p < 0.001). SRMs were 0.65 for DMD and 1.21 for ALS. The SRM was higher in DMD patients for the NdSSS than for the other scales, while it was similar in ALS patients and the other scales. Our originally developed NdSSS demonstrated sufficient reliability, validity, and responsiveness in patients with DMD and ALS. It is also useful in evaluating dysphagia in patients with progressive neuromuscular diseases.	[Wada, Ayako; Otsuka, Tomoyoshi] Natl Higashisaitama Hosp, Dept Rehabil Med, Saitama, Japan; [Kawakami, Michiyuki; Liu, Meigen; Otaka, Eri; Nishimura, Atsuko; Liu, Fumio] Keio Univ, Sch Med, Dept Rehabil Med, Shinjuku Ku, Tokyo 1608582, Japan	Kawakami, M (reprint author), Keio Univ, Sch Med, Dept Rehabil Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	michiyukikawakami@hotmail.com					Crary MA, 2005, ARCH PHYS MED REHAB, V86, P1516, DOI 10.1016/j.apmr.2004.11.049; Martigne L, 2010, CLIN NUTR, V29, P60, DOI 10.1016/j.clnu.2009.06.009; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Shinonaga C, 2008, DEV MED CHILD NEUROL, V50, P478, DOI 10.1111/j.1469-8749.2008.00478.x; Briani C, 1998, J NEUROL, V245, P211, DOI 10.1007/s004150050207; Rosenbek JC, 1996, DYSPHAGIA, V11, P93, DOI 10.1007/BF00417897; Kunieda K, 2013, J PAIN SYMPTOM MANAG, V46, P201, DOI 10.1016/j.jpainsymman.2012.07.020; Han TR, 2008, DYSPHAGIA, V23, P59, DOI 10.1007/s00455-007-9097-0; Higo R, 2004, AURIS NASUS LARYNX, V31, P247, DOI 10.1016/j.anl.2004.05.009; Greenwood DI, 2013, NUTR CLIN PRACT, V28, P392, DOI 10.1177/0884533613476554; Kim J, 2014, DYSPHAGIA, V29, P438, DOI 10.1007/s00455-014-9524-y; Aloysius A, 2008, EUR J PAEDIATR NEURO, V12, P239, DOI 10.1016/j.ejpn.2007.08.009; JAFFE KM, 1990, ARCH PHYS MED REHAB, V71, P742; LIANG MH, 1990, MED CARE, V28, P632, DOI 10.1097/00005650-199007000-00008; Garratt A M, 1994, Qual Health Care, V3, P186, DOI 10.1136/qshc.3.4.186; SWINYARD C A, 1957, Arch Phys Med Rehabil, V38, P574	16	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	OCT	2015	262	10					2225	2231		10.1007/s00415-015-7836-y		7	Clinical Neurology	Neurosciences & Neurology	CT7ZZ	WOS:000363035800003		
J	Sofue, K; Arai, Y; Takeuchi, Y; Tsurusaki, M; Sakamoto, N; Sugimura, K				Sofue, Keitaro; Arai, Yasuaki; Takeuchi, Yoshito; Tsurusaki, Masakatsu; Sakamoto, Noriaki; Sugimura, Kazuro			Ultrasonography-guided central venous port placement with subclavian vein access in pediatric oncology patients	JOURNAL OF PEDIATRIC SURGERY			English	Article						Central venous port; Ultrasonography; Subclavian vein; Oncologic; Children	RANDOMIZED-TRIAL; RADIOLOGICAL PLACEMENT; RETROSPECTIVE ANALYSIS; CHEST PORTS; ULTRASOUND; COMPLICATIONS; POPULATION; CHILDREN; CATHETERIZATION; INFANTS	Background/Purpose: To evaluate the technical success and complications of image-guided central venous port (CVP) placement with subclavian vein (SCV) access in pediatric oncology population. Materials and methods: Ninety-two children (52 boys, 40 girls; mean age, 8.5 years) underwent CVP implantation under local anesthesia with conscious sedation. SCV access was firstly attempted under ultrasonographic guidance and CVP implantation was performed under fluoroscopic guidance. Technical success, peri-procedural (<24 h) complication, and post-procedural (>24 h) complication were assessed. Results: In total, 102 CVPs were implanted in 92 children with a mean catheter time of 364 days (total, 38,224 days; range, 14-1911 days). In three small children, conversion of SCV access to internal jugular vein access yielded a primary technical success rate of 97.1% and overall technical success rate of 100%. Three minor peri-procedural complications were observed (2.9%) and seven post-procedural infectious complications occurred (infection rate, 6.7%; 0.18/1000 catheter days). No pneumothorax, catheter malposition, venous thrombosis, or mortality occurred. Conclusion: Image-guided CVP placement with SCV access in a pediatric population was performed with high technical success and low complication rate without general anesthesia. This procedure can be taken into account as a choice of procedure when internal jugular venous access is not possible. (C) 2015 Elsevier Inc. All rights reserved.	[Sofue, Keitaro; Arai, Yasuaki; Takeuchi, Yoshito; Tsurusaki, Masakatsu; Sakamoto, Noriaki] Natl Canc Ctr, Div Diagnost Radiol, Tokyo 1040045, Japan; [Sofue, Keitaro; Tsurusaki, Masakatsu; Sakamoto, Noriaki; Sugimura, Kazuro] Kobe Univ, Grad Sch Med, Dept Radiol, Kobe, Hyogo, Japan	Sofue, K (reprint author), Natl Canc Ctr, Div Diagnost Radiol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	keitarosofue@yahoo.co.jp					Plumhans C, 2011, EUR J RADIOL, V79, P338, DOI 10.1016/j.ejrad.2009.12.010; Pirotte T, 2007, BRIT J ANAESTH, V98, P509, DOI 10.1093/bja/aem041; Nosher JL, 2001, CARDIOVASC INTER RAD, V24, P395, DOI 10.1007/s00270-001-0071-1; Cil BE, 2004, EUR RADIOL, V14, P2015, DOI 10.1007/s00330-004-2380-7; Byon HJ, 2013, BRIT J ANAESTH, V111, P788, DOI 10.1093/bja/aet202; Samaras P, 2008, ONCOLOGY-BASEL, V74, P237, DOI 10.1159/000151393; Marcy PY, 2008, EUR RADIOL, V18, P2333, DOI 10.1007/s00330-008-0981-2; Pitetti RD, 2003, ARCH PEDIAT ADOL MED, V157, P1090, DOI 10.1001/archpedi.157.11.1090; Chang DH, 2012, ROFO-FORTSCHR RONTG, V184, P726, DOI 10.1055/s-0032-1312745; Gray BW, 2012, J PEDIATR SURG, V47, P1159, DOI 10.1016/j.jpedsurg.2012.03.043; Bruzoni M, 2013, J AM COLL SURGEONS, V216, P939, DOI 10.1016/j.jamcollsurg.2013.01.054; Hengartner H, 2004, EUR J CANCER, V40, P2452, DOI 10.1016/j.ejca.2004.07.017; Biffi R, 2009, ANN ONCOL, V20, P935, DOI 10.1093/annonc/mdn701; Sakamoto N, 2010, CARDIOVASC INTER RAD, V33, P989, DOI 10.1007/s00270-010-9841-y; MORRIS SL, 1992, RADIOLOGY, V184, P149; CIMOCHOWSKI GE, 1990, NEPHRON, V54, P154, DOI 10.1159/000185837; Randolph AG, 1996, CRIT CARE MED, V24, P2053, DOI 10.1097/00003246-199612000-00020; NOSHER JL, 1994, RADIOLOGY, V192, P265; Lin CK, 2010, KAOHSIUNG J MED SCI, V26, P192, DOI 10.1016/S1607-551X(10)70028-0; Sofue K, 2013, EUR J RADIOL, V82, pE691, DOI 10.1016/j.ejrad.2013.07.003; Peynircioglu B, 2007, J VASC INTERV RADIOL, V18, P1389, DOI 10.1016/j.jvir.2007.07.010; Lorenz JM, 2001, AM J ROENTGENOL, V176, P991; Aribas BK, 2012, EXP THER MED, V4, P675, DOI 10.3892/etm.2012.649; Teichgraber UKM, 2011, EUR RADIOL, V21, P1224, DOI 10.1007/s00330-010-2045-7; Biffi R, 2014, ANN SURG ONCOL, V21, P3725, DOI 10.1245/s10434-014-3784-5; MANSFIELD PF, 1994, NEW ENGL J MED, V331, P1735, DOI 10.1056/NEJM199412293312602	26	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	OCT	2015	50	10					1707	1710		10.1016/j.jpedsurg.2015.05.013		4	Pediatrics; Surgery	Pediatrics; Surgery	CU1HI	WOS:000363271000018		
J	Fukumoto, K; Miyano, G; Yamoto, M; Nouso, H; Miyake, H; Kaneshiro, M; Nakajima, H; Koyama, M; Mochizuki, K; Shinkai, M; Urushihara, N				Fukumoto, Koji; Miyano, Go; Yamoto, Masaya; Nouso, Hiroshi; Miyake, Hiromu; Kaneshiro, Masakatsu; Nakajima, Hideaki; Koyama, Mariko; Mochizuki, Kyoko; Shinkai, Masato; Urushihara, Naoto			Endoscopic repair of laryngotracheoesophageal clefts	JOURNAL OF PEDIATRIC SURGERY			English	Article						Laryngotracheoesophageal cleft (LTEC); Endoscopic surgery; Complications	POSTERIOR LARYNGEAL; MANAGEMENT; IV	Background/Purpose: In Japan, surgical repair of a laryngotracheoesophageal cleft (LTEC) typically consists of the anterior approach, with the lateral approach as an alternative. Endoscopic surgery to repair the tracheoesophageal septum has been reported, and this study reviewed our experience treating several cases of LTEC endoscopically. Methods: Endoscopic repair of LTEC was performed in 7 patients (3 boys, 4 girls; age range 4 months to 2 years 10 months; mean age 11 months; mean weight at surgery 7.23 kg; weight range 3.85-12.24 kg) between 2009 and 2014. LTEC was type I in 5 patients and types II and IV in 1 patient each. The patient with type IV was first operated on by the lateral approach, and the remaining cleft, which level was type III, was repaired endoscopically. Postoperative outcomes were retrospectively studied. Results: Endoscopic surgery was successful in all patients. All 6 patients with types I and II LTEC were extubated easily, while in the patient with type IV LTEC, it was difficult to remove the tracheostomy cannula because of tracheomalacia. Postoperatively, tracheostomy cannulation became more stable, and the patient is gradually being weaned off the ventilator. All patients could be fed orally without difficulty postoperatively. Conclusions: Endoscopic surgery provides a view from the cephalic aspect permitting the surgeon to form a normal larynx with only minimal risk of complications. (C) 2015 Elsevier Inc. All rights reserved.	[Fukumoto, Koji; Miyano, Go; Yamoto, Masaya; Nouso, Hiroshi; Miyake, Hiromu; Kaneshiro, Masakatsu; Nakajima, Hideaki; Koyama, Mariko; Urushihara, Naoto] Shizuoka Childrens Hosp, Dept Surg, Shizuoka 4208660, Japan; [Mochizuki, Kyoko; Shinkai, Masato] Kanagawa Childrens Med Ctr, Dept Surg, Yokohama, Kanagawa, Japan	Fukumoto, K (reprint author), Shizuoka Childrens Hosp, Dept Surg, Aoi Ku, 860 Urushiyama, Shizuoka 4208660, Japan.	koji-fukumoto@i.shizuoka-pho.jp					YAMASHITA M, 1979, CAN ANAESTH SOC J, V26, P502, DOI 10.1007/BF03006166; DUBOIS JJ, 1990, J PEDIATR SURG, V25, P855, DOI 10.1016/0022-3468(90)90191-B; Sandu K, 2006, LARYNGOSCOPE, V116, P630, DOI 10.1097/01.mlg.0000200794.78614.87; Mochizuki K, 2014, PEDIATR SURG INT, V30, P941, DOI 10.1007/s00383-014-3568-9; EVANS KL, 1995, ARCH OTOLARYNGOL, V121, P1380; GEIDUSCHEK JM, 1993, ANN OTO RHINOL LARYN, V102, P827; Garabedian EN, 2010, ARCH OTOLARYNGOL, V136, P70, DOI 10.1001/archoto.2009.197; DONAHOE PK, 1984, J PEDIATR SURG, V19, P143, DOI 10.1016/S0022-3468(84)80434-0; Olney DR, 1999, LARYNGOSCOPE, V109, P1770, DOI 10.1097/00005537-199911000-00009; RYAN DP, 1991, J PEDIATR SURG, V26, P962, DOI 10.1016/0022-3468(91)90844-J; BENJAMIN B, 1989, ANN OTO RHINOL LARYN, V98, P417; Pattersson G, 1969, Z KINDERCHIR, V7, P43	12	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	OCT	2015	50	10					1801	1804		10.1016/j.jpedsurg.2015.07.018		4	Pediatrics; Surgery	Pediatrics; Surgery	CU1HI	WOS:000363271000035		
J	Kawai, H; Hanyuda, T; Yamagishi, T; Kai, A; Lane, CE; McDevit, D; Kupper, FC; Saunders, GW				Kawai, Hiroshi; Hanyuda, Takeaki; Yamagishi, Takahiro; Kai, Atsushi; Lane, Chris E.; McDevit, Dan; Kuepper, Frithjof C.; Saunders, Gary W.			REPRODUCTIVE MORPHOLOGY AND DNA SEQUENCES OF THE BROWN ALGA PLATYSIPHON VERTICILLATUS SUPPORT THE NEW COMBINATION PLATYSIPHON GLACIALIS	JOURNAL OF PHYCOLOGY			English	Article						Arctic Ocean; life history; molecular phylogeny; Phaeophyceae; Platysiphon glacialis comb. nov.	LIFE-HISTORY; SEA-ICE; PHAEOPHYCEAE; NOV; PHYLOGENY; IDENTITY; UTILITY	Platysiphon verticillatus, a brown alga endemic to the Arctic, was described based on vegetative specimens collected at Inglefield Bay, West Greenland. The species is distinctive in having a lanceolate blade-like thallus terminated by a terete portion, both covered with hair-like assimilatory filaments. Punctaria glacialis was described from Eastern Greenland, and the species differs from other Punctaria species in lacking hairs and plurilocular zoidangia. Unilocular zoidangia were reported, but instead of zoids being released they formed cell walls in situ developing the appearance of plurilocular zoidangia. However, the fate of the zoids, as well as the walled cells was not traced, and the life history of the alga has remained unclear. By comparing DNA sequences (cox1, cox3, and rDNA ITS2) of specimens morphologically referable to Platysiphon verticillatus and Punctaria glacialis collected at Baffin Island, as well as re-examining morphology and studying crude cultures, we concluded that they are the same taxonomic entity. Furthermore, their cox3 sequence and vegetative morphology agreed with those of the type specimen of Punctaria glacialis. Consequently, we propose Platysiphon glacialis comb. nov. The life cycle could not be completed in culture, but we hypothesize that in situ germination of the unizoids produces reduced gametophytes housed in peripheral tissue of erect sporophytic thalli.	[Kawai, Hiroshi; Hanyuda, Takeaki; Yamagishi, Takahiro; Kai, Atsushi] Kobe Univ, Res Ctr Inland Seas, Kobe, Hyogo 6578501, Japan; [Lane, Chris E.] Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA; [McDevit, Dan] Edison State Coll, Dept Biol, Ft Myers, FL USA; [Kuepper, Frithjof C.] Univ Aberdeen, Oceanlab, Newburgh AB41 6AA, England; [Saunders, Gary W.] Univ New Brunswick, Fredericton, NB, Canada	Kawai, H (reprint author), Kobe Univ, Res Ctr Inland Seas, Kobe, Hyogo 6578501, Japan.	kawai@kobe-u.ac.jp			National Science Foundation in the USA; TOTAL Foundation; NERC (Natural Environment Research Council) UK; NSF [DEB-0212138]; JSPS [22370034, 25291087]; Canadian Barcode of Life Network from Genome Canada through the Ontario Genomics Institute; NSERC; Canada Research Chair Program	The 2003 collecting trip to northern Canada was funded by the National Science Foundation in the USA, on a grant to Dr. Robert ("Arctic Bob") Wilce - we are profoundly indebted to both NSF and Bob for this unique opportunity that has enriched our lives and widened our research directions. The 2009 expedition was supported by grants of the TOTAL Foundation and the NERC (Natural Environment Research Council) UK National Facility for Scientific Diving (NFSD) led by F.C.K. We are very grateful to Martin D.J. Sayer, Elaine Azzopardi and Hugh Brown (UK NFSD diving team). Dr. Eric. C. Henry provided helpful comments, and the University of Copenhagen Herbarium kindly loaned type specimens of Puntaria gracialis. For the Kawai lab a portion of the study was supported by NSF grant DEB-0212138 (PI: R.A. Andersen) and a JSPS Grants-in-Aid for Scientific Research (nos'. 22370034 and 25291087) to H. K. For the Saunders lab support was provided by the Canadian Barcode of Life Network from Genome Canada through the Ontario Genomics Institute, NSERC, and other sponsors listed at www.BOL-NET.ca. Additional support was provided by the Canada Research Chair Program; infrastructure support was from the Canada Foundation for Innovation and the New Brunswick Innovation Foundation.	Kinnard C, 2011, NATURE, V479, P509, DOI 10.1038/nature10581; Kawai H, 2004, J PHYCOL, V40, P1156, DOI 10.1111/j.1529-8817.2004.03153.x; Rousseau F, 2001, CR ACAD SCI III-VIE, V324, P305, DOI 10.1016/S0764-4469(01)01306-3; Kawai H, 2012, PHYCOL RES, V60, P241, DOI 10.1111/j.1440-1835.2012.00651.x; HENRY EC, 1983, PHYCOLOGIA, V22, P387, DOI 10.2216/i0031-8884-22-4-387.1; McDevit DC, 2009, PHYCOL RES, V57, P131, DOI 10.1111/j.1440-1835.2009.00530.x; Kogishi K, 2010, J PHYCOL, V46, P553, DOI 10.1111/j.1529-8817.2010.00818.x; Boo SM, 2011, BOT MAR, V54, P159, DOI 10.1515/BOT.2011.017; WALKER DC, 1978, NEW PHYTOL, V80, P193, DOI 10.1111/j.1469-8137.1978.tb02281.x; Saunders GW, 2012, BOTANY, V90, P191, DOI [10.1139/B11-079, 10.1139/b11-079]; Mathieson AC, 2010, RHODORA, V112, P396, DOI 10.3119/09-12.1; KAWAI H, 1990, BOT MAG TOKYO, V103, P325, DOI 10.1007/BF02488643; Serreze MC, 2007, SCIENCE, V315, P1533, DOI 10.1126/science.1139426; Lane CE, 2007, MOL PHYLOGENET EVOL, V44, P634, DOI 10.1016/j.ympev.2007.03.016; Silberfeld T, 2010, MOL PHYLOGENET EVOL, V56, P659, DOI 10.1016/j.ympev.2010.04.020; Kawai H., 1992, KOREAN J PHYCOLOGY, V7, P33; Kawai H, 2015, J PHYCOL, V51, P918, DOI 10.1111/jpy.12332; Lane E. E., 2006, J PHYCOL, V42, P493; Lee R.K., 1980, NAT MUS NAT SCI CANA, V9, P1; Lis J T, 1980, Methods Enzymol, V65, P347; LUND SOREN, 1959, MEDDEL GR0NLAND, V156, P1; Ni-Ni-Win, 2011, J PHYCOL, V47, P1193; Ni-Ni-Win, 2008, PHYCOL RES, V56, P288; Pedersen P. M., 1976, MEDD GRONL, V199, P80; Rosenvinge L. K., 1910, MARINE ALGAE N E GRE, V43; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; TANAKA A., 2010, EUROPEAN J PHYCOLOGY, V45, P109; Tatewaki M., 1966, PHYCOLOGIA, V6, P62, DOI 10.2216/i0031-8884-6-1-62.1; WILCE R. T., 1962, BOT TIDSSKR, V58, P35	29	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3646	1529-8817		J PHYCOL	J. Phycol.	OCT	2015	51	5					910	917		10.1111/jpy.12331		8	Plant Sciences; Marine & Freshwater Biology	Plant Sciences; Marine & Freshwater Biology	CU1ET	WOS:000363263500008		
J	Kawai, H; Hanyuda, T; Draisma, SGA; Wilce, RT; Andersen, RA				Kawai, Hiroshi; Hanyuda, Takeaki; Draisma, Stefano G. A.; Wilce, Robert T.; Andersen, Robert A.			MOLECULAR PHYLOGENY OF TWO UNUSUAL BROWN ALGAE, PHAEOSTROPHION IRREGULARE AND PLATYSIPHON GLACIALIS, PROPOSAL OF THE STSCHAPOVIALES ORD. NOV AND PLATYSIPHONACEAE FAM. NOV., AND A RE-EXAMINATION OF DIVERGENCE TIMES FOR BROWN ALGAL ORDERS	JOURNAL OF PHYCOLOGY			English	Article						divergence time; molecular phylogeny; Phaeophyceae; Platysiphon; Platysiphonaceae fam. nov.; Stschapoviales ord. nov.	CRETACEOUS-PALEOGENE BOUNDARY; LIFE-HISTORY; MAXIMUM-LIKELIHOOD; AUREOPHYCUS-ALEUTICUS; MASS EXTINCTION; SEQUENCE DATA; PHAEOPHYCEAE; TILOPTERIDALES; LAMINARIALES; MORPHOLOGY	The molecular phylogeny of brown algae was examined using concatenated DNA sequences of seven chloroplast and mitochondrial genes (atpB, psaA, psaB, psbA, psbC, rbcL, and cox1). The study was carried out mostly from unialgal cultures; we included Phaeostrophion irregulare and Platysiphon glacialis because their ordinal taxonomic positions were unclear. Overall, the molecular phylogeny agreed with previously published studies, however, Platysiphon clustered with Halosiphon and Stschapovia and was paraphyletic with the Tilopteridales. Platysiphon resembled Stschapovia in showing remarkable morphological changes between young and mature thalli. Platysiphon, Halosiphon and Stschapovia also shared parenchymatous, terete, erect thalli with assimilatory filaments in whorls or on the distal end. Based on these results, we proposed a new order Stschapoviales and a new family Platysiphonaceae. We proposed to include Phaeostrophion in the Sphacelariales, and we emended the order to include this foliose member. Finally, using basal taxa not included in earlier studies, the origin and divergence times for brown algae were re-investigated. Results showed that the Phaeophyceae branched from Schizocladiophyceae similar to 260 Ma during the Permian Period. The early diverging brown algae had isomorphic life histories, whereas the derived taxa with heteromorphic life histories evolved 155-110 Ma when they branched from the basal taxa. Based on these results, we propose that the development of heteromorphic life histories and their success in the temperate and cold-water regions was induced by the development of the remarkable seasonality caused by the breakup of Pangaea. Most brown algal orders had diverged by roughly 60 Ma, around the last mass extinction event during the Cretaceous Period, and therefore a drastic climate change might have triggered the divergence of brown algae.	[Kawai, Hiroshi; Hanyuda, Takeaki] Kobe Univ, Res Ctr Inland Seas, Kobe, Hyogo 6578501, Japan; [Draisma, Stefano G. A.] Prince Songkla Univ, Hat Yai 90112, Songkhla, Thailand; [Wilce, Robert T.] Univ Massachusetts, Amherst, MA 01003 USA; [Andersen, Robert A.] Univ Washington, Friday Harbor Labs, Friday Harbor, WA 98250 USA	Kawai, H (reprint author), Kobe Univ, Res Ctr Inland Seas, Kobe, Hyogo 6578501, Japan.	kawai@kobe-u.ac.jp			NSF [DEB-0212138]; JSPS [22370034]	We are grateful to Dr. Eric C. Henry for helpful advice in writing the manuscript. A part of this work was supported by the NSF grant DEB-0212138 (PI: R.A. Andersen), and JSPS Grants-in-Aid for Scientific Research (no. 22370034) to H.K.	Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Kawai H, 2004, J PHYCOL, V40, P1156, DOI 10.1111/j.1529-8817.2004.03153.x; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Kawai H, 2003, PROTIST, V154, P211, DOI 10.1078/143446103322166518; Kawai H, 2012, PHYCOL RES, V60, P241, DOI 10.1111/j.1440-1835.2012.00651.x; Daugbjerg N, 1997, J PHYCOL, V33, P1031, DOI 10.1111/j.0022-3646.1997.01031.x; Kawai H, 2007, J PHYCOL, V43, P186, DOI 10.1111/j.1529-8817.2006.00308.x; KAWAI H, 1989, PHYCOLOGIA, V28, P243, DOI 10.2216/i0031-8884-28-2-243.1; Kawai H, 2008, J PHYCOL, V44, P1013, DOI 10.1111/j.1529-8817.2008.00548.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; HENRY EC, 1983, PHYCOLOGIA, V22, P387, DOI 10.2216/i0031-8884-22-4-387.1; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Rannala B, 2007, SYST BIOL, V56, P453, DOI 10.1080/10635150701420643; HENRY EC, 1984, PHYCOLOGIA, V23, P419, DOI 10.2216/i0031-8884-23-4-419.1; RAJANIKANTH A, 1989, CURR SCI INDIA, V58, P78; Jo BY, 2013, PHYCOLOGIA, V52, P266, DOI 10.2216/12-107.1; Kawai H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02491; Mathieson AC, 2010, RHODORA, V112, P396, DOI 10.3119/09-12.1; MAIER I, 1984, BRIT PHYCOL J, V19, P95; HOOPER RG, 1988, PHYCOLOGIA, V27, P395, DOI 10.2216/i0031-8884-27-3-395.1; Draisma SGA, 2010, EUR J PHYCOL, V45, P308, DOI 10.1080/09670262.2010.490959; KAWAI H, 1990, BOT MAG TOKYO, V103, P325, DOI 10.1007/BF02488643; Lim PE, 2007, PHYCOLOGIA, V46, P456, DOI 10.2216/06-90.1; Yoon HS, 2002, P NATL ACAD SCI USA, V99, P11724, DOI 10.1073/pnas.172234799; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Kawai H, 2005, PHYCOLOGIA, V44, P169, DOI 10.2216/0031-8884(2005)44[169:MAMPOP]2.0.CO;2; Schulte P, 2010, SCIENCE, V327, P1214, DOI 10.1126/science.1177265; Alegret L, 2012, P NATL ACAD SCI USA, V109, P728, DOI 10.1073/pnas.1110601109; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Lane CE, 2007, MOL PHYLOGENET EVOL, V44, P634, DOI 10.1016/j.ympev.2007.03.016; Hanyuda T, 2004, J PHYCOL, V40, P581, DOI 10.1046/j.1529-8817.2004.03159.x; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Renne PR, 2013, SCIENCE, V339, P684, DOI 10.1126/science.1230492; Draisma SGA, 2001, J PHYCOL, V37, P586, DOI 10.1046/j.1529-8817.2001.037004586.x; Silberfeld T, 2010, MOL PHYLOGENET EVOL, V56, P659, DOI 10.1016/j.ympev.2010.04.020; Bailey JC, 1998, PROTIST, V149, P245; Theriot EC, 2010, PLANT ECOL EVOL, V143, P278, DOI 10.5091/plecevo.2010.418; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Brown JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012759; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; JAASUND ERIK, 1957, BOT NOTISER, V110, P205; Kawai H., 2014, PERSPECT PHYCOL, V1, P27; Kawai H, 2015, J PHYCOL, V51, P910, DOI 10.1111/jpy.12331; KUHLENKAMP R, 1985, BRIT PHYCOL J, V20, P301; Le Corguille G, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-253; LIM BL, 1986, JPN J GENET, V61, P169, DOI 10.1266/jjg.61.169; Lis J T, 1980, Methods Enzymol, V65, P347; Medlin Linda K., 1997, Plant Systematics and Evolution Supplement, V11, P187; PARKER BRUCE C., 1965, NOVA KEDWIGIA Z KRYPTOGAMENK, V10, P273; Pedersen P.M., 1976, MEDDR GRONLAND, V199, P1; Phillips N, 2008, J PHYCOL, V44, P394, DOI 10.1111/j.1529-8817.2008.00473.x; Rambaut A, 2007, TRACER V 1 5; Silver P. A., 2007, CAN J BOT, V85, P83; Sinninghe Damste Jaap S., 2004, Science (Washington D C), V304, P584; Tatewaki M., 1966, PHYCOLOGIA, V6, P62, DOI 10.2216/i0031-8884-6-1-62.1; Wilce R. T., 2007, JOINT M PHYC SOC AM, P67; WILCE R. T., 1962, BOT TIDSSKR, V58, P35; Zinova A. D., 1954, CONTR BOT I KOMARO 2, V9, P223	59	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3646	1529-8817		J PHYCOL	J. Phycol.	OCT	2015	51	5					918	928		10.1111/jpy.12332		11	Plant Sciences; Marine & Freshwater Biology	Plant Sciences; Marine & Freshwater Biology	CU1ET	WOS:000363263500009		
J	Kawasaki, Y; Nakada, T; Tomita, M				Kawasaki, Yuriko; Nakada, Takashi; Tomita, Masaru			TAXONOMIC REVISION OF OIL-PRODUCING GREEN ALGAE, CHLOROCOCCUM OLEOFACIENS (VOLVOCALES, CHLOROPHYCEAE), AND ITS RELATIVES	JOURNAL OF PHYCOLOGY			English	Article						18S rRNA; Chlorococcum oleofaciens; green algae; ITS rDNA; molecular phylogeny; morphology; taxonomy	GENE SEQUENCE DATA; MOLECULAR PHYLOGENY; ELECTRON-MICROSCOPY; SP-NOV; CHLOROMONAS; MORPHOLOGY; SYSTEMATICS; EMENDATION; POSITION; LIGHT	Historically, species in Volvocales were classified based primarily on morphology. Although the taxonomy of Chlamydomonas has been re-examined using a polyphasic approach including molecular phylogeny, that of Chlorococcum (Cc.), the largest coccoid genus in Volvocales, has yet to be reexamined. Six species thought to be synonymous with the oil-producing alga Cc. oleofaciens were previously not confirmed by molecular phylogeny. In this study, seven authentic strains of Cc. oleofaciens and its putative synonyms, along with 11 relatives, were examined based on the phylogeny of the 18S ribosomal RNA (rRNA) gene, comparisons of secondary structures of internal transcribed spacer 1 (ITS1) and ITS2 rDNA, and morphological observations by light microscopy. Seven 18S rRNA types were recognized among these strains and three were distantly related to Cc. oleofaciens. Comparisons of ITS rDNA structures suggested possible separation of the remaining four types into different species. Shapes of vegetative cells, thickness of the cell walls in old cultures, the size of cells in old cultures, and stigma morphology of zoospores also supported the 18S rRNA grouping. Based on these results, the 18 strains examined were reclassified into seven species. Among the putative synonyms, synonymy of Cc. oleofaciens, Cc. croceum, and Cc. granulosum was confirmed, and Cc. microstigmatum, Cc. rugosum, Cc. aquaticum, and Cc. nivale were distinguished from Cc. oleofaciens. Furthermore, another related strain is described as a new species, Macrochloris rubrioleum sp. nov.	[Nakada, Takashi] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata 9970052, Japan; Keio Univ, Grad Sch Media & Governance, Syst Biol Program, Fujisawa, Kanagawa 2520882, Japan	Nakada, T (reprint author), Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata 9970052, Japan.	naktak@ttck.keio.ac.jp			Yamagata Prefectural Government	The authors thank Drs. Takuro Ito and Kenji Nakahigashi (Keio University) for their technical support and fruitful discussions, and Mr. Hiroaki Abe (Keio University) for his isolation of strains TKAC1016, TKAC1035, and TKAC1036. This work was supported by grants from Yamagata Prefectural Government and Tsuruoka City.	Agardh C. A., 1830, ICONES ALGARUM EUR 3, pxxi; Andersen R. A., 2005, ALGAL CULTURING TECH, P429, DOI 10.1016/B978-012088426-1/50027-5; SWOFFORD DL, 1987, MATH BIOSCI, V87, P199, DOI 10.1016/0025-5564(87)90074-5; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; FRIEDL T, 1994, J PHYCOL, V30, P500, DOI 10.1111/j.0022-3646.1994.00500.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Nakada T, 2008, MOL PHYLOGENET EVOL, V48, P281, DOI 10.1016/j.ympev.2008.03.016; Nakada T, 2010, J PLANT RES, V123, P67, DOI 10.1007/s10265-009-0266-0; Proschold T, 2005, GENETICS, V170, P1601, DOI 10.1534/genetics.105.044503; Krienitz L, 2003, BIOLOGIA, V58, P437; Isaka N, 2012, J PHYCOL, V48, P759, DOI 10.1111/j.1529-8817.2012.01142.x; ETTL H, 1987, NOVA HEDWIGIA, V44, P509; Hayama M, 2010, PHYCOLOGIA, V49, P221, DOI 10.2216/09-56.1; KOMAREK J, 1989, ARCH PROTISTENKD, V137, P255; Matsuzaki R, 2012, PHYCOLOGIA, V51, P74, DOI 10.2216/11-18.1; Buchheim MA, 2013, EUR J PHYCOL, V48, P318, DOI 10.1080/09670262.2013.830344; Proschold T, 2001, PROTIST, V152, P265, DOI 10.1078/1434-4610-00068; Fulneckova J, 2012, GENOME BIOL EVOL, V4, P248, DOI 10.1093/gbe/evs007; Demchenko E, 2012, EUR J PHYCOL, V47, P264, DOI 10.1080/09670262.2012.678388; Wolf M, 2003, BIOLOGIA, V58, P433; TRAINOR FR, 1953, AM J BOT, V40, P758, DOI 10.2307/2438272; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Buchheim MA, 1997, J PHYCOL, V33, P286, DOI 10.1111/j.0022-3646.1997.00286.x; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Nakada T, 2010, PHYCOL RES, V58, P62, DOI 10.1111/j.1440-1835.2009.00559.x; SLUIMAN HJ, 1990, PHYCOLOGIA, V29, P133, DOI 10.2216/i0031-8884-29-2-133.1; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; ARCHIBALD P, 1979, BRIT PHYCOL J, V14, P305; Remias D, 2010, PROTOPLASMA, V243, P73, DOI 10.1007/s00709-010-0123-y; Archibald P. A., 1970, PHYCOL STUD, V11, P1; Chodat R., 1894, B H BOSSIER, V2, P585; Corda K. J., 1833, DEUTSCHLANDS FLORA A, P2; Eftl H., 1988, SUSSWASSERFLORA MITT, V10, P436; Ettl H., 1995, SYLLABUS BODEN LUFT; Ettl H, 2014, SYLLABUS BODEN LUFT; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Graham L. E., 2009, ALGAE; Holzinger Andreas, 2014, Algological Studies, V144, P95, DOI 10.1127/1864-1318/2014/0179; KATO S, 1982, Japanese Journal of Phycology, V30, P63; Nakada T, 2008, J PHYCOL, V44, P751, DOI 10.1111/j.1529-8817.2008.00525.x; Nakayama Takeshi, 1996, Phycological Research, V44, P47, DOI 10.1111/j.1440-1835.1996.tb00037.x; NICHOLS HW, 1965, J PHYCOL, V1, P34, DOI 10.1111/j.1529-8817.1965.tb04552.x; Nylander J.A.A., 2004, MRMODELTEST V2; PASCHER ADOLF, 1928, ARCH PROTISTENK, V61, P239; PROSCHOLD T., 2007, UNRAVELLING ALGAE PR, P123; Satoh Akira, 2010, Journal of the Japan Institute of Energy, V89, DOI 10.3775/jie.89.909; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Swofford D. L., 2002, PAUP PHYLOGENETIC AN	48	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3646	1529-8817		J PHYCOL	J. Phycol.	OCT	2015	51	5					1000	1016		10.1111/jpy.12343		17	Plant Sciences; Marine & Freshwater Biology	Plant Sciences; Marine & Freshwater Biology	CU1ET	WOS:000363263500015		
J	Makino, R; Sugahara, M; Kita, K				Makino, Ryosuke; Sugahara, Misaki; Kita, Kazurni			Nutritional Evaluation of Glycated Valine and Tryptophan as a Precursor for Protein Synthesis in Chicken Embryo Myoblasts	JOURNAL OF POULTRY SCIENCE			English	Article						glycation; myoblast; protein degradation; protein synthesis; tryptophan; valine	GROWTH-FACTOR-I; BROILER-CHICKENS; AMINO-ACIDS; IGF-II; METABOLISM; PLASMA; LEUCINE; GLUCOSE; HUMANS	Valine and Tryptophan play a role of being a precursor for protein synthesis. Glycation is a non-enzymatic reaction causing dehydrating condensation between the carbonyl group of glucose and the alpha-amino group of amino acids. Glycation of tryptophan forms two types of glycated compounds, Amadori product and (1R,3S)-1-(D-gluco-1, 2,3,4,5-pentahydroxypentyl)-1,2,3,4-tetrahydro-8-carboline-3-carboxylic acid (PHP-TH beta C). In ease of valine, only Amadori product is formed by glycation. These compounds are lack of the alpha-amino group, which might not make glycated amino acids be a precursor for protein synthesis. It is known that glycation proceeds more readily in chickens than in mammals because hyperglycemia and high body temperature are features in avian species. In this study, therefore, we attempted to evaluate nutritional value of glycated valine and tryptophan as a precursor for protein synthesis. Myoblasts from chicken embryos were incubated in valine or tryptophan-free medium supplemented with or without insulin-like growth factor-I (IGF-I). In this cell culture system, the effect of glucose-valine Amadori product supplemented in the valine deficient medium was compared to that of supplemented valine. The effect of PHP-TH beta C supplementation, was also examined. Protein synthesis and degradation of myoblasts were measured using a radioactive tracer, [H-3]-phenylalanine. Protein synthesis of chicken embryo myoblasts was not affected by the addition of glucose-valine Amadori product into valine-deficient medium. When IGF-I was added in the medium, and the addition of PHP-TH beta C into tryptophan-deficient medium increased protein synthesis of chicken embryo myoblasts, but the extent of elevation of protein synthesis was lower than that in case of tryptophan supplementation into.tryptophan-deficient medium. In the absence of IGF-I, PHP-TH beta C did not increase protein synthesis. These results suggest that valine-glucose Amadori product and PHP-TH beta C does not have nutritional value for being a precursor of protein synthesis.	[Makino, Ryosuke; Kita, Kazurni] Iwate Univ, United Grad Sch Agr Sci, Morioka, Iwate 0208550, Japan; [Sugahara, Misaki; Kita, Kazurni] Iwate Univ, Fac Agr, Anim Nutr Lab, Morioka, Iwate 0208550, Japan	Kita, K (reprint author), Iwate Univ, Fac Agr, Anim Nutr Lab, Morioka, Iwate 0208550, Japan.	kitak@iwate-u.ac.jp			JSPS from the Ministry of Education, Science and Culture of Japan;  [23658215];  [13J03782]	This study was supported by a Grant-in Aid (No. 23658215, 13J03782) for Challenging Exploratory Research and JSPS Fellows from the Ministry of Education, Science and Culture of Japan.	Rosebrough RW, 1996, J NUTR, V126, P2888; ROPER H, 1983, CARBOHYD RES, V116, P183, DOI 10.1016/0008-6215(83)88108-7; Delplanque J, 2004, J BIOL CHEM, V279, P46606, DOI 10.1074/jbc.M407678200; Oxenkrug GF, 2007, ANN NY ACAD SCI, V1122, P35, DOI 10.1196/annals.1403.003; Kita K, 1996, J ENDOCRINOL, V149, P181, DOI 10.1677/joe.0.1490181; Tomas FM, 1998, GEN COMP ENDOCR, V110, P262, DOI 10.1006/gcen.1998.7072; Dodd KM, 2012, AM J PHYSIOL-ENDOC M, V302, pE1329, DOI 10.1152/ajpendo.00525.2011; DUCLOS MJ, 1993, J ENDOCRINOL, V137, P465, DOI 10.1677/joe.0.1370465; ALVESTRAND A, 1990, EUR J CLIN INVEST, V20, P293, DOI 10.1111/j.1365-2362.1990.tb01858.x; BALLARD FJ, 1990, GEN COMP ENDOCR, V79, P459, DOI 10.1016/0016-6480(90)90076-X; Le Floc'h N, 2011, AMINO ACIDS, V41, P1195, DOI 10.1007/s00726-010-0752-7; Silber BY, 2010, NEUROSCI BIOBEHAV R, V34, P387, DOI 10.1016/j.neubiorev.2009.08.005; NAIR KS, 1992, AM J PHYSIOL, V263, pE928; Kita K, 2014, J POULT SCI, V51, P191, DOI 10.2141/jpsa.0130162; Kita K, 1998, BRIT POULTRY SCI, V39, P679, DOI 10.1080/00071669888566; Blomstrand E, 2006, J NUTR, V136, P544; Kita Kazumi, 1999, Japanese Poultry Science, V36, P25; Makino R, 2015, J POULT SCI, V52, P23, DOI [10.2141/jpsa.0130185, 10.2141/jps]; Nishimagi R, 2012, J POULT SCI, V49, P300, DOI 10.2141/jpsa.011114; Oki Mai, 2007, Journal of Poultry Science, V44, P161, DOI 10.2141/jpsa.44.161; SAS Institute, 2012, SAS STAT US GUID 13	21	0	0	JAPAN POULTRY SCIENCE ASSOC	TSUKUBA	C/O NATL INST LIVESTOCK & GLASSLAND SCIENCE, 2 IKENODAI, TSUKUBA, IBARAKI 305-0901, JAPAN	1346-7395			J POULT SCI	J. Poult. Sci.	OCT	2015	52	4					253	259		10.2141/jpsa.0150016		7	Agriculture, Dairy & Animal Science	Agriculture	CU2KW	WOS:000363353400002		
J	Furukawa, K; Kikusato, M; Kamizono, T; Yoshida, H; Toyomizu, M				Furukawa, Kyohei; Kikusato, Motoi; Kamizono, Tomomi; Yoshida, Hayami; Toyomizu, Masaaki			Possible Involvement of Mitochondrial Reactive Oxygen Species Production in Protein Degradation Induced by Heat Stress in Avian Muscle Cells	JOURNAL OF POULTRY SCIENCE			English	Article						atrogin-1; 4-Hydroxy Tempo; mitochondria superoxide; MuRF1; skeletal muscle cells; ubiquitin-proteasome system	HYDROGEN-PEROXIDE PRODUCTION; SKELETAL-MUSCLE; SUPEROXIDE-PRODUCTION; BROILER-CHICKENS; C2C12 MYOTUBES; DROSOPHILA MITOCHONDRIA; GROWTH-PERFORMANCE; GENE-EXPRESSION; ACTIVATION; ALPHA	Heat stress (HS) stimulates mitochondrial reactive oxygen species (ROS) production and protein degradation in skeletal muscle. The present study investigated the stimulatory effects of HS-induced mitochondrial ROS production on the ubiquitin-proteasome protein degradation system in primary cultured avian muscle cells. Cells were isolated from the breast muscle of neonatal chicks, and then grown for 48 h. Thereafter, the cells were subjected to 37 degrees C or 41 degrees C (HS). Exposure to 6 h of HS treatment significantly decreased the cellular protein content compared to that of normal cells, an effect was completely suppressed by the addition of a proteasome-specific inhibitor. Whereas the mRNA levels of the 20S proteasome C2 subunit, which is one of the subunits of the 26S proteasome, did not change at any time during HS treatment (1, 3, 6 h), the mRNA levels of atrogin-1 and muscle ring-fmger protein 1, both of which are muscle-specific ubiquitin ligases, increased after 1 h of HS but then decreased to near-normal values with time. Intracellular ROS production (the sum of H2O2, hydroxyl radicals, peroxyl radicals, peroxynitrite) did not change in the 1 h HS-exposed cells, but was significantly increased after 3 h and 6 h of HS. Mitochondrial superoxide production was significantly increased after 1 h of HS, which might increase the mRNA expression of ubiquitin ligase in muscle cells. In cells pretreated with 4-hydroxy TEMPO, which is able to decrease mitochondrial superoxide production, the increases in mitochondrial superoxide production and ubiquitin ligase mRNA levels observed after 1 h of HS were suppressed. The protein content of these cells was not decreased, which was observed after the longest period of HS (6 h). These findings suggest that mitochondrial superoxide production may play an important role in activating the ubiquitin-proteasome system, probably via the induction of ubiquitin ligases, in HS-exposed muscle cells.	[Furukawa, Kyohei; Kikusato, Motoi; Kamizono, Tomomi; Yoshida, Hayami; Toyomizu, Masaaki] Tohoku Univ, Anim Nutr, Life Sci, Grad Sch Agr Sci,Aoba Ku, Sendai, Miyagi 9818555, Japan	Kikusato, M (reprint author), Tohoku Univ, Anim Nutr, Life Sci, Grad Sch Agr Sci,Aoba Ku, 1-1 Tsutsumidori Amamiyamachi, Sendai, Miyagi 9818555, Japan.	kmotoi@bios.tohoku.ac.jp			Ministry of Education, Science and Culture of Japan [24380147, 25850182]; Japan Poultry Science Association	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan (24380147: M.T; 25850182: M.K). Acknowledgment is also made to the Japan Poultry Science Association for providing a travel grant to K. F. to allow presentation of some of the findings at the 10th Asian Pacific Poultry Conference, Jeju, Korea	Yunianto VD, 1997, BRIT J NUTR, V77, P897, DOI 10.1079/BJN19970088; Nakashima K, 2009, BIOSCI BIOTECH BIOCH, V73, P1869, DOI 10.1271/bbb.90134; Luo GJ, 2000, AM J PHYSIOL-REG I, V278, pR749; Kastl L, 2014, FEBS LETT, V588, P175, DOI 10.1016/j.febslet.2013.11.033; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Miwa S, 2005, BBA-BIOENERGETICS, V1709, P214, DOI 10.1016/j.bbabio.2005.08.003; Rahman M, 2014, ANTIOXID REDOX SIGN, V20, P443, DOI 10.1089/ars.2013.5410; Mujahid A, 2005, POULTRY SCI, V84, P307; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Abe T, 2006, FEBS LETT, V580, P4815, DOI 10.1016/j.febstet.2006.07.070; McClung JM, 2009, AM J PHYSIOL-CELL PH, V296, pC363, DOI 10.1152/ajpcell.00497.2008; Drahota Z, 2002, J BIOENERG BIOMEMBR, V34, P105, DOI 10.1023/A:1015123908918; Laight DW, 1997, ENVIRON TOXICOL PHAR, V3, P65, DOI 10.1016/S1382-6689(96)00143-3; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Miwa S, 2003, FREE RADICAL BIO MED, V35, P938, DOI 10.1016/S0891-5849(03)00464-7; Sato K, 2012, GEN COMP ENDOCR, V175, P457, DOI 10.1016/j.ygcen.2011.11.043; Ohtsuka A, 2011, J POULT SCI, V48, P92, DOI 10.2141/jpsa.010093; Morita S, 1996, BIOCHEM BIOPH RES CO, V228, P813, DOI 10.1006/bbrc.1996.1737; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Zuo L, 2000, AM J PHYSIOL-CELL PH, V279, pC1058; Krishna MC, 1996, J BIOL CHEM, V271, P26026; Corda S, 2001, AM J RESP CELL MOL, V24, P762; Tretter L, 2007, J NEUROCHEM, V100, P650, DOI 10.1111/j.1471-4159.2006.04223.x; Pereverzev MO, 2003, BIOCHEM SOC T, V31, P1312; Willemsen H, 2011, POULTRY SCI, V90, P2311, DOI 10.3382/ps.2011-01353; Joubert R, 2011, AM J PHYSIOL-REG I, V301, pR201, DOI 10.1152/ajpregu.00087.2010; Gilliam LAA, 2012, AM J PHYSIOL-CELL PH, V302, pC195, DOI 10.1152/ajpcell.00217.2011; Li YP, 1999, ANTIOXID REDOX SIGN, V1, P97, DOI 10.1089/ars.1999.1.1-97; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Menconi M, 2008, J CELL BIOCHEM, V105, P353, DOI 10.1002/jcb.21833; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Inarrea P, 2005, BIOCHEM J, V387, P203, DOI 10.1042/BJ20041683; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Nakashima K, 2006, BIOSCI BIOTECH BIOCH, V70, P2775, DOI 10.1271/bbb.60274; Welc SS, 2012, AM J PHYSIOL-CELL PH, V303, pC455, DOI 10.1152/ajpcell.00028.2012; BARACOS VE, 1984, AM J PHYSIOL, V246, pC125; Bodine SC, 2014, AM J PHYSIOL-ENDOC M, V307, pE469, DOI 10.1152/ajpendo.00204.2014; Bonetto A, 2009, FREE RADICAL BIO MED, V47, P906, DOI 10.1016/j.freeradbiomed.2009.07.002; FIGUEIREDOPEREIRA ME, 1994, J NEUROCHEM, V63, P1578; Finkel T, 2012, J BIOL CHEM, V287, P4434, DOI 10.1074/jbc.R111.271999; Kikusato M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064412; Kikusato M., 2013, EAAP PUBL, V134, P267; Li YP, 2003, AM J PHYSIOL-CELL PH, V285, pC806, DOI 10.1152/ajpcell.00129.2003; Nakashima Kazuki, 2004, Animal Science Journal, V75, P353, DOI 10.1111/j.1740-0929.2004.00197.x; Nakashima K., 2004, ANIM SCI J, V50, P45; On AWF, 2012, J PHARM HLTH SERV RE, V3, P3; Wang ZC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075044; Yoshida H, 2013, EAAP PUBLICATION, V134, P309	48	0	0	JAPAN POULTRY SCIENCE ASSOC	TSUKUBA	C/O NATL INST LIVESTOCK & GLASSLAND SCIENCE, 2 IKENODAI, TSUKUBA, IBARAKI 305-0901, JAPAN	1346-7395			J POULT SCI	J. Poult. Sci.	OCT	2015	52	4					260	267		10.2141/jpsa.0150028		8	Agriculture, Dairy & Animal Science	Agriculture	CU2KW	WOS:000363353400003		
J	Honda, K; Saneyasu, T; Okuda, M; Uemura, T; Kamisoyama, H				Honda, Kazuhisa; Saneyasu, Takaoki; Okuda, Mika; Uemura, Taku; Kamisoyama, Hiroshi			Glucagon and Neuromedin U Suppress Food Intake in Broiler Chicks	JOURNAL OF POULTRY SCIENCE			English	Article						appetite; chickens; glucose; hyperglycemia; wing-flapping	FEEDING-BEHAVIOR; LAYER CHICKS; INJECTION; RESPONSES; POULTRY; NEURONS; PROTEIN; ENERGY; RAT	Several peptides show different effects on food intake between broiler and layer chicks. For example, the central administration of R-melanocyte-stimulating hormone decreased food intake in layer chicks but not in broiler chicks. The central administration of agouti-related protein increased food intake in layer chicks but not in broiler chicks. We previously reported that glucagon and neuromedin U (NMU) suppress food intake in layer chicks when administered centrally. However, the effects of these peptides on food intake in broiler chicks have not been examined. In the present study, we thus examined whether these peptides also show anorexigenic effects in broiler chicks. The intracerebroventricular administration of glucagon significantly suppressed food intake and increased plasma glucose concentration in broiler chicks. The hyperglycemic effect of glucagon had been shown in layer chicks in our previous studies. Intracerebroventricular administration of NMU significantly suppressed food intake and induced wing-flapping behavior in broiler chicks as well as in layer chicks. All our findings demonstrate that glucagon and NMU function as anorxigenic peptides in both broiler and layer chicks.	[Honda, Kazuhisa; Saneyasu, Takaoki; Uemura, Taku; Kamisoyama, Hiroshi] Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo 6578501, Japan; [Okuda, Mika] Kobe Univ, Fac Agr, Kobe, Hyogo 6578501, Japan	Honda, K (reprint author), Kobe Univ, Dept Bioresource Sci, Grad Sch Agr Sci, Kobe, Hyogo 6578501, Japan.	honda@tiger.kobe-u.ac.jp					Ivanov TR, 2004, J NEUROENDOCRINOL, V16, P612, DOI 10.1111/j.1365-2826.2004.01210.x; Tachibana T, 2004, NEUROSCI LETT, V360, P165, DOI 10.1016/j.neulet.2004.02.055; Hanada R, 2004, NAT MED, V10, P1067, DOI 10.1038/nm1106; Honda K, 2015, ANIM SCI J, V86, P312, DOI 10.1111/asj.12282; Honda K, 2012, PEPTIDES, V37, P13, DOI 10.1016/j.peptides.2012.06.015; Howard AD, 2000, NATURE, V406, P70, DOI 10.1038/35017610; Honda K, 2015, J POULT SCI, V52, P183, DOI 10.2141/jpsa.0150011; Honda K, 2014, PEPTIDES, V52, P98, DOI 10.1016/j.peptides.2013.12.008; Bungo T, 2011, J POULT SCI, V48, P1, DOI 10.2141/jpsa.010117; Niimi M, 2001, ENDOCRINE, V16, P201, DOI 10.1385/ENDO:16:3:201; Julian RJ, 2005, VET J, V169, P350, DOI 10.1016/j.tvjl.2004.04.015; Wang YQ, 2010, PUBLIC HEALTH NUTR, V13, P400, DOI 10.1017/S1368980009991157; Hanada R, 2001, BIOCHEM BIOPH RES CO, V289, P225, DOI 10.1006/bbrc.2001.5945; Tachibana T, 2001, NEUROSCI LETT, V305, P131, DOI 10.1016/S0304-3940(01)01827-4; SOMOGYI M, 1952, J BIOL CHEM, V195, P19; Honda K, 2012, COMP BIOCHEM PHYS A, V163, P260, DOI 10.1016/j.cbpa.2012.08.005; Honda K, 2007, NEUROSCI LETT, V416, P198, DOI 10.1016/j.neulet.2007.02.011; Masunari K, 2013, REGUL PEPTIDES, V187, P1, DOI 10.1016/j.regpep.2013.10.004; Shiraishi J, 2011, PHYSIOL BEHAV, V103, P233, DOI 10.1016/j.physbeh.2011.02.008; Richards MP, 2007, POULTRY SCI, V86, P1478; DAVIS JL, 1979, PHYSIOL BEHAV, V22, P693, DOI 10.1016/0031-9384(79)90233-6; Honda K, 2014, NEUROSCI LETT, V564, P57, DOI 10.1016/j.neulet.2014.02.008; Saneyasu T, 2011, COMP BIOCHEM PHYS A, V159, P422, DOI 10.1016/j.cbpa.2011.04.008; Ozaki Y, 2002, ENDOCRINOLOGY, V143, P4320, DOI 10.1210/en.2002-2200201; Vrang N, 2010, PROG NEUROBIOL, V92, P442, DOI 10.1016/j.pneurobio.2010.07.003; Kamisoyama H, 2007, NEUROSCI LETT, V420, P1, DOI 10.1016/j.neulet.2007.03.062; INOKUCHI A, 1984, PHYSIOL BEHAV, V33, P397, DOI 10.1016/0031-9384(84)90160-4; Kurose Y, 2009, ANIM SCI J, V80, P686, DOI 10.1111/j.1740-0929.2009.00685.x; Wren AM, 2002, ENDOCRINOLOGY, V143, P4227, DOI 10.1210/en.2002-220308; Furuse M., 2002, Animal Science Journal, V73, P83, DOI 10.1046/j.1344-3941.2002.00014.x; KUENZEL WJ, 1994, J NUTR, V124, pS1355	31	0	0	JAPAN POULTRY SCIENCE ASSOC	TSUKUBA	C/O NATL INST LIVESTOCK & GLASSLAND SCIENCE, 2 IKENODAI, TSUKUBA, IBARAKI 305-0901, JAPAN	1346-7395			J POULT SCI	J. Poult. Sci.	OCT	2015	52	4					268	273		10.2141/jpsa.0150020		6	Agriculture, Dairy & Animal Science	Agriculture	CU2KW	WOS:000363353400004		
J	Ohtsu, H; Yamazaki, M; Abe, H; Murakami, H; Toyomizu, M				Ohtsu, Haruhiko; Yamazaki, Makoto; Abe, Hiroyuki; Murakami, Hitoshi; Toyomizu, Masaaki			Heat Stress Modulates Cytokine Gene Expression in the Spleen of Broiler Chickens	JOURNAL OF POULTRY SCIENCE			English	Article						broiler chicken; heat stress; spleen involution; splenic cytokine	IMMUNE-RESPONSES; PERFORMANCE; PROFILES; SUPPLEMENTATION; PARAMETERS	Heat stress has negative effects on biological defense mechanisms such as the immune response in chickens, and organs of the immune system, such as the spleen, are atrophied by heat stress in broiler chickens. In order to assess heat stress-induced functional changes of immune mechanisms in the spleen of broiler chickens, expression of genes encoding splenic cytokines (Th1 type, Th2 type, and pro-inflammatory cytokines) was analyzed. Heat exposure at 34 degrees C for 15 days significantly induced the spleen involution, increased interleukin (IL)-4 and IL-12 expression and decreased interferon (IFN)-gamma. However, expression of IL-6, 10, 13, and 18 was not affected. Heat stress reduced feed intake, which may affect the spleen weight and cytokine expression. Therefore, a pair-fed group at 24 degrees C (24PF) was included in which chickens received the same amount of feed as those in the group at 34 degrees C. Spleen weight was not affected by the reduction in feed intake. IL-4 expression in the 24PF group was higher than that in the control group. Further, IFN-gamma expression increased and IL-12 expression was not affected by the reduction of feed intake, suggesting that the feed intake reduction induced by heat stress does not modulate splenic cytokine expression in broiler chickens. These data suggest that heat stress induces spleen involution and affects the expression of splenic cytokines such as IL-12 and IFN-gamma in broiler chickens, but not through the feed intake reduction.	[Ohtsu, Haruhiko; Yamazaki, Makoto; Abe, Hiroyuki; Murakami, Hitoshi] Natl Inst Livestock & Grassland Sci, Tsukuba, Ibaraki 3050902, Japan; [Toyomizu, Masaaki] Tohoku Univ, Dept Anim Sci, Fac Agr, Sendai, Miyagi 9818555, Japan	Ohtsu, H (reprint author), Natl Inst Livestock & Grassland Sci, Tsukuba, Ibaraki 3050901, Japan.	hotsu@affrc.go.jp			Japan Society for the Promotion of Science	This work was supported by a Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science.	Li YP, 2005, VET MICROBIOL, V110, P155, DOI 10.1016/j.vetmic.2005.06.014; Niu ZY, 2009, POULTRY SCI, V88, P2101, DOI 10.3382/ps.2009-00220; Mashaly MM, 2004, POULTRY SCI, V83, P889; Mujahid A, 2006, POULTRY SCI, V85, P1259; Ahn KS, 2005, ANN NY ACAD SCI, V1056, P218, DOI 10.1196/annals.1352.026; Degen WGJ, 2005, VET MICROBIOL, V105, P163, DOI 10.1016/j.vetmic.2004.12.001; Shini S, 2010, POULTRY SCI, V89, P841, DOI 10.3382/ps.2009-00483; Han AY, 2010, POULTRY SCI, V89, P2063, DOI 10.3382/ps.2010-00715; Bartlett JR, 2003, POULTRY SCI, V82, P1580; Coble DJ, 2011, POULTRY SCI, V90, P1659, DOI 10.3382/ps.2010-01279; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; Khajavi M, 2003, BRIT POULTRY SCI, V44, P490, DOI [10.1080/000071660310001598328, 10.1080/00071660301979]; Cheng TK, 1997, J APPL POULTRY RES, V6, P18; Abdul-Careem MF, 2007, POULTRY SCI, V86, P1351; Takahashi K, 2011, ANIM SCI J, V82, P753, DOI 10.1111/j.1740-0929.2011.00898.x; Kaiser P, 2004, DEV COMP IMMUNOL, V28, P375, DOI 10.1016/j.dci.2003.09.004; JEURISSEN SHM, 1991, RES IMMUNOL, V142, P352, DOI 10.1016/0923-2494(91)90090-6; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Quinteiro WM, 2010, POULTRY SCI, V89, P1905, DOI 10.3382/ps.2010-00812	19	0	0	JAPAN POULTRY SCIENCE ASSOC	TSUKUBA	C/O NATL INST LIVESTOCK & GLASSLAND SCIENCE, 2 IKENODAI, TSUKUBA, IBARAKI 305-0901, JAPAN	1346-7395			J POULT SCI	J. Poult. Sci.	OCT	2015	52	4					282	287		10.2141/jpsa.0150062		6	Agriculture, Dairy & Animal Science	Agriculture	CU2KW	WOS:000363353400006		
J	Nishii, M; Yasutomi, M; Sone, Y				Nishii, Mari; Yasutomi, Masaharu; Sone, Yoshiaki			Inhibitory Effect of Whole Grain Paddy Rice Feeding on the Colonization of Campylobacter jejuni in the Cecum of Broiler Chicks	JOURNAL OF POULTRY SCIENCE			English	Article						Campylobacter; broiler chick; gizzard; paddy rice	DIGESTIVE-TRACT; NUTRIENT UTILIZATION; PARTICLE-SIZE; GASTROINTESTINAL-TRACT; MICROBIAL COMPOSITION; GROWTH-PERFORMANCE; CORN; FIBER; DIETS; WHEAT	To examine the inhibitory effect of whole grain paddy rice diet (WPR) feeding on the colonization of Campylobacter jejuni in the cecum of broiler chicks, we performed the following examination. Sixty female broiler chicks (14 days of age) were allocated into two groups, thirty birds were fed a ground corn diet (GC) as a control group, and 30 chicks were fed WPR as an examination group. After feeding with the different diets for 16 days, six chicks were selected from each group (12 chicks in total), and each chick was inoculated with 2 X 10(3) colony-forming units of C. jejuni GTC03263. Forty-eight hours after the bacterial inoculation (the birds continued to be fed with the corresponding diets after the bacterial inoculation), the chicks (six from each group) were killed and dissected to detect bacterial colonization in the cecum. The other six chicks were dissected to weigh the chick gizzard and to measure the pH of its contents. No bacterial colonization was observed in the cecum of chicks in the WPR group, whereas bacteria were found in the cecum of five of six chicks in the GC group. The average ratios of gizzard weight to body weight of the WPR-fed chicks was significantly higher than that of the GC-fed chicks, whereas the average pH value of the gizzard contents was not different between the two groups. These results suggest that WPR feeding in broiler chicks has a positive effect on development of the gizzard muscle and grinding activity of the gizzard. Increased grinding activity may eliminate the regional differences in pH within the gizzard, resulting in less bacterial survival in the gizzard and then less bacterial colonization in the cecum of WPR-fed chicks than in GC-fed chicks.	[Nishii, Mari; Yasutomi, Masaharu] Kyoto Prefecture Agr Expt Stn, Ayabe 6230211, Japan; [Sone, Yoshiaki] Mimasaka Univ, Tuyama 7088511, Japan	Nishii, M (reprint author), Kyoto Prefecture Agr Expt Stn, Ayabe 6230211, Japan.	m-nishii34@pref.kyoto.lg.jp					Sacranie A, 2012, POULTRY SCI, V91, P693, DOI 10.3382/ps.2011-01790; Singh Y, 2014, POULTRY SCI, V93, P607, DOI 10.3382/ps.2013-03542; BEERY JT, 1988, APPL ENVIRON MICROB, V54, P2365; Jimenez-Moreno E, 2009, ANIM FEED SCI TECH, V154, P93, DOI 10.1016/j.anifeedsci.2009.06.020; Jackson DN, 2009, ANTON LEEUW INT J G, V96, P377, DOI 10.1007/s10482-009-9378-8; STERN NJ, 1988, J APPL BACTERIOL, V64, P247, DOI 10.1111/j.1365-2672.1988.tb03382.x; Walk CL, 2012, POULTRY SCI, V91, P1371, DOI 10.3382/ps.2011-01928; Mateos GG, 2012, J APPL POULTRY RES, V21, P156, DOI 10.3382/japr.2011-00477; Hilmi HTA, 2007, APPL ENVIRON MICROB, V73, P7867, DOI 10.1128/AEM.01128-07; Hermans D, 2012, VECTOR-BORNE ZOONOT, V12, P89, DOI 10.1089/vbz.2011.0676; MEINERSMANN RJ, 1991, AM J VET RES, V52, P1518; Jacobs CM, 2010, POULTRY SCI, V89, P539, DOI 10.3382/ps.2009-00434; Svihus B, 2011, WORLD POULTRY SCI J, V67, P207, DOI 10.1017/S0043933911000249; Evans SJ, 2000, PREV VET MED, V46, P209, DOI 10.1016/S0167-5877(00)00143-4; Bjerrum L, 2005, AVIAN DIS, V49, P9, DOI 10.1637/7223-061504R; Achen M, 1998, AVIAN DIS, V42, P732, DOI 10.2307/1592708; Moen B, 2012, J APPL MICROBIOL, V113, P1176, DOI 10.1111/j.1365-2672.2012.05404.x; Engberg RM, 2002, BRIT POULTRY SCI, V43, P569, DOI 10.1080/0007166022000004480; Jimenez-Moreno E, 2013, ANIM FEED SCI TECH, V182, P44, DOI 10.1016/j.anifeedsci.2013.03.012; Sola-Oriol D, 2009, J ANIM SCI, V87, P571, DOI 10.2527/jas.2008-0951; Engberg RM, 2004, POULTRY SCI, V83, P925; Blaser MJ, 1997, J INFECT DIS, V176, pS103, DOI 10.1086/513780; Hetland H, 2002, BRIT POULTRY SCI, V43, P416, DOI 10.1080/00071660120103693; Santos FBO, 2008, POULTRY SCI, V87, P405, DOI 10.3382/ps.2006-00417; Gabriel I, 2003, BRIT POULTRY SCI, V44, P283, DOI [10.1080/0007166031000096470, 10.1080/00071660301955]; Jimenez-Moreno E, 2009, POULTRY SCI, V88, P1925, DOI 10.3382/ps.2009-00193; Kita K, 2013, J POULT SCI, V50, P114, DOI 10.2141/jpsa.011113; Sittiya J, 2014, J POULT SCI, V51, P52, DOI 10.2141/jpsa.0130042; Duke G.E., 1986, P269; Gonzalez-Alvarado JM, 2008, POULTRY SCI, V87, P1779, DOI 10.3382/ps.2008-00070; International Standards Organization, 2006, 102721 ISO; Mituoka T, 1994, STUDIES BIFIDBACTERI; Silva J, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00200; Skånseng B., 2013, Agriculture, V3, P741, DOI 10.3390/agriculture3040741	34	0	0	JAPAN POULTRY SCIENCE ASSOC	TSUKUBA	C/O NATL INST LIVESTOCK & GLASSLAND SCIENCE, 2 IKENODAI, TSUKUBA, IBARAKI 305-0901, JAPAN	1346-7395			J POULT SCI	J. Poult. Sci.	OCT	2015	52	4					312	317		10.2141/jpsa.0140193		6	Agriculture, Dairy & Animal Science	Agriculture	CU2KW	WOS:000363353400010		
J	Nakashima, K; Ishida, A				Nakashima, Kazuki; Ishida, Aiko			Effects of Fasting and Refeeding on Expression of Atrogin-1/MAFbx in Cardiac Muscle of Broiler Chickens	JOURNAL OF POULTRY SCIENCE			English	Article						atrogin-1/MAFbx; broiler; cardiac muscle; fasting; heart; refeeding	FOXO TRANSCRIPTION FACTORS; SKELETAL-MUSCLE; UBIQUITIN LIGASES; PROTEIN BREAKDOWN; GENE-EXPRESSION; ATROPHY; PATHWAY; GROWTH; HEART; MURF1	The expression of atrogin-1/MAFbx, a muscle-specific E3 ubiquitin ligase, is high under catabolic conditions that result in muscle atrophy. We previously showed that expression of atrogin-1/MAFbx was expressed in skeletal, smooth and cardiac muscles of chickens and its expression in skeletal and smooth muscles was regulated by nutritional conditions. In this study, the effects of fasting and refeeding on the expression of atrogin-1/MAFbx and other proteolytic-related genes, including 20S proteasome C2 subunit, m-calpain large,subunit, and cathepsin B, in cardiac muscle of broiler chickens were investigated. Chickens were fasted for 24 h, and refed for 2 h. Atrogin-1/MAFbx mRNA expression was increased by fasting, but subsequent refeeding reduced the increase. The mRNA expression of the 20S proteasome C2 subunit and m-calpain large subunit mRNA was not affected by fasting or refeeding. Cathepsin B mRNA expression was increased by fasting, but unlike atrogin-1/MAFbx mRNA expression, the increase was not reduced by refeeding. These results demonstrate the muscle-specific ubiquitin ligase atrogin-1/MAFbx gene expression in cardiac muscle as well as skeletal and smooth muscles of chicken is regulated by food deprivation and nutritional supply.	[Nakashima, Kazuki; Ishida, Aiko] NARO Inst Livestock & Grassland Sci, Anim Physiol & Nutr Div, Tsukuba, Ibaraki 3050901, Japan	Nakashima, K (reprint author), NARO Inst Livestock & Grassland Sci, Anim Physiol & Nutr Div, Tsukuba, Ibaraki 3050901, Japan.	kaznaka@affrc.go.jp			 [24580414]	This work was supported in part by a Grant-in-Aid for Scientific Research [(C) #24580414].	Rome S, 2003, J BIOL CHEM, V278, P18063, DOI 10.1074/jbc.M300293200; Skurk C, 2005, J BIOL CHEM, V280, P20814, DOI 10.1074/jbc.M500528200; Yoshizawa F, 1997, BIOCHEM BIOPH RES CO, V240, P825, DOI 10.1006/bbrc.1997.7652; Dehoux M, 2004, ENDOCRINOLOGY, V145, P4806, DOI 10.1210/en.2004-0406; Cleveland BM, 2010, COMP BIOCHEM PHYS B, V157, P248, DOI 10.1016/j.cbpb.2010.06.010; HALLANGERAS M, 1991, METABOLISM, V40, P302, DOI 10.1016/0026-0495(91)90114-C; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Sacheck JM, 2004, AM J PHYSIOL-ENDOC M, V287, pE591, DOI 10.1152/ajpendo.00073.2004; Razeghi P, 2006, BIOCHEM BIOPH RES CO, V342, P361, DOI 10.1016/j.bbre.2006.01.163; Ohtsuka A, 2011, J POULT SCI, V48, P92, DOI 10.2141/jpsa.010093; Paula-Gomes S, 2013, HORM METAB RES, V45, P849, DOI 10.1055/s-0033-1347209; Carvalho RF, 2010, J MOL HISTOL, V41, P81, DOI 10.1007/s10735-010-9262-x; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Nakashima K, 2005, J NUTR SCI VITAMINOL, V51, P248; Li QH, 2011, SCI CHINA LIFE SCI, V54, P904, DOI 10.1007/s11427-011-4226-2; Nakashima K, 2013, BIOSCI BIOTECH BIOCH, V77, P1092, DOI 10.1271/bbb.120885; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Nakashima K, 2006, BIOSCI BIOTECH BIOCH, V70, P2775, DOI 10.1271/bbb.60274; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; GOLL DE, 1992, BIOCHIMIE, V74, P225, DOI 10.1016/0300-9084(92)90121-T; GOLL DE, 1991, J BIOL CHEM, V266, P8501; Lecker SH, 1999, J NUTR, V129, p227S; Mitch WE, 1996, NEW ENGL J MED, V335, P1897; SEENE T, 1994, J STEROID BIOCHEM, V50, P1, DOI 10.1016/0960-0760(94)90165-1; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4	27	0	0	JAPAN POULTRY SCIENCE ASSOC	TSUKUBA	C/O NATL INST LIVESTOCK & GLASSLAND SCIENCE, 2 IKENODAI, TSUKUBA, IBARAKI 305-0901, JAPAN	1346-7395			J POULT SCI	J. Poult. Sci.	OCT	2015	52	4					318	322		10.2141/jpsa.0150036		5	Agriculture, Dairy & Animal Science	Agriculture	CU2KW	WOS:000363353400011		
J	Ohara, A; Oyakawa, C; Yoshihara, Y; Ninomiya, S; Sato, S				Ohara, Ai; Oyakawa, Chisako; Yoshihara, Yu; Ninomiya, Shigeru; Sato, Shusuke			Effect of Environmental Enrichment on the Behavior and Welfare of Japanese Broilers at a Commercial Farm	JOURNAL OF POULTRY SCIENCE			English	Article						behavior; footpad dermatitis; hay bale; heterophil/lymphocyte ratio; perch	FOOT-PAD DERMATITIS; SLOW-GROWING BROILERS; PERCHING BEHAVIOR; BREAST BLISTERS; LEG HEALTH; CHICKENS; DENSITY; AVAILABILITY; PERFORMANCE; PREVALENCE	The effect of hay bales and perches as environmental enrichment material was investigated on the behavior, heterophil/lymphocyte (H/L) ratio, footpad dermatitis (FPD), and productivity of Japanese broilers in a commercial farm. About 21,500 birds were allocated to 4 houses: male versus female X control versus treatment house. We observed maintenance behavior, the utilization of hay bales and perches, and the H/L ratio of birds at 3, 5, and 8 weeks of age. FPD was scored and productivity was calculated at about 60 days after hatching. Compared to birds in the control houses, birds in the treatment houses invested more time in stand-resting and moving behaviors (P<0.01, for each behavior) and less time feeding, drinking, and sit-resting (P<0.01, for each behavior). Females used the hay bales and perches more than the males (P<0.1 and P<0.01, respectively). The activity and utilization of hay bales and perches decreased with age (P<0.01, for each behavior, respectively). The H/L ratio of birds in the treatment houses was lower than that in the control houses (P<0.01). The prevalence of FPD was milder in the treatment houses compared to the control houses for females (P<0.01), but not for males. In conclusion, hay bales and perches represent effective enrichment materials, allowing broilers to express normal behavior, alleviating stress in the younger and lighter birds of both sexes, and reducing FPD in female birds using the hay bales and perches more than males.	[Ohara, Ai; Oyakawa, Chisako; Ninomiya, Shigeru; Sato, Shusuke] Tohoku Univ, Grad Sch Agr Sci, Donated Fund Lab Anim Welf Ishii, Ohsaki, Miyagi 9896711, Japan; [Yoshihara, Yu; Sato, Shusuke] Tohoku Univ, Grad Sch Agr Sci, Lab Land Ecol, Ohsaki, Miyagi 9896711, Japan	Sato, S (reprint author), Tohoku Univ, Grad Sch Agr Sci, 232-3 Yomogita, Ohsaki, Miyagi 9896711, Japan.	shusato@bios.tohoku.ac.jp			Ishii Co., Ltd.	This study was supported by a grant from Ishii Co., Ltd. We thank Ishii Co., Ltd. and Nichirei Fresh Farm Inc. for participating in the current study. We are grateful for the constructive advice from the members of Land Ecology, Graduate School of Agricultural Science, Tohoku University, Japan.	Amory JK, 2002, J ANDROL, V23, P84; Taira K, 2014, J VET MED SCI, V76, P583, DOI 10.1292/jvms.13-0321; Nielsen BL, 2004, BRIT POULTRY SCI, V45, P306, DOI 10.1080/00071660410001730798; Bessei W, 2006, WORLD POULTRY SCI J, V62, P455, DOI 10.1079/WPS2005108; Kestin SC, 2001, VET REC, V148, P195; Hashimoto S, 2011, J VET MED SCI, V73, P293, DOI 10.1292/jvms.10-0329; Nielsen BL, 2003, BRIT POULTRY SCI, V44, P161, DOI 10.1080/0007166031000088389; WEEKS CA, 1994, ANIM WELFARE, V3, P179; Bizeray D, 2002, APPL ANIM BEHAV SCI, V79, P27, DOI 10.1016/S0168-1591(02)00083-7; Lee YP, 2007, BRIT POULTRY SCI, V48, P113, DOI 10.1080/00071660701261302; HUGHES BO, 1973, BRIT POULTRY SCI, V14, P341, DOI 10.1080/00071667308416038; Heckert RA, 2002, POULTRY SCI, V81, P451; Bokkers EAM, 2003, APPL ANIM BEHAV SCI, V81, P59, DOI 10.1016/S0168-1591(02)00251-4; MENCH JA, 1988, APPL ANIM BEHAV SCI, V21, P233, DOI 10.1016/0168-1591(88)90112-8; Bailie CL, 2013, ANIMAL, V7, P618, DOI 10.1017/S1751731112002108; Kells A, 2001, ANIM WELFARE, V10, P347; Allain V, 2009, BRIT POULTRY SCI, V50, P407, DOI 10.1080/00071660903110901; Kjaer JB, 2006, POULTRY SCI, V85, P1342; Martrenchar A, 2001, BRIT POULTRY SCI, V42, P161, DOI 10.1080/00071660120048393; Martrenchar A, 2000, BRIT POULTRY SCI, V41, P125, DOI 10.1080/713654921; Ventura BA, 2010, POULTRY SCI, V89, P1574, DOI 10.3382/ps.2009-00576; HUGHES BO, 1977, BRIT POULTRY SCI, V18, P715, DOI 10.1080/00071667708416426; de Jong IC, 2012, POULTRY SCI, V91, P1569, DOI 10.3382/ps.2012-02156; Olsson IAS, 2002, ANIM WELFARE, V11, P11; Rozenboim I, 1999, POULTRY SCI, V78, P135; Pettit-Riley R, 2001, APPL ANIM BEHAV SCI, V71, P127, DOI 10.1016/S0168-1591(00)00174-X; Pagazaurtundua A, 2006, BRIT POULTRY SCI, V47, P529, DOI 10.1080/00071660600963024; Bizeray D, 2002, POULTRY SCI, V81, P767; DAWKINS MS, 1989, APPL ANIM BEHAV SCI, V24, P77, DOI 10.1016/0168-1591(89)90126-3; FAWC (Farm Animal Welfare Council) FAWC updates the five freedoms, 1992, VET REC, V131, P357; Gouveia KG, 2009, ANIM WELFARE, V18, P43; Jockenhövel F, 2004, Aging Male, V7, P319; Mench J., 2004, Measuring and auditing broiler welfare, P3, DOI 10.1079/9780851998053.0003; RSPCA, WELF STAND CHICK; Sato S, 2011, ETHOGRAMS FARM ANIMA, P18	35	0	0	JAPAN POULTRY SCIENCE ASSOC	TSUKUBA	C/O NATL INST LIVESTOCK & GLASSLAND SCIENCE, 2 IKENODAI, TSUKUBA, IBARAKI 305-0901, JAPAN	1346-7395			J POULT SCI	J. Poult. Sci.	OCT	2015	52	4					323	330		10.2141/jpsa.0150034		8	Agriculture, Dairy & Animal Science	Agriculture	CU2KW	WOS:000363353400012		
J	Chowdhury, VS; Shigemura, A; Erwan, E; Ito, K; Bahry, MA; Tran, PV; Furuse, M				Chowdhury, Vishwajit S.; Shigemura, Asako; Erwan, Edi; Ito, Kentaro; Bahry, Mohammad A.; Tran, Phuong V.; Furuse, Mitsuhiro			Oral Administration of L-Citrulline, but not L-Arginine or L-Ornithine, Acts as a Hypothermic Agent in Chicks	JOURNAL OF POULTRY SCIENCE			English	Article						body temperature; chick; L-arginine; L-citrulline; L-ornithine	HIGH AMBIENT-TEMPERATURE; HEAT-EXPOSED CHICKS; FREE AMINO-ACID; BROILER-CHICKENS; NEONATAL CHICKS; NITRIC-OXIDE; D-ASPARTATE; FOOD-INTAKE; STRESS; INJECTION	Some amino acids are important regulators of key metabolic pathways and necessary for several physiological functions. However, little is know about thermoregulatory functions of amino acids. In this study, therefore chicks were either centrally or orally administered with L-citrulline (L-Cit), L-arginine (L-Arg) or L-ornithine (L-Orn) to monitor changes in rectal temperature. In Experiment 1, the amino acids (L-Cit, L-Arg and L-Orn) were administered into the left ventricle of the chicks by intracerebroventricular (i.c.v.) injection at a dose of 1 mu mol/10 mu l to monitor the effects of these amino acids on rectal temperature during 120 min of the experimental period. In Experiment 2, chicks received the same amino acids by oral administration at a dose of 15 mmol/10 ml/kg body weight. In Experiment 3, chicks received three doses of L-Cit (3.75, 7.5 or 15 mmol/10 ml/kg body weight) by oral administration. I.c.v. injection with any of the amino acids studied did not alter body temperature, but oral administration of L-Cit significantly reduced body temperature. Importantly, the highest does effectively reduced body temperature. These results suggest that peripheral L-Cit has a hypothermic function in chicks, which may be a new candidate to minimize high body temperature in poultry during summer heat stress.	[Chowdhury, Vishwajit S.] Kyushu Univ, Fac Arts & Sci, Div Expt Nat Sci, Fukuoka 8190395, Japan; [Shigemura, Asako; Erwan, Edi; Ito, Kentaro; Bahry, Mohammad A.; Tran, Phuong V.; Furuse, Mitsuhiro] Kyushu Univ, Lab Regulat Metab & Behav, Fac Agr, Fukuoka 8128581, Japan	Chowdhury, VS (reprint author), Kyushu Univ, Fac Arts & Sci, Div Expt Nat Sci, Fukuoka 8190395, Japan.	vc-sur@artsci.kyushu-u.ac.jp			Japan Society for the Promotion of Science [23248046, 15K07694]; Kiekai Research Grant	This work was supported by a Grant-in-Aid for Scientific Research (No. 23248046 to MF and No. 15K07694 to VSC) from the Japan Society for the Promotion of Science and Kiekai Research Grant Support to VSC.	Alberts B., 2014, ESSENTIAL CELL BIOL; Chowdhury VS, 2014, COMP BIOCHEM PHYS A, V169, P70, DOI 10.1016/j.cbpa.2013.12.020; Ito K, 2014, BRIT POULTRY SCI, V55, P644, DOI 10.1080/00071668.2014.957653; Szabo C, 1996, BRAIN RES BULL, V41, P131, DOI 10.1016/0361-9230(96)00159-1; Furuse M, 1999, BRIT POULTRY SCI, V40, P698, DOI 10.1080/00071669987115; Curis E, 2005, AMINO ACIDS, V29, P177, DOI 10.1007/s00726-005-0235-4; Soleimani AF, 2010, J ANIM PHYSIOL AN N, V94, P641, DOI 10.1111/j.1439-0396.2009.00951.x; Chowdhury VS, 2012, COMP BIOCHEM PHYS A, V162, P227, DOI 10.1016/j.cbpa.2012.03.009; MARDER J, 1989, COMP BIOCHEM PHYS A, V94, P395, DOI 10.1016/0300-9629(89)90112-6; Koutoku T, 2005, NEUROCHEM INT, V47, P183, DOI 10.1016/j.neuint.2005.03.006; Chowdhury VS, 2012, J POULT SCI, V49, P212, DOI 10.2141/jpsa.011071; Brake J, 1998, BRIT POULTRY SCI, V39, P639, DOI 10.1080/00071669888511; Erwan E, 2014, EUR J PHARMACOL, V736, P138, DOI 10.1016/j.ejphar.2014.04.042; Schwedhelm E, 2008, BRIT J CLIN PHARMACO, V65, P51, DOI 10.1111/j.1365-2125.2007.02990.x; Suenaga R, 2008, AMINO ACIDS, V35, P107, DOI 10.1007/s00726-007-0617-x; TAMIR H, 1963, ARCH BIOCHEM BIOPHYS, V102, P249, DOI 10.1016/0003-9861(63)90178-4; Yahav S, 1996, POULTRY SCI, V75, P402; Erwan E, 2012, AMINO ACIDS, V43, P1969, DOI 10.1007/s00726-012-1272-4; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Rimando AM, 2005, J CHROMATOGR A, V1078, P196, DOI 10.1016/j.chroma.2005.05.009; Monti JM, 2004, LIFE SCI, V75, P2027, DOI 10.1016/j.lfs.2004.02.036; Mendes AA, 1997, POULTRY SCI, V76, P472; Dai SF, 2012, BRIT POULTRY SCI, V53, P471, DOI 10.1080/00071668.2012.719148; DAVIS JL, 1979, PHYSIOL BEHAV, V22, P693, DOI 10.1016/0031-9384(79)90233-6; Willemsen H, 2011, POULTRY SCI, V90, P2311, DOI 10.3382/ps.2011-01353; TEDESCO TA, 1984, PEDIATRICS, V73, P879; Erwan E, 2014, LIFE SCI, V109, P65, DOI 10.1016/j.lfs.2014.05.015; Rose SP, 1997, BRIT POULTRY SCI, V38, pS36; Figueroa A, 2010, AM J HYPERTENS, V8, P1; Windmueller HG, 1981, AM J PHYSIOL, V241, P473	30	0	0	JAPAN POULTRY SCIENCE ASSOC	TSUKUBA	C/O NATL INST LIVESTOCK & GLASSLAND SCIENCE, 2 IKENODAI, TSUKUBA, IBARAKI 305-0901, JAPAN	1346-7395			J POULT SCI	J. Poult. Sci.	OCT	2015	52	4					331	335		10.2141/jpsa.0150014		5	Agriculture, Dairy & Animal Science	Agriculture	CU2KW	WOS:000363353400013		
J	Takahashi, K; Sakurai, N; Emura, N; Hashizume, T; Sawai, K				Takahashi, Kazuki; Sakurai, Nobuyuki; Emura, Natsuko; Hashizume, Tsutomu; Sawai, Ken			Effects of downregulating GLIS1 transcript on preimplantation development and gene expression of bovine embryos	JOURNAL OF REPRODUCTION AND DEVELOPMENT			English	Article						Bovine embryo; Early development; Gene expression; GLIS1; RNA interference	ZINC-FINGER PROTEIN; NUCLEAR TRANSFER; HEAT-SHOCK-PROTEIN-70 FAMILY; SOMATIC-CELLS; MOUSE EMBRYOS; STAGE; METHYLATION; ACTIVATION; MECHANISMS; OOCYTES	Kruppel-like protein Gli-similar 1 (GLIS1) is known as a direct reprogramming factor for the generation of induced pluripotent stem cells. The objective of this study was to investigate the role of GLIS1 in the preimplantation development of bovine embryos. GLIS1 transcripts in in vitro-matured oocytes and 1-cell to 4-cell stage embryos were detected, but they were either absent or at trace levels at the 8-cell to blastocyst stages. We attempted GLIS1 downregulation of bovine early embryos by RNA interference and evaluated developmental competency and gene transcripts, which are involved in zygotic gene activation (ZGA) in GLIS1-downregulated embryos. Injection of specific siRNA resulted in a distinct decrease in GLIS1 transcript in bovine embryos at the 4-cell stage. Although the bovine embryos injected with GLIS1-siRNA could develop to the 16-cell stage, these embryos had difficulty in developing beyond the 32-cell stage. Gene transcripts of PDHAI and HSPA8, which are transcribed after ZGA, showed lower level in GLIS1 downregulated embryos. It is possible that GLIS1-downregulated embryos fail to initiate ZGA. Our results indicated that GLIS1 is an important factor for the preimplantation development of bovine embryos.	[Takahashi, Kazuki; Emura, Natsuko; Hashizume, Tsutomu; Sawai, Ken] Iwate Univ, Fac Agr, Takizawa, Iwate 0208550, Japan; [Sakurai, Nobuyuki; Hashizume, Tsutomu; Sawai, Ken] Iwate Univ, United Grad Sch Agr Sci, Takizawa, Iwate 0208550, Japan	Sawai, K (reprint author), Iwate Univ, Fac Agr, Takizawa, Iwate 0208550, Japan.	kensawai@iwate-u.ac.jp			JSPS [26292162]	This study was supported by JSPS KAKENHI Grant number 26292162.	Zheng P, 2004, BIOL REPROD, V70, P1411, DOI 10.1095/biolreprod.103.023788; HOWLETT SK, 1991, DEVELOPMENT, V113, P119; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; Pliss L, 2004, J NEUROCHEM, V91, P1082, DOI 10.1111/j.1471-4159.2004.02790.x; KIDDER GM, 1985, DEV BIOL, V112, P265, DOI 10.1016/0012-1606(85)90397-5; Hyttel P, 2000, ANIM REPROD SCI, V60, P49, DOI 10.1016/S0378-4320(00)00087-7; Nakashima M, 2002, MECH DEVELOP, V119, P21, DOI 10.1016/S0925-4773(02)00291-5; Schultz RM, 1999, J EXP ZOOL, V285, P276, DOI 10.1002/(SICI)1097-010X(19991015)285:3<276::AID-JEZ11>3.0.CO;2-K; FREI RE, 1989, J REPROD FERTIL, V86, P637; WILLADSEN SM, 1991, THERIOGENOLOGY, V35, P161, DOI 10.1016/0093-691X(91)90155-7; BAVISTER BD, 1983, BIOL REPROD, V28, P235, DOI 10.1095/biolreprod28.1.235; Sawai K, 2011, J REPROD DEVELOP, V57, P236, DOI 10.1262/jrd.10-035A; WILSON JM, 1995, ANIM REPROD SCI, V38, P73, DOI 10.1016/0378-4320(94)01353-N; Mann MRW, 2003, BIOL REPROD, V69, P902, DOI 10.1095/biolreprod.103.017293; Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Minami N, 2007, J REPROD DEVELOP, V53, P707, DOI 10.1262/jrd.19029; Holen T, 2002, NUCLEIC ACIDS RES, V30, P1757, DOI 10.1093/nar/30.8.1757; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; BEHBOODI E, 1995, THERIOGENOLOGY, V44, P227, DOI 10.1016/0093-691X(95)00172-5; Khalesi E, 2013, BIOCHEM BIOPH RES CO, V441, P499, DOI 10.1016/j.bbrc.2013.10.083; Abe H, 1999, MOL REPROD DEV, V53, P325, DOI 10.1002/(SICI)1098-2795(199907)53:3<325::AID-MRD8>3.0.CO;2-T; CAMOUS S, 1986, BIOL CELL, V58, P195; Svarcova O, 2007, MOL REPROD DEV, V74, P1428, DOI 10.1002/mrd.20727; BRAUDE P, 1988, NATURE, V332, P459, DOI 10.1038/332459a0; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kang HS, 2010, HISTOL HISTOPATHOL, V25, P1481; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Jullien J, 2011, NAT REV MOL CELL BIO, V12, P453, DOI 10.1038/nrm3140; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; Sawai K, 2005, CLONING STEM CELLS, V7, P189, DOI 10.1089/clo.2005.7.189; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; DAHL HHM, 1995, AM J HUM GENET, V56, P553; Laurincik J, 2002, MOL REPROD DEV, V61, P477, DOI 10.1002/mrd.10109; Nakanishi G, 2006, J INVEST DERMATOL, V126, P49, DOI 10.1038/sj.jid.5700018; Wrenzycki C, 2005, REPROD FERT DEVELOP, V17, P23, DOI 10.1071/RD04109; Kim YS, 2002, J BIOL CHEM, V277, P30901, DOI 10.1074/jbc.M203563200; MONK M, 1987, DEVELOPMENT, V99, P371; Machado GM, 2013, REPROD FERT DEVELOP, V25, P600, DOI 10.1071/RD11282; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; den Dass JHG, 1997, THERIOGENOLOGY, V47, P43; Song BS, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-44	41	0	0	SOCIETY REPRODUCTION & DEVELOPMENT-SRD	TSUKUBA	C/O KAZUHIRO KIKUCHI, PHD DVM, NATL INST AGROBIOLOGICAL SCIENCES KANNONDAI 2-1-2, TSUKUBA, IBARAKI 305-8602, JAPAN	0916-8818			J REPROD DEVELOP	J. Reprod. Dev.	OCT	2015	61	5					369	374				6	Agriculture, Dairy & Animal Science; Reproductive Biology	Agriculture; Reproductive Biology	CU5VP	WOS:000363600400002		
J	Otaka, K; Hiradate, Y; Kobayashi, N; Shirakata, Y; Tanemura, K				Otaka, Kosuke; Hiradate, Yuuki; Kobayashi, Norio; Shirakata, Yoshiki; Tanemura, Kentaro			Distribution of the sex chromosome during mouse spermatogenesis in testis tissue sections	JOURNAL OF REPRODUCTION AND DEVELOPMENT			English	Article						Fluorescence in situ hybridization; Sex chromosome; Spermatogenesis	IN-SITU HYBRIDIZATION; HUMAN SPERM NUCLEI; CATTLE BOS-TAURUS; Y-CHROMOSOMES; GERM-CELLS; FISH; INACTIVATION; CHROMATIN; MICE; SPERMATOZOA	During mammalian spermatogenesis, spermatogenic cells undergo mitotic division and are subsequently divided into haploid spermatids by meiotic division, but the dynamics of sex chromosomes during spermatogenesis are unclear in vivo. To gain insight into the distribution of sex chromosomes in the testis, we examined the localization of sex chromosomes before and after meiosis in mouse testis sections. Here, we developed a method of fluorescence in situ hybridization (FISH) using specific probes for the X and Y chromosomes to obtain their positional information in histological testis sections. FISH analysis revealed the sex chromosomal position during spermatogenesis in each stage of seminiferous epithelia and in each spermatogenic cell. In the spermatogonia and leptotene spermatocytes, sex chromosomes were distantly positioned in the cell. In the zygotene and pachytene spermatocytes at prophase I, X and Y chromosomes had a random distribution. After meiosis, the X and Y spermatids were random in every seminiferous epithelium. We also detected aneuploidy of sex chromosomes in spermatogenic cells using our developed FISH analysis. Our results provide further insight into the distribution of sex chromosomes during spermatogenesis, which could help to elucidate a specific difference between X and Y speimatids and sex chromosome-specific behavior.	[Otaka, Kosuke; Hiradate, Yuuki; Kobayashi, Norio; Shirakata, Yoshiki; Tanemura, Kentaro] Tohoku Univ, Grad Sch Agr Sci, Lab Anim Reprod & Dev, Sendai, Miyagi 9818555, Japan	Tanemura, K (reprint author), Tohoku Univ, Grad Sch Agr Sci, Lab Anim Reprod & Dev, Sendai, Miyagi 9818555, Japan.	kentaro@m.tohoku.ac.jp					Nicodemo D, 2009, CYTOGENET GENOME RES, V126, P217, DOI 10.1159/000245923; Royo H, 2010, CURR BIOL, V20, P2117, DOI 10.1016/j.cub.2010.11.010; Handel MA, 2004, EXP CELL RES, V296, P57, DOI 10.1016/j.yexcr.2004.03.008; Oi M, 2013, J REPROD DEVELOP, V59, P92; Turner JMA, 2006, DEV CELL, V10, P521, DOI 10.1016/j.devcel.2006.02.009; Bugno M, 2010, REPROD DOMEST ANIM, V45, P1015, DOI 10.1111/j.1439-0531.2009.01478.x; Lowe X, 1996, CHROMOSOMA, V105, P204; MCKEE BD, 1993, CHROMOSOMA, V102, P71, DOI 10.1007/BF00356023; Turner JMA, 2004, CURR BIOL, V14, P2135, DOI 10.1016/j.cub.2004.11.032; Burgoyne PS, 2009, NAT REV GENET, V10, P207, DOI 10.1038/nrg2505; Toth A, 2010, CURR BIOL, V20, pR1022, DOI 10.1016/j.cub.2010.11.002; HECHT NB, 1990, J REPROD FERTIL, V88, P679; Egozcue J, 1997, HUM REPROD UPDATE, V3, P441, DOI 10.1093/humupd/3.5.441; Habermann FA, 2005, J ANIM BREED GENET, V122, P22, DOI 10.1111/j.1439-0388.2005.00488.x; Hamer G, 2008, THERIOGENOLOGY, V69, P333, DOI 10.1016/j.theriogenology.2007.09.029; WYROBEK AJ, 1990, MOL REPROD DEV, V27, P200, DOI 10.1002/mrd.1080270304; Attia SM, 2012, MUTAGENESIS, V27, P31, DOI 10.1093/mutage/ger051; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Turner JMA, 2005, NAT GENET, V37, P41, DOI 10.1038/ng1484; Kitajima TS, 2011, CELL, V146, P568, DOI 10.1016/j.cell.2011.07.031; Whyte JJ, 2007, THERIOGENOLOGY, V67, P1022, DOI 10.1016/j.theriogenology.2006.11.014; BURGOYNE PS, 1982, HUM GENET, V61, P85, DOI 10.1007/BF00274192; Lee JT, 2005, CURR BIOL, V15, pR249, DOI 10.1016/j.cub.2005.03.024; Kauppi L, 2012, ANN NY ACAD SCI, V1267, P18, DOI 10.1111/j.1749-6632.2012.06593.x; Ko E, 2001, CYTOGENET CELL GENET, V95, P143, DOI 10.1159/000059336; Baarends WM, 2003, CYTOGENET GENOME RES, V103, P225, DOI 10.1159/000076808; SOLARI AJ, 1974, INT REV CYTOL, V38, P273, DOI 10.1016/S0074-7696(08)60928-6; Attia SM, 2008, MUTAT RES-GEN TOX EN, V651, P105, DOI 10.1016/j.mrgentox.2007.10.011; LEBLOND CP, 1952, AM J ANAT, V90, P167, DOI 10.1002/aja.1000900202; Kawarasaki T, 1996, MOL REPROD DEV, V43, P548; Komaki H, 2014, THERIOGENOLOGY, V82, P652, DOI 10.1016/j.theriogenology.2014.05.018; Baumgartner A, 2001, MUTAT RES-GEN TOX EN, V490, P11, DOI 10.1016/S1383-5718(00)00141-8; Fernandez-Capetillo O, 2003, DEV CELL, V4, P497, DOI 10.1016/S1534-5807(03)00093-5; Garcia-Quevedo L, 2014, ANDROLOGY-US, V2, P892, DOI 10.1111/j.2047-2927.2014.00272.x; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Kim J, 2015, NATURE, V517, P466, DOI 10.1038/nature14097; Kobayashi J, 1999, THERIOGENOLOGY, V52, P1043, DOI 10.1016/S0093-691X(99)00193-4; Rens W, 2001, REPRODUCTION, V121, P541, DOI 10.1530/rep.0.1210541; Russell L.D., 1990, HISTOLOGICAL HISTOPA	39	0	0	SOCIETY REPRODUCTION & DEVELOPMENT-SRD	TSUKUBA	C/O KAZUHIRO KIKUCHI, PHD DVM, NATL INST AGROBIOLOGICAL SCIENCES KANNONDAI 2-1-2, TSUKUBA, IBARAKI 305-8602, JAPAN	0916-8818			J REPROD DEVELOP	J. Reprod. Dev.	OCT	2015	61	5					375	381				7	Agriculture, Dairy & Animal Science; Reproductive Biology	Agriculture; Reproductive Biology	CU5VP	WOS:000363600400003		
J	Yazama, F; Sato, H; Sonoda, T				Yazama, Futoshi; Sato, Haruki; Sonoda, Tomoko			Malfunction of spermatogenesis in experimental ischemic mice	JOURNAL OF REPRODUCTION AND DEVELOPMENT			English	Article						Blood-testis barrier (BTB); Heat shock protein (HSP) 70; Ischemia; Mouse; Testis	BLOOD-TESTIS BARRIER; GERM-CELL APOPTOSIS; HEAT-SHOCK PROTEINS; MALE-INFERTILITY; SERTOLI-CELLS; EXPRESSION; HSP72; GENE; ELECTROPHORESIS; LOCALIZATION	An experimental ischemia (EI)-induced mouse model was used to analyze pathological and biochemical alterations in testes. Initial morphological changes were observed in Sertoli cells of El testes at the light microscopic level. Examination of the ultrastructure using transmission electron microscopy confirmed that Sertoli cells were partially detached from the basement membrane of the seminiferous epithelium and that the cell membranes of adjacent Sertoli cells were not joined. The functional integrity of the blood-testis barrier (BTB) was assessed using the lanthanum tracer technique. Lanthanum had penetrated into the spaces between adjacent Satoli cells in the adluminal compartment up to the lumen of the seminiferous epithelium in EI testes. Proteome analysis showed that the expression of heat shock protein (HSP) 70 was significantly upregulated in EI testes. Western blot analysis confirmed that the expression of HSP70 increased in a time-dependent manner after the EI procedure. HSP70 immunostaining was observed in spermatocytes and in round and elongated spermatids in El testes. Our results suggest that a change in the junctions between adjacent Sertoli cells on the basal compartment is involved in the BTB disruption in EI testes. Therefore, male infertility caused by the BTB disruption could be associated with heat stress induced by ischemia.	[Yazama, Futoshi; Sato, Haruki] Prefectural Univ Hiroshima, Dept Life Sci, Lab Cell Biol & Morphol, Hiroshima 7270023, Japan; [Sonoda, Tomoko] Yokohama City Univ, Sch Med, Dept Mol Biodef Res, Lab Mol Physiol, Yokohama, Kanagawa 2360004, Japan	Yazama, F (reprint author), Prefectural Univ Hiroshima, Dept Life Sci, Lab Cell Biol & Morphol, Hiroshima 7270023, Japan.	fyzma@pu-hiroshima.ac.jp					Jungwirth A, 2012, EUR UROL, V62, P324, DOI 10.1016/j.eururo.2012.04.048; Sasaki T, 2008, J CELL BIOL, V182, P449, DOI 10.1083/jcb.200802113; Deng Y, 2008, UROLOGY, V71, P878, DOI 10.1016/j.urology.2007.12.055; ALLEN RL, 1988, MOL CELL BIOL, V8, P828; Yazama F, 2008, J REPROD DEVELOP, V54, P299, DOI 10.1262/jrd.19169; HIRANO H, 1982, PHYTOCHEMISTRY, V21, P1513, DOI 10.1016/S0031-9422(82)85008-5; HAGENAS L, 1977, ANDROLOGIA, V9, P250; McLachlan JA, 2001, APMIS, V109, P263, DOI 10.1034/j.1600-0463.2001.d01-119.x; Ellis S, 2000, J HISTOCHEM CYTOCHEM, V48, P321; Itoh N, 2001, J ANDROL, V22, P40; ALLEN RL, 1988, MOL CELL BIOL, V8, P3260; Mori C, 1997, DEV DYNAM, V208, P125; Iammarrone E, 2003, BEST PRACT RES CL OB, V17, P211, DOI 10.1053/ybeog.2003.359; Fink C, 2006, NEOPLASIA, V8, P1019, DOI 10.1593/neo.06559; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; ZAKERI ZF, 1990, J CELL BIOL, V111, P1785, DOI 10.1083/jcb.111.5.1785; Zhou XC, 2001, ENDOCRINE, V16, P89, DOI 10.1385/ENDO:16:2:089; Vydra N, 2006, CELL DEATH DIFFER, V13, P212, DOI 10.1038/sj.cdd.4401758; Dix DJ, 1997, CELL STRESS CHAPERON, V2, P73, DOI 10.1379/1466-1268(1997)002<0073:HEAFDG>2.3.CO;2; Dix DJ, 1996, P NATL ACAD SCI USA, V93, P3264, DOI 10.1073/pnas.93.8.3264; Yazama F, 2006, ANAT SCI INT, V81, P115, DOI 10.1111/j.1447-073X.2006.00139.x; Zaprjanova S, 2013, EUR J OBSTET GYN R B, V168, P54, DOI 10.1016/j.ejogrb.2012.12.021; FUJISAWA M, 1988, J REPROD FERTIL, V84, P123; Krausz C, 2011, BEST PRACT RES CL EN, V25, P271, DOI 10.1016/j.beem.2010.08.006; ROSARIO MO, 1992, DEV BIOL, V150, P1, DOI 10.1016/0012-1606(92)90002-X; Cataldo L, 1997, EXP CELL RES, V231, P206, DOI 10.1006/excr.1996.3447; Kaushal N, 2009, EUR J NUTR, V48, P221, DOI 10.1007/s00394-009-0005-2; Biggiogera M, 1996, EXP CELL RES, V229, P77, DOI 10.1006/excr.1996.0345; Smith JF, 2010, FERTIL STERIL, V93, P2169, DOI 10.1016/j.fertnstert.2010.02.054; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077; Gunn SA, 1975, HDB PHYSL, P117; Hirano H., 1989, METHODS PROTEIN SEQU, P42; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Ruchalski K, 2003, AM J PHYSIOL-CELL PH, V285, pC1483, DOI 10.1152/ajpcell.00049.2003; Setchell BP, 1975, HDB PHYSL, P143	35	0	0	SOCIETY REPRODUCTION & DEVELOPMENT-SRD	TSUKUBA	C/O KAZUHIRO KIKUCHI, PHD DVM, NATL INST AGROBIOLOGICAL SCIENCES KANNONDAI 2-1-2, TSUKUBA, IBARAKI 305-8602, JAPAN	0916-8818			J REPROD DEVELOP	J. Reprod. Dev.	OCT	2015	61	5					399	406				8	Agriculture, Dairy & Animal Science; Reproductive Biology	Agriculture; Reproductive Biology	CU5VP	WOS:000363600400006		
J	Kitayama, C; Sasaki, M; Ishikawa, H; Mogoe, T; Ohsumi, S; Fukui, Y; Budipitojo, T; Kondoh, D; Kitamura, N				Kitayama, Chiyo; Sasaki, Motoki; Ishikawa, Hajime; Mogoe, Toshihiro; Ohsumi, Seiji; Fukui, Yutaka; Budipitojo, Teguh; Kondoh, Daisuke; Kitamura, Nobuo			Structure and functions of the placenta in common minke (Balaenoptera acutorostrata), Bryde's (B. brydei) and sei (B. borealis) whales	JOURNAL OF REPRODUCTION AND DEVELOPMENT			English	Article						Arcola; Aromatase; Placenta; Uteroferrin; Whale	STEROIDOGENIC ENZYMES; CORPUS-LUTEUM; AROMATASE CYTOCHROME-P450; ESTROGEN SYNTHESIS; PORCINE PLACENTA; BALEEN WHALE; UTEROFERRIN; PREGNANCY; IMMUNOLOCALIZATION; EXPRESSION	The structure and functions of placentas were examined in 3 species of rorqual whales, common minke (Balaenoptera acutorostrata), Bryde's (B. brydei) and sei (B. borealis) whales, with the aim of confirming the structural characteristics of the chorion, including the presence of the areolar part, and clarifying steroidogenic activities and fetomatemal interactions in the placentas of these whales. Placentas were collected from the second phase of the Japanese Whale Research Program under Special Permit in the North Pacific (JARPN II). Histological and ultrastructural examinations revealed that these whale placentas were epitheliochorial placentas with the interdigitation of chorionic villi lined by monolayer uninucleate cells (trophoblast cells) and endometrial crypts as well as folded placentation by fold-like chorionic villi. Moreover, well-developed pouch-like areolae were observed in the placentas, and active absorption was suggested in the chorionic epithelial cells of the areolar part (areolar trophoblast cells). Berlin blue staining showed the presence of ferric ions (Fe3+) in the uterine glandular epithelial cells and within the stroma of chorionic villi in the areolar part. An immunohistochemical examination revealed tartrate-resistant acid phosphatase (TRAP; known as uteroferrin in uteri) in the cytoplasm of glandular cells and areolar trophoblast cells. This result suggested that, in cetaceans, uteroferrin is used to supply iron to the fetus. Furthermore, immunoreactivity for P450scc and P450arom was detected in trophoblast cells, but not in areolar trophoblast cells, suggesting that trophoblast cells synthesize estrogen in whale placentas. Therefore, we herein immunohistochemically revealed the localization of aromatase and uteroferrin in cetacean placentas during pregnancy for the first time.	[Kitayama, Chiyo; Sasaki, Motoki; Kondoh, Daisuke; Kitamura, Nobuo] Obihiro Univ Agr & Vet Med, Dept Basic Vet Med, Lab Vet Anat, Sapporo, Hokkaido 0808555, Japan; [Sasaki, Motoki; Kitamura, Nobuo] Gifu Univ, United Grad Sch Vet Med, Gifu 5011193, Japan; [Ishikawa, Hajime; Mogoe, Toshihiro; Ohsumi, Seiji] Inst Cetacean Res, Tokyo 1040055, Japan; [Fukui, Yutaka] Obihiro Univ Agr & Vet Med, Dept Life Sci & Agr, Sapporo, Hokkaido 0808555, Japan; [Budipitojo, Teguh] Gadjah Mada Univ, Fac Vet Med, Yogyakarta 55281, Indonesia	Sasaki, M (reprint author), Obihiro Univ Agr & Vet Med, Dept Basic Vet Med, Lab Vet Anat, Sapporo, Hokkaido 0808555, Japan.	sasakim@obihiro.ac.jp					AMOROSO E. C, 1958, PROC ZOOL SOC LONDON, V130, P437; RYAN KJ, 1971, AM J OBSTET GYNECOL, V109, P299; DANTZER V, 1984, ACTA ANAT, V118, P96; SCHULER G, 1994, EXP CLIN ENDOCRINOL, V102, P169; Wislocki GB, 1941, AM J ANAT, V68, P97, DOI 10.1002/aja.1000680105; Pereira FTV, 2010, REPROD DOMEST ANIM, V45, P907, DOI 10.1111/j.1439-0531.2009.01462.x; BURTON GJ, 1982, PLACENTA, V3, P407, DOI 10.1016/S0143-4004(82)80033-7; BENIRSCHKE K, 1987, MAR MAMMAL SCI, V3, P82, DOI 10.1111/j.1748-7692.1987.tb00153.x; Conley AJ, 2007, PLACENTA, V28, P668, DOI 10.1016/j.placenta.2006.11.004; FRIESS AE, 1981, ANAT EMBRYOL, V163, P43, DOI 10.1007/BF00315769; Wislocki GB, 1933, BIOL BULL-US, V65, P80, DOI 10.2307/1537189; Schuler G, 2006, REPRODUCTION, V131, P669, DOI 10.1530/rep.1.01033; Weng Q, 2005, J REPROD DEVELOP, V51, P247, DOI 10.1262/jrd.16081; Flood PF, 2005, ANIM REPROD SCI, V85, P147, DOI 10.1016/j.anireprosci.2004.03.001; Li Y, 2005, PLACENTA, V26, P387, DOI 10.1016/j.placenta.2004.07.008; PATIL DR, 1974, J ANAT, V118, P33; Olivera L, 2003, ANAT EMBRYOL, V207, P45, DOI 10.1007/s00429-003-0328-3; ROBERTS RM, 1988, J REPROD FERTIL, V82, P875; Enders AC, 2004, PLACENTA, V25, pS3, DOI 10.1016/j.placenta.2004.01.011; Wada S, 2003, NATURE, V426, P278, DOI 10.1038/nature02103; Braun BC, 2012, J STEROID BIOCHEM, V132, P295, DOI 10.1016/j.jsbmb.2012.07.005; Tsubota T, 2001, REPRODUCTION, V121, P587, DOI 10.1530/rep.0.1210587; Hoffmann B, 2002, DOMEST ANIM ENDOCRIN, V23, P309, DOI 10.1016/S0739-7240(02)00166-2; LING P, 1993, J BIOL CHEM, V268, P6896; Silvers LE, 1997, MAR MAMMAL SCI, V13, P711, DOI 10.1111/j.1748-7692.1997.tb00095.x; Wilsher S, 2013, REPRODUCTION, V145, P541, DOI 10.1530/REP-13-0060; de Oliveira CM, 2012, AN ACAD BRAS CIENC, V84, P1115, DOI 10.1590/S0001-37652012005000055; Sasaki M, 2013, J REPROD DEVELOP, V59, P159, DOI 10.1262/jrd.2012-132; Abd-Elnaeim MMM, 2003, ANAT HISTOL EMBRYOL, V32, P326, DOI 10.1111/j.1439-0264.2003.00465.x; Nishiyama T, 1999, ANAT HISTOL EMBRYOL, V28, P125, DOI 10.1046/j.1439-0264.1999.00170.x; Ellenberger C, 2008, THERIOGENOLOGY, V70, P746, DOI 10.1016/j.theriogenology.2008.04.050; Sasaki T, 2006, MOL PHYLOGENET EVOL, V41, P40, DOI 10.1016/j.ympev.2006.03.032; RENEGAR RH, 1982, BIOL REPROD, V27, P1247, DOI 10.1095/biolreprod27.5.1247; Sasaki M, 2014, J REPROD DEVELOP, V60, P62, DOI 10.1262/jrd.2013-063; DANTZER V, 1993, ANAT EMBRYOL, V188, P257; Burton GJ, 2008, COMP PLACENTATION ST, P301; Calle PP, 1994, VERT BER ERKRG ZOOTI, V36, P309; da Silva VMF, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-26; Enders AC, 2006, PLACENTA, V27, pS11, DOI 10.1016/j.placenta.2005.10.013; Gao H. J., 2010, Journal of Animal Science and Biotechnology, V1, P137; HOFFMANN B, 1979, ANIM REPROD SCI, V2, P253, DOI 10.1016/0378-4320(79)90051-4; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577; Kato H, 1990, BIOL MARINE MAMMALS, P128; Mead JG, 2005, MAMMAL SPECIES WORLD, P723; Miller Debra L., 2007, P331; Padua MB, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097964; Pereira F., 2006, Reproduction Fertility and Development, V18, P141, DOI 10.1071/RDv18n2Ab66; Stump C. W., 1960, Australian Journal of Marine and Freshwater Research, V11, P365; Turner W, 1872, T ROY SOC EDINBURGH, V226, P466; YOSHINAGAHIRABAYASHI T, 1990, HISTOCHEMISTRY, V93, P223; ZHEMKOVA Z. P., 1967, FOLIA MORPHOL [PRAGUE], V15, P104	51	0	0	SOCIETY REPRODUCTION & DEVELOPMENT-SRD	TSUKUBA	C/O KAZUHIRO KIKUCHI, PHD DVM, NATL INST AGROBIOLOGICAL SCIENCES KANNONDAI 2-1-2, TSUKUBA, IBARAKI 305-8602, JAPAN	0916-8818			J REPROD DEVELOP	J. Reprod. Dev.	OCT	2015	61	5					415	421				7	Agriculture, Dairy & Animal Science; Reproductive Biology	Agriculture; Reproductive Biology	CU5VP	WOS:000363600400008		
J	Mori, M; Hayashi, T; Isozaki, Y; Takenouchi, N; Sakatani, M				Mori, Miyuki; Hayashi, Takeshi; Isozaki, Yoshihiro; Takenouchi, Naoki; Sakatani, Miki			Heat shock decreases the embryonic quality of frozen-thawed bovine blastocysts produced in vitro	JOURNAL OF REPRODUCTION AND DEVELOPMENT			English	Article						Blastocysts; Cryopreservation; Heat shock; IVF	LACTATING DAIRY-COWS; INCREASE PREGNANCY RATES; PREIMPLANTATION EMBRYOS; HEAT-SHOCK-PROTEIN-70 SYNTHESIS; ARTIFICIAL-INSEMINATION; GENE-EXPRESSION; CONCEPTION RATE; STRESS; CATTLE; CULTURE	In this study, the effect of heat shock on frozen-thawed blastocysts was evaluated using in vitro-produced (IVP) bovine embryos. In experiment 1, the effects of 6 h of heat shock at 41.0 C on fresh blastocysts were evaluated. HSPA14 expression as a reflection of stress was increased by heat shock (P < 0.05), but the expressions of the quality markers IFNT and POU5F1 were not affected. In experiment 2, frozen-thawed blastocysts were incubated at 38.5 C for 6 h (cryo-con) or exposed to heat shock at 41.0 C for 6 h (cryo-HS). Then, blastocysts were cultured at 38.5 C until 48 h after thawing (both conditions). Cryo-HS blastocysts exhibited a decreased recovery rate: HSPA14 expression was dramatically increased compared with that in fresh or cryo-con blastocysts at 6 h, and IFNT expression was decreased compared with that in cryo-con blastocysts at 6 h (both P < 0.05). Cryo-con blastocysts at 6 h also exhibited higher HSPA1A expression than fresh blastocysts (P < 0.05). At 48 h after thawing, the number of hatched blastocysts and blastocyst diameter were lower in cryo-HS blastocysts (P < 0.05). Cryo-con blastocysts showed lower POU5F1 levels at 48 h than fresh, cryo-con or cryo-HS blastocysts at 6 h (P < 0.05), but their POU5F1 levels were not different from those of cryo-HS blastocysts at 48 h. These results indicated that application of heat shock to frozen-thawed blastocysts was highly damaging. The increase in damage by the interaction of freezing-thawing and heat shock might be one reason for the low conception rate in frozen-thawed embryo transfer in summer.	[Mori, Miyuki; Hayashi, Takeshi; Isozaki, Yoshihiro] Fukuoka Agr & Forestry Res Ctr, Fukuoka 8188549, Japan; [Takenouchi, Naoki; Sakatani, Miki] Natl Agr & Food Res Org NARO, Kyushu Okinawa Agr Res Ctr, Livestock & Grassland Res Div, Kumamoto 8611192, Japan	Sakatani, M (reprint author), Natl Agr & Food Res Org NARO, Kyushu Okinawa Agr Res Ctr, Livestock & Grassland Res Div, Kumamoto 8611192, Japan.	msaka@affrc.go.jp			Ito Foundation Research Grant [2014-25]	This project was supported by an Ito Foundation Research Grant (Grant #: 2014-25).	Fair T, 2001, MOL REPROD DEV, V58, P186, DOI 10.1002/1098-2795(200102)58:2<186::AID-MRD8>3.0.CO;2-N; Block J, 2003, J ANIM SCI, V81, P1590; Chebel RC, 2008, THERIOGENOLOGY, V69, P98, DOI 10.1016/j.theriogenology.2007.09.008; Mori M, 2014, THERIOGENOLOGY, V81, P683, DOI 10.1016/j.theriogenology.2013.11.015; Dikmen S, 2012, J DAIRY SCI, V95, P3401, DOI 10.3168/jds.2011-4306; Edwards JL, 1997, MOL REPROD DEV, V46, P138, DOI 10.1002/(SICI)1098-2795(199702)46:2<138::AID-MRD4>3.0.CO;2-R; Rizos D, 2003, BIOL REPROD, V68, P236, DOI 10.1095/biolreprod.102.007799; IMAKAWA K, 1987, NATURE, V330, P377, DOI 10.1038/330377a0; Nabenishi H, 2011, J REPROD DEVELOP, V57, P450, DOI 10.1262/jrd.10-135T; PUTNEY DJ, 1988, BIOL REPROD, V39, P717, DOI 10.1095/biolreprod39.3.717; Correa GA, 2008, ANIM REPROD SCI, V104, P132, DOI 10.1016/j.anireprosci.2007.02.002; Agca Y, 1998, THERIOGENOLOGY, V50, P147, DOI 10.1016/S0093-691X(98)00121-6; EALY AD, 1993, J DAIRY SCI, V76, P2899; Tani M, 2010, J VET MED SCI, V72, P627; da Silva FM, 2005, REPROD DOMEST ANIM, V40, P205, DOI 10.1111/j.1439-0531.2005.00575.x; Hansen PJ, 1999, J ANIM SCI, V77, P36; Rutledge JJ, 2001, THERIOGENOLOGY, V55, P105, DOI 10.1016/S0093-691X(00)00449-0; Sakatani M, 2012, J DAIRY SCI, V95, P3080, DOI 10.3168/jds.2011-4986; PUTNEY DJ, 1989, ANIM REPROD SCI, V19, P37, DOI 10.1016/0378-4320(89)90045-6; Fields SD, 2011, THERIOGENOLOGY, V75, P1466, DOI 10.1016/j.theriogenology.2010.12.007; Chandolia RK, 1999, BIOL REPROD, V61, P1644, DOI 10.1095/biolreprod61.6.1644; Park SY, 2006, ZYGOTE, V14, P125, DOI 10.1017/S0967199406003649; Sagirkaya H, 2006, REPRODUCTION, V131, P895, DOI 10.1530/rep.1.01021; Mori M, 2012, J REPROD DEVELOP, V58, P717, DOI 10.1262/jrd.2012-085; Drost M, 1999, THERIOGENOLOGY, V52, P1161, DOI 10.1016/S0093-691X(99)00208-3; Ambrose JD, 1999, J DAIRY SCI, V82, P2369; Moghaddam A, 2009, VET RES COMMUN, V33, P567, DOI 10.1007/s11259-009-9205-8; Ozawa M, 2012, THERIOGENOLOGY, V78, P1243, DOI 10.1016/j.theriogenology.2012.05.020; Dobson H, 2001, THERIOGENOLOGY, V55, P65, DOI 10.1016/S0093-691X(00)00446-5; Hansen PJ, 2001, THERIOGENOLOGY, V55, P91, DOI 10.1016/S0093-691X(00)00448-9; Sakatani M, 2008, J REPROD DEVELOP, V54, P496, DOI 10.1262/jrd.20017; Edwards JL, 1997, MOL REPROD DEV, V48, P25, DOI 10.1002/(SICI)1098-2795(199709)48:1<25::AID-MRD4>3.0.CO;2-R; Imai K, 2002, J VET MED SCI, V64, P887, DOI 10.1292/jvms.64.887; Villa-Mancera A, 2011, TROP ANIM HEALTH PRO, V43, P597, DOI 10.1007/s11250-010-9737-5; Sakatani M, 2004, MOL REPROD DEV, V67, P77, DOI 10.1002/mrd.20014; Collier RJ, 2006, J DAIRY SCI, V89, P1244; Hickman CF, 2013, AM J REPROD IMMUNOL, V70, P177, DOI 10.1111/aji.12131; Al-Katanani YM, 2002, THERIOGENOLOGY, V58, P171, DOI 10.1016/S0093-691X(02)00916-0; Stewart BM, 2011, J DAIRY SCI, V94, P3437, DOI 10.3168/jds.2010-4008; Mori M, 2002, REPROD DOMEST ANIM, V37, P181, DOI 10.1046/j.1439-0531.2002.00354.x; Rivera RM, 2001, REPRODUCTION, V121, P107, DOI 10.1530/rep.0.1210107; Garcia-Ispierto I, 2007, THERIOGENOLOGY, V67, P1379, DOI 10.1016/j.theriogenology.2007.02.009; Bazer FW, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-23; Hansen PJ, 2002, J ANIM SCI S2, V80, pE33; Leidenfrost S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022121	45	0	0	SOCIETY REPRODUCTION & DEVELOPMENT-SRD	TSUKUBA	C/O KAZUHIRO KIKUCHI, PHD DVM, NATL INST AGROBIOLOGICAL SCIENCES KANNONDAI 2-1-2, TSUKUBA, IBARAKI 305-8602, JAPAN	0916-8818			J REPROD DEVELOP	J. Reprod. Dev.	OCT	2015	61	5					423	429				7	Agriculture, Dairy & Animal Science; Reproductive Biology	Agriculture; Reproductive Biology	CU5VP	WOS:000363600400009		
J	Punyawai, K; Anakkul, N; Srirattana, K; Aikawa, Y; Sangsritavong, S; Nagai, T; Imai, K; Parnpai, R				Punyawai, Kanchana; Anakkul, Nitira; Srirattana, Kanokwan; Aikawa, Yoshio; Sangsritavong, Siwat; Nagai, Takashi; Imai, Kei; Parnpai, Rangsun			Comparison of Cryotop and micro volume air cooling methods for cryopreservation of bovine matured oocytes and blastocysts	JOURNAL OF REPRODUCTION AND DEVELOPMENT			English	Article						Blastocysts; Cryodevice; Cryotop; Micro volume air cooling; Oocytes	PREGNANCIES FOLLOWING TRANSFER; BUBALUS-BUBALIS EMBRYOS; IN-VITRO FERTILIZATION; CELL NUCLEAR TRANSFER; HIGH SURVIVAL RATE; LIQUID-NITROGEN; PORCINE EMBRYOS; VITRIFICATION METHODS; MEIOTIC SPINDLES; VAPOR-PHASE	This study was designed to compare the efficiency of the Cryotop method and that of two methods that employ a micro volume air cooling (MVAC) device by analyzing the survival and development of bovine oocytes and blastocysts vitrified using each method. In experiment I, in vitro-matured (IVM) oocytes were vitrified using an MVAC device without direct contact with liquid nitrogen (LN2; MVAC group) or directly plunged into LN2 (MVAC in LN2 group). A third group of IVM oocytes was vitrified using a Cryotop device (Cryotop group). After warming, vitrified oocytes were fertilized in vitro. There were no significant differences in cleavage and blastocyst formation rates among the three vitrified groups, with the rates ranging from 53.1% to 56.6% and 20.0% to 25.5%, respectively; however, the rates were significantly lower (P < 0.05) than those of the fresh control group (89.3% and 43.3%, respectively) and the solution control group (87.3% and 42.0%, respectively). In experiment II, in vitro-produced (IVP) expanded blastocysts were vitrified using the MVAC, MVAC in LN2 and Cryotop methods, warmed and cultured for survival analysis and then compared with the solution control group. The rate of development of vitrified-warmed expanded blastocysts to the hatched blastocyst stage after 24 h of culture was lower in the MVAC in LN2 group than in the solution control group; however, after 48-72 h of culture, the rates did not significantly differ between the groups. These results indicate that the MVAC method without direct LN2 contact is as effective as the standard Cryotop method for vitrification of bovine IVM oocytes and IVP expanded blastocysts.	[Punyawai, Kanchana; Srirattana, Kanokwan; Parnpai, Rangsun] Suranaree Univ Technol, Embryo Technol & Stem Cell Res Ctr, Nakhon Ratchasima 30000, Thailand; [Punyawai, Kanchana; Srirattana, Kanokwan; Parnpai, Rangsun] Suranaree Univ Technol, Sch Biotechnol, Nakhon Ratchasima 30000, Thailand; [Punyawai, Kanchana; Anakkul, Nitira; Aikawa, Yoshio; Imai, Kei] Natl Livestock Breeding Ctr, Fukushima 9618571, Japan; [Anakkul, Nitira] Chulalongkorn Univ, Fac Vet Sci, Dept Obstet Gynecol & Reprod, Bangkok 10330, Thailand; [Sangsritavong, Siwat] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Pathum Thani 12120, Thailand; [Nagai, Takashi] Food & Fertilizer Technol Ctr, Taipei 10648, Taiwan; [Nagai, Takashi] Seoul Natl Univ, Coll Agr & Life Sci, Dept Agr Biotechnol, Seoul 151742, South Korea; [Nagai, Takashi] Natl Agr & Food Res Org NARO, NARO Inst Livestock & Grassland Sci, Anim Breeding & Reprod Res Div, Ibaraki 3050901, Japan; [Imai, Kei] Rakuno Gakuen Univ, Dept Sustainable Agr, Sapporo, Hokkaido 0698501, Japan	Imai, K (reprint author), Natl Livestock Breeding Ctr, Fukushima 9618571, Japan.	imai@rakuno.ac.jp; rangsun@g.sut.ac.th			NRCT-JSPS; Suranaree University of Technology (SUT); Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission, Thailand; Thailand Graduate Institute of Science and Technology's scholarship program [TGIS-CPMO-22-19-54-008D]	The authors would like to thank all members of the Embryo Transfer Team of the National Livestock Breeding Center, Fukushima, Japan, for technical support and Dr C Laowtammathron for his helpful suggestions regarding the manuscript. This work was supported by the NRCT-JSPS 2010 Joint Research Program, Suranaree University of Technology (SUT) and the Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission, Thailand. K Punyawai was supported by a scholarship from Thailand Graduate Institute of Science and Technology's scholarship program (TGIS-CPMO-22-19-54-008D), awarded through the National Science and Technology Development Agency, Thailand. K Srirattana was supported by SUT postgraduate research fellowships.	AbdelHafez F, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-29; Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Arav A, 2002, MOL CELL ENDOCRINOL, V187, P77, DOI 10.1016/S0303-7207(01)00700-6; Isachenko V, 2001, CRYO-LETT, V22, P157; Bielanski A, 2005, CRYOBIOLOGY, V50, P206, DOI 10.1016/j.cryobiol.2004.12.004; Hochi S, 2004, THERIOGENOLOGY, V61, P267, DOI 10.1016/S0093-691X(03)00232-2; Morato R, 2014, CRYOBIOLOGY, V68, P288, DOI [10.1016/j.cryobiol.2014.02.010, 10.1016/j.cryobio1.2014.02.010]; Vajta G, 1998, MOL REPROD DEV, V51, P53, DOI 10.1002/(SICI)1098-2795(199809)51:1<53::AID-MRD6>3.0.CO;2-V; Min SH, 2013, CRYOBIOLOGY, V66, P195, DOI 10.1016/j.cryobiol.2013.01.004; Chen SU, 2003, MOL CELL ENDOCRINOL, V202, P101, DOI 10.1016/S0303-7207(03)00070-4; BRACKETT BG, 1975, BIOL REPROD, V12, P260, DOI 10.1095/biolreprod12.2.260; Grout BWW, 2009, THERIOGENOLOGY, V71, P1079, DOI 10.1016/j.theriogenology.2008.12.011; Vajta G, 1997, ACTA VET SCAND, V38, P349; Liebermann J, 2002, REPRODUCTION, V124, P483; Morris GJ, 2005, CRYOBIOLOGY, V50, P231, DOI 10.1016/j.crybiol.2005.01.005; Pessoa GA, 2014, REV BRAS ZOOTECN, V43, P244, DOI 10.1590/S1516-35982014000500004; MASSIP A, 1986, CRYO-LETT, V7, P270; Dinnyes A, 2000, BIOL REPROD, V63, P513, DOI 10.1095/biolreprod63.2.513; Lane M, 2001, MOL REPROD DEV, V58, P342, DOI 10.1002/1098-2795(200103)58:3<342::AID-MRD13>3.0.CO;2-X; Dhali A, 2000, THERIOGENOLOGY, V53, P1295, DOI 10.1016/S0093-691X(00)00273-9; Chian RC, 2004, J REPROD DEVELOP, V50, P685, DOI 10.1262/jrd.50.685; HOCHI S, 1994, THERIOGENOLOGY, V42, P483, DOI 10.1016/0093-691X(94)90686-D; Chen SU, 2000, HUM REPROD, V15, P2598, DOI 10.1093/humrep/15.12.2598; Pereira RM, 2008, CELL TISSUE BANK, V9, P267, DOI 10.1007/s10561-008-9075-2; Esaki R, 2004, BIOL REPROD, V71, P432, DOI 10.1095/biolreprod.103.026542; Misumi K, 2013, J REPROD DEVELOP, V59, P520; Arav A, 1996, CRYOBIOLOGY, V33, P589, DOI 10.1006/cryo.1996.0062; Katayama KP, 2003, FERTIL STERIL, V80, P223, DOI 10.1016/S0015-0282(03)00551-X; ROSENKRANS CF, 1993, BIOL REPROD, V49, P459, DOI 10.1095/biolreprod49.3.459; Bielanski A, 2012, THERIOGENOLOGY, V77, P467, DOI 10.1016/j.theriogenology.2011.07.043; Ushijima H, 2004, J REPROD DEVELOP, V50, P481, DOI 10.1262/jrd.50.481; Kuwayama M, 2007, THERIOGENOLOGY, V67, P73, DOI 10.1016/j.theriogenology.2006.09.014; Hufana-Duran D, 2004, THERIOGENOLOGY, V61, P1429, DOI 10.1016/j.theriogenology.2003.08.011; Rho GJ, 2002, MOL REPROD DEV, V63, P464, DOI 10.1002/mrd.10196; Lane M, 1999, FERTIL STERIL, V72, P1073, DOI 10.1016/S0015-0282(99)00418-5; Hamawaki A, 1999, THERIOGENOLOGY, V51, P165, DOI 10.1016/S0093-691X(99)91724-7; ARAV A, 1993, J REPROD FERTIL, V99, P353; Bielanski A, 2003, CRYOBIOLOGY, V46, P146, DOI 10.1016/S0011-2240(03)00020-8; De Rosa A, 2007, ITAL J ANIM SCI, V6, P747; Gasparrini B, 2007, ANIM REPROD SCI, V98, P335, DOI 10.1016/j.anireprosci.2006.04.046; Laowtammathron C, 2005, THERIOGENOLOGY, V64, P1185, DOI 10.1016/j.theriogenology.2005.02.001; Sripunya N, 2010, J REPROD DEVELOP, V56, P176, DOI 10.1262/jrd.09-108H; Imai K, 2006, J REPROD DEVELOP, V52, P19; Kuwayama M, 2000, J ASSIST REPROD GEN, V17, P477, DOI DOI 10.1023/A:1017399518757; Martino A, 1996, BIOL REPROD, V54, P1059, DOI 10.1095/biolreprod54.5.1059; Rall WF, 1985, NATURE, V313, P573; Thouas G. A., 2001, REPROD BIOMED ONLINE, V3, P25, DOI [10.1016/S1472-6483(10)61960-8, DOI 10.1016/S1472-6483(10)61960-8]; Vanderzwalmen P, 2000, FERTIL STERIL, V74, pS215, DOI DOI 10.1016/S0015-0282(00)01358-3	48	0	0	SOCIETY REPRODUCTION & DEVELOPMENT-SRD	TSUKUBA	C/O KAZUHIRO KIKUCHI, PHD DVM, NATL INST AGROBIOLOGICAL SCIENCES KANNONDAI 2-1-2, TSUKUBA, IBARAKI 305-8602, JAPAN	0916-8818			J REPROD DEVELOP	J. Reprod. Dev.	OCT	2015	61	5					431	437				7	Agriculture, Dairy & Animal Science; Reproductive Biology	Agriculture; Reproductive Biology	CU5VP	WOS:000363600400010		
J	Sano, M; Hashiba, K; Nio-Kobayashi, J; Okuda, K				Sano, Masahiro; Hashiba, Kazuhisa; Nio-Kobayashi, Junko; Okuda, Kiyoshi			The luteotrophic function of galectin-1 by binding to the glycans on vascular endothelial growth factor receptor-2 in bovine luteal cells	JOURNAL OF REPRODUCTION AND DEVELOPMENT			English	Article						Corpus luteum; Galectin-1; Lectin; Ovary; vascular endothelial growth factor receptor (VEGFR)	CORPUS-LUTEUM; PROGESTERONE PRODUCTION; LUTEINIZING-HORMONE; GLYCOSYLATION SITES; CANCER PROGRESSION; MAMMARY-CARCINOMA; IMMUNE-RESPONSE; ESTROUS-CYCLE; N-GLYCANS; IN-VITRO	The corpus luteum (CL) is a temporary endocrine gland producing a large amount of progesterone, which is essential for the establishment and maintenance of pregnancy. Galectin-1 is a beta-galactose-binding protein that can modify functions of membrane glycoproteins and is expressed in the CL of mice and women. However, the physiological role of galectin-1 in the CL is unclear. In the present study, we investigated the expression and localization of galectin-1 in the bovine CL and the effect of galectin-1 on cultured luteal steroidogenic cells (LSCs) with special reference to its binding to the glycans on vascular endothelial growth factor receptor-2 (VEGFR-2). Galectin-1 protein was highly expressed at the mid and late luteal stages in the membrane fraction of bovine CL tissue and was localized to the surface of LSCs in a carbohydrate-dependent manner. Galectin-1 increased the viability in cultured LSCs. However, the viability of LSCs was decreased by addition of beta-lactose, a competitive carbohydrate inhibitor of galectin-1 binding activity. VEGFR-2 protein, like galectin-1, is also highly expressed in the mid CL, and it was modified by multi-antennary glycans, which can be recognized by galectin-1. An overlay assay using biotinylated galectin-1 revealed that galectin-1 directly binds to asparagine-linked glycans (N-glycans) on VEGFR-2. Enhancement of LSC viability by galectin-1 was suppressed by a selective inhibitor of VEGFR-2. The overall findings suggest that galectin-1 plays a role as a survival factor in the bovine CL, possibly by binding to N-glycans on VEGFR-2.	[Sano, Masahiro; Hashiba, Kazuhisa; Okuda, Kiyoshi] Okayama Univ, Grad Sch Environm & Life Sci, Reprod Physiol Lab, Okayama 7008530, Japan; [Nio-Kobayashi, Junko] Hokkaido Univ, Grad Sch Med, Dept Anat, Lab Histol & Cytol, Sapporo, Hokkaido 0600808, Japan	Okuda, K (reprint author), Okayama Univ, Grad Sch Environm & Life Sci, Reprod Physiol Lab, Okayama 7008530, Japan.	kokuda@cc.okayama-u.ac.jp			Research Program on Innovative Technology for Animal Breeding, Reproduction and Vaccine Development of the Ministry of Agriculture, Forestry and Fisheries of Japan [REP-1002]	This study was supported by a grant from the Research Program on Innovative Technology for Animal Breeding, Reproduction and Vaccine Development (REP-1002) of the Ministry of Agriculture, Forestry and Fisheries of Japan.	KITANAKA J, 1994, NEUROCHEM RES, V19, P1545, DOI 10.1007/BF00969004; Fischer I, 2009, PLACENTA, V30, P1078, DOI 10.1016/j.placenta.2009.10.003; Okuda K, 2004, BIOL REPROD, V71, P2065, DOI 10.1095/biolreprod.104.028076; Kobayashi S, 2001, J ENDOCRINOL, V170, P369, DOI 10.1677/joe.0.1700369; Skarzynski DJ, 2008, REPROD DOMEST ANIM, V43, P57, DOI 10.1111/j.1439-0531.2008.01143.x; ZHANG R, 1995, J BIOL CHEM, V270, P21722; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Berisha B, 2000, BIOL REPROD, V63, P1106, DOI 10.1095/biolreprod63.4.1106; SHWEIKI D, 1993, J CLIN INVEST, V91, P2235, DOI 10.1172/JCI116450; Wulff C, 2000, J CLIN ENDOCR METAB, V85, P4302, DOI 10.1210/jc.85.11.4302; Kawaguchi S, 2013, J REPROD DEVELOP, V59, P225, DOI 10.1262/jrd.2012-187; Imai N, 2006, BRIT J HAEMATOL, V135, P673, DOI 10.1111/j.1365-2141.2006.06372.x; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Chouhan VS, 2014, ANIM REPROD SCI, V148, P251, DOI 10.1016/j.anireprosci.2014.06.009; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Meidan R, 1999, J Reprod Fertil Suppl, V54, P217; Chouhan VS, 2013, REPROD DOMEST ANIM, V48, P810, DOI 10.1111/rda.12168; Kim HJ, 2013, HUM PATHOL, V44, P62, DOI 10.1016/j.humpath.2012.04.010; Anginot A, 2013, J IMMUNOL, V190, P5526, DOI 10.4049/jimmunol.1201885; Laderach DJ, 2013, CANCER RES, V73, P86, DOI 10.1158/0008-5472.CAN-12-1260; Kawaguchi S, 2013, MOL REPROD DEV, V80, P204, DOI 10.1002/mrd.22150; Stocco C, 2007, ENDOCR REV, V28, P117, DOI 10.1210/er.2006-0022; Kumagai A, 2014, MOL REPROD DEV, V81, P646, DOI 10.1002/mrd.22332; Boscher C, 2011, CURR OPIN CELL BIOL, V23, P383, DOI 10.1016/j.ceb.2011.05.001; McCracken JA, 1999, PHYSIOL REV, V79, P263; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Stanley P, 2014, CELL, V156, P625, DOI 10.1016/j.cell.2014.01.059; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; HIRAIZUMI S, 1992, JPN J CANCER RES, V83, P1063; Liu FT, 2005, INT ARCH ALLERGY IMM, V136, P385, DOI 10.1159/000084545; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Croci DO, 2014, CELL, V156, P744, DOI 10.1016/j.cell.2014.01.043; Miyamoto Y, 2000, BIOL REPROD, V62, P1109, DOI 10.1095/biolreprod62.5.1109; [Anonymous], 2006, GLYCOBIOLOGY, DOI DOI 10.1093/GLYC0B/CWL025; Nio-Kobayashi J, 2010, J HISTOCHEM CYTOCHEM, V58, P741, DOI 10.1369/jhc.2010.956227; Abbott KL, 2008, J BIOL CHEM, V283, P33026, DOI 10.1074/jbc.M803646200; ALLEN HJ, 1993, TUMOR BIOL, V14, P360; Ilarregui JM, 2009, NAT IMMUNOL, V10, P981, DOI 10.1038/ni.1772; BUDNIK LT, 1991, J BIOL CHEM, V266, P13908; VAISMAN N, 1990, J BIOL CHEM, V265, P19461; Zhen YJ, 2003, BIOCHEMISTRY-US, V42, P5478, DOI 10.1021/bi027101p; Niswender GD, 2000, PHYSIOL REV, V80, P1; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Boscher C, 2012, J BIOL CHEM, V287, P32940, DOI 10.1074/jbc.M112.353334; Nio J, 2007, J HISTOCHEM CYTOCHEM, V55, P423, DOI 10.1369/jhc.6A7053.2007; Taniguchi N, 2001, PROTEOMICS, V1, P239; Abroun S, 2008, BRIT J HAEMATOL, V142, P754, DOI 10.1111/j.1365-2141.2008.07252.x; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; FIEDLER K, 1995, CELL, V81, P309, DOI 10.1016/0092-8674(95)90380-1; Wada Y, 2013, ENDOCRINOLOGY, V154, P900, DOI 10.1210/en.2012-1967; KNICKERBOCKER JJ, 1988, DOMEST ANIM ENDOCRIN, V5, P91, DOI 10.1016/0739-7240(88)90011-2; Sugino N, 2007, J REPROD DEVELOP, V53, P977, DOI 10.1262/jrd.19047; Shimizu T, 2006, REPRODUCTION, V131, P555, DOI 10.1530/rep.1.00937; Kawakami A, 1996, J NEUROBIOL, V29, P1, DOI 10.1002/(SICI)1097-4695(199601)29:1<1::AID-NEU1>3.0.CO;2-F; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; OKUDA K, 1992, BIOL REPROD, V46, P1001, DOI 10.1095/biolreprod46.6.1001; Stillman BN, 2006, J IMMUNOL, V176, P778; Hsieh SH, 2008, ONCOGENE, V27, P3746, DOI 10.1038/sj.onc.1211029; Markowska AI, 2011, J BIOL CHEM, V286, P29913, DOI 10.1074/jbc.M111.226423; D'Haene N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067029; Freeze HH, 2005, CURR OPIN STRUC BIOL, V15, P490, DOI 10.1016/j.sbi.2005.08.010; Galvao A, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097147; Hakomori S, 1996, CANCER RES, V56, P5309; Hashiba K, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119057; Nio-Kobayashi J, 2014, J CLIN ENDOCR METAB, V99, P4616, DOI 10.1210/jc.2014-2716; Okuda Kiyoshi, 1998, Journal of Reproduction and Development, V44, P79, DOI 10.1262/jrd.44.79; Vaitaitis GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038708; Yoshioka S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084186	69	0	0	SOCIETY REPRODUCTION & DEVELOPMENT-SRD	TSUKUBA	C/O KAZUHIRO KIKUCHI, PHD DVM, NATL INST AGROBIOLOGICAL SCIENCES KANNONDAI 2-1-2, TSUKUBA, IBARAKI 305-8602, JAPAN	0916-8818			J REPROD DEVELOP	J. Reprod. Dev.	OCT	2015	61	5					439	448				10	Agriculture, Dairy & Animal Science; Reproductive Biology	Agriculture; Reproductive Biology	CU5VP	WOS:000363600400011		
J	Miyagawa, S; Matsunari, H; Watanabe, M; Nakano, K; Umeyama, K; Sakai, R; Takayanagi, S; Takeishi, T; Fukuda, T; Yashima, S; Maeda, A; Eguchii, H; Okuyama, H; Nagaya, M; Nagashima, H				Miyagawa, Shuji; Matsunari, Hitomi; Watanabe, Masahito; Nakano, Kazuaki; Umeyama, Kazuhiro; Sakai, Rieko; Takayanagi, Shuko; Takeishi, Toki; Fukuda, Tooru; Yashima, Sayaka; Maeda, Akira; Eguchii, Hiroshi; Okuyama, Hiroomi; Nagaya, Masaki; Nagashima, Hiroshi			Generation of alpha 1,3-galactosyltransferase and cytidine monophospho-N-acetylneuraminic acid hydroxylase gene double-knockout pigs	JOURNAL OF REPRODUCTION AND DEVELOPMENT			English	Article						Cytidine monophospho-N-acetylneuraminic acid hydroxylase (CMAH); Double knockout pig; H-D antigen; Transcription activator-like effector nucleases (TALENs); Zinc-finger nucleases (ZFNs)	ZINC-FINGER NUCLEASES; GLYCOLYLNEURAMINIC ACID; CLONED PIGS; HUMAN XENOTRANSPLANTATION; HOMOLOGOUS RECOMBINATION; EMBRYO MICROINJECTION; BIALLELIC KNOCKOUT; DEFICIENT PIGS; CELLS; GENOME	Zinc-finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs) are new tools for producing gene knockout (KO) animals. The current study reports produced genetically modified pigs, in which two endogenous genes were knocked out. Porcine fibroblast cell lines were derived from homozygous alpha 1,3-galactosyltransferase (GalT) KO pigs. These cells were subjected to an additional KO for the cytidine monophospho-N-acetylneuraminic acid hydroxylase (CMAH) gene. A pair of ZFN-encoding mRNAs targeting exon 8 of the CMAH gene was used to generate the heterozygous CMAH KO cells, from which cloned pigs were produced by somatic cell nuclear transfer (SCNT). One of the cloned pigs obtained was re-cloned after additional KO of the remaining CMAH allele using the same ZFN-encoding mRNAs to generate GalT/CMAH-double homozygous KO pigs. On the other hand, the use of TALEN-encoding mRNAs targeting exon 7 of the CMAH gene resulted in efficient generation of homozygous CMAHKO cells. These cells were used for SCNT to produce cloned pigs homozygous for a double Gall! CMAH KO. These results demonstrate that the combination of TALEN-encoding mRNA, in vitro selection of the nuclear donor cells and SCNT provides a robust method for generating KO pigs.	[Miyagawa, Shuji; Maeda, Akira; Eguchii, Hiroshi; Okuyama, Hiroomi] Osaka Univ, Grad Sch Med, Dept Surg, Div Organ Transplantat, Suita, Osaka 5650871, Japan; [Miyagawa, Shuji; Matsunari, Hitomi; Watanabe, Masahito; Umeyama, Kazuhiro; Nagaya, Masaki; Nagashima, Hiroshi] Meiji Univ, Int Inst Bioresource Res, Kawasaki, Kanagawa 2148571, Japan; [Matsunari, Hitomi; Watanabe, Masahito; Nakano, Kazuaki; Umeyama, Kazuhiro; Sakai, Rieko; Takayanagi, Shuko; Takeishi, Toki; Fukuda, Tooru; Yashima, Sayaka; Nagashima, Hiroshi] Meiji Univ, Sch Agr, Dept Life Sci, Lab Dev Engn, Kawasaki, Kanagawa 2148571, Japan	Miyagawa, S (reprint author), Osaka Univ, Grad Sch Med, Dept Surg, Div Organ Transplantat, Suita, Osaka 5650871, Japan.	miyagawa@orgtrp.med.osaka-u.ac.jp; hnagas@meiji.ac.jp			Health and Labor Sciences Research Grants, Japan; Meiji University International Institute for Bio-Resource Research (MUIIBR); JSPS [26870630]; JST/ERATO Nakauchi Stem Cell and Organ Regeneration Project	We thank Dr Milton S Feather for his editing of the manuscript and H Kadoi for his help with maintenance of the pigs. This work was supported by Health and Labor Sciences Research Grants, Japan, the Meiji University International Institute for Bio-Resource Research (MUIIBR), JSPS Grant-in-Aid for Young Scientists (B) Grant Number 26870630 and the JST/ERATO Nakauchi Stem Cell and Organ Regeneration Project.	Watanabe M, 2015, J REPROD DEVELOP, V61, P169, DOI 10.1262/jrd.2014-153; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Luo YL, 2012, J INHERIT METAB DIS, V35, P695, DOI 10.1007/s10545-012-9475-0; Doyon Y, 2010, NAT METHODS, V7, P459, DOI [10.1038/nmeth.1456, 10.1038/NMETH.1456]; KOLLER BH, 1989, P NATL ACAD SCI USA, V86, P8927, DOI 10.1073/pnas.86.22.8927; Klymiuk N, 2013, HUM MOL GENET, V22, P4368, DOI 10.1093/hmg/ddt287; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Miwa Y, 2004, XENOTRANSPLANTATION, V11, P247, DOI 10.1111/j.1399-3089.2004.00126.x; Fujimura T, 2008, MOL REPROD DEV, V75, P1372, DOI 10.1002/mrd.20890; Song KH, 2010, BIOCHEM J, V427, P179, DOI 10.1042/BJ20090835; Galili U, 2013, XENOTRANSPLANTATION, V20, P267, DOI 10.1111/xen.12051; Kurome M, 2008, J REPROD DEVELOP, V54, P254, DOI 10.1262/jrd.20038; Basnet NB, 2010, XENOTRANSPLANTATION, V17, P440, DOI 10.1111/j.1399-3089.2010.00610.x; Li P, 2013, J SURG RES, V181, pE39, DOI 10.1016/j.jss.2012.06.035; Watanabe M, 2010, BIOCHEM BIOPH RES CO, V402, P14, DOI 10.1016/j.bbrc.2010.09.092; Yamamoto A, 2013, SURG TODAY, V43, P782, DOI 10.1007/s00595-012-0274-x; Misra RP, 2002, ENDOCRINE, V19, P229, DOI 10.1385/ENDO:19:3:229; Ikeda K, 2012, TRANSPL P, V44, P1136, DOI 10.1016/j.transproceed.2012.01.092; Miyagawa S, 2012, CURR OPIN ORGAN TRAN, V17, P174, DOI 10.1097/MOT.0b013e3283508189; Hauschild J, 2011, P NATL ACAD SCI USA, V108, P12013, DOI 10.1073/pnas.1106422108; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Umeyama K, 2009, TRANSGENIC RES, V18, P697, DOI 10.1007/s11248-009-9262-3; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Whyte JJ, 2012, J ANIM SCI, V90, P1111, DOI 10.2527/jas.2011-4546; Dai YF, 2002, NAT BIOTECHNOL, V20, P251, DOI 10.1038/nbt0302-251; Lutz AJ, 2013, XENOTRANSPLANTATION, V20, P27, DOI 10.1111/xen.12019; Zhu A, 2002, XENOTRANSPLANTATION, V9, P376, DOI 10.1034/j.1399-3089.2002.02138.x; Elliott RB, 2007, XENOTRANSPLANTATION, V14, P157, DOI 10.1111/j.1399-3089.2007.00384.x; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Matsunari H, 2013, P NATL ACAD SCI USA, V110, P4557, DOI 10.1073/pnas.1222902110; Irie A, 1998, J BIOL CHEM, V273, P15866, DOI 10.1074/jbc.273.25.15866; Nottle MB, 2007, XENOTRANSPLANTATION, V14, P339, DOI 10.1111/j.1399-3089.2007.0041.x; Aigner B, 2010, J MOL MED, V88, P653, DOI 10.1007/s00109-010-0610-9; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Guan CM, 2010, GENESIS, V48, P73, DOI 10.1002/dvg.20594; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Varki A, 2009, GLYCOCONJUGATE J, V26, P231, DOI 10.1007/s10719-008-9183-z; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Magnusson S, 2003, XENOTRANSPLANTATION, V10, P432, DOI 10.1034/j.1399-3089.2003.02052.x; Matsunari H, 2009, J REPROD DEVELOP, V55, P225, DOI 10.1262/jrd.20164; Cooper DKC, 2014, XENOTRANSPLANTATION, V21, P397, DOI 10.1111/xen.12127; Fujimura T, 2008, J REPROD DEVELOP, V54, P58, DOI 10.1262/jrd.19110; Kurome M, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-43; Kurome M, 2015, METHODS MOL BIOL, V1222, P37, DOI 10.1007/978-1-4939-1594-1_4; Li P, 2015, XENOTRANSPLANTATION, V22, P20, DOI 10.1111/xen.12131; Lunney JK, 2007, INT J BIOL SCI, V3, P179; Mashimo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008870; Matsunari H, 2012, XENOTRANSPLANTATION, P37; Nakano K, 2013, 12 C INT XEN ASS OS; Prather RS, 2013, ANNU REV ANIM BIOSCI, P203; Watanabe M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076478; Xin JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084250	54	0	0	SOCIETY REPRODUCTION & DEVELOPMENT-SRD	TSUKUBA	C/O KAZUHIRO KIKUCHI, PHD DVM, NATL INST AGROBIOLOGICAL SCIENCES KANNONDAI 2-1-2, TSUKUBA, IBARAKI 305-8602, JAPAN	0916-8818			J REPROD DEVELOP	J. Reprod. Dev.	OCT	2015	61	5					449	457				9	Agriculture, Dairy & Animal Science; Reproductive Biology	Agriculture; Reproductive Biology	CU5VP	WOS:000363600400012		
J	Tanaka, T; Kanatsu-Shinohara, M; Hirose, M; Ogura, A; Shinohara, T				Tanaka, Takashi; Kanatsu-Shinohara, Mito; Hirose, Michiko; Ogura, Atsuo; Shinohara, Takashi			Pluripotent cell derivation from male germline cells by suppression of Dmrt1 and Trp53	JOURNAL OF REPRODUCTION AND DEVELOPMENT			English	Article						Dmrt1; Pluripotency; Primordial germ cells; Spermatogonia; Trp53	SPERMATOGONIAL STEM-CELLS; LONG-TERM PROLIFERATION; SELF-RENEWAL; MOUSE TESTIS; TESTICULAR TERATOMAS; MICE; CULTURE; TUMORS; SPERMATOGENESIS; DIFFERENTIATION	Diploid germ cells are thought to have pluripotency potential. We recently described a method to derive pluripotent stem cells (PSCs) from cultured spermatogonial stem cells (SSCs) by depleting Trp53 and Dmrt1, both of which are known suppressors of teratomas. In this study, we used this technique to analyze the effect of this protocol in deriving PSCs from the male germline at different developmental stages. We collected primordial germ cells (PGCs), gonocytes and spermatogonia, and the cells were transduced with lentiviruses expressing short hairpin RNA against Dmrt1 and/or Trp53. We found that PGCs are highly susceptible to reprogramming induction and that only Trp53 depletion was sufficient to induce pluripotency. In contrast, gonocytes and spermatogonia were resistant to reprogramming by double knockdown of Dmrt1 and Trp53. PSCs derived from PGCs contributed to chimeras produced by blastocyst injection, but some of the embryos showed placentaonly phenotypes suggestive of epigenetic abnormalities of PGC-derived PSCs. These results show that PGCs and gonocytes/spermatogonia have distinct reprogramming potential and also suggest that fresh and cultured SSCs do not necessarily have the same properties.	[Tanaka, Takashi; Kanatsu-Shinohara, Mito; Shinohara, Takashi] Kyoto Univ, Grad Sch Med, Dept Mol Genet, Kyoto 6068501, Japan; [Kanatsu-Shinohara, Mito] Japan Sci & Technol Agcy, PRESTO, Kyoto 6068501, Japan; [Hirose, Michiko; Ogura, Atsuo] Inst Phys & Chem Res RIKEN, Bioresource Ctr, Tsukuba, Ibaraki 3050074, Japan	Shinohara, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Mol Genet, Kyoto 6068501, Japan.	tshinoha@virus.kyoto-u.ac.jp	Ogura, Atsuo/J-3916-2014	Ogura, Atsuo/0000-0003-0447-1988	Uehara Foundation for Medical and Pharmaceutical Research; Japan Science and Technology Agency (PRESTO); Takeda Science Foundation; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	This research was supported by the Uehara Foundation for Medical and Pharmaceutical Research, Japan Science and Technology Agency (PRESTO), Takeda Science Foundation and Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. We thank Ms Y Ogata for technical assistance.	Takashima S, 2013, GENE DEV, V27, P1949, DOI 10.1101/gad.220194.113; Okae H, 2014, HUM MOL GENET, V23, P992, DOI 10.1093/hmg/ddt495; Huang Y, 2011, CELL BIOL INT, V35, P905, DOI 10.1042/CBI20110161; Kimura T, 2008, DEVELOPMENT, V135, P869, DOI 10.1242/dev.013474; LABOSKY PA, 1994, DEVELOPMENT, V120, P3197; Lee J, 2007, DEVELOPMENT, V134, P1853, DOI 10.1242/dev.003004; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Oatley JM, 2007, J BIOL CHEM, V282, P25842, DOI 10.1074/jbc.M703474200; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Goertz MJ, 2011, J CLIN INVEST, V121, P3456, DOI 10.1172/JCI57984; De Rooij DG, 2000, J ANDROL, V21, P776; Kawase Y, 2001, CONTEMP TOP LAB ANIM, V40, P31; Cook MS, 2009, DEV BIOL, V328, P377, DOI 10.1016/j.ydbio.2009.01.041; Nagamatsu G, 2013, STEM CELLS, V31, P479, DOI 10.1002/stem.1303; Krentz AD, 2009, P NATL ACAD SCI USA, V106, P22323, DOI 10.1073/pnas.0905431106; Matson CK, 2011, NATURE, V476, P101, DOI 10.1038/nature10239; Leitch HG, 2013, STEM CELL REP, V1, P66, DOI 10.1016/j.stemcr.2013.03.004; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Leitch HG, 2010, DEVELOPMENT, V137, P2279, DOI 10.1242/dev.050427; Sabour D, 2012, CURR OPIN CELL BIOL, V24, P716, DOI 10.1016/j.ceb.2012.08.006; STEWART CL, 1994, DEV BIOL, V161, P626; HARVEY M, 1993, FASEB J, V7, P938; Spiller CM, 2013, INT J DEV BIOL, V57, P211, DOI 10.1387/ijdb.130028pk; Chuma S, 2005, DEVELOPMENT, V132, P117, DOI 10.1242/dev.01555; Lee JY, 2009, BIOL REPROD, V80, P518, DOI 10.1095/biolreprod.108.072330; Zhu R, 2007, ANN NY ACAD SCI, V1120, P181, DOI 10.1196/annals.1411.006; Hirasawa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076422; Kimura T, 2003, DEVELOPMENT, V130, P1691, DOI 10.1242/dev.00392; Western PS, 2010, FASEB J, V24, P3026, DOI 10.1096/fj.09-151555; Heaney JD, 2012, DEVELOPMENT, V139, P1577, DOI 10.1242/dev.076851; Looijenga LHJ, 2006, CANCER RES, V66, P290, DOI 10.1158/0008-5472.CAN-05-2936; Tada T, 1998, DEV GENES EVOL, V207, P551, DOI 10.1007/s004270050146; Imamura M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-34; Kanatsu-Shinohara M, 2005, DEVELOPMENT, V132, P4155, DOI 10.1242/dev.02004; Kanatsu-Shinohara M, 2008, BIOL REPROD, V78, P611, DOI 10.1095/biolreprod.107.065615; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kanatsu-Shinohara M, 2004, BIOL REPROD, V70, P70, DOI 10.1095/biolreprod.103.020867; Kanatsu-Shinohara M, 2013, ANNU REV CELL DEV BI, V29, P163, DOI 10.1146/annurev-cellbio-101512-122353; Kanatsu-Shinohara M, 2008, BIOL REPROD, V78, P681, DOI 10.1095/biolreprod.107.066068; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biloreprod.103.017012; Page D, 1998, APMIS, V106, P196; Looijenga LHJ, 1998, APMIS, V106, P187; Matsui Y, 2014, DEVELOPMENT, V141, P4457, DOI 10.1242/dev.113779; Meistrich ML, 1993, CELL MOL BIOL TESTIS, P266; Morimoto H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007909; Morimoto H, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095307; Illmensee K, 1979, Sci Am, V240, P120; Takashima S, 2015, STEM CELL REP, V4, P489, DOI 10.1016/j.stemcr.2015.01.010	48	0	0	SOCIETY REPRODUCTION & DEVELOPMENT-SRD	TSUKUBA	C/O KAZUHIRO KIKUCHI, PHD DVM, NATL INST AGROBIOLOGICAL SCIENCES KANNONDAI 2-1-2, TSUKUBA, IBARAKI 305-8602, JAPAN	0916-8818			J REPROD DEVELOP	J. Reprod. Dev.	OCT	2015	61	5					473	484				12	Agriculture, Dairy & Animal Science; Reproductive Biology	Agriculture; Reproductive Biology	CU5VP	WOS:000363600400015		
J	Irshad, AR; Sasaki, T; Kubo, T; Odashima, N; Katano, K; Osawa, T; Takahashi, T; Izaike, Y				Irshad, Abdul Razaq; Sasaki, Taihei; Kubo, Tomoaki; Odashima, Naoyuki; Katano, Keiji; Osawa, Takeshi; Takahashi, Toru; Izaike, Yoshiaki			Development of a programmable piggyback syringe pump and four-times-a-day injection regimen for superovulation in non-lactating Holstein cows	JOURNAL OF REPRODUCTION AND DEVELOPMENT			English	Article						Cows; Follicles; Piggyback syringe pump; Porcine follicle-stimulating hormone (pFSH); Superovulation	FOLLICULAR-GROWTH; CATTLE; LH	The objectives of the present study were to develop a programmable piggyback syringe pump for bovine superovulation and to evaluate the effects of a four-times-a-day injection regimen using the pump. Non-lactating Holstein cows were treated with a total of 30 armour units of porcine FSH by injection four times a day with the pump (study, n = 9) or injection twice a day manually (control, n = 9) for four consecutive days from D10 of the estrous cycle. The pump-driven program successfully induced superovulation in all cows tested. The numbers of small (3- < 5 mm in diameter) and large (>= 10 mm in diameter) follicles were greater in the study group on D11-13 and D14, respectively. There were fewer unovulated follicles detected on D21 (7 days after estrus) in the study group than in the control group (1.2 +/- 0.4 and 3.2 +/- 0.6, respectively).	[Irshad, Abdul Razaq; Kubo, Tomoaki; Takahashi, Toru; Izaike, Yoshiaki] Gifu Univ, United Grad Sch Vet Sci, Gifu 5011193, Japan; [Irshad, Abdul Razaq; Sasaki, Taihei; Kubo, Tomoaki; Takahashi, Toru; Izaike, Yoshiaki] Iwate Univ, Fac Agr, Cooperat Dept Vet Med, Morioka, Iwate 0208550, Japan; [Odashima, Naoyuki; Katano, Keiji] Icomes Lab, Morioka, Iwate 0200857, Japan; [Osawa, Takeshi] Miyazaki Univ, Fac Agr, Dept Vet Med, Miyazaki 8892192, Japan	Izaike, Y (reprint author), Gifu Univ, United Grad Sch Vet Sci, Gifu 5011193, Japan.	izaike@iwate-u.ac.jp			Iwate Industry Promotion Center	The authors thank all of the members of the Laboratory of Theriogenology, Iwate University, for their assistance during experimental procedures and handling of cows. A part of this research was supported by the Iwate Industry Promotion Center.	Monteiro FM, 2009, ANIM REPROD SCI, V110, P128, DOI 10.1016/j.anireprosci.2008.01.003; JENSEN AM, 1982, THERIOGENOLOGY, V18, P33, DOI 10.1016/0093-691X(82)90046-2; LASTER DB, 1972, J REPROD FERTIL, V30, P407; ADAMS GP, 1994, THERIOGENOLOGY, V42, P1103, DOI 10.1016/0093-691X(94)90858-3; HERRLER A, 1991, THERIOGENOLOGY, V35, P633, DOI 10.1016/0093-691X(91)90459-Q; Sato T, 2005, J REPROD DEVELOP, V51, P573, DOI 10.1262/jrd.16070; Mapletoft RJ, 2002, REPROD NUTR DEV, V42, P601, DOI 10.1051/rnd:2002046; Treloar AF, 1997, LAB ANIM SCI, V47, P313; Kelly P, 1997, ANIM REPROD SCI, V46, P1, DOI 10.1016/S0378-4320(96)01589-8; MONNIAUX D, 1983, THERIOGENOLOGY, V19, P55, DOI 10.1016/0093-691X(83)90124-3; MOOR RM, 1984, THERIOGENOLOGY, V21, P103, DOI 10.1016/0093-691X(84)90310-8; Sugano M, 1997, J VET MED SCI, V59, P223, DOI 10.1292/jvms.59.223; DEMOUSTIER MM, 1988, THERIOGENOLOGY, V30, P379, DOI 10.1016/0093-691X(88)90185-9; NAKAMURA Y, 1993, FERTIL STERIL, V60, P254; Takahashi Toru, 2001, Journal of Reproduction and Development, V47, P119, DOI 10.1262/jrd.47.119	15	0	0	SOCIETY REPRODUCTION & DEVELOPMENT-SRD	TSUKUBA	C/O KAZUHIRO KIKUCHI, PHD DVM, NATL INST AGROBIOLOGICAL SCIENCES KANNONDAI 2-1-2, TSUKUBA, IBARAKI 305-8602, JAPAN	0916-8818			J REPROD DEVELOP	J. Reprod. Dev.	OCT	2015	61	5					485	488				4	Agriculture, Dairy & Animal Science; Reproductive Biology	Agriculture; Reproductive Biology	CU5VP	WOS:000363600400016		
J	Sugimoto, H; Kakehi, M; Satomi, Y; Kamiguchi, H; Jinno, F				Sugimoto, Hiroshi; Kakehi, Masaaki; Satomi, Yoshinori; Kamiguchi, Hidenori; Jinno, Fumihiro			Method development for the determination of 24S-hydroxycholesterol in human plasma without derivatization by high-performance liquid chromatography with tandem mass spectrometry in atmospheric pressure chemical ionization mode	JOURNAL OF SEPARATION SCIENCE			English	Article						Atmospheric pressure chemical ionization; Chromatographic separation; 24S-Hydroxycholesterol; Saponification; Surrogate matrices	CHOLESTEROL OXIDATION-PRODUCTS; BIOLOGICAL SAMPLES; BRAIN; 24(S)-HYDROXYCHOLESTEROL; QUANTIFICATION; 24-HYDROXYLASE; QUANTITATION; HOMEOSTASIS; VALIDATION; TURNOVER	We developed a highly sensitive and specific high-performance liquid chromatography with tandem mass spectrometry method with an atmospheric pressure chemical ionization interface to determine 24S-hydroxycholesterol, a major metabolite of cholesterol formed by cytochrome P450 family 46A1, in human plasma without any derivatization step. Phosphate buffered saline including 1% Tween 80 was used as the surrogate matrix for preparation of calibration curves and quality control samples. The saponification process to convert esterified 24S-hydroxycholesterol to free sterols was optimized, followed by liquid-liquid extraction using hexane. Chromatographic separation of 24S-hydroxycholesterol from other isobaric endogenous oxysterols was successfully achieved with gradient mobile phase comprised of 0.1% propionic acid and acetonitrile using L-column2 ODS (2 mu m, 2.1 mm id x 150 mm). This assay was capable of determining 24S-hydroxycholesterol in human plasma (200 mu L) ranging from 1 to 100 ng/mL with acceptable intra-and inter-day precision and accuracy. The potential risk of in vitro formation of 24S-hydroxycholesterol by oxidation from endogenous cholesterol in human plasma was found to be negligible. The stability of 24S-hydroxycholesterol in relevant solvents and human plasma was confirmed. This method was successfully applied to quantify the plasma concentrations of 24S-hydroxycholesterol in male and female volunteers.	[Sugimoto, Hiroshi; Kakehi, Masaaki; Jinno, Fumihiro] Takeda Pharmaceut Co Ltd, Drug Metab & Pharmacokinet Res Labs, Div Pharmaceut Res, Fujisawa, Kanagawa 2518555, Japan; [Satomi, Yoshinori; Kamiguchi, Hidenori] Takeda Pharmaceut Co Ltd, Integrated Technol Res Labs, Div Pharmaceut Res, Fujisawa, Kanagawa 2518555, Japan	Sugimoto, H (reprint author), Takeda Pharmaceut Co Ltd, Drug Metab & Pharmacokinet Res Labs, Div Pharmaceut Res, 26-1,Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan.	hiroshi.sugimoto1@takeda.com					Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; DZELETOVIC S, 1995, ANAL BIOCHEM, V225, P73, DOI 10.1006/abio.1995.1110; Mendiara I, 2012, J SEP SCI, V35, P3308, DOI 10.1002/jssc.201200519; Honda A, 2009, J LIPID RES, V50, P350, DOI 10.1194/jlr.D800040-JLR200; DeBarber AE, 2008, ANAL BIOCHEM, V381, P151, DOI 10.1016/j.ab.2008.05.037; Sidhu R, 2015, J LIPID RES, V56, P1222, DOI 10.1194/jlr.D058487; Diczfalusy U, 2004, J AOAC INT, V87, P467; van de Merbel NC, 2008, TRAC-TREND ANAL CHEM, V27, P924, DOI 10.1016/j.trac.2008.09.002; Leoni V, 2013, BIOCHIMIE, V95, P595, DOI 10.1016/j.biochi.2012.09.025; Bjorkhem I, 1997, J BIOL CHEM, V272, P30178, DOI 10.1074/jbc.272.48.30178; Jones BR, 2012, BIOANALYSIS, V4, P2343, DOI [10.4155/bio.12.200, 10.4155/BIO.12.200]; Sugimoto H, 2015, ANAL BIOANAL CHEM, V407, P7889, DOI 10.1007/s00216-015-8999-1; Bretillon L, 2000, J LIPID RES, V41, P840; Razzazi-Fazeli E, 2000, J CHROMATOGR A, V896, P321, DOI 10.1016/S0021-9673(00)00719-6; Lund EG, 1999, P NATL ACAD SCI USA, V96, P7238, DOI 10.1073/pnas.96.13.7238; Houghton R, 2009, BIOANALYSIS, V1, P1365, DOI [10.4155/bio.09.139, 10.4155/BIO.09.139]; CSALLANY AS, 1989, LIPIDS, V24, P645, DOI 10.1007/BF02535082; Xu YD, 2013, J PHARMACEUT BIOMED, V85, P145, DOI 10.1016/j.jpba.2013.07.016; Ramirez DMO, 2008, J COMP NEUROL, V507, P1676, DOI 10.1002/cne.21605; Sugimoto H, 2015, ANAL BIOCHEM, V487, P38, DOI 10.1016/j.ab.2015.07.004; Burkard I, 2004, J LIPID RES, V45, P776, DOI 10.1194/jlr.D300036-JLR200; Lee JW, 2006, PHARM RES, V23, P312, DOI 10.1007/s11095-005-9045-3; Papassotiropoulos A, 2000, NEUROREPORT, V11, P1959, DOI 10.1097/00001756-200006260-00030; Wang YL, 2015, J SEP SCI, V38, P796, DOI 10.1002/jssc.201400850	24	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1615-9306	1615-9314		J SEP SCI	J. Sep. Sci.	OCT	2015	38	20					3516	3524		10.1002/jssc.201500719		9	Chemistry, Analytical	Chemistry	CU3HF	WOS:000363414300005		
J	Boucard, H; Watanabe, M; Takami, S; Weiss-Hortala, E; Barna, R; Adschiri, T				Boucard, Helene; Watanabe, Masaru; Takami, Seiichi; Weiss-Hortala, Elsa; Barna, Radu; Adschiri, Tadafumi			Beneficial use of CeO2 nanocatalyst for black liquor conversion under sub and supercritical conditions	JOURNAL OF SUPERCRITICAL FLUIDS			English	Article						Hydrothermal conversion; Black liquor; CeO2 nanocatalyst; Hydrogen	WATER GASIFICATION; PYROLYSIS; LIGNIN	Black liquor is an alkaline liquid residue from paper industry, containing similar to 80 wt% of water and similar to 20 wt% of organics and minerals. Hydrothermal conversion of black liquor in a batch reactor is particularly interesting towards hydrogen production, as the carbon dioxide is highly solubilized in the basic aqueous media. Thus hydrogen with higher purity than other processes is obtained. Cerium oxide nanocatalyst (cubic CeO2) is used to improve the amount of hydrogen produced and to decrease the coke formation, based on the water splitting into active species. Experiments have been carried out at sub and supercritical conditions 350 degrees C or 450 degrees C, 25 MPa) in a batch reactor for 15 min or 60 min. CeO2 nanocatalyst improved the conversion of black liquor at sub and supercritical conditions as expected. The amount of carbonaceous solid recovered was decreased due to the catalytic effect. Recovered hydrogen was not significantly affected by the catalyst as it was involved in secondary reactions such as hydrogenation. Oxidations reactions, as well as O-2 production, were also improved using catalyst and supercritical media. Supercritical water media combined with catalyst clearly affects the fragmentation of dissolved lignin compared to subcritical conditions. Then it was assumed that water splitting occurs and produces active hydrogen and oxygen species. Thus these actives species produced using catalyst are able to improve hydrogenation and oxidation reactions, as well as recombination into H-2 and O-2. (C) 2015 Elsevier B.V. All rights reserved.	[Boucard, Helene; Weiss-Hortala, Elsa; Barna, Radu] Univ Toulouse, Mines Albi, CNRS, UMR 5302,Ctr RAPSODEE, F-81013 Albi 09, France; [Watanabe, Masaru] Tohoku Univ, Res Ctr Supercrit Fluid Technol, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Takami, Seiichi; Adschiri, Tadafumi] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Adschiri, Tadafumi] Tohoku Univ, World Premier Int Res Ctr, Adv Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Adschiri, Tadafumi] Tohoku Univ, New Ind Creat Hatchery Ctr, Aoba Ku, Sendai, Miyagi 9808579, Japan	Boucard, H (reprint author), Univ Toulouse, Mines Albi, CNRS, UMR 5302,Ctr RAPSODEE, Campus Jarlard, F-81013 Albi 09, France.	boucard.h@gmail.com; ajiri@tagen.tohoku.ac.jp					Ronnlund I, 2011, ENERGY, V36, P2151, DOI 10.1016/j.energy.2010.03.027; Demirbas A, 2002, ENERG CONVERS MANAGE, V43, P877, DOI 10.1016/S0196-8904(01)00087-5; Titirici MM, 2006, CHEM MATER, V18, P3808, DOI 10.1021/cm052768u; Dejhosseini M, 2013, ENERG FUEL, V27, P4624, DOI 10.1021/ef400855k; Guo DL, 2012, APPL ENERG, V95, P22, DOI 10.1016/j.apenergy.2012.01.042; Kang SM, 2012, BIORESOURCE TECHNOL, V110, P715, DOI 10.1016/j.biortech.2012.01.093; Byrappa K, 2008, ADV DRUG DELIVER REV, V60, P299, DOI 10.1016/j.addr.2007.09.001; Cao CQ, 2011, INT J HYDROGEN ENERG, V36, P13528, DOI 10.1016/j.ijhydene.2011.07.101; Kruse A, 2007, J SUPERCRIT FLUID, V39, P362, DOI 10.1016/j.supflu.2006.03.016; Saisu M, 2003, ENERG FUEL, V17, P922, DOI 10.1021/ef0202844; Boucard H., 2014, P 14 EUR M SUP FLUID; Leask R.A., 1987, MECH PULPING, V2; Wahyudiono, 2008, CHEM ENG PROCESS, V47, P1609; Titirici M., 2012, THESIS U POTSDAM POT; Wu M., 2012, THESIS U TOULOUSE TO	15	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0896-8446	1872-8162		J SUPERCRIT FLUID	J. Supercrit. Fluids	OCT	2015	105				SI		66	76		10.1016/j.supflu.2015.02.008		11	Chemistry, Physical; Engineering, Chemical	Chemistry; Engineering	CU2JV	WOS:000363350700010		
J	Uchida, H; Nishijima, M; Sano, K; Demoto, K; Sakabe, J; Shimoyama, Y				Uchida, Hirohisa; Nishijima, Masamichi; Sano, Kyohei; Demoto, Kohei; Sakabe, Junichi; Shimoyama, Yusuke			Production of theophylline nanoparticles using rapid expansion of supercritical solutions with a solid cosolvent (RESS-SC) technique	JOURNAL OF SUPERCRITICAL FLUIDS			English	Article						RESS-SC; Nanoparticle; Supercritical carbon dioxide; Theophylline; Solid cosolvents; Particle collection conditions effects	WATER-SOLUBLE COMPOUNDS; FLUID TECHNOLOGIES; PARTICLE DESIGN; MICRONIZATION PROCESSES; DISSOLUTION RATES; PHARMACEUTICS; FUNDAMENTALS; EQUILIBRIUM; SOLUBILITY; POWDERS	We report on the production of theophylline nanoparticles by rapid expansion of supercritical solutions with a solid cosolvent (RESS-SC) using CO2 with L-menthol or vanillin. The effects of particle collection conditions such as collection temperatures and spray distances on the theophylline nanoparticles produced were investigated in order to elucidate crystal growth mechanism of the present RESS-SC process. A liquid phase appeared at a pre-expansion section in the case of using L-menthol, and this suggests that it is unsuitable for a solid cosolvent in the present conditions. In the case of using vanillin, nano-sized particles of around 85 nm, which are about one-third as large as those produced by the conventional RESS technique, were obtained. Particle collection conditions have negligible effects on the particle sizes. This result suggests that crystal growth of theophylline particles crystallized in a collection vessel are blocked by crystallized vanillin particles those surrounds theophylline particles. (C) 2015 Elsevier B.V. All rights reserved.	[Uchida, Hirohisa; Nishijima, Masamichi; Sano, Kyohei; Demoto, Kohei] Shinshu Univ, Fac Engn, Dept Chem & Mat Engn, Nagano, Nagano 3808553, Japan; [Sakabe, Junichi; Shimoyama, Yusuke] Tokyo Inst Technol, Dept Chem Engn, Meguro Ku, Tokyo 1528550, Japan	Uchida, H (reprint author), Shinshu Univ, Fac Engn, Dept Chem & Mat Engn, 4-17-1 Wakasato, Nagano, Nagano 3808553, Japan.	uchida@shinshu-u.ac.jp					Yesil-Celiktas O, 2010, IND ENG CHEM RES, V49, P7017, DOI 10.1021/ie100115x; Cocero MJ, 2009, J SUPERCRIT FLUID, V47, P546, DOI 10.1016/j.supflu.2008.08.015; Sovova H, 2007, J SUPERCRIT FLUID, V41, P1, DOI 10.1016/j.supflu.2006.08.007; Chaumeil JC, 1998, METHOD FIND EXP CLIN, V20, P211; Szterner P, 2010, J THERM ANAL CALORIM, V99, P325, DOI 10.1007/s10973-009-0186-1; Pourasghar M, 2012, POWDER TECHNOL, V225, P21, DOI 10.1016/j.powtec.2012.03.027; Seton L, 2010, CRYST GROWTH DES, V10, P3879, DOI 10.1021/cg100165t; MATSON DW, 1986, MATER LETT, V4, P429, DOI 10.1016/0167-577X(86)90113-8; Chehroudi B, 2006, COMBUST SCI TECHNOL, V178, P555, DOI 10.1080/00102200500294247; Zhang XX, 2014, RSC ADV, V4, P61137, DOI 10.1039/c4ra10662h; Blagden N, 2007, ADV DRUG DELIVER REV, V59, P617, DOI 10.1016/j.addr.2007.05.011; Thakur R, 2006, J SUPERCRIT FLUID, V37, P307, DOI 10.1016/j.supflu.2005.12.008; Priamo WL, 2013, ACTA SCI-TECHNOL, V35, P695, DOI 10.4025/actascitechnol.v35i4.18819; Jung J, 2001, J SUPERCRIT FLUID, V20, P179, DOI 10.1016/S0896-8446(01)00064-X; Yasuji T, 2008, ADV DRUG DELIVER REV, V60, P388, DOI 10.1016/j.addr.2007.03.025; Chan HK, 2011, ADV DRUG DELIVER REV, V63, P406, DOI 10.1016/j.addr.2011.03.011; Fages J, 2004, POWDER TECHNOL, V141, P219, DOI 10.1016/j.powtec.2004.02.007; Subramaniam B, 1997, J PHARM SCI-US, V86, P885, DOI 10.1021/js9700661; Girotra P, 2013, PHARM DEV TECHNOL, V18, P22, DOI 10.3109/10837450.2012.726998; Thakur R, 2005, IND ENG CHEM RES, V44, P7380, DOI 10.1021/ie050417j; Lin PC, 2011, RES CHEM INTERMEDIAT, V37, P153, DOI 10.1007/s11164-011-0262-6; Hu JH, 2004, DRUG DEV IND PHARM, V30, P233, DOI 10.1081/DDC-120030422; Fukne-Kokot K, 2000, FLUID PHASE EQUILIBR, V173, P297, DOI 10.1016/S0378-3812(00)00437-4; Samei M, 2012, J SUPERCRIT FLUID, V70, P1, DOI 10.1016/j.supflu.2012.05.011; Martin A, 2008, ADV DRUG DELIVER REV, V60, P339, DOI 10.1016/j.addr.2007.06.019; Thakur R, 2006, INT J PHARM, V308, P190, DOI 10.1016/j.ijpharm.2005.11.005; Khamar D, 2012, CRYST GROWTH DES, V12, P109, DOI 10.1021/cg2008478; Knez Z, 2003, CURR OPIN SOLID ST M, V7, P353, DOI 10.1016/j.cossms.2003.11.002; Sheth P, 2012, CURR DRUG DELIV, V9, P269; PETERSEN RC, 1986, J AM CHEM SOC, V108, P2100, DOI 10.1021/ja00268a066; Foster N, 2003, IND ENG CHEM RES, V42, P6476, DOI 10.1021/ie030219x; Lipinski CA, 2000, J PHARMACOL TOXICOL, V44, P235, DOI 10.1016/S1056-8719(00)00107-6; Pasquali I, 2008, INT J PHARMACEUT, V364, P176, DOI 10.1016/j.ijpharm.2008.05.014; Sinha B, 2013, INT J PHARMACEUT, V453, P126, DOI 10.1016/j.ijpharm.2013.01.019; Ashby M.F., 2009, NANOTECHNOLOGIES DES; Galushko A.A., 2006, CHEM IND CHEM ENG Q, V12, P152; Kohler M., 2007, INTRO NANOSTRUCTURIN; Lipinski C. A., 2001, CURR DRUG DISCOV, V4, P17; Lipinski CA, 2002, AM PHARM REV, V5, P82; Matson D, 1986, ADV CERAM MATER, V1, P242; Merisko-Liversidge E, 2003, EUR J PHARM SCI, V18, P113, DOI 10.1016/S0928-0987(02)00251-8; Merisko-Liversidge EM, 2008, TOXICOL PATHOL, V36, P43, DOI 10.1177/0192623307310946; Nues A.V.M., 2011, MATERIALS, V4, P2017; Parikh D.M., 2010, HDB PHARM GRANULATIO; Pasquali I, 2006, EUR J PHARM SCI, V27, P299, DOI 10.1016/j.ejps.2005.11.007; Radtke M, 2001, NEW DRUGS, V3, P62; Reverchon E, 2006, J SUPERCRIT FLUID, V37, P1, DOI 10.1016/j.supflu.2005.08.003; Sakabe J., 2012, P 10 INT S SUP FLUID, P1505; Sakabe J., 2011, THESIS SHINSHU U JAP; Ttirk M., 2014, PARTICLE FORMATION S; Uchida H., 2011, J SOC POWDER TECHNOL, V48, P641; Williams RO, 2012, AAPS ADV PHARM SCI, V3, P1, DOI 10.1007/978-1-14614-1144-4; York P, 1999, PHARM SCI TECHNOL TO, V2, P430, DOI 10.1016/S1461-5347(99)00209-6	53	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0896-8446	1872-8162		J SUPERCRIT FLUID	J. Supercrit. Fluids	OCT	2015	105				SI		128	135		10.1016/j.supflu.2015.05.005		8	Chemistry, Physical; Engineering, Chemical	Chemistry; Engineering	CU2JV	WOS:000363350700017		
J	Momose, T; Kondo, A; Kamiya, T; Yamada, H; Ohara, J; Kitamura, Y; Uchida, H; Shimogaki, Y; Sugiyama, M				Momose, Takeshi; Kondo, Aiko; Kamiya, Tatsuya; Yamada, Hideo; Ohara, Junji; Kitamura, Yasuhiro; Uchida, Hirohisa; Shimogaki, Yukihiro; Sugiyama, Masakazu			Solubility of bis-(2,2,6,6-tetramethyl-3,5-heptanedionato)copper(II) in mixed supercritical CO2 and H-2 systems for application in supercritical fluid deposition of Cu	JOURNAL OF SUPERCRITICAL FLUIDS			English	Article						Solubility; Supercritical carbon dioxide; Hydrogen; Metal organics; Copper	CARBON-DIOXIDE; THIN-FILMS; REACTIVE DEPOSITION; P-TOLUENESULFONAMIDE; MULTIWAFER REACTOR; REACTION-MECHANISM; PHASE-BEHAVIOR; NICKEL FILMS; METAL-OXIDE; COPPER	We measured the solubility of bis-(2,2,6,6-tetramethyl-3,5-heptanedionato)copper(II) (Cu(tmhd)2) in pure supercritical CO2 (scCO(2)) and binary mixtures of H-2 and scCO(2) at 40-100 degrees C and 11-20 MPa using spectrometric method. The solubility in scCO(2) was dependent on the density of CO2. The addition of H-2 to the scCO(2) had negative impact on the solubility, and the solubility was proportional to density of CO2 with a constant mole fraction of H-2. The equations proposed by Mendez-Santiago and Teja as well as Sauceau et al. were able to correlate the solubility in the pure CO2 and binary systems. This approach provides a framework to determine the precursor concentration for supercritical fluid deposition (SCFD) of Cu. The precursor feed system for optimal Cu-SCFD was discussed. In addition, the same effect was found with the addition of O-2 and N-2 into scCO(2), suggesting that further investigation into the solubility of SCFD precursors in these binary systems is warranted. (C) 2015 Elsevier B.V. All rights reserved.	[Momose, Takeshi; Shimogaki, Yukihiro] Univ Tokyo, Dept Mat Engn, Tokyo, Japan; [Kondo, Aiko] Univ Tokyo, Inst Ind Sci, Tokyo, Japan; [Kamiya, Tatsuya; Yamada, Hideo; Ohara, Junji; Kitamura, Yasuhiro] DENS Corp, Tokyo, Japan; [Uchida, Hirohisa] Shinshu Univ, Fac Engn, Matsumoto, Nagano, Japan; [Sugiyama, Masakazu] Univ Tokyo, Inst Engn Innovat, Tokyo, Japan	Momose, T (reprint author), Univ Tokyo, Dept Mat Engn, Tokyo, Japan.	momo@dpe.mm.t.u-tokyo.ac.jp	Sugiyama, Masakazu/P-9616-2015	Sugiyama, Masakazu/0000-0002-4303-4038			Alsten J.G.V., 1993, J CHEM ENG DATA, V38, P605; RICE JK, 1995, ANAL CHEM, V67, P4354, DOI 10.1021/ac00119a024; Uchida H, 2012, J SUPERCRIT FLUID, V66, P59, DOI 10.1016/j.supflu.2011.12.023; Morere J, 2013, J CHEM THERMODYN, V58, P55, DOI 10.1016/j.jct.2012.09.029; Li JL, 2010, J SUPERCRIT FLUID, V52, P11, DOI 10.1016/j.supflu.2009.11.011; Teoh WH, 2013, J ORGANOMET CHEM, V724, P102, DOI 10.1016/j.jorganchem.2012.10.005; Cortesi A, 1996, J SUPERCRIT FLUID, V9, P141, DOI 10.1016/S0896-8446(96)90024-8; Su ZM, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2189245; Gil L, 2010, J PHYS CHEM B, V114, P5447, DOI 10.1021/jp100184r; Blackburn JM, 2001, SCIENCE, V294, P141, DOI 10.1126/science.1064148; Matsubara M, 2009, J ELECTROCHEM SOC, V156, pH443, DOI 10.1149/1.3110918; Cabanas A, 2004, CHEM MATER, V16, P2028, DOI 10.1021/cm034739u; Tsai CC, 2008, J CHEM ENG DATA, V53, P2163, DOI 10.1021/je8003673; Garriga R, 2001, J SUPERCRIT FLUID, V20, P55, DOI 10.1016/S0896-8446(01)00055-9; Ruckenstein E, 2001, FLUID PHASE EQUILIBR, V180, P345, DOI 10.1016/S0378-3812(01)00372-7; Momose T, 2005, JPN J APPL PHYS 2, V44, pL1199, DOI 10.1143/JJAP.44.L1199; Skerget M, 2011, J CHEM ENG DATA, V56, P694, DOI 10.1021/je1011373; Aschenbrenner O, 2007, J SUPERCRIT FLUID, V41, P179, DOI 10.1016/j.supflu.2006.10.011; DOBBS JM, 1986, J CHEM ENG DATA, V31, P303, DOI 10.1021/je00045a014; Lee HBR, 2012, J ELECTROCHEM SOC, V159, pD46, DOI 10.1149/2.031202jes; Karanikas CF, 2010, MICROELECTRON ENG, V87, P566, DOI 10.1016/j.mee.2009.08.011; Uejima T, 2013, J ELECTROCHEM SOC, V160, pD3290, DOI 10.1149/2.044312jes; Eckert CA, 1996, NATURE, V383, P313, DOI 10.1038/383313a0; Bush D, 1997, ACS SYM SER, V670, P37; Span R, 1996, J PHYS CHEM REF DATA, V25, P1509; Kordikowski A, 1995, J SUPERCRIT FLUID, V8, P205, DOI 10.1016/0896-8446(95)90033-0; DOBBS JM, 1987, IND ENG CHEM RES, V26, P56, DOI 10.1021/ie00061a011; Yang JX, 2009, ADV MATER, V21, P4115, DOI 10.1002/adma.200803751; Haruki M, 2009, FLUID PHASE EQUILIBR, V280, P49, DOI 10.1016/j.fluid.2009.03.010; O'Neil A, 2006, CHEM MATER, V18, P5652, DOI 10.1021/cm060142d; Kondoh E, 2005, JPN J APPL PHYS 1, V44, P5799, DOI 10.1143/JJAP.44.5799; WALSH JM, 1987, FLUID PHASE EQUILIBR, V33, P295, DOI 10.1016/0378-3812(87)85042-2; Andersen WC, 2001, J CHEM ENG DATA, V46, P1045, DOI 10.1021/je000257c; Tsai CC, 2007, FLUID PHASE EQUILIBR, V260, P287, DOI 10.1016/j.fluid.2007.07.070; Hunde ET, 2004, CHEM MATER, V16, P498, DOI 10.1021/cm034433n; LEMERT RM, 1991, IND ENG CHEM RES, V30, P1222, DOI 10.1021/ie00054a024; Momose T, 2008, JPN J APPL PHYS, V47, P885, DOI 10.1143/JJAP.47.885; Zhao B, 2008, MICROELECTRON ENG, V85, P675, DOI 10.1016/j.mee.2007.12.034; Lee JH, 2009, ELECTROCHEM SOLID ST, V12, pD45, DOI 10.1149/1.3092891; Kondoh E, 2002, MICROELECTRON ENG, V64, P495, DOI 10.1016/S0167-9317(02)00826-2; Li JL, 2009, J CHEM ENG DATA, V54, P1142, DOI 10.1021/je8008842; Zong YF, 2005, CHEM MATER, V17, P560, DOI 10.1021/cm048665d; Gougousi T, 2008, THIN SOLID FILMS, V516, P6197, DOI 10.1016/j.tsf.2007.11.104; Barua D, 2006, APPL PHYS LETT, V88, DOI [10.1063/1.2181651, 10.1063/1.218165]; Mendez-Santiago J, 1999, FLUID PHASE EQUILIBR, V158, P501, DOI 10.1016/S0378-3812(99)00154-5; Zhao B, 2006, JPN J APPL PHYS 2, V45, pL1296, DOI 10.1143/JJAP.45.L1296; Haruki M, 2011, J CHEM ENG DATA, V56, P2230, DOI 10.1021/je101255v; O'Neil A, 2007, CHEM MATER, V19, P5460, DOI 10.1021/cm070288s; Smart NG, 1997, TALANTA, V44, P137, DOI 10.1016/S0039-9140(96)02008-5; Song QR, 2010, J CHEM ENG DATA, V55, P3946, DOI 10.1021/je901025f; Sauceau M, 2003, FLUID PHASE EQUILIBR, V208, P99, DOI 10.1016/S0378-3812(03)00005-0; Momose T, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.097002; SAITO N, 1990, B CHEM SOC JPN, V63, P1532, DOI 10.1246/bcsj.63.1532; LAGALANTE AF, 1995, INORG CHEM, V34, P5781, DOI 10.1021/ic00127a015; Zhao Y, 2014, THIN SOLID FILMS, V553, P184, DOI 10.1016/j.tsf.2013.11.062; Jung K, 2013, ECS SOLID STATE LETT, V2, pP79, DOI 10.1149/2.009309ssl; Ohashi A, 2006, ANAL SCI, V22, P1399, DOI 10.2116/analsci.22.1399; Aida T, 2010, J SUPERCRIT FLUID, V55, P71, DOI 10.1016/j.supflu.2010.05.025; Hamdi R.M., 1991, J SUPERCRIT FLUID, V4, P55; Jin JS, 2012, J CHEM ENG DATA, V57, P2217, DOI 10.1021/je300023v; Jung K., 2013, SOLID STATE LETT, V2, pP70; Kubota M., 2012, P IEEE 25 INT C MICR, P204; Kumik R. T., 1982, FLUID PHASE EQUILIBR, V8, P93; Momose T., 2011, P IEEE 24 INT C MICR, P49; Momose T., 2008, P ADV MET C, P289; Momose T, 2014, J CHEM ENG JPN, V47, P743, DOI 10.1252/jcej.13we274; Momose T, 2014, J CHEM ENG JPN, V47, P737, DOI 10.1252/jcej.13we225; Tenorio MJ, 2012, J SUPERCRIT FLUID, V70, P106, DOI 10.1016/j.supflu.2012.06.014; Vafajoo L., 2011, DETERMINING CORRELAT, P790; Zhao Y, 2013, ECS J SOLID STATE SC, V2, pN191, DOI 10.1149/2.003311jss	70	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0896-8446	1872-8162		J SUPERCRIT FLUID	J. Supercrit. Fluids	OCT	2015	105				SI		193	200		10.1016/j.supflu.2015.04.002		8	Chemistry, Physical; Engineering, Chemical	Chemistry; Engineering	CU2JV	WOS:000363350700025		
J	Iwamoto, J; Takada, T				Iwamoto, Jun; Takada, Tetsuya			Effect of minodronate on the speed of sound of the calcaneus in postmenopausal women with an increased risk of fractures: A clinical practice-based observational study	JOURNAL OF THE CHINESE MEDICAL ASSOCIATION			English	Article						bone turnover; minodronate; postmenopausal women; quantitative ultrasound; speed of sound	ONCE-WEEKLY ALENDRONATE; PRIMARY OSTEOPOROSIS; DIAGNOSTIC-CRITERIA; AMERICAN-SOCIETY; MINERAL-RESEARCH; TASK-FORCE; BONE; ULTRASOUND; THERAPY; TRIAL	Background: We previously reported that alendronate and risedronate reduce the urinary levels of cross-linked N-terminal telopeptides of type I collagen (NTX) by 44.9% and 34.7%, respectively, at 3 months after the start of treatment, and increase the speed of sound (SOS) of the calcaneus by 0.6% and 0.65%, respectively, at 12 months after the start of treatment in postmenopausal women with osteoporosis. The aim of the present clinical practice-based observational study was to examine the effect of treatment with minodronate for 12 months on the SOS of the calcaneus and on bone turnover markers in postmenopausal women with an increased risk of fractures. Methods: Forty-two postmenopausal women with osteoporosis or osteopenia with a clinical risk factor for fractures who had been treated with minodronate for > 12 months were enrolled in the study. The SOS and bone turnover markers were monitored during treatment with minodronate for 12 months. Results: Compared to their baseline values, the urinary levels of NTX at 3 months and the serum levels of alkaline phosphatase at 12 months were significantly decreased at 47.5% and 25.8%, respectively. At 12 months, the SOS increased modestly, but significantly, by 0.47%, compared to the baseline value. Conclusion: The present study confirmed that minodronate suppressed bone turnover and modestly increased the SOS of the calcaneus in postmenopausal women with an increased risk of fractures. Copyright (C) 2015 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.	[Iwamoto, Jun] Keio Univ, Sch Med, Inst Integrated Sports Med, Tokyo 1608582, Japan; [Takada, Tetsuya] Hiyoshi Med Clin, Dept Internal Med, Kanagawa, Japan	Iwamoto, J (reprint author), Keio Univ, Sch Med, Inst Integrated Sports Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	jiwamoto@keio.jp					Adami S, 2009, OSTEOPOROSIS INT, V20, P239, DOI 10.1007/s00198-008-0650-y; Ito M, 2003, OSTEOPOROSIS INT, V14, P959, DOI 10.1007/s00198-003-1497-x; Emkey R, 2005, CURR MED RES OPIN, V21, P1895, DOI 10.1185/030079905X74862; Wuster C, 1998, EXP CLIN ENDOCR DIAB, V106, P277; Hagino H, 2009, BONE, V44, P1078, DOI 10.1016/j.bone.2009.02.016; Shane E, 2010, J BONE MINER RES, V25, P2267, DOI 10.1002/jbmr.253; Orimo H, 1998, J BONE MINER METAB, V16, P139, DOI 10.1007/s007740050038; Pazianas M, 2010, J BONE MINER RES, V25, P2, DOI 10.1359/jbmr.091201; Okazaki R, 2012, OSTEOPOROSIS INT, V23, P1737, DOI 10.1007/s00198-011-1782-z; Iwamoto J, 2012, THER CLIN RISK MANAG, V8, P287, DOI 10.2147/TCRM.S32794; Matsumoto T, 2009, OSTEOPOROSIS INT, V20, P1429, DOI 10.1007/s00198-008-0816-7; Sebba AI, 2004, CURR MED RES OPIN, V20, P2031, DOI 10.1185/030079904X16768; Fujiwara S, 2005, OSTEOPOROSIS INT, V16, P2107, DOI 10.1007/s00198-005-2008-z; Orimo H, 2001, J BONE MINER METAB, V19, P331, DOI 10.1007/s007740170001; Nishizawa Y, 2005, J BONE MINER METAB, V23, P97, DOI 10.1007/s00774-004-0547-6; Yamaguchi T, 2011, J BONE MINER METAB, V29, P626, DOI 10.1007/s00774-011-0265-9; Iwamoto Jun, 2013, World J Orthop, V4, P316, DOI 10.5312/wjo.v4.i4.316; Khosla S, 2007, J BONE MINER RES, V22, P1479, DOI 10.1359/JBMR.0707ONJ; Kishimoto H, 2003, OSTEOPOROSIS JPN, V11, P307; Orimo H., 2006, GUIDELINES PREVENTIO	20	1	1	ELSEVIER TAIWAN	TAIPEI	RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2, TAIPEI, 10449, TAIWAN	1726-4901	1728-7731		J CHIN MED ASSOC	J. Chin. Med. Assoc.	OCT	2015	78	10					591	596		10.1016/j.jcma.2015.06.010		6	Medicine, General & Internal	General & Internal Medicine	CU3QE	WOS:000363439100005		
J	Ichikawa, Y; Ogawa, K				Ichikawa, Yuji; Ogawa, Kazuhiro			Effect of Substrate Surface Oxide Film Thickness on Deposition Behavior and Deposition Efficiency in the Cold Spray Process	JOURNAL OF THERMAL SPRAY TECHNOLOGY			English	Article						cold spray; MCrAlY; modeling of coating formation; secondary electron microscopy (SEM); splat morphology; deposition efficiency; substrate preparation	PARTICLE-VELOCITY; SIMULATION; COATINGS; IMPACT	The mechanism of cold spray deposition is not yet completely understood. The impinging velocity and deformation behavior of the particles are believed to be critical deposition conditions. However, such substrate conditions as oxide-film thickness and mechanical properties may also affect cold spray deposition. In this study we investigated the effect of substrate conditions, especially oxide film thickness, on the deposition process. The efficiency of deposition and the relationship between the impinging position of the particles and the number of particles deposited were investigated for two substrates coated with oxide films of different thickness; the particles were deposited sparsely on the substrates. Results showed that efficiency of deposition was lower for the oxide film with the greater thickness. Deposition tendency was also associated with impinging velocity, i.e., the critical velocity on which oxide film thickness depends; this is the reason for the different efficiency of deposition. An oxide film may inhibit deposition on a new surface. These results indicate that oxide film thickness has a substantial effect on the efficiency of deposition on the substrate. They also imply that creation of a newly-formed surface is important to the deposition process.	[Ichikawa, Yuji; Ogawa, Kazuhiro] Tohoku Univ, Fracture & Reliabil Res Inst, Sendai, Miyagi 980, Japan	Ichikawa, Y (reprint author), Tohoku Univ, Fracture & Reliabil Res Inst, Sendai, Miyagi 980, Japan.	ichikawa@rift.mech.tohoku.ac.jp		Ichikawa, Yuji/0000-0002-9474-3467			Kim K, 2010, SCRIPTA MATER, V63, P215, DOI 10.1016/j.scriptamat.2010.03.061; Gilmore DL, 1999, J THERM SPRAY TECHN, V8, P576, DOI 10.1361/105996399770350278; Guetta S, 2009, J THERM SPRAY TECHN, V18, P331, DOI 10.1007/s11666-009-9327-0; Li WY, 2007, APPL SURF SCI, V253, P5084, DOI 10.1016/j.apsusc.2006.11.020; Kosarev VF, 2003, J THERM SPRAY TECHN, V12, P265, DOI 10.1361/105996303770348384; Papyrin A, 2001, ADV MATER PROCESS, V159, P49; Yokoyama K, 2006, MATER TRANS, V47, P1697, DOI 10.2320/matertrans.47.1697; Stoltenhoff T, 2002, J THERM SPRAY TECHN, V11, P542, DOI 10.1361/105996302770348682; Grujicic M, 2004, MATER DESIGN, V25, P681, DOI 10.1016/j.matdes.2004.03.008; Grujicic M, 2003, APPL SURF SCI, V219, P211, DOI 10.1016/S0169-4332(03)00643-3; Alkhimov A. P., 1990, Soviet Physics - Doklady, V35; Achar DRG, 2004, SURF COAT TECH, V187, P272, DOI 10.1016/j.surfocat.2004.02.018; Schmidt T, 2006, ACTA MATER, V54, P729, DOI 10.1016/j.actamat.2005.10.005; Ogawa K, 2008, J THERM SPRAY TECHN, V17, P728, DOI 10.1007/s11666-008-9254-5; Dykhuizen RC, 1999, J THERM SPRAY TECHN, V8, P559, DOI 10.1361/105996399770350250; Dorfman M. R., 2004, ADV TECHNOLOGY APPL, P90; Ichikawa Y., 2007, THERMAL SPRAY 2007 G, P54; Ichikawa Y., 2008, THERMAL SPRAY 2008 C, P281; Karthikeyan J., 2003, THERMAL SPRAY 2003 A, P117; Katanoda H., 2003, J THERM SPRAY TECHN, V16, P627	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1059-9630	1544-1016		J THERM SPRAY TECHN	J. Therm. Spray Technol.	OCT	2015	24	7					1269	1276		10.1007/s11666-015-0299-y		8	Materials Science, Coatings & Films	Materials Science	CT8AZ	WOS:000363038600015		
J	Mori, R; Kamei, N; Okawa, S; Nakabayashi, A; Yokota, K; Higashi, Y; Ochi, M				Mori, Ryo; Kamei, Naosuke; Okawa, Shingo; Nakabayashi, Akihiro; Yokota, Kazunori; Higashi, Yukihito; Ochi, Mitsuo			Promotion of skeletal muscle repair in a rat skeletal muscle injury model by local injection of human adipose tissue-derived regenerative cells	JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE			English	Article						human adipose tissue; adipose tissue derived cell; skeletal muscle; muscle repair; myogenesis; angiogenesis	MESENCHYMAL STEM-CELLS; GROWTH-FACTOR; BONE-MARROW; CD34-POSITIVE CELLS; SATELLITE CELLS; IN-VITRO; DIFFERENTIATION; EXPRESSION; ADULT	Human adipose tissue-derived regenerative cells (ADRCs) can be isolated easily and aseptically from unwanted subcutaneous fat without culturing. ADRCs have been used in clinical cosmetic therapy. In addition, they are expected to be an attractive and feasible source of cell-based therapies in regenerative medicine. Therefore, this paper investigates whether transplantation of human adult ADRCs into skeletal muscle injury models promotes the repair of muscle tissues. This was done by locally injecting human ADRCs into an injured site after laceration of the nude-rat tibialis anterior muscle. Phosphate-buffered saline (PBS) and bone marrow mononuclear cells (MNCs) were injected as negative and positive controls, respectively. After injury, recovery of muscle strength was accelerated by transplantation of ADRCs compared to administration of PBS and MNCs. Moreover, transplantation of ADRCs also enhanced angiogenesis and myogenesis, but the number of vascular and muscular cells labeled with the human cell-specific maker was limited at the injury site. Results showed that transplantation of ADRCs into a skeletal muscle injury model promoted repair of muscle tissues in a paracrine manner rather than differentiation of itself into blood vessels and myofibres. Thus, it is believed that ADRCs are a useful and feasible cell source not only for cosmetic therapy but also for regenerative therapy. Copyright (c) 2012 John Wiley & Sons, Ltd.	[Mori, Ryo; Kamei, Naosuke; Okawa, Shingo; Nakabayashi, Akihiro; Ochi, Mitsuo] Hiroshima Univ, Grad Sch Biomed Sci, Dept Orthoped Surg, Hiroshima 7348551, Japan; [Kamei, Naosuke; Higashi, Yukihito] Hiroshima Univ Hosp, Div Regenerat & Med, Hiroshima, Japan; [Yokota, Kazunori] Hiroshima Univ, Grad Sch Biomed Sci, Dept Plast & Reconstruct Surg, Hiroshima 7348551, Japan	Mori, R (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Orthoped Surg, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	d103584@hiroshima-u.ac.jp		Mori, Ryo/0000-0002-6451-8250	Ministry of Education, Culture, Sports, Science and Technology, Japan [23592188]	This work was supported by a Grant-in-Aid for Scientific Research of Ministry of Education, Culture, Sports, Science and Technology, Japan (No. 23592188 to K Y).	Deasy BM, 2009, MOL THER, V17, P1788, DOI 10.1038/mt.2009.136; Sheehan SM, 2000, MUSCLE NERVE, V23, P239, DOI 10.1002/(SICI)1097-4598(200002)23:2<239::AID-MUS15>3.0.CO;2-U; Romanov YA, 2005, B EXP BIOL MED+, V140, P138, DOI 10.1007/s10517-005-0430-z; Kim M, 2006, BIOCHEM BIOPH RES CO, V348, P386, DOI 10.1016/j.bbrc.2006.07.063; Nakasa T, 2010, J CELL MOL MED, V14, P2495, DOI 10.1111/j.1582-4934.2009.00898.x; Helder MN, 2007, TISSUE ENG, V13, P1799, DOI 10.1089/ten.2006.0165; Tobita M, 2011, DISCOV MED, V57, P160; Bai XW, 2010, EUR HEART J, V31, P489, DOI 10.1093/eurheartj/ehp568; Jackson WM, 2009, J TISSUE ENG REGEN M, V3, P129, DOI 10.1002/term.149; Terayama H, 2011, J TISSUE ENG REGEN M, V5, P32, DOI 10.1002/term.285; Cai L, 2007, STEM CELLS, V25, P3234, DOI 10.1634/stemcells.2007-0388; Aldahmash A, 2012, ANN SAUDI MED, V32, P68, DOI 10.5144/0256-4947.2012.68; BACIGALUPO A, 1992, BONE MARROW TRANSPL, V9, P467; Shi M, 2009, STEM CELLS, V27, P949, DOI 10.1002/stem.4; Tei K, 2008, STEM CELLS, V26, P819, DOI 10.1634/stemcells.2007-0671; Merritt EK, 2010, TISSUE ENG PT A, V16, P2871, DOI 10.1089/ten.TEA.2009.0826; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; Kamakura T, 2011, AESTHET PLAST SURG, V35, P1022, DOI 10.1007/s00266-011-9727-7; Salani S, 2012, J CELL MOL MED, V16, P1353, DOI 10.1111/j.1582-4934.2011.01498.x; Paulin D, 2004, EXP CELL RES, V301, P1, DOI 10.1016/j.yexcr.2004.08.004; Koning M, 2009, J TISSUE ENG REGEN M, V3, P407, DOI 10.1002/term.190; Yamamoto T, 2010, INT J UROL, V17, P75, DOI 10.1111/j.1442-2042.2009.02429.x; Negroni E, 2011, EXPERT OPIN BIOL TH, V11, P157, DOI 10.1517/14712598.2011.542748; Taniguti APT, 2011, MUSCLE NERVE, V43, P82, DOI 10.1002/mus.21869; Aurich H, 2009, GUT, V58, P570, DOI 10.1136/gut.2008.154880; Natsu K, 2004, TISSUE ENG, V10, P1093, DOI 10.1089/ten.2004.10.1093; Li H, 2011, INT J SPORTS MED, V32, P735, DOI 10.1055/s-0031-1279771; Maharaj ASR, 2006, AM J PATHOL, V168, P639, DOI 10.2353/ajpath.2006.050834; Lin K, 2008, CYTOTHERAPY, V10, P417, DOI 10.1080/14653240801982979; Asahara T, 1997, SCIENCE, V14, P275; Pinheiro CHD, 2012, STEM CELL REV REP, V8, P363, DOI 10.1007/s12015-011-9304-0; Hildner F, 2011, J TISSUE ENG REGEN M, V5, P36; Wagatsuma A, 2007, MOL CELL BIOCHEM, V298, P151, DOI 10.1007/s11010-006-9361-x; Xia JH, 2006, CHINESE MED J-PEKING, V119, P117	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-6254	1932-7005		J TISSUE ENG REGEN M	J. Tissue Eng. Regen. Med.	OCT	2015	9	10					1150	1160		10.1002/term.1659		11	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Engineering, Biomedical	Cell Biology; Biotechnology & Applied Microbiology; Engineering	CU1FO	WOS:000363265700004		
J	Asai, Y				Asai, Yukiko			Parental leave reforms and the employment of new mothers: Quasi-experimental evidence from Japan	LABOUR ECONOMICS			English	Article						Parental leave; Cash benefit; Job continuity; Labour supply	INCOME-TAX CREDIT; MATERNAL EMPLOYMENT; YOUNG-CHILDREN; BENEFIT REFORM; IN-DIFFERENCES; FAMILY LEAVE; LABOR; WORK; PARTICIPATION; CONSEQUENCES	This study examines the changes in job continuity of new mothers following an increase in cash benefits provided during parental leave. The cash benefit was first introduced in 1995 and the replacement rate was 25%. The replacement rate was raised from 25% to 40% in 2001. During this period, the maximum duration of paid leave and that of job-protection remained unchanged, and therefore, I can isolate the effects of changes in the amount of cash benefit from those due to changes in duration of leave. By comparing the job continuity of women who gave birth to their child before the reform and those who did so after the reform, I find little evidence that the labour supply pattern of new mothers changed in response to the increased cash benefit. (C) 2015 Elsevier B.V. All rights reserved.	Univ Tokyo, Inst Sociol Sci, Bunkyo Ku, Tokyo 1130033, Japan	Asai, Y (reprint author), Univ Tokyo, Inst Sociol Sci, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	y_asai@iss.u-tokyo.ac.jp					Ai C., 2003, ECON LETT, V80, P123; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Sanchez-Mangas R, 2008, LABOUR ECON, V15, P1127, DOI 10.1016/j.labeco.2007.10.002; Naz G, 2004, J POPUL ECON, V17, P369, DOI 10.1007/s00148-003-0157-y; Conley TG, 2011, REV ECON STAT, V93, P113, DOI 10.1162/REST_a_00049; Lundin D, 2008, LABOUR ECON, V15, P647, DOI 10.1016/j.labeco.2008.04.005; Donald SG, 2007, REV ECON STAT, V89, P221, DOI 10.1162/rest.89.2.221; Azmat G, 2010, LABOUR ECON, V17, P487, DOI 10.1016/j.labeco.2009.09.006; Hanratty M, 2009, J POPUL ECON, V22, P693, DOI 10.1007/s00148-008-0211-x; Waldfogel J, 1999, J POPUL ECON, V12, P523, DOI 10.1007/s001480050112; Berlinski S, 2007, LABOUR ECON, V14, P665, DOI 10.1016/j.labeco.2007.01.003; Lefebvre P, 2008, J LABOR ECON, V26, P519, DOI 10.1086/587760; Jukic AM, 2013, HUM REPROD, V28, P2848, DOI 10.1093/humrep/det297; Baker M, 2008, J LABOR ECON, V26, P655, DOI 10.1086/591955; Baum CL, 2003, LABOUR ECON, V10, P573, DOI 10.1016/S0927-5371(03)00037-X; Francesconi M, 2007, J HUM RESOUR, V42, P1; Gelbach JB, 2002, AM ECON REV, V92, P307, DOI 10.1257/000282802760015748; Asai Y., 2014, PARENTAL LEAVE REFOR; Blundell R, 1999, HDB LABOR EC A, P1559, DOI 10.1016/S1573-4463(99)03008-4; Boeri T., 2013, EC IMPERFECT LABOR M; Eissa N, 1996, Q J ECON, V111, P605, DOI 10.2307/2946689; GEBCO, 2007, WHIT PAP GEND EQ 200; GRUBER J, 1994, AM ECON REV, V84, P622; Kato T., 2013, NBER JAP PROJ M TOK; Klerman A., 1997, GENDER FAMILY ISSUES, P65; Lalive R., 2013, REV ECON STUD, V93, P113; Lalive R, 2009, Q J ECON, V124, P1363, DOI 10.1162/qjec.2009.124.3.1363; Meghir C., 2010, DIMENSIONS TAX DESIG, P202; Meyer BD, 2001, Q J ECON, V116, P1063, DOI 10.1162/00335530152466313; MHLW, 2007, BAS SURV GEND EQ EMP; MHLW, 2002, BAS SURV GEND EQ EMP; MOULTON BR, 1990, REV ECON STAT, V72, P334, DOI 10.2307/2109724; Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588; Ruhm CJ, 1998, Q J ECON, V113, P285, DOI 10.1162/003355398555586; Schone P, 2004, J POPUL ECON, V17, P703, DOI 10.1007/s001-003-0176-58; Schonberg U., 2007, IZA DISCUSSION PAPER; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1; Yamaguchi S., 2014, DYNAMIC EFFECTS PARE	38	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0927-5371	1879-1034		LABOUR ECON	Labour Econ.	OCT	2015	36				SI		72	83		10.1016/j.labeco.2015.02.007		12	Economics	Business & Economics	CT8QB	WOS:000363080000006		
J	Fujiki, M; Miyamoto, S; Hayashi, R; Sakuraba, M				Fujiki, Masahide; Miyamoto, Shimpei; Hayashi, Ryuichi; Sakuraba, Minoru			Evaluation of Routine Contrast Swallow Following Total Pharyngolaryngectomy and Free Jejunal Transfer	LARYNGOSCOPE			English	Article						Total pharyngolaryngectomy; free jejunal transfer; contrast swallow; anastomotic leakage; sensitivity	COMPUTED-TOMOGRAPHY; ANASTOMOTIC LEAKS; RECONSTRUCTION; ESOPHAGECTOMY; FLUOROSCOPY; DEFECTS; FLAP	Objective: Anastomotic leakage is a serious complication following total pharyngolaryngectomy (TPL) and free jejunal transfer (FJT). Although routine radiological assessment using contrast swallow is widely performed postoperatively for the detection of anastomotic leakage before oral intake, the accuracy remains unclear. We evaluated the clinical usefulness of routine contrast swallow for screening of anastomotic leakage. Study Design: Retrospective chart review. Methods: We retrospectively reviewed 232 patients who had undergone TPL and FIT from 2009 to 2013. Initial contrast swallow was performed near the seventh postoperative day in patients without a history of radiation for head and neck region preoperatively and near the 14th postoperative day in patients with a history. The accuracy of routine contrast swallow was calculated. Results: Clinical anastomotic leakage occurred in 12 patients (5.2%); of these, anastomotic leakage was detected by initial contrast swallow in six patients. The sensitivity and specificity of contrast swallow were 50.0% and 99.1%, respectively. Conclusion: Contrast swallow has low sensitivity and a high false-negative rate for the diagnosis of clinical leakage after TPL and FJT, and routine contrast swallow was insufficient for the screening of anastomotic leakage. Therefore, contrast swallow should be performed in a targeted fashion for patients with clinical signs of anastomotic leakage.	[Fujiki, Masahide; Sakuraba, Minoru] Natl Canc Ctr Hosp East, Div Plast & Reconstruct Surg, Kashiwa, Chiba 2778577, Japan; [Hayashi, Ryuichi] Natl Canc Ctr Hosp East, Div Head & Neck Surg, Kashiwa, Chiba 2778577, Japan; [Miyamoto, Shimpei] Natl Canc Ctr, Div Plast & Reconstruct Surg, Tokyo, Japan	Fujiki, M (reprint author), Natl Canc Ctr Hosp East, Div Plast & Reconstruct Surg, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	masahide-fujiki@gumin.ac.jp					Tirnaksiz MB, 2005, EUR SURG RES, V37, P123, DOI 10.1159/000084544; Perez-Smith D, 2013, J PLAST RECONSTR AES, V66, P9, DOI 10.1016/j.bjps.2012.08.033; Sarukawa S, 2006, LARYNGOSCOPE, V116, P976, DOI 10.1097/01.mlg.0000216915.62574.ba; DeArmond DT, 2013, J SURG RES, V182, P192, DOI 10.1016/j.jss.2012.10.025; Hogan BA, 2008, SURG ENDOSC, V22, P767, DOI 10.1007/s00464-007-9629-6; Strauss C, 2010, ANN SURG, V251, P647, DOI 10.1097/SLA.0b013e3181c1aeb8; Kimata Y, 2000, LARYNGOSCOPE, V110, P1230, DOI 10.1097/00005537-200007000-00031; COLEMAN JJ, 1989, PLAST RECONSTR SURG, V84, P589, DOI 10.1097/00006534-198984040-00005; Cools-Lartigue J, 2014, ANN SURG ONCOL, V21, P2573, DOI 10.1245/s10434-014-3654-1; Miyamoto S, 2013, MICROSURG, V33, P119, DOI 10.1002/micr.22017; REECE GP, 1995, PLAST RECONSTR SURG, V96, P1307, DOI 10.1097/00006534-199511000-00012; Tanomkiat W, 2000, ACTA RADIOL, V41, P482, DOI 10.1080/028418500127345730; Upponi S, 2008, BRIT J RADIOL, V81, P545, DOI 10.1259/bjr/30515892; Frezza EE, 2009, ARCH SURG-CHICAGO, V144, P766, DOI 10.1001/archsurg.2009.138; Boone J, 2008, ANZ J SURG, V79, P784; Cordeiro PG, 1999, PLAST RECONSTR SURG, V103, P1165	16	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0023-852X	1531-4995		LARYNGOSCOPE	Laryngoscope	OCT	2015	125	10					2280	2283		10.1002/lary.25302		4	Medicine, Research & Experimental; Otorhinolaryngology	Research & Experimental Medicine; Otorhinolaryngology	CU2XF	WOS:000363386300020		
J	Kanazawa, T; Komazawa, D; Indo, K; Akagi, Y; Lee, Y; Nakamura, K; Matsushima, K; Kunieda, C; Misawa, K; Nishino, H; Watanabe, Y				Kanazawa, Takeharu; Komazawa, Daigo; Indo, Kanako; Akagi, Yusuke; Lee, Yogaku; Nakamura, Kazuhiro; Matsushima, Koji; Kunieda, Chikako; Misawa, Kiyoshi; Nishino, Hiroshi; Watanabe, Yusuke			Single Injection of Basic Fibroblast Growth Factor to Treat Severe Vocal Fold Lesions and Vocal Fold Paralysis	LARYNGOSCOPE			English	Article						Basic fibroblast growth factor; local anesthesia; regenerative medicine; single injection; vocal fold lesion	MESENCHYMAL STEM-CELLS; HYALURONIC-ACID; REGENERATION; SULCUS; BIOMECHANICS; COLLAGEN; CANINE; MODEL; SCAR	Objectives/Hypothesis: Severe vocal fold lesions such as vocal fold sulcus, scars, and atrophy induce a communication disorder due to severe hoarseness, but a treatment has not been established. Basic fibroblast growth factor (bFGF) therapies by either four-time repeated local injections or regenerative surgery for vocal fold scar and sulcus have previously been reported, and favorable outcomes have been observed. In this study, we modified bFGF therapy using a single of bFGF injection, which may potentially be used in office procedures. Study Design: Retrospective chart review. Methods: Five cases of vocal fold sulcus, six cases of scars, seven cases of paralysis, and 17 cases of atrophy were treated by a local injection of bFGF. The injection regimen involved injecting 50 mu g of bFGF dissolved in 0.5 mL saline only once into the superficial lamina propria using a 23-gauge injection needle. Two months to 3 months after the injection, phonological outcomes were evaluated. Results: The maximum phonation time (MPT), mean airflow rate, pitch range, speech fundamental frequency, jitter, and voice handicap index improved significantly after the bFGF injection. Furthermore, improvement in the MPT was significantly greater in patients with (in increasing order) vocal fold atrophy, scar, and paralysis. The improvement in the MPT among all patients was significantly correlated with age; the MPT improved more greatly in younger patients. Conclusions: Regenerative treatments by bFGF injection even a single injection effectively improve vocal function in vocal fold lesions.	[Kanazawa, Takeharu; Komazawa, Daigo; Indo, Kanako; Akagi, Yusuke; Lee, Yogaku; Nakamura, Kazuhiro; Kunieda, Chikako; Watanabe, Yusuke] Int Univ Hlth & Welf, Tokyo Voice Ctr, Tokyo, Japan; [Kanazawa, Takeharu; Nishino, Hiroshi] Jichi Med Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Shimotsuke, Tochigi 3290498, Japan; [Indo, Kanako] Kagawa Univ, Sch Med, Dept Otolaryngol, Miki, Kagawa, Japan; [Akagi, Yusuke] Okayama Med Ctr, Dept Otolaryngol Head & Neck Surg, Okayama, Japan; [Nakamura, Kazuhiro] Tokyo Med Univ, Dept Otolaryngol Head & Neck Surg, Hachioji Med Ctr, Hachioji, Tokyo, Japan; [Matsushima, Koji] Toho Univ, Omori Med Ctr, Dept Otolaryngol Head & Neck Surg, Tokyo, Japan; [Kunieda, Chikako] Hashima City Hosp, Dept Otorhinolaryngol, Hashima, Japan; [Misawa, Kiyoshi] Hamamatsu Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Hamamatsu, Shizuoka 4312102, Japan	Kanazawa, T (reprint author), Jichi Med Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	kanatake@omiya.jichi.ac.jp			Tokyo Voice Center in the International University of Health and Welfare, Tokyo, Japan	This work was performed at and funded internally by the Tokyo Voice Center in the International University of Health and Welfare, Tokyo, Japan.	Hirano S, 2004, LARYNGOSCOPE, V114, P2161, DOI 10.1097/01.mlg.0000149450.37640.db; Nakagawa H, 2012, J VOICE, V26, pE107, DOI 10.1016/j.jvoice.2011.07.005; Chan RW, 2001, OTOLARYNG HEAD NECK, V124, P607, DOI 10.1067/mhn.2001.115906; Hsiung MW, 2006, ACTA OTO-LARYNGOL, V126, P191, DOI 10.1080/00016480500339854; Kim HS, 1998, CYTOGENET CELL GENET, V83, P73, DOI 10.1159/000015129; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Gray SD, 1999, LARYNGOSCOPE, V109, P845, DOI 10.1097/00005537-199906000-00001; Koga C, 1999, BIOCHEM BIOPH RES CO, V261, P756, DOI 10.1006/bbrc.1999.1039; Hirano S, 2012, LARYNGOSCOPE, V122, P327, DOI 10.1002/lary.22393; Kanemaru SI, 2003, ANN OTO RHINOL LARYN, V112, P915; Remacle M, 2000, ANN OTO RHINOL LARYN, V109, P141; Hirano S, 2005, ANN OTO RHINOL LARYN, V114, P304; Hirano S, 2013, LARYNGOSCOPE, V123, P2749, DOI 10.1002/lary.24092; BOUCHAYER M, 1992, FOLIA PHONIATR, V44, P155; Hirano S, 2003, ANN OTO RHINOL LARYN, V112, P617; Roberts T, 2011, CLIN ANAT, V24, P544, DOI 10.1002/ca.21114; Svensson B, 2010, LARYNGOSCOPE, V120, P1370, DOI 10.1002/lary.20926; PONTES P, 1993, J VOICE, V7, P365, DOI 10.1016/S0892-1997(05)80260-7; Sato K, 1997, ANN OTO RHINOL LARYN, V106, P44; Hertegard S, 2006, LARYNGOSCOPE, V116, P1248, DOI 10.1097/01.mlg.0000224548.68499.35; Suehiro A, 2010, ACTA OTO-LARYNGOL, V130, P844, DOI 10.3109/00016480903426618; Xu W, 2011, ANN OTO RHINOL LARYN, V120, P123; Hom David B, 2002, Facial Plast Surg, V18, P41, DOI 10.1055/s-2002-19826; Matsumoto Shigeru, 2013, Plast Reconstr Surg Glob Open, V1, pe44, DOI 10.1097/GOX.0b013e3182a88787; Rammage L, 2001, MANAGEMENT VOICE ITS, P269; Taguchi A, 2012, J VOICE, V26, P668, DOI DOI 10.1016/J.JV0ICE.2011.11.005; Tsunoda Koichi, 2005, Laryngoscope, V115, P1, DOI 10.1097/01.mlg.0000183966.72921.31	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0023-852X	1531-4995		LARYNGOSCOPE	Laryngoscope	OCT	2015	125	10					E338	E344		10.1002/lary.25315		7	Medicine, Research & Experimental; Otorhinolaryngology	Research & Experimental Medicine; Otorhinolaryngology	CU2XF	WOS:000363386300003		
J	Hata, Y; Matsumoto, T; Tanaka, T; Kondo, A				Hata, Yuto; Matsumoto, Takuya; Tanaka, Tsutomu; Kondo, Akihiko			C-Terminal-oriented Immobilization of Enzymes Using Sortase A-mediated Technique	MACROMOLECULAR BIOSCIENCE			English	Article						enzymes; immobilization of enzymes; sortase A	STAPHYLOCOCCUS-AUREUS SORTASE; DIRECT ELECTRON-TRANSFER; SILICA NANOPARTICLES; ESCHERICHIA-COLI; BETA-GLUCOSIDASE; PROTEIN LIGATION; SURFACE-PROTEINS; ALPHA-AMYLASES; CELL-WALL; DEGRADATION	In the present study, sortase A-mediated immobilization of enzymes was used for the preparation of immobilized enzymes. Thermobifida fusca YX -glucosidase (BGL) or Streptococcus bovis 148 -amylase (AmyA) were produced with C-terminal sortase A recognition sequences. The resulting fusion proteins were successfully immobilized on nanoparticle surfaces using sortase A. Some properties (activity, stability, and reusability) of the immobilized fusion proteins were evaluated. Both immobilized BGL and immobilized AmyA prepared by the sortase A-mediated technique retained their catalytic activity, exhibiting activities 3.0- or 1.5-fold (respectively) of those seen with the same enzymes immobilized by chemical crosslinking. Immobilized enzymes prepared by the sortase A-mediated technique did not undergo dramatic changes in stability compared with the respective free enzymes. Thus, the sortase A-mediated technique provides a promising method for immobilization of active, stable enzymes.	[Hata, Yuto; Tanaka, Tsutomu; Kondo, Akihiko] Kobe Univ, Dept Chem Sci & Engn, Grad Sch Engn, Nada Ku, Kobe, Hyogo 6578501, Japan; [Matsumoto, Takuya] Kobe Univ, Org Adv Sci & Technol, Nada Ku, Kobe, Hyogo 6578501, Japan	Tanaka, T (reprint author), Kobe Univ, Dept Chem Sci & Engn, Grad Sch Engn, Nada Ku, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	tanaka@kitty.kobe-u.ac.jp			Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovation Bioproduction Kobe), MEXT, Japan	This work was supported by Special Coordination Funds for Promoting Science and Technology, provided by the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovation Bioproduction Kobe), MEXT, Japan.	Agyei D, 2014, J BIOTECHNOL, V188, P53, DOI 10.1016/j.jbiotec.2014.08.007; Yehezkeli O, 2011, ACS NANO, V5, P2385, DOI 10.1021/nn200313t; Brady D, 2009, BIOTECHNOL LETT, V31, P1639, DOI 10.1007/s10529-009-0076-4; Mao HY, 2004, J AM CHEM SOC, V126, P2670, DOI 10.1021/ja039915e; Zhen GL, 2004, LANGMUIR, V20, P10464, DOI 10.1021/la0482812; Kirk O, 2002, CURR OPIN BIOTECH, V13, P345, DOI 10.1016/S0958-1669(02)00328-2; Guzik U, 2014, MOLECULES, V19, P8995, DOI 10.3390/molecules19078995; Sijbrandij T, 2013, BIOCONJUGATE CHEM, V24, P828, DOI 10.1021/bc4000146; Warden-Rothman R, 2013, ANAL CHEM, V85, P11090, DOI 10.1021/ac402871k; Gupta R, 2003, PROCESS BIOCHEM, V38, P1599, DOI 10.1016/S0032-9592(03)00053-0; Cho EJ, 2012, CHEM COMMUN, V48, P886, DOI 10.1039/c2cc16661e; Liese A, 2013, CHEM SOC REV, V42, P6236, DOI 10.1039/c3cs35511j; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; He SM, 1997, J BIOL CHEM, V272, P24864, DOI 10.1074/jbc.272.40.24864; Blasco MA, 2014, BIOORGAN MED CHEM, V22, P5539, DOI 10.1016/j.bmc.2014.06.024; van der Maarel MJEC, 2002, J BIOTECHNOL, V94, P137, DOI 10.1016/S0168-1656(01)00407-2; Schmohl L, 2014, CURR OPIN CHEM BIOL, V22, P122, DOI 10.1016/j.cbpa.2014.09.020; Parthasarathy R, 2007, BIOCONJUGATE CHEM, V18, P469, DOI 10.1021/bc060339w; Solano DM, 2012, BIORESOURCE TECHNOL, V115, P196, DOI 10.1016/j.biortech.2011.11.131; NAVARRE WW, 1994, MOL MICROBIOL, V14, P115, DOI 10.1111/j.1365-2958.1994.tb01271.x; Yamamoto K, 2013, NEW BIOTECHNOL, V30, P531, DOI 10.1016/j.nbt.2013.04.005; Kuwahara Y, 2012, CHEM COMMUN, V48, P2882, DOI 10.1039/c2cc17896f; Kamiya N, 2005, BIOMACROMOLECULES, V6, P35, DOI 10.1021/bm0494895; Holland JT, 2011, J AM CHEM SOC, V133, P19262, DOI 10.1021/ja2071237; UPDIKE SJ, 1967, NATURE, V214, P986, DOI 10.1038/214986a0; Koeller KM, 2001, NATURE, V409, P232, DOI 10.1038/35051706; Ito T, 2010, BIOCHEMISTRY-US, V49, P2604, DOI 10.1021/bi100094g; Katz E, 2004, ANGEW CHEM INT EDIT, V43, P6042, DOI 10.1002/anie.200400651; Diao JP, 2005, ANAL BIOCHEM, V343, P322, DOI 10.1016/j.ab.2005.05.010; Nakazawa H, 2013, ACS CATAL, V3, P1342, DOI 10.1021/cs400012v; Sheldon RA, 2013, CHEM SOC REV, V42, P6223, DOI 10.1039/c3cs60075k; Davis F, 2007, BIOSENS BIOELECTRON, V22, P1224, DOI 10.1016/j.bios.2006.04.029; He YC, 2014, BIORESOURCE TECHNOL, V161, P461, DOI 10.1016/j.biortech.2014.03.133; Patel SKS, 2014, J MICROBIOL BIOTECHN, V24, P639, DOI 10.4014/jmb.1401.01025; Clouthier CM, 2012, CHEM SOC REV, V41, P1585, DOI 10.1039/c2cs15286j; Bhat MK, 1997, BIOTECHNOL ADV, V15, P583, DOI 10.1016/S0734-9750(97)00006-2; Blanchette C., 2012, PLOS ONE, V7, P8; Nielsen JE, 2000, BBA-PROTEIN STRUCT M, V1543, P253, DOI 10.1016/S0167-4838(00)00240-5; Chan LY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001164; Fernandez-Lorente G, 2006, BIOMACROMOLECULES, V7, P2610, DOI 10.1021/bm060408+; Gutierrez-Sanchez C, 2011, LANGMUIR, V27, P6449, DOI 10.1021/la200141t; Ikeda N, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-67; Li S., 2012, COMPUT STRUCT BIOTEC, V2; Matsumoto Takuya, 2012, Biotechnol J, V7, P1137, DOI 10.1002/biot.201200022; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Shi L, 2014, J HAZARD MATER, V279, P203, DOI 10.1016/j.jhazmat.2014.06.070	47	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1616-5187	1616-5195		MACROMOL BIOSCI	Macromol. Biosci.	OCT	2015	15	10					1375	1380		10.1002/mabi.201500113		6	Biochemistry & Molecular Biology; Materials Science, Biomaterials; Polymer Science	Biochemistry & Molecular Biology; Materials Science; Polymer Science	CU3GV	WOS:000363413300006		
J	Shikinaka, K; Misu, M; Furukawa, H; Kakugo, A; Gong, JP				Shikinaka, Kazuhiro; Misu, Manami; Furukawa, Hidemitsu; Kakugo, Akira; Gong, Jian Ping			Anisotropic Gelation Induced by Very Little Amount of Filamentous Actin	MACROMOLECULAR CHEMISTRY AND PHYSICS			English	Article						actin; hydrogel; liquid crystal; template polymerization	F-ACTIN; BUNDLE FORMATION; POLYELECTROLYTES; GROWTH; MYOSIN	In this paper, the hydrogel is created with oriented structure by addition of very little amount of dopant, filamentous actin (F-actin), which is 1/50 000 of lower critical concentration for nematic phase in F-actin aqueous solution. The orientation mechanism of polymer network differs depending on the concentration of F-actin. Furthermore, it is first exhibited that the role of polyelectrolyte for the emergence of anisotropy of gel is differed depending on its concentration by using digestion method to F-actins, experimentally.	[Shikinaka, Kazuhiro] Tokyo Univ Agr & Technol, Grad Sch Engn, Koganei, Tokyo 1848588, Japan; [Misu, Manami; Gong, Jian Ping] Hokkaido Univ, Fac Adv Life Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Furukawa, Hidemitsu] Yamagata Univ, Grad Sch Sci & Engn, Yonezawa, Yamagata 9918510, Japan; [Kakugo, Akira] Hokkaido Univ, Fac Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan	Shikinaka, K (reprint author), Tokyo Univ Agr & Technol, Grad Sch Engn, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan.	k-shiki@cc.tuat.ac.jp	Gong, Jian Ping/B-7019-2009	Gong, Jian Ping/0000-0003-2228-2750	Ministry of Education, Science, Sports, and Culture, Japan [18002002]	This research was financially supported by the Ministry of Education, Science, Sports, and Culture, Japan (Grant-in-Aid for Specially Promoted Scientific Research, Grant No. 18002002).	Evdokimov YM, 1996, MOL BIOL+, V30, P219; Wu ZL, 2009, ADV MATER, V21, P4696, DOI 10.1002/adma.200900933; Shikinaka K, 2009, J APPL POLYM SCI, V114, P2087, DOI 10.1002/app.30821; Kakugo A, 2003, BIOCONJUGATE CHEM, V14, P1185, DOI 10.1021/bc0340722; Kwon HJ, 2006, BIOCHEMISTRY-US, V45, P10313, DOI 10.1021/bi060721w; Petrache HI, 1998, PHYS REV E, V57, P7014, DOI 10.1103/PhysRevE.57.7014; Tang JX, 1996, J BIOL CHEM, V271, P8556; Tang JX, 1997, BIOCHEMISTRY-US, V36, P12600, DOI 10.1021/bi9711386; Kwon HJ, 2005, BIOMACROMOLECULES, V6, P3005, DOI 10.1021/bm050320g; Lai GH, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.187802; Das P, 1999, J CHEM PHYS, V111, P8240, DOI 10.1063/1.480157; Shigekura Y, 2007, MACROMOLECULES, V40, P2477, DOI 10.1021/ma061511u; Tang JX, 1996, BER BUNSEN PHYS CHEM, V100, P796; YANAGIDA T, 1984, NATURE, V307, P58, DOI 10.1038/307058a0; Shigekura Y, 2005, ADV MATER, V17, P2695, DOI 10.1002/adma.200500707; Wu ZL, 2010, J AM CHEM SOC, V132, P10064, DOI 10.1021/ja101969k; DUVERT M, 1984, TISSUE CELL, V16, P469, DOI 10.1016/0040-8166(84)90064-8; HUXLEY HE, 1990, J BIOL CHEM, V265, P8347; Shikinaka K, 2008, BIOMACROMOLECULES, V9, P537, DOI 10.1021/bm701068n; SPENCER M, 1962, NATURE, V194, P1014, DOI 10.1038/1941014a0; Born M., 1959, PRINCIPLES OPTICS; Bray D., 2001, CELL MOVEMENTS MOL M; COPPIN CM, 1992, BIOPHYS J, V63, P794	23	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1022-1352	1521-3935		MACROMOL CHEM PHYS	Macromol. Chem. Phys.	OCT	2015	216	20					2007	2011		10.1002/macp.201500265		5	Polymer Science	Polymer Science	CU0PN	WOS:000363219600003		
